{"data": [{"Element": "<div class=\"WordSection1\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>ANNEX\nI</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>SUMMARY\nOF PRODUCT CHARACTERISTICS</span></b></p>\n</div>", "ID": "97c36c4d-82ad-4f66-8f7d-012d0cd2d3c7", "Styles": "None", "Classes": "['WordSection1']", "Text": "                           ", "ParentId": "1c150f00-072d-4e15-8c9d-ca2e967e268d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "28c82b14-09d5-42f4-b9ae-364bba314c74", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "97c36c4d-82ad-4f66-8f7d-012d0cd2d3c7"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "cde52bd6-e8c3-4aa9-a74b-bb3a58466aff", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "28c82b14-09d5-42f4-b9ae-364bba314c74"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "f787af84-031c-4cb6-974e-df39d4584712", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "97c36c4d-82ad-4f66-8f7d-012d0cd2d3c7"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "b08af544-a8c7-4946-8077-68e1c9f1172e", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "f787af84-031c-4cb6-974e-df39d4584712"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "27426d97-b45e-4bb8-8c83-1d3d691555b3", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "97c36c4d-82ad-4f66-8f7d-012d0cd2d3c7"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "3ba68d59-f20a-49ae-999d-4840a786553e", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "27426d97-b45e-4bb8-8c83-1d3d691555b3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "d0d54ea5-2412-4ec5-9fef-e0bca622ff83", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "97c36c4d-82ad-4f66-8f7d-012d0cd2d3c7"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "bd048fe4-f424-4da4-86fe-27cebe0b1de0", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "d0d54ea5-2412-4ec5-9fef-e0bca622ff83"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "2f60ab1d-155d-4673-9177-c0098dd27f11", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "97c36c4d-82ad-4f66-8f7d-012d0cd2d3c7"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "154a5ea8-22e3-4166-9e61-1fc8997d7fa6", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "2f60ab1d-155d-4673-9177-c0098dd27f11"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "5c5eef70-1e30-47ec-b265-41b2b816fe85", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "97c36c4d-82ad-4f66-8f7d-012d0cd2d3c7"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "9e28ee8e-908b-43ba-b0ae-0b8360d3cc4e", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "5c5eef70-1e30-47ec-b265-41b2b816fe85"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "5d6b3ef0-b742-44ae-9149-0e4ccdfc0e61", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "97c36c4d-82ad-4f66-8f7d-012d0cd2d3c7"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "a4d8b770-4efd-4276-8de0-796372896fd0", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "5d6b3ef0-b742-44ae-9149-0e4ccdfc0e61"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "f9cad094-bd14-4d8f-bafb-ee456f858afb", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "97c36c4d-82ad-4f66-8f7d-012d0cd2d3c7"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "8d13e348-e0ff-4ce9-8615-b897f7d88aaf", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "f9cad094-bd14-4d8f-bafb-ee456f858afb"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "92d7bc6c-79f1-4ccf-9dae-1e062ab521d4", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "97c36c4d-82ad-4f66-8f7d-012d0cd2d3c7"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "e9f041c2-45f7-403c-8a3f-ed524d77e59d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "92d7bc6c-79f1-4ccf-9dae-1e062ab521d4"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "1485bd25-0b7c-40e6-b681-e000e2942a08", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "97c36c4d-82ad-4f66-8f7d-012d0cd2d3c7"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "f91da9a1-5e8d-4a5c-96b6-5bd099eea789", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "1485bd25-0b7c-40e6-b681-e000e2942a08"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "ef49af64-9f5a-42eb-ad18-6d79b930b881", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "97c36c4d-82ad-4f66-8f7d-012d0cd2d3c7"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "5b4dabfb-c13c-4ab2-9f87-19255782a73d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "ef49af64-9f5a-42eb-ad18-6d79b930b881"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "926bce21-6906-4a10-b1ef-c3fa49d16c4a", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "97c36c4d-82ad-4f66-8f7d-012d0cd2d3c7"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "d2a56252-d927-4286-8f1d-7cb05192d487", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "926bce21-6906-4a10-b1ef-c3fa49d16c4a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "fbcb0690-4336-4a75-8d05-678ba91465d7", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "97c36c4d-82ad-4f66-8f7d-012d0cd2d3c7"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "56658830-2437-4ad5-b528-53eb38b2d05f", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "fbcb0690-4336-4a75-8d05-678ba91465d7"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "be700424-dce1-4c0e-97ba-bfcf3bf41309", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "97c36c4d-82ad-4f66-8f7d-012d0cd2d3c7"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "1fb107a0-03c7-4174-acf6-8fd88408ae84", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "be700424-dce1-4c0e-97ba-bfcf3bf41309"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "dd749e81-954d-4bd0-a6a6-2cb7064e3461", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "97c36c4d-82ad-4f66-8f7d-012d0cd2d3c7"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "d5f767c9-3234-4fcb-9951-fa6260992e47", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "dd749e81-954d-4bd0-a6a6-2cb7064e3461"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "bd60f229-c05b-4fbd-a914-03570abe9321", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "97c36c4d-82ad-4f66-8f7d-012d0cd2d3c7"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "c6517814-d720-4a81-9b89-104775f3a133", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "bd60f229-c05b-4fbd-a914-03570abe9321"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "8ebf8877-da46-4aa5-bf10-55d706ff2300", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "97c36c4d-82ad-4f66-8f7d-012d0cd2d3c7"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "975f5943-13c5-49da-97cf-5c9911a2bbf2", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "8ebf8877-da46-4aa5-bf10-55d706ff2300"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "e7ea6505-0d18-4af5-be6e-844819eb9740", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "97c36c4d-82ad-4f66-8f7d-012d0cd2d3c7"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "a09eb905-f9fe-42c9-9cc2-d796eb10ab29", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "e7ea6505-0d18-4af5-be6e-844819eb9740"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "539a8494-caa6-4fdd-9216-7156b4494861", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "97c36c4d-82ad-4f66-8f7d-012d0cd2d3c7"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "06f3a04f-7d55-4e10-99c4-965e0830003f", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "539a8494-caa6-4fdd-9216-7156b4494861"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "316764ad-d79e-4e07-a044-829d95b1693c", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "97c36c4d-82ad-4f66-8f7d-012d0cd2d3c7"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "20c3f738-71b9-48ed-9e33-a63629bd2ab5", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "316764ad-d79e-4e07-a044-829d95b1693c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "88cb3ce7-8f5a-4c6c-9547-574c78b8c16e", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "97c36c4d-82ad-4f66-8f7d-012d0cd2d3c7"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "91f77f60-cb63-478e-bbeb-270c8183ce99", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "88cb3ce7-8f5a-4c6c-9547-574c78b8c16e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "3067c3f2-aba9-4891-ada6-f14eb8b9a31b", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "97c36c4d-82ad-4f66-8f7d-012d0cd2d3c7"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "e9941410-4d54-4e92-ae76-25c8c81f0fa5", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "3067c3f2-aba9-4891-ada6-f14eb8b9a31b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "dd33615d-71cf-466c-a6ab-623eeb5f0faf", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "97c36c4d-82ad-4f66-8f7d-012d0cd2d3c7"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "c74fc84f-f582-4c9e-acea-c2a606a99063", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "dd33615d-71cf-466c-a6ab-623eeb5f0faf"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>ANNEX\nI</span></b></p>", "ID": "733cac48-b40e-4886-8416-4e8b4d738625", "Styles": "margin-top:0in;margin-right:3.1pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "97c36c4d-82ad-4f66-8f7d-012d0cd2d3c7"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>ANNEX\nI</span></b>", "ID": "a5e2ca4a-8bd1-4592-baae-55d4e1fe4ee2", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "733cac48-b40e-4886-8416-4e8b4d738625"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>ANNEX\nI</span>", "ID": "f06de6ce-b8e9-4095-addb-b10804f7aad0", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "ANNEX I", "ParentId": "a5e2ca4a-8bd1-4592-baae-55d4e1fe4ee2"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "5d5c5bc6-7404-4b30-9868-0352e01fae45", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "97c36c4d-82ad-4f66-8f7d-012d0cd2d3c7"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "31cba62f-ac41-4922-90fa-6783d65706d6", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "5d5c5bc6-7404-4b30-9868-0352e01fae45"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>SUMMARY\nOF PRODUCT CHARACTERISTICS</span></b></p>", "ID": "a3e8a9f8-e348-40fd-b9c6-c3537f5329fd", "Styles": "margin-top:0in;margin-right:3.1pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "97c36c4d-82ad-4f66-8f7d-012d0cd2d3c7"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>SUMMARY\nOF PRODUCT CHARACTERISTICS</span></b>", "ID": "70c55295-3ab1-4ce8-b2bc-33bd6eba33b0", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a3e8a9f8-e348-40fd-b9c6-c3537f5329fd"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>SUMMARY\nOF PRODUCT CHARACTERISTICS</span>", "ID": "56e03b71-7c1b-4709-9013-47eb2b000560", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "SUMMARY OF PRODUCT CHARACTERISTICS", "ParentId": "70c55295-3ab1-4ce8-b2bc-33bd6eba33b0"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span>", "ID": "8b09545c-55a3-452f-997a-8366c2f119da", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": " ", "ParentId": "1c150f00-072d-4e15-8c9d-ca2e967e268d"}, {"Element": "<br clear=\"all\" style=\"page-break-before:always\"/>", "ID": "6c86c22d-ee44-4b08-b042-d4974b257613", "Styles": "page-break-before:always", "Classes": "None", "Text": "", "ParentId": "8b09545c-55a3-452f-997a-8366c2f119da"}, {"Element": "<div class=\"WordSection2\">\n<h1 style=\"margin-right:3.1pt\"><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL\nPRODUCT</span></h1>\n<h1 style=\"margin-right:3.1pt\"><span lang=\"EN-GB\">\u00a0</span></h1>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat Mylan 80\u00a0mg\nfilm-coated tablets</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<h1 style=\"margin-right:3.1pt\"><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 QUALITATIVE AND QUANTITATIVE\nCOMPOSITION</span></h1>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Each tablet contains 80\u00a0mg of\nfebuxostat. </span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Excipient with known effect</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Each tablet contains 236.0\u00a0mg\nof lactose</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>For the full list of excipients,\nsee section 6.1.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<h1 style=\"margin-right:3.1pt\"><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL FORM</span></h1>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Film-coated tablet.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>A yellow, capsule shaped, biconvex\ntablet approximately 16 x 7\u00a0mm, debossed with M on one side of the tablet\nand FX3 on the other side.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<h1 style=\"margin-right:3.1pt\"><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 CLINICAL PARTICULARS</span></h1>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<h1 style=\"margin-right:3.1pt\"><span lang=\"EN-GB\">4.1\u00a0\u00a0\u00a0\u00a0 Therapeutic indications</span></h1>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Treatment of chronic hyperuricaemia\nin conditions where urate deposition has already occurred (including a history,\nor presence of, tophus and/or gouty arthritis). Febuxostat Mylan is indicated\nin adults.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<h1 style=\"margin-right:3.1pt\"><span lang=\"EN-GB\">4.2\u00a0\u00a0\u00a0\u00a0 Posology and method of\nadministration</span></h1>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Posology</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The recommended oral dose of Febuxostat\nMylan is 80\u00a0mg once daily without regard to food. If serum uric acid is\n&gt; 6\u00a0mg/dL (357\u00a0\u00b5mol/L) after 2-4\u00a0weeks, Febuxostat Mylan 120\u00a0mg\nonce daily may be considered.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat Mylan works sufficiently\nquickly to allow retesting of the serum uric acid after 2 weeks. The\ntherapeutic target is to decrease and maintain serum uric acid below 6\u00a0mg/dL\n(357\u00a0\u03bcmol/L).</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Gout flare prophylaxis of at least\n6 months is recommended (see section 4.4).</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Elderly</span></i></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>No dose adjustment is required in\nthe elderly (see section 5.2).</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Renal </span></i><i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>impairment</span></i></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The efficacy and safety have not\nbeen fully evaluated in patients with severe renal impairment (creatinine\nclearance &lt;30 mL/min, see section 5.2).</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>No dose adjustment is necessary in\npatients with mild or moderate renal impairment.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;page-break-after:avoid;text-autospace:none\"><i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Hepatic impairment</span></i></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;page-break-after:avoid;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The efficacy and safety\nof febuxostat has not been studied in patients with severe hepatic impairment (Child\nPugh Class C).</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The recommended dose in patients\nwith mild hepatic impairment is 80\u00a0mg. Limited information is available in\npatients with moderate hepatic impairment.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Paediatric population</span></i></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The safety and the efficacy of febuxostat\nin children aged below the age of 18\u00a0years have not been established. No\ndata are available.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Method of administration</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Oral use.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat Mylan should be taken by\nmouth and can be taken with or without food.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<h1 style=\"margin-right:3.1pt\"><span lang=\"EN-GB\">4.3\u00a0\u00a0\u00a0\u00a0 Contraindications</span></h1>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Hypersensitivity to the active\nsubstance or to any of the excipients listed in section 6.1 (see also section\n4.8).</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<h1 style=\"margin-right:3.1pt\"><span lang=\"EN-GB\">4.4\u00a0\u00a0\u00a0\u00a0 Special warnings and\nprecautions for use</span></h1>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Cardio-vascular disorders</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Treatment with febuxostat in\npatients with ischaemic heart disease or congestive heart failure is not\nrecommended.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>A numerical greater incidence of investigator-reported\ncardiovascular APTC events (defined endpoints from the Anti-Platelet Trialists\u2019\nCollaboration (APTC) including cardiovascular death, non-fatal myocardial\ninfarction, non-fatal stroke) was observed in the febuxostat total group\ncompared to the allopurinol group in the APEX and FACT studies (1.3 vs. 0.3\nevents per 100 Patient Years (PYs)), but not in the CONFIRMS study (see section\n5.1 for detailed characteristics of the studies). The incidence of\ninvestigator-reported cardiovascular APTC events in the combined Phase 3\nstudies (APEX, FACT and CONFIRMS studies) was 0.7 vs. 0.6 events per 100 PYs.\nIn the long-term extension studies the incidences of investigator-reported APTC\nevents were 1.2 and 0.6 events per 100 PYs for febuxostat and allopurinol,\nrespectively. No statistically significant differences were found and no causal\nrelationship with febuxostat was established. Identified risk factors among\nthese patients were a medical history of atherosclerotic disease and/or\nmyocardial infarction, or of congestive heart failure.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Medicinal product allergy /\nhypersensitivity</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare reports of serious\nallergic/hypersensitivity reactions, including life-threatening Stevens-Johnson\nSyndrome, Toxic epidermal necrolysis and acute anaphylactic reaction/shock,\nhave been collected in the post-marketing experience. In most cases, these\nreactions occurred during the first month of therapy with febuxostat. Some, but\nnot all of these patients reported renal impairment and/or previous\nhypersensitivity to allopurinol. Severe hypersensitivity reactions, including\nDrug Reaction with Eosinophilia and Systemic Symptoms (DRESS) were associated\nwith fever, haematological, renal or hepatic involvement in some cases.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Patients should be advised of the\nsigns and symptoms and monitored closely for symptoms of\nallergic/hypersensitivity reactions (see section 4.8). Febuxostat treatment\nshould be immediately stopped if serious allergic/hypersensitivity reactions,\nincluding Stevens-Johnson Syndrome, occur since early withdrawal is associated\nwith a better prognosis. If patient has developed allergic/hypersensitivity\nreactions including Stevens-Johnson Syndrome and acute anaphylactic\nreaction/shock, febuxostat must not be re-started in this patient at any time.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Acute gouty attacks (gout flare)</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat treatment should not be\nstarted until an acute attack of gout has completely subsided. Gout flares may\noccur during initiation of treatment due to changing serum uric acid levels\nresulting in mobilization of urate from tissue deposits (see section 4.8 and\n5.1). At treatment initiation with febuxostat flare prophylaxis for at least 6\nmonths with an NSAID or colchicine is recommended (see section 4.2).</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If a gout flare occurs during\nfebuxostat treatment, it should not be discontinued. The gout flare should be\nmanaged concurrently as appropriate for the individual patient. Continuous\ntreatment with febuxostat decreases frequency and intensity of gout flares.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Xanthine deposition</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>In patients in whom the rate of\nurate formation is greatly increased (e.g. malignant disease and its treatment,\nLesch-Nyhan syndrome) the absolute concentration of xanthine in urine could, in\nrare cases, rise sufficiently to allow deposition in the urinary tract. As\nthere has been no experience with febuxostat, its use in these populations is\nnot recommended.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Mercaptopurine/azathioprine</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat use is not recommended\nin patients concomitantly treated with mercaptopurine/azathioprine as inhibition\nof xanthine oxidase by febuxostat may cause increased plasma concentrations of\nmercaptopurine/azathioprine that could result in severe toxicity. No\ninteraction studies have been performed in humans. </span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Where the combination cannot be\navoided, a reduction of the dose of mercaptopurine/azathioprine is recommended.\nBased on modelling and simulation analysis of data from a pre-clinical study in\nrats, when coadministered with febuxostat, the dose of mercaptopurine/azathioprine\nshould be reduced to the 20\u00a0% or less of the previously prescribed dose in\norder to avoid possible haematological effects (see section 4.5 and 5.3).</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The patients should be closely\nmonitored and the dose of mercaptopurine/azathioprine should be subsequently\nadjusted based on the evaluation of the therapeutic response and the onset of eventual\ntoxic effects.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Organ transplant recipients</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>As there has been no experience in\norgan transplant recipients, the use of febuxostat in such patients is not\nrecommended (see section 5.1).</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Theophylline</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Co-administration of febuxostat 80\u00a0mg\nand theophylline 400\u00a0mg single dose in healthy subjects showed absence of\nany pharmacokinetic interaction (see section 4.5). Febuxostat 80\u00a0mg can be\nused in patients concomitantly treated with theophylline without risk of\nincreasing theophylline plasma levels. No data is available for febuxostat 120\u00a0mg.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Liver disorders</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>During the combined phase 3\nclinical studies, mild liver function test abnormalities were observed in\npatients treated with febuxostat (5.0%). Liver function test is recommended\nprior to the initiation of therapy with febuxostat and periodically thereafter\nbased on clinical judgment (see section 5.1).</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Thyroid disorders</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Increased TSH values (&gt;5.5\u00a0\u00b5IU/mL)\nwere observed in patients on long-term treatment with febuxostat (5.5%) in the\nlong term open label extension studies. Caution is required when febuxostat is\nused in patients with alteration of thyroid function (see section 5.1).</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Lactose</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat tablets contain lactose.\nPatients with rare hereditary problems of galactose intolerance, the Lapp\nlactase deficiency or glucose-galactose malabsorption should not take this\nmedicine.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<h1 style=\"margin-right:3.1pt\"><span lang=\"EN-GB\">4.5\u00a0\u00a0\u00a0\u00a0 Interaction with other\nmedicinal products and other forms of interaction</span></h1>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Mercaptopurine/azathioprine</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>On the basis of the mechanism of action\nof febuxostat on XO inhibition concomitant use is not recommended. Inhibition\nof XO by febuxostat may cause increased plasma concentrations of these drugs\nleading to toxicity. Drug interaction studies of febuxostat with drugs (except\ntheophylline) that are metabolized by XO have not been performed in humans.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Modelling and simulation analysis\nof data from a pre-clinical study in rats indicates that, in case of\nconcomitant administration with febuxostat, the dose of\nmercaptopurine/azathioprine should be reduced to 20% or less of the previously\nprescribed dose (see section 4.4 and 5.3)</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Drug interaction studies of\nfebuxostat with other cytotoxic chemotherapy have not been conducted. No data\nis available regarding the safety of febuxostat during other cytotoxic therapy.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rosiglitazone/CYP2C8 substrates</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat was shown to be a weak\ninhibitor of CYP2C8 <i>in vitro</i>. In a study in healthy subjects,\ncoadministration of 120\u00a0mg febuxostat QD with a single 4\u00a0mg oral dose\nof rosiglitazone had no effect on the pharmacokinetics of rosiglitazone and its\nmetabolite N-desmethyl rosiglitazone, indicating that febuxostat is not a\nCYP2C8 enzyme inhibitor <i>in vivo</i>. Thus, co-administration of febuxostat\nwith rosiglitazone or other CYP2C8 substrates is not expected to require any\ndose adjustment for those compounds.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Theophylline</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>An interaction study in healthy\nsubjects has been performed with febuxostat to evaluate whether the inhibition\nof XO may cause an increase in the theophylline circulating levels as reported\nwith other XO inhibitors. The results of the study showed that the\nco-administration of febuxostat 80\u00a0mg QD with theophylline 400\u00a0mg\nsingle dose has no effect on the pharmacokinetics or safety of theophylline.\nTherefore no special caution is advised when febuxostat 80\u00a0mg and\ntheophylline are given concomitantly. No data is available for febuxostat 120\u00a0mg.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Naproxen and other inhibitors of\nglucuronidation</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat metabolism depends on\nUridine Glucuronosyl Transferase (UGT) enzymes. Medicinal products that inhibit\nglucuronidation, such as NSAIDs and probenecid, could in theory affect the elimination\nof febuxostat. In healthy subjects concomitant use of febuxostat and naproxen\n250\u00a0mg twice daily was associated with an increase in febuxostat exposure\n(C<sub>max</sub> 28%, AUC 41% and t<sub>1/2 </sub>26%). In clinical studies the\nuse of naproxen or other NSAIDs/Cox-2 inhibitors was not related to any clinically\nsignificant increase in adverse events.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat can be co-administered\nwith naproxen with no dose adjustment of febuxostat or naproxen being\nnecessary.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Inducers of glucuronidation</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Potent inducers of UGT enzymes\nmight possibly lead to increased metabolism and decreased efficacy of\nfebuxostat. Monitoring of serum uric acid is therefore recommended 1-2 weeks\nafter start of treatment with a potent inducer of glucuronidation. Conversely,\ncessation of treatment of an inducer might lead to increased plasma levels of\nfebuxostat.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Colchicine/indometacin/hydrochlorothiazide/warfarin</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat can be co-administered\nwith colchicine or indomethacin with no dose adjustment of febuxostat or the\nco-administered active substance being necessary.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>No dose adjustment is necessary for\nfebuxostat when administered with hydrochlorothiazide.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>No dose adjustment is necessary for\nwarfarin when administered with febuxostat. Administration of febuxostat (80\u00a0mg\nor 120\u00a0mg once daily) with warfarin had no effect on the pharmacokinetics\nof warfarin in healthy subjects. INR and Factor VII activity were also not\naffected by the co- administration of febuxostat.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Desipramine/CYP2D6 substrates</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat was shown to be a weak\ninhibitor of CYP2D6 <i>in vitro. </i>In a study in healthy subjects, 120\u00a0mg\nfebuxostat QD resulted in a mean 22% increase in AUC of desipramine, a CYP2D6\nsubstrate indicating a potential weak inhibitory effect of febuxostat on the\nCYP2D6 enzyme <i>in vivo</i>.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Thus, co-administration of\nfebuxostat with other CYP2D6 substrates is not expected to require any dose\nadjustment for those compounds.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Antacids</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Concomitant ingestion of an antacid\ncontaining magnesium hydroxide and aluminium hydroxide has been shown to delay\nabsorption of febuxostat (approximately 1 hour) and to cause a 32% decrease in C<sub>max</sub>,\nbut no significant change in AUC was observed. Therefore, febuxostat may be\ntaken without regard to antacid use.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<h1 style=\"margin-right:3.1pt\"><span lang=\"EN-GB\">4.6\u00a0\u00a0\u00a0\u00a0 Fertility, pregnancy\nand lactation</span></h1>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Pregnancy</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Data on a very limited number of\nexposed pregnancies have not indicated any adverse effects of febuxostat on\npregnancy or on the health of the foetus/new born child. Animal studies do not\nindicate direct or indirect harmful effects with respect to pregnancy,\nembryonal/foetal development or parturition (see section 5.3). The potential\nrisk for human is unknown. Febuxostat should not be used during pregnancy.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Breast-feeding</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>It is unknown whether febuxostat is\nexcreted in human breast milk. Animal studies have shown excretion of this\nactive substance in breast milk and an impaired development of suckling pups. A\nrisk to a suckling infant cannot be excluded. Febuxostat should not be used\nwhile breast-feeding.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Fertility</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>In animals, reproduction studies up\nto 48\u00a0mg/kg/day showed no dose-dependent adverse effects on fertility (see\nsection 5.3). The effect of febuxostat on human fertility is unknown.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<h1 style=\"margin-right:3.1pt\"><span lang=\"EN-GB\">4.7\u00a0\u00a0\u00a0\u00a0 Effects on ability to\ndrive and use machines</span></h1>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Somnolence, dizziness, paraesthesia\nand blurred vision have been reported with the use of febuxostat. Patients\nshould exercise caution before driving, using machinery or participating in\ndangerous activities until they are reasonably certain that febuxostat does not\nadversely affect performance.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<h1 style=\"margin-right:3.1pt\"><span lang=\"EN-GB\">4.8\u00a0\u00a0\u00a0\u00a0 Undesirable effects</span></h1>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Summary of the safety profile</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The most commonly reported adverse\nreactions in clinical trials (4,072 subjects treated at least with a dose from\n10\u00a0mg to 300\u00a0mg) and post-marketing experience are gout flares, liver\nfunction abnormalities, diarrhoea, nausea, headache, rash and oedema. These\nadverse reactions were mostly mild or moderate in severity. Rare serious\nhypersensitivity reactions to febuxostat, some of which were associated to\nsystemic symptoms, have occurred in the post-marketing experience.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Tabulated list of adverse reactions</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common (\u22651/100 to &lt;1/10),\nuncommon (\u22651/1,000 to &lt;1/100) and rare (</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u22651/10,000 to &lt;1/1,000) adverse\nreactions occurring in patients treated with febuxostat are listed below.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Within each frequency grouping, adverse\nreactions are presented in order of decreasing seriousness.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Table 1: Adverse reactions in\ncombined phase 3, long-term extension studies and post-marketing experience</span></i></p>\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"margin-left:.25pt;border-collapse:collapse\" width=\"621\">\n<tr>\n<td style=\"width:161.4pt;border:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"215\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Blood and lymphatic\n  system</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>disorders</span></p>\n</td>\n<td style=\"width:304.65pt;border:solid black 1.0pt;\n  border-left:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Pancytopenia, <span style=\"color:black\">thrombocytopenia, agranulocytosis*</span></span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"215\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Immune system\n  disorders</span></p>\n</td>\n<td style=\"width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Anaphylactic\n  reaction*, drug hypersensitivity*</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"215\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Endocrine disorders</span></p>\n</td>\n<td style=\"width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Blood thyroid\n  stimulating hormone increased</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"215\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Eye disorders</span></p>\n</td>\n<td style=\"width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Blurred vision</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"215\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Metabolism and\n  nutrition</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>disorders</span></p>\n</td>\n<td style=\"width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common***</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Gout flares</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:31.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.7pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Diabetes mellitus,\n  hyperlipidemia, decrease appetite, weight increase</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.45pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Weight decrease,\n  increase appetite, anorexia</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"215\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Psychiatric disorders</span></p>\n</td>\n<td style=\"width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Libido decreased,\n  insomnia</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Nervousness</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"215\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Nervous system\n  disorders</span></p>\n</td>\n<td style=\"width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Headache</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.15pt;margin-right:16.8pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Dizziness,\n  paraesthesia, hemiparesis, somnolence, altered taste, hypoaesthesia, hyposmia</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"215\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.4pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Ear and labyrinth\n  disorders</span></p>\n</td>\n<td style=\"width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.4pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Tinnitus</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"215\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.4pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Cardiac disorders</span></p>\n</td>\n<td style=\"width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.4pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Atrial fibrillation,\n  palpitations, ECG abnormal</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"215\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.4pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Vascular disorders</span></p>\n</td>\n<td style=\"width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.4pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Hypertension,\n  flushing, hot flush</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"215\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.4pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Respiratory system\n  disorders</span></p>\n</td>\n<td style=\"width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.4pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Dyspnoea, bronchitis,\n  upper respiratory tract infection, cough</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"215\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.4pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Gastrointestinal\n  disorders</span></p>\n</td>\n<td style=\"width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.4pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Diarrhoea**, nausea</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon:</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:6.15pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Abdominal pain,\n  abdominal distension, gastro-oesophageal reflux disease, vomiting, dry mouth,\n  dyspepsia, constipation, frequent stools, flatulence, gastrointestinal\n  discomfort</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Pancreatitis, mouth\n  ulceration</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"215\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Hepato-biliary\n  disorders</span></p>\n</td>\n<td style=\"width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:159.3pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.7pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Liver function\n  abnormalities** <u>Uncommon</u></span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.45pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Cholelithiasis</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Hepatitis, jaundice*,\n  liver injury*</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"215\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.4pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Skin and subcutaneous\n  tissue</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>disorders</span></p>\n</td>\n<td style=\"width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.4pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.15pt;margin-right:42.6pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rash (including\n  various types of rash reported with lower frequencies, see below)</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:22.6pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.7pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Dermatitis, urticaria,\n  pruritus, skin discolouration, skin lesion, petechiae, rash macular, rash\n  maculopapular, rash papular</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.45pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:35.1pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.7pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Toxic epidermal\n  necrolysis*, Stevens-Johnson Syndrome*, angioedema*, drug reaction with\n  eosinophilia and systemic</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.45pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>symptoms*, generalized\n  rash (serious)*, erythema, exfoliative</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.25pt;margin-right:15.3pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>rash, rash follicular,\n  rash vesicular, rash pustular, rash pruritic*, rash erythematous, rash\n  morbillifom, alopecia, hyperhidrosis</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"215\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Musculoskeletal and\n  connective</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>tissue disorders</span></p>\n</td>\n<td style=\"width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:35.35pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.7pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Arthralgia, arthritis,\n  myalgia, musculoskeletal pain, muscle weakness, muscle spasm, muscle\n  tightness, bursitis</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.45pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rhabdomyolysis*, joint\n  stiffness, musculoskeletal stiffness</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"215\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Renal and urinary\n  disorders</span></p>\n</td>\n<td style=\"width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Renal failure,\n  nephrolithiasis, haematuria, pollakiuria, proteinuria</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Tubulointerstitial\n  nephritis*, micturition urgency</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"215\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Reproductive system\n  and breast</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>disorder</span></p>\n</td>\n<td style=\"width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Erectile dysfunction</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"215\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>General disorders and</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>administration site\n  conditions</span></p>\n</td>\n<td style=\"width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Oedema</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Fatigue, chest pain,\n  chest discomfort</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Thirst</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"215\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Investigations</span></p>\n</td>\n<td style=\"width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Blood amylase\n  increase, platelet count decrease, WBC decrease, lymphocyte count decrease,\n  blood creatine increase, blood creatinine increase, haemoglobin decrease,\n  blood urea increase, blood triglycerides increase, blood cholesterol\n  increase, haematocritic decrease, blood lactate dehydrogenase increased,\n  blood potassium increase</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Blood glucose\n  increase, activated partial thromboplastin time prolonged, red blood cell\n  count decrease, blood alkaline phosphatase increase, blood creatine\n  phosphokinase increase*</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:11.95pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:99%;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;line-height:99%;font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n</td>\n</tr>\n</table>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:21.3pt;text-indent:-21.3pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>*</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0 Adverse reactions\ncoming from post-marketing experience</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:21.3pt;text-indent:-21.3pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>**\u00a0\u00a0 Treatment-emergent\nnon-infective diarrhoea and abnormal liver function tests in the combined Phase\n3 studies are more frequent in patients concomitantly treated with colchicine.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:21.3pt;text-indent:-21.3pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>*** See section 5.1 for\nincidences of gout flares in the individual Phase 3 randomized controlled\nstudies.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Description of selected adverse\nreactions</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare serious hypersensitivity\nreactions to febuxostat, including Stevens-Johnson Syndrome, Toxic epidermal\nnecrolysis and anaphylactic reaction/shock, have occurred in the post-marketing\nexperience. Stevens-Johnson Syndrome and Toxic epidermal necrolysis are\ncharacterised by progressive skin rashes associated with blisters or mucosal\nlesions and eye irritation. Hypersensitivity reactions to febuxostat can be\nassociated to the following symptoms: skin reactions characterised by\ninfiltrated maculopapular eruption, generalised or exfoliative rashes, but also\nskin lesions, facial oedema, fever, haematologic abnormalities such as\nthrombocytopenia and eosinophilia, and single or multiple organ involvement\n(liver and kidney including tubulointerstitial nephritis) (see section 4.4).</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Gout flares were commonly observed\nsoon after the start of treatment and during the first months. Thereafter, the\nfrequency of gout flare decreases in a time-dependent manner. Gout flare\nprophylaxis is recommended (see section 4.2 and 4.4).</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Reporting of suspected adverse\nreactions</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Reporting suspected adverse\nreactions after authorisation of the medicinal product is important. It allows\ncontinued monitoring of the benefit/risk balance of the medicinal product.\nHealthcare professionals are asked to report any suspected adverse reactions\nvia the national reporting system listed in </span><span lang=\"EN-GB\"><a href=\"http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc\"><span style='font-family:\"Times New Roman\",serif;color:windowtext'>Appendix V.</span></a></span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<h1 style=\"margin-right:3.3pt\"><span lang=\"EN-GB\">4.9\u00a0\u00a0\u00a0\u00a0 Overdose</span></h1>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Patients with an overdose should be\nmanaged by symptomatic and supportive care.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<h1 style=\"margin-right:3.3pt\"><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACOLOGICAL\nPROPERTIES</span></h1>\n<h1 style=\"margin-right:3.3pt\"><span lang=\"EN-GB\">\u00a0</span></h1>\n<h1 style=\"margin-right:3.3pt\"><span lang=\"EN-GB\">5.1\u00a0\u00a0\u00a0\u00a0 Pharmacodynamic\nproperties</span></h1>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Pharmacotherapeutic group: Antigout\npreparation, preparations inhibiting uric acid production, ATC code: M04AA03</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Mechanism of action</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uric acid is the end product of\npurine metabolism in humans and is generated in the cascade of hypoxanthine\n\u2192 xanthine \u2192 uric acid. Both steps in the above transformations are\ncatalyzed by xanthine oxidase (XO). Febuxostat is a 2-arylthiazole derivative\nthat achieves its therapeutic effect of decreasing serum uric acid by\nselectively inhibiting XO. Febuxostat is a potent, non-purine selective\ninhibitor of XO (NP-SIXO) with an <i>in vitro</i> inhibition Ki value less than\none nanomolar. Febuxostat has been shown to potently inhibit both the oxidized\nand reduced forms of XO. At therapeutic concentrations febuxostat does not\ninhibit other enzymes involved in purine or pyrimidine metabolism, namely,\nguanine deaminase, hypoxanthine guanine phosphoribosyltransferase, orotate\nphosphoribosyltransferase, orotidine monophosphate decarboxylase or purine\nnucleoside phosphorylase.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Clinical efficacy and safety</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The efficacy of </span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>febuxostat</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'> was demonstrated in\nthree Phase 3 pivotal studies (the two pivotal APEX and FACT studies, and the\nadditional CONFIRMS study described below) that were conducted in 4101 patients\nwith hyperuricaemia and gout. In each phase 3 pivotal study, febuxostat\ndemonstrated superior ability to lower and maintain serum uric acid levels\ncompared to allopurinol. The primary efficacy endpoint in the APEX and FACT\nstudies was the proportion of patients whose last 3 monthly serum uric acid\nlevels were &lt; 6.0\u00a0mg/dL (357\u00a0\u00b5mol/L). In the additional phase 3\nCONFIRMS study, for which results became available after the marketing\nauthorisation for febuxostat was first issued, the primary efficacy endpoint\nwas the proportion of patients whose serum urate level was &lt; 6.0\u00a0mg/dL at\nthe final visit. No patients with organ transplant have been included in these\nstudies (see section 4.2).</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>APEX Study</span></i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>: The Allopurinol and\nPlacebo-Controlled Efficacy Study of Febuxostat (APEX) was a Phase 3,\nrandomized, double-blind, multicenter, 28-week study. One thousand and\nseventy-two (1072) patients were randomized: placebo (n=134), </span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>febuxostat</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'> 80\u00a0mg QD (n=267), </span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>febuxostat</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'> 120\u00a0mg QD (n=269),\n</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>febuxostat</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'> 240\u00a0mg QD (n=134)\nor allopurinol (300\u00a0mg QD [n=258] for patients with a baseline serum\ncreatinine \u22641.5\u00a0mg/dL or 100\u00a0mg QD [n=10] for patients with a\nbaseline serum creatinine &gt;1.5\u00a0mg/dL and \u22642.0\u00a0mg/dL). Two\nhundred and forty\u00a0mg febuxostat (2 times the recommended highest dose) was\nused as a safety evaluation dose.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The APEX study showed statistically\nsignificant superiority of both the </span><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>febuxostat</span><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'> 80\u00a0mg QD and the </span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>febuxostat</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'> 120\u00a0mg QD treatment arms <i>versus\n</i>the conventionally used doses of allopurinol 300\u00a0mg (n = 258) /100\u00a0mg\n(n = 10) treatment arm in reducing the sUA below 6\u00a0mg/dL (357\u00a0\u00b5mol/L)\n(see Table 2 and Figure 1).</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>FACT Study</span></i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>: The Febuxostat\nAllopurinol Controlled Trial (FACT) Study was a Phase 3, randomized,\ndouble-blind, multicenter, 52-week study. Seven hundred sixty (760) patients\nwere randomized: febuxostat 80\u00a0mg QD (n=256), febuxostat C 120\u00a0mg QD\n(n=251), or allopurinol 300\u00a0mg QD (n=253).</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The FACT study showed the\nstatistically significant superiority of both </span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>febuxostat</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'> 80\u00a0mg and </span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>febuxostat</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'> 120\u00a0mg QD\ntreatment arms <i>versus </i>the conventionally used dose of allopurinol 300\u00a0mg\ntreatment arm in reducing and maintaining sUA below 6\u00a0mg/dL (357\u00a0\u00b5mol/L).</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Table 2 summarises the primary\nefficacy endpoint results:</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Table 2</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Proportion of Patients with Serum\nUric Acid Levels &lt;6.0\u00a0mg/dL (357\u00a0\u00b5mol/L) Last Three Monthly Visits</span></b></p>\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"margin-left:57.1pt;border-collapse:collapse\">\n<tr>\n<td style=\"width:87.6pt;border:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"117\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;text-autospace:\n  none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:27.7pt;\n  margin-bottom:0in;margin-left:28.85pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Study</span></p>\n</td>\n<td style=\"width:90.75pt;border:solid black 1.0pt;\n  border-left:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"121\">\n<p class=\"MsoNormal\" style=\"margin-top:.25pt;margin-right:0in;margin-bottom:\n  0in;margin-left:0in;line-height:12.0pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:19.15pt;\n  margin-bottom:0in;margin-left:19.95pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat\n  80\u00a0mg QD</span></p>\n</td>\n<td style=\"width:76.55pt;border:solid black 1.0pt;\n  border-left:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"102\">\n<p class=\"MsoNormal\" style=\"margin-top:.25pt;margin-right:0in;margin-bottom:\n  0in;margin-left:0in;line-height:12.0pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:11.95pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:11.95pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0120\u00a0mg QD</span></p>\n</td>\n<td style=\"width:95.75pt;border:solid black 1.0pt;\n  border-left:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"128\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:19.15pt;\n  margin-bottom:0in;margin-left:19.95pt;text-align:center;line-height:12.3pt;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Allopurinol</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:33.65pt;\n  margin-bottom:0in;margin-left:34.5pt;text-align:center;line-height:12.45pt;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>300\n  /</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:17.15pt;\n  margin-bottom:0in;margin-left:17.8pt;text-align:center;line-height:12.85pt;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>100\u00a0mg\n  QD</span><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1</span></sup></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:87.6pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"117\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:26.35pt;\n  margin-bottom:0in;margin-left:27.3pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>APEX</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:16.35pt;\n  margin-bottom:0in;margin-left:17.3pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(28\n  weeks)</span></p>\n</td>\n<td style=\"width:90.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"121\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:29.25pt;\n  margin-bottom:0in;margin-left:30.4pt;text-align:center;line-height:12.3pt;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>48%</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>*</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:24.4pt;\n  margin-bottom:0in;margin-left:25.5pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=262)</span></p>\n</td>\n<td style=\"width:76.55pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"102\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:21.65pt;line-height:12.25pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>65%</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>*<sup>, #</sup></span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.1pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:20.1pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=269)</span></p>\n</td>\n<td style=\"width:95.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"128\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:34.7pt;\n  margin-bottom:0in;margin-left:35.3pt;text-align:center;line-height:12.3pt;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>22%</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:27.05pt;\n  margin-bottom:0in;margin-left:27.9pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=268)</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:87.6pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"117\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:26.75pt;\n  margin-bottom:0in;margin-left:27.5pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>FACT</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:16.35pt;\n  margin-bottom:0in;margin-left:17.3pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(52\n  weeks)</span></p>\n</td>\n<td style=\"width:90.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"121\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:30.1pt;\n  margin-bottom:0in;margin-left:31.35pt;text-align:center;line-height:12.3pt;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>53%</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>*</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:24.4pt;\n  margin-bottom:0in;margin-left:25.5pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=255)</span></p>\n</td>\n<td style=\"width:76.55pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"102\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:23.15pt;\n  margin-bottom:0in;margin-left:24.15pt;text-align:center;line-height:12.3pt;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>62%</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>*</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:17.45pt;\n  margin-bottom:0in;margin-left:18.3pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=250)</span></p>\n</td>\n<td style=\"width:95.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"128\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:34.7pt;\n  margin-bottom:0in;margin-left:35.3pt;text-align:center;line-height:12.3pt;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>21%</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:27.05pt;\n  margin-bottom:0in;margin-left:27.9pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=251)</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:87.6pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"117\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:17.75pt;\n  margin-bottom:0in;margin-left:18.75pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Combined</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:24.4pt;\n  margin-bottom:0in;margin-left:25.5pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Results</span></p>\n</td>\n<td style=\"width:90.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"121\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:30.25pt;\n  margin-bottom:0in;margin-left:31.25pt;text-align:center;line-height:12.3pt;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>51%</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>*</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:24.4pt;\n  margin-bottom:0in;margin-left:25.5pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=517)</span></p>\n</td>\n<td style=\"width:76.55pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"102\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:22.5pt;line-height:12.25pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>63%</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>*<sup>, #</sup></span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.1pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:20.1pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=519)</span></p>\n</td>\n<td style=\"width:95.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"128\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:34.6pt;\n  margin-bottom:0in;margin-left:35.45pt;text-align:center;line-height:12.3pt;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>22%</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:27.05pt;\n  margin-bottom:0in;margin-left:27.9pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=519)</span></p>\n</td>\n</tr>\n<tr>\n<td colspan=\"4\" style=\"width:350.65pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"468\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.3pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:normal;text-autospace:none\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'> results from subjects\n  receiving either 100\u00a0mg QD (n=10: patients with serum creatinine &gt;1.5\n  and </span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u22642.0\u00a0mg/dL)\n  or 300\u00a0mg QD (n=509) were pooled </span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>for analyses.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>* p &lt; 0.001 vs\n  allopurinol, # p &lt; 0.001 vs 80\u00a0mg</span></p>\n</td>\n</tr>\n</table>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The ability of febuxostat to lower\nserum uric acid levels was prompt and persistent. Reduction in serum uric acid\nlevel to &lt;6.0\u00a0mg/dL (357\u00a0\u00b5mol/L) was noted by the Week 2 visit and\nwas maintained throughout treatment. The mean serum uric acid levels over time\nfor each treatment group from the two pivotal Phase 3 studies are shown in\nFigure 1.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;page-break-after:avoid;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Figure 1 Mean Serum Uric\nAcid Levels in Combined Pivotal Phase 3 Studies</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;page-break-after:avoid;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:98.75pt;line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span style=\"position:absolute;z-index:-1895828992;left:0px;margin-left:\n234px;margin-top:8px;width:344px;height:262px\"><img height=\"262\" src=\"Febuxostat%20Mylan%20not%20most%20recent_files/image001.png\" width=\"344\"/></span><span lang=\"EN-GB\" style='font-size:8.0pt;font-family:\"Times New Roman\",serif'>11</span></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;page-break-after:\navoid;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:10.0pt;font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:98.75pt;line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span style=\"position:absolute;z-index:-1895827968;left:0px;margin-left:\n254px;margin-top:5px;width:308px;height:209px\"><img height=\"209\" src=\"Febuxostat%20Mylan%20not%20most%20recent_files/image002.png\" width=\"308\"/></span><span style=\"position:relative;z-index:-1895826944\"><span style=\"left:0px;position:\nabsolute;left:195px;top:-1px;width:13px;height:204px\"><img alt=\"Mean (\u00b1SEM) Serum Uric Acid Level (mg/dL)\" height=\"204\" src=\"Febuxostat%20Mylan%20not%20most%20recent_files/image003.png\" width=\"13\"/></span></span><span lang=\"EN-GB\" style='font-size:8.0pt;font-family:\"Times New Roman\",serif'>10\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 </span><span lang=\"EN-GB\" style='font-size:6.0pt;font-family:\"Times New Roman\",serif'>Placebo</span></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;page-break-after:\navoid;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:8.5pt;font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:102.75pt;line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-size:8.0pt;font-family:\"Times New Roman\",serif'>9</span></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;page-break-after:\navoid;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:10.0pt;font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:102.75pt;line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-size:8.0pt;font-family:\"Times New Roman\",serif'>8</span></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;page-break-after:\navoid;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:10.0pt;font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:102.75pt;line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-size:8.0pt;font-family:\"Times New Roman\",serif'>7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 </span><span lang=\"EN-GB\" style='font-size:6.0pt;font-family:\"Times New Roman\",serif'>Allopurinol</span></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;page-break-after:\navoid;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:10.0pt;font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:102.75pt;line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-size:8.0pt;font-family:\"Times New Roman\",serif'>6</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:260.5pt;line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-size:6.0pt;font-family:\"Times New Roman\",serif'>Febuxostat\n80\u00a0mg</span></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;page-break-after:\navoid;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:5.0pt;font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:102.75pt;line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-size:8.0pt;font-family:\"Times New Roman\",serif'>5</span></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;page-break-after:\navoid;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:10.0pt;font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:102.75pt;line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-size:8.0pt;font-family:\"Times New Roman\",serif'>4</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:260.5pt;line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-size:6.0pt;font-family:\"Times New Roman\",serif'>Febuxostat\n120\u00a0mg</span></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;page-break-after:\navoid;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:7.5pt;font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:102.75pt;line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-size:8.0pt;font-family:\"Times New Roman\",serif'>3\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <u>\n</u></span></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;page-break-after:\navoid;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:7.0pt;font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:260.5pt;line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-size:6.0pt;font-family:\"Times New Roman\",serif'>Febuxostat\n240\u00a0mg</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:102.75pt;line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-size:8.0pt;font-family:\"Times New Roman\",serif'>2</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:123.6pt;line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-size:8.0pt;font-family:\"Times New Roman\",serif'>BL\u00a0\u00a0\n2\u00a0\u00a0\u00a0\u00a0 4\u00a0\u00a0\u00a0\u00a0 6\u00a0\u00a0\u00a0\u00a0 8\u00a0\u00a0\u00a0 12\u00a0\u00a0 16\u00a0\u00a0 20\u00a0\u00a0 24\u00a0\u00a0 28\u00a0\u00a0 32\u00a0\u00a0 36\u00a0\u00a0 40\u00a0\u00a0 44\u00a0\u00a0 48\u00a0\u00a0 52</span></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;page-break-after:\navoid;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:8.5pt;font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:210.8pt;\nmargin-bottom:0in;margin-left:230.0pt;text-align:center;line-height:normal;\npage-break-after:avoid;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:\n8.0pt;font-family:\"Times New Roman\",serif'>Week</span></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;page-break-after:\navoid;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:6.0pt;font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:114.4pt;line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-size:6.0pt;font-family:\"Times New Roman\",serif'>BL=baseline\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\nSEM=standard error of the mean</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Note: 509 patients received\nallopurinol 300\u00a0mg QD; 10 patients with serum creatinine &gt;1.5 and \u22642.0\u00a0mg/dL\nwere dosed with 100\u00a0mg QD. (10 patients out of 268 in APEX study).</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>240\u00a0mg febuxostat was used to\nevaluate the safety of febuxostat at twice the recommended highest dose.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>CONFIRMS Study: The CONFIRMS study\nwas a Phase 3, randomized, controlled, 26-week study to evaluate the safety and\nefficacy of febuxostat 40\u00a0mg and 80\u00a0mg, in comparison with\nallopurinol 300\u00a0mg or 200\u00a0mg, in patients with gout and\nhyperuricaemia. Two thousand and two hundred-sixty nine (2269) patients were\nrandomized: febuxostat 40\u00a0mg QD (n=757), febuxostat 80\u00a0mg QD (n=756),\nor allopurinol 300/200\u00a0mg QD (n=756). At least 65% of the patients had\nmild-moderate renal impairment (with creatinine clearance of 30-89\u00a0mL/min).\nProphylaxis against gout flares was obligatory over the 26-week period.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The proportion of patients with\nserum urate levels of &lt; 6.0\u00a0mg/dL (357\u00a0\u00b5mol/L) at the final visit,\nwas 45% for 40\u00a0mg febuxostat, 67% for febuxostat 80\u00a0mg and 42% for\nallopurinol 300/200\u00a0mg, respectively.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Primary endpoint in the sub-group\nof patients with renal impairment</span></i></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The APEX Study evaluated efficacy\nin 40 patients with renal impairment (i.e., baseline serum creatinine &gt; 1.5\u00a0mg/dL\nand \u22642.0\u00a0mg/dL). For renally impaired subjects who were randomized\nto allopurinol, the dose was capped at 100\u00a0mg QD. Febuxostat achieved the\nprimary efficacy endpoint in 44% (80\u00a0mg QD), 45% (120\u00a0mg QD), and 60%\n(240\u00a0mg QD) of patients compared to 0% in the allopurinol 100\u00a0mg QD\nand placebo groups.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>There were no clinically\nsignificant differences in the percent decrease in serum uric acid\nconcentration in healthy subjects irrespective of their renal function (58% in\nthe normal renal function group and 55% in the severe renal dysfunction group).</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>An analysis in patients with gout\nand renal impairment was prospectively defined in the CONFIRMS study, and\nshowed that febuxostat was significantly more efficacious in lowering serum\nurate levels to &lt; 6\u00a0mg/dL compared to allopurinol 300\u00a0mg/200\u00a0mg\nin patients who had gout with mild to moderate renal impairment (65% of\npatients studied).</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Primary endpoint in the sub group\nof patients with sUA \u2265 10\u00a0mg/dL</span></i></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Approximately 40% of patients\n(combined APEX and FACT) had a baseline sUA of \u2265 10\u00a0mg/dL. In this\nsubgroup </span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>febuxostat</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'> achieved the primary\nefficacy endpoint (sUA &lt; 6.0\u00a0mg/dL at the last 3 visits) in 41% (80\u00a0mg\nQD), 48% (120\u00a0mg QD), and 66% (240\u00a0mg QD) of patients compared to 9%\nin the allopurinol 300\u00a0mg/100\u00a0mg QD and 0% in the placebo groups.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>In the CONFIRMS study, the\nproportion of patients achieving the primary efficacy endpoint (sUA &lt;6.0\u00a0mg/dL\nat the final visit) for patients with a baseline serum urate level of \u2265\n10\u00a0mg/dL treated with febuxostat 40\u00a0mg QD was 27% (66/249), with\nfebuxostat 80\u00a0mg QD 49% (125/254) and with allopurinol 300\u00a0mg/200\u00a0mg\nQD 31% (72/230), respectively.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Clinical Outcomes: proportion of\npatients requiring treatment for a gout flare</span></i></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>APEX study: During the 8-week\nprophylaxis period, a greater proportion of subjects in the febuxostat 120\u00a0mg\n(36%) treatment group required treatment for gout flare compared to febuxostat\n80\u00a0mg (28%), allopurinol 300\u00a0mg (23%) and placebo (20%). Flares\nincreased following the prophylaxis period and gradually decreased over time. Between\n46% and 55% of subjects received treatment for gout flares from Week 8 and Week\n28. Gout flares during the last 4 weeks of the study (Weeks 24-28) were\nobserved in 15% (febuxostat 80, 120\u00a0mg), 14% (allopurinol 300\u00a0mg) and\n20% (placebo) of subjects.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>FACT study: During the 8-week\nprophylaxis period, a greater proportion of subjects in the febuxostat 120\u00a0mg\n(36%) treatment group required treatment for a gout flare compared to both the\nfebuxostat 80\u00a0mg (22%) and allopurinol 300\u00a0mg (21%) treatment groups.\nAfter the 8-week prophylaxis period, the incidences of flares increased and\ngradually decreased over time (64% and 70% of subjects received treatment for\ngout flares from Week 8-52). Gout flares during the last 4 weeks of the study (Weeks\n49-52) were observed in 6-8% (febuxostat 80\u00a0mg, 120\u00a0mg) and 11%\n(allopurinol 300\u00a0mg) of subjects.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The proportion of subjects\nrequiring treatment for a gout flare (APEX and FACT Study) was numerically\nlower in the groups that achieved an average post-baseline serum urate level\n&lt;6.0\u00a0mg/dL, &lt;5.0\u00a0mg/dL, or &lt;4.0\u00a0mg/dL compared to the\ngroup that achieved an average post-baseline serum urate level \u22656.0\u00a0mg/dL\nduring the last 32 weeks of the treatment period (Week 20 - Week 24 to Week 49\n- 52 intervals).</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>During the CONFIRMS study, the\npercentages of patients who required treatment for gout flares (Day 1 through\nMonth 6) were 31% and 25% for the febuxostat 80\u00a0mg and allopurinol groups,\nrespectively. No difference in the proportion of patients requiring treatment\nfor gout flares was observed between the febuxostat 80\u00a0mg and 40\u00a0mg\ngroups.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Long-term, open label extension\nStudies</span></i></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EXCEL Study (C02-021): The Excel\nstudy was a three years Phase 3, open label, multicenter, randomised,\nallopurinol-controlled, safety extension study for patients who had completed\nthe pivotal Phase 3 studies (APEX or FACT).\u00a0 A total of 1,086 patients were\nenrolled: </span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'> 80\u00a0mg QD (n=649), </span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>febuxostat</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'> 120\u00a0mg QD (n=292)\nand allopurinol 300/100\u00a0mg QD (n=145). About 69% of patients required no\ntreatment change to achieve a final stable treatment. Patients who had 3\nconsecutive sUA levels &gt;6.0\u00a0mg/dL were withdrawn.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Serum urate levels were maintained\nover time (i.e. 91% and 93% of patients on initial treatment with febuxostat 80\u00a0mg\nand 120\u00a0mg, respectively, had sUA &lt;6\u00a0mg/dL at Month 36).</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Three years data showed a decrease\nin the incidence of gout flares with less than 4% of patients requiring\ntreatment for a flare (i.e. more than 96% of patients did not require treatment\nfor a flare) at Month 16-24 and at Month 30-36.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>46% and 38%, of patients on final\nstable treatment of febuxostat 80 or 120\u00a0mg QD, respectively, had complete\nresolution of the primary palpable tophus from baseline to the Final Visit.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>FOCUS Study (TMX-01-005) was a 5\nyears Phase 2, open-label, multicenter, safety extension study for patients who\nhad completed the febuxostat 4 weeks of double blind dosing in study\nTMX-00-004.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>116 patients were enrolled and\nreceived initially febuxostat 80\u00a0mg QD. 62% of patients required no dose\nadjustment to maintain sUA &lt;6\u00a0mg/dL and 38% of patients required a dose\nadjustment to achieve a final stable dose.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The proportion of patients with\nserum urate levels of &lt;6.0\u00a0mg/dL (357\u00a0\u00b5mol/L) at the final visit\nwas greater than 80% (81-100%) at each febuxostat dose.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>During the phase 3 clinical\nstudies, mild liver function test abnormalities were observed in patients\ntreated with febuxostat (5.0%). These rates were similar to the rates reported\non allopurinol (4.2%) (see section 4.4). Increased TSH values (&gt;5.5\u00a0\u00b5IU/mL)\nwere observed in patients on long-term treatment with febuxostat (5.5%) and\npatients with allopurinol (5.8%) in the long term open label extension studies\n(see section 4.4).</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<h1 style=\"margin-right:6.4pt\"><span lang=\"EN-GB\">5.2\u00a0\u00a0\u00a0\u00a0 Pharmacokinetic\nproperties</span></h1>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>In healthy subjects, maximum plasma\nconcentrations (C<sub>max</sub>) and area under the plasma concentration time\ncurve (AUC) of febuxostat increased in a dose proportional manner following\nsingle and multiple doses of 10\u00a0mg to 120\u00a0mg. For doses between 120\u00a0mg\nand 300\u00a0mg, a greater than dose proportional increase in AUC is observed\nfor febuxostat. There is no appreciable accumulation when doses of 10\u00a0mg\nto 240\u00a0mg are administered every 24 hours. Febuxostat has an apparent mean\nterminal elimination half-life (t<sub>1/2</sub>) of approximately 5 to 8 hours.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Population\npharmacokinetic/pharmacodynamic analyses were conducted in 211 patients with\nhyperuricaemia and gout, treated with febuxostat 40-240\u00a0mg QD. In general,\nfebuxostat pharmacokinetic parameters estimated by these analyses are\nconsistent with those obtained from healthy subjects, indicating that healthy\nsubjects are representative for pharmacokinetic/pharmacodynamic assessment in\nthe patient population with gout.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Absorption</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat is rapidly (t<sub>max</sub>\nof 1.0-1.5 h) and well absorbed (at least 84%). After single or multiple oral 80\nand 120\u00a0mg once daily doses, C<sub>max</sub> is approximately 2.8-3.2\u00a0\u00b5g/mL,\nand 5.0-5.3\u00a0\u00b5g/mL, respectively. Absolute bioavailability of the\nfebuxostat tablet formulation has not been studied.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Following multiple oral 80\u00a0mg\nonce daily doses or a single 120\u00a0mg dose with a high fat meal, there was a\n49% and 38% decrease in C<sub>max</sub> and an 18% and 16% decrease in AUC,\nrespectively. However, no clinically significant change in the percent decrease\nin serum uric acid concentration was observed where tested (80\u00a0mg multiple\ndose). Thus, </span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>febuxostat</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'> may be taken without\nregard to food.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Distribution</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The apparent steady state volume of\ndistribution (Vss/F) of febuxostat ranges from 29 to 75 L after oral doses of\n10-300\u00a0mg. The plasma protein binding of febuxostat is approximately\n99.2%, (primarily to albumin), and is constant over the concentration range\nachieved with 80 and 120\u00a0mg doses. Plasma protein binding of the active\nmetabolites ranges from about 82% to 91%.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Biotransformation</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat is extensively\nmetabolized by conjugation <i>via </i>uridine diphosphate glucuronosyltransferase\n(UDPGT) enzyme system and oxidation <i>via </i>the cytochrome P450 (CYP)\nsystem. Four pharmacologically active hydroxyl metabolites have been\nidentified, of which three occur in plasma of humans. <i>In vitro </i>studies\nwith human liver microsomes showed that those oxidative metabolites were formed\nprimarily by CYP1A1, CYP1A2, CYP2C8 or CYP2C9 and febuxostat glucuronide was formed\nmainly by UGT 1A1, 1A8, and 1A9.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Elimination</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat is eliminated by both\nhepatic and renal pathways. Following an 80\u00a0mg oral dose of <sup>14</sup>C-labeled\nfebuxostat, approximately 49% of the dose was recovered in the urine as\nunchanged febuxostat (3%), the acyl glucuronide of the active substance (30%),\nits known oxidative metabolites and their conjugates (13%), and other unknown\nmetabolites (3%). In addition to the urinary excretion, approximately 45% of\nthe dose was recovered in the faeces as the unchanged febuxostat (12%), the\nacyl glucuronide of the active substance (1%), its known oxidative metabolites\nand their conjugates (25%), and other unknown metabolites (7%).</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Renal impairment</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Following multiple doses of 80\u00a0mg\nof febuxostat in patients with mild, moderate or severe renal impairment, the C<sub>max</sub>\nof febuxostat did not change, relative to subjects with normal renal function.\nThe mean total AUC of febuxostat increased by approximately 1.8-fold from 7.5\u00a0\u00b5g</span><span lang=\"EN-GB\" style='font-family:\"Cambria Math\",serif'>\u22c5</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>h/mL in the normal renal\nfunction group to 13.2\u00a0\u00b5g.h/mL in the severe renal dysfunction group. The\nC<sub>max</sub> and AUC of active metabolites increased up to 2- and 4-fold,\nrespectively. However, no dose adjustment is necessary in patients with mild or\nmoderate renal impairment.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Hepatic impairment</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Following multiple doses of 80\u00a0mg\nof </span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>febuxostat</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'> in patients with mild\n(Child-Pugh Class A) or moderate (Child-Pugh Class B) hepatic impairment, the C<sub>max</sub>\nand AUC of febuxostat and its metabolites did not change significantly compared\nto subjects with normal hepatic function. No studies have been conducted in\npatients with severe hepatic impairment (Child-Pugh Class C).</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Age</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>There were no significant changes\nobserved in AUC of febuxostat or its metabolites following multiple oral doses\nof febuxostat in elderly as compared to younger healthy subjects.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Gender</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Following multiple oral doses of </span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>febuxostat</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>, the C<sub>max</sub>\nand AUC were 24% and 12% higher in females than in males, respectively.\nHowever, weight-corrected C<sub>max</sub> and AUC were similar between the\ngenders. No dose adjustment is needed based on gender.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<h1 style=\"margin-right:6.4pt\"><span lang=\"EN-GB\">5.3\u00a0\u00a0\u00a0\u00a0 Preclinical safety data</span></h1>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Effects in non-clinical studies\nwere generally observed at exposures in excess of the maximum human exposure.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Pharmacokinetic modelling and\nsimulation of rat data suggests that, when co-administered with febuxostat, the\nclinical dose of mercaptopurine/azathioprine should be reduced to 20% or less\nof the previously prescribed dose in order to avoid possible haematological\neffects (see section 4.4 and 4.5).</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Carcinogenesis, mutagenesis,\nimpairment of fertility</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>In male rats, a statistically\nsignificant increase in urinary bladder tumours (transitional cell papilloma\nand carcinoma) was found only in association with xanthine calculi in the high\ndose group, at approximately 11 times human exposure. There was no significant\nincrease in any other tumour type in either male or female mice or rats. These\nfindings are considered a consequence of species specific purine metabolism and\nurine composition and of no relevance to clinical use.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>A standard battery of test for\ngenotoxicity did not reveal any biologically relevant genotoxic effects for\nfebuxostat.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat at oral doses up to 48\u00a0mg/kg/day\nwas found to have no effect on fertility and reproductive performance of male\nand female rats.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>There was no evidence of impaired\nfertility, teratogenic effects, or harm to the foetus due to febuxostat. There\nwas high dose maternal toxicity accompanied by a reduction in weaning index and\nreduced development of offspring in rats at approximately 4.3 times human\nexposure. Teratology studies, performed in pregnant rats at approximately 4.3\ntimes and pregnant rabbits at approximately</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>13 times human exposure did not\nreveal any teratogenic effects.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<h1 style=\"margin-right:6.4pt\"><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\nPARTICULARS</span></h1>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<h1 style=\"margin-right:6.4pt\"><span lang=\"EN-GB\">6.1\u00a0\u00a0\u00a0\u00a0 List of excipients</span></h1>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Tablet core</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Lactose</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Microcrystalline cellulose</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Magnesium stearate</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Hydroxypropylcellulose</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Croscarmellose sodium</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Colloidal hydrated silica</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Colloidal anhydrous silica</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Crospovidone</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Talc</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Tablet coating</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Hypromellose</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Titanium dioxide (E171) </span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Ethylcellulose</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Iron oxide yellow (E172)</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Triacetin</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Iron oxide black (E172)</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<h1 style=\"margin-right:6.4pt\"><span lang=\"EN-GB\">6.2\u00a0\u00a0\u00a0\u00a0 Incompatibilities</span></h1>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Not applicable.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<h1 style=\"margin-right:6.4pt\"><span lang=\"EN-GB\">6.3\u00a0\u00a0\u00a0\u00a0 Shelf life</span></h1>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>2 years.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>For bottles: After first opening\nuse within 180 days</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<h1 style=\"margin-right:6.4pt\"><span lang=\"EN-GB\">6.4\u00a0\u00a0\u00a0\u00a0 Special precautions for\nstorage</span></h1>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>This medicinal product does not\nrequire any special storage conditions.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<h1 style=\"margin-right:6.4pt\"><span lang=\"EN-GB\">6.5\u00a0\u00a0\u00a0\u00a0 Nature and contents of\ncontainer</span></h1>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(PVC/oPA/Alu)/Alu (desiccant\nembedded) blisters of 14, 28, 84 tablets, calendar blisters of 28, 84 tablets and\nperforated unit dose blisters of 28 x 1 tablets.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(PVC/oPA/Alu)/Alu blisters of 14,\n28, 42 tablets, calendar blisters of 28 tablets and perforated unit dose\nblisters of 28 x 1 tablets and multipacks of 84 (2 packs of 42) tablets.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>HDPE bottle with polypropylene (PP)\nscrew cap closure with desiccant containing 28 or 84 tablets.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Not all pack sizes may be marketed.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<h1 style=\"margin-right:6.4pt\"><span lang=\"EN-GB\">6.6\u00a0\u00a0\u00a0\u00a0 Special precautions for\ndisposal</span></h1>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>No special requirements.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<h1 style=\"margin-right:6.5pt;page-break-after:auto\"><span lang=\"EN-GB\" style=\"font-weight:normal\">\u00a0</span></h1>\n<h1 style=\"margin-right:6.4pt\"><span lang=\"EN-GB\">7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MARKETING\nAUTHORISATION HOLDER</span></h1>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Mylan\nS.A.S.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>117\nAllee des Parcs</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>69\n800 Saint Priest</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>France</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<h1 style=\"margin-right:6.4pt\"><span lang=\"EN-GB\">8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MARKETING\nAUTHORISATION NUMBER(S)</span></h1>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/001</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/002</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/003</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/004</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/005</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/006</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/007</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/008</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/017</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/018</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/019</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/020</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/021</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/022</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<h1 style=\"margin-right:6.4pt\"><span lang=\"EN-GB\">9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 DATE OF FIRST\nAUTHORISATION/RENEWAL OF THE AUTHORISATION</span></h1>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Date of first authorisation: </span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<h1 style=\"margin-right:6.4pt\"><span lang=\"EN-GB\">10.\u00a0\u00a0\u00a0\u00a0 DATE OF REVISION OF THE\nTEXT</span></h1>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Detailed information on this\nmedicinal product is available on the website of the European Medicines Agency </span><span lang=\"EN-GB\"><a href=\"http://www.ema.europa.eu/\"><span style='font-family:\"Times New Roman\",serif;\ncolor:windowtext'>http://www.ema.europa.eu</span></a></span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<h1 style=\"margin-right:3.1pt;page-break-before:always\"><span lang=\"EN-GB\">1<span class=\"Heading1Char\">.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT</span></span></h1>\n<h1 style=\"margin-right:3.1pt\"><span lang=\"EN-GB\">\u00a0</span></h1>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat Mylan 120\u00a0mg\nfilm-coated tablets</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<h1 style=\"margin-right:3.1pt\"><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 QUALITATIVE AND\nQUANTITATIVE COMPOSITION</span></h1>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Each tablet contains 120\u00a0mg of\nfebuxostat.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Excipient with known effect</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Each tablet contains 354.0\u00a0mg\nof lactose</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>For the full list of excipients,\nsee section 6.1.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<h1 style=\"margin-right:3.1pt\"><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL FORM</span></h1>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Film-coated tablet.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>A yellow, capsule shaped, biconvex\ntablet, approximately 18 x 8 mm, debossed with M on one side of the tablet and\nFX4 on the other side.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<h1 style=\"margin-right:3.1pt\"><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 CLINICAL PARTICULARS</span></h1>\n<h1 style=\"margin-right:3.1pt\"><span lang=\"EN-GB\">\u00a0</span></h1>\n<h1 style=\"margin-right:3.1pt\"><span lang=\"EN-GB\">4.1\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Therapeutic indications</span></h1>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat Mylan is indicated for\nthe treatment of chronic hyperuricaemia in conditions where urate deposition\nhas already occurred (including a history, or presence of, tophus and/or gouty\narthritis).</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat Mylan is indicated for\nthe prevention and treatment of hyperuricaemia in adult patients undergoing\nchemotherapy for haematologic malignancies at intermediate to high risk of\nTumor Lysis Syndrome (TLS).</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat Mylan is indicated in\nadults.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<h1 style=\"margin-right:3.1pt\"><span lang=\"EN-GB\">4.2\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Posology and method\nof administration</span></h1>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Posology</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Gout</span></i></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The recommended oral dose of Febuxostat\nMylan is 80\u00a0mg once daily without regard to food. If serum uric acid is\n&gt; 6\u00a0mg/dL (357\u00a0\u00b5mol/L) after 2-4 weeks, Febuxostat Mylan 120\u00a0mg\nonce daily may be considered.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat Mylan works sufficiently\nquickly to allow retesting of the serum uric acid after 2 weeks. The therapeutic\ntarget is to decrease and maintain serum uric acid below 6\u00a0mg/dL (357\u00a0\u03bcmol/L).</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Gout flare prophylaxis of at least\n6 months is recommended (see section 4.4).</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Tumor Lysis Syndrome</span></i></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The recommended oral dose of Febuxostat\nMylan is 120\u00a0mg once daily without regard to food.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat Mylan should be started\ntwo days before the beginning of cytotoxic therapy and continued for a minimum\nof 7 days; however treatment may be prolonged up to 9 days according to\nchemotherapy duration as per clinical judgment.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Elderly</span></i></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>No dose adjustment is required in\nthe elderly (see section 5.2).</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Renal impairment</span></i></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The efficacy and safety have not\nbeen fully evaluated in patients with severe renal impairment (creatinine\nclearance &lt;30 mL/min, see section 5.2).</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>No dose adjustment is necessary in\npatients with mild or moderate renal impairment.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Hepatic impairment</span></i></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The efficacy and safety of\nfebuxostat has not been studied in patients with severe hepatic impairment (Child\nPugh Class C).</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Gout: The recommended dose in\npatients with mild hepatic impairment is 80\u00a0mg. Limited information is\navailable in patients with moderate hepatic impairment.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Tumour Lysis Syndrome: in the pivotal\nPhase III trial (FLORENCE) only subjects with severe hepatic insufficiency were\nexcluded from trial participation. No dose adjustment was required for enrolled\npatients on the basis of hepatic function.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Paediatric population</span></i></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The safety and the efficacy of febuxostat\nin children aged below the age of 18 years have not been established. No data\nare available.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Method of administration</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Oral use</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat Mylan should be taken by\nmouth and can be taken with or without food.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<h1 style=\"margin-right:3.1pt\"><span lang=\"EN-GB\">4.3\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Contraindications</span></h1>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Hypersensitivity to the active\nsubstance or to any of the excipients listed in section 6.1 (see also section\n4.8).</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<h1 style=\"margin-right:3.1pt\"><span lang=\"EN-GB\">4.4\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Special warnings and\nprecautions for use</span></h1>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Cardio-vascular disorders</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><i><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'><span style=\"text-decoration:none\">\u00a0</span></span></u></i></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Treatment of chronic hyperuricaemia</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Treatment with febuxostat in\npatients with ischaemic heart disease or congestive heart failure is not\nrecommended. A numerical greater incidence of investigator-reported\ncardiovascular APTC events (defined endpoints from the Anti-Platelet Trialists\u2019\nCollaboration (APTC) including cardiovascular death, non-fatal myocardial\ninfarction, non-fatal stroke) was observed in the febuxostat total group\ncompared to the allopurinol group in the APEX and FACT studies (1.3 vs. 0.3\nevents per 100 Patient Years (PYs)), but not in the CONFIRMS study (see section\n5.1 for detailed characteristics of the studies). The incidence of\ninvestigator-reported cardiovascular APTC events in the combined Phase 3\nstudies (APEX, FACT and CONFIRMS studies) was 0.7 vs. 0.6 events per 100 PYs.\nIn the long-term extension studies the incidences of investigator-reported APTC\nevents were 1.2 and 0.6 events per 100\u00a0PYs for febuxostat and allopurinol,\nrespectively. No statistically significant differences were found and no causal\nrelationship with febuxostat was established. Identified risk factors among\nthese patients were a medical history of atherosclerotic disease and/or\nmyocardial infarction, or of congestive heart failure.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Prevention and treatment of\nhyperuricaemia in patients at risk of TLS</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Patients undergoing chemotherapy\nfor haematologic malignancies at intermediate to high risk of Tumor Lysis\nSyndrome treated with febuxostat should be under cardiac monitoring as\nclinically appropriate.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Medicinal product allergy /\nhypersensitivity</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare reports of serious\nallergic/hypersensitivity reactions, including life-threatening Stevens-Johnson\nSyndrome, Toxic epidermal necrolysis and acute anaphylactic reaction/shock,\nhave been collected in the post-marketing experience. In most cases, these\nreactions occurred during the first month of therapy with febuxostat. Some, but\nnot all of these patients reported renal impairment and/or previous\nhypersensitivity to allopurinol. Severe hypersensitivity reactions, including\nDrug Reaction with Eosinophilia and Systemic Symptoms (DRESS) were associated\nwith fever, haematological, renal or hepatic involvement in some cases.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Patients should be advised of the\nsigns and symptoms and monitored closely for symptoms of allergic/hypersensitivity\nreactions (see section 4.8). Febuxostat treatment should be immediately stopped\nif serious allergic/hypersensitivity reactions, including Stevens-Johnson\nSyndrome, occur since early withdrawal is associated with a better prognosis.\nIf patient has developed allergic/hypersensitivity reactions including\nStevens-Johnson Syndrome and acute anaphylactic reaction/shock, febuxostat must\nnot be re-started in this patient at any time.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Acute gouty attacks (gout flare)</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat treatment should not be\nstarted until an acute attack of gout has completely subsided. Gout flares may\noccur during initiation of treatment due to changing serum uric acid levels\nresulting in mobilization of urate from tissue deposits (see sections 4.8 and\n5.1). At treatment initiation with febuxostat flare prophylaxis for at least 6\nmonths with an NSAID or colchicine is recommended (see section 4.2).</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If a gout flare occurs during\nfebuxostat treatment, it should not be discontinued. The gout flare should be\nmanaged concurrently as appropriate for the individual patient. Continuous\ntreatment with febuxostat decreases frequency and intensity of gout flares.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Xanthine deposition</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>In patients in whom the rate of\nurate formation is greatly increased (e.g. malignant disease and its treatment,\nLesch-Nyhan syndrome) the absolute concentration of xanthine in urine could, in\nrare cases, rise sufficiently to allow deposition in the urinary tract. This\nhas not been observed in the pivotal clinical study with febuxostat in the\nTumor Lysis Syndrome. As there has been no experience with febuxostat, its use\nin patients with Lesch-Nyhan Syndrome is not recommended.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Mercaptopurine/azathioprine</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat use is not recommended\nin patients concomitantly treated with mercaptopurine/azathioprine as inhibition\nof xanthine oxidase by febuxostat may cause increased plasma concentrations of\nmercaptopurine/azathioprine that could result in severe toxicity. No\ninteraction studies have been performed in humans.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Where the combination cannot be\navoided, a reduction of the dose of mercaptopurine/azathioprine is recommended.\nBased on modelling and simulation analysis of data from a pre-clinical study in\nrats, when coadministered with febuxostat, the dose of\nmercaptopurine/azathioprine should be reduced to the 20% or less of the\npreviously prescribed dose in order to avoid possible haematological effects\n(see section 4.5 and 5.3).</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The patients should be closely monitored\nand the dose of mercaptopurine/azathioprine should be subsequently adjusted\nbased on the evaluation of the therapeutic response and the onset of eventual\ntoxic effects.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Organ transplant recipients</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>As there has been no experience in\norgan transplant recipients, the use of febuxostat in such patients is not\nrecommended (see section 5.1).</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Theophylline</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Co-administration of febuxostat 80\u00a0mg\nand theophylline 400\u00a0mg single dose in healthy subjects showed absence of\nany pharmacokinetic interaction (see section 4.5). Febuxostat 80\u00a0mg can be\nused in patients concomitantly treated with theophylline without risk of\nincreasing theophylline plasma levels.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>No data is available for febuxostat\n120\u00a0mg.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Liver disorders</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>During the combined phase 3 clinical\nstudies, mild liver function test abnormalities were observed in patients\ntreated with febuxostat (5.0%). Liver function test is recommended prior to the\ninitiation of therapy with febuxostat and periodically thereafter based on\nclinical judgment (see section 5.1).</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Thyroid disorders</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Increased TSH values (&gt;5.5\u00a0\u00b5IU/mL)\nwere observed in patients on long-term treatment with febuxostat (5.5%) in the\nlong term open label extension studies. Caution is required when febuxostat is\nused in patients with alteration of thyroid function (see section 5.1).</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Lactose</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat tablets contain lactose.\nPatients with rare hereditary problems of galactose intolerance, the Lapp\nlactase deficiency or glucose-galactose malabsorption should not take this\nmedicine.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<h1 style=\"margin-right:3.1pt\"><span lang=\"EN-GB\">4.5\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Interaction with\nother medicinal products and other forms of interaction</span></h1>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Mercaptopurine/azathioprine</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>On the basis of the mechanism of\naction of febuxostat on XO inhibition concomitant use is not recommended.\nInhibition of XO by febuxostat may cause increased plasma concentrations of\nthese drugs leading to toxicity. Drug interaction studies of febuxostat with\ndrugs (except theophylline) that are metabolized by XO have not been performed\nin humans.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Modelling and simulation analysis\nof data from a pre-clinical study in rats, indicates that, in case of\nconcomitant administration with febuxostat, the dose of\nmercaptopurine/azathioprine should be reduced to the 20% or less of the\npreviously prescribed dose (see section 4.4 and 5.3).</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Drug interaction studies of\nfebuxostat with other cytotoxic chemotherapy have not been conducted. </span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>In the Tumor Lysis Syndrome pivotal\ntrial febuxostat 120\u00a0mg daily was administered to patients undergoing\nseveral chemotherapy regimens, including monoclonal antibodies. However,\ndrug-drug and drug-disease interactions were not explored during this study.\nTherefore, possible interactions with any concomitantly administered cytotoxic\ndrug cannot be ruled out.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rosiglitazone/CYP2C8 substrates</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat was shown to be a weak inhibitor\nof CYP2C8 <i>in vitro. </i>In a study in healthy subjects, coadministration of\n120\u00a0mg febuxostat QD with a single 4\u00a0mg oral dose of rosiglitazone\nhad no effect on the pharmacokinetics of rosiglitazone and its metabolite\nN-desmethyl rosiglitazone, indicating that febuxostat is not a CYP2C8 enzyme\ninhibitor <i>in vivo</i>. Thus, co-administration of febuxostat with rosiglitazone\nor other CYP2C8 substrates is not expected to require any dose adjustment for\nthose compounds.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Theophylline</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>An interaction study in healthy\nsubjects has been performed with febuxostat to evaluate whether the inhibition\nof XO may cause an increase in the theophylline circulating levels as reported\nwith other XO inhibitors. The results of the study showed that the\nco-administration of febuxostat 80\u00a0mg QD with theophylline 400\u00a0mg\nsingle dose has no effect on the pharmacokinetics or safety of theophylline.\nTherefore no special caution is advised when febuxostat 80\u00a0mg and\ntheophylline are given concomitantly. No data is available for febuxostat 120\u00a0mg.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Naproxen and other inhibitors of\nglucuronidation</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat metabolism depends on\nUridine Glucuronosyl Transferase (UGT) enzymes. Medicinal products that inhibit\nglucuronidation, such as NSAIDs and probenecid, could in theory affect the\nelimination of febuxostat. In healthy subjects concomitant use of febuxostat\nand naproxen 250\u00a0mg twice daily was associated with an increase in\nfebuxostat exposure (C<sub>max</sub> 28%, AUC 41% and t<sub>1/2</sub> 26%). In\nclinical studies the use of naproxen or other NSAIDs/Cox-2 inhibitors was not\nrelated to any clinically significant increase in adverse events.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat can be co-administered\nwith naproxen with no dose adjustment of febuxostat or naproxen being\nnecessary.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Inducers of glucuronidation</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Potent inducers of UGT enzymes\nmight possibly lead to increased metabolism and decreased efficacy of\nfebuxostat. Monitoring of serum uric acid is therefore recommended 1-2 weeks\nafter start of treatment with a potent inducer of glucuronidation. Conversely,\ncessation of treatment of an inducer might lead to increased plasma levels of\nfebuxostat.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Colchicine/indometacin/hydrochlorothiazide/warfarin</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat can be co-administered\nwith colchicine or indomethacin with no dose adjustment of febuxostat or the\nco-administered active substance being necessary.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>No dose adjustment is necessary for\nfebuxostat when administered with hydrochlorothiazide.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>No dose adjustment is necessary for\nwarfarin when administered with febuxostat. Administration of febuxostat (80\u00a0mg\nor 120\u00a0mg once daily) with warfarin had no effect on the pharmacokinetics\nof warfarin in healthy subjects. INR and Factor VII activity were also not\naffected by the co-administration of febuxostat.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Desipramine/CYP2D6 substrates</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat was shown to be a weak\ninhibitor of CYP2D6 <i>in vitro. </i>In a study in healthy subjects, 120\u00a0mg\nfebuxostat QD resulted in a mean 22% increase in AUC of desipramine, a CYP2D6\nsubstrate indicating a potential weak inhibitory effect of febuxostat on the\nCYP2D6 enzyme <i>in vivo</i>. Thus, co-administration of febuxostat with other CYP2D6\nsubstrates is not expected to require any dose adjustment for those compounds.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Antacids</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Concomitant ingestion of an antacid\ncontaining magnesium hydroxide and aluminium hydroxide has been shown to delay\nabsorption of febuxostat (approximately 1 hour) and to cause a 32% decrease in C<sub>max</sub>,\nbut no significant change in AUC was observed. Therefore, febuxostat may be\ntaken without regard to antacid use.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<h1 style=\"margin-right:3.1pt\"><span lang=\"EN-GB\">4.6\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Fertility, pregnancy\nand lactation</span></h1>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Pregnancy</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Data on a very limited number of\nexposed pregnancies have not indicated any adverse effects of febuxostat on\npregnancy or on the health of the foetus/new born child. Animal studies do not\nindicate direct or indirect harmful effects with respect to pregnancy,\nembryonal/foetal development or parturition (see section 5.3). The potential\nrisk for human is unknown. Febuxostat should not be used during pregnancy.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Breast-feeding</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>It is unknown whether febuxostat is\nexcreted in human breast milk. Animal studies have shown excretion of this\nactive substance in breast milk and an impaired development of suckling pups. A\nrisk to a suckling infant cannot be excluded. Febuxostat should not be used\nwhile breast-feeding.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Fertility</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>In animals, reproduction studies up\nto 48\u00a0mg/kg/day showed no dose-dependent adverse effects on fertility (see\nsection 5.3). The effect of febuxostat on human fertility is unknown.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<h1 style=\"margin-right:3.1pt\"><span lang=\"EN-GB\">4.7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Effects on ability to\ndrive and use machines</span></h1>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Somnolence, dizziness, paraesthesia\nand blurred vision have been reported with the use of febuxostat. Patients\nshould exercise caution before driving, using machinery or participating in\ndangerous activities until they are reasonably certain that febuxostat does not\nadversely affect performance.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<h1 style=\"margin-right:3.1pt\"><span lang=\"EN-GB\">4.8\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Undesirable effects</span></h1>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Summary of the safety profile</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The most commonly reported adverse\nreactions in clinical trials (4,072 subjects treated at least with a dose from\n10\u00a0mg to 300\u00a0mg) and post-marketing experience in gout patients are\ngout flares, liver function abnormalities, diarrhoea, nausea, headache, rash\nand oedema. These adverse reactions were mostly mild or moderate in severity.\nRare serious hypersensitivity reactions to febuxostat, some of which were\nassociated to systemic symptoms, have occurred in the post-marketing experience.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Tabulated list of adverse reactions</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common (\u22651/100 to &lt;1/10),\nuncommon (\u22651/1,000 to &lt;1/100) and rare (\u22651/10,000 to\n&lt;1/1,000) adverse reactions occurring in patients treated with febuxostat\nare listed below.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The frequencies are based on studies\nand post-marketing experience in gout patients.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Within each frequency grouping,\nadverse reactions are presented in order of decreasing seriousness.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;page-break-after:avoid;text-autospace:none\"><i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Table 1: Adverse\nreactions in combined phase 3, long-term extension studies and post-marketing\nexperience in gout patients.</span></i></p>\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"margin-left:.25pt;border-collapse:collapse\" width=\"624\">\n<tr>\n<td style=\"width:163.05pt;border:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"217\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;page-break-after:avoid;text-autospace:\n  none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Blood and\n  lymphatic system</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:normal;page-break-after:avoid;text-autospace:\n  none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>disorders</span></p>\n</td>\n<td style=\"width:304.75pt;border:solid black 1.0pt;\n  border-left:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;page-break-after:avoid;text-autospace:\n  none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;page-break-after:avoid;text-autospace:\n  none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Pancytopenia,\n  <span style=\"color:black\">thrombocytopenia, agranulocytosis*</span></span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:163.05pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"217\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Immune system\n  disorders</span></p>\n</td>\n<td style=\"width:304.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Anaphylactic\n  reaction*, drug hypersensitivity*</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:163.05pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"217\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Endocrine disorders</span></p>\n</td>\n<td style=\"width:304.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Blood thyroid stimulating\n  hormone increased</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:163.05pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"217\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Eye disorders</span></p>\n</td>\n<td style=\"width:304.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Blurred vision</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:163.05pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"217\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Metabolism and\n  nutrition</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>disorders</span></p>\n</td>\n<td style=\"width:304.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common***</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Gout flares</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.25pt;margin-right:31.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Diabetes mellitus,\n  hyperlipidemia, decrease appetite, weight increase</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.45pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Weight decrease,\n  increase appetite, anorexia</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:163.05pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"217\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Psychiatric disorders</span></p>\n</td>\n<td style=\"width:304.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Libido decreased,\n  insomnia</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Nervousness</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:163.05pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"217\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Nervous system\n  disorders</span></p>\n</td>\n<td style=\"width:304.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Headache</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:16.8pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.7pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Dizziness,\n  paraesthesia, hemiparesis, somnolence, altered taste, hypoaesthesia, hyposmia</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:163.05pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"217\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Ear and labyrinth disorders</span></p>\n</td>\n<td style=\"width:304.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Tinnitus</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:163.05pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"217\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Cardiac disorders</span></p>\n</td>\n<td style=\"width:304.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:244.6pt;margin-bottom:\n  0in;margin-left:5.0pt;text-align:justify;line-height:12.3pt;text-autospace:\n  none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:4.4pt;margin-bottom:\n  0in;margin-left:5.0pt;text-align:justify;line-height:normal;text-autospace:\n  none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Atrial\n  fibrillation, palpitations, ECG abnormal, left bundle branch block (see\n  section Tumor Lysis Syndrome), sinus tachycardia (see section Tumor Lysis\n  Syndrome)</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:163.05pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"217\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Vascular disorders</span></p>\n</td>\n<td style=\"width:304.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Hypertension,\n  flushing, hot flush, haemorrhage (see section Tumor Lysis Syndrome)</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:163.05pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"217\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.4pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Respiratory system\n  disorders</span></p>\n</td>\n<td style=\"width:304.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.4pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Dyspnoea, bronchitis,\n  upper respiratory tract infection, cough</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:163.05pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"217\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.4pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Gastrointestinal\n  disorders</span></p>\n</td>\n<td style=\"width:304.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.4pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Diarrhoea**, nausea</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon:</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:6.15pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Abdominal pain,\n  abdominal distension, gastro-oesophageal reflux disease, vomiting, dry mouth,\n  dyspepsia, constipation, frequent stools, flatulence, gastrointestinal\n  discomfort</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Pancreatitis, mouth\n  ulceration</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:163.05pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"217\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Hepato-biliary\n  disorders</span></p>\n</td>\n<td style=\"width:304.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:159.3pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.7pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Liver function\n  abnormalities** <u>Uncommon</u></span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.45pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Cholelithiasis</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Hepatitis, jaundice*,\n  liver injury*</span></p>\n</td>\n</tr>\n<tr style=\"height:151.95pt\">\n<td style=\"width:163.05pt;border-top:none;border-left:\n  solid black 1.0pt;border-bottom:none;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in;height:151.95pt\" valign=\"top\" width=\"217\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.4pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Skin and subcutaneous\n  tissue</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>disorders</span></p>\n</td>\n<td style=\"width:304.75pt;border:none;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in;height:151.95pt\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.4pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.15pt;margin-right:42.6pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rash (including\n  various types of rash reported with lower frequencies, see below)</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:22.6pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.7pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Dermatitis, urticaria,\n  pruritus, skin discolouration, skin lesion, petechiae, rash macular, rash\n  maculopapular, rash papular</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.4pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.15pt;margin-right:35.1pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Toxic epidermal\n  necrolysis*, Stevens-Johnson Syndrome*, angioedema*, drug reaction with\n  eosinophilia and systemic symptoms*, generalized rash (serious)*, erythema,\n  exfoliative rash, rash follicular, rash vesicular, rash pustular, rash\n  pruritic*, rash erythematous, rash morbillifom, alopecia, hyperhidrosis</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:163.05pt;border:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"217\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Musculoskeletal and\n  connective</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>tissue disorders</span></p>\n</td>\n<td style=\"width:304.75pt;border:solid black 1.0pt;\n  border-left:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.25pt;margin-right:35.4pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Arthralgia, arthritis,\n  myalgia, musculoskeletal pain, muscle weakness, muscle spasm, muscle\n  tightness, bursitis</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rhabdomyolysis*, joint\n  stiffness, musculoskeletal stiffness</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:163.05pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"217\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Renal and urinary\n  disorders</span></p>\n</td>\n<td style=\"width:304.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Renal failure,\n  nephrolithiasis, haematuria, pollakiuria, proteinuria</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Tubulointerstitial\n  nephritis*, micturition urgency</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:163.05pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"217\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Reproductive system\n  and breast</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>disorder</span></p>\n</td>\n<td style=\"width:304.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Erectile dysfunction</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:163.05pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"217\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>General disorders and</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>administration site\n  conditions</span></p>\n</td>\n<td style=\"width:304.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Oedema</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Fatigue, chest pain,\n  chest discomfort</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Thirst</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:163.05pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"217\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Investigations</span></p>\n</td>\n<td style=\"width:304.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:11.95pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.7pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Blood amylase\n  increase, platelet count decrease, WBC decrease, lymphocyte count decrease,\n  blood creatine increase, blood creatinine increase, haemoglobin decrease,\n  blood urea increase, blood triglycerides increase, blood cholesterol\n  increase, haematocritic decrease, blood lactate dehydrogenase increased,\n  blood potassium increase</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:21.05pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.7pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Blood glucose\n  increased, activated partial thromboplastin time prolonged, red blood cell\n  count decrease, blood alkaline phosphatase increase, blood creatine\n  phosphokinase increase*</span></p>\n</td>\n</tr>\n</table>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:21.3pt;text-indent:-21.3pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>*</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0 Adverse reactions\ncoming from post-marketing experience</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:21.3pt;text-indent:-21.3pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>**\u00a0\u00a0 Treatment-emergent\nnon-infective diarrhoea and abnormal liver function tests in the combined Phase\n3 studies are more frequent in patients concomitantly treated with colchicine.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:21.3pt;text-indent:-21.3pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>*** See section 5.1 for\nincidences of gout flares in the individual Phase 3 randomized controlled\nstudies.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Description of selected adverse\nreactions</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:12.7pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:12.7pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare serious hypersensitivity\nreactions to febuxostat, including Stevens-Johnson Syndrome, Toxic epidermal\nnecrolysis and anaphylactic reaction/shock, have occurred in the post-marketing\nexperience. Stevens-Johnson Syndrome and Toxic epidermal necrolysis are\ncharacterised by progressive skin rashes associated with blisters or mucosal\nlesions and eye irritation. Hypersensitivity reactions to febuxostat can be\nassociated to the following symptoms: skin reactions characterised by\ninfiltrated maculopapular eruption, generalised or exfoliative rashes, but also\nskin lesions, facial oedema, fever, haematologic abnormalities such as\nthrombocytopenia and eosinophilia, and single or multiple organ involvement\n(liver and kidney including tubulointerstitial nephritis) (see section 4.4).</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.65pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:12.0pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Gout flares were commonly observed\nsoon after the start of treatment and during the first months. Thereafter, the\nfrequency of gout flare decreases in a time-dependent manner. Gout flare\nprophylaxis is recommended (see section 4.2 and 4.4).</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Tumor Lysis Syndrome</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Summary of the safety\nprofile</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:12.7pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:12.7pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>In the randomized, double-blind,\nPhase 3 pivotal FLORENCE (FLO-01) study comparing febuxostat with allopurinol\n(346 patients undergoing chemotherapy for haematologic malignancies and at intermediate-to-high\nrisk of TLS), only 22 (6.4%) patients overall experienced adverse reactions, namely\n11 (6.4%) patients in each treatment group. The majority of adverse reactions\nwere either mild or moderate.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.25pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:12.45pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Overall, the FLORENCE trial did not\nhighlight any particular safety concern in addition to the previous experience\nwith febuxostat in gout, with the exception of the following three adverse\nreactions (listed above in table 1).</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.55pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:12.0pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Cardiac disorders:</span></i></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon: Left bundle branch block,\nsinus tachycardia</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.65pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:12.0pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:100%;text-autospace:none\"><i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Vascular disorders:</span></i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'> </span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:100%;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon: haemorrhage</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.55pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:12.0pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Reporting of suspected adverse\nreactions</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:99%;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:99%;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Reporting suspected adverse\nreactions after authorisation of the medicinal product is important. It allows\ncontinued monitoring of the benefit/risk balance of the medicinal product.\nHealthcare professionals are asked to report any suspected adverse reactions\nvia the national reporting system listed in </span><span lang=\"EN-GB\"><a href=\"http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc\"><span style='font-family:\"Times New Roman\",serif;color:windowtext'>Appendix V</span><span style='font-family:\"Times New Roman\",serif;color:windowtext;text-decoration:\nnone'>.</span></a></span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.9pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:12.0pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>4.9\u00a0\u00a0\u00a0\u00a0\u00a0 Overdose</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:.45pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:12.0pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Patients with an overdose should be\nmanaged by symptomatic and supportive care.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:10.0pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:10.0pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACOLOGICAL\nPROPERTIES</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:.65pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:12.0pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>5.1\u00a0\u00a0\u00a0\u00a0\u00a0 Pharmacodynamic properties</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:.45pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:12.0pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Pharmacotherapeutic group: Antigout\npreparation, preparations inhibiting uric acid production, ATC code: M04AA03</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.7pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:12.0pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:12.45pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Mechanism of action</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:12.45pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:12.45pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uric acid is the end product of\npurine metabolism in humans and is generated in the cascade of hypoxanthine\n\u2192 xanthine \u2192 uric acid. Both steps in the above transformations are\ncatalyzed by xanthine oxidase (XO). Febuxostat is a 2-arylthiazole derivative\nthat achieves its therapeutic effect of decreasing serum uric acid by\nselectively inhibiting XO. Febuxostat is a potent, non-purine selective\ninhibitor of XO (NP-SIXO) with an <i>in vitro</i> inhibition Ki value less than\none nanomolar. Febuxostat has been shown to potently inhibit both the oxidized\nand reduced forms of XO. At therapeutic concentrations febuxostat does not\ninhibit other enzymes involved in purine or pyrimidine metabolism, namely, guanine\ndeaminase, hypoxanthine guanine phosphoribosyltransferase, orotate\nphosphoribosyltransferase, orotidine monophosphate decarboxylase or purine\nnucleoside phosphorylase.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.9pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:13.0pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:12.45pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Clinical efficacy and safety</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.15pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:11.0pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:1.6pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:12.45pt;text-autospace:none\"><i><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Gout</span></u></i></p>\n<p class=\"MsoNormal\" style=\"margin-top:.3pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:11.0pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:1.6pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The efficacy of febuxostat was\ndemonstrated in three Phase 3 pivotal studies (the two pivotal APEX and FACT\nstudies, and the additional CONFIRMS study, described below) that were\nconducted in 4101 patients with hyperuricaemia and gout. In each phase 3\npivotal study, febuxostat demonstrated superior ability to lower and maintain\nserum uric acid levels compared to allopurinol. The primary efficacy endpoint\nin the APEX and FACT studies was the proportion of patients whose last 3 monthly\nserum uric acid levels were &lt; 6.0\u00a0mg/dL (357\u00a0\u00b5mol/L). In the\nadditional phase 3 CONFIRMS study, for which results became available after the\nmarketing authorisation for febuxostat was first issued, the primary efficacy\nendpoint was the proportion of patients whose serum urate level was &lt; 6.0\u00a0mg/dL\nat the final visit. No patients with organ transplant have been included in\nthese studies (see section 4.2).</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.7pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:12.0pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>APEX Study</span></i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>: The Allopurinol and\nPlacebo-Controlled Efficacy Study of Febuxostat (APEX) was a Phase 3,\nrandomized, double-blind, multicenter, 28-week study. One thousand and\nseventy-two (1072) patients were randomized: placebo (n=134), febuxostat 80\u00a0mg\nQD (n=267), febuxostat 120\u00a0mg QD (n=269), febuxostat 240\u00a0mg QD\n(n=134) or allopurinol (300\u00a0mg QD [n=258] for patients with a baseline\nserum creatinine \u22641.5\u00a0mg/dL or 100\u00a0mg QD [n=10] for patients\nwith a baseline serum creatinine &gt;1.5\u00a0mg/dL and \u22642.0\u00a0mg/dL).\nTwo hundred and forty\u00a0mg febuxostat (2 times the recommended highest dose)\nwas used as a safety evaluation dose.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.85pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:12.0pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The APEX study showed statistically\nsignificant superiority of both the febuxostat 80\u00a0mg QD and the febuxostat\n120\u00a0mg QD treatment arms <i>versus </i>the conventionally used doses of\nallopurinol 300\u00a0mg (n=258) /100\u00a0mg (n = 10) treatment arm in reducing\nthe sUA below 6\u00a0mg/dL (357\u00a0\u00b5mol/L) (see Table 2 and Figure 1).</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.55pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:12.0pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:99%;text-autospace:none\"><i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>FACT Study</span></i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>: The Febuxostat\nAllopurinol Controlled Trial (FACT) Study was a Phase 3, randomized,\ndouble-blind, multicenter, 52-week study. Seven hundred sixty (760) patients\nwere randomized: febuxostat 80\u00a0mg QD (n=256), febuxostat 120\u00a0mg QD\n(n=251), or allopurinol 300\u00a0mg QD (n=253).</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.65pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:12.0pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The FACT study showed the\nstatistically significant superiority of both febuxostat 80\u00a0mg and febuxostat\n120\u00a0mg QD treatment arms <i>versus </i>the conventionally used dose of\nallopurinol 300\u00a0mg treatment arm in reducing and maintaining sUA below 6\u00a0mg/dL\n(357\u00a0\u00b5mol/L).</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.65pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:12.0pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Table 2 summarises the primary\nefficacy endpoint results:</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.9pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:12.0pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Table 2</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:.1pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:12.6pt;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Proportion of Patients\nwith Serum Uric Acid Levels &lt;6.0\u00a0mg/dL (357\u00a0\u00b5mol/L) Last Three\nMonthly Visits</span></b></p>\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"margin-left:57.0pt;border-collapse:collapse\">\n<tr>\n<td style=\"width:89.9pt;border:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"120\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;text-autospace:\n  none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:28.9pt;\n  margin-bottom:0in;margin-left:29.9pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Study</span></p>\n</td>\n<td style=\"width:90.7pt;border:solid black 1.0pt;\n  border-left:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"121\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;text-autospace:\n  none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:19.25pt;\n  margin-bottom:0in;margin-left:19.85pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat\n  </span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>80\u00a0mg\n  QD</span></p>\n</td>\n<td style=\"width:76.45pt;border:solid black 1.0pt;\n  border-left:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"102\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;text-autospace:\n  none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:9.55pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:11.95pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>120\u00a0mg QD</span></p>\n</td>\n<td style=\"width:90.2pt;border:solid black 1.0pt;\n  border-left:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"120\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:18.05pt;\n  margin-bottom:0in;margin-left:19.0pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Allopurinol</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:32.55pt;\n  margin-bottom:0in;margin-left:33.5pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>300\n  /</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:16.05pt;\n  margin-bottom:0in;margin-left:16.85pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>100\u00a0mg\n  QD<sup>1</sup></span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:89.9pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"120\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:27.55pt;\n  margin-bottom:0in;margin-left:28.35pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>APEX</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:17.55pt;\n  margin-bottom:0in;margin-left:18.4pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(28\n  weeks)</span></p>\n</td>\n<td style=\"width:90.7pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"121\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:29.4pt;\n  margin-bottom:0in;margin-left:30.25pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>48%*</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:24.55pt;\n  margin-bottom:0in;margin-left:25.35pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=262)</span></p>\n</td>\n<td style=\"width:76.45pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"102\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:21.65pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>65%*<sup>, #</sup></span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:20.1pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=269)</span></p>\n</td>\n<td style=\"width:90.2pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"120\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:33.65pt;\n  margin-bottom:0in;margin-left:34.35pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>22%</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:25.95pt;\n  margin-bottom:0in;margin-left:26.9pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=268)</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:89.9pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"120\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:27.95pt;\n  margin-bottom:0in;margin-left:28.6pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>FACT</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:17.55pt;\n  margin-bottom:0in;margin-left:18.4pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(52\n  weeks)</span></p>\n</td>\n<td style=\"width:90.7pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"121\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:30.25pt;\n  margin-bottom:0in;margin-left:31.25pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>53%*</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:24.55pt;\n  margin-bottom:0in;margin-left:25.35pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=255)</span></p>\n</td>\n<td style=\"width:76.45pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"102\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:23.05pt;\n  margin-bottom:0in;margin-left:24.15pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>62%*</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:17.35pt;\n  margin-bottom:0in;margin-left:18.3pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=250)</span></p>\n</td>\n<td style=\"width:90.2pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"120\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:33.65pt;\n  margin-bottom:0in;margin-left:34.35pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>21%</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:25.95pt;\n  margin-bottom:0in;margin-left:26.9pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=251)</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:89.9pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"120\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:18.95pt;\n  margin-bottom:0in;margin-left:19.85pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Combined</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:25.6pt;\n  margin-bottom:0in;margin-left:26.55pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Results</span></p>\n</td>\n<td style=\"width:90.7pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"121\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:30.35pt;\n  margin-bottom:0in;margin-left:31.1pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>51%*</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:24.55pt;\n  margin-bottom:0in;margin-left:25.35pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=517)</span></p>\n</td>\n<td style=\"width:76.45pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"102\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:22.5pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>63%*<sup>, #</sup></span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:20.1pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=519)</span></p>\n</td>\n<td style=\"width:90.2pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"120\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:33.5pt;\n  margin-bottom:0in;margin-left:34.45pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>22%</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:25.95pt;\n  margin-bottom:0in;margin-left:26.9pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=519)</span></p>\n</td>\n</tr>\n<tr>\n<td colspan=\"4\" style=\"width:347.25pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"463\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.5pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:normal;text-autospace:none\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'> results from subjects\n  receiving either 100\u00a0mg QD (n=10: patients with serum creatinine &gt;1.5\n  and </span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u22642.0\u00a0mg/dL)\n  or 300\u00a0mg QD (n=509) were pooled </span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>for analyses.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>* p &lt; 0.001 vs\n  allopurinol, # p &lt; 0.001 vs 80\u00a0mg</span></p>\n</td>\n</tr>\n</table>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:5.9pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:5.9pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The ability of </span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>febuxostat</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'> to lower serum uric\nacid levels was prompt and persistent. Reduction in serum uric acid level to\n&lt;6.0\u00a0mg/dL (357\u00a0\u00b5mol/L) was noted by the Week 2 visit and was\nmaintained throughout treatment. The mean serum uric acid levels over time for\neach treatment group from the two pivotal Phase 3 studies are shown in Figure\n1.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:5.9pt;line-height:12.45pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:3.5pt;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:53.3pt;line-height:12.45pt;page-break-after:avoid;text-autospace:\nnone\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Figure 1\nMean Serum Uric Acid Levels in Combined Pivotal Phase 3 Studies</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:.1pt;margin-right:0in;margin-bottom:0in;\nmargin-left:0in;line-height:12.0pt;page-break-after:avoid;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:1.9pt;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:98.75pt;line-height:9.0pt;page-break-after:avoid;text-autospace:\nnone\"><span style=\"position:absolute;z-index:-1895825920;left:0px;margin-left:\n234px;margin-top:8px;width:344px;height:262px\"><img height=\"262\" src=\"Febuxostat%20Mylan%20not%20most%20recent_files/image004.png\" width=\"344\"/></span><span lang=\"EN-GB\" style='font-size:8.0pt;font-family:\"Times New Roman\",serif'>11</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.5pt;margin-right:0in;margin-bottom:0in;\nmargin-left:0in;line-height:10.0pt;page-break-after:avoid;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:10.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:1.75pt;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:98.75pt;line-height:11.2pt;page-break-after:avoid;text-autospace:\nnone\"><span style=\"position:absolute;z-index:-1895823872;left:0px;margin-left:\n254px;margin-top:5px;width:308px;height:209px\"><img height=\"209\" src=\"Febuxostat%20Mylan%20not%20most%20recent_files/image002.png\" width=\"308\"/></span><span style=\"position:relative;z-index:-1895822848\"><span style=\"left:0px;position:\nabsolute;left:195px;top:-1px;width:13px;height:204px\"><img alt=\"Mean (\u00b1SEM) Serum Uric Acid Level (mg/dL)\" height=\"204\" src=\"Febuxostat%20Mylan%20not%20most%20recent_files/image005.png\" width=\"13\"/></span></span><span lang=\"EN-GB\" style='font-size:8.0pt;font-family:\"Times New Roman\",serif'>10\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 </span><span lang=\"EN-GB\" style='font-size:6.0pt;font-family:\"Times New Roman\",serif'>Placebo</span></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:8.5pt;page-break-after:\navoid;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:8.5pt;font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:1.9pt;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:102.75pt;line-height:9.0pt;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-size:8.0pt;font-family:\"Times New Roman\",serif'>9</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.5pt;margin-right:0in;margin-bottom:0in;\nmargin-left:0in;line-height:10.0pt;page-break-after:avoid;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:10.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:1.9pt;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:102.75pt;line-height:9.0pt;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-size:8.0pt;font-family:\"Times New Roman\",serif'>8</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.5pt;margin-right:0in;margin-bottom:0in;\nmargin-left:0in;line-height:10.0pt;page-break-after:avoid;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:10.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:1.9pt;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:102.75pt;line-height:9.0pt;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-size:8.0pt;font-family:\"Times New Roman\",serif'>7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 </span><span lang=\"EN-GB\" style='font-size:6.0pt;font-family:\"Times New Roman\",serif'>Allopurinol</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.5pt;margin-right:0in;margin-bottom:0in;\nmargin-left:0in;line-height:10.0pt;page-break-after:avoid;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:10.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:1.9pt;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:102.75pt;line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-size:8.0pt;font-family:\"Times New Roman\",serif'>6</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:260.5pt;line-height:6.8pt;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-size:6.0pt;font-family:\"Times New Roman\",serif'>Febuxostat\n80\u00a0mg</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.45pt;margin-right:0in;margin-bottom:0in;\nmargin-left:0in;line-height:5.0pt;page-break-after:avoid;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:5.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:102.75pt;line-height:9.0pt;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-size:8.0pt;font-family:\"Times New Roman\",serif'>5</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.5pt;margin-right:0in;margin-bottom:0in;\nmargin-left:0in;line-height:10.0pt;page-break-after:avoid;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:10.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:1.9pt;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:102.75pt;line-height:8.25pt;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-size:8.0pt;font-family:\"Times New Roman\",serif'>4</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:260.5pt;line-height:5.3pt;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-size:6.0pt;font-family:\"Times New Roman\",serif'>Febuxostat\n120\u00a0mg</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.35pt;margin-right:0in;margin-bottom:0in;\nmargin-left:0in;line-height:7.5pt;page-break-after:avoid;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:7.5pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:102.75pt;line-height:9.0pt;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-size:8.0pt;font-family:\"Times New Roman\",serif'>3\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <u>\n</u></span></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:7.0pt;page-break-after:\navoid;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:7.0pt;font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:260.5pt;line-height:6.7pt;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-size:6.0pt;font-family:\"Times New Roman\",serif'>Febuxostat\n240\u00a0mg</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:102.75pt;line-height:7.15pt;page-break-after:avoid;text-autospace:\nnone\"><span style=\"position:absolute;z-index:-1895824896;left:0px;margin-left:\n577px;margin-top:5px;width:1px;height:4px\"><img height=\"4\" src=\"Febuxostat%20Mylan%20not%20most%20recent_files/image006.png\" width=\"1\"/></span><span lang=\"EN-GB\" style='font-size:8.0pt;font-family:\"Times New Roman\",serif'>2</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:123.6pt;line-height:7.15pt;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-size:8.0pt;font-family:\"Times New Roman\",serif'>BL\u00a0\u00a0\n2\u00a0\u00a0\u00a0\u00a0 4\u00a0\u00a0\u00a0\u00a0 6\u00a0\u00a0\u00a0\u00a0 8\u00a0\u00a0\u00a0 12\u00a0\u00a0 16\u00a0\u00a0 20\u00a0\u00a0 24\u00a0\u00a0 28\u00a0\u00a0 32\u00a0\u00a0 36\u00a0\u00a0 40\u00a0\u00a0 44\u00a0\u00a0 48\u00a0\u00a0 52</span></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:8.5pt;page-break-after:\navoid;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:8.5pt;font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:210.8pt;\nmargin-bottom:0in;margin-left:230.0pt;text-align:center;line-height:9.0pt;\npage-break-after:avoid;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:\n8.0pt;font-family:\"Times New Roman\",serif'>Week</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.25pt;margin-right:0in;margin-bottom:0in;\nmargin-left:0in;line-height:6.0pt;page-break-after:avoid;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:6.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:114.4pt;line-height:6.8pt;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-size:6.0pt;font-family:\"Times New Roman\",serif'>BL=baseline\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\nSEM=standard error of the mean</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.6pt;margin-right:0in;margin-bottom:0in;\nmargin-left:0in;line-height:11.0pt;page-break-after:avoid;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:1.6pt;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Note: 509\npatients received allopurinol 300\u00a0mg QD; 10 patients with serum creatinine\n&gt;1.5 and \u22642.0\u00a0mg/dL were dosed with 100\u00a0mg QD. (10 patients\nout of 268 in APEX study).<br/>\n240\u00a0mg febuxostat was used to evaluate the safety of febuxostat at twice\nthe recommended highest dose.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>CONFIRMS Study: The CONFIRMS study\nwas a Phase 3, randomized, controlled, 26-week study to evaluate the safety and\nefficacy of febuxostat 40\u00a0mg and 80\u00a0mg, in comparison with\nallopurinol 300\u00a0mg or 200\u00a0mg, in patients with gout and\nhyperuricaemia. Two thousand and two hundred-sixty nine (2269) patients were\nrandomized: febuxostat 40\u00a0mg QD (n=757), </span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>febuxostat </span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>80\u00a0mg QD (n=756), or\nallopurinol 300/200\u00a0mg QD (n=756). At least 65% of the patients had\nmild-moderate renal impairment (with creatinine clearance of 30-89 mL/min).\nProphylaxis against gout flares was obligatory over the 26-week period.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The proportion of patients with\nserum urate levels of &lt; 6.0\u00a0mg/dL (357\u00a0\u00b5mol/L) at the final visit,\nwas 45% for 40\u00a0mg febuxostat, 67% for febuxostat 80\u00a0mg and 42% for\nallopurinol 300/200\u00a0mg, respectively.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Primary endpoint in the sub-group\nof patients with renal impairment</span></i></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The APEX Study evaluated efficacy\nin 40 patients with renal impairment (i.e., baseline serum creatinine &gt; 1.5\u00a0mg/dL\nand \u22642.0\u00a0mg/dL). For renally impaired subjects who were randomized\nto allopurinol, the dose was capped at 100\u00a0mg QD. Febuxostat achieved the\nprimary efficacy endpoint in 44% (80\u00a0mg QD), 45% (120\u00a0mg QD), and 60%\n(240\u00a0mg QD) of patients compared to 0% in the allopurinol 100\u00a0mg QD\nand placebo groups.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>There were no clinically\nsignificant differences in the percent decrease in serum uric acid\nconcentration in healthy subjects irrespective of their renal function (58% in\nthe normal renal function group and 55% in the severe renal dysfunction group).</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>An analysis in patients with gout\nand renal impairment was prospectively defined in the CONFIRMS study, and\nshowed that febuxostat was significantly more efficacious in lowering serum\nurate levels to &lt; 6\u00a0mg/dL compared to allopurinol 300\u00a0mg/200\u00a0mg\nin patients who had gout with mild to moderate renal impairment (65% of\npatients studied).</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Primary endpoint in the sub group\nof patients with sUA \u2265 10\u00a0mg/dL</span></i></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Approximately 40% of patients\n(combined APEX and FACT) had a baseline sUA of \u2265 10\u00a0mg/dL. In this\nsubgroup febuxostat achieved the primary efficacy endpoint (sUA &lt; 6.0\u00a0mg/dL\nat the last 3 visits) in 41% (80\u00a0mg QD), 48% (120\u00a0mg QD), and 66%\n(240\u00a0mg QD) of patients compared to 9% in the allopurinol 300\u00a0mg/100\u00a0mg\nQD and 0% in the placebo groups.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>In the CONFIRMS study, the\nproportion of patients achieving the primary efficacy endpoint (sUA &lt;6.0\u00a0mg/dL\nat the final visit) for patients with a baseline serum urate level of \u2265\n10\u00a0mg/dL treated with febuxostat 40\u00a0mg QD was 27% (66/249), with\nfebuxostat 80\u00a0mg QD 49% (125/254) and with allopurinol 300\u00a0mg/200\u00a0mg\nQD 31% (72/230), respectively.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Clinical Outcomes: proportion of\npatients requiring treatment for a gout flare</span></i></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Apex study: During the 8-week\nprophylaxis period, a greater proportion of subjects in the febuxostat 120\u00a0mg\n(36%) treatment group required treatment for gout flare compared to febuxostat\n80\u00a0mg (28%), allopurinol 300\u00a0mg (23%) and placebo (20%). Flares\nincreased following the prophylaxis period and gradually decreased over time.\nBetween 46% and 55% of subjects received treatment for gout flares from Week 8\nand Week 28. Gout flares during the last 4 weeks of the study (Weeks 24-28)\nwere observed in 15% (febuxostat 80, 120\u00a0mg), 14% (allopurinol 300\u00a0mg)\nand 20% (placebo) of subjects.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Fact study: During the 8-week\nprophylaxis period, a greater proportion of subjects in the febuxostat 120\u00a0mg\n(36%) treatment group required treatment for a gout flare compared to both the\nfebuxostat 80\u00a0mg (22%) and allopurinol 300\u00a0mg (21%) treatment groups.\nAfter the 8-week prophylaxis period, the incidences of flares increased and\ngradually decreased over time (64% and 70% of subjects received treatment for\ngout flares from Week 8-52). Gout flares during the last 4 weeks of the study\n(Weeks 49-52) were observed in 6-8% (febuxostat 80\u00a0mg, 120\u00a0mg) and\n11% (allopurinol 300\u00a0mg) of subjects.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The proportion of subjects\nrequiring treatment for a gout flare (APEX and FACT Study) was numerically\nlower in the groups that achieved an average post-baseline serum urate level\n&lt;6.0\u00a0mg/dL, &lt;5.0\u00a0mg/dL, or &lt;4.0\u00a0mg/dL compared to the\ngroup that achieved an average post-baseline serum urate level \u22656.0\u00a0mg/dL\nduring the last 32 weeks of the treatment period (Week 20-Week 24 to Week 49 -\n52 intervals).</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>During the CONFIRMS study, the\npercentages of patients who required treatment for gout flares (Day 1 through\nMonth 6) were 31% and 25% for the febuxostat 80\u00a0mg and allopurinol groups,\nrespectively. No difference in the proportion of patients requiring treatment\nfor gout flares was observed between the febuxostat 80\u00a0mg and 40\u00a0mg\ngroups.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Long-term, open label extension\nStudies</span></i></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EXCEL Study (C02-021): The Excel\nstudy was a three years Phase 3, open label, multicenter, randomised,\nallopurinol-controlled, safety extension study for patients who had completed\nthe pivotal Phase 3 studies (APEX or FACT). A total of 1,086 patients were\nenrolled: Febuxostat 80\u00a0mg QD (n=649), febuxostat 120\u00a0mg QD (n=292)\nand allopurinol 300/100\u00a0mg QD (n=145). About 69% of patients required no\ntreatment change to achieve a final stable treatment. Patients who had 3 consecutive\nsUA levels &gt;6.0\u00a0mg/dL were withdrawn.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Serum urate levels were maintained\nover time (i.e. 91% and 93% of patients on initial treatment with febuxostat 80\u00a0mg\nand 120\u00a0mg, respectively, had sUA &lt;6\u00a0mg/dL at Month 36).</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Three years data showed a decrease\nin the incidence of gout flares with less than 4% of patients requiring\ntreatment for a flare (i.e. more than 96% of patients did not require treatment\nfor a flare) at Month 16-24 and at Month 30-36.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>46% and 38%, of patients on final\nstable treatment of febuxostat 80 or 120\u00a0mg QD, respectively, had complete\nresolution of the primary palpable tophus from baseline to the Final Visit.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>FOCUS Study (TMX-01-005) was a 5\nyears Phase 2, open-label, multicenter, safety extension study for patients who\nhad completed the febuxostat 4 weeks of double blind dosing in study\nTMX-00-004. 116 patients were enrolled and received initially febuxostat 80\u00a0mg\nQD. 62% of patients required no dose adjustment to maintain sUA &lt;6\u00a0mg/dL\nand 38% of patients required a dose adjustment to achieve a final stable dose.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The proportion of patients with\nserum urate levels of &lt;6.0\u00a0mg/dL (357\u00a0\u00b5mol/L) at the final visit\nwas greater than 80% (81-100%) at each febuxostat dose.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>During the phase 3 clinical\nstudies, mild liver function test abnormalities were observed in patients treated\nwith febuxostat (5.0%). These rates were similar to the rates reported on\nallopurinol (4.2%) (see section 4.4). Increased TSH values (&gt;5.5\u00a0\u00b5IU/mL)\nwere observed in patients on long-term treatment with febuxostat (5.5%) and\npatients with allopurinol (5.8%) in the long term open label extension studies\n(see section 4.4).</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:13.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><i><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Tumor Lysis Syndrome</span></u></i></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The efficacy and safety of febuxostat\nin the prevention and treatment of Tumor Lysis Syndrome was evaluated in the\nFLORENCE (FLO-01) study. Febuxostat C showed a superior and faster urate\nlowering activity compared to allopurinol.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>FLORENCE was a randomized (1:1),\ndouble blind, phase III, pivotal trial comparing febuxostat 120\u00a0mg once\ndaily with allopurinol 200 to 600\u00a0mg daily (mean allopurinol daily dose [\u00b1\nstandard deviation]: 349.7 \u00b1 112.90\u00a0mg) in terms of control of serum uric\nacid level. Eligible patients had to be candidates for allopurinol treatment or\nhave no access to rasburicase. Primary endpoints were serum uric acid area\nunder the curve (AUC sUA</span><span lang=\"EN-GB\" style='font-size:7.0pt;\nfont-family:\"Times New Roman\",serif'>1-8</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>) and change in serum creatinine\n(sC) level both from baseline to Day 8.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Overall, 346 patients with\nhaematological malignancies undergoing chemotherapy and at intermediate/high\nrisk of Tumor Lysis Syndrome were included. Mean AUC sUA</span><span lang=\"EN-GB\" style='font-size:7.0pt;font-family:\"Times New Roman\",serif'>1-8 </span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(mgxh/dl) was\nsignificantly lower with febuxostat (514.0 \u00b1 225.71 vs 708.0 \u00b1 234.42; least\nsquare means difference: -196.794 [95% confidence interval: -238.600 ;\n-154.988]; p &lt; .0001). Furthermore, the mean serum uric acid level was\nsignificantly lower with febuxostat since the first 24 hours of treatment and\nat any following time point. No significant difference in mean serum creatinine\nchange (%) occurred between febuxostat and allopurinol (-0.83 \u00b1 26.98 vs -4.92\n\u00b1 16.70 respectively; least square means difference: 4.0970 [95% confidence\ninterval: -0.6467 ; 8.8406]; p=0.0903). With regard to secondary endpoints, no\nsignificant difference was detected in terms of incidence of laboratory TLS\n(8.1% and 9.2% in febuxostat and allopurinol arm, respectively; relative risk:\n0.875 [95% confidence interval: 0.4408 ; 1.7369]; p=0.8488) nor of clinical TLS\n(1.7% and 1.2% in febuxostat and allopurinol arm, respectively; relative risk:\n0.994 [95% confidence interval: 0.9691 ; 1.0199]; p=1.0000).\u00a0 Incidence of overall\ntreatment-emergent signs and symptoms and adverse drug reactions was 67.6% vs\n64.7% and 6.4% vs 6.4% with febuxostat and allopurinol respectively. In the\nFLORENCE study febuxostat demonstrated a superior control of serum uric acid level\ncompared to allopurinol in patients scheduled to receive the latter drug. No\ndata comparing febuxostat with rasburicase are currently available. The\nefficacy and safety of febuxostat has not been established in patients with\nacute severe TLS, e.g. in patients who failed on other urate lowering\ntherapies.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>5.2\u00a0\u00a0\u00a0\u00a0\u00a0 Pharmacokinetic properties</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>In healthy subjects, maximum plasma\nconcentrations (C</span><span lang=\"EN-GB\" style='font-size:7.0pt;font-family:\n\"Times New Roman\",serif'>max</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>)\nand area under the plasma concentration time curve (AUC) of febuxostat\nincreased in a dose proportional manner following single and multiple doses of\n10\u00a0mg to 120\u00a0mg. For doses between 120\u00a0mg and 300\u00a0mg, a\ngreater than dose proportional increase in AUC is observed for febuxostat.\nThere is no appreciable accumulation when doses of 10\u00a0mg to 240\u00a0mg\nare administered every 24 hours. Febuxostat has an apparent mean terminal\nelimination half-life (t<sub>1/2</sub>) of approximately 5 to 8 hours.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Population\npharmacokinetic/pharmacodynamic analyses were conducted in 211 patients with\nhyperuricaemia and gout, treated with febuxostat 40-240\u00a0mg QD. In general,\nfebuxostat pharmacokinetic parameters estimated by these analyses are\nconsistent with those obtained from healthy subjects, indicating that healthy\nsubjects are representative for pharmacokinetic/pharmacodynamic assessment in\nthe patient population with gout.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Absorption</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat is rapidly (t</span><span lang=\"EN-GB\" style='font-size:7.0pt;font-family:\"Times New Roman\",serif'>max </span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>of 1.0-1.5 h) and well\nabsorbed (at least 84%). After single or multiple oral 80 and 120\u00a0mg once\ndaily doses, C</span><span lang=\"EN-GB\" style='font-size:7.0pt;font-family:\"Times New Roman\",serif'>max\n</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>is\napproximately 2.8-3.2\u00a0\u00b5g/mL, and 5.0-5.3\u00a0\u00b5g/mL, respectively.\nAbsolute bioavailability of the febuxostat tablet formulation has not been\nstudied.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Following multiple oral 80\u00a0mg\nonce daily doses or a single 120\u00a0mg dose with a high fat meal, there was a\n49% and 38% decrease in C</span><span lang=\"EN-GB\" style='font-size:7.0pt;\nfont-family:\"Times New Roman\",serif'>max </span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>and a 18% and 16% decrease in AUC,\nrespectively. However, no clinically significant change in the percent decrease\nin serum uric acid concentration was observed where tested (80\u00a0mg multiple\ndose). Thus, febuxostat may be taken without regard to food.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Distribution</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The apparent steady state volume of\ndistribution (V</span><span lang=\"EN-GB\" style='font-size:7.0pt;font-family:\"Times New Roman\",serif'>ss</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>/F) of febuxostat ranges\nfrom 29 to 75 L after oral doses of 10-300\u00a0mg. The plasma protein binding\nof febuxostat is approximately 99.2%, (primarily to albumin), and is constant\nover the concentration range achieved with 80 and 120\u00a0mg doses. Plasma\nprotein binding of the active metabolites ranges from about 82% to 91%.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Biotransformation</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat is extensively\nmetabolized by conjugation <i>via </i>uridine diphosphate\nglucuronosyltransferase (UDPGT) enzyme system and oxidation <i>via </i>the\ncytochrome P450 (CYP) system. Four pharmacologically active hydroxyl\nmetabolites have been identified, of which three occur in plasma of humans. <i>In\nvitro </i>studies with human liver microsomes showed that those oxidative\nmetabolites were formed primarily by CYP1A1, CYP1A2, CYP2C8 or CYP2C9 and\nfebuxostat glucuronide was formed mainly by UGT 1A1, 1A8, and 1A9.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Elimination</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat is eliminated by both\nhepatic and renal pathways. Following an 80\u00a0mg oral dose of <sup>14</sup>C-\nlabeled febuxostat, approximately 49% of the dose was recovered in the urine as\nunchanged febuxostat (3%), the acyl glucuronide of the active substance (30%),\nits known oxidative metabolites and their conjugates (13%), and other unknown metabolites\n(3%). In addition to the urinary excretion, approximately 45% of the dose was\nrecovered in the faeces as the unchanged febuxostat (12%), the acyl glucuronide\nof the active substance (1%), its known oxidative metabolites and their\nconjugates (25%), and other unknown metabolites (7%).</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Renal impairment</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Following multiple doses of 80\u00a0mg\nof febuxostat in patients with mild, moderate or severe renal impairment, the C<sub>max</sub>\nof febuxostat did not change, relative to subjects with normal renal function.\nThe mean total AUC of febuxostat increased by approximately 1.8-fold from 7.5\u00a0\u00b5g</span><span lang=\"EN-GB\" style='font-family:\"Cambria Math\",serif'>\u22c5</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>h/mL in the normal renal\nfunction group to 13.2\u00a0\u00b5g.h/mL in the severe renal dysfunction group. The\nC<sub>max</sub> and AUC of active metabolites increased up to 2- and 4-fold, respectively.\nHowever, no dose adjustment is necessary in patients with mild or moderate\nrenal impairment.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Hepatic impairment</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Following multiple doses of 80\u00a0mg\nof febuxostat in patients with mild (Child-Pugh Class A) or moderate\n(Child-Pugh Class B) hepatic impairment, the C</span><span lang=\"EN-GB\" style='font-size:7.0pt;font-family:\"Times New Roman\",serif'>max </span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>and AUC of febuxostat\nand its metabolites did not change significantly compared to subjects with\nnormal hepatic function. No studies have been conducted in patients with severe\nhepatic impairment (Child-Pugh Class C).</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Age</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>There were no significant changes\nobserved in AUC of febuxostat or its metabolites following multiple oral doses\nof febuxostat in elderly as compared to younger healthy subjects.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Gender</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Following multiple oral doses of febuxostat,\nthe C</span><span lang=\"EN-GB\" style='font-size:7.0pt;font-family:\"Times New Roman\",serif'>max\n</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>and AUC\nwere 24% and 12% higher in females than in males, respectively. However,\nweight-corrected C</span><span lang=\"EN-GB\" style='font-size:7.0pt;font-family:\n\"Times New Roman\",serif'>max </span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>and\nAUC were similar between the genders. No dose adjustment is needed based on\ngender.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>5.3\u00a0\u00a0\u00a0\u00a0\u00a0 Preclinical safety data</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Effects in non-clinical studies\nwere generally observed at exposures in excess of the maximum human exposure.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Pharmacokinetic modelling and\nsimulation of rat data suggests that, when co-administered with febuxostat, the\nclinical dose of mercaptopurine/azathioprine should be reduced to 20% or less\nof the previously prescribed dose in order to avoid possible haematological\neffects (see section 4.4 and 4.5).</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Carcinogenesis, mutagenesis,\nimpairment of fertility</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>In male rats, a statistically\nsignificant increase in urinary bladder tumours (transitional cell papilloma\nand carcinoma) was found only in association with xanthine calculi in the high\ndose group, at approximately 11 times human exposure. There was no significant\nincrease in any other tumour type in either male or female mice or rats. These\nfindings are considered a consequence of species specific purine metabolism and\nurine composition and of no relevance to clinical use.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>A standard battery of test for\ngenotoxicity did not reveal any biologically relevant genotoxic effects for febuxostat.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat at oral doses up to 48\u00a0mg/kg/day\nwas found to have no effect on fertility and reproductive performance of male\nand female rats.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>There was no evidence of impaired\nfertility, teratogenic effects, or harm to the foetus due to febuxostat. There\nwas high dose maternal toxicity accompanied by a reduction in weaning index and\nreduced development of offspring in rats at approximately 4.3 times human\nexposure. Teratology studies, performed in pregnant rats at approximately 4.3\ntimes and pregnant rabbits at approximately 13 times human exposure did not\nreveal any teratogenic effects.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\nPARTICULARS</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>6.1\u00a0\u00a0\u00a0\u00a0\u00a0 List of excipients</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Tablet core</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Lactose</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Microcrystalline cellulose</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Magnesium stearate</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Hydroxypropylcellulose</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Croscarmellose sodium</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Colloidal hydrated silica</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Colloidal anhydrous silica</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Crospovidone</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Talc</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Tablet coating</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Hypromellose</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Titanium dioxide (E171)</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Ethylcellulose</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Iron oxide yellow (E172)</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Triacetin</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Iron oxide black (E172)</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>6.2\u00a0\u00a0\u00a0\u00a0\u00a0 Incompatibilities</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Not applicable.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>6.3\u00a0\u00a0\u00a0\u00a0\u00a0 Shelf life</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>2 years.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>For bottles: After first opening\nuse within 180 days</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>6.4\u00a0\u00a0\u00a0\u00a0\u00a0 Special precautions for\nstorage</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>This medicinal product does not\nrequire any special storage conditions.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>6.5\u00a0\u00a0\u00a0\u00a0\u00a0 Nature and contents of\ncontainer</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(PVC/oPA/Alu)/Alu (desiccant\nembedded) blisters of 14, 28, 84 tablets, calendar blisters of 28, 84 tablets\nand perforated unit dose blisters of 28 x 1 tablets.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(PVC/oPA/Alu)/Alu blisters of 14,\n28, 42 tablets, calendar blisters of 28 tablets and perforated unit dose\nblisters of 28 x 1 tablets and multipacks of 84 (2 packs of 42) tablets.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>HDPE bottle with polypropylene (PP)\nscrew cap closure with desiccant containing 28 or 84 tablets.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;background:yellow'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Not all pack sizes may be marketed.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>6.6\u00a0\u00a0\u00a0\u00a0\u00a0 Special precautions for\ndisposal</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>No special requirements.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION\nHOLDER</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Mylan\nS.A.S.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>117\nAllee des Parcs</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>69\n800 Saint Priest</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>France</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION\nNUMBER(S)</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/009</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/010</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/011</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/012</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/013</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/014</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/015</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/016</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/023</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/024</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/025</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/026</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/027</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/028</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 DATE OF FIRST\nAUTHORISATION/RENEWAL OF THE AUTHORISATION</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Date of first authorisation: </span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>10.\u00a0\u00a0\u00a0\u00a0\u00a0 DATE OF REVISION OF THE\nTEXT</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Detailed information on this\nmedicinal product is available on the website of the European Medicines Agency </span><span lang=\"EN-GB\"><a href=\"http://www.emea.europa.eu/\"><span style='font-family:\"Times New Roman\",serif;\ncolor:windowtext'>http://www.ema.europa.eu</span></a></span></p>\n<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span>\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>ANNEX\nII</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:70.8pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:70.8pt;margin-bottom:\n0in;margin-left:85.05pt;text-indent:-35.4pt;line-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>A.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MANUFACTURERS\nRESPONSIBLE FOR BATCH RELEASE</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\nmargin-left:28.35pt;text-indent:-28.35pt;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:70.9pt;margin-bottom:\n0in;margin-left:85.05pt;text-indent:-35.45pt;line-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>B.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 CONDITIONS OR\nRESTRICTIONS REGARDING SUPPLY AND USE</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\nmargin-left:28.35pt;text-indent:-28.35pt;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:77.95pt;margin-bottom:\n0in;margin-left:85.05pt;text-indent:-35.45pt;line-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>C.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER\nCONDITIONS AND REQUIREMENTS OF THE MARKETING AUTHORISATION</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:77.9pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:70.8pt;margin-bottom:\n0in;margin-left:85.05pt;text-indent:-35.4pt;line-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>D.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <span style=\"text-transform:uppercase\">conditions or restrictions with regard to the\nsafe and effective use of the medicinal product</span></span></b></p>\n<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>A.\u00a0\u00a0\u00a0\u00a0\u00a0 MANUFACTURERS\nRESPONSIBLE FOR BATCH RELEASE</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Name and address of the\nmanufacturers responsible for batch release</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Mylan Hungary Kft</span></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Mylan utca 1</span></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>H-2900 Kom\u00e1rom</span></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Hungary</span></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>McDermott Laboratories\nLimited trading as Gerard Laboratories</span></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>35/36 Baldoyle\nIndustrial Estate</span></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Grange Road</span></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Dublin 13</span></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Ireland</span></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The printed package\nleaflet of the medicinal product must state the name and address of the\nmanufacturer responsible for the release of the concerned batch.</span></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\nmargin-left:28.35pt;text-indent:-28.35pt;line-height:normal\"><a name=\"OLE_LINK2\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>B.</span></b></a><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0 CONDITIONS OR\nRESTRICTIONS REGARDING SUPPLY AND USE </span></b></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Medicinal product subject\nto medical prescription.</span></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\nmargin-left:28.35pt;text-indent:-28.35pt;line-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>C. \u00a0\u00a0\u00a0\u00a0 OTHER CONDITIONS\nAND REQUIREMENTS OF THE MARKETING AUTHORISATION</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.05pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><u><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'><span style=\"text-decoration:none\">\u00a0</span></span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.05pt;margin-bottom:\n0in;margin-left:.5in;text-indent:-.5in;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Periodic\nSafety Update Reports</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:28.35pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:28.35pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>The requirements for submission of periodic safety\nupdate reports for this medicinal product are set out in the list of Union\nreference dates (EURD list) </span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>provided\nfor under Article 107c(7) of Directive 2001/83</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>/EC</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'> and </span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>any subsequent updates published on\nthe European medicines web-portal.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.05pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><u><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'><span style=\"text-decoration:none\">\u00a0</span></span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.05pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><u><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'><span style=\"text-decoration:none\">\u00a0</span></span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\nmargin-left:28.35pt;text-indent:-28.35pt;line-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>D.\u00a0\u00a0\u00a0\u00a0\u00a0 CONDITIONS OR\nRESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL\nPRODUCT\u00a0 </span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.05pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><u><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'><span style=\"text-decoration:none\">\u00a0</span></span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.05pt;margin-bottom:\n0in;margin-left:.5in;text-indent:-.5in;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Risk\nManagement Plan (RMP)</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.05pt;margin-bottom:\n0in;margin-left:.5in;line-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:28.35pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>The MAH shall perform the required pharmacovigilance\nactivities and interventions detailed in the agreed RMP presented in Module\n1.8.2 of the Marketing Authorisation and any agreed subsequent updates of the\nRMP.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.05pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.05pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>An updated RMP should be submitted:</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.05pt;margin-bottom:\n0in;margin-left:.5in;text-indent:-.25in;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>At\nthe request of the European Medicines Agency;</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.05pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-10.35pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Whenever\nthe risk management system is modified, especially as the result of new\ninformation being received that may lead to a significant change to the\nbenefit/risk profile or as the result of an important (pharmacovigilance or\nrisk minimisation) milestone being reached.</span></p>\n<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span>\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>ANNEX III</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>LABELLING AND PACKAGE\nLEAFLET</span></b></p>\n<b><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span></b>\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>A.\nLABELLING</span></b></p>\n<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\ncolor:black'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;background:white\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>PARTICULARS\nTO APPEAR ON THE OUTER PACKAGING </span></b></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>OUTER\nCARTON (BLISTERS AND BOTTLES)</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\nOF THE MEDICINAL PRODUCT</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Febuxostat Mylan 80\u00a0mg film-coated tablets </span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>febuxostat</span><b><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'> </span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT\nOF ACTIVE SUBSTANCE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Each tablet contains 80\u00a0mg febuxostat.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST\nOF EXCIPIENTS</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Also contains lactose.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>See leaflet for further information.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\nFORM AND CONTENTS</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"DE\" style='font-family:\"Times New Roman\",serif;\nbackground:lightgrey;layout-grid-mode:line'>Film-coated tablets</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><i><span lang=\"DE\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey;layout-grid-mode:line'>[Blisters]</span></i></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>14 film-coated tablets</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"DE\" style='font-family:\"Times New Roman\",serif;\nbackground:lightgrey;layout-grid-mode:line'>28 film-coated tablets</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"DE\" style='font-family:\"Times New Roman\",serif;\nbackground:lightgrey;layout-grid-mode:line'>42 film-coated tablets</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"DE\" style='font-family:\"Times New Roman\",serif;\nbackground:lightgrey;layout-grid-mode:line'>84 film-coated tablets</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"DE\" style='font-family:\"Times New Roman\",serif;\nbackground:lightgrey;layout-grid-mode:line'>28 x 1 film-coated tablets</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"DE\" style='font-family:\"Times New Roman\",serif;\nbackground:lightgrey;layout-grid-mode:line'>28 film-coated tablets (calendar)</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"DE\" style='font-family:\"Times New Roman\",serif;\nbackground:lightgrey;layout-grid-mode:line'>84 film-coated tablets (calendar)</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"DE\" style='font-family:\"Times New Roman\",serif;\nlayout-grid-mode:line'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><i><span lang=\"DE\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey;layout-grid-mode:line'>[Bottles]</span></i></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"DE\" style='font-family:\"Times New Roman\",serif;\nbackground:lightgrey;layout-grid-mode:line'>28 film-coated tablets </span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"DE\" style='font-family:\"Times New Roman\",serif;\nbackground:lightgrey;layout-grid-mode:line'>84 film-coated tablets </span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD\nAND ROUTE(S) OF ADMINISTRATION</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>For oral use.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Read the package leaflet before use.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nWARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF\nCHILDREN</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Keep out of the sight and reach of children.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER\nSPECIAL WARNING(S), IF NECESSARY</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY\nDATE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>EXP</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey'>For bottles:</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'> After first opening use\nwithin 180 days</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;page-break-after:\navoid;border:none;padding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>10.\u00a0\u00a0\u00a0\u00a0 SPECIAL\nPRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS\nDERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>11.\u00a0\u00a0\u00a0\u00a0 NAME\nAND ADDRESS OF THE MARKETING AUTHORISATION HOLDER</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"DE-AT\" style='font-family:\n\"Times New Roman\",serif'>Mylan S.A.S.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"DE-AT\" style='font-family:\n\"Times New Roman\",serif'>117 Allee des Parcs</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>69 800 Saint Priest</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>France</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>12.\u00a0\u00a0\u00a0\u00a0 MARKETING\nAUTHORISATION NUMBER(S) </span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>EU/1/17/1194/001</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey'>EU/1/17/1194/002</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey'>EU/1/17/1194/003</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey'>EU/1/17/1194/004</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey'>EU/1/17/1194/005</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey'>EU/1/17/1194/006</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey'>EU/1/17/1194/007</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey'>EU/1/17/1194/008</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;background:lightgrey'>EU/1/17/1194/017</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;background:lightgrey'>EU/1/17/1194/018</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;background:lightgrey'>EU/1/17/1194/019</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;background:lightgrey'>EU/1/17/1194/020</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;background:lightgrey'>EU/1/17/1194/021</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>13.\u00a0\u00a0\u00a0\u00a0 BATCH\nNUMBER</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><i><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></i></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Lot</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>14.\u00a0\u00a0\u00a0\u00a0 GENERAL\nCLASSIFICATION FOR SUPPLY</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><i><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></i></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:2.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS\nON USE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>16.\u00a0\u00a0\u00a0\u00a0 INFORMATION\nIN BRAILLE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Febuxostat Mylan 80\u00a0mg</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:#CCCCCC'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:#CCCCCC'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>17.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 2D BARCODE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC'>2D barcode carrying the\nunique identifier included.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>18.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 HUMAN READABLE DATA</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>PC:</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>SN:</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>NN:</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:#CCCCCC'>\u00a0</span></p>\n<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\ncolor:black;background:#CCCCCC'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>PARTICULARS\nTO APPEAR ON THE OUTER PACKAGING </span></b></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>OUTER\nCARTON OF MULTIPACK (WITH BLUE BOX)</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\nOF THE MEDICINAL PRODUCT</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Febuxostat Mylan 80\u00a0mg film-coated tablets</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>febuxostat</span><b><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'> </span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT\nOF ACTIVE SUBSTANCE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Each tablet contains 80\u00a0mg febuxostat.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST\nOF EXCIPIENTS</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Also contains lactose.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>See leaflet for further information.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\nFORM AND CONTENTS</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"DE\" style='font-family:\"Times New Roman\",serif;\nlayout-grid-mode:line'>Multipack: 84 (2 packs of 42) film-coated tablets</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD\nAND ROUTE(S) OF ADMINISTRATION</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>For oral use.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Read the package leaflet before use.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nWARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF\nCHILDREN</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Keep out of the sight and reach of children.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER\nSPECIAL WARNING(S), IF NECESSARY</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY\nDATE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>EXP</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;page-break-after:\navoid;border:none;padding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>10.\u00a0\u00a0\u00a0\u00a0 SPECIAL\nPRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS\nDERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>11.\u00a0\u00a0\u00a0\u00a0 NAME\nAND ADDRESS OF THE MARKETING AUTHORISATION HOLDER</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"DE-AT\" style='font-family:\n\"Times New Roman\",serif'>Mylan S.A.S.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"DE-AT\" style='font-family:\n\"Times New Roman\",serif'>117 Allee des Parcs</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>69 800 Saint Priest</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>France</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>12.\u00a0\u00a0\u00a0\u00a0 MARKETING\nAUTHORISATION NUMBER(S) </span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/022</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>13.\u00a0\u00a0\u00a0\u00a0 BATCH\nNUMBER</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><i><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></i></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Lot</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>14.\u00a0\u00a0\u00a0\u00a0 GENERAL\nCLASSIFICATION FOR SUPPLY</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><i><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></i></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:2.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS\nON USE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>16.\u00a0\u00a0\u00a0\u00a0 INFORMATION\nIN BRAILLE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Febuxostat Mylan 80\u00a0mg</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:#CCCCCC'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:#CCCCCC'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>17.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 2D BARCODE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC'>2D barcode carrying the\nunique identifier included.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>18.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 HUMAN READABLE DATA</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>PC:</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>SN:</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>NN:</span></p>\n<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\ncolor:black;background:#CCCCCC'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span>\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;background:#CCCCCC'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>PARTICULARS\nTO APPEAR ON THE OUTER PACKAGING </span></b></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>INNER\nCARTON OF MULTIPACK (WITHOUT BLUE BOX)</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\nOF THE MEDICINAL PRODUCT</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Febuxostat Mylan 80\u00a0mg film-coated tablets</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>febuxostat</span><b><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'> </span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT\nOF ACTIVE SUBSTANCE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Each tablet contains 80\u00a0mg febuxostat.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST\nOF EXCIPIENTS</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Also contains lactose.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>See leaflet for further information.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\nFORM AND CONTENTS</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>42 film-coated tablets</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Components of a multipack, can\u2019t be sold separately.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD\nAND ROUTE(S) OF ADMINISTRATION</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>For oral use.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Read the package leaflet before use.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nWARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF\nCHILDREN</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Keep out of the sight and reach of children.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER\nSPECIAL WARNING(S), IF NECESSARY</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY\nDATE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>EXP</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;page-break-after:\navoid;border:none;padding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>10.\u00a0\u00a0\u00a0\u00a0 SPECIAL\nPRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS\nDERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>11.\u00a0\u00a0\u00a0\u00a0 NAME\nAND ADDRESS OF THE MARKETING AUTHORISATION HOLDER</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"DE-AT\" style='font-family:\n\"Times New Roman\",serif'>Mylan S.A.S.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"DE-AT\" style='font-family:\n\"Times New Roman\",serif'>117 Allee des Parcs</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>69 800 Saint Priest</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>France</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>12.\u00a0\u00a0\u00a0\u00a0 MARKETING\nAUTHORISATION NUMBER(S) </span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/022</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>13.\u00a0\u00a0\u00a0\u00a0 BATCH\nNUMBER</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><i><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></i></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Lot</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>14.\u00a0\u00a0\u00a0\u00a0 GENERAL\nCLASSIFICATION FOR SUPPLY</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><i><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></i></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:2.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS\nON USE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>16.\u00a0\u00a0\u00a0\u00a0 INFORMATION\nIN BRAILLE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Febuxostat Mylan 80\u00a0mg</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:#CCCCCC'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:#CCCCCC'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>17.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 2D BARCODE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC'>2D barcode carrying the\nunique identifier included.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>18.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 HUMAN READABLE DATA</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>PC:</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>SN:</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>NN:</span></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;background:#CCCCCC'>\u00a0</span></p>\n<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\ncolor:black;background:#CCCCCC'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span>\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;background:#CCCCCC'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>PARTICULARS\nTO APPEAR ON THE IMMEDIATE PACKAGING </span></b></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>BOTTLE\nLABEL</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\nOF THE MEDICINAL PRODUCT</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Febuxostat Mylan 80\u00a0mg film-coated tablets </span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>febuxostat</span><b><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'> </span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT\nOF ACTIVE SUBSTANCE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Each tablet contains 80\u00a0mg febuxostat.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST\nOF EXCIPIENTS</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Also contains lactose.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>See the package leaflet for further information.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\nFORM AND CONTENTS</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC'>Film-coated tablets</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>28 film-coated tablets </span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC'>84 film-coated tablets </span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD\nAND ROUTE OF ADMINISTRATION</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>For oral use.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Read the package leaflet before use.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nWARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF\nCHILDREN</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Keep out of the sight and reach of children.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER\nSPECIAL WARNING(S), IF NECESSARY</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY\nDATE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>EXP</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>After first opening use within 180 days</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;page-break-after:\navoid;border:none;padding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>10.\u00a0\u00a0\u00a0\u00a0 SPECIAL\nPRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS\nDERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>11.\u00a0\u00a0\u00a0\u00a0 NAME\nAND ADDRESS OF THE MARKETING AUTHORISATION HOLDER</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"DE-AT\" style='font-family:\n\"Times New Roman\",serif'>Mylan S.A.S.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"DE-AT\" style='font-family:\n\"Times New Roman\",serif'>117 Allee des Parcs</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>69 800 Saint Priest</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>France</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>12.\u00a0\u00a0\u00a0\u00a0 MARKETING\nAUTHORISATION NUMBER(S) </span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>EU/1/17/1194/007</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey'>EU/1/17/1194/008</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>13.\u00a0\u00a0\u00a0\u00a0 BATCH\nNUMBER</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><i><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></i></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Lot</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>14.\u00a0\u00a0\u00a0\u00a0 GENERAL\nCLASSIFICATION FOR SUPPLY</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><i><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></i></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:2.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS\nON USE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>16.\u00a0\u00a0\u00a0\u00a0 INFORMATION\nIN BRAILLE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:#CCCCCC'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:#CCCCCC'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>17.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 2D BARCODE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:#CCCCCC'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>18.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 HUMAN READABLE DATA</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\ncolor:black;background:#CCCCCC'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></b></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>MINIMUM\nPARTICULARS TO APPEAR ON BLISTERS OR STRIPS</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>BLISTERS</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\nOF THE MEDICINAL PRODUCT</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><i><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></i></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Febuxostat Mylan 80\u00a0mg film-coated tablets </span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>febuxostat</span><b><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'> </span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\nOF THE MARKETING AUTHORISATION HOLDER</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Mylan S.A.S.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 2.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY\nDATE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>EXP</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 BATCH\nNUMBER</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Lot</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><i><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey'>[For calendar blisters only]:</span></i></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>MON</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>TUE</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>WED</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>THU</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>FRI</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>SAT</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>SUN</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<b><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\ncolor:black'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span></b>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;background:white\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>PARTICULARS\nTO APPEAR ON THE OUTER PACKAGING </span></b></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>OUTER\nCARTON (BLISTERS AND BOTTLES)</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\nOF THE MEDICINAL PRODUCT</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Febuxostat Mylan 120\u00a0mg film-coated tablets </span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>febuxostat</span><b><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'> </span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT\nOF ACTIVE SUBSTANCE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Each tablet contains 120\u00a0mg febuxostat.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST\nOF EXCIPIENTS</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Also contains lactose.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>See leaflet for further information.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\nFORM AND CONTENTS</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"DE\" style='font-family:\"Times New Roman\",serif;\nbackground:lightgrey;layout-grid-mode:line'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC'>Film-coated tablets</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><i><span lang=\"DE\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey;layout-grid-mode:line'>\u00a0</span></i></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><i><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC'>[Blisters]</span></i></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>14 film-coated tablets</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC'>28 film-coated tablets</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC'>42 film-coated tablets</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC'>84 film-coated tablets</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC'>28 x 1 film-coated\ntablets</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC'>28 film-coated tablets\n(calendar)</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC'>84 film-coated tablets\n(calendar)</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"DE\" style='font-family:\"Times New Roman\",serif;\nbackground:lightgrey;layout-grid-mode:line'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><i><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC'>[Bottles]</span></i></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC'>28 film-coated tablets </span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC'>84 film-coated tablets </span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD\nAND ROUTE(S) OF ADMINISTRATION</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>For oral use.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Read the package leaflet before use.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nWARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF\nCHILDREN</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Keep out of the sight and reach of children.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER\nSPECIAL WARNING(S), IF NECESSARY</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY\nDATE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>EXP</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey'>For bottles:</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'> After first opening use\nwithin 180 days</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;page-break-after:\navoid;border:none;padding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>10.\u00a0\u00a0\u00a0\u00a0 SPECIAL\nPRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS\nDERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>11.\u00a0\u00a0\u00a0\u00a0 NAME\nAND ADDRESS OF THE MARKETING AUTHORISATION HOLDER</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"DE-AT\" style='font-family:\n\"Times New Roman\",serif'>Mylan S.A.S.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"DE-AT\" style='font-family:\n\"Times New Roman\",serif'>117 Allee des Parcs</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>69 800 Saint Priest</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>France</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>12.\u00a0\u00a0\u00a0\u00a0 MARKETING\nAUTHORISATION NUMBER(S) </span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>EU/1/17/1194/009</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey'>EU/1/17/1194/010</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey'>EU/1/17/1194/011</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey'>EU/1/17/1194/012</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey'>EU/1/17/1194/013</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey'>EU/1/17/1194/014</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey'>EU/1/17/1194/015</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey'>EU/1/17/1194/016</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;background:lightgrey'>EU/1/17/1194/023</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;background:lightgrey'>EU/1/17/1194/024</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;background:lightgrey'>EU/1/17/1194/025</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;background:lightgrey'>EU/1/17/1194/026</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;background:lightgrey'>EU/1/17/1194/027</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>13.\u00a0\u00a0\u00a0\u00a0 BATCH\nNUMBER</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><i><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></i></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Lot</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>14.\u00a0\u00a0\u00a0\u00a0 GENERAL\nCLASSIFICATION FOR SUPPLY</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><i><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></i></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:2.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS\nON USE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>16.\u00a0\u00a0\u00a0\u00a0 INFORMATION\nIN BRAILLE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Febuxostat Mylan 120\u00a0mg</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:#CCCCCC'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:#CCCCCC'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>17.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 2D BARCODE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC'>2D barcode carrying the\nunique identifier included.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:#CCCCCC'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>18.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 HUMAN READABLE DATA</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>PC:</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>SN:</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>NN:</span></p>\n<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\ncolor:black;background:lightgrey'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;background:white\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;background:#CCCCCC'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>PARTICULARS\nTO APPEAR ON THE OUTER PACKAGING</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>OUTER\nCARTON OF MULTIPACK (WITH BLUE BOX)</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\nOF THE MEDICINAL PRODUCT</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Febuxostat Mylan 120\u00a0mg film-coated tablets</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>febuxostat</span><b><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'> </span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT\nOF ACTIVE SUBSTANCE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Each tablet contains 120\u00a0mg febuxostat.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST\nOF EXCIPIENTS</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Also contains lactose.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>See leaflet for further information.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\nFORM AND CONTENTS</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"DE\" style='font-family:\"Times New Roman\",serif;\nlayout-grid-mode:line'>Multipack: 84 (2 packs of 42) film-coated tablets</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD\nAND ROUTE(S) OF ADMINISTRATION</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>For oral use.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Read the package leaflet before use.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nWARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF\nCHILDREN</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Keep out of the sight and reach of children.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER\nSPECIAL WARNING(S), IF NECESSARY</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY\nDATE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>EXP</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;page-break-after:\navoid;border:none;padding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>10.\u00a0\u00a0\u00a0\u00a0 SPECIAL\nPRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS\nDERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>11.\u00a0\u00a0\u00a0\u00a0 NAME\nAND ADDRESS OF THE MARKETING AUTHORISATION HOLDER</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"DE-AT\" style='font-family:\n\"Times New Roman\",serif'>Mylan S.A.S.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"DE-AT\" style='font-family:\n\"Times New Roman\",serif'>117 Allee des Parcs</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>69 800 Saint Priest</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>France</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>12.\u00a0\u00a0\u00a0\u00a0 MARKETING\nAUTHORISATION NUMBER(S) </span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/028</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>13.\u00a0\u00a0\u00a0\u00a0 BATCH\nNUMBER</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><i><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></i></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Lot</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>14.\u00a0\u00a0\u00a0\u00a0 GENERAL\nCLASSIFICATION FOR SUPPLY</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><i><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></i></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:2.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS\nON USE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>16.\u00a0\u00a0\u00a0\u00a0 INFORMATION\nIN BRAILLE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Febuxostat Mylan 120\u00a0mg</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:#CCCCCC'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:#CCCCCC'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>17.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 2D BARCODE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC'>2D barcode carrying the\nunique identifier included.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>18.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 HUMAN READABLE DATA</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>PC:</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>SN:</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>NN:</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;background:white\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span>\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>PARTICULARS\nTO APPEAR ON THE OUTER PACKAGING </span></b></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>INNER\nCARTON OF MULTIPACK (WITHOUT BLUE BOX)</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\nOF THE MEDICINAL PRODUCT</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Febuxostat Mylan 120\u00a0mg film-coated tablets</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>febuxostat</span><b><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'> </span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT\nOF ACTIVE SUBSTANCE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Each tablet contains 120\u00a0mg febuxostat.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST\nOF EXCIPIENTS</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Also contains lactose.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>See leaflet for further information.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\nFORM AND CONTENTS</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>42 film-coated tablets</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Components of a multipack, can\u2019t be sold separately.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD\nAND ROUTE(S) OF ADMINISTRATION</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>For oral use.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Read the package leaflet before use.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nWARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF\nCHILDREN</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Keep out of the sight and reach of children.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER\nSPECIAL WARNING(S), IF NECESSARY</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY\nDATE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>EXP</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;page-break-after:\navoid;border:none;padding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>10.\u00a0\u00a0\u00a0\u00a0 SPECIAL\nPRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS\nDERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>11.\u00a0\u00a0\u00a0\u00a0 NAME\nAND ADDRESS OF THE MARKETING AUTHORISATION HOLDER</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"DE-AT\" style='font-family:\n\"Times New Roman\",serif'>Mylan S.A.S.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"DE-AT\" style='font-family:\n\"Times New Roman\",serif'>117 Allee des Parcs</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>69 800 Saint Priest</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>France</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>12.\u00a0\u00a0\u00a0\u00a0 MARKETING\nAUTHORISATION NUMBER(S) </span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/028</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>13.\u00a0\u00a0\u00a0\u00a0 BATCH\nNUMBER</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><i><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></i></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Lot</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>14.\u00a0\u00a0\u00a0\u00a0 GENERAL\nCLASSIFICATION FOR SUPPLY</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><i><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></i></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:2.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS\nON USE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>16.\u00a0\u00a0\u00a0\u00a0 INFORMATION\nIN BRAILLE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Febuxostat Mylan 120\u00a0mg</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:#CCCCCC'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:#CCCCCC'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>17.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 2D BARCODE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC'>2D barcode carrying the\nunique identifier included.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>18.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 HUMAN READABLE DATA</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>PC:</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>SN:</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>NN:</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;background:white\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span>\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;background:white\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;background:white\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>PARTICULARS\nTO APPEAR ON THE IMMEDIATE PACKAGING </span></b></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>BOTTLE\nLABEL</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\nOF THE MEDICINAL PRODUCT</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Febuxostat Mylan 120\u00a0mg film-coated tablets </span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>febuxostat</span><b><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'> </span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT\nOF ACTIVE SUBSTANCE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Each tablet contains 120\u00a0mg febuxostat.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST\nOF EXCIPIENTS</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Also contains lactose.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>See the package leaflet for further information.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\nFORM AND CONTENTS</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC'>Film-coated tablets</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>28 film-coated tablets </span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC'>84 film-coated tablets</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD\nAND ROUTE(S) OF ADMINISTRATION</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>For oral use.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Read the package leaflet before use.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nWARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF\nCHILDREN</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Keep out of the sight and reach of children.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER\nSPECIAL WARNING(S), IF NECESSARY</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY\nDATE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>EXP</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>After first opening use within 180 days</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;page-break-after:\navoid;border:none;padding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>10.\u00a0\u00a0\u00a0\u00a0 SPECIAL\nPRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS\nDERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>11.\u00a0\u00a0\u00a0\u00a0 NAME\nAND ADDRESS OF THE MARKETING AUTHORISATION HOLDER</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"DE-AT\" style='font-family:\n\"Times New Roman\",serif'>Mylan S.A.S.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"DE-AT\" style='font-family:\n\"Times New Roman\",serif'>117 Allee des Parcs</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>69 800 Saint Priest</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>France</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>12.\u00a0\u00a0\u00a0\u00a0 MARKETING\nAUTHORISATION NUMBER(S) </span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>EU/1/17/1194/015</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey'>EU/1/17/1194/016</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>13.\u00a0\u00a0\u00a0\u00a0 BATCH\nNUMBER</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><i><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></i></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Lot</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>14.\u00a0\u00a0\u00a0\u00a0 GENERAL\nCLASSIFICATION FOR SUPPLY</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:2.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS\nON USE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>16.\u00a0\u00a0\u00a0\u00a0 INFORMATION\nIN BRAILLE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:#CCCCCC'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>17.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 2D BARCODE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:#CCCCCC'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>18.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 HUMAN READABLE DATA</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:#CCCCCC'>\u00a0</span></p>\n<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\ncolor:black;background:#CCCCCC'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></b></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>MINIMUM\nPARTICULARS TO APPEAR ON BLISTERS OR STRIPS</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>BLISTERS</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\nOF THE MEDICINAL PRODUCT</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><i><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></i></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Febuxostat Mylan 120\u00a0mg film-coated tablets </span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>febuxostat</span><b><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'> </span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\nOF THE MARKETING AUTHORISATION HOLDER</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Mylan S.A.S.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 2.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY\nDATE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>EXP</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 BATCH\nNUMBER</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Lot</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey'>[<i>For calendar blisters only]:</i></span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>MON</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>TUE</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>WED<br/>\nTHU</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>FRI</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>SAT</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>SUN</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<b><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span></b>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<h1 align=\"center\" style=\"margin-right:2.75pt;text-align:center\"><span lang=\"EN-GB\">B. PACKAGE LEAFLET</span></h1>\n<b><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span></b>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Package leaflet:\nInformation for the patient</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat\nMylan 80\u00a0mg film-coated tablets </span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat\nMylan 120\u00a0mg film-coated tablets </span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>febuxostat</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Read all of this leaflet\ncarefully before you start taking this medicine because it contains important\ninformation for you.</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Keep\nthis leaflet. You may need to read it again.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If\nyou have any further questions, ask your doctor or pharmacist.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>This\nmedicine has been prescribed for you only. Do not pass it on to others. It may\nharm them, even if their signs of illness are the same as yours.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If\nyou get any side effects talk to your doctor or pharmacist. This includes any\npossible side effects not listed in this leaflet. See section 4.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>What is in this leaflet</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1.<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>What\nFebuxostat Mylan is and what it is used for</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>2.<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>What\nyou need to know before you take Febuxostat Mylan</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>3.<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>How\nto take Febuxostat Mylan</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>4.<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Possible\nside effects</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>5.<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>How\nto store Febuxostat Mylan</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>6.<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Contents\nof the pack and other information</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 What Febuxostat\nMylan is and what it is used for</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat Mylan tablets contain\nthe active substance febuxostat and are used to treat gout, which is associated\nwith an excess of a chemical called uric acid (urate) in the body. In some\npeople, the amount of uric acid builds up in the blood and may become too high\nto remain soluble. When this happens, urate crystals may form in and around the\njoints and kidneys. These crystals can cause sudden, severe pain, redness,\nwarmth and swelling in a joint (known as a gout attack). Left untreated, larger\ndeposits called tophi may form in and around joints. These tophi may cause\njoint and bone damage.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat Mylan works by reducing\nuric acid levels. Keeping uric acid levels low by taking Febuxostat Mylan once\nevery day stops crystals building up, and over time it reduces symptoms.\nKeeping uric acid levels sufficiently low for a long enough period can also\nshrink tophi.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat Mylan 120\u00a0mg tablets\nare also used to treat and prevent high blood levels of uric acid that may\noccur when you start to receive chemotherapy for blood cancers.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>When chemotherapy is given, cancer\ncells are destroyed, and uric acid levels increase in the blood accordingly,\nunless the formation of uric acid is prevented.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat Mylan is for adults.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 What you need\nto know before you take Febuxostat Mylan </span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Do not take Febuxostat\nMylan</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If\nyou are allergic to febuxostat or any of the other ingredients of this medicine\n(listed in section 6).</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Warnings and precautions</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Talk to your doctor before taking Febuxostat\nMylan:</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If\nyou have or have had heart failure or heart problems</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If\nyou have or have had renal disease and/or serious allergic reaction to allopurinol\n(a medication used for the treatment of Gout)</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If\nyou have or have had liver disease or liver function test abnormalities</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If\nyou are being treated for high uric acid levels as a result of Lesch-Nyhan\nsyndrome (a rare inherited condition in which there is too much uric acid in\nthe blood)</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If\nyou have thyroid problems.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Should you experience allergic\nreactions to Febuxostat Mylan, stop taking this medicine (see also section 4).\nPossible symptoms of allergic reactions might be:</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>rash\nincluding severe forms (e.g. blisters, nodules, itchy, exfoliative rash), itchiness</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>swelling\nof limbs or face</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>difficulties\nin breathing</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>fever\nwith enlarged lymph nodes</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>but\nalso serious life threatening allergic conditions with cardiac and circulatory\narrest. Your doctor might decide to permanently stop treatment with Febuxostat Mylan.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>There have been rare reports of\npotentially life-threatening skin rashes (Stevens-Johnson Syndrome) with the\nuse of febuxostat, appearing initially as reddish target-like spots or circular\npatches often with central blister on the trunk. It may also include ulcers in\nthe mouth, throat, nose, genitals and conjunctivitis (red and swollen eyes).\nThe rash may progress to widespread blistering or peeling of the skin.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If you have developed\nStevens-Johnson Syndrome with the use of febuxostat, you must not be re-started\non Febuxostat Mylan at any time. If you develop a rash or these skin symptoms,\nseek immediate advice from a doctor and tell them that you are taking this\nmedicine.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If you are having a gout attack at\nthe moment (a sudden onset of severe pain, tenderness, redness, warmth and\nswelling in a joint), wait for the gout attack to subside first before starting\ntreatment with Febuxostat Mylan.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>For some people, gout attacks may\nflare up when starting certain medicines that control uric acid levels. Not\neveryone gets flares, but you could get a flare-up even if you are taking Febuxostat\nMylan, and especially during the first weeks or months of treatment. It is\nimportant to keep taking Febuxostat Mylan even if you have a flare, as Febuxostat\nMylan is still working to lower uric acid. Over time, gout flares will occur\nless often and be less painful if you keep taking Febuxostat Mylan every day.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Your doctor will often prescribe\nother medicines, if they are needed, to help prevent or treat the symptoms of flares\n(such as pain and swelling in a joint).</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>In patients with very high urate\nlevels (e.g. those undergoing cancer chemotherapy), treatment with uric\nacid-lowering medicines could lead to the build-up of xanthine in the urinary\ntract, with possible stones, even though this has not been observed in patients\nbeing treated with febuxostat for Tumor Lysis Syndrome.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Your doctor may ask you to have\nblood tests to check that your liver is working normally.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Children and adolescents</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Do not give this medicine to\nchildren under the age of 18 because the safety and efficacy have not been\nestablished.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Other medicines and Febuxostat\nMylan</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Tell your doctor or pharmacist if\nyou are taking, have recently taken or might take any other medicines,\nincluding medicines obtained without a prescription.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>It is especially important to tell\nyour doctor or pharmacist if you are taking medicines containing any of the\nfollowing substances as they may interact with Febuxostat Mylan and your doctor\nmay wish to consider necessary measures:</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Mercaptopurine\n(used to treat cancer)</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Azathioprine\n(used to reduce immune response)</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Theophylline\n(used to treat asthma)</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Pregnancy and\nbreast-feeding</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>It is not known if febuxostat may\nharm your unborn child. Febuxostat Mylan should not be used during pregnancy.\nIt is not known if febuxostat may pass into human breast milk. You should not\nuse Febuxostat Mylan if you are breast-feeding, or if you are planning to\nbreast-feed.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If you are pregnant or\nbreast-feeding, think you may be pregnant or are planning to have a baby, ask\nyour doctor or pharmacist for advice before taking this medicine.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Driving and using\nmachines</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Be aware that you may experience\ndizziness, sleepiness, blurred vision and numbness or tingling sensation during\ntreatment and should not drive or operate machines if affected.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat Mylan\ncontains lactose</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat Mylan tablets contain\nlactose (a type of sugar). If you have been told that you have an intolerance\nto some sugars contact your doctor before taking this medicine.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<h1 style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 How to take Febuxostat\nMylan</span></h1>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Always take this medicine exactly\nas your doctor has told you. Check with your doctor or pharmacist if you are\nnot sure.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The\nusual dose is one tablet daily. The back of the calendar blister pack is marked\nwith the days of the week to help you check that you have taken a dose each\nday.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The\ntablets should be taken by mouth and can be taken with or without food.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Gout</span></i></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat Mylan is available as\neither an 80</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>mg tablet or a 120\u00a0mg\ntablet. Your doctor will have prescribed the strength most suitable for you.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Continue to take Febuxostat Mylan\nevery day even when you are not experiencing gout flare or attack.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Prevention and treatment\nof high uric acid levels in patients undergoing cancer chemotherapy</span></i></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat Mylan is available as a\n120\u00a0mg tablet.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Start taking Febuxostat Mylan two\ndays before chemotherapy and continue its use according to your doctor\u2019s\nadvice. Usually treatment is short-term.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.85pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If you\ntake more Febuxostat Mylan than you should</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.85pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.85pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>In the event\nof an accidental overdose ask your doctor what to do, or contact your nearest\naccident and emergency department.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If you forget to take Febuxostat\nMylan</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;text-align:justify;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If you miss a dose of Febuxostat\nMylan take it as soon as you remember unless it is almost time for your next\ndose, in which case miss out the forgotten dose and take your next dose at the\nnormal time. Do not take a double dose to make up for a forgotten dose.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If you stop taking Febuxostat\nMylan</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Do not stop taking Febuxostat Mylan\nwithout the advice of your doctor even if you feel better. If you stop taking Febuxostat\nMylan your uric acid levels may begin to rise and your symptoms may worsen due\nto the formation of new crystals of urate in and around your joints and\nkidneys.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If you have any further questions\non the use of this medicine, ask your doctor or pharmacist.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Possible side\neffects</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Like all medicines, this medicine\ncan cause side effects, although not everybody gets them.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Stop taking this medicine and\ncontact your doctor immediately or go to an emergency department nearby if the\nfollowing rare (may affect up to 1 in 1,000 people) side effects occur, because\na serious allergic reaction might follow:</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>anaphylactic\nreactions, drug hypersensitivity (see also section 2 \u201cWarnings and\nprecautions\u201d)</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>potentially\nlife-threatening skin rashes characterised by formation of blisters and\nshedding of the skin and inner surfaces of body cavities, e.g. mouth and\ngenitals, painful ulcers in the mouth and/or genital areas, accompanied by\nfever, sore throat and fatigue (Stevens- Johnson Syndrome/ Toxic Epidermal\nNecrolysis), or by enlarged lymph nodes, liver enlargement, hepatitis (up to\nliver failure), raising of the white-cells count in the blood (drug reaction\nwith eosinophilia and systemic symptoms-DRESS) (see section 2)</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>generalised\nskin rashes</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Other side effects which are not\nmentioned above are listed below.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common side effects </span></b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(may affect up to 1 in\n10 people) are:</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>abnormal\nliver test results</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>diarrhoea</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>headache</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>rash\n(including various types of rash, please see below under \u201cuncommon\u201d and \u201crare\u201d\nsections)</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>nausea</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>increase\nin gout symptoms</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>localised\nswelling due to retention of fluids in tissues (oedema)</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon side effects </span></b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(may affect up to 1 in\n100 people) are:</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>decreased\nappetite, change in blood sugar levels (diabetes) of which a symptom may be excessive\nthirst, increased blood fat levels, weight increase</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>loss\nof sex drive</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>difficulty\nin sleeping, sleepiness</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>dizziness,\nnumbness, tingling, reduced or altered sensation (hypoesthesia, hemiparesis or paraesthesia),\naltered sense of taste, diminished sense of smell (hyposmia)</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>abnormal\nECG heart tracing, irregular or rapid heartbeats, feeling your heart beat\n(palpitation)</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>hot\nflushes or flushing (e.g. redness of the face or neck), increased blood\npressure, bleeding (haemorrhage, seen only in patients taking chemotherapy for\nblood disorders)</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>cough,\nshortness of breath, chest discomfort or pain, inflammation of nasal passage\nand/or throat (upper respiratory tract infection), bronchitis</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>dry\nmouth, abdominal pain/discomfort or wind, heartburn/indigestion, constipation,\nmore frequent passing of stools, vomiting, stomach discomfort</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>itching,\nhives, skin inflammation, skin discoloration, small red or purple spots on the\nskin, small, flat red spots on the skin, flat, red area on the skin that is\ncovered with small confluent bumps, rash, areas of redness and spots on the\nskin, other type of skin conditions</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>muscle\ncramp, muscle weakness, pain/ache in muscles/joints, bursitis or arthritis\n(inflammation of joints usually accompanied by pain, swelling and/or stiffness),\npain in extremity, back pain, muscle spasm</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>blood\nin the urine, abnormal frequent urination, abnormal urine tests (increased\nlevel of proteins in the urine), a reduction in the ability of the kidneys to\nfunction properly</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>fatigue,\nchest pain, chest discomfort</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>stones\nin the gallbladder or in bile ducts (cholelithiasis)</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>increase\nin blood thyroid stimulating hormone (TSH) level</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>changes\nin blood chemistry or amount of blood cells or platelets (abnormal blood test\nresults)</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>kidney\nstones</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>erectile\ndifficulties</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare side effects </span></b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(may affect up to 1 in\n1,000 people) are:</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>muscle\ndamage, a condition which on rare occasions can be serious. It may cause muscle\nproblems and particularly, if at the same time, you feel unwell or have a high\ntemperature it may be caused by an abnormal muscle breakdown. Contact your\ndoctor immediately if you experience muscle pain, tenderness or weakness</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>severe\nswelling of the deeper layers of the skin, especially around the lips, eyes,\ngenitals, hands, feet or tongue, with possible sudden difficult breathing</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>high\nfever in combination with measles-like skin rash, enlarged lymph nodes, liver\nenlargement, hepatitis (up to liver failure), raising of the white-cells count\nin the blood (leukocytosis, with or without eosinophilia)</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>reddening\nof the skin (erythema), rash in various types (e.g. itchy, with white spots,\nwith blisters, with blisters containing pus, with shedding of the skin,\nmeasles-like rash), widespread erythema, necrosis, and bullous detachment of\nthe epidermis and mucous membranes, resulting in exfoliation and possible\nsepsis (Stevens-Johnson Syndrome/Toxic epidermal necrolysis)</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>nervousness</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>feeling\nthirsty</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>ringing\nin the ears</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>blurred\nvision, change in vision</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>hair\nloss</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>mouth\nulceration</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>inflammation\nof the pancreas: common symptoms are abdominal pain, nausea and vomiting</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>increased\nsweating</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>weight\ndecrease, increased appetite, uncontrolled loss of appetite (anorexia)</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>muscle\nand/or joint stiffness</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>abnormally\nlow blood cell counts (white or red blood cells or platelets)</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>urgent\nneed to urinate</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>changes\nor decrease in urine amount due to inflammation in the kidneys\n(tubulointerstitial nephritis)</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>inflammation\nof the liver (hepatitis)</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>yellowing\nof the skin (jaundice)</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>liver\ndamage</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>increased\nlevel of creatine phosphokinase in blood (an indicator of muscle damage)</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Reporting of side\neffects</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If you get any side effects, talk\nto your doctor or pharmacist. This includes any possible side effects not\nlisted in this leaflet. You can also report side effects directly via the national\nreporting system listed in </span><span lang=\"EN-GB\"><a href=\"http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc\"><span style='font-family:\"Times New Roman\",serif;color:windowtext'>Appendix V</span></a></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>. By reporting side\neffects you can help provide more information on the safety of this medicine.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 How to store Febuxostat\nMylan</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Keep this medicine out of the sight\nand reach of children.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Do not use this medicine after the\nexpiry date which is stated on the packaging after \u2018EXP.\u2019 The expiry date\nrefers to the last day of that month.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>For bottles, after first opening\nuse within 180 days</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>This medicine does not require any\nspecial storage conditions.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Do not throw away any medicines via\nwastewater or household waste. Ask your pharmacist how to throw away medicines\nyou no longer use. These measures will help protect the environment.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Contents of\nthe pack and other information</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>What Febuxostat Mylan\ncontains</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The active substance is febuxostat.\nEach tablet contains 80\u00a0mg or 120\u00a0mg of febuxostat.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The other ingredients are:</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Tablet core</span></i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>: lactose (see section\n2, \u201cFebuxostat Mylan contains lactose\u201d), microcrystalline cellulose, magnesium\nstearate, hydroxypropylcellulose, croscarmellose sodium, colloidal hydrated silica,\ncolloidal anhydrous silica, crospovidone and talc.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Film-coating: </span></i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>hypromellose, titanium\ndioxide (E171), ethylcellulose, iron oxide yellow (E172), triacetin and iron oxide\nblack (E172).</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>What Febuxostat Mylan\nlooks like and contents of the pack</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat Mylan film-coated\ntablets are yellow, capsule shaped, biconvex tablets. The 80\u00a0mg tablets\nare marked with M on one side of the tablet and FX3 on the other side. The 120\u00a0mg\ntablets are marked with M on one side of the tablet and FX4 on the other side.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat Mylan 80\u00a0mg and 120\u00a0mg\nfilm-coated tablets are available in blister packs of 14, 28, 42 and 84\ntablets, calendar blister packs of 28 and 84 tablets, and perforated unit dose\nblister packs of 28 x 1 tablets and in multipacks of 84\u00a0film-coated\ntablets comprising 2 packs, each containing 42\u00a0film-coated tablets.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat Mylan 80 mg and 120\u00a0mg\nfilm-coated tablets are available in plastic bottles of 28 and 84 tablets. </span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Not all pack sizes may be marketed.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Marketing Authorisation\nHolder</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Mylan S.A.S.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>117 Allee des Parcs</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>69 800 Saint Priest</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>France</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Manufacturer</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Mylan Hungary Kft</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Mylan utca 1</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>H-2900 Kom\u00e1rom</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Hungary</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey'>McDermott Laboratories Limited\ntrading as Gerard Laboratories</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey'>35/36 Baldoyle Industrial Estate</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey'>Grange Road</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey'>Dublin 13</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey'>Ireland</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>For any information about this medicine, please\ncontact the local representative of the Marketing</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Authorisation Holder.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"margin-left:3.7pt;border-collapse:collapse\" width=\"624\">\n<tr>\n<td style=\"border:none;padding:0in 0in 0in 0in\" width=\"2\"><p class=\"MsoNormal\">\u00a0</p></td>\n<td style=\"width:232.2pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"310\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt;page-break-after:avoid\"><b><span lang=\"EN-GB\">Belgi\u00eb/Belgique/Belgien</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt;page-break-after:avoid\"><span lang=\"EN-GB\">Mylan bvba/sprl</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt;page-break-after:avoid\"><span lang=\"EN-GB\">T\u00e9l/Tel: + 32 (0)2 658 61 00</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt;page-break-after:avoid\"><b><span lang=\"EN-GB\">Lietuva</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt;page-break-after:avoid\"><span lang=\"EN-GB\">BGP Products UAB</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt;page-break-after:avoid\"><span lang=\"EN-GB\">Tel: +370 5 205 1288</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"height:71.25pt\">\n<td style=\"border:none;padding:0in 0in 0in 0in\" width=\"2\"><p class=\"MsoNormal\">\u00a0</p></td>\n<td style=\"width:232.2pt;padding:0in 5.4pt 0in 5.4pt;\n  height:71.25pt\" valign=\"top\" width=\"310\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">\u0411\u044a\u043b\u0433\u0430\u0440\u0438\u044f</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u041c\u0430\u0439\u043b\u0430\u043d\n  \u0415\u041e\u041e\u0414</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u0422\u0435\u043b:\n  +359 2 44 55 400</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt;\n  height:71.25pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Luxembourg/Luxemburg</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Mylan\n  bvba/sprl</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: + 32 (0)2\n  658 61 00</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">(Belgique/Belgien)</span></p>\n</td>\n</tr>\n<tr style=\"height:49.1pt\">\n<td style=\"border:none;padding:0in 0in 0in 0in\" width=\"2\"><p class=\"MsoNormal\">\u00a0</p></td>\n<td style=\"width:232.2pt;padding:0in 5.4pt 0in 5.4pt;\n  height:49.1pt\" valign=\"top\" width=\"310\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">\u010cesk\u00e1\n  republika</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Mylan\n  Pharmaceuticals.s.r.o.</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel:\n  +420\u00a0222 004 400</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt;\n  height:49.1pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Magyarorsz\u00e1g</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Mylan EPD\n  Kft</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: + 36 1\u00a0465\n  2100</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"border:none;padding:0in 0in 0in 0in\" width=\"2\"><p class=\"MsoNormal\">\u00a0</p></td>\n<td style=\"width:232.2pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"310\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Danmark</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Mylan AB</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tlf: + 46\n  855 522 750 </span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">(Sverige)</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Malta</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">V.J.\n  Salomone Pharma Ltd</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: + 356\n  21 22 01 74</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"border:none;padding:0in 0in 0in 0in\" width=\"2\"><p class=\"MsoNormal\">\u00a0</p></td>\n<td style=\"width:232.2pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"310\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Deutschland</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Mylan dura\n  GmbH </span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: +\n  49-(0) 6172 888 01</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Nederland</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Mylan BV</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: +31\n  (0)20 426 3300</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"border:none;padding:0in 0in 0in 0in\" width=\"2\"><p class=\"MsoNormal\">\u00a0</p></td>\n<td style=\"width:232.2pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"310\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Eesti</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">BGP\n  Products Switzerland GmbH Eesti filiaal</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: + 372\n  6363 052</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Norge</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Mylan AB</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: + 46\n  855 522 750</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">(Sverige)</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"border:none;padding:0in 0in 0in 0in\" width=\"2\"><p class=\"MsoNormal\">\u00a0</p></td>\n<td style=\"width:232.2pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"310\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">\u0395\u03bb\u03bb\u03ac\u03b4\u03b1\n  </span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Generics\n  Pharma Hellas \u0395\u03a0\u0395 </span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u03a4\u03b7\u03bb:\n  +30 210 993 6410 </span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">\u00d6sterreich</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Arcana\n  Arzneimittel GmbH</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: </span>+43\n  1 416 2418</p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>\n<tr>\n<td colspan=\"2\" style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Espa\u00f1a</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Mylan Pharmaceuticals,\n  S.L</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: </span><span lang=\"EN-GB\">+ 34 900 102 712</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Polska</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Mylan Healthcare\n  Sp. z.o.o.</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: + 48\n  22 546 64 00</span></p>\n</td>\n</tr>\n<tr>\n<td colspan=\"2\" style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">France</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Mylan S.A.S</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: +33 4\n  37 25 75 00</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Portugal</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Mylan, Lda.</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: + 351\n  21 412 72 56</span></p>\n</td>\n</tr>\n<tr>\n<td colspan=\"2\" style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Hrvatska</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Mylan\n  Hrvatska d.o.o.</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: +385 1\n  23 50 599</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Rom\u00e2nia</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">BGP\n  Products SRL</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: +40\n  372 579 000</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n  0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>\u00a0</span></p>\n</td>\n</tr>\n<tr>\n<td colspan=\"2\" style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Ireland</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Mylan\n  Ireland</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: +353\n  (0) 87 1694982</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Slovenija</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n  0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>GSP Proizvodi d.o.o.</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: + 386\n  1 236 31 85</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>\n</tr>\n<tr>\n<td colspan=\"2\" style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">\u00cdsland</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Mylan AB</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: + 46\n  855 522 750</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">(Sv\u00ed\u00fej\u00f3\u00f0)</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Slovensk\u00e1\n  republika</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Mylan\n  s.r.o.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n  0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>Tel: </span><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>+421\u00a02 32 199 100</span></p>\n</td>\n</tr>\n<tr>\n<td colspan=\"2\" style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Italia</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Mylan S.p.A</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: + 39\n  02 612 46921</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n  0in;margin-left:0in;line-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>\u00a0</span></b></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Suomi/Finland</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><strong><span lang=\"EN-GB\" style=\"color:black;border:none windowtext 1.0pt;padding:0in;background:white;\n  font-weight:normal\">Mylan OY</span></strong></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\">Puh/Tel: +358 20 720 9555</p>\n</td>\n</tr>\n<tr>\n<td colspan=\"2\" style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">\u039a\u03cd\u03c0\u03c1\u03bf\u03c2</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Pharmaceutical\n  Trading Co. Ltd.</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u03a4\u03b7\u03bb:\n  + 357 99403969</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Sverige</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Mylan AB </span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: + 46\n  855 522 750</span></p>\n</td>\n</tr>\n<tr>\n<td colspan=\"2\" style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Latvija</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">BGP\n  Products SIA</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: +371\n  676 055 80</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">United\n  Kingdom</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Generics\n  [UK] Ltd</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n  0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>Tel: +44 1707 853000</span></p>\n</td>\n</tr>\n<tr height=\"0\">\n<td style=\"border:none\" width=\"2\"></td>\n<td style=\"border:none\" width=\"310\"></td>\n<td style=\"border:none\" width=\"312\"></td>\n</tr>\n</table>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>This leaflet was last\nrevised in</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Other sources of\ninformation</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Detailed information on this\nmedicine is available on the European Medicines Agency website</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"><a href=\"http://www.ema.europa.eu.\"><span style='font-family:\"Times New Roman\",serif'>http://www.ema.europa.eu.</span></a></span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n</div>", "ID": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964", "Styles": "None", "Classes": "['WordSection2']", "Text": "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              ", "ParentId": "1c150f00-072d-4e15-8c9d-ca2e967e268d"}, {"Element": "<h1 style=\"margin-right:3.1pt\"><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL\nPRODUCT</span></h1>", "ID": "93b390b0-6b49-4dee-9634-d84b90d64445", "Styles": "margin-right:3.1pt", "Classes": "None", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL\nPRODUCT</span>", "ID": "6dddb9b7-4a9a-4fc3-9651-ca5a0c22a723", "Styles": "None", "Classes": "None", "Text": "1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT", "ParentId": "93b390b0-6b49-4dee-9634-d84b90d64445"}, {"Element": "<h1 style=\"margin-right:3.1pt\"><span lang=\"EN-GB\">\u00a0</span></h1>", "ID": "72d7c750-44fb-42d1-a088-6dfdcf2a09f6", "Styles": "margin-right:3.1pt", "Classes": "None", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "06f68245-c1cb-449a-9e4f-4acf947bdddf", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "72d7c750-44fb-42d1-a088-6dfdcf2a09f6"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat Mylan 80\u00a0mg\nfilm-coated tablets</span></p>", "ID": "2c16a998-ce6f-46e5-ac9e-c6c12731dc4a", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat Mylan 80\u00a0mg\nfilm-coated tablets</span>", "ID": "3b04042e-2273-404d-a898-c702e7d98ca6", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Febuxostat Mylan 80\u00a0mg film-coated tablets", "ParentId": "2c16a998-ce6f-46e5-ac9e-c6c12731dc4a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "77c5058b-1b52-48f7-a063-6c27ae5e3cad", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "7bd51b96-02ad-424e-9e50-72eb127edbc7", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "77c5058b-1b52-48f7-a063-6c27ae5e3cad"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "25e4fb49-6c21-4698-8baa-c485f2de1e2c", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "2b7396b3-030b-430d-940e-5aba935c3bc7", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "25e4fb49-6c21-4698-8baa-c485f2de1e2c"}, {"Element": "<h1 style=\"margin-right:3.1pt\"><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 QUALITATIVE AND QUANTITATIVE\nCOMPOSITION</span></h1>", "ID": "82ff60a6-4a98-4cf4-9595-a209907951bf", "Styles": "margin-right:3.1pt", "Classes": "None", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 QUALITATIVE AND QUANTITATIVE\nCOMPOSITION</span>", "ID": "5323a695-2f1f-4649-842d-813323859a33", "Styles": "None", "Classes": "None", "Text": "2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 QUALITATIVE AND QUANTITATIVE COMPOSITION", "ParentId": "82ff60a6-4a98-4cf4-9595-a209907951bf"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "df5e419a-deed-4a24-a6cb-3cd4db6d34e4", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "3b209c90-a3ff-4119-98b2-4341778a36ed", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "df5e419a-deed-4a24-a6cb-3cd4db6d34e4"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Each tablet contains 80\u00a0mg of\nfebuxostat. </span></p>", "ID": "ebb62c3d-f4fb-48e3-a46b-56986befdb74", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Each tablet contains 80\u00a0mg of\nfebuxostat. </span>", "ID": "9ec90364-a721-40c6-8f5b-b03e39076997", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Each tablet contains 80\u00a0mg of febuxostat. ", "ParentId": "ebb62c3d-f4fb-48e3-a46b-56986befdb74"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "09ae41dd-9339-4c5c-98aa-21761ac10851", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "1afb3f1e-48c1-4fee-8359-fc60d70b5ade", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "09ae41dd-9339-4c5c-98aa-21761ac10851"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Excipient with known effect</span></u></p>", "ID": "6614303e-777b-4376-8d8d-c4b98acca248", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Excipient with known effect</span></u>", "ID": "8a43fed4-abf9-43e7-9037-26157ac12880", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6614303e-777b-4376-8d8d-c4b98acca248"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Excipient with known effect</span>", "ID": "b05d819b-d9a5-4cfc-af7c-0e71cb5822d3", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Excipient with known effect", "ParentId": "8a43fed4-abf9-43e7-9037-26157ac12880"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Each tablet contains 236.0\u00a0mg\nof lactose</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>.</span></p>", "ID": "1624f64a-5763-4bd9-bf01-b90c3847964c", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Each tablet contains 236.0\u00a0mg\nof lactose</span>", "ID": "9cfd444b-9296-47b3-afb6-9df3ffd50932", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Each tablet contains 236.0\u00a0mg of lactose", "ParentId": "1624f64a-5763-4bd9-bf01-b90c3847964c"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>.</span>", "ID": "d3817eb1-a5ca-47ce-ab43-83f9243654b5", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": ".", "ParentId": "1624f64a-5763-4bd9-bf01-b90c3847964c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "6c4447a5-1037-43f6-aebb-ed22c64c0f74", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "141d7c01-92dc-4eca-a8eb-2bf223f8d761", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "6c4447a5-1037-43f6-aebb-ed22c64c0f74"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>For the full list of excipients,\nsee section 6.1.</span></p>", "ID": "297956fd-dd2e-4b8c-b3a1-7b2c4783aed0", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>For the full list of excipients,\nsee section 6.1.</span>", "ID": "a44ed159-7742-43c2-b818-d4a899ad6a5d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "For the full list of excipients, see section 6.1.", "ParentId": "297956fd-dd2e-4b8c-b3a1-7b2c4783aed0"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "06937f32-7e8a-4ded-bbdf-955e0266838a", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "bf4213d0-d893-4c3d-b374-54e47bcb04b4", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "06937f32-7e8a-4ded-bbdf-955e0266838a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "5889ee97-3dba-47ce-b270-f8d8bb38c856", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "66fe294f-968c-4285-b30e-3ebb66175b32", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "5889ee97-3dba-47ce-b270-f8d8bb38c856"}, {"Element": "<h1 style=\"margin-right:3.1pt\"><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL FORM</span></h1>", "ID": "9a8b10db-b6b2-4a51-ac15-50f94263e347", "Styles": "margin-right:3.1pt", "Classes": "None", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL FORM</span>", "ID": "c03e2b3a-b76c-4b79-bf21-5f34938a134a", "Styles": "None", "Classes": "None", "Text": "3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL FORM", "ParentId": "9a8b10db-b6b2-4a51-ac15-50f94263e347"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "b960919a-a2a6-4026-bef0-9f748c004f1b", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "a23b08db-5a14-48c0-8dce-884d036a7242", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "b960919a-a2a6-4026-bef0-9f748c004f1b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Film-coated tablet.</span></p>", "ID": "3b43f098-af6a-46fa-998d-97050e258dc3", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Film-coated tablet.</span>", "ID": "aae320a0-5c10-48d7-a6f5-7c390d32b0ce", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Film-coated tablet.", "ParentId": "3b43f098-af6a-46fa-998d-97050e258dc3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "498ba405-0e63-49eb-a44c-f66922adb855", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "9cff9d7f-a67f-41f5-8b72-d6bcece421f9", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "498ba405-0e63-49eb-a44c-f66922adb855"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>A yellow, capsule shaped, biconvex\ntablet approximately 16 x 7\u00a0mm, debossed with M on one side of the tablet\nand FX3 on the other side.</span></p>", "ID": "51cc7262-6fdd-4c33-a6cd-46907df9af18", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>A yellow, capsule shaped, biconvex\ntablet approximately 16 x 7\u00a0mm, debossed with M on one side of the tablet\nand FX3 on the other side.</span>", "ID": "6c42ce50-bf0f-48e6-bf53-a5d8a62a449d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "A yellow, capsule shaped, biconvex tablet approximately 16 x 7\u00a0mm, debossed with M on one side of the tablet and FX3 on the other side.", "ParentId": "51cc7262-6fdd-4c33-a6cd-46907df9af18"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "c1648088-e649-4be5-a47d-83193cbcc0ea", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "6c6803e0-d85e-4cac-9592-d53930809236", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "c1648088-e649-4be5-a47d-83193cbcc0ea"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "6b8cd597-f178-4839-9907-adb2add27b9b", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "1fac8855-072b-4ab7-ad4f-d0610fb6a8bb", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "6b8cd597-f178-4839-9907-adb2add27b9b"}, {"Element": "<h1 style=\"margin-right:3.1pt\"><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 CLINICAL PARTICULARS</span></h1>", "ID": "3e9de38a-f463-4222-962a-5e03e8961881", "Styles": "margin-right:3.1pt", "Classes": "None", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 CLINICAL PARTICULARS</span>", "ID": "cfefe595-648a-4a3a-b305-d5af295a6e00", "Styles": "None", "Classes": "None", "Text": "4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 CLINICAL PARTICULARS", "ParentId": "3e9de38a-f463-4222-962a-5e03e8961881"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "2659e05b-adfb-4390-81f8-f28d8e1c0d7d", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "7ff22cd8-4c6c-4c9b-a234-91b82720e2c2", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "2659e05b-adfb-4390-81f8-f28d8e1c0d7d"}, {"Element": "<h1 style=\"margin-right:3.1pt\"><span lang=\"EN-GB\">4.1\u00a0\u00a0\u00a0\u00a0 Therapeutic indications</span></h1>", "ID": "23a38aef-1518-493e-b79e-1a0fcd6116a7", "Styles": "margin-right:3.1pt", "Classes": "None", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\">4.1\u00a0\u00a0\u00a0\u00a0 Therapeutic indications</span>", "ID": "d1d7eb61-0e01-4322-a78b-763826468e05", "Styles": "None", "Classes": "None", "Text": "4.1\u00a0\u00a0\u00a0\u00a0 Therapeutic indications", "ParentId": "23a38aef-1518-493e-b79e-1a0fcd6116a7"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "a751b6b9-f580-4bf1-9d71-d6e9593ee452", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "835f07ba-3736-4da8-b886-84a981450fc3", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "a751b6b9-f580-4bf1-9d71-d6e9593ee452"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Treatment of chronic hyperuricaemia\nin conditions where urate deposition has already occurred (including a history,\nor presence of, tophus and/or gouty arthritis). Febuxostat Mylan is indicated\nin adults.</span></p>", "ID": "6993bc92-4d56-4031-bf78-9da72c44f565", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Treatment of chronic hyperuricaemia\nin conditions where urate deposition has already occurred (including a history,\nor presence of, tophus and/or gouty arthritis). Febuxostat Mylan is indicated\nin adults.</span>", "ID": "aaf5ad69-0ecb-4f71-b292-1ff27c985258", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Treatment of chronic hyperuricaemia in conditions where urate deposition has already occurred (including a history, or presence of, tophus and/or gouty arthritis). Febuxostat Mylan is indicated in adults.", "ParentId": "6993bc92-4d56-4031-bf78-9da72c44f565"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "3a970f4c-887c-431f-9c16-9f8ee2a2c7b6", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "43fb9b27-03b6-4932-8917-2a216c0040b5", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "3a970f4c-887c-431f-9c16-9f8ee2a2c7b6"}, {"Element": "<h1 style=\"margin-right:3.1pt\"><span lang=\"EN-GB\">4.2\u00a0\u00a0\u00a0\u00a0 Posology and method of\nadministration</span></h1>", "ID": "bae97184-0943-4d67-8e87-0b687a34d7c2", "Styles": "margin-right:3.1pt", "Classes": "None", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\">4.2\u00a0\u00a0\u00a0\u00a0 Posology and method of\nadministration</span>", "ID": "be7cef81-fe04-4e55-a74e-2149b089e61c", "Styles": "None", "Classes": "None", "Text": "4.2\u00a0\u00a0\u00a0\u00a0 Posology and method of administration", "ParentId": "bae97184-0943-4d67-8e87-0b687a34d7c2"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "fbd8d2c2-2612-4296-bb1a-190d347ac3cd", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "4d530d5d-4bb6-4a27-be64-0b346e7f0176", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "fbd8d2c2-2612-4296-bb1a-190d347ac3cd"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Posology</span></u></p>", "ID": "24ea73c2-3167-4fe9-bf93-e30252214fdd", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Posology</span></u>", "ID": "cff0ac38-75a0-44ae-a62b-66004dfcf30b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "24ea73c2-3167-4fe9-bf93-e30252214fdd"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Posology</span>", "ID": "29e124ac-baf1-45ce-a2c9-98b4ee9da22f", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Posology", "ParentId": "cff0ac38-75a0-44ae-a62b-66004dfcf30b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "e2c889f4-47a8-405e-a4d8-385d47b5195e", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "10ce95a2-9892-4b5e-b27e-85d67e4fd778", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "e2c889f4-47a8-405e-a4d8-385d47b5195e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The recommended oral dose of Febuxostat\nMylan is 80\u00a0mg once daily without regard to food. If serum uric acid is\n&gt; 6\u00a0mg/dL (357\u00a0\u00b5mol/L) after 2-4\u00a0weeks, Febuxostat Mylan 120\u00a0mg\nonce daily may be considered.</span></p>", "ID": "fdb5ea20-76f7-471f-9bf2-96c5692c2d1a", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The recommended oral dose of Febuxostat\nMylan is 80\u00a0mg once daily without regard to food. If serum uric acid is\n&gt; 6\u00a0mg/dL (357\u00a0\u00b5mol/L) after 2-4\u00a0weeks, Febuxostat Mylan 120\u00a0mg\nonce daily may be considered.</span>", "ID": "b7250dab-441c-4d49-9b7f-0fcc2f1ef66a", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "The recommended oral dose of Febuxostat Mylan is 80\u00a0mg once daily without regard to food. If serum uric acid is > 6\u00a0mg/dL (357\u00a0\u00b5mol/L) after 2-4\u00a0weeks, Febuxostat Mylan 120\u00a0mg once daily may be considered.", "ParentId": "fdb5ea20-76f7-471f-9bf2-96c5692c2d1a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "152654bc-c118-47a9-8de4-74e63cd61fd4", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "3b3e1f1c-e9fa-4173-81ab-12dcf79ae9f3", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "152654bc-c118-47a9-8de4-74e63cd61fd4"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat Mylan works sufficiently\nquickly to allow retesting of the serum uric acid after 2 weeks. The\ntherapeutic target is to decrease and maintain serum uric acid below 6\u00a0mg/dL\n(357\u00a0\u03bcmol/L).</span></p>", "ID": "56022f77-85cd-4008-a11d-2a04b6e3a9e2", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat Mylan works sufficiently\nquickly to allow retesting of the serum uric acid after 2 weeks. The\ntherapeutic target is to decrease and maintain serum uric acid below 6\u00a0mg/dL\n(357\u00a0\u03bcmol/L).</span>", "ID": "1adb276b-4911-432c-92cf-ac6acd01a809", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Febuxostat Mylan works sufficiently quickly to allow retesting of the serum uric acid after 2 weeks. The therapeutic target is to decrease and maintain serum uric acid below 6\u00a0mg/dL (357\u00a0\u03bcmol/L).", "ParentId": "56022f77-85cd-4008-a11d-2a04b6e3a9e2"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "9eecb79b-50ad-4616-97c7-f25e9a494953", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "682bf03a-3c79-4510-8c72-bc847e33ad3c", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "9eecb79b-50ad-4616-97c7-f25e9a494953"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Gout flare prophylaxis of at least\n6 months is recommended (see section 4.4).</span></p>", "ID": "e9ea02f4-dcc0-4449-aa1e-bb4fa600905a", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Gout flare prophylaxis of at least\n6 months is recommended (see section 4.4).</span>", "ID": "770b5f74-1257-4207-afcc-36026dc8f1b2", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Gout flare prophylaxis of at least 6 months is recommended (see section 4.4).", "ParentId": "e9ea02f4-dcc0-4449-aa1e-bb4fa600905a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "01f3f845-6f7c-414c-b00a-2bdfd5065352", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "41fc28ba-921e-485e-ad86-5b42c56bb72f", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "01f3f845-6f7c-414c-b00a-2bdfd5065352"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Elderly</span></i></p>", "ID": "67839cdd-e6d4-4dd5-9aba-b8ac1eb103f9", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Elderly</span></i>", "ID": "63fed134-2e0c-484c-a0d2-ab3df7322f39", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "67839cdd-e6d4-4dd5-9aba-b8ac1eb103f9"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Elderly</span>", "ID": "caf983af-e985-4655-9f4e-a7f7171e93db", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Elderly", "ParentId": "63fed134-2e0c-484c-a0d2-ab3df7322f39"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>No dose adjustment is required in\nthe elderly (see section 5.2).</span></p>", "ID": "93daab4e-e6be-42c7-9af4-0640b07ebf2b", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>No dose adjustment is required in\nthe elderly (see section 5.2).</span>", "ID": "c556befd-7935-4c2a-93e3-e072a87ad754", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "No dose adjustment is required in the elderly (see section 5.2).", "ParentId": "93daab4e-e6be-42c7-9af4-0640b07ebf2b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "d11c9a04-485b-4914-b944-bf3344326d5a", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "9bd02234-7f4e-46ba-9039-57f208422e69", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "d11c9a04-485b-4914-b944-bf3344326d5a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Renal </span></i><i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>impairment</span></i></p>", "ID": "ccaee15d-f216-46f0-88c9-0cce197fd7d4", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Renal </span></i>", "ID": "d64485f9-729e-4a6f-882a-4fcc059f9ca3", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ccaee15d-f216-46f0-88c9-0cce197fd7d4"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Renal </span>", "ID": "55e8293d-7cc3-434d-a774-11890008f842", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Renal ", "ParentId": "d64485f9-729e-4a6f-882a-4fcc059f9ca3"}, {"Element": "<i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>impairment</span></i>", "ID": "c42ee655-fda4-4c5c-9d6a-7c13351a868c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ccaee15d-f216-46f0-88c9-0cce197fd7d4"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>impairment</span>", "ID": "917e736e-b5de-49aa-8f0d-c3340afc90d5", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "impairment", "ParentId": "c42ee655-fda4-4c5c-9d6a-7c13351a868c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The efficacy and safety have not\nbeen fully evaluated in patients with severe renal impairment (creatinine\nclearance &lt;30 mL/min, see section 5.2).</span></p>", "ID": "6d0d63bf-f0d2-48dc-a533-4305fe6a0ed4", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The efficacy and safety have not\nbeen fully evaluated in patients with severe renal impairment (creatinine\nclearance &lt;30 mL/min, see section 5.2).</span>", "ID": "0bfee365-bc0b-418e-af55-5d33ffca1ee7", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "The efficacy and safety have not been fully evaluated in patients with severe renal impairment (creatinine clearance <30 mL/min, see section 5.2).", "ParentId": "6d0d63bf-f0d2-48dc-a533-4305fe6a0ed4"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "02f981cb-e2e4-4319-96a2-616b498ad70c", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "feab3781-0570-4da1-97d3-a5b9e2a34ecc", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "02f981cb-e2e4-4319-96a2-616b498ad70c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>No dose adjustment is necessary in\npatients with mild or moderate renal impairment.</span></p>", "ID": "e003e94c-a1f3-4079-863f-4e57b1163185", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>No dose adjustment is necessary in\npatients with mild or moderate renal impairment.</span>", "ID": "b8119748-9084-4a9b-b676-64e256f52a7d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "No dose adjustment is necessary in patients with mild or moderate renal impairment.", "ParentId": "e003e94c-a1f3-4079-863f-4e57b1163185"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "52bd3422-db53-4bee-8947-5b009867b299", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "cfbfe080-36c5-417a-a10b-5a7f56b04ad9", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "52bd3422-db53-4bee-8947-5b009867b299"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;page-break-after:avoid;text-autospace:none\"><i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Hepatic impairment</span></i></p>", "ID": "0040e445-8e5c-4673-8f9d-afc98d649e83", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;page-break-after:avoid;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Hepatic impairment</span></i>", "ID": "fafb574a-3097-47fa-aa24-21649f04e2c2", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0040e445-8e5c-4673-8f9d-afc98d649e83"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Hepatic impairment</span>", "ID": "42d43ad5-cf69-47f6-bd59-2ecdfe6e3bcb", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Hepatic impairment", "ParentId": "fafb574a-3097-47fa-aa24-21649f04e2c2"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;page-break-after:avoid;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The efficacy and safety\nof febuxostat has not been studied in patients with severe hepatic impairment (Child\nPugh Class C).</span></p>", "ID": "4b893656-0ea3-44dc-861d-f420be75fc15", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;page-break-after:avoid;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The efficacy and safety\nof febuxostat has not been studied in patients with severe hepatic impairment (Child\nPugh Class C).</span>", "ID": "6c356f5e-c7bf-4250-bb9c-e5960a94c2f6", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "The efficacy and safety of febuxostat has not been studied in patients with severe hepatic impairment (Child Pugh Class C).", "ParentId": "4b893656-0ea3-44dc-861d-f420be75fc15"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The recommended dose in patients\nwith mild hepatic impairment is 80\u00a0mg. Limited information is available in\npatients with moderate hepatic impairment.</span></p>", "ID": "ff5fd76a-13d8-4aa5-a649-475223c0dad8", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The recommended dose in patients\nwith mild hepatic impairment is 80\u00a0mg. Limited information is available in\npatients with moderate hepatic impairment.</span>", "ID": "d4529a69-69da-42d0-92fe-190e8ab8e697", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "The recommended dose in patients with mild hepatic impairment is 80\u00a0mg. Limited information is available in patients with moderate hepatic impairment.", "ParentId": "ff5fd76a-13d8-4aa5-a649-475223c0dad8"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "77ce9b53-f1b2-4d5e-b129-b67d0d2dae92", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "0ba7332c-61f0-4be7-8488-bfd6345fdc8d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "77ce9b53-f1b2-4d5e-b129-b67d0d2dae92"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Paediatric population</span></i></p>", "ID": "f2a64302-f6e3-4d6a-a27b-11e37383e2ac", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Paediatric population</span></i>", "ID": "efb54f67-dbd7-4143-94aa-f794b0e1aee5", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f2a64302-f6e3-4d6a-a27b-11e37383e2ac"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Paediatric population</span>", "ID": "8bf63466-750d-4c14-8584-3ebfa54b8dfe", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Paediatric population", "ParentId": "efb54f67-dbd7-4143-94aa-f794b0e1aee5"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The safety and the efficacy of febuxostat\nin children aged below the age of 18\u00a0years have not been established. No\ndata are available.</span></p>", "ID": "4fc5c7f2-65fd-41b4-b7aa-d9dd727c51c8", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The safety and the efficacy of febuxostat\nin children aged below the age of 18\u00a0years have not been established. No\ndata are available.</span>", "ID": "e61b4ab1-c460-4389-938d-6ee0afcb1070", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "The safety and the efficacy of febuxostat in children aged below the age of 18\u00a0years have not been established. No data are available.", "ParentId": "4fc5c7f2-65fd-41b4-b7aa-d9dd727c51c8"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "a2c180c1-2fc0-4ea6-a62e-809f6592dda7", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "62acab97-76ab-4d22-b012-ea353e149b4a", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "a2c180c1-2fc0-4ea6-a62e-809f6592dda7"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Method of administration</span></u></p>", "ID": "c1ba3ab0-b8d9-4750-936e-e551bd5dfb04", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Method of administration</span></u>", "ID": "5c999df2-3223-4429-b740-bdb8c9291677", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c1ba3ab0-b8d9-4750-936e-e551bd5dfb04"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Method of administration</span>", "ID": "d67ad8b3-ebd4-4513-843e-60607fccf34b", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Method of administration", "ParentId": "5c999df2-3223-4429-b740-bdb8c9291677"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "715c0a36-b9d0-44d4-84ce-39fec1d2d418", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "db09e693-7143-4ffa-af8a-37d0060b0e76", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "715c0a36-b9d0-44d4-84ce-39fec1d2d418"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Oral use.</span></p>", "ID": "665f8c75-2581-4dec-a328-51762f95f731", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Oral use.</span>", "ID": "b1ca93c6-6c77-4e39-b276-54022da9fee2", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Oral use.", "ParentId": "665f8c75-2581-4dec-a328-51762f95f731"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "8f155516-7322-4701-9217-e03a8f158269", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "ce9834cf-ceb5-41fc-a7f7-3b12d27484b5", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "8f155516-7322-4701-9217-e03a8f158269"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat Mylan should be taken by\nmouth and can be taken with or without food.</span></p>", "ID": "bcd70681-2551-409f-862d-44f680ea22d8", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat Mylan should be taken by\nmouth and can be taken with or without food.</span>", "ID": "7708b974-7bf9-48c7-8e60-1e6e168616d8", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Febuxostat Mylan should be taken by mouth and can be taken with or without food.", "ParentId": "bcd70681-2551-409f-862d-44f680ea22d8"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "abf133d4-1aaf-4b1c-8e5d-8b09933d4718", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "99056823-c75a-491f-ac93-6a06f65cc900", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "abf133d4-1aaf-4b1c-8e5d-8b09933d4718"}, {"Element": "<h1 style=\"margin-right:3.1pt\"><span lang=\"EN-GB\">4.3\u00a0\u00a0\u00a0\u00a0 Contraindications</span></h1>", "ID": "776483a8-596c-4bb1-8aee-4223f38d76ae", "Styles": "margin-right:3.1pt", "Classes": "None", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\">4.3\u00a0\u00a0\u00a0\u00a0 Contraindications</span>", "ID": "042a4fa8-b2e8-4d2e-bbdf-980dc51681e7", "Styles": "None", "Classes": "None", "Text": "4.3\u00a0\u00a0\u00a0\u00a0 Contraindications", "ParentId": "776483a8-596c-4bb1-8aee-4223f38d76ae"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "48874102-6843-4ae0-8bde-f3078501b9d0", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "ca98a41a-60e2-42cf-a5e5-5b31caa49a53", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "48874102-6843-4ae0-8bde-f3078501b9d0"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Hypersensitivity to the active\nsubstance or to any of the excipients listed in section 6.1 (see also section\n4.8).</span></p>", "ID": "559d578f-74ad-433e-8c0f-cb93564fb3e7", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Hypersensitivity to the active\nsubstance or to any of the excipients listed in section 6.1 (see also section\n4.8).</span>", "ID": "bc7eebb2-2f7d-49c8-8310-4f889f208121", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Hypersensitivity to the active substance or to any of the excipients listed in section 6.1 (see also section 4.8).", "ParentId": "559d578f-74ad-433e-8c0f-cb93564fb3e7"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "9f7a0da4-f92c-4497-8dee-70f8e197338b", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "be1221b2-c0b2-4640-ae70-224c16d57bde", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "9f7a0da4-f92c-4497-8dee-70f8e197338b"}, {"Element": "<h1 style=\"margin-right:3.1pt\"><span lang=\"EN-GB\">4.4\u00a0\u00a0\u00a0\u00a0 Special warnings and\nprecautions for use</span></h1>", "ID": "6c547ffd-6428-479d-8ac4-fa06673904ea", "Styles": "margin-right:3.1pt", "Classes": "None", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\">4.4\u00a0\u00a0\u00a0\u00a0 Special warnings and\nprecautions for use</span>", "ID": "4f167ae3-a04b-460e-8688-7314dc073277", "Styles": "None", "Classes": "None", "Text": "4.4\u00a0\u00a0\u00a0\u00a0 Special warnings and precautions for use", "ParentId": "6c547ffd-6428-479d-8ac4-fa06673904ea"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "fd2f936c-3543-4a6a-9f2a-f84c91296554", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "0c45ccf7-2fd4-426d-9583-66180ed9f28a", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "fd2f936c-3543-4a6a-9f2a-f84c91296554"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Cardio-vascular disorders</span></u></p>", "ID": "f2003448-740a-47cc-a913-9147d6092f65", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Cardio-vascular disorders</span></u>", "ID": "f21a4c8d-2d12-4c04-afe1-6f1a7e381515", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f2003448-740a-47cc-a913-9147d6092f65"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Cardio-vascular disorders</span>", "ID": "dd3a100e-6af8-4f77-8f59-0b80effc5cbb", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Cardio-vascular disorders", "ParentId": "f21a4c8d-2d12-4c04-afe1-6f1a7e381515"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "6c544870-7cb2-4d3d-98f2-b89a89eb3cbc", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "7c8dedc9-4ac7-4fa9-a1da-cd636ca49cc5", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "6c544870-7cb2-4d3d-98f2-b89a89eb3cbc"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Treatment with febuxostat in\npatients with ischaemic heart disease or congestive heart failure is not\nrecommended.</span></p>", "ID": "bf7ca3ad-0f56-4cc5-a399-5467689fab2a", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Treatment with febuxostat in\npatients with ischaemic heart disease or congestive heart failure is not\nrecommended.</span>", "ID": "a0edf09c-d2f0-47cd-b50d-952f939b2158", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Treatment with febuxostat in patients with ischaemic heart disease or congestive heart failure is not recommended.", "ParentId": "bf7ca3ad-0f56-4cc5-a399-5467689fab2a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "9d02f0aa-7fff-4617-8e8d-4b8f0d7c6efe", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "7b68d98b-0a23-4d22-a9e1-53b9cc92f072", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "9d02f0aa-7fff-4617-8e8d-4b8f0d7c6efe"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>A numerical greater incidence of investigator-reported\ncardiovascular APTC events (defined endpoints from the Anti-Platelet Trialists\u2019\nCollaboration (APTC) including cardiovascular death, non-fatal myocardial\ninfarction, non-fatal stroke) was observed in the febuxostat total group\ncompared to the allopurinol group in the APEX and FACT studies (1.3 vs. 0.3\nevents per 100 Patient Years (PYs)), but not in the CONFIRMS study (see section\n5.1 for detailed characteristics of the studies). The incidence of\ninvestigator-reported cardiovascular APTC events in the combined Phase 3\nstudies (APEX, FACT and CONFIRMS studies) was 0.7 vs. 0.6 events per 100 PYs.\nIn the long-term extension studies the incidences of investigator-reported APTC\nevents were 1.2 and 0.6 events per 100 PYs for febuxostat and allopurinol,\nrespectively. No statistically significant differences were found and no causal\nrelationship with febuxostat was established. Identified risk factors among\nthese patients were a medical history of atherosclerotic disease and/or\nmyocardial infarction, or of congestive heart failure.</span></p>", "ID": "04cd0379-148c-4058-91f7-f72dd0491e9a", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>A numerical greater incidence of investigator-reported\ncardiovascular APTC events (defined endpoints from the Anti-Platelet Trialists\u2019\nCollaboration (APTC) including cardiovascular death, non-fatal myocardial\ninfarction, non-fatal stroke) was observed in the febuxostat total group\ncompared to the allopurinol group in the APEX and FACT studies (1.3 vs. 0.3\nevents per 100 Patient Years (PYs)), but not in the CONFIRMS study (see section\n5.1 for detailed characteristics of the studies). The incidence of\ninvestigator-reported cardiovascular APTC events in the combined Phase 3\nstudies (APEX, FACT and CONFIRMS studies) was 0.7 vs. 0.6 events per 100 PYs.\nIn the long-term extension studies the incidences of investigator-reported APTC\nevents were 1.2 and 0.6 events per 100 PYs for febuxostat and allopurinol,\nrespectively. No statistically significant differences were found and no causal\nrelationship with febuxostat was established. Identified risk factors among\nthese patients were a medical history of atherosclerotic disease and/or\nmyocardial infarction, or of congestive heart failure.</span>", "ID": "728f3645-5a0a-49da-8fa1-65002f668621", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "A numerical greater incidence of investigator-reported cardiovascular APTC events (defined endpoints from the Anti-Platelet Trialists\u2019 Collaboration (APTC) including cardiovascular death, non-fatal myocardial infarction, non-fatal stroke) was observed in the febuxostat total group compared to the allopurinol group in the APEX and FACT studies (1.3 vs. 0.3 events per 100 Patient Years (PYs)), but not in the CONFIRMS study (see section 5.1 for detailed characteristics of the studies). The incidence of investigator-reported cardiovascular APTC events in the combined Phase 3 studies (APEX, FACT and CONFIRMS studies) was 0.7 vs. 0.6 events per 100 PYs. In the long-term extension studies the incidences of investigator-reported APTC events were 1.2 and 0.6 events per 100 PYs for febuxostat and allopurinol, respectively. No statistically significant differences were found and no causal relationship with febuxostat was established. Identified risk factors among these patients were a medical history of atherosclerotic disease and/or myocardial infarction, or of congestive heart failure.", "ParentId": "04cd0379-148c-4058-91f7-f72dd0491e9a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "a600f9c3-6dd6-497e-9f92-9fd3898a7e73", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "f8c8e549-2d38-4fd5-ba60-d48a4b40a8e9", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "a600f9c3-6dd6-497e-9f92-9fd3898a7e73"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Medicinal product allergy /\nhypersensitivity</span></u></p>", "ID": "0f41bafb-c3c0-446d-900f-edbe301592c9", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Medicinal product allergy /\nhypersensitivity</span></u>", "ID": "cf6b9968-e4d8-448a-92d5-9158a5d96e1f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0f41bafb-c3c0-446d-900f-edbe301592c9"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Medicinal product allergy /\nhypersensitivity</span>", "ID": "5be1e95a-f3dc-45b5-b2f4-69c768fb652a", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Medicinal product allergy / hypersensitivity", "ParentId": "cf6b9968-e4d8-448a-92d5-9158a5d96e1f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "3b2c4154-d5e9-4af6-8963-589673572cc3", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "505f01f0-b112-43f4-a002-168f07023ba1", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "3b2c4154-d5e9-4af6-8963-589673572cc3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare reports of serious\nallergic/hypersensitivity reactions, including life-threatening Stevens-Johnson\nSyndrome, Toxic epidermal necrolysis and acute anaphylactic reaction/shock,\nhave been collected in the post-marketing experience. In most cases, these\nreactions occurred during the first month of therapy with febuxostat. Some, but\nnot all of these patients reported renal impairment and/or previous\nhypersensitivity to allopurinol. Severe hypersensitivity reactions, including\nDrug Reaction with Eosinophilia and Systemic Symptoms (DRESS) were associated\nwith fever, haematological, renal or hepatic involvement in some cases.</span></p>", "ID": "f2afcf27-ba9b-4c99-81df-ccd617568165", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare reports of serious\nallergic/hypersensitivity reactions, including life-threatening Stevens-Johnson\nSyndrome, Toxic epidermal necrolysis and acute anaphylactic reaction/shock,\nhave been collected in the post-marketing experience. In most cases, these\nreactions occurred during the first month of therapy with febuxostat. Some, but\nnot all of these patients reported renal impairment and/or previous\nhypersensitivity to allopurinol. Severe hypersensitivity reactions, including\nDrug Reaction with Eosinophilia and Systemic Symptoms (DRESS) were associated\nwith fever, haematological, renal or hepatic involvement in some cases.</span>", "ID": "6560d87e-2844-4779-9bce-61bf8c842f12", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Rare reports of serious allergic/hypersensitivity reactions, including life-threatening Stevens-Johnson Syndrome, Toxic epidermal necrolysis and acute anaphylactic reaction/shock, have been collected in the post-marketing experience. In most cases, these reactions occurred during the first month of therapy with febuxostat. Some, but not all of these patients reported renal impairment and/or previous hypersensitivity to allopurinol. Severe hypersensitivity reactions, including Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) were associated with fever, haematological, renal or hepatic involvement in some cases.", "ParentId": "f2afcf27-ba9b-4c99-81df-ccd617568165"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "d94f3896-f908-4908-82c5-5539e63f4aaa", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "6eb07655-1639-431e-b540-7a825e2fd6d4", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "d94f3896-f908-4908-82c5-5539e63f4aaa"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Patients should be advised of the\nsigns and symptoms and monitored closely for symptoms of\nallergic/hypersensitivity reactions (see section 4.8). Febuxostat treatment\nshould be immediately stopped if serious allergic/hypersensitivity reactions,\nincluding Stevens-Johnson Syndrome, occur since early withdrawal is associated\nwith a better prognosis. If patient has developed allergic/hypersensitivity\nreactions including Stevens-Johnson Syndrome and acute anaphylactic\nreaction/shock, febuxostat must not be re-started in this patient at any time.</span></p>", "ID": "11d590c0-8adf-41f0-b85f-d58440915d81", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Patients should be advised of the\nsigns and symptoms and monitored closely for symptoms of\nallergic/hypersensitivity reactions (see section 4.8). Febuxostat treatment\nshould be immediately stopped if serious allergic/hypersensitivity reactions,\nincluding Stevens-Johnson Syndrome, occur since early withdrawal is associated\nwith a better prognosis. If patient has developed allergic/hypersensitivity\nreactions including Stevens-Johnson Syndrome and acute anaphylactic\nreaction/shock, febuxostat must not be re-started in this patient at any time.</span>", "ID": "e3403ed1-21ef-46a3-a7f5-9644518c184b", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Patients should be advised of the signs and symptoms and monitored closely for symptoms of allergic/hypersensitivity reactions (see section 4.8). Febuxostat treatment should be immediately stopped if serious allergic/hypersensitivity reactions, including Stevens-Johnson Syndrome, occur since early withdrawal is associated with a better prognosis. If patient has developed allergic/hypersensitivity reactions including Stevens-Johnson Syndrome and acute anaphylactic reaction/shock, febuxostat must not be re-started in this patient at any time.", "ParentId": "11d590c0-8adf-41f0-b85f-d58440915d81"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "9d4edc9b-992b-4e48-a3ac-041845da84db", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "3b637a29-df37-489e-aa29-30d02eaf7551", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "9d4edc9b-992b-4e48-a3ac-041845da84db"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Acute gouty attacks (gout flare)</span></u></p>", "ID": "f13d1898-bfae-467d-9392-caa1c1885a1b", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Acute gouty attacks (gout flare)</span></u>", "ID": "2f98cbe5-2dc4-4642-a031-8ba004fd2bfd", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f13d1898-bfae-467d-9392-caa1c1885a1b"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Acute gouty attacks (gout flare)</span>", "ID": "bf381f10-0a19-466a-9da8-585100081cc2", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Acute gouty attacks (gout flare)", "ParentId": "2f98cbe5-2dc4-4642-a031-8ba004fd2bfd"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "4c5fee91-8466-400b-9bce-4d0f8962dad4", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "5ff97637-00eb-455e-a7e3-0ae6493ab981", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "4c5fee91-8466-400b-9bce-4d0f8962dad4"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat treatment should not be\nstarted until an acute attack of gout has completely subsided. Gout flares may\noccur during initiation of treatment due to changing serum uric acid levels\nresulting in mobilization of urate from tissue deposits (see section 4.8 and\n5.1). At treatment initiation with febuxostat flare prophylaxis for at least 6\nmonths with an NSAID or colchicine is recommended (see section 4.2).</span></p>", "ID": "6a8f8c5c-43f2-4346-8ea4-ba0e1ce42371", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat treatment should not be\nstarted until an acute attack of gout has completely subsided. Gout flares may\noccur during initiation of treatment due to changing serum uric acid levels\nresulting in mobilization of urate from tissue deposits (see section 4.8 and\n5.1). At treatment initiation with febuxostat flare prophylaxis for at least 6\nmonths with an NSAID or colchicine is recommended (see section 4.2).</span>", "ID": "1a4f4529-cd12-4e4a-b143-4d77eb3c0038", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Febuxostat treatment should not be started until an acute attack of gout has completely subsided. Gout flares may occur during initiation of treatment due to changing serum uric acid levels resulting in mobilization of urate from tissue deposits (see section 4.8 and 5.1). At treatment initiation with febuxostat flare prophylaxis for at least 6 months with an NSAID or colchicine is recommended (see section 4.2).", "ParentId": "6a8f8c5c-43f2-4346-8ea4-ba0e1ce42371"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "1c814d05-e5e1-42cf-ab15-5d5203771945", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "518fe3fc-8e26-4323-b421-88f3b46c353b", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "1c814d05-e5e1-42cf-ab15-5d5203771945"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If a gout flare occurs during\nfebuxostat treatment, it should not be discontinued. The gout flare should be\nmanaged concurrently as appropriate for the individual patient. Continuous\ntreatment with febuxostat decreases frequency and intensity of gout flares.</span></p>", "ID": "8226d87c-a637-4dd6-99cb-55aec8430ee4", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If a gout flare occurs during\nfebuxostat treatment, it should not be discontinued. The gout flare should be\nmanaged concurrently as appropriate for the individual patient. Continuous\ntreatment with febuxostat decreases frequency and intensity of gout flares.</span>", "ID": "467fe2bd-2a9a-4b96-ad09-9cfcad9d461e", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "If a gout flare occurs during febuxostat treatment, it should not be discontinued. The gout flare should be managed concurrently as appropriate for the individual patient. Continuous treatment with febuxostat decreases frequency and intensity of gout flares.", "ParentId": "8226d87c-a637-4dd6-99cb-55aec8430ee4"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "7a31d975-45fd-4ff7-9e02-de2f57813393", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "54aa13ab-137f-4dee-b077-d8d686a5943a", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "7a31d975-45fd-4ff7-9e02-de2f57813393"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Xanthine deposition</span></u></p>", "ID": "fd28cc91-d610-4eef-a24c-c6bb1079b785", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Xanthine deposition</span></u>", "ID": "bcbaf7bd-f730-462d-9122-e22f90a29cb8", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "fd28cc91-d610-4eef-a24c-c6bb1079b785"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Xanthine deposition</span>", "ID": "df0579b9-bafc-4a0e-bf7e-4abfb0549025", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Xanthine deposition", "ParentId": "bcbaf7bd-f730-462d-9122-e22f90a29cb8"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "5ab9c595-8458-4254-81c4-5e632ad5277c", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "338423ec-7bec-4a66-a09a-5c8e06894866", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "5ab9c595-8458-4254-81c4-5e632ad5277c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>In patients in whom the rate of\nurate formation is greatly increased (e.g. malignant disease and its treatment,\nLesch-Nyhan syndrome) the absolute concentration of xanthine in urine could, in\nrare cases, rise sufficiently to allow deposition in the urinary tract. As\nthere has been no experience with febuxostat, its use in these populations is\nnot recommended.</span></p>", "ID": "27d9af16-a308-4b95-be18-d64abbc3f710", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>In patients in whom the rate of\nurate formation is greatly increased (e.g. malignant disease and its treatment,\nLesch-Nyhan syndrome) the absolute concentration of xanthine in urine could, in\nrare cases, rise sufficiently to allow deposition in the urinary tract. As\nthere has been no experience with febuxostat, its use in these populations is\nnot recommended.</span>", "ID": "d81d6bef-0e21-4eff-9450-925347d8d62c", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "In patients in whom the rate of urate formation is greatly increased (e.g. malignant disease and its treatment, Lesch-Nyhan syndrome) the absolute concentration of xanthine in urine could, in rare cases, rise sufficiently to allow deposition in the urinary tract. As there has been no experience with febuxostat, its use in these populations is not recommended.", "ParentId": "27d9af16-a308-4b95-be18-d64abbc3f710"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "d3b5839e-5221-472f-a5d9-b45a2064ae5e", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "6a7d4c6d-1a1d-4048-a471-0740d34dbfed", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "d3b5839e-5221-472f-a5d9-b45a2064ae5e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Mercaptopurine/azathioprine</span></u></p>", "ID": "ac37b76b-f3f5-4d57-9661-1defc63aab40", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Mercaptopurine/azathioprine</span></u>", "ID": "1a2628b2-a0bb-433a-9eb1-eece7dc07a21", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ac37b76b-f3f5-4d57-9661-1defc63aab40"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Mercaptopurine/azathioprine</span>", "ID": "4eeac53b-cf58-439b-9bb8-f82b2e233f6b", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Mercaptopurine/azathioprine", "ParentId": "1a2628b2-a0bb-433a-9eb1-eece7dc07a21"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "efb896b3-1382-45e6-8a4f-e00c31747128", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "602b46c5-a6e2-4e0b-9e97-213e92a4bf92", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "efb896b3-1382-45e6-8a4f-e00c31747128"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat use is not recommended\nin patients concomitantly treated with mercaptopurine/azathioprine as inhibition\nof xanthine oxidase by febuxostat may cause increased plasma concentrations of\nmercaptopurine/azathioprine that could result in severe toxicity. No\ninteraction studies have been performed in humans. </span></p>", "ID": "d334c307-3748-4c11-a54b-ac32174fef1e", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat use is not recommended\nin patients concomitantly treated with mercaptopurine/azathioprine as inhibition\nof xanthine oxidase by febuxostat may cause increased plasma concentrations of\nmercaptopurine/azathioprine that could result in severe toxicity. No\ninteraction studies have been performed in humans. </span>", "ID": "bcddb0be-52ba-4a92-87a6-4e4120671c35", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Febuxostat use is not recommended in patients concomitantly treated with mercaptopurine/azathioprine as inhibition of xanthine oxidase by febuxostat may cause increased plasma concentrations of mercaptopurine/azathioprine that could result in severe toxicity. No interaction studies have been performed in humans. ", "ParentId": "d334c307-3748-4c11-a54b-ac32174fef1e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Where the combination cannot be\navoided, a reduction of the dose of mercaptopurine/azathioprine is recommended.\nBased on modelling and simulation analysis of data from a pre-clinical study in\nrats, when coadministered with febuxostat, the dose of mercaptopurine/azathioprine\nshould be reduced to the 20\u00a0% or less of the previously prescribed dose in\norder to avoid possible haematological effects (see section 4.5 and 5.3).</span></p>", "ID": "f7fa14a5-3223-4548-8b31-75b8ca28be40", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Where the combination cannot be\navoided, a reduction of the dose of mercaptopurine/azathioprine is recommended.\nBased on modelling and simulation analysis of data from a pre-clinical study in\nrats, when coadministered with febuxostat, the dose of mercaptopurine/azathioprine\nshould be reduced to the 20\u00a0% or less of the previously prescribed dose in\norder to avoid possible haematological effects (see section 4.5 and 5.3).</span>", "ID": "5961839b-150f-4510-b270-c98b8ec28ee7", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Where the combination cannot be avoided, a reduction of the dose of mercaptopurine/azathioprine is recommended. Based on modelling and simulation analysis of data from a pre-clinical study in rats, when coadministered with febuxostat, the dose of mercaptopurine/azathioprine should be reduced to the 20\u00a0% or less of the previously prescribed dose in order to avoid possible haematological effects (see section 4.5 and 5.3).", "ParentId": "f7fa14a5-3223-4548-8b31-75b8ca28be40"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "e1c897fe-8db1-4240-9859-d029194a0e6a", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "87b2a784-5d51-4c5d-9e5a-a3364b5ef792", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "e1c897fe-8db1-4240-9859-d029194a0e6a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The patients should be closely\nmonitored and the dose of mercaptopurine/azathioprine should be subsequently\nadjusted based on the evaluation of the therapeutic response and the onset of eventual\ntoxic effects.</span></p>", "ID": "653f4547-ebe0-4845-9f51-194df5235e2e", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The patients should be closely\nmonitored and the dose of mercaptopurine/azathioprine should be subsequently\nadjusted based on the evaluation of the therapeutic response and the onset of eventual\ntoxic effects.</span>", "ID": "f1407c00-0a61-44ff-92a4-4565d01bdf75", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "The patients should be closely monitored and the dose of mercaptopurine/azathioprine should be subsequently adjusted based on the evaluation of the therapeutic response and the onset of eventual toxic effects.", "ParentId": "653f4547-ebe0-4845-9f51-194df5235e2e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "4cf80ebc-33c5-41b7-a260-0ced5cf7403c", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "6163b1f6-4425-4a9d-9aca-338ee5f4bd5e", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "4cf80ebc-33c5-41b7-a260-0ced5cf7403c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Organ transplant recipients</span></u></p>", "ID": "89ec8d14-a649-45be-8bbb-88d238a59ed6", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Organ transplant recipients</span></u>", "ID": "d89be623-43fa-4908-90e9-cc41465d224c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "89ec8d14-a649-45be-8bbb-88d238a59ed6"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Organ transplant recipients</span>", "ID": "c0902227-4a68-42fd-85fa-1831399fe64b", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Organ transplant recipients", "ParentId": "d89be623-43fa-4908-90e9-cc41465d224c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "262d22aa-0654-447a-838d-57cf33f29872", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "7de409fd-c6f0-4c7f-9884-7e7fe9e1956e", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "262d22aa-0654-447a-838d-57cf33f29872"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>As there has been no experience in\norgan transplant recipients, the use of febuxostat in such patients is not\nrecommended (see section 5.1).</span></p>", "ID": "d714d057-3c87-4ba8-b4fa-1744d9843d2d", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>As there has been no experience in\norgan transplant recipients, the use of febuxostat in such patients is not\nrecommended (see section 5.1).</span>", "ID": "63bd138b-81b3-4b40-8d75-87c61635ebc6", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "As there has been no experience in organ transplant recipients, the use of febuxostat in such patients is not recommended (see section 5.1).", "ParentId": "d714d057-3c87-4ba8-b4fa-1744d9843d2d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "f443ea88-4187-4ad0-ab7d-f6da8f163a3b", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "e2600b04-d895-474d-8c08-52e87a1875c7", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "f443ea88-4187-4ad0-ab7d-f6da8f163a3b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Theophylline</span></u></p>", "ID": "7b17e194-4c76-4439-af83-5241481b938f", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Theophylline</span></u>", "ID": "3db3aefd-77f7-4e8b-9093-10ed32d26727", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "7b17e194-4c76-4439-af83-5241481b938f"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Theophylline</span>", "ID": "07f81bab-3531-40aa-bcc1-3bdd86a51c26", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Theophylline", "ParentId": "3db3aefd-77f7-4e8b-9093-10ed32d26727"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "2d2d4e71-bccb-4204-8d30-2ac061998b15", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "3f305a4d-1cd5-492d-8773-b062feac3fec", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "2d2d4e71-bccb-4204-8d30-2ac061998b15"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Co-administration of febuxostat 80\u00a0mg\nand theophylline 400\u00a0mg single dose in healthy subjects showed absence of\nany pharmacokinetic interaction (see section 4.5). Febuxostat 80\u00a0mg can be\nused in patients concomitantly treated with theophylline without risk of\nincreasing theophylline plasma levels. No data is available for febuxostat 120\u00a0mg.</span></p>", "ID": "b2f76b94-dbcd-454f-8520-0926b7ed3d9f", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Co-administration of febuxostat 80\u00a0mg\nand theophylline 400\u00a0mg single dose in healthy subjects showed absence of\nany pharmacokinetic interaction (see section 4.5). Febuxostat 80\u00a0mg can be\nused in patients concomitantly treated with theophylline without risk of\nincreasing theophylline plasma levels. No data is available for febuxostat 120\u00a0mg.</span>", "ID": "38d985d5-f59b-407c-97f9-f4539a506318", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Co-administration of febuxostat 80\u00a0mg and theophylline 400\u00a0mg single dose in healthy subjects showed absence of any pharmacokinetic interaction (see section 4.5). Febuxostat 80\u00a0mg can be used in patients concomitantly treated with theophylline without risk of increasing theophylline plasma levels. No data is available for febuxostat 120\u00a0mg.", "ParentId": "b2f76b94-dbcd-454f-8520-0926b7ed3d9f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "23d45e80-9f5b-4779-ab88-62f04f39afa5", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "74339b4a-eece-40ae-97ff-b5b1b5b9a816", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "23d45e80-9f5b-4779-ab88-62f04f39afa5"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Liver disorders</span></u></p>", "ID": "c852dfa4-5225-4366-8898-a86c60d4b730", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Liver disorders</span></u>", "ID": "e02b9d33-a469-458e-aad1-40fe235bc6be", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c852dfa4-5225-4366-8898-a86c60d4b730"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Liver disorders</span>", "ID": "51e3a747-72a0-42cc-bcaf-71814032ff2d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Liver disorders", "ParentId": "e02b9d33-a469-458e-aad1-40fe235bc6be"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "6f606adb-c3ca-45e1-a5aa-26cd53544806", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "5e8764dc-326a-409b-97a0-94417b85f8fd", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "6f606adb-c3ca-45e1-a5aa-26cd53544806"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>During the combined phase 3\nclinical studies, mild liver function test abnormalities were observed in\npatients treated with febuxostat (5.0%). Liver function test is recommended\nprior to the initiation of therapy with febuxostat and periodically thereafter\nbased on clinical judgment (see section 5.1).</span></p>", "ID": "9255e803-f7b1-40a6-8558-f022a30265c1", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>During the combined phase 3\nclinical studies, mild liver function test abnormalities were observed in\npatients treated with febuxostat (5.0%). Liver function test is recommended\nprior to the initiation of therapy with febuxostat and periodically thereafter\nbased on clinical judgment (see section 5.1).</span>", "ID": "811d343d-9d95-4269-9b96-a7ecc4c356ec", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "During the combined phase 3 clinical studies, mild liver function test abnormalities were observed in patients treated with febuxostat (5.0%). Liver function test is recommended prior to the initiation of therapy with febuxostat and periodically thereafter based on clinical judgment (see section 5.1).", "ParentId": "9255e803-f7b1-40a6-8558-f022a30265c1"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "2ccf807c-bd98-4872-b477-a7c1e5aaa6a2", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "a4331d6a-7bf3-49e9-87d8-bbeba532acde", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "2ccf807c-bd98-4872-b477-a7c1e5aaa6a2"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Thyroid disorders</span></u></p>", "ID": "bff23dc1-4bd9-4dc1-8495-7136f7cf4c33", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Thyroid disorders</span></u>", "ID": "0eb65f09-e89b-4db7-a20b-a7875962ab08", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "bff23dc1-4bd9-4dc1-8495-7136f7cf4c33"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Thyroid disorders</span>", "ID": "7e1186e9-9f82-47c7-8ee9-2d5e448b2fa9", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Thyroid disorders", "ParentId": "0eb65f09-e89b-4db7-a20b-a7875962ab08"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "b8eed81f-4a82-4b5d-9a94-82bac23abf49", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "76b08e05-b60f-4dc2-b18b-0413cdc66759", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "b8eed81f-4a82-4b5d-9a94-82bac23abf49"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Increased TSH values (&gt;5.5\u00a0\u00b5IU/mL)\nwere observed in patients on long-term treatment with febuxostat (5.5%) in the\nlong term open label extension studies. Caution is required when febuxostat is\nused in patients with alteration of thyroid function (see section 5.1).</span></p>", "ID": "e4cdd268-62a6-43a9-9a45-edefb1cf4c3b", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Increased TSH values (&gt;5.5\u00a0\u00b5IU/mL)\nwere observed in patients on long-term treatment with febuxostat (5.5%) in the\nlong term open label extension studies. Caution is required when febuxostat is\nused in patients with alteration of thyroid function (see section 5.1).</span>", "ID": "3dfe63f4-49d1-4e8b-8d94-b233e637bfb9", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Increased TSH values (>5.5\u00a0\u00b5IU/mL) were observed in patients on long-term treatment with febuxostat (5.5%) in the long term open label extension studies. Caution is required when febuxostat is used in patients with alteration of thyroid function (see section 5.1).", "ParentId": "e4cdd268-62a6-43a9-9a45-edefb1cf4c3b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "84f3865b-a191-4e63-98cd-87b6980dc207", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "a738b22e-554d-4a35-8a5a-84cd1f908b7d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "84f3865b-a191-4e63-98cd-87b6980dc207"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Lactose</span></u></p>", "ID": "ec9ebd48-0dbc-4ba2-9389-80d99b62312e", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Lactose</span></u>", "ID": "e876118b-7b87-45b0-9e2a-b777dee7d9ee", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ec9ebd48-0dbc-4ba2-9389-80d99b62312e"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Lactose</span>", "ID": "91cf122b-5287-4999-bf41-fdb96f51de0b", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Lactose", "ParentId": "e876118b-7b87-45b0-9e2a-b777dee7d9ee"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "01232f06-3b62-4ac1-a6ba-7af2079eed81", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "6a9d8c65-2cc3-4f64-afc2-5f72cd19193d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "01232f06-3b62-4ac1-a6ba-7af2079eed81"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat tablets contain lactose.\nPatients with rare hereditary problems of galactose intolerance, the Lapp\nlactase deficiency or glucose-galactose malabsorption should not take this\nmedicine.</span></p>", "ID": "c80922b2-339f-41f2-866f-b5349a69cbc6", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat tablets contain lactose.\nPatients with rare hereditary problems of galactose intolerance, the Lapp\nlactase deficiency or glucose-galactose malabsorption should not take this\nmedicine.</span>", "ID": "aa9ae559-9cc9-4244-9bdd-1b287a480e44", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Febuxostat tablets contain lactose. Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine.", "ParentId": "c80922b2-339f-41f2-866f-b5349a69cbc6"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "6a54ef67-e63f-4ebf-a19b-ec8877cd99f8", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "297c36b0-1c05-41f4-86ac-0515101a89dd", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "6a54ef67-e63f-4ebf-a19b-ec8877cd99f8"}, {"Element": "<h1 style=\"margin-right:3.1pt\"><span lang=\"EN-GB\">4.5\u00a0\u00a0\u00a0\u00a0 Interaction with other\nmedicinal products and other forms of interaction</span></h1>", "ID": "808e4dba-5db8-4c03-bbe5-e41d5f259c20", "Styles": "margin-right:3.1pt", "Classes": "None", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\">4.5\u00a0\u00a0\u00a0\u00a0 Interaction with other\nmedicinal products and other forms of interaction</span>", "ID": "32b3bf26-5ea0-48d7-87c2-3e707cb90d5c", "Styles": "None", "Classes": "None", "Text": "4.5\u00a0\u00a0\u00a0\u00a0 Interaction with other medicinal products and other forms of interaction", "ParentId": "808e4dba-5db8-4c03-bbe5-e41d5f259c20"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "809fa1f2-c358-413b-906f-049a16b5c51a", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "58b439c9-d484-4e61-a165-f20c3eb72d5f", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "809fa1f2-c358-413b-906f-049a16b5c51a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Mercaptopurine/azathioprine</span></u></p>", "ID": "c862578d-444e-4084-9543-4dbaaf0ff4e0", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Mercaptopurine/azathioprine</span></u>", "ID": "81fa5f18-e673-4175-8d0d-aedaec138735", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c862578d-444e-4084-9543-4dbaaf0ff4e0"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Mercaptopurine/azathioprine</span>", "ID": "b4cb16b9-e038-439b-b6a8-85ab4705cb27", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Mercaptopurine/azathioprine", "ParentId": "81fa5f18-e673-4175-8d0d-aedaec138735"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "76ee4c2c-9717-4e96-80d8-f62416e0a55a", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "f10d90f6-c463-4b10-b70f-2483d9807b38", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "76ee4c2c-9717-4e96-80d8-f62416e0a55a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>On the basis of the mechanism of action\nof febuxostat on XO inhibition concomitant use is not recommended. Inhibition\nof XO by febuxostat may cause increased plasma concentrations of these drugs\nleading to toxicity. Drug interaction studies of febuxostat with drugs (except\ntheophylline) that are metabolized by XO have not been performed in humans.</span></p>", "ID": "5ef9ff05-6ab4-4144-a007-b8246feea46c", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>On the basis of the mechanism of action\nof febuxostat on XO inhibition concomitant use is not recommended. Inhibition\nof XO by febuxostat may cause increased plasma concentrations of these drugs\nleading to toxicity. Drug interaction studies of febuxostat with drugs (except\ntheophylline) that are metabolized by XO have not been performed in humans.</span>", "ID": "2778d77c-7880-49cd-8e76-c23074160bc0", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "On the basis of the mechanism of action of febuxostat on XO inhibition concomitant use is not recommended. Inhibition of XO by febuxostat may cause increased plasma concentrations of these drugs leading to toxicity. Drug interaction studies of febuxostat with drugs (except theophylline) that are metabolized by XO have not been performed in humans.", "ParentId": "5ef9ff05-6ab4-4144-a007-b8246feea46c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Modelling and simulation analysis\nof data from a pre-clinical study in rats indicates that, in case of\nconcomitant administration with febuxostat, the dose of\nmercaptopurine/azathioprine should be reduced to 20% or less of the previously\nprescribed dose (see section 4.4 and 5.3)</span></p>", "ID": "d7e5bc42-9fae-46a8-8c8a-f6085dced697", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Modelling and simulation analysis\nof data from a pre-clinical study in rats indicates that, in case of\nconcomitant administration with febuxostat, the dose of\nmercaptopurine/azathioprine should be reduced to 20% or less of the previously\nprescribed dose (see section 4.4 and 5.3)</span>", "ID": "e52f74e1-b389-4c8d-bc82-442c82066515", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Modelling and simulation analysis of data from a pre-clinical study in rats indicates that, in case of concomitant administration with febuxostat, the dose of mercaptopurine/azathioprine should be reduced to 20% or less of the previously prescribed dose (see section 4.4 and 5.3)", "ParentId": "d7e5bc42-9fae-46a8-8c8a-f6085dced697"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "1e7ad02e-23cd-4b7e-a4d4-585e3b81d3dd", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "6644dc89-961d-43fe-86f8-b3df31902487", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "1e7ad02e-23cd-4b7e-a4d4-585e3b81d3dd"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Drug interaction studies of\nfebuxostat with other cytotoxic chemotherapy have not been conducted. No data\nis available regarding the safety of febuxostat during other cytotoxic therapy.</span></p>", "ID": "18a83460-2ee3-4f63-a25d-e74b9c807eb1", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Drug interaction studies of\nfebuxostat with other cytotoxic chemotherapy have not been conducted. No data\nis available regarding the safety of febuxostat during other cytotoxic therapy.</span>", "ID": "55ee2fed-e289-472b-8224-76b8db992662", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Drug interaction studies of febuxostat with other cytotoxic chemotherapy have not been conducted. No data is available regarding the safety of febuxostat during other cytotoxic therapy.", "ParentId": "18a83460-2ee3-4f63-a25d-e74b9c807eb1"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "4ae9f9cb-f9ea-437e-8f6a-4005052a0115", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "ddd63938-f0e0-4865-b168-20d8b3630990", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "4ae9f9cb-f9ea-437e-8f6a-4005052a0115"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rosiglitazone/CYP2C8 substrates</span></u></p>", "ID": "fb207272-0719-4074-aedb-5b0a0a3963b4", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rosiglitazone/CYP2C8 substrates</span></u>", "ID": "a5062532-68c0-4262-b86f-e18e5e4370e9", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "fb207272-0719-4074-aedb-5b0a0a3963b4"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rosiglitazone/CYP2C8 substrates</span>", "ID": "7390b68c-95a1-4892-af95-baa2393acdc8", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Rosiglitazone/CYP2C8 substrates", "ParentId": "a5062532-68c0-4262-b86f-e18e5e4370e9"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "27187cdf-4256-451e-bdc8-da0cfc5a81bb", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "f5289a17-dd3d-4287-9f69-b0bf35bd34ee", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "27187cdf-4256-451e-bdc8-da0cfc5a81bb"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat was shown to be a weak\ninhibitor of CYP2C8 <i>in vitro</i>. In a study in healthy subjects,\ncoadministration of 120\u00a0mg febuxostat QD with a single 4\u00a0mg oral dose\nof rosiglitazone had no effect on the pharmacokinetics of rosiglitazone and its\nmetabolite N-desmethyl rosiglitazone, indicating that febuxostat is not a\nCYP2C8 enzyme inhibitor <i>in vivo</i>. Thus, co-administration of febuxostat\nwith rosiglitazone or other CYP2C8 substrates is not expected to require any\ndose adjustment for those compounds.</span></p>", "ID": "69da6b96-95be-46c9-b8af-4d7349c3f4e1", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat was shown to be a weak\ninhibitor of CYP2C8 <i>in vitro</i>. In a study in healthy subjects,\ncoadministration of 120\u00a0mg febuxostat QD with a single 4\u00a0mg oral dose\nof rosiglitazone had no effect on the pharmacokinetics of rosiglitazone and its\nmetabolite N-desmethyl rosiglitazone, indicating that febuxostat is not a\nCYP2C8 enzyme inhibitor <i>in vivo</i>. Thus, co-administration of febuxostat\nwith rosiglitazone or other CYP2C8 substrates is not expected to require any\ndose adjustment for those compounds.</span>", "ID": "7f004d57-13d2-4b79-99cd-1928543aac7c", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Febuxostat was shown to be a weak inhibitor of CYP2C8 . In a study in healthy subjects, coadministration of 120\u00a0mg febuxostat QD with a single 4\u00a0mg oral dose of rosiglitazone had no effect on the pharmacokinetics of rosiglitazone and its metabolite N-desmethyl rosiglitazone, indicating that febuxostat is not a CYP2C8 enzyme inhibitor . Thus, co-administration of febuxostat with rosiglitazone or other CYP2C8 substrates is not expected to require any dose adjustment for those compounds.", "ParentId": "69da6b96-95be-46c9-b8af-4d7349c3f4e1"}, {"Element": "<i>in vitro</i>", "ID": "832c7c28-8a11-44ae-b67b-d9926826a2a4", "Styles": "None", "Classes": "None", "Text": "in vitro", "ParentId": "7f004d57-13d2-4b79-99cd-1928543aac7c"}, {"Element": "<i>in vivo</i>", "ID": "c6e67a24-0f83-4a90-9911-f0bc6a8b3be9", "Styles": "None", "Classes": "None", "Text": "in vivo", "ParentId": "7f004d57-13d2-4b79-99cd-1928543aac7c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "ff29dc78-2278-43a0-82d1-c02e316f0534", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "8318ebfe-023b-48c0-8ab4-5ad800e15d04", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "ff29dc78-2278-43a0-82d1-c02e316f0534"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Theophylline</span></u></p>", "ID": "120ee0bb-8733-46ce-95f8-c6aed18680ac", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Theophylline</span></u>", "ID": "5d5388f8-da89-421b-bf9c-4ee3fa408982", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "120ee0bb-8733-46ce-95f8-c6aed18680ac"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Theophylline</span>", "ID": "0d93ef77-a247-4088-bcd6-7cdfdf507338", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Theophylline", "ParentId": "5d5388f8-da89-421b-bf9c-4ee3fa408982"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "4d4107a8-f48a-4524-b3ef-8db8cca20571", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "57266870-7b9d-4e0e-94b5-6edc6423385b", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "4d4107a8-f48a-4524-b3ef-8db8cca20571"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>An interaction study in healthy\nsubjects has been performed with febuxostat to evaluate whether the inhibition\nof XO may cause an increase in the theophylline circulating levels as reported\nwith other XO inhibitors. The results of the study showed that the\nco-administration of febuxostat 80\u00a0mg QD with theophylline 400\u00a0mg\nsingle dose has no effect on the pharmacokinetics or safety of theophylline.\nTherefore no special caution is advised when febuxostat 80\u00a0mg and\ntheophylline are given concomitantly. No data is available for febuxostat 120\u00a0mg.</span></p>", "ID": "06181025-dde5-4387-b66f-9ec2b5e5d283", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>An interaction study in healthy\nsubjects has been performed with febuxostat to evaluate whether the inhibition\nof XO may cause an increase in the theophylline circulating levels as reported\nwith other XO inhibitors. The results of the study showed that the\nco-administration of febuxostat 80\u00a0mg QD with theophylline 400\u00a0mg\nsingle dose has no effect on the pharmacokinetics or safety of theophylline.\nTherefore no special caution is advised when febuxostat 80\u00a0mg and\ntheophylline are given concomitantly. No data is available for febuxostat 120\u00a0mg.</span>", "ID": "b75c45ba-c24b-4575-8f82-8691be58087b", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "An interaction study in healthy subjects has been performed with febuxostat to evaluate whether the inhibition of XO may cause an increase in the theophylline circulating levels as reported with other XO inhibitors. The results of the study showed that the co-administration of febuxostat 80\u00a0mg QD with theophylline 400\u00a0mg single dose has no effect on the pharmacokinetics or safety of theophylline. Therefore no special caution is advised when febuxostat 80\u00a0mg and theophylline are given concomitantly. No data is available for febuxostat 120\u00a0mg.", "ParentId": "06181025-dde5-4387-b66f-9ec2b5e5d283"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "0d5342ce-0731-4acd-86f7-0f59c15da614", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "28fc269c-691d-473b-b1ba-567dd7443aef", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "0d5342ce-0731-4acd-86f7-0f59c15da614"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Naproxen and other inhibitors of\nglucuronidation</span></u></p>", "ID": "c82196b5-92b8-46a4-b56d-c0d556bd05c3", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Naproxen and other inhibitors of\nglucuronidation</span></u>", "ID": "f2b81e98-10bb-402c-8a33-f9db7517421d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c82196b5-92b8-46a4-b56d-c0d556bd05c3"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Naproxen and other inhibitors of\nglucuronidation</span>", "ID": "458a86ff-c889-4f42-a6f0-437571533a0c", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Naproxen and other inhibitors of glucuronidation", "ParentId": "f2b81e98-10bb-402c-8a33-f9db7517421d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "6904feca-3995-499f-8751-34c189e45382", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "02acd10a-d009-456c-a28a-7f43d44db1d2", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "6904feca-3995-499f-8751-34c189e45382"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat metabolism depends on\nUridine Glucuronosyl Transferase (UGT) enzymes. Medicinal products that inhibit\nglucuronidation, such as NSAIDs and probenecid, could in theory affect the elimination\nof febuxostat. In healthy subjects concomitant use of febuxostat and naproxen\n250\u00a0mg twice daily was associated with an increase in febuxostat exposure\n(C<sub>max</sub> 28%, AUC 41% and t<sub>1/2 </sub>26%). In clinical studies the\nuse of naproxen or other NSAIDs/Cox-2 inhibitors was not related to any clinically\nsignificant increase in adverse events.</span></p>", "ID": "d7958f05-5e6a-4a42-9810-61057791c393", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat metabolism depends on\nUridine Glucuronosyl Transferase (UGT) enzymes. Medicinal products that inhibit\nglucuronidation, such as NSAIDs and probenecid, could in theory affect the elimination\nof febuxostat. In healthy subjects concomitant use of febuxostat and naproxen\n250\u00a0mg twice daily was associated with an increase in febuxostat exposure\n(C<sub>max</sub> 28%, AUC 41% and t<sub>1/2 </sub>26%). In clinical studies the\nuse of naproxen or other NSAIDs/Cox-2 inhibitors was not related to any clinically\nsignificant increase in adverse events.</span>", "ID": "fe26461a-cf09-40a1-9918-bcc457e5c5b8", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Febuxostat metabolism depends on Uridine Glucuronosyl Transferase (UGT) enzymes. Medicinal products that inhibit glucuronidation, such as NSAIDs and probenecid, could in theory affect the elimination of febuxostat. In healthy subjects concomitant use of febuxostat and naproxen 250\u00a0mg twice daily was associated with an increase in febuxostat exposure (C 28%, AUC 41% and t26%). In clinical studies the use of naproxen or other NSAIDs/Cox-2 inhibitors was not related to any clinically significant increase in adverse events.", "ParentId": "d7958f05-5e6a-4a42-9810-61057791c393"}, {"Element": "<sub>max</sub>", "ID": "e6308134-e783-4beb-9b84-29aced8948ec", "Styles": "None", "Classes": "None", "Text": "max", "ParentId": "fe26461a-cf09-40a1-9918-bcc457e5c5b8"}, {"Element": "<sub>1/2 </sub>", "ID": "aa0ea2c5-f9ba-41dd-8daf-d645e1c684cc", "Styles": "None", "Classes": "None", "Text": "1/2 ", "ParentId": "fe26461a-cf09-40a1-9918-bcc457e5c5b8"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "28c5604c-f093-408c-bd76-fada7f5e7a34", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "6e65e0a2-6c38-4349-8c91-d6afa47a2717", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "28c5604c-f093-408c-bd76-fada7f5e7a34"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat can be co-administered\nwith naproxen with no dose adjustment of febuxostat or naproxen being\nnecessary.</span></p>", "ID": "130f08b2-ca37-40d4-ae23-59c96425fd49", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat can be co-administered\nwith naproxen with no dose adjustment of febuxostat or naproxen being\nnecessary.</span>", "ID": "7691578c-065e-4d48-976d-6a7e97a55204", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Febuxostat can be co-administered with naproxen with no dose adjustment of febuxostat or naproxen being necessary.", "ParentId": "130f08b2-ca37-40d4-ae23-59c96425fd49"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "59d98f43-9057-4f5d-a5e2-0750fc731737", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "6608f03a-f59f-4d21-a9ce-ed1e0ace8f87", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "59d98f43-9057-4f5d-a5e2-0750fc731737"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Inducers of glucuronidation</span></u></p>", "ID": "f9d2ce09-c9a0-4c86-a7ce-84aad6e561d7", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Inducers of glucuronidation</span></u>", "ID": "de880374-dc2d-452c-8b00-9c0d25dd798d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f9d2ce09-c9a0-4c86-a7ce-84aad6e561d7"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Inducers of glucuronidation</span>", "ID": "e47dd9c8-5f97-4897-a372-01c3688fa843", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Inducers of glucuronidation", "ParentId": "de880374-dc2d-452c-8b00-9c0d25dd798d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "79f595f5-bb29-4dbd-badf-7682cd510c18", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "1c7b7404-93b1-41aa-a3dc-b119d07667cf", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "79f595f5-bb29-4dbd-badf-7682cd510c18"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Potent inducers of UGT enzymes\nmight possibly lead to increased metabolism and decreased efficacy of\nfebuxostat. Monitoring of serum uric acid is therefore recommended 1-2 weeks\nafter start of treatment with a potent inducer of glucuronidation. Conversely,\ncessation of treatment of an inducer might lead to increased plasma levels of\nfebuxostat.</span></p>", "ID": "03ab334a-9669-4765-8edf-c0176d667fb2", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Potent inducers of UGT enzymes\nmight possibly lead to increased metabolism and decreased efficacy of\nfebuxostat. Monitoring of serum uric acid is therefore recommended 1-2 weeks\nafter start of treatment with a potent inducer of glucuronidation. Conversely,\ncessation of treatment of an inducer might lead to increased plasma levels of\nfebuxostat.</span>", "ID": "4d0e403d-4e8d-4df4-b01f-05cfbf46638d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Potent inducers of UGT enzymes might possibly lead to increased metabolism and decreased efficacy of febuxostat. Monitoring of serum uric acid is therefore recommended 1-2 weeks after start of treatment with a potent inducer of glucuronidation. Conversely, cessation of treatment of an inducer might lead to increased plasma levels of febuxostat.", "ParentId": "03ab334a-9669-4765-8edf-c0176d667fb2"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "fba7ced3-09fb-4c02-800a-bca45ca433ac", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "4b8ead42-b0e8-408c-9553-9eb65ac54739", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "fba7ced3-09fb-4c02-800a-bca45ca433ac"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Colchicine/indometacin/hydrochlorothiazide/warfarin</span></u></p>", "ID": "597dc668-269e-415f-b616-a88f24f78347", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Colchicine/indometacin/hydrochlorothiazide/warfarin</span></u>", "ID": "9a987c68-c436-429d-bdf9-5a4b88efc7d3", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "597dc668-269e-415f-b616-a88f24f78347"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Colchicine/indometacin/hydrochlorothiazide/warfarin</span>", "ID": "fb630fe5-f292-4c7f-9595-536dd78e171a", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Colchicine/indometacin/hydrochlorothiazide/warfarin", "ParentId": "9a987c68-c436-429d-bdf9-5a4b88efc7d3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "f463f556-ee24-4114-9f9a-638b0463d4b9", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "62cfe95d-60aa-49c1-81d1-6b33aeb3e94b", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "f463f556-ee24-4114-9f9a-638b0463d4b9"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat can be co-administered\nwith colchicine or indomethacin with no dose adjustment of febuxostat or the\nco-administered active substance being necessary.</span></p>", "ID": "5255a8b5-075e-41ec-a5f1-e1bfea3b6580", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat can be co-administered\nwith colchicine or indomethacin with no dose adjustment of febuxostat or the\nco-administered active substance being necessary.</span>", "ID": "6a9f5ea6-4b31-4c40-a630-42e1c5338112", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Febuxostat can be co-administered with colchicine or indomethacin with no dose adjustment of febuxostat or the co-administered active substance being necessary.", "ParentId": "5255a8b5-075e-41ec-a5f1-e1bfea3b6580"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "081edbfe-4f07-4bbd-b786-a752e78df132", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "693b9d5a-d809-4ee8-a8bb-e923a6f8f043", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "081edbfe-4f07-4bbd-b786-a752e78df132"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>No dose adjustment is necessary for\nfebuxostat when administered with hydrochlorothiazide.</span></p>", "ID": "c090783b-b4cd-496e-b4d7-9e89e4c3ec8a", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>No dose adjustment is necessary for\nfebuxostat when administered with hydrochlorothiazide.</span>", "ID": "5d23ee96-5bf4-4c4e-a300-1df1c06ad792", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "No dose adjustment is necessary for febuxostat when administered with hydrochlorothiazide.", "ParentId": "c090783b-b4cd-496e-b4d7-9e89e4c3ec8a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "93c44841-34dc-4e01-b233-7bf491864a86", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "066ca943-07a7-4b4e-9bbe-df261d4084b5", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "93c44841-34dc-4e01-b233-7bf491864a86"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>No dose adjustment is necessary for\nwarfarin when administered with febuxostat. Administration of febuxostat (80\u00a0mg\nor 120\u00a0mg once daily) with warfarin had no effect on the pharmacokinetics\nof warfarin in healthy subjects. INR and Factor VII activity were also not\naffected by the co- administration of febuxostat.</span></p>", "ID": "914a2b7b-1e62-4be4-ae61-ed42cb3b73d5", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>No dose adjustment is necessary for\nwarfarin when administered with febuxostat. Administration of febuxostat (80\u00a0mg\nor 120\u00a0mg once daily) with warfarin had no effect on the pharmacokinetics\nof warfarin in healthy subjects. INR and Factor VII activity were also not\naffected by the co- administration of febuxostat.</span>", "ID": "161d51d2-8b2b-450c-8795-24e15f98e545", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "No dose adjustment is necessary for warfarin when administered with febuxostat. Administration of febuxostat (80\u00a0mg or 120\u00a0mg once daily) with warfarin had no effect on the pharmacokinetics of warfarin in healthy subjects. INR and Factor VII activity were also not affected by the co- administration of febuxostat.", "ParentId": "914a2b7b-1e62-4be4-ae61-ed42cb3b73d5"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "e62d5a23-21bb-475e-bb1c-137b7ea2beda", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "7fa2aab3-76cb-4688-b2a7-70f98a462138", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "e62d5a23-21bb-475e-bb1c-137b7ea2beda"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Desipramine/CYP2D6 substrates</span></u></p>", "ID": "7a793922-0979-433e-b042-f81cc22d06bd", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Desipramine/CYP2D6 substrates</span></u>", "ID": "b2297ec4-632b-460c-8252-d1d93ca01ec9", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "7a793922-0979-433e-b042-f81cc22d06bd"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Desipramine/CYP2D6 substrates</span>", "ID": "9ec27e8d-848d-43a0-8f62-dc900e39c9b5", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Desipramine/CYP2D6 substrates", "ParentId": "b2297ec4-632b-460c-8252-d1d93ca01ec9"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "2e932483-1c90-4336-b241-72590b6fa013", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "f60ac103-334e-4500-ae61-b7b2f4d3b2c8", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "2e932483-1c90-4336-b241-72590b6fa013"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat was shown to be a weak\ninhibitor of CYP2D6 <i>in vitro. </i>In a study in healthy subjects, 120\u00a0mg\nfebuxostat QD resulted in a mean 22% increase in AUC of desipramine, a CYP2D6\nsubstrate indicating a potential weak inhibitory effect of febuxostat on the\nCYP2D6 enzyme <i>in vivo</i>.</span></p>", "ID": "7850f2b4-7f8c-4914-a4a5-ece5dc76a0a1", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat was shown to be a weak\ninhibitor of CYP2D6 <i>in vitro. </i>In a study in healthy subjects, 120\u00a0mg\nfebuxostat QD resulted in a mean 22% increase in AUC of desipramine, a CYP2D6\nsubstrate indicating a potential weak inhibitory effect of febuxostat on the\nCYP2D6 enzyme <i>in vivo</i>.</span>", "ID": "c459eb02-ae6c-4800-88e3-c598b92fa7f1", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Febuxostat was shown to be a weak inhibitor of CYP2D6 In a study in healthy subjects, 120\u00a0mg febuxostat QD resulted in a mean 22% increase in AUC of desipramine, a CYP2D6 substrate indicating a potential weak inhibitory effect of febuxostat on the CYP2D6 enzyme .", "ParentId": "7850f2b4-7f8c-4914-a4a5-ece5dc76a0a1"}, {"Element": "<i>in vitro. </i>", "ID": "8f2a7fbc-43e5-4dff-898f-8066552f6e0a", "Styles": "None", "Classes": "None", "Text": "in vitro. ", "ParentId": "c459eb02-ae6c-4800-88e3-c598b92fa7f1"}, {"Element": "<i>in vivo</i>", "ID": "9f60351c-3bc6-4ec4-bee0-b02bf662cd39", "Styles": "None", "Classes": "None", "Text": "in vivo", "ParentId": "c459eb02-ae6c-4800-88e3-c598b92fa7f1"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "07e572ef-fe3c-4c68-8c67-93d254304732", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "0e1236a7-28a1-486b-a595-23091ccf22c6", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "07e572ef-fe3c-4c68-8c67-93d254304732"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Thus, co-administration of\nfebuxostat with other CYP2D6 substrates is not expected to require any dose\nadjustment for those compounds.</span></p>", "ID": "35999730-c100-4fc0-bcb2-1055bc8ca0ca", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Thus, co-administration of\nfebuxostat with other CYP2D6 substrates is not expected to require any dose\nadjustment for those compounds.</span>", "ID": "cf03336f-9419-4c17-8051-77950618729d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Thus, co-administration of febuxostat with other CYP2D6 substrates is not expected to require any dose adjustment for those compounds.", "ParentId": "35999730-c100-4fc0-bcb2-1055bc8ca0ca"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "1a31042f-6fac-4ad2-a7d7-00841465ccd1", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "dfdca7e1-5b27-495b-a716-11c19a533cf1", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "1a31042f-6fac-4ad2-a7d7-00841465ccd1"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Antacids</span></u></p>", "ID": "01417bd7-35ba-4de9-bf7b-337d921e533f", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Antacids</span></u>", "ID": "562d590f-bc75-41ce-a4b6-4674e198fb7b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "01417bd7-35ba-4de9-bf7b-337d921e533f"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Antacids</span>", "ID": "01fd5921-6370-4e22-92d6-3a9647771e17", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Antacids", "ParentId": "562d590f-bc75-41ce-a4b6-4674e198fb7b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "2bc05552-9b05-4dd2-80cf-bf3565df103f", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "77d3c971-5964-4a2c-b977-0022166458cd", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "2bc05552-9b05-4dd2-80cf-bf3565df103f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Concomitant ingestion of an antacid\ncontaining magnesium hydroxide and aluminium hydroxide has been shown to delay\nabsorption of febuxostat (approximately 1 hour) and to cause a 32% decrease in C<sub>max</sub>,\nbut no significant change in AUC was observed. Therefore, febuxostat may be\ntaken without regard to antacid use.</span></p>", "ID": "b6bc7bd6-7684-4d78-bfc9-1aa0562f84dc", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Concomitant ingestion of an antacid\ncontaining magnesium hydroxide and aluminium hydroxide has been shown to delay\nabsorption of febuxostat (approximately 1 hour) and to cause a 32% decrease in C<sub>max</sub>,\nbut no significant change in AUC was observed. Therefore, febuxostat may be\ntaken without regard to antacid use.</span>", "ID": "2500aee8-cd50-45ce-8576-cc58f7527b70", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Concomitant ingestion of an antacid containing magnesium hydroxide and aluminium hydroxide has been shown to delay absorption of febuxostat (approximately 1 hour) and to cause a 32% decrease in C, but no significant change in AUC was observed. Therefore, febuxostat may be taken without regard to antacid use.", "ParentId": "b6bc7bd6-7684-4d78-bfc9-1aa0562f84dc"}, {"Element": "<sub>max</sub>", "ID": "8f6248a4-f691-4014-82e4-4303838a4151", "Styles": "None", "Classes": "None", "Text": "max", "ParentId": "2500aee8-cd50-45ce-8576-cc58f7527b70"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "5c1446ad-b105-42b9-9ab7-8bf733957bf3", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "dfeb99f3-1965-4f53-9d95-25805ccf8d36", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "5c1446ad-b105-42b9-9ab7-8bf733957bf3"}, {"Element": "<h1 style=\"margin-right:3.1pt\"><span lang=\"EN-GB\">4.6\u00a0\u00a0\u00a0\u00a0 Fertility, pregnancy\nand lactation</span></h1>", "ID": "653a8956-79a2-41ab-8593-b313b3cda5fd", "Styles": "margin-right:3.1pt", "Classes": "None", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\">4.6\u00a0\u00a0\u00a0\u00a0 Fertility, pregnancy\nand lactation</span>", "ID": "80b3eaf3-4909-4296-aa6d-51126974d0ee", "Styles": "None", "Classes": "None", "Text": "4.6\u00a0\u00a0\u00a0\u00a0 Fertility, pregnancy and lactation", "ParentId": "653a8956-79a2-41ab-8593-b313b3cda5fd"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "662a2946-4093-478a-8ccb-5b4bb6850d7a", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "6601f317-9c0e-4722-b976-d680554d5633", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "662a2946-4093-478a-8ccb-5b4bb6850d7a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Pregnancy</span></u></p>", "ID": "7fc7db40-1bf9-4b17-b840-163a78356c8d", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Pregnancy</span></u>", "ID": "87673b46-1cde-489f-9335-a89221f775be", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "7fc7db40-1bf9-4b17-b840-163a78356c8d"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Pregnancy</span>", "ID": "eb2f18b9-25dd-4d9a-8fa8-b47f714f238f", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Pregnancy", "ParentId": "87673b46-1cde-489f-9335-a89221f775be"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "927025f1-d258-4ba7-bbe1-e48e3f2c72f2", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "d9b28aaa-e17b-4a10-a054-046b7125fe99", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "927025f1-d258-4ba7-bbe1-e48e3f2c72f2"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Data on a very limited number of\nexposed pregnancies have not indicated any adverse effects of febuxostat on\npregnancy or on the health of the foetus/new born child. Animal studies do not\nindicate direct or indirect harmful effects with respect to pregnancy,\nembryonal/foetal development or parturition (see section 5.3). The potential\nrisk for human is unknown. Febuxostat should not be used during pregnancy.</span></p>", "ID": "30b60e2f-3fa8-4818-8201-1de98a6d6e40", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Data on a very limited number of\nexposed pregnancies have not indicated any adverse effects of febuxostat on\npregnancy or on the health of the foetus/new born child. Animal studies do not\nindicate direct or indirect harmful effects with respect to pregnancy,\nembryonal/foetal development or parturition (see section 5.3). The potential\nrisk for human is unknown. Febuxostat should not be used during pregnancy.</span>", "ID": "7c9ddf8a-b773-4bf7-988d-c611a015d772", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Data on a very limited number of exposed pregnancies have not indicated any adverse effects of febuxostat on pregnancy or on the health of the foetus/new born child. Animal studies do not indicate direct or indirect harmful effects with respect to pregnancy, embryonal/foetal development or parturition (see section 5.3). The potential risk for human is unknown. Febuxostat should not be used during pregnancy.", "ParentId": "30b60e2f-3fa8-4818-8201-1de98a6d6e40"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "d5aa728c-8f68-4558-96da-eeb031520447", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "32b55cad-dbe8-4c2a-b99b-d49c58c31b6b", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "d5aa728c-8f68-4558-96da-eeb031520447"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Breast-feeding</span></u></p>", "ID": "6eb7470e-3aa3-4f57-9887-a8371b5a3bb6", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Breast-feeding</span></u>", "ID": "b58239df-fc07-4774-b71e-c2b87a8218af", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6eb7470e-3aa3-4f57-9887-a8371b5a3bb6"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Breast-feeding</span>", "ID": "503e7cec-d68e-4a09-a6b3-6ce2336410f9", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Breast-feeding", "ParentId": "b58239df-fc07-4774-b71e-c2b87a8218af"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "1e44c396-ab7f-492a-9913-96459d5bcf3e", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "c3067089-5b06-4e7d-b825-b77067c5bd86", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "1e44c396-ab7f-492a-9913-96459d5bcf3e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>It is unknown whether febuxostat is\nexcreted in human breast milk. Animal studies have shown excretion of this\nactive substance in breast milk and an impaired development of suckling pups. A\nrisk to a suckling infant cannot be excluded. Febuxostat should not be used\nwhile breast-feeding.</span></p>", "ID": "2985e8c0-5256-4b1e-b379-a115d4191754", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>It is unknown whether febuxostat is\nexcreted in human breast milk. Animal studies have shown excretion of this\nactive substance in breast milk and an impaired development of suckling pups. A\nrisk to a suckling infant cannot be excluded. Febuxostat should not be used\nwhile breast-feeding.</span>", "ID": "f5d6d84d-d2ad-4982-93b5-6fd1d446084f", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "It is unknown whether febuxostat is excreted in human breast milk. Animal studies have shown excretion of this active substance in breast milk and an impaired development of suckling pups. A risk to a suckling infant cannot be excluded. Febuxostat should not be used while breast-feeding.", "ParentId": "2985e8c0-5256-4b1e-b379-a115d4191754"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "44336803-03c6-4e78-adf8-3748da5fc603", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "bb7694c6-ef8d-4960-8441-73b4e8ea7b84", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "44336803-03c6-4e78-adf8-3748da5fc603"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Fertility</span></u></p>", "ID": "ad3cfea2-5bbd-4f8b-8639-576b5a72fc44", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Fertility</span></u>", "ID": "57c33245-5673-4108-9c12-128d403ada10", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ad3cfea2-5bbd-4f8b-8639-576b5a72fc44"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Fertility</span>", "ID": "4ff9e5b2-2194-4655-9e2e-8ec9c99cec37", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Fertility", "ParentId": "57c33245-5673-4108-9c12-128d403ada10"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "47c69dc7-ed46-4ac4-aed7-1bf7e4416a49", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "fb246407-dcf2-4ca2-adce-371b7e7ca4f9", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "47c69dc7-ed46-4ac4-aed7-1bf7e4416a49"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>In animals, reproduction studies up\nto 48\u00a0mg/kg/day showed no dose-dependent adverse effects on fertility (see\nsection 5.3). The effect of febuxostat on human fertility is unknown.</span></p>", "ID": "c4c40ec3-dff1-47ec-8390-8f640b4535bc", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>In animals, reproduction studies up\nto 48\u00a0mg/kg/day showed no dose-dependent adverse effects on fertility (see\nsection 5.3). The effect of febuxostat on human fertility is unknown.</span>", "ID": "a0e138b0-2603-4384-b6a6-346c17657610", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "In animals, reproduction studies up to 48\u00a0mg/kg/day showed no dose-dependent adverse effects on fertility (see section 5.3). The effect of febuxostat on human fertility is unknown.", "ParentId": "c4c40ec3-dff1-47ec-8390-8f640b4535bc"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "3cd65895-63d8-49a1-b0f2-7c77b3873ede", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "f592c7be-093b-4163-9caf-d752e49fc19c", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "3cd65895-63d8-49a1-b0f2-7c77b3873ede"}, {"Element": "<h1 style=\"margin-right:3.1pt\"><span lang=\"EN-GB\">4.7\u00a0\u00a0\u00a0\u00a0 Effects on ability to\ndrive and use machines</span></h1>", "ID": "86ba1c2f-ab77-450a-a62a-f4e541a6add4", "Styles": "margin-right:3.1pt", "Classes": "None", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\">4.7\u00a0\u00a0\u00a0\u00a0 Effects on ability to\ndrive and use machines</span>", "ID": "57734d2b-600b-4387-8eb6-9e130f4e69d9", "Styles": "None", "Classes": "None", "Text": "4.7\u00a0\u00a0\u00a0\u00a0 Effects on ability to drive and use machines", "ParentId": "86ba1c2f-ab77-450a-a62a-f4e541a6add4"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "ca32d42d-bcc3-4a1d-8e85-cf18e603f2dc", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "76558993-a24b-41ae-8d4c-bcdbf8b0266e", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "ca32d42d-bcc3-4a1d-8e85-cf18e603f2dc"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Somnolence, dizziness, paraesthesia\nand blurred vision have been reported with the use of febuxostat. Patients\nshould exercise caution before driving, using machinery or participating in\ndangerous activities until they are reasonably certain that febuxostat does not\nadversely affect performance.</span></p>", "ID": "c72064d2-8d99-4654-bba2-2aabe91815a1", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Somnolence, dizziness, paraesthesia\nand blurred vision have been reported with the use of febuxostat. Patients\nshould exercise caution before driving, using machinery or participating in\ndangerous activities until they are reasonably certain that febuxostat does not\nadversely affect performance.</span>", "ID": "0bde72a4-b6bc-40b8-89fe-293706a2b77c", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Somnolence, dizziness, paraesthesia and blurred vision have been reported with the use of febuxostat. Patients should exercise caution before driving, using machinery or participating in dangerous activities until they are reasonably certain that febuxostat does not adversely affect performance.", "ParentId": "c72064d2-8d99-4654-bba2-2aabe91815a1"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "b5186c99-8418-4c4d-813b-a731940f21eb", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "5c106243-bdb9-4cb3-a439-a2baab713ba3", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "b5186c99-8418-4c4d-813b-a731940f21eb"}, {"Element": "<h1 style=\"margin-right:3.1pt\"><span lang=\"EN-GB\">4.8\u00a0\u00a0\u00a0\u00a0 Undesirable effects</span></h1>", "ID": "d9c5bcd4-135c-4a70-83e9-b2ef97149047", "Styles": "margin-right:3.1pt", "Classes": "None", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\">4.8\u00a0\u00a0\u00a0\u00a0 Undesirable effects</span>", "ID": "04e3fe06-e13c-482f-9c88-53fd240722b2", "Styles": "None", "Classes": "None", "Text": "4.8\u00a0\u00a0\u00a0\u00a0 Undesirable effects", "ParentId": "d9c5bcd4-135c-4a70-83e9-b2ef97149047"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "ff53411f-26a3-4caa-9f0d-e5f0faa7f3de", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "2f5b3812-9c08-4577-bcd7-6a9e12c769a6", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "ff53411f-26a3-4caa-9f0d-e5f0faa7f3de"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Summary of the safety profile</span></u></p>", "ID": "ae0189af-a0a0-4ba1-9e5f-9090a035723b", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Summary of the safety profile</span></u>", "ID": "87909a61-7098-48fa-bd55-debb960c982b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ae0189af-a0a0-4ba1-9e5f-9090a035723b"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Summary of the safety profile</span>", "ID": "5fca26a8-5f22-4f6c-a1fa-0c7c7e0fcf20", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Summary of the safety profile", "ParentId": "87909a61-7098-48fa-bd55-debb960c982b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "f211ff2b-240c-488c-9405-2752116a76e4", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "9516be6d-3f8b-44ef-864c-aad4bf57f6d8", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "f211ff2b-240c-488c-9405-2752116a76e4"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The most commonly reported adverse\nreactions in clinical trials (4,072 subjects treated at least with a dose from\n10\u00a0mg to 300\u00a0mg) and post-marketing experience are gout flares, liver\nfunction abnormalities, diarrhoea, nausea, headache, rash and oedema. These\nadverse reactions were mostly mild or moderate in severity. Rare serious\nhypersensitivity reactions to febuxostat, some of which were associated to\nsystemic symptoms, have occurred in the post-marketing experience.</span></p>", "ID": "14294008-91fe-4de2-9215-7cf8f6eee813", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The most commonly reported adverse\nreactions in clinical trials (4,072 subjects treated at least with a dose from\n10\u00a0mg to 300\u00a0mg) and post-marketing experience are gout flares, liver\nfunction abnormalities, diarrhoea, nausea, headache, rash and oedema. These\nadverse reactions were mostly mild or moderate in severity. Rare serious\nhypersensitivity reactions to febuxostat, some of which were associated to\nsystemic symptoms, have occurred in the post-marketing experience.</span>", "ID": "f28a9c9a-c703-4174-87d9-ab3e390a92a9", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "The most commonly reported adverse reactions in clinical trials (4,072 subjects treated at least with a dose from 10\u00a0mg to 300\u00a0mg) and post-marketing experience are gout flares, liver function abnormalities, diarrhoea, nausea, headache, rash and oedema. These adverse reactions were mostly mild or moderate in severity. Rare serious hypersensitivity reactions to febuxostat, some of which were associated to systemic symptoms, have occurred in the post-marketing experience.", "ParentId": "14294008-91fe-4de2-9215-7cf8f6eee813"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "534c6fec-3263-48cb-a35b-dab607545a98", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "96036b58-bd15-49a6-aae9-b4669bbea1f5", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "534c6fec-3263-48cb-a35b-dab607545a98"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Tabulated list of adverse reactions</span></u></p>", "ID": "4c6fed2a-c293-4356-8669-63c385704f52", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Tabulated list of adverse reactions</span></u>", "ID": "49beeafd-8a04-4134-9fe2-e36a8618267f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4c6fed2a-c293-4356-8669-63c385704f52"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Tabulated list of adverse reactions</span>", "ID": "9d604d82-1d71-40d2-93f3-419f95a1b96a", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Tabulated list of adverse reactions", "ParentId": "49beeafd-8a04-4134-9fe2-e36a8618267f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "16f83dff-62ba-4124-a6c0-0e356a0c3a69", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "ff49da04-2325-4db0-86d6-469e91e191e0", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "16f83dff-62ba-4124-a6c0-0e356a0c3a69"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common (\u22651/100 to &lt;1/10),\nuncommon (\u22651/1,000 to &lt;1/100) and rare (</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u22651/10,000 to &lt;1/1,000) adverse\nreactions occurring in patients treated with febuxostat are listed below.</span></p>", "ID": "247ecc69-828c-4f2a-acc4-f50ac3da527e", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common (\u22651/100 to &lt;1/10),\nuncommon (\u22651/1,000 to &lt;1/100) and rare (</span>", "ID": "d435b4a4-cfd1-436e-a9cc-cd7b53c6e95c", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Common (\u22651/100 to <1/10), uncommon (\u22651/1,000 to <1/100) and rare (", "ParentId": "247ecc69-828c-4f2a-acc4-f50ac3da527e"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u22651/10,000 to &lt;1/1,000) adverse\nreactions occurring in patients treated with febuxostat are listed below.</span>", "ID": "b4c123a3-c7f1-4824-bb5f-96278d2af42c", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u22651/10,000 to <1/1,000) adverse reactions occurring in patients treated with febuxostat are listed below.", "ParentId": "247ecc69-828c-4f2a-acc4-f50ac3da527e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "4ade6bed-b749-4d9b-ba5f-510c92856c3b", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "acfdfe4a-af30-4280-bf51-9f0882000ffc", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "4ade6bed-b749-4d9b-ba5f-510c92856c3b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Within each frequency grouping, adverse\nreactions are presented in order of decreasing seriousness.</span></p>", "ID": "7e3eeb7a-ae20-4669-afdc-332cf7428f5a", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Within each frequency grouping, adverse\nreactions are presented in order of decreasing seriousness.</span>", "ID": "e6853b34-c690-45d1-a041-6da9360ff804", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Within each frequency grouping, adverse reactions are presented in order of decreasing seriousness.", "ParentId": "7e3eeb7a-ae20-4669-afdc-332cf7428f5a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "4005f499-dd9b-4f67-a341-c8d1855246b7", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "bf56e188-01c2-4d11-be1a-3484e3e9a3c6", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "4005f499-dd9b-4f67-a341-c8d1855246b7"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Table 1: Adverse reactions in\ncombined phase 3, long-term extension studies and post-marketing experience</span></i></p>", "ID": "fd5ac421-2651-410a-9e5d-df0f178df151", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Table 1: Adverse reactions in\ncombined phase 3, long-term extension studies and post-marketing experience</span></i>", "ID": "9bf73b92-d094-41fe-9216-7e70cec83cd8", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "fd5ac421-2651-410a-9e5d-df0f178df151"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Table 1: Adverse reactions in\ncombined phase 3, long-term extension studies and post-marketing experience</span>", "ID": "4b225a6e-0b31-4b62-8418-51cf2c6b1278", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Table 1: Adverse reactions in combined phase 3, long-term extension studies and post-marketing experience", "ParentId": "9bf73b92-d094-41fe-9216-7e70cec83cd8"}, {"Element": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"margin-left:.25pt;border-collapse:collapse\" width=\"621\">\n<tr>\n<td style=\"width:161.4pt;border:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"215\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Blood and lymphatic\n  system</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>disorders</span></p>\n</td>\n<td style=\"width:304.65pt;border:solid black 1.0pt;\n  border-left:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Pancytopenia, <span style=\"color:black\">thrombocytopenia, agranulocytosis*</span></span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"215\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Immune system\n  disorders</span></p>\n</td>\n<td style=\"width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Anaphylactic\n  reaction*, drug hypersensitivity*</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"215\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Endocrine disorders</span></p>\n</td>\n<td style=\"width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Blood thyroid\n  stimulating hormone increased</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"215\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Eye disorders</span></p>\n</td>\n<td style=\"width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Blurred vision</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"215\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Metabolism and\n  nutrition</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>disorders</span></p>\n</td>\n<td style=\"width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common***</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Gout flares</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:31.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.7pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Diabetes mellitus,\n  hyperlipidemia, decrease appetite, weight increase</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.45pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Weight decrease,\n  increase appetite, anorexia</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"215\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Psychiatric disorders</span></p>\n</td>\n<td style=\"width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Libido decreased,\n  insomnia</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Nervousness</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"215\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Nervous system\n  disorders</span></p>\n</td>\n<td style=\"width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Headache</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.15pt;margin-right:16.8pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Dizziness,\n  paraesthesia, hemiparesis, somnolence, altered taste, hypoaesthesia, hyposmia</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"215\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.4pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Ear and labyrinth\n  disorders</span></p>\n</td>\n<td style=\"width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.4pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Tinnitus</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"215\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.4pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Cardiac disorders</span></p>\n</td>\n<td style=\"width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.4pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Atrial fibrillation,\n  palpitations, ECG abnormal</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"215\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.4pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Vascular disorders</span></p>\n</td>\n<td style=\"width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.4pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Hypertension,\n  flushing, hot flush</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"215\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.4pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Respiratory system\n  disorders</span></p>\n</td>\n<td style=\"width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.4pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Dyspnoea, bronchitis,\n  upper respiratory tract infection, cough</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"215\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.4pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Gastrointestinal\n  disorders</span></p>\n</td>\n<td style=\"width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.4pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Diarrhoea**, nausea</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon:</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:6.15pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Abdominal pain,\n  abdominal distension, gastro-oesophageal reflux disease, vomiting, dry mouth,\n  dyspepsia, constipation, frequent stools, flatulence, gastrointestinal\n  discomfort</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Pancreatitis, mouth\n  ulceration</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"215\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Hepato-biliary\n  disorders</span></p>\n</td>\n<td style=\"width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:159.3pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.7pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Liver function\n  abnormalities** <u>Uncommon</u></span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.45pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Cholelithiasis</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Hepatitis, jaundice*,\n  liver injury*</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"215\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.4pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Skin and subcutaneous\n  tissue</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>disorders</span></p>\n</td>\n<td style=\"width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.4pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.15pt;margin-right:42.6pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rash (including\n  various types of rash reported with lower frequencies, see below)</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:22.6pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.7pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Dermatitis, urticaria,\n  pruritus, skin discolouration, skin lesion, petechiae, rash macular, rash\n  maculopapular, rash papular</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.45pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:35.1pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.7pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Toxic epidermal\n  necrolysis*, Stevens-Johnson Syndrome*, angioedema*, drug reaction with\n  eosinophilia and systemic</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.45pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>symptoms*, generalized\n  rash (serious)*, erythema, exfoliative</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.25pt;margin-right:15.3pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>rash, rash follicular,\n  rash vesicular, rash pustular, rash pruritic*, rash erythematous, rash\n  morbillifom, alopecia, hyperhidrosis</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"215\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Musculoskeletal and\n  connective</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>tissue disorders</span></p>\n</td>\n<td style=\"width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:35.35pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.7pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Arthralgia, arthritis,\n  myalgia, musculoskeletal pain, muscle weakness, muscle spasm, muscle\n  tightness, bursitis</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.45pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rhabdomyolysis*, joint\n  stiffness, musculoskeletal stiffness</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"215\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Renal and urinary\n  disorders</span></p>\n</td>\n<td style=\"width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Renal failure,\n  nephrolithiasis, haematuria, pollakiuria, proteinuria</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Tubulointerstitial\n  nephritis*, micturition urgency</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"215\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Reproductive system\n  and breast</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>disorder</span></p>\n</td>\n<td style=\"width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Erectile dysfunction</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"215\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>General disorders and</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>administration site\n  conditions</span></p>\n</td>\n<td style=\"width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Oedema</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Fatigue, chest pain,\n  chest discomfort</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Thirst</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"215\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Investigations</span></p>\n</td>\n<td style=\"width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Blood amylase\n  increase, platelet count decrease, WBC decrease, lymphocyte count decrease,\n  blood creatine increase, blood creatinine increase, haemoglobin decrease,\n  blood urea increase, blood triglycerides increase, blood cholesterol\n  increase, haematocritic decrease, blood lactate dehydrogenase increased,\n  blood potassium increase</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Blood glucose\n  increase, activated partial thromboplastin time prolonged, red blood cell\n  count decrease, blood alkaline phosphatase increase, blood creatine\n  phosphokinase increase*</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:11.95pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:99%;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;line-height:99%;font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n</td>\n</tr>\n</table>", "ID": "f346cefe-6a91-424e-a283-2fa13df100ca", "Styles": "margin-left:.25pt;border-collapse:collapse", "Classes": "['MsoNormalTable']", "Text": "                    ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<tr>\n<td style=\"width:161.4pt;border:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"215\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Blood and lymphatic\n  system</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>disorders</span></p>\n</td>\n<td style=\"width:304.65pt;border:solid black 1.0pt;\n  border-left:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Pancytopenia, <span style=\"color:black\">thrombocytopenia, agranulocytosis*</span></span></p>\n</td>\n</tr>", "ID": "e015c433-e026-4922-9e39-41f6c1b3f08f", "Styles": "None", "Classes": "None", "Text": "   ", "ParentId": "f346cefe-6a91-424e-a283-2fa13df100ca"}, {"Element": "<td style=\"width:161.4pt;border:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"215\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Blood and lymphatic\n  system</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>disorders</span></p>\n</td>", "ID": "b5f55b46-4c4e-43fd-beb1-9b67cdd519a4", "Styles": "width:161.4pt;border:solid black 1.0pt;\n  padding:0in 0in 0in 0in", "Classes": "None", "Text": "   ", "ParentId": "e015c433-e026-4922-9e39-41f6c1b3f08f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Blood and lymphatic\n  system</span></p>", "ID": "66de4d42-1eec-4983-ae2d-aafe950cb480", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b5f55b46-4c4e-43fd-beb1-9b67cdd519a4"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Blood and lymphatic\n  system</span>", "ID": "31b91b76-f13c-4c1b-97e7-ae4a1040fe6d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Blood and lymphatic   system", "ParentId": "66de4d42-1eec-4983-ae2d-aafe950cb480"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>disorders</span></p>", "ID": "5bf93afc-56e4-4e48-b317-eee4be379405", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.6pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b5f55b46-4c4e-43fd-beb1-9b67cdd519a4"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>disorders</span>", "ID": "0c2d3308-c596-42fa-8c17-143dd35f2ca6", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "disorders", "ParentId": "5bf93afc-56e4-4e48-b317-eee4be379405"}, {"Element": "<td style=\"width:304.65pt;border:solid black 1.0pt;\n  border-left:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Pancytopenia, <span style=\"color:black\">thrombocytopenia, agranulocytosis*</span></span></p>\n</td>", "ID": "a7544401-a966-4150-9134-7747156c1da7", "Styles": "width:304.65pt;border:solid black 1.0pt;\n  border-left:none;padding:0in 0in 0in 0in", "Classes": "None", "Text": "   ", "ParentId": "e015c433-e026-4922-9e39-41f6c1b3f08f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>", "ID": "c3ad3901-16cf-4295-bc61-4d70a47517b5", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a7544401-a966-4150-9134-7747156c1da7"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u>", "ID": "f015167d-5f87-403a-a9a0-0e04cb82d94c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c3ad3901-16cf-4295-bc61-4d70a47517b5"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span>", "ID": "6616b100-b1a6-4148-91a8-ed98642a395a", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Rare", "ParentId": "f015167d-5f87-403a-a9a0-0e04cb82d94c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Pancytopenia, <span style=\"color:black\">thrombocytopenia, agranulocytosis*</span></span></p>", "ID": "66f5f930-600c-4f23-bd04-74f19fb70d59", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a7544401-a966-4150-9134-7747156c1da7"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Pancytopenia, <span style=\"color:black\">thrombocytopenia, agranulocytosis*</span></span>", "ID": "e12a4737-dfe4-493a-befd-64699be50a69", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Pancytopenia, ", "ParentId": "66f5f930-600c-4f23-bd04-74f19fb70d59"}, {"Element": "<span style=\"color:black\">thrombocytopenia, agranulocytosis*</span>", "ID": "c32e3238-7df0-4382-bc67-e19ef9abc094", "Styles": "color:black", "Classes": "None", "Text": "thrombocytopenia, agranulocytosis*", "ParentId": "e12a4737-dfe4-493a-befd-64699be50a69"}, {"Element": "<tr>\n<td style=\"width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"215\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Immune system\n  disorders</span></p>\n</td>\n<td style=\"width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Anaphylactic\n  reaction*, drug hypersensitivity*</span></p>\n</td>\n</tr>", "ID": "4d3b7019-33db-47b5-85f4-ed1f1624c3ee", "Styles": "None", "Classes": "None", "Text": "   ", "ParentId": "f346cefe-6a91-424e-a283-2fa13df100ca"}, {"Element": "<td style=\"width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"215\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Immune system\n  disorders</span></p>\n</td>", "ID": "58d1f98a-c00e-4122-b991-c0fabe338b49", "Styles": "width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in", "Classes": "None", "Text": "  ", "ParentId": "4d3b7019-33db-47b5-85f4-ed1f1624c3ee"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Immune system\n  disorders</span></p>", "ID": "37103244-b4c5-42d9-bbdf-4ad0ee9ce606", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "58d1f98a-c00e-4122-b991-c0fabe338b49"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Immune system\n  disorders</span>", "ID": "5d69d80f-24fb-48fa-8a1b-5befb15912c0", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Immune system   disorders", "ParentId": "37103244-b4c5-42d9-bbdf-4ad0ee9ce606"}, {"Element": "<td style=\"width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Anaphylactic\n  reaction*, drug hypersensitivity*</span></p>\n</td>", "ID": "46aee4f4-e209-47e0-ad93-0b823eafcedd", "Styles": "width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in", "Classes": "None", "Text": "   ", "ParentId": "4d3b7019-33db-47b5-85f4-ed1f1624c3ee"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>", "ID": "54a7f096-ba24-4b47-84c7-d86f45fb08bd", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "46aee4f4-e209-47e0-ad93-0b823eafcedd"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u>", "ID": "2984b558-9600-4093-9356-2721452a4fee", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "54a7f096-ba24-4b47-84c7-d86f45fb08bd"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span>", "ID": "949e75ca-b7b6-42ea-a3df-0307afab5b7e", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Rare", "ParentId": "2984b558-9600-4093-9356-2721452a4fee"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Anaphylactic\n  reaction*, drug hypersensitivity*</span></p>", "ID": "6279e760-06ac-4044-b085-11c02a3658ed", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "46aee4f4-e209-47e0-ad93-0b823eafcedd"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Anaphylactic\n  reaction*, drug hypersensitivity*</span>", "ID": "1d5b0bfb-fdb6-4abf-902a-343146e4e8a1", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Anaphylactic   reaction*, drug hypersensitivity*", "ParentId": "6279e760-06ac-4044-b085-11c02a3658ed"}, {"Element": "<tr>\n<td style=\"width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"215\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Endocrine disorders</span></p>\n</td>\n<td style=\"width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Blood thyroid\n  stimulating hormone increased</span></p>\n</td>\n</tr>", "ID": "26926ef3-a718-4617-a55d-548bd86b301d", "Styles": "None", "Classes": "None", "Text": "   ", "ParentId": "f346cefe-6a91-424e-a283-2fa13df100ca"}, {"Element": "<td style=\"width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"215\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Endocrine disorders</span></p>\n</td>", "ID": "25497ee3-7304-4b87-890b-ab7ee1a67b9d", "Styles": "width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in", "Classes": "None", "Text": "  ", "ParentId": "26926ef3-a718-4617-a55d-548bd86b301d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Endocrine disorders</span></p>", "ID": "5fe07fee-4be6-4073-9da6-9b9d54c1fa38", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "25497ee3-7304-4b87-890b-ab7ee1a67b9d"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Endocrine disorders</span>", "ID": "794b5d6f-aab1-4cff-bb17-30afe6733bca", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Endocrine disorders", "ParentId": "5fe07fee-4be6-4073-9da6-9b9d54c1fa38"}, {"Element": "<td style=\"width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Blood thyroid\n  stimulating hormone increased</span></p>\n</td>", "ID": "41e68297-6af5-4d39-82b5-6fd9b3847727", "Styles": "width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in", "Classes": "None", "Text": "   ", "ParentId": "26926ef3-a718-4617-a55d-548bd86b301d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>", "ID": "47c2f391-0bdb-4bd1-991a-e120db63da1a", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "41e68297-6af5-4d39-82b5-6fd9b3847727"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u>", "ID": "168613be-9f4a-4e26-b9cc-8cee0936f29b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "47c2f391-0bdb-4bd1-991a-e120db63da1a"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span>", "ID": "3c5be409-489a-4f49-a67b-920ee59ccfc7", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Uncommon", "ParentId": "168613be-9f4a-4e26-b9cc-8cee0936f29b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Blood thyroid\n  stimulating hormone increased</span></p>", "ID": "d2a0d845-be8f-470f-81e3-414071b37b5b", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "41e68297-6af5-4d39-82b5-6fd9b3847727"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Blood thyroid\n  stimulating hormone increased</span>", "ID": "3a4267d7-5f66-41d1-b893-5f97a2bdc19e", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Blood thyroid   stimulating hormone increased", "ParentId": "d2a0d845-be8f-470f-81e3-414071b37b5b"}, {"Element": "<tr>\n<td style=\"width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"215\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Eye disorders</span></p>\n</td>\n<td style=\"width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Blurred vision</span></p>\n</td>\n</tr>", "ID": "2bac77f2-0eee-44a8-ac22-767063cac5aa", "Styles": "None", "Classes": "None", "Text": "   ", "ParentId": "f346cefe-6a91-424e-a283-2fa13df100ca"}, {"Element": "<td style=\"width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"215\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Eye disorders</span></p>\n</td>", "ID": "db102ed8-5484-41b4-962d-529815fb1abc", "Styles": "width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in", "Classes": "None", "Text": "  ", "ParentId": "2bac77f2-0eee-44a8-ac22-767063cac5aa"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Eye disorders</span></p>", "ID": "239ec79c-065d-49bc-8b7b-e229fc444859", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "db102ed8-5484-41b4-962d-529815fb1abc"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Eye disorders</span>", "ID": "448e0cb3-d3e5-4f5e-8cda-9d8d5259dbb5", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Eye disorders", "ParentId": "239ec79c-065d-49bc-8b7b-e229fc444859"}, {"Element": "<td style=\"width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Blurred vision</span></p>\n</td>", "ID": "bac76849-dd27-4d27-b6bd-75626bf34cd2", "Styles": "width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in", "Classes": "None", "Text": "   ", "ParentId": "2bac77f2-0eee-44a8-ac22-767063cac5aa"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>", "ID": "ff2432b4-4253-4049-8008-7dcdf2d8d7ce", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac76849-dd27-4d27-b6bd-75626bf34cd2"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u>", "ID": "16186f56-8856-407e-9409-0d424236a3ec", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ff2432b4-4253-4049-8008-7dcdf2d8d7ce"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span>", "ID": "26fa5c6a-1468-4702-8a68-df6729d5a559", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Rare", "ParentId": "16186f56-8856-407e-9409-0d424236a3ec"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Blurred vision</span></p>", "ID": "22b4c168-a3fd-44a7-bf97-fb873f0419e7", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac76849-dd27-4d27-b6bd-75626bf34cd2"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Blurred vision</span>", "ID": "9c7d4819-e7b4-4527-aba4-7e23150c0ce5", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Blurred vision", "ParentId": "22b4c168-a3fd-44a7-bf97-fb873f0419e7"}, {"Element": "<tr>\n<td style=\"width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"215\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Metabolism and\n  nutrition</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>disorders</span></p>\n</td>\n<td style=\"width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common***</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Gout flares</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:31.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.7pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Diabetes mellitus,\n  hyperlipidemia, decrease appetite, weight increase</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.45pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Weight decrease,\n  increase appetite, anorexia</span></p>\n</td>\n</tr>", "ID": "e36e89b7-4283-4537-95a1-0a7cab17f8db", "Styles": "None", "Classes": "None", "Text": "   ", "ParentId": "f346cefe-6a91-424e-a283-2fa13df100ca"}, {"Element": "<td style=\"width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"215\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Metabolism and\n  nutrition</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>disorders</span></p>\n</td>", "ID": "520f1a66-a1d7-4924-bd68-6302e2d29876", "Styles": "width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in", "Classes": "None", "Text": "   ", "ParentId": "e36e89b7-4283-4537-95a1-0a7cab17f8db"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Metabolism and\n  nutrition</span></p>", "ID": "325fac40-6a8d-4dda-bfed-61432389e4cf", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "520f1a66-a1d7-4924-bd68-6302e2d29876"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Metabolism and\n  nutrition</span>", "ID": "c8c2cb81-1701-4248-ba8e-357e0490e2db", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Metabolism and   nutrition", "ParentId": "325fac40-6a8d-4dda-bfed-61432389e4cf"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>disorders</span></p>", "ID": "a5f86c71-61ed-4c8b-a5e3-d92108a9a5f0", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.6pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "520f1a66-a1d7-4924-bd68-6302e2d29876"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>disorders</span>", "ID": "335434eb-5e6c-476f-8cd2-e788414182df", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "disorders", "ParentId": "a5f86c71-61ed-4c8b-a5e3-d92108a9a5f0"}, {"Element": "<td style=\"width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common***</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Gout flares</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:31.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.7pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Diabetes mellitus,\n  hyperlipidemia, decrease appetite, weight increase</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.45pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Weight decrease,\n  increase appetite, anorexia</span></p>\n</td>", "ID": "b15fe23b-f23a-46af-beba-4788f041080c", "Styles": "width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in", "Classes": "None", "Text": "       ", "ParentId": "e36e89b7-4283-4537-95a1-0a7cab17f8db"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common***</span></u></p>", "ID": "d7e578af-9754-477f-859c-35e771b3e9eb", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b15fe23b-f23a-46af-beba-4788f041080c"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common***</span></u>", "ID": "194ff14d-a35a-4334-a19c-5dd7c105834c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d7e578af-9754-477f-859c-35e771b3e9eb"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common***</span>", "ID": "f8d9445f-2cbe-4be6-a971-ed33290de90d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Common***", "ParentId": "194ff14d-a35a-4334-a19c-5dd7c105834c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Gout flares</span></p>", "ID": "70fa386f-dd05-4e7f-8055-9ecdca20f4f3", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b15fe23b-f23a-46af-beba-4788f041080c"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Gout flares</span>", "ID": "ec8a0ad4-175b-45ec-bf98-615935c3b471", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Gout flares", "ParentId": "70fa386f-dd05-4e7f-8055-9ecdca20f4f3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>", "ID": "4523dede-243c-4ab7-8453-802b66ed3b72", "Styles": "margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b15fe23b-f23a-46af-beba-4788f041080c"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u>", "ID": "5794531b-2ada-48b8-aa3a-d12c7a3e8333", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4523dede-243c-4ab7-8453-802b66ed3b72"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span>", "ID": "ea43d0b8-5050-4118-9bb6-703a44049afe", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Uncommon", "ParentId": "5794531b-2ada-48b8-aa3a-d12c7a3e8333"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:31.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.7pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Diabetes mellitus,\n  hyperlipidemia, decrease appetite, weight increase</span></p>", "ID": "bf53deab-2506-47d8-8f54-81608dd00cf9", "Styles": "margin-top:.05pt;margin-right:31.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.7pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b15fe23b-f23a-46af-beba-4788f041080c"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Diabetes mellitus,\n  hyperlipidemia, decrease appetite, weight increase</span>", "ID": "6fb18edf-557f-49b6-bfdb-6b6774455ed7", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Diabetes mellitus,   hyperlipidemia, decrease appetite, weight increase", "ParentId": "bf53deab-2506-47d8-8f54-81608dd00cf9"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.45pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>", "ID": "7c51a227-18b7-4ee6-a946-8a89d2b169cc", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.45pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b15fe23b-f23a-46af-beba-4788f041080c"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u>", "ID": "300613e1-49b7-4b63-915f-1762be95d14f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "7c51a227-18b7-4ee6-a946-8a89d2b169cc"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span>", "ID": "d6305436-94dd-4182-8f2b-afeb37a5153a", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Rare", "ParentId": "300613e1-49b7-4b63-915f-1762be95d14f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Weight decrease,\n  increase appetite, anorexia</span></p>", "ID": "bf745239-7adb-4a88-938d-a4b093353be8", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b15fe23b-f23a-46af-beba-4788f041080c"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Weight decrease,\n  increase appetite, anorexia</span>", "ID": "ace65aec-db19-41a0-a1f8-d96112a89afa", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Weight decrease,   increase appetite, anorexia", "ParentId": "bf745239-7adb-4a88-938d-a4b093353be8"}, {"Element": "<tr>\n<td style=\"width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"215\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Psychiatric disorders</span></p>\n</td>\n<td style=\"width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Libido decreased,\n  insomnia</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Nervousness</span></p>\n</td>\n</tr>", "ID": "96d26249-fb7e-4694-b642-278acd63913d", "Styles": "None", "Classes": "None", "Text": "   ", "ParentId": "f346cefe-6a91-424e-a283-2fa13df100ca"}, {"Element": "<td style=\"width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"215\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Psychiatric disorders</span></p>\n</td>", "ID": "ee81eeed-957d-444c-a4e8-284f7d7ba402", "Styles": "width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in", "Classes": "None", "Text": "  ", "ParentId": "96d26249-fb7e-4694-b642-278acd63913d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Psychiatric disorders</span></p>", "ID": "96b2ebac-4e4b-486e-9102-39dc573ad0db", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ee81eeed-957d-444c-a4e8-284f7d7ba402"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Psychiatric disorders</span>", "ID": "8235947a-d4f0-44ce-996f-bdd2053cee1e", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Psychiatric disorders", "ParentId": "96b2ebac-4e4b-486e-9102-39dc573ad0db"}, {"Element": "<td style=\"width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Libido decreased,\n  insomnia</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Nervousness</span></p>\n</td>", "ID": "aaf74bcb-0c13-461e-a053-e6035893537a", "Styles": "width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in", "Classes": "None", "Text": "     ", "ParentId": "96d26249-fb7e-4694-b642-278acd63913d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>", "ID": "989edf60-6cef-4b87-bf44-635fb70c1ac9", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "aaf74bcb-0c13-461e-a053-e6035893537a"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u>", "ID": "c778a27f-88f6-47c0-83da-c7990f7f14dc", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "989edf60-6cef-4b87-bf44-635fb70c1ac9"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span>", "ID": "ed751241-015d-4d9c-be63-67646f8933b5", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Uncommon", "ParentId": "c778a27f-88f6-47c0-83da-c7990f7f14dc"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Libido decreased,\n  insomnia</span></p>", "ID": "f8f27a39-ca78-4e17-b19e-e807a4ce5856", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "aaf74bcb-0c13-461e-a053-e6035893537a"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Libido decreased,\n  insomnia</span>", "ID": "5cd9b7ac-da3e-4fbb-81aa-8e2e6f91faec", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Libido decreased,   insomnia", "ParentId": "f8f27a39-ca78-4e17-b19e-e807a4ce5856"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>", "ID": "2b333a71-74e7-4d1e-a19f-7f57ba1fb757", "Styles": "margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "aaf74bcb-0c13-461e-a053-e6035893537a"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u>", "ID": "a2946926-438f-4fb2-8411-7e2b87df979f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "2b333a71-74e7-4d1e-a19f-7f57ba1fb757"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span>", "ID": "732f63cf-4578-4f3c-864d-1aa1a0f04d55", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Rare", "ParentId": "a2946926-438f-4fb2-8411-7e2b87df979f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Nervousness</span></p>", "ID": "d1a3a1f0-17fc-482c-a760-39b68a872af0", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "aaf74bcb-0c13-461e-a053-e6035893537a"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Nervousness</span>", "ID": "119d0c84-83a6-48e4-b61e-571092ab93fc", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Nervousness", "ParentId": "d1a3a1f0-17fc-482c-a760-39b68a872af0"}, {"Element": "<tr>\n<td style=\"width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"215\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Nervous system\n  disorders</span></p>\n</td>\n<td style=\"width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Headache</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.15pt;margin-right:16.8pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Dizziness,\n  paraesthesia, hemiparesis, somnolence, altered taste, hypoaesthesia, hyposmia</span></p>\n</td>\n</tr>", "ID": "60a162d4-2f9b-4f61-8814-48dd9b4b3333", "Styles": "None", "Classes": "None", "Text": "   ", "ParentId": "f346cefe-6a91-424e-a283-2fa13df100ca"}, {"Element": "<td style=\"width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"215\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Nervous system\n  disorders</span></p>\n</td>", "ID": "4d8e0d0b-25b4-4ba4-b971-d30b915720d8", "Styles": "width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in", "Classes": "None", "Text": "  ", "ParentId": "60a162d4-2f9b-4f61-8814-48dd9b4b3333"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Nervous system\n  disorders</span></p>", "ID": "4c254c87-dfcf-4dc0-bca4-1417c2f26728", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "4d8e0d0b-25b4-4ba4-b971-d30b915720d8"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Nervous system\n  disorders</span>", "ID": "9075d216-a550-4e31-bef0-64afc90ae14f", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Nervous system   disorders", "ParentId": "4c254c87-dfcf-4dc0-bca4-1417c2f26728"}, {"Element": "<td style=\"width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Headache</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.15pt;margin-right:16.8pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Dizziness,\n  paraesthesia, hemiparesis, somnolence, altered taste, hypoaesthesia, hyposmia</span></p>\n</td>", "ID": "c17a96b8-06d8-4ec1-a226-a0802588cb99", "Styles": "width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in", "Classes": "None", "Text": "     ", "ParentId": "60a162d4-2f9b-4f61-8814-48dd9b4b3333"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common</span></u></p>", "ID": "9adba54f-58d5-41e6-b817-26d33b114690", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c17a96b8-06d8-4ec1-a226-a0802588cb99"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common</span></u>", "ID": "3fc25582-4adc-4bfc-af46-ec016f301dd5", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9adba54f-58d5-41e6-b817-26d33b114690"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common</span>", "ID": "c13e5294-15f1-4875-b4bf-2ee82e8ea643", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Common", "ParentId": "3fc25582-4adc-4bfc-af46-ec016f301dd5"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Headache</span></p>", "ID": "0599175d-6079-474a-a77a-0c257752e973", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c17a96b8-06d8-4ec1-a226-a0802588cb99"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Headache</span>", "ID": "6069ab4d-464e-4e54-8358-3f5d96ae136e", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Headache", "ParentId": "0599175d-6079-474a-a77a-0c257752e973"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>", "ID": "caaa8164-6a6c-4a59-ae8b-bfd907fe4926", "Styles": "margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c17a96b8-06d8-4ec1-a226-a0802588cb99"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u>", "ID": "1a691c30-3117-4256-82b5-ee1c4319ccde", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "caaa8164-6a6c-4a59-ae8b-bfd907fe4926"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span>", "ID": "18ea6ffd-cc75-42d3-b7f7-efe4fdbda489", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Uncommon", "ParentId": "1a691c30-3117-4256-82b5-ee1c4319ccde"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.15pt;margin-right:16.8pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Dizziness,\n  paraesthesia, hemiparesis, somnolence, altered taste, hypoaesthesia, hyposmia</span></p>", "ID": "4c0b3320-c50c-44da-9637-7ed8c5caf14b", "Styles": "margin-top:.15pt;margin-right:16.8pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c17a96b8-06d8-4ec1-a226-a0802588cb99"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Dizziness,\n  paraesthesia, hemiparesis, somnolence, altered taste, hypoaesthesia, hyposmia</span>", "ID": "e7509999-a580-4f3c-aec4-b050714396c3", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Dizziness,   paraesthesia, hemiparesis, somnolence, altered taste, hypoaesthesia, hyposmia", "ParentId": "4c0b3320-c50c-44da-9637-7ed8c5caf14b"}, {"Element": "<tr>\n<td style=\"width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"215\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.4pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Ear and labyrinth\n  disorders</span></p>\n</td>\n<td style=\"width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.4pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Tinnitus</span></p>\n</td>\n</tr>", "ID": "4785a4d6-280f-4ee1-9dc8-77423235b168", "Styles": "None", "Classes": "None", "Text": "   ", "ParentId": "f346cefe-6a91-424e-a283-2fa13df100ca"}, {"Element": "<td style=\"width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"215\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.4pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Ear and labyrinth\n  disorders</span></p>\n</td>", "ID": "e1788034-fcd5-491f-9ef3-ea44072ab3ce", "Styles": "width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in", "Classes": "None", "Text": "  ", "ParentId": "4785a4d6-280f-4ee1-9dc8-77423235b168"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.4pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Ear and labyrinth\n  disorders</span></p>", "ID": "44ee44c4-df51-4de3-8db9-f466dbbeaa49", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.4pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e1788034-fcd5-491f-9ef3-ea44072ab3ce"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Ear and labyrinth\n  disorders</span>", "ID": "a33e494f-4516-4f3a-b3e9-19e03dd3e114", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Ear and labyrinth   disorders", "ParentId": "44ee44c4-df51-4de3-8db9-f466dbbeaa49"}, {"Element": "<td style=\"width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.4pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Tinnitus</span></p>\n</td>", "ID": "80915f31-e042-469c-9f41-63ce78f8152b", "Styles": "width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in", "Classes": "None", "Text": "   ", "ParentId": "4785a4d6-280f-4ee1-9dc8-77423235b168"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.4pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>", "ID": "f9cde440-8571-4c25-8b14-10099d07542c", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.4pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "80915f31-e042-469c-9f41-63ce78f8152b"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u>", "ID": "263d85a0-6404-4549-86d3-3aa8b983854f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f9cde440-8571-4c25-8b14-10099d07542c"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span>", "ID": "412ff38a-51b5-4950-b484-15d44f67a795", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Rare", "ParentId": "263d85a0-6404-4549-86d3-3aa8b983854f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Tinnitus</span></p>", "ID": "36cacd50-e258-420a-bb83-92c6adfeae2c", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "80915f31-e042-469c-9f41-63ce78f8152b"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Tinnitus</span>", "ID": "b6431176-81c3-4b9a-8440-28afbb0a7bf8", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Tinnitus", "ParentId": "36cacd50-e258-420a-bb83-92c6adfeae2c"}, {"Element": "<tr>\n<td style=\"width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"215\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.4pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Cardiac disorders</span></p>\n</td>\n<td style=\"width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.4pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Atrial fibrillation,\n  palpitations, ECG abnormal</span></p>\n</td>\n</tr>", "ID": "26b157d1-0804-40e2-afef-6290ea016ecf", "Styles": "None", "Classes": "None", "Text": "   ", "ParentId": "f346cefe-6a91-424e-a283-2fa13df100ca"}, {"Element": "<td style=\"width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"215\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.4pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Cardiac disorders</span></p>\n</td>", "ID": "0d1d9a4a-7962-45c1-91a8-d4862b61b6d9", "Styles": "width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in", "Classes": "None", "Text": "  ", "ParentId": "26b157d1-0804-40e2-afef-6290ea016ecf"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.4pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Cardiac disorders</span></p>", "ID": "386c8ad7-b885-4ff4-9399-d4e22ebbc241", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.4pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0d1d9a4a-7962-45c1-91a8-d4862b61b6d9"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Cardiac disorders</span>", "ID": "c5737b00-11a2-4e60-93d9-4bc236b26e47", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Cardiac disorders", "ParentId": "386c8ad7-b885-4ff4-9399-d4e22ebbc241"}, {"Element": "<td style=\"width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.4pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Atrial fibrillation,\n  palpitations, ECG abnormal</span></p>\n</td>", "ID": "841383ca-a4b8-44b7-9af5-11bee0977376", "Styles": "width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in", "Classes": "None", "Text": "   ", "ParentId": "26b157d1-0804-40e2-afef-6290ea016ecf"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.4pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>", "ID": "d2dc4b07-11ea-4e2c-a38a-d4404205c667", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.4pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "841383ca-a4b8-44b7-9af5-11bee0977376"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u>", "ID": "ddfd4686-9fc0-4e04-a07b-67adeb5d35c0", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d2dc4b07-11ea-4e2c-a38a-d4404205c667"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span>", "ID": "95472223-f06d-458e-8ef6-d783774e392c", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Uncommon", "ParentId": "ddfd4686-9fc0-4e04-a07b-67adeb5d35c0"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Atrial fibrillation,\n  palpitations, ECG abnormal</span></p>", "ID": "7190f533-b5f7-4b42-8263-808244c10760", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "841383ca-a4b8-44b7-9af5-11bee0977376"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Atrial fibrillation,\n  palpitations, ECG abnormal</span>", "ID": "49261528-a262-4287-b7b4-e39fac961e59", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Atrial fibrillation,   palpitations, ECG abnormal", "ParentId": "7190f533-b5f7-4b42-8263-808244c10760"}, {"Element": "<tr>\n<td style=\"width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"215\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.4pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Vascular disorders</span></p>\n</td>\n<td style=\"width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.4pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Hypertension,\n  flushing, hot flush</span></p>\n</td>\n</tr>", "ID": "73dab819-b361-496c-a07e-e710b15fafd8", "Styles": "None", "Classes": "None", "Text": "   ", "ParentId": "f346cefe-6a91-424e-a283-2fa13df100ca"}, {"Element": "<td style=\"width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"215\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.4pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Vascular disorders</span></p>\n</td>", "ID": "fb2e03ab-299a-44ac-ba1b-28065c61b515", "Styles": "width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in", "Classes": "None", "Text": "  ", "ParentId": "73dab819-b361-496c-a07e-e710b15fafd8"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.4pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Vascular disorders</span></p>", "ID": "cc0cda0e-86e0-4b4a-8861-ddec40d18350", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.4pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fb2e03ab-299a-44ac-ba1b-28065c61b515"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Vascular disorders</span>", "ID": "556543bb-f4d1-40c6-9e14-5c0b5aadd051", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Vascular disorders", "ParentId": "cc0cda0e-86e0-4b4a-8861-ddec40d18350"}, {"Element": "<td style=\"width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.4pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Hypertension,\n  flushing, hot flush</span></p>\n</td>", "ID": "322fb369-5a9d-4b7b-9fce-99c8ce2dd675", "Styles": "width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in", "Classes": "None", "Text": "   ", "ParentId": "73dab819-b361-496c-a07e-e710b15fafd8"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.4pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>", "ID": "0eedd65f-58f6-4e61-952b-062610c988b6", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.4pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "322fb369-5a9d-4b7b-9fce-99c8ce2dd675"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u>", "ID": "01f3e18b-5173-46c5-9e01-091d8e680b5c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0eedd65f-58f6-4e61-952b-062610c988b6"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span>", "ID": "17216ab0-efce-46f4-a0e8-b5b92eb21a6b", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Uncommon", "ParentId": "01f3e18b-5173-46c5-9e01-091d8e680b5c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Hypertension,\n  flushing, hot flush</span></p>", "ID": "50ed4a36-774a-4cb1-90da-2ccb9e813783", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "322fb369-5a9d-4b7b-9fce-99c8ce2dd675"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Hypertension,\n  flushing, hot flush</span>", "ID": "216f630f-fdad-4a25-9aa0-d25bda286383", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Hypertension,   flushing, hot flush", "ParentId": "50ed4a36-774a-4cb1-90da-2ccb9e813783"}, {"Element": "<tr>\n<td style=\"width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"215\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.4pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Respiratory system\n  disorders</span></p>\n</td>\n<td style=\"width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.4pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Dyspnoea, bronchitis,\n  upper respiratory tract infection, cough</span></p>\n</td>\n</tr>", "ID": "5e381f8c-454e-40fd-9f3d-880be154f6fb", "Styles": "None", "Classes": "None", "Text": "   ", "ParentId": "f346cefe-6a91-424e-a283-2fa13df100ca"}, {"Element": "<td style=\"width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"215\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.4pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Respiratory system\n  disorders</span></p>\n</td>", "ID": "bc12969f-2622-45ba-9233-752b8d4f0e54", "Styles": "width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in", "Classes": "None", "Text": "  ", "ParentId": "5e381f8c-454e-40fd-9f3d-880be154f6fb"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.4pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Respiratory system\n  disorders</span></p>", "ID": "b374a529-d6ba-47ed-934f-f6084d19d891", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.4pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bc12969f-2622-45ba-9233-752b8d4f0e54"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Respiratory system\n  disorders</span>", "ID": "6c1ffebc-0340-4e4a-a264-78bedda67c27", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Respiratory system   disorders", "ParentId": "b374a529-d6ba-47ed-934f-f6084d19d891"}, {"Element": "<td style=\"width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.4pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Dyspnoea, bronchitis,\n  upper respiratory tract infection, cough</span></p>\n</td>", "ID": "83d7f31a-9988-4333-b609-017ab5a045d1", "Styles": "width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in", "Classes": "None", "Text": "   ", "ParentId": "5e381f8c-454e-40fd-9f3d-880be154f6fb"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.4pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>", "ID": "e000a976-50df-45ef-99b1-626884758645", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.4pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "83d7f31a-9988-4333-b609-017ab5a045d1"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u>", "ID": "c972c759-6f06-4e99-ab1c-57e172bccd05", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e000a976-50df-45ef-99b1-626884758645"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span>", "ID": "14242471-cf31-49fc-a3cb-5d0542a8ba6a", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Uncommon", "ParentId": "c972c759-6f06-4e99-ab1c-57e172bccd05"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Dyspnoea, bronchitis,\n  upper respiratory tract infection, cough</span></p>", "ID": "a6226b2b-908a-4a4d-a20c-a5b9be3089c2", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "83d7f31a-9988-4333-b609-017ab5a045d1"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Dyspnoea, bronchitis,\n  upper respiratory tract infection, cough</span>", "ID": "9135f916-e682-4360-8564-1f2a840d5ad3", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Dyspnoea, bronchitis,   upper respiratory tract infection, cough", "ParentId": "a6226b2b-908a-4a4d-a20c-a5b9be3089c2"}, {"Element": "<tr>\n<td style=\"width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"215\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.4pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Gastrointestinal\n  disorders</span></p>\n</td>\n<td style=\"width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.4pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Diarrhoea**, nausea</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon:</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:6.15pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Abdominal pain,\n  abdominal distension, gastro-oesophageal reflux disease, vomiting, dry mouth,\n  dyspepsia, constipation, frequent stools, flatulence, gastrointestinal\n  discomfort</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Pancreatitis, mouth\n  ulceration</span></p>\n</td>\n</tr>", "ID": "cf9dd663-cb4c-4fe8-af70-9ab899654630", "Styles": "None", "Classes": "None", "Text": "   ", "ParentId": "f346cefe-6a91-424e-a283-2fa13df100ca"}, {"Element": "<td style=\"width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"215\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.4pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Gastrointestinal\n  disorders</span></p>\n</td>", "ID": "481fe11e-21fb-4b29-b3a0-f254383f6068", "Styles": "width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in", "Classes": "None", "Text": "  ", "ParentId": "cf9dd663-cb4c-4fe8-af70-9ab899654630"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.4pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Gastrointestinal\n  disorders</span></p>", "ID": "751169c0-80a2-4e37-b67d-d27b255dc52e", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.4pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "481fe11e-21fb-4b29-b3a0-f254383f6068"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Gastrointestinal\n  disorders</span>", "ID": "2cf22d72-aa0c-4dac-a2ed-bdf8190eeeb6", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Gastrointestinal   disorders", "ParentId": "751169c0-80a2-4e37-b67d-d27b255dc52e"}, {"Element": "<td style=\"width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.4pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Diarrhoea**, nausea</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon:</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:6.15pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Abdominal pain,\n  abdominal distension, gastro-oesophageal reflux disease, vomiting, dry mouth,\n  dyspepsia, constipation, frequent stools, flatulence, gastrointestinal\n  discomfort</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Pancreatitis, mouth\n  ulceration</span></p>\n</td>", "ID": "3fee6e8a-ed53-4cc5-93cb-dc34617b0007", "Styles": "width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in", "Classes": "None", "Text": "       ", "ParentId": "cf9dd663-cb4c-4fe8-af70-9ab899654630"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.4pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common</span></u></p>", "ID": "95a0f9d8-f957-4d38-887f-2867c554ccf4", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.4pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3fee6e8a-ed53-4cc5-93cb-dc34617b0007"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common</span></u>", "ID": "22b0b4d0-2e11-4e71-a61b-4ad6819e3362", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "95a0f9d8-f957-4d38-887f-2867c554ccf4"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common</span>", "ID": "d501b290-0d84-491b-b712-a0a05ccc1c1a", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Common", "ParentId": "22b0b4d0-2e11-4e71-a61b-4ad6819e3362"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Diarrhoea**, nausea</span></p>", "ID": "79324bed-e830-4c67-a43b-145e1a068ce1", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3fee6e8a-ed53-4cc5-93cb-dc34617b0007"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Diarrhoea**, nausea</span>", "ID": "22aba4b7-832a-40b3-82a9-49a0d43b6999", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Diarrhoea**, nausea", "ParentId": "79324bed-e830-4c67-a43b-145e1a068ce1"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon:</span></u></p>", "ID": "eb71e672-b3c1-4df1-be47-4cb8bfac392d", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3fee6e8a-ed53-4cc5-93cb-dc34617b0007"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon:</span></u>", "ID": "7baa224b-b039-4842-8bee-92d244424502", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "eb71e672-b3c1-4df1-be47-4cb8bfac392d"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon:</span>", "ID": "ee8fc47a-6494-4246-a8e1-5a77be8f6eaa", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Uncommon:", "ParentId": "7baa224b-b039-4842-8bee-92d244424502"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:6.15pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Abdominal pain,\n  abdominal distension, gastro-oesophageal reflux disease, vomiting, dry mouth,\n  dyspepsia, constipation, frequent stools, flatulence, gastrointestinal\n  discomfort</span></p>", "ID": "3a2559a9-25ee-4820-bb8b-d9a58cfd286b", "Styles": "margin-top:.05pt;margin-right:6.15pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3fee6e8a-ed53-4cc5-93cb-dc34617b0007"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Abdominal pain,\n  abdominal distension, gastro-oesophageal reflux disease, vomiting, dry mouth,\n  dyspepsia, constipation, frequent stools, flatulence, gastrointestinal\n  discomfort</span>", "ID": "0b65df65-04ed-4729-bddd-247258376516", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Abdominal pain,   abdominal distension, gastro-oesophageal reflux disease, vomiting, dry mouth,   dyspepsia, constipation, frequent stools, flatulence, gastrointestinal   discomfort", "ParentId": "3a2559a9-25ee-4820-bb8b-d9a58cfd286b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>", "ID": "bd96595e-69ed-44d7-b416-fd7cd6dd8e65", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3fee6e8a-ed53-4cc5-93cb-dc34617b0007"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u>", "ID": "c7da1c1b-0864-437b-a1e6-3e8dd22b9c67", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "bd96595e-69ed-44d7-b416-fd7cd6dd8e65"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span>", "ID": "566a1e6f-cc4b-43ef-8885-373152381ceb", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Rare", "ParentId": "c7da1c1b-0864-437b-a1e6-3e8dd22b9c67"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Pancreatitis, mouth\n  ulceration</span></p>", "ID": "727993ce-213c-42fc-a21e-3e3b198cb016", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3fee6e8a-ed53-4cc5-93cb-dc34617b0007"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Pancreatitis, mouth\n  ulceration</span>", "ID": "2f505bd2-caa0-4806-b3ec-c2d0c19feb51", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Pancreatitis, mouth   ulceration", "ParentId": "727993ce-213c-42fc-a21e-3e3b198cb016"}, {"Element": "<tr>\n<td style=\"width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"215\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Hepato-biliary\n  disorders</span></p>\n</td>\n<td style=\"width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:159.3pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.7pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Liver function\n  abnormalities** <u>Uncommon</u></span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.45pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Cholelithiasis</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Hepatitis, jaundice*,\n  liver injury*</span></p>\n</td>\n</tr>", "ID": "0ac66976-00ba-4f82-be33-355fc6187ce5", "Styles": "None", "Classes": "None", "Text": "   ", "ParentId": "f346cefe-6a91-424e-a283-2fa13df100ca"}, {"Element": "<td style=\"width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"215\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Hepato-biliary\n  disorders</span></p>\n</td>", "ID": "b635ee74-642a-45ca-b523-fcc9ff0ede7b", "Styles": "width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in", "Classes": "None", "Text": "  ", "ParentId": "0ac66976-00ba-4f82-be33-355fc6187ce5"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Hepato-biliary\n  disorders</span></p>", "ID": "6813d6b5-d2d7-449e-b03c-af4a779892e6", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b635ee74-642a-45ca-b523-fcc9ff0ede7b"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Hepato-biliary\n  disorders</span>", "ID": "823ee0f0-639a-4562-bb33-bfd59e614f8b", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Hepato-biliary   disorders", "ParentId": "6813d6b5-d2d7-449e-b03c-af4a779892e6"}, {"Element": "<td style=\"width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:159.3pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.7pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Liver function\n  abnormalities** <u>Uncommon</u></span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.45pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Cholelithiasis</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Hepatitis, jaundice*,\n  liver injury*</span></p>\n</td>", "ID": "65348a28-0699-407f-807b-5fb949594620", "Styles": "width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in", "Classes": "None", "Text": "      ", "ParentId": "0ac66976-00ba-4f82-be33-355fc6187ce5"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common</span></u></p>", "ID": "7fe9dcf8-1bd6-4cd2-b200-823e800aa275", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "65348a28-0699-407f-807b-5fb949594620"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common</span></u>", "ID": "9d9d7b13-bc68-43b2-8ade-10aa8df8784e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "7fe9dcf8-1bd6-4cd2-b200-823e800aa275"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common</span>", "ID": "4fd65a30-86d0-424c-91ae-35368e8eef64", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Common", "ParentId": "9d9d7b13-bc68-43b2-8ade-10aa8df8784e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:159.3pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.7pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Liver function\n  abnormalities** <u>Uncommon</u></span></p>", "ID": "a781c84f-f317-4f6e-9ac6-3cba53254895", "Styles": "margin-top:.05pt;margin-right:159.3pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.7pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "65348a28-0699-407f-807b-5fb949594620"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Liver function\n  abnormalities** <u>Uncommon</u></span>", "ID": "19883a38-d579-48a6-a6e3-a263915c8fce", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Liver function   abnormalities** ", "ParentId": "a781c84f-f317-4f6e-9ac6-3cba53254895"}, {"Element": "<u>Uncommon</u>", "ID": "d56fbe45-c614-41b3-af5e-34458cc60147", "Styles": "None", "Classes": "None", "Text": "Uncommon", "ParentId": "19883a38-d579-48a6-a6e3-a263915c8fce"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.45pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Cholelithiasis</span></p>", "ID": "8103c729-0db9-4686-b065-02e2ca9c5d5b", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.45pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "65348a28-0699-407f-807b-5fb949594620"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Cholelithiasis</span>", "ID": "6590d839-0b6b-47c3-8457-69e2ae852a50", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Cholelithiasis", "ParentId": "8103c729-0db9-4686-b065-02e2ca9c5d5b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>", "ID": "c9f2c956-49b0-43a8-8217-e70c29a0e89f", "Styles": "margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "65348a28-0699-407f-807b-5fb949594620"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u>", "ID": "46a0840f-1177-4cad-a5db-f49646169eb1", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c9f2c956-49b0-43a8-8217-e70c29a0e89f"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span>", "ID": "248e2f2c-b483-4c0a-a8fd-1e262404df9e", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Rare", "ParentId": "46a0840f-1177-4cad-a5db-f49646169eb1"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Hepatitis, jaundice*,\n  liver injury*</span></p>", "ID": "7d869b70-ccea-40fa-ad4c-839e5084ce73", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "65348a28-0699-407f-807b-5fb949594620"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Hepatitis, jaundice*,\n  liver injury*</span>", "ID": "e7b2895a-e190-4fa5-a9c1-8045d6479e5b", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Hepatitis, jaundice*,   liver injury*", "ParentId": "7d869b70-ccea-40fa-ad4c-839e5084ce73"}, {"Element": "<tr>\n<td style=\"width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"215\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.4pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Skin and subcutaneous\n  tissue</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>disorders</span></p>\n</td>\n<td style=\"width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.4pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.15pt;margin-right:42.6pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rash (including\n  various types of rash reported with lower frequencies, see below)</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:22.6pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.7pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Dermatitis, urticaria,\n  pruritus, skin discolouration, skin lesion, petechiae, rash macular, rash\n  maculopapular, rash papular</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.45pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:35.1pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.7pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Toxic epidermal\n  necrolysis*, Stevens-Johnson Syndrome*, angioedema*, drug reaction with\n  eosinophilia and systemic</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.45pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>symptoms*, generalized\n  rash (serious)*, erythema, exfoliative</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.25pt;margin-right:15.3pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>rash, rash follicular,\n  rash vesicular, rash pustular, rash pruritic*, rash erythematous, rash\n  morbillifom, alopecia, hyperhidrosis</span></p>\n</td>\n</tr>", "ID": "94fcdbea-85ee-4a8d-bddb-ccad62ecbcd0", "Styles": "None", "Classes": "None", "Text": "   ", "ParentId": "f346cefe-6a91-424e-a283-2fa13df100ca"}, {"Element": "<td style=\"width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"215\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.4pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Skin and subcutaneous\n  tissue</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>disorders</span></p>\n</td>", "ID": "8b6799d9-36e5-4878-b982-e9101aa56431", "Styles": "width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in", "Classes": "None", "Text": "   ", "ParentId": "94fcdbea-85ee-4a8d-bddb-ccad62ecbcd0"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.4pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Skin and subcutaneous\n  tissue</span></p>", "ID": "100dab29-fb1f-4ee7-957a-91ea11464021", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.4pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "8b6799d9-36e5-4878-b982-e9101aa56431"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Skin and subcutaneous\n  tissue</span>", "ID": "922a4aa4-b1f9-48d6-a642-666860ca8212", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Skin and subcutaneous   tissue", "ParentId": "100dab29-fb1f-4ee7-957a-91ea11464021"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>disorders</span></p>", "ID": "46c2409b-8c68-4d4e-b7b9-fac251d1e64e", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.6pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "8b6799d9-36e5-4878-b982-e9101aa56431"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>disorders</span>", "ID": "1c1a9e7e-1d60-4bd8-b8c7-171402776d47", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "disorders", "ParentId": "46c2409b-8c68-4d4e-b7b9-fac251d1e64e"}, {"Element": "<td style=\"width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.4pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.15pt;margin-right:42.6pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rash (including\n  various types of rash reported with lower frequencies, see below)</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:22.6pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.7pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Dermatitis, urticaria,\n  pruritus, skin discolouration, skin lesion, petechiae, rash macular, rash\n  maculopapular, rash papular</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.45pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:35.1pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.7pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Toxic epidermal\n  necrolysis*, Stevens-Johnson Syndrome*, angioedema*, drug reaction with\n  eosinophilia and systemic</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.45pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>symptoms*, generalized\n  rash (serious)*, erythema, exfoliative</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.25pt;margin-right:15.3pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>rash, rash follicular,\n  rash vesicular, rash pustular, rash pruritic*, rash erythematous, rash\n  morbillifom, alopecia, hyperhidrosis</span></p>\n</td>", "ID": "f0fec96e-a5c6-4010-9ea8-6edd5433653d", "Styles": "width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in", "Classes": "None", "Text": "         ", "ParentId": "94fcdbea-85ee-4a8d-bddb-ccad62ecbcd0"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.4pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common</span></u></p>", "ID": "ff5f520f-da4b-476c-9815-50cc40b50be3", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.4pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f0fec96e-a5c6-4010-9ea8-6edd5433653d"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common</span></u>", "ID": "4cb7af15-10d0-4278-bbc4-182cc3688e48", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ff5f520f-da4b-476c-9815-50cc40b50be3"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common</span>", "ID": "d5c2b07f-da88-49db-a908-e4c42af08224", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Common", "ParentId": "4cb7af15-10d0-4278-bbc4-182cc3688e48"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.15pt;margin-right:42.6pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rash (including\n  various types of rash reported with lower frequencies, see below)</span></p>", "ID": "50394eb9-17e5-47d8-9603-ab2bf50f6713", "Styles": "margin-top:.15pt;margin-right:42.6pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f0fec96e-a5c6-4010-9ea8-6edd5433653d"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rash (including\n  various types of rash reported with lower frequencies, see below)</span>", "ID": "088c9082-99b9-45f5-a938-aaaf2379ef21", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Rash (including   various types of rash reported with lower frequencies, see below)", "ParentId": "50394eb9-17e5-47d8-9603-ab2bf50f6713"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>", "ID": "3667ae69-f4e4-4947-a57a-281b8fbbeb49", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f0fec96e-a5c6-4010-9ea8-6edd5433653d"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u>", "ID": "12a111c1-c8c9-43cf-b0ad-96998de5a646", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "3667ae69-f4e4-4947-a57a-281b8fbbeb49"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span>", "ID": "2702853b-9cb0-4078-b226-f26396286aaf", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Uncommon", "ParentId": "12a111c1-c8c9-43cf-b0ad-96998de5a646"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:22.6pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.7pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Dermatitis, urticaria,\n  pruritus, skin discolouration, skin lesion, petechiae, rash macular, rash\n  maculopapular, rash papular</span></p>", "ID": "cf6e86f4-7307-43bc-9608-eec275e52496", "Styles": "margin-top:.05pt;margin-right:22.6pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.7pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f0fec96e-a5c6-4010-9ea8-6edd5433653d"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Dermatitis, urticaria,\n  pruritus, skin discolouration, skin lesion, petechiae, rash macular, rash\n  maculopapular, rash papular</span>", "ID": "db91b01f-82dc-4d75-a2a8-ca6afc428263", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Dermatitis, urticaria,   pruritus, skin discolouration, skin lesion, petechiae, rash macular, rash   maculopapular, rash papular", "ParentId": "cf6e86f4-7307-43bc-9608-eec275e52496"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.45pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>", "ID": "ab9fc126-d581-473b-90fc-7fc49164e4e9", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.45pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f0fec96e-a5c6-4010-9ea8-6edd5433653d"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u>", "ID": "f43b30e5-8847-4d62-b7e4-8d5160c5a738", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ab9fc126-d581-473b-90fc-7fc49164e4e9"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span>", "ID": "4dec5d78-4d26-4387-8831-bead6c3f58a6", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Rare", "ParentId": "f43b30e5-8847-4d62-b7e4-8d5160c5a738"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:35.1pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.7pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Toxic epidermal\n  necrolysis*, Stevens-Johnson Syndrome*, angioedema*, drug reaction with\n  eosinophilia and systemic</span></p>", "ID": "e02051a9-ea69-4117-91e2-42573b3ad2ea", "Styles": "margin-top:.05pt;margin-right:35.1pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.7pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f0fec96e-a5c6-4010-9ea8-6edd5433653d"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Toxic epidermal\n  necrolysis*, Stevens-Johnson Syndrome*, angioedema*, drug reaction with\n  eosinophilia and systemic</span>", "ID": "8d31f3c6-7d1b-40d7-ac4e-b043582b6fcb", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Toxic epidermal   necrolysis*, Stevens-Johnson Syndrome*, angioedema*, drug reaction with   eosinophilia and systemic", "ParentId": "e02051a9-ea69-4117-91e2-42573b3ad2ea"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.45pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>symptoms*, generalized\n  rash (serious)*, erythema, exfoliative</span></p>", "ID": "130070be-6bf8-49f3-98fe-c4f58f3fb132", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.45pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f0fec96e-a5c6-4010-9ea8-6edd5433653d"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>symptoms*, generalized\n  rash (serious)*, erythema, exfoliative</span>", "ID": "f8867c47-aaae-4fb0-a201-722cd2d11ab4", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "symptoms*, generalized   rash (serious)*, erythema, exfoliative", "ParentId": "130070be-6bf8-49f3-98fe-c4f58f3fb132"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.25pt;margin-right:15.3pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>rash, rash follicular,\n  rash vesicular, rash pustular, rash pruritic*, rash erythematous, rash\n  morbillifom, alopecia, hyperhidrosis</span></p>", "ID": "314f74e8-9fe4-4c4b-809a-49f7850974ef", "Styles": "margin-top:.25pt;margin-right:15.3pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f0fec96e-a5c6-4010-9ea8-6edd5433653d"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>rash, rash follicular,\n  rash vesicular, rash pustular, rash pruritic*, rash erythematous, rash\n  morbillifom, alopecia, hyperhidrosis</span>", "ID": "3e7e8d97-d193-4a6f-a3a6-bc87d55df3cd", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "rash, rash follicular,   rash vesicular, rash pustular, rash pruritic*, rash erythematous, rash   morbillifom, alopecia, hyperhidrosis", "ParentId": "314f74e8-9fe4-4c4b-809a-49f7850974ef"}, {"Element": "<tr>\n<td style=\"width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"215\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Musculoskeletal and\n  connective</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>tissue disorders</span></p>\n</td>\n<td style=\"width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:35.35pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.7pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Arthralgia, arthritis,\n  myalgia, musculoskeletal pain, muscle weakness, muscle spasm, muscle\n  tightness, bursitis</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.45pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rhabdomyolysis*, joint\n  stiffness, musculoskeletal stiffness</span></p>\n</td>\n</tr>", "ID": "31f427b0-ba0a-4a99-bb2a-9717d3406fec", "Styles": "None", "Classes": "None", "Text": "   ", "ParentId": "f346cefe-6a91-424e-a283-2fa13df100ca"}, {"Element": "<td style=\"width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"215\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Musculoskeletal and\n  connective</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>tissue disorders</span></p>\n</td>", "ID": "c1204ead-5756-4b7f-8ace-f32323f06efd", "Styles": "width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in", "Classes": "None", "Text": "   ", "ParentId": "31f427b0-ba0a-4a99-bb2a-9717d3406fec"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Musculoskeletal and\n  connective</span></p>", "ID": "c7766c7d-4d7a-4671-8ef3-1983e0fc45c0", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c1204ead-5756-4b7f-8ace-f32323f06efd"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Musculoskeletal and\n  connective</span>", "ID": "cd876e0f-c56a-40c5-862e-bfa839bf0ee6", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Musculoskeletal and   connective", "ParentId": "c7766c7d-4d7a-4671-8ef3-1983e0fc45c0"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>tissue disorders</span></p>", "ID": "bb365889-e431-4d04-ab24-cbe65fb16cde", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.6pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c1204ead-5756-4b7f-8ace-f32323f06efd"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>tissue disorders</span>", "ID": "09b58d46-9935-4e7e-b368-ce3bf343d72e", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "tissue disorders", "ParentId": "bb365889-e431-4d04-ab24-cbe65fb16cde"}, {"Element": "<td style=\"width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:35.35pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.7pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Arthralgia, arthritis,\n  myalgia, musculoskeletal pain, muscle weakness, muscle spasm, muscle\n  tightness, bursitis</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.45pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rhabdomyolysis*, joint\n  stiffness, musculoskeletal stiffness</span></p>\n</td>", "ID": "d2c57a11-52b3-4804-b709-8bbcb6019dcc", "Styles": "width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in", "Classes": "None", "Text": "     ", "ParentId": "31f427b0-ba0a-4a99-bb2a-9717d3406fec"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>", "ID": "547d0e96-20e9-4d3a-aa9a-4737f13093c9", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d2c57a11-52b3-4804-b709-8bbcb6019dcc"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u>", "ID": "7d4a672d-96d5-45c9-bc99-af34922622aa", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "547d0e96-20e9-4d3a-aa9a-4737f13093c9"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span>", "ID": "8225260d-d9c7-4fcc-b4ab-06728c9f889a", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Uncommon", "ParentId": "7d4a672d-96d5-45c9-bc99-af34922622aa"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:35.35pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.7pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Arthralgia, arthritis,\n  myalgia, musculoskeletal pain, muscle weakness, muscle spasm, muscle\n  tightness, bursitis</span></p>", "ID": "a1e7470e-a8d3-4260-8ab0-1c9bd5496ca3", "Styles": "margin-top:.05pt;margin-right:35.35pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.7pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d2c57a11-52b3-4804-b709-8bbcb6019dcc"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Arthralgia, arthritis,\n  myalgia, musculoskeletal pain, muscle weakness, muscle spasm, muscle\n  tightness, bursitis</span>", "ID": "6e6008d8-9979-49dc-9136-585800cedbe0", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Arthralgia, arthritis,   myalgia, musculoskeletal pain, muscle weakness, muscle spasm, muscle   tightness, bursitis", "ParentId": "a1e7470e-a8d3-4260-8ab0-1c9bd5496ca3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.45pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>", "ID": "39432442-a148-4248-9ed7-7466f7eaa10b", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.45pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d2c57a11-52b3-4804-b709-8bbcb6019dcc"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u>", "ID": "5c3823a5-97c0-43c2-8f0d-67ab4a3d9d3a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "39432442-a148-4248-9ed7-7466f7eaa10b"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span>", "ID": "fec690c3-bb1c-432e-acba-d22dda5db2f0", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Rare", "ParentId": "5c3823a5-97c0-43c2-8f0d-67ab4a3d9d3a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rhabdomyolysis*, joint\n  stiffness, musculoskeletal stiffness</span></p>", "ID": "cde3aa7b-df04-4acb-85b7-26397963d8fc", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d2c57a11-52b3-4804-b709-8bbcb6019dcc"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rhabdomyolysis*, joint\n  stiffness, musculoskeletal stiffness</span>", "ID": "ef593b01-3185-49e8-b2e7-31b6b93105a7", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Rhabdomyolysis*, joint   stiffness, musculoskeletal stiffness", "ParentId": "cde3aa7b-df04-4acb-85b7-26397963d8fc"}, {"Element": "<tr>\n<td style=\"width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"215\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Renal and urinary\n  disorders</span></p>\n</td>\n<td style=\"width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Renal failure,\n  nephrolithiasis, haematuria, pollakiuria, proteinuria</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Tubulointerstitial\n  nephritis*, micturition urgency</span></p>\n</td>\n</tr>", "ID": "7417d85a-8a0f-4538-abe9-b464f56631d1", "Styles": "None", "Classes": "None", "Text": "   ", "ParentId": "f346cefe-6a91-424e-a283-2fa13df100ca"}, {"Element": "<td style=\"width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"215\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Renal and urinary\n  disorders</span></p>\n</td>", "ID": "ce1f483e-92e2-4e31-8e25-8f1540b3e074", "Styles": "width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in", "Classes": "None", "Text": "  ", "ParentId": "7417d85a-8a0f-4538-abe9-b464f56631d1"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Renal and urinary\n  disorders</span></p>", "ID": "c7f22d50-c946-4cfb-9db8-9f990f47abe9", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ce1f483e-92e2-4e31-8e25-8f1540b3e074"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Renal and urinary\n  disorders</span>", "ID": "fab2f979-ec02-4ad5-aec9-308115386c0b", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Renal and urinary   disorders", "ParentId": "c7f22d50-c946-4cfb-9db8-9f990f47abe9"}, {"Element": "<td style=\"width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Renal failure,\n  nephrolithiasis, haematuria, pollakiuria, proteinuria</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Tubulointerstitial\n  nephritis*, micturition urgency</span></p>\n</td>", "ID": "add78745-3f86-4807-9076-77123b34c5f4", "Styles": "width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in", "Classes": "None", "Text": "     ", "ParentId": "7417d85a-8a0f-4538-abe9-b464f56631d1"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>", "ID": "14bc9858-da05-40fc-96c8-f57155cc06d6", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "add78745-3f86-4807-9076-77123b34c5f4"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u>", "ID": "944d5e6a-fbe6-4715-bdca-1cb190bdcf9a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "14bc9858-da05-40fc-96c8-f57155cc06d6"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span>", "ID": "f422238d-b743-4939-940d-e751ceaa2615", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Uncommon", "ParentId": "944d5e6a-fbe6-4715-bdca-1cb190bdcf9a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Renal failure,\n  nephrolithiasis, haematuria, pollakiuria, proteinuria</span></p>", "ID": "f6ee3083-f835-4e1d-9f3f-42d7eeea46a8", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "add78745-3f86-4807-9076-77123b34c5f4"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Renal failure,\n  nephrolithiasis, haematuria, pollakiuria, proteinuria</span>", "ID": "4a08cb99-2fcc-4631-970d-f4baff7cf947", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Renal failure,   nephrolithiasis, haematuria, pollakiuria, proteinuria", "ParentId": "f6ee3083-f835-4e1d-9f3f-42d7eeea46a8"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>", "ID": "9109c6ba-6f3c-4a39-a203-c5bb99403ef0", "Styles": "margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "add78745-3f86-4807-9076-77123b34c5f4"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u>", "ID": "04ed28ce-192b-4534-98ae-919e9f7f6dec", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9109c6ba-6f3c-4a39-a203-c5bb99403ef0"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span>", "ID": "b8d09ce8-202e-4345-8605-738edeeba5b4", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Rare", "ParentId": "04ed28ce-192b-4534-98ae-919e9f7f6dec"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Tubulointerstitial\n  nephritis*, micturition urgency</span></p>", "ID": "6539b0c6-be44-4fef-a649-cb684d8f0490", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "add78745-3f86-4807-9076-77123b34c5f4"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Tubulointerstitial\n  nephritis*, micturition urgency</span>", "ID": "8470d7da-b44d-4496-b2a9-8b9cf4d70c2e", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Tubulointerstitial   nephritis*, micturition urgency", "ParentId": "6539b0c6-be44-4fef-a649-cb684d8f0490"}, {"Element": "<tr>\n<td style=\"width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"215\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Reproductive system\n  and breast</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>disorder</span></p>\n</td>\n<td style=\"width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Erectile dysfunction</span></p>\n</td>\n</tr>", "ID": "dffe3cc3-7ed7-4aa2-8808-4df60af5573e", "Styles": "None", "Classes": "None", "Text": "   ", "ParentId": "f346cefe-6a91-424e-a283-2fa13df100ca"}, {"Element": "<td style=\"width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"215\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Reproductive system\n  and breast</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>disorder</span></p>\n</td>", "ID": "4a9d4229-5904-4286-bdbd-e1ada6775e9c", "Styles": "width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in", "Classes": "None", "Text": "   ", "ParentId": "dffe3cc3-7ed7-4aa2-8808-4df60af5573e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Reproductive system\n  and breast</span></p>", "ID": "41a22022-0045-4b4b-a844-cc5e2a923423", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "4a9d4229-5904-4286-bdbd-e1ada6775e9c"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Reproductive system\n  and breast</span>", "ID": "601e0c21-8213-476d-9922-c58cf98fc90a", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Reproductive system   and breast", "ParentId": "41a22022-0045-4b4b-a844-cc5e2a923423"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>disorder</span></p>", "ID": "f0b0ca99-08db-4760-863a-a6eacee2673f", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.6pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "4a9d4229-5904-4286-bdbd-e1ada6775e9c"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>disorder</span>", "ID": "2b0923b2-64fa-4a9a-9fd4-3b938dc7a0b6", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "disorder", "ParentId": "f0b0ca99-08db-4760-863a-a6eacee2673f"}, {"Element": "<td style=\"width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Erectile dysfunction</span></p>\n</td>", "ID": "de463827-1aed-4dfd-ad02-649dcbd71053", "Styles": "width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in", "Classes": "None", "Text": "   ", "ParentId": "dffe3cc3-7ed7-4aa2-8808-4df60af5573e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>", "ID": "404868d9-747e-4347-be15-60099c29c04a", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "de463827-1aed-4dfd-ad02-649dcbd71053"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u>", "ID": "ee518bdb-4978-452a-b909-8394e136d06a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "404868d9-747e-4347-be15-60099c29c04a"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span>", "ID": "1333afe2-9278-421b-8424-ef9bcb2d1b96", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Uncommon", "ParentId": "ee518bdb-4978-452a-b909-8394e136d06a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Erectile dysfunction</span></p>", "ID": "9be21b58-861c-45ab-95b3-8e6038517599", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "de463827-1aed-4dfd-ad02-649dcbd71053"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Erectile dysfunction</span>", "ID": "f0429793-d14b-4ac4-86bd-46b2aaf47855", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Erectile dysfunction", "ParentId": "9be21b58-861c-45ab-95b3-8e6038517599"}, {"Element": "<tr>\n<td style=\"width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"215\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>General disorders and</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>administration site\n  conditions</span></p>\n</td>\n<td style=\"width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Oedema</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Fatigue, chest pain,\n  chest discomfort</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Thirst</span></p>\n</td>\n</tr>", "ID": "bd495eb4-234d-40a7-99a6-1026bf671737", "Styles": "None", "Classes": "None", "Text": "   ", "ParentId": "f346cefe-6a91-424e-a283-2fa13df100ca"}, {"Element": "<td style=\"width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"215\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>General disorders and</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>administration site\n  conditions</span></p>\n</td>", "ID": "992f0bd0-b8ff-4062-a0c4-67b3963e82be", "Styles": "width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in", "Classes": "None", "Text": "   ", "ParentId": "bd495eb4-234d-40a7-99a6-1026bf671737"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>General disorders and</span></p>", "ID": "7bb9fd0d-dc3b-4b27-9d51-969ec7cec209", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "992f0bd0-b8ff-4062-a0c4-67b3963e82be"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>General disorders and</span>", "ID": "b79f6a39-3426-40b3-82f6-f47cb5fe1755", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "General disorders and", "ParentId": "7bb9fd0d-dc3b-4b27-9d51-969ec7cec209"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>administration site\n  conditions</span></p>", "ID": "92127669-27e7-4b54-88d7-4b0a7887a325", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.6pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "992f0bd0-b8ff-4062-a0c4-67b3963e82be"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>administration site\n  conditions</span>", "ID": "7280adf7-c188-4ff7-9400-bb64d74648b8", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "administration site   conditions", "ParentId": "92127669-27e7-4b54-88d7-4b0a7887a325"}, {"Element": "<td style=\"width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Oedema</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Fatigue, chest pain,\n  chest discomfort</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Thirst</span></p>\n</td>", "ID": "96f26dd9-65dc-415b-844f-59f2b7deca7c", "Styles": "width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in", "Classes": "None", "Text": "       ", "ParentId": "bd495eb4-234d-40a7-99a6-1026bf671737"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common</span></u></p>", "ID": "d076ef84-fd68-4a01-bcda-8a6d67440c80", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "96f26dd9-65dc-415b-844f-59f2b7deca7c"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common</span></u>", "ID": "7688cc79-2a1f-4425-b75d-f27b50b6d887", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d076ef84-fd68-4a01-bcda-8a6d67440c80"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common</span>", "ID": "b3e521df-78b9-4fc1-9a28-015a270a37c3", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Common", "ParentId": "7688cc79-2a1f-4425-b75d-f27b50b6d887"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Oedema</span></p>", "ID": "cf1d83e3-2f46-4fd7-abda-cc10a863872f", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "96f26dd9-65dc-415b-844f-59f2b7deca7c"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Oedema</span>", "ID": "2ba5d785-641b-44ae-8c2b-fbb6a23a2194", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Oedema", "ParentId": "cf1d83e3-2f46-4fd7-abda-cc10a863872f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>", "ID": "a48ae1a3-f78b-467e-b500-6e5683ee2ad7", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "96f26dd9-65dc-415b-844f-59f2b7deca7c"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u>", "ID": "2747bd99-69df-40d1-8315-30669ac97067", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a48ae1a3-f78b-467e-b500-6e5683ee2ad7"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span>", "ID": "4315fd0f-4678-470c-9511-529b960ba394", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Uncommon", "ParentId": "2747bd99-69df-40d1-8315-30669ac97067"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Fatigue, chest pain,\n  chest discomfort</span></p>", "ID": "4b68ce78-202f-4191-9dbd-e6f739eda4e9", "Styles": "margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "96f26dd9-65dc-415b-844f-59f2b7deca7c"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Fatigue, chest pain,\n  chest discomfort</span>", "ID": "9c319c85-6e08-4ba3-95f9-e89ad29c5061", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Fatigue, chest pain,   chest discomfort", "ParentId": "4b68ce78-202f-4191-9dbd-e6f739eda4e9"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>", "ID": "39edff11-006d-476a-85e6-4ce74f0db07f", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "96f26dd9-65dc-415b-844f-59f2b7deca7c"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u>", "ID": "8435a82d-f9c0-4e1a-b7f0-05b39ad30ea8", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "39edff11-006d-476a-85e6-4ce74f0db07f"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span>", "ID": "48c66041-1478-4e3d-82cf-de206485c791", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Rare", "ParentId": "8435a82d-f9c0-4e1a-b7f0-05b39ad30ea8"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Thirst</span></p>", "ID": "b7b5b0c0-8120-4ec2-8e1d-9ad2c5688ec5", "Styles": "margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "96f26dd9-65dc-415b-844f-59f2b7deca7c"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Thirst</span>", "ID": "e9d0f9d7-a0ed-4e49-9fb5-b0b4011b42fc", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Thirst", "ParentId": "b7b5b0c0-8120-4ec2-8e1d-9ad2c5688ec5"}, {"Element": "<tr>\n<td style=\"width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"215\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Investigations</span></p>\n</td>\n<td style=\"width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Blood amylase\n  increase, platelet count decrease, WBC decrease, lymphocyte count decrease,\n  blood creatine increase, blood creatinine increase, haemoglobin decrease,\n  blood urea increase, blood triglycerides increase, blood cholesterol\n  increase, haematocritic decrease, blood lactate dehydrogenase increased,\n  blood potassium increase</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Blood glucose\n  increase, activated partial thromboplastin time prolonged, red blood cell\n  count decrease, blood alkaline phosphatase increase, blood creatine\n  phosphokinase increase*</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:11.95pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:99%;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;line-height:99%;font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n</td>\n</tr>", "ID": "24748caf-4305-4a6d-95bc-0e16fd49cdf2", "Styles": "None", "Classes": "None", "Text": "   ", "ParentId": "f346cefe-6a91-424e-a283-2fa13df100ca"}, {"Element": "<td style=\"width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"215\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Investigations</span></p>\n</td>", "ID": "bf7ceed7-f592-447f-ab89-699cdf957285", "Styles": "width:161.4pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in", "Classes": "None", "Text": "  ", "ParentId": "24748caf-4305-4a6d-95bc-0e16fd49cdf2"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Investigations</span></p>", "ID": "33b1c0ca-16be-46c8-98e0-5b4e56f0aa43", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bf7ceed7-f592-447f-ab89-699cdf957285"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Investigations</span>", "ID": "c8a77559-c97d-4509-b97a-4404998bc2d8", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Investigations", "ParentId": "33b1c0ca-16be-46c8-98e0-5b4e56f0aa43"}, {"Element": "<td style=\"width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Blood amylase\n  increase, platelet count decrease, WBC decrease, lymphocyte count decrease,\n  blood creatine increase, blood creatinine increase, haemoglobin decrease,\n  blood urea increase, blood triglycerides increase, blood cholesterol\n  increase, haematocritic decrease, blood lactate dehydrogenase increased,\n  blood potassium increase</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Blood glucose\n  increase, activated partial thromboplastin time prolonged, red blood cell\n  count decrease, blood alkaline phosphatase increase, blood creatine\n  phosphokinase increase*</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:11.95pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:99%;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;line-height:99%;font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n</td>", "ID": "0ac87cf3-2892-418e-893c-7412a38590d2", "Styles": "width:304.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in", "Classes": "None", "Text": "      ", "ParentId": "24748caf-4305-4a6d-95bc-0e16fd49cdf2"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>", "ID": "063df25f-6fc7-4086-b596-026375c1df83", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0ac87cf3-2892-418e-893c-7412a38590d2"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u>", "ID": "62eaba90-c2f1-41d5-9afd-6c595fa235e6", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "063df25f-6fc7-4086-b596-026375c1df83"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span>", "ID": "ad24799d-00e5-4c7d-b065-cd329085bf0f", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Uncommon", "ParentId": "62eaba90-c2f1-41d5-9afd-6c595fa235e6"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Blood amylase\n  increase, platelet count decrease, WBC decrease, lymphocyte count decrease,\n  blood creatine increase, blood creatinine increase, haemoglobin decrease,\n  blood urea increase, blood triglycerides increase, blood cholesterol\n  increase, haematocritic decrease, blood lactate dehydrogenase increased,\n  blood potassium increase</span></p>", "ID": "3d1f88b0-7033-4d3d-bec0-0834f7dbd023", "Styles": "margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0ac87cf3-2892-418e-893c-7412a38590d2"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Blood amylase\n  increase, platelet count decrease, WBC decrease, lymphocyte count decrease,\n  blood creatine increase, blood creatinine increase, haemoglobin decrease,\n  blood urea increase, blood triglycerides increase, blood cholesterol\n  increase, haematocritic decrease, blood lactate dehydrogenase increased,\n  blood potassium increase</span>", "ID": "99a28a77-b1f8-4b9f-bb8a-b68a696da4dc", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Blood amylase   increase, platelet count decrease, WBC decrease, lymphocyte count decrease,   blood creatine increase, blood creatinine increase, haemoglobin decrease,   blood urea increase, blood triglycerides increase, blood cholesterol   increase, haematocritic decrease, blood lactate dehydrogenase increased,   blood potassium increase", "ParentId": "3d1f88b0-7033-4d3d-bec0-0834f7dbd023"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>", "ID": "8bb799b8-4aac-4ab1-8a20-24bd6e4336a7", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0ac87cf3-2892-418e-893c-7412a38590d2"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u>", "ID": "5df52786-c2a6-4124-9a6c-f2dd9f95dbce", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "8bb799b8-4aac-4ab1-8a20-24bd6e4336a7"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span>", "ID": "b79cd9d9-beb4-4afd-a7de-31d7e1bf71e0", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Rare", "ParentId": "5df52786-c2a6-4124-9a6c-f2dd9f95dbce"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Blood glucose\n  increase, activated partial thromboplastin time prolonged, red blood cell\n  count decrease, blood alkaline phosphatase increase, blood creatine\n  phosphokinase increase*</span></p>", "ID": "68894a70-2411-44e9-abee-f6b8bd52152f", "Styles": "margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0ac87cf3-2892-418e-893c-7412a38590d2"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Blood glucose\n  increase, activated partial thromboplastin time prolonged, red blood cell\n  count decrease, blood alkaline phosphatase increase, blood creatine\n  phosphokinase increase*</span>", "ID": "95261edc-2f20-4f40-ab26-83bb8966d00a", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Blood glucose   increase, activated partial thromboplastin time prolonged, red blood cell   count decrease, blood alkaline phosphatase increase, blood creatine   phosphokinase increase*", "ParentId": "68894a70-2411-44e9-abee-f6b8bd52152f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:11.95pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:99%;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;line-height:99%;font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "818f2eb9-3992-4132-929e-f534f1127151", "Styles": "margin-top:.05pt;margin-right:11.95pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:99%;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0ac87cf3-2892-418e-893c-7412a38590d2"}, {"Element": "<span lang=\"EN-GB\" style='font-size:12.0pt;line-height:99%;font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "0a2b2b39-13ea-4462-b15c-778a366407e4", "Styles": "font-size:12.0pt;line-height:99%;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "818f2eb9-3992-4132-929e-f534f1127151"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:21.3pt;text-indent:-21.3pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>*</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0 Adverse reactions\ncoming from post-marketing experience</span></p>", "ID": "9831c828-49fd-40dd-b1c8-2609bd9a8eb5", "Styles": "margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:21.3pt;text-indent:-21.3pt;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>*</span>", "ID": "656e24d1-cec9-43e6-848c-724653dcde0f", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "*", "ParentId": "9831c828-49fd-40dd-b1c8-2609bd9a8eb5"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0 Adverse reactions\ncoming from post-marketing experience</span>", "ID": "e6cd0911-dcac-4715-9a10-994edda79548", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0 Adverse reactions coming from post-marketing experience", "ParentId": "9831c828-49fd-40dd-b1c8-2609bd9a8eb5"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:21.3pt;text-indent:-21.3pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>**\u00a0\u00a0 Treatment-emergent\nnon-infective diarrhoea and abnormal liver function tests in the combined Phase\n3 studies are more frequent in patients concomitantly treated with colchicine.</span></p>", "ID": "fb8164cc-789d-433f-a47b-e242334559ee", "Styles": "margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:21.3pt;text-indent:-21.3pt;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>**\u00a0\u00a0 Treatment-emergent\nnon-infective diarrhoea and abnormal liver function tests in the combined Phase\n3 studies are more frequent in patients concomitantly treated with colchicine.</span>", "ID": "ec1b1ef4-b2cf-4f2f-b253-9f298d8634ed", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "**\u00a0\u00a0 Treatment-emergent non-infective diarrhoea and abnormal liver function tests in the combined Phase 3 studies are more frequent in patients concomitantly treated with colchicine.", "ParentId": "fb8164cc-789d-433f-a47b-e242334559ee"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:21.3pt;text-indent:-21.3pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>*** See section 5.1 for\nincidences of gout flares in the individual Phase 3 randomized controlled\nstudies.</span></p>", "ID": "49f197d7-92ab-4495-8074-dee4711c3329", "Styles": "margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:21.3pt;text-indent:-21.3pt;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>*** See section 5.1 for\nincidences of gout flares in the individual Phase 3 randomized controlled\nstudies.</span>", "ID": "1079a8dd-2f79-419a-9344-caa9d7970bb2", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "*** See section 5.1 for incidences of gout flares in the individual Phase 3 randomized controlled studies.", "ParentId": "49f197d7-92ab-4495-8074-dee4711c3329"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "6f2a66ac-3d60-4888-a8a6-fa584d813856", "Styles": "margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "2c7afaaf-1974-4c07-b3bd-92a26ca4dbca", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "6f2a66ac-3d60-4888-a8a6-fa584d813856"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Description of selected adverse\nreactions</span></u></p>", "ID": "8d1a1081-0f6a-43d7-b8f8-283ed6304adb", "Styles": "margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Description of selected adverse\nreactions</span></u>", "ID": "d608b8d5-0956-4db8-b282-0ce878eaa5ce", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "8d1a1081-0f6a-43d7-b8f8-283ed6304adb"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Description of selected adverse\nreactions</span>", "ID": "023c1fe7-eea6-4e88-adef-6d5e635b6b8d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Description of selected adverse reactions", "ParentId": "d608b8d5-0956-4db8-b282-0ce878eaa5ce"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "45259607-9fcf-417a-8ebf-735582e5467b", "Styles": "margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "bc81c14c-448d-4abf-8826-cdb4beb4418e", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "45259607-9fcf-417a-8ebf-735582e5467b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare serious hypersensitivity\nreactions to febuxostat, including Stevens-Johnson Syndrome, Toxic epidermal\nnecrolysis and anaphylactic reaction/shock, have occurred in the post-marketing\nexperience. Stevens-Johnson Syndrome and Toxic epidermal necrolysis are\ncharacterised by progressive skin rashes associated with blisters or mucosal\nlesions and eye irritation. Hypersensitivity reactions to febuxostat can be\nassociated to the following symptoms: skin reactions characterised by\ninfiltrated maculopapular eruption, generalised or exfoliative rashes, but also\nskin lesions, facial oedema, fever, haematologic abnormalities such as\nthrombocytopenia and eosinophilia, and single or multiple organ involvement\n(liver and kidney including tubulointerstitial nephritis) (see section 4.4).</span></p>", "ID": "e3c5b779-ea4c-46af-ba9c-c2452735e407", "Styles": "margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare serious hypersensitivity\nreactions to febuxostat, including Stevens-Johnson Syndrome, Toxic epidermal\nnecrolysis and anaphylactic reaction/shock, have occurred in the post-marketing\nexperience. Stevens-Johnson Syndrome and Toxic epidermal necrolysis are\ncharacterised by progressive skin rashes associated with blisters or mucosal\nlesions and eye irritation. Hypersensitivity reactions to febuxostat can be\nassociated to the following symptoms: skin reactions characterised by\ninfiltrated maculopapular eruption, generalised or exfoliative rashes, but also\nskin lesions, facial oedema, fever, haematologic abnormalities such as\nthrombocytopenia and eosinophilia, and single or multiple organ involvement\n(liver and kidney including tubulointerstitial nephritis) (see section 4.4).</span>", "ID": "7730c2f8-f5bc-4d3f-b484-aa419986080a", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Rare serious hypersensitivity reactions to febuxostat, including Stevens-Johnson Syndrome, Toxic epidermal necrolysis and anaphylactic reaction/shock, have occurred in the post-marketing experience. Stevens-Johnson Syndrome and Toxic epidermal necrolysis are characterised by progressive skin rashes associated with blisters or mucosal lesions and eye irritation. Hypersensitivity reactions to febuxostat can be associated to the following symptoms: skin reactions characterised by infiltrated maculopapular eruption, generalised or exfoliative rashes, but also skin lesions, facial oedema, fever, haematologic abnormalities such as thrombocytopenia and eosinophilia, and single or multiple organ involvement (liver and kidney including tubulointerstitial nephritis) (see section 4.4).", "ParentId": "e3c5b779-ea4c-46af-ba9c-c2452735e407"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "6d64e9c7-3636-4732-bf89-779fb3b02fd2", "Styles": "margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "377e6e56-c7d1-4b1c-be3f-f241e857c113", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "6d64e9c7-3636-4732-bf89-779fb3b02fd2"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Gout flares were commonly observed\nsoon after the start of treatment and during the first months. Thereafter, the\nfrequency of gout flare decreases in a time-dependent manner. Gout flare\nprophylaxis is recommended (see section 4.2 and 4.4).</span></p>", "ID": "685d54ec-0eff-4321-a029-a1d5c41f9bd3", "Styles": "margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Gout flares were commonly observed\nsoon after the start of treatment and during the first months. Thereafter, the\nfrequency of gout flare decreases in a time-dependent manner. Gout flare\nprophylaxis is recommended (see section 4.2 and 4.4).</span>", "ID": "68244b66-0e1b-4f92-9a4b-cfb27c9de73d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Gout flares were commonly observed soon after the start of treatment and during the first months. Thereafter, the frequency of gout flare decreases in a time-dependent manner. Gout flare prophylaxis is recommended (see section 4.2 and 4.4).", "ParentId": "685d54ec-0eff-4321-a029-a1d5c41f9bd3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "a4987b13-bbe5-425b-9ec5-9a360d950c52", "Styles": "margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "d5809ad5-db2b-4f7d-bd26-bd3e38448320", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "a4987b13-bbe5-425b-9ec5-9a360d950c52"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Reporting of suspected adverse\nreactions</span></u></p>", "ID": "f1a342f1-d6a0-4f0b-8e58-ef2263eb710a", "Styles": "margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Reporting of suspected adverse\nreactions</span></u>", "ID": "87c4cdf5-d243-417b-b26d-220fcf3d6a87", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f1a342f1-d6a0-4f0b-8e58-ef2263eb710a"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Reporting of suspected adverse\nreactions</span>", "ID": "cf7a8c96-29c3-4f41-a395-f35f0b25bd9b", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Reporting of suspected adverse reactions", "ParentId": "87c4cdf5-d243-417b-b26d-220fcf3d6a87"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "a3938a4d-c3b0-4174-8bca-c31363ce9da5", "Styles": "margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "302577e8-39d8-4cb2-81d6-7cfaec005616", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "a3938a4d-c3b0-4174-8bca-c31363ce9da5"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Reporting suspected adverse\nreactions after authorisation of the medicinal product is important. It allows\ncontinued monitoring of the benefit/risk balance of the medicinal product.\nHealthcare professionals are asked to report any suspected adverse reactions\nvia the national reporting system listed in </span><span lang=\"EN-GB\"><a href=\"http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc\"><span style='font-family:\"Times New Roman\",serif;color:windowtext'>Appendix V.</span></a></span></p>", "ID": "61d3fbdf-a76a-44b2-8613-727bbd68a87f", "Styles": "margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Reporting suspected adverse\nreactions after authorisation of the medicinal product is important. It allows\ncontinued monitoring of the benefit/risk balance of the medicinal product.\nHealthcare professionals are asked to report any suspected adverse reactions\nvia the national reporting system listed in </span>", "ID": "3404756a-7dcf-4f71-8683-c2f328a0b6ed", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system listed in ", "ParentId": "61d3fbdf-a76a-44b2-8613-727bbd68a87f"}, {"Element": "<span lang=\"EN-GB\"><a href=\"http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc\"><span style='font-family:\"Times New Roman\",serif;color:windowtext'>Appendix V.</span></a></span>", "ID": "d19883fa-3509-4820-9253-ea1d87e2f4ab", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "61d3fbdf-a76a-44b2-8613-727bbd68a87f"}, {"Element": "<a href=\"http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc\"><span style='font-family:\"Times New Roman\",serif;color:windowtext'>Appendix V.</span></a>", "ID": "4cf40a5d-7634-45b7-ad80-9f285ae77539", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d19883fa-3509-4820-9253-ea1d87e2f4ab"}, {"Element": "<span style='font-family:\"Times New Roman\",serif;color:windowtext'>Appendix V.</span>", "ID": "f7a5a16f-85f7-42d8-b684-8cd4a5b4e5f4", "Styles": "font-family:\"Times New Roman\",serif;color:windowtext", "Classes": "None", "Text": "Appendix V.", "ParentId": "4cf40a5d-7634-45b7-ad80-9f285ae77539"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "4b4eb593-7ffb-4992-8112-9f9e85f3bff7", "Styles": "margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "cff6b358-63a8-4cf9-b378-c588603bc171", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "4b4eb593-7ffb-4992-8112-9f9e85f3bff7"}, {"Element": "<h1 style=\"margin-right:3.3pt\"><span lang=\"EN-GB\">4.9\u00a0\u00a0\u00a0\u00a0 Overdose</span></h1>", "ID": "430413b9-845c-4a34-b182-16e66ef8c40a", "Styles": "margin-right:3.3pt", "Classes": "None", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\">4.9\u00a0\u00a0\u00a0\u00a0 Overdose</span>", "ID": "338728d5-c8a6-4f89-a963-395a399982b9", "Styles": "None", "Classes": "None", "Text": "4.9\u00a0\u00a0\u00a0\u00a0 Overdose", "ParentId": "430413b9-845c-4a34-b182-16e66ef8c40a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "5feda817-60a4-4dcd-b81f-00093ddcc1c4", "Styles": "margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "572be6b3-e265-426d-8105-00b7d14d2ddb", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "5feda817-60a4-4dcd-b81f-00093ddcc1c4"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Patients with an overdose should be\nmanaged by symptomatic and supportive care.</span></p>", "ID": "9a53f801-bb5a-4c5e-a574-d488dffc9fdd", "Styles": "margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Patients with an overdose should be\nmanaged by symptomatic and supportive care.</span>", "ID": "5d5c746e-93a3-4784-8cc4-528d9798d099", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Patients with an overdose should be managed by symptomatic and supportive care.", "ParentId": "9a53f801-bb5a-4c5e-a574-d488dffc9fdd"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "db8dd497-b5ab-4937-b56e-d475509c17ac", "Styles": "margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "55abb388-cc4b-4971-8a2d-016d88fc9b00", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "db8dd497-b5ab-4937-b56e-d475509c17ac"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "beafb699-e1dc-45e0-a918-c8d5745ad4b3", "Styles": "margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "c79c10d9-10ba-4671-9176-d5aeecdbb83a", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "beafb699-e1dc-45e0-a918-c8d5745ad4b3"}, {"Element": "<h1 style=\"margin-right:3.3pt\"><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACOLOGICAL\nPROPERTIES</span></h1>", "ID": "252da77b-25d9-47e0-9356-fdf5cac60510", "Styles": "margin-right:3.3pt", "Classes": "None", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACOLOGICAL\nPROPERTIES</span>", "ID": "dafa264b-dcde-45f8-9ec6-1df6bed22405", "Styles": "None", "Classes": "None", "Text": "5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACOLOGICAL PROPERTIES", "ParentId": "252da77b-25d9-47e0-9356-fdf5cac60510"}, {"Element": "<h1 style=\"margin-right:3.3pt\"><span lang=\"EN-GB\">\u00a0</span></h1>", "ID": "5ddc660a-929c-4df5-b6ea-832896e4282f", "Styles": "margin-right:3.3pt", "Classes": "None", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "991b8919-66bb-4c51-bc22-56e963fbba9a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "5ddc660a-929c-4df5-b6ea-832896e4282f"}, {"Element": "<h1 style=\"margin-right:3.3pt\"><span lang=\"EN-GB\">5.1\u00a0\u00a0\u00a0\u00a0 Pharmacodynamic\nproperties</span></h1>", "ID": "6b8729d7-6e92-4105-a2b0-8927449d2055", "Styles": "margin-right:3.3pt", "Classes": "None", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\">5.1\u00a0\u00a0\u00a0\u00a0 Pharmacodynamic\nproperties</span>", "ID": "8ae91c2d-984a-4f3b-81b6-2759d5920670", "Styles": "None", "Classes": "None", "Text": "5.1\u00a0\u00a0\u00a0\u00a0 Pharmacodynamic properties", "ParentId": "6b8729d7-6e92-4105-a2b0-8927449d2055"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "4a6e13e4-02c0-4c55-9241-db22c9c4fc71", "Styles": "margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "2c078b47-4802-4cf7-aaba-9e110f5bac06", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "4a6e13e4-02c0-4c55-9241-db22c9c4fc71"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Pharmacotherapeutic group: Antigout\npreparation, preparations inhibiting uric acid production, ATC code: M04AA03</span></p>", "ID": "12243db3-bc27-459c-aa5a-f24c5cdbe054", "Styles": "margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Pharmacotherapeutic group: Antigout\npreparation, preparations inhibiting uric acid production, ATC code: M04AA03</span>", "ID": "660c23c5-3e42-466d-aaa9-b33b545a7227", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Pharmacotherapeutic group: Antigout preparation, preparations inhibiting uric acid production, ATC code: M04AA03", "ParentId": "12243db3-bc27-459c-aa5a-f24c5cdbe054"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "88db4637-bcac-457c-82dd-a05e8e205d06", "Styles": "margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "35469130-9148-4654-a3d3-93e1daeba2fe", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "88db4637-bcac-457c-82dd-a05e8e205d06"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Mechanism of action</span></u></p>", "ID": "fbf8455b-b903-4003-8192-009b733eacf4", "Styles": "margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Mechanism of action</span></u>", "ID": "8f634673-c502-4052-bae8-e5903c2737a2", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "fbf8455b-b903-4003-8192-009b733eacf4"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Mechanism of action</span>", "ID": "fd9d29ff-9cd3-4874-bfbf-52e21f7f11f8", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Mechanism of action", "ParentId": "8f634673-c502-4052-bae8-e5903c2737a2"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "c1e05bc2-d814-43c8-93e5-f1c5a4edf708", "Styles": "margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "44c6ff9f-1bc2-4042-bbb3-13802b71b745", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "c1e05bc2-d814-43c8-93e5-f1c5a4edf708"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uric acid is the end product of\npurine metabolism in humans and is generated in the cascade of hypoxanthine\n\u2192 xanthine \u2192 uric acid. Both steps in the above transformations are\ncatalyzed by xanthine oxidase (XO). Febuxostat is a 2-arylthiazole derivative\nthat achieves its therapeutic effect of decreasing serum uric acid by\nselectively inhibiting XO. Febuxostat is a potent, non-purine selective\ninhibitor of XO (NP-SIXO) with an <i>in vitro</i> inhibition Ki value less than\none nanomolar. Febuxostat has been shown to potently inhibit both the oxidized\nand reduced forms of XO. At therapeutic concentrations febuxostat does not\ninhibit other enzymes involved in purine or pyrimidine metabolism, namely,\nguanine deaminase, hypoxanthine guanine phosphoribosyltransferase, orotate\nphosphoribosyltransferase, orotidine monophosphate decarboxylase or purine\nnucleoside phosphorylase.</span></p>", "ID": "45d4f7f4-5d66-4099-a7b9-693b8d3a0606", "Styles": "margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uric acid is the end product of\npurine metabolism in humans and is generated in the cascade of hypoxanthine\n\u2192 xanthine \u2192 uric acid. Both steps in the above transformations are\ncatalyzed by xanthine oxidase (XO). Febuxostat is a 2-arylthiazole derivative\nthat achieves its therapeutic effect of decreasing serum uric acid by\nselectively inhibiting XO. Febuxostat is a potent, non-purine selective\ninhibitor of XO (NP-SIXO) with an <i>in vitro</i> inhibition Ki value less than\none nanomolar. Febuxostat has been shown to potently inhibit both the oxidized\nand reduced forms of XO. At therapeutic concentrations febuxostat does not\ninhibit other enzymes involved in purine or pyrimidine metabolism, namely,\nguanine deaminase, hypoxanthine guanine phosphoribosyltransferase, orotate\nphosphoribosyltransferase, orotidine monophosphate decarboxylase or purine\nnucleoside phosphorylase.</span>", "ID": "ed230a56-e4a2-4dac-afbe-5fb8e694fe4e", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Uric acid is the end product of purine metabolism in humans and is generated in the cascade of hypoxanthine \u2192 xanthine \u2192 uric acid. Both steps in the above transformations are catalyzed by xanthine oxidase (XO). Febuxostat is a 2-arylthiazole derivative that achieves its therapeutic effect of decreasing serum uric acid by selectively inhibiting XO. Febuxostat is a potent, non-purine selective inhibitor of XO (NP-SIXO) with an  inhibition Ki value less than one nanomolar. Febuxostat has been shown to potently inhibit both the oxidized and reduced forms of XO. At therapeutic concentrations febuxostat does not inhibit other enzymes involved in purine or pyrimidine metabolism, namely, guanine deaminase, hypoxanthine guanine phosphoribosyltransferase, orotate phosphoribosyltransferase, orotidine monophosphate decarboxylase or purine nucleoside phosphorylase.", "ParentId": "45d4f7f4-5d66-4099-a7b9-693b8d3a0606"}, {"Element": "<i>in vitro</i>", "ID": "a05005ea-f4db-4a83-b95d-b1fedb41b0b2", "Styles": "None", "Classes": "None", "Text": "in vitro", "ParentId": "ed230a56-e4a2-4dac-afbe-5fb8e694fe4e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "76fcaf20-90f7-47c3-a333-1653f57088c7", "Styles": "margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "1b973097-e61b-4281-8015-2d6343ec8b8e", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "76fcaf20-90f7-47c3-a333-1653f57088c7"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Clinical efficacy and safety</span></u></p>", "ID": "dd59a16e-ba9a-4dec-96c2-8395a15aa6d9", "Styles": "margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Clinical efficacy and safety</span></u>", "ID": "533dcd86-2003-4ca2-8d27-1562b1623639", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "dd59a16e-ba9a-4dec-96c2-8395a15aa6d9"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Clinical efficacy and safety</span>", "ID": "fed87336-f538-4686-8297-d56f9a40cd9e", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Clinical efficacy and safety", "ParentId": "533dcd86-2003-4ca2-8d27-1562b1623639"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "cf079231-67f4-4b85-ac53-936168bc803e", "Styles": "margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "2df21ffa-cb78-46c5-9fa2-8cd7a4b11742", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "cf079231-67f4-4b85-ac53-936168bc803e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The efficacy of </span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>febuxostat</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'> was demonstrated in\nthree Phase 3 pivotal studies (the two pivotal APEX and FACT studies, and the\nadditional CONFIRMS study described below) that were conducted in 4101 patients\nwith hyperuricaemia and gout. In each phase 3 pivotal study, febuxostat\ndemonstrated superior ability to lower and maintain serum uric acid levels\ncompared to allopurinol. The primary efficacy endpoint in the APEX and FACT\nstudies was the proportion of patients whose last 3 monthly serum uric acid\nlevels were &lt; 6.0\u00a0mg/dL (357\u00a0\u00b5mol/L). In the additional phase 3\nCONFIRMS study, for which results became available after the marketing\nauthorisation for febuxostat was first issued, the primary efficacy endpoint\nwas the proportion of patients whose serum urate level was &lt; 6.0\u00a0mg/dL at\nthe final visit. No patients with organ transplant have been included in these\nstudies (see section 4.2).</span></p>", "ID": "4cb767e9-80cd-465d-8471-f92231d957b8", "Styles": "margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The efficacy of </span>", "ID": "2010f935-a2e8-4356-8faa-ba2ed28a6134", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "The efficacy of ", "ParentId": "4cb767e9-80cd-465d-8471-f92231d957b8"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>febuxostat</span>", "ID": "4fcf3036-9b2b-45fd-89a3-c83653235d54", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "febuxostat", "ParentId": "4cb767e9-80cd-465d-8471-f92231d957b8"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'> was demonstrated in\nthree Phase 3 pivotal studies (the two pivotal APEX and FACT studies, and the\nadditional CONFIRMS study described below) that were conducted in 4101 patients\nwith hyperuricaemia and gout. In each phase 3 pivotal study, febuxostat\ndemonstrated superior ability to lower and maintain serum uric acid levels\ncompared to allopurinol. The primary efficacy endpoint in the APEX and FACT\nstudies was the proportion of patients whose last 3 monthly serum uric acid\nlevels were &lt; 6.0\u00a0mg/dL (357\u00a0\u00b5mol/L). In the additional phase 3\nCONFIRMS study, for which results became available after the marketing\nauthorisation for febuxostat was first issued, the primary efficacy endpoint\nwas the proportion of patients whose serum urate level was &lt; 6.0\u00a0mg/dL at\nthe final visit. No patients with organ transplant have been included in these\nstudies (see section 4.2).</span>", "ID": "0c278983-569a-400b-ac73-fb75646711a7", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": " was demonstrated in three Phase 3 pivotal studies (the two pivotal APEX and FACT studies, and the additional CONFIRMS study described below) that were conducted in 4101 patients with hyperuricaemia and gout. In each phase 3 pivotal study, febuxostat demonstrated superior ability to lower and maintain serum uric acid levels compared to allopurinol. The primary efficacy endpoint in the APEX and FACT studies was the proportion of patients whose last 3 monthly serum uric acid levels were < 6.0\u00a0mg/dL (357\u00a0\u00b5mol/L). In the additional phase 3 CONFIRMS study, for which results became available after the marketing authorisation for febuxostat was first issued, the primary efficacy endpoint was the proportion of patients whose serum urate level was < 6.0\u00a0mg/dL at the final visit. No patients with organ transplant have been included in these studies (see section 4.2).", "ParentId": "4cb767e9-80cd-465d-8471-f92231d957b8"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "16a620d5-46c2-4d4d-9866-4181955b3274", "Styles": "margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "902b3d65-d1d5-4857-9393-d31a589bb8c6", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "16a620d5-46c2-4d4d-9866-4181955b3274"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>APEX Study</span></i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>: The Allopurinol and\nPlacebo-Controlled Efficacy Study of Febuxostat (APEX) was a Phase 3,\nrandomized, double-blind, multicenter, 28-week study. One thousand and\nseventy-two (1072) patients were randomized: placebo (n=134), </span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>febuxostat</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'> 80\u00a0mg QD (n=267), </span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>febuxostat</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'> 120\u00a0mg QD (n=269),\n</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>febuxostat</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'> 240\u00a0mg QD (n=134)\nor allopurinol (300\u00a0mg QD [n=258] for patients with a baseline serum\ncreatinine \u22641.5\u00a0mg/dL or 100\u00a0mg QD [n=10] for patients with a\nbaseline serum creatinine &gt;1.5\u00a0mg/dL and \u22642.0\u00a0mg/dL). Two\nhundred and forty\u00a0mg febuxostat (2 times the recommended highest dose) was\nused as a safety evaluation dose.</span></p>", "ID": "9a2c827e-c9f8-4743-a260-f53261ef67e6", "Styles": "margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>APEX Study</span></i>", "ID": "0fb878de-8c18-4d7e-9800-47b809113578", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9a2c827e-c9f8-4743-a260-f53261ef67e6"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>APEX Study</span>", "ID": "750b90f5-0d91-4ca0-9d8d-98e09790af05", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "APEX Study", "ParentId": "0fb878de-8c18-4d7e-9800-47b809113578"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>: The Allopurinol and\nPlacebo-Controlled Efficacy Study of Febuxostat (APEX) was a Phase 3,\nrandomized, double-blind, multicenter, 28-week study. One thousand and\nseventy-two (1072) patients were randomized: placebo (n=134), </span>", "ID": "e13a26d8-e11a-459b-a3ce-dd2663a51550", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": ": The Allopurinol and Placebo-Controlled Efficacy Study of Febuxostat (APEX) was a Phase 3, randomized, double-blind, multicenter, 28-week study. One thousand and seventy-two (1072) patients were randomized: placebo (n=134), ", "ParentId": "9a2c827e-c9f8-4743-a260-f53261ef67e6"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>febuxostat</span>", "ID": "a219dafb-acb3-4809-b22b-37b1ed5b8e27", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "febuxostat", "ParentId": "9a2c827e-c9f8-4743-a260-f53261ef67e6"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'> 80\u00a0mg QD (n=267), </span>", "ID": "b59dca25-f936-4713-a559-dd046a661c58", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": " 80\u00a0mg QD (n=267), ", "ParentId": "9a2c827e-c9f8-4743-a260-f53261ef67e6"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>febuxostat</span>", "ID": "2766c5d4-fd2b-44d9-bf29-6455c60b6d5d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "febuxostat", "ParentId": "9a2c827e-c9f8-4743-a260-f53261ef67e6"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'> 120\u00a0mg QD (n=269),\n</span>", "ID": "243e55fd-acbe-4a41-8695-0ba4ef7f2e4a", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": " 120\u00a0mg QD (n=269), ", "ParentId": "9a2c827e-c9f8-4743-a260-f53261ef67e6"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>febuxostat</span>", "ID": "675ab72e-01ac-43e6-83ff-c7045c1dccf6", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "febuxostat", "ParentId": "9a2c827e-c9f8-4743-a260-f53261ef67e6"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'> 240\u00a0mg QD (n=134)\nor allopurinol (300\u00a0mg QD [n=258] for patients with a baseline serum\ncreatinine \u22641.5\u00a0mg/dL or 100\u00a0mg QD [n=10] for patients with a\nbaseline serum creatinine &gt;1.5\u00a0mg/dL and \u22642.0\u00a0mg/dL). Two\nhundred and forty\u00a0mg febuxostat (2 times the recommended highest dose) was\nused as a safety evaluation dose.</span>", "ID": "af96b81a-7765-439a-9dd8-8ff06b4c5cf5", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": " 240\u00a0mg QD (n=134) or allopurinol (300\u00a0mg QD [n=258] for patients with a baseline serum creatinine \u22641.5\u00a0mg/dL or 100\u00a0mg QD [n=10] for patients with a baseline serum creatinine >1.5\u00a0mg/dL and \u22642.0\u00a0mg/dL). Two hundred and forty\u00a0mg febuxostat (2 times the recommended highest dose) was used as a safety evaluation dose.", "ParentId": "9a2c827e-c9f8-4743-a260-f53261ef67e6"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "add36447-1bca-4e6d-94e3-c40611aecdf5", "Styles": "margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "abc8cd3f-ba80-4585-a36e-a8a47181ef44", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "add36447-1bca-4e6d-94e3-c40611aecdf5"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The APEX study showed statistically\nsignificant superiority of both the </span><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>febuxostat</span><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'> 80\u00a0mg QD and the </span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>febuxostat</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'> 120\u00a0mg QD treatment arms <i>versus\n</i>the conventionally used doses of allopurinol 300\u00a0mg (n = 258) /100\u00a0mg\n(n = 10) treatment arm in reducing the sUA below 6\u00a0mg/dL (357\u00a0\u00b5mol/L)\n(see Table 2 and Figure 1).</span></p>", "ID": "610ad9b0-cc03-4e03-86f0-d67284c4954d", "Styles": "margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The APEX study showed statistically\nsignificant superiority of both the </span>", "ID": "39842660-416e-4c52-a69c-a1fc4b119863", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "The APEX study showed statistically significant superiority of both the ", "ParentId": "610ad9b0-cc03-4e03-86f0-d67284c4954d"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>febuxostat</span>", "ID": "8e6fef2a-bbd1-4c55-9cdb-47b0a4421543", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "febuxostat", "ParentId": "610ad9b0-cc03-4e03-86f0-d67284c4954d"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'> 80\u00a0mg QD and the </span>", "ID": "6a813d65-d2fa-46aa-b8f6-a781186b6fc2", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": " 80\u00a0mg QD and the ", "ParentId": "610ad9b0-cc03-4e03-86f0-d67284c4954d"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>febuxostat</span>", "ID": "c4bc8b88-91e5-4310-99db-c39a932802d8", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "febuxostat", "ParentId": "610ad9b0-cc03-4e03-86f0-d67284c4954d"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'> 120\u00a0mg QD treatment arms <i>versus\n</i>the conventionally used doses of allopurinol 300\u00a0mg (n = 258) /100\u00a0mg\n(n = 10) treatment arm in reducing the sUA below 6\u00a0mg/dL (357\u00a0\u00b5mol/L)\n(see Table 2 and Figure 1).</span>", "ID": "1e3f5c42-e242-4b51-9bfd-bef8893b8429", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": " 120\u00a0mg QD treatment arms the conventionally used doses of allopurinol 300\u00a0mg (n = 258) /100\u00a0mg (n = 10) treatment arm in reducing the sUA below 6\u00a0mg/dL (357\u00a0\u00b5mol/L) (see Table 2 and Figure 1).", "ParentId": "610ad9b0-cc03-4e03-86f0-d67284c4954d"}, {"Element": "<i>versus\n</i>", "ID": "07291c70-863b-488f-bca4-c3e17d583b39", "Styles": "None", "Classes": "None", "Text": "versus ", "ParentId": "1e3f5c42-e242-4b51-9bfd-bef8893b8429"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "a758ec4e-ad2d-4a2e-aecb-fac8a34874d5", "Styles": "margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "b135d765-65a6-480b-8d6a-1eeb94f2e053", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "a758ec4e-ad2d-4a2e-aecb-fac8a34874d5"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>FACT Study</span></i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>: The Febuxostat\nAllopurinol Controlled Trial (FACT) Study was a Phase 3, randomized,\ndouble-blind, multicenter, 52-week study. Seven hundred sixty (760) patients\nwere randomized: febuxostat 80\u00a0mg QD (n=256), febuxostat C 120\u00a0mg QD\n(n=251), or allopurinol 300\u00a0mg QD (n=253).</span></p>", "ID": "9253304d-a8ee-4418-b78e-0f4a39295754", "Styles": "margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>FACT Study</span></i>", "ID": "042e8000-0276-49c7-8f6e-129b3fc830bd", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9253304d-a8ee-4418-b78e-0f4a39295754"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>FACT Study</span>", "ID": "f729df1c-8ac1-4455-a579-c0fd0cb1b2db", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "FACT Study", "ParentId": "042e8000-0276-49c7-8f6e-129b3fc830bd"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>: The Febuxostat\nAllopurinol Controlled Trial (FACT) Study was a Phase 3, randomized,\ndouble-blind, multicenter, 52-week study. Seven hundred sixty (760) patients\nwere randomized: febuxostat 80\u00a0mg QD (n=256), febuxostat C 120\u00a0mg QD\n(n=251), or allopurinol 300\u00a0mg QD (n=253).</span>", "ID": "ebd4cf55-09b5-412c-ab8f-98d8f0772c8b", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": ": The Febuxostat Allopurinol Controlled Trial (FACT) Study was a Phase 3, randomized, double-blind, multicenter, 52-week study. Seven hundred sixty (760) patients were randomized: febuxostat 80\u00a0mg QD (n=256), febuxostat C 120\u00a0mg QD (n=251), or allopurinol 300\u00a0mg QD (n=253).", "ParentId": "9253304d-a8ee-4418-b78e-0f4a39295754"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "fd98f869-287f-4644-9770-83dd8de9cd3d", "Styles": "margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "ca14356d-dc59-457b-b285-8fa9f9282f3a", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "fd98f869-287f-4644-9770-83dd8de9cd3d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The FACT study showed the\nstatistically significant superiority of both </span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>febuxostat</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'> 80\u00a0mg and </span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>febuxostat</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'> 120\u00a0mg QD\ntreatment arms <i>versus </i>the conventionally used dose of allopurinol 300\u00a0mg\ntreatment arm in reducing and maintaining sUA below 6\u00a0mg/dL (357\u00a0\u00b5mol/L).</span></p>", "ID": "e188b701-9f8a-4fa2-a9c0-8191b3913812", "Styles": "margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The FACT study showed the\nstatistically significant superiority of both </span>", "ID": "6c13553b-af9b-4328-b449-5f0393b83f61", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "The FACT study showed the statistically significant superiority of both ", "ParentId": "e188b701-9f8a-4fa2-a9c0-8191b3913812"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>febuxostat</span>", "ID": "c3d95557-0aca-42da-9deb-5e01f01091a0", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "febuxostat", "ParentId": "e188b701-9f8a-4fa2-a9c0-8191b3913812"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'> 80\u00a0mg and </span>", "ID": "02fec087-0787-4e1f-bf05-c6b88ffcbbf3", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": " 80\u00a0mg and ", "ParentId": "e188b701-9f8a-4fa2-a9c0-8191b3913812"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>febuxostat</span>", "ID": "8d050428-8e4c-4cda-b3df-c384ea72549d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "febuxostat", "ParentId": "e188b701-9f8a-4fa2-a9c0-8191b3913812"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'> 120\u00a0mg QD\ntreatment arms <i>versus </i>the conventionally used dose of allopurinol 300\u00a0mg\ntreatment arm in reducing and maintaining sUA below 6\u00a0mg/dL (357\u00a0\u00b5mol/L).</span>", "ID": "40d2267e-e8d3-4015-bf3d-278ff55795a1", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": " 120\u00a0mg QD treatment arms the conventionally used dose of allopurinol 300\u00a0mg treatment arm in reducing and maintaining sUA below 6\u00a0mg/dL (357\u00a0\u00b5mol/L).", "ParentId": "e188b701-9f8a-4fa2-a9c0-8191b3913812"}, {"Element": "<i>versus </i>", "ID": "3362cf2a-eb15-4db5-b126-a002b391be47", "Styles": "None", "Classes": "None", "Text": "versus ", "ParentId": "40d2267e-e8d3-4015-bf3d-278ff55795a1"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "dc7c582c-bc8b-4494-b415-b61af671df89", "Styles": "margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "b225d2e9-1390-43dd-b593-5799c66094df", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "dc7c582c-bc8b-4494-b415-b61af671df89"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Table 2 summarises the primary\nefficacy endpoint results:</span></p>", "ID": "06394f57-a856-4388-a73f-b7fb681bc1db", "Styles": "margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Table 2 summarises the primary\nefficacy endpoint results:</span>", "ID": "2f6c118e-e27f-48df-96eb-7a20a6689916", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Table 2 summarises the primary efficacy endpoint results:", "ParentId": "06394f57-a856-4388-a73f-b7fb681bc1db"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "9f7b30b1-9770-40d6-a2d1-da9a38123f72", "Styles": "margin-top:0in;margin-right:3.3pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "f0e73436-156a-48ea-8a8d-360c913225df", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "9f7b30b1-9770-40d6-a2d1-da9a38123f72"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Table 2</span></b></p>", "ID": "d0ca7da4-ce00-45b0-842b-23e58690ed90", "Styles": "margin-top:0in;margin-right:3.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Table 2</span></b>", "ID": "63d944be-9a7f-4e6d-8454-6343b1bf96fb", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d0ca7da4-ce00-45b0-842b-23e58690ed90"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Table 2</span>", "ID": "daa1be6b-b784-439e-b6c7-0eb1c48863c6", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Table 2", "ParentId": "63d944be-9a7f-4e6d-8454-6343b1bf96fb"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Proportion of Patients with Serum\nUric Acid Levels &lt;6.0\u00a0mg/dL (357\u00a0\u00b5mol/L) Last Three Monthly Visits</span></b></p>", "ID": "a25898a6-9ffb-4521-9661-5fbd59f7ecfd", "Styles": "margin-top:0in;margin-right:3.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Proportion of Patients with Serum\nUric Acid Levels &lt;6.0\u00a0mg/dL (357\u00a0\u00b5mol/L) Last Three Monthly Visits</span></b>", "ID": "3c8f6780-8ec0-4e12-ae2f-3db3f740dd35", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a25898a6-9ffb-4521-9661-5fbd59f7ecfd"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Proportion of Patients with Serum\nUric Acid Levels &lt;6.0\u00a0mg/dL (357\u00a0\u00b5mol/L) Last Three Monthly Visits</span>", "ID": "2017de87-05b9-43b9-a9ae-46a58f684504", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Proportion of Patients with Serum Uric Acid Levels <6.0\u00a0mg/dL (357\u00a0\u00b5mol/L) Last Three Monthly Visits", "ParentId": "3c8f6780-8ec0-4e12-ae2f-3db3f740dd35"}, {"Element": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"margin-left:57.1pt;border-collapse:collapse\">\n<tr>\n<td style=\"width:87.6pt;border:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"117\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;text-autospace:\n  none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:27.7pt;\n  margin-bottom:0in;margin-left:28.85pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Study</span></p>\n</td>\n<td style=\"width:90.75pt;border:solid black 1.0pt;\n  border-left:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"121\">\n<p class=\"MsoNormal\" style=\"margin-top:.25pt;margin-right:0in;margin-bottom:\n  0in;margin-left:0in;line-height:12.0pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:19.15pt;\n  margin-bottom:0in;margin-left:19.95pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat\n  80\u00a0mg QD</span></p>\n</td>\n<td style=\"width:76.55pt;border:solid black 1.0pt;\n  border-left:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"102\">\n<p class=\"MsoNormal\" style=\"margin-top:.25pt;margin-right:0in;margin-bottom:\n  0in;margin-left:0in;line-height:12.0pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:11.95pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:11.95pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0120\u00a0mg QD</span></p>\n</td>\n<td style=\"width:95.75pt;border:solid black 1.0pt;\n  border-left:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"128\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:19.15pt;\n  margin-bottom:0in;margin-left:19.95pt;text-align:center;line-height:12.3pt;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Allopurinol</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:33.65pt;\n  margin-bottom:0in;margin-left:34.5pt;text-align:center;line-height:12.45pt;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>300\n  /</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:17.15pt;\n  margin-bottom:0in;margin-left:17.8pt;text-align:center;line-height:12.85pt;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>100\u00a0mg\n  QD</span><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1</span></sup></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:87.6pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"117\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:26.35pt;\n  margin-bottom:0in;margin-left:27.3pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>APEX</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:16.35pt;\n  margin-bottom:0in;margin-left:17.3pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(28\n  weeks)</span></p>\n</td>\n<td style=\"width:90.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"121\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:29.25pt;\n  margin-bottom:0in;margin-left:30.4pt;text-align:center;line-height:12.3pt;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>48%</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>*</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:24.4pt;\n  margin-bottom:0in;margin-left:25.5pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=262)</span></p>\n</td>\n<td style=\"width:76.55pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"102\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:21.65pt;line-height:12.25pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>65%</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>*<sup>, #</sup></span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.1pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:20.1pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=269)</span></p>\n</td>\n<td style=\"width:95.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"128\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:34.7pt;\n  margin-bottom:0in;margin-left:35.3pt;text-align:center;line-height:12.3pt;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>22%</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:27.05pt;\n  margin-bottom:0in;margin-left:27.9pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=268)</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:87.6pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"117\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:26.75pt;\n  margin-bottom:0in;margin-left:27.5pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>FACT</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:16.35pt;\n  margin-bottom:0in;margin-left:17.3pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(52\n  weeks)</span></p>\n</td>\n<td style=\"width:90.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"121\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:30.1pt;\n  margin-bottom:0in;margin-left:31.35pt;text-align:center;line-height:12.3pt;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>53%</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>*</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:24.4pt;\n  margin-bottom:0in;margin-left:25.5pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=255)</span></p>\n</td>\n<td style=\"width:76.55pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"102\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:23.15pt;\n  margin-bottom:0in;margin-left:24.15pt;text-align:center;line-height:12.3pt;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>62%</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>*</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:17.45pt;\n  margin-bottom:0in;margin-left:18.3pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=250)</span></p>\n</td>\n<td style=\"width:95.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"128\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:34.7pt;\n  margin-bottom:0in;margin-left:35.3pt;text-align:center;line-height:12.3pt;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>21%</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:27.05pt;\n  margin-bottom:0in;margin-left:27.9pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=251)</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:87.6pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"117\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:17.75pt;\n  margin-bottom:0in;margin-left:18.75pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Combined</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:24.4pt;\n  margin-bottom:0in;margin-left:25.5pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Results</span></p>\n</td>\n<td style=\"width:90.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"121\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:30.25pt;\n  margin-bottom:0in;margin-left:31.25pt;text-align:center;line-height:12.3pt;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>51%</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>*</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:24.4pt;\n  margin-bottom:0in;margin-left:25.5pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=517)</span></p>\n</td>\n<td style=\"width:76.55pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"102\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:22.5pt;line-height:12.25pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>63%</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>*<sup>, #</sup></span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.1pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:20.1pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=519)</span></p>\n</td>\n<td style=\"width:95.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"128\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:34.6pt;\n  margin-bottom:0in;margin-left:35.45pt;text-align:center;line-height:12.3pt;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>22%</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:27.05pt;\n  margin-bottom:0in;margin-left:27.9pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=519)</span></p>\n</td>\n</tr>\n<tr>\n<td colspan=\"4\" style=\"width:350.65pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"468\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.3pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:normal;text-autospace:none\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'> results from subjects\n  receiving either 100\u00a0mg QD (n=10: patients with serum creatinine &gt;1.5\n  and </span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u22642.0\u00a0mg/dL)\n  or 300\u00a0mg QD (n=509) were pooled </span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>for analyses.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>* p &lt; 0.001 vs\n  allopurinol, # p &lt; 0.001 vs 80\u00a0mg</span></p>\n</td>\n</tr>\n</table>", "ID": "9cb07581-241f-40e1-8588-2f5867ce8171", "Styles": "margin-left:57.1pt;border-collapse:collapse", "Classes": "['MsoNormalTable']", "Text": "      ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<tr>\n<td style=\"width:87.6pt;border:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"117\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;text-autospace:\n  none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:27.7pt;\n  margin-bottom:0in;margin-left:28.85pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Study</span></p>\n</td>\n<td style=\"width:90.75pt;border:solid black 1.0pt;\n  border-left:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"121\">\n<p class=\"MsoNormal\" style=\"margin-top:.25pt;margin-right:0in;margin-bottom:\n  0in;margin-left:0in;line-height:12.0pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:19.15pt;\n  margin-bottom:0in;margin-left:19.95pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat\n  80\u00a0mg QD</span></p>\n</td>\n<td style=\"width:76.55pt;border:solid black 1.0pt;\n  border-left:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"102\">\n<p class=\"MsoNormal\" style=\"margin-top:.25pt;margin-right:0in;margin-bottom:\n  0in;margin-left:0in;line-height:12.0pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:11.95pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:11.95pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0120\u00a0mg QD</span></p>\n</td>\n<td style=\"width:95.75pt;border:solid black 1.0pt;\n  border-left:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"128\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:19.15pt;\n  margin-bottom:0in;margin-left:19.95pt;text-align:center;line-height:12.3pt;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Allopurinol</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:33.65pt;\n  margin-bottom:0in;margin-left:34.5pt;text-align:center;line-height:12.45pt;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>300\n  /</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:17.15pt;\n  margin-bottom:0in;margin-left:17.8pt;text-align:center;line-height:12.85pt;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>100\u00a0mg\n  QD</span><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1</span></sup></p>\n</td>\n</tr>", "ID": "784e0f73-d0bc-49c4-804b-dec39162c2bb", "Styles": "None", "Classes": "None", "Text": "     ", "ParentId": "9cb07581-241f-40e1-8588-2f5867ce8171"}, {"Element": "<td style=\"width:87.6pt;border:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"117\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;text-autospace:\n  none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:27.7pt;\n  margin-bottom:0in;margin-left:28.85pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Study</span></p>\n</td>", "ID": "11d40824-bf1f-42ea-a1d4-802ff21928e3", "Styles": "width:87.6pt;border:solid black 1.0pt;\n  padding:0in 0in 0in 0in", "Classes": "None", "Text": "   ", "ParentId": "784e0f73-d0bc-49c4-804b-dec39162c2bb"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;text-autospace:\n  none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "a774ff92-315c-41a7-be77-0001394abd23", "Styles": "margin-bottom:0in;line-height:normal;text-autospace:\n  none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "11d40824-bf1f-42ea-a1d4-802ff21928e3"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "81a81e62-b62b-47b0-bb86-65247478ce9f", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "a774ff92-315c-41a7-be77-0001394abd23"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:27.7pt;\n  margin-bottom:0in;margin-left:28.85pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Study</span></p>", "ID": "c7f82ccb-8f67-47cc-917f-d88685d3eebe", "Styles": "margin-top:0in;margin-right:27.7pt;\n  margin-bottom:0in;margin-left:28.85pt;text-align:center;line-height:normal;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "11d40824-bf1f-42ea-a1d4-802ff21928e3"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Study</span>", "ID": "e3383ddf-d035-4863-8da2-ff404dbe918b", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Study", "ParentId": "c7f82ccb-8f67-47cc-917f-d88685d3eebe"}, {"Element": "<td style=\"width:90.75pt;border:solid black 1.0pt;\n  border-left:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"121\">\n<p class=\"MsoNormal\" style=\"margin-top:.25pt;margin-right:0in;margin-bottom:\n  0in;margin-left:0in;line-height:12.0pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:19.15pt;\n  margin-bottom:0in;margin-left:19.95pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat\n  80\u00a0mg QD</span></p>\n</td>", "ID": "649a7282-8107-475e-b92f-005cf27b14c3", "Styles": "width:90.75pt;border:solid black 1.0pt;\n  border-left:none;padding:0in 0in 0in 0in", "Classes": "None", "Text": "   ", "ParentId": "784e0f73-d0bc-49c4-804b-dec39162c2bb"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.25pt;margin-right:0in;margin-bottom:\n  0in;margin-left:0in;line-height:12.0pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "ad5f555e-456e-439f-b10b-e170bffe9220", "Styles": "margin-top:.25pt;margin-right:0in;margin-bottom:\n  0in;margin-left:0in;line-height:12.0pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "649a7282-8107-475e-b92f-005cf27b14c3"}, {"Element": "<span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "c81fb8f2-77d2-4d8c-8f60-d356b73a5b97", "Styles": "font-size:12.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "ad5f555e-456e-439f-b10b-e170bffe9220"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:19.15pt;\n  margin-bottom:0in;margin-left:19.95pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat\n  80\u00a0mg QD</span></p>", "ID": "3b2e63e9-b46b-4710-8908-4d85e344fbe3", "Styles": "margin-top:.05pt;margin-right:19.15pt;\n  margin-bottom:0in;margin-left:19.95pt;text-align:center;line-height:normal;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "649a7282-8107-475e-b92f-005cf27b14c3"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat\n  80\u00a0mg QD</span>", "ID": "04aaa5de-ac5d-4790-a5b4-e8a5aff32efd", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Febuxostat   80\u00a0mg QD", "ParentId": "3b2e63e9-b46b-4710-8908-4d85e344fbe3"}, {"Element": "<td style=\"width:76.55pt;border:solid black 1.0pt;\n  border-left:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"102\">\n<p class=\"MsoNormal\" style=\"margin-top:.25pt;margin-right:0in;margin-bottom:\n  0in;margin-left:0in;line-height:12.0pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:11.95pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:11.95pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0120\u00a0mg QD</span></p>\n</td>", "ID": "7721c8ef-e75b-400e-86d2-2f7dfdc2da66", "Styles": "width:76.55pt;border:solid black 1.0pt;\n  border-left:none;padding:0in 0in 0in 0in", "Classes": "None", "Text": "    ", "ParentId": "784e0f73-d0bc-49c4-804b-dec39162c2bb"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.25pt;margin-right:0in;margin-bottom:\n  0in;margin-left:0in;line-height:12.0pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "f7111979-64c0-417e-890f-265c005f8a3e", "Styles": "margin-top:.25pt;margin-right:0in;margin-bottom:\n  0in;margin-left:0in;line-height:12.0pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "7721c8ef-e75b-400e-86d2-2f7dfdc2da66"}, {"Element": "<span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "648d857b-f635-46b3-b5ff-f19c4f71104e", "Styles": "font-size:12.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "f7111979-64c0-417e-890f-265c005f8a3e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:11.95pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat</span></p>", "ID": "55c5a5ae-d0d2-41e2-a604-0d0c57d5818d", "Styles": "margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:11.95pt;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "7721c8ef-e75b-400e-86d2-2f7dfdc2da66"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat</span>", "ID": "6f240a60-d44a-496e-88d2-e9c923e8c390", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Febuxostat", "ParentId": "55c5a5ae-d0d2-41e2-a604-0d0c57d5818d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:11.95pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0120\u00a0mg QD</span></p>", "ID": "54564d64-4bb3-41e8-94a5-9a8dd62e2a5c", "Styles": "margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:11.95pt;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "7721c8ef-e75b-400e-86d2-2f7dfdc2da66"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0120\u00a0mg QD</span>", "ID": "3918e010-6ab2-44e7-90e4-79354e4fbb30", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0120\u00a0mg QD", "ParentId": "54564d64-4bb3-41e8-94a5-9a8dd62e2a5c"}, {"Element": "<td style=\"width:95.75pt;border:solid black 1.0pt;\n  border-left:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"128\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:19.15pt;\n  margin-bottom:0in;margin-left:19.95pt;text-align:center;line-height:12.3pt;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Allopurinol</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:33.65pt;\n  margin-bottom:0in;margin-left:34.5pt;text-align:center;line-height:12.45pt;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>300\n  /</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:17.15pt;\n  margin-bottom:0in;margin-left:17.8pt;text-align:center;line-height:12.85pt;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>100\u00a0mg\n  QD</span><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1</span></sup></p>\n</td>", "ID": "5743046b-8ea2-4095-8c69-010e2fefa721", "Styles": "width:95.75pt;border:solid black 1.0pt;\n  border-left:none;padding:0in 0in 0in 0in", "Classes": "None", "Text": "    ", "ParentId": "784e0f73-d0bc-49c4-804b-dec39162c2bb"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:19.15pt;\n  margin-bottom:0in;margin-left:19.95pt;text-align:center;line-height:12.3pt;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Allopurinol</span></p>", "ID": "a7366397-9a68-406e-baa8-f3c6aa27f219", "Styles": "margin-top:0in;margin-right:19.15pt;\n  margin-bottom:0in;margin-left:19.95pt;text-align:center;line-height:12.3pt;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5743046b-8ea2-4095-8c69-010e2fefa721"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Allopurinol</span>", "ID": "931001b5-7672-4b89-9926-44252ce8cee7", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Allopurinol", "ParentId": "a7366397-9a68-406e-baa8-f3c6aa27f219"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:33.65pt;\n  margin-bottom:0in;margin-left:34.5pt;text-align:center;line-height:12.45pt;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>300\n  /</span></p>", "ID": "701b68bc-463a-496d-8228-3c8e80716b01", "Styles": "margin-top:0in;margin-right:33.65pt;\n  margin-bottom:0in;margin-left:34.5pt;text-align:center;line-height:12.45pt;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5743046b-8ea2-4095-8c69-010e2fefa721"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>300\n  /</span>", "ID": "98d5b969-0f73-4a16-9a17-1f020ff86f58", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "300   /", "ParentId": "701b68bc-463a-496d-8228-3c8e80716b01"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:17.15pt;\n  margin-bottom:0in;margin-left:17.8pt;text-align:center;line-height:12.85pt;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>100\u00a0mg\n  QD</span><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1</span></sup></p>", "ID": "4d862a17-c054-4dbb-a8c0-f91ed2290bcc", "Styles": "margin-top:0in;margin-right:17.15pt;\n  margin-bottom:0in;margin-left:17.8pt;text-align:center;line-height:12.85pt;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5743046b-8ea2-4095-8c69-010e2fefa721"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>100\u00a0mg\n  QD</span>", "ID": "96253886-63ff-4066-9d9d-235629218dd8", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "100\u00a0mg   QD", "ParentId": "4d862a17-c054-4dbb-a8c0-f91ed2290bcc"}, {"Element": "<sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1</span></sup>", "ID": "49b745e8-4647-4510-ba08-185d15ea710b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4d862a17-c054-4dbb-a8c0-f91ed2290bcc"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1</span>", "ID": "a1e47fcb-ce30-4ca5-b1a1-1132fb36138f", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "1", "ParentId": "49b745e8-4647-4510-ba08-185d15ea710b"}, {"Element": "<tr>\n<td style=\"width:87.6pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"117\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:26.35pt;\n  margin-bottom:0in;margin-left:27.3pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>APEX</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:16.35pt;\n  margin-bottom:0in;margin-left:17.3pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(28\n  weeks)</span></p>\n</td>\n<td style=\"width:90.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"121\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:29.25pt;\n  margin-bottom:0in;margin-left:30.4pt;text-align:center;line-height:12.3pt;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>48%</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>*</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:24.4pt;\n  margin-bottom:0in;margin-left:25.5pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=262)</span></p>\n</td>\n<td style=\"width:76.55pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"102\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:21.65pt;line-height:12.25pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>65%</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>*<sup>, #</sup></span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.1pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:20.1pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=269)</span></p>\n</td>\n<td style=\"width:95.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"128\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:34.7pt;\n  margin-bottom:0in;margin-left:35.3pt;text-align:center;line-height:12.3pt;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>22%</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:27.05pt;\n  margin-bottom:0in;margin-left:27.9pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=268)</span></p>\n</td>\n</tr>", "ID": "d84d6851-299c-4577-a8cc-9b2275dde91e", "Styles": "None", "Classes": "None", "Text": "     ", "ParentId": "9cb07581-241f-40e1-8588-2f5867ce8171"}, {"Element": "<td style=\"width:87.6pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"117\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:26.35pt;\n  margin-bottom:0in;margin-left:27.3pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>APEX</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:16.35pt;\n  margin-bottom:0in;margin-left:17.3pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(28\n  weeks)</span></p>\n</td>", "ID": "c836aa11-9d82-4b06-856f-6b53b58d2700", "Styles": "width:87.6pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in", "Classes": "None", "Text": "   ", "ParentId": "d84d6851-299c-4577-a8cc-9b2275dde91e"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:26.35pt;\n  margin-bottom:0in;margin-left:27.3pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>APEX</span></p>", "ID": "b7908ebf-bec0-435a-ab18-391863b39cc2", "Styles": "margin-top:0in;margin-right:26.35pt;\n  margin-bottom:0in;margin-left:27.3pt;text-align:center;line-height:normal;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c836aa11-9d82-4b06-856f-6b53b58d2700"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>APEX</span>", "ID": "807e86da-7974-4110-ad4e-4d7a0fcf006a", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "APEX", "ParentId": "b7908ebf-bec0-435a-ab18-391863b39cc2"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:16.35pt;\n  margin-bottom:0in;margin-left:17.3pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(28\n  weeks)</span></p>", "ID": "b4597f88-48db-4533-b07e-674bba7313a1", "Styles": "margin-top:0in;margin-right:16.35pt;\n  margin-bottom:0in;margin-left:17.3pt;text-align:center;line-height:normal;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c836aa11-9d82-4b06-856f-6b53b58d2700"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(28\n  weeks)</span>", "ID": "c6c37e9d-dbb2-42b2-8d16-1caea9191107", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "(28   weeks)", "ParentId": "b4597f88-48db-4533-b07e-674bba7313a1"}, {"Element": "<td style=\"width:90.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"121\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:29.25pt;\n  margin-bottom:0in;margin-left:30.4pt;text-align:center;line-height:12.3pt;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>48%</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>*</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:24.4pt;\n  margin-bottom:0in;margin-left:25.5pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=262)</span></p>\n</td>", "ID": "612ac443-6287-4212-8d46-d22a0182ef6f", "Styles": "width:90.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in", "Classes": "None", "Text": "   ", "ParentId": "d84d6851-299c-4577-a8cc-9b2275dde91e"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:29.25pt;\n  margin-bottom:0in;margin-left:30.4pt;text-align:center;line-height:12.3pt;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>48%</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>*</span></p>", "ID": "d6af0502-1075-4cf0-bf1a-e7b2df5078be", "Styles": "margin-top:0in;margin-right:29.25pt;\n  margin-bottom:0in;margin-left:30.4pt;text-align:center;line-height:12.3pt;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "612ac443-6287-4212-8d46-d22a0182ef6f"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>48%</span>", "ID": "801f29d9-f575-44c0-a081-528efe5ce6f6", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "48%", "ParentId": "d6af0502-1075-4cf0-bf1a-e7b2df5078be"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>*</span>", "ID": "510282aa-8641-4fc7-8a33-2ae407edd68b", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "*", "ParentId": "d6af0502-1075-4cf0-bf1a-e7b2df5078be"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:24.4pt;\n  margin-bottom:0in;margin-left:25.5pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=262)</span></p>", "ID": "b9e2bfeb-10af-47be-bc3a-0a83be38f9a9", "Styles": "margin-top:.05pt;margin-right:24.4pt;\n  margin-bottom:0in;margin-left:25.5pt;text-align:center;line-height:normal;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "612ac443-6287-4212-8d46-d22a0182ef6f"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=262)</span>", "ID": "999c9bf1-8b5d-45cf-8b06-e4fe750b0be8", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "(n=262)", "ParentId": "b9e2bfeb-10af-47be-bc3a-0a83be38f9a9"}, {"Element": "<td style=\"width:76.55pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"102\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:21.65pt;line-height:12.25pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>65%</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>*<sup>, #</sup></span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.1pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:20.1pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=269)</span></p>\n</td>", "ID": "712dc0c0-b3aa-4d9e-8f76-ab76994342b5", "Styles": "width:76.55pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in", "Classes": "None", "Text": "   ", "ParentId": "d84d6851-299c-4577-a8cc-9b2275dde91e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:21.65pt;line-height:12.25pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>65%</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>*<sup>, #</sup></span></p>", "ID": "4135b045-794b-4b7c-9991-15c4b8b12229", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:21.65pt;line-height:12.25pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "712dc0c0-b3aa-4d9e-8f76-ab76994342b5"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>65%</span>", "ID": "969ac57e-4d65-43e9-9f40-cca8222f3d2f", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "65%", "ParentId": "4135b045-794b-4b7c-9991-15c4b8b12229"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>*<sup>, #</sup></span>", "ID": "0820438a-ce61-4771-83ae-dc25bc1f990a", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "*", "ParentId": "4135b045-794b-4b7c-9991-15c4b8b12229"}, {"Element": "<sup>, #</sup>", "ID": "a4b6b326-13a0-432a-8a66-b7f5650d96e1", "Styles": "None", "Classes": "None", "Text": ", #", "ParentId": "0820438a-ce61-4771-83ae-dc25bc1f990a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.1pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:20.1pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=269)</span></p>", "ID": "5a1f3025-54d8-465c-8ac0-038336229a57", "Styles": "margin-top:.1pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:20.1pt;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "712dc0c0-b3aa-4d9e-8f76-ab76994342b5"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=269)</span>", "ID": "36cc71c1-6370-4c38-a261-619aaa2fc166", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "(n=269)", "ParentId": "5a1f3025-54d8-465c-8ac0-038336229a57"}, {"Element": "<td style=\"width:95.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"128\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:34.7pt;\n  margin-bottom:0in;margin-left:35.3pt;text-align:center;line-height:12.3pt;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>22%</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:27.05pt;\n  margin-bottom:0in;margin-left:27.9pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=268)</span></p>\n</td>", "ID": "2916cf23-32b1-4e6a-904a-98ba04575eeb", "Styles": "width:95.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in", "Classes": "None", "Text": "   ", "ParentId": "d84d6851-299c-4577-a8cc-9b2275dde91e"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:34.7pt;\n  margin-bottom:0in;margin-left:35.3pt;text-align:center;line-height:12.3pt;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>22%</span></p>", "ID": "05e2cd81-7ef1-47d7-8053-bcae4397447d", "Styles": "margin-top:0in;margin-right:34.7pt;\n  margin-bottom:0in;margin-left:35.3pt;text-align:center;line-height:12.3pt;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "2916cf23-32b1-4e6a-904a-98ba04575eeb"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>22%</span>", "ID": "6c2a125a-68b4-41cc-a456-8ce77048a54f", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "22%", "ParentId": "05e2cd81-7ef1-47d7-8053-bcae4397447d"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:27.05pt;\n  margin-bottom:0in;margin-left:27.9pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=268)</span></p>", "ID": "3463b297-e9d4-4f20-a881-d730789f9a12", "Styles": "margin-top:.05pt;margin-right:27.05pt;\n  margin-bottom:0in;margin-left:27.9pt;text-align:center;line-height:normal;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "2916cf23-32b1-4e6a-904a-98ba04575eeb"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=268)</span>", "ID": "3bd439e7-e254-4861-ab0b-ffa34b628127", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "(n=268)", "ParentId": "3463b297-e9d4-4f20-a881-d730789f9a12"}, {"Element": "<tr>\n<td style=\"width:87.6pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"117\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:26.75pt;\n  margin-bottom:0in;margin-left:27.5pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>FACT</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:16.35pt;\n  margin-bottom:0in;margin-left:17.3pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(52\n  weeks)</span></p>\n</td>\n<td style=\"width:90.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"121\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:30.1pt;\n  margin-bottom:0in;margin-left:31.35pt;text-align:center;line-height:12.3pt;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>53%</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>*</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:24.4pt;\n  margin-bottom:0in;margin-left:25.5pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=255)</span></p>\n</td>\n<td style=\"width:76.55pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"102\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:23.15pt;\n  margin-bottom:0in;margin-left:24.15pt;text-align:center;line-height:12.3pt;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>62%</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>*</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:17.45pt;\n  margin-bottom:0in;margin-left:18.3pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=250)</span></p>\n</td>\n<td style=\"width:95.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"128\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:34.7pt;\n  margin-bottom:0in;margin-left:35.3pt;text-align:center;line-height:12.3pt;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>21%</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:27.05pt;\n  margin-bottom:0in;margin-left:27.9pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=251)</span></p>\n</td>\n</tr>", "ID": "b831e8a6-7fab-4b41-973c-827e7c1bb74c", "Styles": "None", "Classes": "None", "Text": "     ", "ParentId": "9cb07581-241f-40e1-8588-2f5867ce8171"}, {"Element": "<td style=\"width:87.6pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"117\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:26.75pt;\n  margin-bottom:0in;margin-left:27.5pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>FACT</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:16.35pt;\n  margin-bottom:0in;margin-left:17.3pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(52\n  weeks)</span></p>\n</td>", "ID": "0d2b1abc-a046-481a-9512-511d0ba1bbf8", "Styles": "width:87.6pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in", "Classes": "None", "Text": "   ", "ParentId": "b831e8a6-7fab-4b41-973c-827e7c1bb74c"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:26.75pt;\n  margin-bottom:0in;margin-left:27.5pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>FACT</span></p>", "ID": "c2cd72cf-8695-48b8-ab13-a22063a3f86d", "Styles": "margin-top:0in;margin-right:26.75pt;\n  margin-bottom:0in;margin-left:27.5pt;text-align:center;line-height:normal;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0d2b1abc-a046-481a-9512-511d0ba1bbf8"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>FACT</span>", "ID": "1286e09e-24d6-4e03-a0a3-dc09e42c0f70", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "FACT", "ParentId": "c2cd72cf-8695-48b8-ab13-a22063a3f86d"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:16.35pt;\n  margin-bottom:0in;margin-left:17.3pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(52\n  weeks)</span></p>", "ID": "9cae6aa3-8fd8-40bc-82a3-5e32f6723664", "Styles": "margin-top:0in;margin-right:16.35pt;\n  margin-bottom:0in;margin-left:17.3pt;text-align:center;line-height:normal;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0d2b1abc-a046-481a-9512-511d0ba1bbf8"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(52\n  weeks)</span>", "ID": "ff2f3d9c-c47b-4e26-8bb3-b4e05410990d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "(52   weeks)", "ParentId": "9cae6aa3-8fd8-40bc-82a3-5e32f6723664"}, {"Element": "<td style=\"width:90.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"121\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:30.1pt;\n  margin-bottom:0in;margin-left:31.35pt;text-align:center;line-height:12.3pt;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>53%</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>*</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:24.4pt;\n  margin-bottom:0in;margin-left:25.5pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=255)</span></p>\n</td>", "ID": "ce0f05e0-b717-4b8a-8e4d-752679107b70", "Styles": "width:90.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in", "Classes": "None", "Text": "   ", "ParentId": "b831e8a6-7fab-4b41-973c-827e7c1bb74c"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:30.1pt;\n  margin-bottom:0in;margin-left:31.35pt;text-align:center;line-height:12.3pt;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>53%</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>*</span></p>", "ID": "02ae6a11-99af-4564-b629-ebd43efe995a", "Styles": "margin-top:0in;margin-right:30.1pt;\n  margin-bottom:0in;margin-left:31.35pt;text-align:center;line-height:12.3pt;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ce0f05e0-b717-4b8a-8e4d-752679107b70"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>53%</span>", "ID": "f40ede41-4b4c-4184-be50-e10987c2b3c9", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "53%", "ParentId": "02ae6a11-99af-4564-b629-ebd43efe995a"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>*</span>", "ID": "ec2d17fd-2656-45fa-a61d-c6e113f59626", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "*", "ParentId": "02ae6a11-99af-4564-b629-ebd43efe995a"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:24.4pt;\n  margin-bottom:0in;margin-left:25.5pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=255)</span></p>", "ID": "ca347cbc-e084-4cc6-b429-450677f3ef5b", "Styles": "margin-top:.05pt;margin-right:24.4pt;\n  margin-bottom:0in;margin-left:25.5pt;text-align:center;line-height:normal;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ce0f05e0-b717-4b8a-8e4d-752679107b70"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=255)</span>", "ID": "6d5041df-e087-40b1-8c3a-532333311671", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "(n=255)", "ParentId": "ca347cbc-e084-4cc6-b429-450677f3ef5b"}, {"Element": "<td style=\"width:76.55pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"102\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:23.15pt;\n  margin-bottom:0in;margin-left:24.15pt;text-align:center;line-height:12.3pt;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>62%</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>*</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:17.45pt;\n  margin-bottom:0in;margin-left:18.3pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=250)</span></p>\n</td>", "ID": "e79d6ca7-273a-4098-8631-42eafc3a05a2", "Styles": "width:76.55pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in", "Classes": "None", "Text": "   ", "ParentId": "b831e8a6-7fab-4b41-973c-827e7c1bb74c"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:23.15pt;\n  margin-bottom:0in;margin-left:24.15pt;text-align:center;line-height:12.3pt;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>62%</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>*</span></p>", "ID": "98b60eaa-0f7e-41d1-a717-1ae2dbdccc2c", "Styles": "margin-top:0in;margin-right:23.15pt;\n  margin-bottom:0in;margin-left:24.15pt;text-align:center;line-height:12.3pt;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e79d6ca7-273a-4098-8631-42eafc3a05a2"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>62%</span>", "ID": "364e73c0-3db7-4820-944d-e5e5bdf8a57a", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "62%", "ParentId": "98b60eaa-0f7e-41d1-a717-1ae2dbdccc2c"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>*</span>", "ID": "b660d4c4-b844-455d-9ad6-0e3a29d17368", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "*", "ParentId": "98b60eaa-0f7e-41d1-a717-1ae2dbdccc2c"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:17.45pt;\n  margin-bottom:0in;margin-left:18.3pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=250)</span></p>", "ID": "960b82bb-8344-46ba-8b92-78591092ee77", "Styles": "margin-top:.05pt;margin-right:17.45pt;\n  margin-bottom:0in;margin-left:18.3pt;text-align:center;line-height:normal;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e79d6ca7-273a-4098-8631-42eafc3a05a2"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=250)</span>", "ID": "c5f9f8b6-06fc-4a3b-b168-1f80e12310fb", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "(n=250)", "ParentId": "960b82bb-8344-46ba-8b92-78591092ee77"}, {"Element": "<td style=\"width:95.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"128\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:34.7pt;\n  margin-bottom:0in;margin-left:35.3pt;text-align:center;line-height:12.3pt;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>21%</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:27.05pt;\n  margin-bottom:0in;margin-left:27.9pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=251)</span></p>\n</td>", "ID": "a3d65f9f-f316-4b6e-a300-ef7da243a2eb", "Styles": "width:95.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in", "Classes": "None", "Text": "   ", "ParentId": "b831e8a6-7fab-4b41-973c-827e7c1bb74c"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:34.7pt;\n  margin-bottom:0in;margin-left:35.3pt;text-align:center;line-height:12.3pt;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>21%</span></p>", "ID": "51adf4af-1a71-45c6-8756-7c8160f2e2e4", "Styles": "margin-top:0in;margin-right:34.7pt;\n  margin-bottom:0in;margin-left:35.3pt;text-align:center;line-height:12.3pt;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a3d65f9f-f316-4b6e-a300-ef7da243a2eb"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>21%</span>", "ID": "9a411508-671d-4de9-8163-6f192fc9822f", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "21%", "ParentId": "51adf4af-1a71-45c6-8756-7c8160f2e2e4"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:27.05pt;\n  margin-bottom:0in;margin-left:27.9pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=251)</span></p>", "ID": "a7584c82-f147-4fd9-8621-5298224cf19a", "Styles": "margin-top:.05pt;margin-right:27.05pt;\n  margin-bottom:0in;margin-left:27.9pt;text-align:center;line-height:normal;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a3d65f9f-f316-4b6e-a300-ef7da243a2eb"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=251)</span>", "ID": "0b643aa2-a144-411a-b95d-a2adb886f1c9", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "(n=251)", "ParentId": "a7584c82-f147-4fd9-8621-5298224cf19a"}, {"Element": "<tr>\n<td style=\"width:87.6pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"117\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:17.75pt;\n  margin-bottom:0in;margin-left:18.75pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Combined</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:24.4pt;\n  margin-bottom:0in;margin-left:25.5pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Results</span></p>\n</td>\n<td style=\"width:90.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"121\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:30.25pt;\n  margin-bottom:0in;margin-left:31.25pt;text-align:center;line-height:12.3pt;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>51%</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>*</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:24.4pt;\n  margin-bottom:0in;margin-left:25.5pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=517)</span></p>\n</td>\n<td style=\"width:76.55pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"102\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:22.5pt;line-height:12.25pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>63%</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>*<sup>, #</sup></span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.1pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:20.1pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=519)</span></p>\n</td>\n<td style=\"width:95.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"128\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:34.6pt;\n  margin-bottom:0in;margin-left:35.45pt;text-align:center;line-height:12.3pt;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>22%</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:27.05pt;\n  margin-bottom:0in;margin-left:27.9pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=519)</span></p>\n</td>\n</tr>", "ID": "36c718ba-83ac-4b92-b396-29d1bc257030", "Styles": "None", "Classes": "None", "Text": "     ", "ParentId": "9cb07581-241f-40e1-8588-2f5867ce8171"}, {"Element": "<td style=\"width:87.6pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"117\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:17.75pt;\n  margin-bottom:0in;margin-left:18.75pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Combined</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:24.4pt;\n  margin-bottom:0in;margin-left:25.5pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Results</span></p>\n</td>", "ID": "1b6754d5-d234-4662-9557-cb7476a7d0ca", "Styles": "width:87.6pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in", "Classes": "None", "Text": "   ", "ParentId": "36c718ba-83ac-4b92-b396-29d1bc257030"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:17.75pt;\n  margin-bottom:0in;margin-left:18.75pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Combined</span></p>", "ID": "8621bdf8-1cd2-4dae-89c4-6202b0243f10", "Styles": "margin-top:0in;margin-right:17.75pt;\n  margin-bottom:0in;margin-left:18.75pt;text-align:center;line-height:normal;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "1b6754d5-d234-4662-9557-cb7476a7d0ca"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Combined</span>", "ID": "4cc40d3c-43ef-43f5-8cea-a5a83760f0e7", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Combined", "ParentId": "8621bdf8-1cd2-4dae-89c4-6202b0243f10"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:24.4pt;\n  margin-bottom:0in;margin-left:25.5pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Results</span></p>", "ID": "da444dbd-31f2-4d29-bfed-38117d422ae1", "Styles": "margin-top:0in;margin-right:24.4pt;\n  margin-bottom:0in;margin-left:25.5pt;text-align:center;line-height:normal;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "1b6754d5-d234-4662-9557-cb7476a7d0ca"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Results</span>", "ID": "164d5635-be2a-40ff-8a47-1f85964411dd", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Results", "ParentId": "da444dbd-31f2-4d29-bfed-38117d422ae1"}, {"Element": "<td style=\"width:90.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"121\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:30.25pt;\n  margin-bottom:0in;margin-left:31.25pt;text-align:center;line-height:12.3pt;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>51%</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>*</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:24.4pt;\n  margin-bottom:0in;margin-left:25.5pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=517)</span></p>\n</td>", "ID": "3e00be93-8c12-4957-b387-2168e9acee6d", "Styles": "width:90.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in", "Classes": "None", "Text": "   ", "ParentId": "36c718ba-83ac-4b92-b396-29d1bc257030"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:30.25pt;\n  margin-bottom:0in;margin-left:31.25pt;text-align:center;line-height:12.3pt;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>51%</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>*</span></p>", "ID": "0dad555a-54ed-4019-92f5-c23f816a2622", "Styles": "margin-top:0in;margin-right:30.25pt;\n  margin-bottom:0in;margin-left:31.25pt;text-align:center;line-height:12.3pt;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3e00be93-8c12-4957-b387-2168e9acee6d"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>51%</span>", "ID": "b5ee839f-150a-49f1-8ff0-fb148f008a57", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "51%", "ParentId": "0dad555a-54ed-4019-92f5-c23f816a2622"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>*</span>", "ID": "da366be6-f652-4c0e-98da-4c14c31d1eec", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "*", "ParentId": "0dad555a-54ed-4019-92f5-c23f816a2622"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:24.4pt;\n  margin-bottom:0in;margin-left:25.5pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=517)</span></p>", "ID": "d0ff07fe-abd0-460b-92fe-46faa93f6ac6", "Styles": "margin-top:.05pt;margin-right:24.4pt;\n  margin-bottom:0in;margin-left:25.5pt;text-align:center;line-height:normal;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3e00be93-8c12-4957-b387-2168e9acee6d"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=517)</span>", "ID": "9f558051-72c3-419a-b1b7-bdff29e67b58", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "(n=517)", "ParentId": "d0ff07fe-abd0-460b-92fe-46faa93f6ac6"}, {"Element": "<td style=\"width:76.55pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"102\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:22.5pt;line-height:12.25pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>63%</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>*<sup>, #</sup></span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.1pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:20.1pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=519)</span></p>\n</td>", "ID": "3192d6c9-5ede-4383-9177-31023ae70f4f", "Styles": "width:76.55pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in", "Classes": "None", "Text": "   ", "ParentId": "36c718ba-83ac-4b92-b396-29d1bc257030"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:22.5pt;line-height:12.25pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>63%</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>*<sup>, #</sup></span></p>", "ID": "787fe6be-20b9-40fc-bd74-fc9e0beac2ed", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:22.5pt;line-height:12.25pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3192d6c9-5ede-4383-9177-31023ae70f4f"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>63%</span>", "ID": "5acd68bc-d020-4f63-a12b-3bbc7fe843a0", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "63%", "ParentId": "787fe6be-20b9-40fc-bd74-fc9e0beac2ed"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>*<sup>, #</sup></span>", "ID": "a7581f27-facf-483b-b114-da50a770bae8", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "*", "ParentId": "787fe6be-20b9-40fc-bd74-fc9e0beac2ed"}, {"Element": "<sup>, #</sup>", "ID": "67974244-9859-4874-a315-3377a35de78e", "Styles": "None", "Classes": "None", "Text": ", #", "ParentId": "a7581f27-facf-483b-b114-da50a770bae8"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.1pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:20.1pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=519)</span></p>", "ID": "e260653b-4349-453f-b4d3-d11082522a63", "Styles": "margin-top:.1pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:20.1pt;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3192d6c9-5ede-4383-9177-31023ae70f4f"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=519)</span>", "ID": "084edd50-d9f9-44bd-b4ab-44a7e15cf3a6", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "(n=519)", "ParentId": "e260653b-4349-453f-b4d3-d11082522a63"}, {"Element": "<td style=\"width:95.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"128\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:34.6pt;\n  margin-bottom:0in;margin-left:35.45pt;text-align:center;line-height:12.3pt;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>22%</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:27.05pt;\n  margin-bottom:0in;margin-left:27.9pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=519)</span></p>\n</td>", "ID": "2b89b31d-179e-48d2-9a4c-f4cb3f9a38d4", "Styles": "width:95.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in", "Classes": "None", "Text": "   ", "ParentId": "36c718ba-83ac-4b92-b396-29d1bc257030"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:34.6pt;\n  margin-bottom:0in;margin-left:35.45pt;text-align:center;line-height:12.3pt;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>22%</span></p>", "ID": "f9fb1b95-d13b-407f-a780-4d269134ab2c", "Styles": "margin-top:0in;margin-right:34.6pt;\n  margin-bottom:0in;margin-left:35.45pt;text-align:center;line-height:12.3pt;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "2b89b31d-179e-48d2-9a4c-f4cb3f9a38d4"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>22%</span>", "ID": "0154c578-41be-42d4-8449-f64ba9af32a0", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "22%", "ParentId": "f9fb1b95-d13b-407f-a780-4d269134ab2c"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:27.05pt;\n  margin-bottom:0in;margin-left:27.9pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=519)</span></p>", "ID": "a5673952-0779-4a3b-8956-0e7cf184fc89", "Styles": "margin-top:.05pt;margin-right:27.05pt;\n  margin-bottom:0in;margin-left:27.9pt;text-align:center;line-height:normal;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "2b89b31d-179e-48d2-9a4c-f4cb3f9a38d4"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=519)</span>", "ID": "e9439e27-75ad-4005-a3c9-4cf96f9090a4", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "(n=519)", "ParentId": "a5673952-0779-4a3b-8956-0e7cf184fc89"}, {"Element": "<tr>\n<td colspan=\"4\" style=\"width:350.65pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"468\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.3pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:normal;text-autospace:none\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'> results from subjects\n  receiving either 100\u00a0mg QD (n=10: patients with serum creatinine &gt;1.5\n  and </span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u22642.0\u00a0mg/dL)\n  or 300\u00a0mg QD (n=509) were pooled </span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>for analyses.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>* p &lt; 0.001 vs\n  allopurinol, # p &lt; 0.001 vs 80\u00a0mg</span></p>\n</td>\n</tr>", "ID": "49f41782-615f-4638-944d-96bfeedbc501", "Styles": "None", "Classes": "None", "Text": "  ", "ParentId": "9cb07581-241f-40e1-8588-2f5867ce8171"}, {"Element": "<td colspan=\"4\" style=\"width:350.65pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"468\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.3pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:normal;text-autospace:none\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'> results from subjects\n  receiving either 100\u00a0mg QD (n=10: patients with serum creatinine &gt;1.5\n  and </span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u22642.0\u00a0mg/dL)\n  or 300\u00a0mg QD (n=509) were pooled </span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>for analyses.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>* p &lt; 0.001 vs\n  allopurinol, # p &lt; 0.001 vs 80\u00a0mg</span></p>\n</td>", "ID": "082ea416-5dd8-4063-8ca5-4567baa725f8", "Styles": "width:350.65pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in", "Classes": "None", "Text": "   ", "ParentId": "49f41782-615f-4638-944d-96bfeedbc501"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.3pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:normal;text-autospace:none\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'> results from subjects\n  receiving either 100\u00a0mg QD (n=10: patients with serum creatinine &gt;1.5\n  and </span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u22642.0\u00a0mg/dL)\n  or 300\u00a0mg QD (n=509) were pooled </span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>for analyses.</span></p>", "ID": "e31f681c-549b-423d-8a50-2d351dc56c36", "Styles": "margin-top:0in;margin-right:6.3pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "082ea416-5dd8-4063-8ca5-4567baa725f8"}, {"Element": "<sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1</span></sup>", "ID": "074e3436-67ce-4611-bd0f-524aeb8b33f1", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e31f681c-549b-423d-8a50-2d351dc56c36"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1</span>", "ID": "e35af3e6-8ad3-416b-a2ed-208ab4e6aea3", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "1", "ParentId": "074e3436-67ce-4611-bd0f-524aeb8b33f1"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'> results from subjects\n  receiving either 100\u00a0mg QD (n=10: patients with serum creatinine &gt;1.5\n  and </span>", "ID": "44b2b033-1eef-4fc5-a0c4-3d06c051ed79", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": " results from subjects   receiving either 100\u00a0mg QD (n=10: patients with serum creatinine >1.5   and ", "ParentId": "e31f681c-549b-423d-8a50-2d351dc56c36"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u22642.0\u00a0mg/dL)\n  or 300\u00a0mg QD (n=509) were pooled </span>", "ID": "fd1720d1-4237-47ca-b4a3-b9d2c29050ac", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u22642.0\u00a0mg/dL)   or 300\u00a0mg QD (n=509) were pooled ", "ParentId": "e31f681c-549b-423d-8a50-2d351dc56c36"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>for analyses.</span>", "ID": "c62e28ba-a074-4ae7-8f1b-276d2dbada89", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "for analyses.", "ParentId": "e31f681c-549b-423d-8a50-2d351dc56c36"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>* p &lt; 0.001 vs\n  allopurinol, # p &lt; 0.001 vs 80\u00a0mg</span></p>", "ID": "b3ff7e38-4631-4af1-8916-2178aa46be8f", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "082ea416-5dd8-4063-8ca5-4567baa725f8"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>* p &lt; 0.001 vs\n  allopurinol, # p &lt; 0.001 vs 80\u00a0mg</span>", "ID": "380a3e6a-db06-4a09-b4f6-ffcee01b9784", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "* p < 0.001 vs   allopurinol, # p < 0.001 vs 80\u00a0mg", "ParentId": "b3ff7e38-4631-4af1-8916-2178aa46be8f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "db6ae055-3f8b-453e-acaa-88ebd3ca8b4c", "Styles": "margin-top:0in;margin-right:3.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "4506372f-a525-48e0-aaba-acdaaf3ae09d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "db6ae055-3f8b-453e-acaa-88ebd3ca8b4c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The ability of febuxostat to lower\nserum uric acid levels was prompt and persistent. Reduction in serum uric acid\nlevel to &lt;6.0\u00a0mg/dL (357\u00a0\u00b5mol/L) was noted by the Week 2 visit and\nwas maintained throughout treatment. The mean serum uric acid levels over time\nfor each treatment group from the two pivotal Phase 3 studies are shown in\nFigure 1.</span></p>", "ID": "9cc67906-b6da-4a6d-a2ca-2d23defd910b", "Styles": "margin-top:0in;margin-right:3.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The ability of febuxostat to lower\nserum uric acid levels was prompt and persistent. Reduction in serum uric acid\nlevel to &lt;6.0\u00a0mg/dL (357\u00a0\u00b5mol/L) was noted by the Week 2 visit and\nwas maintained throughout treatment. The mean serum uric acid levels over time\nfor each treatment group from the two pivotal Phase 3 studies are shown in\nFigure 1.</span>", "ID": "6c797ad0-5058-433b-ab18-0b9f8861537e", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "The ability of febuxostat to lower serum uric acid levels was prompt and persistent. Reduction in serum uric acid level to <6.0\u00a0mg/dL (357\u00a0\u00b5mol/L) was noted by the Week 2 visit and was maintained throughout treatment. The mean serum uric acid levels over time for each treatment group from the two pivotal Phase 3 studies are shown in Figure 1.", "ParentId": "9cc67906-b6da-4a6d-a2ca-2d23defd910b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>", "ID": "4cb1b90d-f661-407c-bc71-59eb298ca8ce", "Styles": "margin-top:0in;margin-right:3.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b>", "ID": "72aa42dd-920a-46f7-becd-631fde2faede", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4cb1b90d-f661-407c-bc71-59eb298ca8ce"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "df64e74c-eb44-4570-bace-aba8acb61e61", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "72aa42dd-920a-46f7-becd-631fde2faede"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;page-break-after:avoid;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Figure 1 Mean Serum Uric\nAcid Levels in Combined Pivotal Phase 3 Studies</span></b></p>", "ID": "19969879-e6fb-4b96-a43a-82e5adc54440", "Styles": "margin-top:0in;margin-right:3.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;page-break-after:avoid;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Figure 1 Mean Serum Uric\nAcid Levels in Combined Pivotal Phase 3 Studies</span></b>", "ID": "6d582837-1dee-43c3-9ef4-e04b596db164", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "19969879-e6fb-4b96-a43a-82e5adc54440"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Figure 1 Mean Serum Uric\nAcid Levels in Combined Pivotal Phase 3 Studies</span>", "ID": "ea54c00c-a2e8-4328-94bd-4414ac416a62", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Figure 1 Mean Serum Uric Acid Levels in Combined Pivotal Phase 3 Studies", "ParentId": "6d582837-1dee-43c3-9ef4-e04b596db164"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;page-break-after:avoid;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "90b349f5-7d08-47ec-8db7-0db756c2a82c", "Styles": "margin-top:0in;margin-right:3.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;page-break-after:avoid;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "8990614c-9bdc-44fe-b869-6b0e35c34a60", "Styles": "font-size:12.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "90b349f5-7d08-47ec-8db7-0db756c2a82c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:98.75pt;line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span style=\"position:absolute;z-index:-1895828992;left:0px;margin-left:\n234px;margin-top:8px;width:344px;height:262px\"><img height=\"262\" src=\"Febuxostat%20Mylan%20not%20most%20recent_files/image001.png\" width=\"344\"/></span><span lang=\"EN-GB\" style='font-size:8.0pt;font-family:\"Times New Roman\",serif'>11</span></p>", "ID": "843473f7-ba4b-4984-96da-733bd39e932b", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:98.75pt;line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span style=\"position:absolute;z-index:-1895828992;left:0px;margin-left:\n234px;margin-top:8px;width:344px;height:262px\"><img height=\"262\" src=\"Febuxostat%20Mylan%20not%20most%20recent_files/image001.png\" width=\"344\"/></span>", "ID": "51e38f41-a19b-452d-b832-024cc8e9232f", "Styles": "position:absolute;z-index:-1895828992;left:0px;margin-left:\n234px;margin-top:8px;width:344px;height:262px", "Classes": "None", "Text": "", "ParentId": "843473f7-ba4b-4984-96da-733bd39e932b"}, {"Element": "<img height=\"262\" src=\"Febuxostat%20Mylan%20not%20most%20recent_files/image001.png\" width=\"344\"/>", "ID": "95ad3fe3-9e9f-40a5-89e8-ceaad2e6bc09", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "51e38f41-a19b-452d-b832-024cc8e9232f"}, {"Element": "<span lang=\"EN-GB\" style='font-size:8.0pt;font-family:\"Times New Roman\",serif'>11</span>", "ID": "a41f3b1d-8ee2-479b-98f6-75f436229196", "Styles": "font-size:8.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "11", "ParentId": "843473f7-ba4b-4984-96da-733bd39e932b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;page-break-after:\navoid;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:10.0pt;font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "6a98a181-90a7-423a-8e30-bc05fc8e91e7", "Styles": "margin-bottom:0in;line-height:normal;page-break-after:\navoid;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:10.0pt;font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "78c51de8-47fc-4ae7-ac32-6be70d147f07", "Styles": "font-size:10.0pt;font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "6a98a181-90a7-423a-8e30-bc05fc8e91e7"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:98.75pt;line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span style=\"position:absolute;z-index:-1895827968;left:0px;margin-left:\n254px;margin-top:5px;width:308px;height:209px\"><img height=\"209\" src=\"Febuxostat%20Mylan%20not%20most%20recent_files/image002.png\" width=\"308\"/></span><span style=\"position:relative;z-index:-1895826944\"><span style=\"left:0px;position:\nabsolute;left:195px;top:-1px;width:13px;height:204px\"><img alt=\"Mean (\u00b1SEM) Serum Uric Acid Level (mg/dL)\" height=\"204\" src=\"Febuxostat%20Mylan%20not%20most%20recent_files/image003.png\" width=\"13\"/></span></span><span lang=\"EN-GB\" style='font-size:8.0pt;font-family:\"Times New Roman\",serif'>10\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 </span><span lang=\"EN-GB\" style='font-size:6.0pt;font-family:\"Times New Roman\",serif'>Placebo</span></p>", "ID": "8d853de1-dbbc-46bc-9ca1-3cdefa05e04d", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:98.75pt;line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span style=\"position:absolute;z-index:-1895827968;left:0px;margin-left:\n254px;margin-top:5px;width:308px;height:209px\"><img height=\"209\" src=\"Febuxostat%20Mylan%20not%20most%20recent_files/image002.png\" width=\"308\"/></span>", "ID": "a49b8aa5-89fe-4911-94d9-e6e593dcf449", "Styles": "position:absolute;z-index:-1895827968;left:0px;margin-left:\n254px;margin-top:5px;width:308px;height:209px", "Classes": "None", "Text": "", "ParentId": "8d853de1-dbbc-46bc-9ca1-3cdefa05e04d"}, {"Element": "<img height=\"209\" src=\"Febuxostat%20Mylan%20not%20most%20recent_files/image002.png\" width=\"308\"/>", "ID": "7638af3f-fe2f-4a55-8cf0-72c85334182f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a49b8aa5-89fe-4911-94d9-e6e593dcf449"}, {"Element": "<span style=\"position:relative;z-index:-1895826944\"><span style=\"left:0px;position:\nabsolute;left:195px;top:-1px;width:13px;height:204px\"><img alt=\"Mean (\u00b1SEM) Serum Uric Acid Level (mg/dL)\" height=\"204\" src=\"Febuxostat%20Mylan%20not%20most%20recent_files/image003.png\" width=\"13\"/></span></span>", "ID": "6ed40d2b-d9db-4f39-a85b-f27e34866feb", "Styles": "position:relative;z-index:-1895826944", "Classes": "None", "Text": "", "ParentId": "8d853de1-dbbc-46bc-9ca1-3cdefa05e04d"}, {"Element": "<span style=\"left:0px;position:\nabsolute;left:195px;top:-1px;width:13px;height:204px\"><img alt=\"Mean (\u00b1SEM) Serum Uric Acid Level (mg/dL)\" height=\"204\" src=\"Febuxostat%20Mylan%20not%20most%20recent_files/image003.png\" width=\"13\"/></span>", "ID": "1a487658-3f3d-4639-9fbe-cc7d052af404", "Styles": "left:0px;position:\nabsolute;left:195px;top:-1px;width:13px;height:204px", "Classes": "None", "Text": "", "ParentId": "6ed40d2b-d9db-4f39-a85b-f27e34866feb"}, {"Element": "<img alt=\"Mean (\u00b1SEM) Serum Uric Acid Level (mg/dL)\" height=\"204\" src=\"Febuxostat%20Mylan%20not%20most%20recent_files/image003.png\" width=\"13\"/>", "ID": "44ebfdab-08b4-47f1-bd5b-3cad1807ba5d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "1a487658-3f3d-4639-9fbe-cc7d052af404"}, {"Element": "<span lang=\"EN-GB\" style='font-size:8.0pt;font-family:\"Times New Roman\",serif'>10\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 </span>", "ID": "a41aa66f-a1c4-4dcc-a998-fd505d2e3303", "Styles": "font-size:8.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "10\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "8d853de1-dbbc-46bc-9ca1-3cdefa05e04d"}, {"Element": "<span lang=\"EN-GB\" style='font-size:6.0pt;font-family:\"Times New Roman\",serif'>Placebo</span>", "ID": "4d972dfa-57d0-4484-b0be-457253e837b8", "Styles": "font-size:6.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Placebo", "ParentId": "8d853de1-dbbc-46bc-9ca1-3cdefa05e04d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;page-break-after:\navoid;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:8.5pt;font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "a551b540-aca2-41a2-8e8e-02ad06d9fe7e", "Styles": "margin-bottom:0in;line-height:normal;page-break-after:\navoid;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:8.5pt;font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "079f19cc-69ac-429b-9608-e951b798ae54", "Styles": "font-size:8.5pt;font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "a551b540-aca2-41a2-8e8e-02ad06d9fe7e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:102.75pt;line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-size:8.0pt;font-family:\"Times New Roman\",serif'>9</span></p>", "ID": "9a4cc888-980c-44a3-aef3-79c74f756113", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:102.75pt;line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:8.0pt;font-family:\"Times New Roman\",serif'>9</span>", "ID": "f893de74-cf08-40cc-9c81-5dd133a99ae2", "Styles": "font-size:8.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "9", "ParentId": "9a4cc888-980c-44a3-aef3-79c74f756113"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;page-break-after:\navoid;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:10.0pt;font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "ceddeb14-4dd8-467e-957d-b4a2548cab30", "Styles": "margin-bottom:0in;line-height:normal;page-break-after:\navoid;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:10.0pt;font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "2d18760c-970e-4584-88d0-d792d5d746be", "Styles": "font-size:10.0pt;font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "ceddeb14-4dd8-467e-957d-b4a2548cab30"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:102.75pt;line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-size:8.0pt;font-family:\"Times New Roman\",serif'>8</span></p>", "ID": "21c24da0-9e51-4ab8-b2b9-7f9f24f8f921", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:102.75pt;line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:8.0pt;font-family:\"Times New Roman\",serif'>8</span>", "ID": "304f7123-c7ec-488b-804a-ab9af89c1635", "Styles": "font-size:8.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "8", "ParentId": "21c24da0-9e51-4ab8-b2b9-7f9f24f8f921"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;page-break-after:\navoid;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:10.0pt;font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "c29eb11a-96b1-4ed9-b910-8a7ba9cf9b24", "Styles": "margin-bottom:0in;line-height:normal;page-break-after:\navoid;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:10.0pt;font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "3ed91b15-0afd-407e-abb3-d471e53e3a84", "Styles": "font-size:10.0pt;font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "c29eb11a-96b1-4ed9-b910-8a7ba9cf9b24"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:102.75pt;line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-size:8.0pt;font-family:\"Times New Roman\",serif'>7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 </span><span lang=\"EN-GB\" style='font-size:6.0pt;font-family:\"Times New Roman\",serif'>Allopurinol</span></p>", "ID": "922e9c22-b9fe-4a9a-8a4a-2713db505eb9", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:102.75pt;line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:8.0pt;font-family:\"Times New Roman\",serif'>7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 </span>", "ID": "5cb369ac-3641-4fc0-9556-90ffb812d3ba", "Styles": "font-size:8.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "922e9c22-b9fe-4a9a-8a4a-2713db505eb9"}, {"Element": "<span lang=\"EN-GB\" style='font-size:6.0pt;font-family:\"Times New Roman\",serif'>Allopurinol</span>", "ID": "d8f69fe2-7af9-4c0d-87d7-c6ca7576fded", "Styles": "font-size:6.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Allopurinol", "ParentId": "922e9c22-b9fe-4a9a-8a4a-2713db505eb9"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;page-break-after:\navoid;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:10.0pt;font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "07b49145-9962-4b49-a5e1-8de62ae48ad7", "Styles": "margin-bottom:0in;line-height:normal;page-break-after:\navoid;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:10.0pt;font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "fd520a33-dba7-48c7-8f78-26074ae2530e", "Styles": "font-size:10.0pt;font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "07b49145-9962-4b49-a5e1-8de62ae48ad7"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:102.75pt;line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-size:8.0pt;font-family:\"Times New Roman\",serif'>6</span></p>", "ID": "d9a640d0-7002-4f5d-b833-cda0046cba29", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:102.75pt;line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:8.0pt;font-family:\"Times New Roman\",serif'>6</span>", "ID": "56921555-1fa9-447e-86a5-7eb95071f712", "Styles": "font-size:8.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "6", "ParentId": "d9a640d0-7002-4f5d-b833-cda0046cba29"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:260.5pt;line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-size:6.0pt;font-family:\"Times New Roman\",serif'>Febuxostat\n80\u00a0mg</span></p>", "ID": "04906ed4-3f91-4622-89dd-033117447ed3", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:260.5pt;line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:6.0pt;font-family:\"Times New Roman\",serif'>Febuxostat\n80\u00a0mg</span>", "ID": "0593f26d-7bd9-4253-a2bb-91caba6bb346", "Styles": "font-size:6.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Febuxostat 80\u00a0mg", "ParentId": "04906ed4-3f91-4622-89dd-033117447ed3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;page-break-after:\navoid;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:5.0pt;font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "a32711a1-e107-4e57-b69f-005ddc0a463d", "Styles": "margin-bottom:0in;line-height:normal;page-break-after:\navoid;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:5.0pt;font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "37e3cb59-94c5-4668-815d-d03e5d95924c", "Styles": "font-size:5.0pt;font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "a32711a1-e107-4e57-b69f-005ddc0a463d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:102.75pt;line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-size:8.0pt;font-family:\"Times New Roman\",serif'>5</span></p>", "ID": "88d9ef1f-df87-444d-bfb3-06f4c11c7b86", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:102.75pt;line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:8.0pt;font-family:\"Times New Roman\",serif'>5</span>", "ID": "eb380f53-cad7-41ec-8137-9875d6d2ebb8", "Styles": "font-size:8.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "5", "ParentId": "88d9ef1f-df87-444d-bfb3-06f4c11c7b86"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;page-break-after:\navoid;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:10.0pt;font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "6695b103-b504-45fb-b8d8-d9c4d3d9fcea", "Styles": "margin-bottom:0in;line-height:normal;page-break-after:\navoid;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:10.0pt;font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "ad0fa45b-3feb-4eda-9ebd-d78f3c45a584", "Styles": "font-size:10.0pt;font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "6695b103-b504-45fb-b8d8-d9c4d3d9fcea"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:102.75pt;line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-size:8.0pt;font-family:\"Times New Roman\",serif'>4</span></p>", "ID": "969659f1-259d-4a76-92a8-7d180e5b8034", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:102.75pt;line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:8.0pt;font-family:\"Times New Roman\",serif'>4</span>", "ID": "64645de4-0bbe-478f-8b5a-19d5fbe0875d", "Styles": "font-size:8.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "4", "ParentId": "969659f1-259d-4a76-92a8-7d180e5b8034"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:260.5pt;line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-size:6.0pt;font-family:\"Times New Roman\",serif'>Febuxostat\n120\u00a0mg</span></p>", "ID": "044a5cdf-131f-4b2d-8a81-77539cb9b5fc", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:260.5pt;line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:6.0pt;font-family:\"Times New Roman\",serif'>Febuxostat\n120\u00a0mg</span>", "ID": "c414c6f3-ef78-4f94-a6c7-44b896872c83", "Styles": "font-size:6.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Febuxostat 120\u00a0mg", "ParentId": "044a5cdf-131f-4b2d-8a81-77539cb9b5fc"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;page-break-after:\navoid;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:7.5pt;font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "8be83a98-f767-4a8c-8494-55fbf8317a4e", "Styles": "margin-bottom:0in;line-height:normal;page-break-after:\navoid;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:7.5pt;font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "b1fc8d70-efbd-4f9e-a074-a5a776a1e03a", "Styles": "font-size:7.5pt;font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "8be83a98-f767-4a8c-8494-55fbf8317a4e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:102.75pt;line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-size:8.0pt;font-family:\"Times New Roman\",serif'>3\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <u>\n</u></span></p>", "ID": "e63dde05-cdb7-423b-8c43-bfaa796301d3", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:102.75pt;line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:8.0pt;font-family:\"Times New Roman\",serif'>3\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <u>\n</u></span>", "ID": "7ea82cda-87fd-48e0-8d9a-e8c76a11436a", "Styles": "font-size:8.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "3\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "e63dde05-cdb7-423b-8c43-bfaa796301d3"}, {"Element": "<u>\n</u>", "ID": "20aef4f3-3803-4eda-9dc6-c5a4df6dc27e", "Styles": "None", "Classes": "None", "Text": " ", "ParentId": "7ea82cda-87fd-48e0-8d9a-e8c76a11436a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;page-break-after:\navoid;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:7.0pt;font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "50c5d23b-6190-4ec3-a3b4-26b2593f11ad", "Styles": "margin-bottom:0in;line-height:normal;page-break-after:\navoid;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:7.0pt;font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "e33c7a3d-7953-45ff-b336-2aba8b337649", "Styles": "font-size:7.0pt;font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "50c5d23b-6190-4ec3-a3b4-26b2593f11ad"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:260.5pt;line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-size:6.0pt;font-family:\"Times New Roman\",serif'>Febuxostat\n240\u00a0mg</span></p>", "ID": "b6325495-e832-4f81-ae35-0709e91375e0", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:260.5pt;line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:6.0pt;font-family:\"Times New Roman\",serif'>Febuxostat\n240\u00a0mg</span>", "ID": "20ec9172-6139-4e8d-ab58-ac16d6f38c05", "Styles": "font-size:6.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Febuxostat 240\u00a0mg", "ParentId": "b6325495-e832-4f81-ae35-0709e91375e0"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:102.75pt;line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-size:8.0pt;font-family:\"Times New Roman\",serif'>2</span></p>", "ID": "efad2573-060f-4feb-bc65-ad9990723777", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:102.75pt;line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:8.0pt;font-family:\"Times New Roman\",serif'>2</span>", "ID": "436e17fc-daf7-4fd1-a817-7486b5878210", "Styles": "font-size:8.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "2", "ParentId": "efad2573-060f-4feb-bc65-ad9990723777"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:123.6pt;line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-size:8.0pt;font-family:\"Times New Roman\",serif'>BL\u00a0\u00a0\n2\u00a0\u00a0\u00a0\u00a0 4\u00a0\u00a0\u00a0\u00a0 6\u00a0\u00a0\u00a0\u00a0 8\u00a0\u00a0\u00a0 12\u00a0\u00a0 16\u00a0\u00a0 20\u00a0\u00a0 24\u00a0\u00a0 28\u00a0\u00a0 32\u00a0\u00a0 36\u00a0\u00a0 40\u00a0\u00a0 44\u00a0\u00a0 48\u00a0\u00a0 52</span></p>", "ID": "7f21e3ec-abac-401f-a179-e7dd2362316a", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:123.6pt;line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:8.0pt;font-family:\"Times New Roman\",serif'>BL\u00a0\u00a0\n2\u00a0\u00a0\u00a0\u00a0 4\u00a0\u00a0\u00a0\u00a0 6\u00a0\u00a0\u00a0\u00a0 8\u00a0\u00a0\u00a0 12\u00a0\u00a0 16\u00a0\u00a0 20\u00a0\u00a0 24\u00a0\u00a0 28\u00a0\u00a0 32\u00a0\u00a0 36\u00a0\u00a0 40\u00a0\u00a0 44\u00a0\u00a0 48\u00a0\u00a0 52</span>", "ID": "b5e3ddbe-d949-4933-9506-89d9e444c9df", "Styles": "font-size:8.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "BL\u00a0\u00a0 2\u00a0\u00a0\u00a0\u00a0 4\u00a0\u00a0\u00a0\u00a0 6\u00a0\u00a0\u00a0\u00a0 8\u00a0\u00a0\u00a0 12\u00a0\u00a0 16\u00a0\u00a0 20\u00a0\u00a0 24\u00a0\u00a0 28\u00a0\u00a0 32\u00a0\u00a0 36\u00a0\u00a0 40\u00a0\u00a0 44\u00a0\u00a0 48\u00a0\u00a0 52", "ParentId": "7f21e3ec-abac-401f-a179-e7dd2362316a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;page-break-after:\navoid;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:8.5pt;font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "c0f001cd-e084-4de0-920d-defb3cba3837", "Styles": "margin-bottom:0in;line-height:normal;page-break-after:\navoid;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:8.5pt;font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "bc8168dc-d0fe-44d3-ab74-33f6c3f6ac8a", "Styles": "font-size:8.5pt;font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "c0f001cd-e084-4de0-920d-defb3cba3837"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:210.8pt;\nmargin-bottom:0in;margin-left:230.0pt;text-align:center;line-height:normal;\npage-break-after:avoid;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:\n8.0pt;font-family:\"Times New Roman\",serif'>Week</span></p>", "ID": "8b25a0c8-1824-406b-9717-4f2f44c27b62", "Styles": "margin-top:0in;margin-right:210.8pt;\nmargin-bottom:0in;margin-left:230.0pt;text-align:center;line-height:normal;\npage-break-after:avoid;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:\n8.0pt;font-family:\"Times New Roman\",serif'>Week</span>", "ID": "f1d4119a-13be-417d-ac95-ea155c216283", "Styles": "font-size:\n8.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Week", "ParentId": "8b25a0c8-1824-406b-9717-4f2f44c27b62"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;page-break-after:\navoid;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:6.0pt;font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "b95dc7ff-239e-4969-b985-f51fcd472a1c", "Styles": "margin-bottom:0in;line-height:normal;page-break-after:\navoid;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:6.0pt;font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "cdec393c-6dc7-4d7c-a6bf-2da31093beaa", "Styles": "font-size:6.0pt;font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "b95dc7ff-239e-4969-b985-f51fcd472a1c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:114.4pt;line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-size:6.0pt;font-family:\"Times New Roman\",serif'>BL=baseline\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\nSEM=standard error of the mean</span></p>", "ID": "432b2f7b-af88-4c40-acd1-3c5d99d78c9e", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:114.4pt;line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:6.0pt;font-family:\"Times New Roman\",serif'>BL=baseline\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\nSEM=standard error of the mean</span>", "ID": "76f129c9-098c-4740-917d-8987cfe72b22", "Styles": "font-size:6.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "BL=baseline\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SEM=standard error of the mean", "ParentId": "432b2f7b-af88-4c40-acd1-3c5d99d78c9e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "d347c196-d8a9-499e-9336-1dd5f852aab1", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "80883fac-c453-46af-9502-3b8bad8be9f2", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "d347c196-d8a9-499e-9336-1dd5f852aab1"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Note: 509 patients received\nallopurinol 300\u00a0mg QD; 10 patients with serum creatinine &gt;1.5 and \u22642.0\u00a0mg/dL\nwere dosed with 100\u00a0mg QD. (10 patients out of 268 in APEX study).</span></p>", "ID": "859a52b8-e60c-40d7-b05a-230a0f863b3c", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Note: 509 patients received\nallopurinol 300\u00a0mg QD; 10 patients with serum creatinine &gt;1.5 and \u22642.0\u00a0mg/dL\nwere dosed with 100\u00a0mg QD. (10 patients out of 268 in APEX study).</span>", "ID": "7c0899eb-d049-4e1b-bb96-93e39ac7e8a3", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Note: 509 patients received allopurinol 300\u00a0mg QD; 10 patients with serum creatinine >1.5 and \u22642.0\u00a0mg/dL were dosed with 100\u00a0mg QD. (10 patients out of 268 in APEX study).", "ParentId": "859a52b8-e60c-40d7-b05a-230a0f863b3c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>240\u00a0mg febuxostat was used to\nevaluate the safety of febuxostat at twice the recommended highest dose.</span></p>", "ID": "e6adc373-c3e0-437b-9222-cc55929aa1a5", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>240\u00a0mg febuxostat was used to\nevaluate the safety of febuxostat at twice the recommended highest dose.</span>", "ID": "96923a8e-b00f-4411-b8f6-2f3b2ff8baa7", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "240\u00a0mg febuxostat was used to evaluate the safety of febuxostat at twice the recommended highest dose.", "ParentId": "e6adc373-c3e0-437b-9222-cc55929aa1a5"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "477d050c-a28a-4cd2-980b-eff8dc1a9386", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "b045e204-20d4-4dc6-a960-7574f52ebca1", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "477d050c-a28a-4cd2-980b-eff8dc1a9386"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>CONFIRMS Study: The CONFIRMS study\nwas a Phase 3, randomized, controlled, 26-week study to evaluate the safety and\nefficacy of febuxostat 40\u00a0mg and 80\u00a0mg, in comparison with\nallopurinol 300\u00a0mg or 200\u00a0mg, in patients with gout and\nhyperuricaemia. Two thousand and two hundred-sixty nine (2269) patients were\nrandomized: febuxostat 40\u00a0mg QD (n=757), febuxostat 80\u00a0mg QD (n=756),\nor allopurinol 300/200\u00a0mg QD (n=756). At least 65% of the patients had\nmild-moderate renal impairment (with creatinine clearance of 30-89\u00a0mL/min).\nProphylaxis against gout flares was obligatory over the 26-week period.</span></p>", "ID": "deae72f0-1b51-4d06-a01e-6f80c6cef348", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>CONFIRMS Study: The CONFIRMS study\nwas a Phase 3, randomized, controlled, 26-week study to evaluate the safety and\nefficacy of febuxostat 40\u00a0mg and 80\u00a0mg, in comparison with\nallopurinol 300\u00a0mg or 200\u00a0mg, in patients with gout and\nhyperuricaemia. Two thousand and two hundred-sixty nine (2269) patients were\nrandomized: febuxostat 40\u00a0mg QD (n=757), febuxostat 80\u00a0mg QD (n=756),\nor allopurinol 300/200\u00a0mg QD (n=756). At least 65% of the patients had\nmild-moderate renal impairment (with creatinine clearance of 30-89\u00a0mL/min).\nProphylaxis against gout flares was obligatory over the 26-week period.</span>", "ID": "17784387-1fe9-43dd-8d5b-69b5a8c8f479", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "CONFIRMS Study: The CONFIRMS study was a Phase 3, randomized, controlled, 26-week study to evaluate the safety and efficacy of febuxostat 40\u00a0mg and 80\u00a0mg, in comparison with allopurinol 300\u00a0mg or 200\u00a0mg, in patients with gout and hyperuricaemia. Two thousand and two hundred-sixty nine (2269) patients were randomized: febuxostat 40\u00a0mg QD (n=757), febuxostat 80\u00a0mg QD (n=756), or allopurinol 300/200\u00a0mg QD (n=756). At least 65% of the patients had mild-moderate renal impairment (with creatinine clearance of 30-89\u00a0mL/min). Prophylaxis against gout flares was obligatory over the 26-week period.", "ParentId": "deae72f0-1b51-4d06-a01e-6f80c6cef348"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "1aa79fad-dfc1-40cd-bca6-285593d930a0", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "c2fcac12-48f0-49d4-89a0-6109347cce0d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "1aa79fad-dfc1-40cd-bca6-285593d930a0"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The proportion of patients with\nserum urate levels of &lt; 6.0\u00a0mg/dL (357\u00a0\u00b5mol/L) at the final visit,\nwas 45% for 40\u00a0mg febuxostat, 67% for febuxostat 80\u00a0mg and 42% for\nallopurinol 300/200\u00a0mg, respectively.</span></p>", "ID": "8ffd66dc-2db3-4649-bdcc-1512106c9582", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The proportion of patients with\nserum urate levels of &lt; 6.0\u00a0mg/dL (357\u00a0\u00b5mol/L) at the final visit,\nwas 45% for 40\u00a0mg febuxostat, 67% for febuxostat 80\u00a0mg and 42% for\nallopurinol 300/200\u00a0mg, respectively.</span>", "ID": "cbfaa8ef-9a29-4868-b386-3880de9c6a01", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "The proportion of patients with serum urate levels of < 6.0\u00a0mg/dL (357\u00a0\u00b5mol/L) at the final visit, was 45% for 40\u00a0mg febuxostat, 67% for febuxostat 80\u00a0mg and 42% for allopurinol 300/200\u00a0mg, respectively.", "ParentId": "8ffd66dc-2db3-4649-bdcc-1512106c9582"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "9fd70811-2d0a-4105-b978-df2a2778911e", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "69f8349a-c894-4785-ae6c-71f5cff95b07", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "9fd70811-2d0a-4105-b978-df2a2778911e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Primary endpoint in the sub-group\nof patients with renal impairment</span></i></p>", "ID": "5ebab755-cfdf-4263-990b-68def48fbc2e", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Primary endpoint in the sub-group\nof patients with renal impairment</span></i>", "ID": "2e7340ba-f028-4fcd-8b18-ce4d3ab29475", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "5ebab755-cfdf-4263-990b-68def48fbc2e"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Primary endpoint in the sub-group\nof patients with renal impairment</span>", "ID": "4bdf6db5-236e-44cf-b82c-9dad3204845f", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Primary endpoint in the sub-group of patients with renal impairment", "ParentId": "2e7340ba-f028-4fcd-8b18-ce4d3ab29475"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The APEX Study evaluated efficacy\nin 40 patients with renal impairment (i.e., baseline serum creatinine &gt; 1.5\u00a0mg/dL\nand \u22642.0\u00a0mg/dL). For renally impaired subjects who were randomized\nto allopurinol, the dose was capped at 100\u00a0mg QD. Febuxostat achieved the\nprimary efficacy endpoint in 44% (80\u00a0mg QD), 45% (120\u00a0mg QD), and 60%\n(240\u00a0mg QD) of patients compared to 0% in the allopurinol 100\u00a0mg QD\nand placebo groups.</span></p>", "ID": "6bea5cc6-964d-4b83-9afe-4b8be2a21e91", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The APEX Study evaluated efficacy\nin 40 patients with renal impairment (i.e., baseline serum creatinine &gt; 1.5\u00a0mg/dL\nand \u22642.0\u00a0mg/dL). For renally impaired subjects who were randomized\nto allopurinol, the dose was capped at 100\u00a0mg QD. Febuxostat achieved the\nprimary efficacy endpoint in 44% (80\u00a0mg QD), 45% (120\u00a0mg QD), and 60%\n(240\u00a0mg QD) of patients compared to 0% in the allopurinol 100\u00a0mg QD\nand placebo groups.</span>", "ID": "1d2170da-f7b5-4f9e-82fc-afa36200d916", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "The APEX Study evaluated efficacy in 40 patients with renal impairment (i.e., baseline serum creatinine > 1.5\u00a0mg/dL and \u22642.0\u00a0mg/dL). For renally impaired subjects who were randomized to allopurinol, the dose was capped at 100\u00a0mg QD. Febuxostat achieved the primary efficacy endpoint in 44% (80\u00a0mg QD), 45% (120\u00a0mg QD), and 60% (240\u00a0mg QD) of patients compared to 0% in the allopurinol 100\u00a0mg QD and placebo groups.", "ParentId": "6bea5cc6-964d-4b83-9afe-4b8be2a21e91"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "3a8263b6-a3fe-4f2c-a4e5-b253f6674b45", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "a8330967-2583-421e-8474-f59aaca58a9d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "3a8263b6-a3fe-4f2c-a4e5-b253f6674b45"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>There were no clinically\nsignificant differences in the percent decrease in serum uric acid\nconcentration in healthy subjects irrespective of their renal function (58% in\nthe normal renal function group and 55% in the severe renal dysfunction group).</span></p>", "ID": "53c9577a-d655-4583-a210-190073ec31a6", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>There were no clinically\nsignificant differences in the percent decrease in serum uric acid\nconcentration in healthy subjects irrespective of their renal function (58% in\nthe normal renal function group and 55% in the severe renal dysfunction group).</span>", "ID": "bb555f50-2933-4421-b8fd-bc3705e42b9a", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "There were no clinically significant differences in the percent decrease in serum uric acid concentration in healthy subjects irrespective of their renal function (58% in the normal renal function group and 55% in the severe renal dysfunction group).", "ParentId": "53c9577a-d655-4583-a210-190073ec31a6"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "99512d74-914f-403b-984b-d75736162a55", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "04b1396b-7aa3-4240-a42a-e282a64bfe4e", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "99512d74-914f-403b-984b-d75736162a55"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>An analysis in patients with gout\nand renal impairment was prospectively defined in the CONFIRMS study, and\nshowed that febuxostat was significantly more efficacious in lowering serum\nurate levels to &lt; 6\u00a0mg/dL compared to allopurinol 300\u00a0mg/200\u00a0mg\nin patients who had gout with mild to moderate renal impairment (65% of\npatients studied).</span></p>", "ID": "02277dfc-b7e3-4431-bd3b-2a24c4c63b45", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>An analysis in patients with gout\nand renal impairment was prospectively defined in the CONFIRMS study, and\nshowed that febuxostat was significantly more efficacious in lowering serum\nurate levels to &lt; 6\u00a0mg/dL compared to allopurinol 300\u00a0mg/200\u00a0mg\nin patients who had gout with mild to moderate renal impairment (65% of\npatients studied).</span>", "ID": "44542476-ac9f-4ab9-b7c9-ca86a6e79f7c", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "An analysis in patients with gout and renal impairment was prospectively defined in the CONFIRMS study, and showed that febuxostat was significantly more efficacious in lowering serum urate levels to < 6\u00a0mg/dL compared to allopurinol 300\u00a0mg/200\u00a0mg in patients who had gout with mild to moderate renal impairment (65% of patients studied).", "ParentId": "02277dfc-b7e3-4431-bd3b-2a24c4c63b45"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "071d9270-85bf-40c3-bded-59c5fdcb484c", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "4780e5d6-a995-40f0-862e-c05ccd733261", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "071d9270-85bf-40c3-bded-59c5fdcb484c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Primary endpoint in the sub group\nof patients with sUA \u2265 10\u00a0mg/dL</span></i></p>", "ID": "10d2ec42-18d5-4a0e-a2e3-fa2a5c01a812", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Primary endpoint in the sub group\nof patients with sUA \u2265 10\u00a0mg/dL</span></i>", "ID": "4c7407ed-397f-47fd-90ac-6447243bcccd", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "10d2ec42-18d5-4a0e-a2e3-fa2a5c01a812"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Primary endpoint in the sub group\nof patients with sUA \u2265 10\u00a0mg/dL</span>", "ID": "36c69f5b-8cda-4c0c-af0d-9b742780b45c", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Primary endpoint in the sub group of patients with sUA \u2265 10\u00a0mg/dL", "ParentId": "4c7407ed-397f-47fd-90ac-6447243bcccd"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Approximately 40% of patients\n(combined APEX and FACT) had a baseline sUA of \u2265 10\u00a0mg/dL. In this\nsubgroup </span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>febuxostat</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'> achieved the primary\nefficacy endpoint (sUA &lt; 6.0\u00a0mg/dL at the last 3 visits) in 41% (80\u00a0mg\nQD), 48% (120\u00a0mg QD), and 66% (240\u00a0mg QD) of patients compared to 9%\nin the allopurinol 300\u00a0mg/100\u00a0mg QD and 0% in the placebo groups.</span></p>", "ID": "3f8282b7-0a30-4469-99a4-8b23f49bdd1c", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Approximately 40% of patients\n(combined APEX and FACT) had a baseline sUA of \u2265 10\u00a0mg/dL. In this\nsubgroup </span>", "ID": "dd29f720-208b-4ece-87ee-c07809c041b6", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Approximately 40% of patients (combined APEX and FACT) had a baseline sUA of \u2265 10\u00a0mg/dL. In this subgroup ", "ParentId": "3f8282b7-0a30-4469-99a4-8b23f49bdd1c"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>febuxostat</span>", "ID": "1e4cc9b7-1dc9-4b9a-94a5-edf63f67e9f4", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "febuxostat", "ParentId": "3f8282b7-0a30-4469-99a4-8b23f49bdd1c"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'> achieved the primary\nefficacy endpoint (sUA &lt; 6.0\u00a0mg/dL at the last 3 visits) in 41% (80\u00a0mg\nQD), 48% (120\u00a0mg QD), and 66% (240\u00a0mg QD) of patients compared to 9%\nin the allopurinol 300\u00a0mg/100\u00a0mg QD and 0% in the placebo groups.</span>", "ID": "504443bb-905c-4b13-a3b7-dbe8fd104c4d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": " achieved the primary efficacy endpoint (sUA < 6.0\u00a0mg/dL at the last 3 visits) in 41% (80\u00a0mg QD), 48% (120\u00a0mg QD), and 66% (240\u00a0mg QD) of patients compared to 9% in the allopurinol 300\u00a0mg/100\u00a0mg QD and 0% in the placebo groups.", "ParentId": "3f8282b7-0a30-4469-99a4-8b23f49bdd1c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "d2017654-85fa-4d13-9b82-11876cbacc61", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "93628e6b-0089-4280-86ff-3824bda802d4", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "d2017654-85fa-4d13-9b82-11876cbacc61"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>In the CONFIRMS study, the\nproportion of patients achieving the primary efficacy endpoint (sUA &lt;6.0\u00a0mg/dL\nat the final visit) for patients with a baseline serum urate level of \u2265\n10\u00a0mg/dL treated with febuxostat 40\u00a0mg QD was 27% (66/249), with\nfebuxostat 80\u00a0mg QD 49% (125/254) and with allopurinol 300\u00a0mg/200\u00a0mg\nQD 31% (72/230), respectively.</span></p>", "ID": "3cfbbcbe-92a3-4e01-aac2-db3a5904b115", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>In the CONFIRMS study, the\nproportion of patients achieving the primary efficacy endpoint (sUA &lt;6.0\u00a0mg/dL\nat the final visit) for patients with a baseline serum urate level of \u2265\n10\u00a0mg/dL treated with febuxostat 40\u00a0mg QD was 27% (66/249), with\nfebuxostat 80\u00a0mg QD 49% (125/254) and with allopurinol 300\u00a0mg/200\u00a0mg\nQD 31% (72/230), respectively.</span>", "ID": "74003207-98f1-48e8-9b6e-0f9c5d1d08df", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "In the CONFIRMS study, the proportion of patients achieving the primary efficacy endpoint (sUA <6.0\u00a0mg/dL at the final visit) for patients with a baseline serum urate level of \u2265 10\u00a0mg/dL treated with febuxostat 40\u00a0mg QD was 27% (66/249), with febuxostat 80\u00a0mg QD 49% (125/254) and with allopurinol 300\u00a0mg/200\u00a0mg QD 31% (72/230), respectively.", "ParentId": "3cfbbcbe-92a3-4e01-aac2-db3a5904b115"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "176ab5be-a66c-4e74-8636-d6c0398bdbad", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "3bf4633e-2bec-4855-8abd-e7523004bc16", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "176ab5be-a66c-4e74-8636-d6c0398bdbad"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Clinical Outcomes: proportion of\npatients requiring treatment for a gout flare</span></i></p>", "ID": "8e3cf75c-379c-4ba0-83c6-629cbdbfffdf", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Clinical Outcomes: proportion of\npatients requiring treatment for a gout flare</span></i>", "ID": "f8f48c9e-4e58-44d4-877a-cfda46b50eec", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "8e3cf75c-379c-4ba0-83c6-629cbdbfffdf"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Clinical Outcomes: proportion of\npatients requiring treatment for a gout flare</span>", "ID": "27a6e83f-9937-443e-b99a-4d924f9d8ff1", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Clinical Outcomes: proportion of patients requiring treatment for a gout flare", "ParentId": "f8f48c9e-4e58-44d4-877a-cfda46b50eec"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>APEX study: During the 8-week\nprophylaxis period, a greater proportion of subjects in the febuxostat 120\u00a0mg\n(36%) treatment group required treatment for gout flare compared to febuxostat\n80\u00a0mg (28%), allopurinol 300\u00a0mg (23%) and placebo (20%). Flares\nincreased following the prophylaxis period and gradually decreased over time. Between\n46% and 55% of subjects received treatment for gout flares from Week 8 and Week\n28. Gout flares during the last 4 weeks of the study (Weeks 24-28) were\nobserved in 15% (febuxostat 80, 120\u00a0mg), 14% (allopurinol 300\u00a0mg) and\n20% (placebo) of subjects.</span></p>", "ID": "a4bede05-e112-409e-81e7-644c628e6fec", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>APEX study: During the 8-week\nprophylaxis period, a greater proportion of subjects in the febuxostat 120\u00a0mg\n(36%) treatment group required treatment for gout flare compared to febuxostat\n80\u00a0mg (28%), allopurinol 300\u00a0mg (23%) and placebo (20%). Flares\nincreased following the prophylaxis period and gradually decreased over time. Between\n46% and 55% of subjects received treatment for gout flares from Week 8 and Week\n28. Gout flares during the last 4 weeks of the study (Weeks 24-28) were\nobserved in 15% (febuxostat 80, 120\u00a0mg), 14% (allopurinol 300\u00a0mg) and\n20% (placebo) of subjects.</span>", "ID": "592618ad-0c7f-4994-8898-58ce725efef4", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "APEX study: During the 8-week prophylaxis period, a greater proportion of subjects in the febuxostat 120\u00a0mg (36%) treatment group required treatment for gout flare compared to febuxostat 80\u00a0mg (28%), allopurinol 300\u00a0mg (23%) and placebo (20%). Flares increased following the prophylaxis period and gradually decreased over time. Between 46% and 55% of subjects received treatment for gout flares from Week 8 and Week 28. Gout flares during the last 4 weeks of the study (Weeks 24-28) were observed in 15% (febuxostat 80, 120\u00a0mg), 14% (allopurinol 300\u00a0mg) and 20% (placebo) of subjects.", "ParentId": "a4bede05-e112-409e-81e7-644c628e6fec"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "1044f019-3969-4b16-b603-9c774decb59b", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "b1354b13-9111-42ee-9c72-0a0cb38082b8", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "1044f019-3969-4b16-b603-9c774decb59b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>FACT study: During the 8-week\nprophylaxis period, a greater proportion of subjects in the febuxostat 120\u00a0mg\n(36%) treatment group required treatment for a gout flare compared to both the\nfebuxostat 80\u00a0mg (22%) and allopurinol 300\u00a0mg (21%) treatment groups.\nAfter the 8-week prophylaxis period, the incidences of flares increased and\ngradually decreased over time (64% and 70% of subjects received treatment for\ngout flares from Week 8-52). Gout flares during the last 4 weeks of the study (Weeks\n49-52) were observed in 6-8% (febuxostat 80\u00a0mg, 120\u00a0mg) and 11%\n(allopurinol 300\u00a0mg) of subjects.</span></p>", "ID": "47ca228f-cbdf-47a8-a72d-5cf6f9c81d88", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>FACT study: During the 8-week\nprophylaxis period, a greater proportion of subjects in the febuxostat 120\u00a0mg\n(36%) treatment group required treatment for a gout flare compared to both the\nfebuxostat 80\u00a0mg (22%) and allopurinol 300\u00a0mg (21%) treatment groups.\nAfter the 8-week prophylaxis period, the incidences of flares increased and\ngradually decreased over time (64% and 70% of subjects received treatment for\ngout flares from Week 8-52). Gout flares during the last 4 weeks of the study (Weeks\n49-52) were observed in 6-8% (febuxostat 80\u00a0mg, 120\u00a0mg) and 11%\n(allopurinol 300\u00a0mg) of subjects.</span>", "ID": "90793c98-d4b0-4dad-a0cb-64b6061aa9e0", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "FACT study: During the 8-week prophylaxis period, a greater proportion of subjects in the febuxostat 120\u00a0mg (36%) treatment group required treatment for a gout flare compared to both the febuxostat 80\u00a0mg (22%) and allopurinol 300\u00a0mg (21%) treatment groups. After the 8-week prophylaxis period, the incidences of flares increased and gradually decreased over time (64% and 70% of subjects received treatment for gout flares from Week 8-52). Gout flares during the last 4 weeks of the study (Weeks 49-52) were observed in 6-8% (febuxostat 80\u00a0mg, 120\u00a0mg) and 11% (allopurinol 300\u00a0mg) of subjects.", "ParentId": "47ca228f-cbdf-47a8-a72d-5cf6f9c81d88"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "4f4adc12-6dfc-40ed-88e6-a3dc9b03e3fb", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "38b6e139-54ae-4704-a0dc-b44b6143a977", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "4f4adc12-6dfc-40ed-88e6-a3dc9b03e3fb"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The proportion of subjects\nrequiring treatment for a gout flare (APEX and FACT Study) was numerically\nlower in the groups that achieved an average post-baseline serum urate level\n&lt;6.0\u00a0mg/dL, &lt;5.0\u00a0mg/dL, or &lt;4.0\u00a0mg/dL compared to the\ngroup that achieved an average post-baseline serum urate level \u22656.0\u00a0mg/dL\nduring the last 32 weeks of the treatment period (Week 20 - Week 24 to Week 49\n- 52 intervals).</span></p>", "ID": "28f0ba63-f2c0-44d9-96f9-22be4580413a", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The proportion of subjects\nrequiring treatment for a gout flare (APEX and FACT Study) was numerically\nlower in the groups that achieved an average post-baseline serum urate level\n&lt;6.0\u00a0mg/dL, &lt;5.0\u00a0mg/dL, or &lt;4.0\u00a0mg/dL compared to the\ngroup that achieved an average post-baseline serum urate level \u22656.0\u00a0mg/dL\nduring the last 32 weeks of the treatment period (Week 20 - Week 24 to Week 49\n- 52 intervals).</span>", "ID": "fd8bbafe-ab9f-4ce2-ad37-8260f9e1b540", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "The proportion of subjects requiring treatment for a gout flare (APEX and FACT Study) was numerically lower in the groups that achieved an average post-baseline serum urate level <6.0\u00a0mg/dL, <5.0\u00a0mg/dL, or <4.0\u00a0mg/dL compared to the group that achieved an average post-baseline serum urate level \u22656.0\u00a0mg/dL during the last 32 weeks of the treatment period (Week 20 - Week 24 to Week 49 - 52 intervals).", "ParentId": "28f0ba63-f2c0-44d9-96f9-22be4580413a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "2fbaacbf-20e1-4f88-ab6f-907fb3c22743", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "55553d7f-2e51-48ab-9988-053cc06961c6", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "2fbaacbf-20e1-4f88-ab6f-907fb3c22743"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>During the CONFIRMS study, the\npercentages of patients who required treatment for gout flares (Day 1 through\nMonth 6) were 31% and 25% for the febuxostat 80\u00a0mg and allopurinol groups,\nrespectively. No difference in the proportion of patients requiring treatment\nfor gout flares was observed between the febuxostat 80\u00a0mg and 40\u00a0mg\ngroups.</span></p>", "ID": "04c38a91-08c2-4d35-bdf1-adebd7d378dd", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>During the CONFIRMS study, the\npercentages of patients who required treatment for gout flares (Day 1 through\nMonth 6) were 31% and 25% for the febuxostat 80\u00a0mg and allopurinol groups,\nrespectively. No difference in the proportion of patients requiring treatment\nfor gout flares was observed between the febuxostat 80\u00a0mg and 40\u00a0mg\ngroups.</span>", "ID": "7581ae1d-4523-4554-9710-8f43ee1c7bdd", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "During the CONFIRMS study, the percentages of patients who required treatment for gout flares (Day 1 through Month 6) were 31% and 25% for the febuxostat 80\u00a0mg and allopurinol groups, respectively. No difference in the proportion of patients requiring treatment for gout flares was observed between the febuxostat 80\u00a0mg and 40\u00a0mg groups.", "ParentId": "04c38a91-08c2-4d35-bdf1-adebd7d378dd"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "dadf8705-ba00-4754-be5c-3af9da063f70", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "f548450d-8a6e-44ad-916d-8b27327a15ad", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "dadf8705-ba00-4754-be5c-3af9da063f70"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Long-term, open label extension\nStudies</span></i></p>", "ID": "0f0c792a-1110-4a54-ab36-16ba43abf25a", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Long-term, open label extension\nStudies</span></i>", "ID": "ed8bfc22-5d8b-49bc-a539-1d82296d2d2e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0f0c792a-1110-4a54-ab36-16ba43abf25a"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Long-term, open label extension\nStudies</span>", "ID": "f055562f-9232-4747-9c3d-a16580317682", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Long-term, open label extension Studies", "ParentId": "ed8bfc22-5d8b-49bc-a539-1d82296d2d2e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EXCEL Study (C02-021): The Excel\nstudy was a three years Phase 3, open label, multicenter, randomised,\nallopurinol-controlled, safety extension study for patients who had completed\nthe pivotal Phase 3 studies (APEX or FACT).\u00a0 A total of 1,086 patients were\nenrolled: </span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'> 80\u00a0mg QD (n=649), </span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>febuxostat</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'> 120\u00a0mg QD (n=292)\nand allopurinol 300/100\u00a0mg QD (n=145). About 69% of patients required no\ntreatment change to achieve a final stable treatment. Patients who had 3\nconsecutive sUA levels &gt;6.0\u00a0mg/dL were withdrawn.</span></p>", "ID": "540e820a-ef0c-45af-bbfc-6c78f3881f87", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EXCEL Study (C02-021): The Excel\nstudy was a three years Phase 3, open label, multicenter, randomised,\nallopurinol-controlled, safety extension study for patients who had completed\nthe pivotal Phase 3 studies (APEX or FACT).\u00a0 A total of 1,086 patients were\nenrolled: </span>", "ID": "e1aa1484-f648-4e01-a03b-123cde74cbad", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "EXCEL Study (C02-021): The Excel study was a three years Phase 3, open label, multicenter, randomised, allopurinol-controlled, safety extension study for patients who had completed the pivotal Phase 3 studies (APEX or FACT).\u00a0 A total of 1,086 patients were enrolled: ", "ParentId": "540e820a-ef0c-45af-bbfc-6c78f3881f87"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat</span>", "ID": "9b413a5a-9db4-488a-92d7-1b9d9070d504", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Febuxostat", "ParentId": "540e820a-ef0c-45af-bbfc-6c78f3881f87"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'> 80\u00a0mg QD (n=649), </span>", "ID": "3180bbc3-854d-4c39-9020-57735f8dea1f", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": " 80\u00a0mg QD (n=649), ", "ParentId": "540e820a-ef0c-45af-bbfc-6c78f3881f87"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>febuxostat</span>", "ID": "c43e8878-b7e8-4b66-8452-d1543a69f331", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "febuxostat", "ParentId": "540e820a-ef0c-45af-bbfc-6c78f3881f87"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'> 120\u00a0mg QD (n=292)\nand allopurinol 300/100\u00a0mg QD (n=145). About 69% of patients required no\ntreatment change to achieve a final stable treatment. Patients who had 3\nconsecutive sUA levels &gt;6.0\u00a0mg/dL were withdrawn.</span>", "ID": "09f81bdc-2868-4638-9054-06a798ec7ced", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": " 120\u00a0mg QD (n=292) and allopurinol 300/100\u00a0mg QD (n=145). About 69% of patients required no treatment change to achieve a final stable treatment. Patients who had 3 consecutive sUA levels >6.0\u00a0mg/dL were withdrawn.", "ParentId": "540e820a-ef0c-45af-bbfc-6c78f3881f87"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "8f08f050-d456-4636-b8e7-8d1d23841316", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "45de72eb-2b69-4c20-a528-75809118e50f", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "8f08f050-d456-4636-b8e7-8d1d23841316"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Serum urate levels were maintained\nover time (i.e. 91% and 93% of patients on initial treatment with febuxostat 80\u00a0mg\nand 120\u00a0mg, respectively, had sUA &lt;6\u00a0mg/dL at Month 36).</span></p>", "ID": "ecbc911b-9af6-4ff6-9c5d-2a5d447481a5", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Serum urate levels were maintained\nover time (i.e. 91% and 93% of patients on initial treatment with febuxostat 80\u00a0mg\nand 120\u00a0mg, respectively, had sUA &lt;6\u00a0mg/dL at Month 36).</span>", "ID": "95176782-39c8-4cab-af0c-793aaed724dc", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Serum urate levels were maintained over time (i.e. 91% and 93% of patients on initial treatment with febuxostat 80\u00a0mg and 120\u00a0mg, respectively, had sUA <6\u00a0mg/dL at Month 36).", "ParentId": "ecbc911b-9af6-4ff6-9c5d-2a5d447481a5"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "4017dda3-510d-473b-b250-957d5831ab12", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "009c457c-6fbf-4122-a8e4-5472a4ff232a", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "4017dda3-510d-473b-b250-957d5831ab12"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Three years data showed a decrease\nin the incidence of gout flares with less than 4% of patients requiring\ntreatment for a flare (i.e. more than 96% of patients did not require treatment\nfor a flare) at Month 16-24 and at Month 30-36.</span></p>", "ID": "d0661aa9-060f-4cc8-9a76-e809a516565d", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Three years data showed a decrease\nin the incidence of gout flares with less than 4% of patients requiring\ntreatment for a flare (i.e. more than 96% of patients did not require treatment\nfor a flare) at Month 16-24 and at Month 30-36.</span>", "ID": "af59c8ac-e226-4e83-abb0-88fba3cc97cd", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Three years data showed a decrease in the incidence of gout flares with less than 4% of patients requiring treatment for a flare (i.e. more than 96% of patients did not require treatment for a flare) at Month 16-24 and at Month 30-36.", "ParentId": "d0661aa9-060f-4cc8-9a76-e809a516565d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "bf058587-7749-4b6d-bba7-5f70deb6f2ab", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "24d4d8a8-6208-4061-9957-de6a07d3fbb8", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "bf058587-7749-4b6d-bba7-5f70deb6f2ab"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>46% and 38%, of patients on final\nstable treatment of febuxostat 80 or 120\u00a0mg QD, respectively, had complete\nresolution of the primary palpable tophus from baseline to the Final Visit.</span></p>", "ID": "3e49c6fe-5b7d-4d1f-9e5b-44e9061b24b9", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>46% and 38%, of patients on final\nstable treatment of febuxostat 80 or 120\u00a0mg QD, respectively, had complete\nresolution of the primary palpable tophus from baseline to the Final Visit.</span>", "ID": "d3812862-9f3f-4f62-8a88-bbbe82212552", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "46% and 38%, of patients on final stable treatment of febuxostat 80 or 120\u00a0mg QD, respectively, had complete resolution of the primary palpable tophus from baseline to the Final Visit.", "ParentId": "3e49c6fe-5b7d-4d1f-9e5b-44e9061b24b9"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "6c7db81d-d573-44e4-bbad-09d45c7f33a3", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "c2a496fe-e712-4308-932d-a24bcf48f547", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "6c7db81d-d573-44e4-bbad-09d45c7f33a3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>FOCUS Study (TMX-01-005) was a 5\nyears Phase 2, open-label, multicenter, safety extension study for patients who\nhad completed the febuxostat 4 weeks of double blind dosing in study\nTMX-00-004.</span></p>", "ID": "19687002-f441-4174-b379-0b98fe4d0c14", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>FOCUS Study (TMX-01-005) was a 5\nyears Phase 2, open-label, multicenter, safety extension study for patients who\nhad completed the febuxostat 4 weeks of double blind dosing in study\nTMX-00-004.</span>", "ID": "7ae1a357-7179-451b-a8fc-908cf8fb4086", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "FOCUS Study (TMX-01-005) was a 5 years Phase 2, open-label, multicenter, safety extension study for patients who had completed the febuxostat 4 weeks of double blind dosing in study TMX-00-004.", "ParentId": "19687002-f441-4174-b379-0b98fe4d0c14"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "d5497446-a392-45fa-ad6d-351093f89441", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "6dd4687f-7c0e-4e60-b515-389828b35a06", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "d5497446-a392-45fa-ad6d-351093f89441"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>116 patients were enrolled and\nreceived initially febuxostat 80\u00a0mg QD. 62% of patients required no dose\nadjustment to maintain sUA &lt;6\u00a0mg/dL and 38% of patients required a dose\nadjustment to achieve a final stable dose.</span></p>", "ID": "58bccf89-5370-43d4-af45-9a11f71efa8a", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>116 patients were enrolled and\nreceived initially febuxostat 80\u00a0mg QD. 62% of patients required no dose\nadjustment to maintain sUA &lt;6\u00a0mg/dL and 38% of patients required a dose\nadjustment to achieve a final stable dose.</span>", "ID": "977bbc58-c151-483c-b275-aa53e960bbd7", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "116 patients were enrolled and received initially febuxostat 80\u00a0mg QD. 62% of patients required no dose adjustment to maintain sUA <6\u00a0mg/dL and 38% of patients required a dose adjustment to achieve a final stable dose.", "ParentId": "58bccf89-5370-43d4-af45-9a11f71efa8a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "e6c71318-e36c-407f-ba9d-702ad535b1a7", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "083f75ed-058c-47cd-987c-57e736490220", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "e6c71318-e36c-407f-ba9d-702ad535b1a7"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The proportion of patients with\nserum urate levels of &lt;6.0\u00a0mg/dL (357\u00a0\u00b5mol/L) at the final visit\nwas greater than 80% (81-100%) at each febuxostat dose.</span></p>", "ID": "9e8598c8-10e6-4ed2-813b-03063b5c8a43", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The proportion of patients with\nserum urate levels of &lt;6.0\u00a0mg/dL (357\u00a0\u00b5mol/L) at the final visit\nwas greater than 80% (81-100%) at each febuxostat dose.</span>", "ID": "284aa6ca-e37e-41ab-b919-15c332bf94e0", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "The proportion of patients with serum urate levels of <6.0\u00a0mg/dL (357\u00a0\u00b5mol/L) at the final visit was greater than 80% (81-100%) at each febuxostat dose.", "ParentId": "9e8598c8-10e6-4ed2-813b-03063b5c8a43"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "0c321765-7c87-4c37-a1ce-b4ffece0099a", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "0e6f3c8d-7cd0-460f-83cb-648537bc70e0", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "0c321765-7c87-4c37-a1ce-b4ffece0099a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>During the phase 3 clinical\nstudies, mild liver function test abnormalities were observed in patients\ntreated with febuxostat (5.0%). These rates were similar to the rates reported\non allopurinol (4.2%) (see section 4.4). Increased TSH values (&gt;5.5\u00a0\u00b5IU/mL)\nwere observed in patients on long-term treatment with febuxostat (5.5%) and\npatients with allopurinol (5.8%) in the long term open label extension studies\n(see section 4.4).</span></p>", "ID": "9d467c3c-26d3-4bab-bbf7-29710f7f9428", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>During the phase 3 clinical\nstudies, mild liver function test abnormalities were observed in patients\ntreated with febuxostat (5.0%). These rates were similar to the rates reported\non allopurinol (4.2%) (see section 4.4). Increased TSH values (&gt;5.5\u00a0\u00b5IU/mL)\nwere observed in patients on long-term treatment with febuxostat (5.5%) and\npatients with allopurinol (5.8%) in the long term open label extension studies\n(see section 4.4).</span>", "ID": "8fc9a0a1-a2be-45ec-bf8e-09b2f3339b62", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "During the phase 3 clinical studies, mild liver function test abnormalities were observed in patients treated with febuxostat (5.0%). These rates were similar to the rates reported on allopurinol (4.2%) (see section 4.4). Increased TSH values (>5.5\u00a0\u00b5IU/mL) were observed in patients on long-term treatment with febuxostat (5.5%) and patients with allopurinol (5.8%) in the long term open label extension studies (see section 4.4).", "ParentId": "9d467c3c-26d3-4bab-bbf7-29710f7f9428"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "c35f8ae6-3aa3-4f50-a1d3-926431716179", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "bd3b49bb-aa32-46b2-94aa-94bec4c14a3f", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "c35f8ae6-3aa3-4f50-a1d3-926431716179"}, {"Element": "<h1 style=\"margin-right:6.4pt\"><span lang=\"EN-GB\">5.2\u00a0\u00a0\u00a0\u00a0 Pharmacokinetic\nproperties</span></h1>", "ID": "8997ef0e-d35a-492e-8f4f-c39b249252ab", "Styles": "margin-right:6.4pt", "Classes": "None", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\">5.2\u00a0\u00a0\u00a0\u00a0 Pharmacokinetic\nproperties</span>", "ID": "cfe8e7b1-54f4-4ecf-897a-03c657670af2", "Styles": "None", "Classes": "None", "Text": "5.2\u00a0\u00a0\u00a0\u00a0 Pharmacokinetic properties", "ParentId": "8997ef0e-d35a-492e-8f4f-c39b249252ab"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "911b9a29-001e-48f8-a2d7-bb60917efd54", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "2dedac32-7b03-480c-bf2e-1de3adbded84", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "911b9a29-001e-48f8-a2d7-bb60917efd54"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>In healthy subjects, maximum plasma\nconcentrations (C<sub>max</sub>) and area under the plasma concentration time\ncurve (AUC) of febuxostat increased in a dose proportional manner following\nsingle and multiple doses of 10\u00a0mg to 120\u00a0mg. For doses between 120\u00a0mg\nand 300\u00a0mg, a greater than dose proportional increase in AUC is observed\nfor febuxostat. There is no appreciable accumulation when doses of 10\u00a0mg\nto 240\u00a0mg are administered every 24 hours. Febuxostat has an apparent mean\nterminal elimination half-life (t<sub>1/2</sub>) of approximately 5 to 8 hours.</span></p>", "ID": "75a733fd-7cbb-4789-9347-1f861c0716a1", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>In healthy subjects, maximum plasma\nconcentrations (C<sub>max</sub>) and area under the plasma concentration time\ncurve (AUC) of febuxostat increased in a dose proportional manner following\nsingle and multiple doses of 10\u00a0mg to 120\u00a0mg. For doses between 120\u00a0mg\nand 300\u00a0mg, a greater than dose proportional increase in AUC is observed\nfor febuxostat. There is no appreciable accumulation when doses of 10\u00a0mg\nto 240\u00a0mg are administered every 24 hours. Febuxostat has an apparent mean\nterminal elimination half-life (t<sub>1/2</sub>) of approximately 5 to 8 hours.</span>", "ID": "21300885-14a3-442b-8aac-39835df5ab42", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "In healthy subjects, maximum plasma concentrations (C) and area under the plasma concentration time curve (AUC) of febuxostat increased in a dose proportional manner following single and multiple doses of 10\u00a0mg to 120\u00a0mg. For doses between 120\u00a0mg and 300\u00a0mg, a greater than dose proportional increase in AUC is observed for febuxostat. There is no appreciable accumulation when doses of 10\u00a0mg to 240\u00a0mg are administered every 24 hours. Febuxostat has an apparent mean terminal elimination half-life (t) of approximately 5 to 8 hours.", "ParentId": "75a733fd-7cbb-4789-9347-1f861c0716a1"}, {"Element": "<sub>max</sub>", "ID": "cb2fced9-205f-4e39-8edc-b9549be0aa9c", "Styles": "None", "Classes": "None", "Text": "max", "ParentId": "21300885-14a3-442b-8aac-39835df5ab42"}, {"Element": "<sub>1/2</sub>", "ID": "6e2d4d63-54aa-4af8-a243-ce46d01fb5f1", "Styles": "None", "Classes": "None", "Text": "1/2", "ParentId": "21300885-14a3-442b-8aac-39835df5ab42"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "c194050b-f273-48f3-929c-fca6221b0b1e", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "9f079978-3ad2-445d-acc5-67109db0bbde", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "c194050b-f273-48f3-929c-fca6221b0b1e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Population\npharmacokinetic/pharmacodynamic analyses were conducted in 211 patients with\nhyperuricaemia and gout, treated with febuxostat 40-240\u00a0mg QD. In general,\nfebuxostat pharmacokinetic parameters estimated by these analyses are\nconsistent with those obtained from healthy subjects, indicating that healthy\nsubjects are representative for pharmacokinetic/pharmacodynamic assessment in\nthe patient population with gout.</span></p>", "ID": "88d48653-4bf3-49ed-94c2-7373f53c5ab3", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Population\npharmacokinetic/pharmacodynamic analyses were conducted in 211 patients with\nhyperuricaemia and gout, treated with febuxostat 40-240\u00a0mg QD. In general,\nfebuxostat pharmacokinetic parameters estimated by these analyses are\nconsistent with those obtained from healthy subjects, indicating that healthy\nsubjects are representative for pharmacokinetic/pharmacodynamic assessment in\nthe patient population with gout.</span>", "ID": "21708766-af12-4b23-a3e5-79eb6e46af52", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Population pharmacokinetic/pharmacodynamic analyses were conducted in 211 patients with hyperuricaemia and gout, treated with febuxostat 40-240\u00a0mg QD. In general, febuxostat pharmacokinetic parameters estimated by these analyses are consistent with those obtained from healthy subjects, indicating that healthy subjects are representative for pharmacokinetic/pharmacodynamic assessment in the patient population with gout.", "ParentId": "88d48653-4bf3-49ed-94c2-7373f53c5ab3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "9a826284-016d-47c5-9059-3a59ad197464", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "61aaeaf5-f470-4aa2-b4e9-5fc18a986313", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "9a826284-016d-47c5-9059-3a59ad197464"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Absorption</span></u></p>", "ID": "5a2e8725-5018-4ff1-9904-c529438b586d", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Absorption</span></u>", "ID": "c8b1de04-6205-4947-97c0-0457a4fd2e49", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "5a2e8725-5018-4ff1-9904-c529438b586d"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Absorption</span>", "ID": "53f92df5-a31e-4d5f-89c4-b00030267e3a", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Absorption", "ParentId": "c8b1de04-6205-4947-97c0-0457a4fd2e49"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "68780f49-7269-42b1-b8cd-12d3ae00dbbe", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "2d693e8f-7c68-4993-aa00-41f3a394fd6c", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "68780f49-7269-42b1-b8cd-12d3ae00dbbe"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat is rapidly (t<sub>max</sub>\nof 1.0-1.5 h) and well absorbed (at least 84%). After single or multiple oral 80\nand 120\u00a0mg once daily doses, C<sub>max</sub> is approximately 2.8-3.2\u00a0\u00b5g/mL,\nand 5.0-5.3\u00a0\u00b5g/mL, respectively. Absolute bioavailability of the\nfebuxostat tablet formulation has not been studied.</span></p>", "ID": "c2dcb0bf-b401-4ec7-a95a-0293c77760a6", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat is rapidly (t<sub>max</sub>\nof 1.0-1.5 h) and well absorbed (at least 84%). After single or multiple oral 80\nand 120\u00a0mg once daily doses, C<sub>max</sub> is approximately 2.8-3.2\u00a0\u00b5g/mL,\nand 5.0-5.3\u00a0\u00b5g/mL, respectively. Absolute bioavailability of the\nfebuxostat tablet formulation has not been studied.</span>", "ID": "45e0d4fa-ecae-49b7-bba7-7064dd982902", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Febuxostat is rapidly (t of 1.0-1.5 h) and well absorbed (at least 84%). After single or multiple oral 80 and 120\u00a0mg once daily doses, C is approximately 2.8-3.2\u00a0\u00b5g/mL, and 5.0-5.3\u00a0\u00b5g/mL, respectively. Absolute bioavailability of the febuxostat tablet formulation has not been studied.", "ParentId": "c2dcb0bf-b401-4ec7-a95a-0293c77760a6"}, {"Element": "<sub>max</sub>", "ID": "bc4e7885-8193-4347-9a43-d151d58c9cc1", "Styles": "None", "Classes": "None", "Text": "max", "ParentId": "45e0d4fa-ecae-49b7-bba7-7064dd982902"}, {"Element": "<sub>max</sub>", "ID": "932a9b82-27e9-45cd-a53b-52bbce88cc7f", "Styles": "None", "Classes": "None", "Text": "max", "ParentId": "45e0d4fa-ecae-49b7-bba7-7064dd982902"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "a52d2640-ee56-40f4-a959-53cb875c2a13", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "12dd4094-601b-470e-9619-b0949acf02d8", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "a52d2640-ee56-40f4-a959-53cb875c2a13"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Following multiple oral 80\u00a0mg\nonce daily doses or a single 120\u00a0mg dose with a high fat meal, there was a\n49% and 38% decrease in C<sub>max</sub> and an 18% and 16% decrease in AUC,\nrespectively. However, no clinically significant change in the percent decrease\nin serum uric acid concentration was observed where tested (80\u00a0mg multiple\ndose). Thus, </span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>febuxostat</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'> may be taken without\nregard to food.</span></p>", "ID": "f4ba57ce-a89a-40a5-8f76-6f4f4e4e8419", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Following multiple oral 80\u00a0mg\nonce daily doses or a single 120\u00a0mg dose with a high fat meal, there was a\n49% and 38% decrease in C<sub>max</sub> and an 18% and 16% decrease in AUC,\nrespectively. However, no clinically significant change in the percent decrease\nin serum uric acid concentration was observed where tested (80\u00a0mg multiple\ndose). Thus, </span>", "ID": "b7b27734-bdcc-40ee-850c-5fe6bd6b4a6f", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Following multiple oral 80\u00a0mg once daily doses or a single 120\u00a0mg dose with a high fat meal, there was a 49% and 38% decrease in C and an 18% and 16% decrease in AUC, respectively. However, no clinically significant change in the percent decrease in serum uric acid concentration was observed where tested (80\u00a0mg multiple dose). Thus, ", "ParentId": "f4ba57ce-a89a-40a5-8f76-6f4f4e4e8419"}, {"Element": "<sub>max</sub>", "ID": "0249d166-21b6-4ba9-81e0-61d7df0de424", "Styles": "None", "Classes": "None", "Text": "max", "ParentId": "b7b27734-bdcc-40ee-850c-5fe6bd6b4a6f"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>febuxostat</span>", "ID": "99f01cca-a085-4ae1-ba12-6f0cfc97e9df", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "febuxostat", "ParentId": "f4ba57ce-a89a-40a5-8f76-6f4f4e4e8419"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'> may be taken without\nregard to food.</span>", "ID": "036a5458-b05e-4fa4-8493-fd8f95644a5d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": " may be taken without regard to food.", "ParentId": "f4ba57ce-a89a-40a5-8f76-6f4f4e4e8419"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "f559412b-92e9-4677-9dff-87360f4b968b", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "0f66433b-3231-487d-8771-29a6e190efe8", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "f559412b-92e9-4677-9dff-87360f4b968b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Distribution</span></u></p>", "ID": "f181a761-bdf2-4fd4-aa1b-d731851f2b94", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Distribution</span></u>", "ID": "70b08080-c610-4e0e-b064-220c543b7fb2", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f181a761-bdf2-4fd4-aa1b-d731851f2b94"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Distribution</span>", "ID": "279c3ddc-ff98-4319-b013-eaa0b5b3c50b", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Distribution", "ParentId": "70b08080-c610-4e0e-b064-220c543b7fb2"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "89a629e4-7e7d-493b-a5d6-9c7eed6be00f", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "d5b195b0-e8d6-42b4-82fe-8952cce1a7be", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "89a629e4-7e7d-493b-a5d6-9c7eed6be00f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The apparent steady state volume of\ndistribution (Vss/F) of febuxostat ranges from 29 to 75 L after oral doses of\n10-300\u00a0mg. The plasma protein binding of febuxostat is approximately\n99.2%, (primarily to albumin), and is constant over the concentration range\nachieved with 80 and 120\u00a0mg doses. Plasma protein binding of the active\nmetabolites ranges from about 82% to 91%.</span></p>", "ID": "00f30425-cb85-4cbf-9a37-dd4dd36e34f2", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The apparent steady state volume of\ndistribution (Vss/F) of febuxostat ranges from 29 to 75 L after oral doses of\n10-300\u00a0mg. The plasma protein binding of febuxostat is approximately\n99.2%, (primarily to albumin), and is constant over the concentration range\nachieved with 80 and 120\u00a0mg doses. Plasma protein binding of the active\nmetabolites ranges from about 82% to 91%.</span>", "ID": "278ebba2-1504-4a0d-8ee8-bc544e83af26", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "The apparent steady state volume of distribution (Vss/F) of febuxostat ranges from 29 to 75 L after oral doses of 10-300\u00a0mg. The plasma protein binding of febuxostat is approximately 99.2%, (primarily to albumin), and is constant over the concentration range achieved with 80 and 120\u00a0mg doses. Plasma protein binding of the active metabolites ranges from about 82% to 91%.", "ParentId": "00f30425-cb85-4cbf-9a37-dd4dd36e34f2"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "497a9b2d-b8c7-42b0-9f0c-67c8681d4d3f", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "44778801-55c2-4f4e-b316-d5f438da6862", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "497a9b2d-b8c7-42b0-9f0c-67c8681d4d3f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Biotransformation</span></u></p>", "ID": "57f1be63-5074-498a-843c-5c436e1f7b77", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Biotransformation</span></u>", "ID": "c061d8b9-cb18-492c-acdc-96a43fae7b85", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "57f1be63-5074-498a-843c-5c436e1f7b77"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Biotransformation</span>", "ID": "1ed8290c-cb08-4b98-a71f-05ba8c23f637", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Biotransformation", "ParentId": "c061d8b9-cb18-492c-acdc-96a43fae7b85"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "2d934f24-cb25-421b-8aaa-9354353fa98c", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "98d61090-e48f-45ff-89d0-79bde09b2beb", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "2d934f24-cb25-421b-8aaa-9354353fa98c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat is extensively\nmetabolized by conjugation <i>via </i>uridine diphosphate glucuronosyltransferase\n(UDPGT) enzyme system and oxidation <i>via </i>the cytochrome P450 (CYP)\nsystem. Four pharmacologically active hydroxyl metabolites have been\nidentified, of which three occur in plasma of humans. <i>In vitro </i>studies\nwith human liver microsomes showed that those oxidative metabolites were formed\nprimarily by CYP1A1, CYP1A2, CYP2C8 or CYP2C9 and febuxostat glucuronide was formed\nmainly by UGT 1A1, 1A8, and 1A9.</span></p>", "ID": "3ccf15d7-4c59-44da-b4ab-501fbcc85a4c", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat is extensively\nmetabolized by conjugation <i>via </i>uridine diphosphate glucuronosyltransferase\n(UDPGT) enzyme system and oxidation <i>via </i>the cytochrome P450 (CYP)\nsystem. Four pharmacologically active hydroxyl metabolites have been\nidentified, of which three occur in plasma of humans. <i>In vitro </i>studies\nwith human liver microsomes showed that those oxidative metabolites were formed\nprimarily by CYP1A1, CYP1A2, CYP2C8 or CYP2C9 and febuxostat glucuronide was formed\nmainly by UGT 1A1, 1A8, and 1A9.</span>", "ID": "9dd91d25-0a6e-4c52-910e-c2fe46fba201", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Febuxostat is extensively metabolized by conjugation uridine diphosphate glucuronosyltransferase (UDPGT) enzyme system and oxidation the cytochrome P450 (CYP) system. Four pharmacologically active hydroxyl metabolites have been identified, of which three occur in plasma of humans. studies with human liver microsomes showed that those oxidative metabolites were formed primarily by CYP1A1, CYP1A2, CYP2C8 or CYP2C9 and febuxostat glucuronide was formed mainly by UGT 1A1, 1A8, and 1A9.", "ParentId": "3ccf15d7-4c59-44da-b4ab-501fbcc85a4c"}, {"Element": "<i>via </i>", "ID": "dc38b94d-f0ad-41f8-91d4-8dc21d8bbcd6", "Styles": "None", "Classes": "None", "Text": "via ", "ParentId": "9dd91d25-0a6e-4c52-910e-c2fe46fba201"}, {"Element": "<i>via </i>", "ID": "b1afc242-6439-4f83-bc9c-3ebe8f754584", "Styles": "None", "Classes": "None", "Text": "via ", "ParentId": "9dd91d25-0a6e-4c52-910e-c2fe46fba201"}, {"Element": "<i>In vitro </i>", "ID": "ebb2fdee-884c-4ef9-8ad9-1fbe667c6740", "Styles": "None", "Classes": "None", "Text": "In vitro ", "ParentId": "9dd91d25-0a6e-4c52-910e-c2fe46fba201"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "a7a2a321-effa-4329-b43d-7ec740c8d85b", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "c05b0956-bbaf-4187-9795-55a8e9099ba6", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "a7a2a321-effa-4329-b43d-7ec740c8d85b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Elimination</span></u></p>", "ID": "5d1a9954-2237-41d6-9b59-40a68d1588ee", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Elimination</span></u>", "ID": "9908dd8e-665f-44f0-aa6b-2a34d278fb58", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "5d1a9954-2237-41d6-9b59-40a68d1588ee"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Elimination</span>", "ID": "436b6c9e-fb04-42f2-8f20-10172cc7dbfc", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Elimination", "ParentId": "9908dd8e-665f-44f0-aa6b-2a34d278fb58"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "2e25b7cf-649a-4858-8200-a1eb9f4813ed", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "b7e85d74-b3a5-4b3b-9751-69d0c0820515", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "2e25b7cf-649a-4858-8200-a1eb9f4813ed"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat is eliminated by both\nhepatic and renal pathways. Following an 80\u00a0mg oral dose of <sup>14</sup>C-labeled\nfebuxostat, approximately 49% of the dose was recovered in the urine as\nunchanged febuxostat (3%), the acyl glucuronide of the active substance (30%),\nits known oxidative metabolites and their conjugates (13%), and other unknown\nmetabolites (3%). In addition to the urinary excretion, approximately 45% of\nthe dose was recovered in the faeces as the unchanged febuxostat (12%), the\nacyl glucuronide of the active substance (1%), its known oxidative metabolites\nand their conjugates (25%), and other unknown metabolites (7%).</span></p>", "ID": "e75beed1-0af3-4a88-b8c6-6aae132fffad", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat is eliminated by both\nhepatic and renal pathways. Following an 80\u00a0mg oral dose of <sup>14</sup>C-labeled\nfebuxostat, approximately 49% of the dose was recovered in the urine as\nunchanged febuxostat (3%), the acyl glucuronide of the active substance (30%),\nits known oxidative metabolites and their conjugates (13%), and other unknown\nmetabolites (3%). In addition to the urinary excretion, approximately 45% of\nthe dose was recovered in the faeces as the unchanged febuxostat (12%), the\nacyl glucuronide of the active substance (1%), its known oxidative metabolites\nand their conjugates (25%), and other unknown metabolites (7%).</span>", "ID": "d0128c15-d8c0-482b-b81a-9df5acda4b24", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Febuxostat is eliminated by both hepatic and renal pathways. Following an 80\u00a0mg oral dose of C-labeled febuxostat, approximately 49% of the dose was recovered in the urine as unchanged febuxostat (3%), the acyl glucuronide of the active substance (30%), its known oxidative metabolites and their conjugates (13%), and other unknown metabolites (3%). In addition to the urinary excretion, approximately 45% of the dose was recovered in the faeces as the unchanged febuxostat (12%), the acyl glucuronide of the active substance (1%), its known oxidative metabolites and their conjugates (25%), and other unknown metabolites (7%).", "ParentId": "e75beed1-0af3-4a88-b8c6-6aae132fffad"}, {"Element": "<sup>14</sup>", "ID": "49c0d741-55cf-47da-877f-e06dd7c7fe14", "Styles": "None", "Classes": "None", "Text": "14", "ParentId": "d0128c15-d8c0-482b-b81a-9df5acda4b24"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "cdeac67d-6859-4815-9e7b-07e22a8289fc", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "ca7acca4-0e1f-4b6c-b9a9-0de5cddc76b3", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "cdeac67d-6859-4815-9e7b-07e22a8289fc"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Renal impairment</span></u></p>", "ID": "d2da54ae-f9d2-40fe-a16d-72517a9a9c13", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Renal impairment</span></u>", "ID": "a05001bf-9085-4561-82be-5890a10d53e4", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d2da54ae-f9d2-40fe-a16d-72517a9a9c13"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Renal impairment</span>", "ID": "0425aef9-9bb4-4829-9372-634a0794dbb3", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Renal impairment", "ParentId": "a05001bf-9085-4561-82be-5890a10d53e4"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "33ebca9b-206f-4acd-9533-b455255f50aa", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "f8c38139-15d9-46da-bf48-23a9bd78477d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "33ebca9b-206f-4acd-9533-b455255f50aa"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Following multiple doses of 80\u00a0mg\nof febuxostat in patients with mild, moderate or severe renal impairment, the C<sub>max</sub>\nof febuxostat did not change, relative to subjects with normal renal function.\nThe mean total AUC of febuxostat increased by approximately 1.8-fold from 7.5\u00a0\u00b5g</span><span lang=\"EN-GB\" style='font-family:\"Cambria Math\",serif'>\u22c5</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>h/mL in the normal renal\nfunction group to 13.2\u00a0\u00b5g.h/mL in the severe renal dysfunction group. The\nC<sub>max</sub> and AUC of active metabolites increased up to 2- and 4-fold,\nrespectively. However, no dose adjustment is necessary in patients with mild or\nmoderate renal impairment.</span></p>", "ID": "44c74de8-018e-4584-8dd9-50954d4e3eb5", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Following multiple doses of 80\u00a0mg\nof febuxostat in patients with mild, moderate or severe renal impairment, the C<sub>max</sub>\nof febuxostat did not change, relative to subjects with normal renal function.\nThe mean total AUC of febuxostat increased by approximately 1.8-fold from 7.5\u00a0\u00b5g</span>", "ID": "e5c20fb0-4676-4f84-b084-8fab840305c8", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Following multiple doses of 80\u00a0mg of febuxostat in patients with mild, moderate or severe renal impairment, the C of febuxostat did not change, relative to subjects with normal renal function. The mean total AUC of febuxostat increased by approximately 1.8-fold from 7.5\u00a0\u00b5g", "ParentId": "44c74de8-018e-4584-8dd9-50954d4e3eb5"}, {"Element": "<sub>max</sub>", "ID": "c5e13f57-ca1c-4417-a713-cdaa69419093", "Styles": "None", "Classes": "None", "Text": "max", "ParentId": "e5c20fb0-4676-4f84-b084-8fab840305c8"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Cambria Math\",serif'>\u22c5</span>", "ID": "b816cd90-90d4-4234-b7b7-1e7db6507f75", "Styles": "font-family:\"Cambria Math\",serif", "Classes": "None", "Text": "\u22c5", "ParentId": "44c74de8-018e-4584-8dd9-50954d4e3eb5"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>h/mL in the normal renal\nfunction group to 13.2\u00a0\u00b5g.h/mL in the severe renal dysfunction group. The\nC<sub>max</sub> and AUC of active metabolites increased up to 2- and 4-fold,\nrespectively. However, no dose adjustment is necessary in patients with mild or\nmoderate renal impairment.</span>", "ID": "bc3beb0b-574c-44be-9bf9-562e442f2e2a", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "h/mL in the normal renal function group to 13.2\u00a0\u00b5g.h/mL in the severe renal dysfunction group. The C and AUC of active metabolites increased up to 2- and 4-fold, respectively. However, no dose adjustment is necessary in patients with mild or moderate renal impairment.", "ParentId": "44c74de8-018e-4584-8dd9-50954d4e3eb5"}, {"Element": "<sub>max</sub>", "ID": "ecfa74d3-ad83-44f7-8a61-707eb9e5fde7", "Styles": "None", "Classes": "None", "Text": "max", "ParentId": "bc3beb0b-574c-44be-9bf9-562e442f2e2a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "e40dce1c-ee0f-4445-b1c0-56b6beac56b1", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "874fb66d-238a-4ba0-91d6-41a0c0ef45a2", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "e40dce1c-ee0f-4445-b1c0-56b6beac56b1"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Hepatic impairment</span></u></p>", "ID": "abac2af4-825c-4bfb-8392-fb8cfdb5aa5f", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Hepatic impairment</span></u>", "ID": "ebd9e7c8-2509-4703-99f7-62ba3ec1c444", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "abac2af4-825c-4bfb-8392-fb8cfdb5aa5f"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Hepatic impairment</span>", "ID": "025394d0-de2c-4cfa-93a6-e8f2498c84c5", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Hepatic impairment", "ParentId": "ebd9e7c8-2509-4703-99f7-62ba3ec1c444"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "85677167-2002-4a01-8059-a039cf352aec", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "528c2a4d-9f02-46e9-91a0-54e831920996", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "85677167-2002-4a01-8059-a039cf352aec"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Following multiple doses of 80\u00a0mg\nof </span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>febuxostat</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'> in patients with mild\n(Child-Pugh Class A) or moderate (Child-Pugh Class B) hepatic impairment, the C<sub>max</sub>\nand AUC of febuxostat and its metabolites did not change significantly compared\nto subjects with normal hepatic function. No studies have been conducted in\npatients with severe hepatic impairment (Child-Pugh Class C).</span></p>", "ID": "cb344f52-f8c0-49fe-bac9-3574413686c1", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Following multiple doses of 80\u00a0mg\nof </span>", "ID": "58ce3096-6be6-4aab-888d-3515b129a452", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Following multiple doses of 80\u00a0mg of ", "ParentId": "cb344f52-f8c0-49fe-bac9-3574413686c1"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>febuxostat</span>", "ID": "06581bdf-d381-4e6d-8308-4adbe677abc5", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "febuxostat", "ParentId": "cb344f52-f8c0-49fe-bac9-3574413686c1"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'> in patients with mild\n(Child-Pugh Class A) or moderate (Child-Pugh Class B) hepatic impairment, the C<sub>max</sub>\nand AUC of febuxostat and its metabolites did not change significantly compared\nto subjects with normal hepatic function. No studies have been conducted in\npatients with severe hepatic impairment (Child-Pugh Class C).</span>", "ID": "c02e74c3-9af2-4e3d-9e20-4165c5741a97", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": " in patients with mild (Child-Pugh Class A) or moderate (Child-Pugh Class B) hepatic impairment, the C and AUC of febuxostat and its metabolites did not change significantly compared to subjects with normal hepatic function. No studies have been conducted in patients with severe hepatic impairment (Child-Pugh Class C).", "ParentId": "cb344f52-f8c0-49fe-bac9-3574413686c1"}, {"Element": "<sub>max</sub>", "ID": "dc8686a3-fc93-4aec-a168-42a32e1ddcb4", "Styles": "None", "Classes": "None", "Text": "max", "ParentId": "c02e74c3-9af2-4e3d-9e20-4165c5741a97"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "da48b6a2-4bc7-446e-a1cd-afc6d0c7cc16", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "f7963d2c-c492-427f-8af6-c554808c78a7", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "da48b6a2-4bc7-446e-a1cd-afc6d0c7cc16"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Age</span></u></p>", "ID": "3ecda4f9-085e-420f-abc0-e17d736b47a2", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Age</span></u>", "ID": "1387396b-d7d3-4afd-9683-69d9bda223ea", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "3ecda4f9-085e-420f-abc0-e17d736b47a2"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Age</span>", "ID": "97a15277-da6d-4647-9a88-18384c046a16", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Age", "ParentId": "1387396b-d7d3-4afd-9683-69d9bda223ea"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "a59a2e13-a2ca-45f1-9bd7-27514cfd994c", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "bcc01ee8-555d-4d82-9625-946cc48d7975", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "a59a2e13-a2ca-45f1-9bd7-27514cfd994c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>There were no significant changes\nobserved in AUC of febuxostat or its metabolites following multiple oral doses\nof febuxostat in elderly as compared to younger healthy subjects.</span></p>", "ID": "590fd950-42ef-453e-9ac2-cdbbaca74085", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>There were no significant changes\nobserved in AUC of febuxostat or its metabolites following multiple oral doses\nof febuxostat in elderly as compared to younger healthy subjects.</span>", "ID": "d64f6a62-ed3b-4846-b383-a7dc9b7c0b3f", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "There were no significant changes observed in AUC of febuxostat or its metabolites following multiple oral doses of febuxostat in elderly as compared to younger healthy subjects.", "ParentId": "590fd950-42ef-453e-9ac2-cdbbaca74085"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "36c5782b-3609-4b2d-810a-2f67dd9e5c38", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "e4d19da6-dacd-416e-bf99-405ba8d7c516", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "36c5782b-3609-4b2d-810a-2f67dd9e5c38"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Gender</span></u></p>", "ID": "fe312b7d-1094-4148-81fc-da0ff6eef425", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Gender</span></u>", "ID": "8b2e128b-0c8d-4f45-b58f-1b441bc09be5", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "fe312b7d-1094-4148-81fc-da0ff6eef425"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Gender</span>", "ID": "02eca54f-424e-46d7-8fcf-6e78dd6fcfe1", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Gender", "ParentId": "8b2e128b-0c8d-4f45-b58f-1b441bc09be5"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "38e5d93e-775d-4756-9fd8-0dfe82690846", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "f2e1caa4-dd3c-4183-a22d-22e7b78ed3e6", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "38e5d93e-775d-4756-9fd8-0dfe82690846"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Following multiple oral doses of </span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>febuxostat</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>, the C<sub>max</sub>\nand AUC were 24% and 12% higher in females than in males, respectively.\nHowever, weight-corrected C<sub>max</sub> and AUC were similar between the\ngenders. No dose adjustment is needed based on gender.</span></p>", "ID": "fe92d6ab-f216-4d51-8216-ffcc16f136fb", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Following multiple oral doses of </span>", "ID": "1a6aa66d-cf57-4085-9ded-6cbf490129c9", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Following multiple oral doses of ", "ParentId": "fe92d6ab-f216-4d51-8216-ffcc16f136fb"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>febuxostat</span>", "ID": "ccc9aa9e-916e-456d-9b5f-b8a2fc869e5c", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "febuxostat", "ParentId": "fe92d6ab-f216-4d51-8216-ffcc16f136fb"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>, the C<sub>max</sub>\nand AUC were 24% and 12% higher in females than in males, respectively.\nHowever, weight-corrected C<sub>max</sub> and AUC were similar between the\ngenders. No dose adjustment is needed based on gender.</span>", "ID": "65ea32af-f6ae-4234-bc46-bdf0b7b04f42", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": ", the C and AUC were 24% and 12% higher in females than in males, respectively. However, weight-corrected C and AUC were similar between the genders. No dose adjustment is needed based on gender.", "ParentId": "fe92d6ab-f216-4d51-8216-ffcc16f136fb"}, {"Element": "<sub>max</sub>", "ID": "351c145b-bb0b-489e-8285-fcde47c08753", "Styles": "None", "Classes": "None", "Text": "max", "ParentId": "65ea32af-f6ae-4234-bc46-bdf0b7b04f42"}, {"Element": "<sub>max</sub>", "ID": "8ad518f3-bacf-4b94-a9a0-1e8a17e1d425", "Styles": "None", "Classes": "None", "Text": "max", "ParentId": "65ea32af-f6ae-4234-bc46-bdf0b7b04f42"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "9f966855-67e6-463d-8514-3cd9116fe983", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "633770b0-6411-48ac-8a54-01b4d0d6b2a6", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "9f966855-67e6-463d-8514-3cd9116fe983"}, {"Element": "<h1 style=\"margin-right:6.4pt\"><span lang=\"EN-GB\">5.3\u00a0\u00a0\u00a0\u00a0 Preclinical safety data</span></h1>", "ID": "3cf3462e-ba8a-40c0-93dc-5ab96cfebd62", "Styles": "margin-right:6.4pt", "Classes": "None", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\">5.3\u00a0\u00a0\u00a0\u00a0 Preclinical safety data</span>", "ID": "8bb39dcd-7694-4537-b9b6-5d400e2ce661", "Styles": "None", "Classes": "None", "Text": "5.3\u00a0\u00a0\u00a0\u00a0 Preclinical safety data", "ParentId": "3cf3462e-ba8a-40c0-93dc-5ab96cfebd62"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "8ebe9bee-b726-4b44-ab59-ae2a7eba1d33", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "a0c70b6d-34c7-47e2-b6d8-a53b9cf3ad8d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "8ebe9bee-b726-4b44-ab59-ae2a7eba1d33"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Effects in non-clinical studies\nwere generally observed at exposures in excess of the maximum human exposure.</span></p>", "ID": "f00ee3c0-02af-4a76-a2fd-c075bdf1f96f", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Effects in non-clinical studies\nwere generally observed at exposures in excess of the maximum human exposure.</span>", "ID": "873ae088-46f0-4a5f-a439-2856362a5ce8", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Effects in non-clinical studies were generally observed at exposures in excess of the maximum human exposure.", "ParentId": "f00ee3c0-02af-4a76-a2fd-c075bdf1f96f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "39ec8bcb-b0ad-495c-ab61-56b4057465ae", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "d37ed0ee-a5d1-4c00-b977-2d0ce450aae1", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "39ec8bcb-b0ad-495c-ab61-56b4057465ae"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Pharmacokinetic modelling and\nsimulation of rat data suggests that, when co-administered with febuxostat, the\nclinical dose of mercaptopurine/azathioprine should be reduced to 20% or less\nof the previously prescribed dose in order to avoid possible haematological\neffects (see section 4.4 and 4.5).</span></p>", "ID": "fb5b16f1-74d2-4ba7-9947-3a79b808ee61", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Pharmacokinetic modelling and\nsimulation of rat data suggests that, when co-administered with febuxostat, the\nclinical dose of mercaptopurine/azathioprine should be reduced to 20% or less\nof the previously prescribed dose in order to avoid possible haematological\neffects (see section 4.4 and 4.5).</span>", "ID": "0e5c8bdb-1063-4d6a-9cca-9fa5ddfa9c5c", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Pharmacokinetic modelling and simulation of rat data suggests that, when co-administered with febuxostat, the clinical dose of mercaptopurine/azathioprine should be reduced to 20% or less of the previously prescribed dose in order to avoid possible haematological effects (see section 4.4 and 4.5).", "ParentId": "fb5b16f1-74d2-4ba7-9947-3a79b808ee61"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "7bec4cdd-9ecd-46ab-8926-5881a11da1da", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "5d1fc598-0e2a-4487-8cb3-33d86e32e3a5", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "7bec4cdd-9ecd-46ab-8926-5881a11da1da"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Carcinogenesis, mutagenesis,\nimpairment of fertility</span></u></p>", "ID": "afc81e43-7834-430c-97fb-83e30319d94e", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Carcinogenesis, mutagenesis,\nimpairment of fertility</span></u>", "ID": "6c45395d-6960-4da1-8f83-83db1824f7e9", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "afc81e43-7834-430c-97fb-83e30319d94e"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Carcinogenesis, mutagenesis,\nimpairment of fertility</span>", "ID": "68d275d0-0643-4e1a-a6eb-de9ebe3a863e", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Carcinogenesis, mutagenesis, impairment of fertility", "ParentId": "6c45395d-6960-4da1-8f83-83db1824f7e9"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "a74c0021-67b4-4c0b-a268-75c7ccf9e67a", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "1e57438d-3028-42f6-8e8f-f69e20533176", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "a74c0021-67b4-4c0b-a268-75c7ccf9e67a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>In male rats, a statistically\nsignificant increase in urinary bladder tumours (transitional cell papilloma\nand carcinoma) was found only in association with xanthine calculi in the high\ndose group, at approximately 11 times human exposure. There was no significant\nincrease in any other tumour type in either male or female mice or rats. These\nfindings are considered a consequence of species specific purine metabolism and\nurine composition and of no relevance to clinical use.</span></p>", "ID": "e404e095-93fd-4434-b4cb-47dd8713df70", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>In male rats, a statistically\nsignificant increase in urinary bladder tumours (transitional cell papilloma\nand carcinoma) was found only in association with xanthine calculi in the high\ndose group, at approximately 11 times human exposure. There was no significant\nincrease in any other tumour type in either male or female mice or rats. These\nfindings are considered a consequence of species specific purine metabolism and\nurine composition and of no relevance to clinical use.</span>", "ID": "0ee9092a-21a2-45a2-a6a3-0788363dd664", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "In male rats, a statistically significant increase in urinary bladder tumours (transitional cell papilloma and carcinoma) was found only in association with xanthine calculi in the high dose group, at approximately 11 times human exposure. There was no significant increase in any other tumour type in either male or female mice or rats. These findings are considered a consequence of species specific purine metabolism and urine composition and of no relevance to clinical use.", "ParentId": "e404e095-93fd-4434-b4cb-47dd8713df70"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "9f8f545e-1917-42b2-9e93-6b4fe72b1046", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "874d42c7-7659-45af-be7a-4ebc1fe5edc7", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "9f8f545e-1917-42b2-9e93-6b4fe72b1046"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>A standard battery of test for\ngenotoxicity did not reveal any biologically relevant genotoxic effects for\nfebuxostat.</span></p>", "ID": "cd121756-45c2-4ef4-bf20-f53fc7f283b7", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>A standard battery of test for\ngenotoxicity did not reveal any biologically relevant genotoxic effects for\nfebuxostat.</span>", "ID": "721451a1-a570-480e-8200-e8beb956eec9", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "A standard battery of test for genotoxicity did not reveal any biologically relevant genotoxic effects for febuxostat.", "ParentId": "cd121756-45c2-4ef4-bf20-f53fc7f283b7"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "6948196d-4784-4e8c-86c9-13531cd3d4e1", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "c08ca21b-a2b3-4907-86ac-990465747c1d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "6948196d-4784-4e8c-86c9-13531cd3d4e1"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat at oral doses up to 48\u00a0mg/kg/day\nwas found to have no effect on fertility and reproductive performance of male\nand female rats.</span></p>", "ID": "e8fff49a-b97c-4ba8-acfa-bf61fbf3b297", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat at oral doses up to 48\u00a0mg/kg/day\nwas found to have no effect on fertility and reproductive performance of male\nand female rats.</span>", "ID": "6b9dfeef-08da-400a-82d3-7ceead747cbe", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Febuxostat at oral doses up to 48\u00a0mg/kg/day was found to have no effect on fertility and reproductive performance of male and female rats.", "ParentId": "e8fff49a-b97c-4ba8-acfa-bf61fbf3b297"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "44bc4ce6-5e44-4d92-891c-b338d3215276", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "c080bfe8-4e54-4925-ab92-1c620131117a", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "44bc4ce6-5e44-4d92-891c-b338d3215276"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>There was no evidence of impaired\nfertility, teratogenic effects, or harm to the foetus due to febuxostat. There\nwas high dose maternal toxicity accompanied by a reduction in weaning index and\nreduced development of offspring in rats at approximately 4.3 times human\nexposure. Teratology studies, performed in pregnant rats at approximately 4.3\ntimes and pregnant rabbits at approximately</span></p>", "ID": "504bc079-4fd5-4877-8655-3ecf0146e0df", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>There was no evidence of impaired\nfertility, teratogenic effects, or harm to the foetus due to febuxostat. There\nwas high dose maternal toxicity accompanied by a reduction in weaning index and\nreduced development of offspring in rats at approximately 4.3 times human\nexposure. Teratology studies, performed in pregnant rats at approximately 4.3\ntimes and pregnant rabbits at approximately</span>", "ID": "2f14d5ea-e046-458e-9ebd-78e07d8b3bab", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "There was no evidence of impaired fertility, teratogenic effects, or harm to the foetus due to febuxostat. There was high dose maternal toxicity accompanied by a reduction in weaning index and reduced development of offspring in rats at approximately 4.3 times human exposure. Teratology studies, performed in pregnant rats at approximately 4.3 times and pregnant rabbits at approximately", "ParentId": "504bc079-4fd5-4877-8655-3ecf0146e0df"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>13 times human exposure did not\nreveal any teratogenic effects.</span></p>", "ID": "09c92571-99e1-43f6-8b4c-261fc48917bb", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>13 times human exposure did not\nreveal any teratogenic effects.</span>", "ID": "79ae609b-6f92-4385-aa5c-5e34ef5cf6ad", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "13 times human exposure did not reveal any teratogenic effects.", "ParentId": "09c92571-99e1-43f6-8b4c-261fc48917bb"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "bcd574a7-a2eb-4942-a540-f4db78e86f64", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "27eedeb6-d3d6-4633-b3de-4caefb0b78a3", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "bcd574a7-a2eb-4942-a540-f4db78e86f64"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "0c1c9d2b-37bf-4474-8a5f-6e7457e7865e", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "1506efdd-a998-4580-8540-7a44ee8380a8", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "0c1c9d2b-37bf-4474-8a5f-6e7457e7865e"}, {"Element": "<h1 style=\"margin-right:6.4pt\"><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\nPARTICULARS</span></h1>", "ID": "8c2c2c84-e87d-4718-95aa-8dbc6a5b14c2", "Styles": "margin-right:6.4pt", "Classes": "None", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\nPARTICULARS</span>", "ID": "ef4b6a64-7087-46d3-96d6-ab70ae1b56df", "Styles": "None", "Classes": "None", "Text": "6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL PARTICULARS", "ParentId": "8c2c2c84-e87d-4718-95aa-8dbc6a5b14c2"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "8b1c3b5c-7c41-4606-a934-6237796f2c1d", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "5af3bf2f-d4c6-411a-a4cd-35f65501d9b9", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "8b1c3b5c-7c41-4606-a934-6237796f2c1d"}, {"Element": "<h1 style=\"margin-right:6.4pt\"><span lang=\"EN-GB\">6.1\u00a0\u00a0\u00a0\u00a0 List of excipients</span></h1>", "ID": "27c6fbe4-f832-49e1-8a26-cc0874375149", "Styles": "margin-right:6.4pt", "Classes": "None", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\">6.1\u00a0\u00a0\u00a0\u00a0 List of excipients</span>", "ID": "12d01115-bab3-4787-8bd5-6731814ab5b3", "Styles": "None", "Classes": "None", "Text": "6.1\u00a0\u00a0\u00a0\u00a0 List of excipients", "ParentId": "27c6fbe4-f832-49e1-8a26-cc0874375149"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "194facee-6d19-4a11-adcf-80d06930b0c4", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "c1d03008-0eee-4e22-88a3-2ef9bb3fb1ea", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "194facee-6d19-4a11-adcf-80d06930b0c4"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Tablet core</span></u></p>", "ID": "2ca218de-33f0-42ae-b56f-11f8a21079b2", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Tablet core</span></u>", "ID": "6a59d3b8-c73f-4d29-8996-b7ecd041c019", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "2ca218de-33f0-42ae-b56f-11f8a21079b2"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Tablet core</span>", "ID": "9e390313-883c-48d1-b970-8f861f18f5a0", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Tablet core", "ParentId": "6a59d3b8-c73f-4d29-8996-b7ecd041c019"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "6e75d9af-440f-4033-bd8e-75cde9932c1b", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "43c24ae9-7cbb-4476-91b1-f3ff01840136", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "6e75d9af-440f-4033-bd8e-75cde9932c1b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Lactose</span></p>", "ID": "8af5fa1d-48dd-41ea-a005-2b06791b25b5", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Lactose</span>", "ID": "ebd35ebf-da77-41c3-b21b-e25b65ef9a0a", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Lactose", "ParentId": "8af5fa1d-48dd-41ea-a005-2b06791b25b5"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Microcrystalline cellulose</span></p>", "ID": "b0b8d1d3-be81-45fa-b408-dd4bc2933c78", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Microcrystalline cellulose</span>", "ID": "9e332173-f428-4a4c-b478-05b5a0be0af5", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Microcrystalline cellulose", "ParentId": "b0b8d1d3-be81-45fa-b408-dd4bc2933c78"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Magnesium stearate</span></p>", "ID": "cc46e2b5-c26a-49ba-b80d-6fe4beefbc2b", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Magnesium stearate</span>", "ID": "2de0ce67-1711-43d1-96a3-1433b855d5cd", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Magnesium stearate", "ParentId": "cc46e2b5-c26a-49ba-b80d-6fe4beefbc2b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Hydroxypropylcellulose</span></p>", "ID": "506a8e1b-7867-4934-9346-d1d927a4e14f", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Hydroxypropylcellulose</span>", "ID": "e78679a1-6fa3-41a8-87f9-d93baa3b7b40", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Hydroxypropylcellulose", "ParentId": "506a8e1b-7867-4934-9346-d1d927a4e14f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Croscarmellose sodium</span></p>", "ID": "7298edfb-6fb0-43e8-99d3-1a57de9a1a6a", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Croscarmellose sodium</span>", "ID": "ee933826-e0e2-405e-bc85-ecb7b13526d4", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Croscarmellose sodium", "ParentId": "7298edfb-6fb0-43e8-99d3-1a57de9a1a6a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Colloidal hydrated silica</span></p>", "ID": "679b6712-28af-4a7a-9e91-bfe218542ccd", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Colloidal hydrated silica</span>", "ID": "6ca6a118-81ff-4a4d-91df-d34b7f6f0493", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Colloidal hydrated silica", "ParentId": "679b6712-28af-4a7a-9e91-bfe218542ccd"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Colloidal anhydrous silica</span></p>", "ID": "66137e34-ad6d-43b6-b2d3-264c616db09a", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Colloidal anhydrous silica</span>", "ID": "1e74a46b-295b-4630-b9e2-364221e996d9", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Colloidal anhydrous silica", "ParentId": "66137e34-ad6d-43b6-b2d3-264c616db09a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Crospovidone</span></p>", "ID": "efb2a99a-fe0a-4704-99ec-ba848e17e621", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Crospovidone</span>", "ID": "8ca434ae-69de-488b-b765-37bcab2232fa", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Crospovidone", "ParentId": "efb2a99a-fe0a-4704-99ec-ba848e17e621"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Talc</span></p>", "ID": "a5d17fcc-c8b6-406c-901d-a2c3ad7c1cc3", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Talc</span>", "ID": "169f152e-80b2-436d-a88b-3e7794b724ad", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Talc", "ParentId": "a5d17fcc-c8b6-406c-901d-a2c3ad7c1cc3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "19f04270-1dac-4936-8059-53130961acb3", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "52fcb7ee-7e71-48cd-b54e-843a694c82a6", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "19f04270-1dac-4936-8059-53130961acb3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Tablet coating</span></u></p>", "ID": "45a01118-d844-4f7e-92a2-a93fb10fa773", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Tablet coating</span></u>", "ID": "5597766a-769f-4b5d-8e70-542619de4f07", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "45a01118-d844-4f7e-92a2-a93fb10fa773"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Tablet coating</span>", "ID": "895f295d-0e3e-4cea-b131-9ed388c6a3f4", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Tablet coating", "ParentId": "5597766a-769f-4b5d-8e70-542619de4f07"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "f5195cd4-0aec-4366-8824-54ef052b2d37", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "3b6cedc7-0594-4fad-98ce-c434e7cb9dc5", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "f5195cd4-0aec-4366-8824-54ef052b2d37"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Hypromellose</span></p>", "ID": "9b1e5b9a-c6fe-4451-9256-58ba3c618302", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Hypromellose</span>", "ID": "52c02dfc-09bf-4dac-89b2-bad3a559a509", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Hypromellose", "ParentId": "9b1e5b9a-c6fe-4451-9256-58ba3c618302"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Titanium dioxide (E171) </span></p>", "ID": "613f0db4-9fe7-403b-baea-f8392f260cf3", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Titanium dioxide (E171) </span>", "ID": "a7e9ed39-7c68-4ab1-ae91-e7fa26826720", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Titanium dioxide (E171) ", "ParentId": "613f0db4-9fe7-403b-baea-f8392f260cf3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Ethylcellulose</span></p>", "ID": "2cc25b3e-a4cd-4b8f-84e1-2d49f0de848f", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Ethylcellulose</span>", "ID": "2f9e82c6-168b-49cc-b480-b3636cdd9d4f", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Ethylcellulose", "ParentId": "2cc25b3e-a4cd-4b8f-84e1-2d49f0de848f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Iron oxide yellow (E172)</span></p>", "ID": "2a90e3bf-0b61-45c5-86bf-83e3dfd6832f", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Iron oxide yellow (E172)</span>", "ID": "df783c0a-8376-4e69-a695-bb4bb8c496e3", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Iron oxide yellow (E172)", "ParentId": "2a90e3bf-0b61-45c5-86bf-83e3dfd6832f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Triacetin</span></p>", "ID": "f92b7628-7fe0-48c0-afc4-36257046a88d", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Triacetin</span>", "ID": "7f8f36dc-c033-456a-9d0c-354275bfd768", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Triacetin", "ParentId": "f92b7628-7fe0-48c0-afc4-36257046a88d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Iron oxide black (E172)</span></p>", "ID": "f06063c6-d643-4413-bec1-4fa7cbd61ea2", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Iron oxide black (E172)</span>", "ID": "15182899-5be9-481b-b060-56f1384504f1", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Iron oxide black (E172)", "ParentId": "f06063c6-d643-4413-bec1-4fa7cbd61ea2"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "532c75e2-6428-4654-a98b-693199cfba82", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "219bfc4e-ceef-4701-ac9e-b2adfc5f6cca", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "532c75e2-6428-4654-a98b-693199cfba82"}, {"Element": "<h1 style=\"margin-right:6.4pt\"><span lang=\"EN-GB\">6.2\u00a0\u00a0\u00a0\u00a0 Incompatibilities</span></h1>", "ID": "ce9f1767-df41-477e-8ede-606d2d292faf", "Styles": "margin-right:6.4pt", "Classes": "None", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\">6.2\u00a0\u00a0\u00a0\u00a0 Incompatibilities</span>", "ID": "74dd85e3-7ba8-4122-b465-77814ce4a9f8", "Styles": "None", "Classes": "None", "Text": "6.2\u00a0\u00a0\u00a0\u00a0 Incompatibilities", "ParentId": "ce9f1767-df41-477e-8ede-606d2d292faf"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "05129960-bd00-40c2-8020-7c41925ec1d5", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "a9b50a36-cc3a-4a3f-8f71-531eab9c272e", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "05129960-bd00-40c2-8020-7c41925ec1d5"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Not applicable.</span></p>", "ID": "c25d899b-36d5-4e33-a349-d42f235b6b88", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Not applicable.</span>", "ID": "aabef9ec-906e-48c0-b8a7-ebffd0f20b24", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Not applicable.", "ParentId": "c25d899b-36d5-4e33-a349-d42f235b6b88"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "dd0a88ac-5c80-47f5-b19e-0d771a67f687", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "7cb137a4-87cd-4b3a-b405-574d357bca8d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "dd0a88ac-5c80-47f5-b19e-0d771a67f687"}, {"Element": "<h1 style=\"margin-right:6.4pt\"><span lang=\"EN-GB\">6.3\u00a0\u00a0\u00a0\u00a0 Shelf life</span></h1>", "ID": "d34a604b-625d-484a-9f80-aefb0dd66194", "Styles": "margin-right:6.4pt", "Classes": "None", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\">6.3\u00a0\u00a0\u00a0\u00a0 Shelf life</span>", "ID": "94d78e91-35ca-454b-8d93-2b9fe44a6fe1", "Styles": "None", "Classes": "None", "Text": "6.3\u00a0\u00a0\u00a0\u00a0 Shelf life", "ParentId": "d34a604b-625d-484a-9f80-aefb0dd66194"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "030617fc-a86a-46ec-927c-410dde08ed6c", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "34d61f4c-61c0-45d5-bb28-6af8534f72b7", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "030617fc-a86a-46ec-927c-410dde08ed6c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>2 years.</span></p>", "ID": "2889e5ac-3c8a-4118-8c8a-965972837db9", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>2 years.</span>", "ID": "284ca909-27ec-4155-b723-782e5a315435", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "2 years.", "ParentId": "2889e5ac-3c8a-4118-8c8a-965972837db9"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>For bottles: After first opening\nuse within 180 days</span></p>", "ID": "ea0393e3-6120-4774-b8cd-f146ca5d9dda", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>For bottles: After first opening\nuse within 180 days</span>", "ID": "cbcaae8a-5bd6-416a-b827-24e9145f0fb1", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "For bottles: After first opening use within 180 days", "ParentId": "ea0393e3-6120-4774-b8cd-f146ca5d9dda"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "e4949d17-ebe2-442f-86f2-9511dce6e0ea", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "1265ddb4-4975-4830-8972-344721aedf86", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "e4949d17-ebe2-442f-86f2-9511dce6e0ea"}, {"Element": "<h1 style=\"margin-right:6.4pt\"><span lang=\"EN-GB\">6.4\u00a0\u00a0\u00a0\u00a0 Special precautions for\nstorage</span></h1>", "ID": "5fb9f5e4-7f5c-495d-ba71-0e17e62fdca5", "Styles": "margin-right:6.4pt", "Classes": "None", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\">6.4\u00a0\u00a0\u00a0\u00a0 Special precautions for\nstorage</span>", "ID": "1f1ec2e3-5d5b-4255-9e4b-6becdd9df3a3", "Styles": "None", "Classes": "None", "Text": "6.4\u00a0\u00a0\u00a0\u00a0 Special precautions for storage", "ParentId": "5fb9f5e4-7f5c-495d-ba71-0e17e62fdca5"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "f987688f-8be7-434b-a264-b6c83c9f44bd", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "7ba00ccc-c8d5-4021-847d-0f04d6d7383e", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "f987688f-8be7-434b-a264-b6c83c9f44bd"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>This medicinal product does not\nrequire any special storage conditions.</span></p>", "ID": "438f02f8-b7bc-40ab-b1b1-debc6a9c94c2", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>This medicinal product does not\nrequire any special storage conditions.</span>", "ID": "ca31e223-c8a5-4261-b851-e744adec986f", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "This medicinal product does not require any special storage conditions.", "ParentId": "438f02f8-b7bc-40ab-b1b1-debc6a9c94c2"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "23d524a4-6498-4b7d-936b-4b1098fecb52", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "74ce96f8-05ed-4557-8f20-dd48bfdf0482", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "23d524a4-6498-4b7d-936b-4b1098fecb52"}, {"Element": "<h1 style=\"margin-right:6.4pt\"><span lang=\"EN-GB\">6.5\u00a0\u00a0\u00a0\u00a0 Nature and contents of\ncontainer</span></h1>", "ID": "338859ed-c5b2-4def-b617-3999627942f6", "Styles": "margin-right:6.4pt", "Classes": "None", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\">6.5\u00a0\u00a0\u00a0\u00a0 Nature and contents of\ncontainer</span>", "ID": "181c4487-d4bd-46ea-b107-96dc8f25ff1f", "Styles": "None", "Classes": "None", "Text": "6.5\u00a0\u00a0\u00a0\u00a0 Nature and contents of container", "ParentId": "338859ed-c5b2-4def-b617-3999627942f6"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "f6c1afd0-68b3-42c4-b005-3230b94ec8d9", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "fb050e3d-e722-4be6-9542-7f0d2f219b81", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "f6c1afd0-68b3-42c4-b005-3230b94ec8d9"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(PVC/oPA/Alu)/Alu (desiccant\nembedded) blisters of 14, 28, 84 tablets, calendar blisters of 28, 84 tablets and\nperforated unit dose blisters of 28 x 1 tablets.</span></p>", "ID": "fb8e53c9-b823-4371-897f-2d6f7db95970", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(PVC/oPA/Alu)/Alu (desiccant\nembedded) blisters of 14, 28, 84 tablets, calendar blisters of 28, 84 tablets and\nperforated unit dose blisters of 28 x 1 tablets.</span>", "ID": "f9f19f07-f51f-4291-941f-2d3d5d8bccde", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "(PVC/oPA/Alu)/Alu (desiccant embedded) blisters of 14, 28, 84 tablets, calendar blisters of 28, 84 tablets and perforated unit dose blisters of 28 x 1 tablets.", "ParentId": "fb8e53c9-b823-4371-897f-2d6f7db95970"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "1f040343-a37f-450f-bab2-93f4603d16d6", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "ab2d04b8-248b-4b4f-b474-0ac7b357727e", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "1f040343-a37f-450f-bab2-93f4603d16d6"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(PVC/oPA/Alu)/Alu blisters of 14,\n28, 42 tablets, calendar blisters of 28 tablets and perforated unit dose\nblisters of 28 x 1 tablets and multipacks of 84 (2 packs of 42) tablets.</span></p>", "ID": "0d1f044d-56e2-4f2d-bb8b-a7c698e2eb2c", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(PVC/oPA/Alu)/Alu blisters of 14,\n28, 42 tablets, calendar blisters of 28 tablets and perforated unit dose\nblisters of 28 x 1 tablets and multipacks of 84 (2 packs of 42) tablets.</span>", "ID": "ea5f211c-edbf-4782-a499-03746718bc26", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "(PVC/oPA/Alu)/Alu blisters of 14, 28, 42 tablets, calendar blisters of 28 tablets and perforated unit dose blisters of 28 x 1 tablets and multipacks of 84 (2 packs of 42) tablets.", "ParentId": "0d1f044d-56e2-4f2d-bb8b-a7c698e2eb2c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "bb970531-3e81-4a74-9384-3f96cdf7a440", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "108bf416-24bf-44fb-a9e4-e65c1c03c189", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "bb970531-3e81-4a74-9384-3f96cdf7a440"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>HDPE bottle with polypropylene (PP)\nscrew cap closure with desiccant containing 28 or 84 tablets.</span></p>", "ID": "43474948-bfd7-4b6c-88f9-75f2be586b00", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>HDPE bottle with polypropylene (PP)\nscrew cap closure with desiccant containing 28 or 84 tablets.</span>", "ID": "0e7af2ad-8c32-4dc8-843c-28d08c64a7be", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "HDPE bottle with polypropylene (PP) screw cap closure with desiccant containing 28 or 84 tablets.", "ParentId": "43474948-bfd7-4b6c-88f9-75f2be586b00"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "731c64a4-34cf-4a0d-8699-0c6224992357", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "bd0996af-231b-4ede-915e-9b466c7becee", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "731c64a4-34cf-4a0d-8699-0c6224992357"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Not all pack sizes may be marketed.</span></p>", "ID": "85e2ff69-16ea-42a8-9d6a-a400e7bcc46b", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Not all pack sizes may be marketed.</span>", "ID": "a47a13ed-10cd-4a60-9c95-242e99fc42a7", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Not all pack sizes may be marketed.", "ParentId": "85e2ff69-16ea-42a8-9d6a-a400e7bcc46b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "26036fd9-8897-4f85-9b5e-c2116b337fa0", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "c959cdf6-cd94-46c3-9de3-57488e91408c", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "26036fd9-8897-4f85-9b5e-c2116b337fa0"}, {"Element": "<h1 style=\"margin-right:6.4pt\"><span lang=\"EN-GB\">6.6\u00a0\u00a0\u00a0\u00a0 Special precautions for\ndisposal</span></h1>", "ID": "7e6be6eb-147f-472d-9849-9fb85750cbb8", "Styles": "margin-right:6.4pt", "Classes": "None", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\">6.6\u00a0\u00a0\u00a0\u00a0 Special precautions for\ndisposal</span>", "ID": "b9b913c9-7b24-4e61-9c75-5cbfb0c63487", "Styles": "None", "Classes": "None", "Text": "6.6\u00a0\u00a0\u00a0\u00a0 Special precautions for disposal", "ParentId": "7e6be6eb-147f-472d-9849-9fb85750cbb8"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "d16287c4-166d-45d1-be99-702bf3b29e1f", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "833e12e7-c4d8-4188-b8ef-736eacf8f4c1", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "d16287c4-166d-45d1-be99-702bf3b29e1f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>No special requirements.</span></p>", "ID": "005d9661-88d4-4476-8062-35371f20a96f", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>No special requirements.</span>", "ID": "de948ae4-3376-41dc-ac49-acc1e8014dea", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "No special requirements.", "ParentId": "005d9661-88d4-4476-8062-35371f20a96f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "f8d44239-1220-407c-8a74-b8a65fbf4ed0", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "3f615e3a-caf9-48b8-bcfb-23d3079e5eaf", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "f8d44239-1220-407c-8a74-b8a65fbf4ed0"}, {"Element": "<h1 style=\"margin-right:6.5pt;page-break-after:auto\"><span lang=\"EN-GB\" style=\"font-weight:normal\">\u00a0</span></h1>", "ID": "2d6592ba-035f-4fcc-8ec1-e17811f065d2", "Styles": "margin-right:6.5pt;page-break-after:auto", "Classes": "None", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style=\"font-weight:normal\">\u00a0</span>", "ID": "1326cdbe-01e0-4bbc-a290-e6ea61b6f31b", "Styles": "font-weight:normal", "Classes": "None", "Text": "\u00a0", "ParentId": "2d6592ba-035f-4fcc-8ec1-e17811f065d2"}, {"Element": "<h1 style=\"margin-right:6.4pt\"><span lang=\"EN-GB\">7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MARKETING\nAUTHORISATION HOLDER</span></h1>", "ID": "1cb84375-283e-4d03-a983-3ae014ddbea4", "Styles": "margin-right:6.4pt", "Classes": "None", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\">7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MARKETING\nAUTHORISATION HOLDER</span>", "ID": "96ae25d9-8036-4cf6-b928-fe0973bcd22f", "Styles": "None", "Classes": "None", "Text": "7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION HOLDER", "ParentId": "1cb84375-283e-4d03-a983-3ae014ddbea4"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "b5faf449-72c0-42e1-a43f-8c115eff654e", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "62b61d6c-a3d6-4ede-aafa-21889f1178a0", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "b5faf449-72c0-42e1-a43f-8c115eff654e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Mylan\nS.A.S.</span></p>", "ID": "a58df482-ec5b-4377-b65c-bb2830b5e797", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Mylan\nS.A.S.</span>", "ID": "18ea02d2-aa4e-4f75-8b2b-ca9ee362eb7c", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Mylan S.A.S.", "ParentId": "a58df482-ec5b-4377-b65c-bb2830b5e797"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>117\nAllee des Parcs</span></p>", "ID": "7a7bc62d-e2c9-4b9c-82be-1fe5d2e137bc", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>117\nAllee des Parcs</span>", "ID": "10e17489-bbf1-4bb0-8e58-7709c2bce55f", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "117 Allee des Parcs", "ParentId": "7a7bc62d-e2c9-4b9c-82be-1fe5d2e137bc"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>69\n800 Saint Priest</span></p>", "ID": "52675b40-4290-4d82-a7f4-6733b9d67a7e", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>69\n800 Saint Priest</span>", "ID": "0824b1b3-8d87-4d43-8203-c9c05c6fbe6d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "69 800 Saint Priest", "ParentId": "52675b40-4290-4d82-a7f4-6733b9d67a7e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>France</span></p>", "ID": "fc412159-ae37-45cc-881b-353098f68f7e", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>France</span>", "ID": "ed814217-d613-4136-9673-b55ce689c925", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "France", "ParentId": "fc412159-ae37-45cc-881b-353098f68f7e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "4dc8d978-2379-4ef1-a577-ea61b342b8b2", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "54320ac9-ca92-4a96-84eb-2093a1238e16", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "4dc8d978-2379-4ef1-a577-ea61b342b8b2"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "3814dfa6-d416-4c69-8d01-56eaf94bd3b6", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "f3250276-6cc9-4aaf-9541-8b995bb91c69", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "3814dfa6-d416-4c69-8d01-56eaf94bd3b6"}, {"Element": "<h1 style=\"margin-right:6.4pt\"><span lang=\"EN-GB\">8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MARKETING\nAUTHORISATION NUMBER(S)</span></h1>", "ID": "d841dc79-c6bc-4277-aff6-72666d739769", "Styles": "margin-right:6.4pt", "Classes": "None", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\">8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MARKETING\nAUTHORISATION NUMBER(S)</span>", "ID": "288ab817-e641-4bd6-a146-0579d186fe91", "Styles": "None", "Classes": "None", "Text": "8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION NUMBER(S)", "ParentId": "d841dc79-c6bc-4277-aff6-72666d739769"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "25415e22-7160-43ce-b209-9f8d955a97b4", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "d8ab3ddf-afff-41a3-a847-b004f37ba8d8", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "25415e22-7160-43ce-b209-9f8d955a97b4"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/001</span></p>", "ID": "b7bd54a2-cae6-4b5f-9cc2-6ac5069fb5e3", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/001</span>", "ID": "3492630d-4729-488e-bbc5-8304c1be001b", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "EU/1/17/1194/001", "ParentId": "b7bd54a2-cae6-4b5f-9cc2-6ac5069fb5e3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/002</span></p>", "ID": "87516dc0-12fe-46ab-a3fc-e062519c33e7", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/002</span>", "ID": "5ce1e151-6057-426b-98aa-0046170accf5", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "EU/1/17/1194/002", "ParentId": "87516dc0-12fe-46ab-a3fc-e062519c33e7"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/003</span></p>", "ID": "19b6a1a5-5ddd-4c26-9551-ac3f0751f8b5", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/003</span>", "ID": "301f4ed6-32f7-436a-8017-7148232e1df3", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "EU/1/17/1194/003", "ParentId": "19b6a1a5-5ddd-4c26-9551-ac3f0751f8b5"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/004</span></p>", "ID": "1547f73d-0aea-4ecf-870b-ea5662a9f27e", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/004</span>", "ID": "300e610f-c53a-43ec-9c9b-94bc9ee2f475", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "EU/1/17/1194/004", "ParentId": "1547f73d-0aea-4ecf-870b-ea5662a9f27e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/005</span></p>", "ID": "4b614cde-178d-439d-aab1-c1dd0f738346", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/005</span>", "ID": "b0a7ce0c-57f3-48f4-a9c0-5d65c60aa2df", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "EU/1/17/1194/005", "ParentId": "4b614cde-178d-439d-aab1-c1dd0f738346"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/006</span></p>", "ID": "15d535c9-ec8b-4619-9442-3dac9190dc84", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/006</span>", "ID": "8edea9d2-0666-4044-93dc-bb6162980289", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "EU/1/17/1194/006", "ParentId": "15d535c9-ec8b-4619-9442-3dac9190dc84"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/007</span></p>", "ID": "16d360de-3cb3-4ae2-8e2e-87bb472240aa", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/007</span>", "ID": "57b80521-c521-4370-8e52-9ccd9d6940b1", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "EU/1/17/1194/007", "ParentId": "16d360de-3cb3-4ae2-8e2e-87bb472240aa"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/008</span></p>", "ID": "32a2b1d1-fd34-4369-b35d-5c76beacc3c7", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/008</span>", "ID": "21e81842-23a0-4772-bec0-e6fb9bb72c3d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "EU/1/17/1194/008", "ParentId": "32a2b1d1-fd34-4369-b35d-5c76beacc3c7"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/017</span></p>", "ID": "4354280a-4684-481b-adad-83d8380b0035", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/017</span>", "ID": "eff834bd-03a1-42a1-9508-9372df446897", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "EU/1/17/1194/017", "ParentId": "4354280a-4684-481b-adad-83d8380b0035"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/018</span></p>", "ID": "217d1c5e-593d-4bf4-98b6-eb0dbc9bf54e", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/018</span>", "ID": "3aca134f-7b7a-4323-ab31-e441b48f969e", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "EU/1/17/1194/018", "ParentId": "217d1c5e-593d-4bf4-98b6-eb0dbc9bf54e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/019</span></p>", "ID": "b5e99b4e-5146-46fc-8020-42cd98b9073a", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/019</span>", "ID": "2dd3e7cf-4a5f-4605-b3cd-5e85b89b93b7", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "EU/1/17/1194/019", "ParentId": "b5e99b4e-5146-46fc-8020-42cd98b9073a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/020</span></p>", "ID": "88f7544b-6f33-44d0-85e8-0022b6e82b6d", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/020</span>", "ID": "5325e1b9-5946-4c6b-8b16-9b1eda512de7", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "EU/1/17/1194/020", "ParentId": "88f7544b-6f33-44d0-85e8-0022b6e82b6d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/021</span></p>", "ID": "746a6e15-2ad5-437f-abcb-81c3626bb83b", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/021</span>", "ID": "a8444c01-fb37-49ba-beb0-3b606748b2bd", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "EU/1/17/1194/021", "ParentId": "746a6e15-2ad5-437f-abcb-81c3626bb83b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/022</span></p>", "ID": "05292f2e-5690-4754-9bbc-e4c5624bc8de", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/022</span>", "ID": "24bd25a4-c3c6-4181-abcc-7f4d213eeecb", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "EU/1/17/1194/022", "ParentId": "05292f2e-5690-4754-9bbc-e4c5624bc8de"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "d2fe6543-f67a-49c7-8e54-5ad10d54c151", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "3e4ecdd1-7120-4d7d-b3c9-6e6b69319952", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "d2fe6543-f67a-49c7-8e54-5ad10d54c151"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "0262aa8f-2f8f-4b56-ba17-4d50699dc63a", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "a2da4981-a714-413c-90c7-c8214fca9a6d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "0262aa8f-2f8f-4b56-ba17-4d50699dc63a"}, {"Element": "<h1 style=\"margin-right:6.4pt\"><span lang=\"EN-GB\">9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 DATE OF FIRST\nAUTHORISATION/RENEWAL OF THE AUTHORISATION</span></h1>", "ID": "6816363d-f33a-4d1c-9a50-ae577b607918", "Styles": "margin-right:6.4pt", "Classes": "None", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\">9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 DATE OF FIRST\nAUTHORISATION/RENEWAL OF THE AUTHORISATION</span>", "ID": "33c57da4-ba3a-48d7-9435-0028fa3914f7", "Styles": "None", "Classes": "None", "Text": "9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION", "ParentId": "6816363d-f33a-4d1c-9a50-ae577b607918"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "f4e04779-fef4-41ef-a5c9-c737597ab054", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "429f2427-333e-4792-9059-6e25492db89e", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "f4e04779-fef4-41ef-a5c9-c737597ab054"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Date of first authorisation: </span></p>", "ID": "1753018f-ab76-4276-bc11-fa1da6a1f3d2", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Date of first authorisation: </span>", "ID": "afa42193-db18-4dc7-b004-d387c0ef2e94", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Date of first authorisation: ", "ParentId": "1753018f-ab76-4276-bc11-fa1da6a1f3d2"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "8ec974ad-8c13-4f87-aea3-4668ac0a3051", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "b08bf632-f0d8-41cb-9c58-89e66aa67ab8", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "8ec974ad-8c13-4f87-aea3-4668ac0a3051"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "9caee14d-0339-4c7a-972d-ae813a30dfc5", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "5494e202-462c-481d-9d81-a58e3d0482a3", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "9caee14d-0339-4c7a-972d-ae813a30dfc5"}, {"Element": "<h1 style=\"margin-right:6.4pt\"><span lang=\"EN-GB\">10.\u00a0\u00a0\u00a0\u00a0 DATE OF REVISION OF THE\nTEXT</span></h1>", "ID": "880439d8-3c7f-4a55-9d8a-d0e38b2714a6", "Styles": "margin-right:6.4pt", "Classes": "None", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\">10.\u00a0\u00a0\u00a0\u00a0 DATE OF REVISION OF THE\nTEXT</span>", "ID": "9f3146c4-3bcb-4a15-b130-7df7153ffe3a", "Styles": "None", "Classes": "None", "Text": "10.\u00a0\u00a0\u00a0\u00a0 DATE OF REVISION OF THE TEXT", "ParentId": "880439d8-3c7f-4a55-9d8a-d0e38b2714a6"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "7a28d611-934a-4b25-9d11-27a2be435ac5", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "bfbf93c0-43d6-46ad-8f5a-6a2636e36dff", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "7a28d611-934a-4b25-9d11-27a2be435ac5"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Detailed information on this\nmedicinal product is available on the website of the European Medicines Agency </span><span lang=\"EN-GB\"><a href=\"http://www.ema.europa.eu/\"><span style='font-family:\"Times New Roman\",serif;\ncolor:windowtext'>http://www.ema.europa.eu</span></a></span></p>", "ID": "e218593e-b397-41cc-a73c-1afbbbd09fa6", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Detailed information on this\nmedicinal product is available on the website of the European Medicines Agency </span>", "ID": "6bd55d9c-4a35-4bf9-82d7-3f94e2174e26", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Detailed information on this medicinal product is available on the website of the European Medicines Agency ", "ParentId": "e218593e-b397-41cc-a73c-1afbbbd09fa6"}, {"Element": "<span lang=\"EN-GB\"><a href=\"http://www.ema.europa.eu/\"><span style='font-family:\"Times New Roman\",serif;\ncolor:windowtext'>http://www.ema.europa.eu</span></a></span>", "ID": "9106bdbb-6ee6-4ea3-b0c4-857feedaf8fb", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e218593e-b397-41cc-a73c-1afbbbd09fa6"}, {"Element": "<a href=\"http://www.ema.europa.eu/\"><span style='font-family:\"Times New Roman\",serif;\ncolor:windowtext'>http://www.ema.europa.eu</span></a>", "ID": "b657a551-9ca0-46bd-9a01-80c9f6ef3a1b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9106bdbb-6ee6-4ea3-b0c4-857feedaf8fb"}, {"Element": "<span style='font-family:\"Times New Roman\",serif;\ncolor:windowtext'>http://www.ema.europa.eu</span>", "ID": "2d5a28ee-37b3-44a0-98db-160eb8f50644", "Styles": "font-family:\"Times New Roman\",serif;\ncolor:windowtext", "Classes": "None", "Text": "http://www.ema.europa.eu", "ParentId": "b657a551-9ca0-46bd-9a01-80c9f6ef3a1b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "3f8adacc-d49e-4e2e-9fe8-13804b832af0", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "4b0f7377-3de7-4dfd-aea3-60c0a7a298ef", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "3f8adacc-d49e-4e2e-9fe8-13804b832af0"}, {"Element": "<h1 style=\"margin-right:3.1pt;page-break-before:always\"><span lang=\"EN-GB\">1<span class=\"Heading1Char\">.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT</span></span></h1>", "ID": "1d63bf26-778d-4822-9ee5-6912932967d2", "Styles": "margin-right:3.1pt;page-break-before:always", "Classes": "None", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\">1<span class=\"Heading1Char\">.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT</span></span>", "ID": "9fe895b1-f8b8-469d-9993-8d807b8c8c13", "Styles": "None", "Classes": "None", "Text": "1", "ParentId": "1d63bf26-778d-4822-9ee5-6912932967d2"}, {"Element": "<span class=\"Heading1Char\">.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT</span>", "ID": "ffb00b7c-6084-46d9-b434-a8c09f900b8b", "Styles": "None", "Classes": "['Heading1Char']", "Text": ".\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT", "ParentId": "9fe895b1-f8b8-469d-9993-8d807b8c8c13"}, {"Element": "<h1 style=\"margin-right:3.1pt\"><span lang=\"EN-GB\">\u00a0</span></h1>", "ID": "4bfac0ba-a997-4e2d-b690-fd3c599bb8f4", "Styles": "margin-right:3.1pt", "Classes": "None", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "7e5f232f-9072-464f-8327-0558433892bc", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "4bfac0ba-a997-4e2d-b690-fd3c599bb8f4"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat Mylan 120\u00a0mg\nfilm-coated tablets</span></p>", "ID": "54b5e5f2-960a-442b-b770-da3e3fa09fac", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat Mylan 120\u00a0mg\nfilm-coated tablets</span>", "ID": "2c254f1b-21ad-43e6-be5f-937409307bec", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Febuxostat Mylan 120\u00a0mg film-coated tablets", "ParentId": "54b5e5f2-960a-442b-b770-da3e3fa09fac"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "675ed6a7-4bbd-439f-a3db-6105918bc7a6", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "f80db40d-5aae-4559-8ede-e141a4f1dcfe", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "675ed6a7-4bbd-439f-a3db-6105918bc7a6"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "0d9c6dca-108b-4bbe-a82f-aaba25041f5a", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "7b6c3837-1bd6-4d2f-971f-a3efe43e52ac", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "0d9c6dca-108b-4bbe-a82f-aaba25041f5a"}, {"Element": "<h1 style=\"margin-right:3.1pt\"><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 QUALITATIVE AND\nQUANTITATIVE COMPOSITION</span></h1>", "ID": "78cb1f82-5d3f-4c3b-8f7d-576a7de5d62d", "Styles": "margin-right:3.1pt", "Classes": "None", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 QUALITATIVE AND\nQUANTITATIVE COMPOSITION</span>", "ID": "2d1888a3-8610-4575-8ba7-590813861cf0", "Styles": "None", "Classes": "None", "Text": "2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 QUALITATIVE AND QUANTITATIVE COMPOSITION", "ParentId": "78cb1f82-5d3f-4c3b-8f7d-576a7de5d62d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "cf331f9f-6fac-4fd8-9709-3b7f62304883", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "4995ae94-3d61-423c-b24f-4a16cf4abdad", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "cf331f9f-6fac-4fd8-9709-3b7f62304883"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Each tablet contains 120\u00a0mg of\nfebuxostat.</span></p>", "ID": "409f7e2d-05e4-48a1-8df3-f0602e724359", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Each tablet contains 120\u00a0mg of\nfebuxostat.</span>", "ID": "4d59d808-692c-4f8a-be04-8d95da18070d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Each tablet contains 120\u00a0mg of febuxostat.", "ParentId": "409f7e2d-05e4-48a1-8df3-f0602e724359"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "4f847780-22ae-49d8-a970-ec8ad923b24e", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "73512698-aa6b-4ec0-b6aa-6ecb4e958976", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "4f847780-22ae-49d8-a970-ec8ad923b24e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Excipient with known effect</span></u></p>", "ID": "178c9d24-e6ee-4e4f-9ac4-3875a9e42157", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Excipient with known effect</span></u>", "ID": "017beace-9d00-4e9b-bf46-5ff7c21d52fc", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "178c9d24-e6ee-4e4f-9ac4-3875a9e42157"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Excipient with known effect</span>", "ID": "8ffe5a8b-b672-4b6f-9d66-288af690ab6b", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Excipient with known effect", "ParentId": "017beace-9d00-4e9b-bf46-5ff7c21d52fc"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Each tablet contains 354.0\u00a0mg\nof lactose</span></p>", "ID": "676118c4-3929-4ab7-809f-dc1e6d9bba34", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Each tablet contains 354.0\u00a0mg\nof lactose</span>", "ID": "a102002c-ea33-4366-906d-eb63d0612316", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Each tablet contains 354.0\u00a0mg of lactose", "ParentId": "676118c4-3929-4ab7-809f-dc1e6d9bba34"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "1b47d2dd-cf73-41b8-937b-ec74e71d6959", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "65a87ea4-816a-43b9-855b-89edb485bba6", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "1b47d2dd-cf73-41b8-937b-ec74e71d6959"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>For the full list of excipients,\nsee section 6.1.</span></p>", "ID": "574e06f5-1573-4684-93b4-3456711c2d8e", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>For the full list of excipients,\nsee section 6.1.</span>", "ID": "4663c73a-9fbe-4880-ae86-63d3a0f69399", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "For the full list of excipients, see section 6.1.", "ParentId": "574e06f5-1573-4684-93b4-3456711c2d8e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "4a81c324-cd29-4cac-be97-76de46b3a651", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "d2ad4e4a-caeb-41aa-b80a-e6a4fbf2b893", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "4a81c324-cd29-4cac-be97-76de46b3a651"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "d36455f3-3bb7-4d95-bd91-ba91653e1d04", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "cc5b531e-afdf-4f8e-9ea4-db45d047f129", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "d36455f3-3bb7-4d95-bd91-ba91653e1d04"}, {"Element": "<h1 style=\"margin-right:3.1pt\"><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL FORM</span></h1>", "ID": "b2ef71a4-8b64-4faf-869b-bcb0b6a5e008", "Styles": "margin-right:3.1pt", "Classes": "None", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL FORM</span>", "ID": "530b3253-c28a-41fd-8783-5aa5bec571ba", "Styles": "None", "Classes": "None", "Text": "3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL FORM", "ParentId": "b2ef71a4-8b64-4faf-869b-bcb0b6a5e008"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "1cf62018-5e4a-462f-8a79-f8d213a90fb0", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "8607d5ac-88a3-4467-9d48-b1cb03020859", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "1cf62018-5e4a-462f-8a79-f8d213a90fb0"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Film-coated tablet.</span></p>", "ID": "d2ecc70e-1ba0-471a-a833-cf35d51ee763", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Film-coated tablet.</span>", "ID": "e46a5830-57a8-4d7c-a863-38b96325b3ba", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Film-coated tablet.", "ParentId": "d2ecc70e-1ba0-471a-a833-cf35d51ee763"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "3eb36d84-9826-4054-8b07-00a3c9cbdfeb", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "a71014a6-f03d-4e22-8afc-324659d903b4", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "3eb36d84-9826-4054-8b07-00a3c9cbdfeb"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>A yellow, capsule shaped, biconvex\ntablet, approximately 18 x 8 mm, debossed with M on one side of the tablet and\nFX4 on the other side.</span></p>", "ID": "08afb0a7-4c29-4058-97a5-376714b1620a", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>A yellow, capsule shaped, biconvex\ntablet, approximately 18 x 8 mm, debossed with M on one side of the tablet and\nFX4 on the other side.</span>", "ID": "00061214-ec90-424d-b82a-ac3c808824f9", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "A yellow, capsule shaped, biconvex tablet, approximately 18 x 8 mm, debossed with M on one side of the tablet and FX4 on the other side.", "ParentId": "08afb0a7-4c29-4058-97a5-376714b1620a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "f7d3eb0d-cece-4c84-b1eb-00e53458f28e", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "b9e34b4e-0c87-42bb-bb0d-d86ec79375ad", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "f7d3eb0d-cece-4c84-b1eb-00e53458f28e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "352c0426-23b3-4bac-8771-80fb69454a36", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "0215085c-15a5-4ca0-9263-c72420b29121", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "352c0426-23b3-4bac-8771-80fb69454a36"}, {"Element": "<h1 style=\"margin-right:3.1pt\"><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 CLINICAL PARTICULARS</span></h1>", "ID": "78c4cdec-0372-4a39-9562-5b8dd755c3f2", "Styles": "margin-right:3.1pt", "Classes": "None", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 CLINICAL PARTICULARS</span>", "ID": "0857a805-09b2-457a-a95a-7b38b97c73ef", "Styles": "None", "Classes": "None", "Text": "4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 CLINICAL PARTICULARS", "ParentId": "78c4cdec-0372-4a39-9562-5b8dd755c3f2"}, {"Element": "<h1 style=\"margin-right:3.1pt\"><span lang=\"EN-GB\">\u00a0</span></h1>", "ID": "db54c7c6-0c42-461c-adaf-300172edc159", "Styles": "margin-right:3.1pt", "Classes": "None", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f9568dc8-6920-4b07-9d46-73a07c184c4c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "db54c7c6-0c42-461c-adaf-300172edc159"}, {"Element": "<h1 style=\"margin-right:3.1pt\"><span lang=\"EN-GB\">4.1\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Therapeutic indications</span></h1>", "ID": "a53d80c9-4ea6-4109-a0b8-bc7dbca95e70", "Styles": "margin-right:3.1pt", "Classes": "None", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\">4.1\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Therapeutic indications</span>", "ID": "f1ee1208-f2b1-42da-807b-f07a5881bef0", "Styles": "None", "Classes": "None", "Text": "4.1\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Therapeutic indications", "ParentId": "a53d80c9-4ea6-4109-a0b8-bc7dbca95e70"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "24808d62-bbab-4ec7-9278-d7d70641fbbb", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "cbdcb1ae-37a4-451c-8a6e-80fac8ce98e5", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "24808d62-bbab-4ec7-9278-d7d70641fbbb"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat Mylan is indicated for\nthe treatment of chronic hyperuricaemia in conditions where urate deposition\nhas already occurred (including a history, or presence of, tophus and/or gouty\narthritis).</span></p>", "ID": "d7f4de2b-3fb0-4190-a346-3746e753c37b", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat Mylan is indicated for\nthe treatment of chronic hyperuricaemia in conditions where urate deposition\nhas already occurred (including a history, or presence of, tophus and/or gouty\narthritis).</span>", "ID": "ae4e91b5-f3f9-434c-9f68-c411a306681b", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Febuxostat Mylan is indicated for the treatment of chronic hyperuricaemia in conditions where urate deposition has already occurred (including a history, or presence of, tophus and/or gouty arthritis).", "ParentId": "d7f4de2b-3fb0-4190-a346-3746e753c37b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "e78dd183-90c1-4d19-b770-2e2277499b16", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "2aab91e6-1ecf-4e31-9d7c-e43fbd7e6586", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "e78dd183-90c1-4d19-b770-2e2277499b16"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat Mylan is indicated for\nthe prevention and treatment of hyperuricaemia in adult patients undergoing\nchemotherapy for haematologic malignancies at intermediate to high risk of\nTumor Lysis Syndrome (TLS).</span></p>", "ID": "60e7257d-c32d-4518-ae7e-b05c1736aee2", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat Mylan is indicated for\nthe prevention and treatment of hyperuricaemia in adult patients undergoing\nchemotherapy for haematologic malignancies at intermediate to high risk of\nTumor Lysis Syndrome (TLS).</span>", "ID": "79b78394-d673-44ca-9f70-38b64aa11594", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Febuxostat Mylan is indicated for the prevention and treatment of hyperuricaemia in adult patients undergoing chemotherapy for haematologic malignancies at intermediate to high risk of Tumor Lysis Syndrome (TLS).", "ParentId": "60e7257d-c32d-4518-ae7e-b05c1736aee2"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "7c939c15-6ab8-4cd1-b638-51ce610d77d9", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "9e9d494a-97db-4a74-b1d9-0f8e28310d7b", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "7c939c15-6ab8-4cd1-b638-51ce610d77d9"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat Mylan is indicated in\nadults.</span></p>", "ID": "42e3dd94-c415-413c-8c8a-2a1699037736", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat Mylan is indicated in\nadults.</span>", "ID": "4d67757b-ded9-4f06-bcfc-0c8ba665d9f9", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Febuxostat Mylan is indicated in adults.", "ParentId": "42e3dd94-c415-413c-8c8a-2a1699037736"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "37218c6d-3ea4-488a-b429-a97bf0cd2434", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "4d4a50f5-edcf-4bf1-9cce-d03c35025e4c", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "37218c6d-3ea4-488a-b429-a97bf0cd2434"}, {"Element": "<h1 style=\"margin-right:3.1pt\"><span lang=\"EN-GB\">4.2\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Posology and method\nof administration</span></h1>", "ID": "ca742339-23ac-4536-820e-35c122ff0992", "Styles": "margin-right:3.1pt", "Classes": "None", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\">4.2\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Posology and method\nof administration</span>", "ID": "0a29eb47-672d-42aa-9df0-6131c2e46529", "Styles": "None", "Classes": "None", "Text": "4.2\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Posology and method of administration", "ParentId": "ca742339-23ac-4536-820e-35c122ff0992"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "cdbb40d7-9a6a-4679-a69b-b8ca85359cdc", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "63e9df39-82d8-41df-af79-3b1821e72c16", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "cdbb40d7-9a6a-4679-a69b-b8ca85359cdc"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Posology</span></u></p>", "ID": "e9e437d2-e645-4007-9e44-a8df542bebfe", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Posology</span></u>", "ID": "b55db9ed-ae6c-4e6c-8931-c1e2b87aece0", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e9e437d2-e645-4007-9e44-a8df542bebfe"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Posology</span>", "ID": "294c147a-7db9-45fc-92f8-163b462e9bb2", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Posology", "ParentId": "b55db9ed-ae6c-4e6c-8931-c1e2b87aece0"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "dffc7400-3676-4a0e-b491-93391abe7ec7", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "b748497c-533e-4a90-9cbd-df02aa5dd4a8", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "dffc7400-3676-4a0e-b491-93391abe7ec7"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Gout</span></i></p>", "ID": "5bb4913e-0b60-46b3-ac83-b5bcf4aef3c4", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Gout</span></i>", "ID": "fbdff048-ff9c-4509-b447-dd5d825870fe", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "5bb4913e-0b60-46b3-ac83-b5bcf4aef3c4"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Gout</span>", "ID": "06cb21ba-0664-482f-8cce-05bbee1b3d66", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Gout", "ParentId": "fbdff048-ff9c-4509-b447-dd5d825870fe"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The recommended oral dose of Febuxostat\nMylan is 80\u00a0mg once daily without regard to food. If serum uric acid is\n&gt; 6\u00a0mg/dL (357\u00a0\u00b5mol/L) after 2-4 weeks, Febuxostat Mylan 120\u00a0mg\nonce daily may be considered.</span></p>", "ID": "fc3f3870-1200-4dd0-8976-e4d0ba91e79a", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The recommended oral dose of Febuxostat\nMylan is 80\u00a0mg once daily without regard to food. If serum uric acid is\n&gt; 6\u00a0mg/dL (357\u00a0\u00b5mol/L) after 2-4 weeks, Febuxostat Mylan 120\u00a0mg\nonce daily may be considered.</span>", "ID": "73d3d2c7-3eb1-43ef-b5f0-34dbaf9550b5", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "The recommended oral dose of Febuxostat Mylan is 80\u00a0mg once daily without regard to food. If serum uric acid is > 6\u00a0mg/dL (357\u00a0\u00b5mol/L) after 2-4 weeks, Febuxostat Mylan 120\u00a0mg once daily may be considered.", "ParentId": "fc3f3870-1200-4dd0-8976-e4d0ba91e79a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "b4402609-f33b-42a6-994e-7ad13bc9995f", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "37934742-6c71-4f84-9f28-0f98da5a0f75", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "b4402609-f33b-42a6-994e-7ad13bc9995f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat Mylan works sufficiently\nquickly to allow retesting of the serum uric acid after 2 weeks. The therapeutic\ntarget is to decrease and maintain serum uric acid below 6\u00a0mg/dL (357\u00a0\u03bcmol/L).</span></p>", "ID": "51ecaf45-362c-4ae2-a20a-bae4644e91d6", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat Mylan works sufficiently\nquickly to allow retesting of the serum uric acid after 2 weeks. The therapeutic\ntarget is to decrease and maintain serum uric acid below 6\u00a0mg/dL (357\u00a0\u03bcmol/L).</span>", "ID": "28d02b57-797f-43a4-ad00-88110c0e52b6", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Febuxostat Mylan works sufficiently quickly to allow retesting of the serum uric acid after 2 weeks. The therapeutic target is to decrease and maintain serum uric acid below 6\u00a0mg/dL (357\u00a0\u03bcmol/L).", "ParentId": "51ecaf45-362c-4ae2-a20a-bae4644e91d6"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "bac93cfe-47ad-45f2-a9b0-a7d723b343ab", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "40995949-b8a0-4c77-af31-56974f66dce8", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "bac93cfe-47ad-45f2-a9b0-a7d723b343ab"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Gout flare prophylaxis of at least\n6 months is recommended (see section 4.4).</span></p>", "ID": "865b03d7-3073-451e-af2d-1b946ef3fda2", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Gout flare prophylaxis of at least\n6 months is recommended (see section 4.4).</span>", "ID": "e8b70413-a2a4-49ef-8629-e170a374207d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Gout flare prophylaxis of at least 6 months is recommended (see section 4.4).", "ParentId": "865b03d7-3073-451e-af2d-1b946ef3fda2"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "6d583b43-0273-4d0a-8a81-0ba4e9ab3a9d", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "6227eab8-0440-4a3f-b660-f543960a4e78", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "6d583b43-0273-4d0a-8a81-0ba4e9ab3a9d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Tumor Lysis Syndrome</span></i></p>", "ID": "dc261022-ff4f-42f4-936f-f1c3044fc02a", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Tumor Lysis Syndrome</span></i>", "ID": "6a002b7e-00bf-44e5-b064-8090dc102ed8", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "dc261022-ff4f-42f4-936f-f1c3044fc02a"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Tumor Lysis Syndrome</span>", "ID": "86df7307-3c46-420d-af19-a6cd8a0fd04a", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Tumor Lysis Syndrome", "ParentId": "6a002b7e-00bf-44e5-b064-8090dc102ed8"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The recommended oral dose of Febuxostat\nMylan is 120\u00a0mg once daily without regard to food.</span></p>", "ID": "84bf28f9-05a3-4353-9ac1-aa7b17c3c3ea", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The recommended oral dose of Febuxostat\nMylan is 120\u00a0mg once daily without regard to food.</span>", "ID": "dacea8e7-70c6-4110-b45d-789332a9512f", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "The recommended oral dose of Febuxostat Mylan is 120\u00a0mg once daily without regard to food.", "ParentId": "84bf28f9-05a3-4353-9ac1-aa7b17c3c3ea"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "1474e950-4ca0-46ff-ba53-7e3fa1f08625", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "5c6db338-36f5-48f7-aa9a-01fcb29f42de", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "1474e950-4ca0-46ff-ba53-7e3fa1f08625"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat Mylan should be started\ntwo days before the beginning of cytotoxic therapy and continued for a minimum\nof 7 days; however treatment may be prolonged up to 9 days according to\nchemotherapy duration as per clinical judgment.</span></p>", "ID": "c66cf877-0b65-46ae-b22e-ae890f38746a", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat Mylan should be started\ntwo days before the beginning of cytotoxic therapy and continued for a minimum\nof 7 days; however treatment may be prolonged up to 9 days according to\nchemotherapy duration as per clinical judgment.</span>", "ID": "ca72e9ef-540d-413d-9ce6-2176ee2b52d0", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Febuxostat Mylan should be started two days before the beginning of cytotoxic therapy and continued for a minimum of 7 days; however treatment may be prolonged up to 9 days according to chemotherapy duration as per clinical judgment.", "ParentId": "c66cf877-0b65-46ae-b22e-ae890f38746a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "2f311611-ff3d-4506-987d-86c7046e3560", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "dff20f01-9b72-4ab4-ab41-916e69f1fb8f", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "2f311611-ff3d-4506-987d-86c7046e3560"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Elderly</span></i></p>", "ID": "b8e09fa6-2395-49e9-b95b-b3a25f9fe926", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Elderly</span></i>", "ID": "b239e2b1-7b40-4379-9666-98eb19dc6ef1", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b8e09fa6-2395-49e9-b95b-b3a25f9fe926"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Elderly</span>", "ID": "2688fa66-a180-4500-85e3-98b0df34cab1", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Elderly", "ParentId": "b239e2b1-7b40-4379-9666-98eb19dc6ef1"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>No dose adjustment is required in\nthe elderly (see section 5.2).</span></p>", "ID": "ff737368-c605-4a12-beef-6c2e33c6f483", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>No dose adjustment is required in\nthe elderly (see section 5.2).</span>", "ID": "6ca87775-0955-4d39-896c-67587e98b1b0", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "No dose adjustment is required in the elderly (see section 5.2).", "ParentId": "ff737368-c605-4a12-beef-6c2e33c6f483"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "faafcc9e-115b-446d-805e-86105fc12c7a", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "d79d2aeb-ea20-46ae-9e71-fb79f86f811b", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "faafcc9e-115b-446d-805e-86105fc12c7a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Renal impairment</span></i></p>", "ID": "a9152fae-47dc-458c-9537-b91a64843775", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Renal impairment</span></i>", "ID": "1b7b573c-09a5-4a8d-a169-3940e7d99f72", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a9152fae-47dc-458c-9537-b91a64843775"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Renal impairment</span>", "ID": "076a799a-fd25-463d-8bab-66c0e598b9fe", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Renal impairment", "ParentId": "1b7b573c-09a5-4a8d-a169-3940e7d99f72"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The efficacy and safety have not\nbeen fully evaluated in patients with severe renal impairment (creatinine\nclearance &lt;30 mL/min, see section 5.2).</span></p>", "ID": "40cf8aff-3b63-4af2-803b-80aeb0e58672", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The efficacy and safety have not\nbeen fully evaluated in patients with severe renal impairment (creatinine\nclearance &lt;30 mL/min, see section 5.2).</span>", "ID": "5f699da4-e9dc-4245-a340-8b316f6b5cd2", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "The efficacy and safety have not been fully evaluated in patients with severe renal impairment (creatinine clearance <30 mL/min, see section 5.2).", "ParentId": "40cf8aff-3b63-4af2-803b-80aeb0e58672"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "02049a39-4b64-46e9-9f78-9c8d5932db0d", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "24a0c1c7-488f-46de-a072-a078fe9447e9", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "02049a39-4b64-46e9-9f78-9c8d5932db0d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>No dose adjustment is necessary in\npatients with mild or moderate renal impairment.</span></p>", "ID": "7d847316-4275-45e9-abd8-a110b6dec702", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>No dose adjustment is necessary in\npatients with mild or moderate renal impairment.</span>", "ID": "57678c75-7026-428c-89b1-937575c93c24", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "No dose adjustment is necessary in patients with mild or moderate renal impairment.", "ParentId": "7d847316-4275-45e9-abd8-a110b6dec702"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "5efc4e99-efff-4050-8965-1f0787791e95", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "2391bd8a-770d-46ab-a7ca-d1274fbb20b4", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "5efc4e99-efff-4050-8965-1f0787791e95"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Hepatic impairment</span></i></p>", "ID": "e3f7fb44-fb9d-4db1-9459-23f1bbfbbfd8", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Hepatic impairment</span></i>", "ID": "2b1ff61f-44aa-4f15-add7-f7bc424436a0", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e3f7fb44-fb9d-4db1-9459-23f1bbfbbfd8"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Hepatic impairment</span>", "ID": "fed0bf8d-538f-4be1-bd14-e5d58faf580c", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Hepatic impairment", "ParentId": "2b1ff61f-44aa-4f15-add7-f7bc424436a0"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The efficacy and safety of\nfebuxostat has not been studied in patients with severe hepatic impairment (Child\nPugh Class C).</span></p>", "ID": "d7c4784e-2f3e-411e-bbce-2d5fc78ccd29", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The efficacy and safety of\nfebuxostat has not been studied in patients with severe hepatic impairment (Child\nPugh Class C).</span>", "ID": "fbd960f6-f1ef-4b54-aa2c-7cc9ea1c1150", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "The efficacy and safety of febuxostat has not been studied in patients with severe hepatic impairment (Child Pugh Class C).", "ParentId": "d7c4784e-2f3e-411e-bbce-2d5fc78ccd29"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "af4d2010-7591-4a15-8595-efa29b13a584", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "acf84d08-a027-4774-91d1-4953d17beeca", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "af4d2010-7591-4a15-8595-efa29b13a584"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Gout: The recommended dose in\npatients with mild hepatic impairment is 80\u00a0mg. Limited information is\navailable in patients with moderate hepatic impairment.</span></p>", "ID": "e9c1b977-878e-474a-83e7-57d7183806a9", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Gout: The recommended dose in\npatients with mild hepatic impairment is 80\u00a0mg. Limited information is\navailable in patients with moderate hepatic impairment.</span>", "ID": "1edc5517-202b-4c8c-8a38-759d4eb6b60e", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Gout: The recommended dose in patients with mild hepatic impairment is 80\u00a0mg. Limited information is available in patients with moderate hepatic impairment.", "ParentId": "e9c1b977-878e-474a-83e7-57d7183806a9"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "d0dce2b9-3d87-4c44-8eb9-a0ebe6881a8e", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "f92d6ac3-16e7-489c-a282-3c25b7aa2ae1", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "d0dce2b9-3d87-4c44-8eb9-a0ebe6881a8e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Tumour Lysis Syndrome: in the pivotal\nPhase III trial (FLORENCE) only subjects with severe hepatic insufficiency were\nexcluded from trial participation. No dose adjustment was required for enrolled\npatients on the basis of hepatic function.</span></p>", "ID": "f5e0178e-dbe9-40a8-a223-29da741d6838", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Tumour Lysis Syndrome: in the pivotal\nPhase III trial (FLORENCE) only subjects with severe hepatic insufficiency were\nexcluded from trial participation. No dose adjustment was required for enrolled\npatients on the basis of hepatic function.</span>", "ID": "363c6936-5d58-41ff-b831-eaea6b95692b", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Tumour Lysis Syndrome: in the pivotal Phase III trial (FLORENCE) only subjects with severe hepatic insufficiency were excluded from trial participation. No dose adjustment was required for enrolled patients on the basis of hepatic function.", "ParentId": "f5e0178e-dbe9-40a8-a223-29da741d6838"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "035c01c8-38ba-4e78-b3a5-108f36b61c2c", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "a6578a84-0233-4276-8051-9582f283aedc", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "035c01c8-38ba-4e78-b3a5-108f36b61c2c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Paediatric population</span></i></p>", "ID": "842b40aa-952e-4c32-8f03-b776f65c7341", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Paediatric population</span></i>", "ID": "74c28928-5e9b-450e-9764-f1a7090c982e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "842b40aa-952e-4c32-8f03-b776f65c7341"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Paediatric population</span>", "ID": "b495909f-7298-4dc2-b8fc-feb24c9992b9", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Paediatric population", "ParentId": "74c28928-5e9b-450e-9764-f1a7090c982e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The safety and the efficacy of febuxostat\nin children aged below the age of 18 years have not been established. No data\nare available.</span></p>", "ID": "77c61b50-e1f0-48b1-80a4-108aa4debeb1", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The safety and the efficacy of febuxostat\nin children aged below the age of 18 years have not been established. No data\nare available.</span>", "ID": "0fd8829a-edb2-473c-9ee1-685ad3f3e68a", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "The safety and the efficacy of febuxostat in children aged below the age of 18 years have not been established. No data are available.", "ParentId": "77c61b50-e1f0-48b1-80a4-108aa4debeb1"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "d30c1c5d-d499-45d0-9913-2b40e0fde29f", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "29ecbfe0-e405-4e8b-bbb1-6504fef75d52", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "d30c1c5d-d499-45d0-9913-2b40e0fde29f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Method of administration</span></u></p>", "ID": "059dfd0c-3822-43ce-8c82-eadf3c7ded58", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Method of administration</span></u>", "ID": "6cffaf86-9e7b-401d-9fed-04b6c6464084", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "059dfd0c-3822-43ce-8c82-eadf3c7ded58"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Method of administration</span>", "ID": "df987e59-281c-49b4-af95-48fdf25d718e", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Method of administration", "ParentId": "6cffaf86-9e7b-401d-9fed-04b6c6464084"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "2283bbb7-4730-4988-8685-164ee0408f72", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "e136023d-5922-469d-91fb-01c4673ed1c4", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "2283bbb7-4730-4988-8685-164ee0408f72"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Oral use</span></p>", "ID": "e2f7df66-9a97-4873-8806-0a7a9374a210", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Oral use</span>", "ID": "1bed635d-0241-41fc-b576-479122b7057c", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Oral use", "ParentId": "e2f7df66-9a97-4873-8806-0a7a9374a210"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "00460437-9e6d-4277-8e96-92b305e9e63f", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "6f0f391d-5365-43c0-afc0-2f83b54be590", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "00460437-9e6d-4277-8e96-92b305e9e63f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat Mylan should be taken by\nmouth and can be taken with or without food.</span></p>", "ID": "3522f037-3919-427a-8abe-c6186f018419", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat Mylan should be taken by\nmouth and can be taken with or without food.</span>", "ID": "67e1fa6c-1eca-44d0-b76e-031555470e61", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Febuxostat Mylan should be taken by mouth and can be taken with or without food.", "ParentId": "3522f037-3919-427a-8abe-c6186f018419"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "4358fee6-6419-4747-a4d6-e465bf1eca25", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "8e708125-5e66-4da3-8c8a-16c810480dce", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "4358fee6-6419-4747-a4d6-e465bf1eca25"}, {"Element": "<h1 style=\"margin-right:3.1pt\"><span lang=\"EN-GB\">4.3\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Contraindications</span></h1>", "ID": "bf97dbe5-c701-4772-ae3e-3ecb1acd69aa", "Styles": "margin-right:3.1pt", "Classes": "None", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\">4.3\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Contraindications</span>", "ID": "c3a8599d-c45b-4f72-985a-c60646351fbc", "Styles": "None", "Classes": "None", "Text": "4.3\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Contraindications", "ParentId": "bf97dbe5-c701-4772-ae3e-3ecb1acd69aa"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "d9058a55-284e-45f5-b761-f4b5617a6169", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "a14d859c-b934-46bb-a878-5e9469aca212", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "d9058a55-284e-45f5-b761-f4b5617a6169"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Hypersensitivity to the active\nsubstance or to any of the excipients listed in section 6.1 (see also section\n4.8).</span></p>", "ID": "5826febb-ef4b-4bb6-b0b3-236d9f240464", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Hypersensitivity to the active\nsubstance or to any of the excipients listed in section 6.1 (see also section\n4.8).</span>", "ID": "7cb04111-7e45-4fb2-84db-1930751448bb", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Hypersensitivity to the active substance or to any of the excipients listed in section 6.1 (see also section 4.8).", "ParentId": "5826febb-ef4b-4bb6-b0b3-236d9f240464"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "7d917827-db52-4432-a41b-a2e7c4d8ad83", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "35029931-6c6b-4c43-bb39-a17965b73382", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "7d917827-db52-4432-a41b-a2e7c4d8ad83"}, {"Element": "<h1 style=\"margin-right:3.1pt\"><span lang=\"EN-GB\">4.4\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Special warnings and\nprecautions for use</span></h1>", "ID": "3ed30bd8-35bb-4b74-b74d-b039c1a3af82", "Styles": "margin-right:3.1pt", "Classes": "None", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\">4.4\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Special warnings and\nprecautions for use</span>", "ID": "f58b3625-c210-4402-90fe-2545e8eb27b5", "Styles": "None", "Classes": "None", "Text": "4.4\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Special warnings and precautions for use", "ParentId": "3ed30bd8-35bb-4b74-b74d-b039c1a3af82"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "c671f7ee-f2cc-4301-95bc-9d3b1b98b28b", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "662b3a1b-33f8-4527-9f57-4f0df6916ddc", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "c671f7ee-f2cc-4301-95bc-9d3b1b98b28b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Cardio-vascular disorders</span></u></p>", "ID": "293c7bd1-19ab-4911-acad-40026f1a82de", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Cardio-vascular disorders</span></u>", "ID": "eb43dded-6e9b-4495-b37c-c9d5890f6636", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "293c7bd1-19ab-4911-acad-40026f1a82de"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Cardio-vascular disorders</span>", "ID": "709c2937-51cd-42ea-b7e9-b0c405eeac77", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Cardio-vascular disorders", "ParentId": "eb43dded-6e9b-4495-b37c-c9d5890f6636"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><i><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'><span style=\"text-decoration:none\">\u00a0</span></span></u></i></p>", "ID": "ff3ae5ad-af1b-4329-be06-1d5d2136a3e8", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<i><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'><span style=\"text-decoration:none\">\u00a0</span></span></u></i>", "ID": "8e25bad9-41ee-495a-80ae-91614dc39009", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ff3ae5ad-af1b-4329-be06-1d5d2136a3e8"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "22c0970e-c0dd-479e-b7fe-a341214a64b0", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "8e25bad9-41ee-495a-80ae-91614dc39009"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "6678a076-34b3-4c06-aab8-a8e757f772c0", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "", "ParentId": "22c0970e-c0dd-479e-b7fe-a341214a64b0"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "32dfbfd9-6ddf-471e-87aa-cefba51991d4", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "6678a076-34b3-4c06-aab8-a8e757f772c0"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Treatment of chronic hyperuricaemia</span></u></p>", "ID": "f297ca73-e5cc-48f0-97e3-0c58942184c6", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Treatment of chronic hyperuricaemia</span></u>", "ID": "2275837a-7c7e-47de-b254-2d2d9a9fa7ef", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f297ca73-e5cc-48f0-97e3-0c58942184c6"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Treatment of chronic hyperuricaemia</span>", "ID": "e0d206e2-ce15-4330-8645-5575c6930fe9", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Treatment of chronic hyperuricaemia", "ParentId": "2275837a-7c7e-47de-b254-2d2d9a9fa7ef"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "e27544ac-4ba7-4a22-b529-da38e5ac1609", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "327413b8-11ae-4a31-9dc2-b3981de4ea09", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "e27544ac-4ba7-4a22-b529-da38e5ac1609"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Treatment with febuxostat in\npatients with ischaemic heart disease or congestive heart failure is not\nrecommended. A numerical greater incidence of investigator-reported\ncardiovascular APTC events (defined endpoints from the Anti-Platelet Trialists\u2019\nCollaboration (APTC) including cardiovascular death, non-fatal myocardial\ninfarction, non-fatal stroke) was observed in the febuxostat total group\ncompared to the allopurinol group in the APEX and FACT studies (1.3 vs. 0.3\nevents per 100 Patient Years (PYs)), but not in the CONFIRMS study (see section\n5.1 for detailed characteristics of the studies). The incidence of\ninvestigator-reported cardiovascular APTC events in the combined Phase 3\nstudies (APEX, FACT and CONFIRMS studies) was 0.7 vs. 0.6 events per 100 PYs.\nIn the long-term extension studies the incidences of investigator-reported APTC\nevents were 1.2 and 0.6 events per 100\u00a0PYs for febuxostat and allopurinol,\nrespectively. No statistically significant differences were found and no causal\nrelationship with febuxostat was established. Identified risk factors among\nthese patients were a medical history of atherosclerotic disease and/or\nmyocardial infarction, or of congestive heart failure.</span></p>", "ID": "09ce0bff-dc36-4e09-a870-83db9ece8a32", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Treatment with febuxostat in\npatients with ischaemic heart disease or congestive heart failure is not\nrecommended. A numerical greater incidence of investigator-reported\ncardiovascular APTC events (defined endpoints from the Anti-Platelet Trialists\u2019\nCollaboration (APTC) including cardiovascular death, non-fatal myocardial\ninfarction, non-fatal stroke) was observed in the febuxostat total group\ncompared to the allopurinol group in the APEX and FACT studies (1.3 vs. 0.3\nevents per 100 Patient Years (PYs)), but not in the CONFIRMS study (see section\n5.1 for detailed characteristics of the studies). The incidence of\ninvestigator-reported cardiovascular APTC events in the combined Phase 3\nstudies (APEX, FACT and CONFIRMS studies) was 0.7 vs. 0.6 events per 100 PYs.\nIn the long-term extension studies the incidences of investigator-reported APTC\nevents were 1.2 and 0.6 events per 100\u00a0PYs for febuxostat and allopurinol,\nrespectively. No statistically significant differences were found and no causal\nrelationship with febuxostat was established. Identified risk factors among\nthese patients were a medical history of atherosclerotic disease and/or\nmyocardial infarction, or of congestive heart failure.</span>", "ID": "e0a9056b-c7f5-49a7-a49d-545cf4f64ef9", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Treatment with febuxostat in patients with ischaemic heart disease or congestive heart failure is not recommended. A numerical greater incidence of investigator-reported cardiovascular APTC events (defined endpoints from the Anti-Platelet Trialists\u2019 Collaboration (APTC) including cardiovascular death, non-fatal myocardial infarction, non-fatal stroke) was observed in the febuxostat total group compared to the allopurinol group in the APEX and FACT studies (1.3 vs. 0.3 events per 100 Patient Years (PYs)), but not in the CONFIRMS study (see section 5.1 for detailed characteristics of the studies). The incidence of investigator-reported cardiovascular APTC events in the combined Phase 3 studies (APEX, FACT and CONFIRMS studies) was 0.7 vs. 0.6 events per 100 PYs. In the long-term extension studies the incidences of investigator-reported APTC events were 1.2 and 0.6 events per 100\u00a0PYs for febuxostat and allopurinol, respectively. No statistically significant differences were found and no causal relationship with febuxostat was established. Identified risk factors among these patients were a medical history of atherosclerotic disease and/or myocardial infarction, or of congestive heart failure.", "ParentId": "09ce0bff-dc36-4e09-a870-83db9ece8a32"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "7021d09b-3b5a-4d51-a24e-956d15ffe2f6", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "abcc3f7f-00ee-469d-949a-61b30824f389", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "7021d09b-3b5a-4d51-a24e-956d15ffe2f6"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Prevention and treatment of\nhyperuricaemia in patients at risk of TLS</span></u></p>", "ID": "7fdf65c0-e502-4027-8a0a-4fc676f301e4", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Prevention and treatment of\nhyperuricaemia in patients at risk of TLS</span></u>", "ID": "fce3f1d0-bb26-4a93-a247-2011308fb693", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "7fdf65c0-e502-4027-8a0a-4fc676f301e4"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Prevention and treatment of\nhyperuricaemia in patients at risk of TLS</span>", "ID": "2f10c7d3-f3b4-4fd9-b2ac-fc9bd74f8016", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Prevention and treatment of hyperuricaemia in patients at risk of TLS", "ParentId": "fce3f1d0-bb26-4a93-a247-2011308fb693"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "bec19efa-f3f8-4d57-a86c-7c307e2b165f", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "155750cc-2581-4351-9718-1823d6dc85e2", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "bec19efa-f3f8-4d57-a86c-7c307e2b165f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Patients undergoing chemotherapy\nfor haematologic malignancies at intermediate to high risk of Tumor Lysis\nSyndrome treated with febuxostat should be under cardiac monitoring as\nclinically appropriate.</span></p>", "ID": "faef345f-4baa-476f-a980-19c4c3d5e501", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Patients undergoing chemotherapy\nfor haematologic malignancies at intermediate to high risk of Tumor Lysis\nSyndrome treated with febuxostat should be under cardiac monitoring as\nclinically appropriate.</span>", "ID": "48668961-7b9e-477b-92fe-7db007e404a6", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Patients undergoing chemotherapy for haematologic malignancies at intermediate to high risk of Tumor Lysis Syndrome treated with febuxostat should be under cardiac monitoring as clinically appropriate.", "ParentId": "faef345f-4baa-476f-a980-19c4c3d5e501"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "65c889bb-593a-4f2e-926b-9bb8b98e54df", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "07fc9a56-1258-4484-a4f7-3219b26e834c", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "65c889bb-593a-4f2e-926b-9bb8b98e54df"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Medicinal product allergy /\nhypersensitivity</span></u></p>", "ID": "33b34b19-6551-4d9a-ba86-08d8718ee1b4", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Medicinal product allergy /\nhypersensitivity</span></u>", "ID": "a7830ae5-298f-4a8a-95a9-67b40d1cd2da", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "33b34b19-6551-4d9a-ba86-08d8718ee1b4"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Medicinal product allergy /\nhypersensitivity</span>", "ID": "45e405ab-2161-4090-bf8e-6d31dd6d5a72", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Medicinal product allergy / hypersensitivity", "ParentId": "a7830ae5-298f-4a8a-95a9-67b40d1cd2da"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "c0f40bd3-4fd4-4f66-b8aa-b6c8018c06b0", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "81da3bdb-b8d6-41a5-b474-4bf44656519b", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "c0f40bd3-4fd4-4f66-b8aa-b6c8018c06b0"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare reports of serious\nallergic/hypersensitivity reactions, including life-threatening Stevens-Johnson\nSyndrome, Toxic epidermal necrolysis and acute anaphylactic reaction/shock,\nhave been collected in the post-marketing experience. In most cases, these\nreactions occurred during the first month of therapy with febuxostat. Some, but\nnot all of these patients reported renal impairment and/or previous\nhypersensitivity to allopurinol. Severe hypersensitivity reactions, including\nDrug Reaction with Eosinophilia and Systemic Symptoms (DRESS) were associated\nwith fever, haematological, renal or hepatic involvement in some cases.</span></p>", "ID": "b7f8e9d9-6deb-44f8-936d-d7938ad40a7d", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare reports of serious\nallergic/hypersensitivity reactions, including life-threatening Stevens-Johnson\nSyndrome, Toxic epidermal necrolysis and acute anaphylactic reaction/shock,\nhave been collected in the post-marketing experience. In most cases, these\nreactions occurred during the first month of therapy with febuxostat. Some, but\nnot all of these patients reported renal impairment and/or previous\nhypersensitivity to allopurinol. Severe hypersensitivity reactions, including\nDrug Reaction with Eosinophilia and Systemic Symptoms (DRESS) were associated\nwith fever, haematological, renal or hepatic involvement in some cases.</span>", "ID": "43d0e529-0089-4455-8ee3-e9212e574cef", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Rare reports of serious allergic/hypersensitivity reactions, including life-threatening Stevens-Johnson Syndrome, Toxic epidermal necrolysis and acute anaphylactic reaction/shock, have been collected in the post-marketing experience. In most cases, these reactions occurred during the first month of therapy with febuxostat. Some, but not all of these patients reported renal impairment and/or previous hypersensitivity to allopurinol. Severe hypersensitivity reactions, including Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) were associated with fever, haematological, renal or hepatic involvement in some cases.", "ParentId": "b7f8e9d9-6deb-44f8-936d-d7938ad40a7d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "4e4609e7-d946-44e5-b293-61f843e66ea8", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "cc894b89-b8e1-4eb1-b615-0b4df467dbcc", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "4e4609e7-d946-44e5-b293-61f843e66ea8"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Patients should be advised of the\nsigns and symptoms and monitored closely for symptoms of allergic/hypersensitivity\nreactions (see section 4.8). Febuxostat treatment should be immediately stopped\nif serious allergic/hypersensitivity reactions, including Stevens-Johnson\nSyndrome, occur since early withdrawal is associated with a better prognosis.\nIf patient has developed allergic/hypersensitivity reactions including\nStevens-Johnson Syndrome and acute anaphylactic reaction/shock, febuxostat must\nnot be re-started in this patient at any time.</span></p>", "ID": "c4016ccc-4326-4ac1-bd45-7d4c9b61eea2", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Patients should be advised of the\nsigns and symptoms and monitored closely for symptoms of allergic/hypersensitivity\nreactions (see section 4.8). Febuxostat treatment should be immediately stopped\nif serious allergic/hypersensitivity reactions, including Stevens-Johnson\nSyndrome, occur since early withdrawal is associated with a better prognosis.\nIf patient has developed allergic/hypersensitivity reactions including\nStevens-Johnson Syndrome and acute anaphylactic reaction/shock, febuxostat must\nnot be re-started in this patient at any time.</span>", "ID": "10e0fc44-5770-4b69-91d3-053bea382bc2", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Patients should be advised of the signs and symptoms and monitored closely for symptoms of allergic/hypersensitivity reactions (see section 4.8). Febuxostat treatment should be immediately stopped if serious allergic/hypersensitivity reactions, including Stevens-Johnson Syndrome, occur since early withdrawal is associated with a better prognosis. If patient has developed allergic/hypersensitivity reactions including Stevens-Johnson Syndrome and acute anaphylactic reaction/shock, febuxostat must not be re-started in this patient at any time.", "ParentId": "c4016ccc-4326-4ac1-bd45-7d4c9b61eea2"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "040fd4bf-01b1-4e95-b518-238f68f0020a", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "f34d4336-5520-45ba-a036-c02388ca4dc9", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "040fd4bf-01b1-4e95-b518-238f68f0020a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Acute gouty attacks (gout flare)</span></u></p>", "ID": "488ec9a6-529a-402b-88a1-19b274285660", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Acute gouty attacks (gout flare)</span></u>", "ID": "a5b3b259-8160-43c1-8f3d-4a2fbc4b5603", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "488ec9a6-529a-402b-88a1-19b274285660"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Acute gouty attacks (gout flare)</span>", "ID": "7f593ffe-506c-4993-989e-c1f53e066350", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Acute gouty attacks (gout flare)", "ParentId": "a5b3b259-8160-43c1-8f3d-4a2fbc4b5603"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "bcbed629-3083-4d21-9403-fcd6752e6594", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "609fd8bf-e2b9-4d78-b0cd-fc512270ea70", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "bcbed629-3083-4d21-9403-fcd6752e6594"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat treatment should not be\nstarted until an acute attack of gout has completely subsided. Gout flares may\noccur during initiation of treatment due to changing serum uric acid levels\nresulting in mobilization of urate from tissue deposits (see sections 4.8 and\n5.1). At treatment initiation with febuxostat flare prophylaxis for at least 6\nmonths with an NSAID or colchicine is recommended (see section 4.2).</span></p>", "ID": "6978c1d0-2641-444f-ac0d-c786edc04c85", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat treatment should not be\nstarted until an acute attack of gout has completely subsided. Gout flares may\noccur during initiation of treatment due to changing serum uric acid levels\nresulting in mobilization of urate from tissue deposits (see sections 4.8 and\n5.1). At treatment initiation with febuxostat flare prophylaxis for at least 6\nmonths with an NSAID or colchicine is recommended (see section 4.2).</span>", "ID": "5df3c889-0472-442a-a665-3c544d48ea2e", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Febuxostat treatment should not be started until an acute attack of gout has completely subsided. Gout flares may occur during initiation of treatment due to changing serum uric acid levels resulting in mobilization of urate from tissue deposits (see sections 4.8 and 5.1). At treatment initiation with febuxostat flare prophylaxis for at least 6 months with an NSAID or colchicine is recommended (see section 4.2).", "ParentId": "6978c1d0-2641-444f-ac0d-c786edc04c85"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "ecc031ae-264f-4892-b03a-144b2bfef956", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "71b6d472-8a87-4e6c-beb5-4f30fa74802f", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "ecc031ae-264f-4892-b03a-144b2bfef956"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If a gout flare occurs during\nfebuxostat treatment, it should not be discontinued. The gout flare should be\nmanaged concurrently as appropriate for the individual patient. Continuous\ntreatment with febuxostat decreases frequency and intensity of gout flares.</span></p>", "ID": "a57d0180-607e-491c-ab52-cccf2aa783cc", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If a gout flare occurs during\nfebuxostat treatment, it should not be discontinued. The gout flare should be\nmanaged concurrently as appropriate for the individual patient. Continuous\ntreatment with febuxostat decreases frequency and intensity of gout flares.</span>", "ID": "04f09163-4c7e-4871-8394-fb47a7aaae1a", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "If a gout flare occurs during febuxostat treatment, it should not be discontinued. The gout flare should be managed concurrently as appropriate for the individual patient. Continuous treatment with febuxostat decreases frequency and intensity of gout flares.", "ParentId": "a57d0180-607e-491c-ab52-cccf2aa783cc"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "ede4a531-b185-4d38-be6d-2340c38b50d0", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "1a5a68ab-1482-4981-af60-9ec4f6b1d0e6", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "ede4a531-b185-4d38-be6d-2340c38b50d0"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Xanthine deposition</span></u></p>", "ID": "2b73cfd5-20c8-4e1f-b329-25b9b964c772", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Xanthine deposition</span></u>", "ID": "3c51e4b1-4361-45b1-a679-16f0933699c3", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "2b73cfd5-20c8-4e1f-b329-25b9b964c772"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Xanthine deposition</span>", "ID": "3b6b4041-9db6-4477-8e1c-e5e56086f562", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Xanthine deposition", "ParentId": "3c51e4b1-4361-45b1-a679-16f0933699c3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "b87cd907-733b-449b-b94c-62192d253db3", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "2a2cf769-b2b4-46b8-a428-ab702077f0e9", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "b87cd907-733b-449b-b94c-62192d253db3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>In patients in whom the rate of\nurate formation is greatly increased (e.g. malignant disease and its treatment,\nLesch-Nyhan syndrome) the absolute concentration of xanthine in urine could, in\nrare cases, rise sufficiently to allow deposition in the urinary tract. This\nhas not been observed in the pivotal clinical study with febuxostat in the\nTumor Lysis Syndrome. As there has been no experience with febuxostat, its use\nin patients with Lesch-Nyhan Syndrome is not recommended.</span></p>", "ID": "5d9bfce9-ccff-46a6-801c-d1d56dcf7106", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>In patients in whom the rate of\nurate formation is greatly increased (e.g. malignant disease and its treatment,\nLesch-Nyhan syndrome) the absolute concentration of xanthine in urine could, in\nrare cases, rise sufficiently to allow deposition in the urinary tract. This\nhas not been observed in the pivotal clinical study with febuxostat in the\nTumor Lysis Syndrome. As there has been no experience with febuxostat, its use\nin patients with Lesch-Nyhan Syndrome is not recommended.</span>", "ID": "7aefe6d0-3f1f-4d86-8fbb-c4d577e98649", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "In patients in whom the rate of urate formation is greatly increased (e.g. malignant disease and its treatment, Lesch-Nyhan syndrome) the absolute concentration of xanthine in urine could, in rare cases, rise sufficiently to allow deposition in the urinary tract. This has not been observed in the pivotal clinical study with febuxostat in the Tumor Lysis Syndrome. As there has been no experience with febuxostat, its use in patients with Lesch-Nyhan Syndrome is not recommended.", "ParentId": "5d9bfce9-ccff-46a6-801c-d1d56dcf7106"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "753892f1-0c5d-4921-9a27-0abe9bd53a74", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "8dea0391-2804-49fd-887b-8c4da1eecafb", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "753892f1-0c5d-4921-9a27-0abe9bd53a74"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Mercaptopurine/azathioprine</span></u></p>", "ID": "5bba4c19-4f34-4c8c-9ab6-b511450081e1", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Mercaptopurine/azathioprine</span></u>", "ID": "397da83b-f814-4e39-9142-93147f9e4aef", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "5bba4c19-4f34-4c8c-9ab6-b511450081e1"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Mercaptopurine/azathioprine</span>", "ID": "20fb7ca0-4401-46c4-b9d5-bf35e22c135e", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Mercaptopurine/azathioprine", "ParentId": "397da83b-f814-4e39-9142-93147f9e4aef"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "a8d94e23-5a63-4e85-83ed-fd5fa7ae7535", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "f6fe1d71-11b8-49f8-84c6-b7292d8a2d64", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "a8d94e23-5a63-4e85-83ed-fd5fa7ae7535"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat use is not recommended\nin patients concomitantly treated with mercaptopurine/azathioprine as inhibition\nof xanthine oxidase by febuxostat may cause increased plasma concentrations of\nmercaptopurine/azathioprine that could result in severe toxicity. No\ninteraction studies have been performed in humans.</span></p>", "ID": "66b647fc-71cf-4ce7-b2ed-4b32246317ad", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat use is not recommended\nin patients concomitantly treated with mercaptopurine/azathioprine as inhibition\nof xanthine oxidase by febuxostat may cause increased plasma concentrations of\nmercaptopurine/azathioprine that could result in severe toxicity. No\ninteraction studies have been performed in humans.</span>", "ID": "887e8399-7513-489b-a336-1d4f68620402", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Febuxostat use is not recommended in patients concomitantly treated with mercaptopurine/azathioprine as inhibition of xanthine oxidase by febuxostat may cause increased plasma concentrations of mercaptopurine/azathioprine that could result in severe toxicity. No interaction studies have been performed in humans.", "ParentId": "66b647fc-71cf-4ce7-b2ed-4b32246317ad"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Where the combination cannot be\navoided, a reduction of the dose of mercaptopurine/azathioprine is recommended.\nBased on modelling and simulation analysis of data from a pre-clinical study in\nrats, when coadministered with febuxostat, the dose of\nmercaptopurine/azathioprine should be reduced to the 20% or less of the\npreviously prescribed dose in order to avoid possible haematological effects\n(see section 4.5 and 5.3).</span></p>", "ID": "fae4b96f-1386-4b0b-93c0-652ad26ead56", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Where the combination cannot be\navoided, a reduction of the dose of mercaptopurine/azathioprine is recommended.\nBased on modelling and simulation analysis of data from a pre-clinical study in\nrats, when coadministered with febuxostat, the dose of\nmercaptopurine/azathioprine should be reduced to the 20% or less of the\npreviously prescribed dose in order to avoid possible haematological effects\n(see section 4.5 and 5.3).</span>", "ID": "87962ed1-ea96-4007-b9ff-ba76b5c2e94d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Where the combination cannot be avoided, a reduction of the dose of mercaptopurine/azathioprine is recommended. Based on modelling and simulation analysis of data from a pre-clinical study in rats, when coadministered with febuxostat, the dose of mercaptopurine/azathioprine should be reduced to the 20% or less of the previously prescribed dose in order to avoid possible haematological effects (see section 4.5 and 5.3).", "ParentId": "fae4b96f-1386-4b0b-93c0-652ad26ead56"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "b712ed6b-e52e-41e6-a316-434941cd1ade", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "7690a598-51cd-414f-b07c-7f7b16a7612e", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "b712ed6b-e52e-41e6-a316-434941cd1ade"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The patients should be closely monitored\nand the dose of mercaptopurine/azathioprine should be subsequently adjusted\nbased on the evaluation of the therapeutic response and the onset of eventual\ntoxic effects.</span></p>", "ID": "8be1ed88-c029-47c7-bfc8-784418ccfe99", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The patients should be closely monitored\nand the dose of mercaptopurine/azathioprine should be subsequently adjusted\nbased on the evaluation of the therapeutic response and the onset of eventual\ntoxic effects.</span>", "ID": "b1f36915-f4f3-460d-b5d1-124fa20ebccd", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "The patients should be closely monitored and the dose of mercaptopurine/azathioprine should be subsequently adjusted based on the evaluation of the therapeutic response and the onset of eventual toxic effects.", "ParentId": "8be1ed88-c029-47c7-bfc8-784418ccfe99"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "1c299359-db92-42ad-9e92-f7f2c54dbd85", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "1ac25a32-5d4c-4f63-99ed-1534f300a780", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "1c299359-db92-42ad-9e92-f7f2c54dbd85"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Organ transplant recipients</span></u></p>", "ID": "621d367e-634f-4fed-bb28-79554f83b6c8", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Organ transplant recipients</span></u>", "ID": "359748b8-ce9c-4598-8b00-11582c500f70", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "621d367e-634f-4fed-bb28-79554f83b6c8"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Organ transplant recipients</span>", "ID": "70a8ae9e-d9c4-4724-8c88-551a2a598fcb", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Organ transplant recipients", "ParentId": "359748b8-ce9c-4598-8b00-11582c500f70"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "d3a01b5b-6b55-4379-bc49-268114909345", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "71f4fa0b-bb1b-4e0f-a026-f2b2fad4f362", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "d3a01b5b-6b55-4379-bc49-268114909345"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>As there has been no experience in\norgan transplant recipients, the use of febuxostat in such patients is not\nrecommended (see section 5.1).</span></p>", "ID": "5275e89c-67cb-43e2-9f0f-5c8bb114120d", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>As there has been no experience in\norgan transplant recipients, the use of febuxostat in such patients is not\nrecommended (see section 5.1).</span>", "ID": "316aad8b-a9e0-482c-89f6-62e3bf0b872d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "As there has been no experience in organ transplant recipients, the use of febuxostat in such patients is not recommended (see section 5.1).", "ParentId": "5275e89c-67cb-43e2-9f0f-5c8bb114120d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "dc6a4425-47b1-4c70-8f61-8c75e5a74994", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "1816e73c-cd3f-4fbd-afe9-c6da51657f2b", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "dc6a4425-47b1-4c70-8f61-8c75e5a74994"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Theophylline</span></u></p>", "ID": "250ed9a8-9b65-4944-9660-df5bda79bc0b", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Theophylline</span></u>", "ID": "ca3620a8-0ef2-4a62-974f-a26823732380", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "250ed9a8-9b65-4944-9660-df5bda79bc0b"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Theophylline</span>", "ID": "90eea4ed-0fa8-418b-a46d-cadaba1fa269", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Theophylline", "ParentId": "ca3620a8-0ef2-4a62-974f-a26823732380"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "e4111489-36f3-40d8-af5e-3d1431c40c97", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "7656ae2b-5b37-4a97-a078-e0d119bfcfe5", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "e4111489-36f3-40d8-af5e-3d1431c40c97"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Co-administration of febuxostat 80\u00a0mg\nand theophylline 400\u00a0mg single dose in healthy subjects showed absence of\nany pharmacokinetic interaction (see section 4.5). Febuxostat 80\u00a0mg can be\nused in patients concomitantly treated with theophylline without risk of\nincreasing theophylline plasma levels.</span></p>", "ID": "7f521630-baf2-4bfc-9eaa-8277d951e6b4", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Co-administration of febuxostat 80\u00a0mg\nand theophylline 400\u00a0mg single dose in healthy subjects showed absence of\nany pharmacokinetic interaction (see section 4.5). Febuxostat 80\u00a0mg can be\nused in patients concomitantly treated with theophylline without risk of\nincreasing theophylline plasma levels.</span>", "ID": "509e0e91-7008-419a-97e0-6ecaaadda06b", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Co-administration of febuxostat 80\u00a0mg and theophylline 400\u00a0mg single dose in healthy subjects showed absence of any pharmacokinetic interaction (see section 4.5). Febuxostat 80\u00a0mg can be used in patients concomitantly treated with theophylline without risk of increasing theophylline plasma levels.", "ParentId": "7f521630-baf2-4bfc-9eaa-8277d951e6b4"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "6bffb170-3b15-459d-b010-933b92fef077", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "8478a8d5-5cbc-40fb-b4f3-2f4025cfaee4", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "6bffb170-3b15-459d-b010-933b92fef077"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>No data is available for febuxostat\n120\u00a0mg.</span></p>", "ID": "b50781c1-758e-4a71-acff-c345571a4716", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>No data is available for febuxostat\n120\u00a0mg.</span>", "ID": "83afca42-dbbd-48a0-b398-89ec6eba7e07", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "No data is available for febuxostat 120\u00a0mg.", "ParentId": "b50781c1-758e-4a71-acff-c345571a4716"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "f217e63e-8313-4d61-b582-152645792baf", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "78d96e7d-f257-4d39-be5f-7027f7982a41", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "f217e63e-8313-4d61-b582-152645792baf"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Liver disorders</span></u></p>", "ID": "a08d8ebf-5b55-44b3-9fb9-c50a90900618", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Liver disorders</span></u>", "ID": "3034c922-8049-4e52-8a51-5cb53dcb98a4", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a08d8ebf-5b55-44b3-9fb9-c50a90900618"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Liver disorders</span>", "ID": "d2531fdd-998e-4427-ae51-4a62f9777e43", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Liver disorders", "ParentId": "3034c922-8049-4e52-8a51-5cb53dcb98a4"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "7370beea-1f93-41be-97d6-845c48bf4349", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "1634bfcc-d60a-45b6-8582-ed81938826b6", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "7370beea-1f93-41be-97d6-845c48bf4349"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>During the combined phase 3 clinical\nstudies, mild liver function test abnormalities were observed in patients\ntreated with febuxostat (5.0%). Liver function test is recommended prior to the\ninitiation of therapy with febuxostat and periodically thereafter based on\nclinical judgment (see section 5.1).</span></p>", "ID": "be93e099-979a-4e97-8df8-b06ba888fe46", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>During the combined phase 3 clinical\nstudies, mild liver function test abnormalities were observed in patients\ntreated with febuxostat (5.0%). Liver function test is recommended prior to the\ninitiation of therapy with febuxostat and periodically thereafter based on\nclinical judgment (see section 5.1).</span>", "ID": "578217d8-fb7b-4237-a8a9-dab6c03605df", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "During the combined phase 3 clinical studies, mild liver function test abnormalities were observed in patients treated with febuxostat (5.0%). Liver function test is recommended prior to the initiation of therapy with febuxostat and periodically thereafter based on clinical judgment (see section 5.1).", "ParentId": "be93e099-979a-4e97-8df8-b06ba888fe46"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "eced2d92-0b84-4e2b-b628-ec3d9f0ee2ae", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "6e349c0c-0d44-4e1d-8f4e-20b2eba28317", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "eced2d92-0b84-4e2b-b628-ec3d9f0ee2ae"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Thyroid disorders</span></u></p>", "ID": "35a49d28-2bde-4dc1-98f0-ec9df876987b", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Thyroid disorders</span></u>", "ID": "b43554c3-377d-4528-9abf-bb0374e22b73", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "35a49d28-2bde-4dc1-98f0-ec9df876987b"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Thyroid disorders</span>", "ID": "89bf9124-77c2-4f16-873a-ea722ca07c3f", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Thyroid disorders", "ParentId": "b43554c3-377d-4528-9abf-bb0374e22b73"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "05ac26ad-b6dd-4e01-bf78-dd2e74f5b8df", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "67b1caf3-9043-4c0a-8648-4ab76091226e", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "05ac26ad-b6dd-4e01-bf78-dd2e74f5b8df"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Increased TSH values (&gt;5.5\u00a0\u00b5IU/mL)\nwere observed in patients on long-term treatment with febuxostat (5.5%) in the\nlong term open label extension studies. Caution is required when febuxostat is\nused in patients with alteration of thyroid function (see section 5.1).</span></p>", "ID": "bb1732cc-e598-4bab-ab07-e13f12395dfa", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Increased TSH values (&gt;5.5\u00a0\u00b5IU/mL)\nwere observed in patients on long-term treatment with febuxostat (5.5%) in the\nlong term open label extension studies. Caution is required when febuxostat is\nused in patients with alteration of thyroid function (see section 5.1).</span>", "ID": "a385bfe5-1fc9-4217-b975-29ca60835af0", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Increased TSH values (>5.5\u00a0\u00b5IU/mL) were observed in patients on long-term treatment with febuxostat (5.5%) in the long term open label extension studies. Caution is required when febuxostat is used in patients with alteration of thyroid function (see section 5.1).", "ParentId": "bb1732cc-e598-4bab-ab07-e13f12395dfa"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "242628f0-ec3e-41f8-9030-e27bbd4ea9d7", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "8c8a59a5-4bff-42f0-a7f3-421da53cc52c", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "242628f0-ec3e-41f8-9030-e27bbd4ea9d7"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Lactose</span></u></p>", "ID": "071ce46a-7cf4-4cca-8869-17b7ebc549ad", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Lactose</span></u>", "ID": "ec997359-0988-4bcb-8a6f-44a65f6e5e9c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "071ce46a-7cf4-4cca-8869-17b7ebc549ad"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Lactose</span>", "ID": "0b1b732a-b477-4bdb-a064-e7509663d76f", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Lactose", "ParentId": "ec997359-0988-4bcb-8a6f-44a65f6e5e9c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "23136acc-d658-42fe-a692-5c15dcdea6f9", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "869b8ee1-b9a5-4741-8b48-a20acb1d8360", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "23136acc-d658-42fe-a692-5c15dcdea6f9"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat tablets contain lactose.\nPatients with rare hereditary problems of galactose intolerance, the Lapp\nlactase deficiency or glucose-galactose malabsorption should not take this\nmedicine.</span></p>", "ID": "15f8dd41-4021-42d2-afce-fb5533004f19", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat tablets contain lactose.\nPatients with rare hereditary problems of galactose intolerance, the Lapp\nlactase deficiency or glucose-galactose malabsorption should not take this\nmedicine.</span>", "ID": "2dc3a5fd-534d-4f96-a715-5617604623f5", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Febuxostat tablets contain lactose. Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine.", "ParentId": "15f8dd41-4021-42d2-afce-fb5533004f19"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "ff8a05cd-c5cf-4f14-9846-c491ec47d8c3", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "558418d0-524e-4073-bd82-3ea87cf848f3", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "ff8a05cd-c5cf-4f14-9846-c491ec47d8c3"}, {"Element": "<h1 style=\"margin-right:3.1pt\"><span lang=\"EN-GB\">4.5\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Interaction with\nother medicinal products and other forms of interaction</span></h1>", "ID": "b918752c-67aa-4861-a057-aa037c0f4c09", "Styles": "margin-right:3.1pt", "Classes": "None", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\">4.5\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Interaction with\nother medicinal products and other forms of interaction</span>", "ID": "367d2084-ef64-43c1-8275-bb613b4ae9ba", "Styles": "None", "Classes": "None", "Text": "4.5\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Interaction with other medicinal products and other forms of interaction", "ParentId": "b918752c-67aa-4861-a057-aa037c0f4c09"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "2976180c-0e35-414e-9323-7e3913c29a67", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "e3a2fa3a-570b-4cd3-a748-4abdc64be1a0", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "2976180c-0e35-414e-9323-7e3913c29a67"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Mercaptopurine/azathioprine</span></u></p>", "ID": "3b8e066b-b345-4cf5-b002-aa218b39bd5a", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Mercaptopurine/azathioprine</span></u>", "ID": "2be85209-cbd2-4552-b572-a815ed204df5", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "3b8e066b-b345-4cf5-b002-aa218b39bd5a"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Mercaptopurine/azathioprine</span>", "ID": "6ed0b4c9-2f1a-4344-8edd-d6e40ecd3ebc", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Mercaptopurine/azathioprine", "ParentId": "2be85209-cbd2-4552-b572-a815ed204df5"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "43c7e5f1-bbe2-4fc9-923e-184beb9eccb0", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "dbe925f1-68d3-4436-9561-e6573715f07e", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "43c7e5f1-bbe2-4fc9-923e-184beb9eccb0"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>On the basis of the mechanism of\naction of febuxostat on XO inhibition concomitant use is not recommended.\nInhibition of XO by febuxostat may cause increased plasma concentrations of\nthese drugs leading to toxicity. Drug interaction studies of febuxostat with\ndrugs (except theophylline) that are metabolized by XO have not been performed\nin humans.</span></p>", "ID": "693118b4-7010-4459-a868-d8daac4e4d64", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>On the basis of the mechanism of\naction of febuxostat on XO inhibition concomitant use is not recommended.\nInhibition of XO by febuxostat may cause increased plasma concentrations of\nthese drugs leading to toxicity. Drug interaction studies of febuxostat with\ndrugs (except theophylline) that are metabolized by XO have not been performed\nin humans.</span>", "ID": "c4deab15-9c10-4c92-8013-b111506624e4", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "On the basis of the mechanism of action of febuxostat on XO inhibition concomitant use is not recommended. Inhibition of XO by febuxostat may cause increased plasma concentrations of these drugs leading to toxicity. Drug interaction studies of febuxostat with drugs (except theophylline) that are metabolized by XO have not been performed in humans.", "ParentId": "693118b4-7010-4459-a868-d8daac4e4d64"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Modelling and simulation analysis\nof data from a pre-clinical study in rats, indicates that, in case of\nconcomitant administration with febuxostat, the dose of\nmercaptopurine/azathioprine should be reduced to the 20% or less of the\npreviously prescribed dose (see section 4.4 and 5.3).</span></p>", "ID": "a07a1bdd-5b8c-4c89-8003-567d837a2d6e", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Modelling and simulation analysis\nof data from a pre-clinical study in rats, indicates that, in case of\nconcomitant administration with febuxostat, the dose of\nmercaptopurine/azathioprine should be reduced to the 20% or less of the\npreviously prescribed dose (see section 4.4 and 5.3).</span>", "ID": "7561e49d-6861-4abf-bbdb-25149465e0a3", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Modelling and simulation analysis of data from a pre-clinical study in rats, indicates that, in case of concomitant administration with febuxostat, the dose of mercaptopurine/azathioprine should be reduced to the 20% or less of the previously prescribed dose (see section 4.4 and 5.3).", "ParentId": "a07a1bdd-5b8c-4c89-8003-567d837a2d6e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "e45b2ae0-1f23-4552-95be-1c55a6414421", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "bb52c98b-e02f-459d-a942-6d5e2a7d394e", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "e45b2ae0-1f23-4552-95be-1c55a6414421"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Drug interaction studies of\nfebuxostat with other cytotoxic chemotherapy have not been conducted. </span></p>", "ID": "b6ee1d15-7dca-488f-b458-dc6d78864421", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Drug interaction studies of\nfebuxostat with other cytotoxic chemotherapy have not been conducted. </span>", "ID": "0e427eda-f88e-447b-a9a5-e24951f54202", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Drug interaction studies of febuxostat with other cytotoxic chemotherapy have not been conducted. ", "ParentId": "b6ee1d15-7dca-488f-b458-dc6d78864421"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "fb37600a-ec05-4ef5-85ae-f9e25870a608", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "1e47c84f-a086-4cc7-8764-345a6609108c", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "fb37600a-ec05-4ef5-85ae-f9e25870a608"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>In the Tumor Lysis Syndrome pivotal\ntrial febuxostat 120\u00a0mg daily was administered to patients undergoing\nseveral chemotherapy regimens, including monoclonal antibodies. However,\ndrug-drug and drug-disease interactions were not explored during this study.\nTherefore, possible interactions with any concomitantly administered cytotoxic\ndrug cannot be ruled out.</span></p>", "ID": "3a1b23ab-41b6-4ca2-b7e0-136c9b5b8dea", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>In the Tumor Lysis Syndrome pivotal\ntrial febuxostat 120\u00a0mg daily was administered to patients undergoing\nseveral chemotherapy regimens, including monoclonal antibodies. However,\ndrug-drug and drug-disease interactions were not explored during this study.\nTherefore, possible interactions with any concomitantly administered cytotoxic\ndrug cannot be ruled out.</span>", "ID": "e5f57d8b-60b9-48a5-b742-5745153f6a2a", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "In the Tumor Lysis Syndrome pivotal trial febuxostat 120\u00a0mg daily was administered to patients undergoing several chemotherapy regimens, including monoclonal antibodies. However, drug-drug and drug-disease interactions were not explored during this study. Therefore, possible interactions with any concomitantly administered cytotoxic drug cannot be ruled out.", "ParentId": "3a1b23ab-41b6-4ca2-b7e0-136c9b5b8dea"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "32640068-69bc-4f68-84dd-2f489a8a4142", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "9dd65745-777c-42e2-9fde-0ca74fd09050", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "32640068-69bc-4f68-84dd-2f489a8a4142"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rosiglitazone/CYP2C8 substrates</span></u></p>", "ID": "656e3dca-cced-4efa-b88b-8f2a070f0f58", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rosiglitazone/CYP2C8 substrates</span></u>", "ID": "a654eaa6-0351-4e45-b686-8b981fa08d10", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "656e3dca-cced-4efa-b88b-8f2a070f0f58"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rosiglitazone/CYP2C8 substrates</span>", "ID": "ddea6500-961f-40e0-a2ac-a1634b89270d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Rosiglitazone/CYP2C8 substrates", "ParentId": "a654eaa6-0351-4e45-b686-8b981fa08d10"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "de1e4b60-b5ce-4eaa-8277-0b21ec87a72a", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "a8e9c31e-ef02-4093-a30e-4217a1c2931a", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "de1e4b60-b5ce-4eaa-8277-0b21ec87a72a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat was shown to be a weak inhibitor\nof CYP2C8 <i>in vitro. </i>In a study in healthy subjects, coadministration of\n120\u00a0mg febuxostat QD with a single 4\u00a0mg oral dose of rosiglitazone\nhad no effect on the pharmacokinetics of rosiglitazone and its metabolite\nN-desmethyl rosiglitazone, indicating that febuxostat is not a CYP2C8 enzyme\ninhibitor <i>in vivo</i>. Thus, co-administration of febuxostat with rosiglitazone\nor other CYP2C8 substrates is not expected to require any dose adjustment for\nthose compounds.</span></p>", "ID": "8d3575c5-909b-4529-aa9a-6ae7352d3db8", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat was shown to be a weak inhibitor\nof CYP2C8 <i>in vitro. </i>In a study in healthy subjects, coadministration of\n120\u00a0mg febuxostat QD with a single 4\u00a0mg oral dose of rosiglitazone\nhad no effect on the pharmacokinetics of rosiglitazone and its metabolite\nN-desmethyl rosiglitazone, indicating that febuxostat is not a CYP2C8 enzyme\ninhibitor <i>in vivo</i>. Thus, co-administration of febuxostat with rosiglitazone\nor other CYP2C8 substrates is not expected to require any dose adjustment for\nthose compounds.</span>", "ID": "7b6e12e8-5ede-4c0c-bece-ee095cfcdff7", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Febuxostat was shown to be a weak inhibitor of CYP2C8 In a study in healthy subjects, coadministration of 120\u00a0mg febuxostat QD with a single 4\u00a0mg oral dose of rosiglitazone had no effect on the pharmacokinetics of rosiglitazone and its metabolite N-desmethyl rosiglitazone, indicating that febuxostat is not a CYP2C8 enzyme inhibitor . Thus, co-administration of febuxostat with rosiglitazone or other CYP2C8 substrates is not expected to require any dose adjustment for those compounds.", "ParentId": "8d3575c5-909b-4529-aa9a-6ae7352d3db8"}, {"Element": "<i>in vitro. </i>", "ID": "f2dcda69-3d71-464c-889f-86d49cd16036", "Styles": "None", "Classes": "None", "Text": "in vitro. ", "ParentId": "7b6e12e8-5ede-4c0c-bece-ee095cfcdff7"}, {"Element": "<i>in vivo</i>", "ID": "e883172e-3231-406f-92d5-33dda2a2163e", "Styles": "None", "Classes": "None", "Text": "in vivo", "ParentId": "7b6e12e8-5ede-4c0c-bece-ee095cfcdff7"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "ff3f55cb-a625-44e5-93e1-6ce0c60f3cd5", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "4598a8bc-3993-4ad4-b606-a78a45a306d6", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "ff3f55cb-a625-44e5-93e1-6ce0c60f3cd5"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Theophylline</span></u></p>", "ID": "3613fad5-6fe2-4942-b2e6-c0bcaff59eaf", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Theophylline</span></u>", "ID": "e5717f91-0327-4821-8d84-8475f7c4bffd", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "3613fad5-6fe2-4942-b2e6-c0bcaff59eaf"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Theophylline</span>", "ID": "55718f53-8d14-4065-861f-3b71b45e689b", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Theophylline", "ParentId": "e5717f91-0327-4821-8d84-8475f7c4bffd"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "23060807-3741-4ef4-a318-8d2fe88d9ed9", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "d026c599-8fad-41c9-aa95-84bd5c5c2b54", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "23060807-3741-4ef4-a318-8d2fe88d9ed9"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>An interaction study in healthy\nsubjects has been performed with febuxostat to evaluate whether the inhibition\nof XO may cause an increase in the theophylline circulating levels as reported\nwith other XO inhibitors. The results of the study showed that the\nco-administration of febuxostat 80\u00a0mg QD with theophylline 400\u00a0mg\nsingle dose has no effect on the pharmacokinetics or safety of theophylline.\nTherefore no special caution is advised when febuxostat 80\u00a0mg and\ntheophylline are given concomitantly. No data is available for febuxostat 120\u00a0mg.</span></p>", "ID": "d8d89d97-8e28-4244-9347-29f31d358955", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>An interaction study in healthy\nsubjects has been performed with febuxostat to evaluate whether the inhibition\nof XO may cause an increase in the theophylline circulating levels as reported\nwith other XO inhibitors. The results of the study showed that the\nco-administration of febuxostat 80\u00a0mg QD with theophylline 400\u00a0mg\nsingle dose has no effect on the pharmacokinetics or safety of theophylline.\nTherefore no special caution is advised when febuxostat 80\u00a0mg and\ntheophylline are given concomitantly. No data is available for febuxostat 120\u00a0mg.</span>", "ID": "5189f52c-0ff3-4d1f-b7ef-d420adc98797", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "An interaction study in healthy subjects has been performed with febuxostat to evaluate whether the inhibition of XO may cause an increase in the theophylline circulating levels as reported with other XO inhibitors. The results of the study showed that the co-administration of febuxostat 80\u00a0mg QD with theophylline 400\u00a0mg single dose has no effect on the pharmacokinetics or safety of theophylline. Therefore no special caution is advised when febuxostat 80\u00a0mg and theophylline are given concomitantly. No data is available for febuxostat 120\u00a0mg.", "ParentId": "d8d89d97-8e28-4244-9347-29f31d358955"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "81b39840-de9d-449c-a915-ff7ee0682b1c", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "cbbe1f6c-b1de-46fe-ad5c-4f355ef556f8", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "81b39840-de9d-449c-a915-ff7ee0682b1c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Naproxen and other inhibitors of\nglucuronidation</span></u></p>", "ID": "d8ef8a41-69c2-44b1-bb3c-a0c23fa0499f", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Naproxen and other inhibitors of\nglucuronidation</span></u>", "ID": "70f8938a-0136-42a0-b0a6-662aa879eff7", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d8ef8a41-69c2-44b1-bb3c-a0c23fa0499f"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Naproxen and other inhibitors of\nglucuronidation</span>", "ID": "b05c5631-6d4a-44d9-980b-e6e04a9c5637", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Naproxen and other inhibitors of glucuronidation", "ParentId": "70f8938a-0136-42a0-b0a6-662aa879eff7"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "24e4ad78-5b83-4b77-b0ce-a332afcae749", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "b2d74f2c-00da-4fb3-b4ff-24360096a473", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "24e4ad78-5b83-4b77-b0ce-a332afcae749"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat metabolism depends on\nUridine Glucuronosyl Transferase (UGT) enzymes. Medicinal products that inhibit\nglucuronidation, such as NSAIDs and probenecid, could in theory affect the\nelimination of febuxostat. In healthy subjects concomitant use of febuxostat\nand naproxen 250\u00a0mg twice daily was associated with an increase in\nfebuxostat exposure (C<sub>max</sub> 28%, AUC 41% and t<sub>1/2</sub> 26%). In\nclinical studies the use of naproxen or other NSAIDs/Cox-2 inhibitors was not\nrelated to any clinically significant increase in adverse events.</span></p>", "ID": "eb530f5a-532e-44ee-abe4-a726c68a40a2", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat metabolism depends on\nUridine Glucuronosyl Transferase (UGT) enzymes. Medicinal products that inhibit\nglucuronidation, such as NSAIDs and probenecid, could in theory affect the\nelimination of febuxostat. In healthy subjects concomitant use of febuxostat\nand naproxen 250\u00a0mg twice daily was associated with an increase in\nfebuxostat exposure (C<sub>max</sub> 28%, AUC 41% and t<sub>1/2</sub> 26%). In\nclinical studies the use of naproxen or other NSAIDs/Cox-2 inhibitors was not\nrelated to any clinically significant increase in adverse events.</span>", "ID": "9523991d-6f6c-459e-bc2d-3ee215cccdb1", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Febuxostat metabolism depends on Uridine Glucuronosyl Transferase (UGT) enzymes. Medicinal products that inhibit glucuronidation, such as NSAIDs and probenecid, could in theory affect the elimination of febuxostat. In healthy subjects concomitant use of febuxostat and naproxen 250\u00a0mg twice daily was associated with an increase in febuxostat exposure (C 28%, AUC 41% and t 26%). In clinical studies the use of naproxen or other NSAIDs/Cox-2 inhibitors was not related to any clinically significant increase in adverse events.", "ParentId": "eb530f5a-532e-44ee-abe4-a726c68a40a2"}, {"Element": "<sub>max</sub>", "ID": "99260acf-8389-4755-bbb9-94f9014b25a3", "Styles": "None", "Classes": "None", "Text": "max", "ParentId": "9523991d-6f6c-459e-bc2d-3ee215cccdb1"}, {"Element": "<sub>1/2</sub>", "ID": "abaded5f-ac29-460d-a4b2-f5b46174f3a3", "Styles": "None", "Classes": "None", "Text": "1/2", "ParentId": "9523991d-6f6c-459e-bc2d-3ee215cccdb1"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "741afa9e-40ce-4539-b21b-cb4b45c8738b", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "58f29a1a-14c3-45fd-902c-eef1688ecd52", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "741afa9e-40ce-4539-b21b-cb4b45c8738b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat can be co-administered\nwith naproxen with no dose adjustment of febuxostat or naproxen being\nnecessary.</span></p>", "ID": "c488ed3b-1084-4674-9be8-6705863b82cb", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat can be co-administered\nwith naproxen with no dose adjustment of febuxostat or naproxen being\nnecessary.</span>", "ID": "2aa45130-abb6-4b3b-af3b-f154f0682c3a", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Febuxostat can be co-administered with naproxen with no dose adjustment of febuxostat or naproxen being necessary.", "ParentId": "c488ed3b-1084-4674-9be8-6705863b82cb"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "a65d7d08-c3db-453a-b8ed-8e5c89ac6055", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "07ad556d-34f9-4184-b8f9-f570a1957d5a", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "a65d7d08-c3db-453a-b8ed-8e5c89ac6055"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Inducers of glucuronidation</span></u></p>", "ID": "0d2b4963-8b11-43b3-a416-f1e36d4f1882", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Inducers of glucuronidation</span></u>", "ID": "5133f44f-135a-4284-af4c-802c0d186abf", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0d2b4963-8b11-43b3-a416-f1e36d4f1882"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Inducers of glucuronidation</span>", "ID": "4015043f-09cc-41b7-83f3-6a78f7f08fd6", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Inducers of glucuronidation", "ParentId": "5133f44f-135a-4284-af4c-802c0d186abf"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "eb04eabb-6e4a-4ab4-96d0-fea8e53c5d99", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "ae604eb2-4b1c-49c3-a9cf-edcf17052c35", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "eb04eabb-6e4a-4ab4-96d0-fea8e53c5d99"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Potent inducers of UGT enzymes\nmight possibly lead to increased metabolism and decreased efficacy of\nfebuxostat. Monitoring of serum uric acid is therefore recommended 1-2 weeks\nafter start of treatment with a potent inducer of glucuronidation. Conversely,\ncessation of treatment of an inducer might lead to increased plasma levels of\nfebuxostat.</span></p>", "ID": "98db21c1-d4bb-473b-98bb-4d6cd768ee7e", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Potent inducers of UGT enzymes\nmight possibly lead to increased metabolism and decreased efficacy of\nfebuxostat. Monitoring of serum uric acid is therefore recommended 1-2 weeks\nafter start of treatment with a potent inducer of glucuronidation. Conversely,\ncessation of treatment of an inducer might lead to increased plasma levels of\nfebuxostat.</span>", "ID": "0caebb9c-51b5-4dc7-9101-ecf57074e703", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Potent inducers of UGT enzymes might possibly lead to increased metabolism and decreased efficacy of febuxostat. Monitoring of serum uric acid is therefore recommended 1-2 weeks after start of treatment with a potent inducer of glucuronidation. Conversely, cessation of treatment of an inducer might lead to increased plasma levels of febuxostat.", "ParentId": "98db21c1-d4bb-473b-98bb-4d6cd768ee7e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "cce43137-9eff-4e1e-b927-cf0478e24512", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "1de9e970-8917-4311-9de6-aed7b39e43b2", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "cce43137-9eff-4e1e-b927-cf0478e24512"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Colchicine/indometacin/hydrochlorothiazide/warfarin</span></u></p>", "ID": "fe3897c6-609a-4708-b48b-75f29778e533", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Colchicine/indometacin/hydrochlorothiazide/warfarin</span></u>", "ID": "c9ecb7cb-1d35-41f4-86c2-2277f6cf3b96", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "fe3897c6-609a-4708-b48b-75f29778e533"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Colchicine/indometacin/hydrochlorothiazide/warfarin</span>", "ID": "4b8b0140-7586-43c6-a943-879947ec49fe", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Colchicine/indometacin/hydrochlorothiazide/warfarin", "ParentId": "c9ecb7cb-1d35-41f4-86c2-2277f6cf3b96"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "d3198a4f-e119-4db5-8b43-101fd2449ecc", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "f1f96509-b8e1-4196-b6e3-adc541c37426", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "d3198a4f-e119-4db5-8b43-101fd2449ecc"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat can be co-administered\nwith colchicine or indomethacin with no dose adjustment of febuxostat or the\nco-administered active substance being necessary.</span></p>", "ID": "8a5422ca-08a2-4d2e-959b-429e487c9b31", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat can be co-administered\nwith colchicine or indomethacin with no dose adjustment of febuxostat or the\nco-administered active substance being necessary.</span>", "ID": "2c423ef9-324d-446f-94dc-81e13b9fb490", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Febuxostat can be co-administered with colchicine or indomethacin with no dose adjustment of febuxostat or the co-administered active substance being necessary.", "ParentId": "8a5422ca-08a2-4d2e-959b-429e487c9b31"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "2dd6c134-76b7-4705-87b5-7b57a29f7bc5", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "01e01d56-9914-43dc-80f5-347f90d40173", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "2dd6c134-76b7-4705-87b5-7b57a29f7bc5"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>No dose adjustment is necessary for\nfebuxostat when administered with hydrochlorothiazide.</span></p>", "ID": "14ac4aae-525f-4aa6-9def-8a9a91ddfa10", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>No dose adjustment is necessary for\nfebuxostat when administered with hydrochlorothiazide.</span>", "ID": "396f9784-4fa2-4b13-8a39-c92bc029b019", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "No dose adjustment is necessary for febuxostat when administered with hydrochlorothiazide.", "ParentId": "14ac4aae-525f-4aa6-9def-8a9a91ddfa10"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "800be730-6062-40c9-9a48-4284587e7e8b", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "6b09c6c9-9ba8-4baa-85a2-19b800d32943", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "800be730-6062-40c9-9a48-4284587e7e8b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>No dose adjustment is necessary for\nwarfarin when administered with febuxostat. Administration of febuxostat (80\u00a0mg\nor 120\u00a0mg once daily) with warfarin had no effect on the pharmacokinetics\nof warfarin in healthy subjects. INR and Factor VII activity were also not\naffected by the co-administration of febuxostat.</span></p>", "ID": "09d438d4-f700-41be-8760-8505b515bf01", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>No dose adjustment is necessary for\nwarfarin when administered with febuxostat. Administration of febuxostat (80\u00a0mg\nor 120\u00a0mg once daily) with warfarin had no effect on the pharmacokinetics\nof warfarin in healthy subjects. INR and Factor VII activity were also not\naffected by the co-administration of febuxostat.</span>", "ID": "b1fdea45-33de-43c8-8465-066bee1510bf", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "No dose adjustment is necessary for warfarin when administered with febuxostat. Administration of febuxostat (80\u00a0mg or 120\u00a0mg once daily) with warfarin had no effect on the pharmacokinetics of warfarin in healthy subjects. INR and Factor VII activity were also not affected by the co-administration of febuxostat.", "ParentId": "09d438d4-f700-41be-8760-8505b515bf01"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "148d9029-bf68-4390-af1d-cddfb9f521ae", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "1c848237-db8c-425e-a211-feedee7f873c", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "148d9029-bf68-4390-af1d-cddfb9f521ae"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Desipramine/CYP2D6 substrates</span></u></p>", "ID": "012d9796-ff3a-4830-aa62-53a379f0ec37", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Desipramine/CYP2D6 substrates</span></u>", "ID": "dfc8260a-d7ec-4923-b387-5e5968fdf92b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "012d9796-ff3a-4830-aa62-53a379f0ec37"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Desipramine/CYP2D6 substrates</span>", "ID": "0a47dd56-7eb9-4c9a-8b82-dc1b7b91db71", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Desipramine/CYP2D6 substrates", "ParentId": "dfc8260a-d7ec-4923-b387-5e5968fdf92b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "d19c84b7-783d-410f-8704-5111f6a78e8a", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "4b307923-b488-4c61-9489-6fc7c2147bdd", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "d19c84b7-783d-410f-8704-5111f6a78e8a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat was shown to be a weak\ninhibitor of CYP2D6 <i>in vitro. </i>In a study in healthy subjects, 120\u00a0mg\nfebuxostat QD resulted in a mean 22% increase in AUC of desipramine, a CYP2D6\nsubstrate indicating a potential weak inhibitory effect of febuxostat on the\nCYP2D6 enzyme <i>in vivo</i>. Thus, co-administration of febuxostat with other CYP2D6\nsubstrates is not expected to require any dose adjustment for those compounds.</span></p>", "ID": "1c5b64a3-9c3d-4ab4-81af-c59a877c73ee", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat was shown to be a weak\ninhibitor of CYP2D6 <i>in vitro. </i>In a study in healthy subjects, 120\u00a0mg\nfebuxostat QD resulted in a mean 22% increase in AUC of desipramine, a CYP2D6\nsubstrate indicating a potential weak inhibitory effect of febuxostat on the\nCYP2D6 enzyme <i>in vivo</i>. Thus, co-administration of febuxostat with other CYP2D6\nsubstrates is not expected to require any dose adjustment for those compounds.</span>", "ID": "40d12962-42fc-481a-989d-315672f32d93", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Febuxostat was shown to be a weak inhibitor of CYP2D6 In a study in healthy subjects, 120\u00a0mg febuxostat QD resulted in a mean 22% increase in AUC of desipramine, a CYP2D6 substrate indicating a potential weak inhibitory effect of febuxostat on the CYP2D6 enzyme . Thus, co-administration of febuxostat with other CYP2D6 substrates is not expected to require any dose adjustment for those compounds.", "ParentId": "1c5b64a3-9c3d-4ab4-81af-c59a877c73ee"}, {"Element": "<i>in vitro. </i>", "ID": "7fca4dab-a95b-42bd-9e40-97a38cec2e18", "Styles": "None", "Classes": "None", "Text": "in vitro. ", "ParentId": "40d12962-42fc-481a-989d-315672f32d93"}, {"Element": "<i>in vivo</i>", "ID": "6399c4ff-689c-46c9-a4b5-638382f198b6", "Styles": "None", "Classes": "None", "Text": "in vivo", "ParentId": "40d12962-42fc-481a-989d-315672f32d93"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "f6226f0b-de3a-4995-8b2a-11cc6d3ed940", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "7371a4f5-b5ce-4064-899a-ea806adecc8f", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "f6226f0b-de3a-4995-8b2a-11cc6d3ed940"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Antacids</span></u></p>", "ID": "8ed963d2-74cf-456f-8d30-affb8c88692d", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Antacids</span></u>", "ID": "9598be70-5432-4534-bfe8-ff3b3b888dbe", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "8ed963d2-74cf-456f-8d30-affb8c88692d"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Antacids</span>", "ID": "1fbd4167-b15d-4c7e-a471-eec883782977", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Antacids", "ParentId": "9598be70-5432-4534-bfe8-ff3b3b888dbe"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "72333a7b-bd83-4a58-ad73-f97deef51fe3", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "0ce532e0-beab-4ade-8555-3ad4f1a57a73", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "72333a7b-bd83-4a58-ad73-f97deef51fe3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Concomitant ingestion of an antacid\ncontaining magnesium hydroxide and aluminium hydroxide has been shown to delay\nabsorption of febuxostat (approximately 1 hour) and to cause a 32% decrease in C<sub>max</sub>,\nbut no significant change in AUC was observed. Therefore, febuxostat may be\ntaken without regard to antacid use.</span></p>", "ID": "d2eb83d9-b4d3-41be-b291-a5879e7d147c", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Concomitant ingestion of an antacid\ncontaining magnesium hydroxide and aluminium hydroxide has been shown to delay\nabsorption of febuxostat (approximately 1 hour) and to cause a 32% decrease in C<sub>max</sub>,\nbut no significant change in AUC was observed. Therefore, febuxostat may be\ntaken without regard to antacid use.</span>", "ID": "cbaf2bf5-a9e3-40fd-a0ae-66b4d4b748ed", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Concomitant ingestion of an antacid containing magnesium hydroxide and aluminium hydroxide has been shown to delay absorption of febuxostat (approximately 1 hour) and to cause a 32% decrease in C, but no significant change in AUC was observed. Therefore, febuxostat may be taken without regard to antacid use.", "ParentId": "d2eb83d9-b4d3-41be-b291-a5879e7d147c"}, {"Element": "<sub>max</sub>", "ID": "e5e351c2-4b96-4cd7-97ce-4003a4b2ef82", "Styles": "None", "Classes": "None", "Text": "max", "ParentId": "cbaf2bf5-a9e3-40fd-a0ae-66b4d4b748ed"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "bacd6cc0-7e84-425f-9576-8715a85bad81", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "08b27c2e-24cf-499b-a509-5a40f7d34869", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "bacd6cc0-7e84-425f-9576-8715a85bad81"}, {"Element": "<h1 style=\"margin-right:3.1pt\"><span lang=\"EN-GB\">4.6\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Fertility, pregnancy\nand lactation</span></h1>", "ID": "eeae2761-6770-46fd-bbc1-5f5cdc4ade4c", "Styles": "margin-right:3.1pt", "Classes": "None", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\">4.6\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Fertility, pregnancy\nand lactation</span>", "ID": "e60e8c88-501a-42fd-9895-3fb8bbccab3b", "Styles": "None", "Classes": "None", "Text": "4.6\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Fertility, pregnancy and lactation", "ParentId": "eeae2761-6770-46fd-bbc1-5f5cdc4ade4c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "30151056-606f-4b0d-a00d-b113ec9b69a4", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "607df2eb-9b87-40ee-9ec4-fdd4e917340e", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "30151056-606f-4b0d-a00d-b113ec9b69a4"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Pregnancy</span></u></p>", "ID": "d000b158-d369-40bc-8d4b-89a24cb138d5", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Pregnancy</span></u>", "ID": "80172ba7-b1b0-48e3-8a25-d9b260575d9f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d000b158-d369-40bc-8d4b-89a24cb138d5"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Pregnancy</span>", "ID": "4814a483-1ed9-4309-8133-d716c9936330", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Pregnancy", "ParentId": "80172ba7-b1b0-48e3-8a25-d9b260575d9f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "5dc61cba-0d12-409f-a6e3-6f184f8c1a19", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "183d05d8-6964-4036-8cdf-86cd3836e869", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "5dc61cba-0d12-409f-a6e3-6f184f8c1a19"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Data on a very limited number of\nexposed pregnancies have not indicated any adverse effects of febuxostat on\npregnancy or on the health of the foetus/new born child. Animal studies do not\nindicate direct or indirect harmful effects with respect to pregnancy,\nembryonal/foetal development or parturition (see section 5.3). The potential\nrisk for human is unknown. Febuxostat should not be used during pregnancy.</span></p>", "ID": "c454b9e1-ad17-4627-82d7-e35318a950a0", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Data on a very limited number of\nexposed pregnancies have not indicated any adverse effects of febuxostat on\npregnancy or on the health of the foetus/new born child. Animal studies do not\nindicate direct or indirect harmful effects with respect to pregnancy,\nembryonal/foetal development or parturition (see section 5.3). The potential\nrisk for human is unknown. Febuxostat should not be used during pregnancy.</span>", "ID": "84137ca5-fd9a-437c-8db7-4bacf71ee9db", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Data on a very limited number of exposed pregnancies have not indicated any adverse effects of febuxostat on pregnancy or on the health of the foetus/new born child. Animal studies do not indicate direct or indirect harmful effects with respect to pregnancy, embryonal/foetal development or parturition (see section 5.3). The potential risk for human is unknown. Febuxostat should not be used during pregnancy.", "ParentId": "c454b9e1-ad17-4627-82d7-e35318a950a0"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "b380d88b-9427-4615-84b6-80a8a0c18405", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "46554cb5-416d-4599-96a1-263bca810312", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "b380d88b-9427-4615-84b6-80a8a0c18405"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Breast-feeding</span></u></p>", "ID": "18808ce9-4acc-4d4d-b7ee-90c41f215dbb", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Breast-feeding</span></u>", "ID": "7adc9724-bb4e-45a9-a02a-b1bfff46c206", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "18808ce9-4acc-4d4d-b7ee-90c41f215dbb"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Breast-feeding</span>", "ID": "aaf7eb37-7e38-4ba6-b03e-74a94670e552", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Breast-feeding", "ParentId": "7adc9724-bb4e-45a9-a02a-b1bfff46c206"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "a05d1699-4bfa-441a-bfb8-a99f66710bf6", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "a6c561cb-1455-4123-b449-b4ccb26caba7", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "a05d1699-4bfa-441a-bfb8-a99f66710bf6"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>It is unknown whether febuxostat is\nexcreted in human breast milk. Animal studies have shown excretion of this\nactive substance in breast milk and an impaired development of suckling pups. A\nrisk to a suckling infant cannot be excluded. Febuxostat should not be used\nwhile breast-feeding.</span></p>", "ID": "79353951-a9bb-45bc-b57f-ea432fa9f2ed", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>It is unknown whether febuxostat is\nexcreted in human breast milk. Animal studies have shown excretion of this\nactive substance in breast milk and an impaired development of suckling pups. A\nrisk to a suckling infant cannot be excluded. Febuxostat should not be used\nwhile breast-feeding.</span>", "ID": "d894ca26-43bd-4fe4-a5d8-8ecbb98f5287", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "It is unknown whether febuxostat is excreted in human breast milk. Animal studies have shown excretion of this active substance in breast milk and an impaired development of suckling pups. A risk to a suckling infant cannot be excluded. Febuxostat should not be used while breast-feeding.", "ParentId": "79353951-a9bb-45bc-b57f-ea432fa9f2ed"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "9cb03f0e-8685-4037-b227-4749201f2c92", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "70605330-e5ca-4690-b1b7-73eb7360de17", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "9cb03f0e-8685-4037-b227-4749201f2c92"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Fertility</span></u></p>", "ID": "b9865dcb-a2c2-4084-b874-d3b508fab0f0", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Fertility</span></u>", "ID": "1081201a-b4cf-43d6-a694-fa6fdd3a39dd", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b9865dcb-a2c2-4084-b874-d3b508fab0f0"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Fertility</span>", "ID": "a551802a-77e5-401a-ac16-328563430462", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Fertility", "ParentId": "1081201a-b4cf-43d6-a694-fa6fdd3a39dd"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "7e9fafa6-bb2e-4cea-aa57-99574d45946e", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "9ab027ec-2084-4559-aae6-0f5675539eab", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "7e9fafa6-bb2e-4cea-aa57-99574d45946e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>In animals, reproduction studies up\nto 48\u00a0mg/kg/day showed no dose-dependent adverse effects on fertility (see\nsection 5.3). The effect of febuxostat on human fertility is unknown.</span></p>", "ID": "315f3ba3-2c75-476a-bc8c-6fbb73deaae4", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>In animals, reproduction studies up\nto 48\u00a0mg/kg/day showed no dose-dependent adverse effects on fertility (see\nsection 5.3). The effect of febuxostat on human fertility is unknown.</span>", "ID": "606d1eed-ac72-440d-97a2-7bede02fd8ed", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "In animals, reproduction studies up to 48\u00a0mg/kg/day showed no dose-dependent adverse effects on fertility (see section 5.3). The effect of febuxostat on human fertility is unknown.", "ParentId": "315f3ba3-2c75-476a-bc8c-6fbb73deaae4"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "35434dfc-1a95-4503-a597-9972b6522239", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "33971772-80e8-4ac4-8e5d-3219e8aed9b6", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "35434dfc-1a95-4503-a597-9972b6522239"}, {"Element": "<h1 style=\"margin-right:3.1pt\"><span lang=\"EN-GB\">4.7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Effects on ability to\ndrive and use machines</span></h1>", "ID": "ea673cb3-1f21-4678-a8ad-4cd693ee7b13", "Styles": "margin-right:3.1pt", "Classes": "None", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\">4.7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Effects on ability to\ndrive and use machines</span>", "ID": "8dce67b4-f863-488a-8758-2e851e9b763d", "Styles": "None", "Classes": "None", "Text": "4.7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Effects on ability to drive and use machines", "ParentId": "ea673cb3-1f21-4678-a8ad-4cd693ee7b13"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "a1bd27b8-a003-4705-8b80-da9d794aa1be", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "dccc2b85-c5a8-4ad6-b0f2-d9b4ebab477a", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "a1bd27b8-a003-4705-8b80-da9d794aa1be"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Somnolence, dizziness, paraesthesia\nand blurred vision have been reported with the use of febuxostat. Patients\nshould exercise caution before driving, using machinery or participating in\ndangerous activities until they are reasonably certain that febuxostat does not\nadversely affect performance.</span></p>", "ID": "3b1b7af0-a973-436a-bad6-d76805cbf191", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Somnolence, dizziness, paraesthesia\nand blurred vision have been reported with the use of febuxostat. Patients\nshould exercise caution before driving, using machinery or participating in\ndangerous activities until they are reasonably certain that febuxostat does not\nadversely affect performance.</span>", "ID": "ecbbab18-ad66-4dc0-abf8-5146e1795a9b", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Somnolence, dizziness, paraesthesia and blurred vision have been reported with the use of febuxostat. Patients should exercise caution before driving, using machinery or participating in dangerous activities until they are reasonably certain that febuxostat does not adversely affect performance.", "ParentId": "3b1b7af0-a973-436a-bad6-d76805cbf191"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "4ea27ea0-a5c4-4f06-a19a-7dce270e13ad", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "5395c4fd-4fdb-4509-be7f-5d40db988ba9", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "4ea27ea0-a5c4-4f06-a19a-7dce270e13ad"}, {"Element": "<h1 style=\"margin-right:3.1pt\"><span lang=\"EN-GB\">4.8\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Undesirable effects</span></h1>", "ID": "9fc61cba-4aa0-450f-8138-6c384f347881", "Styles": "margin-right:3.1pt", "Classes": "None", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\">4.8\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Undesirable effects</span>", "ID": "2eed5aab-0e95-4416-bd39-e6aabfceed0d", "Styles": "None", "Classes": "None", "Text": "4.8\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Undesirable effects", "ParentId": "9fc61cba-4aa0-450f-8138-6c384f347881"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "4e8bde5d-381d-4a8a-93ae-8a1a1badc164", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "88e846e7-1093-43a3-afb6-09cf38dd3b82", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "4e8bde5d-381d-4a8a-93ae-8a1a1badc164"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Summary of the safety profile</span></u></p>", "ID": "64f3cdd1-bc78-4888-8fe1-fc8896a222d7", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Summary of the safety profile</span></u>", "ID": "cf4cf147-3acb-43e3-b204-2ceff7bfb973", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "64f3cdd1-bc78-4888-8fe1-fc8896a222d7"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Summary of the safety profile</span>", "ID": "dc9d9270-d48e-4d03-83ed-cf8483592f64", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Summary of the safety profile", "ParentId": "cf4cf147-3acb-43e3-b204-2ceff7bfb973"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "0413e519-dcae-4169-912e-d9793ee7c8dc", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "4ce54857-a82d-4688-8369-0d7fa57e3e62", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "0413e519-dcae-4169-912e-d9793ee7c8dc"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The most commonly reported adverse\nreactions in clinical trials (4,072 subjects treated at least with a dose from\n10\u00a0mg to 300\u00a0mg) and post-marketing experience in gout patients are\ngout flares, liver function abnormalities, diarrhoea, nausea, headache, rash\nand oedema. These adverse reactions were mostly mild or moderate in severity.\nRare serious hypersensitivity reactions to febuxostat, some of which were\nassociated to systemic symptoms, have occurred in the post-marketing experience.</span></p>", "ID": "ba63405b-eb95-4de9-a2f8-68047b4d6244", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The most commonly reported adverse\nreactions in clinical trials (4,072 subjects treated at least with a dose from\n10\u00a0mg to 300\u00a0mg) and post-marketing experience in gout patients are\ngout flares, liver function abnormalities, diarrhoea, nausea, headache, rash\nand oedema. These adverse reactions were mostly mild or moderate in severity.\nRare serious hypersensitivity reactions to febuxostat, some of which were\nassociated to systemic symptoms, have occurred in the post-marketing experience.</span>", "ID": "70214159-0015-40d6-b967-5cba01d7ce12", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "The most commonly reported adverse reactions in clinical trials (4,072 subjects treated at least with a dose from 10\u00a0mg to 300\u00a0mg) and post-marketing experience in gout patients are gout flares, liver function abnormalities, diarrhoea, nausea, headache, rash and oedema. These adverse reactions were mostly mild or moderate in severity. Rare serious hypersensitivity reactions to febuxostat, some of which were associated to systemic symptoms, have occurred in the post-marketing experience.", "ParentId": "ba63405b-eb95-4de9-a2f8-68047b4d6244"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "28eb5957-282d-42a1-b9ec-fe9714ab0813", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "5a4753ac-cfea-4a31-bcc9-e9a33568af65", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "28eb5957-282d-42a1-b9ec-fe9714ab0813"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Tabulated list of adverse reactions</span></u></p>", "ID": "93aa79d9-6c23-4543-be64-ba37a9311b4b", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Tabulated list of adverse reactions</span></u>", "ID": "5f226721-a430-405f-8f3f-dfd5d64b207c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "93aa79d9-6c23-4543-be64-ba37a9311b4b"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Tabulated list of adverse reactions</span>", "ID": "3b488aa5-9e71-4ce3-84e3-c167a4019aba", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Tabulated list of adverse reactions", "ParentId": "5f226721-a430-405f-8f3f-dfd5d64b207c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "99b53875-d43e-41a6-917a-87896b716322", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "ebe236ca-d313-4304-ac24-92d04c9e3bed", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "99b53875-d43e-41a6-917a-87896b716322"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common (\u22651/100 to &lt;1/10),\nuncommon (\u22651/1,000 to &lt;1/100) and rare (\u22651/10,000 to\n&lt;1/1,000) adverse reactions occurring in patients treated with febuxostat\nare listed below.</span></p>", "ID": "6815ba39-6759-4106-878a-0fa25c7dbd0c", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common (\u22651/100 to &lt;1/10),\nuncommon (\u22651/1,000 to &lt;1/100) and rare (\u22651/10,000 to\n&lt;1/1,000) adverse reactions occurring in patients treated with febuxostat\nare listed below.</span>", "ID": "b881a825-87e5-4bfa-a89f-2ec9a0a476d2", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Common (\u22651/100 to <1/10), uncommon (\u22651/1,000 to <1/100) and rare (\u22651/10,000 to <1/1,000) adverse reactions occurring in patients treated with febuxostat are listed below.", "ParentId": "6815ba39-6759-4106-878a-0fa25c7dbd0c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The frequencies are based on studies\nand post-marketing experience in gout patients.</span></p>", "ID": "87d2a4d3-6dd7-48ef-a10d-e92d6cba85da", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The frequencies are based on studies\nand post-marketing experience in gout patients.</span>", "ID": "2c9de285-0752-4e86-8c43-4c9558e57b8c", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "The frequencies are based on studies and post-marketing experience in gout patients.", "ParentId": "87d2a4d3-6dd7-48ef-a10d-e92d6cba85da"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "8c130e17-8e3e-40cc-a12d-77892ade9e6d", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "1dc2bfbb-7f50-4863-857b-dec95f6619c0", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "8c130e17-8e3e-40cc-a12d-77892ade9e6d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Within each frequency grouping,\nadverse reactions are presented in order of decreasing seriousness.</span></p>", "ID": "5216afb2-b2a6-4276-bd1f-602713551056", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Within each frequency grouping,\nadverse reactions are presented in order of decreasing seriousness.</span>", "ID": "2797a498-2d4a-4a22-82d8-eb4bbfdbcd83", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Within each frequency grouping, adverse reactions are presented in order of decreasing seriousness.", "ParentId": "5216afb2-b2a6-4276-bd1f-602713551056"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "3d4f7c21-b6c4-44f8-aa62-174422259237", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "5fc47edc-b320-476a-8fef-fc232829c9d4", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "3d4f7c21-b6c4-44f8-aa62-174422259237"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;page-break-after:avoid;text-autospace:none\"><i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Table 1: Adverse\nreactions in combined phase 3, long-term extension studies and post-marketing\nexperience in gout patients.</span></i></p>", "ID": "fdc24739-6a18-4f14-8de6-46f2426b0c08", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;page-break-after:avoid;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Table 1: Adverse\nreactions in combined phase 3, long-term extension studies and post-marketing\nexperience in gout patients.</span></i>", "ID": "9f697877-20f4-400d-afa9-dddd679b667b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "fdc24739-6a18-4f14-8de6-46f2426b0c08"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Table 1: Adverse\nreactions in combined phase 3, long-term extension studies and post-marketing\nexperience in gout patients.</span>", "ID": "cd252e3e-d609-476a-9b56-9d99b2d111f7", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Table 1: Adverse reactions in combined phase 3, long-term extension studies and post-marketing experience in gout patients.", "ParentId": "9f697877-20f4-400d-afa9-dddd679b667b"}, {"Element": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"margin-left:.25pt;border-collapse:collapse\" width=\"624\">\n<tr>\n<td style=\"width:163.05pt;border:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"217\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;page-break-after:avoid;text-autospace:\n  none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Blood and\n  lymphatic system</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:normal;page-break-after:avoid;text-autospace:\n  none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>disorders</span></p>\n</td>\n<td style=\"width:304.75pt;border:solid black 1.0pt;\n  border-left:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;page-break-after:avoid;text-autospace:\n  none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;page-break-after:avoid;text-autospace:\n  none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Pancytopenia,\n  <span style=\"color:black\">thrombocytopenia, agranulocytosis*</span></span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:163.05pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"217\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Immune system\n  disorders</span></p>\n</td>\n<td style=\"width:304.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Anaphylactic\n  reaction*, drug hypersensitivity*</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:163.05pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"217\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Endocrine disorders</span></p>\n</td>\n<td style=\"width:304.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Blood thyroid stimulating\n  hormone increased</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:163.05pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"217\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Eye disorders</span></p>\n</td>\n<td style=\"width:304.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Blurred vision</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:163.05pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"217\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Metabolism and\n  nutrition</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>disorders</span></p>\n</td>\n<td style=\"width:304.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common***</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Gout flares</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.25pt;margin-right:31.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Diabetes mellitus,\n  hyperlipidemia, decrease appetite, weight increase</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.45pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Weight decrease,\n  increase appetite, anorexia</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:163.05pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"217\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Psychiatric disorders</span></p>\n</td>\n<td style=\"width:304.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Libido decreased,\n  insomnia</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Nervousness</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:163.05pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"217\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Nervous system\n  disorders</span></p>\n</td>\n<td style=\"width:304.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Headache</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:16.8pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.7pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Dizziness,\n  paraesthesia, hemiparesis, somnolence, altered taste, hypoaesthesia, hyposmia</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:163.05pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"217\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Ear and labyrinth disorders</span></p>\n</td>\n<td style=\"width:304.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Tinnitus</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:163.05pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"217\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Cardiac disorders</span></p>\n</td>\n<td style=\"width:304.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:244.6pt;margin-bottom:\n  0in;margin-left:5.0pt;text-align:justify;line-height:12.3pt;text-autospace:\n  none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:4.4pt;margin-bottom:\n  0in;margin-left:5.0pt;text-align:justify;line-height:normal;text-autospace:\n  none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Atrial\n  fibrillation, palpitations, ECG abnormal, left bundle branch block (see\n  section Tumor Lysis Syndrome), sinus tachycardia (see section Tumor Lysis\n  Syndrome)</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:163.05pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"217\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Vascular disorders</span></p>\n</td>\n<td style=\"width:304.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Hypertension,\n  flushing, hot flush, haemorrhage (see section Tumor Lysis Syndrome)</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:163.05pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"217\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.4pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Respiratory system\n  disorders</span></p>\n</td>\n<td style=\"width:304.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.4pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Dyspnoea, bronchitis,\n  upper respiratory tract infection, cough</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:163.05pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"217\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.4pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Gastrointestinal\n  disorders</span></p>\n</td>\n<td style=\"width:304.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.4pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Diarrhoea**, nausea</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon:</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:6.15pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Abdominal pain,\n  abdominal distension, gastro-oesophageal reflux disease, vomiting, dry mouth,\n  dyspepsia, constipation, frequent stools, flatulence, gastrointestinal\n  discomfort</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Pancreatitis, mouth\n  ulceration</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:163.05pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"217\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Hepato-biliary\n  disorders</span></p>\n</td>\n<td style=\"width:304.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:159.3pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.7pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Liver function\n  abnormalities** <u>Uncommon</u></span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.45pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Cholelithiasis</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Hepatitis, jaundice*,\n  liver injury*</span></p>\n</td>\n</tr>\n<tr style=\"height:151.95pt\">\n<td style=\"width:163.05pt;border-top:none;border-left:\n  solid black 1.0pt;border-bottom:none;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in;height:151.95pt\" valign=\"top\" width=\"217\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.4pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Skin and subcutaneous\n  tissue</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>disorders</span></p>\n</td>\n<td style=\"width:304.75pt;border:none;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in;height:151.95pt\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.4pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.15pt;margin-right:42.6pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rash (including\n  various types of rash reported with lower frequencies, see below)</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:22.6pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.7pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Dermatitis, urticaria,\n  pruritus, skin discolouration, skin lesion, petechiae, rash macular, rash\n  maculopapular, rash papular</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.4pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.15pt;margin-right:35.1pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Toxic epidermal\n  necrolysis*, Stevens-Johnson Syndrome*, angioedema*, drug reaction with\n  eosinophilia and systemic symptoms*, generalized rash (serious)*, erythema,\n  exfoliative rash, rash follicular, rash vesicular, rash pustular, rash\n  pruritic*, rash erythematous, rash morbillifom, alopecia, hyperhidrosis</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:163.05pt;border:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"217\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Musculoskeletal and\n  connective</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>tissue disorders</span></p>\n</td>\n<td style=\"width:304.75pt;border:solid black 1.0pt;\n  border-left:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.25pt;margin-right:35.4pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Arthralgia, arthritis,\n  myalgia, musculoskeletal pain, muscle weakness, muscle spasm, muscle\n  tightness, bursitis</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rhabdomyolysis*, joint\n  stiffness, musculoskeletal stiffness</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:163.05pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"217\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Renal and urinary\n  disorders</span></p>\n</td>\n<td style=\"width:304.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Renal failure,\n  nephrolithiasis, haematuria, pollakiuria, proteinuria</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Tubulointerstitial\n  nephritis*, micturition urgency</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:163.05pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"217\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Reproductive system\n  and breast</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>disorder</span></p>\n</td>\n<td style=\"width:304.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Erectile dysfunction</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:163.05pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"217\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>General disorders and</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>administration site\n  conditions</span></p>\n</td>\n<td style=\"width:304.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Oedema</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Fatigue, chest pain,\n  chest discomfort</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Thirst</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:163.05pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"217\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Investigations</span></p>\n</td>\n<td style=\"width:304.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:11.95pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.7pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Blood amylase\n  increase, platelet count decrease, WBC decrease, lymphocyte count decrease,\n  blood creatine increase, blood creatinine increase, haemoglobin decrease,\n  blood urea increase, blood triglycerides increase, blood cholesterol\n  increase, haematocritic decrease, blood lactate dehydrogenase increased,\n  blood potassium increase</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:21.05pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.7pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Blood glucose\n  increased, activated partial thromboplastin time prolonged, red blood cell\n  count decrease, blood alkaline phosphatase increase, blood creatine\n  phosphokinase increase*</span></p>\n</td>\n</tr>\n</table>", "ID": "14402be6-54ec-445c-8aba-e8faa2f92a9f", "Styles": "margin-left:.25pt;border-collapse:collapse", "Classes": "['MsoNormalTable']", "Text": "                    ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<tr>\n<td style=\"width:163.05pt;border:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"217\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;page-break-after:avoid;text-autospace:\n  none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Blood and\n  lymphatic system</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:normal;page-break-after:avoid;text-autospace:\n  none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>disorders</span></p>\n</td>\n<td style=\"width:304.75pt;border:solid black 1.0pt;\n  border-left:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;page-break-after:avoid;text-autospace:\n  none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;page-break-after:avoid;text-autospace:\n  none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Pancytopenia,\n  <span style=\"color:black\">thrombocytopenia, agranulocytosis*</span></span></p>\n</td>\n</tr>", "ID": "7b1e5ea4-44ef-4554-96df-43b8537a3c52", "Styles": "None", "Classes": "None", "Text": "   ", "ParentId": "14402be6-54ec-445c-8aba-e8faa2f92a9f"}, {"Element": "<td style=\"width:163.05pt;border:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"217\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;page-break-after:avoid;text-autospace:\n  none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Blood and\n  lymphatic system</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:normal;page-break-after:avoid;text-autospace:\n  none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>disorders</span></p>\n</td>", "ID": "15bd6061-10a2-4e19-a267-d7df2700b987", "Styles": "width:163.05pt;border:solid black 1.0pt;\n  padding:0in 0in 0in 0in", "Classes": "None", "Text": "   ", "ParentId": "7b1e5ea4-44ef-4554-96df-43b8537a3c52"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;page-break-after:avoid;text-autospace:\n  none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Blood and\n  lymphatic system</span></p>", "ID": "c4c8b780-e0fc-429c-aa06-0e1d26ac0e37", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;page-break-after:avoid;text-autospace:\n  none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "15bd6061-10a2-4e19-a267-d7df2700b987"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Blood and\n  lymphatic system</span>", "ID": "99dad21a-605e-4dac-9fe6-9c4652d04cc4", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Blood and   lymphatic system", "ParentId": "c4c8b780-e0fc-429c-aa06-0e1d26ac0e37"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:normal;page-break-after:avoid;text-autospace:\n  none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>disorders</span></p>", "ID": "1d5dc700-94cd-4f38-a899-a74bfe487afb", "Styles": "margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:normal;page-break-after:avoid;text-autospace:\n  none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "15bd6061-10a2-4e19-a267-d7df2700b987"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>disorders</span>", "ID": "7a913a10-a2f9-4ea7-ba47-4611c932172b", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "disorders", "ParentId": "1d5dc700-94cd-4f38-a899-a74bfe487afb"}, {"Element": "<td style=\"width:304.75pt;border:solid black 1.0pt;\n  border-left:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;page-break-after:avoid;text-autospace:\n  none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;page-break-after:avoid;text-autospace:\n  none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Pancytopenia,\n  <span style=\"color:black\">thrombocytopenia, agranulocytosis*</span></span></p>\n</td>", "ID": "db37ac4e-656b-44ea-8e98-d3c2171fddb9", "Styles": "width:304.75pt;border:solid black 1.0pt;\n  border-left:none;padding:0in 0in 0in 0in", "Classes": "None", "Text": "   ", "ParentId": "7b1e5ea4-44ef-4554-96df-43b8537a3c52"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;page-break-after:avoid;text-autospace:\n  none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>", "ID": "b93b6e48-ad1c-465a-b74a-52577dd5a40d", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;page-break-after:avoid;text-autospace:\n  none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "db37ac4e-656b-44ea-8e98-d3c2171fddb9"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u>", "ID": "4da9ceb0-df1b-438e-b921-fc01e91a9558", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b93b6e48-ad1c-465a-b74a-52577dd5a40d"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span>", "ID": "6f63f7ca-8327-40a9-9a35-78e849b5a852", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Rare", "ParentId": "4da9ceb0-df1b-438e-b921-fc01e91a9558"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;page-break-after:avoid;text-autospace:\n  none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Pancytopenia,\n  <span style=\"color:black\">thrombocytopenia, agranulocytosis*</span></span></p>", "ID": "b86ce4d1-d08e-4bd1-9e85-70700ccc8412", "Styles": "margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;page-break-after:avoid;text-autospace:\n  none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "db37ac4e-656b-44ea-8e98-d3c2171fddb9"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Pancytopenia,\n  <span style=\"color:black\">thrombocytopenia, agranulocytosis*</span></span>", "ID": "ba2b4cbe-dbdf-45fc-8c00-a46ca117f861", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Pancytopenia,   ", "ParentId": "b86ce4d1-d08e-4bd1-9e85-70700ccc8412"}, {"Element": "<span style=\"color:black\">thrombocytopenia, agranulocytosis*</span>", "ID": "ee7e03d1-e743-4568-bef6-1ae891cc8f1c", "Styles": "color:black", "Classes": "None", "Text": "thrombocytopenia, agranulocytosis*", "ParentId": "ba2b4cbe-dbdf-45fc-8c00-a46ca117f861"}, {"Element": "<tr>\n<td style=\"width:163.05pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"217\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Immune system\n  disorders</span></p>\n</td>\n<td style=\"width:304.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Anaphylactic\n  reaction*, drug hypersensitivity*</span></p>\n</td>\n</tr>", "ID": "3b741de4-332a-4a84-abb5-1b3438535c16", "Styles": "None", "Classes": "None", "Text": "   ", "ParentId": "14402be6-54ec-445c-8aba-e8faa2f92a9f"}, {"Element": "<td style=\"width:163.05pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"217\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Immune system\n  disorders</span></p>\n</td>", "ID": "dae8b150-0bc9-4b88-ba2b-8fd9018b739c", "Styles": "width:163.05pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in", "Classes": "None", "Text": "  ", "ParentId": "3b741de4-332a-4a84-abb5-1b3438535c16"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Immune system\n  disorders</span></p>", "ID": "4302df21-79fd-49b8-b35b-a1cf7aae9b5c", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "dae8b150-0bc9-4b88-ba2b-8fd9018b739c"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Immune system\n  disorders</span>", "ID": "9fab3f80-8396-4bb6-ab26-175fd0ecb09f", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Immune system   disorders", "ParentId": "4302df21-79fd-49b8-b35b-a1cf7aae9b5c"}, {"Element": "<td style=\"width:304.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Anaphylactic\n  reaction*, drug hypersensitivity*</span></p>\n</td>", "ID": "0cdfd04d-5fcf-458c-bc91-9f9dad2f5879", "Styles": "width:304.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in", "Classes": "None", "Text": "   ", "ParentId": "3b741de4-332a-4a84-abb5-1b3438535c16"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>", "ID": "b951e54c-bc51-480c-8695-c3e1f4ba1335", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0cdfd04d-5fcf-458c-bc91-9f9dad2f5879"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u>", "ID": "4261462a-2dc8-4f76-ad93-ca15361db327", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b951e54c-bc51-480c-8695-c3e1f4ba1335"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span>", "ID": "9b1d0d20-abe9-42bd-9c63-7dfecccdb42b", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Rare", "ParentId": "4261462a-2dc8-4f76-ad93-ca15361db327"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Anaphylactic\n  reaction*, drug hypersensitivity*</span></p>", "ID": "d8a99d71-b60c-42b7-a828-dfe6967f8699", "Styles": "margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0cdfd04d-5fcf-458c-bc91-9f9dad2f5879"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Anaphylactic\n  reaction*, drug hypersensitivity*</span>", "ID": "e7b54311-d4e7-48b6-b876-300c390d4ace", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Anaphylactic   reaction*, drug hypersensitivity*", "ParentId": "d8a99d71-b60c-42b7-a828-dfe6967f8699"}, {"Element": "<tr>\n<td style=\"width:163.05pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"217\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Endocrine disorders</span></p>\n</td>\n<td style=\"width:304.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Blood thyroid stimulating\n  hormone increased</span></p>\n</td>\n</tr>", "ID": "ad21dff2-573e-4d85-82ac-a3903a66bfca", "Styles": "None", "Classes": "None", "Text": "   ", "ParentId": "14402be6-54ec-445c-8aba-e8faa2f92a9f"}, {"Element": "<td style=\"width:163.05pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"217\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Endocrine disorders</span></p>\n</td>", "ID": "33ac7f26-392f-4130-a7ba-439b76ff750e", "Styles": "width:163.05pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in", "Classes": "None", "Text": "  ", "ParentId": "ad21dff2-573e-4d85-82ac-a3903a66bfca"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Endocrine disorders</span></p>", "ID": "79251ad0-5bb5-45c5-970c-e47366bc6523", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "33ac7f26-392f-4130-a7ba-439b76ff750e"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Endocrine disorders</span>", "ID": "737bd0d3-3fad-4753-b885-30a49c25f2c4", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Endocrine disorders", "ParentId": "79251ad0-5bb5-45c5-970c-e47366bc6523"}, {"Element": "<td style=\"width:304.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Blood thyroid stimulating\n  hormone increased</span></p>\n</td>", "ID": "25ee381c-1c47-451d-89e8-df0ca433968c", "Styles": "width:304.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in", "Classes": "None", "Text": "   ", "ParentId": "ad21dff2-573e-4d85-82ac-a3903a66bfca"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>", "ID": "d01148bd-e3a7-4334-9d3e-a5830e4481a9", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "25ee381c-1c47-451d-89e8-df0ca433968c"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u>", "ID": "28e29e7d-4dea-47d2-8dab-d6232e5d502b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d01148bd-e3a7-4334-9d3e-a5830e4481a9"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span>", "ID": "60235db4-ac79-47a1-b66a-cc4a1f18f692", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Uncommon", "ParentId": "28e29e7d-4dea-47d2-8dab-d6232e5d502b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Blood thyroid stimulating\n  hormone increased</span></p>", "ID": "012104ca-f0d5-44d8-a950-0c72ab2e2ba7", "Styles": "margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "25ee381c-1c47-451d-89e8-df0ca433968c"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Blood thyroid stimulating\n  hormone increased</span>", "ID": "923b4d7e-66ed-4962-add5-dc8e59cf368d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Blood thyroid stimulating   hormone increased", "ParentId": "012104ca-f0d5-44d8-a950-0c72ab2e2ba7"}, {"Element": "<tr>\n<td style=\"width:163.05pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"217\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Eye disorders</span></p>\n</td>\n<td style=\"width:304.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Blurred vision</span></p>\n</td>\n</tr>", "ID": "ad0d0df4-c19c-4a54-a7bb-36f8062d357d", "Styles": "None", "Classes": "None", "Text": "   ", "ParentId": "14402be6-54ec-445c-8aba-e8faa2f92a9f"}, {"Element": "<td style=\"width:163.05pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"217\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Eye disorders</span></p>\n</td>", "ID": "2474bfda-030d-45fd-b6af-2fab329ff3db", "Styles": "width:163.05pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in", "Classes": "None", "Text": "  ", "ParentId": "ad0d0df4-c19c-4a54-a7bb-36f8062d357d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Eye disorders</span></p>", "ID": "2c85a5dd-c525-4ae7-bbc2-80511b5d974f", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "2474bfda-030d-45fd-b6af-2fab329ff3db"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Eye disorders</span>", "ID": "8b1cbb8f-6ebf-4eb4-89a5-ca386195f8d4", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Eye disorders", "ParentId": "2c85a5dd-c525-4ae7-bbc2-80511b5d974f"}, {"Element": "<td style=\"width:304.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Blurred vision</span></p>\n</td>", "ID": "ddd32d89-6d00-4ec7-aec0-b0858ce89186", "Styles": "width:304.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in", "Classes": "None", "Text": "   ", "ParentId": "ad0d0df4-c19c-4a54-a7bb-36f8062d357d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>", "ID": "42c70992-f72f-4db5-9650-cc00d11aa8bd", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ddd32d89-6d00-4ec7-aec0-b0858ce89186"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u>", "ID": "a105aa8e-8fb9-431c-9d96-e469cbb88c61", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "42c70992-f72f-4db5-9650-cc00d11aa8bd"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span>", "ID": "2cb2de61-4d5e-44ba-b5d9-48ff47d31bb9", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Rare", "ParentId": "a105aa8e-8fb9-431c-9d96-e469cbb88c61"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Blurred vision</span></p>", "ID": "70f9266c-2590-4619-848d-b9d73dccd1a4", "Styles": "margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ddd32d89-6d00-4ec7-aec0-b0858ce89186"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Blurred vision</span>", "ID": "9330077e-3311-45c1-8574-7750e466e206", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Blurred vision", "ParentId": "70f9266c-2590-4619-848d-b9d73dccd1a4"}, {"Element": "<tr>\n<td style=\"width:163.05pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"217\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Metabolism and\n  nutrition</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>disorders</span></p>\n</td>\n<td style=\"width:304.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common***</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Gout flares</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.25pt;margin-right:31.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Diabetes mellitus,\n  hyperlipidemia, decrease appetite, weight increase</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.45pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Weight decrease,\n  increase appetite, anorexia</span></p>\n</td>\n</tr>", "ID": "dd9bce5d-ddcd-444b-b567-54732f73e69d", "Styles": "None", "Classes": "None", "Text": "   ", "ParentId": "14402be6-54ec-445c-8aba-e8faa2f92a9f"}, {"Element": "<td style=\"width:163.05pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"217\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Metabolism and\n  nutrition</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>disorders</span></p>\n</td>", "ID": "bdd04b2f-922e-4a26-b7ec-1dc015b5d3bc", "Styles": "width:163.05pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in", "Classes": "None", "Text": "   ", "ParentId": "dd9bce5d-ddcd-444b-b567-54732f73e69d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Metabolism and\n  nutrition</span></p>", "ID": "90d5bd2f-9d8e-475e-a23b-0e5d8b8aed84", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bdd04b2f-922e-4a26-b7ec-1dc015b5d3bc"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Metabolism and\n  nutrition</span>", "ID": "de6d8441-8d69-4e75-a5bf-b257310820c5", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Metabolism and   nutrition", "ParentId": "90d5bd2f-9d8e-475e-a23b-0e5d8b8aed84"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>disorders</span></p>", "ID": "92e39a37-b6b2-4064-acac-7b9c6358bc51", "Styles": "margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bdd04b2f-922e-4a26-b7ec-1dc015b5d3bc"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>disorders</span>", "ID": "6564f88a-446b-4fb9-8cf3-79bdbfcd8754", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "disorders", "ParentId": "92e39a37-b6b2-4064-acac-7b9c6358bc51"}, {"Element": "<td style=\"width:304.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common***</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Gout flares</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.25pt;margin-right:31.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Diabetes mellitus,\n  hyperlipidemia, decrease appetite, weight increase</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.45pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Weight decrease,\n  increase appetite, anorexia</span></p>\n</td>", "ID": "288b216e-d99c-41c1-8c90-9555311916a0", "Styles": "width:304.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in", "Classes": "None", "Text": "       ", "ParentId": "dd9bce5d-ddcd-444b-b567-54732f73e69d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common***</span></u></p>", "ID": "269d52c1-755d-44f3-b814-170045e5199a", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "288b216e-d99c-41c1-8c90-9555311916a0"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common***</span></u>", "ID": "45ed64b9-21b6-43c5-abbe-2b674fb0bb78", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "269d52c1-755d-44f3-b814-170045e5199a"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common***</span>", "ID": "48d136a3-570d-4fbd-bc29-3ea303b609ef", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Common***", "ParentId": "45ed64b9-21b6-43c5-abbe-2b674fb0bb78"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Gout flares</span></p>", "ID": "0ce4b24e-c1b9-4d58-abc4-a9769308013c", "Styles": "margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "288b216e-d99c-41c1-8c90-9555311916a0"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Gout flares</span>", "ID": "92645242-2950-4b59-85d6-713b3f07fef9", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Gout flares", "ParentId": "0ce4b24e-c1b9-4d58-abc4-a9769308013c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>", "ID": "7f583108-9fae-4a85-bee7-a8ae47481c31", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "288b216e-d99c-41c1-8c90-9555311916a0"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u>", "ID": "760dd12c-6e2f-44f4-935d-2365cfce27d9", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "7f583108-9fae-4a85-bee7-a8ae47481c31"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span>", "ID": "46436449-e9b7-4438-afb2-4318b222f842", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Uncommon", "ParentId": "760dd12c-6e2f-44f4-935d-2365cfce27d9"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.25pt;margin-right:31.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Diabetes mellitus,\n  hyperlipidemia, decrease appetite, weight increase</span></p>", "ID": "1f91b83e-600e-4375-98de-334324fee017", "Styles": "margin-top:.25pt;margin-right:31.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "288b216e-d99c-41c1-8c90-9555311916a0"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Diabetes mellitus,\n  hyperlipidemia, decrease appetite, weight increase</span>", "ID": "08e1992c-c4f0-4360-9115-e2f7825d9bbb", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Diabetes mellitus,   hyperlipidemia, decrease appetite, weight increase", "ParentId": "1f91b83e-600e-4375-98de-334324fee017"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.45pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>", "ID": "22f743e9-0767-4572-83fc-f3f05da04e86", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.45pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "288b216e-d99c-41c1-8c90-9555311916a0"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u>", "ID": "c112ebfc-8a03-4a05-a088-919dc9b84257", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "22f743e9-0767-4572-83fc-f3f05da04e86"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span>", "ID": "969f2405-baa4-4a9b-97b4-5ac1b238d9cb", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Rare", "ParentId": "c112ebfc-8a03-4a05-a088-919dc9b84257"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Weight decrease,\n  increase appetite, anorexia</span></p>", "ID": "604a08f9-859f-4da8-a9ba-5dd1b81b18a1", "Styles": "margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "288b216e-d99c-41c1-8c90-9555311916a0"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Weight decrease,\n  increase appetite, anorexia</span>", "ID": "0cc67f66-2e10-40ef-87f4-93f13fb75ed4", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Weight decrease,   increase appetite, anorexia", "ParentId": "604a08f9-859f-4da8-a9ba-5dd1b81b18a1"}, {"Element": "<tr>\n<td style=\"width:163.05pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"217\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Psychiatric disorders</span></p>\n</td>\n<td style=\"width:304.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Libido decreased,\n  insomnia</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Nervousness</span></p>\n</td>\n</tr>", "ID": "89bd5cec-107a-494a-9b76-6fa34853e82e", "Styles": "None", "Classes": "None", "Text": "   ", "ParentId": "14402be6-54ec-445c-8aba-e8faa2f92a9f"}, {"Element": "<td style=\"width:163.05pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"217\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Psychiatric disorders</span></p>\n</td>", "ID": "2543bfb4-95cf-411e-b785-51a7bf8c7bd4", "Styles": "width:163.05pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in", "Classes": "None", "Text": "  ", "ParentId": "89bd5cec-107a-494a-9b76-6fa34853e82e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Psychiatric disorders</span></p>", "ID": "5b9b5bd8-5894-4cd0-9017-01912b0f0d87", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "2543bfb4-95cf-411e-b785-51a7bf8c7bd4"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Psychiatric disorders</span>", "ID": "4de4b119-3a6c-4cb2-9646-0b52c7403636", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Psychiatric disorders", "ParentId": "5b9b5bd8-5894-4cd0-9017-01912b0f0d87"}, {"Element": "<td style=\"width:304.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Libido decreased,\n  insomnia</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Nervousness</span></p>\n</td>", "ID": "b37a3ced-07a9-4188-8ba2-02cafffeb981", "Styles": "width:304.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in", "Classes": "None", "Text": "     ", "ParentId": "89bd5cec-107a-494a-9b76-6fa34853e82e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>", "ID": "0bde7528-05d5-40b3-8cca-a9379a4e180a", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b37a3ced-07a9-4188-8ba2-02cafffeb981"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u>", "ID": "4ca07d3b-13ba-40cf-be4e-3480b6a16a2a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0bde7528-05d5-40b3-8cca-a9379a4e180a"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span>", "ID": "e6befc6b-ef7e-4c7d-b297-a7d3c23539d0", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Uncommon", "ParentId": "4ca07d3b-13ba-40cf-be4e-3480b6a16a2a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Libido decreased,\n  insomnia</span></p>", "ID": "c5b6e0e6-97a0-4219-8fc6-b4c488e042c9", "Styles": "margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b37a3ced-07a9-4188-8ba2-02cafffeb981"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Libido decreased,\n  insomnia</span>", "ID": "3c2981af-6619-47aa-8a9f-a16a2b72a448", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Libido decreased,   insomnia", "ParentId": "c5b6e0e6-97a0-4219-8fc6-b4c488e042c9"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>", "ID": "485bd006-3c40-4182-9bd7-533be796fe8a", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b37a3ced-07a9-4188-8ba2-02cafffeb981"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u>", "ID": "f5c2dfc5-9f9c-4695-ae98-5f58d462c2f2", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "485bd006-3c40-4182-9bd7-533be796fe8a"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span>", "ID": "31df78c2-340e-4e7a-a032-d0cb95c7d416", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Rare", "ParentId": "f5c2dfc5-9f9c-4695-ae98-5f58d462c2f2"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Nervousness</span></p>", "ID": "a1f42318-c323-4d2a-a96a-2afd7ce46803", "Styles": "margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b37a3ced-07a9-4188-8ba2-02cafffeb981"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Nervousness</span>", "ID": "98cdfbba-2471-4e69-8c8f-18ef8e21dab1", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Nervousness", "ParentId": "a1f42318-c323-4d2a-a96a-2afd7ce46803"}, {"Element": "<tr>\n<td style=\"width:163.05pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"217\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Nervous system\n  disorders</span></p>\n</td>\n<td style=\"width:304.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Headache</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:16.8pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.7pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Dizziness,\n  paraesthesia, hemiparesis, somnolence, altered taste, hypoaesthesia, hyposmia</span></p>\n</td>\n</tr>", "ID": "1b32b8cf-fb32-440e-843a-44c50339f8d4", "Styles": "None", "Classes": "None", "Text": "   ", "ParentId": "14402be6-54ec-445c-8aba-e8faa2f92a9f"}, {"Element": "<td style=\"width:163.05pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"217\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Nervous system\n  disorders</span></p>\n</td>", "ID": "167bf0f1-41dd-43f8-8bc4-b04a7bb160e3", "Styles": "width:163.05pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in", "Classes": "None", "Text": "  ", "ParentId": "1b32b8cf-fb32-440e-843a-44c50339f8d4"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Nervous system\n  disorders</span></p>", "ID": "7e3e407b-7f36-4588-b57f-fc9eb6970bd8", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "167bf0f1-41dd-43f8-8bc4-b04a7bb160e3"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Nervous system\n  disorders</span>", "ID": "f382c21f-fe96-44f3-a932-a700851b71b5", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Nervous system   disorders", "ParentId": "7e3e407b-7f36-4588-b57f-fc9eb6970bd8"}, {"Element": "<td style=\"width:304.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Headache</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:16.8pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.7pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Dizziness,\n  paraesthesia, hemiparesis, somnolence, altered taste, hypoaesthesia, hyposmia</span></p>\n</td>", "ID": "b6144246-fbbe-458c-b1eb-8650ac185349", "Styles": "width:304.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in", "Classes": "None", "Text": "     ", "ParentId": "1b32b8cf-fb32-440e-843a-44c50339f8d4"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common</span></u></p>", "ID": "d7ffd2d6-1836-43e1-a99b-8ae1b4a88044", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b6144246-fbbe-458c-b1eb-8650ac185349"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common</span></u>", "ID": "ccec8c94-f4e5-41b5-a9d1-efb2cf86dad9", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d7ffd2d6-1836-43e1-a99b-8ae1b4a88044"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common</span>", "ID": "d5a32c71-b98d-4c0b-892e-0aed0d698c40", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Common", "ParentId": "ccec8c94-f4e5-41b5-a9d1-efb2cf86dad9"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Headache</span></p>", "ID": "3d5753b9-b0ae-4049-bf4a-3b3e0b541f76", "Styles": "margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b6144246-fbbe-458c-b1eb-8650ac185349"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Headache</span>", "ID": "1e533152-1cd8-4176-a52a-6b544c7475b9", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Headache", "ParentId": "3d5753b9-b0ae-4049-bf4a-3b3e0b541f76"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>", "ID": "572e6fdc-65c5-4dc8-aa40-2eeea9a7d9e4", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b6144246-fbbe-458c-b1eb-8650ac185349"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u>", "ID": "cbc346ea-c9e0-40b1-a65d-ffb86ae79e16", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "572e6fdc-65c5-4dc8-aa40-2eeea9a7d9e4"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span>", "ID": "b9d01f69-ac80-405d-bf55-b113bc0b8c9f", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Uncommon", "ParentId": "cbc346ea-c9e0-40b1-a65d-ffb86ae79e16"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:16.8pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.7pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Dizziness,\n  paraesthesia, hemiparesis, somnolence, altered taste, hypoaesthesia, hyposmia</span></p>", "ID": "0db404e8-52c6-4f9f-b62a-de75a74c77af", "Styles": "margin-top:.05pt;margin-right:16.8pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.7pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b6144246-fbbe-458c-b1eb-8650ac185349"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Dizziness,\n  paraesthesia, hemiparesis, somnolence, altered taste, hypoaesthesia, hyposmia</span>", "ID": "3395bf0a-7f70-4dcd-82f4-eacebfc05c48", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Dizziness,   paraesthesia, hemiparesis, somnolence, altered taste, hypoaesthesia, hyposmia", "ParentId": "0db404e8-52c6-4f9f-b62a-de75a74c77af"}, {"Element": "<tr>\n<td style=\"width:163.05pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"217\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Ear and labyrinth disorders</span></p>\n</td>\n<td style=\"width:304.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Tinnitus</span></p>\n</td>\n</tr>", "ID": "c9c787f3-eea5-4636-aff8-d808d449adf4", "Styles": "None", "Classes": "None", "Text": "   ", "ParentId": "14402be6-54ec-445c-8aba-e8faa2f92a9f"}, {"Element": "<td style=\"width:163.05pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"217\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Ear and labyrinth disorders</span></p>\n</td>", "ID": "e27d1b9d-1ff2-4c7f-b284-5171e00a3bd0", "Styles": "width:163.05pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in", "Classes": "None", "Text": "  ", "ParentId": "c9c787f3-eea5-4636-aff8-d808d449adf4"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Ear and labyrinth disorders</span></p>", "ID": "616ffe3a-d87f-42c2-8aad-640485127a56", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e27d1b9d-1ff2-4c7f-b284-5171e00a3bd0"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Ear and labyrinth disorders</span>", "ID": "cae96b1c-fe2d-47c1-8b91-2c268b149380", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Ear and labyrinth disorders", "ParentId": "616ffe3a-d87f-42c2-8aad-640485127a56"}, {"Element": "<td style=\"width:304.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Tinnitus</span></p>\n</td>", "ID": "e0c73adc-fdc7-4c5e-8c33-f7c96e5fbacc", "Styles": "width:304.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in", "Classes": "None", "Text": "   ", "ParentId": "c9c787f3-eea5-4636-aff8-d808d449adf4"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>", "ID": "8b5ef88e-faae-415c-a61a-1076f048dedf", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e0c73adc-fdc7-4c5e-8c33-f7c96e5fbacc"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u>", "ID": "ec8c412a-d1e0-4035-a71b-2a446a703ff4", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "8b5ef88e-faae-415c-a61a-1076f048dedf"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span>", "ID": "b8cc8b96-a98a-46e5-af62-25bb3e6937d4", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Rare", "ParentId": "ec8c412a-d1e0-4035-a71b-2a446a703ff4"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Tinnitus</span></p>", "ID": "f4589c6f-6122-4b26-a530-daf5971b63da", "Styles": "margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e0c73adc-fdc7-4c5e-8c33-f7c96e5fbacc"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Tinnitus</span>", "ID": "405fdcf9-9b09-4364-add4-df371d9393cd", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Tinnitus", "ParentId": "f4589c6f-6122-4b26-a530-daf5971b63da"}, {"Element": "<tr>\n<td style=\"width:163.05pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"217\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Cardiac disorders</span></p>\n</td>\n<td style=\"width:304.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:244.6pt;margin-bottom:\n  0in;margin-left:5.0pt;text-align:justify;line-height:12.3pt;text-autospace:\n  none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:4.4pt;margin-bottom:\n  0in;margin-left:5.0pt;text-align:justify;line-height:normal;text-autospace:\n  none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Atrial\n  fibrillation, palpitations, ECG abnormal, left bundle branch block (see\n  section Tumor Lysis Syndrome), sinus tachycardia (see section Tumor Lysis\n  Syndrome)</span></p>\n</td>\n</tr>", "ID": "efa8cadf-c491-4beb-85d2-d94ba93bffab", "Styles": "None", "Classes": "None", "Text": "   ", "ParentId": "14402be6-54ec-445c-8aba-e8faa2f92a9f"}, {"Element": "<td style=\"width:163.05pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"217\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Cardiac disorders</span></p>\n</td>", "ID": "e8ec9eb9-201e-4b27-a5e0-2f324f3730af", "Styles": "width:163.05pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in", "Classes": "None", "Text": "  ", "ParentId": "efa8cadf-c491-4beb-85d2-d94ba93bffab"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Cardiac disorders</span></p>", "ID": "8078e8e7-3ca6-4950-bc6c-8e55e9102a9e", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e8ec9eb9-201e-4b27-a5e0-2f324f3730af"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Cardiac disorders</span>", "ID": "4d58477a-ed9e-4d50-ab17-235bacfcda8a", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Cardiac disorders", "ParentId": "8078e8e7-3ca6-4950-bc6c-8e55e9102a9e"}, {"Element": "<td style=\"width:304.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:244.6pt;margin-bottom:\n  0in;margin-left:5.0pt;text-align:justify;line-height:12.3pt;text-autospace:\n  none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:4.4pt;margin-bottom:\n  0in;margin-left:5.0pt;text-align:justify;line-height:normal;text-autospace:\n  none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Atrial\n  fibrillation, palpitations, ECG abnormal, left bundle branch block (see\n  section Tumor Lysis Syndrome), sinus tachycardia (see section Tumor Lysis\n  Syndrome)</span></p>\n</td>", "ID": "b1369d9b-15cf-4eb2-be92-6cc747d00acc", "Styles": "width:304.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in", "Classes": "None", "Text": "   ", "ParentId": "efa8cadf-c491-4beb-85d2-d94ba93bffab"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:244.6pt;margin-bottom:\n  0in;margin-left:5.0pt;text-align:justify;line-height:12.3pt;text-autospace:\n  none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>", "ID": "b70186b0-6900-4796-b2b0-883beb026602", "Styles": "margin-top:0in;margin-right:244.6pt;margin-bottom:\n  0in;margin-left:5.0pt;text-align:justify;line-height:12.3pt;text-autospace:\n  none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b1369d9b-15cf-4eb2-be92-6cc747d00acc"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u>", "ID": "8765e0d8-7962-4b83-b70f-c7ef5db1ed27", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b70186b0-6900-4796-b2b0-883beb026602"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span>", "ID": "633453a9-7ac3-47ea-85d7-7fb028973e08", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Uncommon", "ParentId": "8765e0d8-7962-4b83-b70f-c7ef5db1ed27"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:4.4pt;margin-bottom:\n  0in;margin-left:5.0pt;text-align:justify;line-height:normal;text-autospace:\n  none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Atrial\n  fibrillation, palpitations, ECG abnormal, left bundle branch block (see\n  section Tumor Lysis Syndrome), sinus tachycardia (see section Tumor Lysis\n  Syndrome)</span></p>", "ID": "ec276d10-f3ee-473a-9937-aed15223831a", "Styles": "margin-top:.05pt;margin-right:4.4pt;margin-bottom:\n  0in;margin-left:5.0pt;text-align:justify;line-height:normal;text-autospace:\n  none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b1369d9b-15cf-4eb2-be92-6cc747d00acc"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Atrial\n  fibrillation, palpitations, ECG abnormal, left bundle branch block (see\n  section Tumor Lysis Syndrome), sinus tachycardia (see section Tumor Lysis\n  Syndrome)</span>", "ID": "5265c984-8ce1-497f-abb6-f5d3edb40db1", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Atrial   fibrillation, palpitations, ECG abnormal, left bundle branch block (see   section Tumor Lysis Syndrome), sinus tachycardia (see section Tumor Lysis   Syndrome)", "ParentId": "ec276d10-f3ee-473a-9937-aed15223831a"}, {"Element": "<tr>\n<td style=\"width:163.05pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"217\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Vascular disorders</span></p>\n</td>\n<td style=\"width:304.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Hypertension,\n  flushing, hot flush, haemorrhage (see section Tumor Lysis Syndrome)</span></p>\n</td>\n</tr>", "ID": "f68b43e9-e122-482f-80c4-fd9adde8ee43", "Styles": "None", "Classes": "None", "Text": "   ", "ParentId": "14402be6-54ec-445c-8aba-e8faa2f92a9f"}, {"Element": "<td style=\"width:163.05pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"217\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Vascular disorders</span></p>\n</td>", "ID": "f7ddad25-7c1f-4153-b32f-a86f7649a9a5", "Styles": "width:163.05pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in", "Classes": "None", "Text": "  ", "ParentId": "f68b43e9-e122-482f-80c4-fd9adde8ee43"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Vascular disorders</span></p>", "ID": "157ab0f3-b4e1-4565-bd9a-28fbabc9d0b2", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f7ddad25-7c1f-4153-b32f-a86f7649a9a5"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Vascular disorders</span>", "ID": "e39e9c77-92e8-4e81-a6de-d1740030bcf2", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Vascular disorders", "ParentId": "157ab0f3-b4e1-4565-bd9a-28fbabc9d0b2"}, {"Element": "<td style=\"width:304.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Hypertension,\n  flushing, hot flush, haemorrhage (see section Tumor Lysis Syndrome)</span></p>\n</td>", "ID": "3a0a96ea-ed0a-45b6-b832-173ecef1c57a", "Styles": "width:304.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in", "Classes": "None", "Text": "   ", "ParentId": "f68b43e9-e122-482f-80c4-fd9adde8ee43"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>", "ID": "d45d67e2-ba46-4197-b785-a4d19dd77c54", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3a0a96ea-ed0a-45b6-b832-173ecef1c57a"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u>", "ID": "453bda8d-6b8b-48c2-ab1d-c65c1cf2bb60", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d45d67e2-ba46-4197-b785-a4d19dd77c54"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span>", "ID": "013eedf7-1af2-41d6-8d78-f9ac9f55d178", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Uncommon", "ParentId": "453bda8d-6b8b-48c2-ab1d-c65c1cf2bb60"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Hypertension,\n  flushing, hot flush, haemorrhage (see section Tumor Lysis Syndrome)</span></p>", "ID": "ca176255-242c-40f4-963a-15377a6252d3", "Styles": "margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3a0a96ea-ed0a-45b6-b832-173ecef1c57a"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Hypertension,\n  flushing, hot flush, haemorrhage (see section Tumor Lysis Syndrome)</span>", "ID": "1df33a74-a56d-47d5-a2dc-f2dce0e3f54f", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Hypertension,   flushing, hot flush, haemorrhage (see section Tumor Lysis Syndrome)", "ParentId": "ca176255-242c-40f4-963a-15377a6252d3"}, {"Element": "<tr>\n<td style=\"width:163.05pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"217\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.4pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Respiratory system\n  disorders</span></p>\n</td>\n<td style=\"width:304.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.4pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Dyspnoea, bronchitis,\n  upper respiratory tract infection, cough</span></p>\n</td>\n</tr>", "ID": "64d9fc88-d3dc-46a4-8f68-6ef64d8dd13e", "Styles": "None", "Classes": "None", "Text": "   ", "ParentId": "14402be6-54ec-445c-8aba-e8faa2f92a9f"}, {"Element": "<td style=\"width:163.05pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"217\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.4pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Respiratory system\n  disorders</span></p>\n</td>", "ID": "17e73a6f-6516-463e-959d-e7b3be95d9b9", "Styles": "width:163.05pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in", "Classes": "None", "Text": "  ", "ParentId": "64d9fc88-d3dc-46a4-8f68-6ef64d8dd13e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.4pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Respiratory system\n  disorders</span></p>", "ID": "22ec08c9-d08e-4b2f-8f0a-243fb1ec7651", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.4pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "17e73a6f-6516-463e-959d-e7b3be95d9b9"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Respiratory system\n  disorders</span>", "ID": "3715c43d-c436-46b9-8079-739bb89a2a15", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Respiratory system   disorders", "ParentId": "22ec08c9-d08e-4b2f-8f0a-243fb1ec7651"}, {"Element": "<td style=\"width:304.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.4pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Dyspnoea, bronchitis,\n  upper respiratory tract infection, cough</span></p>\n</td>", "ID": "78373238-4034-435c-8165-7cc2d37f1668", "Styles": "width:304.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in", "Classes": "None", "Text": "   ", "ParentId": "64d9fc88-d3dc-46a4-8f68-6ef64d8dd13e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.4pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>", "ID": "226356cb-aaca-41c1-94f6-1bb0340b698c", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.4pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "78373238-4034-435c-8165-7cc2d37f1668"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u>", "ID": "80c94da8-866d-4149-9c34-42762bc48b49", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "226356cb-aaca-41c1-94f6-1bb0340b698c"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span>", "ID": "ec6d2d3e-c5c8-4e8c-83ad-852de4d4419f", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Uncommon", "ParentId": "80c94da8-866d-4149-9c34-42762bc48b49"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Dyspnoea, bronchitis,\n  upper respiratory tract infection, cough</span></p>", "ID": "bc65f00e-4c87-415e-8f15-ab5db786bf1b", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "78373238-4034-435c-8165-7cc2d37f1668"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Dyspnoea, bronchitis,\n  upper respiratory tract infection, cough</span>", "ID": "f5e254cf-c926-459c-b097-7b94e391c8f9", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Dyspnoea, bronchitis,   upper respiratory tract infection, cough", "ParentId": "bc65f00e-4c87-415e-8f15-ab5db786bf1b"}, {"Element": "<tr>\n<td style=\"width:163.05pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"217\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.4pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Gastrointestinal\n  disorders</span></p>\n</td>\n<td style=\"width:304.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.4pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Diarrhoea**, nausea</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon:</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:6.15pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Abdominal pain,\n  abdominal distension, gastro-oesophageal reflux disease, vomiting, dry mouth,\n  dyspepsia, constipation, frequent stools, flatulence, gastrointestinal\n  discomfort</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Pancreatitis, mouth\n  ulceration</span></p>\n</td>\n</tr>", "ID": "764293f1-bfcf-4b1b-af53-600630af7a02", "Styles": "None", "Classes": "None", "Text": "   ", "ParentId": "14402be6-54ec-445c-8aba-e8faa2f92a9f"}, {"Element": "<td style=\"width:163.05pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"217\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.4pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Gastrointestinal\n  disorders</span></p>\n</td>", "ID": "0a6d96f6-39f8-4c72-b837-c9e712a3d390", "Styles": "width:163.05pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in", "Classes": "None", "Text": "  ", "ParentId": "764293f1-bfcf-4b1b-af53-600630af7a02"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.4pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Gastrointestinal\n  disorders</span></p>", "ID": "b3b43d8d-5866-4b87-8944-4ac8bf7787d5", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.4pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0a6d96f6-39f8-4c72-b837-c9e712a3d390"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Gastrointestinal\n  disorders</span>", "ID": "b52d0839-68f8-400c-a0a5-f593e7155f85", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Gastrointestinal   disorders", "ParentId": "b3b43d8d-5866-4b87-8944-4ac8bf7787d5"}, {"Element": "<td style=\"width:304.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.4pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Diarrhoea**, nausea</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon:</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:6.15pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Abdominal pain,\n  abdominal distension, gastro-oesophageal reflux disease, vomiting, dry mouth,\n  dyspepsia, constipation, frequent stools, flatulence, gastrointestinal\n  discomfort</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Pancreatitis, mouth\n  ulceration</span></p>\n</td>", "ID": "88c66e08-2c47-49f0-ac2d-86dc28a5c57d", "Styles": "width:304.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in", "Classes": "None", "Text": "       ", "ParentId": "764293f1-bfcf-4b1b-af53-600630af7a02"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.4pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common</span></u></p>", "ID": "1db3973b-c017-47e3-a4be-275558f03364", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.4pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "88c66e08-2c47-49f0-ac2d-86dc28a5c57d"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common</span></u>", "ID": "b8023674-855f-4a21-a487-941a3638b2d5", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "1db3973b-c017-47e3-a4be-275558f03364"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common</span>", "ID": "7df5a740-add8-40ef-bdfd-4deda498a6b0", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Common", "ParentId": "b8023674-855f-4a21-a487-941a3638b2d5"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Diarrhoea**, nausea</span></p>", "ID": "713372c2-75d7-4e48-8611-39f3a226be53", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "88c66e08-2c47-49f0-ac2d-86dc28a5c57d"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Diarrhoea**, nausea</span>", "ID": "9160faec-0b9c-41de-ba16-468b3cee0284", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Diarrhoea**, nausea", "ParentId": "713372c2-75d7-4e48-8611-39f3a226be53"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon:</span></u></p>", "ID": "ce5d2f60-ccd1-4c04-81b7-f42e1ffad279", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "88c66e08-2c47-49f0-ac2d-86dc28a5c57d"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon:</span></u>", "ID": "5cf427d6-6fd3-4825-b376-39b54e7744f8", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ce5d2f60-ccd1-4c04-81b7-f42e1ffad279"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon:</span>", "ID": "dede0265-0df8-4d65-94b4-402f2e36e387", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Uncommon:", "ParentId": "5cf427d6-6fd3-4825-b376-39b54e7744f8"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:6.15pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Abdominal pain,\n  abdominal distension, gastro-oesophageal reflux disease, vomiting, dry mouth,\n  dyspepsia, constipation, frequent stools, flatulence, gastrointestinal\n  discomfort</span></p>", "ID": "42596282-3817-4259-98ca-3fd39d398f78", "Styles": "margin-top:.05pt;margin-right:6.15pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "88c66e08-2c47-49f0-ac2d-86dc28a5c57d"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Abdominal pain,\n  abdominal distension, gastro-oesophageal reflux disease, vomiting, dry mouth,\n  dyspepsia, constipation, frequent stools, flatulence, gastrointestinal\n  discomfort</span>", "ID": "961ea8f6-cc55-41b7-bf30-8b02152ebada", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Abdominal pain,   abdominal distension, gastro-oesophageal reflux disease, vomiting, dry mouth,   dyspepsia, constipation, frequent stools, flatulence, gastrointestinal   discomfort", "ParentId": "42596282-3817-4259-98ca-3fd39d398f78"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>", "ID": "d4f3e997-3e85-466c-b188-d0dd93113ed3", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "88c66e08-2c47-49f0-ac2d-86dc28a5c57d"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u>", "ID": "fbd4caa1-0499-4e6f-a346-bb6853bde40d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d4f3e997-3e85-466c-b188-d0dd93113ed3"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span>", "ID": "ac13ab20-2596-454f-8265-fd9babee951f", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Rare", "ParentId": "fbd4caa1-0499-4e6f-a346-bb6853bde40d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Pancreatitis, mouth\n  ulceration</span></p>", "ID": "533d13fc-093c-4959-91f0-40158068043c", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "88c66e08-2c47-49f0-ac2d-86dc28a5c57d"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Pancreatitis, mouth\n  ulceration</span>", "ID": "d1e4a188-1bfa-4dd8-add1-8d3429cc590d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Pancreatitis, mouth   ulceration", "ParentId": "533d13fc-093c-4959-91f0-40158068043c"}, {"Element": "<tr>\n<td style=\"width:163.05pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"217\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Hepato-biliary\n  disorders</span></p>\n</td>\n<td style=\"width:304.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:159.3pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.7pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Liver function\n  abnormalities** <u>Uncommon</u></span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.45pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Cholelithiasis</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Hepatitis, jaundice*,\n  liver injury*</span></p>\n</td>\n</tr>", "ID": "6a998bdc-8d6c-4a9b-a8ba-a2a61afc6b51", "Styles": "None", "Classes": "None", "Text": "   ", "ParentId": "14402be6-54ec-445c-8aba-e8faa2f92a9f"}, {"Element": "<td style=\"width:163.05pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"217\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Hepato-biliary\n  disorders</span></p>\n</td>", "ID": "67ad96b5-cc65-48bb-8997-9d3fcf56aaba", "Styles": "width:163.05pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in", "Classes": "None", "Text": "  ", "ParentId": "6a998bdc-8d6c-4a9b-a8ba-a2a61afc6b51"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Hepato-biliary\n  disorders</span></p>", "ID": "cb40bf37-b53f-4b45-a2e4-a2f6d4069693", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "67ad96b5-cc65-48bb-8997-9d3fcf56aaba"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Hepato-biliary\n  disorders</span>", "ID": "7103ad9f-cf1e-44e7-a39d-d94466c20a28", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Hepato-biliary   disorders", "ParentId": "cb40bf37-b53f-4b45-a2e4-a2f6d4069693"}, {"Element": "<td style=\"width:304.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:159.3pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.7pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Liver function\n  abnormalities** <u>Uncommon</u></span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.45pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Cholelithiasis</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Hepatitis, jaundice*,\n  liver injury*</span></p>\n</td>", "ID": "11e6e687-c4a5-426a-8715-b449e544470e", "Styles": "width:304.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in", "Classes": "None", "Text": "      ", "ParentId": "6a998bdc-8d6c-4a9b-a8ba-a2a61afc6b51"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common</span></u></p>", "ID": "6a4a928e-34db-464a-9031-b39931405640", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "11e6e687-c4a5-426a-8715-b449e544470e"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common</span></u>", "ID": "fdb9b5a2-0032-4bb9-a2df-e90ea6fcd466", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6a4a928e-34db-464a-9031-b39931405640"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common</span>", "ID": "723489d7-4cf9-4baf-888d-f2bcc10e2329", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Common", "ParentId": "fdb9b5a2-0032-4bb9-a2df-e90ea6fcd466"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:159.3pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.7pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Liver function\n  abnormalities** <u>Uncommon</u></span></p>", "ID": "1c546ed5-1324-4170-ac99-8ad0f4ec92f3", "Styles": "margin-top:.05pt;margin-right:159.3pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.7pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "11e6e687-c4a5-426a-8715-b449e544470e"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Liver function\n  abnormalities** <u>Uncommon</u></span>", "ID": "7cc0fa29-73e2-4cb6-8e08-667e214395b5", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Liver function   abnormalities** ", "ParentId": "1c546ed5-1324-4170-ac99-8ad0f4ec92f3"}, {"Element": "<u>Uncommon</u>", "ID": "1383cc8c-0913-4381-bdae-29b88df3d784", "Styles": "None", "Classes": "None", "Text": "Uncommon", "ParentId": "7cc0fa29-73e2-4cb6-8e08-667e214395b5"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.45pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Cholelithiasis</span></p>", "ID": "03c91481-b3d3-4dd3-ac62-67140b33af57", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.45pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "11e6e687-c4a5-426a-8715-b449e544470e"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Cholelithiasis</span>", "ID": "343b64e0-3062-4596-a3f6-0f89ebf4841f", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Cholelithiasis", "ParentId": "03c91481-b3d3-4dd3-ac62-67140b33af57"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>", "ID": "450fd709-52eb-4dbb-9fef-908ccd12d992", "Styles": "margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "11e6e687-c4a5-426a-8715-b449e544470e"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u>", "ID": "85c2b863-f131-4d1d-acf4-3c1d31a28283", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "450fd709-52eb-4dbb-9fef-908ccd12d992"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span>", "ID": "45e629fe-327c-4f41-b85c-49caa77e8b2f", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Rare", "ParentId": "85c2b863-f131-4d1d-acf4-3c1d31a28283"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Hepatitis, jaundice*,\n  liver injury*</span></p>", "ID": "45b8321c-26b1-417b-b847-f04bfeaa72df", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "11e6e687-c4a5-426a-8715-b449e544470e"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Hepatitis, jaundice*,\n  liver injury*</span>", "ID": "5e515595-5817-4ec2-b11c-5d3a4b457624", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Hepatitis, jaundice*,   liver injury*", "ParentId": "45b8321c-26b1-417b-b847-f04bfeaa72df"}, {"Element": "<tr style=\"height:151.95pt\">\n<td style=\"width:163.05pt;border-top:none;border-left:\n  solid black 1.0pt;border-bottom:none;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in;height:151.95pt\" valign=\"top\" width=\"217\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.4pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Skin and subcutaneous\n  tissue</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>disorders</span></p>\n</td>\n<td style=\"width:304.75pt;border:none;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in;height:151.95pt\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.4pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.15pt;margin-right:42.6pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rash (including\n  various types of rash reported with lower frequencies, see below)</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:22.6pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.7pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Dermatitis, urticaria,\n  pruritus, skin discolouration, skin lesion, petechiae, rash macular, rash\n  maculopapular, rash papular</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.4pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.15pt;margin-right:35.1pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Toxic epidermal\n  necrolysis*, Stevens-Johnson Syndrome*, angioedema*, drug reaction with\n  eosinophilia and systemic symptoms*, generalized rash (serious)*, erythema,\n  exfoliative rash, rash follicular, rash vesicular, rash pustular, rash\n  pruritic*, rash erythematous, rash morbillifom, alopecia, hyperhidrosis</span></p>\n</td>\n</tr>", "ID": "9548a45d-a07a-460a-89ae-18693c7d2f3c", "Styles": "height:151.95pt", "Classes": "None", "Text": "   ", "ParentId": "14402be6-54ec-445c-8aba-e8faa2f92a9f"}, {"Element": "<td style=\"width:163.05pt;border-top:none;border-left:\n  solid black 1.0pt;border-bottom:none;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in;height:151.95pt\" valign=\"top\" width=\"217\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.4pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Skin and subcutaneous\n  tissue</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>disorders</span></p>\n</td>", "ID": "080ad189-796b-4b8b-9c78-e73469b1444f", "Styles": "width:163.05pt;border-top:none;border-left:\n  solid black 1.0pt;border-bottom:none;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in;height:151.95pt", "Classes": "None", "Text": "   ", "ParentId": "9548a45d-a07a-460a-89ae-18693c7d2f3c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.4pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Skin and subcutaneous\n  tissue</span></p>", "ID": "ac77ab27-d6e2-4d62-b6ff-ddc1fd18a5ab", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.4pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "080ad189-796b-4b8b-9c78-e73469b1444f"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Skin and subcutaneous\n  tissue</span>", "ID": "939187a3-9174-4f3c-9840-7efa0043c4d5", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Skin and subcutaneous   tissue", "ParentId": "ac77ab27-d6e2-4d62-b6ff-ddc1fd18a5ab"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>disorders</span></p>", "ID": "24bad76f-3fa2-4178-9a1a-6f6aac625e5c", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.6pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "080ad189-796b-4b8b-9c78-e73469b1444f"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>disorders</span>", "ID": "11711c34-311e-4367-8fe5-72b785f9a8f8", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "disorders", "ParentId": "24bad76f-3fa2-4178-9a1a-6f6aac625e5c"}, {"Element": "<td style=\"width:304.75pt;border:none;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in;height:151.95pt\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.4pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.15pt;margin-right:42.6pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rash (including\n  various types of rash reported with lower frequencies, see below)</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:22.6pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.7pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Dermatitis, urticaria,\n  pruritus, skin discolouration, skin lesion, petechiae, rash macular, rash\n  maculopapular, rash papular</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.4pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.15pt;margin-right:35.1pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Toxic epidermal\n  necrolysis*, Stevens-Johnson Syndrome*, angioedema*, drug reaction with\n  eosinophilia and systemic symptoms*, generalized rash (serious)*, erythema,\n  exfoliative rash, rash follicular, rash vesicular, rash pustular, rash\n  pruritic*, rash erythematous, rash morbillifom, alopecia, hyperhidrosis</span></p>\n</td>", "ID": "75a9d0a7-cb16-426f-b044-8fdc9ee8548d", "Styles": "width:304.75pt;border:none;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in;height:151.95pt", "Classes": "None", "Text": "       ", "ParentId": "9548a45d-a07a-460a-89ae-18693c7d2f3c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.4pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common</span></u></p>", "ID": "4d9384ff-2edc-4711-93f3-d7013672e9a6", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.4pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "75a9d0a7-cb16-426f-b044-8fdc9ee8548d"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common</span></u>", "ID": "d92b79f8-ff56-4ac5-99e7-d3cfe8ff7c04", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4d9384ff-2edc-4711-93f3-d7013672e9a6"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common</span>", "ID": "50b67fa8-d574-4f04-b0bb-25e9fbfe8102", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Common", "ParentId": "d92b79f8-ff56-4ac5-99e7-d3cfe8ff7c04"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.15pt;margin-right:42.6pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rash (including\n  various types of rash reported with lower frequencies, see below)</span></p>", "ID": "16701b11-f324-42ec-9845-41af90161148", "Styles": "margin-top:.15pt;margin-right:42.6pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "75a9d0a7-cb16-426f-b044-8fdc9ee8548d"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rash (including\n  various types of rash reported with lower frequencies, see below)</span>", "ID": "cb355b79-cdba-40cc-8770-47bb1c5340eb", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Rash (including   various types of rash reported with lower frequencies, see below)", "ParentId": "16701b11-f324-42ec-9845-41af90161148"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>", "ID": "745743ff-892c-4f45-bee7-eb1ea73732cf", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "75a9d0a7-cb16-426f-b044-8fdc9ee8548d"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u>", "ID": "96919b75-47d4-4b59-ad7c-7cc3701df79e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "745743ff-892c-4f45-bee7-eb1ea73732cf"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span>", "ID": "f4423100-e85e-4768-9b86-117a4951e55c", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Uncommon", "ParentId": "96919b75-47d4-4b59-ad7c-7cc3701df79e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:22.6pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.7pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Dermatitis, urticaria,\n  pruritus, skin discolouration, skin lesion, petechiae, rash macular, rash\n  maculopapular, rash papular</span></p>", "ID": "56caa3df-89bb-4a92-9719-3c7f6401dc84", "Styles": "margin-top:.05pt;margin-right:22.6pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.7pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "75a9d0a7-cb16-426f-b044-8fdc9ee8548d"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Dermatitis, urticaria,\n  pruritus, skin discolouration, skin lesion, petechiae, rash macular, rash\n  maculopapular, rash papular</span>", "ID": "c1a0dc98-b86a-4b2b-8e95-dd48f5fe1976", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Dermatitis, urticaria,   pruritus, skin discolouration, skin lesion, petechiae, rash macular, rash   maculopapular, rash papular", "ParentId": "56caa3df-89bb-4a92-9719-3c7f6401dc84"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.4pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>", "ID": "de6a9e5d-bc99-4a4c-b3fa-c5b90c5e9905", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.4pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "75a9d0a7-cb16-426f-b044-8fdc9ee8548d"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u>", "ID": "2034f651-7807-4605-be7a-7fdf54e4abf0", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "de6a9e5d-bc99-4a4c-b3fa-c5b90c5e9905"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span>", "ID": "bbbd753e-ba9c-415a-9ba0-f0ca0f47bbef", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Rare", "ParentId": "2034f651-7807-4605-be7a-7fdf54e4abf0"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.15pt;margin-right:35.1pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Toxic epidermal\n  necrolysis*, Stevens-Johnson Syndrome*, angioedema*, drug reaction with\n  eosinophilia and systemic symptoms*, generalized rash (serious)*, erythema,\n  exfoliative rash, rash follicular, rash vesicular, rash pustular, rash\n  pruritic*, rash erythematous, rash morbillifom, alopecia, hyperhidrosis</span></p>", "ID": "6ffdf24a-62cf-42cc-af17-4f8a6fb8e2e6", "Styles": "margin-top:.15pt;margin-right:35.1pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "75a9d0a7-cb16-426f-b044-8fdc9ee8548d"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Toxic epidermal\n  necrolysis*, Stevens-Johnson Syndrome*, angioedema*, drug reaction with\n  eosinophilia and systemic symptoms*, generalized rash (serious)*, erythema,\n  exfoliative rash, rash follicular, rash vesicular, rash pustular, rash\n  pruritic*, rash erythematous, rash morbillifom, alopecia, hyperhidrosis</span>", "ID": "e5ea9fcb-9c00-4cf4-842f-036ce3db1cb8", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Toxic epidermal   necrolysis*, Stevens-Johnson Syndrome*, angioedema*, drug reaction with   eosinophilia and systemic symptoms*, generalized rash (serious)*, erythema,   exfoliative rash, rash follicular, rash vesicular, rash pustular, rash   pruritic*, rash erythematous, rash morbillifom, alopecia, hyperhidrosis", "ParentId": "6ffdf24a-62cf-42cc-af17-4f8a6fb8e2e6"}, {"Element": "<tr>\n<td style=\"width:163.05pt;border:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"217\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Musculoskeletal and\n  connective</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>tissue disorders</span></p>\n</td>\n<td style=\"width:304.75pt;border:solid black 1.0pt;\n  border-left:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.25pt;margin-right:35.4pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Arthralgia, arthritis,\n  myalgia, musculoskeletal pain, muscle weakness, muscle spasm, muscle\n  tightness, bursitis</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rhabdomyolysis*, joint\n  stiffness, musculoskeletal stiffness</span></p>\n</td>\n</tr>", "ID": "9a248272-fdca-46cb-8b54-097e2bba317e", "Styles": "None", "Classes": "None", "Text": "   ", "ParentId": "14402be6-54ec-445c-8aba-e8faa2f92a9f"}, {"Element": "<td style=\"width:163.05pt;border:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"217\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Musculoskeletal and\n  connective</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>tissue disorders</span></p>\n</td>", "ID": "773a1400-2040-4971-9200-16a9d1339ea7", "Styles": "width:163.05pt;border:solid black 1.0pt;\n  padding:0in 0in 0in 0in", "Classes": "None", "Text": "   ", "ParentId": "9a248272-fdca-46cb-8b54-097e2bba317e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Musculoskeletal and\n  connective</span></p>", "ID": "7048ff63-f4e8-494a-8149-e2f68f190d35", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "773a1400-2040-4971-9200-16a9d1339ea7"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Musculoskeletal and\n  connective</span>", "ID": "7809e179-6f9b-4797-8642-afb17857806e", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Musculoskeletal and   connective", "ParentId": "7048ff63-f4e8-494a-8149-e2f68f190d35"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>tissue disorders</span></p>", "ID": "e37873a4-44ce-4fc0-8808-1e72272d6bed", "Styles": "margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "773a1400-2040-4971-9200-16a9d1339ea7"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>tissue disorders</span>", "ID": "be0dcd37-7d37-4bbb-b9be-8e4ecb5f6b94", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "tissue disorders", "ParentId": "e37873a4-44ce-4fc0-8808-1e72272d6bed"}, {"Element": "<td style=\"width:304.75pt;border:solid black 1.0pt;\n  border-left:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.25pt;margin-right:35.4pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Arthralgia, arthritis,\n  myalgia, musculoskeletal pain, muscle weakness, muscle spasm, muscle\n  tightness, bursitis</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rhabdomyolysis*, joint\n  stiffness, musculoskeletal stiffness</span></p>\n</td>", "ID": "8fda9fef-2892-42dc-a60b-c3571bbd3b9d", "Styles": "width:304.75pt;border:solid black 1.0pt;\n  border-left:none;padding:0in 0in 0in 0in", "Classes": "None", "Text": "     ", "ParentId": "9a248272-fdca-46cb-8b54-097e2bba317e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>", "ID": "53cc968f-9acc-434a-a350-504e725763b0", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "8fda9fef-2892-42dc-a60b-c3571bbd3b9d"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u>", "ID": "d1e66f13-8073-4fc8-86e6-6447947516a2", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "53cc968f-9acc-434a-a350-504e725763b0"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span>", "ID": "1e2a3b7d-2030-499f-a28d-e24798f97ed5", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Uncommon", "ParentId": "d1e66f13-8073-4fc8-86e6-6447947516a2"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.25pt;margin-right:35.4pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Arthralgia, arthritis,\n  myalgia, musculoskeletal pain, muscle weakness, muscle spasm, muscle\n  tightness, bursitis</span></p>", "ID": "c6a4808c-834b-44dc-9ab4-8a6ce5f55b04", "Styles": "margin-top:.25pt;margin-right:35.4pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "8fda9fef-2892-42dc-a60b-c3571bbd3b9d"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Arthralgia, arthritis,\n  myalgia, musculoskeletal pain, muscle weakness, muscle spasm, muscle\n  tightness, bursitis</span>", "ID": "df9bf56b-4223-4bf9-b172-82b2a91a9e78", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Arthralgia, arthritis,   myalgia, musculoskeletal pain, muscle weakness, muscle spasm, muscle   tightness, bursitis", "ParentId": "c6a4808c-834b-44dc-9ab4-8a6ce5f55b04"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>", "ID": "ae92056c-2e40-4fbb-bf6f-161930e463e1", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "8fda9fef-2892-42dc-a60b-c3571bbd3b9d"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u>", "ID": "0bb0e460-f158-4c3f-83aa-4306561ac356", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ae92056c-2e40-4fbb-bf6f-161930e463e1"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span>", "ID": "05b152a3-46fb-4df7-87ae-6bf1de36cf20", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Rare", "ParentId": "0bb0e460-f158-4c3f-83aa-4306561ac356"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rhabdomyolysis*, joint\n  stiffness, musculoskeletal stiffness</span></p>", "ID": "8dcca878-d8b1-4d36-b170-e1f48b0aa93f", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "8fda9fef-2892-42dc-a60b-c3571bbd3b9d"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rhabdomyolysis*, joint\n  stiffness, musculoskeletal stiffness</span>", "ID": "bf167a35-2186-4938-a0d7-54db2d022dd7", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Rhabdomyolysis*, joint   stiffness, musculoskeletal stiffness", "ParentId": "8dcca878-d8b1-4d36-b170-e1f48b0aa93f"}, {"Element": "<tr>\n<td style=\"width:163.05pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"217\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Renal and urinary\n  disorders</span></p>\n</td>\n<td style=\"width:304.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Renal failure,\n  nephrolithiasis, haematuria, pollakiuria, proteinuria</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Tubulointerstitial\n  nephritis*, micturition urgency</span></p>\n</td>\n</tr>", "ID": "9aae863f-a660-4c38-b607-f1848eeba015", "Styles": "None", "Classes": "None", "Text": "   ", "ParentId": "14402be6-54ec-445c-8aba-e8faa2f92a9f"}, {"Element": "<td style=\"width:163.05pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"217\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Renal and urinary\n  disorders</span></p>\n</td>", "ID": "c235b66f-804b-4aa3-9d99-5a6e267a8bd7", "Styles": "width:163.05pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in", "Classes": "None", "Text": "  ", "ParentId": "9aae863f-a660-4c38-b607-f1848eeba015"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Renal and urinary\n  disorders</span></p>", "ID": "85f6d304-d5e9-435f-a7b5-550bfe5db8bd", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c235b66f-804b-4aa3-9d99-5a6e267a8bd7"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Renal and urinary\n  disorders</span>", "ID": "17dbac76-7586-4a46-8a06-d7d852b3a890", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Renal and urinary   disorders", "ParentId": "85f6d304-d5e9-435f-a7b5-550bfe5db8bd"}, {"Element": "<td style=\"width:304.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Renal failure,\n  nephrolithiasis, haematuria, pollakiuria, proteinuria</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Tubulointerstitial\n  nephritis*, micturition urgency</span></p>\n</td>", "ID": "bb859b89-bcfc-489d-842d-9386ce7ee89a", "Styles": "width:304.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in", "Classes": "None", "Text": "     ", "ParentId": "9aae863f-a660-4c38-b607-f1848eeba015"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>", "ID": "dc392f1f-1b71-432b-823d-19232ce98dcb", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bb859b89-bcfc-489d-842d-9386ce7ee89a"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u>", "ID": "457ef8cc-ec12-4987-a227-18207a406cc6", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "dc392f1f-1b71-432b-823d-19232ce98dcb"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span>", "ID": "1cff7dd3-1aa5-4620-a674-a009e881a300", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Uncommon", "ParentId": "457ef8cc-ec12-4987-a227-18207a406cc6"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Renal failure,\n  nephrolithiasis, haematuria, pollakiuria, proteinuria</span></p>", "ID": "3f462c89-2c2b-4867-b78a-de77a30ffc31", "Styles": "margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bb859b89-bcfc-489d-842d-9386ce7ee89a"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Renal failure,\n  nephrolithiasis, haematuria, pollakiuria, proteinuria</span>", "ID": "a62b4eba-244a-4592-83a6-a2c6364b0dc1", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Renal failure,   nephrolithiasis, haematuria, pollakiuria, proteinuria", "ParentId": "3f462c89-2c2b-4867-b78a-de77a30ffc31"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>", "ID": "9b852ae1-9506-48b9-b322-d4badb02b007", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bb859b89-bcfc-489d-842d-9386ce7ee89a"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u>", "ID": "c439f343-b657-4504-9993-3a3a07f00ce7", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9b852ae1-9506-48b9-b322-d4badb02b007"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span>", "ID": "efaa5a3f-e39d-4ac7-a570-47ee1badf863", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Rare", "ParentId": "c439f343-b657-4504-9993-3a3a07f00ce7"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Tubulointerstitial\n  nephritis*, micturition urgency</span></p>", "ID": "d1027f54-0daa-4473-ac7a-1b0f8e23c345", "Styles": "margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bb859b89-bcfc-489d-842d-9386ce7ee89a"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Tubulointerstitial\n  nephritis*, micturition urgency</span>", "ID": "2e90ae1f-28c9-4003-afee-bc2e227fb039", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Tubulointerstitial   nephritis*, micturition urgency", "ParentId": "d1027f54-0daa-4473-ac7a-1b0f8e23c345"}, {"Element": "<tr>\n<td style=\"width:163.05pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"217\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Reproductive system\n  and breast</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>disorder</span></p>\n</td>\n<td style=\"width:304.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Erectile dysfunction</span></p>\n</td>\n</tr>", "ID": "b83f88cf-068a-46d7-b22d-a9209e903b55", "Styles": "None", "Classes": "None", "Text": "   ", "ParentId": "14402be6-54ec-445c-8aba-e8faa2f92a9f"}, {"Element": "<td style=\"width:163.05pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"217\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Reproductive system\n  and breast</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>disorder</span></p>\n</td>", "ID": "695c4808-8b74-4acb-b506-c0d883472abe", "Styles": "width:163.05pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in", "Classes": "None", "Text": "   ", "ParentId": "b83f88cf-068a-46d7-b22d-a9209e903b55"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Reproductive system\n  and breast</span></p>", "ID": "376c3003-22f6-4bd0-92c2-97067364d327", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "695c4808-8b74-4acb-b506-c0d883472abe"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Reproductive system\n  and breast</span>", "ID": "a774f57b-6b9d-4332-87ee-6bd21ce38614", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Reproductive system   and breast", "ParentId": "376c3003-22f6-4bd0-92c2-97067364d327"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>disorder</span></p>", "ID": "237663c3-0903-41f8-87ad-70a690b0afc2", "Styles": "margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "695c4808-8b74-4acb-b506-c0d883472abe"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>disorder</span>", "ID": "dc13d958-cbbb-4a8d-91e0-6384eb58f3da", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "disorder", "ParentId": "237663c3-0903-41f8-87ad-70a690b0afc2"}, {"Element": "<td style=\"width:304.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Erectile dysfunction</span></p>\n</td>", "ID": "1f469145-ec04-427e-bdb8-9f77826d3103", "Styles": "width:304.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in", "Classes": "None", "Text": "   ", "ParentId": "b83f88cf-068a-46d7-b22d-a9209e903b55"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>", "ID": "c4937bc3-f7ee-49f7-a5f1-26ca82282330", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "1f469145-ec04-427e-bdb8-9f77826d3103"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u>", "ID": "840066c5-1e32-4266-9b4d-3e6d3bbe3384", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c4937bc3-f7ee-49f7-a5f1-26ca82282330"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span>", "ID": "9c6ec3c0-7491-4ad8-a960-97cc3fc271fc", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Uncommon", "ParentId": "840066c5-1e32-4266-9b4d-3e6d3bbe3384"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Erectile dysfunction</span></p>", "ID": "c9e08b82-2a30-43c4-bd7a-4189b730d286", "Styles": "margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "1f469145-ec04-427e-bdb8-9f77826d3103"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Erectile dysfunction</span>", "ID": "7d92e138-90c6-4817-9f60-9c41c1d3b7b7", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Erectile dysfunction", "ParentId": "c9e08b82-2a30-43c4-bd7a-4189b730d286"}, {"Element": "<tr>\n<td style=\"width:163.05pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"217\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>General disorders and</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>administration site\n  conditions</span></p>\n</td>\n<td style=\"width:304.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Oedema</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Fatigue, chest pain,\n  chest discomfort</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Thirst</span></p>\n</td>\n</tr>", "ID": "e595e210-df88-4fc9-953c-ca6baafedbf8", "Styles": "None", "Classes": "None", "Text": "   ", "ParentId": "14402be6-54ec-445c-8aba-e8faa2f92a9f"}, {"Element": "<td style=\"width:163.05pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"217\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>General disorders and</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>administration site\n  conditions</span></p>\n</td>", "ID": "1594465a-c378-4aaa-9db5-1797c590a3ef", "Styles": "width:163.05pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in", "Classes": "None", "Text": "   ", "ParentId": "e595e210-df88-4fc9-953c-ca6baafedbf8"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>General disorders and</span></p>", "ID": "97d22bbe-2dc1-47c9-b00e-7dc24b483344", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "1594465a-c378-4aaa-9db5-1797c590a3ef"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>General disorders and</span>", "ID": "b5d00cb2-b103-4ad2-ba63-87d4a06309bc", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "General disorders and", "ParentId": "97d22bbe-2dc1-47c9-b00e-7dc24b483344"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>administration site\n  conditions</span></p>", "ID": "612e4d0c-3da6-4a78-88dd-bc9f3bd9c91a", "Styles": "margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "1594465a-c378-4aaa-9db5-1797c590a3ef"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>administration site\n  conditions</span>", "ID": "f38c93bb-f52c-4c06-acff-c26c4d3be3c9", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "administration site   conditions", "ParentId": "612e4d0c-3da6-4a78-88dd-bc9f3bd9c91a"}, {"Element": "<td style=\"width:304.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Oedema</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Fatigue, chest pain,\n  chest discomfort</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Thirst</span></p>\n</td>", "ID": "93748c89-02ef-4b7e-ac5e-249016c01d71", "Styles": "width:304.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in", "Classes": "None", "Text": "       ", "ParentId": "e595e210-df88-4fc9-953c-ca6baafedbf8"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common</span></u></p>", "ID": "d16dfaea-708a-4c10-912b-f1f0c5ed524e", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "93748c89-02ef-4b7e-ac5e-249016c01d71"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common</span></u>", "ID": "64ac8e3e-41d3-4cc7-b8e0-ff100916f27c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d16dfaea-708a-4c10-912b-f1f0c5ed524e"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common</span>", "ID": "53f45396-5184-401e-810c-fbece861d53a", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Common", "ParentId": "64ac8e3e-41d3-4cc7-b8e0-ff100916f27c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Oedema</span></p>", "ID": "cead8bf8-0da8-43e8-91c8-250b1ad2e030", "Styles": "margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "93748c89-02ef-4b7e-ac5e-249016c01d71"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Oedema</span>", "ID": "36262afa-2c3f-42a5-b807-d294a5bbdb23", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Oedema", "ParentId": "cead8bf8-0da8-43e8-91c8-250b1ad2e030"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>", "ID": "1d6939bc-c6bc-476f-b7a2-bb7956c05dd9", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "93748c89-02ef-4b7e-ac5e-249016c01d71"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u>", "ID": "67186ed9-a150-47f0-8788-7312b2dd169a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "1d6939bc-c6bc-476f-b7a2-bb7956c05dd9"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span>", "ID": "4533b81d-c120-4c05-b637-6e05dd6b525d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Uncommon", "ParentId": "67186ed9-a150-47f0-8788-7312b2dd169a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Fatigue, chest pain,\n  chest discomfort</span></p>", "ID": "e810a644-3013-4aa3-8c86-17613487b04e", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "93748c89-02ef-4b7e-ac5e-249016c01d71"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Fatigue, chest pain,\n  chest discomfort</span>", "ID": "cca78d12-042c-435b-a7d4-464014b2f5aa", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Fatigue, chest pain,   chest discomfort", "ParentId": "e810a644-3013-4aa3-8c86-17613487b04e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>", "ID": "0eafe26a-91b2-4b78-a1f4-02eff30769a8", "Styles": "margin-top:.05pt;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "93748c89-02ef-4b7e-ac5e-249016c01d71"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u>", "ID": "549fecde-853d-4f46-8e78-b808652f09ee", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0eafe26a-91b2-4b78-a1f4-02eff30769a8"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span>", "ID": "f053b7f3-de91-4ee2-bf05-b9ff974131e4", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Rare", "ParentId": "549fecde-853d-4f46-8e78-b808652f09ee"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Thirst</span></p>", "ID": "26b38944-b97e-4867-ae79-b16245f4c371", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "93748c89-02ef-4b7e-ac5e-249016c01d71"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Thirst</span>", "ID": "afa90dc0-8f3c-4d97-bfc8-84ba27232652", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Thirst", "ParentId": "26b38944-b97e-4867-ae79-b16245f4c371"}, {"Element": "<tr>\n<td style=\"width:163.05pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"217\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Investigations</span></p>\n</td>\n<td style=\"width:304.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:11.95pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.7pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Blood amylase\n  increase, platelet count decrease, WBC decrease, lymphocyte count decrease,\n  blood creatine increase, blood creatinine increase, haemoglobin decrease,\n  blood urea increase, blood triglycerides increase, blood cholesterol\n  increase, haematocritic decrease, blood lactate dehydrogenase increased,\n  blood potassium increase</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:21.05pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.7pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Blood glucose\n  increased, activated partial thromboplastin time prolonged, red blood cell\n  count decrease, blood alkaline phosphatase increase, blood creatine\n  phosphokinase increase*</span></p>\n</td>\n</tr>", "ID": "93078a88-a906-406b-92b3-595a894e4230", "Styles": "None", "Classes": "None", "Text": "   ", "ParentId": "14402be6-54ec-445c-8aba-e8faa2f92a9f"}, {"Element": "<td style=\"width:163.05pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"217\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Investigations</span></p>\n</td>", "ID": "887cb143-da7e-4732-9b02-060793e55796", "Styles": "width:163.05pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in", "Classes": "None", "Text": "  ", "ParentId": "93078a88-a906-406b-92b3-595a894e4230"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Investigations</span></p>", "ID": "a12bb828-5c3f-4229-a6cc-9264e2f9b455", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:12.3pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "887cb143-da7e-4732-9b02-060793e55796"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Investigations</span>", "ID": "9dd38fc4-2f9a-4095-82b7-6018a27d211d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Investigations", "ParentId": "a12bb828-5c3f-4229-a6cc-9264e2f9b455"}, {"Element": "<td style=\"width:304.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"406\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:11.95pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.7pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Blood amylase\n  increase, platelet count decrease, WBC decrease, lymphocyte count decrease,\n  blood creatine increase, blood creatinine increase, haemoglobin decrease,\n  blood urea increase, blood triglycerides increase, blood cholesterol\n  increase, haematocritic decrease, blood lactate dehydrogenase increased,\n  blood potassium increase</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:21.05pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.7pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Blood glucose\n  increased, activated partial thromboplastin time prolonged, red blood cell\n  count decrease, blood alkaline phosphatase increase, blood creatine\n  phosphokinase increase*</span></p>\n</td>", "ID": "5ebf29a8-e1ab-4c9c-b116-76dfa4dfd348", "Styles": "width:304.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in", "Classes": "None", "Text": "     ", "ParentId": "93078a88-a906-406b-92b3-595a894e4230"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u></p>", "ID": "82ff2760-159f-4a0e-93e4-aaa31967f527", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.3pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5ebf29a8-e1ab-4c9c-b116-76dfa4dfd348"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></u>", "ID": "be73de9d-4c40-4c9f-aeda-6743c9f33544", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "82ff2760-159f-4a0e-93e4-aaa31967f527"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span>", "ID": "e241b62c-53f9-4a29-b22f-34af4e17287d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Uncommon", "ParentId": "be73de9d-4c40-4c9f-aeda-6743c9f33544"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:11.95pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.7pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Blood amylase\n  increase, platelet count decrease, WBC decrease, lymphocyte count decrease,\n  blood creatine increase, blood creatinine increase, haemoglobin decrease,\n  blood urea increase, blood triglycerides increase, blood cholesterol\n  increase, haematocritic decrease, blood lactate dehydrogenase increased,\n  blood potassium increase</span></p>", "ID": "de301c3e-4dea-42ee-a4da-43ca6f638991", "Styles": "margin-top:.05pt;margin-right:11.95pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.7pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5ebf29a8-e1ab-4c9c-b116-76dfa4dfd348"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Blood amylase\n  increase, platelet count decrease, WBC decrease, lymphocyte count decrease,\n  blood creatine increase, blood creatinine increase, haemoglobin decrease,\n  blood urea increase, blood triglycerides increase, blood cholesterol\n  increase, haematocritic decrease, blood lactate dehydrogenase increased,\n  blood potassium increase</span>", "ID": "3698b551-3823-44c8-bbe4-beea0c956df0", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Blood amylase   increase, platelet count decrease, WBC decrease, lymphocyte count decrease,   blood creatine increase, blood creatinine increase, haemoglobin decrease,   blood urea increase, blood triglycerides increase, blood cholesterol   increase, haematocritic decrease, blood lactate dehydrogenase increased,   blood potassium increase", "ParentId": "de301c3e-4dea-42ee-a4da-43ca6f638991"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u></p>", "ID": "09daddca-a9a2-4137-9641-6830cba087ea", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.6pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5ebf29a8-e1ab-4c9c-b116-76dfa4dfd348"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span></u>", "ID": "ef02ea90-2766-46fe-b2c7-b0e5b1fff352", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "09daddca-a9a2-4137-9641-6830cba087ea"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare</span>", "ID": "3b171e90-846c-4b58-8ff7-b41cb9c2bd33", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Rare", "ParentId": "ef02ea90-2766-46fe-b2c7-b0e5b1fff352"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:21.05pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.7pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Blood glucose\n  increased, activated partial thromboplastin time prolonged, red blood cell\n  count decrease, blood alkaline phosphatase increase, blood creatine\n  phosphokinase increase*</span></p>", "ID": "c17b1c3a-6cfe-4a2c-ab48-b94f7847bfce", "Styles": "margin-top:.05pt;margin-right:21.05pt;margin-bottom:\n  0in;margin-left:5.0pt;line-height:12.7pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5ebf29a8-e1ab-4c9c-b116-76dfa4dfd348"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Blood glucose\n  increased, activated partial thromboplastin time prolonged, red blood cell\n  count decrease, blood alkaline phosphatase increase, blood creatine\n  phosphokinase increase*</span>", "ID": "c5c3ae26-8221-42c7-b50f-1e5db8be8b0d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Blood glucose   increased, activated partial thromboplastin time prolonged, red blood cell   count decrease, blood alkaline phosphatase increase, blood creatine   phosphokinase increase*", "ParentId": "c17b1c3a-6cfe-4a2c-ab48-b94f7847bfce"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:21.3pt;text-indent:-21.3pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>*</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0 Adverse reactions\ncoming from post-marketing experience</span></p>", "ID": "08fc23c9-1077-4084-b4e4-d9acbb2f7b1e", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:21.3pt;text-indent:-21.3pt;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>*</span>", "ID": "c51873b4-db7c-41d7-b376-a609ce510dd1", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "*", "ParentId": "08fc23c9-1077-4084-b4e4-d9acbb2f7b1e"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0 Adverse reactions\ncoming from post-marketing experience</span>", "ID": "897ddf70-ad69-4953-9e3a-5d4c8062a6d1", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0 Adverse reactions coming from post-marketing experience", "ParentId": "08fc23c9-1077-4084-b4e4-d9acbb2f7b1e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:21.3pt;text-indent:-21.3pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>**\u00a0\u00a0 Treatment-emergent\nnon-infective diarrhoea and abnormal liver function tests in the combined Phase\n3 studies are more frequent in patients concomitantly treated with colchicine.</span></p>", "ID": "5658fd49-0481-46b2-b8da-909fc03d76f7", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:21.3pt;text-indent:-21.3pt;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>**\u00a0\u00a0 Treatment-emergent\nnon-infective diarrhoea and abnormal liver function tests in the combined Phase\n3 studies are more frequent in patients concomitantly treated with colchicine.</span>", "ID": "e0ac18fd-b46a-4bd5-8706-541b113781b8", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "**\u00a0\u00a0 Treatment-emergent non-infective diarrhoea and abnormal liver function tests in the combined Phase 3 studies are more frequent in patients concomitantly treated with colchicine.", "ParentId": "5658fd49-0481-46b2-b8da-909fc03d76f7"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:21.3pt;text-indent:-21.3pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>*** See section 5.1 for\nincidences of gout flares in the individual Phase 3 randomized controlled\nstudies.</span></p>", "ID": "ebaf9890-4b72-4adf-8f99-6eef5c28c631", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:21.3pt;text-indent:-21.3pt;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>*** See section 5.1 for\nincidences of gout flares in the individual Phase 3 randomized controlled\nstudies.</span>", "ID": "24e3adec-dd19-41d2-9dfd-ea3f15b57a90", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "*** See section 5.1 for incidences of gout flares in the individual Phase 3 randomized controlled studies.", "ParentId": "ebaf9890-4b72-4adf-8f99-6eef5c28c631"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "692c92fb-3fac-4717-afa5-1c8966fd9887", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "48ea8743-01d5-452b-9924-ec359873aafb", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "692c92fb-3fac-4717-afa5-1c8966fd9887"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Description of selected adverse\nreactions</span></u></p>", "ID": "38fc8dd9-9321-4990-9bfa-09afb388db2d", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Description of selected adverse\nreactions</span></u>", "ID": "84f2f768-3c71-4135-9999-4fd1156ed558", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "38fc8dd9-9321-4990-9bfa-09afb388db2d"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Description of selected adverse\nreactions</span>", "ID": "75bc0d1b-c44e-4cda-8eac-e2b43c44c03a", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Description of selected adverse reactions", "ParentId": "84f2f768-3c71-4135-9999-4fd1156ed558"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:12.7pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "1013fc6f-4e91-47c3-80d8-d6d52b43216a", "Styles": "margin-top:.05pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:12.7pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "13c75894-c741-422a-8476-fddba22ac23b", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "1013fc6f-4e91-47c3-80d8-d6d52b43216a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:12.7pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare serious hypersensitivity\nreactions to febuxostat, including Stevens-Johnson Syndrome, Toxic epidermal\nnecrolysis and anaphylactic reaction/shock, have occurred in the post-marketing\nexperience. Stevens-Johnson Syndrome and Toxic epidermal necrolysis are\ncharacterised by progressive skin rashes associated with blisters or mucosal\nlesions and eye irritation. Hypersensitivity reactions to febuxostat can be\nassociated to the following symptoms: skin reactions characterised by\ninfiltrated maculopapular eruption, generalised or exfoliative rashes, but also\nskin lesions, facial oedema, fever, haematologic abnormalities such as\nthrombocytopenia and eosinophilia, and single or multiple organ involvement\n(liver and kidney including tubulointerstitial nephritis) (see section 4.4).</span></p>", "ID": "84a20175-6db3-4eb8-b063-da27d66f2c14", "Styles": "margin-top:.05pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:12.7pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare serious hypersensitivity\nreactions to febuxostat, including Stevens-Johnson Syndrome, Toxic epidermal\nnecrolysis and anaphylactic reaction/shock, have occurred in the post-marketing\nexperience. Stevens-Johnson Syndrome and Toxic epidermal necrolysis are\ncharacterised by progressive skin rashes associated with blisters or mucosal\nlesions and eye irritation. Hypersensitivity reactions to febuxostat can be\nassociated to the following symptoms: skin reactions characterised by\ninfiltrated maculopapular eruption, generalised or exfoliative rashes, but also\nskin lesions, facial oedema, fever, haematologic abnormalities such as\nthrombocytopenia and eosinophilia, and single or multiple organ involvement\n(liver and kidney including tubulointerstitial nephritis) (see section 4.4).</span>", "ID": "2a95ae13-f7cf-41c3-a390-d6012cfc35f4", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Rare serious hypersensitivity reactions to febuxostat, including Stevens-Johnson Syndrome, Toxic epidermal necrolysis and anaphylactic reaction/shock, have occurred in the post-marketing experience. Stevens-Johnson Syndrome and Toxic epidermal necrolysis are characterised by progressive skin rashes associated with blisters or mucosal lesions and eye irritation. Hypersensitivity reactions to febuxostat can be associated to the following symptoms: skin reactions characterised by infiltrated maculopapular eruption, generalised or exfoliative rashes, but also skin lesions, facial oedema, fever, haematologic abnormalities such as thrombocytopenia and eosinophilia, and single or multiple organ involvement (liver and kidney including tubulointerstitial nephritis) (see section 4.4).", "ParentId": "84a20175-6db3-4eb8-b063-da27d66f2c14"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.65pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:12.0pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "b6645c45-3a18-455e-a290-e2d2c8a933a9", "Styles": "margin-top:.65pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:12.0pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "921e312f-69ae-4dc6-a499-821b6eccc45b", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "b6645c45-3a18-455e-a290-e2d2c8a933a9"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Gout flares were commonly observed\nsoon after the start of treatment and during the first months. Thereafter, the\nfrequency of gout flare decreases in a time-dependent manner. Gout flare\nprophylaxis is recommended (see section 4.2 and 4.4).</span></p>", "ID": "4b0872be-7ad7-4f04-a2c8-5a2a060a4d2b", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Gout flares were commonly observed\nsoon after the start of treatment and during the first months. Thereafter, the\nfrequency of gout flare decreases in a time-dependent manner. Gout flare\nprophylaxis is recommended (see section 4.2 and 4.4).</span>", "ID": "886f98cc-770f-4fbb-a40b-3cd16658fe71", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Gout flares were commonly observed soon after the start of treatment and during the first months. Thereafter, the frequency of gout flare decreases in a time-dependent manner. Gout flare prophylaxis is recommended (see section 4.2 and 4.4).", "ParentId": "4b0872be-7ad7-4f04-a2c8-5a2a060a4d2b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "06f08164-c84b-4b06-9424-a5a86f0ca2ae", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "bb01c38f-187e-4eb2-ae3b-a76725aec28c", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "06f08164-c84b-4b06-9424-a5a86f0ca2ae"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Tumor Lysis Syndrome</span></u></p>", "ID": "3d3a561a-0b7e-4e85-84e8-48160e172552", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Tumor Lysis Syndrome</span></u>", "ID": "85b1633d-b032-4ea3-abf9-004fb9391cb3", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "3d3a561a-0b7e-4e85-84e8-48160e172552"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Tumor Lysis Syndrome</span>", "ID": "68752c90-1d0d-4b2a-93e2-ea45766dfce6", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Tumor Lysis Syndrome", "ParentId": "85b1633d-b032-4ea3-abf9-004fb9391cb3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "575d46c0-9c1f-4ca0-bf85-f987688ac76d", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "676fd078-4baf-4cba-8be0-f59a37abfa7c", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "575d46c0-9c1f-4ca0-bf85-f987688ac76d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Summary of the safety\nprofile</span></u></p>", "ID": "5acaf0f9-5553-43a5-9ea4-dc507e98a083", "Styles": "margin-top:.05pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Summary of the safety\nprofile</span></u>", "ID": "d073cba3-bf39-491f-9959-8ee570988de8", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "5acaf0f9-5553-43a5-9ea4-dc507e98a083"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Summary of the safety\nprofile</span>", "ID": "0d10d3fd-7e4a-4ed7-9ff2-2e21c8870075", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Summary of the safety profile", "ParentId": "d073cba3-bf39-491f-9959-8ee570988de8"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:12.7pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "4ce1a324-4a58-42fe-aacc-df0494564ec3", "Styles": "margin-top:.05pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:12.7pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "4395f1da-4e10-41eb-8710-3b71a66a9afa", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "4ce1a324-4a58-42fe-aacc-df0494564ec3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:12.7pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>In the randomized, double-blind,\nPhase 3 pivotal FLORENCE (FLO-01) study comparing febuxostat with allopurinol\n(346 patients undergoing chemotherapy for haematologic malignancies and at intermediate-to-high\nrisk of TLS), only 22 (6.4%) patients overall experienced adverse reactions, namely\n11 (6.4%) patients in each treatment group. The majority of adverse reactions\nwere either mild or moderate.</span></p>", "ID": "a7b355c1-04dd-4f9a-be03-925edd258f4e", "Styles": "margin-top:.05pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:12.7pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>In the randomized, double-blind,\nPhase 3 pivotal FLORENCE (FLO-01) study comparing febuxostat with allopurinol\n(346 patients undergoing chemotherapy for haematologic malignancies and at intermediate-to-high\nrisk of TLS), only 22 (6.4%) patients overall experienced adverse reactions, namely\n11 (6.4%) patients in each treatment group. The majority of adverse reactions\nwere either mild or moderate.</span>", "ID": "3d13df2a-89c6-40ec-958c-67fc2a6f3b57", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "In the randomized, double-blind, Phase 3 pivotal FLORENCE (FLO-01) study comparing febuxostat with allopurinol (346 patients undergoing chemotherapy for haematologic malignancies and at intermediate-to-high risk of TLS), only 22 (6.4%) patients overall experienced adverse reactions, namely 11 (6.4%) patients in each treatment group. The majority of adverse reactions were either mild or moderate.", "ParentId": "a7b355c1-04dd-4f9a-be03-925edd258f4e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.25pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "6ef79fcc-6f13-42dc-94f6-43614a546e79", "Styles": "margin-top:.25pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:12.6pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "9d9e4162-8cbc-4adf-aeea-035a022a01f0", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "6ef79fcc-6f13-42dc-94f6-43614a546e79"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:12.45pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Overall, the FLORENCE trial did not\nhighlight any particular safety concern in addition to the previous experience\nwith febuxostat in gout, with the exception of the following three adverse\nreactions (listed above in table 1).</span></p>", "ID": "8bb3fe77-202e-46e5-92fe-b1c8d548058f", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:12.45pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Overall, the FLORENCE trial did not\nhighlight any particular safety concern in addition to the previous experience\nwith febuxostat in gout, with the exception of the following three adverse\nreactions (listed above in table 1).</span>", "ID": "a8320ecb-3417-40ae-ab1a-3b2241a75032", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Overall, the FLORENCE trial did not highlight any particular safety concern in addition to the previous experience with febuxostat in gout, with the exception of the following three adverse reactions (listed above in table 1).", "ParentId": "8bb3fe77-202e-46e5-92fe-b1c8d548058f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.55pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:12.0pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "352c40b0-913f-4eae-85c0-1626e47182c8", "Styles": "margin-top:.55pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:12.0pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "f9a91d95-3ad1-452d-973d-bb92b92a714f", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "352c40b0-913f-4eae-85c0-1626e47182c8"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Cardiac disorders:</span></i></p>", "ID": "20a508cd-f0b9-4107-a50d-8f785ef1fdf3", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Cardiac disorders:</span></i>", "ID": "82f74103-8f55-467e-b538-08e327b37740", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "20a508cd-f0b9-4107-a50d-8f785ef1fdf3"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Cardiac disorders:</span>", "ID": "152f186d-c9f6-4e43-acfc-7dfb672e75c5", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Cardiac disorders:", "ParentId": "82f74103-8f55-467e-b538-08e327b37740"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon: Left bundle branch block,\nsinus tachycardia</span></p>", "ID": "a93f09b5-23a5-46ee-b373-0a9b1d8c1dbc", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:12.6pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon: Left bundle branch block,\nsinus tachycardia</span>", "ID": "f7dfa766-c6c7-4bc6-8d78-00f764ab0337", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Uncommon: Left bundle branch block, sinus tachycardia", "ParentId": "a93f09b5-23a5-46ee-b373-0a9b1d8c1dbc"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.65pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:12.0pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "49b52d54-a0e7-41be-b6be-539a0ebee653", "Styles": "margin-top:.65pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:12.0pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "923eba81-fe45-4c6a-8362-0088bd4495d7", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "49b52d54-a0e7-41be-b6be-539a0ebee653"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:100%;text-autospace:none\"><i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Vascular disorders:</span></i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'> </span></p>", "ID": "25cbe3d5-9434-4f2c-a9c8-b597bc74f593", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:100%;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Vascular disorders:</span></i>", "ID": "943e0772-0f04-4559-893e-395885fa48d8", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "25cbe3d5-9434-4f2c-a9c8-b597bc74f593"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Vascular disorders:</span>", "ID": "c7172e8e-16e1-4585-a087-f15499eaddb8", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Vascular disorders:", "ParentId": "943e0772-0f04-4559-893e-395885fa48d8"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'> </span>", "ID": "ca4b6db0-dce1-4608-af28-e827c029e69f", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": " ", "ParentId": "25cbe3d5-9434-4f2c-a9c8-b597bc74f593"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:100%;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon: haemorrhage</span></p>", "ID": "e68f7a92-dd86-4da4-8815-c3dbc397ff51", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:100%;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon: haemorrhage</span>", "ID": "adf53941-0485-4f81-a5e0-4fc5aa498f7b", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Uncommon: haemorrhage", "ParentId": "e68f7a92-dd86-4da4-8815-c3dbc397ff51"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.55pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:12.0pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "819359f9-3de6-4751-882e-c6f416e02fc0", "Styles": "margin-top:.55pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:12.0pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "20e6423c-3758-46c6-8693-27a3c9f5c7bb", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "819359f9-3de6-4751-882e-c6f416e02fc0"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Reporting of suspected adverse\nreactions</span></u></p>", "ID": "5aff0a31-8b33-4af4-8d51-36a325ee84ce", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Reporting of suspected adverse\nreactions</span></u>", "ID": "41135ce9-b712-4ab7-ba27-0d3610abd7ad", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "5aff0a31-8b33-4af4-8d51-36a325ee84ce"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Reporting of suspected adverse\nreactions</span>", "ID": "d0cb43df-8225-4db0-96b6-e60ea56d287b", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Reporting of suspected adverse reactions", "ParentId": "41135ce9-b712-4ab7-ba27-0d3610abd7ad"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:99%;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "4b4ea5c2-550a-4b65-bef8-052b8320f5be", "Styles": "margin-top:.05pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:99%;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "0781498f-f59b-4743-bcfd-ddab40728ee4", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "4b4ea5c2-550a-4b65-bef8-052b8320f5be"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.05pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:99%;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Reporting suspected adverse\nreactions after authorisation of the medicinal product is important. It allows\ncontinued monitoring of the benefit/risk balance of the medicinal product.\nHealthcare professionals are asked to report any suspected adverse reactions\nvia the national reporting system listed in </span><span lang=\"EN-GB\"><a href=\"http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc\"><span style='font-family:\"Times New Roman\",serif;color:windowtext'>Appendix V</span><span style='font-family:\"Times New Roman\",serif;color:windowtext;text-decoration:\nnone'>.</span></a></span></p>", "ID": "9b6f7c64-68a8-47fe-b3c8-ee460d3a96d8", "Styles": "margin-top:.05pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:99%;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Reporting suspected adverse\nreactions after authorisation of the medicinal product is important. It allows\ncontinued monitoring of the benefit/risk balance of the medicinal product.\nHealthcare professionals are asked to report any suspected adverse reactions\nvia the national reporting system listed in </span>", "ID": "4b069f36-f260-4ca2-b7d6-d47a252d682b", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system listed in ", "ParentId": "9b6f7c64-68a8-47fe-b3c8-ee460d3a96d8"}, {"Element": "<span lang=\"EN-GB\"><a href=\"http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc\"><span style='font-family:\"Times New Roman\",serif;color:windowtext'>Appendix V</span><span style='font-family:\"Times New Roman\",serif;color:windowtext;text-decoration:\nnone'>.</span></a></span>", "ID": "56889d58-5ff0-4c3b-a2cb-c3ba1be05abf", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9b6f7c64-68a8-47fe-b3c8-ee460d3a96d8"}, {"Element": "<a href=\"http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc\"><span style='font-family:\"Times New Roman\",serif;color:windowtext'>Appendix V</span><span style='font-family:\"Times New Roman\",serif;color:windowtext;text-decoration:\nnone'>.</span></a>", "ID": "dbd96fa0-9863-48a0-82b2-faae29ab7904", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "56889d58-5ff0-4c3b-a2cb-c3ba1be05abf"}, {"Element": "<span style='font-family:\"Times New Roman\",serif;color:windowtext'>Appendix V</span>", "ID": "4e847ef9-4461-4ddf-804b-a8d01ea48c4c", "Styles": "font-family:\"Times New Roman\",serif;color:windowtext", "Classes": "None", "Text": "Appendix V", "ParentId": "dbd96fa0-9863-48a0-82b2-faae29ab7904"}, {"Element": "<span style='font-family:\"Times New Roman\",serif;color:windowtext;text-decoration:\nnone'>.</span>", "ID": "1c2eb64e-7316-4be2-b47b-90a505921647", "Styles": "font-family:\"Times New Roman\",serif;color:windowtext;text-decoration:\nnone", "Classes": "None", "Text": ".", "ParentId": "dbd96fa0-9863-48a0-82b2-faae29ab7904"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.9pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:12.0pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "373f2b82-acfb-4528-adf2-229959fa35ee", "Styles": "margin-top:.9pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:12.0pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "391d400e-0ace-417a-8cef-28f20f256890", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "373f2b82-acfb-4528-adf2-229959fa35ee"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>4.9\u00a0\u00a0\u00a0\u00a0\u00a0 Overdose</span></b></p>", "ID": "b1fec523-34fe-4e14-bf62-6c0c90afb3b1", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>4.9\u00a0\u00a0\u00a0\u00a0\u00a0 Overdose</span></b>", "ID": "2d1b4f78-9204-4ea3-8311-608d411e1cef", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b1fec523-34fe-4e14-bf62-6c0c90afb3b1"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>4.9\u00a0\u00a0\u00a0\u00a0\u00a0 Overdose</span>", "ID": "46c4ad31-9041-4c0f-aaf2-7e3c9beb8477", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "4.9\u00a0\u00a0\u00a0\u00a0\u00a0 Overdose", "ParentId": "2d1b4f78-9204-4ea3-8311-608d411e1cef"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.45pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:12.0pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "8b3abb05-7664-4077-a0ea-3921db925980", "Styles": "margin-top:.45pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:12.0pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "edec225c-89cc-48af-8994-011d82456c87", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "8b3abb05-7664-4077-a0ea-3921db925980"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Patients with an overdose should be\nmanaged by symptomatic and supportive care.</span></p>", "ID": "e62adb78-10a8-41d8-b3e4-fe0b46ca461e", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Patients with an overdose should be\nmanaged by symptomatic and supportive care.</span>", "ID": "9d6fd2c9-36dc-4411-a8a9-a1ad3cad3747", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Patients with an overdose should be managed by symptomatic and supportive care.", "ParentId": "e62adb78-10a8-41d8-b3e4-fe0b46ca461e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:10.0pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "9e6c9a28-200f-413d-9b03-b5c1b462ebdf", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:10.0pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "5dd12905-bb9f-40f5-8dac-b7e83bffeb27", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "9e6c9a28-200f-413d-9b03-b5c1b462ebdf"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:10.0pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "7126a7b7-3b3e-4ebe-ae82-baadca977be3", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:10.0pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "06ee5788-0061-41f6-96d4-a78a2195c27e", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "7126a7b7-3b3e-4ebe-ae82-baadca977be3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACOLOGICAL\nPROPERTIES</span></b></p>", "ID": "237f39ec-426a-46c3-81b3-177274ddc3d5", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACOLOGICAL\nPROPERTIES</span></b>", "ID": "fd589dfd-49f5-4fe7-b998-1acb3b684bbf", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "237f39ec-426a-46c3-81b3-177274ddc3d5"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACOLOGICAL\nPROPERTIES</span>", "ID": "fd9a3ac4-d4f1-4fee-9857-d0e042534bb6", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACOLOGICAL PROPERTIES", "ParentId": "fd589dfd-49f5-4fe7-b998-1acb3b684bbf"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.65pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:12.0pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "54431946-51d7-49a5-a920-c4894161da13", "Styles": "margin-top:.65pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:12.0pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "e3c18334-2137-447e-88d6-11677feb6c97", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "54431946-51d7-49a5-a920-c4894161da13"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>5.1\u00a0\u00a0\u00a0\u00a0\u00a0 Pharmacodynamic properties</span></b></p>", "ID": "373d6cef-7183-4bfd-9a56-b05b965014ee", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>5.1\u00a0\u00a0\u00a0\u00a0\u00a0 Pharmacodynamic properties</span></b>", "ID": "b9a4f565-2955-4054-b95e-524242ae9b6a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "373d6cef-7183-4bfd-9a56-b05b965014ee"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>5.1\u00a0\u00a0\u00a0\u00a0\u00a0 Pharmacodynamic properties</span>", "ID": "5319fe0e-1a0d-4135-a9d2-1545b7762bb1", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "5.1\u00a0\u00a0\u00a0\u00a0\u00a0 Pharmacodynamic properties", "ParentId": "b9a4f565-2955-4054-b95e-524242ae9b6a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.45pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:12.0pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "99166e7e-0903-4a92-98d2-6d962bfd2fca", "Styles": "margin-top:.45pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:12.0pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "fcf059b9-f45e-4b37-b4e5-f6ec249866c5", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "99166e7e-0903-4a92-98d2-6d962bfd2fca"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Pharmacotherapeutic group: Antigout\npreparation, preparations inhibiting uric acid production, ATC code: M04AA03</span></p>", "ID": "569391a3-6efc-446b-b070-1bd798183fc9", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Pharmacotherapeutic group: Antigout\npreparation, preparations inhibiting uric acid production, ATC code: M04AA03</span>", "ID": "35e7bf30-3f5b-4a0d-bdf9-bfac70cbe987", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Pharmacotherapeutic group: Antigout preparation, preparations inhibiting uric acid production, ATC code: M04AA03", "ParentId": "569391a3-6efc-446b-b070-1bd798183fc9"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.7pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:12.0pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "bde28a0e-9dc2-46c6-8a8d-f906bcebc096", "Styles": "margin-top:.7pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:12.0pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "ec9370b5-d4a7-4e42-9d29-72cd70fdca6c", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "bde28a0e-9dc2-46c6-8a8d-f906bcebc096"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:12.45pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Mechanism of action</span></u></p>", "ID": "27c3af83-72d4-460d-9f21-c94fb02836cb", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:12.45pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Mechanism of action</span></u>", "ID": "6f51bc9b-28dd-4571-88ec-43da35a778e8", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "27c3af83-72d4-460d-9f21-c94fb02836cb"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Mechanism of action</span>", "ID": "095a8284-5d98-4fed-b686-9df32901542c", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Mechanism of action", "ParentId": "6f51bc9b-28dd-4571-88ec-43da35a778e8"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:12.45pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "f15f600f-717e-43ec-ac49-65d7c7175505", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:12.45pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "e0d83d1b-01d6-430a-8b52-9216b088d977", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "f15f600f-717e-43ec-ac49-65d7c7175505"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:12.45pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uric acid is the end product of\npurine metabolism in humans and is generated in the cascade of hypoxanthine\n\u2192 xanthine \u2192 uric acid. Both steps in the above transformations are\ncatalyzed by xanthine oxidase (XO). Febuxostat is a 2-arylthiazole derivative\nthat achieves its therapeutic effect of decreasing serum uric acid by\nselectively inhibiting XO. Febuxostat is a potent, non-purine selective\ninhibitor of XO (NP-SIXO) with an <i>in vitro</i> inhibition Ki value less than\none nanomolar. Febuxostat has been shown to potently inhibit both the oxidized\nand reduced forms of XO. At therapeutic concentrations febuxostat does not\ninhibit other enzymes involved in purine or pyrimidine metabolism, namely, guanine\ndeaminase, hypoxanthine guanine phosphoribosyltransferase, orotate\nphosphoribosyltransferase, orotidine monophosphate decarboxylase or purine\nnucleoside phosphorylase.</span></p>", "ID": "13b67554-08cc-4bdb-ba1c-618220f31c79", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:12.45pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uric acid is the end product of\npurine metabolism in humans and is generated in the cascade of hypoxanthine\n\u2192 xanthine \u2192 uric acid. Both steps in the above transformations are\ncatalyzed by xanthine oxidase (XO). Febuxostat is a 2-arylthiazole derivative\nthat achieves its therapeutic effect of decreasing serum uric acid by\nselectively inhibiting XO. Febuxostat is a potent, non-purine selective\ninhibitor of XO (NP-SIXO) with an <i>in vitro</i> inhibition Ki value less than\none nanomolar. Febuxostat has been shown to potently inhibit both the oxidized\nand reduced forms of XO. At therapeutic concentrations febuxostat does not\ninhibit other enzymes involved in purine or pyrimidine metabolism, namely, guanine\ndeaminase, hypoxanthine guanine phosphoribosyltransferase, orotate\nphosphoribosyltransferase, orotidine monophosphate decarboxylase or purine\nnucleoside phosphorylase.</span>", "ID": "09035e6d-ef55-4c74-a8a7-c05b9ed6605c", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Uric acid is the end product of purine metabolism in humans and is generated in the cascade of hypoxanthine \u2192 xanthine \u2192 uric acid. Both steps in the above transformations are catalyzed by xanthine oxidase (XO). Febuxostat is a 2-arylthiazole derivative that achieves its therapeutic effect of decreasing serum uric acid by selectively inhibiting XO. Febuxostat is a potent, non-purine selective inhibitor of XO (NP-SIXO) with an  inhibition Ki value less than one nanomolar. Febuxostat has been shown to potently inhibit both the oxidized and reduced forms of XO. At therapeutic concentrations febuxostat does not inhibit other enzymes involved in purine or pyrimidine metabolism, namely, guanine deaminase, hypoxanthine guanine phosphoribosyltransferase, orotate phosphoribosyltransferase, orotidine monophosphate decarboxylase or purine nucleoside phosphorylase.", "ParentId": "13b67554-08cc-4bdb-ba1c-618220f31c79"}, {"Element": "<i>in vitro</i>", "ID": "12d91c2d-a17a-4dee-85e4-35e9e4ba0687", "Styles": "None", "Classes": "None", "Text": "in vitro", "ParentId": "09035e6d-ef55-4c74-a8a7-c05b9ed6605c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.9pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:13.0pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "e512f6ad-e112-425e-9137-67750937783f", "Styles": "margin-top:.9pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:13.0pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "d52cd0b1-1a40-45dc-bc2d-c71e069a8515", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "e512f6ad-e112-425e-9137-67750937783f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:12.45pt;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Clinical efficacy and safety</span></u></p>", "ID": "6d90aa1c-4a30-4fd6-a576-2520f6f7600d", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:12.45pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Clinical efficacy and safety</span></u>", "ID": "4f10298a-a0ed-471a-9362-039120af42d4", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6d90aa1c-4a30-4fd6-a576-2520f6f7600d"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Clinical efficacy and safety</span>", "ID": "817e4cd9-115b-4f80-a712-d4746e5ef9f1", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Clinical efficacy and safety", "ParentId": "4f10298a-a0ed-471a-9362-039120af42d4"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.15pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:11.0pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "bf952f83-304f-483b-bb15-a46b5861a21c", "Styles": "margin-top:.15pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:11.0pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "4b194f68-223f-4d85-b7cc-21f7f4ddfe56", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "bf952f83-304f-483b-bb15-a46b5861a21c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:1.6pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:12.45pt;text-autospace:none\"><i><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Gout</span></u></i></p>", "ID": "951dddac-d988-4f81-be7e-6f79b9cc50c4", "Styles": "margin-top:1.6pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:12.45pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<i><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Gout</span></u></i>", "ID": "888c8636-1fd5-404e-be4e-c26b2ab96bfc", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "951dddac-d988-4f81-be7e-6f79b9cc50c4"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Gout</span></u>", "ID": "227575a0-ee44-42fc-86cc-3fe2f2cd4aae", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "888c8636-1fd5-404e-be4e-c26b2ab96bfc"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Gout</span>", "ID": "5a8a2447-68a1-4a44-aaf0-eee8f545a9ba", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Gout", "ParentId": "227575a0-ee44-42fc-86cc-3fe2f2cd4aae"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.3pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:11.0pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "9762e18b-1e43-4ce8-83d0-47edb7290e1f", "Styles": "margin-top:.3pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:11.0pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "6bccc8f8-18fa-4bc1-8dfc-46884228ac16", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "9762e18b-1e43-4ce8-83d0-47edb7290e1f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:1.6pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The efficacy of febuxostat was\ndemonstrated in three Phase 3 pivotal studies (the two pivotal APEX and FACT\nstudies, and the additional CONFIRMS study, described below) that were\nconducted in 4101 patients with hyperuricaemia and gout. In each phase 3\npivotal study, febuxostat demonstrated superior ability to lower and maintain\nserum uric acid levels compared to allopurinol. The primary efficacy endpoint\nin the APEX and FACT studies was the proportion of patients whose last 3 monthly\nserum uric acid levels were &lt; 6.0\u00a0mg/dL (357\u00a0\u00b5mol/L). In the\nadditional phase 3 CONFIRMS study, for which results became available after the\nmarketing authorisation for febuxostat was first issued, the primary efficacy\nendpoint was the proportion of patients whose serum urate level was &lt; 6.0\u00a0mg/dL\nat the final visit. No patients with organ transplant have been included in\nthese studies (see section 4.2).</span></p>", "ID": "a965066f-4996-409f-ab13-661047dcb6e9", "Styles": "margin-top:1.6pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The efficacy of febuxostat was\ndemonstrated in three Phase 3 pivotal studies (the two pivotal APEX and FACT\nstudies, and the additional CONFIRMS study, described below) that were\nconducted in 4101 patients with hyperuricaemia and gout. In each phase 3\npivotal study, febuxostat demonstrated superior ability to lower and maintain\nserum uric acid levels compared to allopurinol. The primary efficacy endpoint\nin the APEX and FACT studies was the proportion of patients whose last 3 monthly\nserum uric acid levels were &lt; 6.0\u00a0mg/dL (357\u00a0\u00b5mol/L). In the\nadditional phase 3 CONFIRMS study, for which results became available after the\nmarketing authorisation for febuxostat was first issued, the primary efficacy\nendpoint was the proportion of patients whose serum urate level was &lt; 6.0\u00a0mg/dL\nat the final visit. No patients with organ transplant have been included in\nthese studies (see section 4.2).</span>", "ID": "a3aaa21e-3a05-4bf2-b8a4-689b4e23acb1", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "The efficacy of febuxostat was demonstrated in three Phase 3 pivotal studies (the two pivotal APEX and FACT studies, and the additional CONFIRMS study, described below) that were conducted in 4101 patients with hyperuricaemia and gout. In each phase 3 pivotal study, febuxostat demonstrated superior ability to lower and maintain serum uric acid levels compared to allopurinol. The primary efficacy endpoint in the APEX and FACT studies was the proportion of patients whose last 3 monthly serum uric acid levels were < 6.0\u00a0mg/dL (357\u00a0\u00b5mol/L). In the additional phase 3 CONFIRMS study, for which results became available after the marketing authorisation for febuxostat was first issued, the primary efficacy endpoint was the proportion of patients whose serum urate level was < 6.0\u00a0mg/dL at the final visit. No patients with organ transplant have been included in these studies (see section 4.2).", "ParentId": "a965066f-4996-409f-ab13-661047dcb6e9"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.7pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:12.0pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "082e6f1e-732f-4a81-a1b2-f12bf4f41eaa", "Styles": "margin-top:.7pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:12.0pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "c20f6103-9ca3-4659-9224-169fe8b66bca", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "082e6f1e-732f-4a81-a1b2-f12bf4f41eaa"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>APEX Study</span></i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>: The Allopurinol and\nPlacebo-Controlled Efficacy Study of Febuxostat (APEX) was a Phase 3,\nrandomized, double-blind, multicenter, 28-week study. One thousand and\nseventy-two (1072) patients were randomized: placebo (n=134), febuxostat 80\u00a0mg\nQD (n=267), febuxostat 120\u00a0mg QD (n=269), febuxostat 240\u00a0mg QD\n(n=134) or allopurinol (300\u00a0mg QD [n=258] for patients with a baseline\nserum creatinine \u22641.5\u00a0mg/dL or 100\u00a0mg QD [n=10] for patients\nwith a baseline serum creatinine &gt;1.5\u00a0mg/dL and \u22642.0\u00a0mg/dL).\nTwo hundred and forty\u00a0mg febuxostat (2 times the recommended highest dose)\nwas used as a safety evaluation dose.</span></p>", "ID": "56695509-6acd-41eb-8bf0-fd781caec283", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>APEX Study</span></i>", "ID": "d3780d71-2826-4bdf-8513-0db7d310582b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "56695509-6acd-41eb-8bf0-fd781caec283"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>APEX Study</span>", "ID": "e229cff8-b19f-407f-af98-54658a896fec", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "APEX Study", "ParentId": "d3780d71-2826-4bdf-8513-0db7d310582b"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>: The Allopurinol and\nPlacebo-Controlled Efficacy Study of Febuxostat (APEX) was a Phase 3,\nrandomized, double-blind, multicenter, 28-week study. One thousand and\nseventy-two (1072) patients were randomized: placebo (n=134), febuxostat 80\u00a0mg\nQD (n=267), febuxostat 120\u00a0mg QD (n=269), febuxostat 240\u00a0mg QD\n(n=134) or allopurinol (300\u00a0mg QD [n=258] for patients with a baseline\nserum creatinine \u22641.5\u00a0mg/dL or 100\u00a0mg QD [n=10] for patients\nwith a baseline serum creatinine &gt;1.5\u00a0mg/dL and \u22642.0\u00a0mg/dL).\nTwo hundred and forty\u00a0mg febuxostat (2 times the recommended highest dose)\nwas used as a safety evaluation dose.</span>", "ID": "81856abf-7e01-4577-8018-b242a5e0ba70", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": ": The Allopurinol and Placebo-Controlled Efficacy Study of Febuxostat (APEX) was a Phase 3, randomized, double-blind, multicenter, 28-week study. One thousand and seventy-two (1072) patients were randomized: placebo (n=134), febuxostat 80\u00a0mg QD (n=267), febuxostat 120\u00a0mg QD (n=269), febuxostat 240\u00a0mg QD (n=134) or allopurinol (300\u00a0mg QD [n=258] for patients with a baseline serum creatinine \u22641.5\u00a0mg/dL or 100\u00a0mg QD [n=10] for patients with a baseline serum creatinine >1.5\u00a0mg/dL and \u22642.0\u00a0mg/dL). Two hundred and forty\u00a0mg febuxostat (2 times the recommended highest dose) was used as a safety evaluation dose.", "ParentId": "56695509-6acd-41eb-8bf0-fd781caec283"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.85pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:12.0pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "0310d8be-363b-4112-9297-f72fbbbb8be5", "Styles": "margin-top:.85pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:12.0pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "7626e397-ff18-4fa7-8ebf-6c1685ae0318", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "0310d8be-363b-4112-9297-f72fbbbb8be5"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:12.6pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The APEX study showed statistically\nsignificant superiority of both the febuxostat 80\u00a0mg QD and the febuxostat\n120\u00a0mg QD treatment arms <i>versus </i>the conventionally used doses of\nallopurinol 300\u00a0mg (n=258) /100\u00a0mg (n = 10) treatment arm in reducing\nthe sUA below 6\u00a0mg/dL (357\u00a0\u00b5mol/L) (see Table 2 and Figure 1).</span></p>", "ID": "565ffa21-dabb-4455-8d5d-267adc9763dc", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:12.6pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The APEX study showed statistically\nsignificant superiority of both the febuxostat 80\u00a0mg QD and the febuxostat\n120\u00a0mg QD treatment arms <i>versus </i>the conventionally used doses of\nallopurinol 300\u00a0mg (n=258) /100\u00a0mg (n = 10) treatment arm in reducing\nthe sUA below 6\u00a0mg/dL (357\u00a0\u00b5mol/L) (see Table 2 and Figure 1).</span>", "ID": "5f4c7265-6d16-4b8b-bab1-1a4bc9fca775", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "The APEX study showed statistically significant superiority of both the febuxostat 80\u00a0mg QD and the febuxostat 120\u00a0mg QD treatment arms the conventionally used doses of allopurinol 300\u00a0mg (n=258) /100\u00a0mg (n = 10) treatment arm in reducing the sUA below 6\u00a0mg/dL (357\u00a0\u00b5mol/L) (see Table 2 and Figure 1).", "ParentId": "565ffa21-dabb-4455-8d5d-267adc9763dc"}, {"Element": "<i>versus </i>", "ID": "9b11d9ac-fbca-4b4a-94e0-dc266c6bed43", "Styles": "None", "Classes": "None", "Text": "versus ", "ParentId": "5f4c7265-6d16-4b8b-bab1-1a4bc9fca775"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.55pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:12.0pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "e11a8cdc-7d5b-4a93-b183-0fb56ffd8c72", "Styles": "margin-top:.55pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:12.0pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "615c74f2-24bf-4be8-9b5c-f4628c3bc426", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "e11a8cdc-7d5b-4a93-b183-0fb56ffd8c72"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:99%;text-autospace:none\"><i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>FACT Study</span></i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>: The Febuxostat\nAllopurinol Controlled Trial (FACT) Study was a Phase 3, randomized,\ndouble-blind, multicenter, 52-week study. Seven hundred sixty (760) patients\nwere randomized: febuxostat 80\u00a0mg QD (n=256), febuxostat 120\u00a0mg QD\n(n=251), or allopurinol 300\u00a0mg QD (n=253).</span></p>", "ID": "8c93e534-1d9c-4fbb-ae01-94760a8b9898", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:99%;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>FACT Study</span></i>", "ID": "f7909e47-90cf-420d-8115-50865b9b66d5", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "8c93e534-1d9c-4fbb-ae01-94760a8b9898"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>FACT Study</span>", "ID": "47cbaed2-7723-4cce-af33-46c41d11dd9b", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "FACT Study", "ParentId": "f7909e47-90cf-420d-8115-50865b9b66d5"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>: The Febuxostat\nAllopurinol Controlled Trial (FACT) Study was a Phase 3, randomized,\ndouble-blind, multicenter, 52-week study. Seven hundred sixty (760) patients\nwere randomized: febuxostat 80\u00a0mg QD (n=256), febuxostat 120\u00a0mg QD\n(n=251), or allopurinol 300\u00a0mg QD (n=253).</span>", "ID": "5f9c0c90-e2b4-47f7-8304-e92004391ade", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": ": The Febuxostat Allopurinol Controlled Trial (FACT) Study was a Phase 3, randomized, double-blind, multicenter, 52-week study. Seven hundred sixty (760) patients were randomized: febuxostat 80\u00a0mg QD (n=256), febuxostat 120\u00a0mg QD (n=251), or allopurinol 300\u00a0mg QD (n=253).", "ParentId": "8c93e534-1d9c-4fbb-ae01-94760a8b9898"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.65pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:12.0pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "29fcec73-1dc7-4172-8da3-95081a1d53dd", "Styles": "margin-top:.65pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:12.0pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "9a07e276-98bc-4179-8cbe-2bc23d99da17", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "29fcec73-1dc7-4172-8da3-95081a1d53dd"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The FACT study showed the\nstatistically significant superiority of both febuxostat 80\u00a0mg and febuxostat\n120\u00a0mg QD treatment arms <i>versus </i>the conventionally used dose of\nallopurinol 300\u00a0mg treatment arm in reducing and maintaining sUA below 6\u00a0mg/dL\n(357\u00a0\u00b5mol/L).</span></p>", "ID": "021a4cc4-f033-44c2-81e3-c0cc8a908302", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The FACT study showed the\nstatistically significant superiority of both febuxostat 80\u00a0mg and febuxostat\n120\u00a0mg QD treatment arms <i>versus </i>the conventionally used dose of\nallopurinol 300\u00a0mg treatment arm in reducing and maintaining sUA below 6\u00a0mg/dL\n(357\u00a0\u00b5mol/L).</span>", "ID": "7cb498af-7195-4db3-bacf-6889d6ea063c", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "The FACT study showed the statistically significant superiority of both febuxostat 80\u00a0mg and febuxostat 120\u00a0mg QD treatment arms the conventionally used dose of allopurinol 300\u00a0mg treatment arm in reducing and maintaining sUA below 6\u00a0mg/dL (357\u00a0\u00b5mol/L).", "ParentId": "021a4cc4-f033-44c2-81e3-c0cc8a908302"}, {"Element": "<i>versus </i>", "ID": "bc30b336-cfce-4ff3-a3e1-f5c1cd9d246a", "Styles": "None", "Classes": "None", "Text": "versus ", "ParentId": "7cb498af-7195-4db3-bacf-6889d6ea063c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.65pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:12.0pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "5106d22a-a4d8-4dab-99f3-648b2bba08df", "Styles": "margin-top:.65pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:12.0pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "a3728f25-e9fe-414a-8ce6-228e70114f3a", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "5106d22a-a4d8-4dab-99f3-648b2bba08df"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Table 2 summarises the primary\nefficacy endpoint results:</span></p>", "ID": "0d1da794-0e6d-4f79-ae4d-9be53954865d", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Table 2 summarises the primary\nefficacy endpoint results:</span>", "ID": "ffe8deef-3cc2-42cf-9b79-ef248dd74fff", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Table 2 summarises the primary efficacy endpoint results:", "ParentId": "0d1da794-0e6d-4f79-ae4d-9be53954865d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.9pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:12.0pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "0b9459ca-174f-4f75-bbb2-8579055900fd", "Styles": "margin-top:.9pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:12.0pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "b2990936-71f7-4f73-8ad7-327bf703efd0", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "0b9459ca-174f-4f75-bbb2-8579055900fd"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Table 2</span></b></p>", "ID": "48c22105-34a9-4089-9dfe-290fb384d832", "Styles": "margin-top:0in;margin-right:3.1pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Table 2</span></b>", "ID": "9d139590-69a2-4619-a125-23e4c8465053", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "48c22105-34a9-4089-9dfe-290fb384d832"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Table 2</span>", "ID": "759f92cb-550a-40eb-84bf-ae4a2944a475", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Table 2", "ParentId": "9d139590-69a2-4619-a125-23e4c8465053"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.1pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:12.6pt;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Proportion of Patients\nwith Serum Uric Acid Levels &lt;6.0\u00a0mg/dL (357\u00a0\u00b5mol/L) Last Three\nMonthly Visits</span></b></p>", "ID": "cff90d01-c3b0-4917-9166-652b18e0864f", "Styles": "margin-top:.1pt;margin-right:3.1pt;margin-bottom:\n0in;margin-left:0in;line-height:12.6pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Proportion of Patients\nwith Serum Uric Acid Levels &lt;6.0\u00a0mg/dL (357\u00a0\u00b5mol/L) Last Three\nMonthly Visits</span></b>", "ID": "8dfaf35a-9901-417f-8ae8-94210527ea80", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "cff90d01-c3b0-4917-9166-652b18e0864f"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Proportion of Patients\nwith Serum Uric Acid Levels &lt;6.0\u00a0mg/dL (357\u00a0\u00b5mol/L) Last Three\nMonthly Visits</span>", "ID": "c107314f-fab4-4c60-a6ee-82791da79968", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Proportion of Patients with Serum Uric Acid Levels <6.0\u00a0mg/dL (357\u00a0\u00b5mol/L) Last Three Monthly Visits", "ParentId": "8dfaf35a-9901-417f-8ae8-94210527ea80"}, {"Element": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"margin-left:57.0pt;border-collapse:collapse\">\n<tr>\n<td style=\"width:89.9pt;border:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"120\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;text-autospace:\n  none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:28.9pt;\n  margin-bottom:0in;margin-left:29.9pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Study</span></p>\n</td>\n<td style=\"width:90.7pt;border:solid black 1.0pt;\n  border-left:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"121\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;text-autospace:\n  none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:19.25pt;\n  margin-bottom:0in;margin-left:19.85pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat\n  </span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>80\u00a0mg\n  QD</span></p>\n</td>\n<td style=\"width:76.45pt;border:solid black 1.0pt;\n  border-left:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"102\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;text-autospace:\n  none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:9.55pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:11.95pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>120\u00a0mg QD</span></p>\n</td>\n<td style=\"width:90.2pt;border:solid black 1.0pt;\n  border-left:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"120\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:18.05pt;\n  margin-bottom:0in;margin-left:19.0pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Allopurinol</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:32.55pt;\n  margin-bottom:0in;margin-left:33.5pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>300\n  /</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:16.05pt;\n  margin-bottom:0in;margin-left:16.85pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>100\u00a0mg\n  QD<sup>1</sup></span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:89.9pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"120\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:27.55pt;\n  margin-bottom:0in;margin-left:28.35pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>APEX</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:17.55pt;\n  margin-bottom:0in;margin-left:18.4pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(28\n  weeks)</span></p>\n</td>\n<td style=\"width:90.7pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"121\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:29.4pt;\n  margin-bottom:0in;margin-left:30.25pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>48%*</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:24.55pt;\n  margin-bottom:0in;margin-left:25.35pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=262)</span></p>\n</td>\n<td style=\"width:76.45pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"102\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:21.65pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>65%*<sup>, #</sup></span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:20.1pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=269)</span></p>\n</td>\n<td style=\"width:90.2pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"120\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:33.65pt;\n  margin-bottom:0in;margin-left:34.35pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>22%</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:25.95pt;\n  margin-bottom:0in;margin-left:26.9pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=268)</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:89.9pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"120\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:27.95pt;\n  margin-bottom:0in;margin-left:28.6pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>FACT</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:17.55pt;\n  margin-bottom:0in;margin-left:18.4pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(52\n  weeks)</span></p>\n</td>\n<td style=\"width:90.7pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"121\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:30.25pt;\n  margin-bottom:0in;margin-left:31.25pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>53%*</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:24.55pt;\n  margin-bottom:0in;margin-left:25.35pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=255)</span></p>\n</td>\n<td style=\"width:76.45pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"102\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:23.05pt;\n  margin-bottom:0in;margin-left:24.15pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>62%*</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:17.35pt;\n  margin-bottom:0in;margin-left:18.3pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=250)</span></p>\n</td>\n<td style=\"width:90.2pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"120\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:33.65pt;\n  margin-bottom:0in;margin-left:34.35pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>21%</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:25.95pt;\n  margin-bottom:0in;margin-left:26.9pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=251)</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:89.9pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"120\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:18.95pt;\n  margin-bottom:0in;margin-left:19.85pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Combined</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:25.6pt;\n  margin-bottom:0in;margin-left:26.55pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Results</span></p>\n</td>\n<td style=\"width:90.7pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"121\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:30.35pt;\n  margin-bottom:0in;margin-left:31.1pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>51%*</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:24.55pt;\n  margin-bottom:0in;margin-left:25.35pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=517)</span></p>\n</td>\n<td style=\"width:76.45pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"102\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:22.5pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>63%*<sup>, #</sup></span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:20.1pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=519)</span></p>\n</td>\n<td style=\"width:90.2pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"120\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:33.5pt;\n  margin-bottom:0in;margin-left:34.45pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>22%</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:25.95pt;\n  margin-bottom:0in;margin-left:26.9pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=519)</span></p>\n</td>\n</tr>\n<tr>\n<td colspan=\"4\" style=\"width:347.25pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"463\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.5pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:normal;text-autospace:none\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'> results from subjects\n  receiving either 100\u00a0mg QD (n=10: patients with serum creatinine &gt;1.5\n  and </span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u22642.0\u00a0mg/dL)\n  or 300\u00a0mg QD (n=509) were pooled </span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>for analyses.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>* p &lt; 0.001 vs\n  allopurinol, # p &lt; 0.001 vs 80\u00a0mg</span></p>\n</td>\n</tr>\n</table>", "ID": "87b0a814-635d-4272-be9c-ca34c35c92f2", "Styles": "margin-left:57.0pt;border-collapse:collapse", "Classes": "['MsoNormalTable']", "Text": "      ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<tr>\n<td style=\"width:89.9pt;border:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"120\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;text-autospace:\n  none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:28.9pt;\n  margin-bottom:0in;margin-left:29.9pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Study</span></p>\n</td>\n<td style=\"width:90.7pt;border:solid black 1.0pt;\n  border-left:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"121\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;text-autospace:\n  none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:19.25pt;\n  margin-bottom:0in;margin-left:19.85pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat\n  </span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>80\u00a0mg\n  QD</span></p>\n</td>\n<td style=\"width:76.45pt;border:solid black 1.0pt;\n  border-left:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"102\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;text-autospace:\n  none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:9.55pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:11.95pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>120\u00a0mg QD</span></p>\n</td>\n<td style=\"width:90.2pt;border:solid black 1.0pt;\n  border-left:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"120\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:18.05pt;\n  margin-bottom:0in;margin-left:19.0pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Allopurinol</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:32.55pt;\n  margin-bottom:0in;margin-left:33.5pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>300\n  /</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:16.05pt;\n  margin-bottom:0in;margin-left:16.85pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>100\u00a0mg\n  QD<sup>1</sup></span></p>\n</td>\n</tr>", "ID": "d5531519-48ea-4286-a8db-61dfa69f7e8d", "Styles": "None", "Classes": "None", "Text": "     ", "ParentId": "87b0a814-635d-4272-be9c-ca34c35c92f2"}, {"Element": "<td style=\"width:89.9pt;border:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"120\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;text-autospace:\n  none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:28.9pt;\n  margin-bottom:0in;margin-left:29.9pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Study</span></p>\n</td>", "ID": "2d969678-d51a-4292-b676-5fb5928e8450", "Styles": "width:89.9pt;border:solid black 1.0pt;\n  padding:0in 0in 0in 0in", "Classes": "None", "Text": "   ", "ParentId": "d5531519-48ea-4286-a8db-61dfa69f7e8d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;text-autospace:\n  none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "9c43472c-684c-47b4-aaf9-f89a2922e15a", "Styles": "margin-bottom:0in;line-height:normal;text-autospace:\n  none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "2d969678-d51a-4292-b676-5fb5928e8450"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "d23ae466-a704-43fa-a255-ad930360ee1c", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "9c43472c-684c-47b4-aaf9-f89a2922e15a"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:28.9pt;\n  margin-bottom:0in;margin-left:29.9pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Study</span></p>", "ID": "809c410e-65e2-4e8a-948c-9df14d9ab0c0", "Styles": "margin-top:0in;margin-right:28.9pt;\n  margin-bottom:0in;margin-left:29.9pt;text-align:center;line-height:normal;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "2d969678-d51a-4292-b676-5fb5928e8450"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Study</span>", "ID": "bee83eb0-227a-4245-8418-d3114fa2089e", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Study", "ParentId": "809c410e-65e2-4e8a-948c-9df14d9ab0c0"}, {"Element": "<td style=\"width:90.7pt;border:solid black 1.0pt;\n  border-left:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"121\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;text-autospace:\n  none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:19.25pt;\n  margin-bottom:0in;margin-left:19.85pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat\n  </span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>80\u00a0mg\n  QD</span></p>\n</td>", "ID": "15b8d181-d478-43c2-92aa-0e5bb78436d5", "Styles": "width:90.7pt;border:solid black 1.0pt;\n  border-left:none;padding:0in 0in 0in 0in", "Classes": "None", "Text": "   ", "ParentId": "d5531519-48ea-4286-a8db-61dfa69f7e8d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;text-autospace:\n  none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "d4fef89d-dfc1-4387-a0c0-1a58a62bb6d5", "Styles": "margin-bottom:0in;line-height:normal;text-autospace:\n  none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "15b8d181-d478-43c2-92aa-0e5bb78436d5"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "ac7d1dfb-7d63-4dbf-be91-444fa9d16462", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "d4fef89d-dfc1-4387-a0c0-1a58a62bb6d5"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:19.25pt;\n  margin-bottom:0in;margin-left:19.85pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat\n  </span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>80\u00a0mg\n  QD</span></p>", "ID": "0a57db2d-8cf2-4d37-8b56-61e7313f53fc", "Styles": "margin-top:0in;margin-right:19.25pt;\n  margin-bottom:0in;margin-left:19.85pt;text-align:center;line-height:normal;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "15b8d181-d478-43c2-92aa-0e5bb78436d5"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat\n  </span>", "ID": "bdd3443b-d886-475a-b447-8944b7f0671d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Febuxostat   ", "ParentId": "0a57db2d-8cf2-4d37-8b56-61e7313f53fc"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>80\u00a0mg\n  QD</span>", "ID": "7562c14a-121a-4b48-a8f7-66f891af97a6", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "80\u00a0mg   QD", "ParentId": "0a57db2d-8cf2-4d37-8b56-61e7313f53fc"}, {"Element": "<td style=\"width:76.45pt;border:solid black 1.0pt;\n  border-left:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"102\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;text-autospace:\n  none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:9.55pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:11.95pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>120\u00a0mg QD</span></p>\n</td>", "ID": "bf5fc9d9-07e8-4d09-ae8d-7d4d5e56a925", "Styles": "width:76.45pt;border:solid black 1.0pt;\n  border-left:none;padding:0in 0in 0in 0in", "Classes": "None", "Text": "    ", "ParentId": "d5531519-48ea-4286-a8db-61dfa69f7e8d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;text-autospace:\n  none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "3f49c8b4-5f0d-41c2-9cee-275d6c816076", "Styles": "margin-bottom:0in;line-height:normal;text-autospace:\n  none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bf5fc9d9-07e8-4d09-ae8d-7d4d5e56a925"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "8909bdcf-bcd0-48ac-83ff-60dd70b32148", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "3f49c8b4-5f0d-41c2-9cee-275d6c816076"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:9.55pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat</span></p>", "ID": "4b1e9baa-7e20-4a62-90ed-1774db867ae1", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:9.55pt;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bf5fc9d9-07e8-4d09-ae8d-7d4d5e56a925"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat</span>", "ID": "697979b6-cab5-42d3-b5d1-df12080098f8", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Febuxostat", "ParentId": "4b1e9baa-7e20-4a62-90ed-1774db867ae1"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:11.95pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>120\u00a0mg QD</span></p>", "ID": "95e2f9e7-cde3-421f-91f7-c8b66ab22055", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:11.95pt;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bf5fc9d9-07e8-4d09-ae8d-7d4d5e56a925"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>120\u00a0mg QD</span>", "ID": "eb5c2a33-46ab-4dfa-b89d-9f997678c524", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "120\u00a0mg QD", "ParentId": "95e2f9e7-cde3-421f-91f7-c8b66ab22055"}, {"Element": "<td style=\"width:90.2pt;border:solid black 1.0pt;\n  border-left:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"120\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:18.05pt;\n  margin-bottom:0in;margin-left:19.0pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Allopurinol</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:32.55pt;\n  margin-bottom:0in;margin-left:33.5pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>300\n  /</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:16.05pt;\n  margin-bottom:0in;margin-left:16.85pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>100\u00a0mg\n  QD<sup>1</sup></span></p>\n</td>", "ID": "cb411f16-f247-4222-b40b-9f1b7e133097", "Styles": "width:90.2pt;border:solid black 1.0pt;\n  border-left:none;padding:0in 0in 0in 0in", "Classes": "None", "Text": "    ", "ParentId": "d5531519-48ea-4286-a8db-61dfa69f7e8d"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:18.05pt;\n  margin-bottom:0in;margin-left:19.0pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Allopurinol</span></p>", "ID": "88e8cd18-d8f9-4929-bc8d-d4e9a35a6f3f", "Styles": "margin-top:0in;margin-right:18.05pt;\n  margin-bottom:0in;margin-left:19.0pt;text-align:center;line-height:normal;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "cb411f16-f247-4222-b40b-9f1b7e133097"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Allopurinol</span>", "ID": "2596d967-3f22-415d-aa69-50699b121c54", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Allopurinol", "ParentId": "88e8cd18-d8f9-4929-bc8d-d4e9a35a6f3f"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:32.55pt;\n  margin-bottom:0in;margin-left:33.5pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>300\n  /</span></p>", "ID": "da5c5c5e-9693-4112-bc89-8fb60b498ee2", "Styles": "margin-top:0in;margin-right:32.55pt;\n  margin-bottom:0in;margin-left:33.5pt;text-align:center;line-height:normal;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "cb411f16-f247-4222-b40b-9f1b7e133097"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>300\n  /</span>", "ID": "eccd25cd-42a4-4427-8e57-b105999e05c7", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "300   /", "ParentId": "da5c5c5e-9693-4112-bc89-8fb60b498ee2"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:16.05pt;\n  margin-bottom:0in;margin-left:16.85pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>100\u00a0mg\n  QD<sup>1</sup></span></p>", "ID": "0d1de357-7b72-49f4-8bfd-b088abf249d4", "Styles": "margin-top:0in;margin-right:16.05pt;\n  margin-bottom:0in;margin-left:16.85pt;text-align:center;line-height:normal;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "cb411f16-f247-4222-b40b-9f1b7e133097"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>100\u00a0mg\n  QD<sup>1</sup></span>", "ID": "5a1d113e-47ad-4be8-a942-9d519fd047e8", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "100\u00a0mg   QD", "ParentId": "0d1de357-7b72-49f4-8bfd-b088abf249d4"}, {"Element": "<sup>1</sup>", "ID": "46bda996-89ab-40b8-9551-01fd8709f156", "Styles": "None", "Classes": "None", "Text": "1", "ParentId": "5a1d113e-47ad-4be8-a942-9d519fd047e8"}, {"Element": "<tr>\n<td style=\"width:89.9pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"120\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:27.55pt;\n  margin-bottom:0in;margin-left:28.35pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>APEX</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:17.55pt;\n  margin-bottom:0in;margin-left:18.4pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(28\n  weeks)</span></p>\n</td>\n<td style=\"width:90.7pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"121\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:29.4pt;\n  margin-bottom:0in;margin-left:30.25pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>48%*</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:24.55pt;\n  margin-bottom:0in;margin-left:25.35pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=262)</span></p>\n</td>\n<td style=\"width:76.45pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"102\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:21.65pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>65%*<sup>, #</sup></span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:20.1pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=269)</span></p>\n</td>\n<td style=\"width:90.2pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"120\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:33.65pt;\n  margin-bottom:0in;margin-left:34.35pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>22%</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:25.95pt;\n  margin-bottom:0in;margin-left:26.9pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=268)</span></p>\n</td>\n</tr>", "ID": "b9cc6466-f6bd-4af8-ab4f-2c1a3cdef93b", "Styles": "None", "Classes": "None", "Text": "     ", "ParentId": "87b0a814-635d-4272-be9c-ca34c35c92f2"}, {"Element": "<td style=\"width:89.9pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"120\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:27.55pt;\n  margin-bottom:0in;margin-left:28.35pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>APEX</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:17.55pt;\n  margin-bottom:0in;margin-left:18.4pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(28\n  weeks)</span></p>\n</td>", "ID": "f5e58210-0d26-4437-84a6-e4638b9f7d58", "Styles": "width:89.9pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in", "Classes": "None", "Text": "   ", "ParentId": "b9cc6466-f6bd-4af8-ab4f-2c1a3cdef93b"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:27.55pt;\n  margin-bottom:0in;margin-left:28.35pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>APEX</span></p>", "ID": "6599601a-ed52-4a49-b550-6bff183c15bd", "Styles": "margin-top:0in;margin-right:27.55pt;\n  margin-bottom:0in;margin-left:28.35pt;text-align:center;line-height:normal;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f5e58210-0d26-4437-84a6-e4638b9f7d58"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>APEX</span>", "ID": "85c66bf3-5339-4321-9573-9e5219fdb2e8", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "APEX", "ParentId": "6599601a-ed52-4a49-b550-6bff183c15bd"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:17.55pt;\n  margin-bottom:0in;margin-left:18.4pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(28\n  weeks)</span></p>", "ID": "6dda1eba-fd22-4132-8aa8-6710878ecee5", "Styles": "margin-top:0in;margin-right:17.55pt;\n  margin-bottom:0in;margin-left:18.4pt;text-align:center;line-height:normal;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f5e58210-0d26-4437-84a6-e4638b9f7d58"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(28\n  weeks)</span>", "ID": "374eddee-6515-4a81-8862-d6bdc354201b", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "(28   weeks)", "ParentId": "6dda1eba-fd22-4132-8aa8-6710878ecee5"}, {"Element": "<td style=\"width:90.7pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"121\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:29.4pt;\n  margin-bottom:0in;margin-left:30.25pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>48%*</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:24.55pt;\n  margin-bottom:0in;margin-left:25.35pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=262)</span></p>\n</td>", "ID": "bca48f13-87d5-4346-ae80-0e879b7f53ab", "Styles": "width:90.7pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in", "Classes": "None", "Text": "   ", "ParentId": "b9cc6466-f6bd-4af8-ab4f-2c1a3cdef93b"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:29.4pt;\n  margin-bottom:0in;margin-left:30.25pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>48%*</span></p>", "ID": "aff1eb1a-c623-41a3-8120-9b77f127f2d9", "Styles": "margin-top:0in;margin-right:29.4pt;\n  margin-bottom:0in;margin-left:30.25pt;text-align:center;line-height:normal;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bca48f13-87d5-4346-ae80-0e879b7f53ab"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>48%*</span>", "ID": "b4e5ee1e-9011-4229-891e-265da32203bd", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "48%*", "ParentId": "aff1eb1a-c623-41a3-8120-9b77f127f2d9"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:24.55pt;\n  margin-bottom:0in;margin-left:25.35pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=262)</span></p>", "ID": "874aa5ab-8c0a-4c0a-8a58-37252b72af57", "Styles": "margin-top:0in;margin-right:24.55pt;\n  margin-bottom:0in;margin-left:25.35pt;text-align:center;line-height:normal;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bca48f13-87d5-4346-ae80-0e879b7f53ab"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=262)</span>", "ID": "4e4d6145-8f1f-495b-8fa5-f4110cf29bfb", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "(n=262)", "ParentId": "874aa5ab-8c0a-4c0a-8a58-37252b72af57"}, {"Element": "<td style=\"width:76.45pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"102\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:21.65pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>65%*<sup>, #</sup></span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:20.1pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=269)</span></p>\n</td>", "ID": "e1bfbdbf-7860-4192-b13d-0bf3ef6f4490", "Styles": "width:76.45pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in", "Classes": "None", "Text": "   ", "ParentId": "b9cc6466-f6bd-4af8-ab4f-2c1a3cdef93b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:21.65pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>65%*<sup>, #</sup></span></p>", "ID": "978c8a98-eaa5-435c-ace8-a1b324cb49c1", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:21.65pt;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e1bfbdbf-7860-4192-b13d-0bf3ef6f4490"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>65%*<sup>, #</sup></span>", "ID": "c235c240-ee48-459c-898e-70648c64bbd8", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "65%*", "ParentId": "978c8a98-eaa5-435c-ace8-a1b324cb49c1"}, {"Element": "<sup>, #</sup>", "ID": "fab2488c-f62e-4a86-b581-1015ac092bdc", "Styles": "None", "Classes": "None", "Text": ", #", "ParentId": "c235c240-ee48-459c-898e-70648c64bbd8"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:20.1pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=269)</span></p>", "ID": "25b2e744-44b7-41c7-8aa7-8d202388da6a", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:20.1pt;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e1bfbdbf-7860-4192-b13d-0bf3ef6f4490"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=269)</span>", "ID": "d1eafaad-9c85-49b2-bbf6-c42910bbba25", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "(n=269)", "ParentId": "25b2e744-44b7-41c7-8aa7-8d202388da6a"}, {"Element": "<td style=\"width:90.2pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"120\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:33.65pt;\n  margin-bottom:0in;margin-left:34.35pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>22%</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:25.95pt;\n  margin-bottom:0in;margin-left:26.9pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=268)</span></p>\n</td>", "ID": "8be52212-60d6-4b88-8439-766356984c2b", "Styles": "width:90.2pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in", "Classes": "None", "Text": "   ", "ParentId": "b9cc6466-f6bd-4af8-ab4f-2c1a3cdef93b"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:33.65pt;\n  margin-bottom:0in;margin-left:34.35pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>22%</span></p>", "ID": "878b87ca-3162-4955-bd99-57781ff61d3b", "Styles": "margin-top:0in;margin-right:33.65pt;\n  margin-bottom:0in;margin-left:34.35pt;text-align:center;line-height:normal;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "8be52212-60d6-4b88-8439-766356984c2b"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>22%</span>", "ID": "4a21e356-5b41-4b14-9006-eac6d2c07005", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "22%", "ParentId": "878b87ca-3162-4955-bd99-57781ff61d3b"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:25.95pt;\n  margin-bottom:0in;margin-left:26.9pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=268)</span></p>", "ID": "c833b5e2-5769-47b7-89cb-56dc33a2d9ef", "Styles": "margin-top:0in;margin-right:25.95pt;\n  margin-bottom:0in;margin-left:26.9pt;text-align:center;line-height:normal;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "8be52212-60d6-4b88-8439-766356984c2b"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=268)</span>", "ID": "4931b8c2-65e5-4530-8042-606617c62de4", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "(n=268)", "ParentId": "c833b5e2-5769-47b7-89cb-56dc33a2d9ef"}, {"Element": "<tr>\n<td style=\"width:89.9pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"120\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:27.95pt;\n  margin-bottom:0in;margin-left:28.6pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>FACT</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:17.55pt;\n  margin-bottom:0in;margin-left:18.4pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(52\n  weeks)</span></p>\n</td>\n<td style=\"width:90.7pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"121\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:30.25pt;\n  margin-bottom:0in;margin-left:31.25pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>53%*</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:24.55pt;\n  margin-bottom:0in;margin-left:25.35pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=255)</span></p>\n</td>\n<td style=\"width:76.45pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"102\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:23.05pt;\n  margin-bottom:0in;margin-left:24.15pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>62%*</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:17.35pt;\n  margin-bottom:0in;margin-left:18.3pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=250)</span></p>\n</td>\n<td style=\"width:90.2pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"120\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:33.65pt;\n  margin-bottom:0in;margin-left:34.35pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>21%</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:25.95pt;\n  margin-bottom:0in;margin-left:26.9pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=251)</span></p>\n</td>\n</tr>", "ID": "04615d35-1110-48f1-8a79-12b257b34e8f", "Styles": "None", "Classes": "None", "Text": "     ", "ParentId": "87b0a814-635d-4272-be9c-ca34c35c92f2"}, {"Element": "<td style=\"width:89.9pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"120\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:27.95pt;\n  margin-bottom:0in;margin-left:28.6pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>FACT</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:17.55pt;\n  margin-bottom:0in;margin-left:18.4pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(52\n  weeks)</span></p>\n</td>", "ID": "4bc89ddb-d8f9-4a3f-8e18-1fd784dfdbae", "Styles": "width:89.9pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in", "Classes": "None", "Text": "   ", "ParentId": "04615d35-1110-48f1-8a79-12b257b34e8f"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:27.95pt;\n  margin-bottom:0in;margin-left:28.6pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>FACT</span></p>", "ID": "53febc0b-1f59-474d-844d-9a8b9825852c", "Styles": "margin-top:0in;margin-right:27.95pt;\n  margin-bottom:0in;margin-left:28.6pt;text-align:center;line-height:normal;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "4bc89ddb-d8f9-4a3f-8e18-1fd784dfdbae"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>FACT</span>", "ID": "36ddb818-3add-4820-aa3a-632aaead5a49", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "FACT", "ParentId": "53febc0b-1f59-474d-844d-9a8b9825852c"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:17.55pt;\n  margin-bottom:0in;margin-left:18.4pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(52\n  weeks)</span></p>", "ID": "48af0146-c279-4e29-ab0a-636134cb05fc", "Styles": "margin-top:0in;margin-right:17.55pt;\n  margin-bottom:0in;margin-left:18.4pt;text-align:center;line-height:normal;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "4bc89ddb-d8f9-4a3f-8e18-1fd784dfdbae"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(52\n  weeks)</span>", "ID": "b0667c58-b1f1-4f02-b9c1-d5b7acfdf81c", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "(52   weeks)", "ParentId": "48af0146-c279-4e29-ab0a-636134cb05fc"}, {"Element": "<td style=\"width:90.7pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"121\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:30.25pt;\n  margin-bottom:0in;margin-left:31.25pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>53%*</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:24.55pt;\n  margin-bottom:0in;margin-left:25.35pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=255)</span></p>\n</td>", "ID": "9d72db82-a1b1-4849-9309-6a5993ee109a", "Styles": "width:90.7pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in", "Classes": "None", "Text": "   ", "ParentId": "04615d35-1110-48f1-8a79-12b257b34e8f"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:30.25pt;\n  margin-bottom:0in;margin-left:31.25pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>53%*</span></p>", "ID": "861e6e7e-9a9e-4c5d-aef4-1e6202013164", "Styles": "margin-top:0in;margin-right:30.25pt;\n  margin-bottom:0in;margin-left:31.25pt;text-align:center;line-height:normal;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "9d72db82-a1b1-4849-9309-6a5993ee109a"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>53%*</span>", "ID": "b81dbf51-29de-4989-a245-8f8ea0651c58", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "53%*", "ParentId": "861e6e7e-9a9e-4c5d-aef4-1e6202013164"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:24.55pt;\n  margin-bottom:0in;margin-left:25.35pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=255)</span></p>", "ID": "02a32208-bd8b-4e36-80e8-e061b48837dd", "Styles": "margin-top:0in;margin-right:24.55pt;\n  margin-bottom:0in;margin-left:25.35pt;text-align:center;line-height:normal;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "9d72db82-a1b1-4849-9309-6a5993ee109a"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=255)</span>", "ID": "d411e3ee-1190-4688-92eb-9de9718ea045", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "(n=255)", "ParentId": "02a32208-bd8b-4e36-80e8-e061b48837dd"}, {"Element": "<td style=\"width:76.45pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"102\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:23.05pt;\n  margin-bottom:0in;margin-left:24.15pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>62%*</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:17.35pt;\n  margin-bottom:0in;margin-left:18.3pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=250)</span></p>\n</td>", "ID": "ecefec69-fbd5-4abd-b46e-9ec68e655f27", "Styles": "width:76.45pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in", "Classes": "None", "Text": "   ", "ParentId": "04615d35-1110-48f1-8a79-12b257b34e8f"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:23.05pt;\n  margin-bottom:0in;margin-left:24.15pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>62%*</span></p>", "ID": "2c967dfc-8ab2-44a6-9739-594f5f1df73e", "Styles": "margin-top:0in;margin-right:23.05pt;\n  margin-bottom:0in;margin-left:24.15pt;text-align:center;line-height:normal;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ecefec69-fbd5-4abd-b46e-9ec68e655f27"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>62%*</span>", "ID": "5a978c44-44e2-413c-8ec9-359890d165dc", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "62%*", "ParentId": "2c967dfc-8ab2-44a6-9739-594f5f1df73e"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:17.35pt;\n  margin-bottom:0in;margin-left:18.3pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=250)</span></p>", "ID": "6a277ac9-a9af-4593-b03b-012b93f63896", "Styles": "margin-top:0in;margin-right:17.35pt;\n  margin-bottom:0in;margin-left:18.3pt;text-align:center;line-height:normal;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ecefec69-fbd5-4abd-b46e-9ec68e655f27"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=250)</span>", "ID": "d6ba25a8-46fc-4849-b75c-95ee3de32181", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "(n=250)", "ParentId": "6a277ac9-a9af-4593-b03b-012b93f63896"}, {"Element": "<td style=\"width:90.2pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"120\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:33.65pt;\n  margin-bottom:0in;margin-left:34.35pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>21%</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:25.95pt;\n  margin-bottom:0in;margin-left:26.9pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=251)</span></p>\n</td>", "ID": "4f3d5ffc-850e-444d-be95-1d7b930fd535", "Styles": "width:90.2pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in", "Classes": "None", "Text": "   ", "ParentId": "04615d35-1110-48f1-8a79-12b257b34e8f"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:33.65pt;\n  margin-bottom:0in;margin-left:34.35pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>21%</span></p>", "ID": "11761ab4-9b08-4e72-bd9f-a8d821f067c4", "Styles": "margin-top:0in;margin-right:33.65pt;\n  margin-bottom:0in;margin-left:34.35pt;text-align:center;line-height:normal;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "4f3d5ffc-850e-444d-be95-1d7b930fd535"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>21%</span>", "ID": "5413fdb8-95ee-4934-b9e8-cab716489cac", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "21%", "ParentId": "11761ab4-9b08-4e72-bd9f-a8d821f067c4"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:25.95pt;\n  margin-bottom:0in;margin-left:26.9pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=251)</span></p>", "ID": "edf04dcb-13e5-4b03-9538-6c0ed771c35e", "Styles": "margin-top:0in;margin-right:25.95pt;\n  margin-bottom:0in;margin-left:26.9pt;text-align:center;line-height:normal;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "4f3d5ffc-850e-444d-be95-1d7b930fd535"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=251)</span>", "ID": "67e10f75-1579-4023-997d-235b0448b6ea", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "(n=251)", "ParentId": "edf04dcb-13e5-4b03-9538-6c0ed771c35e"}, {"Element": "<tr>\n<td style=\"width:89.9pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"120\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:18.95pt;\n  margin-bottom:0in;margin-left:19.85pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Combined</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:25.6pt;\n  margin-bottom:0in;margin-left:26.55pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Results</span></p>\n</td>\n<td style=\"width:90.7pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"121\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:30.35pt;\n  margin-bottom:0in;margin-left:31.1pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>51%*</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:24.55pt;\n  margin-bottom:0in;margin-left:25.35pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=517)</span></p>\n</td>\n<td style=\"width:76.45pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"102\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:22.5pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>63%*<sup>, #</sup></span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:20.1pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=519)</span></p>\n</td>\n<td style=\"width:90.2pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"120\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:33.5pt;\n  margin-bottom:0in;margin-left:34.45pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>22%</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:25.95pt;\n  margin-bottom:0in;margin-left:26.9pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=519)</span></p>\n</td>\n</tr>", "ID": "f8944426-c4f7-4d9f-a75b-928f8bc67457", "Styles": "None", "Classes": "None", "Text": "     ", "ParentId": "87b0a814-635d-4272-be9c-ca34c35c92f2"}, {"Element": "<td style=\"width:89.9pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"120\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:18.95pt;\n  margin-bottom:0in;margin-left:19.85pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Combined</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:25.6pt;\n  margin-bottom:0in;margin-left:26.55pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Results</span></p>\n</td>", "ID": "b6d3260d-3194-4724-b681-90b33321075b", "Styles": "width:89.9pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in", "Classes": "None", "Text": "   ", "ParentId": "f8944426-c4f7-4d9f-a75b-928f8bc67457"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:18.95pt;\n  margin-bottom:0in;margin-left:19.85pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Combined</span></p>", "ID": "de1eca26-e57d-40c0-8081-4c95b7a58020", "Styles": "margin-top:0in;margin-right:18.95pt;\n  margin-bottom:0in;margin-left:19.85pt;text-align:center;line-height:normal;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b6d3260d-3194-4724-b681-90b33321075b"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Combined</span>", "ID": "c3bc3310-4d23-4c2d-a9c7-2fa4d7f50315", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Combined", "ParentId": "de1eca26-e57d-40c0-8081-4c95b7a58020"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:25.6pt;\n  margin-bottom:0in;margin-left:26.55pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Results</span></p>", "ID": "eeae12d0-b9bc-4fa3-ba64-82bf43cfb37b", "Styles": "margin-top:0in;margin-right:25.6pt;\n  margin-bottom:0in;margin-left:26.55pt;text-align:center;line-height:normal;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b6d3260d-3194-4724-b681-90b33321075b"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Results</span>", "ID": "47e8d938-75d3-43d9-b8c9-99c526a58448", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Results", "ParentId": "eeae12d0-b9bc-4fa3-ba64-82bf43cfb37b"}, {"Element": "<td style=\"width:90.7pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"121\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:30.35pt;\n  margin-bottom:0in;margin-left:31.1pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>51%*</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:24.55pt;\n  margin-bottom:0in;margin-left:25.35pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=517)</span></p>\n</td>", "ID": "cdf2fc4c-566e-4d61-a470-e9bbb505590a", "Styles": "width:90.7pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in", "Classes": "None", "Text": "   ", "ParentId": "f8944426-c4f7-4d9f-a75b-928f8bc67457"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:30.35pt;\n  margin-bottom:0in;margin-left:31.1pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>51%*</span></p>", "ID": "14044b2d-8a38-4bc0-bdf2-374313e87f7c", "Styles": "margin-top:0in;margin-right:30.35pt;\n  margin-bottom:0in;margin-left:31.1pt;text-align:center;line-height:normal;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "cdf2fc4c-566e-4d61-a470-e9bbb505590a"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>51%*</span>", "ID": "8f17e82d-455e-495a-9202-0da117c5bb43", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "51%*", "ParentId": "14044b2d-8a38-4bc0-bdf2-374313e87f7c"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:24.55pt;\n  margin-bottom:0in;margin-left:25.35pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=517)</span></p>", "ID": "e18fbd45-b4e6-47c4-aa71-303f7149efb0", "Styles": "margin-top:0in;margin-right:24.55pt;\n  margin-bottom:0in;margin-left:25.35pt;text-align:center;line-height:normal;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "cdf2fc4c-566e-4d61-a470-e9bbb505590a"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=517)</span>", "ID": "dbd4c59a-ba2b-4dc2-bbd8-9e9dd3e28b3f", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "(n=517)", "ParentId": "e18fbd45-b4e6-47c4-aa71-303f7149efb0"}, {"Element": "<td style=\"width:76.45pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"102\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:22.5pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>63%*<sup>, #</sup></span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:20.1pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=519)</span></p>\n</td>", "ID": "a76313a0-48eb-42c8-ad41-2266d2fc4164", "Styles": "width:76.45pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in", "Classes": "None", "Text": "   ", "ParentId": "f8944426-c4f7-4d9f-a75b-928f8bc67457"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:22.5pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>63%*<sup>, #</sup></span></p>", "ID": "3775d118-b3aa-4b4d-9067-9283e41aca1a", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:22.5pt;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a76313a0-48eb-42c8-ad41-2266d2fc4164"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>63%*<sup>, #</sup></span>", "ID": "73aecd8e-07be-4e2a-a277-98e24d1be96d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "63%*", "ParentId": "3775d118-b3aa-4b4d-9067-9283e41aca1a"}, {"Element": "<sup>, #</sup>", "ID": "15b73178-9e4a-46f8-90fe-2b6c4ebe1600", "Styles": "None", "Classes": "None", "Text": ", #", "ParentId": "73aecd8e-07be-4e2a-a277-98e24d1be96d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:20.1pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=519)</span></p>", "ID": "33608838-efab-45e4-8c64-07759eebb18c", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:20.1pt;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a76313a0-48eb-42c8-ad41-2266d2fc4164"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=519)</span>", "ID": "4e2e57ec-0ef2-4ee7-80e0-bf2c40491d01", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "(n=519)", "ParentId": "33608838-efab-45e4-8c64-07759eebb18c"}, {"Element": "<td style=\"width:90.2pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in\" valign=\"top\" width=\"120\">\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:33.5pt;\n  margin-bottom:0in;margin-left:34.45pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>22%</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:25.95pt;\n  margin-bottom:0in;margin-left:26.9pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=519)</span></p>\n</td>", "ID": "df2b9375-3a4e-42db-b102-b4094484a46c", "Styles": "width:90.2pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  padding:0in 0in 0in 0in", "Classes": "None", "Text": "   ", "ParentId": "f8944426-c4f7-4d9f-a75b-928f8bc67457"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:33.5pt;\n  margin-bottom:0in;margin-left:34.45pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>22%</span></p>", "ID": "c22aea4e-b116-4c16-abd7-11f8c789fb69", "Styles": "margin-top:0in;margin-right:33.5pt;\n  margin-bottom:0in;margin-left:34.45pt;text-align:center;line-height:normal;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "df2b9375-3a4e-42db-b102-b4094484a46c"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>22%</span>", "ID": "3b9fa3ae-636c-49e3-b7fb-6bf7cef1e1ef", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "22%", "ParentId": "c22aea4e-b116-4c16-abd7-11f8c789fb69"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:25.95pt;\n  margin-bottom:0in;margin-left:26.9pt;text-align:center;line-height:normal;\n  text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=519)</span></p>", "ID": "a9bda668-597a-46d9-8299-e27a6f87eb9a", "Styles": "margin-top:0in;margin-right:25.95pt;\n  margin-bottom:0in;margin-left:26.9pt;text-align:center;line-height:normal;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "df2b9375-3a4e-42db-b102-b4094484a46c"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(n=519)</span>", "ID": "4ca64d67-02a8-4d66-ac1c-b50500b13053", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "(n=519)", "ParentId": "a9bda668-597a-46d9-8299-e27a6f87eb9a"}, {"Element": "<tr>\n<td colspan=\"4\" style=\"width:347.25pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"463\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.5pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:normal;text-autospace:none\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'> results from subjects\n  receiving either 100\u00a0mg QD (n=10: patients with serum creatinine &gt;1.5\n  and </span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u22642.0\u00a0mg/dL)\n  or 300\u00a0mg QD (n=509) were pooled </span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>for analyses.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>* p &lt; 0.001 vs\n  allopurinol, # p &lt; 0.001 vs 80\u00a0mg</span></p>\n</td>\n</tr>", "ID": "928fd8c4-afd4-4a87-8afb-b3c21bdee273", "Styles": "None", "Classes": "None", "Text": "  ", "ParentId": "87b0a814-635d-4272-be9c-ca34c35c92f2"}, {"Element": "<td colspan=\"4\" style=\"width:347.25pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in\" valign=\"top\" width=\"463\">\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.5pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:normal;text-autospace:none\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'> results from subjects\n  receiving either 100\u00a0mg QD (n=10: patients with serum creatinine &gt;1.5\n  and </span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u22642.0\u00a0mg/dL)\n  or 300\u00a0mg QD (n=509) were pooled </span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>for analyses.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>* p &lt; 0.001 vs\n  allopurinol, # p &lt; 0.001 vs 80\u00a0mg</span></p>\n</td>", "ID": "86ae7e34-b8cc-4891-9fba-deb9ad0cf476", "Styles": "width:347.25pt;border:solid black 1.0pt;\n  border-top:none;padding:0in 0in 0in 0in", "Classes": "None", "Text": "   ", "ParentId": "928fd8c4-afd4-4a87-8afb-b3c21bdee273"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.5pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:normal;text-autospace:none\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'> results from subjects\n  receiving either 100\u00a0mg QD (n=10: patients with serum creatinine &gt;1.5\n  and </span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u22642.0\u00a0mg/dL)\n  or 300\u00a0mg QD (n=509) were pooled </span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>for analyses.</span></p>", "ID": "de9058b5-96a5-440b-b354-bda6a3fdac3d", "Styles": "margin-top:0in;margin-right:6.5pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "86ae7e34-b8cc-4891-9fba-deb9ad0cf476"}, {"Element": "<sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1</span></sup>", "ID": "4b528576-aaa2-43e1-b845-d3cdec99501f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "de9058b5-96a5-440b-b354-bda6a3fdac3d"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1</span>", "ID": "90d5ceab-10ce-4b08-beb6-11279c4c6bb3", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "1", "ParentId": "4b528576-aaa2-43e1-b845-d3cdec99501f"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'> results from subjects\n  receiving either 100\u00a0mg QD (n=10: patients with serum creatinine &gt;1.5\n  and </span>", "ID": "9dcb3f86-ae4a-40ca-b21d-a654705e4feb", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": " results from subjects   receiving either 100\u00a0mg QD (n=10: patients with serum creatinine >1.5   and ", "ParentId": "de9058b5-96a5-440b-b354-bda6a3fdac3d"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u22642.0\u00a0mg/dL)\n  or 300\u00a0mg QD (n=509) were pooled </span>", "ID": "926bb769-8e17-4025-9c96-a75813552dc9", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u22642.0\u00a0mg/dL)   or 300\u00a0mg QD (n=509) were pooled ", "ParentId": "de9058b5-96a5-440b-b354-bda6a3fdac3d"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>for analyses.</span>", "ID": "12e3bb0d-f020-42d7-925b-87effb3629cb", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "for analyses.", "ParentId": "de9058b5-96a5-440b-b354-bda6a3fdac3d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>* p &lt; 0.001 vs\n  allopurinol, # p &lt; 0.001 vs 80\u00a0mg</span></p>", "ID": "c6abb6ee-e459-47b4-9d69-66032f3e7f4f", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n  0in;margin-left:5.1pt;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "86ae7e34-b8cc-4891-9fba-deb9ad0cf476"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>* p &lt; 0.001 vs\n  allopurinol, # p &lt; 0.001 vs 80\u00a0mg</span>", "ID": "13baaf62-1ae4-4b91-beb9-c26944e45ec0", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "* p < 0.001 vs   allopurinol, # p < 0.001 vs 80\u00a0mg", "ParentId": "c6abb6ee-e459-47b4-9d69-66032f3e7f4f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:5.9pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "07a9a331-c3e9-4ce2-84c8-41880493a250", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:5.9pt;line-height:12.3pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "93430ee1-c368-4887-aba0-961516afd367", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "07a9a331-c3e9-4ce2-84c8-41880493a250"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:5.9pt;line-height:12.3pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The ability of </span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>febuxostat</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'> to lower serum uric\nacid levels was prompt and persistent. Reduction in serum uric acid level to\n&lt;6.0\u00a0mg/dL (357\u00a0\u00b5mol/L) was noted by the Week 2 visit and was\nmaintained throughout treatment. The mean serum uric acid levels over time for\neach treatment group from the two pivotal Phase 3 studies are shown in Figure\n1.</span></p>", "ID": "accd79f4-9fde-4da1-8531-c8fd59e013f5", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:5.9pt;line-height:12.3pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The ability of </span>", "ID": "17475e44-67fe-4bae-90d2-74b190d604c2", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "The ability of ", "ParentId": "accd79f4-9fde-4da1-8531-c8fd59e013f5"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>febuxostat</span>", "ID": "c92f7114-c5b4-464d-ac54-03d646c76ca6", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "febuxostat", "ParentId": "accd79f4-9fde-4da1-8531-c8fd59e013f5"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'> to lower serum uric\nacid levels was prompt and persistent. Reduction in serum uric acid level to\n&lt;6.0\u00a0mg/dL (357\u00a0\u00b5mol/L) was noted by the Week 2 visit and was\nmaintained throughout treatment. The mean serum uric acid levels over time for\neach treatment group from the two pivotal Phase 3 studies are shown in Figure\n1.</span>", "ID": "9bd7b9b6-4b53-40d3-b4f9-c8e94efd25f1", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": " to lower serum uric acid levels was prompt and persistent. Reduction in serum uric acid level to <6.0\u00a0mg/dL (357\u00a0\u00b5mol/L) was noted by the Week 2 visit and was maintained throughout treatment. The mean serum uric acid levels over time for each treatment group from the two pivotal Phase 3 studies are shown in Figure 1.", "ParentId": "accd79f4-9fde-4da1-8531-c8fd59e013f5"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:5.9pt;line-height:12.45pt;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "b26a5ee1-d727-4763-a7dc-cb8b642c8336", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:5.9pt;line-height:12.45pt;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "194d7c50-089f-4ec1-9981-9acfdb59518d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "b26a5ee1-d727-4763-a7dc-cb8b642c8336"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:3.5pt;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:53.3pt;line-height:12.45pt;page-break-after:avoid;text-autospace:\nnone\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Figure 1\nMean Serum Uric Acid Levels in Combined Pivotal Phase 3 Studies</span></b></p>", "ID": "b8c9ce7c-f9b0-47b0-b52a-2d46d62d9d8c", "Styles": "margin-top:3.5pt;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:53.3pt;line-height:12.45pt;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Figure 1\nMean Serum Uric Acid Levels in Combined Pivotal Phase 3 Studies</span></b>", "ID": "2a28db2a-c0d5-4311-bf20-9e56d56c7588", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b8c9ce7c-f9b0-47b0-b52a-2d46d62d9d8c"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Figure 1\nMean Serum Uric Acid Levels in Combined Pivotal Phase 3 Studies</span>", "ID": "5d46fb6f-2f9a-417b-b4dc-7ea852854d95", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Figure 1 Mean Serum Uric Acid Levels in Combined Pivotal Phase 3 Studies", "ParentId": "2a28db2a-c0d5-4311-bf20-9e56d56c7588"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.1pt;margin-right:0in;margin-bottom:0in;\nmargin-left:0in;line-height:12.0pt;page-break-after:avoid;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "3f4d6f6c-6fe4-448e-8a33-f8ec3aac6ccf", "Styles": "margin-top:.1pt;margin-right:0in;margin-bottom:0in;\nmargin-left:0in;line-height:12.0pt;page-break-after:avoid;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "54cbb354-58ec-4aba-9aca-53192687c768", "Styles": "font-size:12.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "3f4d6f6c-6fe4-448e-8a33-f8ec3aac6ccf"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:1.9pt;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:98.75pt;line-height:9.0pt;page-break-after:avoid;text-autospace:\nnone\"><span style=\"position:absolute;z-index:-1895825920;left:0px;margin-left:\n234px;margin-top:8px;width:344px;height:262px\"><img height=\"262\" src=\"Febuxostat%20Mylan%20not%20most%20recent_files/image004.png\" width=\"344\"/></span><span lang=\"EN-GB\" style='font-size:8.0pt;font-family:\"Times New Roman\",serif'>11</span></p>", "ID": "cd173b8b-7b22-4ba8-b326-af2747130653", "Styles": "margin-top:1.9pt;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:98.75pt;line-height:9.0pt;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span style=\"position:absolute;z-index:-1895825920;left:0px;margin-left:\n234px;margin-top:8px;width:344px;height:262px\"><img height=\"262\" src=\"Febuxostat%20Mylan%20not%20most%20recent_files/image004.png\" width=\"344\"/></span>", "ID": "10f562a1-e1d0-4adb-97c7-d671a1781c8b", "Styles": "position:absolute;z-index:-1895825920;left:0px;margin-left:\n234px;margin-top:8px;width:344px;height:262px", "Classes": "None", "Text": "", "ParentId": "cd173b8b-7b22-4ba8-b326-af2747130653"}, {"Element": "<img height=\"262\" src=\"Febuxostat%20Mylan%20not%20most%20recent_files/image004.png\" width=\"344\"/>", "ID": "e8af3b8d-cf6a-4ba5-8203-e4822d8beb6f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "10f562a1-e1d0-4adb-97c7-d671a1781c8b"}, {"Element": "<span lang=\"EN-GB\" style='font-size:8.0pt;font-family:\"Times New Roman\",serif'>11</span>", "ID": "d56a7b38-324c-4304-bbde-c0bf25ba0e7e", "Styles": "font-size:8.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "11", "ParentId": "cd173b8b-7b22-4ba8-b326-af2747130653"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.5pt;margin-right:0in;margin-bottom:0in;\nmargin-left:0in;line-height:10.0pt;page-break-after:avoid;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:10.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "bd5afd8e-e2be-4ef3-9cbf-16d59d792263", "Styles": "margin-top:.5pt;margin-right:0in;margin-bottom:0in;\nmargin-left:0in;line-height:10.0pt;page-break-after:avoid;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:10.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "ac48b250-1b52-4042-ba70-cebe82836c6d", "Styles": "font-size:10.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "bd5afd8e-e2be-4ef3-9cbf-16d59d792263"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:1.75pt;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:98.75pt;line-height:11.2pt;page-break-after:avoid;text-autospace:\nnone\"><span style=\"position:absolute;z-index:-1895823872;left:0px;margin-left:\n254px;margin-top:5px;width:308px;height:209px\"><img height=\"209\" src=\"Febuxostat%20Mylan%20not%20most%20recent_files/image002.png\" width=\"308\"/></span><span style=\"position:relative;z-index:-1895822848\"><span style=\"left:0px;position:\nabsolute;left:195px;top:-1px;width:13px;height:204px\"><img alt=\"Mean (\u00b1SEM) Serum Uric Acid Level (mg/dL)\" height=\"204\" src=\"Febuxostat%20Mylan%20not%20most%20recent_files/image005.png\" width=\"13\"/></span></span><span lang=\"EN-GB\" style='font-size:8.0pt;font-family:\"Times New Roman\",serif'>10\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 </span><span lang=\"EN-GB\" style='font-size:6.0pt;font-family:\"Times New Roman\",serif'>Placebo</span></p>", "ID": "63de0bcc-608d-43e5-acd3-491eb067cb2a", "Styles": "margin-top:1.75pt;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:98.75pt;line-height:11.2pt;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span style=\"position:absolute;z-index:-1895823872;left:0px;margin-left:\n254px;margin-top:5px;width:308px;height:209px\"><img height=\"209\" src=\"Febuxostat%20Mylan%20not%20most%20recent_files/image002.png\" width=\"308\"/></span>", "ID": "d1f5be84-1054-4437-9561-09e5640d1f63", "Styles": "position:absolute;z-index:-1895823872;left:0px;margin-left:\n254px;margin-top:5px;width:308px;height:209px", "Classes": "None", "Text": "", "ParentId": "63de0bcc-608d-43e5-acd3-491eb067cb2a"}, {"Element": "<img height=\"209\" src=\"Febuxostat%20Mylan%20not%20most%20recent_files/image002.png\" width=\"308\"/>", "ID": "c2ab93d7-7923-412e-8a2a-da79a3f45de1", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d1f5be84-1054-4437-9561-09e5640d1f63"}, {"Element": "<span style=\"position:relative;z-index:-1895822848\"><span style=\"left:0px;position:\nabsolute;left:195px;top:-1px;width:13px;height:204px\"><img alt=\"Mean (\u00b1SEM) Serum Uric Acid Level (mg/dL)\" height=\"204\" src=\"Febuxostat%20Mylan%20not%20most%20recent_files/image005.png\" width=\"13\"/></span></span>", "ID": "4df78127-88c1-4223-96dc-fda1f117aec9", "Styles": "position:relative;z-index:-1895822848", "Classes": "None", "Text": "", "ParentId": "63de0bcc-608d-43e5-acd3-491eb067cb2a"}, {"Element": "<span style=\"left:0px;position:\nabsolute;left:195px;top:-1px;width:13px;height:204px\"><img alt=\"Mean (\u00b1SEM) Serum Uric Acid Level (mg/dL)\" height=\"204\" src=\"Febuxostat%20Mylan%20not%20most%20recent_files/image005.png\" width=\"13\"/></span>", "ID": "cb8ddba3-394d-443c-858a-1b9bc17e82b4", "Styles": "left:0px;position:\nabsolute;left:195px;top:-1px;width:13px;height:204px", "Classes": "None", "Text": "", "ParentId": "4df78127-88c1-4223-96dc-fda1f117aec9"}, {"Element": "<img alt=\"Mean (\u00b1SEM) Serum Uric Acid Level (mg/dL)\" height=\"204\" src=\"Febuxostat%20Mylan%20not%20most%20recent_files/image005.png\" width=\"13\"/>", "ID": "dcd53240-be60-4f12-b914-812bef5da438", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "cb8ddba3-394d-443c-858a-1b9bc17e82b4"}, {"Element": "<span lang=\"EN-GB\" style='font-size:8.0pt;font-family:\"Times New Roman\",serif'>10\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 </span>", "ID": "64800618-07cf-4f6c-b63e-62909ed60b84", "Styles": "font-size:8.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "10\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "63de0bcc-608d-43e5-acd3-491eb067cb2a"}, {"Element": "<span lang=\"EN-GB\" style='font-size:6.0pt;font-family:\"Times New Roman\",serif'>Placebo</span>", "ID": "b55d824a-f520-4500-82af-e688475b7e79", "Styles": "font-size:6.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Placebo", "ParentId": "63de0bcc-608d-43e5-acd3-491eb067cb2a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:8.5pt;page-break-after:\navoid;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:8.5pt;font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "a5d3b4c4-f4e3-468d-ba16-da55ce02fca7", "Styles": "margin-bottom:0in;line-height:8.5pt;page-break-after:\navoid;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:8.5pt;font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "67b74910-3cb2-463f-b876-6a7d428844a9", "Styles": "font-size:8.5pt;font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "a5d3b4c4-f4e3-468d-ba16-da55ce02fca7"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:1.9pt;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:102.75pt;line-height:9.0pt;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-size:8.0pt;font-family:\"Times New Roman\",serif'>9</span></p>", "ID": "3a299d07-bc2e-45ee-b0a1-0c55addd114c", "Styles": "margin-top:1.9pt;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:102.75pt;line-height:9.0pt;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:8.0pt;font-family:\"Times New Roman\",serif'>9</span>", "ID": "3ad1ebca-44a5-4ffc-946f-f21a21087ab4", "Styles": "font-size:8.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "9", "ParentId": "3a299d07-bc2e-45ee-b0a1-0c55addd114c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.5pt;margin-right:0in;margin-bottom:0in;\nmargin-left:0in;line-height:10.0pt;page-break-after:avoid;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:10.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "38fd5c3c-886a-45a5-9af5-986a0c916c5d", "Styles": "margin-top:.5pt;margin-right:0in;margin-bottom:0in;\nmargin-left:0in;line-height:10.0pt;page-break-after:avoid;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:10.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "29d4b0ea-c465-4c44-89b3-b4ce597bf8dd", "Styles": "font-size:10.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "38fd5c3c-886a-45a5-9af5-986a0c916c5d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:1.9pt;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:102.75pt;line-height:9.0pt;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-size:8.0pt;font-family:\"Times New Roman\",serif'>8</span></p>", "ID": "7600d9f7-188b-44c6-97da-3f0d52ded16d", "Styles": "margin-top:1.9pt;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:102.75pt;line-height:9.0pt;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:8.0pt;font-family:\"Times New Roman\",serif'>8</span>", "ID": "edbd9e3e-35e4-4081-84ec-a54097cadf80", "Styles": "font-size:8.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "8", "ParentId": "7600d9f7-188b-44c6-97da-3f0d52ded16d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.5pt;margin-right:0in;margin-bottom:0in;\nmargin-left:0in;line-height:10.0pt;page-break-after:avoid;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:10.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "ac1abcb5-752c-473c-9fc3-178fa2a46bc5", "Styles": "margin-top:.5pt;margin-right:0in;margin-bottom:0in;\nmargin-left:0in;line-height:10.0pt;page-break-after:avoid;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:10.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "12e8d42b-7e8b-4549-beda-9f8f0e11733b", "Styles": "font-size:10.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "ac1abcb5-752c-473c-9fc3-178fa2a46bc5"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:1.9pt;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:102.75pt;line-height:9.0pt;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-size:8.0pt;font-family:\"Times New Roman\",serif'>7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 </span><span lang=\"EN-GB\" style='font-size:6.0pt;font-family:\"Times New Roman\",serif'>Allopurinol</span></p>", "ID": "1b456be5-6c02-4f28-9dc5-3dada90c49bf", "Styles": "margin-top:1.9pt;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:102.75pt;line-height:9.0pt;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:8.0pt;font-family:\"Times New Roman\",serif'>7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 </span>", "ID": "c6fe253e-b5e7-41a0-9772-b1099e1afb86", "Styles": "font-size:8.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "1b456be5-6c02-4f28-9dc5-3dada90c49bf"}, {"Element": "<span lang=\"EN-GB\" style='font-size:6.0pt;font-family:\"Times New Roman\",serif'>Allopurinol</span>", "ID": "9291f27f-61ea-4f74-9dc6-2548578bb601", "Styles": "font-size:6.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Allopurinol", "ParentId": "1b456be5-6c02-4f28-9dc5-3dada90c49bf"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.5pt;margin-right:0in;margin-bottom:0in;\nmargin-left:0in;line-height:10.0pt;page-break-after:avoid;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:10.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "e8d6cefc-8546-45bc-a418-7e7c449eb4af", "Styles": "margin-top:.5pt;margin-right:0in;margin-bottom:0in;\nmargin-left:0in;line-height:10.0pt;page-break-after:avoid;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:10.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "cd0e1395-d933-43dd-a2c7-f5d58d8dcf65", "Styles": "font-size:10.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "e8d6cefc-8546-45bc-a418-7e7c449eb4af"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:1.9pt;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:102.75pt;line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-size:8.0pt;font-family:\"Times New Roman\",serif'>6</span></p>", "ID": "b92c1076-22b1-4f40-ba00-7ac17cd9878e", "Styles": "margin-top:1.9pt;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:102.75pt;line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:8.0pt;font-family:\"Times New Roman\",serif'>6</span>", "ID": "97698be9-de3f-474e-b30d-40359762077b", "Styles": "font-size:8.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "6", "ParentId": "b92c1076-22b1-4f40-ba00-7ac17cd9878e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:260.5pt;line-height:6.8pt;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-size:6.0pt;font-family:\"Times New Roman\",serif'>Febuxostat\n80\u00a0mg</span></p>", "ID": "60e84194-ebfa-4fc2-b050-fa614b80fdf1", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:260.5pt;line-height:6.8pt;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:6.0pt;font-family:\"Times New Roman\",serif'>Febuxostat\n80\u00a0mg</span>", "ID": "01b17167-bd19-4fa9-9a50-861789267836", "Styles": "font-size:6.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Febuxostat 80\u00a0mg", "ParentId": "60e84194-ebfa-4fc2-b050-fa614b80fdf1"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.45pt;margin-right:0in;margin-bottom:0in;\nmargin-left:0in;line-height:5.0pt;page-break-after:avoid;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:5.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "85505b07-9624-436e-9e3b-c1a04bb77777", "Styles": "margin-top:.45pt;margin-right:0in;margin-bottom:0in;\nmargin-left:0in;line-height:5.0pt;page-break-after:avoid;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:5.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "933e0167-24c8-42ff-ace0-f2d38020f925", "Styles": "font-size:5.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "85505b07-9624-436e-9e3b-c1a04bb77777"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:102.75pt;line-height:9.0pt;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-size:8.0pt;font-family:\"Times New Roman\",serif'>5</span></p>", "ID": "715bc3ef-aa8b-49c5-bef8-731b0d1de1e9", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:102.75pt;line-height:9.0pt;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:8.0pt;font-family:\"Times New Roman\",serif'>5</span>", "ID": "004fd4e5-1488-466c-99a3-8c600635b436", "Styles": "font-size:8.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "5", "ParentId": "715bc3ef-aa8b-49c5-bef8-731b0d1de1e9"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.5pt;margin-right:0in;margin-bottom:0in;\nmargin-left:0in;line-height:10.0pt;page-break-after:avoid;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:10.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "95e66b1b-dc88-4271-b56e-ef2274424a70", "Styles": "margin-top:.5pt;margin-right:0in;margin-bottom:0in;\nmargin-left:0in;line-height:10.0pt;page-break-after:avoid;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:10.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "3928e8c2-425b-4a93-a076-5fdf2aab50a8", "Styles": "font-size:10.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "95e66b1b-dc88-4271-b56e-ef2274424a70"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:1.9pt;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:102.75pt;line-height:8.25pt;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-size:8.0pt;font-family:\"Times New Roman\",serif'>4</span></p>", "ID": "b5ad4251-1df2-41d0-9e06-7e0c0c31782d", "Styles": "margin-top:1.9pt;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:102.75pt;line-height:8.25pt;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:8.0pt;font-family:\"Times New Roman\",serif'>4</span>", "ID": "5f67570a-c90e-4ec0-98c6-963b0ba3d5bf", "Styles": "font-size:8.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "4", "ParentId": "b5ad4251-1df2-41d0-9e06-7e0c0c31782d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:260.5pt;line-height:5.3pt;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-size:6.0pt;font-family:\"Times New Roman\",serif'>Febuxostat\n120\u00a0mg</span></p>", "ID": "ab373cdf-e09c-49ac-a7b8-32aa045e044b", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:260.5pt;line-height:5.3pt;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:6.0pt;font-family:\"Times New Roman\",serif'>Febuxostat\n120\u00a0mg</span>", "ID": "f763591e-70b7-4767-b70d-661ce4f4841c", "Styles": "font-size:6.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Febuxostat 120\u00a0mg", "ParentId": "ab373cdf-e09c-49ac-a7b8-32aa045e044b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.35pt;margin-right:0in;margin-bottom:0in;\nmargin-left:0in;line-height:7.5pt;page-break-after:avoid;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:7.5pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "8266cc67-ef95-4f21-a5ac-74f28fedccb7", "Styles": "margin-top:.35pt;margin-right:0in;margin-bottom:0in;\nmargin-left:0in;line-height:7.5pt;page-break-after:avoid;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:7.5pt;font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "5592a907-69d5-4c69-b9ca-27aed4b922af", "Styles": "font-size:7.5pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "8266cc67-ef95-4f21-a5ac-74f28fedccb7"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:102.75pt;line-height:9.0pt;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-size:8.0pt;font-family:\"Times New Roman\",serif'>3\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <u>\n</u></span></p>", "ID": "1fc0b84d-527c-4539-85b5-d976409ba76f", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:102.75pt;line-height:9.0pt;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:8.0pt;font-family:\"Times New Roman\",serif'>3\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <u>\n</u></span>", "ID": "ad08fa28-b96f-43e3-9a3d-e0fc141d1ff5", "Styles": "font-size:8.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "3\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "1fc0b84d-527c-4539-85b5-d976409ba76f"}, {"Element": "<u>\n</u>", "ID": "76f64396-b6bb-4227-9c6c-085ed3eeaecb", "Styles": "None", "Classes": "None", "Text": " ", "ParentId": "ad08fa28-b96f-43e3-9a3d-e0fc141d1ff5"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:7.0pt;page-break-after:\navoid;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:7.0pt;font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "1604b2ec-8e3b-4b8d-9b8e-dd0069d29fe5", "Styles": "margin-bottom:0in;line-height:7.0pt;page-break-after:\navoid;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:7.0pt;font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "15f3d073-7d1b-4df4-9c32-b57617a58908", "Styles": "font-size:7.0pt;font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "1604b2ec-8e3b-4b8d-9b8e-dd0069d29fe5"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:260.5pt;line-height:6.7pt;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-size:6.0pt;font-family:\"Times New Roman\",serif'>Febuxostat\n240\u00a0mg</span></p>", "ID": "5d892b78-c879-49a6-ae53-d7a56edda093", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:260.5pt;line-height:6.7pt;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:6.0pt;font-family:\"Times New Roman\",serif'>Febuxostat\n240\u00a0mg</span>", "ID": "c0679cbf-181c-4edc-b933-0374c821224a", "Styles": "font-size:6.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Febuxostat 240\u00a0mg", "ParentId": "5d892b78-c879-49a6-ae53-d7a56edda093"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:102.75pt;line-height:7.15pt;page-break-after:avoid;text-autospace:\nnone\"><span style=\"position:absolute;z-index:-1895824896;left:0px;margin-left:\n577px;margin-top:5px;width:1px;height:4px\"><img height=\"4\" src=\"Febuxostat%20Mylan%20not%20most%20recent_files/image006.png\" width=\"1\"/></span><span lang=\"EN-GB\" style='font-size:8.0pt;font-family:\"Times New Roman\",serif'>2</span></p>", "ID": "49a92e8d-ff62-4578-8a8d-b1161a12bc83", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:102.75pt;line-height:7.15pt;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span style=\"position:absolute;z-index:-1895824896;left:0px;margin-left:\n577px;margin-top:5px;width:1px;height:4px\"><img height=\"4\" src=\"Febuxostat%20Mylan%20not%20most%20recent_files/image006.png\" width=\"1\"/></span>", "ID": "f8e1a9ab-febf-4972-90a1-afb4b4ccf1d1", "Styles": "position:absolute;z-index:-1895824896;left:0px;margin-left:\n577px;margin-top:5px;width:1px;height:4px", "Classes": "None", "Text": "", "ParentId": "49a92e8d-ff62-4578-8a8d-b1161a12bc83"}, {"Element": "<img height=\"4\" src=\"Febuxostat%20Mylan%20not%20most%20recent_files/image006.png\" width=\"1\"/>", "ID": "891e63cb-c080-4f7c-b2ab-e4031561a216", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f8e1a9ab-febf-4972-90a1-afb4b4ccf1d1"}, {"Element": "<span lang=\"EN-GB\" style='font-size:8.0pt;font-family:\"Times New Roman\",serif'>2</span>", "ID": "9badd719-3a8e-4cb5-9831-17568ab19cea", "Styles": "font-size:8.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "2", "ParentId": "49a92e8d-ff62-4578-8a8d-b1161a12bc83"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:123.6pt;line-height:7.15pt;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-size:8.0pt;font-family:\"Times New Roman\",serif'>BL\u00a0\u00a0\n2\u00a0\u00a0\u00a0\u00a0 4\u00a0\u00a0\u00a0\u00a0 6\u00a0\u00a0\u00a0\u00a0 8\u00a0\u00a0\u00a0 12\u00a0\u00a0 16\u00a0\u00a0 20\u00a0\u00a0 24\u00a0\u00a0 28\u00a0\u00a0 32\u00a0\u00a0 36\u00a0\u00a0 40\u00a0\u00a0 44\u00a0\u00a0 48\u00a0\u00a0 52</span></p>", "ID": "acc7a8b9-bc8e-436a-b863-6e95f10a2ff8", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:123.6pt;line-height:7.15pt;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:8.0pt;font-family:\"Times New Roman\",serif'>BL\u00a0\u00a0\n2\u00a0\u00a0\u00a0\u00a0 4\u00a0\u00a0\u00a0\u00a0 6\u00a0\u00a0\u00a0\u00a0 8\u00a0\u00a0\u00a0 12\u00a0\u00a0 16\u00a0\u00a0 20\u00a0\u00a0 24\u00a0\u00a0 28\u00a0\u00a0 32\u00a0\u00a0 36\u00a0\u00a0 40\u00a0\u00a0 44\u00a0\u00a0 48\u00a0\u00a0 52</span>", "ID": "04c92df6-e805-419d-9c36-244b9368e54d", "Styles": "font-size:8.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "BL\u00a0\u00a0 2\u00a0\u00a0\u00a0\u00a0 4\u00a0\u00a0\u00a0\u00a0 6\u00a0\u00a0\u00a0\u00a0 8\u00a0\u00a0\u00a0 12\u00a0\u00a0 16\u00a0\u00a0 20\u00a0\u00a0 24\u00a0\u00a0 28\u00a0\u00a0 32\u00a0\u00a0 36\u00a0\u00a0 40\u00a0\u00a0 44\u00a0\u00a0 48\u00a0\u00a0 52", "ParentId": "acc7a8b9-bc8e-436a-b863-6e95f10a2ff8"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:8.5pt;page-break-after:\navoid;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:8.5pt;font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "7fe445a4-7099-4f2e-bcaf-b8f11c75f3ce", "Styles": "margin-bottom:0in;line-height:8.5pt;page-break-after:\navoid;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:8.5pt;font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "9832c2c8-1ad5-443b-818a-2de5ab7869d0", "Styles": "font-size:8.5pt;font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "7fe445a4-7099-4f2e-bcaf-b8f11c75f3ce"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:210.8pt;\nmargin-bottom:0in;margin-left:230.0pt;text-align:center;line-height:9.0pt;\npage-break-after:avoid;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:\n8.0pt;font-family:\"Times New Roman\",serif'>Week</span></p>", "ID": "96142402-13f4-4160-b0ea-ed12c964f75c", "Styles": "margin-top:0in;margin-right:210.8pt;\nmargin-bottom:0in;margin-left:230.0pt;text-align:center;line-height:9.0pt;\npage-break-after:avoid;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:\n8.0pt;font-family:\"Times New Roman\",serif'>Week</span>", "ID": "99ec8fc2-caab-4c35-a8d9-6763a4bc265f", "Styles": "font-size:\n8.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Week", "ParentId": "96142402-13f4-4160-b0ea-ed12c964f75c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.25pt;margin-right:0in;margin-bottom:0in;\nmargin-left:0in;line-height:6.0pt;page-break-after:avoid;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:6.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "61645941-56fc-4b7c-a011-b6f934271696", "Styles": "margin-top:.25pt;margin-right:0in;margin-bottom:0in;\nmargin-left:0in;line-height:6.0pt;page-break-after:avoid;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:6.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "257c693d-f736-46ec-b1ba-b5acf779c0f0", "Styles": "font-size:6.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "61645941-56fc-4b7c-a011-b6f934271696"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:114.4pt;line-height:6.8pt;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-size:6.0pt;font-family:\"Times New Roman\",serif'>BL=baseline\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\nSEM=standard error of the mean</span></p>", "ID": "a3c6a77c-dd90-4cc6-ad2a-4c8120736600", "Styles": "margin-top:0in;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:114.4pt;line-height:6.8pt;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:6.0pt;font-family:\"Times New Roman\",serif'>BL=baseline\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\nSEM=standard error of the mean</span>", "ID": "236c44b3-2d23-4e01-af7a-cdbcc2ee9a69", "Styles": "font-size:6.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "BL=baseline\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SEM=standard error of the mean", "ParentId": "a3c6a77c-dd90-4cc6-ad2a-4c8120736600"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:.6pt;margin-right:0in;margin-bottom:0in;\nmargin-left:0in;line-height:11.0pt;page-break-after:avoid;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "719aaddd-f1e7-459a-b107-db7666b8064d", "Styles": "margin-top:.6pt;margin-right:0in;margin-bottom:0in;\nmargin-left:0in;line-height:11.0pt;page-break-after:avoid;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "0d37722c-82b5-46d3-b2f8-9a7a6c82e1d9", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "719aaddd-f1e7-459a-b107-db7666b8064d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:1.6pt;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Note: 509\npatients received allopurinol 300\u00a0mg QD; 10 patients with serum creatinine\n&gt;1.5 and \u22642.0\u00a0mg/dL were dosed with 100\u00a0mg QD. (10 patients\nout of 268 in APEX study).<br/>\n240\u00a0mg febuxostat was used to evaluate the safety of febuxostat at twice\nthe recommended highest dose.</span></p>", "ID": "ed1f891d-12e3-4464-9b36-aa314863f743", "Styles": "margin-top:1.6pt;margin-right:-1.0pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Note: 509\npatients received allopurinol 300\u00a0mg QD; 10 patients with serum creatinine\n&gt;1.5 and \u22642.0\u00a0mg/dL were dosed with 100\u00a0mg QD. (10 patients\nout of 268 in APEX study).<br/>\n240\u00a0mg febuxostat was used to evaluate the safety of febuxostat at twice\nthe recommended highest dose.</span>", "ID": "62faa4d3-c3a5-48df-94ea-ba9f47f20c0a", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Note: 509 patients received allopurinol 300\u00a0mg QD; 10 patients with serum creatinine >1.5 and \u22642.0\u00a0mg/dL were dosed with 100\u00a0mg QD. (10 patients out of 268 in APEX study). 240\u00a0mg febuxostat was used to evaluate the safety of febuxostat at twice the recommended highest dose.", "ParentId": "ed1f891d-12e3-4464-9b36-aa314863f743"}, {"Element": "<br/>", "ID": "b90e441e-ba45-4e87-9531-6a9c646d9cc8", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "62faa4d3-c3a5-48df-94ea-ba9f47f20c0a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "8b7f975b-07ce-4292-9bcf-8110f567534e", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "de447030-4b0a-46c7-9e87-ff4753451518", "Styles": "font-size:12.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "8b7f975b-07ce-4292-9bcf-8110f567534e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>CONFIRMS Study: The CONFIRMS study\nwas a Phase 3, randomized, controlled, 26-week study to evaluate the safety and\nefficacy of febuxostat 40\u00a0mg and 80\u00a0mg, in comparison with\nallopurinol 300\u00a0mg or 200\u00a0mg, in patients with gout and\nhyperuricaemia. Two thousand and two hundred-sixty nine (2269) patients were\nrandomized: febuxostat 40\u00a0mg QD (n=757), </span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>febuxostat </span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>80\u00a0mg QD (n=756), or\nallopurinol 300/200\u00a0mg QD (n=756). At least 65% of the patients had\nmild-moderate renal impairment (with creatinine clearance of 30-89 mL/min).\nProphylaxis against gout flares was obligatory over the 26-week period.</span></p>", "ID": "6fe56883-1268-4602-9409-29a030e3f8dd", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>CONFIRMS Study: The CONFIRMS study\nwas a Phase 3, randomized, controlled, 26-week study to evaluate the safety and\nefficacy of febuxostat 40\u00a0mg and 80\u00a0mg, in comparison with\nallopurinol 300\u00a0mg or 200\u00a0mg, in patients with gout and\nhyperuricaemia. Two thousand and two hundred-sixty nine (2269) patients were\nrandomized: febuxostat 40\u00a0mg QD (n=757), </span>", "ID": "b88172ef-bae0-4fb7-96ae-85d38cd7a22a", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "CONFIRMS Study: The CONFIRMS study was a Phase 3, randomized, controlled, 26-week study to evaluate the safety and efficacy of febuxostat 40\u00a0mg and 80\u00a0mg, in comparison with allopurinol 300\u00a0mg or 200\u00a0mg, in patients with gout and hyperuricaemia. Two thousand and two hundred-sixty nine (2269) patients were randomized: febuxostat 40\u00a0mg QD (n=757), ", "ParentId": "6fe56883-1268-4602-9409-29a030e3f8dd"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>febuxostat </span>", "ID": "8b464f7d-72f0-456e-b565-2051275e40fc", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "febuxostat ", "ParentId": "6fe56883-1268-4602-9409-29a030e3f8dd"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>80\u00a0mg QD (n=756), or\nallopurinol 300/200\u00a0mg QD (n=756). At least 65% of the patients had\nmild-moderate renal impairment (with creatinine clearance of 30-89 mL/min).\nProphylaxis against gout flares was obligatory over the 26-week period.</span>", "ID": "5fcd3e43-397b-4615-b672-dc0907837af5", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "80\u00a0mg QD (n=756), or allopurinol 300/200\u00a0mg QD (n=756). At least 65% of the patients had mild-moderate renal impairment (with creatinine clearance of 30-89 mL/min). Prophylaxis against gout flares was obligatory over the 26-week period.", "ParentId": "6fe56883-1268-4602-9409-29a030e3f8dd"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "829d028a-ffc5-4602-8a06-768ee9b4c4a8", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "7fd97662-2252-4e78-b169-7876b06d218a", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "829d028a-ffc5-4602-8a06-768ee9b4c4a8"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The proportion of patients with\nserum urate levels of &lt; 6.0\u00a0mg/dL (357\u00a0\u00b5mol/L) at the final visit,\nwas 45% for 40\u00a0mg febuxostat, 67% for febuxostat 80\u00a0mg and 42% for\nallopurinol 300/200\u00a0mg, respectively.</span></p>", "ID": "2e186d1a-f1be-458f-b4b8-9f0e0bf965e5", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The proportion of patients with\nserum urate levels of &lt; 6.0\u00a0mg/dL (357\u00a0\u00b5mol/L) at the final visit,\nwas 45% for 40\u00a0mg febuxostat, 67% for febuxostat 80\u00a0mg and 42% for\nallopurinol 300/200\u00a0mg, respectively.</span>", "ID": "5d014e76-4d9a-416f-ad44-38b2142bff96", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "The proportion of patients with serum urate levels of < 6.0\u00a0mg/dL (357\u00a0\u00b5mol/L) at the final visit, was 45% for 40\u00a0mg febuxostat, 67% for febuxostat 80\u00a0mg and 42% for allopurinol 300/200\u00a0mg, respectively.", "ParentId": "2e186d1a-f1be-458f-b4b8-9f0e0bf965e5"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "d586f664-2770-4b96-8151-99385c15375c", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "3babe25d-8966-4c8d-bf16-188adb4cfb6b", "Styles": "font-size:12.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "d586f664-2770-4b96-8151-99385c15375c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Primary endpoint in the sub-group\nof patients with renal impairment</span></i></p>", "ID": "2f8502f4-2782-4bd5-a8c9-ed8a2f733a9a", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Primary endpoint in the sub-group\nof patients with renal impairment</span></i>", "ID": "136539f4-ea67-49c9-9fae-df83b31a67b5", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "2f8502f4-2782-4bd5-a8c9-ed8a2f733a9a"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Primary endpoint in the sub-group\nof patients with renal impairment</span>", "ID": "c7da178d-ee33-4ad0-b57f-22e9aa90f5e3", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Primary endpoint in the sub-group of patients with renal impairment", "ParentId": "136539f4-ea67-49c9-9fae-df83b31a67b5"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The APEX Study evaluated efficacy\nin 40 patients with renal impairment (i.e., baseline serum creatinine &gt; 1.5\u00a0mg/dL\nand \u22642.0\u00a0mg/dL). For renally impaired subjects who were randomized\nto allopurinol, the dose was capped at 100\u00a0mg QD. Febuxostat achieved the\nprimary efficacy endpoint in 44% (80\u00a0mg QD), 45% (120\u00a0mg QD), and 60%\n(240\u00a0mg QD) of patients compared to 0% in the allopurinol 100\u00a0mg QD\nand placebo groups.</span></p>", "ID": "6f81bec7-b5c2-4398-90bf-71ed9a23a9a9", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The APEX Study evaluated efficacy\nin 40 patients with renal impairment (i.e., baseline serum creatinine &gt; 1.5\u00a0mg/dL\nand \u22642.0\u00a0mg/dL). For renally impaired subjects who were randomized\nto allopurinol, the dose was capped at 100\u00a0mg QD. Febuxostat achieved the\nprimary efficacy endpoint in 44% (80\u00a0mg QD), 45% (120\u00a0mg QD), and 60%\n(240\u00a0mg QD) of patients compared to 0% in the allopurinol 100\u00a0mg QD\nand placebo groups.</span>", "ID": "78e37ddd-3174-4a3f-9389-04eebe8e6dce", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "The APEX Study evaluated efficacy in 40 patients with renal impairment (i.e., baseline serum creatinine > 1.5\u00a0mg/dL and \u22642.0\u00a0mg/dL). For renally impaired subjects who were randomized to allopurinol, the dose was capped at 100\u00a0mg QD. Febuxostat achieved the primary efficacy endpoint in 44% (80\u00a0mg QD), 45% (120\u00a0mg QD), and 60% (240\u00a0mg QD) of patients compared to 0% in the allopurinol 100\u00a0mg QD and placebo groups.", "ParentId": "6f81bec7-b5c2-4398-90bf-71ed9a23a9a9"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "a883237e-cd22-4757-82be-6fda6f6d0328", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "74f7f5b9-1390-4c5b-b6fe-0b4b37c380af", "Styles": "font-size:12.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "a883237e-cd22-4757-82be-6fda6f6d0328"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>There were no clinically\nsignificant differences in the percent decrease in serum uric acid\nconcentration in healthy subjects irrespective of their renal function (58% in\nthe normal renal function group and 55% in the severe renal dysfunction group).</span></p>", "ID": "c3898deb-f206-4d66-9c89-359eef6cea0b", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>There were no clinically\nsignificant differences in the percent decrease in serum uric acid\nconcentration in healthy subjects irrespective of their renal function (58% in\nthe normal renal function group and 55% in the severe renal dysfunction group).</span>", "ID": "8575eb9a-c55d-410d-be06-4befdf61aa47", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "There were no clinically significant differences in the percent decrease in serum uric acid concentration in healthy subjects irrespective of their renal function (58% in the normal renal function group and 55% in the severe renal dysfunction group).", "ParentId": "c3898deb-f206-4d66-9c89-359eef6cea0b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "57673f1b-9346-4bfd-ada6-a0dc3d3c31c1", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "668350f9-713a-4f6b-a733-d898a9cb15e5", "Styles": "font-size:12.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "57673f1b-9346-4bfd-ada6-a0dc3d3c31c1"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>An analysis in patients with gout\nand renal impairment was prospectively defined in the CONFIRMS study, and\nshowed that febuxostat was significantly more efficacious in lowering serum\nurate levels to &lt; 6\u00a0mg/dL compared to allopurinol 300\u00a0mg/200\u00a0mg\nin patients who had gout with mild to moderate renal impairment (65% of\npatients studied).</span></p>", "ID": "755ae4f3-e6e0-44ac-a289-e710c5bf6e83", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>An analysis in patients with gout\nand renal impairment was prospectively defined in the CONFIRMS study, and\nshowed that febuxostat was significantly more efficacious in lowering serum\nurate levels to &lt; 6\u00a0mg/dL compared to allopurinol 300\u00a0mg/200\u00a0mg\nin patients who had gout with mild to moderate renal impairment (65% of\npatients studied).</span>", "ID": "1667e1fd-b4a4-4cd6-af5b-ce4a47bc42d3", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "An analysis in patients with gout and renal impairment was prospectively defined in the CONFIRMS study, and showed that febuxostat was significantly more efficacious in lowering serum urate levels to < 6\u00a0mg/dL compared to allopurinol 300\u00a0mg/200\u00a0mg in patients who had gout with mild to moderate renal impairment (65% of patients studied).", "ParentId": "755ae4f3-e6e0-44ac-a289-e710c5bf6e83"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "a8a3d24e-5e49-43d3-aced-14c357282f3d", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "5fedc23e-feb6-491d-b738-18ff97033b69", "Styles": "font-size:12.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "a8a3d24e-5e49-43d3-aced-14c357282f3d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Primary endpoint in the sub group\nof patients with sUA \u2265 10\u00a0mg/dL</span></i></p>", "ID": "6463fe93-fd04-4542-ba9c-c82e2c6e002f", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Primary endpoint in the sub group\nof patients with sUA \u2265 10\u00a0mg/dL</span></i>", "ID": "87a70201-f5b2-41b7-9784-b689e8c0c425", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6463fe93-fd04-4542-ba9c-c82e2c6e002f"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Primary endpoint in the sub group\nof patients with sUA \u2265 10\u00a0mg/dL</span>", "ID": "25d061e0-5999-492b-9a28-8f333cb7f81f", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Primary endpoint in the sub group of patients with sUA \u2265 10\u00a0mg/dL", "ParentId": "87a70201-f5b2-41b7-9784-b689e8c0c425"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Approximately 40% of patients\n(combined APEX and FACT) had a baseline sUA of \u2265 10\u00a0mg/dL. In this\nsubgroup febuxostat achieved the primary efficacy endpoint (sUA &lt; 6.0\u00a0mg/dL\nat the last 3 visits) in 41% (80\u00a0mg QD), 48% (120\u00a0mg QD), and 66%\n(240\u00a0mg QD) of patients compared to 9% in the allopurinol 300\u00a0mg/100\u00a0mg\nQD and 0% in the placebo groups.</span></p>", "ID": "398d7b35-e330-42b2-8691-43182d1600d7", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Approximately 40% of patients\n(combined APEX and FACT) had a baseline sUA of \u2265 10\u00a0mg/dL. In this\nsubgroup febuxostat achieved the primary efficacy endpoint (sUA &lt; 6.0\u00a0mg/dL\nat the last 3 visits) in 41% (80\u00a0mg QD), 48% (120\u00a0mg QD), and 66%\n(240\u00a0mg QD) of patients compared to 9% in the allopurinol 300\u00a0mg/100\u00a0mg\nQD and 0% in the placebo groups.</span>", "ID": "c6753ff5-6e6c-4720-8a75-c364d46d9f18", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Approximately 40% of patients (combined APEX and FACT) had a baseline sUA of \u2265 10\u00a0mg/dL. In this subgroup febuxostat achieved the primary efficacy endpoint (sUA < 6.0\u00a0mg/dL at the last 3 visits) in 41% (80\u00a0mg QD), 48% (120\u00a0mg QD), and 66% (240\u00a0mg QD) of patients compared to 9% in the allopurinol 300\u00a0mg/100\u00a0mg QD and 0% in the placebo groups.", "ParentId": "398d7b35-e330-42b2-8691-43182d1600d7"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "65514c8b-ce64-43ed-b2a3-bffdf6fe2ebc", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "bf056d03-e745-4e71-81b9-f8d747889821", "Styles": "font-size:12.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "65514c8b-ce64-43ed-b2a3-bffdf6fe2ebc"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>In the CONFIRMS study, the\nproportion of patients achieving the primary efficacy endpoint (sUA &lt;6.0\u00a0mg/dL\nat the final visit) for patients with a baseline serum urate level of \u2265\n10\u00a0mg/dL treated with febuxostat 40\u00a0mg QD was 27% (66/249), with\nfebuxostat 80\u00a0mg QD 49% (125/254) and with allopurinol 300\u00a0mg/200\u00a0mg\nQD 31% (72/230), respectively.</span></p>", "ID": "98a9ae68-a46b-4589-b26f-4721f9ab3354", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>In the CONFIRMS study, the\nproportion of patients achieving the primary efficacy endpoint (sUA &lt;6.0\u00a0mg/dL\nat the final visit) for patients with a baseline serum urate level of \u2265\n10\u00a0mg/dL treated with febuxostat 40\u00a0mg QD was 27% (66/249), with\nfebuxostat 80\u00a0mg QD 49% (125/254) and with allopurinol 300\u00a0mg/200\u00a0mg\nQD 31% (72/230), respectively.</span>", "ID": "10d21154-39a8-4b7f-bdec-7fd764773416", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "In the CONFIRMS study, the proportion of patients achieving the primary efficacy endpoint (sUA <6.0\u00a0mg/dL at the final visit) for patients with a baseline serum urate level of \u2265 10\u00a0mg/dL treated with febuxostat 40\u00a0mg QD was 27% (66/249), with febuxostat 80\u00a0mg QD 49% (125/254) and with allopurinol 300\u00a0mg/200\u00a0mg QD 31% (72/230), respectively.", "ParentId": "98a9ae68-a46b-4589-b26f-4721f9ab3354"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "d5183197-1032-4fa9-8bdf-5a51c6267856", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "d0f20b0a-6b04-464c-9cc9-052160d22050", "Styles": "font-size:12.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "d5183197-1032-4fa9-8bdf-5a51c6267856"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Clinical Outcomes: proportion of\npatients requiring treatment for a gout flare</span></i></p>", "ID": "90c7ea80-5a7a-4bfc-ac67-030b84a22e32", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Clinical Outcomes: proportion of\npatients requiring treatment for a gout flare</span></i>", "ID": "193c3c6c-ca6b-4416-a603-e1c38722fabd", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "90c7ea80-5a7a-4bfc-ac67-030b84a22e32"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Clinical Outcomes: proportion of\npatients requiring treatment for a gout flare</span>", "ID": "9dbe905f-df3c-4e60-876d-845a0900b9dc", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Clinical Outcomes: proportion of patients requiring treatment for a gout flare", "ParentId": "193c3c6c-ca6b-4416-a603-e1c38722fabd"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Apex study: During the 8-week\nprophylaxis period, a greater proportion of subjects in the febuxostat 120\u00a0mg\n(36%) treatment group required treatment for gout flare compared to febuxostat\n80\u00a0mg (28%), allopurinol 300\u00a0mg (23%) and placebo (20%). Flares\nincreased following the prophylaxis period and gradually decreased over time.\nBetween 46% and 55% of subjects received treatment for gout flares from Week 8\nand Week 28. Gout flares during the last 4 weeks of the study (Weeks 24-28)\nwere observed in 15% (febuxostat 80, 120\u00a0mg), 14% (allopurinol 300\u00a0mg)\nand 20% (placebo) of subjects.</span></p>", "ID": "eeefe0b5-2fe9-4b59-b95c-364c9d182b72", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Apex study: During the 8-week\nprophylaxis period, a greater proportion of subjects in the febuxostat 120\u00a0mg\n(36%) treatment group required treatment for gout flare compared to febuxostat\n80\u00a0mg (28%), allopurinol 300\u00a0mg (23%) and placebo (20%). Flares\nincreased following the prophylaxis period and gradually decreased over time.\nBetween 46% and 55% of subjects received treatment for gout flares from Week 8\nand Week 28. Gout flares during the last 4 weeks of the study (Weeks 24-28)\nwere observed in 15% (febuxostat 80, 120\u00a0mg), 14% (allopurinol 300\u00a0mg)\nand 20% (placebo) of subjects.</span>", "ID": "5ccbf1a6-e44a-4ed0-8f56-5a966abcc38b", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Apex study: During the 8-week prophylaxis period, a greater proportion of subjects in the febuxostat 120\u00a0mg (36%) treatment group required treatment for gout flare compared to febuxostat 80\u00a0mg (28%), allopurinol 300\u00a0mg (23%) and placebo (20%). Flares increased following the prophylaxis period and gradually decreased over time. Between 46% and 55% of subjects received treatment for gout flares from Week 8 and Week 28. Gout flares during the last 4 weeks of the study (Weeks 24-28) were observed in 15% (febuxostat 80, 120\u00a0mg), 14% (allopurinol 300\u00a0mg) and 20% (placebo) of subjects.", "ParentId": "eeefe0b5-2fe9-4b59-b95c-364c9d182b72"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "f184d5ac-e59a-49fc-98fa-c6806703d91b", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "cb2370c1-150b-45cc-b9d3-9a2fb344a244", "Styles": "font-size:12.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "f184d5ac-e59a-49fc-98fa-c6806703d91b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Fact study: During the 8-week\nprophylaxis period, a greater proportion of subjects in the febuxostat 120\u00a0mg\n(36%) treatment group required treatment for a gout flare compared to both the\nfebuxostat 80\u00a0mg (22%) and allopurinol 300\u00a0mg (21%) treatment groups.\nAfter the 8-week prophylaxis period, the incidences of flares increased and\ngradually decreased over time (64% and 70% of subjects received treatment for\ngout flares from Week 8-52). Gout flares during the last 4 weeks of the study\n(Weeks 49-52) were observed in 6-8% (febuxostat 80\u00a0mg, 120\u00a0mg) and\n11% (allopurinol 300\u00a0mg) of subjects.</span></p>", "ID": "1b1cdb44-92d8-4720-904e-87d20cb2ed0f", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Fact study: During the 8-week\nprophylaxis period, a greater proportion of subjects in the febuxostat 120\u00a0mg\n(36%) treatment group required treatment for a gout flare compared to both the\nfebuxostat 80\u00a0mg (22%) and allopurinol 300\u00a0mg (21%) treatment groups.\nAfter the 8-week prophylaxis period, the incidences of flares increased and\ngradually decreased over time (64% and 70% of subjects received treatment for\ngout flares from Week 8-52). Gout flares during the last 4 weeks of the study\n(Weeks 49-52) were observed in 6-8% (febuxostat 80\u00a0mg, 120\u00a0mg) and\n11% (allopurinol 300\u00a0mg) of subjects.</span>", "ID": "3116d650-1e70-4547-9bda-a70d1d870631", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Fact study: During the 8-week prophylaxis period, a greater proportion of subjects in the febuxostat 120\u00a0mg (36%) treatment group required treatment for a gout flare compared to both the febuxostat 80\u00a0mg (22%) and allopurinol 300\u00a0mg (21%) treatment groups. After the 8-week prophylaxis period, the incidences of flares increased and gradually decreased over time (64% and 70% of subjects received treatment for gout flares from Week 8-52). Gout flares during the last 4 weeks of the study (Weeks 49-52) were observed in 6-8% (febuxostat 80\u00a0mg, 120\u00a0mg) and 11% (allopurinol 300\u00a0mg) of subjects.", "ParentId": "1b1cdb44-92d8-4720-904e-87d20cb2ed0f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "5793f7cd-76c7-4495-9623-0c1482be5e20", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "315ce7b1-ce75-4c6a-8428-e2ee7ab0b9d8", "Styles": "font-size:12.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "5793f7cd-76c7-4495-9623-0c1482be5e20"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The proportion of subjects\nrequiring treatment for a gout flare (APEX and FACT Study) was numerically\nlower in the groups that achieved an average post-baseline serum urate level\n&lt;6.0\u00a0mg/dL, &lt;5.0\u00a0mg/dL, or &lt;4.0\u00a0mg/dL compared to the\ngroup that achieved an average post-baseline serum urate level \u22656.0\u00a0mg/dL\nduring the last 32 weeks of the treatment period (Week 20-Week 24 to Week 49 -\n52 intervals).</span></p>", "ID": "9a503018-8148-4dc9-aa22-7f6478381224", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The proportion of subjects\nrequiring treatment for a gout flare (APEX and FACT Study) was numerically\nlower in the groups that achieved an average post-baseline serum urate level\n&lt;6.0\u00a0mg/dL, &lt;5.0\u00a0mg/dL, or &lt;4.0\u00a0mg/dL compared to the\ngroup that achieved an average post-baseline serum urate level \u22656.0\u00a0mg/dL\nduring the last 32 weeks of the treatment period (Week 20-Week 24 to Week 49 -\n52 intervals).</span>", "ID": "c3e2d7d7-c684-4c76-a96c-e1240ac40274", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "The proportion of subjects requiring treatment for a gout flare (APEX and FACT Study) was numerically lower in the groups that achieved an average post-baseline serum urate level <6.0\u00a0mg/dL, <5.0\u00a0mg/dL, or <4.0\u00a0mg/dL compared to the group that achieved an average post-baseline serum urate level \u22656.0\u00a0mg/dL during the last 32 weeks of the treatment period (Week 20-Week 24 to Week 49 - 52 intervals).", "ParentId": "9a503018-8148-4dc9-aa22-7f6478381224"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "adbe650f-a8da-4a47-89e1-e99fe986bc2b", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "a4aa0429-fa3e-4887-b734-55f136b35a16", "Styles": "font-size:12.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "adbe650f-a8da-4a47-89e1-e99fe986bc2b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>During the CONFIRMS study, the\npercentages of patients who required treatment for gout flares (Day 1 through\nMonth 6) were 31% and 25% for the febuxostat 80\u00a0mg and allopurinol groups,\nrespectively. No difference in the proportion of patients requiring treatment\nfor gout flares was observed between the febuxostat 80\u00a0mg and 40\u00a0mg\ngroups.</span></p>", "ID": "b0b10776-9a26-40a7-b74f-0370f1ee830b", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>During the CONFIRMS study, the\npercentages of patients who required treatment for gout flares (Day 1 through\nMonth 6) were 31% and 25% for the febuxostat 80\u00a0mg and allopurinol groups,\nrespectively. No difference in the proportion of patients requiring treatment\nfor gout flares was observed between the febuxostat 80\u00a0mg and 40\u00a0mg\ngroups.</span>", "ID": "a33cd69c-99ea-4444-b924-49d68fca0371", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "During the CONFIRMS study, the percentages of patients who required treatment for gout flares (Day 1 through Month 6) were 31% and 25% for the febuxostat 80\u00a0mg and allopurinol groups, respectively. No difference in the proportion of patients requiring treatment for gout flares was observed between the febuxostat 80\u00a0mg and 40\u00a0mg groups.", "ParentId": "b0b10776-9a26-40a7-b74f-0370f1ee830b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "dd1fa248-07a6-4039-807b-799a830f78c2", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "f1e52035-a363-458b-9e72-7dddcd271b00", "Styles": "font-size:12.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "dd1fa248-07a6-4039-807b-799a830f78c2"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Long-term, open label extension\nStudies</span></i></p>", "ID": "f80fe7c9-2550-4d2c-8abc-9815008dbebf", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Long-term, open label extension\nStudies</span></i>", "ID": "3658a57e-8e2b-41ef-8677-6a50f391588a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f80fe7c9-2550-4d2c-8abc-9815008dbebf"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Long-term, open label extension\nStudies</span>", "ID": "13511a9e-61a4-45bd-aa82-348075d799c5", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Long-term, open label extension Studies", "ParentId": "3658a57e-8e2b-41ef-8677-6a50f391588a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EXCEL Study (C02-021): The Excel\nstudy was a three years Phase 3, open label, multicenter, randomised,\nallopurinol-controlled, safety extension study for patients who had completed\nthe pivotal Phase 3 studies (APEX or FACT). A total of 1,086 patients were\nenrolled: Febuxostat 80\u00a0mg QD (n=649), febuxostat 120\u00a0mg QD (n=292)\nand allopurinol 300/100\u00a0mg QD (n=145). About 69% of patients required no\ntreatment change to achieve a final stable treatment. Patients who had 3 consecutive\nsUA levels &gt;6.0\u00a0mg/dL were withdrawn.</span></p>", "ID": "4d22b5a6-0639-488f-893c-c0f0affd00f9", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EXCEL Study (C02-021): The Excel\nstudy was a three years Phase 3, open label, multicenter, randomised,\nallopurinol-controlled, safety extension study for patients who had completed\nthe pivotal Phase 3 studies (APEX or FACT). A total of 1,086 patients were\nenrolled: Febuxostat 80\u00a0mg QD (n=649), febuxostat 120\u00a0mg QD (n=292)\nand allopurinol 300/100\u00a0mg QD (n=145). About 69% of patients required no\ntreatment change to achieve a final stable treatment. Patients who had 3 consecutive\nsUA levels &gt;6.0\u00a0mg/dL were withdrawn.</span>", "ID": "f1ad4218-5b2a-488b-8dc0-8a207698102d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "EXCEL Study (C02-021): The Excel study was a three years Phase 3, open label, multicenter, randomised, allopurinol-controlled, safety extension study for patients who had completed the pivotal Phase 3 studies (APEX or FACT). A total of 1,086 patients were enrolled: Febuxostat 80\u00a0mg QD (n=649), febuxostat 120\u00a0mg QD (n=292) and allopurinol 300/100\u00a0mg QD (n=145). About 69% of patients required no treatment change to achieve a final stable treatment. Patients who had 3 consecutive sUA levels >6.0\u00a0mg/dL were withdrawn.", "ParentId": "4d22b5a6-0639-488f-893c-c0f0affd00f9"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "ce3c28e5-9550-4cc1-b8d1-4bb1d1c1f036", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "d9f0db35-8686-4651-8089-d99f0bea6822", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "ce3c28e5-9550-4cc1-b8d1-4bb1d1c1f036"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Serum urate levels were maintained\nover time (i.e. 91% and 93% of patients on initial treatment with febuxostat 80\u00a0mg\nand 120\u00a0mg, respectively, had sUA &lt;6\u00a0mg/dL at Month 36).</span></p>", "ID": "940f14f4-7704-4fb9-80dd-c04bfba1ba0d", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Serum urate levels were maintained\nover time (i.e. 91% and 93% of patients on initial treatment with febuxostat 80\u00a0mg\nand 120\u00a0mg, respectively, had sUA &lt;6\u00a0mg/dL at Month 36).</span>", "ID": "dd996784-478e-4c9e-a949-94a0cbdbd215", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Serum urate levels were maintained over time (i.e. 91% and 93% of patients on initial treatment with febuxostat 80\u00a0mg and 120\u00a0mg, respectively, had sUA <6\u00a0mg/dL at Month 36).", "ParentId": "940f14f4-7704-4fb9-80dd-c04bfba1ba0d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "969a7fa8-9a22-4a42-a8a2-fbde28ff1d96", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "763197f2-9593-46cf-95cf-4730f05aa6b6", "Styles": "font-size:12.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "969a7fa8-9a22-4a42-a8a2-fbde28ff1d96"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Three years data showed a decrease\nin the incidence of gout flares with less than 4% of patients requiring\ntreatment for a flare (i.e. more than 96% of patients did not require treatment\nfor a flare) at Month 16-24 and at Month 30-36.</span></p>", "ID": "a61f2d5d-64b0-4c5a-9021-0b4b6c5593e6", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Three years data showed a decrease\nin the incidence of gout flares with less than 4% of patients requiring\ntreatment for a flare (i.e. more than 96% of patients did not require treatment\nfor a flare) at Month 16-24 and at Month 30-36.</span>", "ID": "054a1bfe-5f6b-4e76-a05c-244e3b611080", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Three years data showed a decrease in the incidence of gout flares with less than 4% of patients requiring treatment for a flare (i.e. more than 96% of patients did not require treatment for a flare) at Month 16-24 and at Month 30-36.", "ParentId": "a61f2d5d-64b0-4c5a-9021-0b4b6c5593e6"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "ebd8e6e3-2acf-4078-a75c-c2a66b8c9071", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "5601942e-838a-4dac-b0f8-7eda1baebcea", "Styles": "font-size:12.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "ebd8e6e3-2acf-4078-a75c-c2a66b8c9071"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>46% and 38%, of patients on final\nstable treatment of febuxostat 80 or 120\u00a0mg QD, respectively, had complete\nresolution of the primary palpable tophus from baseline to the Final Visit.</span></p>", "ID": "5810ce80-1876-4919-a8cb-414e6ee2b0a1", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>46% and 38%, of patients on final\nstable treatment of febuxostat 80 or 120\u00a0mg QD, respectively, had complete\nresolution of the primary palpable tophus from baseline to the Final Visit.</span>", "ID": "ec0f3b7e-f600-4d25-9219-0ad2514c5402", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "46% and 38%, of patients on final stable treatment of febuxostat 80 or 120\u00a0mg QD, respectively, had complete resolution of the primary palpable tophus from baseline to the Final Visit.", "ParentId": "5810ce80-1876-4919-a8cb-414e6ee2b0a1"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "c7275c7d-4c94-4800-9a08-e9e770119eb0", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "a7719ce8-d693-4c33-ac28-dc4d140fdadd", "Styles": "font-size:12.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "c7275c7d-4c94-4800-9a08-e9e770119eb0"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>FOCUS Study (TMX-01-005) was a 5\nyears Phase 2, open-label, multicenter, safety extension study for patients who\nhad completed the febuxostat 4 weeks of double blind dosing in study\nTMX-00-004. 116 patients were enrolled and received initially febuxostat 80\u00a0mg\nQD. 62% of patients required no dose adjustment to maintain sUA &lt;6\u00a0mg/dL\nand 38% of patients required a dose adjustment to achieve a final stable dose.</span></p>", "ID": "2dea7af1-9b7d-4484-854b-d47cfc4c4259", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>FOCUS Study (TMX-01-005) was a 5\nyears Phase 2, open-label, multicenter, safety extension study for patients who\nhad completed the febuxostat 4 weeks of double blind dosing in study\nTMX-00-004. 116 patients were enrolled and received initially febuxostat 80\u00a0mg\nQD. 62% of patients required no dose adjustment to maintain sUA &lt;6\u00a0mg/dL\nand 38% of patients required a dose adjustment to achieve a final stable dose.</span>", "ID": "bf827d76-be85-45ad-ac5e-fbeed91e3667", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "FOCUS Study (TMX-01-005) was a 5 years Phase 2, open-label, multicenter, safety extension study for patients who had completed the febuxostat 4 weeks of double blind dosing in study TMX-00-004. 116 patients were enrolled and received initially febuxostat 80\u00a0mg QD. 62% of patients required no dose adjustment to maintain sUA <6\u00a0mg/dL and 38% of patients required a dose adjustment to achieve a final stable dose.", "ParentId": "2dea7af1-9b7d-4484-854b-d47cfc4c4259"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "2941a708-caab-4f50-b506-17fcc3903ddc", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "7491c6c4-0840-4888-ac84-70d86f9df556", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "2941a708-caab-4f50-b506-17fcc3903ddc"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The proportion of patients with\nserum urate levels of &lt;6.0\u00a0mg/dL (357\u00a0\u00b5mol/L) at the final visit\nwas greater than 80% (81-100%) at each febuxostat dose.</span></p>", "ID": "81d2747a-d3eb-4922-8528-e7920dcb96c3", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The proportion of patients with\nserum urate levels of &lt;6.0\u00a0mg/dL (357\u00a0\u00b5mol/L) at the final visit\nwas greater than 80% (81-100%) at each febuxostat dose.</span>", "ID": "2c98d687-3971-4453-a2a6-7c455b94a7b6", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "The proportion of patients with serum urate levels of <6.0\u00a0mg/dL (357\u00a0\u00b5mol/L) at the final visit was greater than 80% (81-100%) at each febuxostat dose.", "ParentId": "81d2747a-d3eb-4922-8528-e7920dcb96c3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "89b73a6a-988b-4a21-b246-353fa0e212cc", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "58b3dfb2-2cbb-47ca-a268-a1787685c5ba", "Styles": "font-size:12.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "89b73a6a-988b-4a21-b246-353fa0e212cc"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>During the phase 3 clinical\nstudies, mild liver function test abnormalities were observed in patients treated\nwith febuxostat (5.0%). These rates were similar to the rates reported on\nallopurinol (4.2%) (see section 4.4). Increased TSH values (&gt;5.5\u00a0\u00b5IU/mL)\nwere observed in patients on long-term treatment with febuxostat (5.5%) and\npatients with allopurinol (5.8%) in the long term open label extension studies\n(see section 4.4).</span></p>", "ID": "0a5d3c07-10cd-49f4-a2cb-4aa92abbfdd6", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>During the phase 3 clinical\nstudies, mild liver function test abnormalities were observed in patients treated\nwith febuxostat (5.0%). These rates were similar to the rates reported on\nallopurinol (4.2%) (see section 4.4). Increased TSH values (&gt;5.5\u00a0\u00b5IU/mL)\nwere observed in patients on long-term treatment with febuxostat (5.5%) and\npatients with allopurinol (5.8%) in the long term open label extension studies\n(see section 4.4).</span>", "ID": "7218edc7-f4fe-4490-9455-581d434ab71f", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "During the phase 3 clinical studies, mild liver function test abnormalities were observed in patients treated with febuxostat (5.0%). These rates were similar to the rates reported on allopurinol (4.2%) (see section 4.4). Increased TSH values (>5.5\u00a0\u00b5IU/mL) were observed in patients on long-term treatment with febuxostat (5.5%) and patients with allopurinol (5.8%) in the long term open label extension studies (see section 4.4).", "ParentId": "0a5d3c07-10cd-49f4-a2cb-4aa92abbfdd6"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:13.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "3647b345-c4a6-440a-ba02-0e3528f3fa82", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:13.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "beee8ed4-c125-476a-858c-88a0933a3664", "Styles": "font-size:13.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "3647b345-c4a6-440a-ba02-0e3528f3fa82"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><i><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Tumor Lysis Syndrome</span></u></i></p>", "ID": "e14dac4c-40c5-472a-848f-8d07b17550e0", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<i><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Tumor Lysis Syndrome</span></u></i>", "ID": "c9973409-eda3-4803-b1f2-ea77455fa29f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e14dac4c-40c5-472a-848f-8d07b17550e0"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Tumor Lysis Syndrome</span></u>", "ID": "57734729-9fea-486e-80ee-cc1aa71e60b0", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c9973409-eda3-4803-b1f2-ea77455fa29f"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Tumor Lysis Syndrome</span>", "ID": "b922c0f5-59ed-4fac-8177-00a695e5fc98", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Tumor Lysis Syndrome", "ParentId": "57734729-9fea-486e-80ee-cc1aa71e60b0"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The efficacy and safety of febuxostat\nin the prevention and treatment of Tumor Lysis Syndrome was evaluated in the\nFLORENCE (FLO-01) study. Febuxostat C showed a superior and faster urate\nlowering activity compared to allopurinol.</span></p>", "ID": "7b9102fe-6fae-489f-97d9-c4d07a99f3c6", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The efficacy and safety of febuxostat\nin the prevention and treatment of Tumor Lysis Syndrome was evaluated in the\nFLORENCE (FLO-01) study. Febuxostat C showed a superior and faster urate\nlowering activity compared to allopurinol.</span>", "ID": "b3f0dd30-ca5e-442a-aeb4-ce5f5ad44157", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "The efficacy and safety of febuxostat in the prevention and treatment of Tumor Lysis Syndrome was evaluated in the FLORENCE (FLO-01) study. Febuxostat C showed a superior and faster urate lowering activity compared to allopurinol.", "ParentId": "7b9102fe-6fae-489f-97d9-c4d07a99f3c6"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "51d9229c-d290-40e4-ba20-7af8d87c088f", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "d814ab35-cadd-44c3-a09c-c04d1c673ea7", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "51d9229c-d290-40e4-ba20-7af8d87c088f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>FLORENCE was a randomized (1:1),\ndouble blind, phase III, pivotal trial comparing febuxostat 120\u00a0mg once\ndaily with allopurinol 200 to 600\u00a0mg daily (mean allopurinol daily dose [\u00b1\nstandard deviation]: 349.7 \u00b1 112.90\u00a0mg) in terms of control of serum uric\nacid level. Eligible patients had to be candidates for allopurinol treatment or\nhave no access to rasburicase. Primary endpoints were serum uric acid area\nunder the curve (AUC sUA</span><span lang=\"EN-GB\" style='font-size:7.0pt;\nfont-family:\"Times New Roman\",serif'>1-8</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>) and change in serum creatinine\n(sC) level both from baseline to Day 8.</span></p>", "ID": "9dd4a833-39f2-434d-b15e-b4784859254f", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>FLORENCE was a randomized (1:1),\ndouble blind, phase III, pivotal trial comparing febuxostat 120\u00a0mg once\ndaily with allopurinol 200 to 600\u00a0mg daily (mean allopurinol daily dose [\u00b1\nstandard deviation]: 349.7 \u00b1 112.90\u00a0mg) in terms of control of serum uric\nacid level. Eligible patients had to be candidates for allopurinol treatment or\nhave no access to rasburicase. Primary endpoints were serum uric acid area\nunder the curve (AUC sUA</span>", "ID": "b857626d-2d2a-403c-b178-2ce81fb70354", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "FLORENCE was a randomized (1:1), double blind, phase III, pivotal trial comparing febuxostat 120\u00a0mg once daily with allopurinol 200 to 600\u00a0mg daily (mean allopurinol daily dose [\u00b1 standard deviation]: 349.7 \u00b1 112.90\u00a0mg) in terms of control of serum uric acid level. Eligible patients had to be candidates for allopurinol treatment or have no access to rasburicase. Primary endpoints were serum uric acid area under the curve (AUC sUA", "ParentId": "9dd4a833-39f2-434d-b15e-b4784859254f"}, {"Element": "<span lang=\"EN-GB\" style='font-size:7.0pt;\nfont-family:\"Times New Roman\",serif'>1-8</span>", "ID": "7b202aca-b3b2-4593-87b3-ee2a7b715c42", "Styles": "font-size:7.0pt;\nfont-family:\"Times New Roman\",serif", "Classes": "None", "Text": "1-8", "ParentId": "9dd4a833-39f2-434d-b15e-b4784859254f"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>) and change in serum creatinine\n(sC) level both from baseline to Day 8.</span>", "ID": "5deafcc2-971e-4e31-8fd2-ac46c00361cf", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": ") and change in serum creatinine (sC) level both from baseline to Day 8.", "ParentId": "9dd4a833-39f2-434d-b15e-b4784859254f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "c0929fe1-7b3e-48dd-ab74-9fa5f2dc3fc9", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "bd398f92-db94-4f27-a113-bf35144c852e", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "c0929fe1-7b3e-48dd-ab74-9fa5f2dc3fc9"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Overall, 346 patients with\nhaematological malignancies undergoing chemotherapy and at intermediate/high\nrisk of Tumor Lysis Syndrome were included. Mean AUC sUA</span><span lang=\"EN-GB\" style='font-size:7.0pt;font-family:\"Times New Roman\",serif'>1-8 </span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(mgxh/dl) was\nsignificantly lower with febuxostat (514.0 \u00b1 225.71 vs 708.0 \u00b1 234.42; least\nsquare means difference: -196.794 [95% confidence interval: -238.600 ;\n-154.988]; p &lt; .0001). Furthermore, the mean serum uric acid level was\nsignificantly lower with febuxostat since the first 24 hours of treatment and\nat any following time point. No significant difference in mean serum creatinine\nchange (%) occurred between febuxostat and allopurinol (-0.83 \u00b1 26.98 vs -4.92\n\u00b1 16.70 respectively; least square means difference: 4.0970 [95% confidence\ninterval: -0.6467 ; 8.8406]; p=0.0903). With regard to secondary endpoints, no\nsignificant difference was detected in terms of incidence of laboratory TLS\n(8.1% and 9.2% in febuxostat and allopurinol arm, respectively; relative risk:\n0.875 [95% confidence interval: 0.4408 ; 1.7369]; p=0.8488) nor of clinical TLS\n(1.7% and 1.2% in febuxostat and allopurinol arm, respectively; relative risk:\n0.994 [95% confidence interval: 0.9691 ; 1.0199]; p=1.0000).\u00a0 Incidence of overall\ntreatment-emergent signs and symptoms and adverse drug reactions was 67.6% vs\n64.7% and 6.4% vs 6.4% with febuxostat and allopurinol respectively. In the\nFLORENCE study febuxostat demonstrated a superior control of serum uric acid level\ncompared to allopurinol in patients scheduled to receive the latter drug. No\ndata comparing febuxostat with rasburicase are currently available. The\nefficacy and safety of febuxostat has not been established in patients with\nacute severe TLS, e.g. in patients who failed on other urate lowering\ntherapies.</span></p>", "ID": "33d1710b-9299-4319-b40f-ea4859e20ee5", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Overall, 346 patients with\nhaematological malignancies undergoing chemotherapy and at intermediate/high\nrisk of Tumor Lysis Syndrome were included. Mean AUC sUA</span>", "ID": "7e3b199e-c644-42f9-89e9-2ab7e0e8fe77", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Overall, 346 patients with haematological malignancies undergoing chemotherapy and at intermediate/high risk of Tumor Lysis Syndrome were included. Mean AUC sUA", "ParentId": "33d1710b-9299-4319-b40f-ea4859e20ee5"}, {"Element": "<span lang=\"EN-GB\" style='font-size:7.0pt;font-family:\"Times New Roman\",serif'>1-8 </span>", "ID": "cf1301fa-cecd-43f1-89b5-092fa2fddb46", "Styles": "font-size:7.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "1-8 ", "ParentId": "33d1710b-9299-4319-b40f-ea4859e20ee5"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(mgxh/dl) was\nsignificantly lower with febuxostat (514.0 \u00b1 225.71 vs 708.0 \u00b1 234.42; least\nsquare means difference: -196.794 [95% confidence interval: -238.600 ;\n-154.988]; p &lt; .0001). Furthermore, the mean serum uric acid level was\nsignificantly lower with febuxostat since the first 24 hours of treatment and\nat any following time point. No significant difference in mean serum creatinine\nchange (%) occurred between febuxostat and allopurinol (-0.83 \u00b1 26.98 vs -4.92\n\u00b1 16.70 respectively; least square means difference: 4.0970 [95% confidence\ninterval: -0.6467 ; 8.8406]; p=0.0903). With regard to secondary endpoints, no\nsignificant difference was detected in terms of incidence of laboratory TLS\n(8.1% and 9.2% in febuxostat and allopurinol arm, respectively; relative risk:\n0.875 [95% confidence interval: 0.4408 ; 1.7369]; p=0.8488) nor of clinical TLS\n(1.7% and 1.2% in febuxostat and allopurinol arm, respectively; relative risk:\n0.994 [95% confidence interval: 0.9691 ; 1.0199]; p=1.0000).\u00a0 Incidence of overall\ntreatment-emergent signs and symptoms and adverse drug reactions was 67.6% vs\n64.7% and 6.4% vs 6.4% with febuxostat and allopurinol respectively. In the\nFLORENCE study febuxostat demonstrated a superior control of serum uric acid level\ncompared to allopurinol in patients scheduled to receive the latter drug. No\ndata comparing febuxostat with rasburicase are currently available. The\nefficacy and safety of febuxostat has not been established in patients with\nacute severe TLS, e.g. in patients who failed on other urate lowering\ntherapies.</span>", "ID": "3993ac0b-1e7c-4d27-824f-e0315b232222", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "(mgxh/dl) was significantly lower with febuxostat (514.0 \u00b1 225.71 vs 708.0 \u00b1 234.42; least square means difference: -196.794 [95% confidence interval: -238.600 ; -154.988]; p < .0001). Furthermore, the mean serum uric acid level was significantly lower with febuxostat since the first 24 hours of treatment and at any following time point. No significant difference in mean serum creatinine change (%) occurred between febuxostat and allopurinol (-0.83 \u00b1 26.98 vs -4.92 \u00b1 16.70 respectively; least square means difference: 4.0970 [95% confidence interval: -0.6467 ; 8.8406]; p=0.0903). With regard to secondary endpoints, no significant difference was detected in terms of incidence of laboratory TLS (8.1% and 9.2% in febuxostat and allopurinol arm, respectively; relative risk: 0.875 [95% confidence interval: 0.4408 ; 1.7369]; p=0.8488) nor of clinical TLS (1.7% and 1.2% in febuxostat and allopurinol arm, respectively; relative risk: 0.994 [95% confidence interval: 0.9691 ; 1.0199]; p=1.0000).\u00a0 Incidence of overall treatment-emergent signs and symptoms and adverse drug reactions was 67.6% vs 64.7% and 6.4% vs 6.4% with febuxostat and allopurinol respectively. In the FLORENCE study febuxostat demonstrated a superior control of serum uric acid level compared to allopurinol in patients scheduled to receive the latter drug. No data comparing febuxostat with rasburicase are currently available. The efficacy and safety of febuxostat has not been established in patients with acute severe TLS, e.g. in patients who failed on other urate lowering therapies.", "ParentId": "33d1710b-9299-4319-b40f-ea4859e20ee5"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "2cb15ae9-78df-4b70-8186-64656dafc80c", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "be72f15c-3518-438b-9d56-e84fa7e94d4e", "Styles": "font-size:12.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "2cb15ae9-78df-4b70-8186-64656dafc80c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>5.2\u00a0\u00a0\u00a0\u00a0\u00a0 Pharmacokinetic properties</span></b></p>", "ID": "287d5eb0-973f-42c9-bf01-8827280c0494", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>5.2\u00a0\u00a0\u00a0\u00a0\u00a0 Pharmacokinetic properties</span></b>", "ID": "59fbf556-2c23-4866-b808-71cefb2067dc", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "287d5eb0-973f-42c9-bf01-8827280c0494"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>5.2\u00a0\u00a0\u00a0\u00a0\u00a0 Pharmacokinetic properties</span>", "ID": "2259ca29-0cab-4a85-b946-df7967a817f4", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "5.2\u00a0\u00a0\u00a0\u00a0\u00a0 Pharmacokinetic properties", "ParentId": "59fbf556-2c23-4866-b808-71cefb2067dc"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "a314f238-9ff6-4180-8879-a0558af93303", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "99338981-d0cc-4a12-a6c1-20eb6524bfde", "Styles": "font-size:12.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "a314f238-9ff6-4180-8879-a0558af93303"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>In healthy subjects, maximum plasma\nconcentrations (C</span><span lang=\"EN-GB\" style='font-size:7.0pt;font-family:\n\"Times New Roman\",serif'>max</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>)\nand area under the plasma concentration time curve (AUC) of febuxostat\nincreased in a dose proportional manner following single and multiple doses of\n10\u00a0mg to 120\u00a0mg. For doses between 120\u00a0mg and 300\u00a0mg, a\ngreater than dose proportional increase in AUC is observed for febuxostat.\nThere is no appreciable accumulation when doses of 10\u00a0mg to 240\u00a0mg\nare administered every 24 hours. Febuxostat has an apparent mean terminal\nelimination half-life (t<sub>1/2</sub>) of approximately 5 to 8 hours.</span></p>", "ID": "58d4e077-02c7-4f25-bf6c-d2375fa8c8c4", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>In healthy subjects, maximum plasma\nconcentrations (C</span>", "ID": "36f79e22-bb40-41af-92e8-27ab51ba3ed7", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "In healthy subjects, maximum plasma concentrations (C", "ParentId": "58d4e077-02c7-4f25-bf6c-d2375fa8c8c4"}, {"Element": "<span lang=\"EN-GB\" style='font-size:7.0pt;font-family:\n\"Times New Roman\",serif'>max</span>", "ID": "f89d94e4-032c-4d4e-9cfe-b052ae435385", "Styles": "font-size:7.0pt;font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "max", "ParentId": "58d4e077-02c7-4f25-bf6c-d2375fa8c8c4"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>)\nand area under the plasma concentration time curve (AUC) of febuxostat\nincreased in a dose proportional manner following single and multiple doses of\n10\u00a0mg to 120\u00a0mg. For doses between 120\u00a0mg and 300\u00a0mg, a\ngreater than dose proportional increase in AUC is observed for febuxostat.\nThere is no appreciable accumulation when doses of 10\u00a0mg to 240\u00a0mg\nare administered every 24 hours. Febuxostat has an apparent mean terminal\nelimination half-life (t<sub>1/2</sub>) of approximately 5 to 8 hours.</span>", "ID": "d79a0a95-23ff-42a2-a57f-299520f88894", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": ") and area under the plasma concentration time curve (AUC) of febuxostat increased in a dose proportional manner following single and multiple doses of 10\u00a0mg to 120\u00a0mg. For doses between 120\u00a0mg and 300\u00a0mg, a greater than dose proportional increase in AUC is observed for febuxostat. There is no appreciable accumulation when doses of 10\u00a0mg to 240\u00a0mg are administered every 24 hours. Febuxostat has an apparent mean terminal elimination half-life (t) of approximately 5 to 8 hours.", "ParentId": "58d4e077-02c7-4f25-bf6c-d2375fa8c8c4"}, {"Element": "<sub>1/2</sub>", "ID": "9ecbd291-9795-4da3-b67e-c40bc905335d", "Styles": "None", "Classes": "None", "Text": "1/2", "ParentId": "d79a0a95-23ff-42a2-a57f-299520f88894"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "3b6a3245-1516-4543-a7bb-f783120c6c65", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "8058419f-298d-4fc1-88f6-69f36a503ce0", "Styles": "font-size:12.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "3b6a3245-1516-4543-a7bb-f783120c6c65"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Population\npharmacokinetic/pharmacodynamic analyses were conducted in 211 patients with\nhyperuricaemia and gout, treated with febuxostat 40-240\u00a0mg QD. In general,\nfebuxostat pharmacokinetic parameters estimated by these analyses are\nconsistent with those obtained from healthy subjects, indicating that healthy\nsubjects are representative for pharmacokinetic/pharmacodynamic assessment in\nthe patient population with gout.</span></p>", "ID": "7fa8d1e2-7cb4-4ff4-a4af-26cd79e4def2", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Population\npharmacokinetic/pharmacodynamic analyses were conducted in 211 patients with\nhyperuricaemia and gout, treated with febuxostat 40-240\u00a0mg QD. In general,\nfebuxostat pharmacokinetic parameters estimated by these analyses are\nconsistent with those obtained from healthy subjects, indicating that healthy\nsubjects are representative for pharmacokinetic/pharmacodynamic assessment in\nthe patient population with gout.</span>", "ID": "5ee86eae-1d50-4ecd-8212-d3c62b3f1e81", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Population pharmacokinetic/pharmacodynamic analyses were conducted in 211 patients with hyperuricaemia and gout, treated with febuxostat 40-240\u00a0mg QD. In general, febuxostat pharmacokinetic parameters estimated by these analyses are consistent with those obtained from healthy subjects, indicating that healthy subjects are representative for pharmacokinetic/pharmacodynamic assessment in the patient population with gout.", "ParentId": "7fa8d1e2-7cb4-4ff4-a4af-26cd79e4def2"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "85dfd3cc-b52c-4a26-91af-83eb845a720c", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "0007b8c1-ae48-4f35-917d-d760e4891861", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "85dfd3cc-b52c-4a26-91af-83eb845a720c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Absorption</span></u></p>", "ID": "afc3c8c5-9dc5-4005-9614-a717b97f7a15", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Absorption</span></u>", "ID": "02b28e34-a530-46ae-9411-a3c86dbab32a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "afc3c8c5-9dc5-4005-9614-a717b97f7a15"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Absorption</span>", "ID": "cdcb6f16-e59f-4374-ad3d-507f48a77691", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Absorption", "ParentId": "02b28e34-a530-46ae-9411-a3c86dbab32a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "33fed237-2b33-48a4-8887-893b4e80649d", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "581e54af-37a1-4280-8095-bf449c306157", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "33fed237-2b33-48a4-8887-893b4e80649d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat is rapidly (t</span><span lang=\"EN-GB\" style='font-size:7.0pt;font-family:\"Times New Roman\",serif'>max </span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>of 1.0-1.5 h) and well\nabsorbed (at least 84%). After single or multiple oral 80 and 120\u00a0mg once\ndaily doses, C</span><span lang=\"EN-GB\" style='font-size:7.0pt;font-family:\"Times New Roman\",serif'>max\n</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>is\napproximately 2.8-3.2\u00a0\u00b5g/mL, and 5.0-5.3\u00a0\u00b5g/mL, respectively.\nAbsolute bioavailability of the febuxostat tablet formulation has not been\nstudied.</span></p>", "ID": "b8352972-0777-4555-95a7-45b537d55f15", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat is rapidly (t</span>", "ID": "9f88e3b2-bfbe-4650-ab44-0b7cb5a46c95", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Febuxostat is rapidly (t", "ParentId": "b8352972-0777-4555-95a7-45b537d55f15"}, {"Element": "<span lang=\"EN-GB\" style='font-size:7.0pt;font-family:\"Times New Roman\",serif'>max </span>", "ID": "dc93c53a-35e1-4085-bee4-f532347ea6d1", "Styles": "font-size:7.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "max ", "ParentId": "b8352972-0777-4555-95a7-45b537d55f15"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>of 1.0-1.5 h) and well\nabsorbed (at least 84%). After single or multiple oral 80 and 120\u00a0mg once\ndaily doses, C</span>", "ID": "ca3e13ba-3678-431b-a269-e71c7c31fb08", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "of 1.0-1.5 h) and well absorbed (at least 84%). After single or multiple oral 80 and 120\u00a0mg once daily doses, C", "ParentId": "b8352972-0777-4555-95a7-45b537d55f15"}, {"Element": "<span lang=\"EN-GB\" style='font-size:7.0pt;font-family:\"Times New Roman\",serif'>max\n</span>", "ID": "a6fd4b75-9015-4b96-b2d4-d6072730b5bb", "Styles": "font-size:7.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "max ", "ParentId": "b8352972-0777-4555-95a7-45b537d55f15"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>is\napproximately 2.8-3.2\u00a0\u00b5g/mL, and 5.0-5.3\u00a0\u00b5g/mL, respectively.\nAbsolute bioavailability of the febuxostat tablet formulation has not been\nstudied.</span>", "ID": "925e849d-0596-4f9b-a01e-486ab1cb7735", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "is approximately 2.8-3.2\u00a0\u00b5g/mL, and 5.0-5.3\u00a0\u00b5g/mL, respectively. Absolute bioavailability of the febuxostat tablet formulation has not been studied.", "ParentId": "b8352972-0777-4555-95a7-45b537d55f15"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "09b7ffed-6321-4af7-9968-ddad24fec839", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "c9082f67-e8fa-4afe-b3d3-de97b53884f7", "Styles": "font-size:12.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "09b7ffed-6321-4af7-9968-ddad24fec839"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Following multiple oral 80\u00a0mg\nonce daily doses or a single 120\u00a0mg dose with a high fat meal, there was a\n49% and 38% decrease in C</span><span lang=\"EN-GB\" style='font-size:7.0pt;\nfont-family:\"Times New Roman\",serif'>max </span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>and a 18% and 16% decrease in AUC,\nrespectively. However, no clinically significant change in the percent decrease\nin serum uric acid concentration was observed where tested (80\u00a0mg multiple\ndose). Thus, febuxostat may be taken without regard to food.</span></p>", "ID": "8a9b28c6-6251-45c7-b5fc-685deec37fb3", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Following multiple oral 80\u00a0mg\nonce daily doses or a single 120\u00a0mg dose with a high fat meal, there was a\n49% and 38% decrease in C</span>", "ID": "2cba409a-70e7-4e55-95c0-873f4fa6ff38", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Following multiple oral 80\u00a0mg once daily doses or a single 120\u00a0mg dose with a high fat meal, there was a 49% and 38% decrease in C", "ParentId": "8a9b28c6-6251-45c7-b5fc-685deec37fb3"}, {"Element": "<span lang=\"EN-GB\" style='font-size:7.0pt;\nfont-family:\"Times New Roman\",serif'>max </span>", "ID": "046eb0c3-4a14-4c39-b7d3-98e5162f5df2", "Styles": "font-size:7.0pt;\nfont-family:\"Times New Roman\",serif", "Classes": "None", "Text": "max ", "ParentId": "8a9b28c6-6251-45c7-b5fc-685deec37fb3"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>and a 18% and 16% decrease in AUC,\nrespectively. However, no clinically significant change in the percent decrease\nin serum uric acid concentration was observed where tested (80\u00a0mg multiple\ndose). Thus, febuxostat may be taken without regard to food.</span>", "ID": "ed3513ed-b216-494f-9a2a-7267f208890d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "and a 18% and 16% decrease in AUC, respectively. However, no clinically significant change in the percent decrease in serum uric acid concentration was observed where tested (80\u00a0mg multiple dose). Thus, febuxostat may be taken without regard to food.", "ParentId": "8a9b28c6-6251-45c7-b5fc-685deec37fb3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "5acdeaeb-dcb7-42d5-b098-231ef524d596", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "cfe230b0-c2d0-4cc2-9edd-57cd088eacf7", "Styles": "font-size:12.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "5acdeaeb-dcb7-42d5-b098-231ef524d596"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Distribution</span></u></p>", "ID": "5c10608a-86c6-4b1d-913d-1a76a30a849f", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Distribution</span></u>", "ID": "b723c397-824b-4845-8c97-96c588371346", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "5c10608a-86c6-4b1d-913d-1a76a30a849f"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Distribution</span>", "ID": "b5bd8dab-857d-4442-ba99-f0d0bb0d95fa", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Distribution", "ParentId": "b723c397-824b-4845-8c97-96c588371346"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "5255d6f6-fb05-49fb-b50e-0afaca99dc42", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "2b1fd5ee-223e-425c-a59a-01aebb1b0e3e", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "5255d6f6-fb05-49fb-b50e-0afaca99dc42"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The apparent steady state volume of\ndistribution (V</span><span lang=\"EN-GB\" style='font-size:7.0pt;font-family:\"Times New Roman\",serif'>ss</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>/F) of febuxostat ranges\nfrom 29 to 75 L after oral doses of 10-300\u00a0mg. The plasma protein binding\nof febuxostat is approximately 99.2%, (primarily to albumin), and is constant\nover the concentration range achieved with 80 and 120\u00a0mg doses. Plasma\nprotein binding of the active metabolites ranges from about 82% to 91%.</span></p>", "ID": "6b5f93a0-b779-48d4-886d-2bbe87727e9b", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The apparent steady state volume of\ndistribution (V</span>", "ID": "01dbc364-0374-4e1e-a2c7-b48411011cef", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "The apparent steady state volume of distribution (V", "ParentId": "6b5f93a0-b779-48d4-886d-2bbe87727e9b"}, {"Element": "<span lang=\"EN-GB\" style='font-size:7.0pt;font-family:\"Times New Roman\",serif'>ss</span>", "ID": "110b046a-547d-4893-9d01-f50ecb765f5e", "Styles": "font-size:7.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "ss", "ParentId": "6b5f93a0-b779-48d4-886d-2bbe87727e9b"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>/F) of febuxostat ranges\nfrom 29 to 75 L after oral doses of 10-300\u00a0mg. The plasma protein binding\nof febuxostat is approximately 99.2%, (primarily to albumin), and is constant\nover the concentration range achieved with 80 and 120\u00a0mg doses. Plasma\nprotein binding of the active metabolites ranges from about 82% to 91%.</span>", "ID": "01bd792d-dcb4-4be9-8e8f-47c10180aef6", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "/F) of febuxostat ranges from 29 to 75 L after oral doses of 10-300\u00a0mg. The plasma protein binding of febuxostat is approximately 99.2%, (primarily to albumin), and is constant over the concentration range achieved with 80 and 120\u00a0mg doses. Plasma protein binding of the active metabolites ranges from about 82% to 91%.", "ParentId": "6b5f93a0-b779-48d4-886d-2bbe87727e9b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "3e01f429-9439-45aa-86ba-1847dc2a51c8", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "1f682f46-2cca-4e3b-bfc6-57b9c369eefa", "Styles": "font-size:12.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "3e01f429-9439-45aa-86ba-1847dc2a51c8"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Biotransformation</span></u></p>", "ID": "dd7aaa35-e409-4f8a-bf12-bb602ddfe627", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Biotransformation</span></u>", "ID": "47356291-6b4d-4d10-88b5-edc0c5f2c2ad", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "dd7aaa35-e409-4f8a-bf12-bb602ddfe627"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Biotransformation</span>", "ID": "77df15a3-4d14-44fa-9e3b-0efee80a8c5b", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Biotransformation", "ParentId": "47356291-6b4d-4d10-88b5-edc0c5f2c2ad"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "df7559bb-09d6-480e-8914-e9880e0996cc", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "5e99e196-eb3e-4813-9704-d65747bb05ae", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "df7559bb-09d6-480e-8914-e9880e0996cc"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat is extensively\nmetabolized by conjugation <i>via </i>uridine diphosphate\nglucuronosyltransferase (UDPGT) enzyme system and oxidation <i>via </i>the\ncytochrome P450 (CYP) system. Four pharmacologically active hydroxyl\nmetabolites have been identified, of which three occur in plasma of humans. <i>In\nvitro </i>studies with human liver microsomes showed that those oxidative\nmetabolites were formed primarily by CYP1A1, CYP1A2, CYP2C8 or CYP2C9 and\nfebuxostat glucuronide was formed mainly by UGT 1A1, 1A8, and 1A9.</span></p>", "ID": "73e08b03-bc01-474c-87db-147cda7286d3", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat is extensively\nmetabolized by conjugation <i>via </i>uridine diphosphate\nglucuronosyltransferase (UDPGT) enzyme system and oxidation <i>via </i>the\ncytochrome P450 (CYP) system. Four pharmacologically active hydroxyl\nmetabolites have been identified, of which three occur in plasma of humans. <i>In\nvitro </i>studies with human liver microsomes showed that those oxidative\nmetabolites were formed primarily by CYP1A1, CYP1A2, CYP2C8 or CYP2C9 and\nfebuxostat glucuronide was formed mainly by UGT 1A1, 1A8, and 1A9.</span>", "ID": "1cdc1587-71e6-4c0c-ae9a-78146a2046bc", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Febuxostat is extensively metabolized by conjugation uridine diphosphate glucuronosyltransferase (UDPGT) enzyme system and oxidation the cytochrome P450 (CYP) system. Four pharmacologically active hydroxyl metabolites have been identified, of which three occur in plasma of humans. studies with human liver microsomes showed that those oxidative metabolites were formed primarily by CYP1A1, CYP1A2, CYP2C8 or CYP2C9 and febuxostat glucuronide was formed mainly by UGT 1A1, 1A8, and 1A9.", "ParentId": "73e08b03-bc01-474c-87db-147cda7286d3"}, {"Element": "<i>via </i>", "ID": "00592f5e-6043-4876-8ce5-828e9d295e40", "Styles": "None", "Classes": "None", "Text": "via ", "ParentId": "1cdc1587-71e6-4c0c-ae9a-78146a2046bc"}, {"Element": "<i>via </i>", "ID": "f34e78c3-9822-4c66-952f-017ac5153f07", "Styles": "None", "Classes": "None", "Text": "via ", "ParentId": "1cdc1587-71e6-4c0c-ae9a-78146a2046bc"}, {"Element": "<i>In\nvitro </i>", "ID": "2d79bf2a-1076-4f99-a88e-cd9bb9ed0fec", "Styles": "None", "Classes": "None", "Text": "In vitro ", "ParentId": "1cdc1587-71e6-4c0c-ae9a-78146a2046bc"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "eb2cabd2-d353-43ca-9b37-75b1444a17c7", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "c162e724-e8b3-4234-8273-3dae4ddbf46c", "Styles": "font-size:12.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "eb2cabd2-d353-43ca-9b37-75b1444a17c7"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Elimination</span></u></p>", "ID": "c695d8f4-aedb-440d-b83d-f50424a9f8c1", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Elimination</span></u>", "ID": "edbdec37-1142-4875-900b-7b0da48a277c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c695d8f4-aedb-440d-b83d-f50424a9f8c1"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Elimination</span>", "ID": "3c057580-b6c5-43c6-a00f-34c310baa96d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Elimination", "ParentId": "edbdec37-1142-4875-900b-7b0da48a277c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "82f6ac38-fea1-4f99-906d-466bcf09d186", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "f784ea73-e2e7-4a64-8b27-31233890a0c6", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "82f6ac38-fea1-4f99-906d-466bcf09d186"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat is eliminated by both\nhepatic and renal pathways. Following an 80\u00a0mg oral dose of <sup>14</sup>C-\nlabeled febuxostat, approximately 49% of the dose was recovered in the urine as\nunchanged febuxostat (3%), the acyl glucuronide of the active substance (30%),\nits known oxidative metabolites and their conjugates (13%), and other unknown metabolites\n(3%). In addition to the urinary excretion, approximately 45% of the dose was\nrecovered in the faeces as the unchanged febuxostat (12%), the acyl glucuronide\nof the active substance (1%), its known oxidative metabolites and their\nconjugates (25%), and other unknown metabolites (7%).</span></p>", "ID": "65d3477f-7022-4e2f-882b-2a8488f593cf", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat is eliminated by both\nhepatic and renal pathways. Following an 80\u00a0mg oral dose of <sup>14</sup>C-\nlabeled febuxostat, approximately 49% of the dose was recovered in the urine as\nunchanged febuxostat (3%), the acyl glucuronide of the active substance (30%),\nits known oxidative metabolites and their conjugates (13%), and other unknown metabolites\n(3%). In addition to the urinary excretion, approximately 45% of the dose was\nrecovered in the faeces as the unchanged febuxostat (12%), the acyl glucuronide\nof the active substance (1%), its known oxidative metabolites and their\nconjugates (25%), and other unknown metabolites (7%).</span>", "ID": "b4b877c1-1101-48cc-b246-24576d379516", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Febuxostat is eliminated by both hepatic and renal pathways. Following an 80\u00a0mg oral dose of C- labeled febuxostat, approximately 49% of the dose was recovered in the urine as unchanged febuxostat (3%), the acyl glucuronide of the active substance (30%), its known oxidative metabolites and their conjugates (13%), and other unknown metabolites (3%). In addition to the urinary excretion, approximately 45% of the dose was recovered in the faeces as the unchanged febuxostat (12%), the acyl glucuronide of the active substance (1%), its known oxidative metabolites and their conjugates (25%), and other unknown metabolites (7%).", "ParentId": "65d3477f-7022-4e2f-882b-2a8488f593cf"}, {"Element": "<sup>14</sup>", "ID": "8b929894-c251-4475-b2d7-a03228eb3ce2", "Styles": "None", "Classes": "None", "Text": "14", "ParentId": "b4b877c1-1101-48cc-b246-24576d379516"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "b3e2d29b-7485-4fc9-8485-d6490d615361", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "6d70605a-ed15-41cc-b2d5-3ec3cc55f43a", "Styles": "font-size:12.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "b3e2d29b-7485-4fc9-8485-d6490d615361"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Renal impairment</span></u></p>", "ID": "9cb80d36-7824-466e-8e0e-7703acef95b9", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Renal impairment</span></u>", "ID": "008d2b1b-48c3-4cab-b2ca-497cb5bf4f43", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9cb80d36-7824-466e-8e0e-7703acef95b9"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Renal impairment</span>", "ID": "0385b08b-49b7-49dd-98ce-d8eb7aca8d52", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Renal impairment", "ParentId": "008d2b1b-48c3-4cab-b2ca-497cb5bf4f43"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "3eaa27e0-ec6c-44ec-be9a-bf1cc19218f8", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "e28a9444-3502-4102-98a6-cc34be7828cd", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "3eaa27e0-ec6c-44ec-be9a-bf1cc19218f8"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Following multiple doses of 80\u00a0mg\nof febuxostat in patients with mild, moderate or severe renal impairment, the C<sub>max</sub>\nof febuxostat did not change, relative to subjects with normal renal function.\nThe mean total AUC of febuxostat increased by approximately 1.8-fold from 7.5\u00a0\u00b5g</span><span lang=\"EN-GB\" style='font-family:\"Cambria Math\",serif'>\u22c5</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>h/mL in the normal renal\nfunction group to 13.2\u00a0\u00b5g.h/mL in the severe renal dysfunction group. The\nC<sub>max</sub> and AUC of active metabolites increased up to 2- and 4-fold, respectively.\nHowever, no dose adjustment is necessary in patients with mild or moderate\nrenal impairment.</span></p>", "ID": "f780c570-a75b-4e6a-964c-871ce5eca830", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Following multiple doses of 80\u00a0mg\nof febuxostat in patients with mild, moderate or severe renal impairment, the C<sub>max</sub>\nof febuxostat did not change, relative to subjects with normal renal function.\nThe mean total AUC of febuxostat increased by approximately 1.8-fold from 7.5\u00a0\u00b5g</span>", "ID": "6723dfb4-7288-4e7d-8185-d578c80de6d0", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Following multiple doses of 80\u00a0mg of febuxostat in patients with mild, moderate or severe renal impairment, the C of febuxostat did not change, relative to subjects with normal renal function. The mean total AUC of febuxostat increased by approximately 1.8-fold from 7.5\u00a0\u00b5g", "ParentId": "f780c570-a75b-4e6a-964c-871ce5eca830"}, {"Element": "<sub>max</sub>", "ID": "19c397d8-fdb2-42d1-92ff-52e6b887b69d", "Styles": "None", "Classes": "None", "Text": "max", "ParentId": "6723dfb4-7288-4e7d-8185-d578c80de6d0"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Cambria Math\",serif'>\u22c5</span>", "ID": "bc37705a-6554-486b-ab87-06566d00a5f4", "Styles": "font-family:\"Cambria Math\",serif", "Classes": "None", "Text": "\u22c5", "ParentId": "f780c570-a75b-4e6a-964c-871ce5eca830"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>h/mL in the normal renal\nfunction group to 13.2\u00a0\u00b5g.h/mL in the severe renal dysfunction group. The\nC<sub>max</sub> and AUC of active metabolites increased up to 2- and 4-fold, respectively.\nHowever, no dose adjustment is necessary in patients with mild or moderate\nrenal impairment.</span>", "ID": "f1154400-f728-4cd4-9ef7-ec2f3be83d7f", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "h/mL in the normal renal function group to 13.2\u00a0\u00b5g.h/mL in the severe renal dysfunction group. The C and AUC of active metabolites increased up to 2- and 4-fold, respectively. However, no dose adjustment is necessary in patients with mild or moderate renal impairment.", "ParentId": "f780c570-a75b-4e6a-964c-871ce5eca830"}, {"Element": "<sub>max</sub>", "ID": "dfd07547-2a1b-4497-bc64-f4f586e77c5b", "Styles": "None", "Classes": "None", "Text": "max", "ParentId": "f1154400-f728-4cd4-9ef7-ec2f3be83d7f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "944fc8ee-e451-4ad9-bff1-db31aa5e740a", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "bb6eeb45-cbc7-47de-a9d7-d14bdfc93abb", "Styles": "font-size:12.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "944fc8ee-e451-4ad9-bff1-db31aa5e740a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Hepatic impairment</span></u></p>", "ID": "45e5a7a4-9bec-40c0-8525-feed8ec71593", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Hepatic impairment</span></u>", "ID": "d3cf8155-289d-4b2d-9a25-a69979e40506", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "45e5a7a4-9bec-40c0-8525-feed8ec71593"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Hepatic impairment</span>", "ID": "07318ad0-2d55-4b61-af0e-682e8d5aebf5", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Hepatic impairment", "ParentId": "d3cf8155-289d-4b2d-9a25-a69979e40506"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "003386ca-cbbb-4805-9f64-39f9c507a110", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "06ddd518-bb84-44d0-9428-4075a4084f0c", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "003386ca-cbbb-4805-9f64-39f9c507a110"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Following multiple doses of 80\u00a0mg\nof febuxostat in patients with mild (Child-Pugh Class A) or moderate\n(Child-Pugh Class B) hepatic impairment, the C</span><span lang=\"EN-GB\" style='font-size:7.0pt;font-family:\"Times New Roman\",serif'>max </span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>and AUC of febuxostat\nand its metabolites did not change significantly compared to subjects with\nnormal hepatic function. No studies have been conducted in patients with severe\nhepatic impairment (Child-Pugh Class C).</span></p>", "ID": "ce4e41d5-abff-45c0-bc06-052df65fe62e", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Following multiple doses of 80\u00a0mg\nof febuxostat in patients with mild (Child-Pugh Class A) or moderate\n(Child-Pugh Class B) hepatic impairment, the C</span>", "ID": "eda455da-50d3-470c-b983-ec371e1f919e", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Following multiple doses of 80\u00a0mg of febuxostat in patients with mild (Child-Pugh Class A) or moderate (Child-Pugh Class B) hepatic impairment, the C", "ParentId": "ce4e41d5-abff-45c0-bc06-052df65fe62e"}, {"Element": "<span lang=\"EN-GB\" style='font-size:7.0pt;font-family:\"Times New Roman\",serif'>max </span>", "ID": "21fbaea6-355a-40d4-b13e-28deb4c32d36", "Styles": "font-size:7.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "max ", "ParentId": "ce4e41d5-abff-45c0-bc06-052df65fe62e"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>and AUC of febuxostat\nand its metabolites did not change significantly compared to subjects with\nnormal hepatic function. No studies have been conducted in patients with severe\nhepatic impairment (Child-Pugh Class C).</span>", "ID": "8f29f324-580e-4040-938c-8f0925b5d0a6", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "and AUC of febuxostat and its metabolites did not change significantly compared to subjects with normal hepatic function. No studies have been conducted in patients with severe hepatic impairment (Child-Pugh Class C).", "ParentId": "ce4e41d5-abff-45c0-bc06-052df65fe62e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "64392114-b693-4699-aeed-0297c2a4ce3c", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "4e9f5762-6eed-4ec5-b425-d24ac101ef88", "Styles": "font-size:12.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "64392114-b693-4699-aeed-0297c2a4ce3c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Age</span></u></p>", "ID": "059a303f-fc2a-4f81-92d9-78673e96a074", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Age</span></u>", "ID": "efc9f0af-3555-4b4c-9d36-c41578ad4d04", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "059a303f-fc2a-4f81-92d9-78673e96a074"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Age</span>", "ID": "4277233d-e2ce-4dcf-83e0-0466cc1d35e9", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Age", "ParentId": "efc9f0af-3555-4b4c-9d36-c41578ad4d04"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "f44966a2-9721-4bb6-9a6e-636387a06056", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "307084b0-b27a-4b1c-b381-a696c53970a9", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "f44966a2-9721-4bb6-9a6e-636387a06056"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>There were no significant changes\nobserved in AUC of febuxostat or its metabolites following multiple oral doses\nof febuxostat in elderly as compared to younger healthy subjects.</span></p>", "ID": "7f2fc1ef-4a66-47e9-bb32-740ca4a833e3", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>There were no significant changes\nobserved in AUC of febuxostat or its metabolites following multiple oral doses\nof febuxostat in elderly as compared to younger healthy subjects.</span>", "ID": "78547e75-0d89-4f3f-9b5c-102d43aea03b", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "There were no significant changes observed in AUC of febuxostat or its metabolites following multiple oral doses of febuxostat in elderly as compared to younger healthy subjects.", "ParentId": "7f2fc1ef-4a66-47e9-bb32-740ca4a833e3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "ddd1bd52-4c00-4a2b-83e2-f07e04a83a53", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "344f1f25-73e4-4712-8d96-79255b12d73e", "Styles": "font-size:12.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "ddd1bd52-4c00-4a2b-83e2-f07e04a83a53"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Gender</span></u></p>", "ID": "6a2621c4-2804-432f-bfa9-03921d4eff28", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Gender</span></u>", "ID": "7862f989-96a6-45c7-9fd7-f8c26e1c0b0d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6a2621c4-2804-432f-bfa9-03921d4eff28"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Gender</span>", "ID": "5f390296-09ea-4b64-924d-524b5717b03c", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Gender", "ParentId": "7862f989-96a6-45c7-9fd7-f8c26e1c0b0d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "9aacb32b-98d6-4843-9dca-e239bb018d79", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "3bb66c8b-8f4f-4163-b5db-eef14dcb8d0b", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "9aacb32b-98d6-4843-9dca-e239bb018d79"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Following multiple oral doses of febuxostat,\nthe C</span><span lang=\"EN-GB\" style='font-size:7.0pt;font-family:\"Times New Roman\",serif'>max\n</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>and AUC\nwere 24% and 12% higher in females than in males, respectively. However,\nweight-corrected C</span><span lang=\"EN-GB\" style='font-size:7.0pt;font-family:\n\"Times New Roman\",serif'>max </span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>and\nAUC were similar between the genders. No dose adjustment is needed based on\ngender.</span></p>", "ID": "21b6487e-9c80-4af2-9b97-7ec3dd95716a", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Following multiple oral doses of febuxostat,\nthe C</span>", "ID": "8a6c9656-24d4-4372-89c8-3e317973e39e", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Following multiple oral doses of febuxostat, the C", "ParentId": "21b6487e-9c80-4af2-9b97-7ec3dd95716a"}, {"Element": "<span lang=\"EN-GB\" style='font-size:7.0pt;font-family:\"Times New Roman\",serif'>max\n</span>", "ID": "dd9c0013-5c4e-44c6-97cb-ae8a1cf2c8b8", "Styles": "font-size:7.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "max ", "ParentId": "21b6487e-9c80-4af2-9b97-7ec3dd95716a"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>and AUC\nwere 24% and 12% higher in females than in males, respectively. However,\nweight-corrected C</span>", "ID": "a934fa37-e18f-498e-97bb-8f2dc4c4fa22", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "and AUC were 24% and 12% higher in females than in males, respectively. However, weight-corrected C", "ParentId": "21b6487e-9c80-4af2-9b97-7ec3dd95716a"}, {"Element": "<span lang=\"EN-GB\" style='font-size:7.0pt;font-family:\n\"Times New Roman\",serif'>max </span>", "ID": "c3960c73-72c0-4225-9e1a-c8bccfc06b39", "Styles": "font-size:7.0pt;font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "max ", "ParentId": "21b6487e-9c80-4af2-9b97-7ec3dd95716a"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>and\nAUC were similar between the genders. No dose adjustment is needed based on\ngender.</span>", "ID": "733eb274-44fe-471b-8583-f6d4556016a1", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "and AUC were similar between the genders. No dose adjustment is needed based on gender.", "ParentId": "21b6487e-9c80-4af2-9b97-7ec3dd95716a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "0fb648b6-9b4f-4fbd-9b4f-4011f7d89eab", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "29027dfc-6722-4c0f-ab01-ce8e2e42163c", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "0fb648b6-9b4f-4fbd-9b4f-4011f7d89eab"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>5.3\u00a0\u00a0\u00a0\u00a0\u00a0 Preclinical safety data</span></b></p>", "ID": "69ce7963-0e05-4d91-8a0f-04a012100772", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>5.3\u00a0\u00a0\u00a0\u00a0\u00a0 Preclinical safety data</span></b>", "ID": "03937490-2b0d-49c2-ab0a-a5a5076f92ec", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "69ce7963-0e05-4d91-8a0f-04a012100772"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>5.3\u00a0\u00a0\u00a0\u00a0\u00a0 Preclinical safety data</span>", "ID": "f0f375e5-c76f-44c4-88a4-b73bd2624734", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "5.3\u00a0\u00a0\u00a0\u00a0\u00a0 Preclinical safety data", "ParentId": "03937490-2b0d-49c2-ab0a-a5a5076f92ec"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "e1c555bb-986e-4ad9-89b2-1b565494f20e", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "69789a39-9696-4d30-8a7a-8d29c7dd26aa", "Styles": "font-size:12.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "e1c555bb-986e-4ad9-89b2-1b565494f20e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Effects in non-clinical studies\nwere generally observed at exposures in excess of the maximum human exposure.</span></p>", "ID": "bd1156ab-b231-44a0-aae2-6ed506ab992a", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Effects in non-clinical studies\nwere generally observed at exposures in excess of the maximum human exposure.</span>", "ID": "e18a936b-5b17-4b68-9f53-25a8afbe9af5", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Effects in non-clinical studies were generally observed at exposures in excess of the maximum human exposure.", "ParentId": "bd1156ab-b231-44a0-aae2-6ed506ab992a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "0847fa44-0a2f-4060-9124-30684547ff51", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "9fc73a49-fb7e-45d0-9345-993425aaa373", "Styles": "font-size:12.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "0847fa44-0a2f-4060-9124-30684547ff51"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Pharmacokinetic modelling and\nsimulation of rat data suggests that, when co-administered with febuxostat, the\nclinical dose of mercaptopurine/azathioprine should be reduced to 20% or less\nof the previously prescribed dose in order to avoid possible haematological\neffects (see section 4.4 and 4.5).</span></p>", "ID": "1fbd97f6-e1bd-4e66-9604-efd4f1ec0fcf", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Pharmacokinetic modelling and\nsimulation of rat data suggests that, when co-administered with febuxostat, the\nclinical dose of mercaptopurine/azathioprine should be reduced to 20% or less\nof the previously prescribed dose in order to avoid possible haematological\neffects (see section 4.4 and 4.5).</span>", "ID": "e592778d-1b0e-4a05-b92e-f4ec1b7f03fb", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Pharmacokinetic modelling and simulation of rat data suggests that, when co-administered with febuxostat, the clinical dose of mercaptopurine/azathioprine should be reduced to 20% or less of the previously prescribed dose in order to avoid possible haematological effects (see section 4.4 and 4.5).", "ParentId": "1fbd97f6-e1bd-4e66-9604-efd4f1ec0fcf"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "41a3b421-5db5-4c2c-a286-ac3d4cacca03", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "4155cac5-12f4-4fea-bfc2-26ed6996a96e", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "41a3b421-5db5-4c2c-a286-ac3d4cacca03"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Carcinogenesis, mutagenesis,\nimpairment of fertility</span></u></p>", "ID": "69796b87-f161-4176-96cd-e4c2fd47645e", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Carcinogenesis, mutagenesis,\nimpairment of fertility</span></u>", "ID": "9524575b-e210-4a78-a0ec-b2e571274c29", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "69796b87-f161-4176-96cd-e4c2fd47645e"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Carcinogenesis, mutagenesis,\nimpairment of fertility</span>", "ID": "750d08f4-b34a-4d0b-b758-1103518c0cab", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Carcinogenesis, mutagenesis, impairment of fertility", "ParentId": "9524575b-e210-4a78-a0ec-b2e571274c29"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "1dee2ad1-b361-4daa-b609-b87a96df6f73", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "7bb8a328-8c4f-4075-a7a3-9df1cb1f0bae", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "1dee2ad1-b361-4daa-b609-b87a96df6f73"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>In male rats, a statistically\nsignificant increase in urinary bladder tumours (transitional cell papilloma\nand carcinoma) was found only in association with xanthine calculi in the high\ndose group, at approximately 11 times human exposure. There was no significant\nincrease in any other tumour type in either male or female mice or rats. These\nfindings are considered a consequence of species specific purine metabolism and\nurine composition and of no relevance to clinical use.</span></p>", "ID": "b5915176-f45a-4de1-9560-f93ecd87c2d0", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>In male rats, a statistically\nsignificant increase in urinary bladder tumours (transitional cell papilloma\nand carcinoma) was found only in association with xanthine calculi in the high\ndose group, at approximately 11 times human exposure. There was no significant\nincrease in any other tumour type in either male or female mice or rats. These\nfindings are considered a consequence of species specific purine metabolism and\nurine composition and of no relevance to clinical use.</span>", "ID": "f0783d2b-b31c-4843-b864-36294ba9a0ed", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "In male rats, a statistically significant increase in urinary bladder tumours (transitional cell papilloma and carcinoma) was found only in association with xanthine calculi in the high dose group, at approximately 11 times human exposure. There was no significant increase in any other tumour type in either male or female mice or rats. These findings are considered a consequence of species specific purine metabolism and urine composition and of no relevance to clinical use.", "ParentId": "b5915176-f45a-4de1-9560-f93ecd87c2d0"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "ab9277a3-16e0-407b-9b6e-1cc5a6f7b288", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "ca6b6ecd-b6d6-4159-af5d-d11d6ce087f1", "Styles": "font-size:12.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "ab9277a3-16e0-407b-9b6e-1cc5a6f7b288"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>A standard battery of test for\ngenotoxicity did not reveal any biologically relevant genotoxic effects for febuxostat.</span></p>", "ID": "803f12c3-693f-42c5-a771-182dda5b0743", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>A standard battery of test for\ngenotoxicity did not reveal any biologically relevant genotoxic effects for febuxostat.</span>", "ID": "3615bd4b-eaca-4c88-826a-4d0b149bad0f", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "A standard battery of test for genotoxicity did not reveal any biologically relevant genotoxic effects for febuxostat.", "ParentId": "803f12c3-693f-42c5-a771-182dda5b0743"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "a731157b-9bf0-4af5-bff8-05f5a311b2e6", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "5620598b-4139-498d-acb6-7ebc5b9b647f", "Styles": "font-size:12.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "a731157b-9bf0-4af5-bff8-05f5a311b2e6"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat at oral doses up to 48\u00a0mg/kg/day\nwas found to have no effect on fertility and reproductive performance of male\nand female rats.</span></p>", "ID": "fe69a332-1b97-4a77-8402-32481ffded01", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat at oral doses up to 48\u00a0mg/kg/day\nwas found to have no effect on fertility and reproductive performance of male\nand female rats.</span>", "ID": "d49e4ef4-445d-4d08-987d-3443df9f8e72", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Febuxostat at oral doses up to 48\u00a0mg/kg/day was found to have no effect on fertility and reproductive performance of male and female rats.", "ParentId": "fe69a332-1b97-4a77-8402-32481ffded01"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "2b8560bf-6412-44cb-a7ac-bc0303b3890c", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "c4765630-4526-43a8-9eda-86eed38889a5", "Styles": "font-size:12.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "2b8560bf-6412-44cb-a7ac-bc0303b3890c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>There was no evidence of impaired\nfertility, teratogenic effects, or harm to the foetus due to febuxostat. There\nwas high dose maternal toxicity accompanied by a reduction in weaning index and\nreduced development of offspring in rats at approximately 4.3 times human\nexposure. Teratology studies, performed in pregnant rats at approximately 4.3\ntimes and pregnant rabbits at approximately 13 times human exposure did not\nreveal any teratogenic effects.</span></p>", "ID": "060b779e-8dd2-4fb7-8227-ecdb3c6aa404", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>There was no evidence of impaired\nfertility, teratogenic effects, or harm to the foetus due to febuxostat. There\nwas high dose maternal toxicity accompanied by a reduction in weaning index and\nreduced development of offspring in rats at approximately 4.3 times human\nexposure. Teratology studies, performed in pregnant rats at approximately 4.3\ntimes and pregnant rabbits at approximately 13 times human exposure did not\nreveal any teratogenic effects.</span>", "ID": "46d6b0e3-31a1-4be1-8a6d-1c3fabb103ba", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "There was no evidence of impaired fertility, teratogenic effects, or harm to the foetus due to febuxostat. There was high dose maternal toxicity accompanied by a reduction in weaning index and reduced development of offspring in rats at approximately 4.3 times human exposure. Teratology studies, performed in pregnant rats at approximately 4.3 times and pregnant rabbits at approximately 13 times human exposure did not reveal any teratogenic effects.", "ParentId": "060b779e-8dd2-4fb7-8227-ecdb3c6aa404"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "29c94198-18fc-4d0c-95c9-f493f19dbb6b", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "2f73a7fc-8ae7-4234-9134-5de2fce9adeb", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "29c94198-18fc-4d0c-95c9-f493f19dbb6b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "93fa5d58-9fc2-41ca-a725-6c8630585ebb", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "aa46d9af-a1e4-46c3-b15a-7e353a66a7ec", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "93fa5d58-9fc2-41ca-a725-6c8630585ebb"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\nPARTICULARS</span></b></p>", "ID": "efa4800f-5a9a-43a6-a728-6d85ca7f6f1f", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\nPARTICULARS</span></b>", "ID": "ba76438f-cf9e-433c-978e-e8f7fa373c93", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "efa4800f-5a9a-43a6-a728-6d85ca7f6f1f"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\nPARTICULARS</span>", "ID": "9f50e9d6-9a87-4bae-8cd9-dd5ba92d9f65", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL PARTICULARS", "ParentId": "ba76438f-cf9e-433c-978e-e8f7fa373c93"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "ccf86c65-2417-4349-91cd-11ffcd931081", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "b5e542af-981a-4989-b226-7e5f1b7f0afd", "Styles": "font-size:12.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "ccf86c65-2417-4349-91cd-11ffcd931081"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>6.1\u00a0\u00a0\u00a0\u00a0\u00a0 List of excipients</span></b></p>", "ID": "b2b2ba52-4b41-472a-aa85-7870eec529f8", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>6.1\u00a0\u00a0\u00a0\u00a0\u00a0 List of excipients</span></b>", "ID": "fb8f3924-c4a3-4cb1-8fef-878758055418", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b2b2ba52-4b41-472a-aa85-7870eec529f8"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>6.1\u00a0\u00a0\u00a0\u00a0\u00a0 List of excipients</span>", "ID": "fa91f3e1-8f02-4399-9fd8-3e79fc5d409c", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "6.1\u00a0\u00a0\u00a0\u00a0\u00a0 List of excipients", "ParentId": "fb8f3924-c4a3-4cb1-8fef-878758055418"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "94c6d82f-18b3-408d-b174-1863687970ca", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "2aee78b9-d60e-4f97-83bb-e08a0b4ff229", "Styles": "font-size:12.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "94c6d82f-18b3-408d-b174-1863687970ca"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Tablet core</span></u></p>", "ID": "2d72e655-adf9-48f9-8a78-8daff19938e8", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Tablet core</span></u>", "ID": "851cca25-1a7f-45af-8fb9-991387368e19", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "2d72e655-adf9-48f9-8a78-8daff19938e8"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Tablet core</span>", "ID": "3ade4a0d-81db-41d3-a6ed-c14f54c77d28", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Tablet core", "ParentId": "851cca25-1a7f-45af-8fb9-991387368e19"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "c731cf09-3fcd-408d-bffe-38c276f00e84", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "3fc20516-7420-4366-85f2-dcdbe42dafb4", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "c731cf09-3fcd-408d-bffe-38c276f00e84"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Lactose</span></p>", "ID": "0e22395d-a2ac-47c5-b4ba-2734e9287992", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Lactose</span>", "ID": "58f53065-04e8-4775-893f-44df554d0e2d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Lactose", "ParentId": "0e22395d-a2ac-47c5-b4ba-2734e9287992"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Microcrystalline cellulose</span></p>", "ID": "06857b7c-20ae-4211-b24e-f0aa458a674e", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Microcrystalline cellulose</span>", "ID": "bd817de0-2291-4b3b-a24b-0928c416a1b6", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Microcrystalline cellulose", "ParentId": "06857b7c-20ae-4211-b24e-f0aa458a674e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Magnesium stearate</span></p>", "ID": "908dcfd5-a543-40df-82ef-f41858f47568", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Magnesium stearate</span>", "ID": "0ebad1a0-7c09-4783-a10a-27bb6fc832e3", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Magnesium stearate", "ParentId": "908dcfd5-a543-40df-82ef-f41858f47568"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Hydroxypropylcellulose</span></p>", "ID": "9ede1bff-8f2e-4e59-9aec-d440e73ce177", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Hydroxypropylcellulose</span>", "ID": "2c7f5d76-0d0c-48d7-a22c-4642d71407b1", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Hydroxypropylcellulose", "ParentId": "9ede1bff-8f2e-4e59-9aec-d440e73ce177"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Croscarmellose sodium</span></p>", "ID": "26e2086c-c2f8-4bac-b127-d2fc41ad90d3", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Croscarmellose sodium</span>", "ID": "3cf8341f-d717-4988-abd7-ec22ec45cea1", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Croscarmellose sodium", "ParentId": "26e2086c-c2f8-4bac-b127-d2fc41ad90d3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Colloidal hydrated silica</span></p>", "ID": "737168bb-d1b0-44a9-83e5-c810de02e753", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Colloidal hydrated silica</span>", "ID": "7a0dc011-a6a0-46d7-97dc-47a1342b0579", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Colloidal hydrated silica", "ParentId": "737168bb-d1b0-44a9-83e5-c810de02e753"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Colloidal anhydrous silica</span></p>", "ID": "c45a5816-e9d3-4268-ab3f-da1ca8b8acde", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Colloidal anhydrous silica</span>", "ID": "ca9930bc-eb63-4796-843e-df8b53153b81", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Colloidal anhydrous silica", "ParentId": "c45a5816-e9d3-4268-ab3f-da1ca8b8acde"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Crospovidone</span></p>", "ID": "1636994b-17cc-4341-b5d3-9572918230bd", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Crospovidone</span>", "ID": "fd5482d7-399c-463d-b13c-ef650c2cb9a9", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Crospovidone", "ParentId": "1636994b-17cc-4341-b5d3-9572918230bd"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Talc</span></p>", "ID": "30f6624b-5901-4133-b37f-a934ff0c769a", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Talc</span>", "ID": "6dcbd610-65b1-4ee4-852b-512eff800505", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Talc", "ParentId": "30f6624b-5901-4133-b37f-a934ff0c769a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "64bb1468-ccfa-4bae-9890-633e87a420ac", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "0537267f-ee26-4b03-8d85-877be7e57f8f", "Styles": "font-size:12.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "64bb1468-ccfa-4bae-9890-633e87a420ac"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Tablet coating</span></u></p>", "ID": "6d1511d4-19ff-49ca-b487-dcf514622054", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Tablet coating</span></u>", "ID": "5b36f241-8573-42ca-8c0f-eb909b39ffda", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6d1511d4-19ff-49ca-b487-dcf514622054"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Tablet coating</span>", "ID": "2fe0fb19-552c-4c66-9463-6573660bf28a", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Tablet coating", "ParentId": "5b36f241-8573-42ca-8c0f-eb909b39ffda"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "56efbc83-b47a-469b-a176-15a0bf66f732", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "9685886f-f48e-4a7e-9322-ac6c20a32ae2", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "56efbc83-b47a-469b-a176-15a0bf66f732"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Hypromellose</span></p>", "ID": "cef969ee-2e33-415d-8d97-36f065ec6fc5", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Hypromellose</span>", "ID": "b9491968-d696-4bde-9216-d97e46d2caed", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Hypromellose", "ParentId": "cef969ee-2e33-415d-8d97-36f065ec6fc5"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Titanium dioxide (E171)</span></p>", "ID": "49dff14c-48d5-4707-ae51-36b1a5f9abf2", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Titanium dioxide (E171)</span>", "ID": "e1d0a7ec-28d3-4904-83d7-ae2990c496c6", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Titanium dioxide (E171)", "ParentId": "49dff14c-48d5-4707-ae51-36b1a5f9abf2"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Ethylcellulose</span></p>", "ID": "708da749-e803-4f3c-920d-89fda6dd13a6", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Ethylcellulose</span>", "ID": "ea6f41f0-215f-4464-8955-f272eccb77e5", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Ethylcellulose", "ParentId": "708da749-e803-4f3c-920d-89fda6dd13a6"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Iron oxide yellow (E172)</span></p>", "ID": "46b876ba-d1b0-46d4-8a02-023477d36e29", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Iron oxide yellow (E172)</span>", "ID": "865a7e4f-a9f9-4665-aa82-cd08502c43fb", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Iron oxide yellow (E172)", "ParentId": "46b876ba-d1b0-46d4-8a02-023477d36e29"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Triacetin</span></p>", "ID": "779ab80d-6801-444f-bf6e-bed1fb6067b8", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Triacetin</span>", "ID": "1bccbde5-54cf-464a-85ed-9c5480af3230", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Triacetin", "ParentId": "779ab80d-6801-444f-bf6e-bed1fb6067b8"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Iron oxide black (E172)</span></p>", "ID": "7be2ffea-3a3f-4c19-b005-a64bbbc9f469", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Iron oxide black (E172)</span>", "ID": "31263b07-5113-41e5-9123-869ff553204f", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Iron oxide black (E172)", "ParentId": "7be2ffea-3a3f-4c19-b005-a64bbbc9f469"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "618a067a-a114-4ad0-ae8f-71bdb2920784", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "26912268-0615-4a44-b4a7-a7f906286464", "Styles": "font-size:12.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "618a067a-a114-4ad0-ae8f-71bdb2920784"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>6.2\u00a0\u00a0\u00a0\u00a0\u00a0 Incompatibilities</span></b></p>", "ID": "856ca74b-87e2-47c0-a1ec-a731360b008b", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>6.2\u00a0\u00a0\u00a0\u00a0\u00a0 Incompatibilities</span></b>", "ID": "6640944d-aa81-4205-ac49-b867a27bd616", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "856ca74b-87e2-47c0-a1ec-a731360b008b"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>6.2\u00a0\u00a0\u00a0\u00a0\u00a0 Incompatibilities</span>", "ID": "9e0ecc70-f4bc-43eb-b830-c910260958a9", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "6.2\u00a0\u00a0\u00a0\u00a0\u00a0 Incompatibilities", "ParentId": "6640944d-aa81-4205-ac49-b867a27bd616"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "231b8b84-8830-416d-9ba6-f92ff6220446", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "767f2b5e-87a5-4bc3-9f6a-fe10aab5b522", "Styles": "font-size:12.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "231b8b84-8830-416d-9ba6-f92ff6220446"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Not applicable.</span></p>", "ID": "2ee8fb5a-c403-457c-8cc4-12f8aa096567", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Not applicable.</span>", "ID": "9de44583-28f5-4fc1-93e8-f32322705aec", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Not applicable.", "ParentId": "2ee8fb5a-c403-457c-8cc4-12f8aa096567"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "b05e4be5-2dcb-4b75-87f1-77be457cf5bb", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "af034d9a-b1d4-4de7-8b6c-383c1a2c6a39", "Styles": "font-size:12.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "b05e4be5-2dcb-4b75-87f1-77be457cf5bb"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>6.3\u00a0\u00a0\u00a0\u00a0\u00a0 Shelf life</span></b></p>", "ID": "714d0e70-8e9b-45e2-b3ed-120d5b3b13da", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>6.3\u00a0\u00a0\u00a0\u00a0\u00a0 Shelf life</span></b>", "ID": "b1989b03-ac2d-41b9-8084-1a87fc738722", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "714d0e70-8e9b-45e2-b3ed-120d5b3b13da"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>6.3\u00a0\u00a0\u00a0\u00a0\u00a0 Shelf life</span>", "ID": "bc41b3b5-3b21-44be-863f-30fe690e9f77", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "6.3\u00a0\u00a0\u00a0\u00a0\u00a0 Shelf life", "ParentId": "b1989b03-ac2d-41b9-8084-1a87fc738722"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "6a805d98-3339-4067-8089-ab950f960a0d", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "8bb3e9bd-8e2d-4ee4-b20e-827df30f55b8", "Styles": "font-size:12.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "6a805d98-3339-4067-8089-ab950f960a0d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>2 years.</span></p>", "ID": "94dffcfa-a053-464b-bfb9-4e6be448e95d", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>2 years.</span>", "ID": "ef18a7ed-fedf-4a93-b891-8885e949353e", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "2 years.", "ParentId": "94dffcfa-a053-464b-bfb9-4e6be448e95d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>For bottles: After first opening\nuse within 180 days</span></p>", "ID": "c63e9ee3-c064-4e9a-8ce0-034bdf45da2a", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>For bottles: After first opening\nuse within 180 days</span>", "ID": "0a145859-4e99-4ef3-a8ab-682b373b06bb", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "For bottles: After first opening use within 180 days", "ParentId": "c63e9ee3-c064-4e9a-8ce0-034bdf45da2a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "bbdc8eec-e488-4469-9c43-61469876f526", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "b880418f-5f1d-4248-8beb-65871c3c84d7", "Styles": "font-size:12.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "bbdc8eec-e488-4469-9c43-61469876f526"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>6.4\u00a0\u00a0\u00a0\u00a0\u00a0 Special precautions for\nstorage</span></b></p>", "ID": "333c421f-071c-4fd5-b463-c9077bbfe62d", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>6.4\u00a0\u00a0\u00a0\u00a0\u00a0 Special precautions for\nstorage</span></b>", "ID": "eae1f0e2-8c4f-439b-a118-f12a297ac8ab", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "333c421f-071c-4fd5-b463-c9077bbfe62d"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>6.4\u00a0\u00a0\u00a0\u00a0\u00a0 Special precautions for\nstorage</span>", "ID": "1e0f8a56-11a2-48d6-8994-c82ecc9c883e", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "6.4\u00a0\u00a0\u00a0\u00a0\u00a0 Special precautions for storage", "ParentId": "eae1f0e2-8c4f-439b-a118-f12a297ac8ab"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "722c94cf-9eb0-4d63-95c4-3677ac8a8f1d", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "1fcbdd24-f8a8-417f-8bee-7db485c5da2b", "Styles": "font-size:12.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "722c94cf-9eb0-4d63-95c4-3677ac8a8f1d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>This medicinal product does not\nrequire any special storage conditions.</span></p>", "ID": "5bcd6836-c82e-44d3-9eb1-bdaacf1f0904", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>This medicinal product does not\nrequire any special storage conditions.</span>", "ID": "d6e423e3-9b1c-4bc7-b85e-4d6ddfeab80e", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "This medicinal product does not require any special storage conditions.", "ParentId": "5bcd6836-c82e-44d3-9eb1-bdaacf1f0904"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>", "ID": "ee8e04ae-10e2-427f-911f-fbfef89a9d8d", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b>", "ID": "4633bcb4-f38b-49fe-ab49-db4283ae94e3", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ee8e04ae-10e2-427f-911f-fbfef89a9d8d"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "c2a32ef6-44f9-43c4-80db-110613a70d0c", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "4633bcb4-f38b-49fe-ab49-db4283ae94e3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>6.5\u00a0\u00a0\u00a0\u00a0\u00a0 Nature and contents of\ncontainer</span></b></p>", "ID": "556ed4ed-8b53-453f-97a3-c135e3b134e4", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>6.5\u00a0\u00a0\u00a0\u00a0\u00a0 Nature and contents of\ncontainer</span></b>", "ID": "98201646-7f39-4286-a6f5-c259bb2456ae", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "556ed4ed-8b53-453f-97a3-c135e3b134e4"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>6.5\u00a0\u00a0\u00a0\u00a0\u00a0 Nature and contents of\ncontainer</span>", "ID": "169d5a20-a28f-498c-9cf1-8c22c2b389b4", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "6.5\u00a0\u00a0\u00a0\u00a0\u00a0 Nature and contents of container", "ParentId": "98201646-7f39-4286-a6f5-c259bb2456ae"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "b9312883-7bda-4018-9be5-0f38771950b6", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "7e351b7b-0143-440f-b6fa-44b056920ed0", "Styles": "font-size:12.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "b9312883-7bda-4018-9be5-0f38771950b6"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(PVC/oPA/Alu)/Alu (desiccant\nembedded) blisters of 14, 28, 84 tablets, calendar blisters of 28, 84 tablets\nand perforated unit dose blisters of 28 x 1 tablets.</span></p>", "ID": "54e5aae9-e6f5-44e7-a2f3-a44e09a32760", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(PVC/oPA/Alu)/Alu (desiccant\nembedded) blisters of 14, 28, 84 tablets, calendar blisters of 28, 84 tablets\nand perforated unit dose blisters of 28 x 1 tablets.</span>", "ID": "f3459296-3d73-48e5-bd22-6ccb92c009fc", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "(PVC/oPA/Alu)/Alu (desiccant embedded) blisters of 14, 28, 84 tablets, calendar blisters of 28, 84 tablets and perforated unit dose blisters of 28 x 1 tablets.", "ParentId": "54e5aae9-e6f5-44e7-a2f3-a44e09a32760"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "7cb13309-5c65-4f4e-a986-e909a669239a", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "05689b5c-e24f-4905-b077-c779bb2eeeda", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "7cb13309-5c65-4f4e-a986-e909a669239a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(PVC/oPA/Alu)/Alu blisters of 14,\n28, 42 tablets, calendar blisters of 28 tablets and perforated unit dose\nblisters of 28 x 1 tablets and multipacks of 84 (2 packs of 42) tablets.</span></p>", "ID": "5ba53821-2037-41ab-953a-7b3f52bf1a4c", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(PVC/oPA/Alu)/Alu blisters of 14,\n28, 42 tablets, calendar blisters of 28 tablets and perforated unit dose\nblisters of 28 x 1 tablets and multipacks of 84 (2 packs of 42) tablets.</span>", "ID": "9001578d-f1bc-4c67-b42b-5d314c3c4af8", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "(PVC/oPA/Alu)/Alu blisters of 14, 28, 42 tablets, calendar blisters of 28 tablets and perforated unit dose blisters of 28 x 1 tablets and multipacks of 84 (2 packs of 42) tablets.", "ParentId": "5ba53821-2037-41ab-953a-7b3f52bf1a4c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "f0d88e66-6575-48f5-a677-fd63090b189c", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "cdc5bd42-7b64-4d34-a704-60261fc969b5", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "f0d88e66-6575-48f5-a677-fd63090b189c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>HDPE bottle with polypropylene (PP)\nscrew cap closure with desiccant containing 28 or 84 tablets.</span></p>", "ID": "b3ed8fd8-ff43-406f-9732-2d65129cef66", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>HDPE bottle with polypropylene (PP)\nscrew cap closure with desiccant containing 28 or 84 tablets.</span>", "ID": "ac0a5459-330f-4b6d-bc76-a610a93cdb7b", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "HDPE bottle with polypropylene (PP) screw cap closure with desiccant containing 28 or 84 tablets.", "ParentId": "b3ed8fd8-ff43-406f-9732-2d65129cef66"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;background:yellow'>\u00a0</span></p>", "ID": "ff4eefad-c3ef-457b-8edc-83a37a963540", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;background:yellow'>\u00a0</span>", "ID": "998912c2-7209-45e6-8781-a03c4c12114a", "Styles": "font-family:\"Times New Roman\",serif;background:yellow", "Classes": "None", "Text": "\u00a0", "ParentId": "ff4eefad-c3ef-457b-8edc-83a37a963540"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Not all pack sizes may be marketed.</span></p>", "ID": "0f0e377c-6006-49ec-af22-c37690fbacae", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Not all pack sizes may be marketed.</span>", "ID": "9be0cc7f-4115-4cb1-a433-4fd938a5707f", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Not all pack sizes may be marketed.", "ParentId": "0f0e377c-6006-49ec-af22-c37690fbacae"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "0c61a639-d023-41a9-afab-e2226f7c287f", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "bf06e7b8-37b5-48b5-af5e-1e11a97a2d10", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "0c61a639-d023-41a9-afab-e2226f7c287f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>6.6\u00a0\u00a0\u00a0\u00a0\u00a0 Special precautions for\ndisposal</span></b></p>", "ID": "6b0bfb52-9f56-412e-b7ad-41f3610f295b", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>6.6\u00a0\u00a0\u00a0\u00a0\u00a0 Special precautions for\ndisposal</span></b>", "ID": "c008f63e-128a-457d-994e-e60b751f3be8", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6b0bfb52-9f56-412e-b7ad-41f3610f295b"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>6.6\u00a0\u00a0\u00a0\u00a0\u00a0 Special precautions for\ndisposal</span>", "ID": "a0fcbc69-844f-4943-82b3-a93938193a48", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "6.6\u00a0\u00a0\u00a0\u00a0\u00a0 Special precautions for disposal", "ParentId": "c008f63e-128a-457d-994e-e60b751f3be8"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "81c3b443-8ea1-465b-b0a8-9fd142e520fb", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "a4eab771-e675-4cf9-b391-fd8dbc5a8330", "Styles": "font-size:12.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "81c3b443-8ea1-465b-b0a8-9fd142e520fb"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>No special requirements.</span></p>", "ID": "79d168ff-d0ef-4b0b-a082-84ba154b4022", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>No special requirements.</span>", "ID": "8151d322-7726-4ea3-b1bd-70a5dcad9e08", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "No special requirements.", "ParentId": "79d168ff-d0ef-4b0b-a082-84ba154b4022"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "e1381069-6343-4b67-a625-77a2e027f60d", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "d92afff3-f631-40eb-aecb-46a58f850879", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "e1381069-6343-4b67-a625-77a2e027f60d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "9ee92f00-d04f-4e36-9a03-81b39e739860", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "38159f82-62bc-421c-bc51-66f059de1a67", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "9ee92f00-d04f-4e36-9a03-81b39e739860"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION\nHOLDER</span></b></p>", "ID": "9631cf44-58bf-4675-ae15-17c79638c58e", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION\nHOLDER</span></b>", "ID": "43a9ae26-b808-4220-9f35-64a96c4fc4fa", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9631cf44-58bf-4675-ae15-17c79638c58e"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION\nHOLDER</span>", "ID": "4a732918-4371-409f-8455-37308d4dac9e", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION HOLDER", "ParentId": "43a9ae26-b808-4220-9f35-64a96c4fc4fa"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "12305f83-e2a5-4973-82f3-a6c605172666", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "e8364ea8-ddf1-414e-84d2-715a886fabcc", "Styles": "font-size:12.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "12305f83-e2a5-4973-82f3-a6c605172666"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Mylan\nS.A.S.</span></p>", "ID": "bdae7799-67c1-4be1-8a5f-22568dfab4d9", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Mylan\nS.A.S.</span>", "ID": "9b19519c-5d69-41bf-8b9b-d1e369f1e70b", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Mylan S.A.S.", "ParentId": "bdae7799-67c1-4be1-8a5f-22568dfab4d9"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>117\nAllee des Parcs</span></p>", "ID": "09f8f7f5-155e-4cda-bd4d-e65a5378426c", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>117\nAllee des Parcs</span>", "ID": "1772ddaa-83f1-49c5-b0b0-28b9d9a15614", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "117 Allee des Parcs", "ParentId": "09f8f7f5-155e-4cda-bd4d-e65a5378426c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>69\n800 Saint Priest</span></p>", "ID": "4db1b89a-bab8-4f00-865f-b82ce7c5fade", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>69\n800 Saint Priest</span>", "ID": "69ddc144-f4a1-4958-b626-3273c664930a", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "69 800 Saint Priest", "ParentId": "4db1b89a-bab8-4f00-865f-b82ce7c5fade"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>France</span></p>", "ID": "9be4bd04-19da-4cff-814d-8f5b268b19a1", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>France</span>", "ID": "beadd07c-d751-41f8-a7d1-cc7e58f61383", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "France", "ParentId": "9be4bd04-19da-4cff-814d-8f5b268b19a1"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "450527fd-f3f2-4c7f-b2fe-b93a4f05a40f", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "fb0dc3a0-f1d2-4f20-97e5-138e8069efe5", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "450527fd-f3f2-4c7f-b2fe-b93a4f05a40f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "3e79c2ca-de19-4b98-af3d-b060a0b5c34f", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "53f72158-4a10-41dc-b4d7-a2a7ce069c6c", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "3e79c2ca-de19-4b98-af3d-b060a0b5c34f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION\nNUMBER(S)</span></b></p>", "ID": "fb2f4045-8503-4d21-969f-ad3614b7295a", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION\nNUMBER(S)</span></b>", "ID": "fa9ac895-6718-4121-bb99-a2e236850df8", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "fb2f4045-8503-4d21-969f-ad3614b7295a"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION\nNUMBER(S)</span>", "ID": "581e9fbd-9ac1-4370-b491-de63dd212c56", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION NUMBER(S)", "ParentId": "fa9ac895-6718-4121-bb99-a2e236850df8"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "f48e95c1-3fe9-4ec2-82be-a952b6a5018e", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "a8b679af-2c7a-4ba2-bb4c-b1697c0b857e", "Styles": "font-size:12.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "f48e95c1-3fe9-4ec2-82be-a952b6a5018e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/009</span></p>", "ID": "4a5ae6d8-0f38-4ff7-ab09-35e938684a29", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/009</span>", "ID": "507af3b2-466a-44d9-83d5-16babe1ff9ff", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "EU/1/17/1194/009", "ParentId": "4a5ae6d8-0f38-4ff7-ab09-35e938684a29"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/010</span></p>", "ID": "c2db23e9-b0b2-48b3-8ab8-e630eee2db40", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/010</span>", "ID": "07624589-0351-4aa8-b713-9fec8e22b71e", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "EU/1/17/1194/010", "ParentId": "c2db23e9-b0b2-48b3-8ab8-e630eee2db40"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/011</span></p>", "ID": "d16ec242-6ea6-4b93-9955-8a401432ae15", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/011</span>", "ID": "4d6c904c-b1fb-424f-aff5-4fbb3a756f54", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "EU/1/17/1194/011", "ParentId": "d16ec242-6ea6-4b93-9955-8a401432ae15"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/012</span></p>", "ID": "88322883-5ad1-4c8c-adf7-ced00f5bad04", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/012</span>", "ID": "fa328316-7466-4a64-89e4-965c7420c955", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "EU/1/17/1194/012", "ParentId": "88322883-5ad1-4c8c-adf7-ced00f5bad04"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/013</span></p>", "ID": "12256bfb-5e7e-4ca6-a97c-e2ed656d57b2", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/013</span>", "ID": "0167f57a-15d6-467e-b8d9-71f0c12534e6", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "EU/1/17/1194/013", "ParentId": "12256bfb-5e7e-4ca6-a97c-e2ed656d57b2"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/014</span></p>", "ID": "427dac86-4c07-4c14-a4da-5fa0d82bb1ab", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/014</span>", "ID": "0a20c964-e205-42bb-92eb-af030a664980", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "EU/1/17/1194/014", "ParentId": "427dac86-4c07-4c14-a4da-5fa0d82bb1ab"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/015</span></p>", "ID": "f4aab7cf-5586-4756-8696-a878f1c801f0", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/015</span>", "ID": "9f13d7fb-c1ee-46e7-ba63-867e70ee323b", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "EU/1/17/1194/015", "ParentId": "f4aab7cf-5586-4756-8696-a878f1c801f0"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/016</span></p>", "ID": "1f15c4e0-6146-48a3-9e91-ca50d4339b31", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/016</span>", "ID": "b94ec90f-2650-4c10-95e5-9d745e2f161f", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "EU/1/17/1194/016", "ParentId": "1f15c4e0-6146-48a3-9e91-ca50d4339b31"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/023</span></p>", "ID": "d6afeecf-bcac-42e1-be3a-180fd1d39ab6", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/023</span>", "ID": "6219d2fd-feda-46a2-ae1d-c58e20556daa", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "EU/1/17/1194/023", "ParentId": "d6afeecf-bcac-42e1-be3a-180fd1d39ab6"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/024</span></p>", "ID": "fdb2c607-9f14-445e-a631-65986c28aac1", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/024</span>", "ID": "6e3fb301-bebb-43c8-802e-6fb7e8bf17ce", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "EU/1/17/1194/024", "ParentId": "fdb2c607-9f14-445e-a631-65986c28aac1"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/025</span></p>", "ID": "ed97062e-5d01-497e-b61a-3f10ba34e5d5", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/025</span>", "ID": "34deb0ad-f1c2-43ec-9bac-1a9ee8ff89c5", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "EU/1/17/1194/025", "ParentId": "ed97062e-5d01-497e-b61a-3f10ba34e5d5"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/026</span></p>", "ID": "aa2c7320-f223-45e5-9907-cbef61109650", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/026</span>", "ID": "7e53579f-c788-4aed-8175-c04d0f6f0993", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "EU/1/17/1194/026", "ParentId": "aa2c7320-f223-45e5-9907-cbef61109650"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/027</span></p>", "ID": "79c6fdcc-5f69-4f43-90d8-82e3c6b82df9", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/027</span>", "ID": "0955c8ce-6316-4f56-8978-1f5a617a5c23", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "EU/1/17/1194/027", "ParentId": "79c6fdcc-5f69-4f43-90d8-82e3c6b82df9"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/028</span></p>", "ID": "ddc4775f-1b93-4b77-b368-cc9e909cad5a", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/028</span>", "ID": "e1965bb9-736f-4296-be8c-ac6094df0692", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "EU/1/17/1194/028", "ParentId": "ddc4775f-1b93-4b77-b368-cc9e909cad5a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "9cb273cc-2a3f-4b56-8458-2284ac6f71d2", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "03671529-ce8a-4dba-bbee-72e4b13defda", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "9cb273cc-2a3f-4b56-8458-2284ac6f71d2"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "a745852b-c47b-43f5-a764-f60b0af961be", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "bb5fb9f1-9b6d-454e-8719-295a23f99e1c", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "a745852b-c47b-43f5-a764-f60b0af961be"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 DATE OF FIRST\nAUTHORISATION/RENEWAL OF THE AUTHORISATION</span></b></p>", "ID": "332115b6-018f-40c1-8758-686b101ad4b1", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 DATE OF FIRST\nAUTHORISATION/RENEWAL OF THE AUTHORISATION</span></b>", "ID": "d7be163b-a87f-41ee-82c0-7838bcde2709", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "332115b6-018f-40c1-8758-686b101ad4b1"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 DATE OF FIRST\nAUTHORISATION/RENEWAL OF THE AUTHORISATION</span>", "ID": "6c55194a-4dd8-436f-86d3-1e4c07b7daf5", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION", "ParentId": "d7be163b-a87f-41ee-82c0-7838bcde2709"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "9a7d14ee-72fb-47df-b611-b0875727051b", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "98b1ed58-55e7-4ce5-977c-8d92716bfd73", "Styles": "font-size:12.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "9a7d14ee-72fb-47df-b611-b0875727051b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Date of first authorisation: </span></p>", "ID": "6d66f810-438e-4a65-98e5-12bba49722d0", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Date of first authorisation: </span>", "ID": "dbad4ead-6047-46d3-9368-589b39e061c8", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Date of first authorisation: ", "ParentId": "6d66f810-438e-4a65-98e5-12bba49722d0"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "5b27b496-9aad-4d12-9123-bb78cb633777", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "cc70439a-9588-41d6-ad93-66eb60e7b57b", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "5b27b496-9aad-4d12-9123-bb78cb633777"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "1cab7616-eb54-4a8e-aee7-e5447c401d5d", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "4c3cdc94-f30c-436c-a4c0-e748384b598c", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "1cab7616-eb54-4a8e-aee7-e5447c401d5d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>10.\u00a0\u00a0\u00a0\u00a0\u00a0 DATE OF REVISION OF THE\nTEXT</span></b></p>", "ID": "58e4ae14-3bb2-4e76-a9cc-4825a407a782", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>10.\u00a0\u00a0\u00a0\u00a0\u00a0 DATE OF REVISION OF THE\nTEXT</span></b>", "ID": "86f4a64c-d1c3-4ec7-af8d-40c1ce0b7e66", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "58e4ae14-3bb2-4e76-a9cc-4825a407a782"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>10.\u00a0\u00a0\u00a0\u00a0\u00a0 DATE OF REVISION OF THE\nTEXT</span>", "ID": "54450e19-3947-4527-a855-591ddbac6652", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "10.\u00a0\u00a0\u00a0\u00a0\u00a0 DATE OF REVISION OF THE TEXT", "ParentId": "86f4a64c-d1c3-4ec7-af8d-40c1ce0b7e66"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "4ba10d15-3c10-43be-86de-820a124af4d3", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:12.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "b7733826-b1f8-4149-9f71-8374c2bd66bb", "Styles": "font-size:12.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "4ba10d15-3c10-43be-86de-820a124af4d3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Detailed information on this\nmedicinal product is available on the website of the European Medicines Agency </span><span lang=\"EN-GB\"><a href=\"http://www.emea.europa.eu/\"><span style='font-family:\"Times New Roman\",serif;\ncolor:windowtext'>http://www.ema.europa.eu</span></a></span></p>", "ID": "6b1f4565-f3e4-4862-9a69-1976f2e7bcbc", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Detailed information on this\nmedicinal product is available on the website of the European Medicines Agency </span>", "ID": "5036c234-47f6-4f14-9f92-462429ce467d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Detailed information on this medicinal product is available on the website of the European Medicines Agency ", "ParentId": "6b1f4565-f3e4-4862-9a69-1976f2e7bcbc"}, {"Element": "<span lang=\"EN-GB\"><a href=\"http://www.emea.europa.eu/\"><span style='font-family:\"Times New Roman\",serif;\ncolor:windowtext'>http://www.ema.europa.eu</span></a></span>", "ID": "e2eee895-3e9a-41be-94c6-cbddb24229a7", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6b1f4565-f3e4-4862-9a69-1976f2e7bcbc"}, {"Element": "<a href=\"http://www.emea.europa.eu/\"><span style='font-family:\"Times New Roman\",serif;\ncolor:windowtext'>http://www.ema.europa.eu</span></a>", "ID": "20f564f2-de88-4236-83b0-c819f4e9953e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e2eee895-3e9a-41be-94c6-cbddb24229a7"}, {"Element": "<span style='font-family:\"Times New Roman\",serif;\ncolor:windowtext'>http://www.ema.europa.eu</span>", "ID": "da5253db-1af1-497a-8dfa-b8362787721b", "Styles": "font-family:\"Times New Roman\",serif;\ncolor:windowtext", "Classes": "None", "Text": "http://www.ema.europa.eu", "ParentId": "20f564f2-de88-4236-83b0-c819f4e9953e"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span>", "ID": "c13afd6a-8fc2-4e6d-8dbf-84c089bb3712", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": " ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<br clear=\"all\" style=\"page-break-before:always\"/>", "ID": "e9300c77-0ec3-4b84-8352-1b072f0c0fc4", "Styles": "page-break-before:always", "Classes": "None", "Text": "", "ParentId": "c13afd6a-8fc2-4e6d-8dbf-84c089bb3712"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "a8814088-9c73-4e6d-ab2a-fac88079fc00", "Styles": "margin-bottom:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "1473d109-db6c-421e-9335-e06467e88d69", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "a8814088-9c73-4e6d-ab2a-fac88079fc00"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>", "ID": "26602faf-8f8d-406d-a432-fc98f71ca951", "Styles": "margin-bottom:0in;text-align:center;\nline-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b>", "ID": "1fda8267-68e4-4555-9bee-1eaa1389486c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "26602faf-8f8d-406d-a432-fc98f71ca951"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "ab17e520-6a90-4b25-b5e9-e69817b0ea5d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "1fda8267-68e4-4555-9bee-1eaa1389486c"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>", "ID": "f618451f-ec21-4ef2-a931-07bf1e4c381d", "Styles": "margin-bottom:0in;text-align:center;\nline-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b>", "ID": "b46a2688-8210-489d-aea4-c93849857bd3", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f618451f-ec21-4ef2-a931-07bf1e4c381d"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "582fedfc-7654-4f0e-bf22-64bcd4524980", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "b46a2688-8210-489d-aea4-c93849857bd3"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>", "ID": "d9cc8105-c026-47aa-9e66-c2623cd7ef35", "Styles": "margin-bottom:0in;text-align:center;\nline-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b>", "ID": "7039a228-d51b-43de-86da-d61964e0c057", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d9cc8105-c026-47aa-9e66-c2623cd7ef35"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "cc66e67b-7f3b-468a-8d3e-46f85202b5ec", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "7039a228-d51b-43de-86da-d61964e0c057"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>", "ID": "3d776108-4825-4cd1-b731-cd6064854888", "Styles": "margin-bottom:0in;text-align:center;\nline-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b>", "ID": "e55c27da-18b9-49c6-b03d-7dc0194386c0", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "3d776108-4825-4cd1-b731-cd6064854888"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "83736f9a-8e46-41ad-b2e7-d11efc77a422", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "e55c27da-18b9-49c6-b03d-7dc0194386c0"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>", "ID": "3252416f-10ca-4513-8d74-4b5da2566e63", "Styles": "margin-bottom:0in;text-align:center;\nline-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b>", "ID": "6354a546-c220-4846-bdfe-69a8e51cc60a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "3252416f-10ca-4513-8d74-4b5da2566e63"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "015376de-fc5d-4959-8602-10ad742f03dc", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "6354a546-c220-4846-bdfe-69a8e51cc60a"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>", "ID": "0512dbfa-f913-4b33-b609-23039a80959a", "Styles": "margin-bottom:0in;text-align:center;\nline-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b>", "ID": "60be733e-604a-4e12-b9ce-b4f9c327ff74", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0512dbfa-f913-4b33-b609-23039a80959a"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "691c2145-91c6-43e0-9662-809e91169597", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "60be733e-604a-4e12-b9ce-b4f9c327ff74"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>", "ID": "30b49d32-2010-4837-b951-6476806a0db7", "Styles": "margin-bottom:0in;text-align:center;\nline-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b>", "ID": "f4831b69-bc44-4a54-b928-e35510d88b12", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "30b49d32-2010-4837-b951-6476806a0db7"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "0c0ed356-3416-4bcd-90fe-312004174529", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "f4831b69-bc44-4a54-b928-e35510d88b12"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>", "ID": "24596ac9-cd19-40f2-b968-94bf21b5d4d5", "Styles": "margin-bottom:0in;text-align:center;\nline-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b>", "ID": "9a476a9e-bc69-46f2-b06a-14040e85f83a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "24596ac9-cd19-40f2-b968-94bf21b5d4d5"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "2c5fa87c-770a-4128-b12d-9cbee96bc3f1", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "9a476a9e-bc69-46f2-b06a-14040e85f83a"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>", "ID": "d754cf3f-1eaf-4bf0-891a-29753680fa54", "Styles": "margin-bottom:0in;text-align:center;\nline-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b>", "ID": "105ecf92-70ac-4a08-86c9-bb2bc8ab82ac", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d754cf3f-1eaf-4bf0-891a-29753680fa54"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "2c341633-eb29-490f-963a-18db2533b80d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "105ecf92-70ac-4a08-86c9-bb2bc8ab82ac"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>", "ID": "e77e327a-3bd8-430c-b39c-d4ac3c26ccab", "Styles": "margin-bottom:0in;text-align:center;\nline-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b>", "ID": "dc97dca7-8251-4055-8e0b-687fab673edf", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e77e327a-3bd8-430c-b39c-d4ac3c26ccab"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "35fc929c-c236-4354-bcf6-c3eff776157c", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "dc97dca7-8251-4055-8e0b-687fab673edf"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>", "ID": "cf93af6f-73c4-410d-825c-278c7bc65d74", "Styles": "margin-bottom:0in;text-align:center;\nline-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b>", "ID": "579f85d8-8f8d-42f0-9ba2-28a4f34bc446", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "cf93af6f-73c4-410d-825c-278c7bc65d74"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "7dd411fa-ff01-4e4a-a6de-51a52d6491dd", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "579f85d8-8f8d-42f0-9ba2-28a4f34bc446"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>", "ID": "8d7a20b5-c5c2-4578-9ec6-b00a2dd673e2", "Styles": "margin-bottom:0in;text-align:center;\nline-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b>", "ID": "e5ce4f10-115c-4412-93eb-01dff260b0cb", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "8d7a20b5-c5c2-4578-9ec6-b00a2dd673e2"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "b4717986-87ff-4b12-9a36-18add079eedc", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "e5ce4f10-115c-4412-93eb-01dff260b0cb"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>", "ID": "a55cc800-c47d-4de1-9cf4-3ca634d9f2dc", "Styles": "margin-bottom:0in;text-align:center;\nline-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b>", "ID": "1f9472b7-ce69-452d-b282-a368a3df53ca", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a55cc800-c47d-4de1-9cf4-3ca634d9f2dc"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "5f4960b0-eccb-437e-add3-128e27b68dab", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "1f9472b7-ce69-452d-b282-a368a3df53ca"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>", "ID": "170ca070-9ae1-433b-a533-6153bba23330", "Styles": "margin-bottom:0in;text-align:center;\nline-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b>", "ID": "822c7be1-b461-41e5-a732-c7211ced1b3b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "170ca070-9ae1-433b-a533-6153bba23330"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "12ee27ea-d72d-43a2-9149-bba803782ade", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "822c7be1-b461-41e5-a732-c7211ced1b3b"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>", "ID": "b31cee26-68cd-46ac-a8ed-5b05ab5363a6", "Styles": "margin-bottom:0in;text-align:center;\nline-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b>", "ID": "ae63ddf7-db6d-46f7-b0c6-3fd0f7403e32", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b31cee26-68cd-46ac-a8ed-5b05ab5363a6"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "432b467d-34bf-4287-9ad4-b9cff046cc17", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "ae63ddf7-db6d-46f7-b0c6-3fd0f7403e32"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>", "ID": "115b0ef6-198e-4304-a280-9200d29f564c", "Styles": "margin-bottom:0in;text-align:center;\nline-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b>", "ID": "f93143cc-e578-4a53-8c50-711d4abfe928", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "115b0ef6-198e-4304-a280-9200d29f564c"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "b190dd11-53bc-4643-9b32-121341c68c4b", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "f93143cc-e578-4a53-8c50-711d4abfe928"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>", "ID": "23090e8e-7cde-4c77-a971-969037535f69", "Styles": "margin-bottom:0in;text-align:center;\nline-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b>", "ID": "f412fdeb-10ce-49b6-97aa-2668eba4f668", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "23090e8e-7cde-4c77-a971-969037535f69"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "c17ca406-0644-4095-b17a-40eac771e72e", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "f412fdeb-10ce-49b6-97aa-2668eba4f668"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>", "ID": "fb2804e7-cfbb-4bf2-bb4d-1eed588b44ca", "Styles": "margin-bottom:0in;text-align:center;\nline-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b>", "ID": "7a704f21-b16e-4ce8-b1b7-2fac2a9dcb91", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "fb2804e7-cfbb-4bf2-bb4d-1eed588b44ca"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "8b5a78f3-263c-46ea-90e9-ecaaf14e712e", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "7a704f21-b16e-4ce8-b1b7-2fac2a9dcb91"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>", "ID": "18d201c6-4462-436b-9637-97ebc62ea50a", "Styles": "margin-bottom:0in;text-align:center;\nline-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b>", "ID": "cb84bd8a-242b-4336-ae3a-8340a4009a51", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "18d201c6-4462-436b-9637-97ebc62ea50a"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "2a7cec95-89b6-44eb-a9a3-d5ba4d0b6943", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "cb84bd8a-242b-4336-ae3a-8340a4009a51"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>", "ID": "5add4c69-343c-4940-a0f8-67a513fc4d3c", "Styles": "margin-bottom:0in;text-align:center;\nline-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b>", "ID": "8fde0494-aa68-4ea3-bcba-91fa2e4ed27b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "5add4c69-343c-4940-a0f8-67a513fc4d3c"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "b99607bf-f177-43ca-a953-1b247da7b0c3", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "8fde0494-aa68-4ea3-bcba-91fa2e4ed27b"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>", "ID": "ebb90ada-a489-4cb3-a6d9-54af7adcb217", "Styles": "margin-bottom:0in;text-align:center;\nline-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b>", "ID": "d832acc3-117e-46e8-87b8-8c357f571b4a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ebb90ada-a489-4cb3-a6d9-54af7adcb217"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "b09202d0-bf4b-46de-be0f-c240be160347", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "d832acc3-117e-46e8-87b8-8c357f571b4a"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>", "ID": "ca0bdc5d-a2cf-4f0d-a79b-b313f825d5c7", "Styles": "margin-bottom:0in;text-align:center;\nline-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b>", "ID": "5b17a89e-d58e-4271-a237-2c839e754be3", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ca0bdc5d-a2cf-4f0d-a79b-b313f825d5c7"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "02c8e37d-4331-43c0-92af-2368239aa766", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "5b17a89e-d58e-4271-a237-2c839e754be3"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>", "ID": "e2fb8ebe-d83f-4f8d-8d1f-5848b9c37be5", "Styles": "margin-bottom:0in;text-align:center;\nline-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b>", "ID": "bc8ab0cb-a938-4694-be01-36def9e9faca", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e2fb8ebe-d83f-4f8d-8d1f-5848b9c37be5"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "25da4c63-6287-4f1f-a6c3-e4a702bb083a", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "bc8ab0cb-a938-4694-be01-36def9e9faca"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>ANNEX\nII</span></b></p>", "ID": "c616aba2-66a2-4813-9ca9-4ce0cfdf0cba", "Styles": "margin-bottom:0in;text-align:center;\nline-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>ANNEX\nII</span></b>", "ID": "e205383f-b9d7-4751-b7c7-f7d40edd5412", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c616aba2-66a2-4813-9ca9-4ce0cfdf0cba"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>ANNEX\nII</span>", "ID": "81830330-f853-4d99-844f-5a6346d42e15", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "ANNEX II", "ParentId": "e205383f-b9d7-4751-b7c7-f7d40edd5412"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:70.8pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "2d9337f2-8f12-4acf-9ac6-22031b130550", "Styles": "margin-top:0in;margin-right:70.8pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "7dec4f4e-af55-45af-b8bf-1d36dc514121", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "2d9337f2-8f12-4acf-9ac6-22031b130550"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:70.8pt;margin-bottom:\n0in;margin-left:85.05pt;text-indent:-35.4pt;line-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>A.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MANUFACTURERS\nRESPONSIBLE FOR BATCH RELEASE</span></b></p>", "ID": "7f3f0743-c10d-4e0d-96c6-90290be49b44", "Styles": "margin-top:0in;margin-right:70.8pt;margin-bottom:\n0in;margin-left:85.05pt;text-indent:-35.4pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>A.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MANUFACTURERS\nRESPONSIBLE FOR BATCH RELEASE</span></b>", "ID": "d4b34833-a6a8-4777-938b-b6910294746a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "7f3f0743-c10d-4e0d-96c6-90290be49b44"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>A.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MANUFACTURERS\nRESPONSIBLE FOR BATCH RELEASE</span>", "ID": "10f6a2f5-8aa5-457b-bfdd-606b151129de", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "A.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MANUFACTURERS RESPONSIBLE FOR BATCH RELEASE", "ParentId": "d4b34833-a6a8-4777-938b-b6910294746a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\nmargin-left:28.35pt;text-indent:-28.35pt;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "70001150-ac02-4f04-be85-8d69fbbd8a24", "Styles": "margin-top:0in;margin-right:0in;margin-bottom:0in;\nmargin-left:28.35pt;text-indent:-28.35pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "9b258bac-b32f-44a4-8592-42cde55b9d30", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "70001150-ac02-4f04-be85-8d69fbbd8a24"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:70.9pt;margin-bottom:\n0in;margin-left:85.05pt;text-indent:-35.45pt;line-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>B.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 CONDITIONS OR\nRESTRICTIONS REGARDING SUPPLY AND USE</span></b></p>", "ID": "33afdf7b-80d6-44cc-8b54-b7c4bf66e073", "Styles": "margin-top:0in;margin-right:70.9pt;margin-bottom:\n0in;margin-left:85.05pt;text-indent:-35.45pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>B.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 CONDITIONS OR\nRESTRICTIONS REGARDING SUPPLY AND USE</span></b>", "ID": "a5d1b938-234b-4642-8197-d82a90f9ee38", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "33afdf7b-80d6-44cc-8b54-b7c4bf66e073"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>B.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 CONDITIONS OR\nRESTRICTIONS REGARDING SUPPLY AND USE</span>", "ID": "37504347-7227-421e-afb9-9c1b5f4782d9", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "B.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE", "ParentId": "a5d1b938-234b-4642-8197-d82a90f9ee38"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\nmargin-left:28.35pt;text-indent:-28.35pt;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "16fb441f-89b7-452a-9d50-e4c6bcf27d0b", "Styles": "margin-top:0in;margin-right:0in;margin-bottom:0in;\nmargin-left:28.35pt;text-indent:-28.35pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "25e47615-c688-42dc-b65b-9a71ef6d8ab4", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "16fb441f-89b7-452a-9d50-e4c6bcf27d0b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:77.95pt;margin-bottom:\n0in;margin-left:85.05pt;text-indent:-35.45pt;line-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>C.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER\nCONDITIONS AND REQUIREMENTS OF THE MARKETING AUTHORISATION</span></b></p>", "ID": "4d9e44e5-9ca1-414e-bb2c-ef34ffd781b4", "Styles": "margin-top:0in;margin-right:77.95pt;margin-bottom:\n0in;margin-left:85.05pt;text-indent:-35.45pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>C.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER\nCONDITIONS AND REQUIREMENTS OF THE MARKETING AUTHORISATION</span></b>", "ID": "89240bfc-3a40-432f-be32-e3e2d18aa607", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4d9e44e5-9ca1-414e-bb2c-ef34ffd781b4"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>C.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER\nCONDITIONS AND REQUIREMENTS OF THE MARKETING AUTHORISATION</span>", "ID": "dd51900c-a24a-4377-bdb2-1feb3161bfa7", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "C.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER CONDITIONS AND REQUIREMENTS OF THE MARKETING AUTHORISATION", "ParentId": "89240bfc-3a40-432f-be32-e3e2d18aa607"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:77.9pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></b></p>", "ID": "0a4ff4d0-4d15-40a4-809f-4d70dbe8a126", "Styles": "margin-top:0in;margin-right:77.9pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></b>", "ID": "989b20b3-7ba2-45a7-9261-bb87bad97593", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0a4ff4d0-4d15-40a4-809f-4d70dbe8a126"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "5eb34a17-8e5b-4a42-8591-f38080e70fc7", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "989b20b3-7ba2-45a7-9261-bb87bad97593"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:70.8pt;margin-bottom:\n0in;margin-left:85.05pt;text-indent:-35.4pt;line-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>D.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <span style=\"text-transform:uppercase\">conditions or restrictions with regard to the\nsafe and effective use of the medicinal product</span></span></b></p>", "ID": "69d42c56-eafd-4dd0-87ba-a3ea02d5d09a", "Styles": "margin-top:0in;margin-right:70.8pt;margin-bottom:\n0in;margin-left:85.05pt;text-indent:-35.4pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>D.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <span style=\"text-transform:uppercase\">conditions or restrictions with regard to the\nsafe and effective use of the medicinal product</span></span></b>", "ID": "18f1120d-acdb-4bd7-9898-8fb0305a4d90", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "69d42c56-eafd-4dd0-87ba-a3ea02d5d09a"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>D.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <span style=\"text-transform:uppercase\">conditions or restrictions with regard to the\nsafe and effective use of the medicinal product</span></span>", "ID": "18de4645-f10b-4340-bc41-704db82ed74a", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "D.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "18f1120d-acdb-4bd7-9898-8fb0305a4d90"}, {"Element": "<span style=\"text-transform:uppercase\">conditions or restrictions with regard to the\nsafe and effective use of the medicinal product</span>", "ID": "620891f3-dd87-4640-b1b5-5e10f96c29ea", "Styles": "text-transform:uppercase", "Classes": "None", "Text": "conditions or restrictions with regard to the safe and effective use of the medicinal product", "ParentId": "18de4645-f10b-4340-bc41-704db82ed74a"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span>", "ID": "35a2c66d-3509-4332-895d-47bb1740bc75", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": " ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<br clear=\"all\" style=\"page-break-before:always\"/>", "ID": "cd77a288-9c56-45a5-84dd-00c8bf16ab1b", "Styles": "page-break-before:always", "Classes": "None", "Text": "", "ParentId": "35a2c66d-3509-4332-895d-47bb1740bc75"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>A.\u00a0\u00a0\u00a0\u00a0\u00a0 MANUFACTURERS\nRESPONSIBLE FOR BATCH RELEASE</span></b></p>", "ID": "d63d8ffd-1660-4151-a38f-df85a9d9c1eb", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>A.\u00a0\u00a0\u00a0\u00a0\u00a0 MANUFACTURERS\nRESPONSIBLE FOR BATCH RELEASE</span></b>", "ID": "7f8a2553-2f85-4fe2-a0fb-ff028a0ee666", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d63d8ffd-1660-4151-a38f-df85a9d9c1eb"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>A.\u00a0\u00a0\u00a0\u00a0\u00a0 MANUFACTURERS\nRESPONSIBLE FOR BATCH RELEASE</span>", "ID": "60accea4-7e7f-4ba5-a737-5a8157d3dea5", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "A.\u00a0\u00a0\u00a0\u00a0\u00a0 MANUFACTURERS RESPONSIBLE FOR BATCH RELEASE", "ParentId": "7f8a2553-2f85-4fe2-a0fb-ff028a0ee666"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "bee4cdf4-c275-48e5-baf8-83918ace8820", "Styles": "margin-bottom:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "2c872cbb-a736-4ed9-a1b1-f223f53c39ac", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "bee4cdf4-c275-48e5-baf8-83918ace8820"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Name and address of the\nmanufacturers responsible for batch release</span></u></p>", "ID": "ce44731e-b9a6-4f76-beeb-ebda6d2ec429", "Styles": "margin-bottom:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Name and address of the\nmanufacturers responsible for batch release</span></u>", "ID": "c7f15183-5a61-42bd-8c4e-fe89d2127eae", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ce44731e-b9a6-4f76-beeb-ebda6d2ec429"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Name and address of the\nmanufacturers responsible for batch release</span>", "ID": "fc8f93d5-5105-43e1-88f2-76a4da7c7250", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Name and address of the manufacturers responsible for batch release", "ParentId": "c7f15183-5a61-42bd-8c4e-fe89d2127eae"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "a25de4ba-835e-4269-a17f-eb9d080910eb", "Styles": "margin-bottom:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "2e60f653-5077-4127-8cdf-7c7ed7d95551", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "a25de4ba-835e-4269-a17f-eb9d080910eb"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Mylan Hungary Kft</span></p>", "ID": "414e5088-f06f-4d4f-82d9-66139e2b7645", "Styles": "margin-bottom:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Mylan Hungary Kft</span>", "ID": "e640d2a4-faf4-4f5a-902c-8f5d3ab0364f", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Mylan Hungary Kft", "ParentId": "414e5088-f06f-4d4f-82d9-66139e2b7645"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Mylan utca 1</span></p>", "ID": "97f98a20-72e1-4f8d-a410-884ea2301741", "Styles": "margin-bottom:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Mylan utca 1</span>", "ID": "2def9c8b-c073-47b7-a3e9-ede6e9a9f54b", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Mylan utca 1", "ParentId": "97f98a20-72e1-4f8d-a410-884ea2301741"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>H-2900 Kom\u00e1rom</span></p>", "ID": "1758d051-067d-47a2-9f2b-8fa75c28b145", "Styles": "margin-bottom:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>H-2900 Kom\u00e1rom</span>", "ID": "2fa2857c-66bd-4d9b-ab66-32c4d611bde4", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "H-2900 Kom\u00e1rom", "ParentId": "1758d051-067d-47a2-9f2b-8fa75c28b145"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Hungary</span></p>", "ID": "bf89aabe-1e12-4061-9c81-dc4c9adb00b6", "Styles": "margin-bottom:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Hungary</span>", "ID": "fcabe79b-8c5b-4bfa-9d24-6da5bab18a77", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Hungary", "ParentId": "bf89aabe-1e12-4061-9c81-dc4c9adb00b6"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "b8851eb7-c463-4481-98c2-92369c681087", "Styles": "margin-bottom:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "91d0d199-b648-4679-be9e-45f0a340880c", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "b8851eb7-c463-4481-98c2-92369c681087"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>McDermott Laboratories\nLimited trading as Gerard Laboratories</span></p>", "ID": "2124277c-6fb4-4abc-96f0-357c81364bda", "Styles": "margin-bottom:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>McDermott Laboratories\nLimited trading as Gerard Laboratories</span>", "ID": "9ebf0856-eaa4-4fb6-ab89-19890dd465cc", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "McDermott Laboratories Limited trading as Gerard Laboratories", "ParentId": "2124277c-6fb4-4abc-96f0-357c81364bda"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>35/36 Baldoyle\nIndustrial Estate</span></p>", "ID": "5435eb4a-84d7-43b1-b189-b1f975d8a9f1", "Styles": "margin-bottom:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>35/36 Baldoyle\nIndustrial Estate</span>", "ID": "8eb264e9-5a26-4e54-a8c2-11be3645bd96", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "35/36 Baldoyle Industrial Estate", "ParentId": "5435eb4a-84d7-43b1-b189-b1f975d8a9f1"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Grange Road</span></p>", "ID": "cca144c8-329f-443a-b9d3-bea8c1ea4cbc", "Styles": "margin-bottom:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Grange Road</span>", "ID": "92631e58-39bf-42ce-89f3-ac5e021ca7a2", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Grange Road", "ParentId": "cca144c8-329f-443a-b9d3-bea8c1ea4cbc"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Dublin 13</span></p>", "ID": "6afd38b0-d0a2-4000-b4e2-97588513148e", "Styles": "margin-bottom:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Dublin 13</span>", "ID": "f7e53eaf-dd73-4e6e-83be-9de79674e3e5", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Dublin 13", "ParentId": "6afd38b0-d0a2-4000-b4e2-97588513148e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Ireland</span></p>", "ID": "76661c8a-825c-42e7-bc75-61702f5ca46d", "Styles": "margin-bottom:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Ireland</span>", "ID": "2c8de51d-ab13-4473-ac6c-17b970b30fc9", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Ireland", "ParentId": "76661c8a-825c-42e7-bc75-61702f5ca46d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "12113a70-a255-4a1b-8d69-f824743a4284", "Styles": "margin-bottom:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "72e0805d-71c0-45f7-8ed3-f15696367c73", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "12113a70-a255-4a1b-8d69-f824743a4284"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The printed package\nleaflet of the medicinal product must state the name and address of the\nmanufacturer responsible for the release of the concerned batch.</span></p>", "ID": "8cd49b70-8634-4bc2-9a78-56afe34bb34c", "Styles": "margin-bottom:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The printed package\nleaflet of the medicinal product must state the name and address of the\nmanufacturer responsible for the release of the concerned batch.</span>", "ID": "38f5533d-716a-40e7-b769-a8b8ae144417", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "The printed package leaflet of the medicinal product must state the name and address of the manufacturer responsible for the release of the concerned batch.", "ParentId": "8cd49b70-8634-4bc2-9a78-56afe34bb34c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "d853cf99-38e8-4e88-82f5-25a441246122", "Styles": "margin-bottom:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "a5a3f29a-62c1-4f49-8be4-89a4a26d0109", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "d853cf99-38e8-4e88-82f5-25a441246122"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "a13360d0-187c-43f4-b50c-439d17192dc3", "Styles": "margin-bottom:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "21a60b95-5c18-461b-ab9d-b8e5c5605b37", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "a13360d0-187c-43f4-b50c-439d17192dc3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\nmargin-left:28.35pt;text-indent:-28.35pt;line-height:normal\"><a name=\"OLE_LINK2\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>B.</span></b></a><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0 CONDITIONS OR\nRESTRICTIONS REGARDING SUPPLY AND USE </span></b></p>", "ID": "ef389b74-41e3-4a63-a762-df7257a32480", "Styles": "margin-top:0in;margin-right:0in;margin-bottom:0in;\nmargin-left:28.35pt;text-indent:-28.35pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<a name=\"OLE_LINK2\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>B.</span></b></a>", "ID": "77d2da6b-5fee-471d-9400-d10942b0c554", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ef389b74-41e3-4a63-a762-df7257a32480"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>B.</span></b>", "ID": "1e4afc97-bee0-49b1-9c52-4c0ad5be177a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "77d2da6b-5fee-471d-9400-d10942b0c554"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>B.</span>", "ID": "11890b20-372a-4822-863d-1b411889f537", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "B.", "ParentId": "1e4afc97-bee0-49b1-9c52-4c0ad5be177a"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0 CONDITIONS OR\nRESTRICTIONS REGARDING SUPPLY AND USE </span></b>", "ID": "a4b6f139-ded0-4fe6-92a4-583df08956ae", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ef389b74-41e3-4a63-a762-df7257a32480"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0 CONDITIONS OR\nRESTRICTIONS REGARDING SUPPLY AND USE </span>", "ID": "5d67c583-4198-4371-b55c-9a1f0f41ba2c", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0 CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE ", "ParentId": "a4b6f139-ded0-4fe6-92a4-583df08956ae"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "3c10c1ce-0c4c-4e2f-9560-f04d7ec786e4", "Styles": "margin-bottom:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "3f103562-2dd9-497d-95aa-a84073569506", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "3c10c1ce-0c4c-4e2f-9560-f04d7ec786e4"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Medicinal product subject\nto medical prescription.</span></p>", "ID": "81f430c7-1f47-4e49-b9b9-3cbcd8a2a246", "Styles": "margin-bottom:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Medicinal product subject\nto medical prescription.</span>", "ID": "7206f229-81ac-410c-8eed-6a033769474f", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Medicinal product subject to medical prescription.", "ParentId": "81f430c7-1f47-4e49-b9b9-3cbcd8a2a246"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "a78c83af-ff0c-40fb-a24e-3d52e0cf349d", "Styles": "margin-bottom:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "bf251826-e487-491e-8ef4-3c1f27ca659f", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "a78c83af-ff0c-40fb-a24e-3d52e0cf349d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "ffea2efe-2716-4a19-851d-62421128e62f", "Styles": "margin-bottom:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "4d907b5f-e5fa-4aff-b05a-f05a3de25a32", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "ffea2efe-2716-4a19-851d-62421128e62f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\nmargin-left:28.35pt;text-indent:-28.35pt;line-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>C. \u00a0\u00a0\u00a0\u00a0 OTHER CONDITIONS\nAND REQUIREMENTS OF THE MARKETING AUTHORISATION</span></b></p>", "ID": "5be9c518-6f91-48bf-ab01-77fa7b8bbf62", "Styles": "margin-top:0in;margin-right:0in;margin-bottom:0in;\nmargin-left:28.35pt;text-indent:-28.35pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>C. \u00a0\u00a0\u00a0\u00a0 OTHER CONDITIONS\nAND REQUIREMENTS OF THE MARKETING AUTHORISATION</span></b>", "ID": "31ccfa0f-04b8-4389-987c-59ee42c9eae5", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "5be9c518-6f91-48bf-ab01-77fa7b8bbf62"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>C. \u00a0\u00a0\u00a0\u00a0 OTHER CONDITIONS\nAND REQUIREMENTS OF THE MARKETING AUTHORISATION</span>", "ID": "9733c718-6a01-4808-990d-24b2a340fb79", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "C. \u00a0\u00a0\u00a0\u00a0 OTHER CONDITIONS AND REQUIREMENTS OF THE MARKETING AUTHORISATION", "ParentId": "31ccfa0f-04b8-4389-987c-59ee42c9eae5"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.05pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><u><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'><span style=\"text-decoration:none\">\u00a0</span></span></u></p>", "ID": "328e39a9-5ea8-4c4a-a9a9-9b9c23f3a898", "Styles": "margin-top:0in;margin-right:-.05pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "70e4a079-7cce-4b5e-9712-cede8ff404de", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "328e39a9-5ea8-4c4a-a9a9-9b9c23f3a898"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "6e1db224-c419-4dd2-8b4e-24a568ab7e46", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "", "ParentId": "70e4a079-7cce-4b5e-9712-cede8ff404de"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "ac3b5351-547f-4f80-bfa2-bc6c8dc3daa9", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "6e1db224-c419-4dd2-8b4e-24a568ab7e46"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.05pt;margin-bottom:\n0in;margin-left:.5in;text-indent:-.5in;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Periodic\nSafety Update Reports</span></b></p>", "ID": "eb25e96c-7491-454d-8cb2-3ab340057430", "Styles": "margin-top:0in;margin-right:-.05pt;margin-bottom:\n0in;margin-left:.5in;text-indent:-.5in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "3a4a0719-c5a3-4980-9933-e007c38e9dca", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "eb25e96c-7491-454d-8cb2-3ab340057430"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "77a26e63-329d-4c5e-88f8-eb00bb36d30e", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "3a4a0719-c5a3-4980-9933-e007c38e9dca"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Periodic\nSafety Update Reports</span></b>", "ID": "7a9ce5f4-7106-4474-be8f-e9bd0953291b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "eb25e96c-7491-454d-8cb2-3ab340057430"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Periodic\nSafety Update Reports</span>", "ID": "68bedbb5-9b26-4cc5-af36-e01deea52930", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Periodic Safety Update Reports", "ParentId": "7a9ce5f4-7106-4474-be8f-e9bd0953291b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:28.35pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "badc12f5-dea9-46d5-b456-87c403445bf8", "Styles": "margin-top:0in;margin-right:28.35pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "58964bdb-e2c7-41e7-b243-ecadb393fb41", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "badc12f5-dea9-46d5-b456-87c403445bf8"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:28.35pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>The requirements for submission of periodic safety\nupdate reports for this medicinal product are set out in the list of Union\nreference dates (EURD list) </span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>provided\nfor under Article 107c(7) of Directive 2001/83</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>/EC</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'> and </span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>any subsequent updates published on\nthe European medicines web-portal.</span></p>", "ID": "b60df030-262c-4bdc-a4ff-c3d8b3821c7c", "Styles": "margin-top:0in;margin-right:28.35pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>The requirements for submission of periodic safety\nupdate reports for this medicinal product are set out in the list of Union\nreference dates (EURD list) </span>", "ID": "04604f7b-8f32-429a-bf05-326745434ff4", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "The requirements for submission of periodic safety update reports for this medicinal product are set out in the list of Union reference dates (EURD list) ", "ParentId": "b60df030-262c-4bdc-a4ff-c3d8b3821c7c"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>provided\nfor under Article 107c(7) of Directive 2001/83</span>", "ID": "8ee17714-465c-48b5-b058-28a186872911", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "provided for under Article 107c(7) of Directive 2001/83", "ParentId": "b60df030-262c-4bdc-a4ff-c3d8b3821c7c"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>/EC</span>", "ID": "020bfbfd-1fb2-418f-b0f4-f219f4daa6a3", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "/EC", "ParentId": "b60df030-262c-4bdc-a4ff-c3d8b3821c7c"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'> and </span>", "ID": "6361c281-8c0e-4958-9626-36ed437ccaf4", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": " and ", "ParentId": "b60df030-262c-4bdc-a4ff-c3d8b3821c7c"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>any subsequent updates published on\nthe European medicines web-portal.</span>", "ID": "10f27e49-f19b-42b8-a08c-5a0a75855ce6", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "any subsequent updates published on the European medicines web-portal.", "ParentId": "b60df030-262c-4bdc-a4ff-c3d8b3821c7c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.05pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><u><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'><span style=\"text-decoration:none\">\u00a0</span></span></u></p>", "ID": "b40d6bad-2c65-4297-944f-8684d63acfb2", "Styles": "margin-top:0in;margin-right:-.05pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "e70210a5-c3de-4c18-8d34-14f62783b1a1", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b40d6bad-2c65-4297-944f-8684d63acfb2"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "aef22f8c-edb6-4944-bb1a-8105b06f74f8", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "", "ParentId": "e70210a5-c3de-4c18-8d34-14f62783b1a1"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "874bb71a-f3df-46ca-ba51-2a39b0972774", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "aef22f8c-edb6-4944-bb1a-8105b06f74f8"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.05pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><u><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'><span style=\"text-decoration:none\">\u00a0</span></span></u></p>", "ID": "ed397c2b-ec45-4e69-8fee-b6026dd67ab5", "Styles": "margin-top:0in;margin-right:-.05pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "5c0c5653-dbf0-4d62-93a0-67d5ca31cdfd", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ed397c2b-ec45-4e69-8fee-b6026dd67ab5"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "ca39705d-0e71-41d7-958e-7305c55f36f8", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "", "ParentId": "5c0c5653-dbf0-4d62-93a0-67d5ca31cdfd"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "05a41909-3e98-4126-9f70-149e27b8a004", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "ca39705d-0e71-41d7-958e-7305c55f36f8"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\nmargin-left:28.35pt;text-indent:-28.35pt;line-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>D.\u00a0\u00a0\u00a0\u00a0\u00a0 CONDITIONS OR\nRESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL\nPRODUCT\u00a0 </span></b></p>", "ID": "d9dd8722-6e0d-424d-84d8-6f6b77e42b16", "Styles": "margin-top:0in;margin-right:0in;margin-bottom:0in;\nmargin-left:28.35pt;text-indent:-28.35pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>D.\u00a0\u00a0\u00a0\u00a0\u00a0 CONDITIONS OR\nRESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL\nPRODUCT\u00a0 </span></b>", "ID": "752279f3-e7d1-42d0-8ec2-0d409e68badb", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d9dd8722-6e0d-424d-84d8-6f6b77e42b16"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>D.\u00a0\u00a0\u00a0\u00a0\u00a0 CONDITIONS OR\nRESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL\nPRODUCT\u00a0 </span>", "ID": "c4c5a760-b2f6-4843-ad43-38bde8526b62", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "D.\u00a0\u00a0\u00a0\u00a0\u00a0 CONDITIONS OR RESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT\u00a0 ", "ParentId": "752279f3-e7d1-42d0-8ec2-0d409e68badb"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.05pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><u><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'><span style=\"text-decoration:none\">\u00a0</span></span></u></p>", "ID": "8c2573c9-755c-41c6-a6ba-d7a717c49848", "Styles": "margin-top:0in;margin-right:-.05pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "db3b4379-1c61-4355-b951-c0be64189ed3", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "8c2573c9-755c-41c6-a6ba-d7a717c49848"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "3a465061-bd49-4025-8d31-f7bb4681b2d7", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "", "ParentId": "db3b4379-1c61-4355-b951-c0be64189ed3"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "585a4397-a456-4a0b-a10b-35e5737cef60", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "3a465061-bd49-4025-8d31-f7bb4681b2d7"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.05pt;margin-bottom:\n0in;margin-left:.5in;text-indent:-.5in;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Risk\nManagement Plan (RMP)</span></b></p>", "ID": "0e3e9e77-4d66-4d34-b28e-dd000a8686ea", "Styles": "margin-top:0in;margin-right:-.05pt;margin-bottom:\n0in;margin-left:.5in;text-indent:-.5in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "d62cb984-d145-4407-82d6-8388c1a5b46d", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "0e3e9e77-4d66-4d34-b28e-dd000a8686ea"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "fd56de87-99f4-41b4-bce7-440d785fd0a6", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "d62cb984-d145-4407-82d6-8388c1a5b46d"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Risk\nManagement Plan (RMP)</span></b>", "ID": "2bb06844-b364-41fb-be89-294862ca300c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0e3e9e77-4d66-4d34-b28e-dd000a8686ea"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Risk\nManagement Plan (RMP)</span>", "ID": "e51c5005-9af6-4aab-900f-152cead72a45", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Risk Management Plan (RMP)", "ParentId": "2bb06844-b364-41fb-be89-294862ca300c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.05pt;margin-bottom:\n0in;margin-left:.5in;line-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></b></p>", "ID": "659882cb-9d84-41ea-b90a-f6cd88165774", "Styles": "margin-top:0in;margin-right:-.05pt;margin-bottom:\n0in;margin-left:.5in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></b>", "ID": "c3f6641f-af3b-4de3-b353-f10643538dfd", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "659882cb-9d84-41ea-b90a-f6cd88165774"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "24ff0a85-bcd8-4ee7-bd5d-a474bc4a907a", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "c3f6641f-af3b-4de3-b353-f10643538dfd"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:28.35pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>The MAH shall perform the required pharmacovigilance\nactivities and interventions detailed in the agreed RMP presented in Module\n1.8.2 of the Marketing Authorisation and any agreed subsequent updates of the\nRMP.</span></p>", "ID": "65487b32-31fa-49e5-8472-7ce2d30c683d", "Styles": "margin-top:0in;margin-right:28.35pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>The MAH shall perform the required pharmacovigilance\nactivities and interventions detailed in the agreed RMP presented in Module\n1.8.2 of the Marketing Authorisation and any agreed subsequent updates of the\nRMP.</span>", "ID": "2a169d93-7c37-49cd-900a-fe64e3db732d", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "The MAH shall perform the required pharmacovigilance activities and interventions detailed in the agreed RMP presented in Module 1.8.2 of the Marketing Authorisation and any agreed subsequent updates of the RMP.", "ParentId": "65487b32-31fa-49e5-8472-7ce2d30c683d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.05pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "267ca993-5c81-4e9b-846c-80b246ebdbb1", "Styles": "margin-top:0in;margin-right:-.05pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "d3b4ecdb-d98f-42ef-a815-b7721ebee561", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "267ca993-5c81-4e9b-846c-80b246ebdbb1"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.05pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>An updated RMP should be submitted:</span></p>", "ID": "3ed17885-aaed-4f3c-b691-fc07e2539c34", "Styles": "margin-top:0in;margin-right:-.05pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>An updated RMP should be submitted:</span>", "ID": "5e045f01-909c-43a7-9fd5-f4da24586dd2", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "An updated RMP should be submitted:", "ParentId": "3ed17885-aaed-4f3c-b691-fc07e2539c34"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.05pt;margin-bottom:\n0in;margin-left:.5in;text-indent:-.25in;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>At\nthe request of the European Medicines Agency;</span></p>", "ID": "88560c2d-c87b-4a75-be3a-368351aab180", "Styles": "margin-top:0in;margin-right:-.05pt;margin-bottom:\n0in;margin-left:.5in;text-indent:-.25in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\n</span></span>", "ID": "cc83d5ac-955b-48d9-a3a6-55329ff0ec16", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "88560c2d-c87b-4a75-be3a-368351aab180"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\n</span>", "ID": "5496a0ca-c23b-4105-9c42-b38b3ba82d5c", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0 ", "ParentId": "cc83d5ac-955b-48d9-a3a6-55329ff0ec16"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>At\nthe request of the European Medicines Agency;</span>", "ID": "b788c090-ea57-4a70-aee7-a271babf45fb", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "At the request of the European Medicines Agency;", "ParentId": "88560c2d-c87b-4a75-be3a-368351aab180"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.05pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-10.35pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Whenever\nthe risk management system is modified, especially as the result of new\ninformation being received that may lead to a significant change to the\nbenefit/risk profile or as the result of an important (pharmacovigilance or\nrisk minimisation) milestone being reached.</span></p>", "ID": "fade4690-4da8-43ce-b0b6-b5174f5bb5d9", "Styles": "margin-top:0in;margin-right:-.05pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-10.35pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\n</span></span>", "ID": "063f3044-98a2-4bc9-b6c9-37e2782a6f8a", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "fade4690-4da8-43ce-b0b6-b5174f5bb5d9"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\n</span>", "ID": "98f1167e-d4b0-4a46-a239-5a2d3c0454d9", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0 ", "ParentId": "063f3044-98a2-4bc9-b6c9-37e2782a6f8a"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Whenever\nthe risk management system is modified, especially as the result of new\ninformation being received that may lead to a significant change to the\nbenefit/risk profile or as the result of an important (pharmacovigilance or\nrisk minimisation) milestone being reached.</span>", "ID": "d11a3e68-636c-46c5-b41e-e9ec898e2a39", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Whenever the risk management system is modified, especially as the result of new information being received that may lead to a significant change to the benefit/risk profile or as the result of an important (pharmacovigilance or risk minimisation) milestone being reached.", "ParentId": "fade4690-4da8-43ce-b0b6-b5174f5bb5d9"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span>", "ID": "cd211893-8ab9-4074-b5a1-774f56d4f909", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": " ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<br clear=\"all\" style=\"page-break-before:always\"/>", "ID": "3bbb12f3-c85f-418c-8251-04f861b90123", "Styles": "page-break-before:always", "Classes": "None", "Text": "", "ParentId": "cd211893-8ab9-4074-b5a1-774f56d4f909"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "f81ca411-8307-4acf-912e-c79be3039f01", "Styles": "margin-bottom:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "0b71ab77-ab61-4c3f-995b-a35d09b53369", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "f81ca411-8307-4acf-912e-c79be3039f01"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "d62373e0-9c1f-4863-8e7e-66c0a963ae81", "Styles": "margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "b324c85f-af82-48a0-ba20-30b64ec33ed6", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "d62373e0-9c1f-4863-8e7e-66c0a963ae81"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "6647f3b7-c88e-4719-bb92-19a63a9a4837", "Styles": "margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "0b77bea4-01db-41b9-aa5e-c7ba99e8593e", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "6647f3b7-c88e-4719-bb92-19a63a9a4837"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "2ad46a98-5725-4a30-af9f-f3660ce0c0f8", "Styles": "margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "16bd7ff6-7748-40b2-96f4-332bf74f7030", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "2ad46a98-5725-4a30-af9f-f3660ce0c0f8"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "4eefe920-e61f-451e-bbc2-46ee37daab3e", "Styles": "margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "9f7baad6-770f-4061-af3c-fdfc700e09db", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "4eefe920-e61f-451e-bbc2-46ee37daab3e"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "a92a8686-ab08-4cd7-8765-beb3182dbf99", "Styles": "margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "ab9dcff4-38f3-4d4f-99a7-8aee56ce5f5f", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "a92a8686-ab08-4cd7-8765-beb3182dbf99"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "740fd0d3-86c3-4340-8c92-4f1cd676c091", "Styles": "margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "4b1bfe87-d8cf-4ed3-83f1-28e2bb51ff90", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "740fd0d3-86c3-4340-8c92-4f1cd676c091"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "3a5dd594-9a77-4d17-b72d-48897fc1b4a7", "Styles": "margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "b6e9138a-e6ed-4767-952c-b573c0994282", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "3a5dd594-9a77-4d17-b72d-48897fc1b4a7"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "0822b31f-6725-438d-9048-6d0ac0f6c118", "Styles": "margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "741b5302-9a43-4d63-9fbb-6032c67480be", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "0822b31f-6725-438d-9048-6d0ac0f6c118"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "6c62280e-45b3-46a5-80fa-b5a66410cdd7", "Styles": "margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "81dcdf28-bcbc-438f-b7a7-aa2396297b69", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "6c62280e-45b3-46a5-80fa-b5a66410cdd7"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "47621041-582c-48da-b893-cc5751a6bca7", "Styles": "margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "a39e8f7f-096e-4e34-b640-ecd1e4478e4e", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "47621041-582c-48da-b893-cc5751a6bca7"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "734129ec-88a8-482a-950e-1bbc3d53eceb", "Styles": "margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "1e0e9ccd-6547-4747-b5ee-93a484b35d3a", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "734129ec-88a8-482a-950e-1bbc3d53eceb"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "924b9e53-e36f-4aaf-9220-7d53906bc2ce", "Styles": "margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "8e6e1f9e-3f22-4c74-a0ab-e2c19ec4b3fa", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "924b9e53-e36f-4aaf-9220-7d53906bc2ce"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "bd2e30a1-e643-4274-8b1a-e88822705ddf", "Styles": "margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "08ebe759-4266-4d01-8023-3bf4fe921c06", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "bd2e30a1-e643-4274-8b1a-e88822705ddf"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "60d65e2b-7fdc-4e48-8cef-1f26b75abbc1", "Styles": "margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "98d51aba-8bd3-4873-8805-a20fc050e95c", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "60d65e2b-7fdc-4e48-8cef-1f26b75abbc1"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "55fe20fe-d539-429c-8041-11b11f535c6f", "Styles": "margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "cc1d27e6-8dbf-4a54-8a2d-cde1f0a72513", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "55fe20fe-d539-429c-8041-11b11f535c6f"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "2fa1167e-926d-4c0c-b78d-a393e8b1395c", "Styles": "margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "14afe829-6bd3-4b46-bdd7-c4438bbc7eca", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "2fa1167e-926d-4c0c-b78d-a393e8b1395c"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "3808f15e-2e2d-440c-9796-38542d14f485", "Styles": "margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "12faf9b5-b6f7-45eb-a756-ab0607fec3e7", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "3808f15e-2e2d-440c-9796-38542d14f485"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "e8c166a8-1fca-404e-b1c9-d7aa9cca34cd", "Styles": "margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "d2057608-8bc4-4add-a9e6-717a7baabb75", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "e8c166a8-1fca-404e-b1c9-d7aa9cca34cd"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "ce6fd314-247b-43df-810e-0143a882ec1e", "Styles": "margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "a9596e3f-decb-421f-8e0a-b510ae55c542", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "ce6fd314-247b-43df-810e-0143a882ec1e"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "b9717919-517d-474f-ab5f-93fc5c4b1b98", "Styles": "margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "871d8e96-67a5-4a77-9d23-8a94d98c8195", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "b9717919-517d-474f-ab5f-93fc5c4b1b98"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "e5e7f588-5e15-449c-a608-a83a4b9db873", "Styles": "margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "d89a194c-dbc1-4b77-9ece-ad0bf61e170c", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "e5e7f588-5e15-449c-a608-a83a4b9db873"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "46beb797-c3d4-47cc-8e50-216c9e0906fb", "Styles": "margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "e270b309-1141-46a5-8ba1-f8158bc71fc2", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "46beb797-c3d4-47cc-8e50-216c9e0906fb"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "a0890072-c4e1-4cdb-8d2b-877154d07be9", "Styles": "margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "31186c02-f7bb-45e6-9b82-fe61624aef38", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "a0890072-c4e1-4cdb-8d2b-877154d07be9"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>ANNEX III</span></b></p>", "ID": "316995aa-6aaf-4bda-903a-53cb84e42db1", "Styles": "margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>ANNEX III</span></b>", "ID": "6cf9ce87-562e-4af9-b201-d5bd8c25aba7", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "316995aa-6aaf-4bda-903a-53cb84e42db1"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>ANNEX III</span>", "ID": "eb868540-fbdf-4a38-8340-27646b62caa2", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "ANNEX III", "ParentId": "6cf9ce87-562e-4af9-b201-d5bd8c25aba7"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>", "ID": "18d78bb8-eb8f-4286-875c-fa0081631b29", "Styles": "margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b>", "ID": "a6ba85bf-566b-4930-87ca-c4091bd1427e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "18d78bb8-eb8f-4286-875c-fa0081631b29"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "be0c6586-6036-450a-ac78-3abbb0fbde01", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "a6ba85bf-566b-4930-87ca-c4091bd1427e"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>LABELLING AND PACKAGE\nLEAFLET</span></b></p>", "ID": "97f4959b-cbb6-4074-889c-86c503174374", "Styles": "margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>LABELLING AND PACKAGE\nLEAFLET</span></b>", "ID": "316ae7a9-d034-4a23-8df3-49c8ae52bc37", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "97f4959b-cbb6-4074-889c-86c503174374"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>LABELLING AND PACKAGE\nLEAFLET</span>", "ID": "217f01f3-9c3f-49ae-9e8e-a59dbc56dda8", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "LABELLING AND PACKAGE LEAFLET", "ParentId": "316ae7a9-d034-4a23-8df3-49c8ae52bc37"}, {"Element": "<b><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span></b>", "ID": "c586c6ab-0fd5-4dc6-8f64-4f0b517c79d2", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span>", "ID": "d5802000-6942-47dd-b7fb-6bfee4949fea", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": " ", "ParentId": "c586c6ab-0fd5-4dc6-8f64-4f0b517c79d2"}, {"Element": "<br clear=\"all\" style=\"page-break-before:always\"/>", "ID": "21771435-d4c6-457f-9a6a-ca8c0449f372", "Styles": "page-break-before:always", "Classes": "None", "Text": "", "ParentId": "d5802000-6942-47dd-b7fb-6bfee4949fea"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>", "ID": "5fde79dd-f39f-4dd6-b978-6e6312a14f41", "Styles": "margin-bottom:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b>", "ID": "8c700308-a37b-4a7d-ae1b-b25b9f1d42d0", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "5fde79dd-f39f-4dd6-b978-6e6312a14f41"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "1cb297c3-3dca-4c15-8c64-812259b435c2", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "8c700308-a37b-4a7d-ae1b-b25b9f1d42d0"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>", "ID": "0c5b8405-f667-42c1-ba66-d682b5d46634", "Styles": "margin-bottom:0in;text-align:center;\nline-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b>", "ID": "35902a91-6027-496a-915f-f7372cd9a8c5", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0c5b8405-f667-42c1-ba66-d682b5d46634"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "a2cf186a-269e-4b3e-94c3-639db8c0fecd", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "35902a91-6027-496a-915f-f7372cd9a8c5"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>", "ID": "8b704f04-b41b-4dbe-9a8c-83308530cb89", "Styles": "margin-bottom:0in;text-align:center;\nline-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b>", "ID": "13ff68de-afa2-4724-b715-d68746852e36", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "8b704f04-b41b-4dbe-9a8c-83308530cb89"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "1ec8bb28-c058-4e4b-9c92-1cf92ca53d93", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "13ff68de-afa2-4724-b715-d68746852e36"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>", "ID": "8ba97e2f-9f36-4438-86ce-26ebe15b741b", "Styles": "margin-bottom:0in;text-align:center;\nline-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b>", "ID": "062d638f-7d7b-4c60-a70b-7eefbf0ec6af", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "8ba97e2f-9f36-4438-86ce-26ebe15b741b"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "9bf30ecb-d443-4f74-b433-cc9778a60874", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "062d638f-7d7b-4c60-a70b-7eefbf0ec6af"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>", "ID": "9b4e13d4-4782-4fa2-856e-bffbe3567894", "Styles": "margin-bottom:0in;text-align:center;\nline-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b>", "ID": "29e93d4c-f075-4570-9648-6c216ac9d904", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9b4e13d4-4782-4fa2-856e-bffbe3567894"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "cbb2486f-2713-4732-8a68-3f2990dab001", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "29e93d4c-f075-4570-9648-6c216ac9d904"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>", "ID": "f46bad32-cc70-4f28-8401-a9e1e014638e", "Styles": "margin-bottom:0in;text-align:center;\nline-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b>", "ID": "49e4c7fc-3647-4353-bef4-ec411d256636", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f46bad32-cc70-4f28-8401-a9e1e014638e"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "4cd753c7-b9e3-4382-9e5f-25a7ae2a3ac8", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "49e4c7fc-3647-4353-bef4-ec411d256636"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>", "ID": "a1a8f767-879e-4d01-bdcf-48bccdb813e3", "Styles": "margin-bottom:0in;text-align:center;\nline-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b>", "ID": "6b7614c7-025a-42b3-9c53-a28b6b48f2db", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a1a8f767-879e-4d01-bdcf-48bccdb813e3"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "770f0ec4-c361-413c-b0ae-803a46bec84d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "6b7614c7-025a-42b3-9c53-a28b6b48f2db"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>", "ID": "0cef5ce0-84fa-43e6-8d48-5905fb33eb20", "Styles": "margin-bottom:0in;text-align:center;\nline-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b>", "ID": "acf06318-3e25-4bf3-aa87-3ad0682b4d03", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0cef5ce0-84fa-43e6-8d48-5905fb33eb20"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "3de0b163-a653-4287-9e79-a05f951381a2", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "acf06318-3e25-4bf3-aa87-3ad0682b4d03"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>", "ID": "cf84be1b-5137-444e-b6cd-65c2d8060683", "Styles": "margin-bottom:0in;text-align:center;\nline-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b>", "ID": "2ce252cb-56c7-4520-8df0-7e78e2ca2765", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "cf84be1b-5137-444e-b6cd-65c2d8060683"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "e0cfbf14-feac-4df4-b5e2-74e775d94a0d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "2ce252cb-56c7-4520-8df0-7e78e2ca2765"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>", "ID": "ef16aeca-4eae-49af-8417-a7d0012496b6", "Styles": "margin-bottom:0in;text-align:center;\nline-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b>", "ID": "4f07cd81-c1ab-4e5e-bcd8-3c24490b2e13", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ef16aeca-4eae-49af-8417-a7d0012496b6"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "2fbd8169-11d6-4b64-983b-70998ea6bfc2", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "4f07cd81-c1ab-4e5e-bcd8-3c24490b2e13"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>", "ID": "9a4c8e2d-3431-4279-b7b2-3e6050d07b20", "Styles": "margin-bottom:0in;text-align:center;\nline-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b>", "ID": "18ec9005-f9eb-4053-bb19-76df6782b807", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9a4c8e2d-3431-4279-b7b2-3e6050d07b20"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "86c9cdc6-ffb7-49c2-9003-d447462557ff", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "18ec9005-f9eb-4053-bb19-76df6782b807"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>", "ID": "d6fa66c0-1ae5-4011-9113-4824689f64de", "Styles": "margin-bottom:0in;text-align:center;\nline-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b>", "ID": "3dfff07e-f0e0-479a-9690-409311415d72", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d6fa66c0-1ae5-4011-9113-4824689f64de"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "a442a8ef-9e2e-4a5f-bef7-d21269f40370", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "3dfff07e-f0e0-479a-9690-409311415d72"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>", "ID": "d7881184-096e-4816-af2e-76f9d7e3061d", "Styles": "margin-bottom:0in;text-align:center;\nline-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b>", "ID": "adf66439-22af-4125-adf4-ff055ceb2171", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d7881184-096e-4816-af2e-76f9d7e3061d"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "8ce8790c-c812-41cd-967b-acbe5de8b3e4", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "adf66439-22af-4125-adf4-ff055ceb2171"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>", "ID": "61d908f5-23d3-4385-836d-5404b44cade4", "Styles": "margin-bottom:0in;text-align:center;\nline-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b>", "ID": "a4bc137f-860f-4478-ae28-66d1efacbea8", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "61d908f5-23d3-4385-836d-5404b44cade4"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "b7fd50a9-c127-4272-a931-2ea845eeb6b6", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "a4bc137f-860f-4478-ae28-66d1efacbea8"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>", "ID": "d194b590-86a8-4130-b8a1-51b8d50d9349", "Styles": "margin-bottom:0in;text-align:center;\nline-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b>", "ID": "941fdbce-5b63-4790-a1dd-5d7182806253", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d194b590-86a8-4130-b8a1-51b8d50d9349"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "ed5a46b1-c5c5-401c-8f4b-d9ee3173dd46", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "941fdbce-5b63-4790-a1dd-5d7182806253"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>", "ID": "171f6c8e-b53b-4054-83d2-8747f9cd6002", "Styles": "margin-bottom:0in;text-align:center;\nline-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b>", "ID": "2a699d3f-b5fd-4d1f-b299-9838be33da34", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "171f6c8e-b53b-4054-83d2-8747f9cd6002"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "657a18d9-dd68-4b36-ae20-30ad497c7f2c", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "2a699d3f-b5fd-4d1f-b299-9838be33da34"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>", "ID": "3d0a471c-1287-4fbb-882e-fe77c53d6023", "Styles": "margin-bottom:0in;text-align:center;\nline-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b>", "ID": "4b094904-f57e-4fcf-b708-cfb0a4152c5e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "3d0a471c-1287-4fbb-882e-fe77c53d6023"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "fd732e04-487a-4cc7-b7e5-c7e4f80253b7", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "4b094904-f57e-4fcf-b708-cfb0a4152c5e"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>", "ID": "92c5c996-5516-4d09-981f-2fab50347f60", "Styles": "margin-bottom:0in;text-align:center;\nline-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b>", "ID": "95da117d-e335-4771-a134-8ea7f800e220", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "92c5c996-5516-4d09-981f-2fab50347f60"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "9613d855-3a5d-4c57-ad78-7ae78c3d2a88", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "95da117d-e335-4771-a134-8ea7f800e220"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>", "ID": "259bec1b-63b8-423f-b1d4-91b757932a65", "Styles": "margin-bottom:0in;text-align:center;\nline-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b>", "ID": "c2af3ff4-8a46-4e99-8175-cc993088bf08", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "259bec1b-63b8-423f-b1d4-91b757932a65"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "aba4da9b-db5d-48d2-8454-09a8060daeda", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "c2af3ff4-8a46-4e99-8175-cc993088bf08"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>", "ID": "c227c170-8de6-48e6-98c2-60f8f519f14b", "Styles": "margin-bottom:0in;text-align:center;\nline-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b>", "ID": "79d45927-ca4e-4516-87e6-50d80def783e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c227c170-8de6-48e6-98c2-60f8f519f14b"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "831cf3cb-225a-4b2e-8691-cd092bdbe1df", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "79d45927-ca4e-4516-87e6-50d80def783e"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>", "ID": "ce391f44-50bd-4f1e-8c1f-5ebd0efe105f", "Styles": "margin-bottom:0in;text-align:center;\nline-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b>", "ID": "6d826a67-9145-4c9b-8622-650ce2c6b88b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ce391f44-50bd-4f1e-8c1f-5ebd0efe105f"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "42e64872-4ebe-4566-b602-7bdf3283a4be", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "6d826a67-9145-4c9b-8622-650ce2c6b88b"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>", "ID": "eaa4e3c6-0730-481f-9bf5-5136aa2b938b", "Styles": "margin-bottom:0in;text-align:center;\nline-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b>", "ID": "fb6bd94f-ec7b-4d07-b3ef-5d5b74ac50fa", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "eaa4e3c6-0730-481f-9bf5-5136aa2b938b"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "b6a6f64c-d7f9-4dc5-a49d-256ab20784d1", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "fb6bd94f-ec7b-4d07-b3ef-5d5b74ac50fa"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>", "ID": "1ad8458c-1cb8-41fa-a91d-0ab1beecb9d2", "Styles": "margin-bottom:0in;text-align:center;\nline-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b>", "ID": "55012e80-28a9-4249-acc4-586df3d09c7f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "1ad8458c-1cb8-41fa-a91d-0ab1beecb9d2"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "a3e6eb7c-666c-40f5-99b3-486a4dce0c70", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "55012e80-28a9-4249-acc4-586df3d09c7f"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>", "ID": "0f1ed7e1-618b-4677-b4db-db68627619aa", "Styles": "margin-bottom:0in;text-align:center;\nline-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b>", "ID": "ea20514c-a77a-4c41-a91e-3122ad5f8661", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0f1ed7e1-618b-4677-b4db-db68627619aa"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "e162a5bf-f4d5-4e15-b70e-e4ca75aad127", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "ea20514c-a77a-4c41-a91e-3122ad5f8661"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>A.\nLABELLING</span></b></p>", "ID": "68a90bed-3c35-49e2-a3d0-451fb622da19", "Styles": "margin-bottom:0in;text-align:center;\nline-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>A.\nLABELLING</span></b>", "ID": "74049f5c-3e32-431e-96fa-8b909e11df21", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "68a90bed-3c35-49e2-a3d0-451fb622da19"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>A.\nLABELLING</span>", "ID": "4b484174-75c1-46dd-9cdf-3cf81ffa9510", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "A. LABELLING", "ParentId": "74049f5c-3e32-431e-96fa-8b909e11df21"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\ncolor:black'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span>", "ID": "ed45eb59-b8eb-4d76-a4d7-9cc17b354783", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif;\ncolor:black", "Classes": "None", "Text": " ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<br clear=\"all\" style=\"page-break-before:always\"/>", "ID": "7670c4e6-30d9-4ddf-834e-7305d9c06b04", "Styles": "page-break-before:always", "Classes": "None", "Text": "", "ParentId": "ed45eb59-b8eb-4d76-a4d7-9cc17b354783"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;background:white\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "358b5608-b12b-4cbc-9c64-7d4313d06baa", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;background:white", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "e33ccde5-fc26-441c-b201-a5125cf29454", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "358b5608-b12b-4cbc-9c64-7d4313d06baa"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>PARTICULARS\nTO APPEAR ON THE OUTER PACKAGING </span></b></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>OUTER\nCARTON (BLISTERS AND BOTTLES)</span></b></p>\n</div>", "ID": "16476189-0ea8-425d-8836-04a14f0f2c12", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "    ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>PARTICULARS\nTO APPEAR ON THE OUTER PACKAGING </span></b></p>", "ID": "a28599c9-e28a-4849-ace0-55fc32cdb98a", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "16476189-0ea8-425d-8836-04a14f0f2c12"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>PARTICULARS\nTO APPEAR ON THE OUTER PACKAGING </span></b>", "ID": "eac61925-f61f-4a4a-b8f8-5ede16da52ac", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a28599c9-e28a-4849-ace0-55fc32cdb98a"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>PARTICULARS\nTO APPEAR ON THE OUTER PACKAGING </span>", "ID": "c81c6bb3-b988-4d5c-bae4-24e811c7aff1", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "PARTICULARS TO APPEAR ON THE OUTER PACKAGING ", "ParentId": "eac61925-f61f-4a4a-b8f8-5ede16da52ac"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "4ae7a211-7a60-4316-b6ee-9a28c76c7560", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "16476189-0ea8-425d-8836-04a14f0f2c12"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "1a577e9a-d132-4b1f-9a4f-2bc3e5c5d2cb", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "4ae7a211-7a60-4316-b6ee-9a28c76c7560"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>OUTER\nCARTON (BLISTERS AND BOTTLES)</span></b></p>", "ID": "32873162-3905-42cc-8d58-6371e7b95bff", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "16476189-0ea8-425d-8836-04a14f0f2c12"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>OUTER\nCARTON (BLISTERS AND BOTTLES)</span></b>", "ID": "a09f5739-5109-48e3-9f02-6aee54212698", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "32873162-3905-42cc-8d58-6371e7b95bff"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>OUTER\nCARTON (BLISTERS AND BOTTLES)</span>", "ID": "26c11fd8-f0c3-4802-a5af-ea9bfaacdf75", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "OUTER CARTON (BLISTERS AND BOTTLES)", "ParentId": "a09f5739-5109-48e3-9f02-6aee54212698"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "a87ed5ff-b879-4a07-a30b-9ea0ed9888ba", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "c667948b-201f-4c77-8a2f-a65a38381a8a", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "a87ed5ff-b879-4a07-a30b-9ea0ed9888ba"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "de48a299-cde9-4341-ac35-b2d2989d9dd7", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "a795d92f-e04b-45c5-a928-74d751cefdb1", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "de48a299-cde9-4341-ac35-b2d2989d9dd7"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\nOF THE MEDICINAL PRODUCT</span></b></p>\n</div>", "ID": "7f15cfa9-5402-40d2-8551-428828ee3bb9", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\nOF THE MEDICINAL PRODUCT</span></b></p>", "ID": "c59655b9-740c-4566-9a90-e3d6b252ae8f", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "7f15cfa9-5402-40d2-8551-428828ee3bb9"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\nOF THE MEDICINAL PRODUCT</span></b>", "ID": "02187b7a-7cbf-4d58-894c-c6226b49b381", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c59655b9-740c-4566-9a90-e3d6b252ae8f"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\nOF THE MEDICINAL PRODUCT</span>", "ID": "a5074aeb-2490-47af-bd95-c4b57d801ee5", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT", "ParentId": "02187b7a-7cbf-4d58-894c-c6226b49b381"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "07967cf3-33f3-4758-93d0-1e57fa0ce8f2", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "77951982-f51b-4858-8808-2729aa50529e", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "07967cf3-33f3-4758-93d0-1e57fa0ce8f2"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Febuxostat Mylan 80\u00a0mg film-coated tablets </span></p>", "ID": "3162eed6-83be-40c4-a7be-effc990bd5e6", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Febuxostat Mylan 80\u00a0mg film-coated tablets </span>", "ID": "a6cac1e3-7124-4a8d-839f-e73788a198e6", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "Febuxostat Mylan 80\u00a0mg film-coated tablets ", "ParentId": "3162eed6-83be-40c4-a7be-effc990bd5e6"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>febuxostat</span><b><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'> </span></b></p>", "ID": "e39a9100-fb37-4863-8e72-7177822eb16f", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>febuxostat</span>", "ID": "a6ca1d04-b099-4e31-b310-ed9b5e45fa28", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "febuxostat", "ParentId": "e39a9100-fb37-4863-8e72-7177822eb16f"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'> </span></b>", "ID": "92436c5b-e0e3-4ba8-bf62-2505d9bd2831", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e39a9100-fb37-4863-8e72-7177822eb16f"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'> </span>", "ID": "51fc4011-5a8b-4465-9aba-93cc10bd7b5a", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": " ", "ParentId": "92436c5b-e0e3-4ba8-bf62-2505d9bd2831"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "83767ab9-99fd-407e-bd8a-ec9676da991b", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "1d0e27da-1751-47cf-9eaa-3a094cfacd6b", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "83767ab9-99fd-407e-bd8a-ec9676da991b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "943c3d49-1a4c-4649-b1f6-8069e8da8b03", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "4202e384-0934-4546-9b9c-204d667ccdf0", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "943c3d49-1a4c-4649-b1f6-8069e8da8b03"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT\nOF ACTIVE SUBSTANCE</span></b></p>\n</div>", "ID": "d6342322-71e0-4a9c-8d6e-b676841ffe06", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT\nOF ACTIVE SUBSTANCE</span></b></p>", "ID": "5de6dbf0-d789-420f-b13c-578aee686a26", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d6342322-71e0-4a9c-8d6e-b676841ffe06"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT\nOF ACTIVE SUBSTANCE</span></b>", "ID": "7cede790-38a0-429d-bc97-69f703af2601", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "5de6dbf0-d789-420f-b13c-578aee686a26"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT\nOF ACTIVE SUBSTANCE</span>", "ID": "fd15d09a-28ee-4dad-89c9-0c95b1383d57", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT OF ACTIVE SUBSTANCE", "ParentId": "7cede790-38a0-429d-bc97-69f703af2601"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "d91cfcc5-4676-4cfa-aa3d-7ac219b6f6c3", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "6c7375a4-aef3-4fbe-85b0-590547ce1c6c", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "d91cfcc5-4676-4cfa-aa3d-7ac219b6f6c3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Each tablet contains 80\u00a0mg febuxostat.</span></p>", "ID": "a18bcea6-8b30-47e6-8c35-7727106e80fb", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Each tablet contains 80\u00a0mg febuxostat.</span>", "ID": "8bc7dad2-593f-4eaa-b807-814178d0aef6", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "Each tablet contains 80\u00a0mg febuxostat.", "ParentId": "a18bcea6-8b30-47e6-8c35-7727106e80fb"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "a722bc6a-9cc0-4dce-9023-c150e13d5822", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "2b3ddafc-2c99-4809-8ca1-e359c99e559f", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "a722bc6a-9cc0-4dce-9023-c150e13d5822"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "26aeac06-3fd7-4389-a24c-1eafbeb48a9e", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "d8ac11ce-2581-4e55-bda0-156fae4e08b4", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "26aeac06-3fd7-4389-a24c-1eafbeb48a9e"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST\nOF EXCIPIENTS</span></b></p>\n</div>", "ID": "d94ece01-c195-4ab1-a844-ead3489bbc16", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST\nOF EXCIPIENTS</span></b></p>", "ID": "0f5a6168-f946-4238-a1fd-5e2fc3fd8c66", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d94ece01-c195-4ab1-a844-ead3489bbc16"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST\nOF EXCIPIENTS</span></b>", "ID": "9054cadb-7fe2-4e62-ab1f-57cb513d811d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0f5a6168-f946-4238-a1fd-5e2fc3fd8c66"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST\nOF EXCIPIENTS</span>", "ID": "9c4ba355-8aee-4267-840c-98fae7511c6f", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST OF EXCIPIENTS", "ParentId": "9054cadb-7fe2-4e62-ab1f-57cb513d811d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "1141c99c-c581-4573-afb6-d4c6b77d87fb", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "6b78c879-bb14-4e30-996d-bf4a40bf48a3", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "1141c99c-c581-4573-afb6-d4c6b77d87fb"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Also contains lactose.</span></p>", "ID": "fc9944a6-9180-42a8-9bf9-de1745bf1836", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Also contains lactose.</span>", "ID": "65764cc8-4367-4043-a657-8a07ff4d2139", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Also contains lactose.", "ParentId": "fc9944a6-9180-42a8-9bf9-de1745bf1836"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>See leaflet for further information.</span></p>", "ID": "8b165690-be66-4db9-858c-5556bffb7827", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>See leaflet for further information.</span>", "ID": "07190d5a-94c3-46ae-b19c-e8fe7048136f", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "See leaflet for further information.", "ParentId": "8b165690-be66-4db9-858c-5556bffb7827"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "f4524ddb-36e7-4585-9a69-a7e60fca21d7", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "30238bfa-e44d-40b8-8206-76a633ed9f21", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "f4524ddb-36e7-4585-9a69-a7e60fca21d7"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "be139dc7-6a75-4629-b521-84a693448618", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "40b0b004-783a-481e-a5a9-955d6b46402f", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "be139dc7-6a75-4629-b521-84a693448618"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\nFORM AND CONTENTS</span></b></p>\n</div>", "ID": "e9defdc6-d1e5-46d7-9a87-63b7889eff1b", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\nFORM AND CONTENTS</span></b></p>", "ID": "4228b974-8b80-48ac-960e-a6797d48316e", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9defdc6-d1e5-46d7-9a87-63b7889eff1b"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\nFORM AND CONTENTS</span></b>", "ID": "76de6281-0b6d-4a83-af48-d378362176f7", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4228b974-8b80-48ac-960e-a6797d48316e"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\nFORM AND CONTENTS</span>", "ID": "af114e6c-3aa8-4a50-bb04-ea187355a1bc", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL FORM AND CONTENTS", "ParentId": "76de6281-0b6d-4a83-af48-d378362176f7"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "8af69c67-cad7-4d66-8444-d7288f4d361f", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "cb55778d-ab55-46f2-9691-bf604588022e", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "8af69c67-cad7-4d66-8444-d7288f4d361f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"DE\" style='font-family:\"Times New Roman\",serif;\nbackground:lightgrey;layout-grid-mode:line'>Film-coated tablets</span></p>", "ID": "3aa0a49c-9e3c-4346-99a7-e3ed4ccae403", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"DE\" style='font-family:\"Times New Roman\",serif;\nbackground:lightgrey;layout-grid-mode:line'>Film-coated tablets</span>", "ID": "07b4ea2b-bd9a-4bc4-9b77-19735502ca4a", "Styles": "font-family:\"Times New Roman\",serif;\nbackground:lightgrey;layout-grid-mode:line", "Classes": "None", "Text": "Film-coated tablets", "ParentId": "3aa0a49c-9e3c-4346-99a7-e3ed4ccae403"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "4855fc1d-6fee-4e8c-b798-c1a93f78efb8", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "b89a69ff-d99a-4c48-bec3-06813db91d7d", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "4855fc1d-6fee-4e8c-b798-c1a93f78efb8"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><i><span lang=\"DE\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey;layout-grid-mode:line'>[Blisters]</span></i></p>", "ID": "192cedb4-6807-40d7-8a0f-b26e189d8ead", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<i><span lang=\"DE\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey;layout-grid-mode:line'>[Blisters]</span></i>", "ID": "8c9aabd8-da44-42c8-939f-510e5b39cad2", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "192cedb4-6807-40d7-8a0f-b26e189d8ead"}, {"Element": "<span lang=\"DE\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey;layout-grid-mode:line'>[Blisters]</span>", "ID": "61a1c359-2271-47a3-a78d-30509b75e05f", "Styles": "font-family:\n\"Times New Roman\",serif;background:lightgrey;layout-grid-mode:line", "Classes": "None", "Text": "[Blisters]", "ParentId": "8c9aabd8-da44-42c8-939f-510e5b39cad2"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>14 film-coated tablets</span></p>", "ID": "d324e61c-69f2-4e25-b4d4-c13161df524e", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>14 film-coated tablets</span>", "ID": "934484f9-049d-4391-a713-1f699e514903", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "14 film-coated tablets", "ParentId": "d324e61c-69f2-4e25-b4d4-c13161df524e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"DE\" style='font-family:\"Times New Roman\",serif;\nbackground:lightgrey;layout-grid-mode:line'>28 film-coated tablets</span></p>", "ID": "4001a74d-c7c9-42e6-a97a-9000ed2c8b83", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"DE\" style='font-family:\"Times New Roman\",serif;\nbackground:lightgrey;layout-grid-mode:line'>28 film-coated tablets</span>", "ID": "19143b4c-5393-4ffc-8b03-e33ae7ab508d", "Styles": "font-family:\"Times New Roman\",serif;\nbackground:lightgrey;layout-grid-mode:line", "Classes": "None", "Text": "28 film-coated tablets", "ParentId": "4001a74d-c7c9-42e6-a97a-9000ed2c8b83"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"DE\" style='font-family:\"Times New Roman\",serif;\nbackground:lightgrey;layout-grid-mode:line'>42 film-coated tablets</span></p>", "ID": "cd0cac9a-7a5c-4a51-8076-369404e8af15", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"DE\" style='font-family:\"Times New Roman\",serif;\nbackground:lightgrey;layout-grid-mode:line'>42 film-coated tablets</span>", "ID": "c0f9370d-ba41-481e-9c44-1c19b7db5701", "Styles": "font-family:\"Times New Roman\",serif;\nbackground:lightgrey;layout-grid-mode:line", "Classes": "None", "Text": "42 film-coated tablets", "ParentId": "cd0cac9a-7a5c-4a51-8076-369404e8af15"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"DE\" style='font-family:\"Times New Roman\",serif;\nbackground:lightgrey;layout-grid-mode:line'>84 film-coated tablets</span></p>", "ID": "dc11a809-5459-4dd8-9402-b81a91a7f46c", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"DE\" style='font-family:\"Times New Roman\",serif;\nbackground:lightgrey;layout-grid-mode:line'>84 film-coated tablets</span>", "ID": "d1054bf8-88fb-4f86-a116-3353699a4b63", "Styles": "font-family:\"Times New Roman\",serif;\nbackground:lightgrey;layout-grid-mode:line", "Classes": "None", "Text": "84 film-coated tablets", "ParentId": "dc11a809-5459-4dd8-9402-b81a91a7f46c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"DE\" style='font-family:\"Times New Roman\",serif;\nbackground:lightgrey;layout-grid-mode:line'>28 x 1 film-coated tablets</span></p>", "ID": "0cca42f8-9bf2-48b3-8a3a-dfa266974ad9", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"DE\" style='font-family:\"Times New Roman\",serif;\nbackground:lightgrey;layout-grid-mode:line'>28 x 1 film-coated tablets</span>", "ID": "5cf60057-c4e9-48ee-b946-f7314d3cf559", "Styles": "font-family:\"Times New Roman\",serif;\nbackground:lightgrey;layout-grid-mode:line", "Classes": "None", "Text": "28 x 1 film-coated tablets", "ParentId": "0cca42f8-9bf2-48b3-8a3a-dfa266974ad9"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"DE\" style='font-family:\"Times New Roman\",serif;\nbackground:lightgrey;layout-grid-mode:line'>28 film-coated tablets (calendar)</span></p>", "ID": "a7ae991f-4ae7-4506-9804-da3533af11da", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"DE\" style='font-family:\"Times New Roman\",serif;\nbackground:lightgrey;layout-grid-mode:line'>28 film-coated tablets (calendar)</span>", "ID": "fd939804-832c-4569-9525-252f7617f294", "Styles": "font-family:\"Times New Roman\",serif;\nbackground:lightgrey;layout-grid-mode:line", "Classes": "None", "Text": "28 film-coated tablets (calendar)", "ParentId": "a7ae991f-4ae7-4506-9804-da3533af11da"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"DE\" style='font-family:\"Times New Roman\",serif;\nbackground:lightgrey;layout-grid-mode:line'>84 film-coated tablets (calendar)</span></p>", "ID": "fd0462e1-388e-48a7-b02d-ee9d78270d3c", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"DE\" style='font-family:\"Times New Roman\",serif;\nbackground:lightgrey;layout-grid-mode:line'>84 film-coated tablets (calendar)</span>", "ID": "b948cd09-4965-4259-8eac-ddb7daa2bbbb", "Styles": "font-family:\"Times New Roman\",serif;\nbackground:lightgrey;layout-grid-mode:line", "Classes": "None", "Text": "84 film-coated tablets (calendar)", "ParentId": "fd0462e1-388e-48a7-b02d-ee9d78270d3c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"DE\" style='font-family:\"Times New Roman\",serif;\nlayout-grid-mode:line'>\u00a0</span></p>", "ID": "cbef1fa2-f9ce-46da-aecc-c91107ced5ad", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"DE\" style='font-family:\"Times New Roman\",serif;\nlayout-grid-mode:line'>\u00a0</span>", "ID": "c8086e7b-0580-42d8-b295-af97637ff404", "Styles": "font-family:\"Times New Roman\",serif;\nlayout-grid-mode:line", "Classes": "None", "Text": "\u00a0", "ParentId": "cbef1fa2-f9ce-46da-aecc-c91107ced5ad"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><i><span lang=\"DE\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey;layout-grid-mode:line'>[Bottles]</span></i></p>", "ID": "f7820061-c789-4657-9782-904ab80840e3", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<i><span lang=\"DE\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey;layout-grid-mode:line'>[Bottles]</span></i>", "ID": "53094b98-8552-418c-9d52-0aaddf79bf66", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f7820061-c789-4657-9782-904ab80840e3"}, {"Element": "<span lang=\"DE\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey;layout-grid-mode:line'>[Bottles]</span>", "ID": "46a413c2-b322-45e8-b183-bf2d35dc6f29", "Styles": "font-family:\n\"Times New Roman\",serif;background:lightgrey;layout-grid-mode:line", "Classes": "None", "Text": "[Bottles]", "ParentId": "53094b98-8552-418c-9d52-0aaddf79bf66"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"DE\" style='font-family:\"Times New Roman\",serif;\nbackground:lightgrey;layout-grid-mode:line'>28 film-coated tablets </span></p>", "ID": "61e69d12-d58c-4178-8a3e-c4fcf64f903d", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"DE\" style='font-family:\"Times New Roman\",serif;\nbackground:lightgrey;layout-grid-mode:line'>28 film-coated tablets </span>", "ID": "a324bb40-91b8-453f-a2ac-efc20bda6d40", "Styles": "font-family:\"Times New Roman\",serif;\nbackground:lightgrey;layout-grid-mode:line", "Classes": "None", "Text": "28 film-coated tablets ", "ParentId": "61e69d12-d58c-4178-8a3e-c4fcf64f903d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"DE\" style='font-family:\"Times New Roman\",serif;\nbackground:lightgrey;layout-grid-mode:line'>84 film-coated tablets </span></p>", "ID": "06ef53fa-6da1-4899-aee0-2eb0e1fcc45e", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"DE\" style='font-family:\"Times New Roman\",serif;\nbackground:lightgrey;layout-grid-mode:line'>84 film-coated tablets </span>", "ID": "edadce67-cb5c-4938-ba59-fc69307d9af2", "Styles": "font-family:\"Times New Roman\",serif;\nbackground:lightgrey;layout-grid-mode:line", "Classes": "None", "Text": "84 film-coated tablets ", "ParentId": "06ef53fa-6da1-4899-aee0-2eb0e1fcc45e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "55a44d9c-90ea-428b-91e6-0f4c104d2ff3", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "ea0a2105-b88f-4953-985f-08d44e8195d0", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "55a44d9c-90ea-428b-91e6-0f4c104d2ff3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "066ff357-5bcf-4b78-a977-df9a22925dd6", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "9708695a-56d4-4f0a-9391-815d5fd6f41b", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "066ff357-5bcf-4b78-a977-df9a22925dd6"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD\nAND ROUTE(S) OF ADMINISTRATION</span></b></p>\n</div>", "ID": "4380bba9-6128-499b-b07f-1a8f2430f1e0", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD\nAND ROUTE(S) OF ADMINISTRATION</span></b></p>", "ID": "7b54fb9d-44c2-48e9-9530-c46423378fce", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "4380bba9-6128-499b-b07f-1a8f2430f1e0"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD\nAND ROUTE(S) OF ADMINISTRATION</span></b>", "ID": "3d76a945-e499-4049-94fa-9167ee3cd006", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "7b54fb9d-44c2-48e9-9530-c46423378fce"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD\nAND ROUTE(S) OF ADMINISTRATION</span>", "ID": "1ad2b64d-69be-4625-8c6f-4e65290a8eaf", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD AND ROUTE(S) OF ADMINISTRATION", "ParentId": "3d76a945-e499-4049-94fa-9167ee3cd006"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "91f7426c-1e7d-4acd-bb37-ef48ccb4dafb", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "3f461144-1ad0-4160-a085-f8b8e848bdb7", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "91f7426c-1e7d-4acd-bb37-ef48ccb4dafb"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>For oral use.</span></p>", "ID": "04a72973-55fa-4301-bc0e-cad2eb954e4b", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>For oral use.</span>", "ID": "51ef6ed2-ff9a-4ab1-a08c-0505e7ea263c", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "For oral use.", "ParentId": "04a72973-55fa-4301-bc0e-cad2eb954e4b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Read the package leaflet before use.</span></p>", "ID": "c71b6f93-166c-4b87-9a1d-a7106e7749e0", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Read the package leaflet before use.</span>", "ID": "656e35ab-a3ed-48e6-85d1-6f7147941fb7", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "Read the package leaflet before use.", "ParentId": "c71b6f93-166c-4b87-9a1d-a7106e7749e0"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "6d8fec6f-85d0-4c07-8129-66d015cc3e60", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "08248a15-c278-45a0-8b73-1cd15be91502", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "6d8fec6f-85d0-4c07-8129-66d015cc3e60"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "264c99b8-1f17-4da6-9ba9-1ec3890e2791", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "5cf387a6-97ec-4ea9-b158-e24a8eaeea11", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "264c99b8-1f17-4da6-9ba9-1ec3890e2791"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nWARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF\nCHILDREN</span></b></p>\n</div>", "ID": "566c1682-5aef-46a7-901c-f0c421db5888", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nWARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF\nCHILDREN</span></b></p>", "ID": "63bee49c-4d98-4132-b68b-994bd78a6fb4", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "566c1682-5aef-46a7-901c-f0c421db5888"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nWARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF\nCHILDREN</span></b>", "ID": "19aeeacc-3dba-4541-961f-26c6cee96324", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "63bee49c-4d98-4132-b68b-994bd78a6fb4"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nWARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF\nCHILDREN</span>", "ID": "345eb706-35cb-4a23-8bd9-e67d2e490afa", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN", "ParentId": "19aeeacc-3dba-4541-961f-26c6cee96324"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "01b6dc97-7053-4855-8044-61d9f14ffa1d", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "419ee131-ac84-4c59-b361-d72f5c250d17", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "01b6dc97-7053-4855-8044-61d9f14ffa1d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Keep out of the sight and reach of children.</span></p>", "ID": "f04d237b-4bd8-4354-8db7-08eca6425abb", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Keep out of the sight and reach of children.</span>", "ID": "9cddd6be-3556-4470-be56-e174e611a55f", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "Keep out of the sight and reach of children.", "ParentId": "f04d237b-4bd8-4354-8db7-08eca6425abb"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "f2f40a06-b4c6-43f4-acae-4903d8a5633d", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "843c6961-41f0-464a-92f7-2d0d4643d869", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "f2f40a06-b4c6-43f4-acae-4903d8a5633d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "e3def348-8697-40cf-a61d-cfd83ccf5e82", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "ad5b5435-8ead-477a-bd5d-d726047cd5dc", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "e3def348-8697-40cf-a61d-cfd83ccf5e82"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER\nSPECIAL WARNING(S), IF NECESSARY</span></b></p>\n</div>", "ID": "746f2050-2b9f-4f40-86a2-a5eb977f1451", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER\nSPECIAL WARNING(S), IF NECESSARY</span></b></p>", "ID": "56fa316a-3a1b-4ab9-9b2f-c3d2fdc8f95b", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "746f2050-2b9f-4f40-86a2-a5eb977f1451"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER\nSPECIAL WARNING(S), IF NECESSARY</span></b>", "ID": "0d5a3b73-7f78-41a1-ae40-c6fa710131c5", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "56fa316a-3a1b-4ab9-9b2f-c3d2fdc8f95b"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER\nSPECIAL WARNING(S), IF NECESSARY</span>", "ID": "59035b83-2a5a-4277-8f00-bdd059eeef3e", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER SPECIAL WARNING(S), IF NECESSARY", "ParentId": "0d5a3b73-7f78-41a1-ae40-c6fa710131c5"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "3f22a580-0bfd-4832-a0c1-143070b64421", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "35f7afba-6700-4150-aa9b-6e960990d3df", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "3f22a580-0bfd-4832-a0c1-143070b64421"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "47d44178-0768-43fc-8a4b-32585a989d89", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "7e98ad06-740d-48b0-8553-4ee4f5be523e", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "47d44178-0768-43fc-8a4b-32585a989d89"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "1690c8b7-f60e-4a30-890f-05a1e41ce632", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "cf2eb355-a59d-4fd0-8291-1f2a411ba09c", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "1690c8b7-f60e-4a30-890f-05a1e41ce632"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY\nDATE</span></b></p>\n</div>", "ID": "0a293220-a3d8-4b09-a628-c70b375cd3ae", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY\nDATE</span></b></p>", "ID": "c7cc13dd-19b4-4939-871b-15b15cd23d10", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0a293220-a3d8-4b09-a628-c70b375cd3ae"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY\nDATE</span></b>", "ID": "fa58a04c-d283-43a4-8ecb-f072b5cf91bf", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c7cc13dd-19b4-4939-871b-15b15cd23d10"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY\nDATE</span>", "ID": "8a41edc9-0f22-483e-8444-e26c2e3323b3", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE", "ParentId": "fa58a04c-d283-43a4-8ecb-f072b5cf91bf"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "fd975db1-08ec-488a-8355-b1c63f6f667f", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "c698b523-85f6-4549-9f4a-1b063b988066", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "fd975db1-08ec-488a-8355-b1c63f6f667f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>EXP</span></p>", "ID": "87d669d7-a81c-42d1-bf64-e8d2a92b0765", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>EXP</span>", "ID": "16db1887-8363-404a-bb47-a7cf238b99e3", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "EXP", "ParentId": "87d669d7-a81c-42d1-bf64-e8d2a92b0765"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey'>For bottles:</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'> After first opening use\nwithin 180 days</span></p>", "ID": "b6fb92e9-2094-4b79-a9b9-1dbd3f8cb948", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey'>For bottles:</span>", "ID": "eceab5a0-1d1e-4df3-90cb-50b689a5dd7a", "Styles": "font-family:\n\"Times New Roman\",serif;background:lightgrey", "Classes": "None", "Text": "For bottles:", "ParentId": "b6fb92e9-2094-4b79-a9b9-1dbd3f8cb948"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'> After first opening use\nwithin 180 days</span>", "ID": "8c01c4ec-1c4f-4d3f-9cd4-9876af2c1fdc", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": " After first opening use within 180 days", "ParentId": "b6fb92e9-2094-4b79-a9b9-1dbd3f8cb948"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "c7926d22-2985-48ae-8bc2-fa1a2a78c677", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "5de1c5b6-d872-4b61-ab3d-27f8742ce28d", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "c7926d22-2985-48ae-8bc2-fa1a2a78c677"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "7ee72190-5763-475e-82c1-beb54422c41b", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "fb71bf91-2df0-4669-b30c-d2957557d8c2", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "7ee72190-5763-475e-82c1-beb54422c41b"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;page-break-after:\navoid;border:none;padding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span></b></p>\n</div>", "ID": "7afb8269-c5c5-4b7f-a346-a941f7b60e60", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;page-break-after:\navoid;border:none;padding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span></b></p>", "ID": "b95859f5-796e-4866-84aa-b6b9659f05b4", "Styles": "margin-bottom:0in;line-height:normal;page-break-after:\navoid;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "7afb8269-c5c5-4b7f-a346-a941f7b60e60"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span></b>", "ID": "1e742d4c-ec7f-4a4c-917d-c2926f14fa04", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b95859f5-796e-4866-84aa-b6b9659f05b4"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span>", "ID": "940035bd-34f6-40bf-a734-aabb6d79532d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL STORAGE CONDITIONS", "ParentId": "1e742d4c-ec7f-4a4c-917d-c2926f14fa04"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "4c19c850-771d-43d4-bb50-0ab4303f66cb", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "d11436d1-9540-4d11-8a48-49e5c5763ea4", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "4c19c850-771d-43d4-bb50-0ab4303f66cb"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "0eab54e1-a67d-43a8-98cf-4c857076c020", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "04a72938-c47b-4ecb-a3a8-c595fbbab422", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "0eab54e1-a67d-43a8-98cf-4c857076c020"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "ba3a07a6-a88e-427c-9d81-c6f846d0e8d4", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "b412fbd3-a65a-458a-ad48-20cdd28935cc", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "ba3a07a6-a88e-427c-9d81-c6f846d0e8d4"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>10.\u00a0\u00a0\u00a0\u00a0 SPECIAL\nPRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS\nDERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE</span></b></p>\n</div>", "ID": "8288a712-2007-4a39-b2ce-33b5f7b0a0b4", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>10.\u00a0\u00a0\u00a0\u00a0 SPECIAL\nPRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS\nDERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE</span></b></p>", "ID": "1b80b046-4710-4481-8673-adb57e5467ff", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "8288a712-2007-4a39-b2ce-33b5f7b0a0b4"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>10.\u00a0\u00a0\u00a0\u00a0 SPECIAL\nPRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS\nDERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE</span></b>", "ID": "85d93ded-e1f7-4849-bca3-27259446b332", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "1b80b046-4710-4481-8673-adb57e5467ff"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>10.\u00a0\u00a0\u00a0\u00a0 SPECIAL\nPRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS\nDERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE</span>", "ID": "7ba3dc47-24d1-43a7-87a2-7d413f91deac", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "10.\u00a0\u00a0\u00a0\u00a0 SPECIAL PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE", "ParentId": "85d93ded-e1f7-4849-bca3-27259446b332"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "22008cb6-d345-429c-8c78-651b5a284ee6", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "a4b5e3e5-a3dc-4cb9-a531-38138e823eed", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "22008cb6-d345-429c-8c78-651b5a284ee6"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "32c558c3-6acf-4aae-bdfc-11794c94ea61", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "a17e73b8-c564-4e52-9d8a-c9c86394b8fa", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "32c558c3-6acf-4aae-bdfc-11794c94ea61"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "ca5e6d03-d9a1-4472-a4e9-732967a9c04b", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "33d55c01-0ef9-448e-844c-b2d7b504c148", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "ca5e6d03-d9a1-4472-a4e9-732967a9c04b"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>11.\u00a0\u00a0\u00a0\u00a0 NAME\nAND ADDRESS OF THE MARKETING AUTHORISATION HOLDER</span></b></p>\n</div>", "ID": "3babdb1e-91ed-49d6-bca0-ec648f7ffa6e", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>11.\u00a0\u00a0\u00a0\u00a0 NAME\nAND ADDRESS OF THE MARKETING AUTHORISATION HOLDER</span></b></p>", "ID": "c76987b5-0c7d-4f90-9074-e17559a133c3", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3babdb1e-91ed-49d6-bca0-ec648f7ffa6e"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>11.\u00a0\u00a0\u00a0\u00a0 NAME\nAND ADDRESS OF THE MARKETING AUTHORISATION HOLDER</span></b>", "ID": "0a3e4c77-367c-4493-ae06-cfeb02f18565", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c76987b5-0c7d-4f90-9074-e17559a133c3"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>11.\u00a0\u00a0\u00a0\u00a0 NAME\nAND ADDRESS OF THE MARKETING AUTHORISATION HOLDER</span>", "ID": "7c0affac-ff4c-4573-a9bc-71d8bf5aa4e4", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "11.\u00a0\u00a0\u00a0\u00a0 NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER", "ParentId": "0a3e4c77-367c-4493-ae06-cfeb02f18565"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "cfa641b4-c8a8-4570-b638-aa4090ff7253", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "dc350b22-fabb-4025-9efd-f6277b8c691b", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "cfa641b4-c8a8-4570-b638-aa4090ff7253"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"DE-AT\" style='font-family:\n\"Times New Roman\",serif'>Mylan S.A.S.</span></p>", "ID": "8ca55d02-6398-47fc-a033-70870e21053c", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"DE-AT\" style='font-family:\n\"Times New Roman\",serif'>Mylan S.A.S.</span>", "ID": "db7aeaa1-eb16-4af1-88d4-13074ca9979f", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "Mylan S.A.S.", "ParentId": "8ca55d02-6398-47fc-a033-70870e21053c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"DE-AT\" style='font-family:\n\"Times New Roman\",serif'>117 Allee des Parcs</span></p>", "ID": "91ac58bb-a562-4865-adab-8a374fd1a417", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"DE-AT\" style='font-family:\n\"Times New Roman\",serif'>117 Allee des Parcs</span>", "ID": "7e5115b1-fea4-431b-95d8-4923faeadb44", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "117 Allee des Parcs", "ParentId": "91ac58bb-a562-4865-adab-8a374fd1a417"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>69 800 Saint Priest</span></p>", "ID": "ce3e7336-56da-413a-9c3e-f3ef57d27f3f", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>69 800 Saint Priest</span>", "ID": "d4517b08-bc6a-4b36-998b-174b0e46a3e5", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "69 800 Saint Priest", "ParentId": "ce3e7336-56da-413a-9c3e-f3ef57d27f3f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>France</span></p>", "ID": "53c3a291-5308-435b-b7aa-8b0cfc6340f6", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>France</span>", "ID": "a613f3c4-5043-464d-910a-c15d23f1e0dd", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "France", "ParentId": "53c3a291-5308-435b-b7aa-8b0cfc6340f6"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "b740d035-67c0-4abb-9122-034e268b555e", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "320dcdcc-f282-4e46-bea3-a72d6ce93938", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "b740d035-67c0-4abb-9122-034e268b555e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "e050f2f2-f02e-436f-8286-2b5fb4374ccd", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "c8a5165a-39a5-48cf-85dc-4065c7f0cccc", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "e050f2f2-f02e-436f-8286-2b5fb4374ccd"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>12.\u00a0\u00a0\u00a0\u00a0 MARKETING\nAUTHORISATION NUMBER(S) </span></b></p>\n</div>", "ID": "35bd8afc-a046-4f42-9c18-79905e869b0a", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>12.\u00a0\u00a0\u00a0\u00a0 MARKETING\nAUTHORISATION NUMBER(S) </span></b></p>", "ID": "639ec8ea-5bfe-4a19-9773-155672767845", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "35bd8afc-a046-4f42-9c18-79905e869b0a"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>12.\u00a0\u00a0\u00a0\u00a0 MARKETING\nAUTHORISATION NUMBER(S) </span></b>", "ID": "084f504e-2d47-4f25-9659-2b6dfc9f7e68", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "639ec8ea-5bfe-4a19-9773-155672767845"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>12.\u00a0\u00a0\u00a0\u00a0 MARKETING\nAUTHORISATION NUMBER(S) </span>", "ID": "8f90b676-a21d-4a67-9ac5-e20bf038533b", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "12.\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION NUMBER(S) ", "ParentId": "084f504e-2d47-4f25-9659-2b6dfc9f7e68"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "0bba56ef-5595-4e6c-b311-cbfb15769736", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "82dd3da5-123f-4bf9-a00d-544aaba81556", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "0bba56ef-5595-4e6c-b311-cbfb15769736"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>EU/1/17/1194/001</span></p>", "ID": "6ddc9676-2a6b-4cb4-964c-dba82def4697", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>EU/1/17/1194/001</span>", "ID": "51d6f99d-82ae-484f-a272-bd02d872d2c4", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "EU/1/17/1194/001", "ParentId": "6ddc9676-2a6b-4cb4-964c-dba82def4697"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey'>EU/1/17/1194/002</span></p>", "ID": "43b4fa41-441c-45ca-bf61-faf60b5e7356", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey'>EU/1/17/1194/002</span>", "ID": "eaf301d6-c9a6-4a41-9821-1260da6d1539", "Styles": "font-family:\n\"Times New Roman\",serif;background:lightgrey", "Classes": "None", "Text": "EU/1/17/1194/002", "ParentId": "43b4fa41-441c-45ca-bf61-faf60b5e7356"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey'>EU/1/17/1194/003</span></p>", "ID": "8cbc0cf5-3b2e-4e6f-b58f-a45a4f34f23e", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey'>EU/1/17/1194/003</span>", "ID": "7940144d-45a8-4daa-993c-5d05f5f465ab", "Styles": "font-family:\n\"Times New Roman\",serif;background:lightgrey", "Classes": "None", "Text": "EU/1/17/1194/003", "ParentId": "8cbc0cf5-3b2e-4e6f-b58f-a45a4f34f23e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey'>EU/1/17/1194/004</span></p>", "ID": "624e1f34-8a4c-4a14-8e51-9ab306c44f30", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey'>EU/1/17/1194/004</span>", "ID": "0b662906-3c12-491c-ae6e-afa266918eb5", "Styles": "font-family:\n\"Times New Roman\",serif;background:lightgrey", "Classes": "None", "Text": "EU/1/17/1194/004", "ParentId": "624e1f34-8a4c-4a14-8e51-9ab306c44f30"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey'>EU/1/17/1194/005</span></p>", "ID": "1dcf41a5-041c-4708-ad9a-d3c0965f74d3", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey'>EU/1/17/1194/005</span>", "ID": "43f9e7d5-e67d-4ed1-8bf7-834129b99ef9", "Styles": "font-family:\n\"Times New Roman\",serif;background:lightgrey", "Classes": "None", "Text": "EU/1/17/1194/005", "ParentId": "1dcf41a5-041c-4708-ad9a-d3c0965f74d3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey'>EU/1/17/1194/006</span></p>", "ID": "0e1eef62-fb4e-48f2-ab79-e5b76c625895", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey'>EU/1/17/1194/006</span>", "ID": "6374881e-5fd4-4046-a0a7-3fb4612729a5", "Styles": "font-family:\n\"Times New Roman\",serif;background:lightgrey", "Classes": "None", "Text": "EU/1/17/1194/006", "ParentId": "0e1eef62-fb4e-48f2-ab79-e5b76c625895"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey'>EU/1/17/1194/007</span></p>", "ID": "7fa98e66-eacd-4998-a18a-2e2c0e100352", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey'>EU/1/17/1194/007</span>", "ID": "e64c28be-1577-4d6a-a7ff-1991864a473e", "Styles": "font-family:\n\"Times New Roman\",serif;background:lightgrey", "Classes": "None", "Text": "EU/1/17/1194/007", "ParentId": "7fa98e66-eacd-4998-a18a-2e2c0e100352"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey'>EU/1/17/1194/008</span></p>", "ID": "ec020645-d691-4a4c-b24b-ab18d68671f5", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey'>EU/1/17/1194/008</span>", "ID": "c9956d21-f7bf-4351-8eb1-c0cd574799cc", "Styles": "font-family:\n\"Times New Roman\",serif;background:lightgrey", "Classes": "None", "Text": "EU/1/17/1194/008", "ParentId": "ec020645-d691-4a4c-b24b-ab18d68671f5"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;background:lightgrey'>EU/1/17/1194/017</span></p>", "ID": "658bf8a2-2bbd-476d-9c88-f92b461e75c9", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;background:lightgrey'>EU/1/17/1194/017</span>", "ID": "c39e76b0-11df-4c84-b468-5aab022c30a2", "Styles": "font-family:\"Times New Roman\",serif;background:lightgrey", "Classes": "None", "Text": "EU/1/17/1194/017", "ParentId": "658bf8a2-2bbd-476d-9c88-f92b461e75c9"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;background:lightgrey'>EU/1/17/1194/018</span></p>", "ID": "73845564-0c9b-416e-9cc9-9e6c887ad081", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;background:lightgrey'>EU/1/17/1194/018</span>", "ID": "b49af4f7-f971-4118-9c91-f24cf719db27", "Styles": "font-family:\"Times New Roman\",serif;background:lightgrey", "Classes": "None", "Text": "EU/1/17/1194/018", "ParentId": "73845564-0c9b-416e-9cc9-9e6c887ad081"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;background:lightgrey'>EU/1/17/1194/019</span></p>", "ID": "487dd0a0-2b2f-40b3-877e-85cfe11f3c0b", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;background:lightgrey'>EU/1/17/1194/019</span>", "ID": "9e14357f-c5c9-44f0-8150-b557f9049d61", "Styles": "font-family:\"Times New Roman\",serif;background:lightgrey", "Classes": "None", "Text": "EU/1/17/1194/019", "ParentId": "487dd0a0-2b2f-40b3-877e-85cfe11f3c0b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;background:lightgrey'>EU/1/17/1194/020</span></p>", "ID": "0325c32a-e15c-4f3c-a6ec-dfc3b4f088a5", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;background:lightgrey'>EU/1/17/1194/020</span>", "ID": "5bba313a-5390-46bf-876d-ec6cf6821e31", "Styles": "font-family:\"Times New Roman\",serif;background:lightgrey", "Classes": "None", "Text": "EU/1/17/1194/020", "ParentId": "0325c32a-e15c-4f3c-a6ec-dfc3b4f088a5"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;background:lightgrey'>EU/1/17/1194/021</span></p>", "ID": "2db94f0d-61d8-4cb1-b192-9e88a1b9a1bd", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;background:lightgrey'>EU/1/17/1194/021</span>", "ID": "1a458733-e667-47c8-b163-c8b22ad9ae09", "Styles": "font-family:\"Times New Roman\",serif;background:lightgrey", "Classes": "None", "Text": "EU/1/17/1194/021", "ParentId": "2db94f0d-61d8-4cb1-b192-9e88a1b9a1bd"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "68ae313b-3e85-428a-af10-8bfa036ea9ee", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "7629e41d-df37-4a55-bf86-84f900ebcffc", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "68ae313b-3e85-428a-af10-8bfa036ea9ee"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "fa9b1eff-6ab1-40fb-8b42-a751e6a06e73", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "a4d49c3e-4e21-4383-b2f4-021f44ef6044", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "fa9b1eff-6ab1-40fb-8b42-a751e6a06e73"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>13.\u00a0\u00a0\u00a0\u00a0 BATCH\nNUMBER</span></b></p>\n</div>", "ID": "409c768f-fc8f-4562-977f-ad9af9359182", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>13.\u00a0\u00a0\u00a0\u00a0 BATCH\nNUMBER</span></b></p>", "ID": "be5ad996-bd59-4085-9771-3a436aa7bfa8", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "409c768f-fc8f-4562-977f-ad9af9359182"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>13.\u00a0\u00a0\u00a0\u00a0 BATCH\nNUMBER</span></b>", "ID": "cd795e0f-8f36-467c-aec5-a24cdf66bd9b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "be5ad996-bd59-4085-9771-3a436aa7bfa8"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>13.\u00a0\u00a0\u00a0\u00a0 BATCH\nNUMBER</span>", "ID": "63eb0f85-9ae6-4ee9-8623-317b923c0264", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "13.\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER", "ParentId": "cd795e0f-8f36-467c-aec5-a24cdf66bd9b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><i><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></i></p>", "ID": "64e9e66c-7a12-4bee-9a7b-e7b8c2228bf0", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<i><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></i>", "ID": "c2134681-2e1d-49a0-a665-6d153a53ca7b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "64e9e66c-7a12-4bee-9a7b-e7b8c2228bf0"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "23a1ea07-9399-4504-bf4f-7089637be0fe", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "c2134681-2e1d-49a0-a665-6d153a53ca7b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Lot</span></p>", "ID": "c2664cf8-45e5-4746-a04d-aa63b63e2651", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Lot</span>", "ID": "8b05bdfc-ddc1-42d9-bba7-99efa0860b27", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "Lot", "ParentId": "c2664cf8-45e5-4746-a04d-aa63b63e2651"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "f71541a4-6b83-48e8-97ed-8e5e68d19635", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "6026a96d-6603-437b-8d83-1a595f3f7cca", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "f71541a4-6b83-48e8-97ed-8e5e68d19635"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "e9fbdb68-f473-4004-877e-f22349f67f15", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "dd11dc89-75a7-4c73-85fc-78e5b4c1568a", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "e9fbdb68-f473-4004-877e-f22349f67f15"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>14.\u00a0\u00a0\u00a0\u00a0 GENERAL\nCLASSIFICATION FOR SUPPLY</span></b></p>\n</div>", "ID": "6d4736f4-a960-46e1-a3e2-8646f38d67f1", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>14.\u00a0\u00a0\u00a0\u00a0 GENERAL\nCLASSIFICATION FOR SUPPLY</span></b></p>", "ID": "43b49a07-b09f-4c00-89e3-8182433a161e", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "6d4736f4-a960-46e1-a3e2-8646f38d67f1"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>14.\u00a0\u00a0\u00a0\u00a0 GENERAL\nCLASSIFICATION FOR SUPPLY</span></b>", "ID": "be2f5d4c-e6a4-4937-99b9-b5815bffe563", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "43b49a07-b09f-4c00-89e3-8182433a161e"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>14.\u00a0\u00a0\u00a0\u00a0 GENERAL\nCLASSIFICATION FOR SUPPLY</span>", "ID": "febef5de-94e7-4636-ba16-6b46a5ad0468", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "14.\u00a0\u00a0\u00a0\u00a0 GENERAL CLASSIFICATION FOR SUPPLY", "ParentId": "be2f5d4c-e6a4-4937-99b9-b5815bffe563"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><i><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></i></p>", "ID": "3ca21fda-2bf3-4ead-b2ea-9e88c5011ed4", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<i><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></i>", "ID": "433c0a30-67a8-43c7-9d3e-a7dec95b0aa9", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "3ca21fda-2bf3-4ead-b2ea-9e88c5011ed4"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "e70afdb5-c3ef-4ab8-9ff5-55316cbf8326", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "433c0a30-67a8-43c7-9d3e-a7dec95b0aa9"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "16afb6a6-fb11-42c3-b89b-41df3c33115f", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "eb5c0a15-6886-49f6-bd37-c22219b31afd", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "16afb6a6-fb11-42c3-b89b-41df3c33115f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "e47f25a1-967b-4010-8397-a58c3ab973cd", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "87266afa-1ede-4d68-8932-3853041296f0", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "e47f25a1-967b-4010-8397-a58c3ab973cd"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:2.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS\nON USE</span></b></p>\n</div>", "ID": "a7b2ceb8-1aef-4b78-99c0-60ee9367351f", "Styles": "border:solid windowtext 1.0pt;padding:2.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS\nON USE</span></b></p>", "ID": "21cd386f-e3a0-49bf-9097-133947ac8c37", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a7b2ceb8-1aef-4b78-99c0-60ee9367351f"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS\nON USE</span></b>", "ID": "d7298fcf-de6e-4b43-a712-e0a864dce2c3", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "21cd386f-e3a0-49bf-9097-133947ac8c37"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS\nON USE</span>", "ID": "caf48c7e-dce6-46b2-94ab-706f04b4fc22", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS ON USE", "ParentId": "d7298fcf-de6e-4b43-a712-e0a864dce2c3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "88830b70-89ef-485b-b596-2ee3334cb37d", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "4765a6ec-f0f4-46e4-a805-4c035325a60b", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "88830b70-89ef-485b-b596-2ee3334cb37d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "a7a321bd-ad40-4671-9b99-314478f2f616", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "6083372e-742e-4eeb-9426-6d91293d9365", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "a7a321bd-ad40-4671-9b99-314478f2f616"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "2f5d252c-ed2f-4e58-8d8f-84b3d1f23412", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "be5d96a3-4fd8-41c7-888a-c1e7737e4ce3", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "2f5d252c-ed2f-4e58-8d8f-84b3d1f23412"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>16.\u00a0\u00a0\u00a0\u00a0 INFORMATION\nIN BRAILLE</span></b></p>\n</div>", "ID": "aedc3c16-2b41-4132-8c8b-877a1574b0b0", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>16.\u00a0\u00a0\u00a0\u00a0 INFORMATION\nIN BRAILLE</span></b></p>", "ID": "9eea299c-feb1-451a-9419-344f80cf7f17", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "aedc3c16-2b41-4132-8c8b-877a1574b0b0"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>16.\u00a0\u00a0\u00a0\u00a0 INFORMATION\nIN BRAILLE</span></b>", "ID": "669f8bf7-1206-4ed7-9761-300362ce1cea", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9eea299c-feb1-451a-9419-344f80cf7f17"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>16.\u00a0\u00a0\u00a0\u00a0 INFORMATION\nIN BRAILLE</span>", "ID": "56d96635-6fe4-4890-9d5c-5b50203b330a", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "16.\u00a0\u00a0\u00a0\u00a0 INFORMATION IN BRAILLE", "ParentId": "669f8bf7-1206-4ed7-9761-300362ce1cea"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "622b15db-0fd5-4c2d-b945-d55aad30beba", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "4bc908b5-25c9-4f34-8241-04aee964c127", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "622b15db-0fd5-4c2d-b945-d55aad30beba"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Febuxostat Mylan 80\u00a0mg</span></p>", "ID": "bf01b08a-498e-47e7-8d82-0771615ff849", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Febuxostat Mylan 80\u00a0mg</span>", "ID": "e1df3781-ed2b-45f0-955e-77b1a7cc9dd1", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "Febuxostat Mylan 80\u00a0mg", "ParentId": "bf01b08a-498e-47e7-8d82-0771615ff849"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:#CCCCCC'>\u00a0</span></p>", "ID": "e5e5c8af-8ba1-4d95-b6c5-c06f4bf37b5c", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:#CCCCCC'>\u00a0</span>", "ID": "2aefce72-067e-4c8f-9304-d9a8860d5e7c", "Styles": "font-family:\n\"Times New Roman\",serif;background:#CCCCCC", "Classes": "None", "Text": "\u00a0", "ParentId": "e5e5c8af-8ba1-4d95-b6c5-c06f4bf37b5c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:#CCCCCC'>\u00a0</span></p>", "ID": "5970a367-2844-4ac9-af60-13de22f427ef", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:#CCCCCC'>\u00a0</span>", "ID": "c61fc6b2-46db-4ed8-acde-686b20b923b3", "Styles": "font-family:\n\"Times New Roman\",serif;background:#CCCCCC", "Classes": "None", "Text": "\u00a0", "ParentId": "5970a367-2844-4ac9-af60-13de22f427ef"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>17.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 2D BARCODE</span></b></p>\n</div>", "ID": "a1975747-87a0-49f3-a602-544d298a97f7", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>17.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 2D BARCODE</span></b></p>", "ID": "8737dbf2-b8ce-41cf-a9e5-35509360914e", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a1975747-87a0-49f3-a602-544d298a97f7"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>17.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 2D BARCODE</span></b>", "ID": "3dc44bbb-03b2-459e-906a-9eacadb89b00", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "8737dbf2-b8ce-41cf-a9e5-35509360914e"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>17.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 2D BARCODE</span>", "ID": "a45905c7-9c6d-4f2c-9a7a-38bccf6aeb22", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "17.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE IDENTIFIER \u2013 2D BARCODE", "ParentId": "3dc44bbb-03b2-459e-906a-9eacadb89b00"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "ab7c32cd-e5be-47cd-ae40-991fc81aa40d", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "ccdff377-5c05-4f3a-b5b6-1708aa9bb904", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "ab7c32cd-e5be-47cd-ae40-991fc81aa40d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC'>2D barcode carrying the\nunique identifier included.</span></p>", "ID": "0c4a68c0-72ce-4374-80f4-b37735fb1b16", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC'>2D barcode carrying the\nunique identifier included.</span>", "ID": "c5c7bce0-c0ac-4c1e-94f1-00eaaf627f5e", "Styles": "font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC", "Classes": "None", "Text": "2D barcode carrying the unique identifier included.", "ParentId": "0c4a68c0-72ce-4374-80f4-b37735fb1b16"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "ee705f23-2ffb-4283-9e84-62a52102b45d", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "eef5fd1a-2b7c-4e90-81df-eb4ae91d5cf1", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "ee705f23-2ffb-4283-9e84-62a52102b45d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "4c253c11-ed0f-4fb8-b18a-b7f8a763c423", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "897eb4ef-92d0-4ef6-80d7-f8359cf639df", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "4c253c11-ed0f-4fb8-b18a-b7f8a763c423"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>18.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 HUMAN READABLE DATA</span></b></p>\n</div>", "ID": "02095269-58af-4f1f-b223-3bff301fb99c", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>18.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 HUMAN READABLE DATA</span></b></p>", "ID": "2788714e-a68b-483c-a824-2621a78f7168", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "02095269-58af-4f1f-b223-3bff301fb99c"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>18.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 HUMAN READABLE DATA</span></b>", "ID": "0c7c0a68-0810-439b-b97b-9c3adea58402", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "2788714e-a68b-483c-a824-2621a78f7168"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>18.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 HUMAN READABLE DATA</span>", "ID": "c15919c9-e3b2-426e-8999-ab612deeac49", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "18.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE IDENTIFIER \u2013 HUMAN READABLE DATA", "ParentId": "0c7c0a68-0810-439b-b97b-9c3adea58402"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "39a778ed-799e-4213-afb3-df5403dd0e89", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "3958e088-05de-43ab-8437-ae788f50e36e", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "39a778ed-799e-4213-afb3-df5403dd0e89"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>PC:</span></p>", "ID": "23be42a7-13d4-4d67-8478-920bb36dc67f", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>PC:</span>", "ID": "0213f32c-0c0b-4287-8f46-a2a668512593", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "PC:", "ParentId": "23be42a7-13d4-4d67-8478-920bb36dc67f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>SN:</span></p>", "ID": "6f564e7d-6a3d-49d5-af6c-44ba3c4dc3f1", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>SN:</span>", "ID": "ef6bb8d3-5b1a-43d0-bdfd-059fa4ca1a16", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "SN:", "ParentId": "6f564e7d-6a3d-49d5-af6c-44ba3c4dc3f1"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>NN:</span></p>", "ID": "1b6b4652-ba9f-439f-b4dc-76b2a109ba52", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>NN:</span>", "ID": "1f538c78-8a38-4dd2-8f2d-a422567fdcfc", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "NN:", "ParentId": "1b6b4652-ba9f-439f-b4dc-76b2a109ba52"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:#CCCCCC'>\u00a0</span></p>", "ID": "e6c13e64-821d-4812-b1ce-43a01c85b4b0", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:#CCCCCC'>\u00a0</span>", "ID": "cf73c382-b658-4461-9c6a-00df580ac329", "Styles": "font-family:\n\"Times New Roman\",serif;background:#CCCCCC", "Classes": "None", "Text": "\u00a0", "ParentId": "e6c13e64-821d-4812-b1ce-43a01c85b4b0"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\ncolor:black;background:#CCCCCC'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span>", "ID": "798ad8bb-7dba-4efd-8b1e-e573cc4b6ae2", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif;\ncolor:black;background:#CCCCCC", "Classes": "None", "Text": " ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<br clear=\"all\" style=\"page-break-before:always\"/>", "ID": "49fb934f-421c-4636-8694-87d0d03b1f1e", "Styles": "page-break-before:always", "Classes": "None", "Text": "", "ParentId": "798ad8bb-7dba-4efd-8b1e-e573cc4b6ae2"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>PARTICULARS\nTO APPEAR ON THE OUTER PACKAGING </span></b></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>OUTER\nCARTON OF MULTIPACK (WITH BLUE BOX)</span></b></p>\n</div>", "ID": "5073d4dc-2ea2-41fe-8e79-82c18640dbca", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "    ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>PARTICULARS\nTO APPEAR ON THE OUTER PACKAGING </span></b></p>", "ID": "5e9e1798-b9c8-4824-ba57-da4a971d2ce0", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5073d4dc-2ea2-41fe-8e79-82c18640dbca"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>PARTICULARS\nTO APPEAR ON THE OUTER PACKAGING </span></b>", "ID": "95ee6422-3e02-4a3c-9303-0b4fe8cca2fb", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "5e9e1798-b9c8-4824-ba57-da4a971d2ce0"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>PARTICULARS\nTO APPEAR ON THE OUTER PACKAGING </span>", "ID": "6411f550-02e1-4f89-87ad-f587710edb52", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "PARTICULARS TO APPEAR ON THE OUTER PACKAGING ", "ParentId": "95ee6422-3e02-4a3c-9303-0b4fe8cca2fb"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "a89b07bc-d1e7-4260-a31a-3b20bb6ee438", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5073d4dc-2ea2-41fe-8e79-82c18640dbca"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "6d5d3b84-ac50-4e15-b54a-243b66490c61", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "a89b07bc-d1e7-4260-a31a-3b20bb6ee438"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>OUTER\nCARTON OF MULTIPACK (WITH BLUE BOX)</span></b></p>", "ID": "181988eb-0bde-4c96-b206-8baf2544c009", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5073d4dc-2ea2-41fe-8e79-82c18640dbca"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>OUTER\nCARTON OF MULTIPACK (WITH BLUE BOX)</span></b>", "ID": "a39690cb-26cc-49ff-bee4-c09e9586e245", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "181988eb-0bde-4c96-b206-8baf2544c009"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>OUTER\nCARTON OF MULTIPACK (WITH BLUE BOX)</span>", "ID": "b5274f54-0ad2-4c0f-8065-1ec358ba0ed8", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "OUTER CARTON OF MULTIPACK (WITH BLUE BOX)", "ParentId": "a39690cb-26cc-49ff-bee4-c09e9586e245"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "23031086-c396-489f-b5e2-0aee1c95d039", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "0e589de2-a79a-4fb3-9660-3e24d5213551", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "23031086-c396-489f-b5e2-0aee1c95d039"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "d1bacce7-6460-4a48-9dd4-4b9dc739249a", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "0ba225b1-c4b7-45b4-9aef-68fee6665fe1", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "d1bacce7-6460-4a48-9dd4-4b9dc739249a"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\nOF THE MEDICINAL PRODUCT</span></b></p>\n</div>", "ID": "fde3ef5a-b09e-4637-931a-75bcc011dd9c", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\nOF THE MEDICINAL PRODUCT</span></b></p>", "ID": "d20c32b3-5579-4ab1-b5e7-5a1ce4586c68", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fde3ef5a-b09e-4637-931a-75bcc011dd9c"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\nOF THE MEDICINAL PRODUCT</span></b>", "ID": "0f52f231-2717-47ca-a840-02058c14d22c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d20c32b3-5579-4ab1-b5e7-5a1ce4586c68"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\nOF THE MEDICINAL PRODUCT</span>", "ID": "53557628-5e0f-436e-8270-0c6b797fa00d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT", "ParentId": "0f52f231-2717-47ca-a840-02058c14d22c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "d8a6be3b-318f-4673-9726-4f1fbbe2f805", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "4107dd2e-50ae-487e-af23-032f77e9e4be", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "d8a6be3b-318f-4673-9726-4f1fbbe2f805"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Febuxostat Mylan 80\u00a0mg film-coated tablets</span></p>", "ID": "9f0de55b-ddbc-40a5-96c3-cb453b330425", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Febuxostat Mylan 80\u00a0mg film-coated tablets</span>", "ID": "a2fbbdef-daad-4076-9156-12548222da19", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "Febuxostat Mylan 80\u00a0mg film-coated tablets", "ParentId": "9f0de55b-ddbc-40a5-96c3-cb453b330425"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "38361bce-dd66-4b43-b8f2-393014249d47", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "66c4e441-a454-4779-b4d9-a5b7d9122fea", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "38361bce-dd66-4b43-b8f2-393014249d47"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>febuxostat</span><b><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'> </span></b></p>", "ID": "00a383b4-d20c-42d6-b46c-cad897bde028", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>febuxostat</span>", "ID": "168104a6-c9e9-4cb4-a5ae-1c8132a7277f", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "febuxostat", "ParentId": "00a383b4-d20c-42d6-b46c-cad897bde028"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'> </span></b>", "ID": "3eac45fa-213d-45d8-b3ee-8164799f251f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "00a383b4-d20c-42d6-b46c-cad897bde028"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'> </span>", "ID": "a9731c8e-4cd7-4289-aa52-9a67059f6bc9", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": " ", "ParentId": "3eac45fa-213d-45d8-b3ee-8164799f251f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "6e78c052-cde8-442a-862c-97883a9176b1", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "2e73cc1d-c3c2-43e7-a624-e90f481a529e", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "6e78c052-cde8-442a-862c-97883a9176b1"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "fd0b0ffc-c2d7-4f0c-bb92-e3f84d9471c2", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "df14e7c2-21f4-4f8b-bb5b-3a66b400c049", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "fd0b0ffc-c2d7-4f0c-bb92-e3f84d9471c2"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT\nOF ACTIVE SUBSTANCE</span></b></p>\n</div>", "ID": "48a11841-c7f8-4218-bdd6-0747fff0cf20", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT\nOF ACTIVE SUBSTANCE</span></b></p>", "ID": "eae3fab7-9448-41ee-a765-e0c8804b86b3", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "48a11841-c7f8-4218-bdd6-0747fff0cf20"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT\nOF ACTIVE SUBSTANCE</span></b>", "ID": "c790fb88-c7cb-40e7-88a8-7e50c24d0280", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "eae3fab7-9448-41ee-a765-e0c8804b86b3"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT\nOF ACTIVE SUBSTANCE</span>", "ID": "ad94d347-8929-4e34-872d-268aaa596769", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT OF ACTIVE SUBSTANCE", "ParentId": "c790fb88-c7cb-40e7-88a8-7e50c24d0280"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "26966ffc-d14a-4306-8a2c-c488240e3127", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "66151d76-31c4-4b10-a6ad-886ebad62a80", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "26966ffc-d14a-4306-8a2c-c488240e3127"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Each tablet contains 80\u00a0mg febuxostat.</span></p>", "ID": "98d159cb-29bf-4ef6-8e76-ebfa08e88074", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Each tablet contains 80\u00a0mg febuxostat.</span>", "ID": "7d9b84cb-5288-4ff8-856e-5356ef975325", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "Each tablet contains 80\u00a0mg febuxostat.", "ParentId": "98d159cb-29bf-4ef6-8e76-ebfa08e88074"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "e9951087-ea79-4ac7-a961-13938654cfb5", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "be0f354f-0cce-4aa2-b7d0-f79bbdc08756", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "e9951087-ea79-4ac7-a961-13938654cfb5"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "6b927d60-c3e5-49bb-bbdc-2ff4c1fbff2b", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "83b55c06-d6f9-4631-bf12-b668da43f512", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "6b927d60-c3e5-49bb-bbdc-2ff4c1fbff2b"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST\nOF EXCIPIENTS</span></b></p>\n</div>", "ID": "60a1ace6-9bc9-4a7a-98f1-5663955bfa92", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST\nOF EXCIPIENTS</span></b></p>", "ID": "45796a8d-c527-49b5-91b7-9853e585531f", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "60a1ace6-9bc9-4a7a-98f1-5663955bfa92"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST\nOF EXCIPIENTS</span></b>", "ID": "8472476d-bf26-481f-af67-7cfa0ced7cbe", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "45796a8d-c527-49b5-91b7-9853e585531f"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST\nOF EXCIPIENTS</span>", "ID": "70abaf8b-c9f6-4505-b8a5-01d7a0f4c296", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST OF EXCIPIENTS", "ParentId": "8472476d-bf26-481f-af67-7cfa0ced7cbe"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "428a4ccc-bbf7-4e54-9f9f-c10e0bbd906c", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "e8dbd3ce-f3e8-473b-8b18-5fb8347ca3f8", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "428a4ccc-bbf7-4e54-9f9f-c10e0bbd906c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Also contains lactose.</span></p>", "ID": "79d77a78-a862-4472-a206-8bd7930a5fa3", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Also contains lactose.</span>", "ID": "def6035e-4e53-4b43-b5ae-14b7c360bf81", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Also contains lactose.", "ParentId": "79d77a78-a862-4472-a206-8bd7930a5fa3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "113319e5-1155-4de5-b3c2-2b3825ea60f2", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "c642982e-8b75-433e-b48e-82938c59172d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "113319e5-1155-4de5-b3c2-2b3825ea60f2"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>See leaflet for further information.</span></p>", "ID": "8a7d7c57-1dd7-4cdf-8985-c1a6b388eb96", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>See leaflet for further information.</span>", "ID": "9332cadd-ae39-40a4-ab9a-e16e3cd0b499", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "See leaflet for further information.", "ParentId": "8a7d7c57-1dd7-4cdf-8985-c1a6b388eb96"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "4c7d902d-442e-4fee-b3fd-bc4faa84a2e3", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "26d7e57b-aaf0-443d-b3b4-84541bc65dcd", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "4c7d902d-442e-4fee-b3fd-bc4faa84a2e3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "f62acf56-d7e2-4fb2-bce5-0bd87c72f656", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "b0eafb29-f503-495d-9a00-d3e119897eb6", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "f62acf56-d7e2-4fb2-bce5-0bd87c72f656"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\nFORM AND CONTENTS</span></b></p>\n</div>", "ID": "f28126a2-1231-484d-8fe6-df0f16f548c7", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\nFORM AND CONTENTS</span></b></p>", "ID": "d6007e42-40db-42bc-84bc-6ae7cf8f39fc", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f28126a2-1231-484d-8fe6-df0f16f548c7"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\nFORM AND CONTENTS</span></b>", "ID": "6e1d1dc4-cad6-4b85-b0a0-3170ef7008d6", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d6007e42-40db-42bc-84bc-6ae7cf8f39fc"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\nFORM AND CONTENTS</span>", "ID": "e30c3d09-0c49-4b62-a89e-697213d98ff0", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL FORM AND CONTENTS", "ParentId": "6e1d1dc4-cad6-4b85-b0a0-3170ef7008d6"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "2dcc20d2-2379-443e-8ad8-38f8b793ae06", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "ee72fdd0-5939-49de-8052-69852b2d60ac", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "2dcc20d2-2379-443e-8ad8-38f8b793ae06"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"DE\" style='font-family:\"Times New Roman\",serif;\nlayout-grid-mode:line'>Multipack: 84 (2 packs of 42) film-coated tablets</span></p>", "ID": "ee2b2407-3c25-4511-aede-94d61c043111", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"DE\" style='font-family:\"Times New Roman\",serif;\nlayout-grid-mode:line'>Multipack: 84 (2 packs of 42) film-coated tablets</span>", "ID": "e99e953e-d623-462e-b6f3-91ed695af847", "Styles": "font-family:\"Times New Roman\",serif;\nlayout-grid-mode:line", "Classes": "None", "Text": "Multipack: 84 (2 packs of 42) film-coated tablets", "ParentId": "ee2b2407-3c25-4511-aede-94d61c043111"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "0dc9d489-2bc1-42a2-aa1c-c76f1390b68b", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "c88efaf4-beb6-4aef-82cb-ba47eb60cfb0", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "0dc9d489-2bc1-42a2-aa1c-c76f1390b68b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "a615c04f-15e0-4013-a993-01d59ea44c09", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "511b2a00-eed9-4866-98e9-f52ab982c251", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "a615c04f-15e0-4013-a993-01d59ea44c09"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD\nAND ROUTE(S) OF ADMINISTRATION</span></b></p>\n</div>", "ID": "5f770161-48d6-4c68-8482-9b77371b6c53", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD\nAND ROUTE(S) OF ADMINISTRATION</span></b></p>", "ID": "4181b6db-9fba-48d8-a89f-20f87ce653b8", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5f770161-48d6-4c68-8482-9b77371b6c53"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD\nAND ROUTE(S) OF ADMINISTRATION</span></b>", "ID": "d806c204-67d0-47a1-aa39-6dd82c00f897", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4181b6db-9fba-48d8-a89f-20f87ce653b8"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD\nAND ROUTE(S) OF ADMINISTRATION</span>", "ID": "ebc9e7b7-95eb-46c0-b11c-6cb1ce762592", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD AND ROUTE(S) OF ADMINISTRATION", "ParentId": "d806c204-67d0-47a1-aa39-6dd82c00f897"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "4a30310d-61b7-4c30-a91e-9f2bf9be577d", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "757303f6-90d1-4ef7-8311-1a52fe6aaecc", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "4a30310d-61b7-4c30-a91e-9f2bf9be577d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>For oral use.</span></p>", "ID": "a03e08eb-0233-4019-9b2e-eab42b16afff", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>For oral use.</span>", "ID": "bddad50d-fdb3-40af-964f-c610cc0f5f56", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "For oral use.", "ParentId": "a03e08eb-0233-4019-9b2e-eab42b16afff"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "4779b867-2212-4c34-9c8c-bc781bb3b2b7", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "e1aa9c58-6500-49a9-b103-8a5620701765", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "4779b867-2212-4c34-9c8c-bc781bb3b2b7"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Read the package leaflet before use.</span></p>", "ID": "86f5de08-602f-47af-bf5a-78e66702a002", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Read the package leaflet before use.</span>", "ID": "43d314aa-a00e-4d82-8b14-8ee167244d46", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "Read the package leaflet before use.", "ParentId": "86f5de08-602f-47af-bf5a-78e66702a002"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "cb908837-ada9-472c-ab0c-c3c336b06cc9", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "4abffe8c-48c8-4cf2-a5a3-815d7c916b7d", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "cb908837-ada9-472c-ab0c-c3c336b06cc9"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "8b7084a0-c8e7-4768-aa0e-1ab80e7916d0", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "8b6d03b6-445c-4293-a81b-cbfb47160022", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "8b7084a0-c8e7-4768-aa0e-1ab80e7916d0"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nWARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF\nCHILDREN</span></b></p>\n</div>", "ID": "040916b6-17c9-4fc3-bb33-50917537d3c7", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nWARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF\nCHILDREN</span></b></p>", "ID": "4f6d50ff-5cbc-445d-8b5d-44e07e490c7f", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "040916b6-17c9-4fc3-bb33-50917537d3c7"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nWARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF\nCHILDREN</span></b>", "ID": "9d757cf0-fede-4790-8ad5-34d814751747", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4f6d50ff-5cbc-445d-8b5d-44e07e490c7f"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nWARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF\nCHILDREN</span>", "ID": "1322077b-babc-45a5-9704-8708c0c0a2e2", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN", "ParentId": "9d757cf0-fede-4790-8ad5-34d814751747"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "30ea7beb-a0d5-44f3-ba9a-5c6a19fc6c84", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "30ccf329-da8a-4af9-8a6b-5d0b23bb3d2c", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "30ea7beb-a0d5-44f3-ba9a-5c6a19fc6c84"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Keep out of the sight and reach of children.</span></p>", "ID": "fb7aa20c-8e54-445f-b4af-4faa1603f1c4", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Keep out of the sight and reach of children.</span>", "ID": "fc73572e-0514-419a-8e1d-d5da07a5a12d", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "Keep out of the sight and reach of children.", "ParentId": "fb7aa20c-8e54-445f-b4af-4faa1603f1c4"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "b2131c9e-f8e9-4c7a-8a88-4804202d6b2a", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "3d35f5eb-75cf-4b34-aa9c-eaa800703394", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "b2131c9e-f8e9-4c7a-8a88-4804202d6b2a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "663a8405-fead-41cd-99ac-9427aa324dfe", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "49dd11f1-8dba-4fdd-bd9a-43bb8e7a82f4", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "663a8405-fead-41cd-99ac-9427aa324dfe"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER\nSPECIAL WARNING(S), IF NECESSARY</span></b></p>\n</div>", "ID": "54a645f8-107e-4051-92db-4b03b033dfcc", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER\nSPECIAL WARNING(S), IF NECESSARY</span></b></p>", "ID": "131b13cf-8564-4025-bf48-72c7a3422471", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "54a645f8-107e-4051-92db-4b03b033dfcc"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER\nSPECIAL WARNING(S), IF NECESSARY</span></b>", "ID": "d215cd76-edb1-4b4b-b938-65047db958dd", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "131b13cf-8564-4025-bf48-72c7a3422471"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER\nSPECIAL WARNING(S), IF NECESSARY</span>", "ID": "5d012d2b-77ce-4c4c-a5f4-68e5c7e9b1ae", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER SPECIAL WARNING(S), IF NECESSARY", "ParentId": "d215cd76-edb1-4b4b-b938-65047db958dd"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "1ed7dd30-cbb5-4a9a-97d9-c522587c9b8a", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "67710443-a4c8-4cc0-9b4d-9c27c113285b", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "1ed7dd30-cbb5-4a9a-97d9-c522587c9b8a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "d61dd700-a8f0-4d3a-a25f-1a177f776832", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "3ca21e88-8a0e-46de-acfe-86d88fc59ae6", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "d61dd700-a8f0-4d3a-a25f-1a177f776832"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "5b9698be-28ad-4598-af74-93e01b939afa", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "d1647740-04cd-407e-a49d-2467b6bed481", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "5b9698be-28ad-4598-af74-93e01b939afa"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY\nDATE</span></b></p>\n</div>", "ID": "1b611a62-7e96-4ce9-a8cf-c0c3dd35d156", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY\nDATE</span></b></p>", "ID": "5ad90562-4d0a-4d5e-bd4d-eddc82546a15", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "1b611a62-7e96-4ce9-a8cf-c0c3dd35d156"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY\nDATE</span></b>", "ID": "26b900f7-248d-4eaf-aa76-c00cb4c80164", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "5ad90562-4d0a-4d5e-bd4d-eddc82546a15"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY\nDATE</span>", "ID": "fc51a16b-05ce-460d-ac02-3d57d61a4761", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE", "ParentId": "26b900f7-248d-4eaf-aa76-c00cb4c80164"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "6371ec46-16cc-4cc9-abe3-bba92e93214b", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "7ccbc171-87a9-4c37-896a-5ebad54a3afa", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "6371ec46-16cc-4cc9-abe3-bba92e93214b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>EXP</span></p>", "ID": "33077ecc-47c1-4964-9a81-8608ad9c28c3", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>EXP</span>", "ID": "8f9af3a1-50cf-4f56-a8b3-51965254bcda", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "EXP", "ParentId": "33077ecc-47c1-4964-9a81-8608ad9c28c3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "d525940e-dcda-485c-8ef9-f0bc6ffd5a0f", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "9e596632-8a0b-4e59-8b46-8ad853a355be", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "d525940e-dcda-485c-8ef9-f0bc6ffd5a0f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "db571ab9-cb91-4935-8ddc-06d89047c7f6", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "064ed497-0fbf-4c3e-8bd4-6bf2368529cb", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "db571ab9-cb91-4935-8ddc-06d89047c7f6"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;page-break-after:\navoid;border:none;padding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span></b></p>\n</div>", "ID": "fc92b5d9-410f-4742-b645-6141677ddaa8", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;page-break-after:\navoid;border:none;padding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span></b></p>", "ID": "06f20766-561d-4de2-8d59-2156a8a10d09", "Styles": "margin-bottom:0in;line-height:normal;page-break-after:\navoid;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fc92b5d9-410f-4742-b645-6141677ddaa8"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span></b>", "ID": "4b7f374c-74e7-406f-9757-5f84414b38b7", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "06f20766-561d-4de2-8d59-2156a8a10d09"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span>", "ID": "69a160ec-1a7d-48d8-ad05-a29dfd2d61f4", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL STORAGE CONDITIONS", "ParentId": "4b7f374c-74e7-406f-9757-5f84414b38b7"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "9143ad44-3741-49f8-aa29-eb7e9fe59f26", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "b61308c2-1e09-4eff-be90-13b6c4e79e8e", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "9143ad44-3741-49f8-aa29-eb7e9fe59f26"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "e0146e1c-8dad-4913-977e-e8c0697c51ba", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "771510c3-58a0-460d-9074-edd9953be06f", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "e0146e1c-8dad-4913-977e-e8c0697c51ba"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "a5827f05-2179-444e-bdab-10b209a7f2be", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "50fc9ffe-d3ca-4b1b-a046-9b2b2e33ffd2", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "a5827f05-2179-444e-bdab-10b209a7f2be"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>10.\u00a0\u00a0\u00a0\u00a0 SPECIAL\nPRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS\nDERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE</span></b></p>\n</div>", "ID": "8d4b1643-a1f3-467c-8c11-b9d836048f89", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>10.\u00a0\u00a0\u00a0\u00a0 SPECIAL\nPRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS\nDERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE</span></b></p>", "ID": "f9068fcd-b56c-44d4-a158-e1c8491f277c", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "8d4b1643-a1f3-467c-8c11-b9d836048f89"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>10.\u00a0\u00a0\u00a0\u00a0 SPECIAL\nPRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS\nDERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE</span></b>", "ID": "7f83ec18-2d18-4fa9-af05-de7eb8775177", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f9068fcd-b56c-44d4-a158-e1c8491f277c"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>10.\u00a0\u00a0\u00a0\u00a0 SPECIAL\nPRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS\nDERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE</span>", "ID": "207718b7-0e4b-414a-95f0-82122bd520c6", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "10.\u00a0\u00a0\u00a0\u00a0 SPECIAL PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE", "ParentId": "7f83ec18-2d18-4fa9-af05-de7eb8775177"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "bf603f2f-c53e-43d1-b58f-25832db26e58", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "6319d75b-07f3-4a1e-a765-53fd4458bcd7", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "bf603f2f-c53e-43d1-b58f-25832db26e58"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "c7cabbab-95aa-4be1-a60d-5fce48c83fb4", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "0892b955-d9e5-4873-94ac-f6e332496e36", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "c7cabbab-95aa-4be1-a60d-5fce48c83fb4"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "81a2ac4b-ee86-4e27-9c18-0af0513a66ce", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "d21ae346-ee3d-4123-a40e-47fbda28dbf6", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "81a2ac4b-ee86-4e27-9c18-0af0513a66ce"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>11.\u00a0\u00a0\u00a0\u00a0 NAME\nAND ADDRESS OF THE MARKETING AUTHORISATION HOLDER</span></b></p>\n</div>", "ID": "8ff5a576-6c93-4cea-aa98-c9fcdfda242c", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>11.\u00a0\u00a0\u00a0\u00a0 NAME\nAND ADDRESS OF THE MARKETING AUTHORISATION HOLDER</span></b></p>", "ID": "cf11207d-bc78-418e-a6a6-81b77a5e5b3e", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "8ff5a576-6c93-4cea-aa98-c9fcdfda242c"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>11.\u00a0\u00a0\u00a0\u00a0 NAME\nAND ADDRESS OF THE MARKETING AUTHORISATION HOLDER</span></b>", "ID": "43c640f9-8b73-4d94-abce-3068fb088a0f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "cf11207d-bc78-418e-a6a6-81b77a5e5b3e"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>11.\u00a0\u00a0\u00a0\u00a0 NAME\nAND ADDRESS OF THE MARKETING AUTHORISATION HOLDER</span>", "ID": "c0f9d568-7f99-46d4-bc7a-cb009ddfd104", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "11.\u00a0\u00a0\u00a0\u00a0 NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER", "ParentId": "43c640f9-8b73-4d94-abce-3068fb088a0f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "50a3f062-2898-42b3-9d7f-a7efde9226d4", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "ce5a0d8d-e2c4-4d0e-a55e-273e5e506e6e", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "50a3f062-2898-42b3-9d7f-a7efde9226d4"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"DE-AT\" style='font-family:\n\"Times New Roman\",serif'>Mylan S.A.S.</span></p>", "ID": "cac7d44c-f96c-445f-97bd-42f44187c97d", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"DE-AT\" style='font-family:\n\"Times New Roman\",serif'>Mylan S.A.S.</span>", "ID": "836e7bc0-552c-4429-a789-c41ef19d8b7d", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "Mylan S.A.S.", "ParentId": "cac7d44c-f96c-445f-97bd-42f44187c97d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"DE-AT\" style='font-family:\n\"Times New Roman\",serif'>117 Allee des Parcs</span></p>", "ID": "dd1cf630-5ecb-4dfa-b88f-c5c8d7f46755", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"DE-AT\" style='font-family:\n\"Times New Roman\",serif'>117 Allee des Parcs</span>", "ID": "cd30a1d1-7259-4791-a97f-29b9e8ba32ea", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "117 Allee des Parcs", "ParentId": "dd1cf630-5ecb-4dfa-b88f-c5c8d7f46755"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>69 800 Saint Priest</span></p>", "ID": "f93a3f30-1b17-4315-9676-4e7509548d1f", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>69 800 Saint Priest</span>", "ID": "02ca94e3-86e5-42cd-8f74-d017b19a9bd1", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "69 800 Saint Priest", "ParentId": "f93a3f30-1b17-4315-9676-4e7509548d1f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>France</span></p>", "ID": "434bf60b-ab17-46e5-add4-0e8640072734", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>France</span>", "ID": "5c22f913-68f9-4896-a282-bf3b9189d091", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "France", "ParentId": "434bf60b-ab17-46e5-add4-0e8640072734"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "b5877fb8-135b-4bb3-b15e-9cb424b3ab57", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "a5808f02-59f8-4762-bcc9-0e0d8541a4a0", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "b5877fb8-135b-4bb3-b15e-9cb424b3ab57"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "76851835-a1da-401c-b1e9-66ce693b33d6", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "7992e171-6d11-42e5-92f1-7f793a707b4c", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "76851835-a1da-401c-b1e9-66ce693b33d6"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>12.\u00a0\u00a0\u00a0\u00a0 MARKETING\nAUTHORISATION NUMBER(S) </span></b></p>\n</div>", "ID": "cf4a321a-ca03-45ee-9db6-5efe61b11ad0", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>12.\u00a0\u00a0\u00a0\u00a0 MARKETING\nAUTHORISATION NUMBER(S) </span></b></p>", "ID": "23a24392-2e5c-473d-a5e2-6d0f5f49c705", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "cf4a321a-ca03-45ee-9db6-5efe61b11ad0"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>12.\u00a0\u00a0\u00a0\u00a0 MARKETING\nAUTHORISATION NUMBER(S) </span></b>", "ID": "41bc3138-9bbd-47ec-9e60-cc25fb76beee", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "23a24392-2e5c-473d-a5e2-6d0f5f49c705"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>12.\u00a0\u00a0\u00a0\u00a0 MARKETING\nAUTHORISATION NUMBER(S) </span>", "ID": "6550589b-69e1-4d03-9eed-1ccbeaee1b2d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "12.\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION NUMBER(S) ", "ParentId": "41bc3138-9bbd-47ec-9e60-cc25fb76beee"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "409835a9-0f87-4e26-b638-e8b6cb8c8a35", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "e59afe62-5716-480a-a228-595ae5a22ce8", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "409835a9-0f87-4e26-b638-e8b6cb8c8a35"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/022</span></p>", "ID": "576149bd-cf47-4129-b024-d1b5f5e59a1e", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/022</span>", "ID": "6725ba01-483c-4dc1-b347-ace247613cc4", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "EU/1/17/1194/022", "ParentId": "576149bd-cf47-4129-b024-d1b5f5e59a1e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "4972cbca-fc95-4bb2-bf6e-ca12f4bf8e82", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "f77e0da5-16f2-417a-af14-53f774ba7ce9", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "4972cbca-fc95-4bb2-bf6e-ca12f4bf8e82"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "5cf6bddc-1ec2-43f2-a2d4-756e2614cfcb", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "0959f332-ba3b-4693-96d4-36a7c29ccaf3", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "5cf6bddc-1ec2-43f2-a2d4-756e2614cfcb"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>13.\u00a0\u00a0\u00a0\u00a0 BATCH\nNUMBER</span></b></p>\n</div>", "ID": "3915eb12-7754-40fd-9875-a1b2ccb84409", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>13.\u00a0\u00a0\u00a0\u00a0 BATCH\nNUMBER</span></b></p>", "ID": "58f30b73-8a70-4484-a292-0ba124885e57", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3915eb12-7754-40fd-9875-a1b2ccb84409"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>13.\u00a0\u00a0\u00a0\u00a0 BATCH\nNUMBER</span></b>", "ID": "9825504c-b160-4c92-86cd-4bd12099c85b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "58f30b73-8a70-4484-a292-0ba124885e57"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>13.\u00a0\u00a0\u00a0\u00a0 BATCH\nNUMBER</span>", "ID": "5eef375b-eb4c-4ed5-9d3c-c868f022b55f", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "13.\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER", "ParentId": "9825504c-b160-4c92-86cd-4bd12099c85b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><i><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></i></p>", "ID": "58816e7e-99a0-4d52-9b4d-b1a0b65fe2e6", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<i><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></i>", "ID": "00a15220-ac4e-4434-bee4-58f054ada99a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "58816e7e-99a0-4d52-9b4d-b1a0b65fe2e6"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "f2231bd8-aa97-405a-9cb7-27dfc653416b", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "00a15220-ac4e-4434-bee4-58f054ada99a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Lot</span></p>", "ID": "fa5f6508-6265-4c25-98cb-dd9246d69875", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Lot</span>", "ID": "4dbf91be-1d40-4679-95f9-589b93afe610", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "Lot", "ParentId": "fa5f6508-6265-4c25-98cb-dd9246d69875"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "15e777cb-14a5-4176-bbba-075c45570b3a", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "360bb533-7179-4bda-b95c-adca5877200a", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "15e777cb-14a5-4176-bbba-075c45570b3a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "5a14073a-af85-48b8-89e5-a9bf0d859ec4", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "b5e09af0-5b3f-4f26-b097-c282c8b0ffe4", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "5a14073a-af85-48b8-89e5-a9bf0d859ec4"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>14.\u00a0\u00a0\u00a0\u00a0 GENERAL\nCLASSIFICATION FOR SUPPLY</span></b></p>\n</div>", "ID": "d5428791-154f-4a16-b0c7-b7f41d30ea99", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>14.\u00a0\u00a0\u00a0\u00a0 GENERAL\nCLASSIFICATION FOR SUPPLY</span></b></p>", "ID": "5ef85c03-9741-4e9c-b2bd-fbec61ce188a", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d5428791-154f-4a16-b0c7-b7f41d30ea99"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>14.\u00a0\u00a0\u00a0\u00a0 GENERAL\nCLASSIFICATION FOR SUPPLY</span></b>", "ID": "ba11d12a-4fb0-4b0c-8efc-bd70b56c80e8", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "5ef85c03-9741-4e9c-b2bd-fbec61ce188a"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>14.\u00a0\u00a0\u00a0\u00a0 GENERAL\nCLASSIFICATION FOR SUPPLY</span>", "ID": "e20f85f5-9fb6-4bee-ac9f-b068391261d2", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "14.\u00a0\u00a0\u00a0\u00a0 GENERAL CLASSIFICATION FOR SUPPLY", "ParentId": "ba11d12a-4fb0-4b0c-8efc-bd70b56c80e8"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><i><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></i></p>", "ID": "50d8a7f1-ad98-41c9-bc89-36e7383485d3", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<i><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></i>", "ID": "9c498981-3370-4734-8b04-9517566f1847", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "50d8a7f1-ad98-41c9-bc89-36e7383485d3"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "8ef5832d-9694-43bc-9ace-1730d62f922a", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "9c498981-3370-4734-8b04-9517566f1847"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "fd539f08-e200-4744-bee1-d4b75a2f4def", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "8b0ce752-17d0-4d64-b695-9187b7947ad6", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "fd539f08-e200-4744-bee1-d4b75a2f4def"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "1ccecaba-bd0a-4bb3-9adb-5e3631990cc4", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "55d53292-4c80-429b-a6d2-24c2367ad90c", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "1ccecaba-bd0a-4bb3-9adb-5e3631990cc4"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:2.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS\nON USE</span></b></p>\n</div>", "ID": "b5ab46b1-566c-4d14-b728-b0693ff87142", "Styles": "border:solid windowtext 1.0pt;padding:2.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS\nON USE</span></b></p>", "ID": "0b119e73-8b40-4daa-9deb-8b793c5cc511", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b5ab46b1-566c-4d14-b728-b0693ff87142"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS\nON USE</span></b>", "ID": "4ea1bb99-fdae-4837-b4fa-db54ddfa2753", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0b119e73-8b40-4daa-9deb-8b793c5cc511"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS\nON USE</span>", "ID": "05cab78d-ca79-44ca-bfaf-8cf3e88e71c1", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS ON USE", "ParentId": "4ea1bb99-fdae-4837-b4fa-db54ddfa2753"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "199f81fc-3305-451c-91e4-70ae8c33b47b", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "27c0caf0-ce99-40dc-b59e-35bef27b9fa6", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "199f81fc-3305-451c-91e4-70ae8c33b47b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "8505d06f-749b-482d-bda0-891afc0ce416", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "aa48d08f-517a-4f95-a894-700ea022fbfb", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "8505d06f-749b-482d-bda0-891afc0ce416"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "f16aa925-dfe5-4d75-ab47-a302129cd5a2", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "18ad5182-bb99-4e0c-aca1-3d2396d7afb4", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "f16aa925-dfe5-4d75-ab47-a302129cd5a2"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>16.\u00a0\u00a0\u00a0\u00a0 INFORMATION\nIN BRAILLE</span></b></p>\n</div>", "ID": "ad05f7fc-bda0-4cea-a81b-b330309690f7", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>16.\u00a0\u00a0\u00a0\u00a0 INFORMATION\nIN BRAILLE</span></b></p>", "ID": "0a20a0e8-5d98-467b-8bac-1f46214ce370", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ad05f7fc-bda0-4cea-a81b-b330309690f7"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>16.\u00a0\u00a0\u00a0\u00a0 INFORMATION\nIN BRAILLE</span></b>", "ID": "102c244f-f7e2-4f9e-87fd-97db8fd4c370", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0a20a0e8-5d98-467b-8bac-1f46214ce370"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>16.\u00a0\u00a0\u00a0\u00a0 INFORMATION\nIN BRAILLE</span>", "ID": "8b890fd8-f784-408b-9dcb-594108a0d778", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "16.\u00a0\u00a0\u00a0\u00a0 INFORMATION IN BRAILLE", "ParentId": "102c244f-f7e2-4f9e-87fd-97db8fd4c370"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "9fd966bd-4a5a-4a4e-8605-f905036d0bbb", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "9820a11a-2558-4502-96b7-67006abc0708", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "9fd966bd-4a5a-4a4e-8605-f905036d0bbb"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Febuxostat Mylan 80\u00a0mg</span></p>", "ID": "e9e48799-76de-4aac-98b6-9f1aa14f3064", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Febuxostat Mylan 80\u00a0mg</span>", "ID": "4f51b583-254b-4651-98a9-f943e1ef63a4", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "Febuxostat Mylan 80\u00a0mg", "ParentId": "e9e48799-76de-4aac-98b6-9f1aa14f3064"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:#CCCCCC'>\u00a0</span></p>", "ID": "19ad8c20-f6da-4ae8-b128-51f8abb6bccb", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:#CCCCCC'>\u00a0</span>", "ID": "dae9499f-e0de-4604-a7ef-2a976c718283", "Styles": "font-family:\n\"Times New Roman\",serif;background:#CCCCCC", "Classes": "None", "Text": "\u00a0", "ParentId": "19ad8c20-f6da-4ae8-b128-51f8abb6bccb"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:#CCCCCC'>\u00a0</span></p>", "ID": "b2585bef-c336-4b28-81f7-2ff38f5e6b47", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:#CCCCCC'>\u00a0</span>", "ID": "56075e85-615f-4e98-9e29-82633bbfce5d", "Styles": "font-family:\n\"Times New Roman\",serif;background:#CCCCCC", "Classes": "None", "Text": "\u00a0", "ParentId": "b2585bef-c336-4b28-81f7-2ff38f5e6b47"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>17.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 2D BARCODE</span></b></p>\n</div>", "ID": "9e1d71b6-6f6c-4d42-a626-c3b760220957", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>17.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 2D BARCODE</span></b></p>", "ID": "6059f36c-0e36-4c6b-9f0e-c52954bd2d2f", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "9e1d71b6-6f6c-4d42-a626-c3b760220957"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>17.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 2D BARCODE</span></b>", "ID": "2f484920-483a-40ab-b98e-fa2821d836ff", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6059f36c-0e36-4c6b-9f0e-c52954bd2d2f"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>17.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 2D BARCODE</span>", "ID": "c86a1f3b-7efe-42ca-9785-37534f3b6dee", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "17.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE IDENTIFIER \u2013 2D BARCODE", "ParentId": "2f484920-483a-40ab-b98e-fa2821d836ff"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "df825b09-a369-4886-916a-4a961129c467", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "6e4380a3-cab9-41d3-af0c-a72ffa2e2f2a", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "df825b09-a369-4886-916a-4a961129c467"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC'>2D barcode carrying the\nunique identifier included.</span></p>", "ID": "da185188-b280-4b48-b6b7-352a8c4d8f7a", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC'>2D barcode carrying the\nunique identifier included.</span>", "ID": "a39d0c92-6108-4cfd-8584-0d1e6168deec", "Styles": "font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC", "Classes": "None", "Text": "2D barcode carrying the unique identifier included.", "ParentId": "da185188-b280-4b48-b6b7-352a8c4d8f7a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "8fe9ffbc-2e1f-476f-b948-657c85022754", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "8c3c16a0-1150-426f-a6ec-b8a13b7800f7", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "8fe9ffbc-2e1f-476f-b948-657c85022754"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "0a913d76-6624-4e47-a785-c5b558834748", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "3a9b44df-a478-4afe-8508-f4e9a00527f0", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "0a913d76-6624-4e47-a785-c5b558834748"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>18.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 HUMAN READABLE DATA</span></b></p>\n</div>", "ID": "d5c2add4-0e6d-4ef4-b65d-faccbb39d3e1", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>18.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 HUMAN READABLE DATA</span></b></p>", "ID": "673c79b8-1db2-4702-b8d5-a13baf118bf6", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d5c2add4-0e6d-4ef4-b65d-faccbb39d3e1"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>18.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 HUMAN READABLE DATA</span></b>", "ID": "5364f849-bf54-4a68-952d-7c72efd09931", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "673c79b8-1db2-4702-b8d5-a13baf118bf6"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>18.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 HUMAN READABLE DATA</span>", "ID": "ca53ae28-b067-440e-a2db-9a113cf0609c", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "18.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE IDENTIFIER \u2013 HUMAN READABLE DATA", "ParentId": "5364f849-bf54-4a68-952d-7c72efd09931"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "345f4286-0570-4ff7-8ec0-e25e4d59fc17", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "47b29675-0f2a-44d4-a507-253937ca75e9", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "345f4286-0570-4ff7-8ec0-e25e4d59fc17"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>PC:</span></p>", "ID": "bdf33044-b51a-46d6-9d90-b23fff05816b", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>PC:</span>", "ID": "6be8432f-c57c-40d8-9400-f933cb1da2c1", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "PC:", "ParentId": "bdf33044-b51a-46d6-9d90-b23fff05816b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>SN:</span></p>", "ID": "5eade61b-a095-40b9-bfe0-bff0f684aafb", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>SN:</span>", "ID": "3859f42d-56a0-49e8-8c73-1e497eeef267", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "SN:", "ParentId": "5eade61b-a095-40b9-bfe0-bff0f684aafb"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>NN:</span></p>", "ID": "606bac7e-f45a-4fb7-98c8-0c67f31d423d", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>NN:</span>", "ID": "9692f7f5-eba6-4585-bee4-54cfd65cd1c2", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "NN:", "ParentId": "606bac7e-f45a-4fb7-98c8-0c67f31d423d"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\ncolor:black;background:#CCCCCC'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span>", "ID": "f770459c-85e5-42a4-bf26-1c2061083223", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif;\ncolor:black;background:#CCCCCC", "Classes": "None", "Text": " ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<br clear=\"all\" style=\"page-break-before:always\"/>", "ID": "04b28946-2b8b-4f44-abb4-2d061f861acc", "Styles": "page-break-before:always", "Classes": "None", "Text": "", "ParentId": "f770459c-85e5-42a4-bf26-1c2061083223"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;background:#CCCCCC'>\u00a0</span></p>", "ID": "b0df2310-530f-41ba-9134-d869f3b7e3b3", "Styles": "margin-bottom:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;background:#CCCCCC'>\u00a0</span>", "ID": "2417da0f-05b7-41df-b06a-dc7051ffb33a", "Styles": "font-family:\"Times New Roman\",serif;background:#CCCCCC", "Classes": "None", "Text": "\u00a0", "ParentId": "b0df2310-530f-41ba-9134-d869f3b7e3b3"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>PARTICULARS\nTO APPEAR ON THE OUTER PACKAGING </span></b></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>INNER\nCARTON OF MULTIPACK (WITHOUT BLUE BOX)</span></b></p>\n</div>", "ID": "b2028760-071f-498b-9e0b-d74971b45ce1", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "    ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>PARTICULARS\nTO APPEAR ON THE OUTER PACKAGING </span></b></p>", "ID": "b6142edc-35a5-4d56-be8d-a8745b8e0f6c", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b2028760-071f-498b-9e0b-d74971b45ce1"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>PARTICULARS\nTO APPEAR ON THE OUTER PACKAGING </span></b>", "ID": "65b5d86c-cb67-4e40-aee0-e859fe837d9e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b6142edc-35a5-4d56-be8d-a8745b8e0f6c"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>PARTICULARS\nTO APPEAR ON THE OUTER PACKAGING </span>", "ID": "e2cc45a7-a693-4f81-9493-92a0b594da1d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "PARTICULARS TO APPEAR ON THE OUTER PACKAGING ", "ParentId": "65b5d86c-cb67-4e40-aee0-e859fe837d9e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "e237a83b-97b7-4dd3-ad51-468541a7c864", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b2028760-071f-498b-9e0b-d74971b45ce1"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "77c86b89-2392-4068-b660-c30b7d237e6d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "e237a83b-97b7-4dd3-ad51-468541a7c864"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>INNER\nCARTON OF MULTIPACK (WITHOUT BLUE BOX)</span></b></p>", "ID": "71c8a0e0-3487-4e7d-b206-3c2957c48384", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b2028760-071f-498b-9e0b-d74971b45ce1"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>INNER\nCARTON OF MULTIPACK (WITHOUT BLUE BOX)</span></b>", "ID": "d796ab69-cd46-486c-ae80-f7873e65fc8f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "71c8a0e0-3487-4e7d-b206-3c2957c48384"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>INNER\nCARTON OF MULTIPACK (WITHOUT BLUE BOX)</span>", "ID": "ccacc966-73db-4d67-95a7-60c3f481c3a3", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "INNER CARTON OF MULTIPACK (WITHOUT BLUE BOX)", "ParentId": "d796ab69-cd46-486c-ae80-f7873e65fc8f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "42e1e6b4-bde5-4e83-89d0-ae01e7a20bbf", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "1acf2df7-72a8-4f6e-ade7-7acc19afffec", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "42e1e6b4-bde5-4e83-89d0-ae01e7a20bbf"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "f9640531-950c-4cb8-96a3-f77ae4f4b082", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "847a7838-8e3a-4abb-beb8-bf90b5272464", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "f9640531-950c-4cb8-96a3-f77ae4f4b082"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\nOF THE MEDICINAL PRODUCT</span></b></p>\n</div>", "ID": "b237fd0c-599c-44d3-bfca-777e34a05382", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\nOF THE MEDICINAL PRODUCT</span></b></p>", "ID": "1d84b30d-c3b6-4f29-ba55-988433312f05", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b237fd0c-599c-44d3-bfca-777e34a05382"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\nOF THE MEDICINAL PRODUCT</span></b>", "ID": "a996b44c-1ad4-4074-9de7-02db198fa3cb", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "1d84b30d-c3b6-4f29-ba55-988433312f05"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\nOF THE MEDICINAL PRODUCT</span>", "ID": "a86d062a-a7f6-4702-9aee-5d2b5029b817", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT", "ParentId": "a996b44c-1ad4-4074-9de7-02db198fa3cb"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "2f6454b1-9b5d-410d-aba5-f21b4e4923c0", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "a284d33b-ec7e-4171-8bd0-33c5839d6d90", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "2f6454b1-9b5d-410d-aba5-f21b4e4923c0"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Febuxostat Mylan 80\u00a0mg film-coated tablets</span></p>", "ID": "dda5a3a7-e421-4878-9d98-0825e79b8923", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Febuxostat Mylan 80\u00a0mg film-coated tablets</span>", "ID": "e17d063d-ac02-4698-a5ef-20418abeae65", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "Febuxostat Mylan 80\u00a0mg film-coated tablets", "ParentId": "dda5a3a7-e421-4878-9d98-0825e79b8923"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "964f08dc-847b-4583-9976-7261a8680847", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "54d28a89-7fe8-42ed-abe2-bf077ab1410d", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "964f08dc-847b-4583-9976-7261a8680847"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>febuxostat</span><b><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'> </span></b></p>", "ID": "23193210-9614-44d9-965f-d1ae2e744108", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>febuxostat</span>", "ID": "a50803d3-2a5d-4dd1-ab53-16119c659dcc", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "febuxostat", "ParentId": "23193210-9614-44d9-965f-d1ae2e744108"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'> </span></b>", "ID": "4fcef925-1af2-48db-9fc2-4373d8ff7fc8", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "23193210-9614-44d9-965f-d1ae2e744108"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'> </span>", "ID": "3871dd0b-e74d-40ea-9436-088bcc364840", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": " ", "ParentId": "4fcef925-1af2-48db-9fc2-4373d8ff7fc8"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "b6974e3c-28b6-494a-b1f3-327384966acd", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "fb932c1c-51c5-4019-87ca-152ed1835845", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "b6974e3c-28b6-494a-b1f3-327384966acd"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "5e248000-57cd-4983-8721-3d548654cb36", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "51ed13eb-d6c5-4a41-b7db-b0a430e10b32", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "5e248000-57cd-4983-8721-3d548654cb36"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT\nOF ACTIVE SUBSTANCE</span></b></p>\n</div>", "ID": "3f772400-a470-4847-bede-62494a5ecc25", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT\nOF ACTIVE SUBSTANCE</span></b></p>", "ID": "663c7811-cf75-4a42-950a-168861ece8c0", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3f772400-a470-4847-bede-62494a5ecc25"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT\nOF ACTIVE SUBSTANCE</span></b>", "ID": "409cf9e2-f830-4c35-a84b-58303c92eb52", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "663c7811-cf75-4a42-950a-168861ece8c0"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT\nOF ACTIVE SUBSTANCE</span>", "ID": "e10738ac-26c2-4848-8538-0f41c4a9b483", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT OF ACTIVE SUBSTANCE", "ParentId": "409cf9e2-f830-4c35-a84b-58303c92eb52"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "546901a4-94a7-4bfe-b16a-b7cdc001ce7a", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "333319c9-8eb1-40d9-9edc-e3559962e407", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "546901a4-94a7-4bfe-b16a-b7cdc001ce7a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Each tablet contains 80\u00a0mg febuxostat.</span></p>", "ID": "03d1a416-3669-4f2a-943f-e3ad5d380824", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Each tablet contains 80\u00a0mg febuxostat.</span>", "ID": "8d904c2b-817c-4516-a9e0-50af6b111dc7", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "Each tablet contains 80\u00a0mg febuxostat.", "ParentId": "03d1a416-3669-4f2a-943f-e3ad5d380824"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "c3eb66ff-62af-4f38-957c-ed5c00e70410", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "22b8ddbf-6b66-4067-8073-bbdec48b9a4c", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "c3eb66ff-62af-4f38-957c-ed5c00e70410"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "295d7ee4-5c55-4682-bcae-08cf7cc92003", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "191c9053-e9a1-4415-b975-dbec6f3f1317", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "295d7ee4-5c55-4682-bcae-08cf7cc92003"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST\nOF EXCIPIENTS</span></b></p>\n</div>", "ID": "33aaa60c-7476-49ca-a8ff-5f820ff6edf4", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST\nOF EXCIPIENTS</span></b></p>", "ID": "091d7d78-4789-4695-999e-e8c8732fa756", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "33aaa60c-7476-49ca-a8ff-5f820ff6edf4"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST\nOF EXCIPIENTS</span></b>", "ID": "5f39e33c-b9a5-436b-90f8-23d25675d088", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "091d7d78-4789-4695-999e-e8c8732fa756"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST\nOF EXCIPIENTS</span>", "ID": "b6459ce9-2144-4e8f-92bf-d00461889431", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST OF EXCIPIENTS", "ParentId": "5f39e33c-b9a5-436b-90f8-23d25675d088"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "b008bf70-f7b8-4399-aa95-1f77cd9d81c1", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "8f926ce0-fe05-48cc-b86b-a4eb6d277186", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "b008bf70-f7b8-4399-aa95-1f77cd9d81c1"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Also contains lactose.</span></p>", "ID": "ae37a264-50cc-4def-88d8-cddc1ade6243", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Also contains lactose.</span>", "ID": "499f98dc-6c1a-47ef-a129-533201ae1314", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Also contains lactose.", "ParentId": "ae37a264-50cc-4def-88d8-cddc1ade6243"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "a989532e-95c8-4048-bdab-f4b787b3e777", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "4a1ad172-0fdc-4fdf-9437-db23ac954565", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "a989532e-95c8-4048-bdab-f4b787b3e777"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>See leaflet for further information.</span></p>", "ID": "b0454c78-3444-48d2-8f64-eb4e60b488bd", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>See leaflet for further information.</span>", "ID": "2a212a58-45ba-4ac0-b8b3-87b8ccb43ad0", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "See leaflet for further information.", "ParentId": "b0454c78-3444-48d2-8f64-eb4e60b488bd"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "fdf5a311-00f4-46f7-925d-17edf55d3539", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "5483b72f-47e4-4abb-9e31-85902e7af721", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "fdf5a311-00f4-46f7-925d-17edf55d3539"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "731d32f9-a228-417b-8a43-fef7b2befe27", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "fac26fe4-7736-476f-814e-a409f4baefae", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "731d32f9-a228-417b-8a43-fef7b2befe27"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\nFORM AND CONTENTS</span></b></p>\n</div>", "ID": "8b973396-9f3f-4ad0-b986-6627f12ffc21", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\nFORM AND CONTENTS</span></b></p>", "ID": "00b48a26-1e66-44c0-835b-1166334b4ae4", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "8b973396-9f3f-4ad0-b986-6627f12ffc21"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\nFORM AND CONTENTS</span></b>", "ID": "7b9a73f8-a072-48c4-b7b0-211a7895bfd4", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "00b48a26-1e66-44c0-835b-1166334b4ae4"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\nFORM AND CONTENTS</span>", "ID": "e03d16bb-5b25-4902-83e6-8c824abb22c5", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL FORM AND CONTENTS", "ParentId": "7b9a73f8-a072-48c4-b7b0-211a7895bfd4"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "82b5efbb-ea01-42da-8c9e-7a12ed5b3109", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "fd8ee3e6-a87c-47ce-aaab-6b67c08e8b82", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "82b5efbb-ea01-42da-8c9e-7a12ed5b3109"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>42 film-coated tablets</span></p>", "ID": "c7a25860-9ac1-407f-8a03-b6586825ea00", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>42 film-coated tablets</span>", "ID": "28336dcd-bdd5-4c2a-8471-571193c9bb09", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "42 film-coated tablets", "ParentId": "c7a25860-9ac1-407f-8a03-b6586825ea00"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "de601f33-901b-4fb7-9aba-544f684ad9c0", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "5c0485f2-cc0a-40d6-b38e-98723935813b", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "de601f33-901b-4fb7-9aba-544f684ad9c0"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Components of a multipack, can\u2019t be sold separately.</span></p>", "ID": "17e44517-e01d-405c-8d67-608cd04c7c46", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Components of a multipack, can\u2019t be sold separately.</span>", "ID": "0432960a-130f-4849-a4ab-d18af045b621", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "Components of a multipack, can\u2019t be sold separately.", "ParentId": "17e44517-e01d-405c-8d67-608cd04c7c46"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "e71f35f9-711f-4b25-9ece-b3c323c57879", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "1ea5d65e-ae61-4f85-b522-b2c92584424c", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "e71f35f9-711f-4b25-9ece-b3c323c57879"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "7a557fd4-4626-48af-bf6c-307ae760b3e4", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "8fe752e0-f2e7-48f6-b8c8-6e0b2d5d6a62", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "7a557fd4-4626-48af-bf6c-307ae760b3e4"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD\nAND ROUTE(S) OF ADMINISTRATION</span></b></p>\n</div>", "ID": "d3ebb6cd-4fde-4eb0-abeb-98cfdc71ccd8", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD\nAND ROUTE(S) OF ADMINISTRATION</span></b></p>", "ID": "cc330cb6-2df2-47e2-a006-0ad9e9cdbe09", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d3ebb6cd-4fde-4eb0-abeb-98cfdc71ccd8"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD\nAND ROUTE(S) OF ADMINISTRATION</span></b>", "ID": "b0c323e9-4c19-4547-9436-703f88e5005f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "cc330cb6-2df2-47e2-a006-0ad9e9cdbe09"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD\nAND ROUTE(S) OF ADMINISTRATION</span>", "ID": "fd090748-9fe2-4f3d-bc3e-00455e976a67", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD AND ROUTE(S) OF ADMINISTRATION", "ParentId": "b0c323e9-4c19-4547-9436-703f88e5005f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "9de689fc-6e4e-4823-9156-878b1963e9db", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "bc79550c-80ca-46f7-b1a1-49f5d0bd3c15", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "9de689fc-6e4e-4823-9156-878b1963e9db"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>For oral use.</span></p>", "ID": "eeda73b2-bbaf-42d5-910d-31049c36cfc1", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>For oral use.</span>", "ID": "0ec2becc-9bd1-4272-81c9-a7f31434a02a", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "For oral use.", "ParentId": "eeda73b2-bbaf-42d5-910d-31049c36cfc1"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "5ce4ac4f-71d1-422e-818b-a730612296ea", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "e4054aa6-51f0-4117-8ab4-77795e9a901d", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "5ce4ac4f-71d1-422e-818b-a730612296ea"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Read the package leaflet before use.</span></p>", "ID": "b0ab65dc-32a3-4f16-8e34-c944524929c0", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Read the package leaflet before use.</span>", "ID": "a767d0ff-f68d-4eaa-97d9-8e3a8ac2a072", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "Read the package leaflet before use.", "ParentId": "b0ab65dc-32a3-4f16-8e34-c944524929c0"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "818d4dd2-98e7-4b40-a8af-521fbab3942c", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "38de161f-7be4-4028-8b1c-7a4687d755b2", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "818d4dd2-98e7-4b40-a8af-521fbab3942c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "00f0289e-9e88-43ed-9735-d623564a7334", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "d2b9d9a8-e2c2-483a-bc76-f3d2408eeb82", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "00f0289e-9e88-43ed-9735-d623564a7334"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nWARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF\nCHILDREN</span></b></p>\n</div>", "ID": "f888c987-e29f-46c3-a9c7-335ea18da312", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nWARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF\nCHILDREN</span></b></p>", "ID": "f132017e-3496-4b67-8496-a4868349e9ec", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f888c987-e29f-46c3-a9c7-335ea18da312"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nWARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF\nCHILDREN</span></b>", "ID": "1bc322da-6af7-408f-b56f-b66dba9af361", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f132017e-3496-4b67-8496-a4868349e9ec"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nWARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF\nCHILDREN</span>", "ID": "97c0f98e-3ae0-4c67-9808-7471edee346f", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN", "ParentId": "1bc322da-6af7-408f-b56f-b66dba9af361"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "baf2a15f-607b-489c-9b20-85826ec950ad", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "b1b74c92-9c6d-41f1-9403-bcbed4025c30", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "baf2a15f-607b-489c-9b20-85826ec950ad"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Keep out of the sight and reach of children.</span></p>", "ID": "1944a39b-6568-42ed-b970-0fd60561846b", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Keep out of the sight and reach of children.</span>", "ID": "4a05f982-5166-44ce-94e9-eec030084960", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "Keep out of the sight and reach of children.", "ParentId": "1944a39b-6568-42ed-b970-0fd60561846b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "6234b89b-1406-4908-807f-e6130b77f692", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "b432b65e-014e-4f83-9cb2-a1daa8fdf54a", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "6234b89b-1406-4908-807f-e6130b77f692"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "55e9de5c-bd85-4c3f-ab47-faca02f0a7b0", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "101f00a9-c139-4738-84f9-a12f6dab85ad", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "55e9de5c-bd85-4c3f-ab47-faca02f0a7b0"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER\nSPECIAL WARNING(S), IF NECESSARY</span></b></p>\n</div>", "ID": "ef8cfe92-f0a3-4295-ac2f-0f39473a7899", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER\nSPECIAL WARNING(S), IF NECESSARY</span></b></p>", "ID": "500760f4-6a57-4b5e-9160-2b20d65621f7", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ef8cfe92-f0a3-4295-ac2f-0f39473a7899"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER\nSPECIAL WARNING(S), IF NECESSARY</span></b>", "ID": "36225598-1f2e-4a33-b2aa-ace338d8e888", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "500760f4-6a57-4b5e-9160-2b20d65621f7"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER\nSPECIAL WARNING(S), IF NECESSARY</span>", "ID": "b8482c40-1a2c-43bd-b9a2-c5a1cf40e783", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER SPECIAL WARNING(S), IF NECESSARY", "ParentId": "36225598-1f2e-4a33-b2aa-ace338d8e888"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "55495b99-0949-4e1c-a4a5-5c670435f0e3", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "91c470f8-e7ef-43a7-8fe8-95ff2dee8a17", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "55495b99-0949-4e1c-a4a5-5c670435f0e3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "8f521348-32c3-4e06-b585-9cbb6b5e7130", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "55fe48e8-97cd-4b14-8ab0-bf562d99c526", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "8f521348-32c3-4e06-b585-9cbb6b5e7130"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "83f2013d-965b-4088-8019-5e38a3d7b83d", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "ac346680-5e01-4710-ac19-f54cbfccb4f1", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "83f2013d-965b-4088-8019-5e38a3d7b83d"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY\nDATE</span></b></p>\n</div>", "ID": "6c11863a-dd20-4e9e-901c-2527628c6e8f", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY\nDATE</span></b></p>", "ID": "873c23ab-e471-4503-918c-b92bcd97898c", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "6c11863a-dd20-4e9e-901c-2527628c6e8f"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY\nDATE</span></b>", "ID": "3e0d88e5-b376-4ce3-840c-bc29a71d827a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "873c23ab-e471-4503-918c-b92bcd97898c"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY\nDATE</span>", "ID": "8a94b832-9784-4bca-a0be-4e4f4423600c", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE", "ParentId": "3e0d88e5-b376-4ce3-840c-bc29a71d827a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "035a3998-7ef8-4be9-a1c9-e25852ee7be0", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "4a2abeaf-7fa2-4eb3-9ab6-ddc8a80a1a17", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "035a3998-7ef8-4be9-a1c9-e25852ee7be0"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>EXP</span></p>", "ID": "c95fe13e-673a-4a51-898c-4ba256c1e7de", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>EXP</span>", "ID": "f67945d7-4b61-4e69-999b-c90a5b2e320a", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "EXP", "ParentId": "c95fe13e-673a-4a51-898c-4ba256c1e7de"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "3d2c83d3-ecb4-4119-8e18-3b1e5ba975d1", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "a66b57fa-0c15-4c24-adb3-b8bdf663de31", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "3d2c83d3-ecb4-4119-8e18-3b1e5ba975d1"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "11027f31-28bf-4ec4-b6d5-cd66d6e22b69", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "e0cfdc2c-452f-4385-b383-f1d0fca74950", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "11027f31-28bf-4ec4-b6d5-cd66d6e22b69"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;page-break-after:\navoid;border:none;padding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span></b></p>\n</div>", "ID": "5c2fb1e5-29af-4c53-9cd2-2a0e38b45754", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;page-break-after:\navoid;border:none;padding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span></b></p>", "ID": "363804ed-cce6-4ce6-ac5c-2ff1e1818032", "Styles": "margin-bottom:0in;line-height:normal;page-break-after:\navoid;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5c2fb1e5-29af-4c53-9cd2-2a0e38b45754"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span></b>", "ID": "41667484-1b3e-4302-add1-a9508be8b992", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "363804ed-cce6-4ce6-ac5c-2ff1e1818032"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span>", "ID": "f7b5f9f7-9b59-4c16-8376-c1b7d5307751", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL STORAGE CONDITIONS", "ParentId": "41667484-1b3e-4302-add1-a9508be8b992"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "bd02d062-89b8-4ccc-8677-5b2036d714d6", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "5196d4ad-f56a-4139-b4b9-7b83f7bc249a", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "bd02d062-89b8-4ccc-8677-5b2036d714d6"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "116cfd6e-d6b3-4bc2-b482-8c260820ccbf", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "5b23603d-5571-4b6a-a12c-a6cf5c360a6a", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "116cfd6e-d6b3-4bc2-b482-8c260820ccbf"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "d7809a3a-1b7b-4379-b377-585aba68c12a", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "aabcc449-888b-46f1-bf7b-6393455873d2", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "d7809a3a-1b7b-4379-b377-585aba68c12a"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>10.\u00a0\u00a0\u00a0\u00a0 SPECIAL\nPRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS\nDERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE</span></b></p>\n</div>", "ID": "88bfc17c-d451-4a73-8424-5325979d015a", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>10.\u00a0\u00a0\u00a0\u00a0 SPECIAL\nPRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS\nDERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE</span></b></p>", "ID": "9a63e716-5e39-4dfb-af31-4618465bef76", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "88bfc17c-d451-4a73-8424-5325979d015a"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>10.\u00a0\u00a0\u00a0\u00a0 SPECIAL\nPRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS\nDERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE</span></b>", "ID": "38bd5499-4203-452d-9895-e7215fe506af", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9a63e716-5e39-4dfb-af31-4618465bef76"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>10.\u00a0\u00a0\u00a0\u00a0 SPECIAL\nPRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS\nDERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE</span>", "ID": "81c9b99c-04ac-4ab7-a405-40cc3980978b", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "10.\u00a0\u00a0\u00a0\u00a0 SPECIAL PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE", "ParentId": "38bd5499-4203-452d-9895-e7215fe506af"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "a5f55c89-6016-42ec-8da5-fcfc08f46813", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "8eddb248-a91f-4137-b7e2-e409521a4403", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "a5f55c89-6016-42ec-8da5-fcfc08f46813"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "97f27176-0938-4a36-bc84-440f30d0fcea", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "4048dbbf-dab1-4864-b847-ac67d53d4764", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "97f27176-0938-4a36-bc84-440f30d0fcea"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "1d7187b6-2647-46f6-baa6-6e8c94a4428d", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "625dcff1-6c82-423f-b96c-ffce32f0b6db", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "1d7187b6-2647-46f6-baa6-6e8c94a4428d"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>11.\u00a0\u00a0\u00a0\u00a0 NAME\nAND ADDRESS OF THE MARKETING AUTHORISATION HOLDER</span></b></p>\n</div>", "ID": "683aa787-b9c1-4b13-a59f-5f0ec6255528", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>11.\u00a0\u00a0\u00a0\u00a0 NAME\nAND ADDRESS OF THE MARKETING AUTHORISATION HOLDER</span></b></p>", "ID": "7457be4f-8f23-4167-9cae-65fc43b30b54", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "683aa787-b9c1-4b13-a59f-5f0ec6255528"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>11.\u00a0\u00a0\u00a0\u00a0 NAME\nAND ADDRESS OF THE MARKETING AUTHORISATION HOLDER</span></b>", "ID": "e6170e27-20c8-4b0c-b05c-bef17b105ff1", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "7457be4f-8f23-4167-9cae-65fc43b30b54"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>11.\u00a0\u00a0\u00a0\u00a0 NAME\nAND ADDRESS OF THE MARKETING AUTHORISATION HOLDER</span>", "ID": "e911b3be-f082-4e72-9188-378798731e3e", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "11.\u00a0\u00a0\u00a0\u00a0 NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER", "ParentId": "e6170e27-20c8-4b0c-b05c-bef17b105ff1"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "00129630-f504-40b4-a5cf-329610467637", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "8263c480-c288-4f0d-ab38-6a4f160ca4ef", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "00129630-f504-40b4-a5cf-329610467637"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"DE-AT\" style='font-family:\n\"Times New Roman\",serif'>Mylan S.A.S.</span></p>", "ID": "496a008d-4a53-4ffc-a888-3244fb2d076b", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"DE-AT\" style='font-family:\n\"Times New Roman\",serif'>Mylan S.A.S.</span>", "ID": "44d62fdc-8bc3-47f1-9734-a01f136a6c8d", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "Mylan S.A.S.", "ParentId": "496a008d-4a53-4ffc-a888-3244fb2d076b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"DE-AT\" style='font-family:\n\"Times New Roman\",serif'>117 Allee des Parcs</span></p>", "ID": "c722932a-8d19-47ea-98f0-1fbee5044744", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"DE-AT\" style='font-family:\n\"Times New Roman\",serif'>117 Allee des Parcs</span>", "ID": "e15a67e0-1fd4-421b-98f5-02216e570a03", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "117 Allee des Parcs", "ParentId": "c722932a-8d19-47ea-98f0-1fbee5044744"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>69 800 Saint Priest</span></p>", "ID": "489968b0-6898-4623-b4dc-02442c5186e7", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>69 800 Saint Priest</span>", "ID": "274caa57-fe70-49ee-a563-8a0c972de121", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "69 800 Saint Priest", "ParentId": "489968b0-6898-4623-b4dc-02442c5186e7"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>France</span></p>", "ID": "62c70ac6-df10-48c0-bae5-c3f069f8523b", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>France</span>", "ID": "bc336e4e-c688-417a-b7d4-8ce27f81e4c4", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "France", "ParentId": "62c70ac6-df10-48c0-bae5-c3f069f8523b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "de1b7f74-1432-42cc-a738-d227249f0b2d", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "c788bc5e-906f-49e0-8e1a-f89f306b675a", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "de1b7f74-1432-42cc-a738-d227249f0b2d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "c79bf09c-c2a0-4fba-811b-e86735856022", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "cc24d5b3-28cd-4338-b655-86342de12243", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "c79bf09c-c2a0-4fba-811b-e86735856022"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>12.\u00a0\u00a0\u00a0\u00a0 MARKETING\nAUTHORISATION NUMBER(S) </span></b></p>\n</div>", "ID": "c2552cc5-8034-4fe0-9679-95fa0122af82", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>12.\u00a0\u00a0\u00a0\u00a0 MARKETING\nAUTHORISATION NUMBER(S) </span></b></p>", "ID": "9a074edb-31b6-47bf-8ced-7a2368cab285", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c2552cc5-8034-4fe0-9679-95fa0122af82"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>12.\u00a0\u00a0\u00a0\u00a0 MARKETING\nAUTHORISATION NUMBER(S) </span></b>", "ID": "9d6709dd-a26f-434a-909a-9051d1330825", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9a074edb-31b6-47bf-8ced-7a2368cab285"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>12.\u00a0\u00a0\u00a0\u00a0 MARKETING\nAUTHORISATION NUMBER(S) </span>", "ID": "28f645a1-7ca1-4d66-b278-e812087ebad2", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "12.\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION NUMBER(S) ", "ParentId": "9d6709dd-a26f-434a-909a-9051d1330825"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "4940aa2e-b541-4f8e-a6ef-7c36c9c7b064", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "65dacfda-4f1f-41a5-b1b8-00711dc0f892", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "4940aa2e-b541-4f8e-a6ef-7c36c9c7b064"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/022</span></p>", "ID": "146b663c-df7c-4fab-95c1-1b3f51326c7a", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/022</span>", "ID": "bb72172e-94d9-4c3b-90b4-6db92e5a2023", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "EU/1/17/1194/022", "ParentId": "146b663c-df7c-4fab-95c1-1b3f51326c7a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "54abf70b-febb-42cf-a421-288399e9e8b4", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "f05de321-2485-4026-8e62-13b4760a6a85", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "54abf70b-febb-42cf-a421-288399e9e8b4"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "b6574227-d79c-4f92-af7e-1a7e093b66d9", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "418b5333-6185-4ff8-ba03-32695825c764", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "b6574227-d79c-4f92-af7e-1a7e093b66d9"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>13.\u00a0\u00a0\u00a0\u00a0 BATCH\nNUMBER</span></b></p>\n</div>", "ID": "dba6b162-526c-4487-acf2-f6848c9cadca", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>13.\u00a0\u00a0\u00a0\u00a0 BATCH\nNUMBER</span></b></p>", "ID": "277fd6be-648f-46db-97fc-ffa657173e28", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "dba6b162-526c-4487-acf2-f6848c9cadca"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>13.\u00a0\u00a0\u00a0\u00a0 BATCH\nNUMBER</span></b>", "ID": "4b891741-58bb-49e3-9299-f3605b6418dd", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "277fd6be-648f-46db-97fc-ffa657173e28"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>13.\u00a0\u00a0\u00a0\u00a0 BATCH\nNUMBER</span>", "ID": "a3845afb-b2af-4721-8822-ba9c57cef20d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "13.\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER", "ParentId": "4b891741-58bb-49e3-9299-f3605b6418dd"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><i><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></i></p>", "ID": "af9608ad-00e0-48cc-8f1a-1b1d963a9f7a", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<i><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></i>", "ID": "1150a4e5-edf7-409a-b92d-c960d72d95b9", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "af9608ad-00e0-48cc-8f1a-1b1d963a9f7a"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "1c13673e-a54a-48ac-9068-228c62d1815e", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "1150a4e5-edf7-409a-b92d-c960d72d95b9"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Lot</span></p>", "ID": "aff4f28c-72ca-4b3d-80da-933fa10eaf8c", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Lot</span>", "ID": "12f71f9e-23be-4b5e-b6fa-d7b9ff08ec03", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "Lot", "ParentId": "aff4f28c-72ca-4b3d-80da-933fa10eaf8c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "b158e6f5-9c28-43e9-9ec0-0a3d706a48f5", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "febf36e4-46c0-4eee-9dd1-5f015b9ef46e", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "b158e6f5-9c28-43e9-9ec0-0a3d706a48f5"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "751932a6-94dd-4d24-b3ad-aec18ea8e42a", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "c4253099-bc85-426a-841c-140a85de6b75", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "751932a6-94dd-4d24-b3ad-aec18ea8e42a"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>14.\u00a0\u00a0\u00a0\u00a0 GENERAL\nCLASSIFICATION FOR SUPPLY</span></b></p>\n</div>", "ID": "b7abae30-8787-457f-96fc-57bcc167fbe5", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>14.\u00a0\u00a0\u00a0\u00a0 GENERAL\nCLASSIFICATION FOR SUPPLY</span></b></p>", "ID": "807c7ae9-aaf0-44d6-afab-b86b8bba4ecd", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b7abae30-8787-457f-96fc-57bcc167fbe5"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>14.\u00a0\u00a0\u00a0\u00a0 GENERAL\nCLASSIFICATION FOR SUPPLY</span></b>", "ID": "a9794c29-d952-4098-9c50-3e486535d71a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "807c7ae9-aaf0-44d6-afab-b86b8bba4ecd"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>14.\u00a0\u00a0\u00a0\u00a0 GENERAL\nCLASSIFICATION FOR SUPPLY</span>", "ID": "04907fbc-9357-4edd-982c-d8b449ab29ba", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "14.\u00a0\u00a0\u00a0\u00a0 GENERAL CLASSIFICATION FOR SUPPLY", "ParentId": "a9794c29-d952-4098-9c50-3e486535d71a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><i><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></i></p>", "ID": "c3ec8b8b-ca3e-4801-8bcc-dfc327bfc5f0", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<i><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></i>", "ID": "43a5bf70-fbef-48ac-892a-8a9284e6ed63", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c3ec8b8b-ca3e-4801-8bcc-dfc327bfc5f0"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "67fca034-5f3a-42e5-87ef-36355b2a8b31", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "43a5bf70-fbef-48ac-892a-8a9284e6ed63"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "98a25d1b-46c7-44a0-a734-3e2bc629b50d", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "0039aa89-9807-4cf5-a1c0-4c4a2d52c986", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "98a25d1b-46c7-44a0-a734-3e2bc629b50d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "d2270c74-a2e6-4162-b428-9fa9e37793df", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "cb21dbb3-45c5-4a2d-90c2-466ecf27f50d", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "d2270c74-a2e6-4162-b428-9fa9e37793df"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:2.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS\nON USE</span></b></p>\n</div>", "ID": "70d28665-5915-4ab9-8f77-fe559e62355c", "Styles": "border:solid windowtext 1.0pt;padding:2.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS\nON USE</span></b></p>", "ID": "3d8291d4-4f97-4776-a50e-a4f71cd82525", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "70d28665-5915-4ab9-8f77-fe559e62355c"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS\nON USE</span></b>", "ID": "76789b8e-fef7-420c-bb6e-4eab250f871b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "3d8291d4-4f97-4776-a50e-a4f71cd82525"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS\nON USE</span>", "ID": "3e188dd0-e176-442d-837e-66407e50ea52", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS ON USE", "ParentId": "76789b8e-fef7-420c-bb6e-4eab250f871b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "d248c2b9-9307-4f34-a453-1e6095d0b913", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "2c962fe7-17d4-431a-b71c-e9eea96128c4", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "d248c2b9-9307-4f34-a453-1e6095d0b913"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "22c90c61-e438-4e35-b82a-a0ce648afe17", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "0c2a2864-6de4-4632-bbc7-ab9b820eb571", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "22c90c61-e438-4e35-b82a-a0ce648afe17"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "a526ca12-e04d-44c3-a4d2-7b59ab1344c4", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "cf560128-8136-47ab-9043-acb369b22187", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "a526ca12-e04d-44c3-a4d2-7b59ab1344c4"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>16.\u00a0\u00a0\u00a0\u00a0 INFORMATION\nIN BRAILLE</span></b></p>\n</div>", "ID": "41db1d62-a434-4b8f-b1a2-49378dc91a8f", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>16.\u00a0\u00a0\u00a0\u00a0 INFORMATION\nIN BRAILLE</span></b></p>", "ID": "3a90a1c2-a837-48a4-9c4e-437445464371", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "41db1d62-a434-4b8f-b1a2-49378dc91a8f"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>16.\u00a0\u00a0\u00a0\u00a0 INFORMATION\nIN BRAILLE</span></b>", "ID": "fcf8aeb2-f736-41d8-9316-cd235bd1fa8a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "3a90a1c2-a837-48a4-9c4e-437445464371"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>16.\u00a0\u00a0\u00a0\u00a0 INFORMATION\nIN BRAILLE</span>", "ID": "e5d6c114-bc15-40d3-ad32-35ef5febd4f4", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "16.\u00a0\u00a0\u00a0\u00a0 INFORMATION IN BRAILLE", "ParentId": "fcf8aeb2-f736-41d8-9316-cd235bd1fa8a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "0975578f-eb54-485e-8bc2-96ea8b9d528f", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "f333ac89-fe27-4b06-9f11-9d8e275a0022", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "0975578f-eb54-485e-8bc2-96ea8b9d528f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Febuxostat Mylan 80\u00a0mg</span></p>", "ID": "c314e22b-2997-4ef8-a03b-eefb6fb3a63b", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Febuxostat Mylan 80\u00a0mg</span>", "ID": "d02d4186-f62d-4bfd-ab36-135370de4f52", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "Febuxostat Mylan 80\u00a0mg", "ParentId": "c314e22b-2997-4ef8-a03b-eefb6fb3a63b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:#CCCCCC'>\u00a0</span></p>", "ID": "192db25d-d7d0-4265-a056-27e9c6677a68", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:#CCCCCC'>\u00a0</span>", "ID": "0d653e18-e19e-4085-b603-75711996dc65", "Styles": "font-family:\n\"Times New Roman\",serif;background:#CCCCCC", "Classes": "None", "Text": "\u00a0", "ParentId": "192db25d-d7d0-4265-a056-27e9c6677a68"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:#CCCCCC'>\u00a0</span></p>", "ID": "b52879b8-8ea0-4f05-8439-0377c3bd65b5", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:#CCCCCC'>\u00a0</span>", "ID": "45cd6b0d-a0b6-46b5-8b2e-9d7fa001de67", "Styles": "font-family:\n\"Times New Roman\",serif;background:#CCCCCC", "Classes": "None", "Text": "\u00a0", "ParentId": "b52879b8-8ea0-4f05-8439-0377c3bd65b5"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>17.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 2D BARCODE</span></b></p>\n</div>", "ID": "51c9945d-35a9-43f6-8913-7e9dc7d3d023", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>17.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 2D BARCODE</span></b></p>", "ID": "68f812f2-5e3b-4e16-b35b-3cd26797f67f", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "51c9945d-35a9-43f6-8913-7e9dc7d3d023"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>17.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 2D BARCODE</span></b>", "ID": "69864928-d945-488d-a6b2-7796b00884df", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "68f812f2-5e3b-4e16-b35b-3cd26797f67f"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>17.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 2D BARCODE</span>", "ID": "cf9f30e8-a85a-4f48-92ab-07beb87ca54f", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "17.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE IDENTIFIER \u2013 2D BARCODE", "ParentId": "69864928-d945-488d-a6b2-7796b00884df"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "be9d2333-e15b-40bd-a407-7b2996eb0b27", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "78a8438b-f207-42a4-b34b-2d51ba08bdbe", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "be9d2333-e15b-40bd-a407-7b2996eb0b27"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC'>2D barcode carrying the\nunique identifier included.</span></p>", "ID": "250febce-0b7f-46b7-b9c1-a042298a0c7c", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC'>2D barcode carrying the\nunique identifier included.</span>", "ID": "15f5cb9c-3926-4c8a-92fe-22c53459b5f5", "Styles": "font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC", "Classes": "None", "Text": "2D barcode carrying the unique identifier included.", "ParentId": "250febce-0b7f-46b7-b9c1-a042298a0c7c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "ddc0a990-7002-415c-885d-b14ae6a6ae92", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "75dc46e8-bcdb-4775-8174-5e03a23b5aee", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "ddc0a990-7002-415c-885d-b14ae6a6ae92"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "7f7e1871-4245-4586-bffb-d052b0cbf92d", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "2070f637-7bcc-405b-9429-d76dc55f9343", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "7f7e1871-4245-4586-bffb-d052b0cbf92d"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>18.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 HUMAN READABLE DATA</span></b></p>\n</div>", "ID": "679dbb43-cb88-4c81-9df3-b59dfd0ac9d0", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>18.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 HUMAN READABLE DATA</span></b></p>", "ID": "ae38a1b9-52ca-4366-988f-cd161a53bcea", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "679dbb43-cb88-4c81-9df3-b59dfd0ac9d0"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>18.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 HUMAN READABLE DATA</span></b>", "ID": "f4db5e18-c7ed-44c0-b819-9fbfda37aa64", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ae38a1b9-52ca-4366-988f-cd161a53bcea"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>18.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 HUMAN READABLE DATA</span>", "ID": "64c1e556-5f73-4c0a-8277-6571bcae291f", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "18.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE IDENTIFIER \u2013 HUMAN READABLE DATA", "ParentId": "f4db5e18-c7ed-44c0-b819-9fbfda37aa64"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "a16ee8f5-394b-411b-953c-b4562bdbfb67", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "555786ec-4065-43ae-a7a3-6003e103245d", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "a16ee8f5-394b-411b-953c-b4562bdbfb67"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>PC:</span></p>", "ID": "fa291ee8-06f4-4344-9edb-426ef39d021d", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>PC:</span>", "ID": "7e2dfc91-e67e-4c23-b8e8-4815e463beae", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "PC:", "ParentId": "fa291ee8-06f4-4344-9edb-426ef39d021d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>SN:</span></p>", "ID": "cdf031db-d4d5-486b-aed0-b2e0de4522d6", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>SN:</span>", "ID": "8368cbfe-deb7-4eef-aa28-5cb2346f3ea1", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "SN:", "ParentId": "cdf031db-d4d5-486b-aed0-b2e0de4522d6"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>NN:</span></p>", "ID": "b028cd5e-6077-40f5-8d7d-f6c1ab1e4e16", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>NN:</span>", "ID": "ece19526-ac6b-4eb9-a439-c29b74369191", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "NN:", "ParentId": "b028cd5e-6077-40f5-8d7d-f6c1ab1e4e16"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;background:#CCCCCC'>\u00a0</span></p>", "ID": "1f73609a-1e22-41f8-a6eb-42ddc3ae9769", "Styles": "margin-bottom:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;background:#CCCCCC'>\u00a0</span>", "ID": "73af4fc9-c579-4f72-b152-b40fff9c01a0", "Styles": "font-family:\"Times New Roman\",serif;background:#CCCCCC", "Classes": "None", "Text": "\u00a0", "ParentId": "1f73609a-1e22-41f8-a6eb-42ddc3ae9769"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\ncolor:black;background:#CCCCCC'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span>", "ID": "28f355f7-2244-4720-8a15-e44ad22401db", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif;\ncolor:black;background:#CCCCCC", "Classes": "None", "Text": " ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<br clear=\"all\" style=\"page-break-before:always\"/>", "ID": "824e1f91-7822-40c5-8376-2048364ccef2", "Styles": "page-break-before:always", "Classes": "None", "Text": "", "ParentId": "28f355f7-2244-4720-8a15-e44ad22401db"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;background:#CCCCCC'>\u00a0</span></p>", "ID": "4f4f390c-ba68-4c58-ac82-af9f0297d41c", "Styles": "margin-bottom:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;background:#CCCCCC'>\u00a0</span>", "ID": "c07553fc-7294-4bab-80ab-1be626be9110", "Styles": "font-family:\"Times New Roman\",serif;background:#CCCCCC", "Classes": "None", "Text": "\u00a0", "ParentId": "4f4f390c-ba68-4c58-ac82-af9f0297d41c"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>PARTICULARS\nTO APPEAR ON THE IMMEDIATE PACKAGING </span></b></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>BOTTLE\nLABEL</span></b></p>\n</div>", "ID": "197b1b2e-48cb-4a88-8784-ded79a3d689f", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "    ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>PARTICULARS\nTO APPEAR ON THE IMMEDIATE PACKAGING </span></b></p>", "ID": "cbe6100b-8aef-4fa9-8eed-b1d3b00d1868", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "197b1b2e-48cb-4a88-8784-ded79a3d689f"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>PARTICULARS\nTO APPEAR ON THE IMMEDIATE PACKAGING </span></b>", "ID": "0c4037b6-dee3-4f7b-b3cf-c8ae99f98abf", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "cbe6100b-8aef-4fa9-8eed-b1d3b00d1868"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>PARTICULARS\nTO APPEAR ON THE IMMEDIATE PACKAGING </span>", "ID": "856fc72c-5017-4205-ba5b-1cce2943799f", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGING ", "ParentId": "0c4037b6-dee3-4f7b-b3cf-c8ae99f98abf"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "4e0ba308-ea07-4f0e-b1b3-2f92aa986f83", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "197b1b2e-48cb-4a88-8784-ded79a3d689f"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "bdf13c09-a71d-43c6-8a10-4f0f37dba9d0", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "4e0ba308-ea07-4f0e-b1b3-2f92aa986f83"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>BOTTLE\nLABEL</span></b></p>", "ID": "0b85a7e0-5f19-4bed-ac92-fbd76d861007", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "197b1b2e-48cb-4a88-8784-ded79a3d689f"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>BOTTLE\nLABEL</span></b>", "ID": "0d2da70e-7075-44ec-a335-b062c401d272", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0b85a7e0-5f19-4bed-ac92-fbd76d861007"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>BOTTLE\nLABEL</span>", "ID": "e43de18e-874d-416c-bd84-046d8833897d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "BOTTLE LABEL", "ParentId": "0d2da70e-7075-44ec-a335-b062c401d272"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "b3242110-9e66-4907-a89a-8a4184baebb7", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "1d4797a1-f64d-427b-9796-8e2f1f0b9fbf", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "b3242110-9e66-4907-a89a-8a4184baebb7"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "94838dee-0537-4a1b-8ab8-e5bc5660572e", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "49af4335-0021-4e49-a3bd-078a3ddd32d8", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "94838dee-0537-4a1b-8ab8-e5bc5660572e"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\nOF THE MEDICINAL PRODUCT</span></b></p>\n</div>", "ID": "40b44a2d-a9cd-433c-b615-7b8c9a007686", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\nOF THE MEDICINAL PRODUCT</span></b></p>", "ID": "2ab06921-b8d1-44fd-a11a-59600a02ddb6", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "40b44a2d-a9cd-433c-b615-7b8c9a007686"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\nOF THE MEDICINAL PRODUCT</span></b>", "ID": "8a6ced99-3404-4473-b206-d691f6646aa5", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "2ab06921-b8d1-44fd-a11a-59600a02ddb6"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\nOF THE MEDICINAL PRODUCT</span>", "ID": "47b91406-e710-4082-81e4-9cf82ad06c2e", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT", "ParentId": "8a6ced99-3404-4473-b206-d691f6646aa5"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "c72934bb-e7a9-4935-83e0-d43bb61e4171", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "adf8c2e2-2f9f-4a0a-9b93-38c6ebf7c082", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "c72934bb-e7a9-4935-83e0-d43bb61e4171"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Febuxostat Mylan 80\u00a0mg film-coated tablets </span></p>", "ID": "fb49d022-0c34-41cf-afbe-856683b17420", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Febuxostat Mylan 80\u00a0mg film-coated tablets </span>", "ID": "9dd15cdf-59d3-4bb3-96f6-e0afa930fca2", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "Febuxostat Mylan 80\u00a0mg film-coated tablets ", "ParentId": "fb49d022-0c34-41cf-afbe-856683b17420"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>febuxostat</span><b><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'> </span></b></p>", "ID": "638453f2-5710-4857-bc64-d741759a413c", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>febuxostat</span>", "ID": "d94c2297-2b8c-44b4-b949-0460b442bf94", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "febuxostat", "ParentId": "638453f2-5710-4857-bc64-d741759a413c"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'> </span></b>", "ID": "b10efe29-b58f-4690-8296-f0249598ea7a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "638453f2-5710-4857-bc64-d741759a413c"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'> </span>", "ID": "f78b3512-a7c9-47b1-bfe4-b5400d12d442", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": " ", "ParentId": "b10efe29-b58f-4690-8296-f0249598ea7a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "7d2cc6a3-9f33-464c-874c-547c886ab40f", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "00521fe8-8ef1-4314-a09a-0ab71f5cffd6", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "7d2cc6a3-9f33-464c-874c-547c886ab40f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "0197794f-a5dc-490c-b18b-5412afa13667", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "cbafc276-ab86-4043-854a-88a23326df49", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "0197794f-a5dc-490c-b18b-5412afa13667"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT\nOF ACTIVE SUBSTANCE</span></b></p>\n</div>", "ID": "9fad3f91-d903-4d30-ba54-cae575493d79", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT\nOF ACTIVE SUBSTANCE</span></b></p>", "ID": "14202d3f-64b7-4511-9b81-3bc4aae02769", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "9fad3f91-d903-4d30-ba54-cae575493d79"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT\nOF ACTIVE SUBSTANCE</span></b>", "ID": "c2d57f14-aeea-42fb-ba74-83c1d96620cc", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "14202d3f-64b7-4511-9b81-3bc4aae02769"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT\nOF ACTIVE SUBSTANCE</span>", "ID": "2a4f97b1-80f3-4938-a9c4-f3b117594acf", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT OF ACTIVE SUBSTANCE", "ParentId": "c2d57f14-aeea-42fb-ba74-83c1d96620cc"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "a49f7fb7-6bdc-47b3-981b-36a7ebbe0076", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "383a9d04-9af3-4eed-a53d-aa8985745caf", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "a49f7fb7-6bdc-47b3-981b-36a7ebbe0076"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Each tablet contains 80\u00a0mg febuxostat.</span></p>", "ID": "a7a0817c-93d7-4bd2-b475-7af38a28c6c7", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Each tablet contains 80\u00a0mg febuxostat.</span>", "ID": "0fd3b180-12a2-431d-a884-7a222a75b0bb", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "Each tablet contains 80\u00a0mg febuxostat.", "ParentId": "a7a0817c-93d7-4bd2-b475-7af38a28c6c7"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "dd8aa22f-c244-439b-ac33-eb58c0dcc093", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "019e1b3c-a7d6-4268-8c06-4627af667f34", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "dd8aa22f-c244-439b-ac33-eb58c0dcc093"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "f08d0845-5d9c-41dc-8643-81e7a584adbb", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "d071344b-f147-4192-b1e5-3f1d663353e1", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "f08d0845-5d9c-41dc-8643-81e7a584adbb"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST\nOF EXCIPIENTS</span></b></p>\n</div>", "ID": "871b1267-92e6-45ba-9b1f-1778f5530b65", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST\nOF EXCIPIENTS</span></b></p>", "ID": "ab025880-6d5c-44ee-9980-5fb45615e928", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "871b1267-92e6-45ba-9b1f-1778f5530b65"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST\nOF EXCIPIENTS</span></b>", "ID": "c63c4584-09ea-470f-a9ff-9a606652d466", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ab025880-6d5c-44ee-9980-5fb45615e928"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST\nOF EXCIPIENTS</span>", "ID": "64d5aa9f-6ac8-4cf8-b5c1-d5ec991c474c", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST OF EXCIPIENTS", "ParentId": "c63c4584-09ea-470f-a9ff-9a606652d466"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "1d64f4a2-03a1-4608-9ec8-83aa18be2cb0", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "f1f604e4-5027-47b0-b704-3fa2106546f8", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "1d64f4a2-03a1-4608-9ec8-83aa18be2cb0"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Also contains lactose.</span></p>", "ID": "35f765c2-61c7-40bb-b449-7d18bae7392a", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Also contains lactose.</span>", "ID": "b7789691-9e21-46a2-9c41-0686533976aa", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Also contains lactose.", "ParentId": "35f765c2-61c7-40bb-b449-7d18bae7392a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>See the package leaflet for further information.</span></p>", "ID": "a6bc8507-d725-4610-99c4-7dd6e0f665af", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>See the package leaflet for further information.</span>", "ID": "9e2d2439-f974-490a-982f-37689ec9680d", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "See the package leaflet for further information.", "ParentId": "a6bc8507-d725-4610-99c4-7dd6e0f665af"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "239e0445-1e2f-4f68-8561-b1b460bad23c", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "4c2cbb1b-96c8-4f65-9d6f-95e356bdb394", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "239e0445-1e2f-4f68-8561-b1b460bad23c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "c85fba90-c1f5-4ca2-ac0b-1dc8e33eed51", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "4a6b7aa4-9f68-4d5d-86b3-dfb6bdf6b19d", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "c85fba90-c1f5-4ca2-ac0b-1dc8e33eed51"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\nFORM AND CONTENTS</span></b></p>\n</div>", "ID": "4a7eb15b-2c94-4fe6-8671-debaaae50ce1", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\nFORM AND CONTENTS</span></b></p>", "ID": "2f95242e-9de5-4213-a632-60fe50c892c2", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "4a7eb15b-2c94-4fe6-8671-debaaae50ce1"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\nFORM AND CONTENTS</span></b>", "ID": "d23df098-7a56-44a5-bdeb-c2cce8bde384", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "2f95242e-9de5-4213-a632-60fe50c892c2"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\nFORM AND CONTENTS</span>", "ID": "795d7890-de7d-4c4b-afc1-d73463eff071", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL FORM AND CONTENTS", "ParentId": "d23df098-7a56-44a5-bdeb-c2cce8bde384"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "50efe04e-9e5c-49f4-9b33-1fc432099b7e", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "238a1702-4f81-46f8-8df8-088d7ee367a9", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "50efe04e-9e5c-49f4-9b33-1fc432099b7e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC'>Film-coated tablets</span></p>", "ID": "c93891da-9bea-4d92-a619-15433eff40a1", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC'>Film-coated tablets</span>", "ID": "420c0d6e-9779-4a48-8771-268dc7e109a1", "Styles": "font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC", "Classes": "None", "Text": "Film-coated tablets", "ParentId": "c93891da-9bea-4d92-a619-15433eff40a1"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey'>\u00a0</span></p>", "ID": "ff0d63aa-5380-4c39-b9ef-cc89b653db83", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey'>\u00a0</span>", "ID": "d641790b-eda9-4646-b6fe-d2f3711a5686", "Styles": "font-family:\n\"Times New Roman\",serif;background:lightgrey", "Classes": "None", "Text": "\u00a0", "ParentId": "ff0d63aa-5380-4c39-b9ef-cc89b653db83"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>28 film-coated tablets </span></p>", "ID": "83ae609b-b6ae-4a5d-95df-2aa2d911fcf9", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>28 film-coated tablets </span>", "ID": "57d892bd-7747-4493-b657-21e044de0726", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "28 film-coated tablets ", "ParentId": "83ae609b-b6ae-4a5d-95df-2aa2d911fcf9"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC'>84 film-coated tablets </span></p>", "ID": "2ec91d33-9a81-45b0-b219-8a74851518a4", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC'>84 film-coated tablets </span>", "ID": "4c2a9ae8-3de5-40c4-a7a1-87f240f304a5", "Styles": "font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC", "Classes": "None", "Text": "84 film-coated tablets ", "ParentId": "2ec91d33-9a81-45b0-b219-8a74851518a4"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "01f8544b-174c-4693-9c88-c6070d3c00a8", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "d3cd221d-b409-47dc-ab0d-47b153fd1b2f", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "01f8544b-174c-4693-9c88-c6070d3c00a8"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "27415b5b-8b0e-41e1-817b-3c1edbbd5b35", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "c2997b0a-c0b4-4645-a3c0-8ff25c6befd1", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "27415b5b-8b0e-41e1-817b-3c1edbbd5b35"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD\nAND ROUTE OF ADMINISTRATION</span></b></p>\n</div>", "ID": "bb0de36f-bb7d-4276-ba9b-3a016664ccc9", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD\nAND ROUTE OF ADMINISTRATION</span></b></p>", "ID": "b622858a-f404-454c-b1a7-41e87f5f9dcc", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bb0de36f-bb7d-4276-ba9b-3a016664ccc9"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD\nAND ROUTE OF ADMINISTRATION</span></b>", "ID": "bf262520-ce48-4447-b8c4-11b89d8c551b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b622858a-f404-454c-b1a7-41e87f5f9dcc"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD\nAND ROUTE OF ADMINISTRATION</span>", "ID": "6609d1c9-09fb-4317-8ba2-1055c2242eeb", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD AND ROUTE OF ADMINISTRATION", "ParentId": "bf262520-ce48-4447-b8c4-11b89d8c551b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "8be65764-b561-426d-9ac6-250dbb1db032", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "282d8270-98c3-4dad-938f-47245ba69cfd", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "8be65764-b561-426d-9ac6-250dbb1db032"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>For oral use.</span></p>", "ID": "ef3b359c-788e-4488-bf8b-17c06cb21bd4", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>For oral use.</span>", "ID": "70a8f366-76be-4c6b-aecb-5c32269833c3", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "For oral use.", "ParentId": "ef3b359c-788e-4488-bf8b-17c06cb21bd4"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Read the package leaflet before use.</span></p>", "ID": "849b5edc-5000-4522-9d5f-66b7556cc398", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Read the package leaflet before use.</span>", "ID": "94da7391-a98f-49c4-b274-00c2e0dd3ce3", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "Read the package leaflet before use.", "ParentId": "849b5edc-5000-4522-9d5f-66b7556cc398"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "d2dba001-6573-4638-a77f-87b71b99fb3a", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "49a85921-b2d7-48ff-bd56-4b3b4b4c70a8", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "d2dba001-6573-4638-a77f-87b71b99fb3a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "407c7d16-4c66-4ed1-9b88-96633dceb4a8", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "4dd55757-f3c0-4ff8-aee6-6f95c3d6253c", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "407c7d16-4c66-4ed1-9b88-96633dceb4a8"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nWARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF\nCHILDREN</span></b></p>\n</div>", "ID": "c7572c32-c7aa-4119-b695-b80d02bb5485", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nWARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF\nCHILDREN</span></b></p>", "ID": "9b9eaf3f-59b8-4408-baf7-4775ab015e2f", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c7572c32-c7aa-4119-b695-b80d02bb5485"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nWARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF\nCHILDREN</span></b>", "ID": "ca20d7c9-3aac-49f0-9043-8d033f74ed44", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9b9eaf3f-59b8-4408-baf7-4775ab015e2f"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nWARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF\nCHILDREN</span>", "ID": "38254948-7645-4ded-bb6f-0249ff6f3465", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN", "ParentId": "ca20d7c9-3aac-49f0-9043-8d033f74ed44"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "c951bf38-68d9-412d-ad43-009c89d94c5d", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "8f8e13ea-f2c0-4af5-a948-4ef1b7f5abe1", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "c951bf38-68d9-412d-ad43-009c89d94c5d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Keep out of the sight and reach of children.</span></p>", "ID": "654e3dec-9a37-444b-b8fd-395828448b0d", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Keep out of the sight and reach of children.</span>", "ID": "420492bb-e958-4f48-ac28-768d78c2c185", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "Keep out of the sight and reach of children.", "ParentId": "654e3dec-9a37-444b-b8fd-395828448b0d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "a635a0c0-4a77-42ea-8cfb-5a596aeb8d38", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "34e388f4-e5de-435a-aa7f-2fe718f356ea", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "a635a0c0-4a77-42ea-8cfb-5a596aeb8d38"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "131e5fa1-c3eb-417a-b5c1-0df9c1b5374e", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "99614e75-8586-48d1-9c31-078630efa3db", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "131e5fa1-c3eb-417a-b5c1-0df9c1b5374e"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER\nSPECIAL WARNING(S), IF NECESSARY</span></b></p>\n</div>", "ID": "0303a6ca-01b8-4b6c-8730-e9c653186340", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER\nSPECIAL WARNING(S), IF NECESSARY</span></b></p>", "ID": "9e6c2ed2-2be4-49c3-bb13-d3c8bb301b5d", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0303a6ca-01b8-4b6c-8730-e9c653186340"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER\nSPECIAL WARNING(S), IF NECESSARY</span></b>", "ID": "31a7e78d-ece5-4c07-b98f-9871787c2694", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9e6c2ed2-2be4-49c3-bb13-d3c8bb301b5d"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER\nSPECIAL WARNING(S), IF NECESSARY</span>", "ID": "4f5739fb-e802-4346-b23d-e6caf0778629", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER SPECIAL WARNING(S), IF NECESSARY", "ParentId": "31a7e78d-ece5-4c07-b98f-9871787c2694"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "55476a40-5fed-4d83-be85-5bbf2efb8450", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "7cca494b-8e1e-4bc5-ae8b-2541cdd87195", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "55476a40-5fed-4d83-be85-5bbf2efb8450"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "9fa24ec2-f06e-4110-9b8f-6a39c0ae6bba", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "9b898364-8f29-494c-a9a0-6ada1bea01fd", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "9fa24ec2-f06e-4110-9b8f-6a39c0ae6bba"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "c07a1bd2-0f2b-49c2-886d-3d08239a86d6", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "1be1a3f2-a494-4f38-a18b-289067f7380d", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "c07a1bd2-0f2b-49c2-886d-3d08239a86d6"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY\nDATE</span></b></p>\n</div>", "ID": "21f86222-c22e-4ff4-bece-475ebc3474a0", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY\nDATE</span></b></p>", "ID": "a3a2e3e0-9052-42f5-9358-d110c38a1cf0", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "21f86222-c22e-4ff4-bece-475ebc3474a0"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY\nDATE</span></b>", "ID": "e5e7a346-4231-4543-97f0-00bce26d047b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a3a2e3e0-9052-42f5-9358-d110c38a1cf0"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY\nDATE</span>", "ID": "56d19100-a1c1-4464-96d8-e135a27e703a", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE", "ParentId": "e5e7a346-4231-4543-97f0-00bce26d047b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "50e2e58a-c62b-446d-82e8-fe1a96f23165", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "5c092b2e-b363-4eb0-8ff7-2636158dd10e", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "50e2e58a-c62b-446d-82e8-fe1a96f23165"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>EXP</span></p>", "ID": "c89acc7c-09b8-4f8b-adf7-89685a12f040", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>EXP</span>", "ID": "fd93aee6-525b-4c8b-9b7b-afe1e1dde670", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "EXP", "ParentId": "c89acc7c-09b8-4f8b-adf7-89685a12f040"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>After first opening use within 180 days</span></p>", "ID": "fb8f4c15-8d03-4ac4-b10e-fc8af9373714", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>After first opening use within 180 days</span>", "ID": "a217fb22-dd99-4b4b-bdd4-db1518f1c5c6", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "After first opening use within 180 days", "ParentId": "fb8f4c15-8d03-4ac4-b10e-fc8af9373714"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "29caec19-ee21-438b-8e7d-97588017acd5", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "031f202b-e911-41e5-995f-6614fe9fbe64", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "29caec19-ee21-438b-8e7d-97588017acd5"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "ef8601c6-2c6d-4c54-91aa-013e5917f2ea", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "079e5bf3-09f6-4472-a051-6ce39618d303", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "ef8601c6-2c6d-4c54-91aa-013e5917f2ea"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;page-break-after:\navoid;border:none;padding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span></b></p>\n</div>", "ID": "da907820-eda3-4cb4-b004-e390bb6c5417", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;page-break-after:\navoid;border:none;padding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span></b></p>", "ID": "ec982288-28d7-4024-a52f-381fc17a1e7e", "Styles": "margin-bottom:0in;line-height:normal;page-break-after:\navoid;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "da907820-eda3-4cb4-b004-e390bb6c5417"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span></b>", "ID": "a276b080-b3d7-4a67-99d8-d5d135d8cb98", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ec982288-28d7-4024-a52f-381fc17a1e7e"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span>", "ID": "44b463e0-b1a9-490e-9904-a2b02e2a2aa2", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL STORAGE CONDITIONS", "ParentId": "a276b080-b3d7-4a67-99d8-d5d135d8cb98"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "3121f933-b8f2-4798-b584-108db489d6fe", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "f07aee4c-36cc-4cc6-a23d-ca80c77fcab9", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "3121f933-b8f2-4798-b584-108db489d6fe"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "784cff48-dc93-4b99-8fef-72cecf48d3a9", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "8f8a321b-7d9b-4d77-bbb7-cab5f954ff4e", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "784cff48-dc93-4b99-8fef-72cecf48d3a9"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "b6ee91e6-a54f-4a31-8a5f-47c7dd464947", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "4641bd59-b8d1-43ef-93b7-cfd64d0a6bff", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "b6ee91e6-a54f-4a31-8a5f-47c7dd464947"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>10.\u00a0\u00a0\u00a0\u00a0 SPECIAL\nPRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS\nDERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE</span></b></p>\n</div>", "ID": "0e72710d-1c4f-49cc-bd83-b232885f5ae5", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>10.\u00a0\u00a0\u00a0\u00a0 SPECIAL\nPRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS\nDERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE</span></b></p>", "ID": "f9d8348b-32b0-4e2e-a884-c9a2f12b02d5", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0e72710d-1c4f-49cc-bd83-b232885f5ae5"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>10.\u00a0\u00a0\u00a0\u00a0 SPECIAL\nPRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS\nDERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE</span></b>", "ID": "0dc479d9-c279-4965-b951-2f0adda5a967", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f9d8348b-32b0-4e2e-a884-c9a2f12b02d5"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>10.\u00a0\u00a0\u00a0\u00a0 SPECIAL\nPRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS\nDERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE</span>", "ID": "a113bbff-3f67-4c8c-bda8-a3c994336b61", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "10.\u00a0\u00a0\u00a0\u00a0 SPECIAL PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE", "ParentId": "0dc479d9-c279-4965-b951-2f0adda5a967"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "b1e608f0-4d4a-413f-b931-2b974b0f018e", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "e13957b3-e262-40cb-a0fe-63a7d4b65a9f", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "b1e608f0-4d4a-413f-b931-2b974b0f018e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "50ef549f-5b78-4279-895f-dd4f94a4b156", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "3103c221-ce02-43ba-ad47-48582078d98d", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "50ef549f-5b78-4279-895f-dd4f94a4b156"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "5f9bc6a6-7d46-4154-9bb6-882f1cb8f3b9", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "ef98ab17-7831-4c12-af4f-8a62a834bb31", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "5f9bc6a6-7d46-4154-9bb6-882f1cb8f3b9"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>11.\u00a0\u00a0\u00a0\u00a0 NAME\nAND ADDRESS OF THE MARKETING AUTHORISATION HOLDER</span></b></p>\n</div>", "ID": "099b63fc-44be-4d6a-9c2e-8a9716ddcafe", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>11.\u00a0\u00a0\u00a0\u00a0 NAME\nAND ADDRESS OF THE MARKETING AUTHORISATION HOLDER</span></b></p>", "ID": "cd4b8d8a-43d2-40c0-b1e6-0e25533d1555", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "099b63fc-44be-4d6a-9c2e-8a9716ddcafe"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>11.\u00a0\u00a0\u00a0\u00a0 NAME\nAND ADDRESS OF THE MARKETING AUTHORISATION HOLDER</span></b>", "ID": "6c1e7cf4-5850-4102-a777-ead1261fc108", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "cd4b8d8a-43d2-40c0-b1e6-0e25533d1555"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>11.\u00a0\u00a0\u00a0\u00a0 NAME\nAND ADDRESS OF THE MARKETING AUTHORISATION HOLDER</span>", "ID": "d77647cc-7859-4e5b-81e8-24a4e66d495b", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "11.\u00a0\u00a0\u00a0\u00a0 NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER", "ParentId": "6c1e7cf4-5850-4102-a777-ead1261fc108"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "70bde495-ef71-4a5f-9170-945672f004da", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "86f07f51-1100-42e8-a1c1-bd580b68ef5e", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "70bde495-ef71-4a5f-9170-945672f004da"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"DE-AT\" style='font-family:\n\"Times New Roman\",serif'>Mylan S.A.S.</span></p>", "ID": "b4d774ad-ff41-4638-826c-00f1521deb48", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"DE-AT\" style='font-family:\n\"Times New Roman\",serif'>Mylan S.A.S.</span>", "ID": "79a14199-6dae-4443-a421-8ec5a62cbd6c", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "Mylan S.A.S.", "ParentId": "b4d774ad-ff41-4638-826c-00f1521deb48"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"DE-AT\" style='font-family:\n\"Times New Roman\",serif'>117 Allee des Parcs</span></p>", "ID": "b8ffa2e1-1c1c-493f-83e4-28f0a86e10ee", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"DE-AT\" style='font-family:\n\"Times New Roman\",serif'>117 Allee des Parcs</span>", "ID": "b7e271a3-e9b2-4b3c-88bd-ce5f7166380c", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "117 Allee des Parcs", "ParentId": "b8ffa2e1-1c1c-493f-83e4-28f0a86e10ee"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>69 800 Saint Priest</span></p>", "ID": "3686e24d-7463-48a2-8568-18268c14420f", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>69 800 Saint Priest</span>", "ID": "9e27a3ae-ada6-4bcf-a23a-3451133de209", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "69 800 Saint Priest", "ParentId": "3686e24d-7463-48a2-8568-18268c14420f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>France</span></p>", "ID": "b130b312-1dad-4b8c-bd3b-a7b4de5b8149", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>France</span>", "ID": "e9bf2ce8-3445-4242-abb1-811e55b071c0", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "France", "ParentId": "b130b312-1dad-4b8c-bd3b-a7b4de5b8149"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "9a4e10f9-97bc-4171-8bc3-7d3187e22def", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "c51bb53c-7586-41f2-ad51-44782860f221", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "9a4e10f9-97bc-4171-8bc3-7d3187e22def"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "2419a3cb-8689-42be-9502-b801b63ab34b", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "32eb63a9-d420-464f-a8af-e586328b7f82", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "2419a3cb-8689-42be-9502-b801b63ab34b"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>12.\u00a0\u00a0\u00a0\u00a0 MARKETING\nAUTHORISATION NUMBER(S) </span></b></p>\n</div>", "ID": "3eb15056-596c-4206-8841-0fdca00bf852", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>12.\u00a0\u00a0\u00a0\u00a0 MARKETING\nAUTHORISATION NUMBER(S) </span></b></p>", "ID": "d98b6226-54ed-4560-ae4c-ffc476fea46a", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3eb15056-596c-4206-8841-0fdca00bf852"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>12.\u00a0\u00a0\u00a0\u00a0 MARKETING\nAUTHORISATION NUMBER(S) </span></b>", "ID": "3c26f37f-522a-48e6-abed-fd409425bcdf", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d98b6226-54ed-4560-ae4c-ffc476fea46a"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>12.\u00a0\u00a0\u00a0\u00a0 MARKETING\nAUTHORISATION NUMBER(S) </span>", "ID": "ad6f1232-2a0a-45f5-a9b1-4953e5e7e3e4", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "12.\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION NUMBER(S) ", "ParentId": "3c26f37f-522a-48e6-abed-fd409425bcdf"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "2e36cf6a-a8d3-42a6-b431-d54a60c48d2b", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "6a763c2e-eedb-4cc0-a192-a3914e0b2ead", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "2e36cf6a-a8d3-42a6-b431-d54a60c48d2b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>EU/1/17/1194/007</span></p>", "ID": "c1ccf2fb-5bf1-401a-adfa-fbaa0da85813", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>EU/1/17/1194/007</span>", "ID": "56b04f6a-b1df-400d-bde8-1d1d57145b6e", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "EU/1/17/1194/007", "ParentId": "c1ccf2fb-5bf1-401a-adfa-fbaa0da85813"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey'>EU/1/17/1194/008</span></p>", "ID": "c3c73335-499e-49da-82c1-40aed73efb27", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey'>EU/1/17/1194/008</span>", "ID": "32602381-df46-459e-a974-7425d036e03e", "Styles": "font-family:\n\"Times New Roman\",serif;background:lightgrey", "Classes": "None", "Text": "EU/1/17/1194/008", "ParentId": "c3c73335-499e-49da-82c1-40aed73efb27"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "47877ca2-bc32-4c86-b796-cc6692eeeece", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "5a7c65a3-f3cf-498e-bc8b-1c84da5983ae", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "47877ca2-bc32-4c86-b796-cc6692eeeece"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "23303568-e19f-4c42-9f76-a18b4d67a402", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "2e6cb3b9-180d-41dd-a7de-6e303d6cdfb9", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "23303568-e19f-4c42-9f76-a18b4d67a402"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>13.\u00a0\u00a0\u00a0\u00a0 BATCH\nNUMBER</span></b></p>\n</div>", "ID": "19e9477e-1b67-495e-be0b-4521c09d217d", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>13.\u00a0\u00a0\u00a0\u00a0 BATCH\nNUMBER</span></b></p>", "ID": "94bd6da4-18ae-4558-b5a3-046c9d1dedb8", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "19e9477e-1b67-495e-be0b-4521c09d217d"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>13.\u00a0\u00a0\u00a0\u00a0 BATCH\nNUMBER</span></b>", "ID": "a9e838af-f005-4d99-a4ec-a5febd33ef1e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "94bd6da4-18ae-4558-b5a3-046c9d1dedb8"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>13.\u00a0\u00a0\u00a0\u00a0 BATCH\nNUMBER</span>", "ID": "95a6b633-d84f-44de-b626-cec92b0210c8", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "13.\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER", "ParentId": "a9e838af-f005-4d99-a4ec-a5febd33ef1e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><i><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></i></p>", "ID": "7dd22a9c-0b29-46b2-80f1-dc9f4aee2f56", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<i><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></i>", "ID": "6849e8a2-3e25-4863-9dfc-63e84290fa26", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "7dd22a9c-0b29-46b2-80f1-dc9f4aee2f56"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "726da60f-db73-4be4-9fc6-531029f59f87", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "6849e8a2-3e25-4863-9dfc-63e84290fa26"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Lot</span></p>", "ID": "7b5d5ec2-9505-4473-b0cd-158ac8acaf84", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Lot</span>", "ID": "45a69e98-749e-4137-846d-7d31781aca5a", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "Lot", "ParentId": "7b5d5ec2-9505-4473-b0cd-158ac8acaf84"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "4aa4689c-2267-4609-bcef-74aae137eb67", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "c9ca60a8-2420-48ac-b954-752a8a45a07b", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "4aa4689c-2267-4609-bcef-74aae137eb67"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "9a5817d0-ee86-4e49-b124-c9957ad54df1", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "6d125dd7-acf0-45df-8c33-1cbb840e7e00", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "9a5817d0-ee86-4e49-b124-c9957ad54df1"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>14.\u00a0\u00a0\u00a0\u00a0 GENERAL\nCLASSIFICATION FOR SUPPLY</span></b></p>\n</div>", "ID": "1da53b6d-391d-4436-b287-77a6d7fa5b3c", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>14.\u00a0\u00a0\u00a0\u00a0 GENERAL\nCLASSIFICATION FOR SUPPLY</span></b></p>", "ID": "a3508266-ace2-4195-9ef7-0b0d13b0fe78", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "1da53b6d-391d-4436-b287-77a6d7fa5b3c"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>14.\u00a0\u00a0\u00a0\u00a0 GENERAL\nCLASSIFICATION FOR SUPPLY</span></b>", "ID": "33adf878-2f8b-47e0-b2ed-fcd72673977b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a3508266-ace2-4195-9ef7-0b0d13b0fe78"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>14.\u00a0\u00a0\u00a0\u00a0 GENERAL\nCLASSIFICATION FOR SUPPLY</span>", "ID": "3eb09320-02c1-438d-86f2-47c5619265d7", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "14.\u00a0\u00a0\u00a0\u00a0 GENERAL CLASSIFICATION FOR SUPPLY", "ParentId": "33adf878-2f8b-47e0-b2ed-fcd72673977b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><i><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></i></p>", "ID": "575a5ea4-0ada-4fc7-9036-cbc9a72fdd94", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<i><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></i>", "ID": "e153eca2-4b0a-4aeb-9e27-b04027fad589", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "575a5ea4-0ada-4fc7-9036-cbc9a72fdd94"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "17b43a2c-d7a7-4a87-9d87-c2c25ae69098", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "e153eca2-4b0a-4aeb-9e27-b04027fad589"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "525acdc3-c262-4401-b747-3634174a60a4", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "6437ff98-fa39-4fcf-97c0-622b5617f2ed", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "525acdc3-c262-4401-b747-3634174a60a4"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "c96052f0-cb41-4100-8b8a-3c0b849c96d0", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "8bd93514-2b86-48f3-b42f-100e3c8cc865", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "c96052f0-cb41-4100-8b8a-3c0b849c96d0"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:2.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS\nON USE</span></b></p>\n</div>", "ID": "e908fc26-ec0d-4643-96b5-733493d01833", "Styles": "border:solid windowtext 1.0pt;padding:2.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS\nON USE</span></b></p>", "ID": "aa12f05a-04fa-417d-856a-781382d2dee2", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e908fc26-ec0d-4643-96b5-733493d01833"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS\nON USE</span></b>", "ID": "23070166-a350-4c9c-8c4d-70955aa4a63e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "aa12f05a-04fa-417d-856a-781382d2dee2"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS\nON USE</span>", "ID": "cb9239f3-b3f6-441f-b79f-ecac0a45a2be", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS ON USE", "ParentId": "23070166-a350-4c9c-8c4d-70955aa4a63e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "278a39d8-2af6-477a-b4c1-58575909fa2e", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "76949a25-c3eb-40ad-87b8-cce0baa98a3a", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "278a39d8-2af6-477a-b4c1-58575909fa2e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "f4dfa5f9-fd11-45ef-9fa2-ebdaa9df73ff", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "75056a4a-05b5-4ee1-8c42-01560918e4ad", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "f4dfa5f9-fd11-45ef-9fa2-ebdaa9df73ff"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "9dfa1c40-b5f2-4fa6-936d-6630d22d3457", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "1c1e9dea-ac29-4def-bdae-c36c31f6a826", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "9dfa1c40-b5f2-4fa6-936d-6630d22d3457"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>16.\u00a0\u00a0\u00a0\u00a0 INFORMATION\nIN BRAILLE</span></b></p>\n</div>", "ID": "300f2782-2dc5-4528-9022-ef8964d00e1f", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>16.\u00a0\u00a0\u00a0\u00a0 INFORMATION\nIN BRAILLE</span></b></p>", "ID": "01a87e70-a4af-4756-9dc9-761314c6dd3d", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "300f2782-2dc5-4528-9022-ef8964d00e1f"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>16.\u00a0\u00a0\u00a0\u00a0 INFORMATION\nIN BRAILLE</span></b>", "ID": "2473820f-6e27-4fa4-b657-64d53eb0e05e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "01a87e70-a4af-4756-9dc9-761314c6dd3d"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>16.\u00a0\u00a0\u00a0\u00a0 INFORMATION\nIN BRAILLE</span>", "ID": "1d86a2ab-3a13-4aef-9445-fab7af921eed", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "16.\u00a0\u00a0\u00a0\u00a0 INFORMATION IN BRAILLE", "ParentId": "2473820f-6e27-4fa4-b657-64d53eb0e05e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "ce22f198-2d29-4c57-9f23-7956bcf9524b", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "60f36708-d03c-427e-aa04-cfaa4fb9d23c", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "ce22f198-2d29-4c57-9f23-7956bcf9524b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:#CCCCCC'>\u00a0</span></p>", "ID": "e28cfc38-22f2-469e-893c-14788d215c3d", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:#CCCCCC'>\u00a0</span>", "ID": "6730bb97-6a84-4eca-9c8f-7570e60ebad3", "Styles": "font-family:\n\"Times New Roman\",serif;background:#CCCCCC", "Classes": "None", "Text": "\u00a0", "ParentId": "e28cfc38-22f2-469e-893c-14788d215c3d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:#CCCCCC'>\u00a0</span></p>", "ID": "ef4fc6b1-b291-4e4f-850d-115ccc31e1c2", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:#CCCCCC'>\u00a0</span>", "ID": "dceda44e-6605-4b29-8b56-cae137d85024", "Styles": "font-family:\n\"Times New Roman\",serif;background:#CCCCCC", "Classes": "None", "Text": "\u00a0", "ParentId": "ef4fc6b1-b291-4e4f-850d-115ccc31e1c2"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>17.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 2D BARCODE</span></b></p>\n</div>", "ID": "0a5a32a2-d372-41be-97ef-2147cfb19fc2", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>17.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 2D BARCODE</span></b></p>", "ID": "8295bcc4-2867-48b5-9657-833741b3835f", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0a5a32a2-d372-41be-97ef-2147cfb19fc2"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>17.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 2D BARCODE</span></b>", "ID": "1250f50c-87d3-4f93-851a-dc3376032add", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "8295bcc4-2867-48b5-9657-833741b3835f"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>17.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 2D BARCODE</span>", "ID": "2a30c674-3c5a-4458-8389-24ea6092293b", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "17.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE IDENTIFIER \u2013 2D BARCODE", "ParentId": "1250f50c-87d3-4f93-851a-dc3376032add"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "c91a48fc-3a46-4ff8-99e0-3baae7b554a6", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "f69ebbe4-ba0c-4296-8de5-f2a3c59d3dc3", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "c91a48fc-3a46-4ff8-99e0-3baae7b554a6"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:#CCCCCC'>\u00a0</span></p>", "ID": "9c7e7adf-31c2-4e5e-8acc-be6296ac7971", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:#CCCCCC'>\u00a0</span>", "ID": "8b3e4abc-bc62-48c4-b481-7c82901b64d7", "Styles": "font-family:\n\"Times New Roman\",serif;background:#CCCCCC", "Classes": "None", "Text": "\u00a0", "ParentId": "9c7e7adf-31c2-4e5e-8acc-be6296ac7971"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "1c77d2e6-d656-453e-9433-b895f5a14040", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "3eacfb6f-f673-4f86-9b60-7188879d0489", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "1c77d2e6-d656-453e-9433-b895f5a14040"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>18.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 HUMAN READABLE DATA</span></b></p>\n</div>", "ID": "13d6d78d-f814-4a40-9201-94dfefaa6b54", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>18.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 HUMAN READABLE DATA</span></b></p>", "ID": "89943882-e115-4842-93b6-72114b9e4892", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "13d6d78d-f814-4a40-9201-94dfefaa6b54"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>18.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 HUMAN READABLE DATA</span></b>", "ID": "99e03869-ee73-4283-b537-73cc786f920c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "89943882-e115-4842-93b6-72114b9e4892"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>18.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 HUMAN READABLE DATA</span>", "ID": "e9e3741b-9470-4d90-9fbe-b4327c40bb4f", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "18.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE IDENTIFIER \u2013 HUMAN READABLE DATA", "ParentId": "99e03869-ee73-4283-b537-73cc786f920c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "fef448de-f92c-458d-8e7d-169bf79013b4", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "4629819f-f40f-4e01-adf1-365023780be1", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "fef448de-f92c-458d-8e7d-169bf79013b4"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\ncolor:black;background:#CCCCCC'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span>", "ID": "e8e45665-1acb-4de0-998f-d2b7408fbbf1", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif;\ncolor:black;background:#CCCCCC", "Classes": "None", "Text": " ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<br clear=\"all\" style=\"page-break-before:always\"/>", "ID": "712a9597-fc37-4cfc-b18f-d4346312c93e", "Styles": "page-break-before:always", "Classes": "None", "Text": "", "ParentId": "e8e45665-1acb-4de0-998f-d2b7408fbbf1"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></b></p>", "ID": "aa8f2cce-b938-4d6c-9322-d8fa999cf02e", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></b>", "ID": "8e2ebf12-3d8b-4feb-92c7-5427a452cafc", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "aa8f2cce-b938-4d6c-9322-d8fa999cf02e"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "0d35affa-9166-4b42-a3b6-89b1d87a5ec1", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "8e2ebf12-3d8b-4feb-92c7-5427a452cafc"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>MINIMUM\nPARTICULARS TO APPEAR ON BLISTERS OR STRIPS</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>BLISTERS</span></b></p>\n</div>", "ID": "613bef30-1964-475c-bd66-773ad8968960", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "    ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>MINIMUM\nPARTICULARS TO APPEAR ON BLISTERS OR STRIPS</span></b></p>", "ID": "4cf1174c-35c5-4494-af04-1f38fe996e68", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "613bef30-1964-475c-bd66-773ad8968960"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>MINIMUM\nPARTICULARS TO APPEAR ON BLISTERS OR STRIPS</span></b>", "ID": "a31881fd-9450-4e2d-946e-82a14025fb0d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4cf1174c-35c5-4494-af04-1f38fe996e68"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>MINIMUM\nPARTICULARS TO APPEAR ON BLISTERS OR STRIPS</span>", "ID": "1455b178-cbe8-44ed-a4a3-98f9c7351f1b", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS", "ParentId": "a31881fd-9450-4e2d-946e-82a14025fb0d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>", "ID": "62b305d3-bcdc-4f1c-b778-1fe4c53529f9", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "613bef30-1964-475c-bd66-773ad8968960"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b>", "ID": "7211f8df-9c94-4814-92fb-ceea4c40c3c3", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "62b305d3-bcdc-4f1c-b778-1fe4c53529f9"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "6c162a22-0f0a-4ed6-91ef-501ea37237b3", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "7211f8df-9c94-4814-92fb-ceea4c40c3c3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>BLISTERS</span></b></p>", "ID": "73232bef-1024-407e-a8b3-0534747f7efb", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "613bef30-1964-475c-bd66-773ad8968960"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>BLISTERS</span></b>", "ID": "674a6c7d-0efb-472f-a24e-979a954e8cfb", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "73232bef-1024-407e-a8b3-0534747f7efb"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>BLISTERS</span>", "ID": "9e06bbf7-6471-4b38-834d-75df8da650a8", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "BLISTERS", "ParentId": "674a6c7d-0efb-472f-a24e-979a954e8cfb"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "e88e83a2-0509-421c-beb2-9405e1dbecc0", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "bd461e19-9253-49d0-80f5-51f3c1a38b0f", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "e88e83a2-0509-421c-beb2-9405e1dbecc0"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "7369d39b-61df-4cf0-bd77-dbe8e91f812e", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "e3843132-46df-4cbf-a51b-a6cc976ea732", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "7369d39b-61df-4cf0-bd77-dbe8e91f812e"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\nOF THE MEDICINAL PRODUCT</span></b></p>\n</div>", "ID": "4b4990bc-2cfc-4b91-a8ba-2227301fb659", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\nOF THE MEDICINAL PRODUCT</span></b></p>", "ID": "2ff73ef2-2d31-4c4f-be26-ac9ff36c1c42", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "4b4990bc-2cfc-4b91-a8ba-2227301fb659"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\nOF THE MEDICINAL PRODUCT</span></b>", "ID": "ac5393c5-45ca-440d-8409-0d5f2c5af105", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "2ff73ef2-2d31-4c4f-be26-ac9ff36c1c42"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\nOF THE MEDICINAL PRODUCT</span>", "ID": "f90fdc41-7c94-4608-8b22-22cbc3260375", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT", "ParentId": "ac5393c5-45ca-440d-8409-0d5f2c5af105"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><i><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></i></p>", "ID": "e379b7a5-f27d-4aa7-aa4f-11f8cacafdc8", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<i><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></i>", "ID": "d263d149-d5d2-468c-bbea-2b8e122fb435", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e379b7a5-f27d-4aa7-aa4f-11f8cacafdc8"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "e51fb14d-b0c4-4dd7-a3d4-284c552bf5a6", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "d263d149-d5d2-468c-bbea-2b8e122fb435"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Febuxostat Mylan 80\u00a0mg film-coated tablets </span></p>", "ID": "21250ffb-0b12-4e1a-afd1-26930fa318f6", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Febuxostat Mylan 80\u00a0mg film-coated tablets </span>", "ID": "cf9b54e0-a78a-439e-b9fc-ad4ea1175fd2", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "Febuxostat Mylan 80\u00a0mg film-coated tablets ", "ParentId": "21250ffb-0b12-4e1a-afd1-26930fa318f6"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>febuxostat</span><b><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'> </span></b></p>", "ID": "50b107ee-59df-48b9-9bb4-7c1aff762961", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>febuxostat</span>", "ID": "e08966f8-a89a-4670-8590-de2c357f5c44", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "febuxostat", "ParentId": "50b107ee-59df-48b9-9bb4-7c1aff762961"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'> </span></b>", "ID": "94c4960a-05db-4992-8e62-9f6c67346c18", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "50b107ee-59df-48b9-9bb4-7c1aff762961"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'> </span>", "ID": "994fcb61-c0e7-46d1-b855-2f7c9c42c26c", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": " ", "ParentId": "94c4960a-05db-4992-8e62-9f6c67346c18"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "68edd00b-26d0-4eac-b21e-5f306f50d341", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "ea22846f-33bd-4e12-a59f-5de7b19d486b", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "68edd00b-26d0-4eac-b21e-5f306f50d341"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "434e96d8-7d94-4927-a07a-f663252d5b94", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "92089f13-b9b9-4d80-b0bb-dab8a84f17ee", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "434e96d8-7d94-4927-a07a-f663252d5b94"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\nOF THE MARKETING AUTHORISATION HOLDER</span></b></p>\n</div>", "ID": "b8eb1423-d327-4997-9914-84688c1dba54", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\nOF THE MARKETING AUTHORISATION HOLDER</span></b></p>", "ID": "30e2670b-247a-496b-8284-bfffd6da085c", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b8eb1423-d327-4997-9914-84688c1dba54"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\nOF THE MARKETING AUTHORISATION HOLDER</span></b>", "ID": "51e920b5-a29e-48f4-af57-38dd18598884", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "30e2670b-247a-496b-8284-bfffd6da085c"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\nOF THE MARKETING AUTHORISATION HOLDER</span>", "ID": "9487608f-358b-408e-a8fb-e927ea546701", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MARKETING AUTHORISATION HOLDER", "ParentId": "51e920b5-a29e-48f4-af57-38dd18598884"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "21a0a522-4328-46a5-a046-274f4bdaeac1", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "dd059e7d-3982-4dae-9bb1-33687a36dfdc", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "21a0a522-4328-46a5-a046-274f4bdaeac1"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Mylan S.A.S.</span></p>", "ID": "7260e886-5a47-4cc2-8679-41c83948bb85", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Mylan S.A.S.</span>", "ID": "2d513eec-c78e-4611-833e-ca4048e5aaa2", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "Mylan S.A.S.", "ParentId": "7260e886-5a47-4cc2-8679-41c83948bb85"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "616e1d85-e763-4400-9c71-27c37ed970cb", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "9bd8e4b5-5a21-4e4c-902e-2f9cf071c3da", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "616e1d85-e763-4400-9c71-27c37ed970cb"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "ac9f8c44-9a88-4f63-a1b3-28ddf2b812b0", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "8d4358a8-6646-46c9-9a92-812c58991afc", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "ac9f8c44-9a88-4f63-a1b3-28ddf2b812b0"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 2.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY\nDATE</span></b></p>\n</div>", "ID": "5665bfa3-5d84-4e0f-bc3f-001d827f4c7d", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 2.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY\nDATE</span></b></p>", "ID": "c80b89ea-b321-4bc0-a854-2dec75eb2a9d", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5665bfa3-5d84-4e0f-bc3f-001d827f4c7d"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY\nDATE</span></b>", "ID": "a5f68512-bdaf-48c5-a038-9b0f874b1815", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c80b89ea-b321-4bc0-a854-2dec75eb2a9d"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY\nDATE</span>", "ID": "eba91ae3-8b99-4a5f-97b9-29aaa8f23e0d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE", "ParentId": "a5f68512-bdaf-48c5-a038-9b0f874b1815"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "e57b2c20-f08f-432c-bc3b-5f1d34bf9955", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "43f248cf-922d-4efe-b2e3-afeee27c1b84", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "e57b2c20-f08f-432c-bc3b-5f1d34bf9955"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>EXP</span></p>", "ID": "cc74b7dc-f258-4d4b-9af5-cd277f30aae8", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>EXP</span>", "ID": "66dc9edb-c954-44d5-966c-abca7f4b1f71", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "EXP", "ParentId": "cc74b7dc-f258-4d4b-9af5-cd277f30aae8"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "8f22387b-221b-413d-aa8b-1269749a6f48", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "579c8951-8aa5-414d-8a18-609498b3a426", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "8f22387b-221b-413d-aa8b-1269749a6f48"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "c151f497-5c60-4643-9574-9cc7c1ce1bbc", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "68b81b22-7052-4f05-90bd-8b7630916211", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "c151f497-5c60-4643-9574-9cc7c1ce1bbc"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 BATCH\nNUMBER</span></b></p>\n</div>", "ID": "600377c3-52a4-41a4-bac5-fc39b4f9e444", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 BATCH\nNUMBER</span></b></p>", "ID": "d776b683-6cfa-4b2e-b5dd-92afe993c5cd", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "600377c3-52a4-41a4-bac5-fc39b4f9e444"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 BATCH\nNUMBER</span></b>", "ID": "2bd60bc8-0849-41bb-a4d3-d7c5155247dd", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d776b683-6cfa-4b2e-b5dd-92afe993c5cd"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 BATCH\nNUMBER</span>", "ID": "eb0536e4-14da-4623-8dd7-a6cf21ffb60b", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER", "ParentId": "2bd60bc8-0849-41bb-a4d3-d7c5155247dd"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "20002a7f-c946-4345-9ec9-c963e1e0265b", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "7bc3a3a7-65ab-430f-a970-71f237c5c551", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "20002a7f-c946-4345-9ec9-c963e1e0265b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Lot</span></p>", "ID": "0681a67c-1e50-4b96-8a31-33762003df7e", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Lot</span>", "ID": "c7beb7e2-451b-4ba1-b012-1dead99a40b8", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "Lot", "ParentId": "0681a67c-1e50-4b96-8a31-33762003df7e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "c8eb34b0-7f69-4103-85a3-fa7fdd9af3cb", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "b065dc42-bb5e-4e57-98a6-8dfbf36f27bd", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "c8eb34b0-7f69-4103-85a3-fa7fdd9af3cb"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "ec07ba1c-f7f5-426e-b617-2d81b41fec5b", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "e215809a-341d-405e-b668-f5b76046e273", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "ec07ba1c-f7f5-426e-b617-2d81b41fec5b"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER</span></b></p>\n</div>", "ID": "b72aef4b-ba97-42d0-b3ec-37ae55d02439", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER</span></b></p>", "ID": "b1616b33-3360-4541-a773-0235145a6cd4", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b72aef4b-ba97-42d0-b3ec-37ae55d02439"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER</span></b>", "ID": "dd8450c0-7c93-4116-9f1b-03f2fc4df302", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b1616b33-3360-4541-a773-0235145a6cd4"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER</span>", "ID": "f7f4a856-6d38-4915-a7c7-772e2eb8b7a3", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER", "ParentId": "dd8450c0-7c93-4116-9f1b-03f2fc4df302"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "62a3175f-e48b-40d6-9032-afedb52a0139", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "e46227f7-fb7e-4572-9fe2-42d4e51e6f1f", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "62a3175f-e48b-40d6-9032-afedb52a0139"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><i><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey'>[For calendar blisters only]:</span></i></p>", "ID": "17f0e87e-eba1-43ab-9e02-febc7a69ddc8", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<i><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey'>[For calendar blisters only]:</span></i>", "ID": "4f2224a5-9641-4f3e-aa1f-7d0a1d44d036", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "17f0e87e-eba1-43ab-9e02-febc7a69ddc8"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey'>[For calendar blisters only]:</span>", "ID": "02700692-e5f6-41b2-85fd-ed2972c30e0d", "Styles": "font-family:\n\"Times New Roman\",serif;background:lightgrey", "Classes": "None", "Text": "[For calendar blisters only]:", "ParentId": "4f2224a5-9641-4f3e-aa1f-7d0a1d44d036"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>MON</span></p>", "ID": "fa82cfb8-4a6a-46ec-bde1-de73a14b22d8", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>MON</span>", "ID": "dd4017df-58f9-4692-8dea-4d18ba9c51e3", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "MON", "ParentId": "fa82cfb8-4a6a-46ec-bde1-de73a14b22d8"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>TUE</span></p>", "ID": "b8f1b5d9-7e55-4ccd-a0cf-3c9beb902392", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>TUE</span>", "ID": "c3c8a9f3-009d-4272-ad7a-8aa3fdd8dfa9", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "TUE", "ParentId": "b8f1b5d9-7e55-4ccd-a0cf-3c9beb902392"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>WED</span></p>", "ID": "7c76c3c5-5710-40e7-bb5f-0436b22b8d50", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>WED</span>", "ID": "296c1b16-71dc-440a-940d-94225e8a3cf6", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "WED", "ParentId": "7c76c3c5-5710-40e7-bb5f-0436b22b8d50"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>THU</span></p>", "ID": "5320a1f5-a231-48a2-bbe0-f870c2fd74b4", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>THU</span>", "ID": "247170bc-121a-46b4-992a-6f4cee53db13", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "THU", "ParentId": "5320a1f5-a231-48a2-bbe0-f870c2fd74b4"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>FRI</span></p>", "ID": "1a6861af-f11a-48be-bd95-ff814c15129b", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>FRI</span>", "ID": "88f37bc1-145f-478d-929d-b4a662767c43", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "FRI", "ParentId": "1a6861af-f11a-48be-bd95-ff814c15129b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>SAT</span></p>", "ID": "117f2200-70bd-4791-95b5-c37704118030", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>SAT</span>", "ID": "7a49f5fc-ceaf-4926-8b96-c0b1a6fdc866", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "SAT", "ParentId": "117f2200-70bd-4791-95b5-c37704118030"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>SUN</span></p>", "ID": "1ca7e9de-3dfc-468f-b0ff-3f55bd101d21", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>SUN</span>", "ID": "317e569c-9e1e-4b1d-912b-7cb0e7ca120a", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "SUN", "ParentId": "1ca7e9de-3dfc-468f-b0ff-3f55bd101d21"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "3b19767a-eba8-40ed-844d-5b350ed1b183", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "f48731aa-06a9-4eac-825c-3cd87353d82e", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "3b19767a-eba8-40ed-844d-5b350ed1b183"}, {"Element": "<b><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\ncolor:black'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span></b>", "ID": "ec807e7e-ed0f-410a-bfab-7b0fb2666c97", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\ncolor:black'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span>", "ID": "3f4ada40-7a7d-419f-9b3a-f8a8edd931d0", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif;\ncolor:black", "Classes": "None", "Text": " ", "ParentId": "ec807e7e-ed0f-410a-bfab-7b0fb2666c97"}, {"Element": "<br clear=\"all\" style=\"page-break-before:always\"/>", "ID": "c6bf0f2b-a5f1-4059-b2c9-fcd585369367", "Styles": "page-break-before:always", "Classes": "None", "Text": "", "ParentId": "3f4ada40-7a7d-419f-9b3a-f8a8edd931d0"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;background:white\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>", "ID": "af33ac2e-631b-4147-be5b-e772b5e6e769", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;background:white", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b>", "ID": "e1239d94-a9f7-4e1d-a790-c6ba3142b88a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "af33ac2e-631b-4147-be5b-e772b5e6e769"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "2ee276bc-4e20-4ce1-8809-43e189d70785", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "e1239d94-a9f7-4e1d-a790-c6ba3142b88a"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>PARTICULARS\nTO APPEAR ON THE OUTER PACKAGING </span></b></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>OUTER\nCARTON (BLISTERS AND BOTTLES)</span></b></p>\n</div>", "ID": "12bdebc5-7534-485a-a767-b464d26db5e0", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "    ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>PARTICULARS\nTO APPEAR ON THE OUTER PACKAGING </span></b></p>", "ID": "f7b6a353-a0d8-4c42-9576-34cade6ba326", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "12bdebc5-7534-485a-a767-b464d26db5e0"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>PARTICULARS\nTO APPEAR ON THE OUTER PACKAGING </span></b>", "ID": "cdab2055-4bdb-45d5-aec8-26e4d66c4481", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f7b6a353-a0d8-4c42-9576-34cade6ba326"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>PARTICULARS\nTO APPEAR ON THE OUTER PACKAGING </span>", "ID": "9fc87e7e-b343-4350-a108-ace4381275e8", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "PARTICULARS TO APPEAR ON THE OUTER PACKAGING ", "ParentId": "cdab2055-4bdb-45d5-aec8-26e4d66c4481"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "2ff06e0f-e297-4f6b-b7f7-4b0ce6077919", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "12bdebc5-7534-485a-a767-b464d26db5e0"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "99ab04d6-a396-4cbe-83ed-6cf19a774c6f", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "2ff06e0f-e297-4f6b-b7f7-4b0ce6077919"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>OUTER\nCARTON (BLISTERS AND BOTTLES)</span></b></p>", "ID": "d505be45-6800-4e13-8856-db5784f7864d", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "12bdebc5-7534-485a-a767-b464d26db5e0"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>OUTER\nCARTON (BLISTERS AND BOTTLES)</span></b>", "ID": "1357e1a8-32b1-494d-b8bc-1f4b41b04e43", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d505be45-6800-4e13-8856-db5784f7864d"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>OUTER\nCARTON (BLISTERS AND BOTTLES)</span>", "ID": "3f382450-b959-4342-b351-f1ed1407fcab", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "OUTER CARTON (BLISTERS AND BOTTLES)", "ParentId": "1357e1a8-32b1-494d-b8bc-1f4b41b04e43"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "2ddbae68-82b7-44c4-b384-9ee249afa30b", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "e0e9ae15-de89-499c-9985-7d791602d007", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "2ddbae68-82b7-44c4-b384-9ee249afa30b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "efba6138-16ff-4bee-b1c8-f4d82b7aeb7f", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "3257b9ec-e117-477f-900e-1145edfe1afc", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "efba6138-16ff-4bee-b1c8-f4d82b7aeb7f"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\nOF THE MEDICINAL PRODUCT</span></b></p>\n</div>", "ID": "7df538af-4725-4f62-9c2d-3b094720be40", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\nOF THE MEDICINAL PRODUCT</span></b></p>", "ID": "53d71f86-a975-4092-9c1b-93983944c232", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "7df538af-4725-4f62-9c2d-3b094720be40"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\nOF THE MEDICINAL PRODUCT</span></b>", "ID": "2b0dd333-0fca-4f95-a88f-73b2e1271677", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "53d71f86-a975-4092-9c1b-93983944c232"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\nOF THE MEDICINAL PRODUCT</span>", "ID": "eb11d138-cd45-4328-b59e-0b41200a25e7", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT", "ParentId": "2b0dd333-0fca-4f95-a88f-73b2e1271677"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "e000ff64-332d-4c63-aa55-e4253b27cc88", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "023d41eb-3d98-4369-9985-1c56d7662dbc", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "e000ff64-332d-4c63-aa55-e4253b27cc88"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Febuxostat Mylan 120\u00a0mg film-coated tablets </span></p>", "ID": "ccc4d1c2-74e4-4374-b970-8756558f357e", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Febuxostat Mylan 120\u00a0mg film-coated tablets </span>", "ID": "58c594ed-db33-4e4e-9946-3e8293c3b3c2", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "Febuxostat Mylan 120\u00a0mg film-coated tablets ", "ParentId": "ccc4d1c2-74e4-4374-b970-8756558f357e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>febuxostat</span><b><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'> </span></b></p>", "ID": "a2c121d4-ae50-45b2-93d8-23954025b392", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>febuxostat</span>", "ID": "84f3f0e5-7f26-4bb6-bf11-8fec57dd56d5", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "febuxostat", "ParentId": "a2c121d4-ae50-45b2-93d8-23954025b392"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'> </span></b>", "ID": "12018b3e-242a-40bf-8c59-23817d85d910", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a2c121d4-ae50-45b2-93d8-23954025b392"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'> </span>", "ID": "4286b923-a41b-40b0-aa8e-b0a1d21296f0", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": " ", "ParentId": "12018b3e-242a-40bf-8c59-23817d85d910"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "8bd83154-6757-4c8f-bb94-27448d96e231", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "a10b2d45-164a-470d-b5a8-c0ba8f6a477a", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "8bd83154-6757-4c8f-bb94-27448d96e231"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "3b1e64a5-7e34-4fdc-a1c1-9fac32a972d3", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "f2190bb9-6ff5-493e-bc77-03164010c826", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "3b1e64a5-7e34-4fdc-a1c1-9fac32a972d3"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT\nOF ACTIVE SUBSTANCE</span></b></p>\n</div>", "ID": "509a0b76-4f55-4014-bbdc-78302d698ec4", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT\nOF ACTIVE SUBSTANCE</span></b></p>", "ID": "7aba2658-f681-4666-b928-b580e08657d4", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "509a0b76-4f55-4014-bbdc-78302d698ec4"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT\nOF ACTIVE SUBSTANCE</span></b>", "ID": "7d64939d-0dcc-41bb-9ea5-5c9ab9742d21", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "7aba2658-f681-4666-b928-b580e08657d4"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT\nOF ACTIVE SUBSTANCE</span>", "ID": "3714ecb2-4aa8-4ad8-a396-fefbac5b9e3b", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT OF ACTIVE SUBSTANCE", "ParentId": "7d64939d-0dcc-41bb-9ea5-5c9ab9742d21"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "2f08b278-f5ac-4371-906b-b2020cb1e5f7", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "c44aeb8a-90f5-4eba-9a93-62850b9420b0", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "2f08b278-f5ac-4371-906b-b2020cb1e5f7"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Each tablet contains 120\u00a0mg febuxostat.</span></p>", "ID": "f154d3bf-633c-42fa-a994-34e32c15dec3", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Each tablet contains 120\u00a0mg febuxostat.</span>", "ID": "bf728c1f-b67c-4c2e-9632-37f7cae120bf", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "Each tablet contains 120\u00a0mg febuxostat.", "ParentId": "f154d3bf-633c-42fa-a994-34e32c15dec3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "544c126f-02a9-4ccb-a4d0-9fb94ef28909", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "4058f456-568b-420b-89bc-4f7b3c9420ba", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "544c126f-02a9-4ccb-a4d0-9fb94ef28909"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "a911b406-3d7f-4938-ab46-a5af09530304", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "60debf4b-6e46-4cbf-a6a1-0ba8052d2d90", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "a911b406-3d7f-4938-ab46-a5af09530304"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST\nOF EXCIPIENTS</span></b></p>\n</div>", "ID": "f9117e8b-0979-451a-8b50-d093368ee7a4", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST\nOF EXCIPIENTS</span></b></p>", "ID": "1a3819ee-04ce-40d7-be09-c63827ab7c83", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f9117e8b-0979-451a-8b50-d093368ee7a4"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST\nOF EXCIPIENTS</span></b>", "ID": "27fbae9e-51e3-4b2e-907c-0d851f8e8d32", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "1a3819ee-04ce-40d7-be09-c63827ab7c83"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST\nOF EXCIPIENTS</span>", "ID": "ab3ac189-0a62-431c-8fce-a31937d7b2f1", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST OF EXCIPIENTS", "ParentId": "27fbae9e-51e3-4b2e-907c-0d851f8e8d32"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "83b14fa6-997c-4516-bd98-4904c30c9db4", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "3a82d2c2-d938-44f7-9318-6a75e9d73697", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "83b14fa6-997c-4516-bd98-4904c30c9db4"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Also contains lactose.</span></p>", "ID": "95da2996-2c49-473b-986c-30137b74da6e", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Also contains lactose.</span>", "ID": "8e80badd-916c-4e86-84dc-0b7049d9d39c", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Also contains lactose.", "ParentId": "95da2996-2c49-473b-986c-30137b74da6e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>See leaflet for further information.</span></p>", "ID": "f504c99b-be00-4670-9b84-280357202abc", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>See leaflet for further information.</span>", "ID": "82be9b4a-0ff6-42a3-b1ab-dbe9c0a3979f", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "See leaflet for further information.", "ParentId": "f504c99b-be00-4670-9b84-280357202abc"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "28a1180a-3743-4b6a-9406-2a8bb2ac6082", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "c1e8979a-7585-4751-9798-8c304bf108a3", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "28a1180a-3743-4b6a-9406-2a8bb2ac6082"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "66349ad9-f77d-416c-870f-c980e3258b44", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "26fea3d6-f127-43ff-8abb-63debae62973", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "66349ad9-f77d-416c-870f-c980e3258b44"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\nFORM AND CONTENTS</span></b></p>\n</div>", "ID": "c0607d16-1dfd-4d23-ba37-42793629b737", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\nFORM AND CONTENTS</span></b></p>", "ID": "588a0ceb-8807-4817-bc3f-1ba4b7f84584", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c0607d16-1dfd-4d23-ba37-42793629b737"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\nFORM AND CONTENTS</span></b>", "ID": "0909d4af-839e-47a6-ab41-a84d0c6c5f43", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "588a0ceb-8807-4817-bc3f-1ba4b7f84584"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\nFORM AND CONTENTS</span>", "ID": "4a12ee3a-0734-4b37-a6f6-fd80ef60b643", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL FORM AND CONTENTS", "ParentId": "0909d4af-839e-47a6-ab41-a84d0c6c5f43"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"DE\" style='font-family:\"Times New Roman\",serif;\nbackground:lightgrey;layout-grid-mode:line'>\u00a0</span></p>", "ID": "c0b1f5c0-bf66-43b8-8c0d-b73df4a2f935", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"DE\" style='font-family:\"Times New Roman\",serif;\nbackground:lightgrey;layout-grid-mode:line'>\u00a0</span>", "ID": "6f7f2501-7f13-4fcf-bf7f-bf277575047a", "Styles": "font-family:\"Times New Roman\",serif;\nbackground:lightgrey;layout-grid-mode:line", "Classes": "None", "Text": "\u00a0", "ParentId": "c0b1f5c0-bf66-43b8-8c0d-b73df4a2f935"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC'>Film-coated tablets</span></p>", "ID": "240bf35d-75d2-4ad3-b507-1e9a8a00ffa8", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC'>Film-coated tablets</span>", "ID": "a616d193-fc36-451c-a271-d41bd6958da9", "Styles": "font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC", "Classes": "None", "Text": "Film-coated tablets", "ParentId": "240bf35d-75d2-4ad3-b507-1e9a8a00ffa8"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><i><span lang=\"DE\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey;layout-grid-mode:line'>\u00a0</span></i></p>", "ID": "4b496595-37aa-4398-8b4e-c40cfa43b4c8", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<i><span lang=\"DE\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey;layout-grid-mode:line'>\u00a0</span></i>", "ID": "749e88bf-16bc-4e32-8173-63d5c2d72ca8", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4b496595-37aa-4398-8b4e-c40cfa43b4c8"}, {"Element": "<span lang=\"DE\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey;layout-grid-mode:line'>\u00a0</span>", "ID": "f673ad15-3adc-435e-8abc-0228a56c8d57", "Styles": "font-family:\n\"Times New Roman\",serif;background:lightgrey;layout-grid-mode:line", "Classes": "None", "Text": "\u00a0", "ParentId": "749e88bf-16bc-4e32-8173-63d5c2d72ca8"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><i><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC'>[Blisters]</span></i></p>", "ID": "c86ea6b1-3054-4c4e-aae1-6dc9dd26c2b6", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<i><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC'>[Blisters]</span></i>", "ID": "f09189dc-2856-44d6-b190-89b1320953a3", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c86ea6b1-3054-4c4e-aae1-6dc9dd26c2b6"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC'>[Blisters]</span>", "ID": "c1b7afa6-6037-4552-b6dd-fe8e7177231b", "Styles": "font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC", "Classes": "None", "Text": "[Blisters]", "ParentId": "f09189dc-2856-44d6-b190-89b1320953a3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>14 film-coated tablets</span></p>", "ID": "0434160e-6b80-4e58-9563-e3757350dad4", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>14 film-coated tablets</span>", "ID": "cb4b1ecf-d5ea-4cb6-a137-8bfbe46b6c99", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "14 film-coated tablets", "ParentId": "0434160e-6b80-4e58-9563-e3757350dad4"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC'>28 film-coated tablets</span></p>", "ID": "9bda1df3-1486-4542-9b49-adc950be89e8", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC'>28 film-coated tablets</span>", "ID": "6c2680cd-6c2f-4e8a-a4a3-4f6ae8e132da", "Styles": "font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC", "Classes": "None", "Text": "28 film-coated tablets", "ParentId": "9bda1df3-1486-4542-9b49-adc950be89e8"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC'>42 film-coated tablets</span></p>", "ID": "f8af1ff0-ca57-451b-b513-7cf14648a791", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC'>42 film-coated tablets</span>", "ID": "8b87acd5-de6f-46a2-89ef-3ae2c9da86c1", "Styles": "font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC", "Classes": "None", "Text": "42 film-coated tablets", "ParentId": "f8af1ff0-ca57-451b-b513-7cf14648a791"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC'>84 film-coated tablets</span></p>", "ID": "2941d6f4-4f7a-4db7-bd7a-c23753d04744", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC'>84 film-coated tablets</span>", "ID": "d437a30b-dac1-455c-b1eb-f74951c10625", "Styles": "font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC", "Classes": "None", "Text": "84 film-coated tablets", "ParentId": "2941d6f4-4f7a-4db7-bd7a-c23753d04744"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC'>28 x 1 film-coated\ntablets</span></p>", "ID": "76855b4a-037d-4904-ba49-fd2a7eaaa1e8", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC'>28 x 1 film-coated\ntablets</span>", "ID": "4b504a83-af3c-4ae1-a999-2a7e0232c093", "Styles": "font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC", "Classes": "None", "Text": "28 x 1 film-coated tablets", "ParentId": "76855b4a-037d-4904-ba49-fd2a7eaaa1e8"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC'>28 film-coated tablets\n(calendar)</span></p>", "ID": "c7f21ae7-7734-4f9b-8ac4-1c4164bfc002", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC'>28 film-coated tablets\n(calendar)</span>", "ID": "8546153c-bfac-4c30-b2dd-a7b62b81f74e", "Styles": "font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC", "Classes": "None", "Text": "28 film-coated tablets (calendar)", "ParentId": "c7f21ae7-7734-4f9b-8ac4-1c4164bfc002"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC'>84 film-coated tablets\n(calendar)</span></p>", "ID": "5b5373b9-a8c9-433d-9d70-597cb20f4392", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC'>84 film-coated tablets\n(calendar)</span>", "ID": "04bec675-2fc4-43ce-937a-5467a36152a9", "Styles": "font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC", "Classes": "None", "Text": "84 film-coated tablets (calendar)", "ParentId": "5b5373b9-a8c9-433d-9d70-597cb20f4392"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"DE\" style='font-family:\"Times New Roman\",serif;\nbackground:lightgrey;layout-grid-mode:line'>\u00a0</span></p>", "ID": "236184e1-0667-4730-a13f-10c44a438702", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"DE\" style='font-family:\"Times New Roman\",serif;\nbackground:lightgrey;layout-grid-mode:line'>\u00a0</span>", "ID": "baf89ef2-7c6b-4c5f-9d04-8c9d0aa513a3", "Styles": "font-family:\"Times New Roman\",serif;\nbackground:lightgrey;layout-grid-mode:line", "Classes": "None", "Text": "\u00a0", "ParentId": "236184e1-0667-4730-a13f-10c44a438702"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><i><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC'>[Bottles]</span></i></p>", "ID": "333c7d28-73d7-4828-9c99-349847321b96", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<i><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC'>[Bottles]</span></i>", "ID": "b707d1df-8056-428b-8ba5-74d293254343", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "333c7d28-73d7-4828-9c99-349847321b96"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC'>[Bottles]</span>", "ID": "a5ec30f2-e65c-436f-a98b-96ce2815547d", "Styles": "font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC", "Classes": "None", "Text": "[Bottles]", "ParentId": "b707d1df-8056-428b-8ba5-74d293254343"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC'>28 film-coated tablets </span></p>", "ID": "9993ace6-9c83-4942-81eb-471193a90de3", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC'>28 film-coated tablets </span>", "ID": "a1a0285d-ec00-4c9d-af7e-1772113cc781", "Styles": "font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC", "Classes": "None", "Text": "28 film-coated tablets ", "ParentId": "9993ace6-9c83-4942-81eb-471193a90de3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC'>84 film-coated tablets </span></p>", "ID": "1728fba7-dea1-4581-b643-32499b08d430", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC'>84 film-coated tablets </span>", "ID": "2909d2f0-b471-4d06-8d2b-066cdfaeb24b", "Styles": "font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC", "Classes": "None", "Text": "84 film-coated tablets ", "ParentId": "1728fba7-dea1-4581-b643-32499b08d430"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "e28cea25-e106-4bd0-aa35-44165370037f", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "1b259ea0-86b5-4299-83e2-831e2b442422", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "e28cea25-e106-4bd0-aa35-44165370037f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "ade73a0f-e2f7-4454-8ce5-e52445564037", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "38e233f6-ab09-4d8e-b683-6625930f5933", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "ade73a0f-e2f7-4454-8ce5-e52445564037"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD\nAND ROUTE(S) OF ADMINISTRATION</span></b></p>\n</div>", "ID": "4c8f57e2-30a0-4107-8188-117116e66ecc", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD\nAND ROUTE(S) OF ADMINISTRATION</span></b></p>", "ID": "7f1ae233-ab3e-4138-a673-f763844d39bc", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "4c8f57e2-30a0-4107-8188-117116e66ecc"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD\nAND ROUTE(S) OF ADMINISTRATION</span></b>", "ID": "b6cee08b-3bd6-4926-bcb1-2569c7160682", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "7f1ae233-ab3e-4138-a673-f763844d39bc"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD\nAND ROUTE(S) OF ADMINISTRATION</span>", "ID": "ab9dcc41-848c-4e57-987e-f48837f9706e", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD AND ROUTE(S) OF ADMINISTRATION", "ParentId": "b6cee08b-3bd6-4926-bcb1-2569c7160682"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "a6572408-6383-403f-a4f5-407be4878d8c", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "bf5f22ed-b4e5-4c3c-97cf-b870d580f31f", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "a6572408-6383-403f-a4f5-407be4878d8c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>For oral use.</span></p>", "ID": "c6934a81-12b4-4b10-9eb7-d602f914eb9d", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>For oral use.</span>", "ID": "5b540c79-3fe6-4a1d-bb6e-83ce889e2b4b", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "For oral use.", "ParentId": "c6934a81-12b4-4b10-9eb7-d602f914eb9d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Read the package leaflet before use.</span></p>", "ID": "11b741d4-e239-4dfa-ac2e-559f6063d161", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Read the package leaflet before use.</span>", "ID": "bbda7975-e5df-462c-ba6b-e42838bd2950", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "Read the package leaflet before use.", "ParentId": "11b741d4-e239-4dfa-ac2e-559f6063d161"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "8ca79cf0-b993-45fd-8567-7795918a011f", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "610f2ce4-3a4a-4134-ac5b-244934edbc89", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "8ca79cf0-b993-45fd-8567-7795918a011f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "3ef7ae24-d1d3-4e8d-af9c-0e871cd92558", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "005707c5-f13c-40b0-9391-f4312cff3d9d", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "3ef7ae24-d1d3-4e8d-af9c-0e871cd92558"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nWARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF\nCHILDREN</span></b></p>\n</div>", "ID": "1404cbc2-eca0-42e2-8e36-a3fbfb22879b", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nWARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF\nCHILDREN</span></b></p>", "ID": "078b00d4-a165-4d17-8b74-5f75c59a4037", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "1404cbc2-eca0-42e2-8e36-a3fbfb22879b"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nWARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF\nCHILDREN</span></b>", "ID": "bea200df-52c8-4e3d-82bb-0c3c0ad28921", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "078b00d4-a165-4d17-8b74-5f75c59a4037"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nWARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF\nCHILDREN</span>", "ID": "a49bd566-bcfb-4774-9069-b6ce7efdd7bc", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN", "ParentId": "bea200df-52c8-4e3d-82bb-0c3c0ad28921"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "867c1eb8-6daf-4ff0-83ec-b5fd8ac96f39", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "2753721d-860c-4fcf-9dc9-cd68124441b7", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "867c1eb8-6daf-4ff0-83ec-b5fd8ac96f39"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Keep out of the sight and reach of children.</span></p>", "ID": "6a9a23eb-ff4d-42ea-b0b5-425dea9744db", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Keep out of the sight and reach of children.</span>", "ID": "84c6d7ff-de9b-4eec-ad49-9bcb7ac1d7a5", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "Keep out of the sight and reach of children.", "ParentId": "6a9a23eb-ff4d-42ea-b0b5-425dea9744db"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "54232fb8-a482-462c-aba5-fade43cd308b", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "c8a11ef5-77f7-4e5f-a247-795e73c1bfb7", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "54232fb8-a482-462c-aba5-fade43cd308b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "e3e9530c-ef62-41e4-bbb1-e0677320832a", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "3f6483ff-0a28-4ce5-959e-c56ed986d50b", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "e3e9530c-ef62-41e4-bbb1-e0677320832a"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER\nSPECIAL WARNING(S), IF NECESSARY</span></b></p>\n</div>", "ID": "efce6b59-55b3-4559-8612-7c6f03474b83", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER\nSPECIAL WARNING(S), IF NECESSARY</span></b></p>", "ID": "f7c65619-c8dd-4c10-bc26-1b71c99d4455", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "efce6b59-55b3-4559-8612-7c6f03474b83"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER\nSPECIAL WARNING(S), IF NECESSARY</span></b>", "ID": "914df070-d176-4ca7-ae22-820709a627d5", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f7c65619-c8dd-4c10-bc26-1b71c99d4455"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER\nSPECIAL WARNING(S), IF NECESSARY</span>", "ID": "e6be8ada-26cd-42a5-86a3-6714633f9fca", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER SPECIAL WARNING(S), IF NECESSARY", "ParentId": "914df070-d176-4ca7-ae22-820709a627d5"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "ff4b836c-2115-4f26-a373-afd7b363e6ce", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "9881073f-c9e9-4533-872c-fa4d5d482a00", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "ff4b836c-2115-4f26-a373-afd7b363e6ce"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "97a79422-da10-4d39-9de0-55e69abfed91", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "bee35a3d-7e65-4a7b-b414-3d7e5d515c1f", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "97a79422-da10-4d39-9de0-55e69abfed91"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "82922f81-e47a-49da-bbf3-30dc4f51b607", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "dd8865a9-ca44-47e7-b672-1d6f2c6a89e2", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "82922f81-e47a-49da-bbf3-30dc4f51b607"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY\nDATE</span></b></p>\n</div>", "ID": "1da4722f-9080-4e82-bcc0-731fa4bb0027", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY\nDATE</span></b></p>", "ID": "bbf224a0-4f2c-4728-9177-f3727c228a49", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "1da4722f-9080-4e82-bcc0-731fa4bb0027"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY\nDATE</span></b>", "ID": "f67383b1-02c9-4f57-9adc-9fd389e8df6c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "bbf224a0-4f2c-4728-9177-f3727c228a49"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY\nDATE</span>", "ID": "c5bf74ec-ecd3-41aa-94ff-2a8f68abad68", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE", "ParentId": "f67383b1-02c9-4f57-9adc-9fd389e8df6c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "126992fd-61a4-4395-9f27-8cc510cee80f", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "ebfe4a81-5a37-44ba-bb0e-c9a2ed2be2c9", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "126992fd-61a4-4395-9f27-8cc510cee80f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>EXP</span></p>", "ID": "b3f9de8c-70e4-4dac-a7a9-5ae9bae5c5ac", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>EXP</span>", "ID": "de5df221-db2d-438b-81d5-334ed49ee11c", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "EXP", "ParentId": "b3f9de8c-70e4-4dac-a7a9-5ae9bae5c5ac"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey'>For bottles:</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'> After first opening use\nwithin 180 days</span></p>", "ID": "bbc7177e-486b-4e95-b6f1-dbfe92bc4690", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey'>For bottles:</span>", "ID": "e9e3f0c1-4d2e-4b6f-a7eb-8b633ad05ffc", "Styles": "font-family:\n\"Times New Roman\",serif;background:lightgrey", "Classes": "None", "Text": "For bottles:", "ParentId": "bbc7177e-486b-4e95-b6f1-dbfe92bc4690"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'> After first opening use\nwithin 180 days</span>", "ID": "d6b93f58-e914-4b9a-a9e4-54408782f072", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": " After first opening use within 180 days", "ParentId": "bbc7177e-486b-4e95-b6f1-dbfe92bc4690"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "e3c15093-72fa-4549-8832-5de6f2c4dcb5", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "17b9e2ce-c6f6-451d-bc17-865c20a5cfae", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "e3c15093-72fa-4549-8832-5de6f2c4dcb5"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "6290d79c-dc96-4590-85ee-ad1b2a347ff6", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "540d4085-2d75-4dfc-b1c5-ef964cd8b1a6", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "6290d79c-dc96-4590-85ee-ad1b2a347ff6"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;page-break-after:\navoid;border:none;padding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span></b></p>\n</div>", "ID": "1501ea9e-43eb-4851-ac93-997552acc15f", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;page-break-after:\navoid;border:none;padding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span></b></p>", "ID": "afee022d-8bff-4b28-ae3d-3e4d91b57b78", "Styles": "margin-bottom:0in;line-height:normal;page-break-after:\navoid;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "1501ea9e-43eb-4851-ac93-997552acc15f"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span></b>", "ID": "5486599a-37d2-4de4-af13-7d93a492e379", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "afee022d-8bff-4b28-ae3d-3e4d91b57b78"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span>", "ID": "ee84f1b2-df9b-4cf9-91a5-bc5c3a7eb7b4", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL STORAGE CONDITIONS", "ParentId": "5486599a-37d2-4de4-af13-7d93a492e379"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "96468224-6061-4576-9187-693b16ca67b0", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "d09ade59-ca59-4149-8f91-1b830d33e5c8", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "96468224-6061-4576-9187-693b16ca67b0"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "737ebae4-1e5b-4ce8-a1d0-48ffe0907869", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "0566dbf8-677d-4195-8370-153d7cfd49a6", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "737ebae4-1e5b-4ce8-a1d0-48ffe0907869"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "cc86a961-e5b2-43a2-9635-816dfb72e306", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "a7b96b11-cdbe-488c-8cc2-04f9e26cd529", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "cc86a961-e5b2-43a2-9635-816dfb72e306"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>10.\u00a0\u00a0\u00a0\u00a0 SPECIAL\nPRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS\nDERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE</span></b></p>\n</div>", "ID": "079ef5b9-57cc-49ea-806f-7b60d7e1d20f", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>10.\u00a0\u00a0\u00a0\u00a0 SPECIAL\nPRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS\nDERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE</span></b></p>", "ID": "f1a25b91-1e1d-4cc0-b773-a59eee7d6872", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "079ef5b9-57cc-49ea-806f-7b60d7e1d20f"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>10.\u00a0\u00a0\u00a0\u00a0 SPECIAL\nPRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS\nDERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE</span></b>", "ID": "8938b34e-01e0-4321-ad20-3beae0670c33", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f1a25b91-1e1d-4cc0-b773-a59eee7d6872"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>10.\u00a0\u00a0\u00a0\u00a0 SPECIAL\nPRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS\nDERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE</span>", "ID": "2cdebfe1-3895-43da-9908-a786921547f0", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "10.\u00a0\u00a0\u00a0\u00a0 SPECIAL PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE", "ParentId": "8938b34e-01e0-4321-ad20-3beae0670c33"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "6beef400-6ef7-4d8c-8aa9-409544758665", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "74f9c810-2924-47cb-9070-16d4514910f1", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "6beef400-6ef7-4d8c-8aa9-409544758665"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "3af2be01-2253-4f47-9275-0c49da112fe6", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "4478d4f0-7da4-4c5e-aaca-38b1cb6c3bf1", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "3af2be01-2253-4f47-9275-0c49da112fe6"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "26456550-877c-4278-affa-ec3b853ba4c6", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "7a16f687-561d-497c-ad5a-937e1972daa7", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "26456550-877c-4278-affa-ec3b853ba4c6"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>11.\u00a0\u00a0\u00a0\u00a0 NAME\nAND ADDRESS OF THE MARKETING AUTHORISATION HOLDER</span></b></p>\n</div>", "ID": "37cd9e5f-16ec-4019-8bc0-f67616cae03f", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>11.\u00a0\u00a0\u00a0\u00a0 NAME\nAND ADDRESS OF THE MARKETING AUTHORISATION HOLDER</span></b></p>", "ID": "ac27718e-dd72-4de6-be67-a48396e68602", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "37cd9e5f-16ec-4019-8bc0-f67616cae03f"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>11.\u00a0\u00a0\u00a0\u00a0 NAME\nAND ADDRESS OF THE MARKETING AUTHORISATION HOLDER</span></b>", "ID": "0666ea52-f6b0-48a5-bec9-2e06409364c9", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ac27718e-dd72-4de6-be67-a48396e68602"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>11.\u00a0\u00a0\u00a0\u00a0 NAME\nAND ADDRESS OF THE MARKETING AUTHORISATION HOLDER</span>", "ID": "e9546970-88e5-4496-b51e-ff75ef8c4e44", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "11.\u00a0\u00a0\u00a0\u00a0 NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER", "ParentId": "0666ea52-f6b0-48a5-bec9-2e06409364c9"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "5b38d8f3-6d22-44cd-9c92-4118aeb4f2bf", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "11cca34b-228c-4575-aa2b-bc69db52f96a", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "5b38d8f3-6d22-44cd-9c92-4118aeb4f2bf"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"DE-AT\" style='font-family:\n\"Times New Roman\",serif'>Mylan S.A.S.</span></p>", "ID": "74dd96aa-fce3-4477-82e1-ac7682b3fc9f", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"DE-AT\" style='font-family:\n\"Times New Roman\",serif'>Mylan S.A.S.</span>", "ID": "0f74bd56-1c7e-4b0e-8ca4-dee1c69f07bb", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "Mylan S.A.S.", "ParentId": "74dd96aa-fce3-4477-82e1-ac7682b3fc9f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"DE-AT\" style='font-family:\n\"Times New Roman\",serif'>117 Allee des Parcs</span></p>", "ID": "1316f141-2da5-4674-a054-9741a5600179", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"DE-AT\" style='font-family:\n\"Times New Roman\",serif'>117 Allee des Parcs</span>", "ID": "e0b731b7-d36d-48d1-8457-8a4dd3a753e1", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "117 Allee des Parcs", "ParentId": "1316f141-2da5-4674-a054-9741a5600179"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>69 800 Saint Priest</span></p>", "ID": "4c4f83d7-a422-4f0d-8d4b-8e43f57492b3", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>69 800 Saint Priest</span>", "ID": "dfa26c85-6f71-46cd-b3cb-a28f87a106cc", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "69 800 Saint Priest", "ParentId": "4c4f83d7-a422-4f0d-8d4b-8e43f57492b3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>France</span></p>", "ID": "3691c916-a336-4785-8105-d9bcbf5ac5f2", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>France</span>", "ID": "267e2b21-3016-4eca-8b36-bc049de8544a", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "France", "ParentId": "3691c916-a336-4785-8105-d9bcbf5ac5f2"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "b4ad0de6-cb1d-443e-89c1-c0b2611e7101", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "e17883e1-755c-4519-bb91-58b8e13121eb", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "b4ad0de6-cb1d-443e-89c1-c0b2611e7101"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "297df4c1-1a5b-4405-9a99-c10be8ed2d3a", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "98419d09-fa09-46d3-95ff-86598be99288", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "297df4c1-1a5b-4405-9a99-c10be8ed2d3a"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>12.\u00a0\u00a0\u00a0\u00a0 MARKETING\nAUTHORISATION NUMBER(S) </span></b></p>\n</div>", "ID": "1ca385a2-690b-4c29-bb2a-d9f3aa6127d0", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>12.\u00a0\u00a0\u00a0\u00a0 MARKETING\nAUTHORISATION NUMBER(S) </span></b></p>", "ID": "a4aa7ad8-a984-4142-9d39-5a4b4931e4c2", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "1ca385a2-690b-4c29-bb2a-d9f3aa6127d0"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>12.\u00a0\u00a0\u00a0\u00a0 MARKETING\nAUTHORISATION NUMBER(S) </span></b>", "ID": "65470c15-d507-4836-986c-ceec0cb35221", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a4aa7ad8-a984-4142-9d39-5a4b4931e4c2"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>12.\u00a0\u00a0\u00a0\u00a0 MARKETING\nAUTHORISATION NUMBER(S) </span>", "ID": "1ff132b3-48ed-4e65-a32d-55d15e66d21e", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "12.\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION NUMBER(S) ", "ParentId": "65470c15-d507-4836-986c-ceec0cb35221"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "3b5c36dc-8e20-4d8d-9733-6390d92d860b", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "403a236d-4c4a-4719-8fac-563a508f4c4b", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "3b5c36dc-8e20-4d8d-9733-6390d92d860b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>EU/1/17/1194/009</span></p>", "ID": "1d81fc81-7650-4224-bfc5-17478abac2f4", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>EU/1/17/1194/009</span>", "ID": "b734704d-2a43-4765-b49a-54586073df2a", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "EU/1/17/1194/009", "ParentId": "1d81fc81-7650-4224-bfc5-17478abac2f4"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey'>EU/1/17/1194/010</span></p>", "ID": "78e0c96a-5f3e-4b45-b71a-9967515d766c", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey'>EU/1/17/1194/010</span>", "ID": "2ca4023d-be9d-4122-b30e-eb4ff412dba0", "Styles": "font-family:\n\"Times New Roman\",serif;background:lightgrey", "Classes": "None", "Text": "EU/1/17/1194/010", "ParentId": "78e0c96a-5f3e-4b45-b71a-9967515d766c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey'>EU/1/17/1194/011</span></p>", "ID": "d08032ba-50c6-4641-b26f-350a3769bb0f", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey'>EU/1/17/1194/011</span>", "ID": "d42c7423-c9b7-4500-b023-c8cbfca68e28", "Styles": "font-family:\n\"Times New Roman\",serif;background:lightgrey", "Classes": "None", "Text": "EU/1/17/1194/011", "ParentId": "d08032ba-50c6-4641-b26f-350a3769bb0f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey'>EU/1/17/1194/012</span></p>", "ID": "90030080-483d-4173-9c82-2f659834ec90", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey'>EU/1/17/1194/012</span>", "ID": "d990ab49-f2e8-4163-ac33-49e29fe13e75", "Styles": "font-family:\n\"Times New Roman\",serif;background:lightgrey", "Classes": "None", "Text": "EU/1/17/1194/012", "ParentId": "90030080-483d-4173-9c82-2f659834ec90"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey'>EU/1/17/1194/013</span></p>", "ID": "af23e755-f7d1-4de1-bf54-8ce782695145", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey'>EU/1/17/1194/013</span>", "ID": "00aa178c-ba3a-4b36-9ee5-91f079014c03", "Styles": "font-family:\n\"Times New Roman\",serif;background:lightgrey", "Classes": "None", "Text": "EU/1/17/1194/013", "ParentId": "af23e755-f7d1-4de1-bf54-8ce782695145"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey'>EU/1/17/1194/014</span></p>", "ID": "3b9181a9-090d-4cd4-9288-1f520e96d1ce", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey'>EU/1/17/1194/014</span>", "ID": "1c91b16c-c50f-4e5c-9085-98a5237b09e1", "Styles": "font-family:\n\"Times New Roman\",serif;background:lightgrey", "Classes": "None", "Text": "EU/1/17/1194/014", "ParentId": "3b9181a9-090d-4cd4-9288-1f520e96d1ce"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey'>EU/1/17/1194/015</span></p>", "ID": "e90ed6be-d17f-48cb-96ee-f60381ebd02a", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey'>EU/1/17/1194/015</span>", "ID": "3545b241-5270-4f2b-b3c0-ce531f483115", "Styles": "font-family:\n\"Times New Roman\",serif;background:lightgrey", "Classes": "None", "Text": "EU/1/17/1194/015", "ParentId": "e90ed6be-d17f-48cb-96ee-f60381ebd02a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey'>EU/1/17/1194/016</span></p>", "ID": "3b4a1c37-69d2-4e5a-a263-57eca5252fb4", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey'>EU/1/17/1194/016</span>", "ID": "0a16d78b-73fa-4ef5-a598-8f60a0b326e2", "Styles": "font-family:\n\"Times New Roman\",serif;background:lightgrey", "Classes": "None", "Text": "EU/1/17/1194/016", "ParentId": "3b4a1c37-69d2-4e5a-a263-57eca5252fb4"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;background:lightgrey'>EU/1/17/1194/023</span></p>", "ID": "6b196644-a7e8-40f6-a6aa-215f2a8e7b57", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;background:lightgrey'>EU/1/17/1194/023</span>", "ID": "2eb54240-592b-478a-b37f-1e6bec4fa1e4", "Styles": "font-family:\"Times New Roman\",serif;background:lightgrey", "Classes": "None", "Text": "EU/1/17/1194/023", "ParentId": "6b196644-a7e8-40f6-a6aa-215f2a8e7b57"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;background:lightgrey'>EU/1/17/1194/024</span></p>", "ID": "5ec99507-92c1-4773-9d6b-b02029614e49", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;background:lightgrey'>EU/1/17/1194/024</span>", "ID": "d4ecd365-bb69-497a-9d17-cc8165b81b07", "Styles": "font-family:\"Times New Roman\",serif;background:lightgrey", "Classes": "None", "Text": "EU/1/17/1194/024", "ParentId": "5ec99507-92c1-4773-9d6b-b02029614e49"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;background:lightgrey'>EU/1/17/1194/025</span></p>", "ID": "1175ccaa-8e84-4b68-92c8-4b5c62a63507", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;background:lightgrey'>EU/1/17/1194/025</span>", "ID": "e5aae71f-4b02-453f-9b69-2c00b48a12e9", "Styles": "font-family:\"Times New Roman\",serif;background:lightgrey", "Classes": "None", "Text": "EU/1/17/1194/025", "ParentId": "1175ccaa-8e84-4b68-92c8-4b5c62a63507"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;background:lightgrey'>EU/1/17/1194/026</span></p>", "ID": "2ef7f302-031c-4260-872c-f1ed284715ec", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;background:lightgrey'>EU/1/17/1194/026</span>", "ID": "3deb3e33-cdc9-4aed-a198-67117b66e331", "Styles": "font-family:\"Times New Roman\",serif;background:lightgrey", "Classes": "None", "Text": "EU/1/17/1194/026", "ParentId": "2ef7f302-031c-4260-872c-f1ed284715ec"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;background:lightgrey'>EU/1/17/1194/027</span></p>", "ID": "5cc25160-7853-45b7-bfec-cb77aad2c01d", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;background:lightgrey'>EU/1/17/1194/027</span>", "ID": "dfb7bc5e-8cef-44b7-901d-abbd47d16436", "Styles": "font-family:\"Times New Roman\",serif;background:lightgrey", "Classes": "None", "Text": "EU/1/17/1194/027", "ParentId": "5cc25160-7853-45b7-bfec-cb77aad2c01d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "1a770636-c3c7-438c-ab01-557157ec6b51", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "8c055e38-7c26-4cd1-8dab-b4ed359e1b15", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "1a770636-c3c7-438c-ab01-557157ec6b51"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "90cf8e25-a6db-48c9-83c6-febe4cb192d7", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "f4f97546-a95e-4b67-91e8-ef2a0d2c3e05", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "90cf8e25-a6db-48c9-83c6-febe4cb192d7"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>13.\u00a0\u00a0\u00a0\u00a0 BATCH\nNUMBER</span></b></p>\n</div>", "ID": "6c92e056-9b7d-4b0a-81f0-b7d039b35cc0", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>13.\u00a0\u00a0\u00a0\u00a0 BATCH\nNUMBER</span></b></p>", "ID": "a9547e47-ce01-4302-b0de-680779105c2e", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "6c92e056-9b7d-4b0a-81f0-b7d039b35cc0"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>13.\u00a0\u00a0\u00a0\u00a0 BATCH\nNUMBER</span></b>", "ID": "428e245d-328b-48dc-971b-590be2d532e0", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a9547e47-ce01-4302-b0de-680779105c2e"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>13.\u00a0\u00a0\u00a0\u00a0 BATCH\nNUMBER</span>", "ID": "68b934ba-cc3d-4ee4-b884-b551a53ec400", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "13.\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER", "ParentId": "428e245d-328b-48dc-971b-590be2d532e0"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><i><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></i></p>", "ID": "0626266d-013f-4cc4-b63b-4f4f9eccb1e5", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<i><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></i>", "ID": "fca0da5c-27a8-403b-993e-dbd875f4b7b5", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0626266d-013f-4cc4-b63b-4f4f9eccb1e5"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "f80e9f40-8e33-4f87-9afa-441d36d1bcc2", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "fca0da5c-27a8-403b-993e-dbd875f4b7b5"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Lot</span></p>", "ID": "3ba9d3fb-4a57-4097-baee-5f2d3ce4c16c", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Lot</span>", "ID": "b2f277b4-3b5b-4a3f-95a0-20bf82b519f7", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "Lot", "ParentId": "3ba9d3fb-4a57-4097-baee-5f2d3ce4c16c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "a4c471e4-f8b0-44a2-92bb-ef9d893a86cd", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "f880d671-2fa7-4d65-89f8-784fb5ff4835", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "a4c471e4-f8b0-44a2-92bb-ef9d893a86cd"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "59a3d7f4-2e78-4de3-b305-85d9ec6cdb9c", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "58a7c8fb-9ef9-4e2b-b594-463ad17447aa", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "59a3d7f4-2e78-4de3-b305-85d9ec6cdb9c"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>14.\u00a0\u00a0\u00a0\u00a0 GENERAL\nCLASSIFICATION FOR SUPPLY</span></b></p>\n</div>", "ID": "44766fc3-c121-4248-a847-4b7734022dca", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>14.\u00a0\u00a0\u00a0\u00a0 GENERAL\nCLASSIFICATION FOR SUPPLY</span></b></p>", "ID": "40c1c7c1-e181-4713-a268-caf2009c6333", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "44766fc3-c121-4248-a847-4b7734022dca"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>14.\u00a0\u00a0\u00a0\u00a0 GENERAL\nCLASSIFICATION FOR SUPPLY</span></b>", "ID": "44e07236-cc1c-45af-b003-7533aa18f18d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "40c1c7c1-e181-4713-a268-caf2009c6333"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>14.\u00a0\u00a0\u00a0\u00a0 GENERAL\nCLASSIFICATION FOR SUPPLY</span>", "ID": "c0bf8465-ae17-4589-b5a3-e86349426f09", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "14.\u00a0\u00a0\u00a0\u00a0 GENERAL CLASSIFICATION FOR SUPPLY", "ParentId": "44e07236-cc1c-45af-b003-7533aa18f18d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><i><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></i></p>", "ID": "cb54a053-7b3d-42c7-93ff-ef5d3afcd17d", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<i><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></i>", "ID": "b6fa3335-5eb9-4dda-a189-73985ea8f4bb", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "cb54a053-7b3d-42c7-93ff-ef5d3afcd17d"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "045d6e04-31f8-49f7-949c-3dd0c1aaaf1d", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "b6fa3335-5eb9-4dda-a189-73985ea8f4bb"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "b0251d92-6b7d-4193-9e59-f9cdcb59b738", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "9c9d26db-b426-4ea4-a9ee-97ddcbccc9a8", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "b0251d92-6b7d-4193-9e59-f9cdcb59b738"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "0c0f4cbe-d276-4894-8a9c-daa368e08356", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "7e83cda0-d082-4de2-8535-017aaae1b540", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "0c0f4cbe-d276-4894-8a9c-daa368e08356"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:2.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS\nON USE</span></b></p>\n</div>", "ID": "73eca5c9-4a92-4705-9062-cb31bd2a44b8", "Styles": "border:solid windowtext 1.0pt;padding:2.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS\nON USE</span></b></p>", "ID": "54bb36bc-e45c-4fb0-a6ed-a912d9857a8e", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "73eca5c9-4a92-4705-9062-cb31bd2a44b8"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS\nON USE</span></b>", "ID": "8d2c19ba-ef8c-4961-9197-7d05fed12476", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "54bb36bc-e45c-4fb0-a6ed-a912d9857a8e"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS\nON USE</span>", "ID": "50c2082e-fb11-4032-b912-e772fe2f97be", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS ON USE", "ParentId": "8d2c19ba-ef8c-4961-9197-7d05fed12476"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "82900d33-e969-4295-bc5e-b2fccbf22f29", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "54481536-103b-477c-8263-9709f9ca01a9", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "82900d33-e969-4295-bc5e-b2fccbf22f29"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "a43a9e69-d1cd-47b4-9513-0726688a4520", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "2779405f-f90d-4039-ac49-d7c64494ee31", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "a43a9e69-d1cd-47b4-9513-0726688a4520"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "7759e8ca-58d4-484c-8607-f0527f882c4e", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "0f8abb14-da9f-42dc-ac61-033b89106c9d", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "7759e8ca-58d4-484c-8607-f0527f882c4e"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>16.\u00a0\u00a0\u00a0\u00a0 INFORMATION\nIN BRAILLE</span></b></p>\n</div>", "ID": "c4859b3e-52b2-48ec-85a2-afa7a43bbcda", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>16.\u00a0\u00a0\u00a0\u00a0 INFORMATION\nIN BRAILLE</span></b></p>", "ID": "57a083f0-eb0f-4bc9-87e9-35fa4d5acbd2", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c4859b3e-52b2-48ec-85a2-afa7a43bbcda"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>16.\u00a0\u00a0\u00a0\u00a0 INFORMATION\nIN BRAILLE</span></b>", "ID": "1f21aedf-1685-4b13-8dc0-c2bf769094a9", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "57a083f0-eb0f-4bc9-87e9-35fa4d5acbd2"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>16.\u00a0\u00a0\u00a0\u00a0 INFORMATION\nIN BRAILLE</span>", "ID": "3cc8f9d7-8c5f-4de3-85dd-eceb737ce58e", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "16.\u00a0\u00a0\u00a0\u00a0 INFORMATION IN BRAILLE", "ParentId": "1f21aedf-1685-4b13-8dc0-c2bf769094a9"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "1f3fd42a-5b3f-4dc2-81b3-0685938deac8", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "d14b56f3-6184-49c0-ad5a-a1eb2dbb23fb", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "1f3fd42a-5b3f-4dc2-81b3-0685938deac8"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Febuxostat Mylan 120\u00a0mg</span></p>", "ID": "2e621ea8-4d9f-43ca-83f8-155449eefcf2", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Febuxostat Mylan 120\u00a0mg</span>", "ID": "531c08b2-89cd-4800-8264-d72a56c6e05a", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "Febuxostat Mylan 120\u00a0mg", "ParentId": "2e621ea8-4d9f-43ca-83f8-155449eefcf2"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:#CCCCCC'>\u00a0</span></p>", "ID": "5294f700-4278-454f-98e6-c4831db53d1e", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:#CCCCCC'>\u00a0</span>", "ID": "998bca2a-858a-4109-a354-9244914ce6c7", "Styles": "font-family:\n\"Times New Roman\",serif;background:#CCCCCC", "Classes": "None", "Text": "\u00a0", "ParentId": "5294f700-4278-454f-98e6-c4831db53d1e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:#CCCCCC'>\u00a0</span></p>", "ID": "687939f1-3460-4251-b21b-039658ae0c3e", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:#CCCCCC'>\u00a0</span>", "ID": "7796933d-53dc-489e-b685-0d15be68eaed", "Styles": "font-family:\n\"Times New Roman\",serif;background:#CCCCCC", "Classes": "None", "Text": "\u00a0", "ParentId": "687939f1-3460-4251-b21b-039658ae0c3e"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>17.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 2D BARCODE</span></b></p>\n</div>", "ID": "477007bb-8a31-4b22-b50a-41cff2ddda06", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>17.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 2D BARCODE</span></b></p>", "ID": "4a006e98-2192-4410-97c2-9c2e1ab3f310", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "477007bb-8a31-4b22-b50a-41cff2ddda06"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>17.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 2D BARCODE</span></b>", "ID": "04a24648-5d9b-4122-b589-84882629b14c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4a006e98-2192-4410-97c2-9c2e1ab3f310"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>17.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 2D BARCODE</span>", "ID": "539af493-7c21-4956-bf29-2cb57516d62c", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "17.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE IDENTIFIER \u2013 2D BARCODE", "ParentId": "04a24648-5d9b-4122-b589-84882629b14c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "314b1b05-b27a-4676-9ab8-b246e983a1ce", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "4f22a198-645e-4f24-af2a-3ae4e74de5ed", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "314b1b05-b27a-4676-9ab8-b246e983a1ce"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC'>2D barcode carrying the\nunique identifier included.</span></p>", "ID": "570d7376-41e7-4f5f-a0fd-0473d31bf210", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC'>2D barcode carrying the\nunique identifier included.</span>", "ID": "f7261add-ac7e-4091-81b3-e54ff6095435", "Styles": "font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC", "Classes": "None", "Text": "2D barcode carrying the unique identifier included.", "ParentId": "570d7376-41e7-4f5f-a0fd-0473d31bf210"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:#CCCCCC'>\u00a0</span></p>", "ID": "f1645137-fd2c-41a2-bd4e-7d45796b0e54", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:#CCCCCC'>\u00a0</span>", "ID": "a5a79da0-e1a9-4799-9ba9-64a9b8aec8eb", "Styles": "font-family:\n\"Times New Roman\",serif;background:#CCCCCC", "Classes": "None", "Text": "\u00a0", "ParentId": "f1645137-fd2c-41a2-bd4e-7d45796b0e54"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "a65dec74-dfc3-4e4e-b619-c767f8d5ea62", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "2d2accaf-044c-475f-9c13-37435be30321", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "a65dec74-dfc3-4e4e-b619-c767f8d5ea62"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>18.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 HUMAN READABLE DATA</span></b></p>\n</div>", "ID": "ee94a188-b364-4001-b6c6-4e274429e685", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>18.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 HUMAN READABLE DATA</span></b></p>", "ID": "15a46370-927d-4e33-87f5-0fd6c1747f04", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ee94a188-b364-4001-b6c6-4e274429e685"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>18.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 HUMAN READABLE DATA</span></b>", "ID": "b929da0c-4742-4fc2-b423-0ceb28673c40", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "15a46370-927d-4e33-87f5-0fd6c1747f04"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>18.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 HUMAN READABLE DATA</span>", "ID": "effc9f01-5aee-4536-a624-93b8e067686d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "18.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE IDENTIFIER \u2013 HUMAN READABLE DATA", "ParentId": "b929da0c-4742-4fc2-b423-0ceb28673c40"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "c5e0a007-241c-408b-b6e1-92f01dd16a0e", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "a3a897a0-1324-45c8-a260-db3c35a8b75c", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "c5e0a007-241c-408b-b6e1-92f01dd16a0e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>PC:</span></p>", "ID": "71e916b3-a634-494e-8524-b64243962a19", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>PC:</span>", "ID": "0aed68fe-ac9f-4632-b510-468c66a42460", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "PC:", "ParentId": "71e916b3-a634-494e-8524-b64243962a19"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>SN:</span></p>", "ID": "56919ebf-77fe-466a-ae5d-6f0d608e8f8a", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>SN:</span>", "ID": "b206e9ce-1150-4fc8-9e38-24f949aec3d3", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "SN:", "ParentId": "56919ebf-77fe-466a-ae5d-6f0d608e8f8a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>NN:</span></p>", "ID": "6bc66d3f-9202-4cc4-91d7-6d766578a0e8", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>NN:</span>", "ID": "cf1cf295-4ae1-4397-a730-f9c238411731", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "NN:", "ParentId": "6bc66d3f-9202-4cc4-91d7-6d766578a0e8"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\ncolor:black;background:lightgrey'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span>", "ID": "491fcaa2-d1a8-42a5-b583-c8d777ba52c8", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif;\ncolor:black;background:lightgrey", "Classes": "None", "Text": " ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<br clear=\"all\" style=\"page-break-before:always\"/>", "ID": "1d6f38d3-8c7b-40f8-a737-f6db01f62fb6", "Styles": "page-break-before:always", "Classes": "None", "Text": "", "ParentId": "491fcaa2-d1a8-42a5-b583-c8d777ba52c8"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;background:white\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;background:#CCCCCC'>\u00a0</span></p>", "ID": "7fe06fa2-4b9a-43f0-86c1-fc23638f55c3", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;background:white", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;background:#CCCCCC'>\u00a0</span>", "ID": "6276f615-957f-4baa-bed2-9e82f85ccdf2", "Styles": "font-family:\"Times New Roman\",serif;background:#CCCCCC", "Classes": "None", "Text": "\u00a0", "ParentId": "7fe06fa2-4b9a-43f0-86c1-fc23638f55c3"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>PARTICULARS\nTO APPEAR ON THE OUTER PACKAGING</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>OUTER\nCARTON OF MULTIPACK (WITH BLUE BOX)</span></b></p>\n</div>", "ID": "7545c43b-0897-4077-8cb3-314bbac8a5f8", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "    ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>PARTICULARS\nTO APPEAR ON THE OUTER PACKAGING</span></b></p>", "ID": "dbfd9b63-e9b4-4135-9f16-1abdd43b0f02", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "7545c43b-0897-4077-8cb3-314bbac8a5f8"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>PARTICULARS\nTO APPEAR ON THE OUTER PACKAGING</span></b>", "ID": "dfff7232-2279-46af-8e3b-68a01385c8c0", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "dbfd9b63-e9b4-4135-9f16-1abdd43b0f02"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>PARTICULARS\nTO APPEAR ON THE OUTER PACKAGING</span>", "ID": "9850cd62-97ad-4a0e-9631-9135f13abaa3", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "PARTICULARS TO APPEAR ON THE OUTER PACKAGING", "ParentId": "dfff7232-2279-46af-8e3b-68a01385c8c0"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "2171da70-395a-43f8-87b9-cd265576968e", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "7545c43b-0897-4077-8cb3-314bbac8a5f8"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "0e356fdc-1682-4848-b194-c50d875d3f3a", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "2171da70-395a-43f8-87b9-cd265576968e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>OUTER\nCARTON OF MULTIPACK (WITH BLUE BOX)</span></b></p>", "ID": "7da197cc-eb4f-4e09-a56d-41f2494e31d9", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "7545c43b-0897-4077-8cb3-314bbac8a5f8"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>OUTER\nCARTON OF MULTIPACK (WITH BLUE BOX)</span></b>", "ID": "4d36a17d-7a35-4604-893b-d02713b23668", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "7da197cc-eb4f-4e09-a56d-41f2494e31d9"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>OUTER\nCARTON OF MULTIPACK (WITH BLUE BOX)</span>", "ID": "2f30f45e-2589-4148-b20e-f8d475e8771a", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "OUTER CARTON OF MULTIPACK (WITH BLUE BOX)", "ParentId": "4d36a17d-7a35-4604-893b-d02713b23668"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "1348db77-1249-4a44-83c8-49ac92ea0628", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "d69bdc83-3846-4518-887a-e5be202a91f5", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "1348db77-1249-4a44-83c8-49ac92ea0628"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "12c8667f-3727-441c-b2f6-add365f96235", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "3d93cbc2-d97f-4a3c-8472-f6d713016fa7", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "12c8667f-3727-441c-b2f6-add365f96235"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\nOF THE MEDICINAL PRODUCT</span></b></p>\n</div>", "ID": "49f30f50-1677-4d40-b9a9-cfd4834599be", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\nOF THE MEDICINAL PRODUCT</span></b></p>", "ID": "642bc1a2-2406-41dc-bc23-da06f3f79412", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "49f30f50-1677-4d40-b9a9-cfd4834599be"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\nOF THE MEDICINAL PRODUCT</span></b>", "ID": "fe37cafb-974c-4ad9-bc2e-82f7f3e6d754", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "642bc1a2-2406-41dc-bc23-da06f3f79412"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\nOF THE MEDICINAL PRODUCT</span>", "ID": "18fb9887-c4b0-44ab-8321-66d795fc0264", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT", "ParentId": "fe37cafb-974c-4ad9-bc2e-82f7f3e6d754"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "76da9121-9fbb-4d5d-a731-9abb3cc3e687", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "a457de73-7292-4521-ac6c-6116808ee284", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "76da9121-9fbb-4d5d-a731-9abb3cc3e687"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Febuxostat Mylan 120\u00a0mg film-coated tablets</span></p>", "ID": "5b5ee671-4a39-4e3e-b787-2d3d763661e7", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Febuxostat Mylan 120\u00a0mg film-coated tablets</span>", "ID": "fb6387d7-f3bd-47e9-a07f-50080a940977", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "Febuxostat Mylan 120\u00a0mg film-coated tablets", "ParentId": "5b5ee671-4a39-4e3e-b787-2d3d763661e7"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "6cd6b354-42a8-4aa7-8f5a-5cbd052dcd1b", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "ede1605a-dcee-40bc-8229-a4e9ffc86f87", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "6cd6b354-42a8-4aa7-8f5a-5cbd052dcd1b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>febuxostat</span><b><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'> </span></b></p>", "ID": "e2db3c02-db33-459a-b705-fb2ac302cf57", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>febuxostat</span>", "ID": "04ef50c0-09c7-45cc-bb44-8b02bee54be2", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "febuxostat", "ParentId": "e2db3c02-db33-459a-b705-fb2ac302cf57"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'> </span></b>", "ID": "bdd6436a-3c43-425f-af99-87fc81e9a3e8", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e2db3c02-db33-459a-b705-fb2ac302cf57"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'> </span>", "ID": "83bdce8c-b6b6-426b-9630-40acf49b1954", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": " ", "ParentId": "bdd6436a-3c43-425f-af99-87fc81e9a3e8"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "83fc040d-2903-4904-b7cb-f5ede7ee68e8", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "28b8ed9a-ddb5-45bb-8783-163f0d7be4bd", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "83fc040d-2903-4904-b7cb-f5ede7ee68e8"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "8be9acab-2c0a-48e7-9429-798c23c95c62", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "440d5618-494f-464f-aa80-1470386942ea", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "8be9acab-2c0a-48e7-9429-798c23c95c62"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT\nOF ACTIVE SUBSTANCE</span></b></p>\n</div>", "ID": "3269d001-e175-4cd3-827a-0e8742e290ef", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT\nOF ACTIVE SUBSTANCE</span></b></p>", "ID": "dd72c923-766b-4f2e-86db-674f778177e8", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3269d001-e175-4cd3-827a-0e8742e290ef"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT\nOF ACTIVE SUBSTANCE</span></b>", "ID": "03cf23a8-97bb-49d6-afee-150e102756de", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "dd72c923-766b-4f2e-86db-674f778177e8"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT\nOF ACTIVE SUBSTANCE</span>", "ID": "d5e1a105-fc4d-4e5a-9a5c-f80fd4357a74", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT OF ACTIVE SUBSTANCE", "ParentId": "03cf23a8-97bb-49d6-afee-150e102756de"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "c0a6d123-68f9-4979-8ffa-faf407334fed", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "9359321a-bc84-4bd1-bc8f-57d96e2da1a4", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "c0a6d123-68f9-4979-8ffa-faf407334fed"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Each tablet contains 120\u00a0mg febuxostat.</span></p>", "ID": "264e6d78-b938-4fb9-a69d-cb58c0193e75", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Each tablet contains 120\u00a0mg febuxostat.</span>", "ID": "e29dbc26-ba17-43c4-add7-0011c37570a3", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "Each tablet contains 120\u00a0mg febuxostat.", "ParentId": "264e6d78-b938-4fb9-a69d-cb58c0193e75"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "45035058-2798-4210-94ca-27890b8c2b38", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "9d704a0a-8ee9-4543-9ef6-835ff34746bd", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "45035058-2798-4210-94ca-27890b8c2b38"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "4b57776e-192d-4640-b688-5106bb401587", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "5a4e1703-2d4f-460c-9e90-2af736794bdf", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "4b57776e-192d-4640-b688-5106bb401587"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST\nOF EXCIPIENTS</span></b></p>\n</div>", "ID": "b3d7470b-8949-4917-afd9-0e8bb3e3cf5d", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST\nOF EXCIPIENTS</span></b></p>", "ID": "9c55145e-6869-4c3f-abf7-71a67e0bf5c4", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b3d7470b-8949-4917-afd9-0e8bb3e3cf5d"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST\nOF EXCIPIENTS</span></b>", "ID": "7c0f303a-a277-42ed-8979-b767a7e22b33", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9c55145e-6869-4c3f-abf7-71a67e0bf5c4"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST\nOF EXCIPIENTS</span>", "ID": "34e0f7cd-8cb2-45c4-abb9-b169a9443c7a", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST OF EXCIPIENTS", "ParentId": "7c0f303a-a277-42ed-8979-b767a7e22b33"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "fa3d42ae-43cd-4cdb-9ca3-88e17b2c97f5", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "16de1c19-126e-4fe7-8aa9-f8ea88f95ee9", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "fa3d42ae-43cd-4cdb-9ca3-88e17b2c97f5"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Also contains lactose.</span></p>", "ID": "8e250e58-51fb-4460-8c57-f5c8179e34f9", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Also contains lactose.</span>", "ID": "15c3fe82-ebe9-44f3-b625-7b8a14e749b7", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Also contains lactose.", "ParentId": "8e250e58-51fb-4460-8c57-f5c8179e34f9"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "4059b2c4-ff5e-4f71-9b9f-174bb2403b29", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "8dadd721-97a9-4652-8641-f6a23b0057f9", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "4059b2c4-ff5e-4f71-9b9f-174bb2403b29"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>See leaflet for further information.</span></p>", "ID": "7915effc-f060-4d67-bb30-832c9dee627a", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>See leaflet for further information.</span>", "ID": "905ea3e5-bcb4-4fdc-957d-c99d4f1ed1c4", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "See leaflet for further information.", "ParentId": "7915effc-f060-4d67-bb30-832c9dee627a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "b5883880-5304-48bb-a5f4-0d8dd6223c71", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "0c38d94f-a3cc-43c3-86f2-ac6dd825daa6", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "b5883880-5304-48bb-a5f4-0d8dd6223c71"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "8ed71d79-32b7-4e22-8181-34f13c2f1f8a", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "41c2a73b-4103-4d7b-965b-361e9ce5157d", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "8ed71d79-32b7-4e22-8181-34f13c2f1f8a"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\nFORM AND CONTENTS</span></b></p>\n</div>", "ID": "2c6fe4b2-93cb-469c-9c5f-2658f29024b9", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\nFORM AND CONTENTS</span></b></p>", "ID": "63856e9e-f801-4a0a-bf64-82afbab5ba64", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "2c6fe4b2-93cb-469c-9c5f-2658f29024b9"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\nFORM AND CONTENTS</span></b>", "ID": "bce54369-c0fb-45cb-ba8d-ff034f813f76", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "63856e9e-f801-4a0a-bf64-82afbab5ba64"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\nFORM AND CONTENTS</span>", "ID": "78d128d0-b14d-4595-9711-c5f2ecc30b50", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL FORM AND CONTENTS", "ParentId": "bce54369-c0fb-45cb-ba8d-ff034f813f76"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "f0ec432a-68e5-4daa-b160-fec622196eba", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "498e6ef4-4824-46b4-aae3-f5c94366d738", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "f0ec432a-68e5-4daa-b160-fec622196eba"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"DE\" style='font-family:\"Times New Roman\",serif;\nlayout-grid-mode:line'>Multipack: 84 (2 packs of 42) film-coated tablets</span></p>", "ID": "b34f1fac-6be1-4a2c-9205-6d75758aa2c3", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"DE\" style='font-family:\"Times New Roman\",serif;\nlayout-grid-mode:line'>Multipack: 84 (2 packs of 42) film-coated tablets</span>", "ID": "4ae83a51-befb-4d92-b6b2-96f0c42e82f7", "Styles": "font-family:\"Times New Roman\",serif;\nlayout-grid-mode:line", "Classes": "None", "Text": "Multipack: 84 (2 packs of 42) film-coated tablets", "ParentId": "b34f1fac-6be1-4a2c-9205-6d75758aa2c3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "f0a35994-08ba-41a3-9558-86e872ba35aa", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "dcf8a14e-a731-4d26-b6c5-92caf1c0b988", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "f0a35994-08ba-41a3-9558-86e872ba35aa"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "626256da-83f5-4c81-a640-f9354c739ed9", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "415e4a2c-0179-43c3-861b-aa035a4e9764", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "626256da-83f5-4c81-a640-f9354c739ed9"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD\nAND ROUTE(S) OF ADMINISTRATION</span></b></p>\n</div>", "ID": "b6ab0ca8-201a-4dc4-a600-b986ab509dc5", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD\nAND ROUTE(S) OF ADMINISTRATION</span></b></p>", "ID": "9a489336-e5c9-48ba-9d28-4907035bfb31", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b6ab0ca8-201a-4dc4-a600-b986ab509dc5"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD\nAND ROUTE(S) OF ADMINISTRATION</span></b>", "ID": "4efc4961-f3d1-430f-b82b-f6acdf541e95", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9a489336-e5c9-48ba-9d28-4907035bfb31"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD\nAND ROUTE(S) OF ADMINISTRATION</span>", "ID": "2f69e9e8-9518-4ffe-8ed9-2bc4e3189056", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD AND ROUTE(S) OF ADMINISTRATION", "ParentId": "4efc4961-f3d1-430f-b82b-f6acdf541e95"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "d00a7a80-ba4c-486f-8a48-23e9f0d2cc27", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "43b1ac66-4224-495f-9196-82d9979e2d5b", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "d00a7a80-ba4c-486f-8a48-23e9f0d2cc27"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>For oral use.</span></p>", "ID": "ab843621-2097-4b53-9c1f-fa182411a2fe", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>For oral use.</span>", "ID": "c505a74a-7879-48ea-93c5-2185a9ac01f6", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "For oral use.", "ParentId": "ab843621-2097-4b53-9c1f-fa182411a2fe"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "6dbdd3a9-c097-42e2-91e5-381358ab9493", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "9a1390bd-3e8f-4890-acb9-3b5c260cece7", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "6dbdd3a9-c097-42e2-91e5-381358ab9493"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Read the package leaflet before use.</span></p>", "ID": "729e43a8-f6c2-4a40-8cd8-f133eae8d9b4", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Read the package leaflet before use.</span>", "ID": "2da5cacd-dee0-4f67-b7c6-833893a2cbd0", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "Read the package leaflet before use.", "ParentId": "729e43a8-f6c2-4a40-8cd8-f133eae8d9b4"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "d89b8ead-d70b-4e37-b436-80bba78f56f1", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "5a79d76b-6296-459e-84e5-01e30e752f27", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "d89b8ead-d70b-4e37-b436-80bba78f56f1"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "731c00d5-3c5b-49e1-8b24-a65f4593f8b6", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "44a9b49c-a2b9-44f7-8ea6-b6dd54480f56", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "731c00d5-3c5b-49e1-8b24-a65f4593f8b6"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nWARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF\nCHILDREN</span></b></p>\n</div>", "ID": "d9c1191f-4991-48ac-971c-4aeadb8851e8", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nWARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF\nCHILDREN</span></b></p>", "ID": "2f672db4-10b7-4018-a59f-21b5516b7e5b", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d9c1191f-4991-48ac-971c-4aeadb8851e8"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nWARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF\nCHILDREN</span></b>", "ID": "42f17d1b-46fe-417d-9b26-1f98f96532a4", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "2f672db4-10b7-4018-a59f-21b5516b7e5b"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nWARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF\nCHILDREN</span>", "ID": "508592a6-b78f-4a0a-9269-9d8fbc3941c5", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN", "ParentId": "42f17d1b-46fe-417d-9b26-1f98f96532a4"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "b82481fb-0cb8-4c7d-90b9-642f643d523b", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "97cfeb60-c1fe-4e08-9c76-07931f3c7ad9", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "b82481fb-0cb8-4c7d-90b9-642f643d523b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Keep out of the sight and reach of children.</span></p>", "ID": "b44f8fb2-4a72-4397-9716-032e0fc60ab2", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Keep out of the sight and reach of children.</span>", "ID": "6c72e299-7805-4645-b99d-f234d830cc56", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "Keep out of the sight and reach of children.", "ParentId": "b44f8fb2-4a72-4397-9716-032e0fc60ab2"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "b5806dbd-93d7-400c-90cc-808f5934a83c", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "f0c5132e-cecf-4510-90d3-4cec7b9177bc", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "b5806dbd-93d7-400c-90cc-808f5934a83c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "61f3d7c9-d2ba-47c6-a0f2-d86c07e9969d", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "70ad38fb-21f8-46ab-8413-c6822c3be055", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "61f3d7c9-d2ba-47c6-a0f2-d86c07e9969d"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER\nSPECIAL WARNING(S), IF NECESSARY</span></b></p>\n</div>", "ID": "fa3fbe0f-26b1-4d5d-803f-90e4e3b8f5c8", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER\nSPECIAL WARNING(S), IF NECESSARY</span></b></p>", "ID": "9606e855-4905-43f7-a4da-5bcff9a4f3da", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa3fbe0f-26b1-4d5d-803f-90e4e3b8f5c8"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER\nSPECIAL WARNING(S), IF NECESSARY</span></b>", "ID": "3262d328-2984-4248-aaa1-18577b2f6bb1", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9606e855-4905-43f7-a4da-5bcff9a4f3da"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER\nSPECIAL WARNING(S), IF NECESSARY</span>", "ID": "ded247df-d208-4e7c-8554-c69410d9ae45", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER SPECIAL WARNING(S), IF NECESSARY", "ParentId": "3262d328-2984-4248-aaa1-18577b2f6bb1"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "c781d24c-1c78-4c3a-83a6-97ca15965b54", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "1169416f-b807-4ce2-88a7-77868967e8df", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "c781d24c-1c78-4c3a-83a6-97ca15965b54"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "0ebb2658-dfad-4331-9c6f-a59be39a8acf", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "f87be638-baf8-4a03-8416-f267bd7d3f89", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "0ebb2658-dfad-4331-9c6f-a59be39a8acf"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "a13e587f-3e8b-4ae1-8a6b-a03c70758c78", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "3c15691c-f72b-4c32-85b9-99f221944497", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "a13e587f-3e8b-4ae1-8a6b-a03c70758c78"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY\nDATE</span></b></p>\n</div>", "ID": "78cebc57-254f-4b24-a05c-a0e26b11b71d", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY\nDATE</span></b></p>", "ID": "648c8aba-9dd7-44f3-8808-d831ab6d19cd", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "78cebc57-254f-4b24-a05c-a0e26b11b71d"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY\nDATE</span></b>", "ID": "fe08f009-5b96-4fa9-b7e6-6813c549e39f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "648c8aba-9dd7-44f3-8808-d831ab6d19cd"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY\nDATE</span>", "ID": "f06bf136-550f-4028-9108-3cf2e14daf98", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE", "ParentId": "fe08f009-5b96-4fa9-b7e6-6813c549e39f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "841ec997-c326-4135-aff5-e70ff0b8efa4", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "9ad33aa4-5896-4ee3-8a04-32c0224382bf", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "841ec997-c326-4135-aff5-e70ff0b8efa4"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>EXP</span></p>", "ID": "43a985a1-f378-418d-9087-7088c98a9b6c", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>EXP</span>", "ID": "fc102d91-76fd-43ea-b60a-c1063679feb6", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "EXP", "ParentId": "43a985a1-f378-418d-9087-7088c98a9b6c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "7779bc62-c37f-47eb-93ed-78fe3ba6659d", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "80138fe7-0982-4c4d-85cf-fe090fcd8394", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "7779bc62-c37f-47eb-93ed-78fe3ba6659d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "53ea087e-01f6-4f7d-a98b-591aba6c4e09", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "d5763ac4-75b6-4905-a800-9f1d8b401781", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "53ea087e-01f6-4f7d-a98b-591aba6c4e09"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;page-break-after:\navoid;border:none;padding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span></b></p>\n</div>", "ID": "4925c90e-1631-4cf4-b3ff-80caa85f68ae", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;page-break-after:\navoid;border:none;padding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span></b></p>", "ID": "08cf08f6-785c-40bb-91f8-350800681088", "Styles": "margin-bottom:0in;line-height:normal;page-break-after:\navoid;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "4925c90e-1631-4cf4-b3ff-80caa85f68ae"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span></b>", "ID": "dd279ded-8833-4aae-8c19-d67d9e3210ae", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "08cf08f6-785c-40bb-91f8-350800681088"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span>", "ID": "e0318b9b-503f-47bb-9630-77bfe172cbc2", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL STORAGE CONDITIONS", "ParentId": "dd279ded-8833-4aae-8c19-d67d9e3210ae"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "b2f30e55-785f-445c-8092-82f58f2710ca", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "080880c4-7e6a-43aa-9b70-46c864e96400", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "b2f30e55-785f-445c-8092-82f58f2710ca"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "ba884bdf-7562-46c8-bb67-f84ec05fbdce", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "a7acc7c7-8d05-421a-8cf2-6f3b7dbd3f9a", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "ba884bdf-7562-46c8-bb67-f84ec05fbdce"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "91ae0055-53ba-4bcc-9731-220ab18b6a5a", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "5a42281a-3312-467a-a513-6e225da65520", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "91ae0055-53ba-4bcc-9731-220ab18b6a5a"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>10.\u00a0\u00a0\u00a0\u00a0 SPECIAL\nPRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS\nDERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE</span></b></p>\n</div>", "ID": "759ea9fa-53ec-43aa-86c5-ac17ee6f840d", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>10.\u00a0\u00a0\u00a0\u00a0 SPECIAL\nPRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS\nDERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE</span></b></p>", "ID": "8f6c460e-7c80-4ae7-bd72-51277aa03a28", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "759ea9fa-53ec-43aa-86c5-ac17ee6f840d"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>10.\u00a0\u00a0\u00a0\u00a0 SPECIAL\nPRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS\nDERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE</span></b>", "ID": "324d32a8-57f5-4a0b-9797-9f8c79fcb590", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "8f6c460e-7c80-4ae7-bd72-51277aa03a28"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>10.\u00a0\u00a0\u00a0\u00a0 SPECIAL\nPRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS\nDERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE</span>", "ID": "940028be-8411-40db-bd28-09c772554e51", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "10.\u00a0\u00a0\u00a0\u00a0 SPECIAL PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE", "ParentId": "324d32a8-57f5-4a0b-9797-9f8c79fcb590"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "ea5e1c0e-4b23-4412-b1f0-e58f13bb17d6", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "e5d7d63c-14e3-4ecf-b02c-e73dcc28555c", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "ea5e1c0e-4b23-4412-b1f0-e58f13bb17d6"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "04cbfddf-4675-425e-9d02-6ce5b7caf3dd", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "085a00d0-c5d4-4ee3-acab-1156afef8443", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "04cbfddf-4675-425e-9d02-6ce5b7caf3dd"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "be290c6e-18c0-4e08-a9c2-ffa02da64f1f", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "fc383586-4b0e-4b5b-86e4-daf8faee291c", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "be290c6e-18c0-4e08-a9c2-ffa02da64f1f"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>11.\u00a0\u00a0\u00a0\u00a0 NAME\nAND ADDRESS OF THE MARKETING AUTHORISATION HOLDER</span></b></p>\n</div>", "ID": "c50964eb-3978-4824-99c3-dd472fd3fbd0", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>11.\u00a0\u00a0\u00a0\u00a0 NAME\nAND ADDRESS OF THE MARKETING AUTHORISATION HOLDER</span></b></p>", "ID": "6a3ac787-1f0f-4565-aa49-933f32464f2e", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c50964eb-3978-4824-99c3-dd472fd3fbd0"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>11.\u00a0\u00a0\u00a0\u00a0 NAME\nAND ADDRESS OF THE MARKETING AUTHORISATION HOLDER</span></b>", "ID": "dc7697ed-03d2-4da4-b9ca-68c5dcaa4f0f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6a3ac787-1f0f-4565-aa49-933f32464f2e"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>11.\u00a0\u00a0\u00a0\u00a0 NAME\nAND ADDRESS OF THE MARKETING AUTHORISATION HOLDER</span>", "ID": "21b28378-af1d-4d5a-a2d5-eede08280b65", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "11.\u00a0\u00a0\u00a0\u00a0 NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER", "ParentId": "dc7697ed-03d2-4da4-b9ca-68c5dcaa4f0f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "f77f8b39-0a83-4a24-8906-e7d30f19da0e", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "e40542ae-e6b2-45ca-8b95-03b50fbd06f2", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "f77f8b39-0a83-4a24-8906-e7d30f19da0e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"DE-AT\" style='font-family:\n\"Times New Roman\",serif'>Mylan S.A.S.</span></p>", "ID": "9be44775-0c5e-427a-a2a6-1327472a4fcf", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"DE-AT\" style='font-family:\n\"Times New Roman\",serif'>Mylan S.A.S.</span>", "ID": "3793a9ff-1d67-459a-93c9-5e31ff397bf4", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "Mylan S.A.S.", "ParentId": "9be44775-0c5e-427a-a2a6-1327472a4fcf"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"DE-AT\" style='font-family:\n\"Times New Roman\",serif'>117 Allee des Parcs</span></p>", "ID": "1326fa5d-d0bd-4a8e-9a76-003f3b7ce7b8", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"DE-AT\" style='font-family:\n\"Times New Roman\",serif'>117 Allee des Parcs</span>", "ID": "5e23cc48-1c66-4c8b-b054-b6c7092c8706", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "117 Allee des Parcs", "ParentId": "1326fa5d-d0bd-4a8e-9a76-003f3b7ce7b8"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>69 800 Saint Priest</span></p>", "ID": "ea4bc20b-3544-4a73-9d72-ae32bc57cbfc", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>69 800 Saint Priest</span>", "ID": "f631fb8c-45cd-45e8-a645-086b888d0230", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "69 800 Saint Priest", "ParentId": "ea4bc20b-3544-4a73-9d72-ae32bc57cbfc"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>France</span></p>", "ID": "ef675976-3d96-4d2f-910a-2eaef62ee6c7", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>France</span>", "ID": "7457ade5-4c1a-412e-8995-d9a5182e8675", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "France", "ParentId": "ef675976-3d96-4d2f-910a-2eaef62ee6c7"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "02da4678-c04b-4722-9ff2-7a81811b1b35", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "e46ecfcc-90a0-4a2e-816b-f22692c131d7", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "02da4678-c04b-4722-9ff2-7a81811b1b35"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "458597b4-0567-46c0-a498-f62b476b561b", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "8f73a9e0-28d5-4422-91b0-848ba3343a86", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "458597b4-0567-46c0-a498-f62b476b561b"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>12.\u00a0\u00a0\u00a0\u00a0 MARKETING\nAUTHORISATION NUMBER(S) </span></b></p>\n</div>", "ID": "1dabaa54-3cee-47bd-a4cc-4f77d3073c9d", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>12.\u00a0\u00a0\u00a0\u00a0 MARKETING\nAUTHORISATION NUMBER(S) </span></b></p>", "ID": "86243d6e-29e6-49a0-92a6-4e9860ec5eea", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "1dabaa54-3cee-47bd-a4cc-4f77d3073c9d"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>12.\u00a0\u00a0\u00a0\u00a0 MARKETING\nAUTHORISATION NUMBER(S) </span></b>", "ID": "8fa482b2-9d83-4e78-a236-60b5fd9ec76b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "86243d6e-29e6-49a0-92a6-4e9860ec5eea"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>12.\u00a0\u00a0\u00a0\u00a0 MARKETING\nAUTHORISATION NUMBER(S) </span>", "ID": "9ffa2c99-6012-4310-8748-419617b4880d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "12.\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION NUMBER(S) ", "ParentId": "8fa482b2-9d83-4e78-a236-60b5fd9ec76b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "f3b7b7ee-6112-46be-ba69-11b8e062549c", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "a0396e53-fece-4089-8239-ab49e70bb958", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "f3b7b7ee-6112-46be-ba69-11b8e062549c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/028</span></p>", "ID": "515db232-9358-4709-a757-f5df94eea332", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/028</span>", "ID": "6db48cd6-9f2f-49b7-b87a-8fabcfab9a27", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "EU/1/17/1194/028", "ParentId": "515db232-9358-4709-a757-f5df94eea332"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "94672f10-5bb3-463a-bcf3-4c20e4ca7db1", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "c14fc11b-a137-4632-a9c6-7b1dfa9d04c3", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "94672f10-5bb3-463a-bcf3-4c20e4ca7db1"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "ef9fe0c0-4d24-4677-8054-34ba4129d0d4", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "fd5e949f-bebc-4bd1-a793-2c1d46c0195f", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "ef9fe0c0-4d24-4677-8054-34ba4129d0d4"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>13.\u00a0\u00a0\u00a0\u00a0 BATCH\nNUMBER</span></b></p>\n</div>", "ID": "b2570799-2eb2-444a-b93e-5a61f03da7e5", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>13.\u00a0\u00a0\u00a0\u00a0 BATCH\nNUMBER</span></b></p>", "ID": "e74879fb-8a26-424c-a223-aa50c89e09c8", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b2570799-2eb2-444a-b93e-5a61f03da7e5"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>13.\u00a0\u00a0\u00a0\u00a0 BATCH\nNUMBER</span></b>", "ID": "d255f0c3-43e9-406c-bd54-7da1c740f0cf", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e74879fb-8a26-424c-a223-aa50c89e09c8"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>13.\u00a0\u00a0\u00a0\u00a0 BATCH\nNUMBER</span>", "ID": "775cb72d-325b-4b19-8be6-1d73b942c592", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "13.\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER", "ParentId": "d255f0c3-43e9-406c-bd54-7da1c740f0cf"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><i><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></i></p>", "ID": "2795071f-2112-4001-9ea4-7a536a5ef2f2", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<i><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></i>", "ID": "3c8209d9-3420-46c7-8335-69fca0874a36", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "2795071f-2112-4001-9ea4-7a536a5ef2f2"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "e6d9bb6b-3382-411f-a43a-5161eee8cbaf", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "3c8209d9-3420-46c7-8335-69fca0874a36"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Lot</span></p>", "ID": "2ada3dc4-f396-4e85-9a47-4f017e0c3a9d", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Lot</span>", "ID": "dad4b917-4968-476d-80c9-156d628199a9", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "Lot", "ParentId": "2ada3dc4-f396-4e85-9a47-4f017e0c3a9d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "70a6a582-8b3b-40f0-91a3-90414d91a7cf", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "12ff0f55-df34-4161-9c07-c443222d9ce6", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "70a6a582-8b3b-40f0-91a3-90414d91a7cf"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "2d36c1f2-ef41-42f0-a082-f178505a7d5c", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "3887225b-1914-400e-b473-c38c3cc5eed8", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "2d36c1f2-ef41-42f0-a082-f178505a7d5c"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>14.\u00a0\u00a0\u00a0\u00a0 GENERAL\nCLASSIFICATION FOR SUPPLY</span></b></p>\n</div>", "ID": "92d1de22-f00e-4952-a0cc-fca94c77251d", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>14.\u00a0\u00a0\u00a0\u00a0 GENERAL\nCLASSIFICATION FOR SUPPLY</span></b></p>", "ID": "43625791-7dae-4dd3-9b83-009206da1f97", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "92d1de22-f00e-4952-a0cc-fca94c77251d"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>14.\u00a0\u00a0\u00a0\u00a0 GENERAL\nCLASSIFICATION FOR SUPPLY</span></b>", "ID": "97eff9c5-405c-4be6-b5d9-80678e848e60", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "43625791-7dae-4dd3-9b83-009206da1f97"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>14.\u00a0\u00a0\u00a0\u00a0 GENERAL\nCLASSIFICATION FOR SUPPLY</span>", "ID": "452b22d7-92e6-4c7d-a94e-d48ec452fc0e", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "14.\u00a0\u00a0\u00a0\u00a0 GENERAL CLASSIFICATION FOR SUPPLY", "ParentId": "97eff9c5-405c-4be6-b5d9-80678e848e60"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><i><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></i></p>", "ID": "a714d3c8-9461-4ff3-86a7-90a640c396da", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<i><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></i>", "ID": "10ad0137-b7d4-4c6e-8f81-1fcb8bf65e13", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a714d3c8-9461-4ff3-86a7-90a640c396da"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "53d6e117-3c22-4c14-b45c-f831a61f1ff1", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "10ad0137-b7d4-4c6e-8f81-1fcb8bf65e13"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "5883fa2c-6b5a-418e-8c85-29111ee661a4", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "5b622953-cf6f-4c5e-bc3c-c6d1db53ed15", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "5883fa2c-6b5a-418e-8c85-29111ee661a4"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "b2e664ac-d967-44e5-8b81-84dd2a13b88b", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "d3db180d-9a10-4bdb-abb4-a6315f3d7719", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "b2e664ac-d967-44e5-8b81-84dd2a13b88b"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:2.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS\nON USE</span></b></p>\n</div>", "ID": "6ea15936-7fc3-4db2-a943-4c2719fe033e", "Styles": "border:solid windowtext 1.0pt;padding:2.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS\nON USE</span></b></p>", "ID": "132f4a58-6035-45b5-be39-406dfbfb2b53", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "6ea15936-7fc3-4db2-a943-4c2719fe033e"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS\nON USE</span></b>", "ID": "b2a41fed-4278-457f-af33-de70cada8767", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "132f4a58-6035-45b5-be39-406dfbfb2b53"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS\nON USE</span>", "ID": "5ae42e5a-8ce8-4bb1-8ee9-e9bb9854637e", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS ON USE", "ParentId": "b2a41fed-4278-457f-af33-de70cada8767"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "d80c4377-d03a-46cc-9bc6-e93a0055025a", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "96e12ded-3b3e-4190-8291-8e77835c135c", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "d80c4377-d03a-46cc-9bc6-e93a0055025a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "b8da1831-17cd-4425-8572-79dc67c090da", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "6cdb403a-5476-4253-b56a-95abee6764cb", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "b8da1831-17cd-4425-8572-79dc67c090da"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "7cd01bb2-cdd3-492d-a003-22ae577ee975", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "4914ad5a-77e1-4949-8014-08592999dbaf", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "7cd01bb2-cdd3-492d-a003-22ae577ee975"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>16.\u00a0\u00a0\u00a0\u00a0 INFORMATION\nIN BRAILLE</span></b></p>\n</div>", "ID": "68bd25fe-b06a-47aa-8611-fb3bcab7fdd5", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>16.\u00a0\u00a0\u00a0\u00a0 INFORMATION\nIN BRAILLE</span></b></p>", "ID": "7249a777-7c41-4e04-8d13-00674b58888a", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "68bd25fe-b06a-47aa-8611-fb3bcab7fdd5"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>16.\u00a0\u00a0\u00a0\u00a0 INFORMATION\nIN BRAILLE</span></b>", "ID": "27fab8af-c6d7-4196-8fe5-1364204646b8", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "7249a777-7c41-4e04-8d13-00674b58888a"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>16.\u00a0\u00a0\u00a0\u00a0 INFORMATION\nIN BRAILLE</span>", "ID": "73734230-1208-4d79-aae6-644662206dd6", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "16.\u00a0\u00a0\u00a0\u00a0 INFORMATION IN BRAILLE", "ParentId": "27fab8af-c6d7-4196-8fe5-1364204646b8"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "6c0f702f-dace-4132-a775-906a7434691c", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "8c56ad38-984c-4f07-b9cf-3e73a0a1d8b6", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "6c0f702f-dace-4132-a775-906a7434691c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Febuxostat Mylan 120\u00a0mg</span></p>", "ID": "23d793e8-844b-44fe-8b26-dc5f142852b6", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Febuxostat Mylan 120\u00a0mg</span>", "ID": "8ffe44bc-d3a1-4e0f-9e32-58904888ab7c", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "Febuxostat Mylan 120\u00a0mg", "ParentId": "23d793e8-844b-44fe-8b26-dc5f142852b6"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:#CCCCCC'>\u00a0</span></p>", "ID": "d3e08c7f-895f-41a3-b43b-9d01357a2e83", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:#CCCCCC'>\u00a0</span>", "ID": "0ae63a43-4e4f-4eea-86c8-b8d6409bc684", "Styles": "font-family:\n\"Times New Roman\",serif;background:#CCCCCC", "Classes": "None", "Text": "\u00a0", "ParentId": "d3e08c7f-895f-41a3-b43b-9d01357a2e83"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:#CCCCCC'>\u00a0</span></p>", "ID": "9bdb83be-d952-478f-ac7e-325a285a69f7", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:#CCCCCC'>\u00a0</span>", "ID": "f4689c04-c59c-4670-b8ca-f4f2ea70fb3e", "Styles": "font-family:\n\"Times New Roman\",serif;background:#CCCCCC", "Classes": "None", "Text": "\u00a0", "ParentId": "9bdb83be-d952-478f-ac7e-325a285a69f7"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>17.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 2D BARCODE</span></b></p>\n</div>", "ID": "0adeda0a-8950-4dca-b80b-358ebbd49b95", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>17.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 2D BARCODE</span></b></p>", "ID": "d0d8c9ae-8997-4012-b03b-ebc469724537", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0adeda0a-8950-4dca-b80b-358ebbd49b95"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>17.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 2D BARCODE</span></b>", "ID": "cd35bb3a-13e5-43a5-93a4-ed6902b3220a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d0d8c9ae-8997-4012-b03b-ebc469724537"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>17.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 2D BARCODE</span>", "ID": "84fb3ad8-3765-4e89-8046-6996a4a12ea6", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "17.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE IDENTIFIER \u2013 2D BARCODE", "ParentId": "cd35bb3a-13e5-43a5-93a4-ed6902b3220a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "4a2f50bf-43c2-48e4-a19c-9903f965b16a", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "b53c76b4-fab7-4bf2-8fa5-dcc0ee2993e8", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "4a2f50bf-43c2-48e4-a19c-9903f965b16a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC'>2D barcode carrying the\nunique identifier included.</span></p>", "ID": "3cb9c16d-5fef-4bc0-90c9-084b643652ef", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC'>2D barcode carrying the\nunique identifier included.</span>", "ID": "927cc1e4-7f7d-45e8-bf8e-645468643cf0", "Styles": "font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC", "Classes": "None", "Text": "2D barcode carrying the unique identifier included.", "ParentId": "3cb9c16d-5fef-4bc0-90c9-084b643652ef"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "c276a661-4b22-4dd0-a58f-5868db37b16b", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "139cea9c-6419-42b5-bfad-030b9f587fbf", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "c276a661-4b22-4dd0-a58f-5868db37b16b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "365e0f4f-93ed-4fc0-9c9d-5e8064e7b2e8", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "4e624545-6f3f-401e-915d-bab028413f61", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "365e0f4f-93ed-4fc0-9c9d-5e8064e7b2e8"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>18.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 HUMAN READABLE DATA</span></b></p>\n</div>", "ID": "049b10ec-d251-435b-8c5a-3b4894aaafbe", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>18.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 HUMAN READABLE DATA</span></b></p>", "ID": "b874d160-811a-4d2b-a409-f452c57867ca", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "049b10ec-d251-435b-8c5a-3b4894aaafbe"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>18.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 HUMAN READABLE DATA</span></b>", "ID": "e480504e-2650-492b-8d2b-1c61efdcc0b9", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b874d160-811a-4d2b-a409-f452c57867ca"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>18.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 HUMAN READABLE DATA</span>", "ID": "631fe4b2-939a-45a0-872a-a644c899f808", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "18.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE IDENTIFIER \u2013 HUMAN READABLE DATA", "ParentId": "e480504e-2650-492b-8d2b-1c61efdcc0b9"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "abc31baf-eaa5-4931-86c2-4710389cadb3", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "f62f7541-2852-4262-96c5-4865daf96233", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "abc31baf-eaa5-4931-86c2-4710389cadb3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>PC:</span></p>", "ID": "f64129b4-7e60-4881-bf8c-0a30f1f6b935", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>PC:</span>", "ID": "6f912543-b814-4cba-93e2-50067126a1ef", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "PC:", "ParentId": "f64129b4-7e60-4881-bf8c-0a30f1f6b935"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>SN:</span></p>", "ID": "aefd697e-0f63-49e5-9ef3-683a8ac7514b", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>SN:</span>", "ID": "0ced54e1-9c4d-470a-b5ff-9fd6771ab665", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "SN:", "ParentId": "aefd697e-0f63-49e5-9ef3-683a8ac7514b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>NN:</span></p>", "ID": "f53ee4a6-6804-4cd8-9e39-04a111caa440", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>NN:</span>", "ID": "14a5800f-f5c1-411a-8bef-56aab1fbdeec", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "NN:", "ParentId": "f53ee4a6-6804-4cd8-9e39-04a111caa440"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;background:white\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "491cf545-5a49-4d35-ad36-dd08408ba73d", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;background:white", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "62e06f00-b9f9-4278-9e88-a49cd5445fb7", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "491cf545-5a49-4d35-ad36-dd08408ba73d"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span>", "ID": "f9a11501-62f5-4942-a6d4-1d6d574373a7", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": " ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<br clear=\"all\" style=\"page-break-before:always\"/>", "ID": "fdf8ce69-d25f-4bb2-bc10-4bf6f434dc7b", "Styles": "page-break-before:always", "Classes": "None", "Text": "", "ParentId": "f9a11501-62f5-4942-a6d4-1d6d574373a7"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "c502ccc1-8c65-4c4f-bd10-a09e9f6909c4", "Styles": "margin-bottom:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "9343b943-f9c2-49ad-966b-4891f0b81b1a", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "c502ccc1-8c65-4c4f-bd10-a09e9f6909c4"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>PARTICULARS\nTO APPEAR ON THE OUTER PACKAGING </span></b></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>INNER\nCARTON OF MULTIPACK (WITHOUT BLUE BOX)</span></b></p>\n</div>", "ID": "0b5ac04d-20d1-43bb-9d18-a4deb9c60e71", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "    ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>PARTICULARS\nTO APPEAR ON THE OUTER PACKAGING </span></b></p>", "ID": "d720d565-e60f-429d-a5b8-2d96c758a365", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0b5ac04d-20d1-43bb-9d18-a4deb9c60e71"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>PARTICULARS\nTO APPEAR ON THE OUTER PACKAGING </span></b>", "ID": "6f7d9673-b451-4849-b49f-c8630ed5c2e3", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d720d565-e60f-429d-a5b8-2d96c758a365"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>PARTICULARS\nTO APPEAR ON THE OUTER PACKAGING </span>", "ID": "5d36e9ba-5413-448d-b4d2-27520ec62f6f", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "PARTICULARS TO APPEAR ON THE OUTER PACKAGING ", "ParentId": "6f7d9673-b451-4849-b49f-c8630ed5c2e3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "7fc61403-b7e6-4415-b090-7fbc4d606043", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0b5ac04d-20d1-43bb-9d18-a4deb9c60e71"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "a7c96997-9f1f-40ec-ace9-9a7b0b4e3c04", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "7fc61403-b7e6-4415-b090-7fbc4d606043"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>INNER\nCARTON OF MULTIPACK (WITHOUT BLUE BOX)</span></b></p>", "ID": "3142b515-a414-470f-b5be-83101cb14ab3", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0b5ac04d-20d1-43bb-9d18-a4deb9c60e71"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>INNER\nCARTON OF MULTIPACK (WITHOUT BLUE BOX)</span></b>", "ID": "13552f94-82c3-4ba4-8bde-32c325e8e5a4", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "3142b515-a414-470f-b5be-83101cb14ab3"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>INNER\nCARTON OF MULTIPACK (WITHOUT BLUE BOX)</span>", "ID": "388b42c0-8aca-42a8-95e6-9c25dd884838", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "INNER CARTON OF MULTIPACK (WITHOUT BLUE BOX)", "ParentId": "13552f94-82c3-4ba4-8bde-32c325e8e5a4"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "5079bc38-1f60-442e-912d-13cb2a1615ac", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "cc08a7e4-ec80-41a5-97ee-63857127e05c", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "5079bc38-1f60-442e-912d-13cb2a1615ac"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "0054f9f9-3372-4eb8-b75f-95a3c6b6c323", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "e33d447e-dcdf-47bd-bc71-31f2981383e0", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "0054f9f9-3372-4eb8-b75f-95a3c6b6c323"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\nOF THE MEDICINAL PRODUCT</span></b></p>\n</div>", "ID": "4c813350-4092-4c14-9a5b-b258fd406bda", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\nOF THE MEDICINAL PRODUCT</span></b></p>", "ID": "500ac41e-c62d-425f-9431-6596e8575b72", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "4c813350-4092-4c14-9a5b-b258fd406bda"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\nOF THE MEDICINAL PRODUCT</span></b>", "ID": "1b6a5bcd-226d-45f6-980f-e73b4e8a0d2c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "500ac41e-c62d-425f-9431-6596e8575b72"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\nOF THE MEDICINAL PRODUCT</span>", "ID": "2cdfdac2-8401-4299-ba8b-94ed7a18c51f", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT", "ParentId": "1b6a5bcd-226d-45f6-980f-e73b4e8a0d2c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "1c613872-663b-4af7-b418-b3912d15de6a", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "a94dc496-2c4d-4018-94d0-269bf88fed24", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "1c613872-663b-4af7-b418-b3912d15de6a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Febuxostat Mylan 120\u00a0mg film-coated tablets</span></p>", "ID": "740596a4-442e-47ea-82da-651f3f32a85b", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Febuxostat Mylan 120\u00a0mg film-coated tablets</span>", "ID": "9c0bcbe5-133e-4386-9969-5c2147c9c4a4", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "Febuxostat Mylan 120\u00a0mg film-coated tablets", "ParentId": "740596a4-442e-47ea-82da-651f3f32a85b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "a583f5fc-b172-4c45-a1c6-2fbb09878ffd", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "bad56639-2d72-4119-9b69-2f153617e009", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "a583f5fc-b172-4c45-a1c6-2fbb09878ffd"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>febuxostat</span><b><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'> </span></b></p>", "ID": "6498b883-874d-4e68-9115-8d71c2234301", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>febuxostat</span>", "ID": "be068276-fccf-4a9f-a63e-ad410a1df6f4", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "febuxostat", "ParentId": "6498b883-874d-4e68-9115-8d71c2234301"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'> </span></b>", "ID": "98a741df-8ff7-4d24-b5a3-1bb31877b861", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6498b883-874d-4e68-9115-8d71c2234301"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'> </span>", "ID": "eb51bb9e-917a-4682-81b7-d27cc5dc2308", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": " ", "ParentId": "98a741df-8ff7-4d24-b5a3-1bb31877b861"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "18ff8790-8d4f-4700-bdf7-cec357925966", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "6306cc06-2a5a-43b3-8dae-42d81fe4f8c2", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "18ff8790-8d4f-4700-bdf7-cec357925966"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "a3e450da-b010-42d8-9dc9-67bb4902304e", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "a447f0c3-aa4c-42d8-9290-6af5802624ee", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "a3e450da-b010-42d8-9dc9-67bb4902304e"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT\nOF ACTIVE SUBSTANCE</span></b></p>\n</div>", "ID": "203f4c59-f4f5-4fb7-bbd0-f11932097236", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT\nOF ACTIVE SUBSTANCE</span></b></p>", "ID": "008a16b0-3da6-44ad-90b8-c6ba56faa54e", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "203f4c59-f4f5-4fb7-bbd0-f11932097236"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT\nOF ACTIVE SUBSTANCE</span></b>", "ID": "e5f0f29e-2b07-44a4-a52a-30fb248d41db", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "008a16b0-3da6-44ad-90b8-c6ba56faa54e"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT\nOF ACTIVE SUBSTANCE</span>", "ID": "9b9f9e06-48cc-48c2-a873-294b8f5bbe91", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT OF ACTIVE SUBSTANCE", "ParentId": "e5f0f29e-2b07-44a4-a52a-30fb248d41db"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "df70721a-a9fc-44cd-88c5-02daedfea30f", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "a827d7ac-662c-4c7e-a41d-5f715de57d8f", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "df70721a-a9fc-44cd-88c5-02daedfea30f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Each tablet contains 120\u00a0mg febuxostat.</span></p>", "ID": "3ceb9fcf-3f33-435f-8cd9-7c5ee5a60208", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Each tablet contains 120\u00a0mg febuxostat.</span>", "ID": "0e634e0d-4ad5-4442-bc18-d7774cd0ab45", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "Each tablet contains 120\u00a0mg febuxostat.", "ParentId": "3ceb9fcf-3f33-435f-8cd9-7c5ee5a60208"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "8187dc5f-be89-4745-80ce-9bb9c5749d76", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "3c9c3cbb-6493-4dc6-b4a2-adb440890db4", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "8187dc5f-be89-4745-80ce-9bb9c5749d76"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "ff6f728d-8b32-4fbf-827f-651c08e390f4", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "88c19783-3e4f-46bd-8b08-47eded71c033", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "ff6f728d-8b32-4fbf-827f-651c08e390f4"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST\nOF EXCIPIENTS</span></b></p>\n</div>", "ID": "78669013-8b82-435f-bb62-6cce532ac1f5", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST\nOF EXCIPIENTS</span></b></p>", "ID": "8995c2cd-31b9-4b9e-9972-78f3b84faa48", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "78669013-8b82-435f-bb62-6cce532ac1f5"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST\nOF EXCIPIENTS</span></b>", "ID": "02e3eb5d-3d18-4254-af61-9ba4e640530a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "8995c2cd-31b9-4b9e-9972-78f3b84faa48"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST\nOF EXCIPIENTS</span>", "ID": "29ae3a3e-2515-479f-9460-f8a04640f822", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST OF EXCIPIENTS", "ParentId": "02e3eb5d-3d18-4254-af61-9ba4e640530a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "27ecd5e5-49a6-4990-93e8-89a163d5b85a", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "8f41c463-69b7-45dc-965b-1bde6900c258", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "27ecd5e5-49a6-4990-93e8-89a163d5b85a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Also contains lactose.</span></p>", "ID": "8347fadd-3c5f-4f65-a592-2daa239e62da", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Also contains lactose.</span>", "ID": "f19881db-7253-4d84-b369-d3c80dbf22b0", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Also contains lactose.", "ParentId": "8347fadd-3c5f-4f65-a592-2daa239e62da"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "2f032ada-b55d-436d-9d29-5db572283e3b", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "3552781c-0234-4428-93fa-be38ea77e4ba", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "2f032ada-b55d-436d-9d29-5db572283e3b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>See leaflet for further information.</span></p>", "ID": "4f805fad-a7cc-47ef-b618-69019744bfdb", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>See leaflet for further information.</span>", "ID": "215f1657-b3d6-44e6-9e37-a10f4a4c171a", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "See leaflet for further information.", "ParentId": "4f805fad-a7cc-47ef-b618-69019744bfdb"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "e7e636f7-fa22-4d91-a4c2-d81821669a99", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "b15602e0-f1fe-4d67-9a5f-030691165681", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "e7e636f7-fa22-4d91-a4c2-d81821669a99"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "002b75b8-7ca0-4c62-893b-e43373078f12", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "b900222e-8e44-4541-94f5-3127b4e77f66", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "002b75b8-7ca0-4c62-893b-e43373078f12"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\nFORM AND CONTENTS</span></b></p>\n</div>", "ID": "2db1c0e2-2fc9-4022-a5a0-0434c4f8b23c", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\nFORM AND CONTENTS</span></b></p>", "ID": "272fb91f-967f-4dc4-b138-384445f4e7f2", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "2db1c0e2-2fc9-4022-a5a0-0434c4f8b23c"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\nFORM AND CONTENTS</span></b>", "ID": "e484efa1-e64a-4122-b853-dd3afbde7b42", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "272fb91f-967f-4dc4-b138-384445f4e7f2"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\nFORM AND CONTENTS</span>", "ID": "ca564470-5b9b-43ad-ba28-28570220e329", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL FORM AND CONTENTS", "ParentId": "e484efa1-e64a-4122-b853-dd3afbde7b42"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "4188c0cb-3c6d-49e6-8c29-f779841a37b2", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "7ff737a9-4bf8-45e5-98e6-3f9678a2aff0", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "4188c0cb-3c6d-49e6-8c29-f779841a37b2"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>42 film-coated tablets</span></p>", "ID": "b2b6e182-6b18-4bdc-a84e-6b7af630b15e", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>42 film-coated tablets</span>", "ID": "c2f0efa5-0cab-4724-8105-451f3992fe21", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "42 film-coated tablets", "ParentId": "b2b6e182-6b18-4bdc-a84e-6b7af630b15e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "c829462b-0d0e-4860-accf-2c26d1e8a18e", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "e6c14c61-6971-43c8-94d3-b22626560ee7", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "c829462b-0d0e-4860-accf-2c26d1e8a18e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Components of a multipack, can\u2019t be sold separately.</span></p>", "ID": "08416889-bcfc-490e-ad6e-446ebd50a5f9", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Components of a multipack, can\u2019t be sold separately.</span>", "ID": "d077b06e-5d42-4217-9c29-322dd64535c1", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "Components of a multipack, can\u2019t be sold separately.", "ParentId": "08416889-bcfc-490e-ad6e-446ebd50a5f9"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "e41e2eec-0f29-41d2-a289-66f8a96cbc56", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "17e38b30-97f2-4318-b938-9e6959abb454", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "e41e2eec-0f29-41d2-a289-66f8a96cbc56"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "e4dd83fb-542f-48c3-bae5-c57100c0a3d5", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "6d4bb34e-105d-440f-85cb-201cfb068882", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "e4dd83fb-542f-48c3-bae5-c57100c0a3d5"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD\nAND ROUTE(S) OF ADMINISTRATION</span></b></p>\n</div>", "ID": "9b69d0b6-3315-4a34-9d29-fe3de060f8fb", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD\nAND ROUTE(S) OF ADMINISTRATION</span></b></p>", "ID": "7c52c216-f9ce-4777-b727-280966758267", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "9b69d0b6-3315-4a34-9d29-fe3de060f8fb"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD\nAND ROUTE(S) OF ADMINISTRATION</span></b>", "ID": "0a8e992b-b003-47d9-b3a2-c21f59431123", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "7c52c216-f9ce-4777-b727-280966758267"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD\nAND ROUTE(S) OF ADMINISTRATION</span>", "ID": "ca5c3b3b-9530-4ea9-92e8-be0403976afe", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD AND ROUTE(S) OF ADMINISTRATION", "ParentId": "0a8e992b-b003-47d9-b3a2-c21f59431123"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "910119e7-70f3-481a-a695-f7838896ebcd", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "d4fc6790-b61b-474b-81cf-7cf60a8555b6", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "910119e7-70f3-481a-a695-f7838896ebcd"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>For oral use.</span></p>", "ID": "d113cc29-e99d-45e6-9572-5f7152401f3e", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>For oral use.</span>", "ID": "a4e71891-a902-4723-a8ae-52cd46a054b9", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "For oral use.", "ParentId": "d113cc29-e99d-45e6-9572-5f7152401f3e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "8a1e4023-ef4e-4ded-8d00-676b2d45ca65", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "88611e96-11b3-48cb-ada6-5995a48964ca", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "8a1e4023-ef4e-4ded-8d00-676b2d45ca65"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Read the package leaflet before use.</span></p>", "ID": "8bb9a6ef-af21-4f82-a43f-0e112907bbbe", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Read the package leaflet before use.</span>", "ID": "3d71fd24-1a7d-4b4e-ad30-557e3a572bfa", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "Read the package leaflet before use.", "ParentId": "8bb9a6ef-af21-4f82-a43f-0e112907bbbe"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "1e4ad56e-665e-4278-969e-22d70d185d33", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "5de7a060-db22-4aeb-a524-53cdd65f2a89", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "1e4ad56e-665e-4278-969e-22d70d185d33"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "f4f4f002-6a48-4c9b-9fe5-ab109225ce00", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "81a7d6e1-40ff-4144-b6b1-24ab12399d74", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "f4f4f002-6a48-4c9b-9fe5-ab109225ce00"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nWARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF\nCHILDREN</span></b></p>\n</div>", "ID": "361a76a4-8503-461e-9221-455bb7de759c", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nWARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF\nCHILDREN</span></b></p>", "ID": "858e5b8a-b413-420e-9d98-1e72f74702c3", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "361a76a4-8503-461e-9221-455bb7de759c"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nWARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF\nCHILDREN</span></b>", "ID": "185456b1-468a-49eb-bedb-aa11e46e17ab", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "858e5b8a-b413-420e-9d98-1e72f74702c3"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nWARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF\nCHILDREN</span>", "ID": "28cc2e1e-3c9f-4b8e-a71e-9f26ce0fb2c4", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN", "ParentId": "185456b1-468a-49eb-bedb-aa11e46e17ab"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "bdeaac6c-4ede-4826-ba78-3b1568dd4572", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "605addbb-f725-4501-a49a-50fa54b86d57", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "bdeaac6c-4ede-4826-ba78-3b1568dd4572"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Keep out of the sight and reach of children.</span></p>", "ID": "718f4336-a25e-419e-a7e1-875f1ffc9813", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Keep out of the sight and reach of children.</span>", "ID": "357f1c84-5950-4a73-9d9d-e57a952d0ff6", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "Keep out of the sight and reach of children.", "ParentId": "718f4336-a25e-419e-a7e1-875f1ffc9813"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "d71d9eb7-6d54-4767-9ef1-f8c10448f77a", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "0b088f3c-f626-4d73-a9fe-07e367af11b3", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "d71d9eb7-6d54-4767-9ef1-f8c10448f77a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "e796d175-7a8b-41e7-9598-ba3edff1d593", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "8a538403-0523-4a30-a677-7f49027e6fc6", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "e796d175-7a8b-41e7-9598-ba3edff1d593"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER\nSPECIAL WARNING(S), IF NECESSARY</span></b></p>\n</div>", "ID": "714497c1-d719-46e4-ad2e-6711fdf9131c", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER\nSPECIAL WARNING(S), IF NECESSARY</span></b></p>", "ID": "f421abb6-8229-413c-8b78-a93e9bf12a4d", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "714497c1-d719-46e4-ad2e-6711fdf9131c"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER\nSPECIAL WARNING(S), IF NECESSARY</span></b>", "ID": "99d611af-2bc3-4f03-b44f-3ee8f320fb5e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f421abb6-8229-413c-8b78-a93e9bf12a4d"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER\nSPECIAL WARNING(S), IF NECESSARY</span>", "ID": "576dbfe6-1999-4375-a44e-916d28d50a49", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER SPECIAL WARNING(S), IF NECESSARY", "ParentId": "99d611af-2bc3-4f03-b44f-3ee8f320fb5e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "b510d6dc-13e3-4c9b-bae6-6be7d16a7432", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "525d48ad-0e84-42e3-a622-2b2697d69d59", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "b510d6dc-13e3-4c9b-bae6-6be7d16a7432"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "87250f79-328c-4c44-a533-8ceb31b8f4b1", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "a9e9bf21-b6c9-41aa-b0cb-a13729bca39d", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "87250f79-328c-4c44-a533-8ceb31b8f4b1"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "30262b56-c9ae-4aee-b937-475766d22eb7", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "e5208e24-abef-4174-8ad5-01be6bd993a1", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "30262b56-c9ae-4aee-b937-475766d22eb7"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY\nDATE</span></b></p>\n</div>", "ID": "8ae31f36-91c0-4a65-b741-7cb5a375b3c3", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY\nDATE</span></b></p>", "ID": "bd9a85a7-9fe9-4822-b439-bf9b4f862b3d", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "8ae31f36-91c0-4a65-b741-7cb5a375b3c3"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY\nDATE</span></b>", "ID": "1e34c708-f2cf-4247-be87-163a688377b4", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "bd9a85a7-9fe9-4822-b439-bf9b4f862b3d"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY\nDATE</span>", "ID": "bef49011-1af9-48de-afee-dd1b2a061553", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE", "ParentId": "1e34c708-f2cf-4247-be87-163a688377b4"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "f49f2e9d-051c-4ea6-bfde-e8c3536e463a", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "c80dd894-df89-41d9-880b-f5b1fad1128d", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "f49f2e9d-051c-4ea6-bfde-e8c3536e463a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>EXP</span></p>", "ID": "1c56041e-8df8-446e-8b05-bcbde41416c1", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>EXP</span>", "ID": "c8a6bb26-f8f3-44f9-813c-76f54b6d7f2c", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "EXP", "ParentId": "1c56041e-8df8-446e-8b05-bcbde41416c1"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "15f61e3f-196b-46c0-b6ff-6581da05a7c4", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "294c1a98-687b-41e3-a304-83585ec2976c", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "15f61e3f-196b-46c0-b6ff-6581da05a7c4"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "3295eac7-6dae-4363-aeb1-ab368f27d1e1", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "afe2252e-ec9b-4d43-9baa-c21d529cb184", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "3295eac7-6dae-4363-aeb1-ab368f27d1e1"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;page-break-after:\navoid;border:none;padding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span></b></p>\n</div>", "ID": "4abb4def-3f77-4bec-ac13-6ab454e4f82e", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;page-break-after:\navoid;border:none;padding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span></b></p>", "ID": "198fab56-d217-4b7e-a170-a3fab30df8e0", "Styles": "margin-bottom:0in;line-height:normal;page-break-after:\navoid;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "4abb4def-3f77-4bec-ac13-6ab454e4f82e"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span></b>", "ID": "297e0ee7-d701-4cea-854e-b7d37090ed5d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "198fab56-d217-4b7e-a170-a3fab30df8e0"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span>", "ID": "14c6bcff-e6cf-4e11-be39-883517cffb76", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL STORAGE CONDITIONS", "ParentId": "297e0ee7-d701-4cea-854e-b7d37090ed5d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "46ffc888-9067-4ec6-ae83-58af43bbf442", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "fdd0261b-62bb-434c-a026-9fd9d6fae752", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "46ffc888-9067-4ec6-ae83-58af43bbf442"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "81411851-d753-453f-af8d-25828fece214", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "d8b02f54-ce11-40c6-bd8c-4592d422a5a0", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "81411851-d753-453f-af8d-25828fece214"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "d09ab432-0ba9-4cc9-8be0-9a0ffc6348a7", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "d1ce989e-420a-46c6-bc08-4d0b442de734", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "d09ab432-0ba9-4cc9-8be0-9a0ffc6348a7"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>10.\u00a0\u00a0\u00a0\u00a0 SPECIAL\nPRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS\nDERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE</span></b></p>\n</div>", "ID": "f0ef8749-51ce-4d1f-808e-fdfdd9785ca5", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>10.\u00a0\u00a0\u00a0\u00a0 SPECIAL\nPRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS\nDERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE</span></b></p>", "ID": "a5c66a87-eb80-4b89-bf3e-9c2d753cda9d", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f0ef8749-51ce-4d1f-808e-fdfdd9785ca5"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>10.\u00a0\u00a0\u00a0\u00a0 SPECIAL\nPRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS\nDERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE</span></b>", "ID": "2694e553-9c36-41b9-a032-a083e3bff6eb", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a5c66a87-eb80-4b89-bf3e-9c2d753cda9d"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>10.\u00a0\u00a0\u00a0\u00a0 SPECIAL\nPRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS\nDERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE</span>", "ID": "75a16102-d61a-4aa1-a4cd-95a7c52fdaee", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "10.\u00a0\u00a0\u00a0\u00a0 SPECIAL PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE", "ParentId": "2694e553-9c36-41b9-a032-a083e3bff6eb"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "1cd1c033-0e8a-4855-848f-49d1fc4f375f", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "60274a2b-fa3c-4a4d-ab7f-6a2eff7e52e9", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "1cd1c033-0e8a-4855-848f-49d1fc4f375f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "85155106-e0b8-42e2-823c-7b7a23fd36bc", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "e2f2b691-1419-43b3-99bd-006dddb1879a", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "85155106-e0b8-42e2-823c-7b7a23fd36bc"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "89185971-ec2e-41a3-b9f5-1d85548c38c3", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "9d7adf05-d244-4e51-8176-825674540b5e", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "89185971-ec2e-41a3-b9f5-1d85548c38c3"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>11.\u00a0\u00a0\u00a0\u00a0 NAME\nAND ADDRESS OF THE MARKETING AUTHORISATION HOLDER</span></b></p>\n</div>", "ID": "692179e0-5cbe-45bb-8876-4d0dc8566e5a", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>11.\u00a0\u00a0\u00a0\u00a0 NAME\nAND ADDRESS OF THE MARKETING AUTHORISATION HOLDER</span></b></p>", "ID": "ad47d7f0-d6a4-4fb0-aa49-6f9463b18084", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "692179e0-5cbe-45bb-8876-4d0dc8566e5a"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>11.\u00a0\u00a0\u00a0\u00a0 NAME\nAND ADDRESS OF THE MARKETING AUTHORISATION HOLDER</span></b>", "ID": "1cb43742-94dc-42af-b433-138c34b2af68", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ad47d7f0-d6a4-4fb0-aa49-6f9463b18084"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>11.\u00a0\u00a0\u00a0\u00a0 NAME\nAND ADDRESS OF THE MARKETING AUTHORISATION HOLDER</span>", "ID": "0108e175-94b8-478f-9e05-9c7334b0cbe4", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "11.\u00a0\u00a0\u00a0\u00a0 NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER", "ParentId": "1cb43742-94dc-42af-b433-138c34b2af68"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "e994295b-5625-4ccd-9ccf-a99c1f68499c", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "f887ea4e-0798-46bc-a243-e3d475561156", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "e994295b-5625-4ccd-9ccf-a99c1f68499c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"DE-AT\" style='font-family:\n\"Times New Roman\",serif'>Mylan S.A.S.</span></p>", "ID": "fa2cd68d-b582-428e-a976-6e27ddd8071c", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"DE-AT\" style='font-family:\n\"Times New Roman\",serif'>Mylan S.A.S.</span>", "ID": "d4b3012d-29c0-4f26-a3c5-a5149626cfb4", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "Mylan S.A.S.", "ParentId": "fa2cd68d-b582-428e-a976-6e27ddd8071c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"DE-AT\" style='font-family:\n\"Times New Roman\",serif'>117 Allee des Parcs</span></p>", "ID": "43c718db-c7b2-4f2e-b2a1-5974f13e2936", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"DE-AT\" style='font-family:\n\"Times New Roman\",serif'>117 Allee des Parcs</span>", "ID": "ab4933f4-24ee-4277-ae6b-a24b0babac0b", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "117 Allee des Parcs", "ParentId": "43c718db-c7b2-4f2e-b2a1-5974f13e2936"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>69 800 Saint Priest</span></p>", "ID": "c828a549-123e-42d6-9fc8-2c0dc4761d21", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>69 800 Saint Priest</span>", "ID": "4714491e-390e-4774-8bc9-7227e9aef648", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "69 800 Saint Priest", "ParentId": "c828a549-123e-42d6-9fc8-2c0dc4761d21"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>France</span></p>", "ID": "7053845d-d1d8-4423-9921-f2fac2bf6e14", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>France</span>", "ID": "c0d424b6-0084-460d-bb79-103610ad7a48", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "France", "ParentId": "7053845d-d1d8-4423-9921-f2fac2bf6e14"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "da6cb027-909d-4825-924c-28cba4347547", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "3c94b064-f224-48c3-9c8a-0d2120be44b9", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "da6cb027-909d-4825-924c-28cba4347547"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "36e70a24-d7fc-4d74-b1b5-57c6aeb258c8", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "d3f027d5-dccc-41af-a87c-639966512602", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "36e70a24-d7fc-4d74-b1b5-57c6aeb258c8"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>12.\u00a0\u00a0\u00a0\u00a0 MARKETING\nAUTHORISATION NUMBER(S) </span></b></p>\n</div>", "ID": "d26d1d3a-0ceb-44d4-9e16-aa5723a4d644", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>12.\u00a0\u00a0\u00a0\u00a0 MARKETING\nAUTHORISATION NUMBER(S) </span></b></p>", "ID": "398d0584-f9db-454f-91f2-30819f15a30f", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d26d1d3a-0ceb-44d4-9e16-aa5723a4d644"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>12.\u00a0\u00a0\u00a0\u00a0 MARKETING\nAUTHORISATION NUMBER(S) </span></b>", "ID": "b43c5a42-e117-4cab-9dbd-5ba0cb62be30", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "398d0584-f9db-454f-91f2-30819f15a30f"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>12.\u00a0\u00a0\u00a0\u00a0 MARKETING\nAUTHORISATION NUMBER(S) </span>", "ID": "d2f9a1fc-e7a9-4aaf-9059-5986512650c4", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "12.\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION NUMBER(S) ", "ParentId": "b43c5a42-e117-4cab-9dbd-5ba0cb62be30"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "159b41c2-4cfc-48ec-892c-be4d0a624017", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "95a43c3e-34e2-4f8e-a703-d3e62a58020d", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "159b41c2-4cfc-48ec-892c-be4d0a624017"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/028</span></p>", "ID": "bec14252-af50-4502-b130-4e35030d293a", "Styles": "margin-top:0in;margin-right:6.4pt;margin-bottom:0in;\nmargin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>EU/1/17/1194/028</span>", "ID": "2ffde07b-6b4b-424a-97d3-2cc7fc10b356", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "EU/1/17/1194/028", "ParentId": "bec14252-af50-4502-b130-4e35030d293a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "8b716660-18d3-4973-907a-1b9da2c4cbfb", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "ed56b7f3-d93b-4017-8f5c-d74b85d4cb76", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "8b716660-18d3-4973-907a-1b9da2c4cbfb"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "8412eeb2-4054-4857-afa0-86efd159778a", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "50fa63ce-1770-46b8-a603-4bdb186593fe", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "8412eeb2-4054-4857-afa0-86efd159778a"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>13.\u00a0\u00a0\u00a0\u00a0 BATCH\nNUMBER</span></b></p>\n</div>", "ID": "15a55bd5-2bb6-449c-9030-5ff68c86ea19", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>13.\u00a0\u00a0\u00a0\u00a0 BATCH\nNUMBER</span></b></p>", "ID": "42c34b28-16fa-49b3-bb9a-93206cdd92f7", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "15a55bd5-2bb6-449c-9030-5ff68c86ea19"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>13.\u00a0\u00a0\u00a0\u00a0 BATCH\nNUMBER</span></b>", "ID": "30841a5e-b323-4e47-aa9e-e13ec4307e72", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "42c34b28-16fa-49b3-bb9a-93206cdd92f7"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>13.\u00a0\u00a0\u00a0\u00a0 BATCH\nNUMBER</span>", "ID": "19d9062c-d125-4de9-ac57-7012af7dde03", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "13.\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER", "ParentId": "30841a5e-b323-4e47-aa9e-e13ec4307e72"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><i><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></i></p>", "ID": "e4960bf9-dd92-4fe7-aa8d-20fb142b299d", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<i><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></i>", "ID": "53ec0f4d-d9fd-42e7-a650-6e26b5169991", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e4960bf9-dd92-4fe7-aa8d-20fb142b299d"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "359ba3d9-092e-49fb-af58-1a9efc617a67", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "53ec0f4d-d9fd-42e7-a650-6e26b5169991"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Lot</span></p>", "ID": "457e412a-18e6-4759-98bb-ef7430b61d72", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Lot</span>", "ID": "67f2c8ca-03c8-4ceb-b625-7646c21b2c86", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "Lot", "ParentId": "457e412a-18e6-4759-98bb-ef7430b61d72"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "635b4f46-50d6-40e9-9c12-7f07dc666e7f", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "154d65a7-390f-488b-857a-22d72ac54a3c", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "635b4f46-50d6-40e9-9c12-7f07dc666e7f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "3137162c-3b5f-4905-b8a7-113566ded0d2", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "c31beed4-3f31-4798-a8d8-35cdf57e246d", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "3137162c-3b5f-4905-b8a7-113566ded0d2"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>14.\u00a0\u00a0\u00a0\u00a0 GENERAL\nCLASSIFICATION FOR SUPPLY</span></b></p>\n</div>", "ID": "85d325bb-2d1a-4b4e-bfc0-2d8b2ca23479", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>14.\u00a0\u00a0\u00a0\u00a0 GENERAL\nCLASSIFICATION FOR SUPPLY</span></b></p>", "ID": "a6bd9331-8efc-4e01-b16f-3b8ad5ef8826", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "85d325bb-2d1a-4b4e-bfc0-2d8b2ca23479"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>14.\u00a0\u00a0\u00a0\u00a0 GENERAL\nCLASSIFICATION FOR SUPPLY</span></b>", "ID": "f5a2de71-ddf3-4901-b053-b13612d54440", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a6bd9331-8efc-4e01-b16f-3b8ad5ef8826"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>14.\u00a0\u00a0\u00a0\u00a0 GENERAL\nCLASSIFICATION FOR SUPPLY</span>", "ID": "aeb71aa0-b5da-41e2-b142-dfe664f952d7", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "14.\u00a0\u00a0\u00a0\u00a0 GENERAL CLASSIFICATION FOR SUPPLY", "ParentId": "f5a2de71-ddf3-4901-b053-b13612d54440"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><i><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></i></p>", "ID": "130684c9-9f65-4370-8256-9794254ce4d3", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<i><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></i>", "ID": "04889842-8b37-4187-8b3c-9f4b41f94ad0", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "130684c9-9f65-4370-8256-9794254ce4d3"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "430104c9-ea50-4196-95ad-d8dbb28778b7", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "04889842-8b37-4187-8b3c-9f4b41f94ad0"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "81b70750-7aad-466e-83a3-cebd458eaa26", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "1f2f2958-0090-4de1-a785-ca586deefd93", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "81b70750-7aad-466e-83a3-cebd458eaa26"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "1f3250f3-8bb9-4e04-a638-2cf8cdc05fc2", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "f6f510e6-a8e2-4c3a-bd45-5bebc5ef0746", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "1f3250f3-8bb9-4e04-a638-2cf8cdc05fc2"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:2.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS\nON USE</span></b></p>\n</div>", "ID": "74d3fce1-bb69-455d-9616-ae4227b59d0d", "Styles": "border:solid windowtext 1.0pt;padding:2.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS\nON USE</span></b></p>", "ID": "a3a79bcb-c5ef-45a3-8b6b-c3f0f286e82b", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "74d3fce1-bb69-455d-9616-ae4227b59d0d"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS\nON USE</span></b>", "ID": "2476fdc3-bfdf-41fa-9739-e369dd547073", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a3a79bcb-c5ef-45a3-8b6b-c3f0f286e82b"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS\nON USE</span>", "ID": "55dbdef1-3977-496f-81b0-829095b3368c", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS ON USE", "ParentId": "2476fdc3-bfdf-41fa-9739-e369dd547073"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "a3a59943-140f-4f94-ac85-2612878048df", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "decf549c-db03-43da-8e63-84e673c533a3", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "a3a59943-140f-4f94-ac85-2612878048df"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "f2807173-a8ab-42a7-ac13-804a28e2ca6a", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "8d00a20d-8160-41f5-a7c8-c9dbf662a46c", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "f2807173-a8ab-42a7-ac13-804a28e2ca6a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "7dc6ab69-abeb-4374-8a68-c19cbeb38309", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "3365dfcb-16a2-444d-b37e-8b7a2825cd5b", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "7dc6ab69-abeb-4374-8a68-c19cbeb38309"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>16.\u00a0\u00a0\u00a0\u00a0 INFORMATION\nIN BRAILLE</span></b></p>\n</div>", "ID": "484f1c81-e31c-4fa6-8f45-c3c7faa272b2", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>16.\u00a0\u00a0\u00a0\u00a0 INFORMATION\nIN BRAILLE</span></b></p>", "ID": "8f79cc18-d9f5-4006-86d1-5ac0b3403b5e", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "484f1c81-e31c-4fa6-8f45-c3c7faa272b2"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>16.\u00a0\u00a0\u00a0\u00a0 INFORMATION\nIN BRAILLE</span></b>", "ID": "622606e1-1649-4e62-8c07-bf48c4a5a59f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "8f79cc18-d9f5-4006-86d1-5ac0b3403b5e"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>16.\u00a0\u00a0\u00a0\u00a0 INFORMATION\nIN BRAILLE</span>", "ID": "83dd55c5-1085-4ca3-a717-c4624bd4824c", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "16.\u00a0\u00a0\u00a0\u00a0 INFORMATION IN BRAILLE", "ParentId": "622606e1-1649-4e62-8c07-bf48c4a5a59f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "486fe683-ec27-43a5-8f8b-322cb89a5096", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "67aac976-fa3f-48de-8310-b8ae1cba7060", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "486fe683-ec27-43a5-8f8b-322cb89a5096"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Febuxostat Mylan 120\u00a0mg</span></p>", "ID": "b1df4dfa-179f-40c1-85a9-102c5915ca6a", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Febuxostat Mylan 120\u00a0mg</span>", "ID": "879249b1-62d6-4f2d-bf2e-3d19f37eef1d", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "Febuxostat Mylan 120\u00a0mg", "ParentId": "b1df4dfa-179f-40c1-85a9-102c5915ca6a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:#CCCCCC'>\u00a0</span></p>", "ID": "ad94d322-ec83-44e1-9b72-674502a3013d", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:#CCCCCC'>\u00a0</span>", "ID": "13510dee-3106-4194-ae97-5b5dce2d0370", "Styles": "font-family:\n\"Times New Roman\",serif;background:#CCCCCC", "Classes": "None", "Text": "\u00a0", "ParentId": "ad94d322-ec83-44e1-9b72-674502a3013d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:#CCCCCC'>\u00a0</span></p>", "ID": "7531e1a5-cdd5-4868-b1cd-c781aba474ac", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:#CCCCCC'>\u00a0</span>", "ID": "88f64d26-8ca1-4fb6-bf05-4ef15e558d99", "Styles": "font-family:\n\"Times New Roman\",serif;background:#CCCCCC", "Classes": "None", "Text": "\u00a0", "ParentId": "7531e1a5-cdd5-4868-b1cd-c781aba474ac"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>17.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 2D BARCODE</span></b></p>\n</div>", "ID": "e5770c9a-e5a2-4020-aa60-e3e11e552e37", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>17.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 2D BARCODE</span></b></p>", "ID": "e09f68ec-b16a-40ef-82b5-fa84c43c3ae1", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e5770c9a-e5a2-4020-aa60-e3e11e552e37"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>17.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 2D BARCODE</span></b>", "ID": "26a1a317-c7c5-415c-9355-538ffab91069", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e09f68ec-b16a-40ef-82b5-fa84c43c3ae1"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>17.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 2D BARCODE</span>", "ID": "33a864ca-5257-4eeb-a177-0fe509b7bf9b", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "17.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE IDENTIFIER \u2013 2D BARCODE", "ParentId": "26a1a317-c7c5-415c-9355-538ffab91069"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "bd63bdb5-1136-4d6e-baf2-4308fd2b490c", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "ea30f610-ad48-4ad6-9f50-8231df65c348", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "bd63bdb5-1136-4d6e-baf2-4308fd2b490c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC'>2D barcode carrying the\nunique identifier included.</span></p>", "ID": "5ca86fed-139b-49a5-b5d0-60b8faed9edc", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC'>2D barcode carrying the\nunique identifier included.</span>", "ID": "9801d432-05f6-4929-8916-3c6355dc8767", "Styles": "font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC", "Classes": "None", "Text": "2D barcode carrying the unique identifier included.", "ParentId": "5ca86fed-139b-49a5-b5d0-60b8faed9edc"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "c68c8dbc-c892-4d89-847a-82419584d6af", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "1f3c1599-eac8-4324-bc57-6ee4e5b7b9f0", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "c68c8dbc-c892-4d89-847a-82419584d6af"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "4ae126f1-be86-417b-aacf-51f3b67b162c", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "105ec16e-4327-4f73-bb31-76baa5c472e9", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "4ae126f1-be86-417b-aacf-51f3b67b162c"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>18.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 HUMAN READABLE DATA</span></b></p>\n</div>", "ID": "a9472657-39e0-4c64-91b9-bb072d2abee1", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>18.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 HUMAN READABLE DATA</span></b></p>", "ID": "705fe9bd-3918-4ef7-b8db-8aba899741da", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a9472657-39e0-4c64-91b9-bb072d2abee1"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>18.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 HUMAN READABLE DATA</span></b>", "ID": "cb3ca9b4-a7af-419a-b62e-9a0300186b54", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "705fe9bd-3918-4ef7-b8db-8aba899741da"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>18.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 HUMAN READABLE DATA</span>", "ID": "90be5ef2-76f8-413e-ab53-048143655832", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "18.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE IDENTIFIER \u2013 HUMAN READABLE DATA", "ParentId": "cb3ca9b4-a7af-419a-b62e-9a0300186b54"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "19eeafc7-9392-4cea-9b2a-fd4b47d3c465", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "60b9e7b5-79bb-445e-9318-f6cb3825320e", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "19eeafc7-9392-4cea-9b2a-fd4b47d3c465"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>PC:</span></p>", "ID": "dad3d1a3-3789-4a9d-b45b-76a75dbbbe87", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>PC:</span>", "ID": "aae115a1-f6d5-4d91-9671-253e5ecb70c7", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "PC:", "ParentId": "dad3d1a3-3789-4a9d-b45b-76a75dbbbe87"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>SN:</span></p>", "ID": "6773ab3d-2549-4e71-b600-750b46283440", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>SN:</span>", "ID": "3d98c41b-1e30-48c2-b7f1-e284c4ca67a5", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "SN:", "ParentId": "6773ab3d-2549-4e71-b600-750b46283440"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>NN:</span></p>", "ID": "a352b851-3033-40df-8427-e847c8fb8784", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>NN:</span>", "ID": "4a0557d2-8101-4481-a616-d6a16613955d", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "NN:", "ParentId": "a352b851-3033-40df-8427-e847c8fb8784"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;background:white\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "0a47caf3-3196-40fb-be6d-9671996035ec", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;background:white", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "d3d65d4e-aef9-408e-bb68-40bee89adc66", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "0a47caf3-3196-40fb-be6d-9671996035ec"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span>", "ID": "a9d1b560-5695-49d5-976b-581b8a65596a", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": " ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<br clear=\"all\" style=\"page-break-before:always\"/>", "ID": "2e1d9c13-1ff7-4236-af35-b924ab7e1588", "Styles": "page-break-before:always", "Classes": "None", "Text": "", "ParentId": "a9d1b560-5695-49d5-976b-581b8a65596a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "a6afb134-b33b-4625-bb09-d39f5e340f29", "Styles": "margin-bottom:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "be480b8f-cea0-43f5-a3cf-25955e9d4526", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "a6afb134-b33b-4625-bb09-d39f5e340f29"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;background:white\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "1ed702a3-cdad-4670-b485-a27a969ae55f", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;background:white", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "eaee5ebd-6368-4fd9-886a-dc8a42baafda", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "1ed702a3-cdad-4670-b485-a27a969ae55f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;background:white\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "e0c7fccf-4746-414f-873f-3a076d110b00", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;background:white", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "ed9563ab-3379-4f78-891c-673e5da8258d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "e0c7fccf-4746-414f-873f-3a076d110b00"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>PARTICULARS\nTO APPEAR ON THE IMMEDIATE PACKAGING </span></b></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>BOTTLE\nLABEL</span></b></p>\n</div>", "ID": "92cc8a1b-25c8-4d41-93a5-2cea6d5453f4", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "    ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>PARTICULARS\nTO APPEAR ON THE IMMEDIATE PACKAGING </span></b></p>", "ID": "ba66decd-b4fc-44f8-8ed6-8dab37b62a1c", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "92cc8a1b-25c8-4d41-93a5-2cea6d5453f4"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>PARTICULARS\nTO APPEAR ON THE IMMEDIATE PACKAGING </span></b>", "ID": "2e10612a-468b-4080-91ff-96c73651c3d6", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ba66decd-b4fc-44f8-8ed6-8dab37b62a1c"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>PARTICULARS\nTO APPEAR ON THE IMMEDIATE PACKAGING </span>", "ID": "cc3c0c5e-6845-44d1-b5d8-d96d29872787", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGING ", "ParentId": "2e10612a-468b-4080-91ff-96c73651c3d6"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "eaab8e3a-1cf6-4f42-9776-82e7424d24d6", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "92cc8a1b-25c8-4d41-93a5-2cea6d5453f4"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "792350db-16ca-4c71-bc52-50a6996cba64", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "eaab8e3a-1cf6-4f42-9776-82e7424d24d6"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>BOTTLE\nLABEL</span></b></p>", "ID": "828af48d-37dd-4f2b-bea3-ebab4456ac3e", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "92cc8a1b-25c8-4d41-93a5-2cea6d5453f4"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>BOTTLE\nLABEL</span></b>", "ID": "ce5c070d-b517-4fef-a4be-9c716d04c447", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "828af48d-37dd-4f2b-bea3-ebab4456ac3e"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>BOTTLE\nLABEL</span>", "ID": "c433cd90-1cac-40da-a599-67233889ff96", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "BOTTLE LABEL", "ParentId": "ce5c070d-b517-4fef-a4be-9c716d04c447"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "ea0bd607-24b6-4541-8b02-4bf45862a029", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "a03292d5-e7ab-41a2-b46c-ec37f7d7bff0", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "ea0bd607-24b6-4541-8b02-4bf45862a029"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "0056df1b-4989-4456-b868-5e1c421721b8", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "bc796d76-a5ed-488e-9db9-16c12c82fa6d", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "0056df1b-4989-4456-b868-5e1c421721b8"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\nOF THE MEDICINAL PRODUCT</span></b></p>\n</div>", "ID": "2964220a-8434-42cf-a89c-99946f6dd1cb", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\nOF THE MEDICINAL PRODUCT</span></b></p>", "ID": "9fce8f3b-f0f1-4e5e-838e-8a7cf0351a34", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "2964220a-8434-42cf-a89c-99946f6dd1cb"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\nOF THE MEDICINAL PRODUCT</span></b>", "ID": "76c233e0-1c11-44e8-a2ee-42243b0ba5c7", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9fce8f3b-f0f1-4e5e-838e-8a7cf0351a34"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\nOF THE MEDICINAL PRODUCT</span>", "ID": "cd444d53-40c4-4d50-89cc-f45ff4bd3cd8", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT", "ParentId": "76c233e0-1c11-44e8-a2ee-42243b0ba5c7"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "198b80c2-9a56-4e53-8508-284bdb2c2a3c", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "655ed175-eac7-441d-987e-9f4fde68841a", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "198b80c2-9a56-4e53-8508-284bdb2c2a3c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Febuxostat Mylan 120\u00a0mg film-coated tablets </span></p>", "ID": "5dd09c3e-da8f-4619-bdb2-4d5aa334d5c8", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Febuxostat Mylan 120\u00a0mg film-coated tablets </span>", "ID": "49797d95-ad68-4de5-bba6-92963bfe0efa", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "Febuxostat Mylan 120\u00a0mg film-coated tablets ", "ParentId": "5dd09c3e-da8f-4619-bdb2-4d5aa334d5c8"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>febuxostat</span><b><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'> </span></b></p>", "ID": "61840e8f-a1fa-4759-9813-b8cb5d798a1f", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>febuxostat</span>", "ID": "9c9069c3-cd06-4ed8-8006-747160d15a63", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "febuxostat", "ParentId": "61840e8f-a1fa-4759-9813-b8cb5d798a1f"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'> </span></b>", "ID": "f84d4f40-a3d0-45d0-bbf5-3bd6f1897fba", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "61840e8f-a1fa-4759-9813-b8cb5d798a1f"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'> </span>", "ID": "35683901-3f34-42ca-861e-74c370a88d7c", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": " ", "ParentId": "f84d4f40-a3d0-45d0-bbf5-3bd6f1897fba"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "79d7b787-5ce4-4b5f-a49e-f0b119109047", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "7f75d1a9-277c-46e0-9ebb-9c628559d623", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "79d7b787-5ce4-4b5f-a49e-f0b119109047"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "77f08ffe-6ea2-41d5-acdc-8979c533d9f8", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "e9530714-6f3d-4461-8d64-6785f2eed123", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "77f08ffe-6ea2-41d5-acdc-8979c533d9f8"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT\nOF ACTIVE SUBSTANCE</span></b></p>\n</div>", "ID": "b0494df1-c072-4991-86bc-0b23ae2679b8", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT\nOF ACTIVE SUBSTANCE</span></b></p>", "ID": "bc514152-2b03-476d-917b-93e0ea8ce775", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b0494df1-c072-4991-86bc-0b23ae2679b8"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT\nOF ACTIVE SUBSTANCE</span></b>", "ID": "bba9e844-521c-4a5f-8408-e7029a44d7be", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "bc514152-2b03-476d-917b-93e0ea8ce775"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT\nOF ACTIVE SUBSTANCE</span>", "ID": "f624b545-3ab7-4af1-8e22-2c6cd45cd79f", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT OF ACTIVE SUBSTANCE", "ParentId": "bba9e844-521c-4a5f-8408-e7029a44d7be"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "1cb75ed3-1e8f-485b-94b7-38745e4d5974", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "685e6c7d-d29d-4bdc-abe6-961625a1cf86", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "1cb75ed3-1e8f-485b-94b7-38745e4d5974"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Each tablet contains 120\u00a0mg febuxostat.</span></p>", "ID": "70b4311f-9ef4-4663-be8d-426ab9ceea4e", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Each tablet contains 120\u00a0mg febuxostat.</span>", "ID": "f023afaa-eff7-4c45-92e8-65f828e48096", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "Each tablet contains 120\u00a0mg febuxostat.", "ParentId": "70b4311f-9ef4-4663-be8d-426ab9ceea4e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "9ae95e76-515d-4bcc-8a5e-3f7de852ee21", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "6a72ca40-7df1-4cde-9f4f-5b21f28d652c", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "9ae95e76-515d-4bcc-8a5e-3f7de852ee21"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "b22c6cdc-d6b7-4e2c-b2b2-2f3c1901a633", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "31b0411d-dbab-408c-8881-82f9569324dd", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "b22c6cdc-d6b7-4e2c-b2b2-2f3c1901a633"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST\nOF EXCIPIENTS</span></b></p>\n</div>", "ID": "98567daf-2d68-430a-a25e-adff5af96290", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST\nOF EXCIPIENTS</span></b></p>", "ID": "e84d5328-b276-404d-ad67-f06f45797e4f", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "98567daf-2d68-430a-a25e-adff5af96290"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST\nOF EXCIPIENTS</span></b>", "ID": "1b9b40d1-f127-43c9-8e52-c9359d1d5d16", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e84d5328-b276-404d-ad67-f06f45797e4f"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST\nOF EXCIPIENTS</span>", "ID": "536c64e2-e738-4aae-a520-fe5e662ef3da", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST OF EXCIPIENTS", "ParentId": "1b9b40d1-f127-43c9-8e52-c9359d1d5d16"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "8214c884-f2d2-4564-bc64-a8bc83df203e", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "2c3e52ec-d14b-4d0f-994b-de914a2e55a2", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "8214c884-f2d2-4564-bc64-a8bc83df203e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Also contains lactose.</span></p>", "ID": "402b0429-084a-426b-a45c-9b49a1c6d0bb", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Also contains lactose.</span>", "ID": "821990cd-e79f-4cd4-b7b8-ea6c1e637bb7", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Also contains lactose.", "ParentId": "402b0429-084a-426b-a45c-9b49a1c6d0bb"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>See the package leaflet for further information.</span></p>", "ID": "31539acf-b06f-4f5f-801e-836be552942c", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>See the package leaflet for further information.</span>", "ID": "4c92dbd9-7b12-407d-a409-b192bd25ce78", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "See the package leaflet for further information.", "ParentId": "31539acf-b06f-4f5f-801e-836be552942c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "78aa7e79-7430-45b5-a50a-90e508a61390", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "0873b324-8022-4245-9635-a39c3142a2e7", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "78aa7e79-7430-45b5-a50a-90e508a61390"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "2c1f01ad-da4b-47ef-b756-46cb49710c6a", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "e4fa98d8-5332-4b2f-8c25-69584b4ca94d", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "2c1f01ad-da4b-47ef-b756-46cb49710c6a"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\nFORM AND CONTENTS</span></b></p>\n</div>", "ID": "88d82b67-83dc-4798-a417-5336bb1b131e", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\nFORM AND CONTENTS</span></b></p>", "ID": "abb3f8ae-20de-42e1-8fb2-672c112a8251", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "88d82b67-83dc-4798-a417-5336bb1b131e"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\nFORM AND CONTENTS</span></b>", "ID": "67be3e6c-4a44-4173-8270-7bb3252fcb2c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "abb3f8ae-20de-42e1-8fb2-672c112a8251"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\nFORM AND CONTENTS</span>", "ID": "f88c40d3-5edb-4c29-8609-7d960085249a", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL FORM AND CONTENTS", "ParentId": "67be3e6c-4a44-4173-8270-7bb3252fcb2c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "4f150db4-256d-4eed-a09b-cc846dfe1a39", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "a2cbdf7f-670a-4bc8-b45b-44f969a6b9f2", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "4f150db4-256d-4eed-a09b-cc846dfe1a39"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC'>Film-coated tablets</span></p>", "ID": "c3e8e35c-453e-433e-a1ec-a35408cafd2a", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC'>Film-coated tablets</span>", "ID": "c7879b12-d00d-44d5-8eca-0551ecd20e52", "Styles": "font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC", "Classes": "None", "Text": "Film-coated tablets", "ParentId": "c3e8e35c-453e-433e-a1ec-a35408cafd2a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "91ec7f1c-61cd-41ad-9812-281df1be472f", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "38ee771a-5a76-4f4a-a996-5ece1bfcb533", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "91ec7f1c-61cd-41ad-9812-281df1be472f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>28 film-coated tablets </span></p>", "ID": "67480f96-5705-48ba-b10a-f2cfe79f30ce", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>28 film-coated tablets </span>", "ID": "ffbfdbfd-4ce9-4c61-b7f1-615e07896083", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "28 film-coated tablets ", "ParentId": "67480f96-5705-48ba-b10a-f2cfe79f30ce"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC'>84 film-coated tablets</span></p>", "ID": "5e8a8b6f-6bc0-4c69-8618-0ff4eb32148e", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC'>84 film-coated tablets</span>", "ID": "ef12d51e-bbac-41a6-b1dc-0e76e25694b0", "Styles": "font-family:\n\"Times New Roman\",serif;color:black;background:#CCCCCC", "Classes": "None", "Text": "84 film-coated tablets", "ParentId": "5e8a8b6f-6bc0-4c69-8618-0ff4eb32148e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "62d20205-9710-4ca7-91a5-d181d0fd0122", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "b4153740-e2eb-4853-8401-50ac33320b0f", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "62d20205-9710-4ca7-91a5-d181d0fd0122"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "45483b77-17df-49a6-94b7-06a778b5f7b0", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "10702a27-5499-4614-807c-23322eb35d30", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "45483b77-17df-49a6-94b7-06a778b5f7b0"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD\nAND ROUTE(S) OF ADMINISTRATION</span></b></p>\n</div>", "ID": "de48c4d5-9359-4564-9ef9-8a9480c97927", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD\nAND ROUTE(S) OF ADMINISTRATION</span></b></p>", "ID": "da74b7c8-7679-409e-ba2a-8c9d59059401", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "de48c4d5-9359-4564-9ef9-8a9480c97927"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD\nAND ROUTE(S) OF ADMINISTRATION</span></b>", "ID": "7714a184-e002-41ba-9873-66d8089268b2", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "da74b7c8-7679-409e-ba2a-8c9d59059401"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD\nAND ROUTE(S) OF ADMINISTRATION</span>", "ID": "702ca47a-2b11-4a94-9ced-942d86abdf8f", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD AND ROUTE(S) OF ADMINISTRATION", "ParentId": "7714a184-e002-41ba-9873-66d8089268b2"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "ddeccba4-1974-479f-94be-e11d06d0886c", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "29a1e527-807e-4dc9-8268-556c9ca14544", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "ddeccba4-1974-479f-94be-e11d06d0886c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>For oral use.</span></p>", "ID": "4e2745c6-2068-407a-b97e-ac1ab75ef1aa", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>For oral use.</span>", "ID": "7ea7c1f7-b68b-4d2c-a1e4-12b23406928f", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "For oral use.", "ParentId": "4e2745c6-2068-407a-b97e-ac1ab75ef1aa"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Read the package leaflet before use.</span></p>", "ID": "ea37a4d3-6806-4693-aa84-006c36ef974c", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Read the package leaflet before use.</span>", "ID": "d4de703b-8b56-4cbf-8a47-3fb0941757cc", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "Read the package leaflet before use.", "ParentId": "ea37a4d3-6806-4693-aa84-006c36ef974c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "48dd1eba-01da-45c6-81de-abd36edfb10c", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "a0a8f7c7-9dac-4f52-ab19-a13a52e32bf3", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "48dd1eba-01da-45c6-81de-abd36edfb10c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "103473df-2c06-4961-94bc-b645202265f7", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "2b382a83-db5e-4045-9357-2dd295d11fc8", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "103473df-2c06-4961-94bc-b645202265f7"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nWARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF\nCHILDREN</span></b></p>\n</div>", "ID": "0f849a15-8175-4187-a9cf-3b0a218bd661", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nWARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF\nCHILDREN</span></b></p>", "ID": "fca16d50-7992-4a24-ada5-bdc4d3b5559c", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0f849a15-8175-4187-a9cf-3b0a218bd661"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nWARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF\nCHILDREN</span></b>", "ID": "c74cc638-4dd3-4820-af34-6627f5020069", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "fca16d50-7992-4a24-ada5-bdc4d3b5559c"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nWARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF\nCHILDREN</span>", "ID": "8bc6cbed-1da4-4d73-9435-6855b931ba18", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN", "ParentId": "c74cc638-4dd3-4820-af34-6627f5020069"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "84db7fba-f8ab-45e5-817e-b69bdeb90f08", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "d808b714-ffbc-4f07-8eba-47717e00c770", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "84db7fba-f8ab-45e5-817e-b69bdeb90f08"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Keep out of the sight and reach of children.</span></p>", "ID": "8113ca15-94b3-46bf-a4b6-004b57615d77", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Keep out of the sight and reach of children.</span>", "ID": "6804a181-e6f9-4044-ad91-62ab84ded5c2", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "Keep out of the sight and reach of children.", "ParentId": "8113ca15-94b3-46bf-a4b6-004b57615d77"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "5ed45b66-78e3-4965-be4b-e4e22126fb7d", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "7bdf2e1e-6560-47eb-a1f6-dd24a8c7aeef", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "5ed45b66-78e3-4965-be4b-e4e22126fb7d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "fa4b67c6-0e1c-4212-bcd9-00961678c560", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "b543d166-6cbd-432b-a251-d58228750758", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "fa4b67c6-0e1c-4212-bcd9-00961678c560"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER\nSPECIAL WARNING(S), IF NECESSARY</span></b></p>\n</div>", "ID": "6b900d77-3aeb-4f4e-9046-17f9c1ff904f", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER\nSPECIAL WARNING(S), IF NECESSARY</span></b></p>", "ID": "378a7995-d52d-42cf-a5e6-f293bf73c8f5", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "6b900d77-3aeb-4f4e-9046-17f9c1ff904f"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER\nSPECIAL WARNING(S), IF NECESSARY</span></b>", "ID": "ed9a944d-7a58-4a0e-995b-e038f499882c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "378a7995-d52d-42cf-a5e6-f293bf73c8f5"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER\nSPECIAL WARNING(S), IF NECESSARY</span>", "ID": "9885215d-c6a9-492c-a7ed-8dd1815db82d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER SPECIAL WARNING(S), IF NECESSARY", "ParentId": "ed9a944d-7a58-4a0e-995b-e038f499882c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "cdc80e19-bc1f-4481-a620-02ee88c9426c", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "f6c0243a-e045-42a8-87b4-f683b2e5a0e5", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "cdc80e19-bc1f-4481-a620-02ee88c9426c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "0423ee20-c2fe-42cd-a3ae-883f6d7183db", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "72627615-33e6-48bd-9464-ff9257e0a94d", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "0423ee20-c2fe-42cd-a3ae-883f6d7183db"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "dace38f5-943b-4024-8ea0-67bf31d5ba13", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "14e74368-0649-4b40-9727-07ec449a8791", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "dace38f5-943b-4024-8ea0-67bf31d5ba13"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY\nDATE</span></b></p>\n</div>", "ID": "8a5c85b9-ec93-4a8d-8547-e74672528969", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY\nDATE</span></b></p>", "ID": "b278ba99-d2fa-42b4-bb7a-3ad10d0e997e", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "8a5c85b9-ec93-4a8d-8547-e74672528969"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY\nDATE</span></b>", "ID": "89f2e4d6-def6-47d4-9390-36e3cba003b5", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b278ba99-d2fa-42b4-bb7a-3ad10d0e997e"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY\nDATE</span>", "ID": "1616e670-1b89-47e9-a466-ac8f5799ab03", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE", "ParentId": "89f2e4d6-def6-47d4-9390-36e3cba003b5"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "d1b2ad28-a1e1-4bac-bef1-20d36637d1c4", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "08f11658-9617-4bbe-923c-cc3c73e093c8", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "d1b2ad28-a1e1-4bac-bef1-20d36637d1c4"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>EXP</span></p>", "ID": "469f895b-b9b8-4f25-8bde-879086fea72f", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>EXP</span>", "ID": "2ddb5515-b985-41e5-8222-063cfd1cf810", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "EXP", "ParentId": "469f895b-b9b8-4f25-8bde-879086fea72f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>After first opening use within 180 days</span></p>", "ID": "bad531d5-1162-49f5-9f2f-b22b06cb828c", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>After first opening use within 180 days</span>", "ID": "0516bb7a-a0c4-4d4a-97dc-d9155d98beb9", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "After first opening use within 180 days", "ParentId": "bad531d5-1162-49f5-9f2f-b22b06cb828c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "6f9516e3-c2f6-4100-8ca1-072ba53ce300", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "780d07fc-bf98-4b16-b1fa-502d6491ae08", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "6f9516e3-c2f6-4100-8ca1-072ba53ce300"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "fbb1be87-8892-4d60-9e0a-1cafc4f729aa", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "883a535e-82e0-4719-80cd-b586bbb5f818", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "fbb1be87-8892-4d60-9e0a-1cafc4f729aa"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;page-break-after:\navoid;border:none;padding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span></b></p>\n</div>", "ID": "d65ddd28-6be7-4098-9ad3-9b23136b2fd2", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;page-break-after:\navoid;border:none;padding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span></b></p>", "ID": "0df8b024-bb00-4b4d-a993-f870fe7d6da5", "Styles": "margin-bottom:0in;line-height:normal;page-break-after:\navoid;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d65ddd28-6be7-4098-9ad3-9b23136b2fd2"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span></b>", "ID": "9a07b371-b850-4d9a-ab45-dcbf0a65569b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0df8b024-bb00-4b4d-a993-f870fe7d6da5"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span>", "ID": "7e68e5f3-f6d7-4c71-a224-a73e056d4466", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL STORAGE CONDITIONS", "ParentId": "9a07b371-b850-4d9a-ab45-dcbf0a65569b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "fa8f1053-1c05-4dde-ae3c-da91c702b773", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "93a7f3bc-daff-4aff-8617-151cb5ebe70b", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "fa8f1053-1c05-4dde-ae3c-da91c702b773"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "8cc5cb43-7a7c-411a-9642-772c5c11dfa2", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "3d8895cb-6482-4353-b58d-f7762819ce55", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "8cc5cb43-7a7c-411a-9642-772c5c11dfa2"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "3d40ca4e-3324-422e-a7a3-41202c3d93b5", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "98a4a9f2-a07a-443b-b2b6-f6a7eb6977f4", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "3d40ca4e-3324-422e-a7a3-41202c3d93b5"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>10.\u00a0\u00a0\u00a0\u00a0 SPECIAL\nPRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS\nDERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE</span></b></p>\n</div>", "ID": "3b14800f-814c-4e86-bdee-fd9b24008f36", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>10.\u00a0\u00a0\u00a0\u00a0 SPECIAL\nPRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS\nDERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE</span></b></p>", "ID": "542070b2-6a6b-43fa-a4bc-09cd9b87565d", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3b14800f-814c-4e86-bdee-fd9b24008f36"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>10.\u00a0\u00a0\u00a0\u00a0 SPECIAL\nPRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS\nDERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE</span></b>", "ID": "9eba8487-b9d8-40b3-9dba-a715f76a602e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "542070b2-6a6b-43fa-a4bc-09cd9b87565d"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>10.\u00a0\u00a0\u00a0\u00a0 SPECIAL\nPRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS\nDERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE</span>", "ID": "3b1053fe-78bb-4458-9506-d12d694ba247", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "10.\u00a0\u00a0\u00a0\u00a0 SPECIAL PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE", "ParentId": "9eba8487-b9d8-40b3-9dba-a715f76a602e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "b062b172-b512-40bf-98bf-e827cd59d322", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "3ddda1e0-29ba-4e68-893c-e9047f80e310", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "b062b172-b512-40bf-98bf-e827cd59d322"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "da43d7ce-9136-4fc2-81c0-58b0ccc04e7c", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "cd2ab7cc-0f8a-483e-8c4f-6636cef76a51", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "da43d7ce-9136-4fc2-81c0-58b0ccc04e7c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "60fcf4a8-94c9-4239-a161-36af358b8cd3", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "acfeef12-fb64-49c5-9a22-70667e43d459", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "60fcf4a8-94c9-4239-a161-36af358b8cd3"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>11.\u00a0\u00a0\u00a0\u00a0 NAME\nAND ADDRESS OF THE MARKETING AUTHORISATION HOLDER</span></b></p>\n</div>", "ID": "912e2216-3e98-48e9-88d1-08589e420b94", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>11.\u00a0\u00a0\u00a0\u00a0 NAME\nAND ADDRESS OF THE MARKETING AUTHORISATION HOLDER</span></b></p>", "ID": "51614326-7a52-4950-9c86-409d9475a9f1", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "912e2216-3e98-48e9-88d1-08589e420b94"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>11.\u00a0\u00a0\u00a0\u00a0 NAME\nAND ADDRESS OF THE MARKETING AUTHORISATION HOLDER</span></b>", "ID": "c549db4b-0419-4710-bc38-a449b808cfc2", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "51614326-7a52-4950-9c86-409d9475a9f1"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>11.\u00a0\u00a0\u00a0\u00a0 NAME\nAND ADDRESS OF THE MARKETING AUTHORISATION HOLDER</span>", "ID": "7c6ff34a-cd98-4a82-8d88-2588478b6fbb", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "11.\u00a0\u00a0\u00a0\u00a0 NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER", "ParentId": "c549db4b-0419-4710-bc38-a449b808cfc2"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "738c0c6e-2947-49bd-b7f7-41125e93d557", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "579e1b8e-cc19-477a-b7f6-ebfe3e49f3e5", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "738c0c6e-2947-49bd-b7f7-41125e93d557"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"DE-AT\" style='font-family:\n\"Times New Roman\",serif'>Mylan S.A.S.</span></p>", "ID": "b327fd63-e432-4a00-894f-397c035ee624", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"DE-AT\" style='font-family:\n\"Times New Roman\",serif'>Mylan S.A.S.</span>", "ID": "30d0c7bf-03bc-47ab-8379-f13b4b99f5cb", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "Mylan S.A.S.", "ParentId": "b327fd63-e432-4a00-894f-397c035ee624"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"DE-AT\" style='font-family:\n\"Times New Roman\",serif'>117 Allee des Parcs</span></p>", "ID": "80e6eef9-4dda-4b3b-8749-864b823431c6", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"DE-AT\" style='font-family:\n\"Times New Roman\",serif'>117 Allee des Parcs</span>", "ID": "a8059d5d-1c35-408d-82d3-5110e3087b05", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "117 Allee des Parcs", "ParentId": "80e6eef9-4dda-4b3b-8749-864b823431c6"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>69 800 Saint Priest</span></p>", "ID": "db08fd3a-15b9-4a64-b649-5daaf43660da", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>69 800 Saint Priest</span>", "ID": "db7c9605-fcb7-41ed-a311-0259cd90747d", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "69 800 Saint Priest", "ParentId": "db08fd3a-15b9-4a64-b649-5daaf43660da"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>France</span></p>", "ID": "b262f7e1-f8e6-4d3d-ad1e-c2469150c107", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>France</span>", "ID": "c0aa1ed2-265a-4eb6-9add-7d082d176696", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "France", "ParentId": "b262f7e1-f8e6-4d3d-ad1e-c2469150c107"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "eee87fae-5117-416f-b816-944e10f9261b", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "66141bcb-8557-475e-b5f7-c75da5cc663c", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "eee87fae-5117-416f-b816-944e10f9261b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "3b4bcec7-8e35-4061-b194-c7d189d0aa70", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "a6c0f393-c9ea-47bd-a30a-61c7c3c4e12a", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "3b4bcec7-8e35-4061-b194-c7d189d0aa70"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>12.\u00a0\u00a0\u00a0\u00a0 MARKETING\nAUTHORISATION NUMBER(S) </span></b></p>\n</div>", "ID": "0a70f6e2-beb3-4513-bcc1-35867c135f20", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>12.\u00a0\u00a0\u00a0\u00a0 MARKETING\nAUTHORISATION NUMBER(S) </span></b></p>", "ID": "f06aca76-dbe7-49cb-b717-9f8af8967ed5", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0a70f6e2-beb3-4513-bcc1-35867c135f20"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>12.\u00a0\u00a0\u00a0\u00a0 MARKETING\nAUTHORISATION NUMBER(S) </span></b>", "ID": "ac548b78-ab8b-4c9b-8d77-e46bcaf301bb", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f06aca76-dbe7-49cb-b717-9f8af8967ed5"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>12.\u00a0\u00a0\u00a0\u00a0 MARKETING\nAUTHORISATION NUMBER(S) </span>", "ID": "25def389-193f-4841-8270-7167ea8086e0", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "12.\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION NUMBER(S) ", "ParentId": "ac548b78-ab8b-4c9b-8d77-e46bcaf301bb"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "75508606-5c5b-40a8-ac73-65739359722d", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "f9396e09-5215-42cb-b1f3-4d9ad8ef62af", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "75508606-5c5b-40a8-ac73-65739359722d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>EU/1/17/1194/015</span></p>", "ID": "ea48cf90-dfee-4165-ab6c-caf9faa5eab4", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>EU/1/17/1194/015</span>", "ID": "877e6848-0f7a-42b6-80f9-8525a591467b", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "EU/1/17/1194/015", "ParentId": "ea48cf90-dfee-4165-ab6c-caf9faa5eab4"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey'>EU/1/17/1194/016</span></p>", "ID": "ee36673a-7a5a-4f71-9689-9436f4e35d56", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey'>EU/1/17/1194/016</span>", "ID": "1a43b3da-98de-4410-b29a-3f1021486d57", "Styles": "font-family:\n\"Times New Roman\",serif;background:lightgrey", "Classes": "None", "Text": "EU/1/17/1194/016", "ParentId": "ee36673a-7a5a-4f71-9689-9436f4e35d56"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "c03fcae5-9ed1-47a7-ab5c-d5b1ee665b59", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "a06e616c-1968-48e4-94f2-35a7c76f40dc", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "c03fcae5-9ed1-47a7-ab5c-d5b1ee665b59"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "261098da-548f-4fe2-910f-fafdcde42c2f", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "375fdf16-0875-46cd-8798-8117393a854b", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "261098da-548f-4fe2-910f-fafdcde42c2f"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>13.\u00a0\u00a0\u00a0\u00a0 BATCH\nNUMBER</span></b></p>\n</div>", "ID": "fbce0883-5159-42e4-b0e4-5897315d5409", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>13.\u00a0\u00a0\u00a0\u00a0 BATCH\nNUMBER</span></b></p>", "ID": "711f4e5b-f096-4bdd-87df-fb8223b23445", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fbce0883-5159-42e4-b0e4-5897315d5409"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>13.\u00a0\u00a0\u00a0\u00a0 BATCH\nNUMBER</span></b>", "ID": "a1fc2092-b8d7-436f-b7c4-7fccbb75e5e3", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "711f4e5b-f096-4bdd-87df-fb8223b23445"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>13.\u00a0\u00a0\u00a0\u00a0 BATCH\nNUMBER</span>", "ID": "d0e0a93d-2490-4b77-ad70-4eeb2d679a2a", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "13.\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER", "ParentId": "a1fc2092-b8d7-436f-b7c4-7fccbb75e5e3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><i><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></i></p>", "ID": "4ca5a866-040b-45af-817b-e7b9935a589f", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<i><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></i>", "ID": "ad66eef1-a69f-471b-bae9-c7582f9adefb", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4ca5a866-040b-45af-817b-e7b9935a589f"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "90d167d8-8e3a-4de0-980d-ef4193b9376b", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "ad66eef1-a69f-471b-bae9-c7582f9adefb"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Lot</span></p>", "ID": "7090aaf3-b094-4d46-9319-b6d4c68bf4e6", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Lot</span>", "ID": "9cd9affc-24f6-4488-b64e-d198a7cb59b1", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "Lot", "ParentId": "7090aaf3-b094-4d46-9319-b6d4c68bf4e6"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "3c993c34-e2ba-4f94-aec6-5d828b8d5a0b", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "9739157e-32bd-4db1-8764-32efb47eb12b", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "3c993c34-e2ba-4f94-aec6-5d828b8d5a0b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "af35966e-34cd-4105-ba27-09b7fbd77cdd", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "c2178501-90c3-4c3b-88a1-a5260740c8a8", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "af35966e-34cd-4105-ba27-09b7fbd77cdd"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>14.\u00a0\u00a0\u00a0\u00a0 GENERAL\nCLASSIFICATION FOR SUPPLY</span></b></p>\n</div>", "ID": "cda45f09-7158-4279-9653-060ddf12de3d", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>14.\u00a0\u00a0\u00a0\u00a0 GENERAL\nCLASSIFICATION FOR SUPPLY</span></b></p>", "ID": "ee538702-4977-444d-b1ce-35a5f73ff17e", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "cda45f09-7158-4279-9653-060ddf12de3d"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>14.\u00a0\u00a0\u00a0\u00a0 GENERAL\nCLASSIFICATION FOR SUPPLY</span></b>", "ID": "2bf931b5-7f2c-41e1-9c4a-9b626055c955", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ee538702-4977-444d-b1ce-35a5f73ff17e"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>14.\u00a0\u00a0\u00a0\u00a0 GENERAL\nCLASSIFICATION FOR SUPPLY</span>", "ID": "203cb6ae-4103-471d-8e2f-664a3bf447f7", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "14.\u00a0\u00a0\u00a0\u00a0 GENERAL CLASSIFICATION FOR SUPPLY", "ParentId": "2bf931b5-7f2c-41e1-9c4a-9b626055c955"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "e84e8810-53d9-49fd-a283-a458f7120c07", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "2f9fc948-ba67-4ddd-a869-80b616289865", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "e84e8810-53d9-49fd-a283-a458f7120c07"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "c73f7e2b-73de-4d29-85dd-fe53ecb53f66", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "1fc5a40d-c190-4c82-ad20-c572754154b9", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "c73f7e2b-73de-4d29-85dd-fe53ecb53f66"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "64ebc84e-9481-4368-bfd4-8746c43aa382", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "76460e31-f5d9-4c5b-a5c8-7527ece02743", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "64ebc84e-9481-4368-bfd4-8746c43aa382"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:2.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS\nON USE</span></b></p>\n</div>", "ID": "67861d3f-4f24-44c2-8e34-47261c22d2b9", "Styles": "border:solid windowtext 1.0pt;padding:2.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS\nON USE</span></b></p>", "ID": "9ea0b3ae-f662-4c7d-ac8c-8984461f5c6b", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "67861d3f-4f24-44c2-8e34-47261c22d2b9"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS\nON USE</span></b>", "ID": "4adb7014-f2c8-4da4-a966-f819608303e9", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9ea0b3ae-f662-4c7d-ac8c-8984461f5c6b"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS\nON USE</span>", "ID": "d074d49f-180b-4df5-aeab-145f3b21faa3", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS ON USE", "ParentId": "4adb7014-f2c8-4da4-a966-f819608303e9"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "b383ea7a-a378-40e2-902a-5aa7e4cd48cb", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "0913646e-dfb6-4662-9cb5-a8513b8e08cf", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "b383ea7a-a378-40e2-902a-5aa7e4cd48cb"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "e28fcc9e-9775-469a-a4b9-fb83dd2106df", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "6d5e647d-ff97-4250-a2bc-d994db27ce4e", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "e28fcc9e-9775-469a-a4b9-fb83dd2106df"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "0e54d047-369a-4f39-8682-3622d9a9da2c", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "a342dd44-48ac-4206-b880-27cb09252ee5", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "0e54d047-369a-4f39-8682-3622d9a9da2c"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>16.\u00a0\u00a0\u00a0\u00a0 INFORMATION\nIN BRAILLE</span></b></p>\n</div>", "ID": "3151d6bd-a761-4311-a966-8a13ea9abab1", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>16.\u00a0\u00a0\u00a0\u00a0 INFORMATION\nIN BRAILLE</span></b></p>", "ID": "4d0abcfc-7e9b-4e33-8983-c9766b225508", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3151d6bd-a761-4311-a966-8a13ea9abab1"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>16.\u00a0\u00a0\u00a0\u00a0 INFORMATION\nIN BRAILLE</span></b>", "ID": "d8d2c184-479d-4ce6-8be4-7799f9b48098", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4d0abcfc-7e9b-4e33-8983-c9766b225508"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>16.\u00a0\u00a0\u00a0\u00a0 INFORMATION\nIN BRAILLE</span>", "ID": "97f83216-3943-461b-819e-47b4e9aafcd2", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "16.\u00a0\u00a0\u00a0\u00a0 INFORMATION IN BRAILLE", "ParentId": "d8d2c184-479d-4ce6-8be4-7799f9b48098"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "daee33a2-09b6-4896-8ec3-a3236717cc5c", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "483e0e15-9029-40df-95ce-96b3df3a93bf", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "daee33a2-09b6-4896-8ec3-a3236717cc5c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "8f113100-9ff6-4679-b54b-eb31e66c0a40", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "d8dd607a-03e4-41e1-902a-09032034cf15", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "8f113100-9ff6-4679-b54b-eb31e66c0a40"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:#CCCCCC'>\u00a0</span></p>", "ID": "648b45dc-61b8-467c-bd0d-f75440999123", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:#CCCCCC'>\u00a0</span>", "ID": "a89cfff7-d5e3-4fe6-b82c-db55c54b9c91", "Styles": "font-family:\n\"Times New Roman\",serif;background:#CCCCCC", "Classes": "None", "Text": "\u00a0", "ParentId": "648b45dc-61b8-467c-bd0d-f75440999123"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>17.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 2D BARCODE</span></b></p>\n</div>", "ID": "3a019ec2-c78b-4115-9607-2c2188ce22ab", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>17.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 2D BARCODE</span></b></p>", "ID": "9adbdf5a-5a0d-4c46-830e-4ded775267ab", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3a019ec2-c78b-4115-9607-2c2188ce22ab"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>17.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 2D BARCODE</span></b>", "ID": "0fdab348-5aff-455a-a13a-69a46e4add01", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9adbdf5a-5a0d-4c46-830e-4ded775267ab"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>17.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 2D BARCODE</span>", "ID": "4f42d8c1-acfa-4819-b074-61f59d02f32f", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "17.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE IDENTIFIER \u2013 2D BARCODE", "ParentId": "0fdab348-5aff-455a-a13a-69a46e4add01"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "e96e8e84-a0e8-4097-b736-46d9d2496b13", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "638ccf14-05e5-42c8-9b00-caa1f7e0584d", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "e96e8e84-a0e8-4097-b736-46d9d2496b13"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:#CCCCCC'>\u00a0</span></p>", "ID": "59d7c1b7-01e2-4653-812e-c07e295667b7", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:#CCCCCC'>\u00a0</span>", "ID": "ed26f5d0-1e88-46d9-a70c-5522c870ff9a", "Styles": "font-family:\n\"Times New Roman\",serif;background:#CCCCCC", "Classes": "None", "Text": "\u00a0", "ParentId": "59d7c1b7-01e2-4653-812e-c07e295667b7"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "3bbf8c5e-26f1-4233-a255-e6487f15eafb", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "1ce4df33-cf73-4b80-852c-42db9c20885e", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "3bbf8c5e-26f1-4233-a255-e6487f15eafb"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>18.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 HUMAN READABLE DATA</span></b></p>\n</div>", "ID": "e3c46f5e-bfab-4131-866c-09fc2b0d3608", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>18.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 HUMAN READABLE DATA</span></b></p>", "ID": "a8013ffc-352c-42d4-aa99-e8cf490afe8f", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e3c46f5e-bfab-4131-866c-09fc2b0d3608"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>18.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 HUMAN READABLE DATA</span></b>", "ID": "f20ab8da-f0a9-4f90-84df-2f2c4b5472ee", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a8013ffc-352c-42d4-aa99-e8cf490afe8f"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>18.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 HUMAN READABLE DATA</span>", "ID": "df463739-7af0-4721-9519-e7123dffc896", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "18.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UNIQUE IDENTIFIER \u2013 HUMAN READABLE DATA", "ParentId": "f20ab8da-f0a9-4f90-84df-2f2c4b5472ee"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "b77753d3-23e1-4a9f-a29f-d64a4c238b8b", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "b4548dcf-deda-4c6f-84b5-28e3c7e148ad", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "b77753d3-23e1-4a9f-a29f-d64a4c238b8b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:#CCCCCC'>\u00a0</span></p>", "ID": "0aaefedc-6336-4169-b45b-75926118ae42", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:#CCCCCC'>\u00a0</span>", "ID": "f3bb9092-5f88-4be4-986f-44b423916442", "Styles": "font-family:\n\"Times New Roman\",serif;background:#CCCCCC", "Classes": "None", "Text": "\u00a0", "ParentId": "0aaefedc-6336-4169-b45b-75926118ae42"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\ncolor:black;background:#CCCCCC'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span>", "ID": "b9c5f8df-dbac-4fa2-9edb-b7bfc770faf2", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif;\ncolor:black;background:#CCCCCC", "Classes": "None", "Text": " ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<br clear=\"all\" style=\"page-break-before:always\"/>", "ID": "1554befd-7a59-40a4-8cb2-81db946bd47e", "Styles": "page-break-before:always", "Classes": "None", "Text": "", "ParentId": "b9c5f8df-dbac-4fa2-9edb-b7bfc770faf2"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></b></p>", "ID": "26e8e508-9267-4f5d-9f90-d8460e0cce0c", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></b>", "ID": "0ddf6f95-d08a-4c25-9e8a-945412c3c241", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "26e8e508-9267-4f5d-9f90-d8460e0cce0c"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "164011e7-91b7-4adc-ad66-270833ed25f9", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "0ddf6f95-d08a-4c25-9e8a-945412c3c241"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>MINIMUM\nPARTICULARS TO APPEAR ON BLISTERS OR STRIPS</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>BLISTERS</span></b></p>\n</div>", "ID": "a969fae9-52d2-4625-a524-53f01e85a42a", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "    ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>MINIMUM\nPARTICULARS TO APPEAR ON BLISTERS OR STRIPS</span></b></p>", "ID": "76fe6f48-a4bb-4d30-95ec-a2738be44f35", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a969fae9-52d2-4625-a524-53f01e85a42a"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>MINIMUM\nPARTICULARS TO APPEAR ON BLISTERS OR STRIPS</span></b>", "ID": "fb05c613-1317-43a8-b5c2-eff7c7b9a9d5", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "76fe6f48-a4bb-4d30-95ec-a2738be44f35"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>MINIMUM\nPARTICULARS TO APPEAR ON BLISTERS OR STRIPS</span>", "ID": "91a06268-a6d7-4a8a-9e50-0bec960465f3", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS", "ParentId": "fb05c613-1317-43a8-b5c2-eff7c7b9a9d5"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>", "ID": "f15f145b-cb61-456e-b5be-4bee1955ed04", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a969fae9-52d2-4625-a524-53f01e85a42a"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b>", "ID": "13aa4715-5652-4d75-b2cd-186ba44a7cd3", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f15f145b-cb61-456e-b5be-4bee1955ed04"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "e3dabd84-adb6-449e-a773-92673a19613e", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "13aa4715-5652-4d75-b2cd-186ba44a7cd3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>BLISTERS</span></b></p>", "ID": "9c7aae7d-d979-47ee-a59b-cdf0f7757448", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a969fae9-52d2-4625-a524-53f01e85a42a"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>BLISTERS</span></b>", "ID": "2de78afe-b837-4941-bb4e-e0dab952dac4", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9c7aae7d-d979-47ee-a59b-cdf0f7757448"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>BLISTERS</span>", "ID": "3294bc06-cf60-44cb-bf14-bbf2407489cd", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "BLISTERS", "ParentId": "2de78afe-b837-4941-bb4e-e0dab952dac4"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "9e1602ae-f4f5-4196-a987-2c01aad16eca", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "a0bf8eb9-b9e2-4284-bd9a-dcddba8beb8c", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "9e1602ae-f4f5-4196-a987-2c01aad16eca"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "e9c6236c-caf1-4285-bf55-ff7394fc882c", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "d16fa96a-3658-4f39-a59b-3c7f9a04435b", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "e9c6236c-caf1-4285-bf55-ff7394fc882c"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\nOF THE MEDICINAL PRODUCT</span></b></p>\n</div>", "ID": "3909066b-0086-406c-be72-29616d4de5f6", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\nOF THE MEDICINAL PRODUCT</span></b></p>", "ID": "806a266f-b680-440b-badf-9f5cad1734a8", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3909066b-0086-406c-be72-29616d4de5f6"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\nOF THE MEDICINAL PRODUCT</span></b>", "ID": "a2349ba2-a9b3-48d5-a666-8716034d5a80", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "806a266f-b680-440b-badf-9f5cad1734a8"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\nOF THE MEDICINAL PRODUCT</span>", "ID": "ae58abdf-1cd2-462c-860e-0d67c05f84e8", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT", "ParentId": "a2349ba2-a9b3-48d5-a666-8716034d5a80"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><i><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></i></p>", "ID": "4aff85f4-3bbf-4542-9a9f-b279ed574da1", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<i><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></i>", "ID": "1ee2ae1f-5996-409a-955a-3f264b155f41", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4aff85f4-3bbf-4542-9a9f-b279ed574da1"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "d3baa78d-3f55-4b67-9a91-12557171f139", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "1ee2ae1f-5996-409a-955a-3f264b155f41"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Febuxostat Mylan 120\u00a0mg film-coated tablets </span></p>", "ID": "af0c4b8f-ab55-4e32-98aa-e6b548ee714d", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Febuxostat Mylan 120\u00a0mg film-coated tablets </span>", "ID": "5b7709d6-183e-4e4c-9173-b696bdc8358e", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "Febuxostat Mylan 120\u00a0mg film-coated tablets ", "ParentId": "af0c4b8f-ab55-4e32-98aa-e6b548ee714d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>febuxostat</span><b><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'> </span></b></p>", "ID": "e7a23a6d-5528-444e-b0ca-89e54327f797", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>febuxostat</span>", "ID": "9d7e8d0a-efb8-44e0-8053-bb774a60e44e", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "febuxostat", "ParentId": "e7a23a6d-5528-444e-b0ca-89e54327f797"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'> </span></b>", "ID": "b4305892-e915-4530-ac40-6e28a8fcad69", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e7a23a6d-5528-444e-b0ca-89e54327f797"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'> </span>", "ID": "39e5d58c-e0bb-4529-8cb0-a4fd988ff11e", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": " ", "ParentId": "b4305892-e915-4530-ac40-6e28a8fcad69"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "bbd2e143-f9c5-4681-b9b2-a7e7928d786c", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "2c75af2c-fbf5-4a6f-a137-dbda804db213", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "bbd2e143-f9c5-4681-b9b2-a7e7928d786c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "b6abdb9c-8a46-4a05-8d22-747df615d828", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "705473d2-28e4-4103-859d-43dec82a874b", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "b6abdb9c-8a46-4a05-8d22-747df615d828"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\nOF THE MARKETING AUTHORISATION HOLDER</span></b></p>\n</div>", "ID": "b0bd9bd8-6812-48c0-87de-3fcc2247ff5a", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\nOF THE MARKETING AUTHORISATION HOLDER</span></b></p>", "ID": "4575cb81-c219-40c7-a027-bca146e80279", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b0bd9bd8-6812-48c0-87de-3fcc2247ff5a"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\nOF THE MARKETING AUTHORISATION HOLDER</span></b>", "ID": "88f3eb96-c0b4-4b78-bca5-2ce3ca6f7bc9", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4575cb81-c219-40c7-a027-bca146e80279"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME\nOF THE MARKETING AUTHORISATION HOLDER</span>", "ID": "99331b0c-689a-4e1d-88b2-c0513d6cd67c", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MARKETING AUTHORISATION HOLDER", "ParentId": "88f3eb96-c0b4-4b78-bca5-2ce3ca6f7bc9"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "ae09e02d-00fe-41c5-8a67-f9a4351608ac", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "974eee18-2d5d-40a1-a2ef-568eb2edfba2", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "ae09e02d-00fe-41c5-8a67-f9a4351608ac"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Mylan S.A.S.</span></p>", "ID": "8ebd8b89-daba-4506-95ee-432fc5a83e68", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Mylan S.A.S.</span>", "ID": "0b9ae617-569c-4f2f-8052-723ee3ba90ed", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "Mylan S.A.S.", "ParentId": "8ebd8b89-daba-4506-95ee-432fc5a83e68"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "b452185a-968c-439a-8606-7e4e73a7fd51", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "0e8c00fc-071f-4854-bde1-b1ef0980dd15", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "b452185a-968c-439a-8606-7e4e73a7fd51"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "1f693d24-f1ac-4fe4-9fbd-7861d87c7ff3", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "5bbd641e-a324-438f-8d41-2e60c1cfe0fe", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "1f693d24-f1ac-4fe4-9fbd-7861d87c7ff3"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 2.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY\nDATE</span></b></p>\n</div>", "ID": "fa0e55ec-4e63-4776-bb68-62b822aa9f11", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 2.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY\nDATE</span></b></p>", "ID": "3424a6a5-0328-4669-a6de-cfa0f2b7f0d0", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa0e55ec-4e63-4776-bb68-62b822aa9f11"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY\nDATE</span></b>", "ID": "7cf55f3b-f25a-40bb-b06b-0e82de6286ff", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "3424a6a5-0328-4669-a6de-cfa0f2b7f0d0"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY\nDATE</span>", "ID": "fef25121-176f-4cd7-a242-dae5998f58f1", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE", "ParentId": "7cf55f3b-f25a-40bb-b06b-0e82de6286ff"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "9b6325fb-3488-40fe-a2a7-e345274ebce7", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "e2e0e61b-6e9f-45c9-a694-64ed4945465d", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "9b6325fb-3488-40fe-a2a7-e345274ebce7"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>EXP</span></p>", "ID": "95e7d78e-a678-4600-a32a-f47ba0546943", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>EXP</span>", "ID": "084ecd7b-d230-4b74-a94a-c8b2304a1395", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "EXP", "ParentId": "95e7d78e-a678-4600-a32a-f47ba0546943"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "bea075f1-6ef7-40a4-9068-847877fd9b66", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "943ec573-3770-4977-8958-e978381bf85c", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "bea075f1-6ef7-40a4-9068-847877fd9b66"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "7364558c-1af3-4d8b-806b-4b44602098ad", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "30d79c5e-4274-4b45-aacd-135ff137ca03", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "7364558c-1af3-4d8b-806b-4b44602098ad"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 BATCH\nNUMBER</span></b></p>\n</div>", "ID": "c254eefe-fba3-430d-9a19-4ae4b0a97fb6", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 BATCH\nNUMBER</span></b></p>", "ID": "383dcc09-b6be-4c0a-b66b-1f5b3b63d9aa", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c254eefe-fba3-430d-9a19-4ae4b0a97fb6"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 BATCH\nNUMBER</span></b>", "ID": "89c27046-44cf-449d-90b0-7c68b8b01c57", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "383dcc09-b6be-4c0a-b66b-1f5b3b63d9aa"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 BATCH\nNUMBER</span>", "ID": "91f4a20d-e988-4e28-9d4c-83d0606d34e3", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER", "ParentId": "89c27046-44cf-449d-90b0-7c68b8b01c57"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "5108ebb5-1c97-4c74-a17c-19ad9424368d", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "f5e93d40-5edf-4111-bea0-59d9f3757b70", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "5108ebb5-1c97-4c74-a17c-19ad9424368d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Lot</span></p>", "ID": "48df74a0-9384-4d5e-8351-b305aa35fb4d", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Lot</span>", "ID": "8b5cca11-1cf7-4aa0-ac36-459664783804", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "Lot", "ParentId": "48df74a0-9384-4d5e-8351-b305aa35fb4d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "a169fac1-7833-4fd0-96dd-724c284d258f", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "857ae9de-12e0-4831-acdb-f982af261965", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "a169fac1-7833-4fd0-96dd-724c284d258f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "a27f9d55-f458-4679-b53f-41f3ec4e6857", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "29e2a3c3-c0e4-458c-98f2-99e25fbed930", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "a27f9d55-f458-4679-b53f-41f3ec4e6857"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt\">\n<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER</span></b></p>\n</div>", "ID": "81468b4c-e4aa-4e94-973e-ff7505e41639", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;\nmargin-left:0in;margin-right:2.75pt", "Classes": "None", "Text": "  ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal;border:none;\npadding:0in\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER</span></b></p>", "ID": "faf4aab5-0655-440e-945b-12e0a01ed762", "Styles": "margin-bottom:0in;line-height:normal;border:none;\npadding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "81468b4c-e4aa-4e94-973e-ff7505e41639"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER</span></b>", "ID": "3ed006d9-64c0-4943-a513-f89e0f35a7a3", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "faf4aab5-0655-440e-945b-12e0a01ed762"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER</span>", "ID": "95354fb0-c243-42ba-82d4-f4ca03217fc5", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER", "ParentId": "3ed006d9-64c0-4943-a513-f89e0f35a7a3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "0da61ce5-ba97-43b0-93e8-b5a5044ddf98", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "2b20709e-ee12-408e-9aef-0a187d3ef958", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "0da61ce5-ba97-43b0-93e8-b5a5044ddf98"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey'>[<i>For calendar blisters only]:</i></span></p>", "ID": "f84dd032-b23e-4958-b118-3e52651b280f", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey'>[<i>For calendar blisters only]:</i></span>", "ID": "3fb67d85-3cef-4e61-9281-cde3a280e163", "Styles": "font-family:\n\"Times New Roman\",serif;background:lightgrey", "Classes": "None", "Text": "[", "ParentId": "f84dd032-b23e-4958-b118-3e52651b280f"}, {"Element": "<i>For calendar blisters only]:</i>", "ID": "c333adaa-5f33-4d45-8448-7b587552bc9b", "Styles": "None", "Classes": "None", "Text": "For calendar blisters only]:", "ParentId": "3fb67d85-3cef-4e61-9281-cde3a280e163"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>MON</span></p>", "ID": "0a6d2ebb-b3b5-4071-b36b-9fa9b65c1e6e", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>MON</span>", "ID": "3b344cb9-0182-4a01-bb0a-ac7dda2abef4", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "MON", "ParentId": "0a6d2ebb-b3b5-4071-b36b-9fa9b65c1e6e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>TUE</span></p>", "ID": "74b81137-5bc3-410c-b21d-153ab8a792ef", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>TUE</span>", "ID": "db574338-23e7-4d32-84ef-00517241cf95", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "TUE", "ParentId": "74b81137-5bc3-410c-b21d-153ab8a792ef"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>WED<br/>\nTHU</span></p>", "ID": "d0ce88cf-d37e-4479-b46b-a1f8ef17c2fa", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>WED<br/>\nTHU</span>", "ID": "629c1632-de3d-4694-a7db-bce90ceef89f", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "WED THU", "ParentId": "d0ce88cf-d37e-4479-b46b-a1f8ef17c2fa"}, {"Element": "<br/>", "ID": "cb2d7f62-9904-4c0d-a3ab-ef2372d00bb1", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "629c1632-de3d-4694-a7db-bce90ceef89f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>FRI</span></p>", "ID": "9ed34388-da82-4682-a6d3-9932fcd88819", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>FRI</span>", "ID": "96d99de2-0f40-4b49-be10-dbb4248d13f5", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "FRI", "ParentId": "9ed34388-da82-4682-a6d3-9932fcd88819"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>SAT</span></p>", "ID": "c8d3a792-13b3-467a-a7c6-86d0bd5aa99e", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>SAT</span>", "ID": "4269d400-b7c7-41f3-9725-71a25356e81d", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "SAT", "ParentId": "c8d3a792-13b3-467a-a7c6-86d0bd5aa99e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>SUN</span></p>", "ID": "79c97239-5e88-491b-aca3-69ed25860c91", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>SUN</span>", "ID": "f914abb0-a833-469c-8afb-ca0edb63336b", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "SUN", "ParentId": "79c97239-5e88-491b-aca3-69ed25860c91"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "ab54c61d-0077-4515-826d-bca9291b7b14", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "228202e9-7d46-40c7-9ac9-282f22ce537e", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "ab54c61d-0077-4515-826d-bca9291b7b14"}, {"Element": "<b><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span></b>", "ID": "2943fb81-0caa-438a-84bf-921400edafcb", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span>", "ID": "b469708b-e1ed-4fcf-b18b-3e070c123059", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": " ", "ParentId": "2943fb81-0caa-438a-84bf-921400edafcb"}, {"Element": "<br clear=\"all\" style=\"page-break-before:always\"/>", "ID": "29aa1f75-da9f-4e41-965b-f586f5b1cc78", "Styles": "page-break-before:always", "Classes": "None", "Text": "", "ParentId": "b469708b-e1ed-4fcf-b18b-3e070c123059"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "a50d483e-f66c-480b-a722-676ef691005c", "Styles": "margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "4bc30d0b-a8b6-49d7-9b7d-e2f1efa9a476", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "a50d483e-f66c-480b-a722-676ef691005c"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "7795470c-ad72-42f5-a168-0418aa8c9e23", "Styles": "margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "ba04bdf6-336f-4e8f-9384-31adef8fd800", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "7795470c-ad72-42f5-a168-0418aa8c9e23"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "4def9480-174f-4beb-9c38-6dd98281a055", "Styles": "margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "71735860-9b66-4cf7-b3e0-d767727557e5", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "4def9480-174f-4beb-9c38-6dd98281a055"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "f77c0f30-8822-41b6-a027-22d7a1d6eaee", "Styles": "margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "919d9248-b507-40b9-bf6d-2209142b9d52", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "f77c0f30-8822-41b6-a027-22d7a1d6eaee"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "3ea62eab-bcc4-4ac9-b8d2-8d6c45e42b76", "Styles": "margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "74aa8ffe-4b4a-45f9-a495-c5a4431a3ba9", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "3ea62eab-bcc4-4ac9-b8d2-8d6c45e42b76"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "6ffaebed-dce9-49b6-9328-2eb4ee0381ac", "Styles": "margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "51b3e488-60ec-43fc-bbaa-2f9fd5208f1f", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "6ffaebed-dce9-49b6-9328-2eb4ee0381ac"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "2b168d33-699e-4fe8-904b-ea800fe93159", "Styles": "margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "bca4388d-e894-4589-8267-63c5e1b66825", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "2b168d33-699e-4fe8-904b-ea800fe93159"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "c234dbca-0f8e-4012-bef5-5321eb7d5b69", "Styles": "margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "b4684750-c072-461c-8763-179166d3115e", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "c234dbca-0f8e-4012-bef5-5321eb7d5b69"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "08a10c4a-3276-4175-b8f7-585765cb935b", "Styles": "margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "046f3d97-0464-4ce5-808b-48f7280fbff8", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "08a10c4a-3276-4175-b8f7-585765cb935b"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "50289e4d-8d1d-4674-8055-fb780311f13f", "Styles": "margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "b28d3c4a-18d6-43db-b2d7-707812813d32", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "50289e4d-8d1d-4674-8055-fb780311f13f"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "55b6e336-ddf1-4b6f-a182-0a826e528667", "Styles": "margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "3b786f69-554f-4da1-bb21-bd4e8f2cd184", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "55b6e336-ddf1-4b6f-a182-0a826e528667"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "b0a8dfbc-7980-4659-a4bd-ea0e8f2b695b", "Styles": "margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "670007b9-5d87-4874-ac96-b72bc2d1a867", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "b0a8dfbc-7980-4659-a4bd-ea0e8f2b695b"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "2255886f-9ee1-4320-b06e-09011a7ef945", "Styles": "margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "5845408f-8375-4c70-9ba1-7ffb2870284f", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "2255886f-9ee1-4320-b06e-09011a7ef945"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "31b35670-7baf-4bc7-ad00-79e8b52fe6d9", "Styles": "margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "13096ffb-33a0-4298-a34c-9a81e054abef", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "31b35670-7baf-4bc7-ad00-79e8b52fe6d9"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "b5a57488-a9cf-4df5-bec8-c51cc0e3caf8", "Styles": "margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "7393b05a-6fd0-4e4f-80b1-1c943a194d9a", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "b5a57488-a9cf-4df5-bec8-c51cc0e3caf8"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "994cbd2c-9148-435d-ac31-edfacb34357d", "Styles": "margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "4ebaba67-6aa3-43d9-bfa6-faf280dbb439", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "994cbd2c-9148-435d-ac31-edfacb34357d"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "169e3965-4bc4-4854-8a4d-aaa77fa8753d", "Styles": "margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "88499f03-5317-47ef-9509-4d36cb88443d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "169e3965-4bc4-4854-8a4d-aaa77fa8753d"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "1e47b1a8-4359-42f1-9a51-816c5f5aa52e", "Styles": "margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "e74963c8-21ec-426d-909e-5ba88f85c1f6", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "1e47b1a8-4359-42f1-9a51-816c5f5aa52e"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "15a118b0-7074-4210-9e54-f92c158a6dda", "Styles": "margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "c0740b36-f460-4466-a788-5471b38aeb46", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "15a118b0-7074-4210-9e54-f92c158a6dda"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "c6cf7e78-f774-4972-87de-ba024d0176f8", "Styles": "margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "c7c693b8-719e-4cde-8e7b-284522badb03", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "c6cf7e78-f774-4972-87de-ba024d0176f8"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "ca55df19-a53c-44cf-bc28-c2764f9c046e", "Styles": "margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "66a06ca5-3bc4-4087-9f22-968ebc57572e", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "ca55df19-a53c-44cf-bc28-c2764f9c046e"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "8f31b75b-055f-44df-93d6-211fecd2ca88", "Styles": "margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "cd4fb6c3-b926-4920-a8ef-30e4fc6aec09", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "8f31b75b-055f-44df-93d6-211fecd2ca88"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "735450a4-6c44-4166-9fe4-7cb7752e275f", "Styles": "margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "2ab46071-d0f6-468e-89dc-97073416414c", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "735450a4-6c44-4166-9fe4-7cb7752e275f"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "7758a944-a5ce-426c-bd40-887cac66b272", "Styles": "margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "e4b6fed3-fa1b-4ed2-af89-a6e877b6076f", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "7758a944-a5ce-426c-bd40-887cac66b272"}, {"Element": "<h1 align=\"center\" style=\"margin-right:2.75pt;text-align:center\"><span lang=\"EN-GB\">B. PACKAGE LEAFLET</span></h1>", "ID": "ef6a08f9-9c13-45ae-a24a-c1c34ff6c221", "Styles": "margin-right:2.75pt;text-align:center", "Classes": "None", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\">B. PACKAGE LEAFLET</span>", "ID": "10b2904e-7ac8-4945-97a2-b964d1fecfbc", "Styles": "None", "Classes": "None", "Text": "B. PACKAGE LEAFLET", "ParentId": "ef6a08f9-9c13-45ae-a24a-c1c34ff6c221"}, {"Element": "<b><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span></b>", "ID": "4d5d61c9-adff-47ae-ac4d-f8d8e147e6f6", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span>", "ID": "f98f3c21-8feb-475f-a0ca-88a8e0b7387e", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": " ", "ParentId": "4d5d61c9-adff-47ae-ac4d-f8d8e147e6f6"}, {"Element": "<br clear=\"all\" style=\"page-break-before:always\"/>", "ID": "f7902af0-a22c-414a-91ca-b82cf1e7b1b7", "Styles": "page-break-before:always", "Classes": "None", "Text": "", "ParentId": "f98f3c21-8feb-475f-a0ca-88a8e0b7387e"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Package leaflet:\nInformation for the patient</span></b></p>", "ID": "63295a4a-5afd-4514-97ef-a578c4b6642c", "Styles": "margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Package leaflet:\nInformation for the patient</span></b>", "ID": "8ddaa5c2-3a5c-45ad-a8ac-eeeeb000d9ca", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "63295a4a-5afd-4514-97ef-a578c4b6642c"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Package leaflet:\nInformation for the patient</span>", "ID": "4344377b-c845-47fd-b2ed-ce59e70cb3c5", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Package leaflet: Information for the patient", "ParentId": "8ddaa5c2-3a5c-45ad-a8ac-eeeeb000d9ca"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "ade521a0-23a2-410e-ac9e-409173aa20da", "Styles": "margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "d4dde952-587c-4c7c-8399-bb21ceff86d1", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "ade521a0-23a2-410e-ac9e-409173aa20da"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat\nMylan 80\u00a0mg film-coated tablets </span></b></p>", "ID": "737e30f8-5fac-4bc5-a451-b2da7a10a2e8", "Styles": "margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat\nMylan 80\u00a0mg film-coated tablets </span></b>", "ID": "91fd0aea-8a87-47c6-8055-5746bc296b10", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "737e30f8-5fac-4bc5-a451-b2da7a10a2e8"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat\nMylan 80\u00a0mg film-coated tablets </span>", "ID": "7cf46a89-10b8-4d10-92d1-5b989768128b", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Febuxostat Mylan 80\u00a0mg film-coated tablets ", "ParentId": "91fd0aea-8a87-47c6-8055-5746bc296b10"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat\nMylan 120\u00a0mg film-coated tablets </span></b></p>", "ID": "8f2ae015-b3ea-4a53-8bb3-b30b3e6a485d", "Styles": "margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat\nMylan 120\u00a0mg film-coated tablets </span></b>", "ID": "6f721c15-365c-4840-8a2b-2a6c9eee6627", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "8f2ae015-b3ea-4a53-8bb3-b30b3e6a485d"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat\nMylan 120\u00a0mg film-coated tablets </span>", "ID": "3d3737e5-2848-47bf-81dd-399adf797949", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Febuxostat Mylan 120\u00a0mg film-coated tablets ", "ParentId": "6f721c15-365c-4840-8a2b-2a6c9eee6627"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>febuxostat</span></p>", "ID": "ace4add9-2eb7-40de-a719-f31522ebba11", "Styles": "margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>febuxostat</span>", "ID": "eb53c07f-3c5f-4ef7-a66f-a86a897e8591", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "febuxostat", "ParentId": "ace4add9-2eb7-40de-a719-f31522ebba11"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "a5835b29-994c-469d-af9c-fb192b3128e1", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "b07b8c7e-e31d-4bc0-ae16-4b65bad4a735", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "a5835b29-994c-469d-af9c-fb192b3128e1"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Read all of this leaflet\ncarefully before you start taking this medicine because it contains important\ninformation for you.</span></b></p>", "ID": "9e0891f3-3964-4031-8c6c-7f1b9f48e39c", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Read all of this leaflet\ncarefully before you start taking this medicine because it contains important\ninformation for you.</span></b>", "ID": "cce51aa3-67e6-4577-a90d-8571fd69ae72", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9e0891f3-3964-4031-8c6c-7f1b9f48e39c"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Read all of this leaflet\ncarefully before you start taking this medicine because it contains important\ninformation for you.</span>", "ID": "28d21cc6-1fc7-4858-80d1-22eb0e76d8c7", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.", "ParentId": "cce51aa3-67e6-4577-a90d-8571fd69ae72"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "a78b1f83-b226-4989-9b33-2fb4ef60681b", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "77fe68bd-63c6-437f-a788-54eea02f30df", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "a78b1f83-b226-4989-9b33-2fb4ef60681b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Keep\nthis leaflet. You may need to read it again.</span></p>", "ID": "d666f842-29c5-41b2-9375-0d81387a470e", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "41c03556-88e5-42ef-8cc1-b864b37a0d46", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "-", "ParentId": "d666f842-29c5-41b2-9375-0d81387a470e"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "ee4778aa-da3e-4fd5-9373-bfde01de670d", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "41c03556-88e5-42ef-8cc1-b864b37a0d46"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Keep\nthis leaflet. You may need to read it again.</span>", "ID": "731b4559-4fb6-4f56-8157-a09a4378021d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Keep this leaflet. You may need to read it again.", "ParentId": "d666f842-29c5-41b2-9375-0d81387a470e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If\nyou have any further questions, ask your doctor or pharmacist.</span></p>", "ID": "ad2029b1-0b78-4180-8177-9dcd911cf2bf", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "184e0dc7-55ec-44f5-bfae-70c5ad0eca89", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "-", "ParentId": "ad2029b1-0b78-4180-8177-9dcd911cf2bf"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "ab09dd76-e356-489a-bde7-dd81129d863b", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "184e0dc7-55ec-44f5-bfae-70c5ad0eca89"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If\nyou have any further questions, ask your doctor or pharmacist.</span>", "ID": "91513dcc-b6e6-4752-95e6-fdbb88b3c0af", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "If you have any further questions, ask your doctor or pharmacist.", "ParentId": "ad2029b1-0b78-4180-8177-9dcd911cf2bf"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>This\nmedicine has been prescribed for you only. Do not pass it on to others. It may\nharm them, even if their signs of illness are the same as yours.</span></p>", "ID": "4af2b168-3faf-4295-b90d-bad919c17b9c", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "37347e8a-4ddf-4404-85a1-1f27e280a803", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "-", "ParentId": "4af2b168-3faf-4295-b90d-bad919c17b9c"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "dd30d97e-7358-405d-84b9-1a5dcadf6679", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "37347e8a-4ddf-4404-85a1-1f27e280a803"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>This\nmedicine has been prescribed for you only. Do not pass it on to others. It may\nharm them, even if their signs of illness are the same as yours.</span>", "ID": "97271ec4-d40a-41d5-b005-5cacb0046ca9", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.", "ParentId": "4af2b168-3faf-4295-b90d-bad919c17b9c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If\nyou get any side effects talk to your doctor or pharmacist. This includes any\npossible side effects not listed in this leaflet. See section 4.</span></p>", "ID": "b7a57c72-c02f-4831-aa21-b7b067d224b4", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "d429d114-5ac4-4b3e-ba3f-30ce1f4b3a85", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "-", "ParentId": "b7a57c72-c02f-4831-aa21-b7b067d224b4"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "2226f275-5a2d-4fd8-b649-cfcea4d4ead2", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "d429d114-5ac4-4b3e-ba3f-30ce1f4b3a85"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If\nyou get any side effects talk to your doctor or pharmacist. This includes any\npossible side effects not listed in this leaflet. See section 4.</span>", "ID": "b1201e2c-0fc4-46f7-9850-fd469b6a3b07", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "If you get any side effects talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.", "ParentId": "b7a57c72-c02f-4831-aa21-b7b067d224b4"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "d47af52d-5ee8-469d-8531-c4e22e91446e", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "1c1c8300-e475-4f89-a124-d99d66610f2e", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "d47af52d-5ee8-469d-8531-c4e22e91446e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>What is in this leaflet</span></b></p>", "ID": "a976976a-f40d-4082-b3dd-73fde309d593", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>What is in this leaflet</span></b>", "ID": "189f12da-1cff-4368-be79-014a6b51f868", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a976976a-f40d-4082-b3dd-73fde309d593"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>What is in this leaflet</span>", "ID": "fa0caf99-4056-4f90-a333-12c0e5a3ebd3", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "What is in this leaflet", "ParentId": "189f12da-1cff-4368-be79-014a6b51f868"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "7519363c-35d9-4134-9fad-c82704fcbe11", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "498e8e71-deb0-4701-abb2-309ca7926f95", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "7519363c-35d9-4134-9fad-c82704fcbe11"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1.<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>What\nFebuxostat Mylan is and what it is used for</span></p>", "ID": "49518532-c79d-4ff2-8e2a-57724b0863c7", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1.<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "d7a91d76-13fd-4d81-b46d-251a37fe4552", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "1.", "ParentId": "49518532-c79d-4ff2-8e2a-57724b0863c7"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "96340b84-5ef6-4cad-b60e-fd30d1a3e7c6", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "d7a91d76-13fd-4d81-b46d-251a37fe4552"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>What\nFebuxostat Mylan is and what it is used for</span>", "ID": "9910870c-38d9-41c3-87f2-6875ae50fec1", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "What Febuxostat Mylan is and what it is used for", "ParentId": "49518532-c79d-4ff2-8e2a-57724b0863c7"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>2.<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>What\nyou need to know before you take Febuxostat Mylan</span></p>", "ID": "5774b2e7-861a-40ac-a8a1-35029b2003e9", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>2.<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "c82a0163-1793-4698-a3f8-8173931d1ebf", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "2.", "ParentId": "5774b2e7-861a-40ac-a8a1-35029b2003e9"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "31d14f8f-649a-4b72-8f74-ebea789a1f5b", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "c82a0163-1793-4698-a3f8-8173931d1ebf"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>What\nyou need to know before you take Febuxostat Mylan</span>", "ID": "b6770c55-6dc7-4946-912a-f9bc740928ab", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "What you need to know before you take Febuxostat Mylan", "ParentId": "5774b2e7-861a-40ac-a8a1-35029b2003e9"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>3.<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>How\nto take Febuxostat Mylan</span></p>", "ID": "593dda97-8a8b-43cd-bf2e-8bd6856334d7", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>3.<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "48aba9ae-b451-4363-8fe4-7842fd36f557", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "3.", "ParentId": "593dda97-8a8b-43cd-bf2e-8bd6856334d7"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "eabcaa7f-537f-4a0c-91a5-4008df2ac04d", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "48aba9ae-b451-4363-8fe4-7842fd36f557"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>How\nto take Febuxostat Mylan</span>", "ID": "f3033178-4c17-4870-8898-362150bab75d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "How to take Febuxostat Mylan", "ParentId": "593dda97-8a8b-43cd-bf2e-8bd6856334d7"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>4.<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Possible\nside effects</span></p>", "ID": "f6c4c3ed-01f8-47e5-913f-87a365398ea9", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>4.<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "af6b8361-c5be-4074-ba47-c43b2d72b218", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "4.", "ParentId": "f6c4c3ed-01f8-47e5-913f-87a365398ea9"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "55949ce0-00c0-4127-b9a0-4f72c8bab752", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "af6b8361-c5be-4074-ba47-c43b2d72b218"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Possible\nside effects</span>", "ID": "f33358cd-c37b-4bf5-b0c4-4824549d83ce", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Possible side effects", "ParentId": "f6c4c3ed-01f8-47e5-913f-87a365398ea9"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>5.<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>How\nto store Febuxostat Mylan</span></p>", "ID": "ce6cf016-3e66-4c28-b98f-c3f4a0ef8b30", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>5.<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "dcebe10c-312c-43e9-a258-f5e4c76c3f67", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "5.", "ParentId": "ce6cf016-3e66-4c28-b98f-c3f4a0ef8b30"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "5d81ffe6-a60b-451b-90b5-f67faaa52546", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "dcebe10c-312c-43e9-a258-f5e4c76c3f67"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>How\nto store Febuxostat Mylan</span>", "ID": "f0956269-b825-45f0-a7d6-42f1d718058a", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "How to store Febuxostat Mylan", "ParentId": "ce6cf016-3e66-4c28-b98f-c3f4a0ef8b30"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>6.<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Contents\nof the pack and other information</span></p>", "ID": "09c09623-cc13-4128-bdc1-a0673fe62e50", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>6.<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "99af6bd9-3db5-4e5b-889b-25c376f8983b", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "6.", "ParentId": "09c09623-cc13-4128-bdc1-a0673fe62e50"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "e11dc17c-b05c-414a-81cb-4ebf8e6be33a", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "99af6bd9-3db5-4e5b-889b-25c376f8983b"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Contents\nof the pack and other information</span>", "ID": "53d399fc-6890-4fa0-b3ad-28b88a3b1e5b", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Contents of the pack and other information", "ParentId": "09c09623-cc13-4128-bdc1-a0673fe62e50"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "a9732ffd-6f55-4247-b72e-1430f5de6efe", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "7e179bb3-c0e0-4963-bf5e-c08068f40a36", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "a9732ffd-6f55-4247-b72e-1430f5de6efe"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "5f1bce70-75b7-4963-9173-beb67b77520b", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "807a4e94-47bf-42c1-ba50-4dab6308f839", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "5f1bce70-75b7-4963-9173-beb67b77520b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 What Febuxostat\nMylan is and what it is used for</span></b></p>", "ID": "89c12720-a85c-47b0-b60a-8f1952d7c786", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 What Febuxostat\nMylan is and what it is used for</span></b>", "ID": "82ef6352-b28e-458c-b697-29197137df20", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "89c12720-a85c-47b0-b60a-8f1952d7c786"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 What Febuxostat\nMylan is and what it is used for</span>", "ID": "43044ee4-9167-40de-a818-70d0d7412f61", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 What Febuxostat Mylan is and what it is used for", "ParentId": "82ef6352-b28e-458c-b697-29197137df20"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "968a9388-aa4f-4392-ac30-f2811576eab6", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "e0f3338b-ab4b-4504-a6fa-3cc84c43c9d9", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "968a9388-aa4f-4392-ac30-f2811576eab6"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat Mylan tablets contain\nthe active substance febuxostat and are used to treat gout, which is associated\nwith an excess of a chemical called uric acid (urate) in the body. In some\npeople, the amount of uric acid builds up in the blood and may become too high\nto remain soluble. When this happens, urate crystals may form in and around the\njoints and kidneys. These crystals can cause sudden, severe pain, redness,\nwarmth and swelling in a joint (known as a gout attack). Left untreated, larger\ndeposits called tophi may form in and around joints. These tophi may cause\njoint and bone damage.</span></p>", "ID": "e55a905f-0e2b-494e-93fd-28f92a61f602", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat Mylan tablets contain\nthe active substance febuxostat and are used to treat gout, which is associated\nwith an excess of a chemical called uric acid (urate) in the body. In some\npeople, the amount of uric acid builds up in the blood and may become too high\nto remain soluble. When this happens, urate crystals may form in and around the\njoints and kidneys. These crystals can cause sudden, severe pain, redness,\nwarmth and swelling in a joint (known as a gout attack). Left untreated, larger\ndeposits called tophi may form in and around joints. These tophi may cause\njoint and bone damage.</span>", "ID": "0753913f-ba9c-4f92-8fb9-c435452bbea4", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Febuxostat Mylan tablets contain the active substance febuxostat and are used to treat gout, which is associated with an excess of a chemical called uric acid (urate) in the body. In some people, the amount of uric acid builds up in the blood and may become too high to remain soluble. When this happens, urate crystals may form in and around the joints and kidneys. These crystals can cause sudden, severe pain, redness, warmth and swelling in a joint (known as a gout attack). Left untreated, larger deposits called tophi may form in and around joints. These tophi may cause joint and bone damage.", "ParentId": "e55a905f-0e2b-494e-93fd-28f92a61f602"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "ae9e1a71-c453-4497-91d1-d88b0d83878e", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "832eaf5f-051c-4b4b-8268-aaf1604ac2aa", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "ae9e1a71-c453-4497-91d1-d88b0d83878e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat Mylan works by reducing\nuric acid levels. Keeping uric acid levels low by taking Febuxostat Mylan once\nevery day stops crystals building up, and over time it reduces symptoms.\nKeeping uric acid levels sufficiently low for a long enough period can also\nshrink tophi.</span></p>", "ID": "5fc0399b-2af1-438a-9401-aa40ac6cda13", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat Mylan works by reducing\nuric acid levels. Keeping uric acid levels low by taking Febuxostat Mylan once\nevery day stops crystals building up, and over time it reduces symptoms.\nKeeping uric acid levels sufficiently low for a long enough period can also\nshrink tophi.</span>", "ID": "a53983ab-3dfd-48f5-b787-e15b47ca2ffd", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Febuxostat Mylan works by reducing uric acid levels. Keeping uric acid levels low by taking Febuxostat Mylan once every day stops crystals building up, and over time it reduces symptoms. Keeping uric acid levels sufficiently low for a long enough period can also shrink tophi.", "ParentId": "5fc0399b-2af1-438a-9401-aa40ac6cda13"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "93182078-3f5f-44da-9f93-6fad782705a8", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "a9ae2deb-8905-4114-a569-90f4104591a0", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "93182078-3f5f-44da-9f93-6fad782705a8"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat Mylan 120\u00a0mg tablets\nare also used to treat and prevent high blood levels of uric acid that may\noccur when you start to receive chemotherapy for blood cancers.</span></p>", "ID": "d7ede761-973e-4b84-bab4-d71fa37ca23d", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat Mylan 120\u00a0mg tablets\nare also used to treat and prevent high blood levels of uric acid that may\noccur when you start to receive chemotherapy for blood cancers.</span>", "ID": "b7508814-af92-4de0-9ce7-ca2aadcba083", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Febuxostat Mylan 120\u00a0mg tablets are also used to treat and prevent high blood levels of uric acid that may occur when you start to receive chemotherapy for blood cancers.", "ParentId": "d7ede761-973e-4b84-bab4-d71fa37ca23d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>When chemotherapy is given, cancer\ncells are destroyed, and uric acid levels increase in the blood accordingly,\nunless the formation of uric acid is prevented.</span></p>", "ID": "7734e8d2-82f8-4f82-9017-bf48e8ffadbc", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>When chemotherapy is given, cancer\ncells are destroyed, and uric acid levels increase in the blood accordingly,\nunless the formation of uric acid is prevented.</span>", "ID": "ea913413-4eaf-4522-94fc-42bd98edb3f9", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "When chemotherapy is given, cancer cells are destroyed, and uric acid levels increase in the blood accordingly, unless the formation of uric acid is prevented.", "ParentId": "7734e8d2-82f8-4f82-9017-bf48e8ffadbc"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "ff97c43b-2fc6-427d-afa4-2986da284098", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "121e0407-f605-4cc0-9cfb-44716f641f14", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "ff97c43b-2fc6-427d-afa4-2986da284098"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat Mylan is for adults.</span></p>", "ID": "3893f4f3-8bbe-4156-8966-d2b82fc19e22", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat Mylan is for adults.</span>", "ID": "2602e1b7-de52-40b0-8bac-a500ad2a7fa5", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Febuxostat Mylan is for adults.", "ParentId": "3893f4f3-8bbe-4156-8966-d2b82fc19e22"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "6877cc1f-18fc-4ada-95ea-394d1837433d", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "2699c6c8-e9bd-4321-ae1d-a2f6f2f49d67", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "6877cc1f-18fc-4ada-95ea-394d1837433d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "b6a0162e-9bea-4c63-ae3a-d04c418e9aab", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "1b537db5-cb2e-4a3a-8073-7be63af3a1bf", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "b6a0162e-9bea-4c63-ae3a-d04c418e9aab"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 What you need\nto know before you take Febuxostat Mylan </span></b></p>", "ID": "7f09f87a-3239-4abd-943b-97819b30a7b5", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 What you need\nto know before you take Febuxostat Mylan </span></b>", "ID": "2b5de1dd-9eec-4adf-9ed0-9c9a61b222d1", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "7f09f87a-3239-4abd-943b-97819b30a7b5"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 What you need\nto know before you take Febuxostat Mylan </span>", "ID": "44b4f62d-2d2f-4d20-8bd7-3e2318e0cd89", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 What you need to know before you take Febuxostat Mylan ", "ParentId": "2b5de1dd-9eec-4adf-9ed0-9c9a61b222d1"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>", "ID": "50e850c8-e232-4467-95f2-6d9dcb2c4be6", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b>", "ID": "5bc95ab8-8df6-4ec4-ba42-57163e94b24a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "50e850c8-e232-4467-95f2-6d9dcb2c4be6"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "5ca80663-bb5c-49cb-9a7a-76f24d1eb780", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "5bc95ab8-8df6-4ec4-ba42-57163e94b24a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Do not take Febuxostat\nMylan</span></b></p>", "ID": "a23f3cd1-3a63-4452-b727-12b8a3d76489", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Do not take Febuxostat\nMylan</span></b>", "ID": "17b7b829-107d-4cf7-a995-0294d809e4af", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a23f3cd1-3a63-4452-b727-12b8a3d76489"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Do not take Febuxostat\nMylan</span>", "ID": "938ab961-fd68-40fb-807e-0e637572ea22", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Do not take Febuxostat Mylan", "ParentId": "17b7b829-107d-4cf7-a995-0294d809e4af"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If\nyou are allergic to febuxostat or any of the other ingredients of this medicine\n(listed in section 6).</span></p>", "ID": "e6e6bd74-ed3a-4798-81ac-8486d171109c", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "131595d5-efe8-4e3c-9ee3-a130e56670c7", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "e6e6bd74-ed3a-4798-81ac-8486d171109c"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "7ffc5cbe-60ca-4cf6-ad0b-0935b2830be6", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "131595d5-efe8-4e3c-9ee3-a130e56670c7"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If\nyou are allergic to febuxostat or any of the other ingredients of this medicine\n(listed in section 6).</span>", "ID": "0588cec8-25b9-4a17-be75-56fdf19f2733", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "If you are allergic to febuxostat or any of the other ingredients of this medicine (listed in section 6).", "ParentId": "e6e6bd74-ed3a-4798-81ac-8486d171109c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>", "ID": "b6685bfb-ea4f-4cbe-b088-0eb98cca4e79", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b>", "ID": "7efd324a-201a-40ea-8473-296dba0fa71b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b6685bfb-ea4f-4cbe-b088-0eb98cca4e79"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "ccc0d154-9cc3-4387-9fd7-cebfcddd8504", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "7efd324a-201a-40ea-8473-296dba0fa71b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Warnings and precautions</span></b></p>", "ID": "467a672b-13f5-46e7-9a90-437ea18cd6ea", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Warnings and precautions</span></b>", "ID": "3c5e5fdc-e04d-4284-bf2e-a95a50f14c6e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "467a672b-13f5-46e7-9a90-437ea18cd6ea"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Warnings and precautions</span>", "ID": "f210e4a1-44da-4021-b1c9-b67c441bbbfa", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Warnings and precautions", "ParentId": "3c5e5fdc-e04d-4284-bf2e-a95a50f14c6e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "a276ed38-4ff1-4acd-91fe-72bb1152cc0c", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "0b45d711-d11c-49b9-9c9a-632b4a72d561", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "a276ed38-4ff1-4acd-91fe-72bb1152cc0c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Talk to your doctor before taking Febuxostat\nMylan:</span></p>", "ID": "d9da3a20-87ec-4b44-a1f4-3ddafcaee445", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Talk to your doctor before taking Febuxostat\nMylan:</span>", "ID": "1dbb40a4-c8c9-41c4-985a-594446c2572c", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Talk to your doctor before taking Febuxostat Mylan:", "ParentId": "d9da3a20-87ec-4b44-a1f4-3ddafcaee445"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If\nyou have or have had heart failure or heart problems</span></p>", "ID": "b32d7bc3-091d-4540-9522-7736acadd702", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "cdb127a3-cbfb-4b42-8641-3d1c51b40dc3", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "b32d7bc3-091d-4540-9522-7736acadd702"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "fc26b56a-f31e-426f-822c-90318d8f0f53", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "cdb127a3-cbfb-4b42-8641-3d1c51b40dc3"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If\nyou have or have had heart failure or heart problems</span>", "ID": "4038401e-f3a2-49f1-875e-37a37b26f40e", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "If you have or have had heart failure or heart problems", "ParentId": "b32d7bc3-091d-4540-9522-7736acadd702"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If\nyou have or have had renal disease and/or serious allergic reaction to allopurinol\n(a medication used for the treatment of Gout)</span></p>", "ID": "0f9f20f4-1e88-4b36-a651-633935883b3d", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "ef363d6c-3eb9-4aa2-bef0-8b4267401d67", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "0f9f20f4-1e88-4b36-a651-633935883b3d"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "5eeb29fd-5d94-4c9f-89af-80d1caee29ad", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "ef363d6c-3eb9-4aa2-bef0-8b4267401d67"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If\nyou have or have had renal disease and/or serious allergic reaction to allopurinol\n(a medication used for the treatment of Gout)</span>", "ID": "4b14a333-7608-4c86-91e4-43f29cf396c7", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "If you have or have had renal disease and/or serious allergic reaction to allopurinol (a medication used for the treatment of Gout)", "ParentId": "0f9f20f4-1e88-4b36-a651-633935883b3d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If\nyou have or have had liver disease or liver function test abnormalities</span></p>", "ID": "72eb13ab-a4dc-40a8-a31d-e66670825735", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "d03bdc34-1712-4336-be46-410bed383947", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "72eb13ab-a4dc-40a8-a31d-e66670825735"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "f2c495ec-5928-4344-81ed-5618526bee20", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "d03bdc34-1712-4336-be46-410bed383947"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If\nyou have or have had liver disease or liver function test abnormalities</span>", "ID": "96574554-e6f4-4dc2-ab95-6ecd57109bd7", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "If you have or have had liver disease or liver function test abnormalities", "ParentId": "72eb13ab-a4dc-40a8-a31d-e66670825735"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If\nyou are being treated for high uric acid levels as a result of Lesch-Nyhan\nsyndrome (a rare inherited condition in which there is too much uric acid in\nthe blood)</span></p>", "ID": "c0bc8f3c-0e42-47dd-a974-6c088eadd20b", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "e8e37bca-b8d4-485b-ba3e-a39e77c426b0", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "c0bc8f3c-0e42-47dd-a974-6c088eadd20b"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "86ed3722-bc14-4ec1-9710-83d2be543d4c", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "e8e37bca-b8d4-485b-ba3e-a39e77c426b0"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If\nyou are being treated for high uric acid levels as a result of Lesch-Nyhan\nsyndrome (a rare inherited condition in which there is too much uric acid in\nthe blood)</span>", "ID": "81fd8b73-94df-4439-b3d3-c8b512e8ede6", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "If you are being treated for high uric acid levels as a result of Lesch-Nyhan syndrome (a rare inherited condition in which there is too much uric acid in the blood)", "ParentId": "c0bc8f3c-0e42-47dd-a974-6c088eadd20b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If\nyou have thyroid problems.</span></p>", "ID": "fc1d35d0-ec44-4af6-8520-d29458b27b80", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "a2ce079d-372c-4e94-b3b9-6e28f5a0e760", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "fc1d35d0-ec44-4af6-8520-d29458b27b80"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "5a90f369-f0f5-40b8-8096-aeb0ed7166a6", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "a2ce079d-372c-4e94-b3b9-6e28f5a0e760"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If\nyou have thyroid problems.</span>", "ID": "bc1767f2-7b70-4456-8b5d-89ba98ea2802", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "If you have thyroid problems.", "ParentId": "fc1d35d0-ec44-4af6-8520-d29458b27b80"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "2f9f0ec9-1976-40b0-bcb0-dc4ae65bbfac", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "326d8466-8b95-4d75-9979-decfc0855a17", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "2f9f0ec9-1976-40b0-bcb0-dc4ae65bbfac"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Should you experience allergic\nreactions to Febuxostat Mylan, stop taking this medicine (see also section 4).\nPossible symptoms of allergic reactions might be:</span></p>", "ID": "80536438-e9be-4b6d-a920-7fbb34602d9c", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Should you experience allergic\nreactions to Febuxostat Mylan, stop taking this medicine (see also section 4).\nPossible symptoms of allergic reactions might be:</span>", "ID": "80f6d760-015a-442d-9041-0fd18f4bd1b0", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Should you experience allergic reactions to Febuxostat Mylan, stop taking this medicine (see also section 4). Possible symptoms of allergic reactions might be:", "ParentId": "80536438-e9be-4b6d-a920-7fbb34602d9c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>rash\nincluding severe forms (e.g. blisters, nodules, itchy, exfoliative rash), itchiness</span></p>", "ID": "efd1f8b9-9f01-41c9-a32b-2127b3e0e8b0", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "b921af1f-a6d6-4a71-a77b-00dc0d4f305d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "-", "ParentId": "efd1f8b9-9f01-41c9-a32b-2127b3e0e8b0"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "0a0f31fb-f106-46e7-b6fd-0e84e518cc78", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "b921af1f-a6d6-4a71-a77b-00dc0d4f305d"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>rash\nincluding severe forms (e.g. blisters, nodules, itchy, exfoliative rash), itchiness</span>", "ID": "c4158747-3cc9-48dc-ad9d-8c1da211f945", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "rash including severe forms (e.g. blisters, nodules, itchy, exfoliative rash), itchiness", "ParentId": "efd1f8b9-9f01-41c9-a32b-2127b3e0e8b0"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>swelling\nof limbs or face</span></p>", "ID": "963300a3-8d02-4bfa-b0e7-3c4e59912214", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "940cdfb9-b396-4729-8d85-c6ea93b5727e", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "-", "ParentId": "963300a3-8d02-4bfa-b0e7-3c4e59912214"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "28265eea-ba16-41d0-b068-e8f7f7f2ac76", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "940cdfb9-b396-4729-8d85-c6ea93b5727e"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>swelling\nof limbs or face</span>", "ID": "c4c5451f-8a04-4b94-b58b-b273a6b81c36", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "swelling of limbs or face", "ParentId": "963300a3-8d02-4bfa-b0e7-3c4e59912214"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>difficulties\nin breathing</span></p>", "ID": "555882b8-61df-462e-a577-5bbee5a5f50a", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "c6cf6555-74c2-4a11-86d8-8a0d2562ec5c", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "-", "ParentId": "555882b8-61df-462e-a577-5bbee5a5f50a"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "37a86731-f126-43c2-b980-ca00f7087347", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "c6cf6555-74c2-4a11-86d8-8a0d2562ec5c"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>difficulties\nin breathing</span>", "ID": "6d4ce228-347b-401b-9295-bbbbf26ac97f", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "difficulties in breathing", "ParentId": "555882b8-61df-462e-a577-5bbee5a5f50a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>fever\nwith enlarged lymph nodes</span></p>", "ID": "910ed40b-99eb-48f3-8cd2-613748b9fab6", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "1ed4a86a-48d9-4560-a6a1-169af7e01176", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "-", "ParentId": "910ed40b-99eb-48f3-8cd2-613748b9fab6"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "0ca59945-850f-4da0-9973-ce79d2fca55b", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "1ed4a86a-48d9-4560-a6a1-169af7e01176"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>fever\nwith enlarged lymph nodes</span>", "ID": "f307d23a-ea2b-4a5f-9fef-812c9632682f", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "fever with enlarged lymph nodes", "ParentId": "910ed40b-99eb-48f3-8cd2-613748b9fab6"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>but\nalso serious life threatening allergic conditions with cardiac and circulatory\narrest. Your doctor might decide to permanently stop treatment with Febuxostat Mylan.</span></p>", "ID": "4286d673-082e-4876-9c5b-609d2eac9cc5", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "08898d0e-797c-4dcb-bba4-5576aed10be0", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "-", "ParentId": "4286d673-082e-4876-9c5b-609d2eac9cc5"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "90fa15e1-0912-4ee2-a652-be71c5abd1ac", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "08898d0e-797c-4dcb-bba4-5576aed10be0"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>but\nalso serious life threatening allergic conditions with cardiac and circulatory\narrest. Your doctor might decide to permanently stop treatment with Febuxostat Mylan.</span>", "ID": "d38ba570-6d04-48a6-a914-5ed288f88d29", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "but also serious life threatening allergic conditions with cardiac and circulatory arrest. Your doctor might decide to permanently stop treatment with Febuxostat Mylan.", "ParentId": "4286d673-082e-4876-9c5b-609d2eac9cc5"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "6b2c1864-340c-445f-bbc7-9be8d06ff068", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "364ed327-e311-4f85-80a5-e1366ce403ce", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "6b2c1864-340c-445f-bbc7-9be8d06ff068"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>There have been rare reports of\npotentially life-threatening skin rashes (Stevens-Johnson Syndrome) with the\nuse of febuxostat, appearing initially as reddish target-like spots or circular\npatches often with central blister on the trunk. It may also include ulcers in\nthe mouth, throat, nose, genitals and conjunctivitis (red and swollen eyes).\nThe rash may progress to widespread blistering or peeling of the skin.</span></p>", "ID": "28c36acd-027b-4d65-827f-a4067bd3d7a8", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>There have been rare reports of\npotentially life-threatening skin rashes (Stevens-Johnson Syndrome) with the\nuse of febuxostat, appearing initially as reddish target-like spots or circular\npatches often with central blister on the trunk. It may also include ulcers in\nthe mouth, throat, nose, genitals and conjunctivitis (red and swollen eyes).\nThe rash may progress to widespread blistering or peeling of the skin.</span>", "ID": "73c6a852-d8fa-4b88-a4f7-0b00c26d4c68", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "There have been rare reports of potentially life-threatening skin rashes (Stevens-Johnson Syndrome) with the use of febuxostat, appearing initially as reddish target-like spots or circular patches often with central blister on the trunk. It may also include ulcers in the mouth, throat, nose, genitals and conjunctivitis (red and swollen eyes). The rash may progress to widespread blistering or peeling of the skin.", "ParentId": "28c36acd-027b-4d65-827f-a4067bd3d7a8"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "85148b8a-6d4d-4b4c-9218-5661a61916ef", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "d7c2f3cc-d80e-4ffd-9442-12b523f3661d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "85148b8a-6d4d-4b4c-9218-5661a61916ef"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If you have developed\nStevens-Johnson Syndrome with the use of febuxostat, you must not be re-started\non Febuxostat Mylan at any time. If you develop a rash or these skin symptoms,\nseek immediate advice from a doctor and tell them that you are taking this\nmedicine.</span></p>", "ID": "e0f820b1-ebc9-40f2-883e-2c7caeee2ce4", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If you have developed\nStevens-Johnson Syndrome with the use of febuxostat, you must not be re-started\non Febuxostat Mylan at any time. If you develop a rash or these skin symptoms,\nseek immediate advice from a doctor and tell them that you are taking this\nmedicine.</span>", "ID": "f12940a5-3ef2-4adb-aba3-aa02cf42613d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "If you have developed Stevens-Johnson Syndrome with the use of febuxostat, you must not be re-started on Febuxostat Mylan at any time. If you develop a rash or these skin symptoms, seek immediate advice from a doctor and tell them that you are taking this medicine.", "ParentId": "e0f820b1-ebc9-40f2-883e-2c7caeee2ce4"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "8572b763-22a2-43a3-9d01-6abdfc8ca2ae", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "d3515f16-e713-4bcf-bfe8-3148989666a0", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "8572b763-22a2-43a3-9d01-6abdfc8ca2ae"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If you are having a gout attack at\nthe moment (a sudden onset of severe pain, tenderness, redness, warmth and\nswelling in a joint), wait for the gout attack to subside first before starting\ntreatment with Febuxostat Mylan.</span></p>", "ID": "ca37abef-f291-4b0c-8d94-2d7ae8f16005", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If you are having a gout attack at\nthe moment (a sudden onset of severe pain, tenderness, redness, warmth and\nswelling in a joint), wait for the gout attack to subside first before starting\ntreatment with Febuxostat Mylan.</span>", "ID": "fd82a2f6-d2f0-415c-a6e9-9588a0974314", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "If you are having a gout attack at the moment (a sudden onset of severe pain, tenderness, redness, warmth and swelling in a joint), wait for the gout attack to subside first before starting treatment with Febuxostat Mylan.", "ParentId": "ca37abef-f291-4b0c-8d94-2d7ae8f16005"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "1d90fb2b-2f65-4c3d-9245-3b8f223765dd", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "c6e05fc8-f9fe-4cb4-9d8a-b5ccd773bca4", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "1d90fb2b-2f65-4c3d-9245-3b8f223765dd"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>For some people, gout attacks may\nflare up when starting certain medicines that control uric acid levels. Not\neveryone gets flares, but you could get a flare-up even if you are taking Febuxostat\nMylan, and especially during the first weeks or months of treatment. It is\nimportant to keep taking Febuxostat Mylan even if you have a flare, as Febuxostat\nMylan is still working to lower uric acid. Over time, gout flares will occur\nless often and be less painful if you keep taking Febuxostat Mylan every day.</span></p>", "ID": "eb8122af-5b4e-42e2-ac20-00b7b42e98bc", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>For some people, gout attacks may\nflare up when starting certain medicines that control uric acid levels. Not\neveryone gets flares, but you could get a flare-up even if you are taking Febuxostat\nMylan, and especially during the first weeks or months of treatment. It is\nimportant to keep taking Febuxostat Mylan even if you have a flare, as Febuxostat\nMylan is still working to lower uric acid. Over time, gout flares will occur\nless often and be less painful if you keep taking Febuxostat Mylan every day.</span>", "ID": "214b048d-4924-47f2-ac52-f418e0d49c64", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "For some people, gout attacks may flare up when starting certain medicines that control uric acid levels. Not everyone gets flares, but you could get a flare-up even if you are taking Febuxostat Mylan, and especially during the first weeks or months of treatment. It is important to keep taking Febuxostat Mylan even if you have a flare, as Febuxostat Mylan is still working to lower uric acid. Over time, gout flares will occur less often and be less painful if you keep taking Febuxostat Mylan every day.", "ParentId": "eb8122af-5b4e-42e2-ac20-00b7b42e98bc"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "a29892c4-8d8d-4c50-8160-e70771317d33", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "d9cab1de-411e-43c2-a9e4-6fb59c982200", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "a29892c4-8d8d-4c50-8160-e70771317d33"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Your doctor will often prescribe\nother medicines, if they are needed, to help prevent or treat the symptoms of flares\n(such as pain and swelling in a joint).</span></p>", "ID": "d64a8bbe-4c48-401b-ab0c-274686b4b556", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Your doctor will often prescribe\nother medicines, if they are needed, to help prevent or treat the symptoms of flares\n(such as pain and swelling in a joint).</span>", "ID": "df274b2f-5e65-4210-9868-fa9c2ddc186c", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Your doctor will often prescribe other medicines, if they are needed, to help prevent or treat the symptoms of flares (such as pain and swelling in a joint).", "ParentId": "d64a8bbe-4c48-401b-ab0c-274686b4b556"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "de392165-9e0c-430a-bc57-126b187c4a39", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "1748f3fe-47d4-4a9b-bcd8-dfc86807098c", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "de392165-9e0c-430a-bc57-126b187c4a39"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>In patients with very high urate\nlevels (e.g. those undergoing cancer chemotherapy), treatment with uric\nacid-lowering medicines could lead to the build-up of xanthine in the urinary\ntract, with possible stones, even though this has not been observed in patients\nbeing treated with febuxostat for Tumor Lysis Syndrome.</span></p>", "ID": "67c2d2ad-85dd-4d6a-a4eb-bb0ea5bb3fac", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>In patients with very high urate\nlevels (e.g. those undergoing cancer chemotherapy), treatment with uric\nacid-lowering medicines could lead to the build-up of xanthine in the urinary\ntract, with possible stones, even though this has not been observed in patients\nbeing treated with febuxostat for Tumor Lysis Syndrome.</span>", "ID": "d117c38b-3613-457d-98c5-b9dbcef29abd", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "In patients with very high urate levels (e.g. those undergoing cancer chemotherapy), treatment with uric acid-lowering medicines could lead to the build-up of xanthine in the urinary tract, with possible stones, even though this has not been observed in patients being treated with febuxostat for Tumor Lysis Syndrome.", "ParentId": "67c2d2ad-85dd-4d6a-a4eb-bb0ea5bb3fac"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "9e2f5f7a-fb28-48f4-8e31-ccc27fe15381", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "d57210e6-d740-46c3-81af-657a37771e47", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "9e2f5f7a-fb28-48f4-8e31-ccc27fe15381"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Your doctor may ask you to have\nblood tests to check that your liver is working normally.</span></p>", "ID": "747f9ad1-a2f3-4fb2-809e-346beeec445f", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Your doctor may ask you to have\nblood tests to check that your liver is working normally.</span>", "ID": "f8d79c1f-5c42-4b73-9101-5dbe8c669c58", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Your doctor may ask you to have blood tests to check that your liver is working normally.", "ParentId": "747f9ad1-a2f3-4fb2-809e-346beeec445f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "a6489a68-f5cc-4ee2-b680-9eed50d0e137", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "ef13e34f-04f9-4443-bc71-5628e588a25e", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "a6489a68-f5cc-4ee2-b680-9eed50d0e137"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Children and adolescents</span></b></p>", "ID": "75c85bf4-aaa9-4951-88a0-56900bc00f63", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Children and adolescents</span></b>", "ID": "11150cd0-cb48-4e41-b2a6-0201a3c8dd71", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "75c85bf4-aaa9-4951-88a0-56900bc00f63"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Children and adolescents</span>", "ID": "8884e095-e4c6-4afe-870f-d80c7468669f", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Children and adolescents", "ParentId": "11150cd0-cb48-4e41-b2a6-0201a3c8dd71"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "42fa261a-0372-4fe1-9f7d-383e5bb27c3b", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "fa0fe270-3b68-412b-8f72-0ae6c685b5ce", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "42fa261a-0372-4fe1-9f7d-383e5bb27c3b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Do not give this medicine to\nchildren under the age of 18 because the safety and efficacy have not been\nestablished.</span></p>", "ID": "befd20fc-f361-4272-916e-3eb60d309427", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Do not give this medicine to\nchildren under the age of 18 because the safety and efficacy have not been\nestablished.</span>", "ID": "73f2f847-0361-463c-9c6b-ff6e55f23b94", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Do not give this medicine to children under the age of 18 because the safety and efficacy have not been established.", "ParentId": "befd20fc-f361-4272-916e-3eb60d309427"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>", "ID": "3f756478-6384-4eed-8a22-277003a24874", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b>", "ID": "7c09c80d-4f4d-419a-b4db-2ceaa49e36c5", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "3f756478-6384-4eed-8a22-277003a24874"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "663645fe-46a7-4399-9043-207ad9d8449d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "7c09c80d-4f4d-419a-b4db-2ceaa49e36c5"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Other medicines and Febuxostat\nMylan</span></b></p>", "ID": "c0394634-dd42-4af5-ba00-237447710a56", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Other medicines and Febuxostat\nMylan</span></b>", "ID": "02c96f7e-55b9-47c8-b698-92684fcbd23a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c0394634-dd42-4af5-ba00-237447710a56"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Other medicines and Febuxostat\nMylan</span>", "ID": "56df0ee6-92da-4415-a280-207cc4e3e0cf", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Other medicines and Febuxostat Mylan", "ParentId": "02c96f7e-55b9-47c8-b698-92684fcbd23a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "0ffbfbfa-c23a-48d5-a445-92b7d963a145", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "c122294b-4c6f-4a63-b367-5aadb283ba24", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "0ffbfbfa-c23a-48d5-a445-92b7d963a145"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Tell your doctor or pharmacist if\nyou are taking, have recently taken or might take any other medicines,\nincluding medicines obtained without a prescription.</span></p>", "ID": "77bd3a56-39a8-4901-bdbf-f40e70ebdbca", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Tell your doctor or pharmacist if\nyou are taking, have recently taken or might take any other medicines,\nincluding medicines obtained without a prescription.</span>", "ID": "fd547170-46d7-4c27-9ce8-fd5a4d234696", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, including medicines obtained without a prescription.", "ParentId": "77bd3a56-39a8-4901-bdbf-f40e70ebdbca"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>It is especially important to tell\nyour doctor or pharmacist if you are taking medicines containing any of the\nfollowing substances as they may interact with Febuxostat Mylan and your doctor\nmay wish to consider necessary measures:</span></p>", "ID": "1b6d8fe6-7a63-4387-b30f-8fe3b30c3375", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>It is especially important to tell\nyour doctor or pharmacist if you are taking medicines containing any of the\nfollowing substances as they may interact with Febuxostat Mylan and your doctor\nmay wish to consider necessary measures:</span>", "ID": "e6bd2bcb-fbcc-46cc-98b9-0f2b8e7f877d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "It is especially important to tell your doctor or pharmacist if you are taking medicines containing any of the following substances as they may interact with Febuxostat Mylan and your doctor may wish to consider necessary measures:", "ParentId": "1b6d8fe6-7a63-4387-b30f-8fe3b30c3375"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Mercaptopurine\n(used to treat cancer)</span></p>", "ID": "ba05d500-df8f-4ea9-b5bd-a6c5ec52b77d", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "df221953-0f55-4e46-ae98-00b369a57b4b", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "ba05d500-df8f-4ea9-b5bd-a6c5ec52b77d"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "35963010-5fd4-4271-bbb1-707d1ebcbfd4", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "df221953-0f55-4e46-ae98-00b369a57b4b"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Mercaptopurine\n(used to treat cancer)</span>", "ID": "e487bfcf-c394-468f-8142-e6ce0a3e3614", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Mercaptopurine (used to treat cancer)", "ParentId": "ba05d500-df8f-4ea9-b5bd-a6c5ec52b77d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Azathioprine\n(used to reduce immune response)</span></p>", "ID": "18247621-c32f-4226-aab5-cc60efda9c3c", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "61194b72-2e05-4624-8cc3-33c89de304f4", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "18247621-c32f-4226-aab5-cc60efda9c3c"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "6d3a14a1-4528-426c-865a-bf800dc4924b", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "61194b72-2e05-4624-8cc3-33c89de304f4"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Azathioprine\n(used to reduce immune response)</span>", "ID": "6210d3bf-d8c4-4740-a614-405360e9dc0d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Azathioprine (used to reduce immune response)", "ParentId": "18247621-c32f-4226-aab5-cc60efda9c3c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Theophylline\n(used to treat asthma)</span></p>", "ID": "0ea8a980-b9f4-4ad3-809e-7098db8efaa6", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "0e09fe70-ae8c-44a7-b84f-e38070ebb689", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "0ea8a980-b9f4-4ad3-809e-7098db8efaa6"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "c9c2be9c-12e2-4ccf-a90e-35256c310f68", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "0e09fe70-ae8c-44a7-b84f-e38070ebb689"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Theophylline\n(used to treat asthma)</span>", "ID": "eab73aa4-86c9-4cdc-bef9-662a5a99b58c", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Theophylline (used to treat asthma)", "ParentId": "0ea8a980-b9f4-4ad3-809e-7098db8efaa6"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "a933fcf3-0af5-4e9f-b6d9-57cdc39f53a4", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "0c9277a4-55c2-44c9-bdb0-7a11fcde6b68", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "a933fcf3-0af5-4e9f-b6d9-57cdc39f53a4"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Pregnancy and\nbreast-feeding</span></b></p>", "ID": "396f4e19-044b-41d8-b49e-f553714a0f36", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Pregnancy and\nbreast-feeding</span></b>", "ID": "a7b63c9d-d7e3-4e9c-8597-8dd1c5031962", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "396f4e19-044b-41d8-b49e-f553714a0f36"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Pregnancy and\nbreast-feeding</span>", "ID": "1f92a5b9-99bc-4e1e-96b3-a463c6ac6766", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Pregnancy and breast-feeding", "ParentId": "a7b63c9d-d7e3-4e9c-8597-8dd1c5031962"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "95c5dfec-963c-4895-a3ad-1773a031104b", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "9f62fe41-e5dd-4bb6-9d74-084646c55137", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "95c5dfec-963c-4895-a3ad-1773a031104b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>It is not known if febuxostat may\nharm your unborn child. Febuxostat Mylan should not be used during pregnancy.\nIt is not known if febuxostat may pass into human breast milk. You should not\nuse Febuxostat Mylan if you are breast-feeding, or if you are planning to\nbreast-feed.</span></p>", "ID": "8eed509d-d6bb-4007-a94a-5c849153d6f7", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>It is not known if febuxostat may\nharm your unborn child. Febuxostat Mylan should not be used during pregnancy.\nIt is not known if febuxostat may pass into human breast milk. You should not\nuse Febuxostat Mylan if you are breast-feeding, or if you are planning to\nbreast-feed.</span>", "ID": "76841c46-d9ed-4c50-ad2b-4f53c4ec5668", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "It is not known if febuxostat may harm your unborn child. Febuxostat Mylan should not be used during pregnancy. It is not known if febuxostat may pass into human breast milk. You should not use Febuxostat Mylan if you are breast-feeding, or if you are planning to breast-feed.", "ParentId": "8eed509d-d6bb-4007-a94a-5c849153d6f7"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "c45b98f9-37ac-473b-8b9d-b4ea4759ae25", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "b882a6f4-cd71-46b1-932c-c0084670fb48", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "c45b98f9-37ac-473b-8b9d-b4ea4759ae25"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If you are pregnant or\nbreast-feeding, think you may be pregnant or are planning to have a baby, ask\nyour doctor or pharmacist for advice before taking this medicine.</span></p>", "ID": "17bf4a73-41cd-406c-bfe5-f3f0f7c1e185", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If you are pregnant or\nbreast-feeding, think you may be pregnant or are planning to have a baby, ask\nyour doctor or pharmacist for advice before taking this medicine.</span>", "ID": "8f4bf28a-1bd4-4bcb-8d20-b350ef9503c1", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.", "ParentId": "17bf4a73-41cd-406c-bfe5-f3f0f7c1e185"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "d67935b3-b2c6-4044-a938-24b8acbf8a39", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "99c69a74-80f4-40bb-8e51-267e23eca13a", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "d67935b3-b2c6-4044-a938-24b8acbf8a39"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Driving and using\nmachines</span></b></p>", "ID": "4e5c70bc-9195-45ae-9c44-acbc036bcf0a", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Driving and using\nmachines</span></b>", "ID": "e0d82125-4c80-415c-ad1d-22274fd87bc5", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4e5c70bc-9195-45ae-9c44-acbc036bcf0a"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Driving and using\nmachines</span>", "ID": "d22b8352-9a01-43ac-baf3-0a7e7909ab2e", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Driving and using machines", "ParentId": "e0d82125-4c80-415c-ad1d-22274fd87bc5"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "6eca7cb7-e46b-4346-a9d1-7a9f608359bc", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "eb301615-0ac4-47af-b115-2107dc010f6f", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "6eca7cb7-e46b-4346-a9d1-7a9f608359bc"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Be aware that you may experience\ndizziness, sleepiness, blurred vision and numbness or tingling sensation during\ntreatment and should not drive or operate machines if affected.</span></p>", "ID": "f472af53-8d2f-47fe-8da6-7cead342430a", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Be aware that you may experience\ndizziness, sleepiness, blurred vision and numbness or tingling sensation during\ntreatment and should not drive or operate machines if affected.</span>", "ID": "fb2139b2-9223-4514-9706-29c466986d7a", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Be aware that you may experience dizziness, sleepiness, blurred vision and numbness or tingling sensation during treatment and should not drive or operate machines if affected.", "ParentId": "f472af53-8d2f-47fe-8da6-7cead342430a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "f2581290-de7f-41f7-a780-fbddaa2a30ff", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "d7316d59-9cd9-4a3e-b546-7432513d6bee", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "f2581290-de7f-41f7-a780-fbddaa2a30ff"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat Mylan\ncontains lactose</span></b></p>", "ID": "c887f59b-9aef-4065-ba5c-3081c0ddaa54", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat Mylan\ncontains lactose</span></b>", "ID": "d6f99ace-fc68-4dce-8d91-c04e4ad3e8b4", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c887f59b-9aef-4065-ba5c-3081c0ddaa54"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat Mylan\ncontains lactose</span>", "ID": "eca3cb7b-00d4-4567-9186-5e0048934935", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Febuxostat Mylan contains lactose", "ParentId": "d6f99ace-fc68-4dce-8d91-c04e4ad3e8b4"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "45004723-f229-4c33-8d04-7d49df968071", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "123f4799-5bbd-4334-adea-2b09006c40b9", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "45004723-f229-4c33-8d04-7d49df968071"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat Mylan tablets contain\nlactose (a type of sugar). If you have been told that you have an intolerance\nto some sugars contact your doctor before taking this medicine.</span></p>", "ID": "86c1235a-6573-4d55-96fd-11844893aaa0", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat Mylan tablets contain\nlactose (a type of sugar). If you have been told that you have an intolerance\nto some sugars contact your doctor before taking this medicine.</span>", "ID": "8a68329c-fac7-4c33-992e-acbe6e572ad0", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Febuxostat Mylan tablets contain lactose (a type of sugar). If you have been told that you have an intolerance to some sugars contact your doctor before taking this medicine.", "ParentId": "86c1235a-6573-4d55-96fd-11844893aaa0"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "927ea641-f5bd-4b5a-ac75-f852dd69e421", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "c001e749-77b0-4bc3-88fb-40c195c5f7e6", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "927ea641-f5bd-4b5a-ac75-f852dd69e421"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "8386724d-19c7-4c48-8d1b-7bc3c9e546ba", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "c95790f6-34d4-4e57-abc2-9f612979e6e9", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "8386724d-19c7-4c48-8d1b-7bc3c9e546ba"}, {"Element": "<h1 style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 How to take Febuxostat\nMylan</span></h1>", "ID": "7f06f406-9d12-4497-b484-a8ef10c56125", "Styles": "margin-right:2.75pt", "Classes": "None", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 How to take Febuxostat\nMylan</span>", "ID": "4e667b6f-d9dd-4d83-8037-9d7118b74b67", "Styles": "None", "Classes": "None", "Text": "3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 How to take Febuxostat Mylan", "ParentId": "7f06f406-9d12-4497-b484-a8ef10c56125"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "b87e91cd-59c5-41e3-8897-41a871a23af1", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "b6543b36-2ed7-4f2c-a596-5bd845ab5f7c", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "b87e91cd-59c5-41e3-8897-41a871a23af1"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Always take this medicine exactly\nas your doctor has told you. Check with your doctor or pharmacist if you are\nnot sure.</span></p>", "ID": "6dd2464a-7e9d-4768-9178-ce88e1fe5d2b", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Always take this medicine exactly\nas your doctor has told you. Check with your doctor or pharmacist if you are\nnot sure.</span>", "ID": "6c27a1cd-3488-492e-adeb-44cf68c8369f", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.", "ParentId": "6dd2464a-7e9d-4768-9178-ce88e1fe5d2b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "75d394c2-5dcb-4b16-ba1b-c2f76f40c6d3", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "d0332ccd-e187-4221-81e9-2c2cabca2096", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "75d394c2-5dcb-4b16-ba1b-c2f76f40c6d3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The\nusual dose is one tablet daily. The back of the calendar blister pack is marked\nwith the days of the week to help you check that you have taken a dose each\nday.</span></p>", "ID": "7e0ce3e2-94ff-429a-9b58-d3524cddfbf5", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "cd5b4804-a590-41fa-9f72-802b4640da1a", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "7e0ce3e2-94ff-429a-9b58-d3524cddfbf5"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "31982d56-4db1-401c-b438-270bf4d7e88a", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "cd5b4804-a590-41fa-9f72-802b4640da1a"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The\nusual dose is one tablet daily. The back of the calendar blister pack is marked\nwith the days of the week to help you check that you have taken a dose each\nday.</span>", "ID": "9380cbf2-78f0-4843-82e8-eac083fef6a7", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "The usual dose is one tablet daily. The back of the calendar blister pack is marked with the days of the week to help you check that you have taken a dose each day.", "ParentId": "7e0ce3e2-94ff-429a-9b58-d3524cddfbf5"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The\ntablets should be taken by mouth and can be taken with or without food.</span></p>", "ID": "f745f0e9-e897-4c42-a85e-da59ba647547", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "11a33c2a-8c32-494d-9246-5f2bb32b7a37", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "f745f0e9-e897-4c42-a85e-da59ba647547"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "91e15e5f-95ac-4b15-8d57-92a5d90eeaa4", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "11a33c2a-8c32-494d-9246-5f2bb32b7a37"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The\ntablets should be taken by mouth and can be taken with or without food.</span>", "ID": "5bf2107b-dacf-4f5a-a4af-f5de6df17a13", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "The tablets should be taken by mouth and can be taken with or without food.", "ParentId": "f745f0e9-e897-4c42-a85e-da59ba647547"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "90a788c8-0db7-410d-8710-629327d849d1", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "350830ed-b92b-4dc4-941c-bf03a8ac6383", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "90a788c8-0db7-410d-8710-629327d849d1"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Gout</span></i></p>", "ID": "15fc0d3c-7724-406d-baf5-4bd7a4a88731", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Gout</span></i>", "ID": "fa5c7a30-991d-40da-85f8-004cbceaff6d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "15fc0d3c-7724-406d-baf5-4bd7a4a88731"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Gout</span>", "ID": "84cc2986-3f9c-43b8-b512-06a9eaa359f7", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Gout", "ParentId": "fa5c7a30-991d-40da-85f8-004cbceaff6d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat Mylan is available as\neither an 80</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>mg tablet or a 120\u00a0mg\ntablet. Your doctor will have prescribed the strength most suitable for you.</span></p>", "ID": "2ca2bd80-731e-4843-9aff-25e29f953a1d", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat Mylan is available as\neither an 80</span>", "ID": "4b1e3099-c52c-405c-8ee0-b0b1bfa13c00", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Febuxostat Mylan is available as either an 80", "ParentId": "2ca2bd80-731e-4843-9aff-25e29f953a1d"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "3461c43f-5985-4c1e-8d4e-7787c7c0f2ff", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "2ca2bd80-731e-4843-9aff-25e29f953a1d"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>mg tablet or a 120\u00a0mg\ntablet. Your doctor will have prescribed the strength most suitable for you.</span>", "ID": "deb2e7a3-40a3-423b-9b0b-690f83d472a3", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "mg tablet or a 120\u00a0mg tablet. Your doctor will have prescribed the strength most suitable for you.", "ParentId": "2ca2bd80-731e-4843-9aff-25e29f953a1d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "637f2ff5-3264-426d-9c11-53f838075623", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "c6cd03c1-6ef8-481a-ac7a-3352dc604d34", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "637f2ff5-3264-426d-9c11-53f838075623"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Continue to take Febuxostat Mylan\nevery day even when you are not experiencing gout flare or attack.</span></p>", "ID": "cb01aadf-d9d0-4cd5-8841-27fde4949a14", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Continue to take Febuxostat Mylan\nevery day even when you are not experiencing gout flare or attack.</span>", "ID": "3e0bb520-4d00-40a8-ae18-09215e5df54f", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Continue to take Febuxostat Mylan every day even when you are not experiencing gout flare or attack.", "ParentId": "cb01aadf-d9d0-4cd5-8841-27fde4949a14"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "c7667122-893b-4be9-bbc7-0a906e674838", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "6ab32c27-6738-42e9-9604-49354954c1d9", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "c7667122-893b-4be9-bbc7-0a906e674838"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Prevention and treatment\nof high uric acid levels in patients undergoing cancer chemotherapy</span></i></p>", "ID": "e20eec3a-bc53-4e16-9a42-2236fdeaebfa", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Prevention and treatment\nof high uric acid levels in patients undergoing cancer chemotherapy</span></i>", "ID": "f0b5ea2b-4171-4b0c-94c4-c68504daffd0", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e20eec3a-bc53-4e16-9a42-2236fdeaebfa"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Prevention and treatment\nof high uric acid levels in patients undergoing cancer chemotherapy</span>", "ID": "6a1a5db3-0588-4aad-828d-7a0366820305", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Prevention and treatment of high uric acid levels in patients undergoing cancer chemotherapy", "ParentId": "f0b5ea2b-4171-4b0c-94c4-c68504daffd0"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat Mylan is available as a\n120\u00a0mg tablet.</span></p>", "ID": "884d786c-5251-456a-a445-798a1c29f0b1", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat Mylan is available as a\n120\u00a0mg tablet.</span>", "ID": "76936eb6-a86e-447d-a7c3-acc896127a05", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Febuxostat Mylan is available as a 120\u00a0mg tablet.", "ParentId": "884d786c-5251-456a-a445-798a1c29f0b1"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Start taking Febuxostat Mylan two\ndays before chemotherapy and continue its use according to your doctor\u2019s\nadvice. Usually treatment is short-term.</span></p>", "ID": "58556c5e-1298-439e-adf9-f9367e5d3f3e", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Start taking Febuxostat Mylan two\ndays before chemotherapy and continue its use according to your doctor\u2019s\nadvice. Usually treatment is short-term.</span>", "ID": "a653969b-d092-4d29-9001-f1eea312e36b", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Start taking Febuxostat Mylan two days before chemotherapy and continue its use according to your doctor\u2019s advice. Usually treatment is short-term.", "ParentId": "58556c5e-1298-439e-adf9-f9367e5d3f3e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "253c004a-919d-473c-861a-9d84a5c21f7a", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "f0deb678-1841-4897-8999-7b021ff1b9f1", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "253c004a-919d-473c-861a-9d84a5c21f7a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.85pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If you\ntake more Febuxostat Mylan than you should</span></b></p>", "ID": "f24fbc94-11ad-4b49-8650-43b0fa697851", "Styles": "margin-top:0in;margin-right:2.85pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If you\ntake more Febuxostat Mylan than you should</span></b>", "ID": "6a8cb83f-ae3c-401d-b1b5-f9eabae51bfc", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f24fbc94-11ad-4b49-8650-43b0fa697851"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If you\ntake more Febuxostat Mylan than you should</span>", "ID": "2b8f63d1-5580-4e3d-a511-1cfc55d3cb33", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "If you take more Febuxostat Mylan than you should", "ParentId": "6a8cb83f-ae3c-401d-b1b5-f9eabae51bfc"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.85pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "1e9a94b4-1399-42f4-8e4a-b88e9bf8eba6", "Styles": "margin-top:0in;margin-right:2.85pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "7d762d00-0e6f-457f-b3b2-8e59b8673e16", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "1e9a94b4-1399-42f4-8e4a-b88e9bf8eba6"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.85pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>In the event\nof an accidental overdose ask your doctor what to do, or contact your nearest\naccident and emergency department.</span></p>", "ID": "5244c883-410d-4cbe-9d81-469eb32eced6", "Styles": "margin-top:0in;margin-right:2.85pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>In the event\nof an accidental overdose ask your doctor what to do, or contact your nearest\naccident and emergency department.</span>", "ID": "11a0748a-778c-4696-9be6-93c3eaf1d352", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "In the event of an accidental overdose ask your doctor what to do, or contact your nearest accident and emergency department.", "ParentId": "5244c883-410d-4cbe-9d81-469eb32eced6"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>", "ID": "afa02468-9915-4d12-91b1-c7dbe908600a", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b>", "ID": "873516c8-3f56-42bc-9e16-b4094ab59574", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "afa02468-9915-4d12-91b1-c7dbe908600a"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "ef80c627-2d57-466a-8a50-1e4e3806b0a7", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "873516c8-3f56-42bc-9e16-b4094ab59574"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If you forget to take Febuxostat\nMylan</span></b></p>", "ID": "da8100f5-028e-4011-90af-19447bdfc4f0", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If you forget to take Febuxostat\nMylan</span></b>", "ID": "0f827083-9061-4231-8546-51fbb2e4f8d1", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "da8100f5-028e-4011-90af-19447bdfc4f0"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If you forget to take Febuxostat\nMylan</span>", "ID": "84b7e909-2447-44cc-a79b-622dd87aaf00", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "If you forget to take Febuxostat Mylan", "ParentId": "0f827083-9061-4231-8546-51fbb2e4f8d1"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "cfe3d420-b689-47ed-9ad1-98f1ed105fd3", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "acfdaa3c-0158-4458-9b54-3f148d70fb64", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "cfe3d420-b689-47ed-9ad1-98f1ed105fd3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;text-align:justify;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If you miss a dose of Febuxostat\nMylan take it as soon as you remember unless it is almost time for your next\ndose, in which case miss out the forgotten dose and take your next dose at the\nnormal time. Do not take a double dose to make up for a forgotten dose.</span></p>", "ID": "e19bae86-5ead-4808-9678-85f2bbd92f78", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;text-align:justify;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If you miss a dose of Febuxostat\nMylan take it as soon as you remember unless it is almost time for your next\ndose, in which case miss out the forgotten dose and take your next dose at the\nnormal time. Do not take a double dose to make up for a forgotten dose.</span>", "ID": "99bcb5c5-5e94-4510-bdf8-71ac0fe904fe", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "If you miss a dose of Febuxostat Mylan take it as soon as you remember unless it is almost time for your next dose, in which case miss out the forgotten dose and take your next dose at the normal time. Do not take a double dose to make up for a forgotten dose.", "ParentId": "e19bae86-5ead-4808-9678-85f2bbd92f78"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "cde32240-a30c-450e-bd9d-c8173ed16cdd", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "d5c98c02-ee93-4fe3-84e7-8c86804da5dd", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "cde32240-a30c-450e-bd9d-c8173ed16cdd"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If you stop taking Febuxostat\nMylan</span></b></p>", "ID": "71807176-3100-407e-82e5-64b71a263f6e", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If you stop taking Febuxostat\nMylan</span></b>", "ID": "84510f87-a696-472a-b214-64b443108e58", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "71807176-3100-407e-82e5-64b71a263f6e"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If you stop taking Febuxostat\nMylan</span>", "ID": "7c8162df-941f-43a2-ad23-5ce2eea7d0ed", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "If you stop taking Febuxostat Mylan", "ParentId": "84510f87-a696-472a-b214-64b443108e58"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "6e75c9e8-a2e2-4e9f-a267-21d9eb9441c7", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "495462b8-ee76-4bb3-b5c4-3b96b9eafdc9", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "6e75c9e8-a2e2-4e9f-a267-21d9eb9441c7"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Do not stop taking Febuxostat Mylan\nwithout the advice of your doctor even if you feel better. If you stop taking Febuxostat\nMylan your uric acid levels may begin to rise and your symptoms may worsen due\nto the formation of new crystals of urate in and around your joints and\nkidneys.</span></p>", "ID": "8053158b-61e1-4305-92d3-ce80c04b8e7c", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Do not stop taking Febuxostat Mylan\nwithout the advice of your doctor even if you feel better. If you stop taking Febuxostat\nMylan your uric acid levels may begin to rise and your symptoms may worsen due\nto the formation of new crystals of urate in and around your joints and\nkidneys.</span>", "ID": "1741f9e8-2d33-4a7f-af23-55e01392a956", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Do not stop taking Febuxostat Mylan without the advice of your doctor even if you feel better. If you stop taking Febuxostat Mylan your uric acid levels may begin to rise and your symptoms may worsen due to the formation of new crystals of urate in and around your joints and kidneys.", "ParentId": "8053158b-61e1-4305-92d3-ce80c04b8e7c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "0a5e5411-0132-483f-88d8-9064de1e0278", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "a15d22a8-9210-4d7f-bb4b-89afe224253a", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "0a5e5411-0132-483f-88d8-9064de1e0278"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If you have any further questions\non the use of this medicine, ask your doctor or pharmacist.</span></p>", "ID": "574b57e3-048d-4390-bc68-7cde710614e4", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If you have any further questions\non the use of this medicine, ask your doctor or pharmacist.</span>", "ID": "5e0da40a-1c90-4aed-8d31-cfb736b65166", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "If you have any further questions on the use of this medicine, ask your doctor or pharmacist.", "ParentId": "574b57e3-048d-4390-bc68-7cde710614e4"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "c09b7a73-9da5-41b5-bbb9-09db7a8f3e12", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "e9cf11c7-56f1-429d-b8df-60778ebcde66", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "c09b7a73-9da5-41b5-bbb9-09db7a8f3e12"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "b6c2fafa-3e36-4c20-b469-fba3fd148574", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "73f49519-afb7-4044-a932-ce73dd75c5f7", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "b6c2fafa-3e36-4c20-b469-fba3fd148574"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Possible side\neffects</span></b></p>", "ID": "4f1a7a0b-fdf2-426a-96a3-4817a43e61c6", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Possible side\neffects</span></b>", "ID": "a1751794-5bfc-488f-8c38-f50954ae124a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4f1a7a0b-fdf2-426a-96a3-4817a43e61c6"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Possible side\neffects</span>", "ID": "300eef2e-b1d6-43f1-8175-3586e51fffe7", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Possible side effects", "ParentId": "a1751794-5bfc-488f-8c38-f50954ae124a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "a2d60d4b-df49-4bf3-93f6-d781972a4a43", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "e6ddaf0c-5ba9-43f7-b5af-0b615a47e6ee", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "a2d60d4b-df49-4bf3-93f6-d781972a4a43"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Like all medicines, this medicine\ncan cause side effects, although not everybody gets them.</span></p>", "ID": "03389c81-cf7f-4592-a9e8-97cbaffad9c1", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Like all medicines, this medicine\ncan cause side effects, although not everybody gets them.</span>", "ID": "dee50e04-bde8-45e4-b4f4-5cec56302473", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Like all medicines, this medicine can cause side effects, although not everybody gets them.", "ParentId": "03389c81-cf7f-4592-a9e8-97cbaffad9c1"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "04cbbebe-2896-4604-8711-19b484d3db73", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "095c9218-c66c-4444-9413-650912bab7c1", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "04cbbebe-2896-4604-8711-19b484d3db73"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Stop taking this medicine and\ncontact your doctor immediately or go to an emergency department nearby if the\nfollowing rare (may affect up to 1 in 1,000 people) side effects occur, because\na serious allergic reaction might follow:</span></p>", "ID": "14999163-1fe9-4457-b965-579d69c987b2", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Stop taking this medicine and\ncontact your doctor immediately or go to an emergency department nearby if the\nfollowing rare (may affect up to 1 in 1,000 people) side effects occur, because\na serious allergic reaction might follow:</span>", "ID": "5002e68d-8b64-4dd9-a659-d2503f72eaed", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Stop taking this medicine and contact your doctor immediately or go to an emergency department nearby if the following rare (may affect up to 1 in 1,000 people) side effects occur, because a serious allergic reaction might follow:", "ParentId": "14999163-1fe9-4457-b965-579d69c987b2"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>anaphylactic\nreactions, drug hypersensitivity (see also section 2 \u201cWarnings and\nprecautions\u201d)</span></p>", "ID": "e496e441-fbe7-48d1-a1f2-c0e836cb6dc7", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "cd836f06-9632-4d77-bed3-5c3b25acf650", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "e496e441-fbe7-48d1-a1f2-c0e836cb6dc7"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "c19ada4a-b1c9-4d5d-bf17-72455cdd81d3", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "cd836f06-9632-4d77-bed3-5c3b25acf650"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>anaphylactic\nreactions, drug hypersensitivity (see also section 2 \u201cWarnings and\nprecautions\u201d)</span>", "ID": "1a87703c-a3af-4031-baf8-1990921ccb5a", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "anaphylactic reactions, drug hypersensitivity (see also section 2 \u201cWarnings and precautions\u201d)", "ParentId": "e496e441-fbe7-48d1-a1f2-c0e836cb6dc7"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>potentially\nlife-threatening skin rashes characterised by formation of blisters and\nshedding of the skin and inner surfaces of body cavities, e.g. mouth and\ngenitals, painful ulcers in the mouth and/or genital areas, accompanied by\nfever, sore throat and fatigue (Stevens- Johnson Syndrome/ Toxic Epidermal\nNecrolysis), or by enlarged lymph nodes, liver enlargement, hepatitis (up to\nliver failure), raising of the white-cells count in the blood (drug reaction\nwith eosinophilia and systemic symptoms-DRESS) (see section 2)</span></p>", "ID": "ecbc905a-6c40-47fa-aef3-4e9a47580e07", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "a9f71613-aea5-46c7-8d41-6239cc8d3eb3", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "ecbc905a-6c40-47fa-aef3-4e9a47580e07"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "ba7c7853-d52a-4184-aa36-32a7ca18047b", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "a9f71613-aea5-46c7-8d41-6239cc8d3eb3"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>potentially\nlife-threatening skin rashes characterised by formation of blisters and\nshedding of the skin and inner surfaces of body cavities, e.g. mouth and\ngenitals, painful ulcers in the mouth and/or genital areas, accompanied by\nfever, sore throat and fatigue (Stevens- Johnson Syndrome/ Toxic Epidermal\nNecrolysis), or by enlarged lymph nodes, liver enlargement, hepatitis (up to\nliver failure), raising of the white-cells count in the blood (drug reaction\nwith eosinophilia and systemic symptoms-DRESS) (see section 2)</span>", "ID": "61632807-cada-47e6-8acf-268315c7e57e", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "potentially life-threatening skin rashes characterised by formation of blisters and shedding of the skin and inner surfaces of body cavities, e.g. mouth and genitals, painful ulcers in the mouth and/or genital areas, accompanied by fever, sore throat and fatigue (Stevens- Johnson Syndrome/ Toxic Epidermal Necrolysis), or by enlarged lymph nodes, liver enlargement, hepatitis (up to liver failure), raising of the white-cells count in the blood (drug reaction with eosinophilia and systemic symptoms-DRESS) (see section 2)", "ParentId": "ecbc905a-6c40-47fa-aef3-4e9a47580e07"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>generalised\nskin rashes</span></p>", "ID": "372910c2-c7cc-4bbb-943a-6c54c0d08014", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "17d0ce45-b161-41c3-a280-95fa8ae46d91", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "372910c2-c7cc-4bbb-943a-6c54c0d08014"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "78e724e5-6db4-487f-a52f-201b6266eadc", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "17d0ce45-b161-41c3-a280-95fa8ae46d91"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>generalised\nskin rashes</span>", "ID": "cf2ccbfb-3645-4e6b-830f-bb2e9cccd0c4", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "generalised skin rashes", "ParentId": "372910c2-c7cc-4bbb-943a-6c54c0d08014"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "c16a0e5d-2bb3-4593-8ff1-83d67697b5c1", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "bad24bd2-5961-4f91-b28c-9d9e2226208e", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "c16a0e5d-2bb3-4593-8ff1-83d67697b5c1"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Other side effects which are not\nmentioned above are listed below.</span></p>", "ID": "976a9d0e-8d00-4e33-9892-04ea4a3a95b6", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Other side effects which are not\nmentioned above are listed below.</span>", "ID": "7017eaae-922c-45b0-b297-2a643e3dab85", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Other side effects which are not mentioned above are listed below.", "ParentId": "976a9d0e-8d00-4e33-9892-04ea4a3a95b6"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "86dac173-2815-4c19-8842-363b1bd63725", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "1e98793a-ca32-40af-b3dc-5b5a10bb8219", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "86dac173-2815-4c19-8842-363b1bd63725"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common side effects </span></b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(may affect up to 1 in\n10 people) are:</span></p>", "ID": "1b46f831-ca4d-4d31-89d8-6e77cd335276", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common side effects </span></b>", "ID": "7e24c8cc-42f9-4290-88cf-77037d5d69bd", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "1b46f831-ca4d-4d31-89d8-6e77cd335276"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common side effects </span>", "ID": "5a3102ce-f3b0-4688-bd4d-8882162f41f6", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Common side effects ", "ParentId": "7e24c8cc-42f9-4290-88cf-77037d5d69bd"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(may affect up to 1 in\n10 people) are:</span>", "ID": "412ccba5-ac10-4e89-ad68-23303be1adfd", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "(may affect up to 1 in 10 people) are:", "ParentId": "1b46f831-ca4d-4d31-89d8-6e77cd335276"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>abnormal\nliver test results</span></p>", "ID": "6ffd04dc-e9dd-4865-b0cc-b0594ed9f9fd", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "536baf07-fbf2-47bf-a609-d4f6d2b63785", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "6ffd04dc-e9dd-4865-b0cc-b0594ed9f9fd"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "9d8f3342-6018-4556-87d9-fdb31a76a9b1", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "536baf07-fbf2-47bf-a609-d4f6d2b63785"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>abnormal\nliver test results</span>", "ID": "6c94bd85-c2cb-4321-afe6-5fbc14145925", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "abnormal liver test results", "ParentId": "6ffd04dc-e9dd-4865-b0cc-b0594ed9f9fd"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>diarrhoea</span></p>", "ID": "504d0d91-b99e-4eda-bb85-66b0de53cfd7", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "b83bd5ec-5289-48bf-b4fd-e3ad61b32a5c", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "504d0d91-b99e-4eda-bb85-66b0de53cfd7"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "19b8bacc-9925-45bb-9230-502c6a5e8d47", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "b83bd5ec-5289-48bf-b4fd-e3ad61b32a5c"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>diarrhoea</span>", "ID": "70622794-ab43-48c4-b9da-a7173758cee3", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "diarrhoea", "ParentId": "504d0d91-b99e-4eda-bb85-66b0de53cfd7"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>headache</span></p>", "ID": "886332dd-a221-4096-ba38-75d0114f8146", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "2650a89d-8546-4a7b-80c4-2d18feaf0d8f", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "886332dd-a221-4096-ba38-75d0114f8146"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "b440005a-fbc3-4e80-9e4c-b031d40a62d6", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "2650a89d-8546-4a7b-80c4-2d18feaf0d8f"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>headache</span>", "ID": "74f31dae-ef38-4ff0-8c7d-57e5c93d2a2a", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "headache", "ParentId": "886332dd-a221-4096-ba38-75d0114f8146"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>rash\n(including various types of rash, please see below under \u201cuncommon\u201d and \u201crare\u201d\nsections)</span></p>", "ID": "52ae90a7-4636-44c9-858a-bd861ad39476", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "beca35ed-f680-4b57-a20d-aa70a191f524", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "52ae90a7-4636-44c9-858a-bd861ad39476"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "283bcf59-6675-4c9a-b828-b22458e925fa", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "beca35ed-f680-4b57-a20d-aa70a191f524"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>rash\n(including various types of rash, please see below under \u201cuncommon\u201d and \u201crare\u201d\nsections)</span>", "ID": "817948d6-df37-40c8-a06d-820868ad0f0e", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "rash (including various types of rash, please see below under \u201cuncommon\u201d and \u201crare\u201d sections)", "ParentId": "52ae90a7-4636-44c9-858a-bd861ad39476"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>nausea</span></p>", "ID": "e288382c-e8ee-41bb-b47d-6db9cc72d7a4", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "1363c7e2-e278-4017-98d7-5523b797f6e7", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "e288382c-e8ee-41bb-b47d-6db9cc72d7a4"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "2864d074-dee0-4970-ae14-03753aa41aba", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "1363c7e2-e278-4017-98d7-5523b797f6e7"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>nausea</span>", "ID": "fadf81c5-7e09-47f4-8d52-de07e6409d56", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "nausea", "ParentId": "e288382c-e8ee-41bb-b47d-6db9cc72d7a4"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>increase\nin gout symptoms</span></p>", "ID": "56b11248-2445-4fd3-93f9-7e692fbbf180", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "02323b92-98c9-4fe5-8797-7c78a42ebdb6", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "56b11248-2445-4fd3-93f9-7e692fbbf180"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "1cf19a09-4e5d-4742-936e-972e38a66193", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "02323b92-98c9-4fe5-8797-7c78a42ebdb6"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>increase\nin gout symptoms</span>", "ID": "040728a0-74bc-499b-87f5-581e87d79360", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "increase in gout symptoms", "ParentId": "56b11248-2445-4fd3-93f9-7e692fbbf180"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>localised\nswelling due to retention of fluids in tissues (oedema)</span></p>", "ID": "a7436b07-a899-4207-937c-9cf99a99a9b2", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "3994214b-bfc5-4016-b436-17c134ad40d6", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "a7436b07-a899-4207-937c-9cf99a99a9b2"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "450d8b7a-1457-465b-87b9-040e170df966", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "3994214b-bfc5-4016-b436-17c134ad40d6"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>localised\nswelling due to retention of fluids in tissues (oedema)</span>", "ID": "999e2ce7-2707-4789-b50c-3490a42e3892", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "localised swelling due to retention of fluids in tissues (oedema)", "ParentId": "a7436b07-a899-4207-937c-9cf99a99a9b2"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "9e2853c4-ee72-473c-abd0-63510a60829b", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "2d046695-ac5b-421c-ad9b-ba5b41f09637", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "9e2853c4-ee72-473c-abd0-63510a60829b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon side effects </span></b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(may affect up to 1 in\n100 people) are:</span></p>", "ID": "0b75ad4a-023e-4f7a-8c73-55bbbfed81bb", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon side effects </span></b>", "ID": "b6316b5f-08c2-4b93-bd73-2006d78e60d6", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0b75ad4a-023e-4f7a-8c73-55bbbfed81bb"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon side effects </span>", "ID": "7aab1f5b-63f1-428f-a872-1fae515d4eac", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Uncommon side effects ", "ParentId": "b6316b5f-08c2-4b93-bd73-2006d78e60d6"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(may affect up to 1 in\n100 people) are:</span>", "ID": "a08b270a-be28-4d54-8db9-1b31dcc28759", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "(may affect up to 1 in 100 people) are:", "ParentId": "0b75ad4a-023e-4f7a-8c73-55bbbfed81bb"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>decreased\nappetite, change in blood sugar levels (diabetes) of which a symptom may be excessive\nthirst, increased blood fat levels, weight increase</span></p>", "ID": "8d6ce2bb-9b33-4e74-b357-1745d7b4d2c4", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "10425576-f395-4e73-9726-e4c600f2197e", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "8d6ce2bb-9b33-4e74-b357-1745d7b4d2c4"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "282cf47a-6850-4a45-90b7-1ec7c2cb515c", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "10425576-f395-4e73-9726-e4c600f2197e"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>decreased\nappetite, change in blood sugar levels (diabetes) of which a symptom may be excessive\nthirst, increased blood fat levels, weight increase</span>", "ID": "c1bd3b71-4161-4db3-abaa-4e0393fc9686", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "decreased appetite, change in blood sugar levels (diabetes) of which a symptom may be excessive thirst, increased blood fat levels, weight increase", "ParentId": "8d6ce2bb-9b33-4e74-b357-1745d7b4d2c4"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>loss\nof sex drive</span></p>", "ID": "cf46e3bb-27db-421d-8600-a57216b0c022", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "c98b69e1-7de4-4ebb-89f5-cdb7482c73d5", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "cf46e3bb-27db-421d-8600-a57216b0c022"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "a03aaaf6-292a-4189-b57c-f216566659a0", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "c98b69e1-7de4-4ebb-89f5-cdb7482c73d5"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>loss\nof sex drive</span>", "ID": "901314c4-3974-4c86-b976-9f08ff5c9448", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "loss of sex drive", "ParentId": "cf46e3bb-27db-421d-8600-a57216b0c022"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>difficulty\nin sleeping, sleepiness</span></p>", "ID": "cca26e35-6042-464f-b8d9-1e4746ae1a70", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "ca7d2f14-6db2-4fe7-92bf-514a9283e946", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "cca26e35-6042-464f-b8d9-1e4746ae1a70"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "2b4da282-dcc7-4622-87b2-ffb82e3334e8", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "ca7d2f14-6db2-4fe7-92bf-514a9283e946"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>difficulty\nin sleeping, sleepiness</span>", "ID": "551ed1e4-f6f2-4401-977e-a4bdc29806fa", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "difficulty in sleeping, sleepiness", "ParentId": "cca26e35-6042-464f-b8d9-1e4746ae1a70"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>dizziness,\nnumbness, tingling, reduced or altered sensation (hypoesthesia, hemiparesis or paraesthesia),\naltered sense of taste, diminished sense of smell (hyposmia)</span></p>", "ID": "6b0661d4-44f3-44ab-bbdf-0fb0234149da", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "365887eb-0b0a-4d64-8fd3-82a4891b16e4", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "6b0661d4-44f3-44ab-bbdf-0fb0234149da"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "f61d88a1-0d6e-4d1e-a527-2601fc9e8359", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "365887eb-0b0a-4d64-8fd3-82a4891b16e4"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>dizziness,\nnumbness, tingling, reduced or altered sensation (hypoesthesia, hemiparesis or paraesthesia),\naltered sense of taste, diminished sense of smell (hyposmia)</span>", "ID": "574a9401-bc50-4c6a-81ca-0b5352ac465b", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "dizziness, numbness, tingling, reduced or altered sensation (hypoesthesia, hemiparesis or paraesthesia), altered sense of taste, diminished sense of smell (hyposmia)", "ParentId": "6b0661d4-44f3-44ab-bbdf-0fb0234149da"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>abnormal\nECG heart tracing, irregular or rapid heartbeats, feeling your heart beat\n(palpitation)</span></p>", "ID": "242c0405-045a-41db-b132-b1ba088a5161", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "f25511ca-17fb-4571-af57-ccf3005be773", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "242c0405-045a-41db-b132-b1ba088a5161"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "a55f9ff5-541d-4871-a4ba-ef702074de1b", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "f25511ca-17fb-4571-af57-ccf3005be773"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>abnormal\nECG heart tracing, irregular or rapid heartbeats, feeling your heart beat\n(palpitation)</span>", "ID": "4efb44da-617f-49d8-9d21-d4a7dec1fcd5", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "abnormal ECG heart tracing, irregular or rapid heartbeats, feeling your heart beat (palpitation)", "ParentId": "242c0405-045a-41db-b132-b1ba088a5161"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>hot\nflushes or flushing (e.g. redness of the face or neck), increased blood\npressure, bleeding (haemorrhage, seen only in patients taking chemotherapy for\nblood disorders)</span></p>", "ID": "bb326597-c8c0-46d6-a757-b9da84be89cb", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "ecd27a83-a6b6-4307-93e0-900d267185f2", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "bb326597-c8c0-46d6-a757-b9da84be89cb"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "6849fa57-0725-4d7e-8d7c-8cd19b3e8107", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "ecd27a83-a6b6-4307-93e0-900d267185f2"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>hot\nflushes or flushing (e.g. redness of the face or neck), increased blood\npressure, bleeding (haemorrhage, seen only in patients taking chemotherapy for\nblood disorders)</span>", "ID": "91921380-715d-4367-b3d4-1dd17b9aeb19", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "hot flushes or flushing (e.g. redness of the face or neck), increased blood pressure, bleeding (haemorrhage, seen only in patients taking chemotherapy for blood disorders)", "ParentId": "bb326597-c8c0-46d6-a757-b9da84be89cb"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>cough,\nshortness of breath, chest discomfort or pain, inflammation of nasal passage\nand/or throat (upper respiratory tract infection), bronchitis</span></p>", "ID": "886e7fa0-1310-4b45-81e6-d0bebab1aeb6", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "1908bb3b-27fc-425f-af51-185049148cae", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "886e7fa0-1310-4b45-81e6-d0bebab1aeb6"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "f55ae21c-d7b2-4dfc-8f12-4b94dd1f2960", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "1908bb3b-27fc-425f-af51-185049148cae"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>cough,\nshortness of breath, chest discomfort or pain, inflammation of nasal passage\nand/or throat (upper respiratory tract infection), bronchitis</span>", "ID": "eb035c09-5bdc-414e-9154-2177160072ac", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "cough, shortness of breath, chest discomfort or pain, inflammation of nasal passage and/or throat (upper respiratory tract infection), bronchitis", "ParentId": "886e7fa0-1310-4b45-81e6-d0bebab1aeb6"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>dry\nmouth, abdominal pain/discomfort or wind, heartburn/indigestion, constipation,\nmore frequent passing of stools, vomiting, stomach discomfort</span></p>", "ID": "51343340-8977-4274-8a11-649a529fbafc", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "fdd3dd78-f836-49ca-b898-6d0dfc43d6bf", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "51343340-8977-4274-8a11-649a529fbafc"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "4bfa2325-0c5a-47d3-b240-7daf43362468", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "fdd3dd78-f836-49ca-b898-6d0dfc43d6bf"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>dry\nmouth, abdominal pain/discomfort or wind, heartburn/indigestion, constipation,\nmore frequent passing of stools, vomiting, stomach discomfort</span>", "ID": "da614d31-6f6d-4d56-a0bc-43772e9cada2", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "dry mouth, abdominal pain/discomfort or wind, heartburn/indigestion, constipation, more frequent passing of stools, vomiting, stomach discomfort", "ParentId": "51343340-8977-4274-8a11-649a529fbafc"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>itching,\nhives, skin inflammation, skin discoloration, small red or purple spots on the\nskin, small, flat red spots on the skin, flat, red area on the skin that is\ncovered with small confluent bumps, rash, areas of redness and spots on the\nskin, other type of skin conditions</span></p>", "ID": "693a6037-1bc4-4ed6-a147-827bae92f063", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "c814f09b-e670-4f97-b85e-bf237585f7c9", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "693a6037-1bc4-4ed6-a147-827bae92f063"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "b03c7841-1f27-4597-9586-47b8efe22431", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "c814f09b-e670-4f97-b85e-bf237585f7c9"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>itching,\nhives, skin inflammation, skin discoloration, small red or purple spots on the\nskin, small, flat red spots on the skin, flat, red area on the skin that is\ncovered with small confluent bumps, rash, areas of redness and spots on the\nskin, other type of skin conditions</span>", "ID": "fcecb462-716a-4fd4-9350-0a9359a64752", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "itching, hives, skin inflammation, skin discoloration, small red or purple spots on the skin, small, flat red spots on the skin, flat, red area on the skin that is covered with small confluent bumps, rash, areas of redness and spots on the skin, other type of skin conditions", "ParentId": "693a6037-1bc4-4ed6-a147-827bae92f063"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>muscle\ncramp, muscle weakness, pain/ache in muscles/joints, bursitis or arthritis\n(inflammation of joints usually accompanied by pain, swelling and/or stiffness),\npain in extremity, back pain, muscle spasm</span></p>", "ID": "bb45173e-0b74-43c3-88fd-4e7d771ec9f0", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "96f5099d-b748-4787-bcb1-5d2491380bdc", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "bb45173e-0b74-43c3-88fd-4e7d771ec9f0"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "f61a6aa8-bb79-4126-a91b-cb9ef9c11b66", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "96f5099d-b748-4787-bcb1-5d2491380bdc"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>muscle\ncramp, muscle weakness, pain/ache in muscles/joints, bursitis or arthritis\n(inflammation of joints usually accompanied by pain, swelling and/or stiffness),\npain in extremity, back pain, muscle spasm</span>", "ID": "275b902b-be65-4375-acc8-230292a581ca", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "muscle cramp, muscle weakness, pain/ache in muscles/joints, bursitis or arthritis (inflammation of joints usually accompanied by pain, swelling and/or stiffness), pain in extremity, back pain, muscle spasm", "ParentId": "bb45173e-0b74-43c3-88fd-4e7d771ec9f0"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>blood\nin the urine, abnormal frequent urination, abnormal urine tests (increased\nlevel of proteins in the urine), a reduction in the ability of the kidneys to\nfunction properly</span></p>", "ID": "aafc1d72-747b-40f9-b603-9d94515bfa02", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "b9a41103-5f31-417c-b853-48d48b19f730", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "aafc1d72-747b-40f9-b603-9d94515bfa02"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "a0de3f91-014d-41dc-960c-a038fed563e7", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "b9a41103-5f31-417c-b853-48d48b19f730"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>blood\nin the urine, abnormal frequent urination, abnormal urine tests (increased\nlevel of proteins in the urine), a reduction in the ability of the kidneys to\nfunction properly</span>", "ID": "afb0b99b-97de-4722-b8da-35f495a8b048", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "blood in the urine, abnormal frequent urination, abnormal urine tests (increased level of proteins in the urine), a reduction in the ability of the kidneys to function properly", "ParentId": "aafc1d72-747b-40f9-b603-9d94515bfa02"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>fatigue,\nchest pain, chest discomfort</span></p>", "ID": "5d1a6b9e-84b3-404e-a9e3-3720c864c18a", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "c5e9ce99-a86b-407c-8293-58d36658acf6", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "5d1a6b9e-84b3-404e-a9e3-3720c864c18a"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "e2e79a3e-e022-4f8a-b0a6-438a57ad8efc", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "c5e9ce99-a86b-407c-8293-58d36658acf6"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>fatigue,\nchest pain, chest discomfort</span>", "ID": "b813b6f7-d332-49e9-a2c9-7d108827fdb4", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "fatigue, chest pain, chest discomfort", "ParentId": "5d1a6b9e-84b3-404e-a9e3-3720c864c18a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>stones\nin the gallbladder or in bile ducts (cholelithiasis)</span></p>", "ID": "fb320510-e9d8-40ab-9ae3-b0149c3fabff", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "54dca7cf-f5df-4190-b6ee-6252bdc9516e", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "fb320510-e9d8-40ab-9ae3-b0149c3fabff"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "a58851dc-a564-4da1-991c-f91575f1f067", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "54dca7cf-f5df-4190-b6ee-6252bdc9516e"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>stones\nin the gallbladder or in bile ducts (cholelithiasis)</span>", "ID": "d6c172ae-019e-4daa-b1e8-1bc584780c45", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "stones in the gallbladder or in bile ducts (cholelithiasis)", "ParentId": "fb320510-e9d8-40ab-9ae3-b0149c3fabff"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>increase\nin blood thyroid stimulating hormone (TSH) level</span></p>", "ID": "0ea18902-cdcf-4eb6-ac04-b19c854eed6f", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "8172f7e0-0a56-4835-b2cd-06f76d8f99b3", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "0ea18902-cdcf-4eb6-ac04-b19c854eed6f"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "d76dd6df-0ba7-4025-a282-14cb4dbefcda", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "8172f7e0-0a56-4835-b2cd-06f76d8f99b3"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>increase\nin blood thyroid stimulating hormone (TSH) level</span>", "ID": "5b4a7d7f-4958-4593-87fe-ecdc58a3685d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "increase in blood thyroid stimulating hormone (TSH) level", "ParentId": "0ea18902-cdcf-4eb6-ac04-b19c854eed6f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>changes\nin blood chemistry or amount of blood cells or platelets (abnormal blood test\nresults)</span></p>", "ID": "34921e72-20b8-4211-b48b-7ac673cb8234", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "0ff5703a-727c-4b4e-ba6b-ed3cf8e6aa45", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "34921e72-20b8-4211-b48b-7ac673cb8234"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "c33dcada-4556-4725-8378-7262982311f5", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "0ff5703a-727c-4b4e-ba6b-ed3cf8e6aa45"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>changes\nin blood chemistry or amount of blood cells or platelets (abnormal blood test\nresults)</span>", "ID": "d8aa264a-5c2d-4e5c-83bb-2dc0bd3eb71d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "changes in blood chemistry or amount of blood cells or platelets (abnormal blood test results)", "ParentId": "34921e72-20b8-4211-b48b-7ac673cb8234"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>kidney\nstones</span></p>", "ID": "e396c004-b8fd-45f3-8d99-58bfd3ba71c8", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "fc43a1b1-0a4f-4433-9990-6ce93dc6f254", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "e396c004-b8fd-45f3-8d99-58bfd3ba71c8"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "9a94db94-2cd8-4c9b-aed4-2c06671a15b0", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "fc43a1b1-0a4f-4433-9990-6ce93dc6f254"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>kidney\nstones</span>", "ID": "8b683b55-7d0f-4a56-8394-9900e986f91b", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "kidney stones", "ParentId": "e396c004-b8fd-45f3-8d99-58bfd3ba71c8"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>erectile\ndifficulties</span></p>", "ID": "02c9171b-33e8-440e-b334-fce1a41ef765", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "b2999835-7cb0-49bc-85dd-d8ad0dc9fb08", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "02c9171b-33e8-440e-b334-fce1a41ef765"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "51d60f43-d4d9-4b86-99a2-a40131fe084d", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "b2999835-7cb0-49bc-85dd-d8ad0dc9fb08"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>erectile\ndifficulties</span>", "ID": "49d9cae6-523b-4810-a6e4-d9dfedca2829", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "erectile difficulties", "ParentId": "02c9171b-33e8-440e-b334-fce1a41ef765"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "83476774-6573-49b1-b357-b06668cd735a", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "1a0dc1c8-c798-47dd-b7bf-e9af4d7bb734", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "83476774-6573-49b1-b357-b06668cd735a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare side effects </span></b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(may affect up to 1 in\n1,000 people) are:</span></p>", "ID": "679d4f88-7387-494d-9ee9-98b70c19021c", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare side effects </span></b>", "ID": "1cd1c9a4-d875-4ce4-b522-c32b133bdc04", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "679d4f88-7387-494d-9ee9-98b70c19021c"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Rare side effects </span>", "ID": "ab8b38a0-b5ea-4c7b-beb6-7be4532b2ce3", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Rare side effects ", "ParentId": "1cd1c9a4-d875-4ce4-b522-c32b133bdc04"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(may affect up to 1 in\n1,000 people) are:</span>", "ID": "be776d15-ed37-4b9c-a608-21a96c77f1d5", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "(may affect up to 1 in 1,000 people) are:", "ParentId": "679d4f88-7387-494d-9ee9-98b70c19021c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>muscle\ndamage, a condition which on rare occasions can be serious. It may cause muscle\nproblems and particularly, if at the same time, you feel unwell or have a high\ntemperature it may be caused by an abnormal muscle breakdown. Contact your\ndoctor immediately if you experience muscle pain, tenderness or weakness</span></p>", "ID": "9410c099-2857-495b-bef1-629754de187b", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "a8c9ffdd-a5b1-4f03-80c2-4be712b737c4", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "9410c099-2857-495b-bef1-629754de187b"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "e446b1ae-d429-40f8-a98e-589cd27bafb1", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "a8c9ffdd-a5b1-4f03-80c2-4be712b737c4"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>muscle\ndamage, a condition which on rare occasions can be serious. It may cause muscle\nproblems and particularly, if at the same time, you feel unwell or have a high\ntemperature it may be caused by an abnormal muscle breakdown. Contact your\ndoctor immediately if you experience muscle pain, tenderness or weakness</span>", "ID": "9d9385bd-3768-4707-b5af-59ec3754a880", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "muscle damage, a condition which on rare occasions can be serious. It may cause muscle problems and particularly, if at the same time, you feel unwell or have a high temperature it may be caused by an abnormal muscle breakdown. Contact your doctor immediately if you experience muscle pain, tenderness or weakness", "ParentId": "9410c099-2857-495b-bef1-629754de187b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>severe\nswelling of the deeper layers of the skin, especially around the lips, eyes,\ngenitals, hands, feet or tongue, with possible sudden difficult breathing</span></p>", "ID": "2fc7f3f8-5ebf-4d84-ae23-be93a2c72d65", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "a0969297-edcd-44a4-8e29-fef7beca1ed6", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "2fc7f3f8-5ebf-4d84-ae23-be93a2c72d65"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "fe95847c-521b-4a28-89be-deac1b3122ae", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "a0969297-edcd-44a4-8e29-fef7beca1ed6"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>severe\nswelling of the deeper layers of the skin, especially around the lips, eyes,\ngenitals, hands, feet or tongue, with possible sudden difficult breathing</span>", "ID": "f31a9b4f-d2b6-463a-b293-2bb84620d868", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "severe swelling of the deeper layers of the skin, especially around the lips, eyes, genitals, hands, feet or tongue, with possible sudden difficult breathing", "ParentId": "2fc7f3f8-5ebf-4d84-ae23-be93a2c72d65"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>high\nfever in combination with measles-like skin rash, enlarged lymph nodes, liver\nenlargement, hepatitis (up to liver failure), raising of the white-cells count\nin the blood (leukocytosis, with or without eosinophilia)</span></p>", "ID": "79a0a046-1722-4491-b046-24dd477c5f67", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "a8a93e59-e7c8-4124-b127-dced8edbee85", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "79a0a046-1722-4491-b046-24dd477c5f67"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "98347702-e288-4e1d-aeac-b3cf100e4d5f", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "a8a93e59-e7c8-4124-b127-dced8edbee85"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>high\nfever in combination with measles-like skin rash, enlarged lymph nodes, liver\nenlargement, hepatitis (up to liver failure), raising of the white-cells count\nin the blood (leukocytosis, with or without eosinophilia)</span>", "ID": "10bc2fa2-058b-4aaa-ac81-28697b2f342e", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "high fever in combination with measles-like skin rash, enlarged lymph nodes, liver enlargement, hepatitis (up to liver failure), raising of the white-cells count in the blood (leukocytosis, with or without eosinophilia)", "ParentId": "79a0a046-1722-4491-b046-24dd477c5f67"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>reddening\nof the skin (erythema), rash in various types (e.g. itchy, with white spots,\nwith blisters, with blisters containing pus, with shedding of the skin,\nmeasles-like rash), widespread erythema, necrosis, and bullous detachment of\nthe epidermis and mucous membranes, resulting in exfoliation and possible\nsepsis (Stevens-Johnson Syndrome/Toxic epidermal necrolysis)</span></p>", "ID": "976968cc-eda2-4b5c-9629-3ad391ac4a57", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "418c7fbe-b406-4475-bbd5-6b856a1178d7", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "976968cc-eda2-4b5c-9629-3ad391ac4a57"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "d83a6bc5-a35a-43d3-8e0d-c3713a57a66c", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "418c7fbe-b406-4475-bbd5-6b856a1178d7"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>reddening\nof the skin (erythema), rash in various types (e.g. itchy, with white spots,\nwith blisters, with blisters containing pus, with shedding of the skin,\nmeasles-like rash), widespread erythema, necrosis, and bullous detachment of\nthe epidermis and mucous membranes, resulting in exfoliation and possible\nsepsis (Stevens-Johnson Syndrome/Toxic epidermal necrolysis)</span>", "ID": "eebd30cd-198f-4b76-ab71-9d830460a4ad", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "reddening of the skin (erythema), rash in various types (e.g. itchy, with white spots, with blisters, with blisters containing pus, with shedding of the skin, measles-like rash), widespread erythema, necrosis, and bullous detachment of the epidermis and mucous membranes, resulting in exfoliation and possible sepsis (Stevens-Johnson Syndrome/Toxic epidermal necrolysis)", "ParentId": "976968cc-eda2-4b5c-9629-3ad391ac4a57"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>nervousness</span></p>", "ID": "97118daf-0d61-4f5c-8ce5-6bb5d254c0d0", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "e54b2cc4-c045-483e-8686-90ebf2f66a9b", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "97118daf-0d61-4f5c-8ce5-6bb5d254c0d0"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "fdf038e4-6e6b-4415-9dd5-f39e3e27ece0", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "e54b2cc4-c045-483e-8686-90ebf2f66a9b"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>nervousness</span>", "ID": "82d0b5a1-f8bb-4f2f-8395-72125acd4719", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "nervousness", "ParentId": "97118daf-0d61-4f5c-8ce5-6bb5d254c0d0"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>feeling\nthirsty</span></p>", "ID": "6129d4c5-e47f-434a-bd02-b092a3e3432d", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "d9b199cb-23ed-4e5e-adb1-5d4bbf552e5f", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "6129d4c5-e47f-434a-bd02-b092a3e3432d"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "d74aa49c-2743-4dc4-a58a-d81214173ca9", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "d9b199cb-23ed-4e5e-adb1-5d4bbf552e5f"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>feeling\nthirsty</span>", "ID": "b02d4c16-1d0d-4ad6-a7ae-3a14f350053d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "feeling thirsty", "ParentId": "6129d4c5-e47f-434a-bd02-b092a3e3432d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>ringing\nin the ears</span></p>", "ID": "5490ed86-ffc6-4a34-a162-f6d28686e7e3", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "73fc5a35-c88c-4a17-890b-024280b452da", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "5490ed86-ffc6-4a34-a162-f6d28686e7e3"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "23a3bb42-92bb-4fd6-9455-d41354cf9322", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "73fc5a35-c88c-4a17-890b-024280b452da"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>ringing\nin the ears</span>", "ID": "bc334c03-089d-4979-a41f-8217d8114f50", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "ringing in the ears", "ParentId": "5490ed86-ffc6-4a34-a162-f6d28686e7e3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>blurred\nvision, change in vision</span></p>", "ID": "f6933b7d-9a73-46a5-be6e-908642d52778", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "fd151595-c0bb-4ed6-9e22-bcb89bbed998", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "f6933b7d-9a73-46a5-be6e-908642d52778"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "89d7586f-334e-4988-9bfb-251525270fc3", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "fd151595-c0bb-4ed6-9e22-bcb89bbed998"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>blurred\nvision, change in vision</span>", "ID": "3e014319-b392-49ce-824c-e0a8f31f1315", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "blurred vision, change in vision", "ParentId": "f6933b7d-9a73-46a5-be6e-908642d52778"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>hair\nloss</span></p>", "ID": "be6123fa-fccd-4cf7-baa3-3add90e74a30", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "e4053a1d-c7ab-4867-93d0-3e9236d6e7c1", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "be6123fa-fccd-4cf7-baa3-3add90e74a30"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "277ea966-bf42-40e8-ad66-c90861f157bd", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "e4053a1d-c7ab-4867-93d0-3e9236d6e7c1"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>hair\nloss</span>", "ID": "c5632158-8979-471e-b835-e3bea837331b", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "hair loss", "ParentId": "be6123fa-fccd-4cf7-baa3-3add90e74a30"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>mouth\nulceration</span></p>", "ID": "2946dcc5-38dc-4585-93a2-6d420405e7c7", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "94006970-184b-4550-bb09-b9b0cf470f47", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "2946dcc5-38dc-4585-93a2-6d420405e7c7"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "83164ecd-a5ed-4aa9-be48-a68dda879157", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "94006970-184b-4550-bb09-b9b0cf470f47"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>mouth\nulceration</span>", "ID": "76e14bca-2e24-4e75-8348-c995d089c40c", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "mouth ulceration", "ParentId": "2946dcc5-38dc-4585-93a2-6d420405e7c7"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>inflammation\nof the pancreas: common symptoms are abdominal pain, nausea and vomiting</span></p>", "ID": "590e0400-c2a6-49cc-899e-18dff8c08a69", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "2a64000e-987c-463f-bb83-b1a830b7d9cb", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "590e0400-c2a6-49cc-899e-18dff8c08a69"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "877ce5fa-9604-48ac-81d8-97b415efe893", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "2a64000e-987c-463f-bb83-b1a830b7d9cb"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>inflammation\nof the pancreas: common symptoms are abdominal pain, nausea and vomiting</span>", "ID": "912f3d84-5dd3-4c40-94e8-9b325142d379", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "inflammation of the pancreas: common symptoms are abdominal pain, nausea and vomiting", "ParentId": "590e0400-c2a6-49cc-899e-18dff8c08a69"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>increased\nsweating</span></p>", "ID": "e2e45544-afc5-4c85-852e-ef1c82ce9280", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "7c59939b-4030-41c2-a15f-23c853a57a6e", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "e2e45544-afc5-4c85-852e-ef1c82ce9280"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "50465072-7b2a-4fa0-8913-c25af1585920", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "7c59939b-4030-41c2-a15f-23c853a57a6e"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>increased\nsweating</span>", "ID": "a214cd5e-3ec7-49f0-b8c7-0a96a3d77e28", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "increased sweating", "ParentId": "e2e45544-afc5-4c85-852e-ef1c82ce9280"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>weight\ndecrease, increased appetite, uncontrolled loss of appetite (anorexia)</span></p>", "ID": "2228cf48-acc9-4f35-8bda-c37f3aa19532", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "e6855fd2-62a8-46ee-a563-f04663647ba2", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "2228cf48-acc9-4f35-8bda-c37f3aa19532"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "c14e8111-871c-4b2f-8f66-be75c5febacb", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "e6855fd2-62a8-46ee-a563-f04663647ba2"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>weight\ndecrease, increased appetite, uncontrolled loss of appetite (anorexia)</span>", "ID": "8ec98a11-fe76-416b-aca3-4694beb2726e", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "weight decrease, increased appetite, uncontrolled loss of appetite (anorexia)", "ParentId": "2228cf48-acc9-4f35-8bda-c37f3aa19532"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>muscle\nand/or joint stiffness</span></p>", "ID": "f43ed5b2-6f04-4c1b-bd94-f6103e34fa66", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "addcd7d4-0a42-4620-a430-25cdd33b2d54", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "f43ed5b2-6f04-4c1b-bd94-f6103e34fa66"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "145bc0d8-a16d-48aa-97aa-ae0f1807898c", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "addcd7d4-0a42-4620-a430-25cdd33b2d54"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>muscle\nand/or joint stiffness</span>", "ID": "4e59acdb-87de-45c8-b2dc-092f9806d609", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "muscle and/or joint stiffness", "ParentId": "f43ed5b2-6f04-4c1b-bd94-f6103e34fa66"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>abnormally\nlow blood cell counts (white or red blood cells or platelets)</span></p>", "ID": "36d7ea55-a274-41cc-a927-b7df48eb2550", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "5e398c00-8c08-4e42-8678-f99ec964bd2b", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "36d7ea55-a274-41cc-a927-b7df48eb2550"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "8198da4b-e5da-4f68-a1eb-7612595b8594", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "5e398c00-8c08-4e42-8678-f99ec964bd2b"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>abnormally\nlow blood cell counts (white or red blood cells or platelets)</span>", "ID": "84c0a82a-f365-4fb3-9b24-684a390350e4", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "abnormally low blood cell counts (white or red blood cells or platelets)", "ParentId": "36d7ea55-a274-41cc-a927-b7df48eb2550"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>urgent\nneed to urinate</span></p>", "ID": "5cef23ac-f721-4922-bb9d-6d427bad6d63", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "e4b07676-d253-4776-92cc-1885daba0624", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "5cef23ac-f721-4922-bb9d-6d427bad6d63"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "a87286f6-3e23-4f01-83d2-60388c4d5bc6", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "e4b07676-d253-4776-92cc-1885daba0624"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>urgent\nneed to urinate</span>", "ID": "2c93b711-2476-43dd-b2ee-006fcb7e7b0c", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "urgent need to urinate", "ParentId": "5cef23ac-f721-4922-bb9d-6d427bad6d63"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>changes\nor decrease in urine amount due to inflammation in the kidneys\n(tubulointerstitial nephritis)</span></p>", "ID": "e97f2bf0-05ef-49ce-9455-c39bf01c26ac", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "ad009f68-1c4b-48f1-aacc-4dbc7edbb26b", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "e97f2bf0-05ef-49ce-9455-c39bf01c26ac"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "18317912-d2a2-486e-8db1-c034926e02ab", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "ad009f68-1c4b-48f1-aacc-4dbc7edbb26b"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>changes\nor decrease in urine amount due to inflammation in the kidneys\n(tubulointerstitial nephritis)</span>", "ID": "4e98c0b9-2d30-4f51-b0e8-0f6cf5007119", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "changes or decrease in urine amount due to inflammation in the kidneys (tubulointerstitial nephritis)", "ParentId": "e97f2bf0-05ef-49ce-9455-c39bf01c26ac"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>inflammation\nof the liver (hepatitis)</span></p>", "ID": "018dd630-dd4a-439e-93be-f1c8131189b4", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "197efbf3-15bc-477f-9afc-fd7031bd0d50", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "018dd630-dd4a-439e-93be-f1c8131189b4"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "5385cb51-7243-4f0d-98a6-39727273d22f", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "197efbf3-15bc-477f-9afc-fd7031bd0d50"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>inflammation\nof the liver (hepatitis)</span>", "ID": "69fc9157-b61f-4a4c-bdee-ee113a4cb333", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "inflammation of the liver (hepatitis)", "ParentId": "018dd630-dd4a-439e-93be-f1c8131189b4"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>yellowing\nof the skin (jaundice)</span></p>", "ID": "9d40b898-0a3f-4c1c-a592-df6c8f92a5cb", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "da96e533-c43f-4661-b65f-c676f73eeacb", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "9d40b898-0a3f-4c1c-a592-df6c8f92a5cb"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "cdeca3b2-ccf1-4289-81be-1cbb0cd7367f", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "da96e533-c43f-4661-b65f-c676f73eeacb"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>yellowing\nof the skin (jaundice)</span>", "ID": "e3254882-464a-416d-a1d5-876fdae0bc8d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "yellowing of the skin (jaundice)", "ParentId": "9d40b898-0a3f-4c1c-a592-df6c8f92a5cb"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>liver\ndamage</span></p>", "ID": "13edd1e3-9d7c-4ccb-bef7-7f6e94aef9a3", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "3665a7de-6c5a-4924-938f-579cc99bdbed", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "13edd1e3-9d7c-4ccb-bef7-7f6e94aef9a3"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "88cf8d5f-fd05-4942-a801-e3604281b74c", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "3665a7de-6c5a-4924-938f-579cc99bdbed"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>liver\ndamage</span>", "ID": "02f85382-7c97-467f-a256-e699aed5bb50", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "liver damage", "ParentId": "13edd1e3-9d7c-4ccb-bef7-7f6e94aef9a3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>increased\nlevel of creatine phosphokinase in blood (an indicator of muscle damage)</span></p>", "ID": "30ac580b-4f6c-4465-a7a4-56998828a7b9", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "569e0ba1-0dc9-446f-b70c-4da56ed503bd", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "30ac580b-4f6c-4465-a7a4-56998828a7b9"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "0ec1f6a9-113e-4986-b725-8285ba816109", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "569e0ba1-0dc9-446f-b70c-4da56ed503bd"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>increased\nlevel of creatine phosphokinase in blood (an indicator of muscle damage)</span>", "ID": "55666a92-9397-4c4e-b500-dabeb73066e9", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "increased level of creatine phosphokinase in blood (an indicator of muscle damage)", "ParentId": "30ac580b-4f6c-4465-a7a4-56998828a7b9"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "6ef3fd7b-be58-4ff7-8d58-82072108d20f", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "d9499537-497a-49f4-93ad-23cbd6ffb2ca", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "6ef3fd7b-be58-4ff7-8d58-82072108d20f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "d515fe1c-935d-4fe4-b9a5-341905be1519", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "ce9c5636-9201-444a-9ac1-174d56ca7ad2", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "d515fe1c-935d-4fe4-b9a5-341905be1519"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Reporting of side\neffects</span></b></p>", "ID": "84b020e4-b6cb-4049-95b6-6bfe162b540a", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Reporting of side\neffects</span></b>", "ID": "fb9aadfb-9243-4810-ac02-3872ba265bfb", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "84b020e4-b6cb-4049-95b6-6bfe162b540a"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Reporting of side\neffects</span>", "ID": "7c2af934-0f05-4e6a-aba5-2514eea06e78", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Reporting of side effects", "ParentId": "fb9aadfb-9243-4810-ac02-3872ba265bfb"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "cb910934-99b3-4f03-9854-75765e0cb7c7", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "82619027-92a8-4bdb-9cbc-1f4274b93d9d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "cb910934-99b3-4f03-9854-75765e0cb7c7"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If you get any side effects, talk\nto your doctor or pharmacist. This includes any possible side effects not\nlisted in this leaflet. You can also report side effects directly via the national\nreporting system listed in </span><span lang=\"EN-GB\"><a href=\"http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc\"><span style='font-family:\"Times New Roman\",serif;color:windowtext'>Appendix V</span></a></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>. By reporting side\neffects you can help provide more information on the safety of this medicine.</span></p>", "ID": "c476de7c-7ec0-4dcc-91be-2c0fbd56598f", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If you get any side effects, talk\nto your doctor or pharmacist. This includes any possible side effects not\nlisted in this leaflet. You can also report side effects directly via the national\nreporting system listed in </span>", "ID": "d1dc1a32-5778-4b72-b159-3aa132e8445e", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in ", "ParentId": "c476de7c-7ec0-4dcc-91be-2c0fbd56598f"}, {"Element": "<span lang=\"EN-GB\"><a href=\"http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc\"><span style='font-family:\"Times New Roman\",serif;color:windowtext'>Appendix V</span></a></span>", "ID": "2fc3e29a-4e97-4fd0-818e-77e73cfe8fd1", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c476de7c-7ec0-4dcc-91be-2c0fbd56598f"}, {"Element": "<a href=\"http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc\"><span style='font-family:\"Times New Roman\",serif;color:windowtext'>Appendix V</span></a>", "ID": "128d842a-dbac-4fe0-a73c-2f9267b5b575", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "2fc3e29a-4e97-4fd0-818e-77e73cfe8fd1"}, {"Element": "<span style='font-family:\"Times New Roman\",serif;color:windowtext'>Appendix V</span>", "ID": "d1995562-f58e-4cae-aa2d-e55bcc0de3a4", "Styles": "font-family:\"Times New Roman\",serif;color:windowtext", "Classes": "None", "Text": "Appendix V", "ParentId": "128d842a-dbac-4fe0-a73c-2f9267b5b575"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>. By reporting side\neffects you can help provide more information on the safety of this medicine.</span>", "ID": "6f35d5b8-2681-418f-b013-9cfab0465d38", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": ". By reporting side effects you can help provide more information on the safety of this medicine.", "ParentId": "c476de7c-7ec0-4dcc-91be-2c0fbd56598f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "b019802c-92af-4d77-ab8d-e27e3ced4eae", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "48dba3b2-5235-4962-9c5f-8149dec70ea1", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "b019802c-92af-4d77-ab8d-e27e3ced4eae"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "59cb794a-40af-4d8e-9588-9732d4c8204e", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "f9d6a02a-ba3f-4c48-bd34-75655232a1fb", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "59cb794a-40af-4d8e-9588-9732d4c8204e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 How to store Febuxostat\nMylan</span></b></p>", "ID": "28c5e64e-2099-4b25-8101-9b0028b77db5", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 How to store Febuxostat\nMylan</span></b>", "ID": "55614f17-f2c2-4cb8-b7bf-e5dc5a860059", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "28c5e64e-2099-4b25-8101-9b0028b77db5"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 How to store Febuxostat\nMylan</span>", "ID": "7f094818-45d0-4fc8-8f07-11a30844934a", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 How to store Febuxostat Mylan", "ParentId": "55614f17-f2c2-4cb8-b7bf-e5dc5a860059"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "6bc5c6fa-349f-493b-a4f0-1d9fa287a29b", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "1ce3995d-a837-4f59-8327-d7652b1f4916", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "6bc5c6fa-349f-493b-a4f0-1d9fa287a29b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Keep this medicine out of the sight\nand reach of children.</span></p>", "ID": "bf4796b0-4c64-49c8-b45a-6be631bfc29b", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Keep this medicine out of the sight\nand reach of children.</span>", "ID": "89bfdc8a-03e9-473b-ad8d-1b647209e3ea", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Keep this medicine out of the sight and reach of children.", "ParentId": "bf4796b0-4c64-49c8-b45a-6be631bfc29b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Do not use this medicine after the\nexpiry date which is stated on the packaging after \u2018EXP.\u2019 The expiry date\nrefers to the last day of that month.</span></p>", "ID": "0e5e2f5c-01a7-4b20-9747-9f35b3d58170", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Do not use this medicine after the\nexpiry date which is stated on the packaging after \u2018EXP.\u2019 The expiry date\nrefers to the last day of that month.</span>", "ID": "5e63781c-0612-429b-93c7-aa81b74fe1d4", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Do not use this medicine after the expiry date which is stated on the packaging after \u2018EXP.\u2019 The expiry date refers to the last day of that month.", "ParentId": "0e5e2f5c-01a7-4b20-9747-9f35b3d58170"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>For bottles, after first opening\nuse within 180 days</span></p>", "ID": "25ebae76-9296-448c-9bbc-837a65be94df", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>For bottles, after first opening\nuse within 180 days</span>", "ID": "7c47973f-b521-48cb-98dc-0ddd74350ef9", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "For bottles, after first opening use within 180 days", "ParentId": "25ebae76-9296-448c-9bbc-837a65be94df"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>This medicine does not require any\nspecial storage conditions.</span></p>", "ID": "e6172cb6-fd44-44aa-a816-dbc290ac6a2b", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>This medicine does not require any\nspecial storage conditions.</span>", "ID": "04079c56-bc66-4a6c-be66-066760df9820", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "This medicine does not require any special storage conditions.", "ParentId": "e6172cb6-fd44-44aa-a816-dbc290ac6a2b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "e2e14029-ec1e-4237-a582-9519ab579ea7", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "da1ec25e-d237-4477-a39e-b2dfcb7539e4", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "e2e14029-ec1e-4237-a582-9519ab579ea7"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Do not throw away any medicines via\nwastewater or household waste. Ask your pharmacist how to throw away medicines\nyou no longer use. These measures will help protect the environment.</span></p>", "ID": "d596c5ec-339b-419b-b94e-b618294cbde3", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Do not throw away any medicines via\nwastewater or household waste. Ask your pharmacist how to throw away medicines\nyou no longer use. These measures will help protect the environment.</span>", "ID": "3facbd0f-2e1b-498e-b168-1e43d4380fbe", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.", "ParentId": "d596c5ec-339b-419b-b94e-b618294cbde3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "2ac162ca-a699-416b-9351-e360563c84c8", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "133dfe29-b853-44fa-9ba9-7b7bab306205", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "2ac162ca-a699-416b-9351-e360563c84c8"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "2d0e56cd-0af8-4018-8ee6-2fec3280278b", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "178b5800-c441-4996-a962-01a4fb59c6fa", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "2d0e56cd-0af8-4018-8ee6-2fec3280278b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Contents of\nthe pack and other information</span></b></p>", "ID": "9b170fdc-88cb-4e14-bd9b-2434b7e116ef", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Contents of\nthe pack and other information</span></b>", "ID": "b2e9cd45-1b7e-467f-8aa7-b0e63dadd83d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9b170fdc-88cb-4e14-bd9b-2434b7e116ef"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Contents of\nthe pack and other information</span>", "ID": "01ce909c-dad7-4ac6-aeae-b6579006bc49", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Contents of the pack and other information", "ParentId": "b2e9cd45-1b7e-467f-8aa7-b0e63dadd83d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "fbe3075b-3bde-4729-90b2-74037c3653cf", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "8b4e8463-8610-4f7b-9d2d-434e46ad7d3a", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "fbe3075b-3bde-4729-90b2-74037c3653cf"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>What Febuxostat Mylan\ncontains</span></b></p>", "ID": "495ecd8a-e4fb-44d6-8a8a-333267b5c264", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>What Febuxostat Mylan\ncontains</span></b>", "ID": "2f750b89-02ad-4bf8-ace3-32d362c1a0eb", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "495ecd8a-e4fb-44d6-8a8a-333267b5c264"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>What Febuxostat Mylan\ncontains</span>", "ID": "50a02e34-e8b7-4a2a-8ada-470902d3f79d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "What Febuxostat Mylan contains", "ParentId": "2f750b89-02ad-4bf8-ace3-32d362c1a0eb"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "2374f2f6-3532-41f8-9c5c-7d0abfeb017c", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "3a5869ee-598b-49c1-b25d-225770064cf5", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "2374f2f6-3532-41f8-9c5c-7d0abfeb017c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The active substance is febuxostat.\nEach tablet contains 80\u00a0mg or 120\u00a0mg of febuxostat.</span></p>", "ID": "94619908-0b26-4f7f-a3e6-b5e45b371750", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The active substance is febuxostat.\nEach tablet contains 80\u00a0mg or 120\u00a0mg of febuxostat.</span>", "ID": "0feecd66-e38b-4e71-92ad-69530cc2df81", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "The active substance is febuxostat. Each tablet contains 80\u00a0mg or 120\u00a0mg of febuxostat.", "ParentId": "94619908-0b26-4f7f-a3e6-b5e45b371750"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "45d2c27b-d366-4e6f-8c70-5647d63ab2ca", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "7a8adec3-9e4a-4abe-b2d3-34b66bdf981f", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "45d2c27b-d366-4e6f-8c70-5647d63ab2ca"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The other ingredients are:</span></p>", "ID": "991450e2-332d-48ea-a13e-8f074f35fab9", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>The other ingredients are:</span>", "ID": "0c337184-e83f-4a2e-aca2-f351da1eb82d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "The other ingredients are:", "ParentId": "991450e2-332d-48ea-a13e-8f074f35fab9"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Tablet core</span></i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>: lactose (see section\n2, \u201cFebuxostat Mylan contains lactose\u201d), microcrystalline cellulose, magnesium\nstearate, hydroxypropylcellulose, croscarmellose sodium, colloidal hydrated silica,\ncolloidal anhydrous silica, crospovidone and talc.</span></p>", "ID": "0212a7f1-0fce-4408-aab3-cadc0aba3793", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Tablet core</span></i>", "ID": "bd5a7f40-c89e-4168-8e32-63833769758e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0212a7f1-0fce-4408-aab3-cadc0aba3793"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Tablet core</span>", "ID": "17cc0f64-8083-4b72-beed-ee3a2a0ecae5", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Tablet core", "ParentId": "bd5a7f40-c89e-4168-8e32-63833769758e"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>: lactose (see section\n2, \u201cFebuxostat Mylan contains lactose\u201d), microcrystalline cellulose, magnesium\nstearate, hydroxypropylcellulose, croscarmellose sodium, colloidal hydrated silica,\ncolloidal anhydrous silica, crospovidone and talc.</span>", "ID": "c0552406-0cff-4b46-9163-97e1a53d9cc3", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": ": lactose (see section 2, \u201cFebuxostat Mylan contains lactose\u201d), microcrystalline cellulose, magnesium stearate, hydroxypropylcellulose, croscarmellose sodium, colloidal hydrated silica, colloidal anhydrous silica, crospovidone and talc.", "ParentId": "0212a7f1-0fce-4408-aab3-cadc0aba3793"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Film-coating: </span></i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>hypromellose, titanium\ndioxide (E171), ethylcellulose, iron oxide yellow (E172), triacetin and iron oxide\nblack (E172).</span></p>", "ID": "b92d8654-b3a0-4570-a6b7-1e26a80f4646", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<i><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Film-coating: </span></i>", "ID": "fd45a6f6-4a23-4021-bb87-b246cf655924", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b92d8654-b3a0-4570-a6b7-1e26a80f4646"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Film-coating: </span>", "ID": "d64e66f7-63ce-4e8d-ac9b-7954f7559334", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Film-coating: ", "ParentId": "fd45a6f6-4a23-4021-bb87-b246cf655924"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>hypromellose, titanium\ndioxide (E171), ethylcellulose, iron oxide yellow (E172), triacetin and iron oxide\nblack (E172).</span>", "ID": "5281761a-87ff-4d9b-a2e9-8edd73f0f199", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "hypromellose, titanium dioxide (E171), ethylcellulose, iron oxide yellow (E172), triacetin and iron oxide black (E172).", "ParentId": "b92d8654-b3a0-4570-a6b7-1e26a80f4646"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "f3bd9ed4-2c05-4f98-bf29-660669376310", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "547c12d2-0ba2-412f-86c8-676004ff8b5d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "f3bd9ed4-2c05-4f98-bf29-660669376310"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>What Febuxostat Mylan\nlooks like and contents of the pack</span></b></p>", "ID": "2721e2ce-36b0-4eed-bfba-aa3b4cd92002", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>What Febuxostat Mylan\nlooks like and contents of the pack</span></b>", "ID": "dca3a667-498f-4355-a111-6ae6b7b25485", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "2721e2ce-36b0-4eed-bfba-aa3b4cd92002"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>What Febuxostat Mylan\nlooks like and contents of the pack</span>", "ID": "024328f1-5f59-434a-9077-656bb8354c38", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "What Febuxostat Mylan looks like and contents of the pack", "ParentId": "dca3a667-498f-4355-a111-6ae6b7b25485"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "90b2bc3d-8ff9-4f06-8326-02accbfa8f47", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "e88be080-f77c-469d-a2bb-9fa348d67988", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "90b2bc3d-8ff9-4f06-8326-02accbfa8f47"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat Mylan film-coated\ntablets are yellow, capsule shaped, biconvex tablets. The 80\u00a0mg tablets\nare marked with M on one side of the tablet and FX3 on the other side. The 120\u00a0mg\ntablets are marked with M on one side of the tablet and FX4 on the other side.</span></p>", "ID": "13eaa759-ce0f-4288-83d6-0df1bea4ed4c", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat Mylan film-coated\ntablets are yellow, capsule shaped, biconvex tablets. The 80\u00a0mg tablets\nare marked with M on one side of the tablet and FX3 on the other side. The 120\u00a0mg\ntablets are marked with M on one side of the tablet and FX4 on the other side.</span>", "ID": "78e99685-f276-4768-85bf-0a49b346c489", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Febuxostat Mylan film-coated tablets are yellow, capsule shaped, biconvex tablets. The 80\u00a0mg tablets are marked with M on one side of the tablet and FX3 on the other side. The 120\u00a0mg tablets are marked with M on one side of the tablet and FX4 on the other side.", "ParentId": "13eaa759-ce0f-4288-83d6-0df1bea4ed4c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "87836293-10b7-4d44-8b3e-fe201a7cd5ed", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "e91a1262-6834-43f4-be9b-a1760f5fddb5", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "87836293-10b7-4d44-8b3e-fe201a7cd5ed"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat Mylan 80\u00a0mg and 120\u00a0mg\nfilm-coated tablets are available in blister packs of 14, 28, 42 and 84\ntablets, calendar blister packs of 28 and 84 tablets, and perforated unit dose\nblister packs of 28 x 1 tablets and in multipacks of 84\u00a0film-coated\ntablets comprising 2 packs, each containing 42\u00a0film-coated tablets.</span></p>", "ID": "f7459565-d7f6-4e9d-a5d2-011f0687198c", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat Mylan 80\u00a0mg and 120\u00a0mg\nfilm-coated tablets are available in blister packs of 14, 28, 42 and 84\ntablets, calendar blister packs of 28 and 84 tablets, and perforated unit dose\nblister packs of 28 x 1 tablets and in multipacks of 84\u00a0film-coated\ntablets comprising 2 packs, each containing 42\u00a0film-coated tablets.</span>", "ID": "96972705-2417-47f8-9bec-4ec94b3263b2", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Febuxostat Mylan 80\u00a0mg and 120\u00a0mg film-coated tablets are available in blister packs of 14, 28, 42 and 84 tablets, calendar blister packs of 28 and 84 tablets, and perforated unit dose blister packs of 28 x 1 tablets and in multipacks of 84\u00a0film-coated tablets comprising 2 packs, each containing 42\u00a0film-coated tablets.", "ParentId": "f7459565-d7f6-4e9d-a5d2-011f0687198c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "a6d7add6-64d2-45f0-b414-e01de87d788c", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "81bb2574-ca26-427f-9735-13811519c173", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "a6d7add6-64d2-45f0-b414-e01de87d788c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat Mylan 80 mg and 120\u00a0mg\nfilm-coated tablets are available in plastic bottles of 28 and 84 tablets. </span></p>", "ID": "92001bc3-b131-4ee2-b59e-179b11727044", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Febuxostat Mylan 80 mg and 120\u00a0mg\nfilm-coated tablets are available in plastic bottles of 28 and 84 tablets. </span>", "ID": "18ae5ff4-0336-44a4-b63d-00b85984ce2d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Febuxostat Mylan 80 mg and 120\u00a0mg film-coated tablets are available in plastic bottles of 28 and 84 tablets. ", "ParentId": "92001bc3-b131-4ee2-b59e-179b11727044"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Not all pack sizes may be marketed.</span></p>", "ID": "f3926827-e201-479a-aeac-34d7c17d0b0a", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Not all pack sizes may be marketed.</span>", "ID": "88c2609c-65a5-49f8-a604-f6e86461b9a5", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Not all pack sizes may be marketed.", "ParentId": "f3926827-e201-479a-aeac-34d7c17d0b0a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "fa468065-4f6b-4baf-b9d8-00c35254a197", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "eb3a2cba-96df-433e-b29c-9e333d491e49", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "fa468065-4f6b-4baf-b9d8-00c35254a197"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "dbd29e02-65eb-4ebb-af05-fa82614b0d58", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "3688ca55-d69c-4b77-8d8b-929572f8016e", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "dbd29e02-65eb-4ebb-af05-fa82614b0d58"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Marketing Authorisation\nHolder</span></b></p>", "ID": "1cb41aa3-408f-44ac-adf1-dc43576d27ba", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Marketing Authorisation\nHolder</span></b>", "ID": "4a773ea6-7259-424e-aac1-5a1a67063cc3", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "1cb41aa3-408f-44ac-adf1-dc43576d27ba"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Marketing Authorisation\nHolder</span>", "ID": "57c35467-8326-490a-b21b-d2592bc5bcc2", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Marketing Authorisation Holder", "ParentId": "4a773ea6-7259-424e-aac1-5a1a67063cc3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Mylan S.A.S.</span></p>", "ID": "e58d6339-9c61-4e22-bc08-1233a113cea4", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Mylan S.A.S.</span>", "ID": "a8ed407c-7af6-4ad3-8add-98583f8351fc", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Mylan S.A.S.", "ParentId": "e58d6339-9c61-4e22-bc08-1233a113cea4"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>117 Allee des Parcs</span></p>", "ID": "3d99a60e-c81a-4047-9068-8d3b6fbd0e25", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>117 Allee des Parcs</span>", "ID": "4cb32eaa-115a-4406-a820-5a88777c1ade", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "117 Allee des Parcs", "ParentId": "3d99a60e-c81a-4047-9068-8d3b6fbd0e25"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>69 800 Saint Priest</span></p>", "ID": "33b0b244-844a-47d3-8633-b5b3d094d69c", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>69 800 Saint Priest</span>", "ID": "4e578e7c-d30b-48b1-98bf-a4945b54b474", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "69 800 Saint Priest", "ParentId": "33b0b244-844a-47d3-8633-b5b3d094d69c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>France</span></p>", "ID": "bc9e6ebe-8830-4a29-83e3-4c9813ece3e7", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>France</span>", "ID": "d3dbef05-2ca5-4b93-9246-4102368b9a4a", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "France", "ParentId": "bc9e6ebe-8830-4a29-83e3-4c9813ece3e7"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "92f4e60f-94c1-4c37-9390-6f4b356a52c6", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "92b5ff44-2c5b-4e5f-bc0c-98abb0b04a96", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "92f4e60f-94c1-4c37-9390-6f4b356a52c6"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Manufacturer</span></b></p>", "ID": "74f86cea-b630-4ae8-a347-c212644815df", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Manufacturer</span></b>", "ID": "fb43aa84-275a-48a2-a3e6-96aea27064f3", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "74f86cea-b630-4ae8-a347-c212644815df"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Manufacturer</span>", "ID": "35d1057c-8b7b-4537-9e02-dc4c50b4404a", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Manufacturer", "ParentId": "fb43aa84-275a-48a2-a3e6-96aea27064f3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Mylan Hungary Kft</span></p>", "ID": "85ed74c1-4cef-4b79-b2a2-401a8cc30690", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Mylan Hungary Kft</span>", "ID": "3f83051b-0084-4434-9302-d8a49e8ac882", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "Mylan Hungary Kft", "ParentId": "85ed74c1-4cef-4b79-b2a2-401a8cc30690"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Mylan utca 1</span></p>", "ID": "b653f950-ed0b-46ae-8e69-901aefa6a1c4", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Mylan utca 1</span>", "ID": "71b793a4-808c-4a4e-afa4-93f1ceaf0791", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "Mylan utca 1", "ParentId": "b653f950-ed0b-46ae-8e69-901aefa6a1c4"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>H-2900 Kom\u00e1rom</span></p>", "ID": "392f1bbb-0adc-45ba-a934-cc8cfc0ff666", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>H-2900 Kom\u00e1rom</span>", "ID": "c23f6d8e-06f6-45a0-b72f-67d21055d21b", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "H-2900 Kom\u00e1rom", "ParentId": "392f1bbb-0adc-45ba-a934-cc8cfc0ff666"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Hungary</span></p>", "ID": "162e10e2-23a1-438a-ac33-5f598ac0dc33", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Hungary</span>", "ID": "a369be50-4cab-48b3-b063-62247020aa72", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "Hungary", "ParentId": "162e10e2-23a1-438a-ac33-5f598ac0dc33"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "de5d368d-2a2c-420e-b3f1-765beb15d510", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "7c9d0813-1410-4fdc-a9f6-55ec562842b6", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "de5d368d-2a2c-420e-b3f1-765beb15d510"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey'>McDermott Laboratories Limited\ntrading as Gerard Laboratories</span></p>", "ID": "4758a311-6976-4728-9cb6-bfb1c842b517", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey'>McDermott Laboratories Limited\ntrading as Gerard Laboratories</span>", "ID": "facf56fb-0fb5-43cb-8c22-50ce3127d6b0", "Styles": "font-family:\n\"Times New Roman\",serif;background:lightgrey", "Classes": "None", "Text": "McDermott Laboratories Limited trading as Gerard Laboratories", "ParentId": "4758a311-6976-4728-9cb6-bfb1c842b517"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey'>35/36 Baldoyle Industrial Estate</span></p>", "ID": "97f55f57-627f-44a9-a207-9dd61711fef8", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey'>35/36 Baldoyle Industrial Estate</span>", "ID": "72e45114-485d-4712-8dde-5dde43df2a79", "Styles": "font-family:\n\"Times New Roman\",serif;background:lightgrey", "Classes": "None", "Text": "35/36 Baldoyle Industrial Estate", "ParentId": "97f55f57-627f-44a9-a207-9dd61711fef8"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey'>Grange Road</span></p>", "ID": "4964a5c1-0686-4049-9a20-f724767f8f36", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey'>Grange Road</span>", "ID": "0bd704bc-65b4-444d-870b-826456d12e7f", "Styles": "font-family:\n\"Times New Roman\",serif;background:lightgrey", "Classes": "None", "Text": "Grange Road", "ParentId": "4964a5c1-0686-4049-9a20-f724767f8f36"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey'>Dublin 13</span></p>", "ID": "142ba174-5728-472c-b1d7-8756a46baaa7", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey'>Dublin 13</span>", "ID": "81305071-4732-4956-833e-51ce77b980dc", "Styles": "font-family:\n\"Times New Roman\",serif;background:lightgrey", "Classes": "None", "Text": "Dublin 13", "ParentId": "142ba174-5728-472c-b1d7-8756a46baaa7"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey'>Ireland</span></p>", "ID": "d97a99cf-8d34-4f9e-a8df-3244414e5e6e", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif;background:lightgrey'>Ireland</span>", "ID": "634adb31-0395-49be-9d1f-76f6004d6fe2", "Styles": "font-family:\n\"Times New Roman\",serif;background:lightgrey", "Classes": "None", "Text": "Ireland", "ParentId": "d97a99cf-8d34-4f9e-a8df-3244414e5e6e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "327f23f3-b5c6-4513-9433-9ffead563fe2", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "6cc29304-3091-40c9-a8f5-e740625f9c93", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "327f23f3-b5c6-4513-9433-9ffead563fe2"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>For any information about this medicine, please\ncontact the local representative of the Marketing</span></p>", "ID": "216bf6b2-2bc1-4512-8ad2-31dd503fc0d7", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>For any information about this medicine, please\ncontact the local representative of the Marketing</span>", "ID": "4d173249-2544-4809-965b-26685721aca1", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "For any information about this medicine, please contact the local representative of the Marketing", "ParentId": "216bf6b2-2bc1-4512-8ad2-31dd503fc0d7"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Authorisation Holder.</span></p>", "ID": "8256b3dc-1e3e-4d80-8229-2bd1bd1f0a9d", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Authorisation Holder.</span>", "ID": "72ad89bd-d78e-47c6-95de-ec0b22d4f91d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Authorisation Holder.", "ParentId": "8256b3dc-1e3e-4d80-8229-2bd1bd1f0a9d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "2160607f-a261-4401-8f54-fb1b90eb3c3c", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "332986e7-0b18-4818-8157-b6bb2783d21e", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "2160607f-a261-4401-8f54-fb1b90eb3c3c"}, {"Element": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"margin-left:3.7pt;border-collapse:collapse\" width=\"624\">\n<tr>\n<td style=\"border:none;padding:0in 0in 0in 0in\" width=\"2\"><p class=\"MsoNormal\">\u00a0</p></td>\n<td style=\"width:232.2pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"310\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt;page-break-after:avoid\"><b><span lang=\"EN-GB\">Belgi\u00eb/Belgique/Belgien</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt;page-break-after:avoid\"><span lang=\"EN-GB\">Mylan bvba/sprl</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt;page-break-after:avoid\"><span lang=\"EN-GB\">T\u00e9l/Tel: + 32 (0)2 658 61 00</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt;page-break-after:avoid\"><b><span lang=\"EN-GB\">Lietuva</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt;page-break-after:avoid\"><span lang=\"EN-GB\">BGP Products UAB</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt;page-break-after:avoid\"><span lang=\"EN-GB\">Tel: +370 5 205 1288</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"height:71.25pt\">\n<td style=\"border:none;padding:0in 0in 0in 0in\" width=\"2\"><p class=\"MsoNormal\">\u00a0</p></td>\n<td style=\"width:232.2pt;padding:0in 5.4pt 0in 5.4pt;\n  height:71.25pt\" valign=\"top\" width=\"310\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">\u0411\u044a\u043b\u0433\u0430\u0440\u0438\u044f</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u041c\u0430\u0439\u043b\u0430\u043d\n  \u0415\u041e\u041e\u0414</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u0422\u0435\u043b:\n  +359 2 44 55 400</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt;\n  height:71.25pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Luxembourg/Luxemburg</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Mylan\n  bvba/sprl</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: + 32 (0)2\n  658 61 00</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">(Belgique/Belgien)</span></p>\n</td>\n</tr>\n<tr style=\"height:49.1pt\">\n<td style=\"border:none;padding:0in 0in 0in 0in\" width=\"2\"><p class=\"MsoNormal\">\u00a0</p></td>\n<td style=\"width:232.2pt;padding:0in 5.4pt 0in 5.4pt;\n  height:49.1pt\" valign=\"top\" width=\"310\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">\u010cesk\u00e1\n  republika</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Mylan\n  Pharmaceuticals.s.r.o.</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel:\n  +420\u00a0222 004 400</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt;\n  height:49.1pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Magyarorsz\u00e1g</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Mylan EPD\n  Kft</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: + 36 1\u00a0465\n  2100</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"border:none;padding:0in 0in 0in 0in\" width=\"2\"><p class=\"MsoNormal\">\u00a0</p></td>\n<td style=\"width:232.2pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"310\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Danmark</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Mylan AB</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tlf: + 46\n  855 522 750 </span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">(Sverige)</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Malta</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">V.J.\n  Salomone Pharma Ltd</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: + 356\n  21 22 01 74</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"border:none;padding:0in 0in 0in 0in\" width=\"2\"><p class=\"MsoNormal\">\u00a0</p></td>\n<td style=\"width:232.2pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"310\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Deutschland</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Mylan dura\n  GmbH </span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: +\n  49-(0) 6172 888 01</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Nederland</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Mylan BV</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: +31\n  (0)20 426 3300</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"border:none;padding:0in 0in 0in 0in\" width=\"2\"><p class=\"MsoNormal\">\u00a0</p></td>\n<td style=\"width:232.2pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"310\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Eesti</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">BGP\n  Products Switzerland GmbH Eesti filiaal</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: + 372\n  6363 052</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Norge</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Mylan AB</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: + 46\n  855 522 750</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">(Sverige)</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"border:none;padding:0in 0in 0in 0in\" width=\"2\"><p class=\"MsoNormal\">\u00a0</p></td>\n<td style=\"width:232.2pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"310\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">\u0395\u03bb\u03bb\u03ac\u03b4\u03b1\n  </span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Generics\n  Pharma Hellas \u0395\u03a0\u0395 </span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u03a4\u03b7\u03bb:\n  +30 210 993 6410 </span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">\u00d6sterreich</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Arcana\n  Arzneimittel GmbH</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: </span>+43\n  1 416 2418</p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>\n<tr>\n<td colspan=\"2\" style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Espa\u00f1a</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Mylan Pharmaceuticals,\n  S.L</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: </span><span lang=\"EN-GB\">+ 34 900 102 712</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Polska</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Mylan Healthcare\n  Sp. z.o.o.</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: + 48\n  22 546 64 00</span></p>\n</td>\n</tr>\n<tr>\n<td colspan=\"2\" style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">France</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Mylan S.A.S</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: +33 4\n  37 25 75 00</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Portugal</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Mylan, Lda.</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: + 351\n  21 412 72 56</span></p>\n</td>\n</tr>\n<tr>\n<td colspan=\"2\" style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Hrvatska</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Mylan\n  Hrvatska d.o.o.</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: +385 1\n  23 50 599</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Rom\u00e2nia</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">BGP\n  Products SRL</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: +40\n  372 579 000</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n  0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>\u00a0</span></p>\n</td>\n</tr>\n<tr>\n<td colspan=\"2\" style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Ireland</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Mylan\n  Ireland</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: +353\n  (0) 87 1694982</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Slovenija</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n  0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>GSP Proizvodi d.o.o.</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: + 386\n  1 236 31 85</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>\n</tr>\n<tr>\n<td colspan=\"2\" style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">\u00cdsland</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Mylan AB</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: + 46\n  855 522 750</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">(Sv\u00ed\u00fej\u00f3\u00f0)</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Slovensk\u00e1\n  republika</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Mylan\n  s.r.o.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n  0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>Tel: </span><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>+421\u00a02 32 199 100</span></p>\n</td>\n</tr>\n<tr>\n<td colspan=\"2\" style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Italia</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Mylan S.p.A</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: + 39\n  02 612 46921</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n  0in;margin-left:0in;line-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>\u00a0</span></b></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Suomi/Finland</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><strong><span lang=\"EN-GB\" style=\"color:black;border:none windowtext 1.0pt;padding:0in;background:white;\n  font-weight:normal\">Mylan OY</span></strong></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\">Puh/Tel: +358 20 720 9555</p>\n</td>\n</tr>\n<tr>\n<td colspan=\"2\" style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">\u039a\u03cd\u03c0\u03c1\u03bf\u03c2</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Pharmaceutical\n  Trading Co. Ltd.</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u03a4\u03b7\u03bb:\n  + 357 99403969</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Sverige</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Mylan AB </span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: + 46\n  855 522 750</span></p>\n</td>\n</tr>\n<tr>\n<td colspan=\"2\" style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Latvija</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">BGP\n  Products SIA</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: +371\n  676 055 80</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">United\n  Kingdom</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Generics\n  [UK] Ltd</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n  0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>Tel: +44 1707 853000</span></p>\n</td>\n</tr>\n<tr height=\"0\">\n<td style=\"border:none\" width=\"2\"></td>\n<td style=\"border:none\" width=\"310\"></td>\n<td style=\"border:none\" width=\"312\"></td>\n</tr>\n</table>", "ID": "322a33b5-fe92-4152-8984-cfa70a8d9bf2", "Styles": "margin-left:3.7pt;border-collapse:collapse", "Classes": "['MsoNormalTable']", "Text": "                 ", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<tr>\n<td style=\"border:none;padding:0in 0in 0in 0in\" width=\"2\"><p class=\"MsoNormal\">\u00a0</p></td>\n<td style=\"width:232.2pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"310\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt;page-break-after:avoid\"><b><span lang=\"EN-GB\">Belgi\u00eb/Belgique/Belgien</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt;page-break-after:avoid\"><span lang=\"EN-GB\">Mylan bvba/sprl</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt;page-break-after:avoid\"><span lang=\"EN-GB\">T\u00e9l/Tel: + 32 (0)2 658 61 00</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt;page-break-after:avoid\"><b><span lang=\"EN-GB\">Lietuva</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt;page-break-after:avoid\"><span lang=\"EN-GB\">BGP Products UAB</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt;page-break-after:avoid\"><span lang=\"EN-GB\">Tel: +370 5 205 1288</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>", "ID": "7998175b-9427-4e69-984e-fe2ffdc18f64", "Styles": "None", "Classes": "None", "Text": "    ", "ParentId": "322a33b5-fe92-4152-8984-cfa70a8d9bf2"}, {"Element": "<td style=\"border:none;padding:0in 0in 0in 0in\" width=\"2\"><p class=\"MsoNormal\">\u00a0</p></td>", "ID": "ebc01713-242a-495c-8925-b05683dc7ffa", "Styles": "border:none;padding:0in 0in 0in 0in", "Classes": "None", "Text": "", "ParentId": "7998175b-9427-4e69-984e-fe2ffdc18f64"}, {"Element": "<p class=\"MsoNormal\">\u00a0</p>", "ID": "9889f32f-5861-4eee-b4e1-8d5cfc9eff99", "Styles": "None", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "ebc01713-242a-495c-8925-b05683dc7ffa"}, {"Element": "<td style=\"width:232.2pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"310\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt;page-break-after:avoid\"><b><span lang=\"EN-GB\">Belgi\u00eb/Belgique/Belgien</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt;page-break-after:avoid\"><span lang=\"EN-GB\">Mylan bvba/sprl</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt;page-break-after:avoid\"><span lang=\"EN-GB\">T\u00e9l/Tel: + 32 (0)2 658 61 00</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "0d2665ce-5532-43c1-8b45-14f65f863ce5", "Styles": "width:232.2pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "     ", "ParentId": "7998175b-9427-4e69-984e-fe2ffdc18f64"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt;page-break-after:avoid\"><b><span lang=\"EN-GB\">Belgi\u00eb/Belgique/Belgien</span></b></p>", "ID": "558b2b75-2efb-49d2-b179-5e8269538ded", "Styles": "margin-right:2.75pt;page-break-after:avoid", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "0d2665ce-5532-43c1-8b45-14f65f863ce5"}, {"Element": "<b><span lang=\"EN-GB\">Belgi\u00eb/Belgique/Belgien</span></b>", "ID": "c8426c51-8a3d-4ae2-9870-7c9c780dcae6", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "558b2b75-2efb-49d2-b179-5e8269538ded"}, {"Element": "<span lang=\"EN-GB\">Belgi\u00eb/Belgique/Belgien</span>", "ID": "196af2ec-de3a-4fae-af4e-85427e60febc", "Styles": "None", "Classes": "None", "Text": "Belgi\u00eb/Belgique/Belgien", "ParentId": "c8426c51-8a3d-4ae2-9870-7c9c780dcae6"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt;page-break-after:avoid\"><span lang=\"EN-GB\">Mylan bvba/sprl</span></p>", "ID": "dc59097b-1e26-490f-a799-5a30c66025be", "Styles": "margin-right:2.75pt;page-break-after:avoid", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "0d2665ce-5532-43c1-8b45-14f65f863ce5"}, {"Element": "<span lang=\"EN-GB\">Mylan bvba/sprl</span>", "ID": "81807a83-1cfe-4ba1-9772-566530f27f93", "Styles": "None", "Classes": "None", "Text": "Mylan bvba/sprl", "ParentId": "dc59097b-1e26-490f-a799-5a30c66025be"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt;page-break-after:avoid\"><span lang=\"EN-GB\">T\u00e9l/Tel: + 32 (0)2 658 61 00</span></p>", "ID": "538bf077-cbeb-4f69-a985-6cba688a8ade", "Styles": "margin-right:2.75pt;page-break-after:avoid", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "0d2665ce-5532-43c1-8b45-14f65f863ce5"}, {"Element": "<span lang=\"EN-GB\">T\u00e9l/Tel: + 32 (0)2 658 61 00</span>", "ID": "1492bf60-af34-4f27-b9a8-e9af2c6546d1", "Styles": "None", "Classes": "None", "Text": "T\u00e9l/Tel: + 32 (0)2 658 61 00", "ParentId": "538bf077-cbeb-4f69-a985-6cba688a8ade"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "ece18be7-235c-4f6b-9a03-e0d91ef652ef", "Styles": "margin-right:2.75pt;page-break-after:avoid", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "0d2665ce-5532-43c1-8b45-14f65f863ce5"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "8b7c1f8f-2f8d-409f-9770-d6ccf2929087", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ece18be7-235c-4f6b-9a03-e0d91ef652ef"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt;page-break-after:avoid\"><b><span lang=\"EN-GB\">Lietuva</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt;page-break-after:avoid\"><span lang=\"EN-GB\">BGP Products UAB</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt;page-break-after:avoid\"><span lang=\"EN-GB\">Tel: +370 5 205 1288</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "4886f3f6-2c1e-4622-b906-7b5e1e41cad0", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "     ", "ParentId": "7998175b-9427-4e69-984e-fe2ffdc18f64"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt;page-break-after:avoid\"><b><span lang=\"EN-GB\">Lietuva</span></b></p>", "ID": "683d1d34-3bbd-47e2-afba-7a2b2e81ce8c", "Styles": "margin-right:2.75pt;page-break-after:avoid", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "4886f3f6-2c1e-4622-b906-7b5e1e41cad0"}, {"Element": "<b><span lang=\"EN-GB\">Lietuva</span></b>", "ID": "ab328eab-1cf5-4449-9711-9fe893588628", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "683d1d34-3bbd-47e2-afba-7a2b2e81ce8c"}, {"Element": "<span lang=\"EN-GB\">Lietuva</span>", "ID": "1ac49b79-ba14-4e4f-9017-59382f717716", "Styles": "None", "Classes": "None", "Text": "Lietuva", "ParentId": "ab328eab-1cf5-4449-9711-9fe893588628"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt;page-break-after:avoid\"><span lang=\"EN-GB\">BGP Products UAB</span></p>", "ID": "7fd7e5db-79c7-4c62-84e0-675ae199a2f8", "Styles": "margin-right:2.75pt;page-break-after:avoid", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "4886f3f6-2c1e-4622-b906-7b5e1e41cad0"}, {"Element": "<span lang=\"EN-GB\">BGP Products UAB</span>", "ID": "d1182d51-08b7-41a1-8432-85ae29aaafcf", "Styles": "None", "Classes": "None", "Text": "BGP Products UAB", "ParentId": "7fd7e5db-79c7-4c62-84e0-675ae199a2f8"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt;page-break-after:avoid\"><span lang=\"EN-GB\">Tel: +370 5 205 1288</span></p>", "ID": "118f5d16-73bd-4b97-b368-a18cf23c1c3e", "Styles": "margin-right:2.75pt;page-break-after:avoid", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "4886f3f6-2c1e-4622-b906-7b5e1e41cad0"}, {"Element": "<span lang=\"EN-GB\">Tel: +370 5 205 1288</span>", "ID": "a45bcaf2-4605-4626-b637-e81265020583", "Styles": "None", "Classes": "None", "Text": "Tel: +370 5 205 1288", "ParentId": "118f5d16-73bd-4b97-b368-a18cf23c1c3e"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "cf591c6f-d707-4f82-a338-2b68fba29ab5", "Styles": "margin-right:2.75pt;page-break-after:avoid", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "4886f3f6-2c1e-4622-b906-7b5e1e41cad0"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "df9747f5-4854-4177-b60c-2cc27cfa973e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "cf591c6f-d707-4f82-a338-2b68fba29ab5"}, {"Element": "<tr style=\"height:71.25pt\">\n<td style=\"border:none;padding:0in 0in 0in 0in\" width=\"2\"><p class=\"MsoNormal\">\u00a0</p></td>\n<td style=\"width:232.2pt;padding:0in 5.4pt 0in 5.4pt;\n  height:71.25pt\" valign=\"top\" width=\"310\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">\u0411\u044a\u043b\u0433\u0430\u0440\u0438\u044f</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u041c\u0430\u0439\u043b\u0430\u043d\n  \u0415\u041e\u041e\u0414</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u0422\u0435\u043b:\n  +359 2 44 55 400</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt;\n  height:71.25pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Luxembourg/Luxemburg</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Mylan\n  bvba/sprl</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: + 32 (0)2\n  658 61 00</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">(Belgique/Belgien)</span></p>\n</td>\n</tr>", "ID": "a7bdf06a-062f-4367-961d-419cced46aaf", "Styles": "height:71.25pt", "Classes": "None", "Text": "    ", "ParentId": "322a33b5-fe92-4152-8984-cfa70a8d9bf2"}, {"Element": "<td style=\"border:none;padding:0in 0in 0in 0in\" width=\"2\"><p class=\"MsoNormal\">\u00a0</p></td>", "ID": "2a454dba-91dc-4fe2-af6c-6cb58904dfc4", "Styles": "border:none;padding:0in 0in 0in 0in", "Classes": "None", "Text": "", "ParentId": "a7bdf06a-062f-4367-961d-419cced46aaf"}, {"Element": "<p class=\"MsoNormal\">\u00a0</p>", "ID": "eedfcfef-5302-4f80-b4d9-d92f21f4720a", "Styles": "None", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "2a454dba-91dc-4fe2-af6c-6cb58904dfc4"}, {"Element": "<td style=\"width:232.2pt;padding:0in 5.4pt 0in 5.4pt;\n  height:71.25pt\" valign=\"top\" width=\"310\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">\u0411\u044a\u043b\u0433\u0430\u0440\u0438\u044f</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u041c\u0430\u0439\u043b\u0430\u043d\n  \u0415\u041e\u041e\u0414</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u0422\u0435\u043b:\n  +359 2 44 55 400</span></p>\n</td>", "ID": "0c903b36-4f06-4d66-af05-90154d914e0b", "Styles": "width:232.2pt;padding:0in 5.4pt 0in 5.4pt;\n  height:71.25pt", "Classes": "None", "Text": "    ", "ParentId": "a7bdf06a-062f-4367-961d-419cced46aaf"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">\u0411\u044a\u043b\u0433\u0430\u0440\u0438\u044f</span></b></p>", "ID": "50259be5-9bbb-45e1-a068-834598189492", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "0c903b36-4f06-4d66-af05-90154d914e0b"}, {"Element": "<b><span lang=\"EN-GB\">\u0411\u044a\u043b\u0433\u0430\u0440\u0438\u044f</span></b>", "ID": "018947a0-f4ff-47bc-ad65-70758e8d7de6", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "50259be5-9bbb-45e1-a068-834598189492"}, {"Element": "<span lang=\"EN-GB\">\u0411\u044a\u043b\u0433\u0430\u0440\u0438\u044f</span>", "ID": "40d73171-a78a-41c3-865b-5c878bacd8ec", "Styles": "None", "Classes": "None", "Text": "\u0411\u044a\u043b\u0433\u0430\u0440\u0438\u044f", "ParentId": "018947a0-f4ff-47bc-ad65-70758e8d7de6"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u041c\u0430\u0439\u043b\u0430\u043d\n  \u0415\u041e\u041e\u0414</span></p>", "ID": "44344208-c1c3-475b-8504-8120f564077d", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "0c903b36-4f06-4d66-af05-90154d914e0b"}, {"Element": "<span lang=\"EN-GB\">\u041c\u0430\u0439\u043b\u0430\u043d\n  \u0415\u041e\u041e\u0414</span>", "ID": "c7ee7cf7-5f9f-4f6d-8726-0f1570cb211d", "Styles": "None", "Classes": "None", "Text": "\u041c\u0430\u0439\u043b\u0430\u043d   \u0415\u041e\u041e\u0414", "ParentId": "44344208-c1c3-475b-8504-8120f564077d"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u0422\u0435\u043b:\n  +359 2 44 55 400</span></p>", "ID": "016572b4-4598-4591-92a6-12135fccbcf2", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "0c903b36-4f06-4d66-af05-90154d914e0b"}, {"Element": "<span lang=\"EN-GB\">\u0422\u0435\u043b:\n  +359 2 44 55 400</span>", "ID": "d69fe94b-b020-43db-8d65-9b9e4be4769e", "Styles": "None", "Classes": "None", "Text": "\u0422\u0435\u043b:   +359 2 44 55 400", "ParentId": "016572b4-4598-4591-92a6-12135fccbcf2"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt;\n  height:71.25pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Luxembourg/Luxemburg</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Mylan\n  bvba/sprl</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: + 32 (0)2\n  658 61 00</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">(Belgique/Belgien)</span></p>\n</td>", "ID": "dcfe2d21-59e5-47ee-ac70-ca56b24d3a00", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt;\n  height:71.25pt", "Classes": "None", "Text": "     ", "ParentId": "a7bdf06a-062f-4367-961d-419cced46aaf"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Luxembourg/Luxemburg</span></b></p>", "ID": "088f21ac-01b2-4dd4-a581-58d2d5e9dc8e", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "dcfe2d21-59e5-47ee-ac70-ca56b24d3a00"}, {"Element": "<b><span lang=\"EN-GB\">Luxembourg/Luxemburg</span></b>", "ID": "b2422750-1154-4de0-b806-f72d78f5db38", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "088f21ac-01b2-4dd4-a581-58d2d5e9dc8e"}, {"Element": "<span lang=\"EN-GB\">Luxembourg/Luxemburg</span>", "ID": "811fc2b7-ccf6-47b0-b0f2-1add43c0a042", "Styles": "None", "Classes": "None", "Text": "Luxembourg/Luxemburg", "ParentId": "b2422750-1154-4de0-b806-f72d78f5db38"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Mylan\n  bvba/sprl</span></p>", "ID": "6b90c7d7-afe7-4dce-802a-bd4898a7f22d", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "dcfe2d21-59e5-47ee-ac70-ca56b24d3a00"}, {"Element": "<span lang=\"EN-GB\">Mylan\n  bvba/sprl</span>", "ID": "9d8f3efd-ef95-4817-b3d6-d112eac49be3", "Styles": "None", "Classes": "None", "Text": "Mylan   bvba/sprl", "ParentId": "6b90c7d7-afe7-4dce-802a-bd4898a7f22d"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: + 32 (0)2\n  658 61 00</span></p>", "ID": "f14377fd-2be3-4e8f-9c36-f24f909b8a27", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "dcfe2d21-59e5-47ee-ac70-ca56b24d3a00"}, {"Element": "<span lang=\"EN-GB\">Tel: + 32 (0)2\n  658 61 00</span>", "ID": "a37d9f65-7d72-40c0-b416-adac7bae791d", "Styles": "None", "Classes": "None", "Text": "Tel: + 32 (0)2   658 61 00", "ParentId": "f14377fd-2be3-4e8f-9c36-f24f909b8a27"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">(Belgique/Belgien)</span></p>", "ID": "e4af995c-b5d8-4007-b460-65229455b10d", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "dcfe2d21-59e5-47ee-ac70-ca56b24d3a00"}, {"Element": "<span lang=\"EN-GB\">(Belgique/Belgien)</span>", "ID": "4b77f93f-9390-4631-a864-084a261c8b47", "Styles": "None", "Classes": "None", "Text": "(Belgique/Belgien)", "ParentId": "e4af995c-b5d8-4007-b460-65229455b10d"}, {"Element": "<tr style=\"height:49.1pt\">\n<td style=\"border:none;padding:0in 0in 0in 0in\" width=\"2\"><p class=\"MsoNormal\">\u00a0</p></td>\n<td style=\"width:232.2pt;padding:0in 5.4pt 0in 5.4pt;\n  height:49.1pt\" valign=\"top\" width=\"310\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">\u010cesk\u00e1\n  republika</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Mylan\n  Pharmaceuticals.s.r.o.</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel:\n  +420\u00a0222 004 400</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt;\n  height:49.1pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Magyarorsz\u00e1g</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Mylan EPD\n  Kft</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: + 36 1\u00a0465\n  2100</span></p>\n</td>\n</tr>", "ID": "6db82422-764c-43c3-9da4-c51dd1f971a0", "Styles": "height:49.1pt", "Classes": "None", "Text": "    ", "ParentId": "322a33b5-fe92-4152-8984-cfa70a8d9bf2"}, {"Element": "<td style=\"border:none;padding:0in 0in 0in 0in\" width=\"2\"><p class=\"MsoNormal\">\u00a0</p></td>", "ID": "373d0383-10a1-45bb-accd-496405c9bd0d", "Styles": "border:none;padding:0in 0in 0in 0in", "Classes": "None", "Text": "", "ParentId": "6db82422-764c-43c3-9da4-c51dd1f971a0"}, {"Element": "<p class=\"MsoNormal\">\u00a0</p>", "ID": "84cf3b05-6533-4ae9-ab94-10ec19ff5766", "Styles": "None", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "373d0383-10a1-45bb-accd-496405c9bd0d"}, {"Element": "<td style=\"width:232.2pt;padding:0in 5.4pt 0in 5.4pt;\n  height:49.1pt\" valign=\"top\" width=\"310\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">\u010cesk\u00e1\n  republika</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Mylan\n  Pharmaceuticals.s.r.o.</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel:\n  +420\u00a0222 004 400</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "954564ef-4b4a-4448-be2c-912f686c3737", "Styles": "width:232.2pt;padding:0in 5.4pt 0in 5.4pt;\n  height:49.1pt", "Classes": "None", "Text": "     ", "ParentId": "6db82422-764c-43c3-9da4-c51dd1f971a0"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">\u010cesk\u00e1\n  republika</span></b></p>", "ID": "d30852ec-1686-435e-93a2-3766a7375164", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "954564ef-4b4a-4448-be2c-912f686c3737"}, {"Element": "<b><span lang=\"EN-GB\">\u010cesk\u00e1\n  republika</span></b>", "ID": "df879d20-7aa4-4b78-8b50-4f10d2dbdba1", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d30852ec-1686-435e-93a2-3766a7375164"}, {"Element": "<span lang=\"EN-GB\">\u010cesk\u00e1\n  republika</span>", "ID": "3ddf751a-fda3-4689-91f5-d049a992388c", "Styles": "None", "Classes": "None", "Text": "\u010cesk\u00e1   republika", "ParentId": "df879d20-7aa4-4b78-8b50-4f10d2dbdba1"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Mylan\n  Pharmaceuticals.s.r.o.</span></p>", "ID": "33416424-4e0c-49c5-addf-9db5ccdcbfb8", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "954564ef-4b4a-4448-be2c-912f686c3737"}, {"Element": "<span lang=\"EN-GB\">Mylan\n  Pharmaceuticals.s.r.o.</span>", "ID": "9ff75be5-1883-4a35-b7a4-45a42fbde163", "Styles": "None", "Classes": "None", "Text": "Mylan   Pharmaceuticals.s.r.o.", "ParentId": "33416424-4e0c-49c5-addf-9db5ccdcbfb8"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel:\n  +420\u00a0222 004 400</span></p>", "ID": "031da931-3243-458b-9547-b0dd0d61dbb8", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "954564ef-4b4a-4448-be2c-912f686c3737"}, {"Element": "<span lang=\"EN-GB\">Tel:\n  +420\u00a0222 004 400</span>", "ID": "785f7aa6-23b8-4c6a-b71e-aca557d2354f", "Styles": "None", "Classes": "None", "Text": "Tel:   +420\u00a0222 004 400", "ParentId": "031da931-3243-458b-9547-b0dd0d61dbb8"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "3186de9c-ac2b-4978-b357-732a3087b5f7", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "954564ef-4b4a-4448-be2c-912f686c3737"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "48e0cf7f-a468-4617-aaac-fedfa44a7a07", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "3186de9c-ac2b-4978-b357-732a3087b5f7"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt;\n  height:49.1pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Magyarorsz\u00e1g</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Mylan EPD\n  Kft</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: + 36 1\u00a0465\n  2100</span></p>\n</td>", "ID": "9458675a-a41f-4acb-a83f-bd49e3904f06", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt;\n  height:49.1pt", "Classes": "None", "Text": "    ", "ParentId": "6db82422-764c-43c3-9da4-c51dd1f971a0"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Magyarorsz\u00e1g</span></b></p>", "ID": "beb77499-c529-4644-950f-e60a8edb2efe", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "9458675a-a41f-4acb-a83f-bd49e3904f06"}, {"Element": "<b><span lang=\"EN-GB\">Magyarorsz\u00e1g</span></b>", "ID": "4f2ddd6f-f17f-4241-8553-b5ac3ebbbdb3", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "beb77499-c529-4644-950f-e60a8edb2efe"}, {"Element": "<span lang=\"EN-GB\">Magyarorsz\u00e1g</span>", "ID": "349cf8d7-692b-49b4-9e93-0ddf02485fae", "Styles": "None", "Classes": "None", "Text": "Magyarorsz\u00e1g", "ParentId": "4f2ddd6f-f17f-4241-8553-b5ac3ebbbdb3"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Mylan EPD\n  Kft</span></p>", "ID": "a49a5604-fbf0-4ee1-820c-1558b08bb7db", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "9458675a-a41f-4acb-a83f-bd49e3904f06"}, {"Element": "<span lang=\"EN-GB\">Mylan EPD\n  Kft</span>", "ID": "aedb2ba7-23b6-469e-915c-49935d82f2f8", "Styles": "None", "Classes": "None", "Text": "Mylan EPD   Kft", "ParentId": "a49a5604-fbf0-4ee1-820c-1558b08bb7db"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: + 36 1\u00a0465\n  2100</span></p>", "ID": "c9a8ec7c-84f0-48ee-adbd-fab55f9cbf7f", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "9458675a-a41f-4acb-a83f-bd49e3904f06"}, {"Element": "<span lang=\"EN-GB\">Tel: + 36 1\u00a0465\n  2100</span>", "ID": "b3357e79-f231-4156-be57-ac1468ee0efa", "Styles": "None", "Classes": "None", "Text": "Tel: + 36 1\u00a0465   2100", "ParentId": "c9a8ec7c-84f0-48ee-adbd-fab55f9cbf7f"}, {"Element": "<tr>\n<td style=\"border:none;padding:0in 0in 0in 0in\" width=\"2\"><p class=\"MsoNormal\">\u00a0</p></td>\n<td style=\"width:232.2pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"310\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Danmark</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Mylan AB</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tlf: + 46\n  855 522 750 </span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">(Sverige)</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Malta</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">V.J.\n  Salomone Pharma Ltd</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: + 356\n  21 22 01 74</span></p>\n</td>\n</tr>", "ID": "2870fe7e-63b9-4c54-9fd1-7429e3e70dd7", "Styles": "None", "Classes": "None", "Text": "    ", "ParentId": "322a33b5-fe92-4152-8984-cfa70a8d9bf2"}, {"Element": "<td style=\"border:none;padding:0in 0in 0in 0in\" width=\"2\"><p class=\"MsoNormal\">\u00a0</p></td>", "ID": "99bc93fd-9e48-48e7-95b5-280eeeca481f", "Styles": "border:none;padding:0in 0in 0in 0in", "Classes": "None", "Text": "", "ParentId": "2870fe7e-63b9-4c54-9fd1-7429e3e70dd7"}, {"Element": "<p class=\"MsoNormal\">\u00a0</p>", "ID": "3779a60f-26ff-4829-81bc-1db1f86df980", "Styles": "None", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "99bc93fd-9e48-48e7-95b5-280eeeca481f"}, {"Element": "<td style=\"width:232.2pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"310\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Danmark</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Mylan AB</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tlf: + 46\n  855 522 750 </span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">(Sverige)</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "fe19d8fd-28ed-400e-856e-3993b49be5cd", "Styles": "width:232.2pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "      ", "ParentId": "2870fe7e-63b9-4c54-9fd1-7429e3e70dd7"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Danmark</span></b></p>", "ID": "4483870c-fa3d-4a68-be70-e13e7f78ad12", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "fe19d8fd-28ed-400e-856e-3993b49be5cd"}, {"Element": "<b><span lang=\"EN-GB\">Danmark</span></b>", "ID": "ee5f00b6-bb4a-4dce-8b8d-d4705d72dab9", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4483870c-fa3d-4a68-be70-e13e7f78ad12"}, {"Element": "<span lang=\"EN-GB\">Danmark</span>", "ID": "15c7fcb6-ae76-4d2d-b251-28e62a757077", "Styles": "None", "Classes": "None", "Text": "Danmark", "ParentId": "ee5f00b6-bb4a-4dce-8b8d-d4705d72dab9"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Mylan AB</span></p>", "ID": "80ddfe3a-bac2-4a71-bf50-583d60bb30bf", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "fe19d8fd-28ed-400e-856e-3993b49be5cd"}, {"Element": "<span lang=\"EN-GB\">Mylan AB</span>", "ID": "31df83d2-1a8d-4faf-9d1b-9a610e62bc2b", "Styles": "None", "Classes": "None", "Text": "Mylan AB", "ParentId": "80ddfe3a-bac2-4a71-bf50-583d60bb30bf"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tlf: + 46\n  855 522 750 </span></p>", "ID": "f524709d-78b9-4ea3-a363-a49ebe69cfc7", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "fe19d8fd-28ed-400e-856e-3993b49be5cd"}, {"Element": "<span lang=\"EN-GB\">Tlf: + 46\n  855 522 750 </span>", "ID": "de0c1403-7117-441b-979f-bb02db91c26e", "Styles": "None", "Classes": "None", "Text": "Tlf: + 46   855 522 750 ", "ParentId": "f524709d-78b9-4ea3-a363-a49ebe69cfc7"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">(Sverige)</span></p>", "ID": "5d7fd954-ed44-4ae5-a9c4-5054bcb7f761", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "fe19d8fd-28ed-400e-856e-3993b49be5cd"}, {"Element": "<span lang=\"EN-GB\">(Sverige)</span>", "ID": "409b044e-6b57-4dbd-a523-ec6fc37d824c", "Styles": "None", "Classes": "None", "Text": "(Sverige)", "ParentId": "5d7fd954-ed44-4ae5-a9c4-5054bcb7f761"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "11a7d9f4-bc1e-464c-91e0-0b4241ef6d1a", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "fe19d8fd-28ed-400e-856e-3993b49be5cd"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "2e02021f-5a68-4cc3-a011-8411cdb9dcaa", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "11a7d9f4-bc1e-464c-91e0-0b4241ef6d1a"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Malta</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">V.J.\n  Salomone Pharma Ltd</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: + 356\n  21 22 01 74</span></p>\n</td>", "ID": "2ef7420b-7461-4367-a88e-7c82fd015faf", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "    ", "ParentId": "2870fe7e-63b9-4c54-9fd1-7429e3e70dd7"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Malta</span></b></p>", "ID": "5268aa6f-26b4-4b40-8d10-84e727321ae5", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "2ef7420b-7461-4367-a88e-7c82fd015faf"}, {"Element": "<b><span lang=\"EN-GB\">Malta</span></b>", "ID": "2a2001db-8c6b-4774-bf55-ec83ed90da92", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "5268aa6f-26b4-4b40-8d10-84e727321ae5"}, {"Element": "<span lang=\"EN-GB\">Malta</span>", "ID": "6cef0b34-cc18-4010-b35e-1e1d474a4f6d", "Styles": "None", "Classes": "None", "Text": "Malta", "ParentId": "2a2001db-8c6b-4774-bf55-ec83ed90da92"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">V.J.\n  Salomone Pharma Ltd</span></p>", "ID": "a3000e00-a737-46f6-a29b-b4aee0361d4f", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "2ef7420b-7461-4367-a88e-7c82fd015faf"}, {"Element": "<span lang=\"EN-GB\">V.J.\n  Salomone Pharma Ltd</span>", "ID": "ec8902a5-1019-4acf-abd1-996c2054eaa4", "Styles": "None", "Classes": "None", "Text": "V.J.   Salomone Pharma Ltd", "ParentId": "a3000e00-a737-46f6-a29b-b4aee0361d4f"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: + 356\n  21 22 01 74</span></p>", "ID": "885a7d1b-6ba7-408f-80f8-1bc1c5aaf6f6", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "2ef7420b-7461-4367-a88e-7c82fd015faf"}, {"Element": "<span lang=\"EN-GB\">Tel: + 356\n  21 22 01 74</span>", "ID": "4da08e7b-7f8d-48e6-90f5-f31684b9be07", "Styles": "None", "Classes": "None", "Text": "Tel: + 356   21 22 01 74", "ParentId": "885a7d1b-6ba7-408f-80f8-1bc1c5aaf6f6"}, {"Element": "<tr>\n<td style=\"border:none;padding:0in 0in 0in 0in\" width=\"2\"><p class=\"MsoNormal\">\u00a0</p></td>\n<td style=\"width:232.2pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"310\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Deutschland</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Mylan dura\n  GmbH </span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: +\n  49-(0) 6172 888 01</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Nederland</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Mylan BV</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: +31\n  (0)20 426 3300</span></p>\n</td>\n</tr>", "ID": "be31bcaf-e702-43c4-a4a3-6dff3499dd79", "Styles": "None", "Classes": "None", "Text": "    ", "ParentId": "322a33b5-fe92-4152-8984-cfa70a8d9bf2"}, {"Element": "<td style=\"border:none;padding:0in 0in 0in 0in\" width=\"2\"><p class=\"MsoNormal\">\u00a0</p></td>", "ID": "6efbbbbe-010b-4126-9d74-33f83c28eff6", "Styles": "border:none;padding:0in 0in 0in 0in", "Classes": "None", "Text": "", "ParentId": "be31bcaf-e702-43c4-a4a3-6dff3499dd79"}, {"Element": "<p class=\"MsoNormal\">\u00a0</p>", "ID": "e09c5b74-24b5-4b12-8733-693c962961dd", "Styles": "None", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "6efbbbbe-010b-4126-9d74-33f83c28eff6"}, {"Element": "<td style=\"width:232.2pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"310\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Deutschland</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Mylan dura\n  GmbH </span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: +\n  49-(0) 6172 888 01</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "76b95dc8-3a0b-4026-9e6c-1c3f0e2712a6", "Styles": "width:232.2pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "     ", "ParentId": "be31bcaf-e702-43c4-a4a3-6dff3499dd79"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Deutschland</span></b></p>", "ID": "45d89672-bf61-429d-b9bd-0ddabfc423a6", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "76b95dc8-3a0b-4026-9e6c-1c3f0e2712a6"}, {"Element": "<b><span lang=\"EN-GB\">Deutschland</span></b>", "ID": "8f4d5264-411c-4153-bf51-bd51f9722d22", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "45d89672-bf61-429d-b9bd-0ddabfc423a6"}, {"Element": "<span lang=\"EN-GB\">Deutschland</span>", "ID": "9e927638-4b98-466b-a5f4-b599cbdedd91", "Styles": "None", "Classes": "None", "Text": "Deutschland", "ParentId": "8f4d5264-411c-4153-bf51-bd51f9722d22"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Mylan dura\n  GmbH </span></p>", "ID": "30a3fb1f-c619-41c4-b0cc-0699d988b089", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "76b95dc8-3a0b-4026-9e6c-1c3f0e2712a6"}, {"Element": "<span lang=\"EN-GB\">Mylan dura\n  GmbH </span>", "ID": "67629785-166b-4a3d-a8a8-3c716abd9a1c", "Styles": "None", "Classes": "None", "Text": "Mylan dura   GmbH ", "ParentId": "30a3fb1f-c619-41c4-b0cc-0699d988b089"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: +\n  49-(0) 6172 888 01</span></p>", "ID": "593904d7-64e8-4d74-8a9f-693323404ea2", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "76b95dc8-3a0b-4026-9e6c-1c3f0e2712a6"}, {"Element": "<span lang=\"EN-GB\">Tel: +\n  49-(0) 6172 888 01</span>", "ID": "a6bc74cf-04b6-4d6e-9a57-4b697c5b05b6", "Styles": "None", "Classes": "None", "Text": "Tel: +   49-(0) 6172 888 01", "ParentId": "593904d7-64e8-4d74-8a9f-693323404ea2"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a63161b6-4765-4738-8df5-530fff16c7dd", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "76b95dc8-3a0b-4026-9e6c-1c3f0e2712a6"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "393d5a90-8e6e-4ba0-9f79-b47902011cce", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a63161b6-4765-4738-8df5-530fff16c7dd"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Nederland</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Mylan BV</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: +31\n  (0)20 426 3300</span></p>\n</td>", "ID": "d9310c15-a72b-495f-9f94-a9d0fc9d4117", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "    ", "ParentId": "be31bcaf-e702-43c4-a4a3-6dff3499dd79"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Nederland</span></b></p>", "ID": "a7322453-656c-4a12-a028-81c62d1b3663", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "d9310c15-a72b-495f-9f94-a9d0fc9d4117"}, {"Element": "<b><span lang=\"EN-GB\">Nederland</span></b>", "ID": "d7fc79aa-0492-4cbd-bdb6-9034f48d6678", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a7322453-656c-4a12-a028-81c62d1b3663"}, {"Element": "<span lang=\"EN-GB\">Nederland</span>", "ID": "a7900d87-2d68-4515-b5c3-b3bf4f2a6c07", "Styles": "None", "Classes": "None", "Text": "Nederland", "ParentId": "d7fc79aa-0492-4cbd-bdb6-9034f48d6678"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Mylan BV</span></p>", "ID": "b21207b2-ecd8-480c-98f7-6471350a0ad8", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "d9310c15-a72b-495f-9f94-a9d0fc9d4117"}, {"Element": "<span lang=\"EN-GB\">Mylan BV</span>", "ID": "a09f1388-86d6-438b-9114-255a9bf1c970", "Styles": "None", "Classes": "None", "Text": "Mylan BV", "ParentId": "b21207b2-ecd8-480c-98f7-6471350a0ad8"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: +31\n  (0)20 426 3300</span></p>", "ID": "be4abc16-e954-49b8-bfdc-b16745fef913", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "d9310c15-a72b-495f-9f94-a9d0fc9d4117"}, {"Element": "<span lang=\"EN-GB\">Tel: +31\n  (0)20 426 3300</span>", "ID": "147fbf4b-e7d9-48fc-bea3-b0493a502011", "Styles": "None", "Classes": "None", "Text": "Tel: +31   (0)20 426 3300", "ParentId": "be4abc16-e954-49b8-bfdc-b16745fef913"}, {"Element": "<tr>\n<td style=\"border:none;padding:0in 0in 0in 0in\" width=\"2\"><p class=\"MsoNormal\">\u00a0</p></td>\n<td style=\"width:232.2pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"310\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Eesti</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">BGP\n  Products Switzerland GmbH Eesti filiaal</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: + 372\n  6363 052</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Norge</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Mylan AB</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: + 46\n  855 522 750</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">(Sverige)</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>", "ID": "eba0ee66-4ee0-4058-90fd-4d7ce0a99f30", "Styles": "None", "Classes": "None", "Text": "    ", "ParentId": "322a33b5-fe92-4152-8984-cfa70a8d9bf2"}, {"Element": "<td style=\"border:none;padding:0in 0in 0in 0in\" width=\"2\"><p class=\"MsoNormal\">\u00a0</p></td>", "ID": "bf049d19-8d47-4199-b5f8-fd168578064e", "Styles": "border:none;padding:0in 0in 0in 0in", "Classes": "None", "Text": "", "ParentId": "eba0ee66-4ee0-4058-90fd-4d7ce0a99f30"}, {"Element": "<p class=\"MsoNormal\">\u00a0</p>", "ID": "17b92b1c-88d3-4566-ac9a-aee166b358e5", "Styles": "None", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "bf049d19-8d47-4199-b5f8-fd168578064e"}, {"Element": "<td style=\"width:232.2pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"310\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Eesti</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">BGP\n  Products Switzerland GmbH Eesti filiaal</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: + 372\n  6363 052</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "cc803b12-ab99-4921-9f97-187a55f4d113", "Styles": "width:232.2pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "     ", "ParentId": "eba0ee66-4ee0-4058-90fd-4d7ce0a99f30"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Eesti</span></b></p>", "ID": "ccf02805-14ce-432a-83a1-b29a0f0bbcb6", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "cc803b12-ab99-4921-9f97-187a55f4d113"}, {"Element": "<b><span lang=\"EN-GB\">Eesti</span></b>", "ID": "5a241a3f-3a15-4c87-8e25-fe177fc7845b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ccf02805-14ce-432a-83a1-b29a0f0bbcb6"}, {"Element": "<span lang=\"EN-GB\">Eesti</span>", "ID": "8548cc4e-27e9-488f-b633-eea9f77a1ea4", "Styles": "None", "Classes": "None", "Text": "Eesti", "ParentId": "5a241a3f-3a15-4c87-8e25-fe177fc7845b"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">BGP\n  Products Switzerland GmbH Eesti filiaal</span></p>", "ID": "745435ac-1191-427b-bfe0-58d3a1e74f1e", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "cc803b12-ab99-4921-9f97-187a55f4d113"}, {"Element": "<span lang=\"EN-GB\">BGP\n  Products Switzerland GmbH Eesti filiaal</span>", "ID": "f0c02ed3-112b-4c16-af35-48719b9e444e", "Styles": "None", "Classes": "None", "Text": "BGP   Products Switzerland GmbH Eesti filiaal", "ParentId": "745435ac-1191-427b-bfe0-58d3a1e74f1e"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: + 372\n  6363 052</span></p>", "ID": "2c390aea-07a2-45ff-adeb-66968ba63db9", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "cc803b12-ab99-4921-9f97-187a55f4d113"}, {"Element": "<span lang=\"EN-GB\">Tel: + 372\n  6363 052</span>", "ID": "e67544a1-99fd-463b-95c5-fc167bf80aa8", "Styles": "None", "Classes": "None", "Text": "Tel: + 372   6363 052", "ParentId": "2c390aea-07a2-45ff-adeb-66968ba63db9"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "91993eca-bf6d-4488-9b99-f92d6c6a5379", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "cc803b12-ab99-4921-9f97-187a55f4d113"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "4a4acdcb-1a9d-4921-9c55-0caab8997a59", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "91993eca-bf6d-4488-9b99-f92d6c6a5379"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Norge</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Mylan AB</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: + 46\n  855 522 750</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">(Sverige)</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "b8723a37-812d-4ec2-a621-729d26a1cce3", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "      ", "ParentId": "eba0ee66-4ee0-4058-90fd-4d7ce0a99f30"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Norge</span></b></p>", "ID": "125bdb78-a7ae-4547-bde4-fde0ac343888", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "b8723a37-812d-4ec2-a621-729d26a1cce3"}, {"Element": "<b><span lang=\"EN-GB\">Norge</span></b>", "ID": "316f76d8-651b-4203-887f-7623c717f076", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "125bdb78-a7ae-4547-bde4-fde0ac343888"}, {"Element": "<span lang=\"EN-GB\">Norge</span>", "ID": "e4ea4c5d-be76-4497-b657-d506c9dcc560", "Styles": "None", "Classes": "None", "Text": "Norge", "ParentId": "316f76d8-651b-4203-887f-7623c717f076"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Mylan AB</span></p>", "ID": "e1258e28-561d-46b1-89af-6bf3b04de984", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "b8723a37-812d-4ec2-a621-729d26a1cce3"}, {"Element": "<span lang=\"EN-GB\">Mylan AB</span>", "ID": "bafd9899-90c0-45e2-b6d5-1a4d0bb27156", "Styles": "None", "Classes": "None", "Text": "Mylan AB", "ParentId": "e1258e28-561d-46b1-89af-6bf3b04de984"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: + 46\n  855 522 750</span></p>", "ID": "f25e04bb-43bd-4d91-a531-e47fe93f438d", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "b8723a37-812d-4ec2-a621-729d26a1cce3"}, {"Element": "<span lang=\"EN-GB\">Tel: + 46\n  855 522 750</span>", "ID": "8d2ecb39-a487-4421-93dc-7ebbb60c34df", "Styles": "None", "Classes": "None", "Text": "Tel: + 46   855 522 750", "ParentId": "f25e04bb-43bd-4d91-a531-e47fe93f438d"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">(Sverige)</span></p>", "ID": "f49d8cd3-0894-4715-8572-906046956547", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "b8723a37-812d-4ec2-a621-729d26a1cce3"}, {"Element": "<span lang=\"EN-GB\">(Sverige)</span>", "ID": "f16b6578-5c65-4c46-aefa-2e9f99583e42", "Styles": "None", "Classes": "None", "Text": "(Sverige)", "ParentId": "f49d8cd3-0894-4715-8572-906046956547"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "68c9ca66-ab27-4bec-879f-c0af7224957e", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "b8723a37-812d-4ec2-a621-729d26a1cce3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "4499d4f2-9ffe-47e8-af63-30683c0843e8", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "68c9ca66-ab27-4bec-879f-c0af7224957e"}, {"Element": "<tr>\n<td style=\"border:none;padding:0in 0in 0in 0in\" width=\"2\"><p class=\"MsoNormal\">\u00a0</p></td>\n<td style=\"width:232.2pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"310\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">\u0395\u03bb\u03bb\u03ac\u03b4\u03b1\n  </span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Generics\n  Pharma Hellas \u0395\u03a0\u0395 </span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u03a4\u03b7\u03bb:\n  +30 210 993 6410 </span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">\u00d6sterreich</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Arcana\n  Arzneimittel GmbH</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: </span>+43\n  1 416 2418</p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>", "ID": "9ac8c525-89e7-47e0-b05e-d21a56380329", "Styles": "None", "Classes": "None", "Text": "    ", "ParentId": "322a33b5-fe92-4152-8984-cfa70a8d9bf2"}, {"Element": "<td style=\"border:none;padding:0in 0in 0in 0in\" width=\"2\"><p class=\"MsoNormal\">\u00a0</p></td>", "ID": "5ce3e26a-712f-4edc-92f1-904918f77944", "Styles": "border:none;padding:0in 0in 0in 0in", "Classes": "None", "Text": "", "ParentId": "9ac8c525-89e7-47e0-b05e-d21a56380329"}, {"Element": "<p class=\"MsoNormal\">\u00a0</p>", "ID": "aec292dd-4fe1-4da2-9ab2-d934fe52c8e8", "Styles": "None", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "5ce3e26a-712f-4edc-92f1-904918f77944"}, {"Element": "<td style=\"width:232.2pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"310\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">\u0395\u03bb\u03bb\u03ac\u03b4\u03b1\n  </span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Generics\n  Pharma Hellas \u0395\u03a0\u0395 </span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u03a4\u03b7\u03bb:\n  +30 210 993 6410 </span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "21545a39-b1e9-4660-a788-f39d544f4030", "Styles": "width:232.2pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "     ", "ParentId": "9ac8c525-89e7-47e0-b05e-d21a56380329"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">\u0395\u03bb\u03bb\u03ac\u03b4\u03b1\n  </span></b></p>", "ID": "d5d0f72c-0aab-4858-a69c-56c06c04febf", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "21545a39-b1e9-4660-a788-f39d544f4030"}, {"Element": "<b><span lang=\"EN-GB\">\u0395\u03bb\u03bb\u03ac\u03b4\u03b1\n  </span></b>", "ID": "74cf4f6e-4ce7-4992-8130-88b3211fd7c6", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d5d0f72c-0aab-4858-a69c-56c06c04febf"}, {"Element": "<span lang=\"EN-GB\">\u0395\u03bb\u03bb\u03ac\u03b4\u03b1\n  </span>", "ID": "cb77e50d-7e9a-4622-a991-3d00b066d60a", "Styles": "None", "Classes": "None", "Text": "\u0395\u03bb\u03bb\u03ac\u03b4\u03b1   ", "ParentId": "74cf4f6e-4ce7-4992-8130-88b3211fd7c6"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Generics\n  Pharma Hellas \u0395\u03a0\u0395 </span></p>", "ID": "3178da51-f892-4a3a-aaf7-6209d3c2eafd", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "21545a39-b1e9-4660-a788-f39d544f4030"}, {"Element": "<span lang=\"EN-GB\">Generics\n  Pharma Hellas \u0395\u03a0\u0395 </span>", "ID": "59d50187-b465-4068-8891-5021fa5e8fdc", "Styles": "None", "Classes": "None", "Text": "Generics   Pharma Hellas \u0395\u03a0\u0395 ", "ParentId": "3178da51-f892-4a3a-aaf7-6209d3c2eafd"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u03a4\u03b7\u03bb:\n  +30 210 993 6410 </span></p>", "ID": "b39b9ba0-e737-44a4-8381-a60873595155", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "21545a39-b1e9-4660-a788-f39d544f4030"}, {"Element": "<span lang=\"EN-GB\">\u03a4\u03b7\u03bb:\n  +30 210 993 6410 </span>", "ID": "71a26e8b-2861-480a-86e8-1fb17ac551ab", "Styles": "None", "Classes": "None", "Text": "\u03a4\u03b7\u03bb:   +30 210 993 6410 ", "ParentId": "b39b9ba0-e737-44a4-8381-a60873595155"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "e5c656a7-87d3-4558-93ba-2b057e959f4c", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "21545a39-b1e9-4660-a788-f39d544f4030"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "2a501a1c-4c11-4113-86d4-c9b5f437cddc", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e5c656a7-87d3-4558-93ba-2b057e959f4c"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">\u00d6sterreich</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Arcana\n  Arzneimittel GmbH</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: </span>+43\n  1 416 2418</p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "cb2dfa3f-da4f-489f-94f6-3ce78975a1ea", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "     ", "ParentId": "9ac8c525-89e7-47e0-b05e-d21a56380329"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">\u00d6sterreich</span></b></p>", "ID": "9682e553-d332-40ba-8c73-e250420cfa41", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "cb2dfa3f-da4f-489f-94f6-3ce78975a1ea"}, {"Element": "<b><span lang=\"EN-GB\">\u00d6sterreich</span></b>", "ID": "64ee307f-7ad0-4d5e-aa4e-cb85c15a1b3f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9682e553-d332-40ba-8c73-e250420cfa41"}, {"Element": "<span lang=\"EN-GB\">\u00d6sterreich</span>", "ID": "fe58ac3d-4088-4e92-a6f2-0cc9541d6dae", "Styles": "None", "Classes": "None", "Text": "\u00d6sterreich", "ParentId": "64ee307f-7ad0-4d5e-aa4e-cb85c15a1b3f"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Arcana\n  Arzneimittel GmbH</span></p>", "ID": "f6c7bcf9-e59b-43f1-a077-a417d3c061e6", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "cb2dfa3f-da4f-489f-94f6-3ce78975a1ea"}, {"Element": "<span lang=\"EN-GB\">Arcana\n  Arzneimittel GmbH</span>", "ID": "aa9bd12a-9d12-48a2-bfac-ef193221cae1", "Styles": "None", "Classes": "None", "Text": "Arcana   Arzneimittel GmbH", "ParentId": "f6c7bcf9-e59b-43f1-a077-a417d3c061e6"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: </span>+43\n  1 416 2418</p>", "ID": "053d8125-5b81-473d-83c1-c353c0e2b5f1", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "+43   1 416 2418", "ParentId": "cb2dfa3f-da4f-489f-94f6-3ce78975a1ea"}, {"Element": "<span lang=\"EN-GB\">Tel: </span>", "ID": "51fff458-0ff4-4e4e-a9a6-3b033eb3d85a", "Styles": "None", "Classes": "None", "Text": "Tel: ", "ParentId": "053d8125-5b81-473d-83c1-c353c0e2b5f1"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "e8b1538e-557a-44ab-8d14-529abf9c1c60", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "cb2dfa3f-da4f-489f-94f6-3ce78975a1ea"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "9aef7459-5c06-4d02-b654-3728dc5f16b9", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e8b1538e-557a-44ab-8d14-529abf9c1c60"}, {"Element": "<tr>\n<td colspan=\"2\" style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Espa\u00f1a</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Mylan Pharmaceuticals,\n  S.L</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: </span><span lang=\"EN-GB\">+ 34 900 102 712</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Polska</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Mylan Healthcare\n  Sp. z.o.o.</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: + 48\n  22 546 64 00</span></p>\n</td>\n</tr>", "ID": "1a174386-fb30-4738-8fb4-86813ebfe63d", "Styles": "None", "Classes": "None", "Text": "   ", "ParentId": "322a33b5-fe92-4152-8984-cfa70a8d9bf2"}, {"Element": "<td colspan=\"2\" style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Espa\u00f1a</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Mylan Pharmaceuticals,\n  S.L</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: </span><span lang=\"EN-GB\">+ 34 900 102 712</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "7d175689-4c74-4e95-8fa1-fc4bcf6860a7", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "     ", "ParentId": "1a174386-fb30-4738-8fb4-86813ebfe63d"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Espa\u00f1a</span></b></p>", "ID": "c74b3149-af54-404b-a2ea-73806211ffd5", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "7d175689-4c74-4e95-8fa1-fc4bcf6860a7"}, {"Element": "<b><span lang=\"EN-GB\">Espa\u00f1a</span></b>", "ID": "32e6d8ab-7214-413f-a092-9a46f386acd1", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c74b3149-af54-404b-a2ea-73806211ffd5"}, {"Element": "<span lang=\"EN-GB\">Espa\u00f1a</span>", "ID": "cb134aac-5e2f-4399-98bd-f0435f48fbf3", "Styles": "None", "Classes": "None", "Text": "Espa\u00f1a", "ParentId": "32e6d8ab-7214-413f-a092-9a46f386acd1"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Mylan Pharmaceuticals,\n  S.L</span></p>", "ID": "d20fa71d-9588-4a58-b13c-069280b63795", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "7d175689-4c74-4e95-8fa1-fc4bcf6860a7"}, {"Element": "<span lang=\"EN-GB\">Mylan Pharmaceuticals,\n  S.L</span>", "ID": "a2547a5d-ef47-4e03-8277-82e40f126999", "Styles": "None", "Classes": "None", "Text": "Mylan Pharmaceuticals,   S.L", "ParentId": "d20fa71d-9588-4a58-b13c-069280b63795"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: </span><span lang=\"EN-GB\">+ 34 900 102 712</span></p>", "ID": "a5df61f2-48e9-477b-985c-ba380cc5d2f1", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "7d175689-4c74-4e95-8fa1-fc4bcf6860a7"}, {"Element": "<span lang=\"EN-GB\">Tel: </span>", "ID": "304bd1d4-f407-44cd-a310-8caf957c3690", "Styles": "None", "Classes": "None", "Text": "Tel: ", "ParentId": "a5df61f2-48e9-477b-985c-ba380cc5d2f1"}, {"Element": "<span lang=\"EN-GB\">+ 34 900 102 712</span>", "ID": "12960506-8b1d-4d6b-ab7a-f1a141f83d05", "Styles": "None", "Classes": "None", "Text": "+ 34 900 102 712", "ParentId": "a5df61f2-48e9-477b-985c-ba380cc5d2f1"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "2a2c594d-050a-44a9-a2df-f3ba2ce5eb2d", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "7d175689-4c74-4e95-8fa1-fc4bcf6860a7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "af08eea0-ad1f-4e2c-8ed0-9d4e951c02d8", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "2a2c594d-050a-44a9-a2df-f3ba2ce5eb2d"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Polska</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Mylan Healthcare\n  Sp. z.o.o.</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: + 48\n  22 546 64 00</span></p>\n</td>", "ID": "24274c4e-d959-49e1-a0e0-66ed1e1bc2a2", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "    ", "ParentId": "1a174386-fb30-4738-8fb4-86813ebfe63d"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Polska</span></b></p>", "ID": "ecc41c88-5f52-429b-ad76-ffa96c2a447b", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "24274c4e-d959-49e1-a0e0-66ed1e1bc2a2"}, {"Element": "<b><span lang=\"EN-GB\">Polska</span></b>", "ID": "d7ef16e5-0a27-4a69-99bc-94b1c5c6d531", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ecc41c88-5f52-429b-ad76-ffa96c2a447b"}, {"Element": "<span lang=\"EN-GB\">Polska</span>", "ID": "3ef4bce8-c3d7-46ea-b0ec-d4f50421dd0b", "Styles": "None", "Classes": "None", "Text": "Polska", "ParentId": "d7ef16e5-0a27-4a69-99bc-94b1c5c6d531"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Mylan Healthcare\n  Sp. z.o.o.</span></p>", "ID": "77ef874e-a2bd-4f72-8751-b5e81e3a90b4", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "24274c4e-d959-49e1-a0e0-66ed1e1bc2a2"}, {"Element": "<span lang=\"EN-GB\">Mylan Healthcare\n  Sp. z.o.o.</span>", "ID": "6c4c64bd-c56d-4dee-aaaa-7d8e69625dd8", "Styles": "None", "Classes": "None", "Text": "Mylan Healthcare   Sp. z.o.o.", "ParentId": "77ef874e-a2bd-4f72-8751-b5e81e3a90b4"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: + 48\n  22 546 64 00</span></p>", "ID": "0f925da1-10bc-4d48-b394-26e9b4444b21", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "24274c4e-d959-49e1-a0e0-66ed1e1bc2a2"}, {"Element": "<span lang=\"EN-GB\">Tel: + 48\n  22 546 64 00</span>", "ID": "7f95731f-4003-49a4-80aa-d284733418d4", "Styles": "None", "Classes": "None", "Text": "Tel: + 48   22 546 64 00", "ParentId": "0f925da1-10bc-4d48-b394-26e9b4444b21"}, {"Element": "<tr>\n<td colspan=\"2\" style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">France</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Mylan S.A.S</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: +33 4\n  37 25 75 00</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Portugal</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Mylan, Lda.</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: + 351\n  21 412 72 56</span></p>\n</td>\n</tr>", "ID": "f6e8ea8c-e8fd-4e8e-943c-e948ecfcbd89", "Styles": "None", "Classes": "None", "Text": "   ", "ParentId": "322a33b5-fe92-4152-8984-cfa70a8d9bf2"}, {"Element": "<td colspan=\"2\" style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">France</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Mylan S.A.S</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: +33 4\n  37 25 75 00</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "f43fc680-d1e6-4710-bc04-6169681ef94f", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "     ", "ParentId": "f6e8ea8c-e8fd-4e8e-943c-e948ecfcbd89"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">France</span></b></p>", "ID": "670ebc3b-60a3-4ce6-840a-2bbb071685b0", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "f43fc680-d1e6-4710-bc04-6169681ef94f"}, {"Element": "<b><span lang=\"EN-GB\">France</span></b>", "ID": "bfd33b3c-d3ea-4196-aa4f-0261dd0bcd18", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "670ebc3b-60a3-4ce6-840a-2bbb071685b0"}, {"Element": "<span lang=\"EN-GB\">France</span>", "ID": "e5fb021f-814e-4627-948d-3b4e078e0d83", "Styles": "None", "Classes": "None", "Text": "France", "ParentId": "bfd33b3c-d3ea-4196-aa4f-0261dd0bcd18"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Mylan S.A.S</span></p>", "ID": "cbd33082-5a15-41f2-92a1-61c159fd36a0", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "f43fc680-d1e6-4710-bc04-6169681ef94f"}, {"Element": "<span lang=\"EN-GB\">Mylan S.A.S</span>", "ID": "d7ebd891-3679-4c47-ac88-7d81a54e7ad3", "Styles": "None", "Classes": "None", "Text": "Mylan S.A.S", "ParentId": "cbd33082-5a15-41f2-92a1-61c159fd36a0"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: +33 4\n  37 25 75 00</span></p>", "ID": "fb5c8cf4-d0ab-401b-83f1-9bb4ce24af63", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "f43fc680-d1e6-4710-bc04-6169681ef94f"}, {"Element": "<span lang=\"EN-GB\">Tel: +33 4\n  37 25 75 00</span>", "ID": "8e8755b5-4408-464c-8896-7d7bb933b622", "Styles": "None", "Classes": "None", "Text": "Tel: +33 4   37 25 75 00", "ParentId": "fb5c8cf4-d0ab-401b-83f1-9bb4ce24af63"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "d5223108-d4b6-42a7-ae67-2b0653284fae", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "f43fc680-d1e6-4710-bc04-6169681ef94f"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a7d8d9de-dc1a-400d-a339-9741e77e1270", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "d5223108-d4b6-42a7-ae67-2b0653284fae"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Portugal</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Mylan, Lda.</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: + 351\n  21 412 72 56</span></p>\n</td>", "ID": "98353357-e68a-49ec-9ba7-345387b8a4d8", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "    ", "ParentId": "f6e8ea8c-e8fd-4e8e-943c-e948ecfcbd89"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Portugal</span></b></p>", "ID": "503291fd-1a88-4a0a-8b56-7686dff45f1c", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "98353357-e68a-49ec-9ba7-345387b8a4d8"}, {"Element": "<b><span lang=\"EN-GB\">Portugal</span></b>", "ID": "29fce492-dc24-41b4-b7eb-4a532f1aa1b1", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "503291fd-1a88-4a0a-8b56-7686dff45f1c"}, {"Element": "<span lang=\"EN-GB\">Portugal</span>", "ID": "8db64ad3-bc91-46b3-9a54-96571c15ebd1", "Styles": "None", "Classes": "None", "Text": "Portugal", "ParentId": "29fce492-dc24-41b4-b7eb-4a532f1aa1b1"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Mylan, Lda.</span></p>", "ID": "cdefefa0-c9d9-400d-814e-36643f9f257a", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "98353357-e68a-49ec-9ba7-345387b8a4d8"}, {"Element": "<span lang=\"EN-GB\">Mylan, Lda.</span>", "ID": "7ffa82d7-484c-4bec-abe9-9a17563408fe", "Styles": "None", "Classes": "None", "Text": "Mylan, Lda.", "ParentId": "cdefefa0-c9d9-400d-814e-36643f9f257a"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: + 351\n  21 412 72 56</span></p>", "ID": "afd2b3d9-d283-4219-8d42-465845aa9663", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "98353357-e68a-49ec-9ba7-345387b8a4d8"}, {"Element": "<span lang=\"EN-GB\">Tel: + 351\n  21 412 72 56</span>", "ID": "bb176ffa-8ced-4d1f-8537-fbe70313d8f8", "Styles": "None", "Classes": "None", "Text": "Tel: + 351   21 412 72 56", "ParentId": "afd2b3d9-d283-4219-8d42-465845aa9663"}, {"Element": "<tr>\n<td colspan=\"2\" style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Hrvatska</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Mylan\n  Hrvatska d.o.o.</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: +385 1\n  23 50 599</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Rom\u00e2nia</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">BGP\n  Products SRL</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: +40\n  372 579 000</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n  0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>\u00a0</span></p>\n</td>\n</tr>", "ID": "14655528-503e-447c-a36c-f5c04924ad25", "Styles": "None", "Classes": "None", "Text": "   ", "ParentId": "322a33b5-fe92-4152-8984-cfa70a8d9bf2"}, {"Element": "<td colspan=\"2\" style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Hrvatska</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Mylan\n  Hrvatska d.o.o.</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: +385 1\n  23 50 599</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "e7489db8-62db-4cec-8986-9fe9416e11f7", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "     ", "ParentId": "14655528-503e-447c-a36c-f5c04924ad25"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span>", "ID": "06a0570e-5515-4145-a087-5822b93ff09a", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": " ", "ParentId": "e7489db8-62db-4cec-8986-9fe9416e11f7"}, {"Element": "<br clear=\"all\" style=\"page-break-before:always\"/>", "ID": "f475cb13-249a-4d11-b872-64e7cfc2c539", "Styles": "page-break-before:always", "Classes": "None", "Text": "", "ParentId": "06a0570e-5515-4145-a087-5822b93ff09a"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Hrvatska</span></b></p>", "ID": "0523e179-0a46-4dda-b66d-ecde2a30ee58", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "e7489db8-62db-4cec-8986-9fe9416e11f7"}, {"Element": "<b><span lang=\"EN-GB\">Hrvatska</span></b>", "ID": "1d2717de-1cc1-4881-b554-ee22a70f37cf", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0523e179-0a46-4dda-b66d-ecde2a30ee58"}, {"Element": "<span lang=\"EN-GB\">Hrvatska</span>", "ID": "2dc9dd3f-5f8e-4457-90e8-67efaf457603", "Styles": "None", "Classes": "None", "Text": "Hrvatska", "ParentId": "1d2717de-1cc1-4881-b554-ee22a70f37cf"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Mylan\n  Hrvatska d.o.o.</span></p>", "ID": "4fd7c7b2-4bd8-4ce8-bc97-bdecd92382e9", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "e7489db8-62db-4cec-8986-9fe9416e11f7"}, {"Element": "<span lang=\"EN-GB\">Mylan\n  Hrvatska d.o.o.</span>", "ID": "b54bfaea-7fda-4753-9d64-f0096a742c83", "Styles": "None", "Classes": "None", "Text": "Mylan   Hrvatska d.o.o.", "ParentId": "4fd7c7b2-4bd8-4ce8-bc97-bdecd92382e9"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: +385 1\n  23 50 599</span></p>", "ID": "c79e1bae-eedd-4d51-b9fb-4352136562e9", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "e7489db8-62db-4cec-8986-9fe9416e11f7"}, {"Element": "<span lang=\"EN-GB\">Tel: +385 1\n  23 50 599</span>", "ID": "ad95f366-54dd-4248-88e6-35df72fef600", "Styles": "None", "Classes": "None", "Text": "Tel: +385 1   23 50 599", "ParentId": "c79e1bae-eedd-4d51-b9fb-4352136562e9"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "e469d0a4-aa81-44ff-8a2e-e66a3251d2e3", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "e7489db8-62db-4cec-8986-9fe9416e11f7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "32e90a6c-f2c7-48d5-9429-6edaa20a7c51", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e469d0a4-aa81-44ff-8a2e-e66a3251d2e3"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Rom\u00e2nia</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">BGP\n  Products SRL</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: +40\n  372 579 000</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n  0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>\u00a0</span></p>\n</td>", "ID": "98668d23-1f8b-4e0d-ab2a-6f4eca45afcd", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "     ", "ParentId": "14655528-503e-447c-a36c-f5c04924ad25"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Rom\u00e2nia</span></b></p>", "ID": "c66e71aa-59dc-42d7-bd9f-8b4ec5fadd3e", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "98668d23-1f8b-4e0d-ab2a-6f4eca45afcd"}, {"Element": "<b><span lang=\"EN-GB\">Rom\u00e2nia</span></b>", "ID": "b3e49eb1-40ea-41ce-9ad3-5335a520f692", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c66e71aa-59dc-42d7-bd9f-8b4ec5fadd3e"}, {"Element": "<span lang=\"EN-GB\">Rom\u00e2nia</span>", "ID": "b71a1019-bde6-495e-b9dc-7b1fa4406f72", "Styles": "None", "Classes": "None", "Text": "Rom\u00e2nia", "ParentId": "b3e49eb1-40ea-41ce-9ad3-5335a520f692"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">BGP\n  Products SRL</span></p>", "ID": "d56a761a-a9ed-4bdc-a568-c9605b5832c0", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "98668d23-1f8b-4e0d-ab2a-6f4eca45afcd"}, {"Element": "<span lang=\"EN-GB\">BGP\n  Products SRL</span>", "ID": "77b9512f-add6-44be-a48b-9978d2028b5f", "Styles": "None", "Classes": "None", "Text": "BGP   Products SRL", "ParentId": "d56a761a-a9ed-4bdc-a568-c9605b5832c0"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: +40\n  372 579 000</span></p>", "ID": "75d296e3-ddf9-47f4-b105-c55814f24de0", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "98668d23-1f8b-4e0d-ab2a-6f4eca45afcd"}, {"Element": "<span lang=\"EN-GB\">Tel: +40\n  372 579 000</span>", "ID": "86f8f82b-949c-4c6a-92a8-47c91efa921e", "Styles": "None", "Classes": "None", "Text": "Tel: +40   372 579 000", "ParentId": "75d296e3-ddf9-47f4-b105-c55814f24de0"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n  0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>\u00a0</span></p>", "ID": "12bb949c-c00f-4421-8d30-01e7dd156883", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n  0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "98668d23-1f8b-4e0d-ab2a-6f4eca45afcd"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>\u00a0</span>", "ID": "56c65a77-d3fc-4930-9d5b-26663bf46384", "Styles": "font-family:\n  \"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "12bb949c-c00f-4421-8d30-01e7dd156883"}, {"Element": "<tr>\n<td colspan=\"2\" style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Ireland</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Mylan\n  Ireland</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: +353\n  (0) 87 1694982</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Slovenija</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n  0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>GSP Proizvodi d.o.o.</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: + 386\n  1 236 31 85</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>\n</tr>", "ID": "f33d9095-01a0-439d-8440-51d5ce83c0bd", "Styles": "None", "Classes": "None", "Text": "   ", "ParentId": "322a33b5-fe92-4152-8984-cfa70a8d9bf2"}, {"Element": "<td colspan=\"2\" style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Ireland</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Mylan\n  Ireland</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: +353\n  (0) 87 1694982</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "25ad29c8-c55a-4229-999d-191f3df5ec07", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "     ", "ParentId": "f33d9095-01a0-439d-8440-51d5ce83c0bd"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Ireland</span></b></p>", "ID": "d7f74939-540c-4a69-acb4-bf5c3fd8a81b", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "25ad29c8-c55a-4229-999d-191f3df5ec07"}, {"Element": "<b><span lang=\"EN-GB\">Ireland</span></b>", "ID": "a5b2d76e-4ee5-4a1f-b047-ba3a8aa38540", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d7f74939-540c-4a69-acb4-bf5c3fd8a81b"}, {"Element": "<span lang=\"EN-GB\">Ireland</span>", "ID": "06233231-bf4f-438f-b9ce-722b9bd889d6", "Styles": "None", "Classes": "None", "Text": "Ireland", "ParentId": "a5b2d76e-4ee5-4a1f-b047-ba3a8aa38540"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Mylan\n  Ireland</span></p>", "ID": "4ee8ea92-4d85-4b94-9cf2-517309753e9e", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "25ad29c8-c55a-4229-999d-191f3df5ec07"}, {"Element": "<span lang=\"EN-GB\">Mylan\n  Ireland</span>", "ID": "bf84b20d-330a-488d-89b8-8353c818851b", "Styles": "None", "Classes": "None", "Text": "Mylan   Ireland", "ParentId": "4ee8ea92-4d85-4b94-9cf2-517309753e9e"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: +353\n  (0) 87 1694982</span></p>", "ID": "64f9d464-1b3a-4c19-b847-449abd9b069f", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "25ad29c8-c55a-4229-999d-191f3df5ec07"}, {"Element": "<span lang=\"EN-GB\">Tel: +353\n  (0) 87 1694982</span>", "ID": "180cd3f2-e7db-48f4-8d07-926491546ad1", "Styles": "None", "Classes": "None", "Text": "Tel: +353   (0) 87 1694982", "ParentId": "64f9d464-1b3a-4c19-b847-449abd9b069f"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "0cc46337-31b7-463a-8e69-7d8fd896ca4c", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "25ad29c8-c55a-4229-999d-191f3df5ec07"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "bd56379e-f259-43b1-9f9c-b182d049e20d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "0cc46337-31b7-463a-8e69-7d8fd896ca4c"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Slovenija</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n  0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>GSP Proizvodi d.o.o.</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: + 386\n  1 236 31 85</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>", "ID": "24f95c82-0854-4ffc-b66e-95623e26d2a8", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "     ", "ParentId": "f33d9095-01a0-439d-8440-51d5ce83c0bd"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Slovenija</span></b></p>", "ID": "636222a6-9ce1-40ca-ae83-875a6143b017", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "24f95c82-0854-4ffc-b66e-95623e26d2a8"}, {"Element": "<b><span lang=\"EN-GB\">Slovenija</span></b>", "ID": "17fdf78c-59a2-4d0d-b274-fa5546e19803", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "636222a6-9ce1-40ca-ae83-875a6143b017"}, {"Element": "<span lang=\"EN-GB\">Slovenija</span>", "ID": "888d0a69-f7ea-4a4e-8e90-33b4e77ac896", "Styles": "None", "Classes": "None", "Text": "Slovenija", "ParentId": "17fdf78c-59a2-4d0d-b274-fa5546e19803"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n  0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>GSP Proizvodi d.o.o.</span></p>", "ID": "cf1e7a5b-5ea6-4dec-80af-12520a7afdc6", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n  0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "24f95c82-0854-4ffc-b66e-95623e26d2a8"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>GSP Proizvodi d.o.o.</span>", "ID": "a96fbfd5-7720-4082-be08-c330862b3f18", "Styles": "font-family:\n  \"Times New Roman\",serif", "Classes": "None", "Text": "GSP Proizvodi d.o.o.", "ParentId": "cf1e7a5b-5ea6-4dec-80af-12520a7afdc6"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: + 386\n  1 236 31 85</span></p>", "ID": "431049a0-f489-4ff7-80c4-c6b6c64dc714", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "24f95c82-0854-4ffc-b66e-95623e26d2a8"}, {"Element": "<span lang=\"EN-GB\">Tel: + 386\n  1 236 31 85</span>", "ID": "de359bd6-8c18-453d-8780-1b2c8bc8ac04", "Styles": "None", "Classes": "None", "Text": "Tel: + 386   1 236 31 85", "ParentId": "431049a0-f489-4ff7-80c4-c6b6c64dc714"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "5441e891-61dd-4e94-9a2a-66c22203f87a", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "24f95c82-0854-4ffc-b66e-95623e26d2a8"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "4f66d4ae-6e17-42b3-98ad-476544d8ae6f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "5441e891-61dd-4e94-9a2a-66c22203f87a"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "0e78151e-dda1-41b3-99f2-7edbccdc8a2d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "4f66d4ae-6e17-42b3-98ad-476544d8ae6f"}, {"Element": "<tr>\n<td colspan=\"2\" style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">\u00cdsland</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Mylan AB</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: + 46\n  855 522 750</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">(Sv\u00ed\u00fej\u00f3\u00f0)</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Slovensk\u00e1\n  republika</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Mylan\n  s.r.o.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n  0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>Tel: </span><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>+421\u00a02 32 199 100</span></p>\n</td>\n</tr>", "ID": "696a0f8f-a458-4f0a-b17d-40e5c2978c2b", "Styles": "None", "Classes": "None", "Text": "   ", "ParentId": "322a33b5-fe92-4152-8984-cfa70a8d9bf2"}, {"Element": "<td colspan=\"2\" style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">\u00cdsland</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Mylan AB</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: + 46\n  855 522 750</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">(Sv\u00ed\u00fej\u00f3\u00f0)</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "f972c850-2c57-43a5-ba1b-444fdd9456a2", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "      ", "ParentId": "696a0f8f-a458-4f0a-b17d-40e5c2978c2b"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">\u00cdsland</span></b></p>", "ID": "316cb8a0-8fc9-46ca-81ed-b8e9b9c16e58", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "f972c850-2c57-43a5-ba1b-444fdd9456a2"}, {"Element": "<b><span lang=\"EN-GB\">\u00cdsland</span></b>", "ID": "07c6b830-c09d-4ac8-b28f-13cb42284f9a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "316cb8a0-8fc9-46ca-81ed-b8e9b9c16e58"}, {"Element": "<span lang=\"EN-GB\">\u00cdsland</span>", "ID": "599d9dfc-679c-4f61-a66a-8616c388d05c", "Styles": "None", "Classes": "None", "Text": "\u00cdsland", "ParentId": "07c6b830-c09d-4ac8-b28f-13cb42284f9a"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Mylan AB</span></p>", "ID": "f15b0ac6-4eb1-4ff3-9727-c1f94e4dfc6c", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "f972c850-2c57-43a5-ba1b-444fdd9456a2"}, {"Element": "<span lang=\"EN-GB\">Mylan AB</span>", "ID": "b8582556-a293-4faf-9108-35c28fa3c3d2", "Styles": "None", "Classes": "None", "Text": "Mylan AB", "ParentId": "f15b0ac6-4eb1-4ff3-9727-c1f94e4dfc6c"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: + 46\n  855 522 750</span></p>", "ID": "5408107f-cffb-4a10-be1c-8582a6bfc366", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "f972c850-2c57-43a5-ba1b-444fdd9456a2"}, {"Element": "<span lang=\"EN-GB\">Tel: + 46\n  855 522 750</span>", "ID": "bce6a23f-25d3-46ae-9321-a6049aa94b72", "Styles": "None", "Classes": "None", "Text": "Tel: + 46   855 522 750", "ParentId": "5408107f-cffb-4a10-be1c-8582a6bfc366"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">(Sv\u00ed\u00fej\u00f3\u00f0)</span></p>", "ID": "b229ab11-b8ea-4b95-b274-cc42445f33e1", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "f972c850-2c57-43a5-ba1b-444fdd9456a2"}, {"Element": "<span lang=\"EN-GB\">(Sv\u00ed\u00fej\u00f3\u00f0)</span>", "ID": "026c004a-cf21-43f5-adec-e5234a04c1bf", "Styles": "None", "Classes": "None", "Text": "(Sv\u00ed\u00fej\u00f3\u00f0)", "ParentId": "b229ab11-b8ea-4b95-b274-cc42445f33e1"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "ed19f033-1f3c-4386-b2f2-bb339d8939de", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "f972c850-2c57-43a5-ba1b-444fdd9456a2"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "2855ebd2-271d-4d0b-b4e1-760702dd6303", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ed19f033-1f3c-4386-b2f2-bb339d8939de"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Slovensk\u00e1\n  republika</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Mylan\n  s.r.o.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n  0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>Tel: </span><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>+421\u00a02 32 199 100</span></p>\n</td>", "ID": "445f4b0b-5e92-4861-a1d5-f78b0de94af3", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "    ", "ParentId": "696a0f8f-a458-4f0a-b17d-40e5c2978c2b"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Slovensk\u00e1\n  republika</span></b></p>", "ID": "62dfdc07-5b14-4e9f-a217-dd7beba8f186", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "445f4b0b-5e92-4861-a1d5-f78b0de94af3"}, {"Element": "<b><span lang=\"EN-GB\">Slovensk\u00e1\n  republika</span></b>", "ID": "73f66f87-b9a1-4514-89f7-b270b81ee433", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "62dfdc07-5b14-4e9f-a217-dd7beba8f186"}, {"Element": "<span lang=\"EN-GB\">Slovensk\u00e1\n  republika</span>", "ID": "b7426745-8634-49fa-9df4-eae5e00049db", "Styles": "None", "Classes": "None", "Text": "Slovensk\u00e1   republika", "ParentId": "73f66f87-b9a1-4514-89f7-b270b81ee433"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Mylan\n  s.r.o.</span></p>", "ID": "d2deb9f7-744e-494d-9fab-de5f35d85504", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "445f4b0b-5e92-4861-a1d5-f78b0de94af3"}, {"Element": "<span lang=\"EN-GB\">Mylan\n  s.r.o.</span>", "ID": "f8e632d4-c812-4ad7-a1af-03c2b516db8d", "Styles": "None", "Classes": "None", "Text": "Mylan   s.r.o.", "ParentId": "d2deb9f7-744e-494d-9fab-de5f35d85504"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n  0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>Tel: </span><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>+421\u00a02 32 199 100</span></p>", "ID": "2d79c47b-9bd1-4935-b55e-7c1d1261884c", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n  0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "445f4b0b-5e92-4861-a1d5-f78b0de94af3"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>Tel: </span>", "ID": "a416f658-c8ee-4a30-8eab-45c047f4f568", "Styles": "font-family:\n  \"Times New Roman\",serif", "Classes": "None", "Text": "Tel: ", "ParentId": "2d79c47b-9bd1-4935-b55e-7c1d1261884c"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>+421\u00a02 32 199 100</span>", "ID": "e02b908f-e8b8-4f61-b605-66ba742af80c", "Styles": "font-family:\n  \"Times New Roman\",serif", "Classes": "None", "Text": "+421\u00a02 32 199 100", "ParentId": "2d79c47b-9bd1-4935-b55e-7c1d1261884c"}, {"Element": "<tr>\n<td colspan=\"2\" style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Italia</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Mylan S.p.A</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: + 39\n  02 612 46921</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n  0in;margin-left:0in;line-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>\u00a0</span></b></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Suomi/Finland</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><strong><span lang=\"EN-GB\" style=\"color:black;border:none windowtext 1.0pt;padding:0in;background:white;\n  font-weight:normal\">Mylan OY</span></strong></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\">Puh/Tel: +358 20 720 9555</p>\n</td>\n</tr>", "ID": "c2a4e7e1-d302-432f-80ff-ca3ce37fc857", "Styles": "None", "Classes": "None", "Text": "   ", "ParentId": "322a33b5-fe92-4152-8984-cfa70a8d9bf2"}, {"Element": "<td colspan=\"2\" style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Italia</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Mylan S.p.A</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: + 39\n  02 612 46921</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n  0in;margin-left:0in;line-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>\u00a0</span></b></p>\n</td>", "ID": "f99de30b-cb61-4933-96b3-7f100300efc0", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "     ", "ParentId": "c2a4e7e1-d302-432f-80ff-ca3ce37fc857"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Italia</span></b></p>", "ID": "bcd04ff7-c7c3-4051-9654-ee0cfe712191", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "f99de30b-cb61-4933-96b3-7f100300efc0"}, {"Element": "<b><span lang=\"EN-GB\">Italia</span></b>", "ID": "5f0aabcf-c22d-44bc-b4f8-269eed0e4e15", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "bcd04ff7-c7c3-4051-9654-ee0cfe712191"}, {"Element": "<span lang=\"EN-GB\">Italia</span>", "ID": "90347ccd-f15a-431f-bea8-78099770e320", "Styles": "None", "Classes": "None", "Text": "Italia", "ParentId": "5f0aabcf-c22d-44bc-b4f8-269eed0e4e15"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Mylan S.p.A</span></p>", "ID": "db8b0879-7c5f-496f-97ae-13937f882d7e", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "f99de30b-cb61-4933-96b3-7f100300efc0"}, {"Element": "<span lang=\"EN-GB\">Mylan S.p.A</span>", "ID": "ecc999dc-bf0a-43e7-bc64-de5bc9b95a29", "Styles": "None", "Classes": "None", "Text": "Mylan S.p.A", "ParentId": "db8b0879-7c5f-496f-97ae-13937f882d7e"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: + 39\n  02 612 46921</span></p>", "ID": "b9d355fe-d526-4666-9ca1-9f16c42838a0", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "f99de30b-cb61-4933-96b3-7f100300efc0"}, {"Element": "<span lang=\"EN-GB\">Tel: + 39\n  02 612 46921</span>", "ID": "4db77ac8-fe0b-412d-84f2-f31fff6448da", "Styles": "None", "Classes": "None", "Text": "Tel: + 39   02 612 46921", "ParentId": "b9d355fe-d526-4666-9ca1-9f16c42838a0"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n  0in;margin-left:0in;line-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>\u00a0</span></b></p>", "ID": "6ad382c0-2c51-4081-abf1-b018a8fe93a2", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n  0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f99de30b-cb61-4933-96b3-7f100300efc0"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>\u00a0</span></b>", "ID": "6e3fac86-e68c-44c9-9705-ca232e555e4e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6ad382c0-2c51-4081-abf1-b018a8fe93a2"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>\u00a0</span>", "ID": "6415df92-cdf1-4007-87c4-e323b2f11e67", "Styles": "font-family:\n  \"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "6e3fac86-e68c-44c9-9705-ca232e555e4e"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Suomi/Finland</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><strong><span lang=\"EN-GB\" style=\"color:black;border:none windowtext 1.0pt;padding:0in;background:white;\n  font-weight:normal\">Mylan OY</span></strong></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\">Puh/Tel: +358 20 720 9555</p>\n</td>", "ID": "9c3c908f-3f8c-426a-bb7e-4204bc1c2e96", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "    ", "ParentId": "c2a4e7e1-d302-432f-80ff-ca3ce37fc857"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Suomi/Finland</span></b></p>", "ID": "1ddc592e-d17a-462d-b295-fcbf6c143a6e", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "9c3c908f-3f8c-426a-bb7e-4204bc1c2e96"}, {"Element": "<b><span lang=\"EN-GB\">Suomi/Finland</span></b>", "ID": "b991a11d-3fe2-4a2d-ad5d-ca35f6e3706d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "1ddc592e-d17a-462d-b295-fcbf6c143a6e"}, {"Element": "<span lang=\"EN-GB\">Suomi/Finland</span>", "ID": "befb16f1-d5e5-485e-8261-4d9b86f6a30e", "Styles": "None", "Classes": "None", "Text": "Suomi/Finland", "ParentId": "b991a11d-3fe2-4a2d-ad5d-ca35f6e3706d"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><strong><span lang=\"EN-GB\" style=\"color:black;border:none windowtext 1.0pt;padding:0in;background:white;\n  font-weight:normal\">Mylan OY</span></strong></p>", "ID": "fe69210a-0b7f-44d2-b394-cf3ab00212ca", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "9c3c908f-3f8c-426a-bb7e-4204bc1c2e96"}, {"Element": "<strong><span lang=\"EN-GB\" style=\"color:black;border:none windowtext 1.0pt;padding:0in;background:white;\n  font-weight:normal\">Mylan OY</span></strong>", "ID": "d2168fe5-639b-4ec4-bfee-3a296df37337", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "fe69210a-0b7f-44d2-b394-cf3ab00212ca"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black;border:none windowtext 1.0pt;padding:0in;background:white;\n  font-weight:normal\">Mylan OY</span>", "ID": "cf990473-8756-46f1-b606-53c3f9690c46", "Styles": "color:black;border:none windowtext 1.0pt;padding:0in;background:white;\n  font-weight:normal", "Classes": "None", "Text": "Mylan OY", "ParentId": "d2168fe5-639b-4ec4-bfee-3a296df37337"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\">Puh/Tel: +358 20 720 9555</p>", "ID": "cb53fa20-62b4-4cb0-954a-cf73865c6e64", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "Puh/Tel: +358 20 720 9555", "ParentId": "9c3c908f-3f8c-426a-bb7e-4204bc1c2e96"}, {"Element": "<tr>\n<td colspan=\"2\" style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">\u039a\u03cd\u03c0\u03c1\u03bf\u03c2</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Pharmaceutical\n  Trading Co. Ltd.</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u03a4\u03b7\u03bb:\n  + 357 99403969</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Sverige</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Mylan AB </span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: + 46\n  855 522 750</span></p>\n</td>\n</tr>", "ID": "0793a3ef-7149-4d5e-bbe0-533526d1584a", "Styles": "None", "Classes": "None", "Text": "   ", "ParentId": "322a33b5-fe92-4152-8984-cfa70a8d9bf2"}, {"Element": "<td colspan=\"2\" style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">\u039a\u03cd\u03c0\u03c1\u03bf\u03c2</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Pharmaceutical\n  Trading Co. Ltd.</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u03a4\u03b7\u03bb:\n  + 357 99403969</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "81e8cf0f-a9f4-40e3-bb3b-ae19c2cc6551", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "     ", "ParentId": "0793a3ef-7149-4d5e-bbe0-533526d1584a"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">\u039a\u03cd\u03c0\u03c1\u03bf\u03c2</span></b></p>", "ID": "fa16c952-a691-47f6-9594-813c10b802bf", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "81e8cf0f-a9f4-40e3-bb3b-ae19c2cc6551"}, {"Element": "<b><span lang=\"EN-GB\">\u039a\u03cd\u03c0\u03c1\u03bf\u03c2</span></b>", "ID": "8bea9090-8491-4a8a-8f4b-6b8c613236ae", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "fa16c952-a691-47f6-9594-813c10b802bf"}, {"Element": "<span lang=\"EN-GB\">\u039a\u03cd\u03c0\u03c1\u03bf\u03c2</span>", "ID": "915a6f61-f1dc-4da0-8044-2841aead8607", "Styles": "None", "Classes": "None", "Text": "\u039a\u03cd\u03c0\u03c1\u03bf\u03c2", "ParentId": "8bea9090-8491-4a8a-8f4b-6b8c613236ae"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Pharmaceutical\n  Trading Co. Ltd.</span></p>", "ID": "317bd456-2b74-4804-818b-4165a849aefa", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "81e8cf0f-a9f4-40e3-bb3b-ae19c2cc6551"}, {"Element": "<span lang=\"EN-GB\">Pharmaceutical\n  Trading Co. Ltd.</span>", "ID": "e8c08d57-a968-47bb-a686-a2781177e6a6", "Styles": "None", "Classes": "None", "Text": "Pharmaceutical   Trading Co. Ltd.", "ParentId": "317bd456-2b74-4804-818b-4165a849aefa"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u03a4\u03b7\u03bb:\n  + 357 99403969</span></p>", "ID": "69afa33c-0697-4e13-8bd7-af7d9b827db7", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "81e8cf0f-a9f4-40e3-bb3b-ae19c2cc6551"}, {"Element": "<span lang=\"EN-GB\">\u03a4\u03b7\u03bb:\n  + 357 99403969</span>", "ID": "36426c3e-749e-4b6c-a1d9-188d9daa0410", "Styles": "None", "Classes": "None", "Text": "\u03a4\u03b7\u03bb:   + 357 99403969", "ParentId": "69afa33c-0697-4e13-8bd7-af7d9b827db7"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "11008c65-d177-4fc6-aa56-fc1422cc0fa8", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "81e8cf0f-a9f4-40e3-bb3b-ae19c2cc6551"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "05b33185-e68e-4d45-98f7-daa86bf38077", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "11008c65-d177-4fc6-aa56-fc1422cc0fa8"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Sverige</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Mylan AB </span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: + 46\n  855 522 750</span></p>\n</td>", "ID": "031c91c7-3ec3-43e6-ab48-63fa2c7bb0ff", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "    ", "ParentId": "0793a3ef-7149-4d5e-bbe0-533526d1584a"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Sverige</span></b></p>", "ID": "45bfc383-4044-4c0d-bf9a-846983839075", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "031c91c7-3ec3-43e6-ab48-63fa2c7bb0ff"}, {"Element": "<b><span lang=\"EN-GB\">Sverige</span></b>", "ID": "8c5e87a3-adec-4047-a68e-73fbb3f73453", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "45bfc383-4044-4c0d-bf9a-846983839075"}, {"Element": "<span lang=\"EN-GB\">Sverige</span>", "ID": "75169e96-9da7-48cf-9b59-8cf2157fb970", "Styles": "None", "Classes": "None", "Text": "Sverige", "ParentId": "8c5e87a3-adec-4047-a68e-73fbb3f73453"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Mylan AB </span></p>", "ID": "8cd57854-2a16-4d3e-91b0-53af36ff7100", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "031c91c7-3ec3-43e6-ab48-63fa2c7bb0ff"}, {"Element": "<span lang=\"EN-GB\">Mylan AB </span>", "ID": "232701fe-77fc-4c0a-b10e-75a30505e4e1", "Styles": "None", "Classes": "None", "Text": "Mylan AB ", "ParentId": "8cd57854-2a16-4d3e-91b0-53af36ff7100"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: + 46\n  855 522 750</span></p>", "ID": "7c04feb8-3a9b-4841-9867-9c5b9a8eead7", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "031c91c7-3ec3-43e6-ab48-63fa2c7bb0ff"}, {"Element": "<span lang=\"EN-GB\">Tel: + 46\n  855 522 750</span>", "ID": "1d4e6ec3-60fe-4d9a-8055-657bfc132977", "Styles": "None", "Classes": "None", "Text": "Tel: + 46   855 522 750", "ParentId": "7c04feb8-3a9b-4841-9867-9c5b9a8eead7"}, {"Element": "<tr>\n<td colspan=\"2\" style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Latvija</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">BGP\n  Products SIA</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: +371\n  676 055 80</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">United\n  Kingdom</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Generics\n  [UK] Ltd</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n  0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>Tel: +44 1707 853000</span></p>\n</td>\n</tr>", "ID": "817b967c-43ac-4c6f-b560-9f3106008fa6", "Styles": "None", "Classes": "None", "Text": "   ", "ParentId": "322a33b5-fe92-4152-8984-cfa70a8d9bf2"}, {"Element": "<td colspan=\"2\" style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Latvija</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">BGP\n  Products SIA</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: +371\n  676 055 80</span></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "b76da904-fa32-4fd4-8168-f3c7c8d8fd3b", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "     ", "ParentId": "817b967c-43ac-4c6f-b560-9f3106008fa6"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">Latvija</span></b></p>", "ID": "3d456947-deed-4b7c-94ee-95e60df999aa", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "b76da904-fa32-4fd4-8168-f3c7c8d8fd3b"}, {"Element": "<b><span lang=\"EN-GB\">Latvija</span></b>", "ID": "9de4f8ed-5925-4aa0-9854-a23b47e207c1", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "3d456947-deed-4b7c-94ee-95e60df999aa"}, {"Element": "<span lang=\"EN-GB\">Latvija</span>", "ID": "1b84b865-8d7d-473e-84ad-fe11ea801ec8", "Styles": "None", "Classes": "None", "Text": "Latvija", "ParentId": "9de4f8ed-5925-4aa0-9854-a23b47e207c1"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">BGP\n  Products SIA</span></p>", "ID": "ff4cb189-b2f3-4056-9e8d-f6b87fb3bd52", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "b76da904-fa32-4fd4-8168-f3c7c8d8fd3b"}, {"Element": "<span lang=\"EN-GB\">BGP\n  Products SIA</span>", "ID": "517cd1a7-2c9e-4105-8e90-9db8043b2dda", "Styles": "None", "Classes": "None", "Text": "BGP   Products SIA", "ParentId": "ff4cb189-b2f3-4056-9e8d-f6b87fb3bd52"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Tel: +371\n  676 055 80</span></p>", "ID": "a30990be-c831-49a5-aa2f-f7c4e9162018", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "b76da904-fa32-4fd4-8168-f3c7c8d8fd3b"}, {"Element": "<span lang=\"EN-GB\">Tel: +371\n  676 055 80</span>", "ID": "9ed1c504-3f70-43a4-b969-da933e5fc0b3", "Styles": "None", "Classes": "None", "Text": "Tel: +371   676 055 80", "ParentId": "a30990be-c831-49a5-aa2f-f7c4e9162018"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "c16bbb87-4c9d-4a60-aaea-af45afaab2ea", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "b76da904-fa32-4fd4-8168-f3c7c8d8fd3b"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "6f4cb433-f3fc-4ff8-8a7a-db30fe56b360", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c16bbb87-4c9d-4a60-aaea-af45afaab2ea"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">United\n  Kingdom</span></b></p>\n<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Generics\n  [UK] Ltd</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n  0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>Tel: +44 1707 853000</span></p>\n</td>", "ID": "ec40a89f-b6d6-473f-b5d1-75fcea8bcaf1", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "    ", "ParentId": "817b967c-43ac-4c6f-b560-9f3106008fa6"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><b><span lang=\"EN-GB\">United\n  Kingdom</span></b></p>", "ID": "5039b734-6f01-44ab-83ab-eab9dcb2c68c", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "ec40a89f-b6d6-473f-b5d1-75fcea8bcaf1"}, {"Element": "<b><span lang=\"EN-GB\">United\n  Kingdom</span></b>", "ID": "8a74a4f2-07f2-4462-9d13-6b84bead9db7", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "5039b734-6f01-44ab-83ab-eab9dcb2c68c"}, {"Element": "<span lang=\"EN-GB\">United\n  Kingdom</span>", "ID": "de41a13b-6323-4b75-a38c-9e881a1ea2a1", "Styles": "None", "Classes": "None", "Text": "United   Kingdom", "ParentId": "8a74a4f2-07f2-4462-9d13-6b84bead9db7"}, {"Element": "<p class=\"MGGTextLeft\" style=\"margin-right:2.75pt\"><span lang=\"EN-GB\">Generics\n  [UK] Ltd</span></p>", "ID": "7d0b365b-8ef4-4055-b6d6-2e85846d8a87", "Styles": "margin-right:2.75pt", "Classes": "['MGGTextLeft']", "Text": "", "ParentId": "ec40a89f-b6d6-473f-b5d1-75fcea8bcaf1"}, {"Element": "<span lang=\"EN-GB\">Generics\n  [UK] Ltd</span>", "ID": "8515ebc9-9c1c-439d-8572-2e134d8a6cc7", "Styles": "None", "Classes": "None", "Text": "Generics   [UK] Ltd", "ParentId": "7d0b365b-8ef4-4055-b6d6-2e85846d8a87"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n  0in;margin-left:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>Tel: +44 1707 853000</span></p>", "ID": "21c8f6c3-bf4b-45d8-8b7f-ab9bf8677332", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n  0in;margin-left:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ec40a89f-b6d6-473f-b5d1-75fcea8bcaf1"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n  \"Times New Roman\",serif'>Tel: +44 1707 853000</span>", "ID": "7be0eb95-5729-4fd3-9024-a51380377d70", "Styles": "font-family:\n  \"Times New Roman\",serif", "Classes": "None", "Text": "Tel: +44 1707 853000", "ParentId": "21c8f6c3-bf4b-45d8-8b7f-ab9bf8677332"}, {"Element": "<tr height=\"0\">\n<td style=\"border:none\" width=\"2\"></td>\n<td style=\"border:none\" width=\"310\"></td>\n<td style=\"border:none\" width=\"312\"></td>\n</tr>", "ID": "96759743-e0a6-46aa-9fc5-ac3be9c4a22f", "Styles": "None", "Classes": "None", "Text": "    ", "ParentId": "322a33b5-fe92-4152-8984-cfa70a8d9bf2"}, {"Element": "<td style=\"border:none\" width=\"2\"></td>", "ID": "5cfa97d2-6e48-4e80-965a-85df8caf1fc7", "Styles": "border:none", "Classes": "None", "Text": "", "ParentId": "96759743-e0a6-46aa-9fc5-ac3be9c4a22f"}, {"Element": "<td style=\"border:none\" width=\"310\"></td>", "ID": "d84b0751-6aed-46cf-8f95-61af51ee5653", "Styles": "border:none", "Classes": "None", "Text": "", "ParentId": "96759743-e0a6-46aa-9fc5-ac3be9c4a22f"}, {"Element": "<td style=\"border:none\" width=\"312\"></td>", "ID": "263aa0f2-3ee1-4008-ac33-ac6ec3b66984", "Styles": "border:none", "Classes": "None", "Text": "", "ParentId": "96759743-e0a6-46aa-9fc5-ac3be9c4a22f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b></p>", "ID": "a55171d4-b0ea-48ea-8071-7c157c9f657f", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></b>", "ID": "3e09fc42-cef8-43d0-9c4c-9934031176f1", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a55171d4-b0ea-48ea-8071-7c157c9f657f"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "5c175271-ea70-4e9f-bdfe-23510593ead0", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "3e09fc42-cef8-43d0-9c4c-9934031176f1"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>This leaflet was last\nrevised in</span></b></p>", "ID": "72368c40-4d99-4503-8103-5ed3ea7cf6fd", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>This leaflet was last\nrevised in</span></b>", "ID": "0ec8f6f6-1f15-4bdd-a7a4-149d2fd2807b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "72368c40-4d99-4503-8103-5ed3ea7cf6fd"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>This leaflet was last\nrevised in</span>", "ID": "78d11346-c17c-46c3-b4f7-3e2bfe145ab7", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "This leaflet was last revised in", "ParentId": "0ec8f6f6-1f15-4bdd-a7a4-149d2fd2807b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "705c7753-2c3c-4364-9f83-180c53e81129", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "e830f180-87a0-4e16-9088-72eb453e4099", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "705c7753-2c3c-4364-9f83-180c53e81129"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Other sources of\ninformation</span></b></p>", "ID": "b620c825-5908-4970-8f92-0e2d4701ea73", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Other sources of\ninformation</span></b>", "ID": "29603a23-bba5-40f5-9e9c-ec6e36b10e85", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b620c825-5908-4970-8f92-0e2d4701ea73"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Other sources of\ninformation</span>", "ID": "2988c5d7-4a84-47a7-a7be-b8d63260ef9b", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Other sources of information", "ParentId": "29603a23-bba5-40f5-9e9c-ec6e36b10e85"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Detailed information on this\nmedicine is available on the European Medicines Agency website</span></p>", "ID": "99519a10-312d-4c11-a04a-c2520b16060f", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Detailed information on this\nmedicine is available on the European Medicines Agency website</span>", "ID": "49b56a24-afd3-4989-b70d-881c9d5ceffc", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Detailed information on this medicine is available on the European Medicines Agency website", "ParentId": "99519a10-312d-4c11-a04a-c2520b16060f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"><a href=\"http://www.ema.europa.eu.\"><span style='font-family:\"Times New Roman\",serif'>http://www.ema.europa.eu.</span></a></span></p>", "ID": "31a179ed-98a1-4d1b-8fe1-56f9ebaa51cb", "Styles": "margin-top:0in;margin-right:2.75pt;margin-bottom:\n0in;margin-left:0in;line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\"><a href=\"http://www.ema.europa.eu.\"><span style='font-family:\"Times New Roman\",serif'>http://www.ema.europa.eu.</span></a></span>", "ID": "62b9e23d-20b1-46a1-bfc2-161eb1e0390b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "31a179ed-98a1-4d1b-8fe1-56f9ebaa51cb"}, {"Element": "<a href=\"http://www.ema.europa.eu.\"><span style='font-family:\"Times New Roman\",serif'>http://www.ema.europa.eu.</span></a>", "ID": "b13fa231-e042-4a1d-ab38-053571a35b19", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "62b9e23d-20b1-46a1-bfc2-161eb1e0390b"}, {"Element": "<span style='font-family:\"Times New Roman\",serif'>http://www.ema.europa.eu.</span>", "ID": "743d8c1e-0b9f-42bc-b2ac-a7617a7f1dcc", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "http://www.ema.europa.eu.", "ParentId": "b13fa231-e042-4a1d-ab38-053571a35b19"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "625c6c7f-fe9b-4593-94cf-64ef7f7bfdf0", "Styles": "margin-top:0in;margin-right:2.75pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;\ntext-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f2cb-bb4c-4d8b-b0bb-da0bf1632964"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "4c66ecd0-38cc-4164-a22e-d5f0e4fdccfe", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "625c6c7f-fe9b-4593-94cf-64ef7f7bfdf0"}]}